Citrus Sinensis ID: 039922
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGX3 | 993 | LRR receptor-like serine/ | yes | no | 0.973 | 0.953 | 0.591 | 0.0 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.952 | 0.930 | 0.463 | 0.0 | |
| P47735 | 999 | Receptor-like protein kin | no | no | 0.951 | 0.926 | 0.448 | 0.0 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.893 | 0.867 | 0.397 | 1e-172 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.907 | 0.880 | 0.378 | 1e-171 | |
| Q9LJM4 | 991 | Receptor-like protein kin | no | no | 0.901 | 0.884 | 0.377 | 1e-168 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.935 | 0.898 | 0.389 | 1e-168 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.919 | 0.913 | 0.368 | 1e-163 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.923 | 0.873 | 0.368 | 1e-161 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.959 | 0.848 | 0.355 | 1e-159 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1124 bits (2907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 574/971 (59%), Positives = 718/971 (73%), Gaps = 24/971 (2%)
Query: 24 ISLHGDAEILIRVKSDQLDDPNRKLGDWVRT-SQQSPCNWTGITCETQNQS---VDGIDL 79
+S +GDAEIL RVK +L DP+ L DWV T +SPCNWTGITC + S V IDL
Sbjct: 22 VSSNGDAEILSRVKKTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDL 81
Query: 80 SGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD 139
SG+++SGGFP GFCRIRTL N+ LS N NGT+ S LS C LQ L L+ N F G+LP+
Sbjct: 82 SGYNISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPE 141
Query: 140 FSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFE 199
FS EF L+VL+L N F+G+IP+S+GR L+VLNL GN LSG++P+FLG LTELT +
Sbjct: 142 FSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLD 201
Query: 200 LGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP 259
L Y SP+PS++GNLS L +L +NL+GEIPDSI L L NLDL+ N L+G+IP
Sbjct: 202 LAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIP 261
Query: 260 HSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLN 319
S L S+ QIEL+DN+LSG+LPES+ NLT L D+SQNNLTG LPE IAA+ L S N
Sbjct: 262 ESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFN 321
Query: 320 LNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPR 379
LNDN+FTG +P+ +A NPNLV+ K+FNNSF+G LP +LGK+S + FDVSTN F+GELP
Sbjct: 322 LNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPP 381
Query: 380 FLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFE 439
+LC+R KLQ II F+N+ SG+IPESYG+C +LNY+R N+L GE+P++FW LP
Sbjct: 382 YLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLEL 441
Query: 440 MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT 499
NN+ +GSI PSIS A L+ + I+ NNF+G +P ++C LR L+ +DLS+N F G +P+
Sbjct: 442 ANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPS 501
Query: 500 CITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLD 559
CI +L L+++E+QENM GE+P +++S T L LNLS N+L G IPPELG+L VL LD
Sbjct: 502 CINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLD 561
Query: 560 LSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPL 619
LS+N LTGEIP EL +LKLNQFN+S NKLYG++PS F D+F S L NP LC+P+L P+
Sbjct: 562 LSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPI 621
Query: 620 PPCSKTKPGTIYIVVILSICVILLVGSLVWFF-KVKSGFFSTSKSPWKVVTFQRVSFNED 678
PC ++K T YI+ I +C++ L G+LVW F K K F K K+ FQRV F E+
Sbjct: 622 RPC-RSKRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFTEE 680
Query: 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGT-HKPETETVFRSEIETLGRV 737
DI P LTE N+IGSGGS VY+VKLKSG+T+AVK+L G T K E+E+VFRSE+ETLGRV
Sbjct: 681 DIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRV 740
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH---EKGRSGSLDWSIRFSIAQGAAK 794
RHGN+VKLLMCC+G++F LVYE+M NGSL D+LH E LDW+ RFSIA GAA+
Sbjct: 741 RHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQ 800
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ--EGQSDDAMSCVAG 852
GL+YLH+D VP IVHRDVKS+NILLD EM PRVADFGLAK L+ + +G SD +MSCVAG
Sbjct: 801 GLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAG 860
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912
SYGYIAPEY YT KV EKSDVYSFGVVL+EL+TGKRPND SFGENKDIV++ EA L P
Sbjct: 861 SYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYP 920
Query: 913 ER------------GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960
G RDL++L+DP+M LST +YEE EKVL+VAL+CTS FPINRP+MR
Sbjct: 921 SPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMR 980
Query: 961 RVVELLRVDKS 971
+VVELL+ KS
Sbjct: 981 KVVELLKEKKS 991
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 826 bits (2134), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/962 (46%), Positives = 621/962 (64%), Gaps = 35/962 (3%)
Query: 25 SLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDL 84
SL+ D IL +VK LDDP+ L W ++ SPC W+G++C SV +DLS +L
Sbjct: 15 SLNQDGFILQQVKL-SLDDPDSYLSSW-NSNDASPCRWSGVSCAGDFSSVTSVDLSSANL 72
Query: 85 SGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREF 144
+G FP+ CR+ L +L+L +N N TL +++ C LQ L L N+ GELP +
Sbjct: 73 AGPFPSVICRLSNLAHLSLYNNSINSTLP-LNIAACKSLQTLDLSQNLLTGELPQTLADI 131
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
L LDL+ NNFSGDIP SFG+F L+VL+L NLL G IP FLGN++ L L YNP
Sbjct: 132 PTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNP 191
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
S +P GNL+ LE +W + +L+G+IPDS+G+L+ L +LDL+ N L G IP S G
Sbjct: 192 FSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGG 251
Query: 265 LASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNY 324
L ++ QIEL++N L+GE+P L NL +L LD S N LTG +P+ + + LESLNL +N
Sbjct: 252 LTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVPLESLNLYENN 311
Query: 325 FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFR 384
GE+P S+A +PNL ++++F N +G LP DLG S L + DVS N+F+G+LP LC +
Sbjct: 312 LEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAK 371
Query: 385 NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNR 444
+L+ ++I +N FSG IPES +C++L +R N G +P+ FWGLP V+ E+ NN
Sbjct: 372 GELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNS 431
Query: 445 FEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQL 504
F G IS SI A L+ ++++ N FTG +P +I +L L + S N+FSG LP + L
Sbjct: 432 FSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSL 491
Query: 505 NKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNL 564
+L L+L N F+GEL + S L LNL+ N+ TG IP E+G+L+VL LDLS N+
Sbjct: 492 GELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNM 551
Query: 565 LTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSK 624
+G+IP+ L LKLNQ N+S+N+L G++P D++ +S + NPGLC D+K L
Sbjct: 552 FSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCG-DIKGLCGSEN 610
Query: 625 TKPGTIYIVVILSICV----ILLVGSLVWFFKVKS--GFFSTSKSPWKVVTFQRVSFNED 678
Y+ ++ SI V +LL G ++FK ++ + +S W +++F ++ F+E
Sbjct: 611 EAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEH 670
Query: 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK------PET-------ET 725
+IL L E N+IG+G S +VYKV L +GETVAVKRL G+ K PE +
Sbjct: 671 EILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDE 730
Query: 726 VFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR 785
F +E+ETLG++RH N+VKL CCS +D +LVYEYMPNGSL D+LH + G L W R
Sbjct: 731 AFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSS-KGGMLGWQTR 789
Query: 786 FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845
F I AA+GL+YLH+D VP IVHRD+KS+NIL+D + RVADFG+AKA+ G++
Sbjct: 790 FKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVD-LTGKAPK 848
Query: 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905
+MS +AGS GYIAPEYAYT +V EKSD+YSFGVV++E+VT KRP DP GE KD+V+WV
Sbjct: 849 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGE-KDLVKWVC 907
Query: 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965
+TL + + +IDP++D +C EE K+LNV L+CTS PINRPSMRRVV++
Sbjct: 908 -STLDQ------KGIEHVIDPKLD--SCFKEEISKILNVGLLCTSPLPINRPSMRRVVKM 958
Query: 966 LR 967
L+
Sbjct: 959 LQ 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 756 bits (1951), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/967 (44%), Positives = 614/967 (63%), Gaps = 41/967 (4%)
Query: 23 AISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGF 82
++SL+ DA IL + K L DP + L W + +PC W G++C+ + V +DLS F
Sbjct: 18 SLSLNQDATILRQAKLG-LSDPAQSLSSWSDNNDVTPCKWLGVSCDATSNVVS-VDLSSF 75
Query: 83 DLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELP-DFS 141
L G FP+ C + +L +L+L +N NG+LS+ C +L L L N+ +G +P
Sbjct: 76 MLVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLP 135
Query: 142 REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELG 201
NL+ L++S NN S IP SFG F L+ LNL GN LSG IP+ LGN+T L +L
Sbjct: 136 FNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLA 195
Query: 202 YNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHS 261
YN S +PS +GNL++L+ LW A NL+G IP S+ +L L NLDL+ N L+G IP
Sbjct: 196 YNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSW 255
Query: 262 FSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLN 321
+ L ++EQIELF+N SGELPES+ N+TTL R D S N LTG +P+ + ++LESLNL
Sbjct: 256 ITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESLNLF 315
Query: 322 DNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFL 381
+N G +PES+ + L +LKLFNN +G LP LG S L+Y D+S N F+GE+P +
Sbjct: 316 ENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANV 375
Query: 382 CFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMY 441
C KL+ +I+ +N FSG+I + G+CK+L +R N+L G++P FWGLP + E+
Sbjct: 376 CGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELS 435
Query: 442 NNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCI 501
+N F GSI +I A L+ + I+ N F+G +P++I +L + + ++N FSG +P +
Sbjct: 436 DNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESL 495
Query: 502 TQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLS 561
+L +L +L+L +N +GE+PR L L LNL+ N L+G IP E+G L VL LDLS
Sbjct: 496 VKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLS 555
Query: 562 SNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPP 621
SN +GEIPLEL LKLN N+S+N L G++P + + ++ + NPGLC DL L
Sbjct: 556 SNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCV-DLDGL-- 612
Query: 622 CSK-TKPGTI-YIVVILSI----CVILLVGSLVWFFK------VKSGFFSTSKSPWKVVT 669
C K T+ I Y+ ++L+I ++ +VG +++ K +KS + SK W+ +
Sbjct: 613 CRKITRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASK--WR--S 668
Query: 670 FQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRL----LGGTHKPETET 725
F ++ F+E +I L E+N+IG G S +VYKV+L+ GE VAVK+L GG + +++
Sbjct: 669 FHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSSDS 728
Query: 726 ----VFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSG-SL 780
VF +E+ETLG +RH ++V+L CCS D +LVYEYMPNGSLAD+LH + G L
Sbjct: 729 LNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVL 788
Query: 781 DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840
W R IA AA+GL+YLH+DCVP IVHRDVKS NILLD++ +VADFG+AK Q
Sbjct: 789 GWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSG 848
Query: 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900
++ +AMS +AGS GYIAPEY YT +V EKSD+YSFGVVL+ELVTGK+P D G+ KD+
Sbjct: 849 SKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGD-KDM 907
Query: 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960
+WV A C L +IDP++DL EE KV+++ L+CTS P+NRPSMR
Sbjct: 908 AKWVCTAL-----DKC--GLEPVIDPKLDLKF--KEEISKVIHIGLLCTSPLPLNRPSMR 958
Query: 961 RVVELLR 967
+VV +L+
Sbjct: 959 KVVIMLQ 965
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 607 bits (1564), Expect = e-172, Method: Compositional matrix adjust.
Identities = 375/943 (39%), Positives = 525/943 (55%), Gaps = 74/943 (7%)
Query: 60 CNWTGITCETQNQSVDGIDLSGFDLSGGF------------------------PNGFCRI 95
C+WTG+TC+ + V +DLSG +LSG P +
Sbjct: 57 CSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNL 116
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155
LR+LNLS+N FNG+ + S +L+VL L N G+LP L+ L L N
Sbjct: 117 YELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGN 176
Query: 156 NFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVG 215
FSG IP ++G +PVL+ L + GN L+G IP +GNLT L +GY + LP +G
Sbjct: 177 YFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIG 236
Query: 216 NLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275
NLS+L AA L GEIP IGKL L L L N +G I ++S++ ++L +
Sbjct: 237 NLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSN 296
Query: 276 NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLA 334
N +GE+P S S L L L++ +N L G +PE I M LE L L +N FTG IP+ L
Sbjct: 297 NMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLG 356
Query: 335 SNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFN 394
N LV L D+S+N TG LP +C N+L +I
Sbjct: 357 ENGRLVIL------------------------DLSSNKLTGTLPPNMCSGNRLMTLITLG 392
Query: 395 NRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSIS 454
N G IP+S G+C++L +R G N L G +P + +GLP++ E+ +N G + S
Sbjct: 393 NFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGG 452
Query: 455 NAP-KLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQ 513
L I ++ N +G +P+ I L +Q + L N+FSG +P I +L +L +L+
Sbjct: 453 GVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFS 512
Query: 514 ENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLEL 573
N+F+G + ++ L ++LS N+L+G IP EL + +L L+LS N L G IP+ +
Sbjct: 513 HNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTI 572
Query: 574 TKLK-LNQFNISHNKLYGEVPSDFDHDLF-ISSLLDNPGLCSPDLKPLPPCSK------T 625
++ L + S+N L G VPS F +S + N LC P L PC K
Sbjct: 573 ASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLG---PCGKGTHQSHV 629
Query: 626 KP--GTIYIVVILSICVILLVGSLVWFFKVKSGFFSTSKSPWKVVTFQRVSFNEDDILPH 683
KP T ++++L + +V ++V K +S ++ W++ FQR+ F DD+L
Sbjct: 630 KPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVLDS 689
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
L E N+IG GG+ VYK + G+ VAVKRL +H + F +EI+TLGR+RH ++V
Sbjct: 690 LKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIV 749
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+LL CS + N+LVYEYMPNGSL ++LH K + G L W+ R+ IA AAKGL YLH+DC
Sbjct: 750 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGHLHWNTRYKIALEAAKGLCYLHHDC 808
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
P IVHRDVKS+NILLD+ VADFGLAK L Q+ + + MS +AGSYGYIAPEYAY
Sbjct: 809 SPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL--QDSGTSECMSAIAGSYGYIAPEYAY 866
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923
T KV EKSDVYSFGVVL+EL+TGK+P FG+ DIV+WV T S+ + C ++
Sbjct: 867 TLKVDEKSDVYSFGVVLLELITGKKPVG-EFGDGVDIVQWVRSMTDSN--KDCVL---KV 920
Query: 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
ID R LS+ E V VAL+C + + RP+MR VV++L
Sbjct: 921 IDLR--LSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQIL 961
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 602 bits (1551), Expect = e-171, Method: Compositional matrix adjust.
Identities = 366/967 (37%), Positives = 531/967 (54%), Gaps = 84/967 (8%)
Query: 42 DDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNL 101
DD N L W ++ S C W G+TC+ + V +DLSG +LSG +R L+NL
Sbjct: 41 DDKNSPLSSWKVST--SFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNL 98
Query: 102 NLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD-FSREFANLQVLDLSRNNFSGD 160
+L++N +G + + +S L+ L L NVF G PD S NL+VLD+ NN +GD
Sbjct: 99 SLAENLISGPIPPE-ISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGD 157
Query: 161 ------------------------IPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELT 196
IP S+G +PV++ L + GN L G IP +GNLT L
Sbjct: 158 LPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLR 217
Query: 197 HFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG 256
+GY LP +GNLS+L A L GEIP IGKL L L L N SG
Sbjct: 218 ELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSG 277
Query: 257 KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLE 316
+ L+S++ ++L +N +GE+P S + L L L++ +N L G +PE
Sbjct: 278 PLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPE-------- 329
Query: 317 SLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE 376
F G++PE L L+L+ N+F+G +P LG+ L D+S+N TG
Sbjct: 330 --------FIGDLPE-------LEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGT 374
Query: 377 LPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVD 436
LP +C NKL+ +I N G IP+S G+C++L +R G N L G +P +GLP++
Sbjct: 375 LPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLT 434
Query: 437 FFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGH 496
E+ +N G + + + L I ++ N +G +P I +Q + L N+F G
Sbjct: 435 QVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGP 494
Query: 497 LPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLT 556
+P+ + +L +L +++ N+F+G + ++ L ++LS N+L+G IP E+ + +L
Sbjct: 495 IPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILN 554
Query: 557 SLDLSSNLLTGEIPLELTKLK-LNQFNISHNKLYGEVPSDFDHDLF-ISSLLDNPGLCSP 614
L+LS N L G IP ++ ++ L + S+N L G VP F +S L NP LC P
Sbjct: 555 YLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGP 614
Query: 615 DLKPL---------------PPCSKTKPGTIYIVVILSICVILLVGSLVWFFKVKSGFFS 659
L P P + K + +++ SI ++V K +S +
Sbjct: 615 YLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAF-----AVVAIIKARSLKKA 669
Query: 660 TSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTH 719
+ W++ FQR+ F DD+L L E N+IG GG+ VYK + +G+ VAVKRL +
Sbjct: 670 SESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSR 729
Query: 720 KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS 779
+ F +EI+TLGR+RH ++V+LL CS + N+LVYEYMPNGSL ++LH K + G
Sbjct: 730 GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGH 788
Query: 780 LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839
L W R+ IA AAKGL YLH+DC P IVHRDVKS+NILLD+ VADFGLAK L Q
Sbjct: 789 LHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL--Q 846
Query: 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
+ + + MS +AGSYGYIAPEYAYT KV EKSDVYSFGVVL+ELVTG++P FG+ D
Sbjct: 847 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVG-EFGDGVD 905
Query: 900 IVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM 959
IV+WV + T S+ + + +++DPR LS+ E V VA++C + + RP+M
Sbjct: 906 IVQWVRKMTDSNKD-----SVLKVLDPR--LSSIPIHEVTHVFYVAMLCVEEQAVERPTM 958
Query: 960 RRVVELL 966
R VV++L
Sbjct: 959 REVVQIL 965
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJM4|IKU2_ARATH Receptor-like protein kinase HAIKU2 OS=Arabidopsis thaliana GN=IKU2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 593 bits (1528), Expect = e-168, Method: Compositional matrix adjust.
Identities = 359/950 (37%), Positives = 527/950 (55%), Gaps = 73/950 (7%)
Query: 54 TSQQSPCNWTGITCETQNQSVD----GIDLSGFDLSGGFPN----GFCRIRTLRNLNLSD 105
T + S C + GI C + V+ L D G F + C ++ L L L +
Sbjct: 50 THRNSACEFAGIVCNSDGNVVEINLGSRSLINRDDDGRFTDLPFDSICDLKLLEKLVLGN 109
Query: 106 NYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESF 165
N G + + +L C L+ LDL NNFSG+ P +
Sbjct: 110 NSLRGQIGT-NLGKC------------------------NRLRYLDLGINNFSGEFP-AI 143
Query: 166 GRFPVLKVLNLGGNLLSGLIP-SFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLW 224
+L+ L+L + +SG+ P S L +L L+ +G N S P P + NL+ L+ ++
Sbjct: 144 DSLQLLEFLSLNASGISGIFPWSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWVY 203
Query: 225 AAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPE 284
+ +++ G+IP+ I L L NL+LSDN +SG+IP L ++ Q+E++ N L+G+LP
Sbjct: 204 LSNSSITGKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLPL 263
Query: 285 SLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKL 344
NLT L D S N+L G+L E +L SL + +N TGEIP+ +L L L
Sbjct: 264 GFRNLTNLRNFDASNNSLEGDLSELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAALSL 323
Query: 345 FNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPES 404
+ N +GKLP LG ++ +Y DVS N G++P ++C + + +++ NRF+G+ PES
Sbjct: 324 YRNQLTGKLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFPES 383
Query: 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILI 464
Y +CKTL LR N L G +PS WGLP + F ++ +N FEG+++ I NA L + +
Sbjct: 384 YAKCKTLIRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSLDL 443
Query: 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN 524
+ N F+G +P QI L +V+L N+FSG +P +L +L L L +N +G +P++
Sbjct: 444 SNNRFSGSLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIPKS 503
Query: 525 LNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNIS 584
L T+L+ LN + N L+ IP LG+L +L SL+LS N L+G IP+ L+ LKL+ ++S
Sbjct: 504 LGLCTSLVDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLDLS 563
Query: 585 HNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSKTKP---GTIYIVVILSICVI 641
+N+L G VP L S N GLCS ++ L PC KP G + + +C I
Sbjct: 564 NNQLTGSVP----ESLVSGSFEGNSGLCSSKIRYLRPCPLGKPHSQGKRKHLSKVDMCFI 619
Query: 642 LLVGSLVWF------FKVKSGFFSTS---KSPWKVVTFQRVSFNEDDILPHLTEQNLIGS 692
+ ++F FK++ + + K+ W+V +F+ ++FNE +I+ + +N+IG
Sbjct: 620 VAAILALFFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEIIDEIKSENIIGR 679
Query: 693 GGSCRVYKVKLKSGETVAVKR----------------LLGGTHKPETETVFRSEIETLGR 736
GG VYKV L+SGET+AVK +L + F +E+ TL
Sbjct: 680 GGQGNVYKVSLRSGETLAVKHIWCPESSHESFRSSTAMLSDGNNRSNNGEFEAEVATLSN 739
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGL 796
++H NVVKL + +D +LVYEYMPNGSL + LHE+ + W +R ++A GAAKGL
Sbjct: 740 IKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHERRGEQEIGWRVRQALALGAAKGL 799
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
YLH+ ++HRDVKS NILLD E PR+ADFGLAK +Q+ Q D + V G+ GY
Sbjct: 800 EYLHHGLDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQRDFSAPLVKGTLGY 859
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916
IAPEYAYT KV EKSDVYSFGVVLMELVTGK+P + FGEN DIV WV + +
Sbjct: 860 IAPEYAYTTKVNEKSDVYSFGVVLMELVTGKKPLETDFGENNDIVMWVWSVSKETNREMM 919
Query: 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ ++ I+ E+A KVL +AL+CT P RP M+ VV +L
Sbjct: 920 MKLIDTSIEDEYK------EDALKVLTIALLCTDKSPQARPFMKSVVSML 963
|
Modulates the seed size by negatively regulating the cellularization of syncytial endosperm. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1526), Expect = e-168, Method: Compositional matrix adjust.
Identities = 377/969 (38%), Positives = 540/969 (55%), Gaps = 59/969 (6%)
Query: 32 ILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNG 91
+L+ VKS L DP L DW + CNWTG+ C + N +V+ +DL+G +L+G +
Sbjct: 33 VLLSVKS-TLVDPLNFLKDWKLSDTSDHCNWTGVRCNS-NGNVEKLDLAGMNLTGKISDS 90
Query: 92 FCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLD 151
++ +L + N+S N F +L +S+ P L+ + + N F G L FS E L L+
Sbjct: 91 ISQLSSLVSFNISCNGFE-SLLPKSIPP---LKSIDISQNSFSGSLFLFSNESLGLVHLN 146
Query: 152 LSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLP 211
S NN SG++ E G L+VL+L GN G +PS NL +L L N L + LP
Sbjct: 147 ASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNL-TGELP 205
Query: 212 SSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQI 271
S +G L LE G IP G + L LDL+ LSG+IP L S+E +
Sbjct: 206 SVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETL 265
Query: 272 ELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLP-ETIAAMSLESLNLNDNYFTGEIP 330
L++N +G +P + ++TTL LD S N LTG +P E +L+ LNL N +G IP
Sbjct: 266 LLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIP 325
Query: 331 ESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCI 390
+++S L L+L+NN+ SG+LP DLGK S L++ DVS+N F+GE+P LC + L +
Sbjct: 326 PAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKL 385
Query: 391 IIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSIS 450
I+FNN F+G+IP + C++L +R N L G +P F L ++ E+ NR G I
Sbjct: 386 ILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIP 445
Query: 451 PSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQL 510
IS++ L+ I + N +PS I ++ LQA ++ N SG +P L L
Sbjct: 446 GDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNL 505
Query: 511 ELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570
+L N TG +P ++ S L+ LNL N LTG IP ++ ++ L LDLS+N LTG +P
Sbjct: 506 DLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLP 565
Query: 571 LEL-TKLKLNQFNISHNKLYGEVP-SDFDHDLFISSLLDNPGLCSPDLKPLPPCSKTKPG 628
+ T L N+S+NKL G VP + F + L N GLC LPPCSK +
Sbjct: 566 ESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCG---GVLPPCSKFQRA 622
Query: 629 T----------------IYIVVILSICVILLVGSLVWFFKVKSGF-----FSTSKSPWKV 667
T I I +L++ ++ +V ++ +GF S + PW++
Sbjct: 623 TSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRL 682
Query: 668 VTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETV-AVKRLLGGTHKPETETV 726
+ F R+ F DIL + E N+IG G + VYK ++ TV AVK+L E T
Sbjct: 683 MAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTT 742
Query: 727 --FRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSL--DW 782
F E+ LG++RH N+V+LL ++VYE+M NG+L D +H K +G L DW
Sbjct: 743 GDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDW 802
Query: 783 SIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842
R++IA G A GLAYLH+DC P ++HRD+KS+NILLDA + R+ADFGLA+ + ++
Sbjct: 803 VSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKK-- 860
Query: 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR 902
+ +S VAGSYGYIAPEY YT KV EK D+YS+GVVL+EL+TG+RP +P FGE+ DIV
Sbjct: 861 --ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVE 918
Query: 903 WVTEATLSSPERGCCRD---LNQLIDPRMDLSTCDY--EEAEKVLNVALMCTSDFPINRP 957
WV R RD L + +DP ++ C Y EE VL +AL+CT+ P +RP
Sbjct: 919 WV---------RRKIRDNISLEEALDP--NVGNCRYVQEEMLLVLQIALLCTTKLPKDRP 967
Query: 958 SMRRVVELL 966
SMR V+ +L
Sbjct: 968 SMRDVISML 976
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 577 bits (1487), Expect = e-163, Method: Compositional matrix adjust.
Identities = 368/999 (36%), Positives = 535/999 (53%), Gaps = 104/999 (10%)
Query: 19 CFSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQ-QSPCNWTGITCETQNQSVD-- 75
CF+ + D E+L+ +KS + L DW+ +S + C+++G++C+ + +
Sbjct: 22 CFA-----YTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLN 76
Query: 76 ---------------------GIDLSGFDLSGGFPNGFCRIRTLRNLNLSDN-YFNGTLS 113
+ L+ + +G P + +L+ LN+S+N GT
Sbjct: 77 VSFTPLFGTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFP 136
Query: 114 SQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKV 173
+ L L+VL N F G+LP E L+ L N FSG+IPES+G L+
Sbjct: 137 GEILKAMVDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEY 196
Query: 174 LNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGE 233
L L G LSG P+FL L L +GY + +P G L+KLE L A L GE
Sbjct: 197 LGLNGAGLSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGE 256
Query: 234 IPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLL 293
IP S+ L L L L N L+G IP SGL S++ ++L NQL+GE+P+S NL +
Sbjct: 257 IPTSLSNLKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNIT 316
Query: 294 RLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKL 353
+++ +NNL G +PE I GE+P+ L +++ N+F+ +L
Sbjct: 317 LINLFRNNLYGQIPEAI----------------GELPK-------LEVFEVWENNFTLQL 353
Query: 354 PDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNY 413
P +LG+ NL DVS N TG +P+ LC KL+ +I+ NN F G IPE G+CK+L
Sbjct: 354 PANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPIPEELGKCKSLTK 413
Query: 414 LRFGGNELQGELPSKFWGLPEVDFFEMY-----------------------NNRFEGSIS 450
+R N L G +P+ + LP V E+ NN F G I
Sbjct: 414 IRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFSGELPVTMSGDVLDQIYLSNNWFSGEIP 473
Query: 451 PSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQL 510
P+I N P L + ++ N F G +P +I L+ L ++ S N +G +P I++ + L +
Sbjct: 474 PAIGNFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGIPDSISRCSTLISV 533
Query: 511 ELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570
+L N GE+P+ +N++ L LN+S NQLTG+IP +GN+ LT+LDLS N L+G +P
Sbjct: 534 DLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVP 593
Query: 571 LELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSKTKPGTI 630
L L N+ + + N Y +P S PG S + P I
Sbjct: 594 LGGQFLVFNETSFAGNT-YLCLPHRV-------SCPTRPGQTSDHNH----TALFSPSRI 641
Query: 631 YIVVILSICVILLVGSLVWFFKVKSGFFSTSKSPWKVVTFQRVSFNEDDILPHLTEQNLI 690
I VI +I ++L+ + K S + WK+ FQ++ F +D+L L E+N+I
Sbjct: 642 VITVIAAITGLILISVAIRQMNKKKNQKSLA---WKLTAFQKLDFKSEDVLECLKEENII 698
Query: 691 GSGGSCRVYKVKLKSGETVAVKRLLG-GTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
G GG+ VY+ + + VA+KRL+G GT + ++ F +EI+TLGR+RH ++V+LL
Sbjct: 699 GKGGAGIVYRGSMPNNVDVAIKRLVGRGTGR--SDHGFTAEIQTLGRIRHRHIVRLLGYV 756
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
+ +D N+L+YEYMPNGSL ++LH + G L W R +A AAKGL YLH+DC P I+H
Sbjct: 757 ANKDTNLLLYEYMPNGSLGELLH-GSKGGHLQWETRHRVAVEAAKGLCYLHHDCSPLILH 815
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTE 869
RDVKS+NILLD++ VADFGLAK L +G + + MS +AGSYGYIAPEYAYT KV E
Sbjct: 816 RDVKSNNILLDSDFEAHVADFGLAKFL--VDGAASECMSSIAGSYGYIAPEYAYTLKVDE 873
Query: 870 KSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV--TEATLSSPERGCCRDLNQLIDPR 927
KSDVYSFGVVL+EL+ GK+P FGE DIVRWV TE ++ P + ++DPR
Sbjct: 874 KSDVYSFGVVLLELIAGKKPVG-EFGEGVDIVRWVRNTEEEITQPSDAAI--VVAIVDPR 930
Query: 928 MDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
L+ V +A+MC + RP+MR VV +L
Sbjct: 931 --LTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHML 967
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 568 bits (1463), Expect = e-161, Method: Compositional matrix adjust.
Identities = 375/1018 (36%), Positives = 531/1018 (52%), Gaps = 119/1018 (11%)
Query: 29 DAEILIRVKSDQLDDPNRKLGDWVRT------SQQSPCNWTGITCETQNQSVDGIDLSGF 82
+ EIL+ KSD L DP+ L DW R S+ C+WTG+ C+ N V + LS
Sbjct: 30 EQEILLAFKSD-LFDPSNNLQDWKRPENATTFSELVHCHWTGVHCDA-NGYVAKLLLSNM 87
Query: 83 DLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSR 142
+LSG + +L+ L+LS+N F +L +SLS L+V+ + N F G P
Sbjct: 88 NLSGNVSDQIQSFPSLQALDLSNNAFESSLP-KSLSNLTSLKVIDVSVNSFFGTFPYGLG 146
Query: 143 EFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGY 202
L ++ S NNFSG +PE G L+VL+ G G +PS NL L L
Sbjct: 147 MATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSG 206
Query: 203 NPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSF 262
N +P +G LS LE + +GEIP+ GKL L LDL+ L+G+IP S
Sbjct: 207 NNF-GGKVPKVIGELSSLETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSL 265
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLN 321
L + + L+ N+L+G+LP L +T+L+ LD+S N +TG +P + + +L+ LNL
Sbjct: 266 GQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLM 325
Query: 322 DNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFL 381
N TG IP +A PNL L+L+ NS G LP LGK S L++ DVS+N +G++P L
Sbjct: 326 RNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGL 385
Query: 382 CFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMY 441
C+ L +I+FNN FSG+IPE C TL +R N + G +P+ LP + E+
Sbjct: 386 CYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELA 445
Query: 442 NNRFEGSISPSIS-----------------------NAPKLTGILINGNNFTGEVPSQIC 478
N G I I+ ++P L + + NNF G++P+QI
Sbjct: 446 KNNLTGKIPDDIALSTSLSFIDISFNHLSSLSSSIFSSPNLQTFIASHNNFAGKIPNQIQ 505
Query: 479 TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLST 538
L +DLS N FSG +P I KL L L+ N GE+P+ L + L VL+LS
Sbjct: 506 DRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSN 565
Query: 539 NQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEV-PSDFD 597
N LTG IP +LG L L++S N L G IP N L+ + P D
Sbjct: 566 NSLTGNIPADLGASPTLEMLNVSFNKLDGPIP--------------SNMLFAAIDPKD-- 609
Query: 598 HDLFISSLLDNPGLCSPDLKPLPPCSKT--------KPGTIYI-----------VVILSI 638
L+ N GLC LPPCSK+ PG I++ VI+++
Sbjct: 610 -------LVGNNGLCG---GVLPPCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAM 659
Query: 639 CVILLVGSLVWF-FKVKSGFFS--------TSKSPWKVVTFQRVSFNEDDILPHLTEQNL 689
++ L G ++ + + S F + PW++V FQR+ F DIL H+ E N+
Sbjct: 660 GMMFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESNI 719
Query: 690 IGSGGSCRVYKVKLKSGE--TVAVKRLLGGTHKPETET------------VFRSEIETLG 735
IG G VYK ++ TVAVK+L + P+ + + R E+ LG
Sbjct: 720 IGMGAIGIVYKAEVMRRPLLTVAVKKLW-RSPSPQNDIEDHHQEEDEEDDILR-EVNLLG 777
Query: 736 RVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSL-DWSIRFSIAQGAAK 794
+RH N+VK+L + ++VYEYMPNG+L LH K L DW R+++A G +
Sbjct: 778 GLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQ 837
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
GL YLHNDC P I+HRD+KS+NILLD+ + R+ADFGLAK + + ++ +S VAGSY
Sbjct: 838 GLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLHK----NETVSMVAGSY 893
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914
GYIAPEY YT K+ EKSD+YS GVVL+ELVTGK P DPSF ++ D+V W+ +
Sbjct: 894 GYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVKKN--- 950
Query: 915 GCCRDLNQLIDPRMDLSTCDY--EEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970
L ++ID + C + EE L +AL+CT+ P +RPS+R V+ +L K
Sbjct: 951 ---ESLEEVIDASIA-GDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAK 1004
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 564 bits (1454), Expect = e-159, Method: Compositional matrix adjust.
Identities = 388/1091 (35%), Positives = 545/1091 (49%), Gaps = 157/1091 (14%)
Query: 10 IALLFSFLLC---FSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGIT 66
I L +LC F L SL+ + +L+ K+ L+D N L W + +PCNWTGI
Sbjct: 5 ICFLAIVILCSFSFILVRSLNEEGRVLLEFKAF-LNDSNGYLASWNQLDS-NPCNWTGIA 62
Query: 67 CETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVL 126
C T ++V +DL+G +LSG C++ LR LN+S N+ +G + Q LS C L+VL
Sbjct: 63 C-THLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIP-QDLSLCRSLEVL 120
Query: 127 ALDYNVFIGELP---------------------DFSREFANL---QVLDLSRNNFSGDIP 162
L N F G +P R+ NL Q L + NN +G IP
Sbjct: 121 DLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIP 180
Query: 163 ESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLEN 222
S + L+++ G N SG+IPS + L L N L+ S LP + L L +
Sbjct: 181 PSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGS-LPKQLEKLQNLTD 239
Query: 223 LWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGEL 282
L + L GEIP S+G ++ L L L +N+ +G IP L ++++ L+ NQL+GE+
Sbjct: 240 LILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEI 299
Query: 283 PESLSNLTTLLRLDISQNNLTGNLPETIAAMS-------------------------LES 317
P + NL +D S+N LTG +P+ + LE
Sbjct: 300 PREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEK 359
Query: 318 LNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGEL 377
L+L+ N G IP+ L P LV L+LF+N GK+P +G YSN D+S N +G +
Sbjct: 360 LDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPI 419
Query: 378 PRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDF 437
P C L + + +N+ SG IP CK+L L G N+L G LP + + L +
Sbjct: 420 PAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTA 479
Query: 438 FEMY------------------------NNRFEGSISPSISNAPKLTGILINGNNFTGEV 473
E++ NN F G I P I N K+ G I+ N TG +
Sbjct: 480 LELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHI 539
Query: 474 PSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL-- 531
P ++ + +Q +DLS N+FSG++ + QL L+ L L +N TGE+P + LT L
Sbjct: 540 PKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLME 599
Query: 532 -----------------------IVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE 568
I LN+S N L+GTIP LGNL +L L L+ N L+GE
Sbjct: 600 LQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGE 659
Query: 569 IPLELTKL-KLNQFNISHNKLYGEVP-SDFDHDLFISSLLDNPGLCSPD---LKPLPPCS 623
IP + L L NIS+N L G VP + + S+ N GLC+ +PL P S
Sbjct: 660 IPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHS 719
Query: 624 KTKPG------------TIYIVVILSICVILLVGSLVWFFKVKSGFFSTSKS-------- 663
+K TI +VI S+ +I +G L W K + F +
Sbjct: 720 DSKLNWLINGSQRQKILTITCIVIGSVFLITFLG-LCWTIKRREPAFVALEDQTKPDVMD 778
Query: 664 ----PWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTH 719
P K T+Q + D + +E ++G G VYK ++ GE +AVK+L
Sbjct: 779 SYYFPKKGFTYQGLV----DATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGE 834
Query: 720 KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS 779
++ FR+EI TLG++RH N+VKL C Q+ N+L+YEYM GSL + L ++
Sbjct: 835 GASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCL 894
Query: 780 LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839
LDW+ R+ IA GAA+GL YLH+DC P IVHRD+KS+NILLD V DFGLAK +
Sbjct: 895 LDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLS 954
Query: 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
+S MS VAGSYGYIAPEYAYT KVTEK D+YSFGVVL+EL+TGK P P + D
Sbjct: 955 YSKS---MSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGD 1010
Query: 900 IVRWVTEATLSSPERGCCRDL---NQLIDPRMDLS-TCDYEEAEKVLNVALMCTSDFPIN 955
+V WV R R++ ++ D R+D + E VL +AL CTS+ P +
Sbjct: 1011 LVNWV---------RRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPAS 1061
Query: 956 RPSMRRVVELL 966
RP+MR VV ++
Sbjct: 1062 RPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | ||||||
| 255582417 | 988 | Receptor protein kinase CLAVATA1 precurs | 0.987 | 0.972 | 0.644 | 0.0 | |
| 299149726 | 988 | receptor kinase [Gossypium hirsutum] | 0.988 | 0.973 | 0.636 | 0.0 | |
| 359496629 | 978 | PREDICTED: LRR receptor-like serine/thre | 0.972 | 0.967 | 0.627 | 0.0 | |
| 356495521 | 985 | PREDICTED: LRR receptor-like serine/thre | 0.975 | 0.963 | 0.607 | 0.0 | |
| 297794181 | 995 | hypothetical protein ARALYDRAFT_496808 [ | 0.977 | 0.955 | 0.598 | 0.0 | |
| 30698151 | 993 | LRR receptor-like serine/threonine-prote | 0.973 | 0.953 | 0.591 | 0.0 | |
| 2827714 | 976 | receptor protein kinase - like protein [ | 0.955 | 0.952 | 0.583 | 0.0 | |
| 357482445 | 1054 | Receptor protein kinase-like protein [Me | 0.987 | 0.911 | 0.548 | 0.0 | |
| 449432972 | 982 | PREDICTED: LRR receptor-like serine/thre | 0.979 | 0.970 | 0.586 | 0.0 | |
| 104642235 | 998 | clavata-like receptor [Picea glauca] | 0.975 | 0.950 | 0.473 | 0.0 |
| >gi|255582417|ref|XP_002531997.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223528356|gb|EEF30396.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1274 bits (3296), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/974 (64%), Positives = 773/974 (79%), Gaps = 13/974 (1%)
Query: 10 IALLFSFLLCFSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRT-SQQSPCNWTGITCE 68
+ +L++ FSL +SL GD+EILIRVK+ QLDD + KL DWV + + SPC WTG+TC+
Sbjct: 10 LVVLYAVSFSFSLVVSLTGDSEILIRVKNAQLDDRDGKLNDWVVSRTDHSPCKWTGVTCD 69
Query: 69 TQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLAL 128
+ N +V IDLSG +++GGFP GFCRI+TL+NL L+DN+FNG+L+S++LSPC HL VL L
Sbjct: 70 SVNNTVVSIDLSGLNVAGGFPTGFCRIQTLKNLTLADNFFNGSLTSRALSPCQHLHVLNL 129
Query: 129 DYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSF 188
N+F+GELPDF +FANL+VLDLS NNFSGDIP SFG L+VL L NLL+G IP F
Sbjct: 130 SANIFVGELPDFPPDFANLRVLDLSCNNFSGDIPASFGALKSLEVLILTENLLTGSIPGF 189
Query: 189 LGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLD 248
LGNL+ELT EL YNP K SPLP +GNL+KLENL+ NL GEIP+SIG+L L+NLD
Sbjct: 190 LGNLSELTRLELAYNPFKPSPLPKDIGNLTKLENLFLPSVNLNGEIPESIGRLVSLTNLD 249
Query: 249 LSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPE 308
LS NF++GKIP SFSGL SI QIEL++NQL GELPESLSNL TLL+ D SQNNLTGNL E
Sbjct: 250 LSSNFITGKIPDSFSGLKSILQIELYNNQLYGELPESLSNLRTLLKFDASQNNLTGNLHE 309
Query: 309 TIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDV 368
IAA+ L+SL LNDNYF+G++PE LA NPNL++L LFNNSF+GKLP +LG+YS+L FDV
Sbjct: 310 KIAALQLQSLFLNDNYFSGDVPEVLAFNPNLLELHLFNNSFTGKLPTNLGRYSDLFDFDV 369
Query: 369 STNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSK 428
STN+FTGELP++LC R KL+ +I FNN SG +PES+G+C +L+Y+R NE+ G + +
Sbjct: 370 STNEFTGELPQYLCHRKKLKNVIAFNNHLSGNLPESFGDCSSLSYVRIANNEISGTVSNS 429
Query: 429 FWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDL 488
WGL + FFE+ NN+FEG IS SIS A LT +L++GNNF+G++PS++C L +L ++L
Sbjct: 430 LWGLSHLGFFELSNNKFEGPISTSISGAKGLTRLLLSGNNFSGKLPSEVCQLHELVEINL 489
Query: 489 SQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPE 548
S+N+F LP+CIT+L K+Q+LE+QENMF+GE+P ++NS L LNLS N+L+G IP E
Sbjct: 490 SRNQFLDKLPSCITELKKVQKLEMQENMFSGEIPSSVNSWIYLTELNLSRNRLSGKIPSE 549
Query: 549 LGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDN 608
LG+L VLTSLDL+ N LTG +P+ELTKLKL QFN+S N L+G+VPS F + ++S L+ N
Sbjct: 550 LGSLPVLTSLDLADNSLTGGVPVELTKLKLVQFNVSDNNLFGKVPSAFGNAFYLSGLMGN 609
Query: 609 PGLCSPDLKPLPPCSK--TKPGTIYIVVILSICVILLVGSLVWFFKVKSGFFSTSKSPWK 666
P LCSPD+ PLP CSK KP T+YIV IL+ICV++LVGSL+WFFKVKS F K +K
Sbjct: 610 PNLCSPDMNPLPSCSKPRPKPATLYIVAILAICVLILVGSLLWFFKVKSVFVRKPKRLYK 669
Query: 667 VVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV 726
V TFQRV FNE+DI P LT++NLIGSGGS +VYKV+LK+G+ VA KRL GGT KPETE V
Sbjct: 670 VTTFQRVGFNEEDIFPCLTKENLIGSGGSGQVYKVELKTGQIVAAKRLWGGTQKPETEIV 729
Query: 727 FRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRF 786
FRSE+ETLGRVRH N+VKLLMCCSG++F ILVYEYM NGSL D+LH + G LDW R+
Sbjct: 730 FRSEVETLGRVRHSNIVKLLMCCSGEEFRILVYEYMENGSLGDVLHGQKGGGLLDWKSRY 789
Query: 787 SIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA 846
++A GAA+GLAYLH+DCVP IVHRDVKS+NILLD E+ PRVADFGLAK LQS+ + D
Sbjct: 790 AVAVGAAQGLAYLHHDCVPPIVHRDVKSNNILLDDEIRPRVADFGLAKTLQSEAVEGDCV 849
Query: 847 MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906
MS +AGSYGYIAPEYAYT KVTEKSDVYSFGVVL+EL+TGKRPND FGENKD+VRWVTE
Sbjct: 850 MSRIAGSYGYIAPEYAYTLKVTEKSDVYSFGVVLLELITGKRPNDSFFGENKDVVRWVTE 909
Query: 907 AT---LSSPERG-------CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINR 956
T SSP+ G C +DL Q+ID ++D STCDYEE EKVLNVAL+CTS FPI R
Sbjct: 910 VTSSATSSPDGGSENGSGNCYKDLGQIIDSKLDQSTCDYEEIEKVLNVALLCTSAFPITR 969
Query: 957 PSMRRVVELLRVDK 970
PSMRRVVELLR K
Sbjct: 970 PSMRRVVELLRDQK 983
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|299149726|gb|ADJ17363.1| receptor kinase [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 1207 bits (3124), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 626/983 (63%), Positives = 753/983 (76%), Gaps = 21/983 (2%)
Query: 1 MRFLGAKSLIALLFSFLLCFSLAISLHGDAEILIRVKSDQLDDPNRKLGDWV-RTSQQSP 59
MR K+LI LF + F+ +S +GD++ILIRVK QLDDPN +L DWV T QSP
Sbjct: 1 MRNPDLKALICFLFWVVCVFTFVVSFNGDSQILIRVKDSQLDDPNGRLRDWVILTPDQSP 60
Query: 60 CNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSP 119
CNWTG+ CE++N++V IDLSGF +SGGFP FCRIRTLR L L+DN NG+LSSQ++SP
Sbjct: 61 CNWTGVWCESRNRTVASIDLSGFGISGGFPFEFCRIRTLRTLYLADNNLNGSLSSQAISP 120
Query: 120 CFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179
CF L+ + L N+F+GELPDFS E +L+VL+LS NNF+GDIP SFGR LKVL+LGGN
Sbjct: 121 CFRLRKIDLSGNIFVGELPDFSSE--HLEVLELSNNNFTGDIPVSFGRMKSLKVLSLGGN 178
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIG 239
LL+G +PSFLGNLTELT F LGYNP K SPLP +GNLSKLE LW ANL+GEIP SIG
Sbjct: 179 LLNGKVPSFLGNLTELTDFALGYNPFKPSPLPDEIGNLSKLEYLWLTNANLVGEIPFSIG 238
Query: 240 KLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQ 299
L L +LDL+ NFL GKIP S S L +EQIEL+ NQL+GELPESL+ LT+LLRLD+SQ
Sbjct: 239 NLISLKSLDLTCNFLIGKIPESLSKLKKLEQIELYQNQLTGELPESLAELTSLLRLDVSQ 298
Query: 300 NNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGK 359
N+LTG LPE IAAM LESLNLNDN+FTGEIPE LASN L QLKLFNNSF+GKLP DLGK
Sbjct: 299 NSLTGKLPEKIAAMPLESLNLNDNFFTGEIPEVLASNQYLSQLKLFNNSFTGKLPPDLGK 358
Query: 360 YSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGN 419
+S LE FDVSTN+F+GELP FLC + KLQ I+IF NRFSG IPESYGEC++LNY+R G N
Sbjct: 359 FSPLEDFDVSTNNFSGELPLFLCHKRKLQRIVIFTNRFSGSIPESYGECESLNYIRMGDN 418
Query: 420 ELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICT 479
G +P KFWGLP + FE+ NN FEGSISPSI KLT + I+GNNF+G++P +C
Sbjct: 419 AFSGNVPEKFWGLPLMQLFELQNNHFEGSISPSIPALQKLTILRISGNNFSGDIPEGMCK 478
Query: 480 LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTN 539
L L ++LSQNRFSG LP CIT L KLQ LEL++N TG LP ++ S T L LNL+ N
Sbjct: 479 LHNLTQINLSQNRFSGGLPLCITDL-KLQTLELEDNELTGNLPGSVGSWTELTELNLARN 537
Query: 540 QLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHD 599
+ TG IPP LGNL L LDLS NLL G+IP +LTKL+LN+FN+S N L G+VP F+++
Sbjct: 538 RFTGEIPPTLGNLPALIYLDLSGNLLIGKIPEDLTKLRLNRFNLSGNLLNGKVPLGFNNE 597
Query: 600 LFISSLLDNPGLCSPDLKPLPPCSKTKPGTIYIVVILSICVILLVGSLVWFFKVKSGFFS 659
FIS LL NP LCSP+L PLPPC + KPGT Y+V IL++C+ILL+GS++WFF+ +S F S
Sbjct: 598 FFISGLLGNPDLCSPNLNPLPPCPRIKPGTFYVVGILTVCLILLIGSVIWFFRTRSKFGS 657
Query: 660 TSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTH 719
++ P+KV FQRV FNED+I + + +IG+GGS RVYKVKLK+G+TVAVKRL G
Sbjct: 658 KTRRPYKVTLFQRVEFNEDEIFQFMKDDCIIGTGGSGRVYKVKLKTGQTVAVKRLWG--V 715
Query: 720 KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS 779
K E E VFRSE ETLGR+RHGN+VKLLMCCSG +F +LVYE M NGSL D+LH G
Sbjct: 716 KREAEEVFRSETETLGRIRHGNIVKLLMCCSGDEFRVLVYECMENGSLGDVLHGDKWGGL 775
Query: 780 LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839
DW RF+IA GAA+GLAYLH+DC+P IVHRDVKS+NILLD EM PRVADFGLAK LQ +
Sbjct: 776 ADWPKRFAIAVGAAQGLAYLHHDCLPPIVHRDVKSNNILLDEEMRPRVADFGLAKTLQIE 835
Query: 840 ---EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE 896
+G + AMS +AG++GYIAPEY YT KVTEKSDVYSFGVVL+EL+TGKRPND SFGE
Sbjct: 836 AGDDGSNGGAMSRIAGTHGYIAPEYGYTLKVTEKSDVYSFGVVLLELITGKRPNDSSFGE 895
Query: 897 NKDIVRWVTEATLSS-PERGCCRDLN-----------QLIDPRMDLSTCDYEEAEKVLNV 944
+KD+V+WVTE LSS P + N +++DPRM ST + +E E+VLNV
Sbjct: 896 SKDLVKWVTEVVLSSLPPSASAQGGNDSGGYFGKKVAEIVDPRMKPSTYEMKEIERVLNV 955
Query: 945 ALMCTSDFPINRPSMRRVVELLR 967
AL CTS FPINRPSMR+VVELL+
Sbjct: 956 ALKCTSAFPINRPSMRKVVELLK 978
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496629|ref|XP_002263151.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase HSL2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1206 bits (3121), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/955 (62%), Positives = 746/955 (78%), Gaps = 9/955 (0%)
Query: 21 SLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLS 80
S ISL+ DA+ILIRVK+ LDDP LGDWV TS PC WTGI C+ + +V IDLS
Sbjct: 17 SPVISLNRDADILIRVKNSGLDDPYAGLGDWVPTSDD-PCKWTGIACDYKTHAVVSIDLS 75
Query: 81 GFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDF 140
GF +SGGFP+GFCRI+TL+NL+L+DN NG+L+S+ +SPCFHL L L N GELP+F
Sbjct: 76 GFGVSGGFPSGFCRIQTLQNLSLADNNLNGSLTSELVSPCFHLHSLNLSSNELTGELPEF 135
Query: 141 SREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFEL 200
EF +L +LDLS NNFSG+IP SFGRFP LKVL L NLL G IPSFL NLTELT E+
Sbjct: 136 VPEFGSLLILDLSFNNFSGEIPASFGRFPALKVLRLCQNLLDGSIPSFLTNLTELTRLEI 195
Query: 201 GYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPH 260
YNP K S LPS++GNL+KLENLW ++LIG+IP+S+G L ++N DLS+N LSGKIP
Sbjct: 196 AYNPFKPSRLPSNIGNLTKLENLWFPCSSLIGDIPESVGSLVSVTNFDLSNNSLSGKIPD 255
Query: 261 SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNL 320
S L ++ QIEL+ N LSGELPES+SN+T L++LD SQNNL+G LPE IA M L+SLNL
Sbjct: 256 SIGRLKNVIQIELYLNNLSGELPESISNMTALVQLDASQNNLSGKLPEKIAGMPLKSLNL 315
Query: 321 NDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRF 380
NDN+F GEIPESLASNPNL +LK+FNN FSG LP++LG+ S L DVS N+FTG+LP F
Sbjct: 316 NDNFFDGEIPESLASNPNLHELKIFNNRFSGSLPENLGRNSALIDIDVSGNNFTGDLPPF 375
Query: 381 LCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEM 440
LC+R +L+ +I+FNN+FSG +PE+YG+C +L+Y+R EL GE+P++FWGLPE+ F ++
Sbjct: 376 LCYRKRLRRLILFNNQFSGNLPETYGDCNSLSYVRIFSTELSGEVPNRFWGLPELHFLQL 435
Query: 441 YNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTC 500
NNRF+GSI PSIS A KLT LI+GN F+ ++P+ IC L++L + D S+N+FSG +P C
Sbjct: 436 ENNRFQGSIPPSISGAQKLTNFLISGNKFSDKLPADICGLKRLMSFDGSRNQFSGDVPVC 495
Query: 501 ITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDL 560
IT L KLQ LELQ+NM +G +P ++S T L LNL+ N+ TG IP ELGNL VLT LDL
Sbjct: 496 ITDLKKLQNLELQQNMLSGGIPSRVSSWTDLTELNLAGNRFTGEIPAELGNLPVLTYLDL 555
Query: 561 SSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLP 620
+ N LTGEIP+ELTKLKLN FN+S+N L GEVP F H ++ SL+ NP LCSP+LKPLP
Sbjct: 556 AGNFLTGEIPVELTKLKLNIFNVSNNLLSGEVPIGFSHKYYLQSLMGNPNLCSPNLKPLP 615
Query: 621 PCSKTKPGTIYIVVILSI-CVILLVGSLVWFFKVKSGFFSTSKS-PWKVVTFQRVSFNED 678
PCS++KP T+Y++ +L+I +ILL+GSL WF K +S F + WK FQ + FNE+
Sbjct: 616 PCSRSKPITLYLIGVLAIFTLILLLGSLFWFLKTRSKIFGDKPNRQWKTTIFQSIRFNEE 675
Query: 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
+I L ++NL+G+GGS +VY+VKLK+G+T+AVK+L GG +PETE +F+SE+ETLG +R
Sbjct: 676 EISSSLKDENLVGTGGSGQVYRVKLKTGQTIAVKKLCGGRREPETEAIFQSEVETLGGIR 735
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H N+VKLL CS +DF +LVYEYM NGSL ++LH G LDW RF IA GAA+GLAY
Sbjct: 736 HCNIVKLLFSCSDEDFRVLVYEYMENGSLGEVLHGDKGEGLLDWHRRFKIAVGAAQGLAY 795
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
LH+DCVPAIVHRDVKS+NILLD E PR+ADFGLAK L + G+SD+ MS VAGSYGYIA
Sbjct: 796 LHHDCVPAIVHRDVKSNNILLDEEFSPRIADFGLAKTLHREVGESDELMSRVAGSYGYIA 855
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE----R 914
PEYAYT KVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN+DIV+WVTEA LS+PE
Sbjct: 856 PEYAYTLKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENRDIVKWVTEAALSAPEGSDGN 915
Query: 915 GC--CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
GC C DL+QL+DPR++ ST DYEE EKVL+VAL+CT+ FP+NRPSMRRVVELL+
Sbjct: 916 GCSGCMDLDQLVDPRLNPSTGDYEEIEKVLDVALLCTAAFPMNRPSMRRVVELLK 970
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495521|ref|XP_003516625.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase HSL2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1159 bits (2998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 585/963 (60%), Positives = 729/963 (75%), Gaps = 14/963 (1%)
Query: 20 FSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDL 79
S +SL + +IL+ VK+ QL+D N+ L +WV + PCNWTGITC+ +N S+ IDL
Sbjct: 27 LSQVLSLERETQILLGVKNTQLEDKNKSLKNWVPNTDHHPCNWTGITCDARNHSLVSIDL 86
Query: 80 SGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD 139
S + G FP GFCRI TL++L+++ N+ ++S SL C HL++L L N F+G LP+
Sbjct: 87 SETGIYGDFPFGFCRIHTLQSLSVASNFLTNSISPNSLLLCSHLRLLNLSDNYFVGVLPE 146
Query: 140 FSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFE 199
F +F L+ LDLS+NNF+GDIP SFG+FP L+ L L GNLLSG IP FLGNL+ELT E
Sbjct: 147 FPPDFTELRELDLSKNNFTGDIPASFGQFPHLRTLVLSGNLLSGTIPPFLGNLSELTRLE 206
Query: 200 LGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP 259
L YNP K PLPS +GNLS LE L+ A NL+GEIP +IG L L N DLS N LSG IP
Sbjct: 207 LAYNPFKPGPLPSQLGNLSNLETLFLADVNLVGEIPHAIGNLTSLKNFDLSQNSLSGTIP 266
Query: 260 HSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLN 319
+S SGL ++EQIELF+NQL GELP+ L NL++L+ LD+SQN LTG LP+TIA++ L+SLN
Sbjct: 267 NSISGLRNVEQIELFENQLFGELPQGLGNLSSLICLDLSQNALTGKLPDTIASLHLQSLN 326
Query: 320 LNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPR 379
LNDN+ GEIPESLASNPNL QLKLFNNSF+GKLP DLG+ S++E FDVSTND GELP+
Sbjct: 327 LNDNFLRGEIPESLASNPNLKQLKLFNNSFTGKLPRDLGRNSDIEDFDVSTNDLVGELPK 386
Query: 380 FLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFE 439
+LC NKL+ +I F NRFSG +P+ YGEC++L Y+R N+ G +P FW L + F E
Sbjct: 387 YLCQGNKLEHLITFANRFSGTLPDQYGECRSLQYVRIQSNQFSGPVPPSFWALAGLQFLE 446
Query: 440 MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT 499
M NNRF+GS+S SIS LT ++++GN+F+G+ P +IC L L +D S+NRF+G +PT
Sbjct: 447 MSNNRFQGSVSASISRG--LTKLILSGNSFSGQFPMEICELHNLMEIDFSKNRFTGEVPT 504
Query: 500 CITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLD 559
C+T+L KLQ+L LQENMFTGE+P N+ T + L+LS N+ TG+IP ELGNL LT LD
Sbjct: 505 CVTKLTKLQKLRLQENMFTGEIPSNVTHWTDMTELDLSFNRFTGSIPSELGNLPDLTYLD 564
Query: 560 LSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPL 619
L+ N LTGEIP+ELT L+LNQFN+S NKL+G VP F+ ++++ L+ NPGLCSP +K L
Sbjct: 565 LAVNSLTGEIPVELTNLRLNQFNVSGNKLHGVVPLGFNRQVYLTGLMGNPGLCSPVMKTL 624
Query: 620 PPCSKTKPGTIYIVVILSICVILLVGSLVWFFKVKS-GFFSTSKSPWKVVTFQRVSFNED 678
PPCSK +P ++ +V+L CV LLVGS +WF K K+ G SKS + FQRV FNE+
Sbjct: 625 PPCSKRRPFSLLAIVVLVCCVSLLVGSTLWFLKSKTRGCSGKSKSSYMSTAFQRVGFNEE 684
Query: 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
DI+P+L N+I +G S RVYKV+LK+G+TVAVK+L GG KP+ E VFR+EIETLGR+R
Sbjct: 685 DIVPNLISNNVIATGSSGRVYKVRLKTGQTVAVKKLFGGAQKPDVEMVFRAEIETLGRIR 744
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSL-DWSIRFSIAQGAAKGLA 797
H N+VKLL CSG +F ILVYEYM NGSL D+LH + + G L DW RF+IA GAA+GLA
Sbjct: 745 HANIVKLLFSCSGDEFRILVYEYMENGSLGDVLHGEDKCGELMDWPRRFAIAVGAAQGLA 804
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
YLH+D VPAIVHRDVKS+NILLD E VPRVADFGLAK LQ + Q AMS VAGSYGYI
Sbjct: 805 YLHHDSVPAIVHRDVKSNNILLDHEFVPRVADFGLAKTLQREATQG--AMSRVAGSYGYI 862
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS-SPERGC 916
APEYAYT KVTEKSDVYSFGVVLMEL+TGKRPND SFGENKDIV+W+TE LS SPERG
Sbjct: 863 APEYAYTMKVTEKSDVYSFGVVLMELITGKRPNDSSFGENKDIVKWITETVLSPSPERGS 922
Query: 917 -----CRD--LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969
+D ++Q++DPR++ +TCDYEE EKVLNVAL+CTS FPINRPSMRRVVELL+
Sbjct: 923 GDIGGGKDYIMSQIVDPRLNPATCDYEEIEKVLNVALLCTSAFPINRPSMRRVVELLKDH 982
Query: 970 KSS 972
K S
Sbjct: 983 KLS 985
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297794181|ref|XP_002864975.1| hypothetical protein ARALYDRAFT_496808 [Arabidopsis lyrata subsp. lyrata] gi|297310810|gb|EFH41234.1| hypothetical protein ARALYDRAFT_496808 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1141 bits (2952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 585/977 (59%), Positives = 726/977 (74%), Gaps = 26/977 (2%)
Query: 19 CFSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQ-QSPCNWTGITCETQNQS---V 74
CF L +S +GDAEIL RVK +L DP+ L DWV T +SPCNWTGITC+ + S V
Sbjct: 19 CF-LQVSSNGDAEILSRVKKTRLFDPDGNLQDWVITGDNRSPCNWTGITCDIRKGSSLAV 77
Query: 75 DGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFI 134
IDLSG+++SGGFP GFCRIRTL N+ LS N NGT+ S LS C +QVL L+ N F
Sbjct: 78 TAIDLSGYNISGGFPYGFCRIRTLINITLSQNNLNGTIDSGPLSLCSKIQVLILNVNNFS 137
Query: 135 GELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTE 194
G+LP+FS +F NL+VL+L N F+G+IP+S+GRF L+VLNL GN LSG++P+FLGNLTE
Sbjct: 138 GKLPEFSPDFRNLRVLELESNLFTGEIPQSYGRFNALQVLNLNGNPLSGIVPAFLGNLTE 197
Query: 195 LTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL 254
LT +L Y S P+PS+ GNL+ L L +NL+GEIPDSI L L NLDL+ N L
Sbjct: 198 LTRLDLAYISFDSGPIPSTFGNLTNLTELRLTHSNLVGEIPDSIMNLVLLENLDLAMNGL 257
Query: 255 SGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS 314
+G+IP S L S+ QIEL+DN+LSG+LPES+ NLT L D+SQNNLTG LPE IAA+
Sbjct: 258 TGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQ 317
Query: 315 LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT 374
L S NLNDN+FTGE+P+ +A NPNLV+ K+FNNSF+G LP +LGK+S L DVSTN FT
Sbjct: 318 LISFNLNDNFFTGELPDIVALNPNLVEFKIFNNSFTGTLPSNLGKFSELSEIDVSTNRFT 377
Query: 375 GELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPE 434
GELP +LC+R KLQ II F+N+ SG+IPE+YG+C +LNY+R N+L GE+P++FW LP
Sbjct: 378 GELPPYLCYRRKLQKIITFSNQLSGEIPEAYGDCHSLNYIRMADNKLSGEVPARFWELPL 437
Query: 435 VDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFS 494
NN+ EGSI PSIS A L+ + I+ NNF+G +P +IC LR L+ +DLS+NRFS
Sbjct: 438 TRLELANNNQLEGSIPPSISKARHLSQLEISDNNFSGVIPVKICDLRDLRVIDLSRNRFS 497
Query: 495 GHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAV 554
G LP CI +L L++LE+QENM GE+P +++S T L LNLS N+L G IPPELG+L V
Sbjct: 498 GPLPPCINKLKNLERLEMQENMLDGEIPSSVSSCTELAELNLSNNRLRGGIPPELGDLPV 557
Query: 555 LTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSP 614
L LDLS+N LTGEIP EL +LKLNQFN+S NKLYG++PS F D+F S L NP LC+P
Sbjct: 558 LNYLDLSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAP 617
Query: 615 DLKPLPPCSKTKPGTIYIVVILSICVILLVGSLVWFF-KVKSGFFSTSKSPWKVVTFQRV 673
+L P+ PC ++KP T YI+VI IC++ L G+LVW F K K F K K+ FQRV
Sbjct: 618 NLDPIRPC-RSKPETRYILVISIICIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRV 676
Query: 674 SFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGT-HKPETETVFRSEIE 732
F E+DI P LTE N+IGSGGS VY+VKLKSG+T+AVK+L GG KPE+E+ FRSE+E
Sbjct: 677 GFTEEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGGPGQKPESESFFRSEVE 736
Query: 733 TLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH---EKGRSGSLDWSIRFSIA 789
TLGR+RHGN+VKLLMCC+G++F LVYE+M NGSL D+LH E LDW+ RFSIA
Sbjct: 737 TLGRLRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIA 796
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL--QSQEGQSD-DA 846
GAA+GL+YLH+D VP +VHRDVKS+NILLD EM PRVADFGLAK+L + +G SD
Sbjct: 797 VGAAQGLSYLHHDSVPPVVHRDVKSNNILLDHEMKPRVADFGLAKSLNREDNDGVSDVSP 856
Query: 847 MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906
MSCVAGSYGYIAPEY YT KV EKSDVYSFGVVL+EL+TGKRPND SFGENKDIV++ E
Sbjct: 857 MSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAME 916
Query: 907 ATLSSP------------ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPI 954
A L P G RDL++++DP+M LST +YEE EKVL+VAL+CTS FPI
Sbjct: 917 AALCYPSPSAEYGAMNQDSPGNYRDLSKIVDPKMKLSTREYEEIEKVLDVALLCTSSFPI 976
Query: 955 NRPSMRRVVELLRVDKS 971
NRP+MR+VVELL+ KS
Sbjct: 977 NRPTMRKVVELLKEKKS 993
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30698151|ref|NP_201372.2| LRR receptor-like serine/threonine-protein kinase HSL2 [Arabidopsis thaliana] gi|259491355|sp|C0LGX3.1|HSL2_ARATH RecName: Full=LRR receptor-like serine/threonine-protein kinase HSL2; AltName: Full=Protein HAESA-LIKE2; Flags: Precursor gi|224589753|gb|ACN59408.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010710|gb|AED98093.1| LRR receptor-like serine/threonine-protein kinase HSL2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1124 bits (2907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 574/971 (59%), Positives = 718/971 (73%), Gaps = 24/971 (2%)
Query: 24 ISLHGDAEILIRVKSDQLDDPNRKLGDWVRT-SQQSPCNWTGITCETQNQS---VDGIDL 79
+S +GDAEIL RVK +L DP+ L DWV T +SPCNWTGITC + S V IDL
Sbjct: 22 VSSNGDAEILSRVKKTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDL 81
Query: 80 SGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD 139
SG+++SGGFP GFCRIRTL N+ LS N NGT+ S LS C LQ L L+ N F G+LP+
Sbjct: 82 SGYNISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPE 141
Query: 140 FSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFE 199
FS EF L+VL+L N F+G+IP+S+GR L+VLNL GN LSG++P+FLG LTELT +
Sbjct: 142 FSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLD 201
Query: 200 LGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP 259
L Y SP+PS++GNLS L +L +NL+GEIPDSI L L NLDL+ N L+G+IP
Sbjct: 202 LAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIP 261
Query: 260 HSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLN 319
S L S+ QIEL+DN+LSG+LPES+ NLT L D+SQNNLTG LPE IAA+ L S N
Sbjct: 262 ESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFN 321
Query: 320 LNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPR 379
LNDN+FTG +P+ +A NPNLV+ K+FNNSF+G LP +LGK+S + FDVSTN F+GELP
Sbjct: 322 LNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPP 381
Query: 380 FLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFE 439
+LC+R KLQ II F+N+ SG+IPESYG+C +LNY+R N+L GE+P++FW LP
Sbjct: 382 YLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLEL 441
Query: 440 MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT 499
NN+ +GSI PSIS A L+ + I+ NNF+G +P ++C LR L+ +DLS+N F G +P+
Sbjct: 442 ANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPS 501
Query: 500 CITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLD 559
CI +L L+++E+QENM GE+P +++S T L LNLS N+L G IPPELG+L VL LD
Sbjct: 502 CINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLD 561
Query: 560 LSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPL 619
LS+N LTGEIP EL +LKLNQFN+S NKLYG++PS F D+F S L NP LC+P+L P+
Sbjct: 562 LSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPI 621
Query: 620 PPCSKTKPGTIYIVVILSICVILLVGSLVWFF-KVKSGFFSTSKSPWKVVTFQRVSFNED 678
PC ++K T YI+ I +C++ L G+LVW F K K F K K+ FQRV F E+
Sbjct: 622 RPC-RSKRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFTEE 680
Query: 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGT-HKPETETVFRSEIETLGRV 737
DI P LTE N+IGSGGS VY+VKLKSG+T+AVK+L G T K E+E+VFRSE+ETLGRV
Sbjct: 681 DIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRV 740
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH---EKGRSGSLDWSIRFSIAQGAAK 794
RHGN+VKLLMCC+G++F LVYE+M NGSL D+LH E LDW+ RFSIA GAA+
Sbjct: 741 RHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQ 800
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ--EGQSDDAMSCVAG 852
GL+YLH+D VP IVHRDVKS+NILLD EM PRVADFGLAK L+ + +G SD +MSCVAG
Sbjct: 801 GLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAG 860
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912
SYGYIAPEY YT KV EKSDVYSFGVVL+EL+TGKRPND SFGENKDIV++ EA L P
Sbjct: 861 SYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYP 920
Query: 913 ER------------GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960
G RDL++L+DP+M LST +YEE EKVL+VAL+CTS FPINRP+MR
Sbjct: 921 SPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMR 980
Query: 961 RVVELLRVDKS 971
+VVELL+ KS
Sbjct: 981 KVVELLKEKKS 991
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|2827714|emb|CAA16687.1| receptor protein kinase - like protein [Arabidopsis thaliana] gi|10177329|dbj|BAB10678.1| receptor protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1099 bits (2842), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 567/971 (58%), Positives = 708/971 (72%), Gaps = 41/971 (4%)
Query: 24 ISLHGDAEILIRVKSDQLDDPNRKLGDWVRT-SQQSPCNWTGITCETQNQS---VDGIDL 79
+S +GDAEIL RVK +L DP+ L DWV T +SPCNWTGITC + S V IDL
Sbjct: 22 VSSNGDAEILSRVKKTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDL 81
Query: 80 SGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD 139
SG+++SGGFP GFCRIRTL N+ LS N NGT+ S LS C LQ L L+ N F G+LP+
Sbjct: 82 SGYNISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPE 141
Query: 140 FSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFE 199
FS EF L+VL+L N F+G+IP+S+GR L+VLNL GN LSG++P+FLG LTELT +
Sbjct: 142 FSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLD 201
Query: 200 LGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP 259
L Y SP+PS++GNLS L +L +NL+GEIPDSI L L NLDL+ N L+G+IP
Sbjct: 202 LAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIP 261
Query: 260 HSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLN 319
S L S+ QIEL+DN+LSG+LPES+ NLT L D+SQNNLTG LPE IAA+ L S N
Sbjct: 262 ESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFN 321
Query: 320 LNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPR 379
LNDN+FTG +P+ +A NPNLV+ K+FNNSF+G LP +LGK+S + FDVSTN F+GELP
Sbjct: 322 LNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPP 381
Query: 380 FLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFE 439
+LC+R KLQ II F+N+ SG+IPESYG+C +LNY+R N+L GE+P++FW LP
Sbjct: 382 YLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLEL 441
Query: 440 MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT 499
NN+ +GSI PSIS A L+ + I+ NNF+G +P ++C LR L+ +DLS+N F G +P+
Sbjct: 442 ANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPS 501
Query: 500 CITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLD 559
CI +L L+++E+QENM GE+P +++S T L LNLS N+L G IPPELG+L VL LD
Sbjct: 502 CINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLD 561
Query: 560 LSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPL 619
LS+N LTGEIP EL +LKLNQFN+S NKLYG NP LC+P+L P+
Sbjct: 562 LSNNQLTGEIPAELLRLKLNQFNVSDNKLYG-----------------NPNLCAPNLDPI 604
Query: 620 PPCSKTKPGTIYIVVILSICVILLVGSLVWFF-KVKSGFFSTSKSPWKVVTFQRVSFNED 678
PC ++K T YI+ I +C++ L G+LVW F K K F K K+ FQRV F E+
Sbjct: 605 RPC-RSKRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFTEE 663
Query: 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGT-HKPETETVFRSEIETLGRV 737
DI P LTE N+IGSGGS VY+VKLKSG+T+AVK+L G T K E+E+VFRSE+ETLGRV
Sbjct: 664 DIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRV 723
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH---EKGRSGSLDWSIRFSIAQGAAK 794
RHGN+VKLLMCC+G++F LVYE+M NGSL D+LH E LDW+ RFSIA GAA+
Sbjct: 724 RHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQ 783
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ--EGQSDDAMSCVAG 852
GL+YLH+D VP IVHRDVKS+NILLD EM PRVADFGLAK L+ + +G SD +MSCVAG
Sbjct: 784 GLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAG 843
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912
SYGYIAPEY YT KV EKSDVYSFGVVL+EL+TGKRPND SFGENKDIV++ EA L P
Sbjct: 844 SYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYP 903
Query: 913 ER------------GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960
G RDL++L+DP+M LST +YEE EKVL+VAL+CTS FPINRP+MR
Sbjct: 904 SPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMR 963
Query: 961 RVVELLRVDKS 971
+VVELL+ KS
Sbjct: 964 KVVELLKEKKS 974
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482445|ref|XP_003611509.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355512844|gb|AES94467.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1097 bits (2838), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 575/1049 (54%), Positives = 723/1049 (68%), Gaps = 88/1049 (8%)
Query: 7 KSLIALLFSFLLCFSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGIT 66
K + LLFS + SL D EIL+ VK+ Q+DD N+ L DW+ + +PCNW GIT
Sbjct: 3 KLIFILLFSLVCSNGTTFSLSRDYEILLHVKNTQIDDKNKSLNDWLPNTDHNPCNWRGIT 62
Query: 67 CETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVL 126
C+++N+SV IDL+ + G FP+ FC I TL+NL+L+ N+ +SS S+ PC HL L
Sbjct: 63 CDSRNKSVVSIDLTETGIYGDFPSNFCHIPTLQNLSLATNFLGNAISSHSMLPCSHLHFL 122
Query: 127 ALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGR------------------- 167
+ N+F+G LPDF+ E L+VLD + NNFSGDIP SFGR
Sbjct: 123 NISDNLFVGALPDFNSEIFELRVLDATGNNFSGDIPASFGRLPKLNVLNLSNNLFTGDIP 182
Query: 168 -----FPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN-PLKSSPLPSSVGNLSKLE 221
FP LKVL L GNL +G IPSFLGNL+ELT+FEL + +K PLPS +GNL+KLE
Sbjct: 183 VSLGQFPQLKVLILSGNLFTGTIPSFLGNLSELTYFELAHTESMKPGPLPSELGNLTKLE 242
Query: 222 NLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGE 281
L+ A NLIG IPDSIG L + N DLS N LSGKIP + S + +EQIEL++N LSGE
Sbjct: 243 FLYLANINLIGSIPDSIGNLISIKNFDLSQNSLSGKIPETISCMKDLEQIELYNNNLSGE 302
Query: 282 LPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQ 341
+P+ L+NL L LD+SQN LTG L E IAAM+L L+LNDN+ +GE+PESLASN NL
Sbjct: 303 IPQGLTNLPNLFLLDLSQNALTGKLSEEIAAMNLSILHLNDNFLSGEVPESLASNSNLKD 362
Query: 342 LKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKI 401
LKLFNNSFSGKLP DLGK S+++ DVSTN+F GELP+FLC + KLQ ++ F NRFSG +
Sbjct: 363 LKLFNNSFSGKLPKDLGKNSSIQELDVSTNNFIGELPKFLCQKKKLQRLVTFKNRFSGPM 422
Query: 402 PESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTG 461
P YGEC +L+Y+R NE G +P +FW LP+++ M +N+FEGS+S SIS A +
Sbjct: 423 PNEYGECDSLHYVRIENNEFSGSVPPRFWNLPKLNTVIMDHNKFEGSVSSSISRAKGIEK 482
Query: 462 ILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGEL 521
+++ GN F+GE P+ +C +L +D+ NRF+G +PTCIT L KLQ+L++QENMFTG++
Sbjct: 483 LVLAGNRFSGEFPAGVCEHVELVLIDIGNNRFTGEVPTCITGLKKLQKLKMQENMFTGKI 542
Query: 522 PRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQF 581
P N+ S T L LNLS N L+ +IPPELG L L LDLS N LTG+IP+ELT LKLNQF
Sbjct: 543 PGNVTSWTELTELNLSHNLLSSSIPPELGKLPDLIYLDLSVNSLTGKIPVELTNLKLNQF 602
Query: 582 NISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSKTKPGTIYIVVILSICVI 641
++S NKL GEVPS F+H++++S L+ NPGLCS +K L PCSK + ++ +V+LS ++
Sbjct: 603 DVSDNKLSGEVPSGFNHEVYLSGLMGNPGLCSNVMKTLNPCSKHRRFSVVAIVVLSAILV 662
Query: 642 LLVGSLVWFFKVKS-GFFSTSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYK 700
L+ S++WF K KS F SK + FQRV FNE+DI+P LT +NLIG GGS +VYK
Sbjct: 663 LIFLSVLWFLKKKSKSFVGKSKRAFMTTAFQRVGFNEEDIVPFLTNENLIGRGGSGQVYK 722
Query: 701 VKLKSGETVAVKRLL-GGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759
VK+K+G+ VAVK+L GGTHKP+TE+ F+SEIETLGR+RH N+VKLL CCS DF ILVY
Sbjct: 723 VKVKTGQIVAVKKLWGGGTHKPDTESEFKSEIETLGRIRHANIVKLLFCCSCDDFRILVY 782
Query: 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819
E+M NGSL D+LHE G+ LDWS RF IA GAAKGLAYLH+DCVPAIVHRDVKS+NILL
Sbjct: 783 EFMENGSLGDVLHE-GKFVELDWSKRFGIALGAAKGLAYLHHDCVPAIVHRDVKSNNILL 841
Query: 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP-------------------- 859
D + VPRVADFGLAK LQ EG ++ AMS VAGSYGYIAP
Sbjct: 842 DHDFVPRVADFGLAKTLQ-HEG-NEGAMSRVAGSYGYIAPAHILLGVSRCRGYVSCQTPN 899
Query: 860 -----------------------------EYAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890
+Y YT KVTEKSDVYS+GVVLMEL+TGKRPN
Sbjct: 900 GLYDYIELCYFLILLFVSMYLCRIWCVCLKYGYTLKVTEKSDVYSYGVVLMELITGKRPN 959
Query: 891 DPSFGENKDIVRWVTEATLSSPERGCCRD---------LNQLIDPRMDLSTCDYEEAEKV 941
D FGENKDIV+WVTE LS+ G + Q++DPR++L TCDYEE EKV
Sbjct: 960 DSCFGENKDIVKWVTEIALSTTHEGGGSGNIGRGYDCVITQIVDPRLNLDTCDYEEVEKV 1019
Query: 942 LNVALMCTSDFPINRPSMRRVVELLRVDK 970
LNVAL+CTS FPI+RPSMR+VVELL+ K
Sbjct: 1020 LNVALLCTSAFPISRPSMRKVVELLKDQK 1048
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432972|ref|XP_004134272.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase HSL2-like [Cucumis sativus] gi|449478276|ref|XP_004155271.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase HSL2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1097 bits (2838), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 560/955 (58%), Positives = 700/955 (73%), Gaps = 2/955 (0%)
Query: 21 SLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLS 80
+ AI D +ILIRVK+ L DPN + +WV + CNWTGITC++ N S+ IDLS
Sbjct: 25 AFAILSDRDYDILIRVKTSYLHDPNGSINNWVPNQAHNACNWTGITCDSTNSSILSIDLS 84
Query: 81 GFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDF 140
GGFP FCRI TL++L++S+ NGTL S S S C HLQ+L L N+ +G LPDF
Sbjct: 85 NSGFVGGFPFVFCRIPTLKSLSISNTNLNGTLLSPSFSLCSHLQLLNLSNNLLVGNLPDF 144
Query: 141 SREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFEL 200
S F LQ LDLS NNF+G+IP S G LKVL L NLL G +PS LGNL+ELT +
Sbjct: 145 SSGFKQLQTLDLSANNFTGEIPHSIGGLSALKVLRLTQNLLDGSLPSVLGNLSELTEMAI 204
Query: 201 GYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPH 260
YNP K PLP +GNL+KL N++ + LIG +PDSIG LA L+NLDLS N +SG IP+
Sbjct: 205 AYNPFKPGPLPPEIGNLTKLVNMFLPSSKLIGPLPDSIGNLALLTNLDLSANSISGPIPY 264
Query: 261 SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNL 320
S GL SI+ I L++NQ+SGELPES+ NLTTL LD+SQN+LTG L E IAA+ L+SL+L
Sbjct: 265 SIGGLRSIKSIRLYNNQISGELPESIGNLTTLFSLDLSQNSLTGKLSEKIAALPLQSLHL 324
Query: 321 NDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRF 380
NDN+ GE+PE+LASN NL+ LKLFNNSFSGKLP +LG S L FDVS+N+F GE+P+F
Sbjct: 325 NDNFLEGEVPETLASNKNLLSLKLFNNSFSGKLPWNLGLTSYLNLFDVSSNNFMGEIPKF 384
Query: 381 LCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEM 440
LC N+LQ I++FNN FSG PE+YG C +L Y+R N+L G++P FW L + + +
Sbjct: 385 LCHGNQLQRIVLFNNHFSGSFPEAYGGCDSLLYVRIENNQLSGQIPDSFWNLSRLTYIRI 444
Query: 441 YNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTC 500
NRFEGSI +IS L ++I+GN F+G++P +IC LR L +D+S+N+FSG +P+C
Sbjct: 445 SENRFEGSIPLAISGIRYLQDLVISGNFFSGQLPKEICKLRDLVRLDVSRNKFSGGVPSC 504
Query: 501 ITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDL 560
IT+L +LQ+L+LQENMFT E+P+ +N+ L LNLS NQ TG IPP+LG+L VL LDL
Sbjct: 505 ITELKQLQKLDLQENMFTREIPKLVNTWKELTELNLSHNQFTGEIPPQLGDLPVLKYLDL 564
Query: 561 SSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLP 620
SSNLL+GEIP ELTKLKL QFN S NKL GEVPS FD++LF++SL+ NPGLCSPDLKPL
Sbjct: 565 SSNLLSGEIPEELTKLKLGQFNFSDNKLTGEVPSGFDNELFVNSLMGNPGLCSPDLKPLN 624
Query: 621 PCSKTKPGTIYIVVILSICVILLVGSLVWFFKVKSGFFSTSKSPWKVVTFQRVSFNEDDI 680
CSK+K + YIV++LS+ +L+GSL+W K K F SKS W V FQRV F+E+D+
Sbjct: 625 RCSKSKSISFYIVIVLSLIAFVLIGSLIWVVKFKMNLFKKSKSSWMVTKFQRVGFDEEDV 684
Query: 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG 740
+PHLT+ N+IGSGGS V+KV LK G+TVAVK L G +K + E++F+SE+ETLGR+RH
Sbjct: 685 IPHLTKANIIGSGGSSTVFKVDLKMGQTVAVKSLWSGHNKLDLESIFQSEVETLGRIRHA 744
Query: 741 NVVKLLMCCS-GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL 799
N+VKLL CS G+ ILVYEYM NGSL D LHE DWS R IA GAA+GLAYL
Sbjct: 745 NIVKLLFSCSNGEGSKILVYEYMENGSLGDALHEHKSQTLSDWSKRLDIAIGAAQGLAYL 804
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ-EGQSDDAMSCVAGSYGYIA 858
H+DCVP I+HRDVKS+NILLD E PRVADFGLAK +Q Q E + + MS +AGSYGYIA
Sbjct: 805 HHDCVPPIIHRDVKSNNILLDEEFHPRVADFGLAKTMQRQGEAEDGNVMSRIAGSYGYIA 864
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918
PEY YT KVTEKSDVYSFGVVLMELVTGKRPND FGENKDIV+W+TE +LS +
Sbjct: 865 PEYGYTMKVTEKSDVYSFGVVLMELVTGKRPNDACFGENKDIVKWMTEISLSECDEENGL 924
Query: 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKSSH 973
L +++D ++D TC EE K+L+VA++CTS P+NRPSMRRVVELL+ K H
Sbjct: 925 SLEEIVDEKLDPKTCVVEEIVKILDVAILCTSALPLNRPSMRRVVELLKDTKLPH 979
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|104642235|gb|ABF73316.1| clavata-like receptor [Picea glauca] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2196), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/978 (47%), Positives = 619/978 (63%), Gaps = 29/978 (2%)
Query: 12 LLFSFLLCFSLAISLHGDAEILIRVKSDQ-LDDPNRKLGDWVRTSQQSPCNWTGITCETQ 70
L F +L S ++ G E LI + + DDP +W SPCNWTGITC+
Sbjct: 10 LFFCIILTISSCFAIRGSQEGLILQELKRGFDDPLEVFRNW-NEHDNSPCNWTGITCDAG 68
Query: 71 NQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDY 130
+ V+ +DLS ++ G FP+ CRI L+ L L+DNY NG++ + L C L L L
Sbjct: 69 EKFVEEVDLSNTNIIGPFPSVVCRIDGLKKLPLADNYVNGSIPAD-LRRCRKLGYLDLSQ 127
Query: 131 NVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLG 190
++ +G LPDF E + L+ LDLS NN SG IP +FG+ L+VLNL NLL+ IP FLG
Sbjct: 128 SLIVGGLPDFISELSRLRHLDLSGNNLSGPIPPAFGQLLELQVLNLVFNLLNTTIPPFLG 187
Query: 191 NLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLS 250
NL L F L YNP + +P +GNL+KL+NLW A NL+GEIP+++G LA L+NLDLS
Sbjct: 188 NLPNLLQFNLAYNPFTGT-VPPELGNLTKLQNLWLAGCNLVGEIPETLGNLAELTNLDLS 246
Query: 251 DNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETI 310
N LSG IP S + L + QIEL+ N LSG +P ++ L L R D S N L G++P +
Sbjct: 247 INRLSGSIPESITKLDKVAQIELYQNLLSGPIPVAMGELKALKRFDASMNMLNGSIPAGL 306
Query: 311 AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVST 370
+++LESLNL N GEIP L S +L +LKLF+N +G+LP+ LG+YS+L+ D++
Sbjct: 307 GSLNLESLNLYQNDLVGEIPPGLGSFASLTELKLFSNRLTGRLPESLGRYSDLQALDIAD 366
Query: 371 NDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFW 430
N +G LP LC KL+ + IFNN F+G IPES G C +LN +R GGN+ G +PS FW
Sbjct: 367 NLLSGSLPPDLCKNKKLEILSIFNNVFAGNIPESLGTCTSLNRVRLGGNKFNGSVPSSFW 426
Query: 431 GLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490
GLP + E+ +N FEG ISP I+NA L+ ++INGN FTG +P++I LR L + S
Sbjct: 427 GLPHISLLELKDNNFEGLISPDIANAKCLSQLVINGNTFTGSLPTEIGELRNLSEIIASN 486
Query: 491 NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELG 550
N +G LP + +L +L +L+L N +GELP ++S L +NLS NQ +G+IP +G
Sbjct: 487 NFLTGALPPSVGKLQQLGKLDLSNNQLSGELPAEISSCKQLGEINLSKNQFSGSIPASVG 546
Query: 551 NLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPG 610
L VL LDLS NLLTG IP E LKLN F++S+N+L G VP F + ++ S L NP
Sbjct: 547 TLPVLNYLDLSDNLLTGLIPSEFGNLKLNTFDVSNNRLSGAVPLAFANPVYEKSFLGNPE 606
Query: 611 LCSPD-LKPLPPCS-------KTKPGTIYIVVILSICVILLVGSLVWFFKVKSGFF---- 658
LCS + CS K + + + ++ +I+ V L WF++ F
Sbjct: 607 LCSREAFNGTKSCSEERSERAKRQSWWWLLRCLFALSIIIFVLGLAWFYRRYRNFANAER 666
Query: 659 --STSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLG 716
S KS W + +F R+ F+E +IL L E N+I S G+ VYK L +GE +A+KRL
Sbjct: 667 KKSVDKSSWMLTSFHRLRFSEYEILDCLDEDNVIVSDGASNVYKATLNNGELLAIKRLWS 726
Query: 717 -GTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKG 775
+ F++E++TLG++RH N+VKL CCS D N+LVYEYMPNGSL D+LH
Sbjct: 727 IYKTNASNDNGFQAEVDTLGKIRHKNIVKLWCCCSKSDSNLLVYEYMPNGSLGDLLHGP- 785
Query: 776 RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835
++ LDW IR+ IA GAA+GLAYLH+ CVPAIVHRDVKS+NILLD + V VADFG+AK
Sbjct: 786 KASVLDWPIRYKIALGAAQGLAYLHHGCVPAIVHRDVKSNNILLDEDYVAHVADFGVAKI 845
Query: 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG 895
LQS + D+MS +AGSYGYIAPEYAYT KV EKSD+YSFGVV++ELVTG+RP DP FG
Sbjct: 846 LQSC-ARGADSMSAIAGSYGYIAPEYAYTLKVNEKSDIYSFGVVILELVTGRRPVDPEFG 904
Query: 896 ENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN 955
ENKD+V+W+ L++++DP+ L C EE V+ V L+CTS PIN
Sbjct: 905 ENKDLVKWLCNKIEKK------NGLHEVLDPK--LVDCFKEEMTMVMRVGLLCTSVLPIN 956
Query: 956 RPSMRRVVELLRVDKSSH 973
RPSMRRVVE+L+ H
Sbjct: 957 RPSMRRVVEMLQEANPHH 974
|
Source: Picea glauca Species: Picea glauca Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | ||||||
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.909 | 0.891 | 0.557 | 8.2e-257 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.949 | 0.927 | 0.434 | 5.4e-205 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.947 | 0.922 | 0.418 | 9.8e-190 | |
| TAIR|locus:2091206 | 991 | IKU2 "HAIKU2" [Arabidopsis tha | 0.628 | 0.617 | 0.322 | 5.5e-156 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.607 | 0.583 | 0.334 | 3.6e-150 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.944 | 0.917 | 0.367 | 4.2e-150 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.935 | 0.907 | 0.365 | 1.6e-148 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.601 | 0.589 | 0.325 | 2.2e-148 | |
| TAIR|locus:2207036 | 977 | AT1G72180 [Arabidopsis thalian | 0.505 | 0.503 | 0.35 | 3.3e-147 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.604 | 0.571 | 0.340 | 6.7e-147 |
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2472 (875.2 bits), Expect = 8.2e-257, P = 8.2e-257
Identities = 500/897 (55%), Positives = 620/897 (69%)
Query: 27 HGDAEILIRVKSDQLDDPNRKLGDWVRTSQ-QSPCNWTGITCETQNQS---VDGIDLSGF 82
+GDAEIL RVK +L DP+ L DWV T +SPCNWTGITC + S V IDLSG+
Sbjct: 25 NGDAEILSRVKKTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGY 84
Query: 83 DLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSR 142
++SGGFP GFCRIRTL N+ LS N NGT+ S LS C LQ L L+ N F G+LP+FS
Sbjct: 85 NISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPEFSP 144
Query: 143 EFANLQVLDLSRNNFSGDIPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFELGY 202
EF L+VL+L N F+G+IP+S+GR L+V +P+FLG LTELT +L Y
Sbjct: 145 EFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAY 204
Query: 203 NPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAXXXXXXXXXXXXXGKIPHSF 262
SP+PS++GNLS L +L +NL+GEIPDSI L G+IP S
Sbjct: 205 ISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESI 264
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322
L S+ QIEL+DN+LSG+LPES+ NLT L D+SQNNLTG LPE IAA+ L S NLND
Sbjct: 265 GRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFNLND 324
Query: 323 NYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLC 382
N+FTG +P+ +A NPNLV+ K+FNNSF+G LP +LGK+S + FDVSTN F+GELP +LC
Sbjct: 325 NFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLC 384
Query: 383 FRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYN 442
+R KLQ II F+N+ SG+IPESYG+C +LNY+R N+L GE+P++FW LP N
Sbjct: 385 YRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANN 444
Query: 443 NRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCIT 502
N+ +GSI PSIS A L+ + I+ NNF+G +P ++C LR L+ +DLS+N F G +P+CI
Sbjct: 445 NQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCIN 504
Query: 503 XXXXXXXXXXXXXMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXXX 562
M GE+P +++S T L LNLS N+L G IPPELG+L V
Sbjct: 505 KLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSN 564
Query: 563 XXXXGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPC 622
GEIP EL +LKLNQFN+S NKLYG++PS F D+F S L NP LC+P+L P+ PC
Sbjct: 565 NQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPC 624
Query: 623 SKTKPGTXXXXXXXXXXXXXXXXXXXWFF-KVKSGFFSTSKSPWKVVTFQRVSFNEDDIL 681
++K T W F K K F K K+ FQRV F E+DI
Sbjct: 625 -RSKRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFTEEDIY 683
Query: 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHG 740
P LTE N+IGSGGS VY+VKLKSG+T+AVK+L G T K E+E+VFRSE+ETLGRVRHG
Sbjct: 684 PQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHG 743
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLH-EKG-RSGS-LDWSIRFSIAQGAAKGLA 797
N+VKLLMCC+G++F LVYE+M NGSL D+LH EK R+ S LDW+ RFSIA GAA+GL+
Sbjct: 744 NIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLS 803
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE--GQSDDAMSCVAGSYG 855
YLH+D VP IVHRDVKS+NILLD EM PRVADFGLAK L+ ++ G SD +MSCVAGSYG
Sbjct: 804 YLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYG 863
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912
YIAPEY YT KV EKSDVYSFGVVL+EL+TGKRPND SFGENKDIV++ EA L P
Sbjct: 864 YIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYP 920
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1983 (703.1 bits), Expect = 5.4e-205, P = 5.4e-205
Identities = 416/957 (43%), Positives = 579/957 (60%)
Query: 29 DAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGF 88
D IL +VK LDDP+ L W ++ SPC W+G++C SV +DLS +L+G F
Sbjct: 19 DGFILQQVKLS-LDDPDSYLSSW-NSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPF 76
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
P+ CR+ L +L+L +N N TL +++ C LQ L L N+ GELP + L
Sbjct: 77 PSVICRLSNLAHLSLYNNSINSTLPL-NIAACKSLQTLDLSQNLLTGELPQTLADIPTLV 135
Query: 149 VLDLSRNNFSGDIPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFELGYNPLKSS 208
LDL+ NNFSGDIP SFG+F L+V IP FLGN++ L L YNP S
Sbjct: 136 HLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPS 195
Query: 209 PLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAXXXXXXXXXXXXXGKIPHSFSGLASI 268
+P GNL+ LE +W + +L+G+IPDS+G+L+ G IP S GL ++
Sbjct: 196 RIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNV 255
Query: 269 EQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGE 328
QIEL++N L+GE+P L NL +L LD S N LTG +P+ + + LESLNL +N GE
Sbjct: 256 VQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVPLESLNLYENNLEGE 315
Query: 329 IPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQ 388
+P S+A +PNL ++++F N +G LP DLG S L + DVS N+F+G+LP LC + +L+
Sbjct: 316 LPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELE 375
Query: 389 CIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGS 448
++I +N FSG IPES +C++L +R N G +P+ FWGLP V+ E+ NN F G
Sbjct: 376 ELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGE 435
Query: 449 ISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITXXXXXX 508
IS SI A L+ ++++ N FTG +P +I +L L + S N+FSG LP +
Sbjct: 436 ISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELG 495
Query: 509 XXXXXXXMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXXXXXXXGE 568
F+GEL + S L LNL+ N+ TG IP E+G+L+V G+
Sbjct: 496 TLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGK 555
Query: 569 IPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSP--DLKPLPPCSKTK 626
IP+ L LKLNQ N+S+N+L G++P D++ +S + NPGLC L +K +
Sbjct: 556 IPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGDIKGLCGSENEAKKR 615
Query: 627 PGTXXXXXXXXXXXXXXXXXXXWF-FKVKS--GFFSTSKSPWKVVTFQRVSFNEDDILPH 683
WF FK ++ + +S W +++F ++ F+E +IL
Sbjct: 616 GYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILES 675
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK------PET-------ETVFRSE 730
L E N+IG+G S +VYKV L +GETVAVKRL G+ K PE + F +E
Sbjct: 676 LDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAE 735
Query: 731 IETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ 790
+ETLG++RH N+VKL CCS +D +LVYEYMPNGSL D+LH + G L W RF I
Sbjct: 736 VETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSS-KGGMLGWQTRFKIIL 794
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV 850
AA+GL+YLH+D VP IVHRD+KS+NIL+D + RVADFG+AKA+ G++ +MS +
Sbjct: 795 DAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLT-GKAPKSMSVI 853
Query: 851 AGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910
AGS GYIAPEYAYT +V EKSD+YSFGVV++E+VT KRP DP GE KD+V+WV +TL
Sbjct: 854 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGE-KDLVKWVC-STLD 911
Query: 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
++G + +IDP++D +C EE K+LNV L+CTS PINRPSMRRVV++L+
Sbjct: 912 --QKG----IEHVIDPKLD--SCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQ 960
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1839 (652.4 bits), Expect = 9.8e-190, P = 9.8e-190
Identities = 401/959 (41%), Positives = 562/959 (58%)
Query: 29 DAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGF 88
DA IL + K L DP + L W + +PC W G++C+ + V +DLS F L G F
Sbjct: 24 DATILRQAKLG-LSDPAQSLSSWSDNNDVTPCKWLGVSCDATSNVVS-VDLSSFMLVGPF 81
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELP-DFSREFANL 147
P+ C + +L +L+L +N NG+LS+ C +L L L N+ +G +P NL
Sbjct: 82 PSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNL 141
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFELGYNPLKS 207
+ L++S NN S IP SFG F L+ IP+ LGN+T L +L YN
Sbjct: 142 KFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNLFSP 201
Query: 208 SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAXXXXXXXXXXXXXGKIPHSFSGLAS 267
S +PS +GNL++L+ LW A NL+G IP S+ +L G IP + L +
Sbjct: 202 SQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKT 261
Query: 268 IEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTG 327
+EQIELF+N SGELPES+ N+TTL R D S N LTG +P+ + ++LESLNL +N G
Sbjct: 262 VEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESLNLFENMLEG 321
Query: 328 EIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKL 387
+PES+ + L +LKLFNN +G LP LG S L+Y D+S N F+GE+P +C KL
Sbjct: 322 PLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKL 381
Query: 388 QCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEG 447
+ +I+ +N FSG+I + G+CK+L +R N+L G++P FWGLP + E+ +N F G
Sbjct: 382 EYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTG 441
Query: 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITXXXXX 507
SI +I A L+ + I+ N F+G +P++I +L + + ++N FSG +P +
Sbjct: 442 SIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQL 501
Query: 508 XXXXXXXXMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXXXXXXXG 567
+GE+PR L L LNL+ N L+G IP E+G L V G
Sbjct: 502 SRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSG 561
Query: 568 EIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSK-TK 626
EIPLEL LKLN N+S+N L G++P + + ++ + NPGLC DL L C K T+
Sbjct: 562 EIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCV-DLDGL--CRKITR 618
Query: 627 P---GTXXXXXXXXXXXXXXXXXXXWFF-----KVKSGFFST-SKSPWKVVTFQRVSFNE 677
G F K+++ ST + S W+ +F ++ F+E
Sbjct: 619 SKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWR--SFHKLHFSE 676
Query: 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRL----LGGTHKPETET----VFRS 729
+I L E+N+IG G S +VYKV+L+ GE VAVK+L GG + +++ VF +
Sbjct: 677 HEIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVFAA 736
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS-LDWSIRFSI 788
E+ETLG +RH ++V+L CCS D +LVYEYMPNGSLAD+LH + G L W R I
Sbjct: 737 EVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRI 796
Query: 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS 848
A AA+GL+YLH+DCVP IVHRDVKS NILLD++ +VADFG+AK Q ++ +AMS
Sbjct: 797 ALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKTPEAMS 856
Query: 849 CVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908
+AGS GYIAPEY YT +V EKSD+YSFGVVL+ELVTGK+P D G+ KD+ +WV A
Sbjct: 857 GIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGD-KDMAKWVCTA- 914
Query: 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
L C L +IDP++DL EE KV+++ L+CTS P+NRPSMR+VV +L+
Sbjct: 915 LDK-----C-GLEPVIDPKLDLKF--KEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQ 965
|
|
| TAIR|locus:2091206 IKU2 "HAIKU2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 5.5e-156, Sum P(2) = 5.5e-156
Identities = 204/632 (32%), Positives = 317/632 (50%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155
R+L N + D F L S+ L+ L L N G++ + L+ LDL N
Sbjct: 77 RSLINRD-DDGRFTD-LPFDSICDLKLLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGIN 134
Query: 156 NFSGDIPESFGRFPVLKVXXXXXXXXXXXIP-SFLGNLTELTHFELGYNPLKSSPLPSSV 214
NFSG+ P + +L+ P S L +L L+ +G N S P P +
Sbjct: 135 NFSGEFP-AIDSLQLLEFLSLNASGISGIFPWSSLKDLKRLSFLSVGDNRFGSHPFPREI 193
Query: 215 GNLSKLENLWAAKANLIGEIPDSIGKLAXXXXXXXXXXXXXGKIPHSFSGLASIEQIELF 274
NL+ L+ ++ + +++ G+IP+ I L G+IP L ++ Q+E++
Sbjct: 194 LNLTALQWVYLSNSSITGKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIY 253
Query: 275 DNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLA 334
N L+G+LP NLT L D S N+L G+L E +L SL + +N TGEIP+
Sbjct: 254 SNDLTGKLPLGFRNLTNLRNFDASNNSLEGDLSELRFLKNLVSLGMFENRLTGEIPKEFG 313
Query: 335 SNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFN 394
+L L L+ N +GKLP LG ++ +Y DVS N G++P ++C + + +++
Sbjct: 314 DFKSLAALSLYRNQLTGKLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQ 373
Query: 395 NRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSIS 454
NRF+G+ PESY +CKTL LR N L G +PS WGLP + F ++ +N FEG+++ I
Sbjct: 374 NRFTGQFPESYAKCKTLIRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIG 433
Query: 455 NAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITXXXXXXXXXXXX 514
NA L + ++ N F+G +P QI L +V+L N+FSG +P
Sbjct: 434 NAKSLGSLDLSNNRFSGSLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQ 493
Query: 515 XMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXXXXXXXGEIPLELT 574
+G +P++L T+L+ LN + N L+ IP LG+L + G IP+ L+
Sbjct: 494 NNLSGAIPKSLGLCTSLVDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLS 553
Query: 575 KLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSKTKP---GTXX 631
LKL+ ++S+N+L G VP L S N GLCS ++ L PC KP G
Sbjct: 554 ALKLSLLDLSNNQLTGSVPES----LVSGSFEGNSGLCSSKIRYLRPCPLGKPHSQGKRK 609
Query: 632 XXXXXXXXXXXXXXXXXWF------FKVKSGFFSTS---KSPWKVVTFQRVSFNEDDILP 682
+F FK++ + + K+ W+V +F+ ++FNE +I+
Sbjct: 610 HLSKVDMCFIVAAILALFFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEIID 669
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRL 714
+ +N+IG GG VYKV L+SGET+AVK +
Sbjct: 670 EIKSENIIGRGGQGNVYKVSLRSGETLAVKHI 701
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 3.6e-150, Sum P(2) = 3.6e-150
Identities = 202/604 (33%), Positives = 299/604 (49%)
Query: 29 DAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGF 88
+ +L+ VKS L DP L DW + CNWTG+ C + N +V+ +DL+G +L+G
Sbjct: 30 ELSVLLSVKST-LVDPLNFLKDWKLSDTSDHCNWTGVRCNS-NGNVEKLDLAGMNLTGKI 87
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
+ ++ +L + N+S N F L +S+ P L+ + + N F G L FS E L
Sbjct: 88 SDSISQLSSLVSFNISCNGFESLLP-KSIPP---LKSIDISQNSFSGSLFLFSNESLGLV 143
Query: 149 VLDLSRNNFSGDIPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFELGYNPLKSS 208
L+ S NN SG++ E G L+V +PS NL +L L N L +
Sbjct: 144 HLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNL-TG 202
Query: 209 PLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAXXXXXXXXXXXXXGKIPHSFSGLASI 268
LPS +G L LE G IP G + G+IP L S+
Sbjct: 203 ELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSL 262
Query: 269 EQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTG 327
E + L++N +G +P + ++TTL LD S N LTG +P I + +L+ LNL N +G
Sbjct: 263 ETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSG 322
Query: 328 EIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKL 387
IP +++S L L+L+NN+ SG+LP DLGK S L++ DVS+N F+GE+P LC + L
Sbjct: 323 SIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNL 382
Query: 388 QCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEG 447
+I+FNN F+G+IP + C++L +R N L G +P F L ++ E+ NR G
Sbjct: 383 TKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSG 442
Query: 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITXXXXX 507
I IS++ L+ I + N +PS I ++ LQA ++ N SG +P
Sbjct: 443 GIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSL 502
Query: 508 XXXXXXXXMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXXXXXXXG 567
TG +P ++ S L+ LNL N LTG IP ++ ++ G
Sbjct: 503 SNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTG 562
Query: 568 EIPLEL-TKLKLNQFNISHNKLYGEVP-SDFDHDLFISSLLDNPGLCSPDLKPLPPCSKT 625
+P + T L N+S+NKL G VP + F + L N GLC LPPCSK
Sbjct: 563 VLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGG---VLPPCSKF 619
Query: 626 KPGT 629
+ T
Sbjct: 620 QRAT 623
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1465 (520.8 bits), Expect = 4.2e-150, P = 4.2e-150
Identities = 348/946 (36%), Positives = 504/946 (53%)
Query: 33 LIRVKSD-QLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNG 91
L+ +KS +D+ + L W ++ + C+WTG+TC+ + V +DLSG +LSG +
Sbjct: 31 LLSLKSSFTIDEHSPLLTSWNLST--TFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSD 88
Query: 92 FCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD-FSREFANLQVL 150
+ L+NL+L+ N +G + Q +S + L+ L L NVF G PD S NL+VL
Sbjct: 89 VAHLPLLQNLSLAANQISGPIPPQ-ISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVL 147
Query: 151 DLSRNNFSGDIPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFELGYNPLKSSPL 210
DL NN +GD+P S L+ IP+ G L + + N L + +
Sbjct: 148 DLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNEL-TGKI 206
Query: 211 PSSVGNLSKLENLWAAKANLIGE-IPDSIGKLAXXXXXXXXXXXXXGKIPHSFSGLASIE 269
P +GNL+ L L+ N +P IG L+ G+IP L ++
Sbjct: 207 PPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLD 266
Query: 270 QIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGE 328
+ L N +G + + L +++L +D+S N TG +P + + + +L LNL N G
Sbjct: 267 TLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGA 326
Query: 329 IPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQ 388
IPE + P L L+L+ N+F+G +P LG+ L D+S+N TG LP +C N+L
Sbjct: 327 IPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLM 386
Query: 389 CIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGS 448
+I N G IP+S G+C++L +R G N L G +P + +GLP++ E+ +N G
Sbjct: 387 TLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGE 446
Query: 449 ISPSISNAPKLTG-ILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITXXXXX 507
+ S G I ++ N +G +P+ I L +Q + L N+FSG +P I
Sbjct: 447 LPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQL 506
Query: 508 XXXXXXXXMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXXXXXXXG 567
+F+G + ++ L ++LS N+L+G IP EL + + G
Sbjct: 507 SKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVG 566
Query: 568 EIPLELTKLK-LNQFNISHNKLYGEVPSDFDHDLF-ISSLLDNPGLCSPDLKPLPPC--- 622
IP+ + ++ L + S+N L G VPS F +S + N LC P L P
Sbjct: 567 SIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQ 626
Query: 623 SKTKP--GTXXXXXXXXXXXXXXXXXXXWFFKVKSGFFSTSKSPWKVVTFQRVSFNEDDI 680
S KP T K +S ++ W++ FQR+ F DD+
Sbjct: 627 SHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDV 686
Query: 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG 740
L L E N+IG GG+ VYK + G+ VAVKRL +H + F +EI+TLGR+RH
Sbjct: 687 LDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHR 746
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
++V+LL CS + N+LVYEYMPNGSL ++LH K + G L W+ R+ IA AAKGL YLH
Sbjct: 747 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGHLHWNTRYKIALEAAKGLCYLH 805
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
+DC P IVHRDVKS+NILLD+ VADFGLAK LQ G S+ MS +AGSYGYIAPE
Sbjct: 806 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDS-GTSE-CMSAIAGSYGYIAPE 863
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920
YAYT KV EKSDVYSFGVVL+EL+TGK+P FG+ DIV+WV T S+ + C +
Sbjct: 864 YAYTLKVDEKSDVYSFGVVLLELITGKKPVG-EFGDGVDIVQWVRSMTDSNKD--C---V 917
Query: 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
++ID R LS+ E V VAL+C + + RP+MR VV++L
Sbjct: 918 LKVIDLR--LSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQIL 961
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1450 (515.5 bits), Expect = 1.6e-148, P = 1.6e-148
Identities = 344/940 (36%), Positives = 496/940 (52%)
Query: 42 DDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNL 101
DD N L W + S S C W G+TC+ + V +DLSG +LSG +R L+NL
Sbjct: 41 DDKNSPLSSW-KVST-SFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNL 98
Query: 102 NLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD-FSREFANLQVLDLSRNNFSGD 160
+L++N +G + + +S L+ L L NVF G PD S NL+VLD+ NN +GD
Sbjct: 99 SLAENLISGPIPPE-ISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGD 157
Query: 161 IPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKL 220
+P S L+ IP G+ + + + N L +P +GNL+ L
Sbjct: 158 LPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGK-IPPEIGNLTTL 216
Query: 221 ENLWAAKANLIGE-IPDSIGKLAXXXXXXXXXXXXXGKIPHSFSGLASIEQIELFDNQLS 279
L+ N + +P IG L+ G+IP L ++ + L N S
Sbjct: 217 RELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFS 276
Query: 280 GELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPN 338
G L L L++L +D+S N TG +P + A + +L LNL N GEIPE + P
Sbjct: 277 GPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPE 336
Query: 339 LVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFS 398
L L+L+ N+F+G +P LG+ L D+S+N TG LP +C NKL+ +I N
Sbjct: 337 LEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLF 396
Query: 399 GKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPK 458
G IP+S G+C++L +R G N L G +P +GLP++ E+ +N G + + +
Sbjct: 397 GSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVN 456
Query: 459 LTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITXXXXXXXXXXXXXMFT 518
L I ++ N +G +P I +Q + L N+F G +P+ + +F+
Sbjct: 457 LGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFS 516
Query: 519 GELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXXXXXXXGEIPLELTKLK- 577
G + ++ L ++LS N+L+G IP E+ + + G IP ++ ++
Sbjct: 517 GRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQS 576
Query: 578 LNQFNISHNKLYGEVPSDFDHDLF-ISSLLDNPGLCSPDLKPLPPC-------SKTK-P- 627
L + S+N L G VP F +S L NP LC P L P S +K P
Sbjct: 577 LTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGHQSHSKGPL 636
Query: 628 -GTXXXXXXXXXXXXXXXXXXXWFFKVKSGFFSTSKSPWKVVTFQRVSFNEDDILPHLTE 686
+ K +S ++ W++ FQR+ F DD+L L E
Sbjct: 637 SASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDDVLDSLKE 696
Query: 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
N+IG GG+ VYK + +G+ VAVKRL + + F +EI+TLGR+RH ++V+LL
Sbjct: 697 DNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 756
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
CS + N+LVYEYMPNGSL ++LH K + G L W R+ IA AAKGL YLH+DC P
Sbjct: 757 GFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGHLHWDTRYKIALEAAKGLCYLHHDCSPL 815
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
IVHRDVKS+NILLD+ VADFGLAK LQ G S+ MS +AGSYGYIAPEYAYT K
Sbjct: 816 IVHRDVKSNNILLDSNFEAHVADFGLAKFLQDS-GTSE-CMSAIAGSYGYIAPEYAYTLK 873
Query: 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926
V EKSDVYSFGVVL+ELVTG++P FG+ DIV+WV + T S+ + + +++DP
Sbjct: 874 VDEKSDVYSFGVVLLELVTGRKPVG-EFGDGVDIVQWVRKMTDSNKD-----SVLKVLDP 927
Query: 927 RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
R LS+ E V VA++C + + RP+MR VV++L
Sbjct: 928 R--LSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQIL 965
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 749 (268.7 bits), Expect = 2.2e-148, Sum P(2) = 2.2e-148
Identities = 195/599 (32%), Positives = 285/599 (47%)
Query: 30 AEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFP 89
A +LI +K D + L W + S C+WTG++C+ NQS+ +DLS ++SG
Sbjct: 35 ANVLISLKQS-FDSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTIS 93
Query: 90 NGFCRIR-TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD--FSREFAN 146
R+ +L L++S N F+G L + + L+VL + NVF GEL FS +
Sbjct: 94 PEISRLSPSLVFLDISSNSFSGELPKE-IYELSGLEVLNISSNVFEGELETRGFS-QMTQ 151
Query: 147 LQVLDLSRNNFSGDIPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFELGYNPLK 206
L LD N+F+G +P S L+ IP G+ L L N L+
Sbjct: 152 LVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDLR 211
Query: 207 SSPLPSSVGNLSKLENLWAAKAN-LIGEIPDSIGKLAXXXXXXXXXXXXXGKIPHSFSGL 265
+P+ + N++ L L+ N G IP G+L G IP L
Sbjct: 212 GR-IPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNL 270
Query: 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS-LESLNLNDNY 324
++E + L N+L+G +P L N+T+L LD+S N L G +P ++ + L+ NL N
Sbjct: 271 KNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNR 330
Query: 325 FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFR 384
GEIPE ++ P+L LKL++N+F+GK+P LG NL D+STN TG +P LCF
Sbjct: 331 LHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFG 390
Query: 385 NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNR 444
+L+ +I+FNN G +PE G+C+ L R G N L +LP LP + E+ NN
Sbjct: 391 RRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNF 450
Query: 445 FEGSI-SPSISNAP--KLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCI 501
G I NA LT I ++ N +G +P I LR LQ + L NR SG +P I
Sbjct: 451 LTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEI 510
Query: 502 TXXXXXXXXXXXXXMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXX 561
F+G+ P +L L+LS NQ++G IP ++ + +
Sbjct: 511 GSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVS 570
Query: 562 XXXXXGEIPLELTKLK-LNQFNISHNKLYGEVPSDFDHDLFIS-SLLDNPGLCSPDLKP 618
+P EL +K L + SHN G VP+ F + S L NP LC P
Sbjct: 571 WNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNP 629
|
|
| TAIR|locus:2207036 AT1G72180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 3.3e-147, Sum P(2) = 3.3e-147
Identities = 175/500 (35%), Positives = 262/500 (52%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156
+L N+NLS GT+S S+S L L+L N G +P NL+VL+L+ N
Sbjct: 80 SLGNVNLS-----GTISP-SISALTKLSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNR 133
Query: 157 FSGDIPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFELGYNPLKSSPLPSSVGN 216
SG IP + L++ S++GN+ +L LG N + +P S+G
Sbjct: 134 LSGTIP-NLSPLKSLEILDISGNFLNGEFQSWIGNMNQLVSLGLGNNHYEEGIIPESIGG 192
Query: 217 LSKLENLWAAKANLIGEIPDSIGKLAXXXXXXXXXXXXXGKIPHSFSGLASIEQIELFDN 276
L KL L+ A++NL G+IP+SI L P S L ++ +IELF+N
Sbjct: 193 LKKLTWLFLARSNLTGKIPNSIFDLNALDTFDIANNAISDDFPILISRLVNLTKIELFNN 252
Query: 277 QLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS-LESLNLNDNYFTGEIPESLAS 335
L+G++P + NLT L DIS N L+G LPE + + L + ++N FTGE P
Sbjct: 253 SLTGKIPPEIKNLTRLREFDISSNQLSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGD 312
Query: 336 NPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNN 395
+L L ++ N+FSG+ P ++G++S L+ D+S N+FTG PRFLC KLQ ++ N
Sbjct: 313 LSHLTSLSIYRNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQN 372
Query: 396 RFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISN 455
FSG+IP SYGECK+L LR N L G++ FW LP ++ +N G +SP I
Sbjct: 373 EFSGEIPRSYGECKSLLRLRINNNRLSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGL 432
Query: 456 APKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITXXXXXXXXXXXXX 515
+ +L+ +++ N F+G++P ++ L ++ + LS N SG +P +
Sbjct: 433 STELSQLILQNNRFSGKIPRELGRLTNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENN 492
Query: 516 MFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXXXXXXXXXGEIPLELTK 575
TG +P+ L + L+ LNL+ N LTG IP L +A GEIP L K
Sbjct: 493 SLTGFIPKELKNCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVK 552
Query: 576 LKLNQFNISHNKLYGEVPSD 595
LKL+ ++S N+L G +P D
Sbjct: 553 LKLSFIDLSGNQLSGRIPPD 572
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 6.7e-147, Sum P(2) = 6.7e-147
Identities = 208/611 (34%), Positives = 298/611 (48%)
Query: 27 HGDAEILIRVKSDQLDDPNRKLGDWVRT------SQQSPCNWTGITCETQNQSVDGIDLS 80
+ + EIL+ KSD L DP+ L DW R S+ C+WTG+ C+ N V + LS
Sbjct: 28 NSEQEILLAFKSD-LFDPSNNLQDWKRPENATTFSELVHCHWTGVHCDA-NGYVAKLLLS 85
Query: 81 GFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDF 140
+LSG + +L+ L+LS+N F +L +SLS L+V+ + N F G P
Sbjct: 86 NMNLSGNVSDQIQSFPSLQALDLSNNAFESSLP-KSLSNLTSLKVIDVSVNSFFGTFPYG 144
Query: 141 SREFANLQVLDLSRNNFSGDIPESFGRFPVLKVXXXXXXXXXXXIPSFLGNLTELTHFEL 200
L ++ S NNFSG +PE G L+V +PS NL L L
Sbjct: 145 LGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGL 204
Query: 201 GYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAXXXXXXXXXXXXXGKIPH 260
N +P +G LS LE + +GEIP+ GKL G+IP
Sbjct: 205 SGNNF-GGKVPKVIGELSSLETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPS 263
Query: 261 SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLN 319
S L + + L+ N+L+G+LP L +T+L+ LD+S N +TG +P + + +L+ LN
Sbjct: 264 SLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLN 323
Query: 320 LNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPR 379
L N TG IP +A PNL L+L+ NS G LP LGK S L++ DVS+N +G++P
Sbjct: 324 LMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPS 383
Query: 380 FLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFE 439
LC+ L +I+FNN FSG+IPE C TL +R N + G +P+ LP + E
Sbjct: 384 GLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLE 443
Query: 440 MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT 499
+ N G I I+ + L+ I I+ N+ + + S I + LQ S N F+G +P
Sbjct: 444 LAKNNLTGKIPDDIALSTSLSFIDISFNHLSS-LSSSIFSSPNLQTFIASHNNFAGKIPN 502
Query: 500 CITXXXXXXXXXXXXXMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVXXXXX 559
I F+G +P + S L+ LNL +NQL G IP L + +
Sbjct: 503 QIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLD 562
Query: 560 XXXXXXXGEIPLEL-TKLKLNQFNISHNKLYGEVPSDFDHDLFIS----SLLDNPGLCSP 614
G IP +L L N+S NKL G +PS+ LF + L+ N GLC
Sbjct: 563 LSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNM---LFAAIDPKDLVGNNGLCGG 619
Query: 615 DLKPLPPCSKT 625
LPPCSK+
Sbjct: 620 ---VLPPCSKS 627
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGX3 | HSL2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5911 | 0.9732 | 0.9536 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.8__2624__AT5G65710.1 | annotation not avaliable (995 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 973 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.0 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 554 bits (1430), Expect = 0.0
Identities = 368/982 (37%), Positives = 533/982 (54%), Gaps = 69/982 (7%)
Query: 9 LIALLFSFLLCFSLAISLHGDA-EILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITC 67
LI +LF L FS+ LH + E+L+ KS ++DP + L +W S C W GITC
Sbjct: 12 LIFMLFFLFLNFSM---LHAEELELLLSFKS-SINDPLKYLSNW--NSSADVCLWQGITC 65
Query: 68 ETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLA 127
+ V IDLSG ++SG + R+ ++ +NLS+N +G + + L+ L
Sbjct: 66 -NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124
Query: 128 LDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPS 187
L N F G +P S NL+ LDLS N SG+IP G F LKVL+LGGN+L G IP+
Sbjct: 125 LSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 188 FLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNL 247
L NLT L L N L +P +G + L+ ++ NL GEIP IG L L++L
Sbjct: 183 SLTNLTSLEFLTLASNQL-VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241
Query: 248 DLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLP 307
DL N L+G IP S L +++ + L+ N+LSG +P S+ +L L+ LD+S N+L+G +P
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
Query: 308 ETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYF 366
E + + +LE L+L N FTG+IP +L S P L L+L++N FSG++P +LGK++NL
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361
Query: 367 DVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELP 426
D+STN+ TGE+P LC L +I+F+N G+IP+S G C++L +R N GELP
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
Query: 427 SKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAV 486
S+F LP V F ++ NN +G I+ + P L + + N F G +P + ++L+ +
Sbjct: 422 SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENL 480
Query: 487 DLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIP 546
DLS+N+FSG +P + L++L QL+L EN +GE+P L+S L+ L+LS NQL+G IP
Sbjct: 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
Query: 547 PELGNLAVLTSLDLSSNLLTGEIPLELTKLK-LNQFNISHNKLYGEVPSDFDHDLFI--- 602
+ VL+ LDLS N L+GEIP L ++ L Q NISHN L+G +PS F+
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST---GAFLAIN 597
Query: 603 -SSLLDNPGLCSPDLKP-LPPC---SKTKPGTIYIVVIL-SICVILLVGSLVWFFKVKSG 656
S++ N LC D LPPC KT YI L + V+ LV F + ++
Sbjct: 598 ASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN 657
Query: 657 F----FSTSKSPWKVVTFQR---VSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGET 708
W++ F S +DIL L E+N+I G YK K +K+G
Sbjct: 658 LELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQ 717
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VK + P SEI +G+++H N+VKL+ C + L++EY+ +L+
Sbjct: 718 FVVKEINDVNSIPS------SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771
Query: 769 DMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828
++L +L W R IA G AK L +LH C PA+V ++ I++D + P +
Sbjct: 772 EVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825
Query: 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKR 888
L L + C S Y+APE TK +TEKSD+Y FG++L+EL+TGK
Sbjct: 826 -LSLPGLLCTD-------TKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876
Query: 889 PNDPSFGENKDIVRWVTEATLSSPERGCCRD--LNQLIDP--RMDLSTCDYEEAEKVLNV 944
P D FG + IV W R C D L+ IDP R D+S E E V+N+
Sbjct: 877 PADAEFGVHGSIVEWA---------RYCYSDCHLDMWIDPSIRGDVSVNQNEIVE-VMNL 926
Query: 945 ALMCTSDFPINRPSMRRVVELL 966
AL CT+ P RP V++ L
Sbjct: 927 ALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 8e-44
Identities = 83/292 (28%), Positives = 131/292 (44%), Gaps = 43/292 (14%)
Query: 684 LTEQNLIGSGGSCRVYKVKLK-----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
L +G G VYK LK + VAVK L G + E E F E + ++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLS 59
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H N+V+LL C+ + +V EYMP G L D L + G L +A AKG+ Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIAKGMEY 117
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE--GQSDDAMSCVAGSYGY 856
L + VHRD+ + N L+ +V +++DFGL++ + + + + +
Sbjct: 118 LESKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----W 170
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPN-DPSFGENKDIVRWVTEATLSSPER 914
+APE K T KSDV+SFGV+L E+ T G++P S N++++ + +
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS---NEEVLELLEDGYRLPRPE 227
Query: 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
C +L +L+ L Y+ P +RP+ +VE L
Sbjct: 228 NCPDELYELM-----LQCWAYD----------------PEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 75/203 (36%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 688 NLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
+G G +VY + K+G+ VA+K + K + E + R EI+ L +++H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR-EIKILKKLKHPNIVRLY 63
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+D LV EY G L D+L ++GR S D RF + Q L YLH+
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDE-ARFYLRQ-ILSALEYLHSKG--- 117
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
IVHRD+K NILLD + ++ADFGLA+ L + + V G+ Y+APE K
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP----GEKLTTFV-GTPEYMAPEVLLGKG 172
Query: 867 VTEKSDVYSFGVVLMELVTGKRP 889
+ D++S GV+L EL+TGK P
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 9e-44
Identities = 80/202 (39%), Positives = 106/202 (52%), Gaps = 12/202 (5%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+GSG VYK K K G+ VAVK L + K + + R EI L R+ H N+V+L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
+D LV EY G L D L G L IA +GL YLH++ I+
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-YAYTKKV 867
HRD+K NILLD V ++ADFGLAK L +S +++ G+ Y+APE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL----LKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 868 TEKSDVYSFGVVLMELVTGKRP 889
K DV+S GV+L EL+TGK P
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 70/197 (35%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G GG VY + K+G+ VA+K + EIE L ++ H N+VKL
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED-SSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
++ LV EY GSL D+L E G L I +GL YLH++ I+
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---II 114
Query: 809 HRDVKSHNILLDA-EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-YAYTKK 866
HRD+K NILLD+ ++ADFGL+K L S + + + G+ Y+APE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL----LKTIVGTPAYMAPEVLLGKGY 170
Query: 867 VTEKSDVYSFGVVLMEL 883
+EKSD++S GV+L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 85/293 (29%), Positives = 132/293 (45%), Gaps = 46/293 (15%)
Query: 684 LTEQNLIGSGGSCRVYKVKLK-----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
LT +G G VYK KLK VAVK L + + E F E + ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLD 59
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H NVVKLL C+ ++ +V EYM G L L + L S S A A+G+ Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEY 117
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS---YG 855
L + +HRD+ + N L+ +V +++DFGL++ L DD G
Sbjct: 118 LESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL------YDDDYYRKRGGKLPIR 168
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA-TLSSPE 913
++APE K T KSDV+SFGV+L E+ T G++P N++++ ++ L P
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLKNGYRLPQPP 226
Query: 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
C ++ ++ L C ++ P +RP+ +VE+L
Sbjct: 227 N--CPP--------------------ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 83/296 (28%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 688 NLIGSGGSCRVYKVKLKSGET----VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+G G VYK KLK + VAVK L E F E + ++ H NVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-ASEEERKDFLKEARVMKKLGHPNVV 59
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEK------GRSGSLDWSIRFSIAQGAAKGLA 797
+LL C+ ++ LV EYM G L D L + +L S A AKG+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG--QSDDAMSCVAGSYG 855
YL + VHRD+ + N L+ ++V +++DFGL++ + + + +
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE--NKDIVRWVTE-ATLSS 911
++APE T KSDV+SFGV+L E+ T G P + N++++ ++ + L
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEVLEYLRKGYRLPK 228
Query: 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
PE C +L +L+ L C P +RP+ +VE L
Sbjct: 229 PE-YCPDELYELM---------------------LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 88/293 (30%), Positives = 133/293 (45%), Gaps = 45/293 (15%)
Query: 684 LTEQNLIGSGGSCRVYKVKLK-----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
LT +G G VYK LK VAVK L + + E F E + ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLD 59
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H N+VKLL C+ ++ ++V EYMP G L D L + R L S S A A+G+ Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEY 118
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI- 857
L + +HRD+ + N L+ +V +++DFGL++ L DD V G I
Sbjct: 119 LESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL------YDDDYYKVKGGKLPIR 169
Query: 858 --APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA-TLSSPE 913
APE K T KSDV+SFGV+L E+ T G+ P N +++ ++ + L P
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM--SNAEVLEYLKKGYRLPKPP 227
Query: 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
C ++ + L C ++ P +RP+ +VE+L
Sbjct: 228 N--CPP--------------------ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 688 NLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
L+G G VY + +GE +AVK + E EI L ++H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 747 MCCSGQDFN-ILVY-EYMPNGSLADMLHEKGRSGSLDWS-IR---FSIAQGAAKGLAYLH 800
++ N + ++ EY+ GSL+ +L + G L IR I +G LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKYTRQILEG----LAYLH 118
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
++ IVHRD+K NIL+D++ V ++ADFG AK L E + V G+ ++APE
Sbjct: 119 SNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--EGTGSVRGTPYWMAPE 173
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
++ +D++S G ++E+ TGK P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 683 HLTEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN 741
+ +LIG G VYK + L++G+ VA+K++ K E EI+ L ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSG-SLDWSIRFSIAQGAAKGLAYLH 800
+VK + D ++ EY NGSL ++ + G SL + + Q +GLAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL--VAVY-VYQ-VLQGLAYLH 116
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
++HRD+K+ NIL + V ++ADFG+A L V G+ ++APE
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS----VVGTPYWMAPE 169
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ SD++S G ++EL+TG P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRS---EIETLGRVRHGNVVKL 745
IG GG VYK + ++G+ VA+K + K E++ EI+ L + +H N+VK
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI-----KLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+D +V E+ GSL D+L ++ + I + + + KGL YLH++
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-IAY-VCKELLKGLEYLHSN--- 117
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
I+HRD+K+ NILL ++ ++ DFGL+ L ++ + M G+ ++APE K
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD--TKARNTM---VGTPYWMAPEVINGK 172
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP 889
K+D++S G+ +EL GK P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 685 TEQNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNV 742
IG G +VY V+ G+ +K + L + E E E++ L ++ H N+
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNI 61
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS-------LDWSIRFSIAQGAAKG 795
+K + +V EY G L+ + ++ + G LDW ++ +A
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------ 115
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
L YLH+ I+HRD+K NI L + + ++ DFG++K L S + D V G+
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS----TVDLAKTVVGTPY 168
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y++PE K KSD++S G VL EL T K P
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 70/213 (32%), Positives = 107/213 (50%), Gaps = 35/213 (16%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G S VYKV+ K +G+ A+K++ E E++TL VVK
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESPYVVK---- 63
Query: 749 CSG---QDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRF--SIAQGAAKGLAYLHND 802
C G ++ I +V EYM GSLAD+L + G+ IA+ KGL YLH
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGK-----IPEPVLAYIARQILKGLDYLHTK 118
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-- 860
I+HRD+K N+L++++ ++ADFG++K L E D + V G+ Y++PE
Sbjct: 119 --RHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFV-GTVTYMSPERI 172
Query: 861 ----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y+Y +D++S G+ L+E GK P
Sbjct: 173 QGESYSY------AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 72/209 (34%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLL-GGTHKPETETVFRSEIETLGRVRH-GNVVKLL 746
+G G VY + + + VA+K L K + F EI+ L + H N+VKL
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ LV EY+ GSL D+L + GR G L S I L YLH+
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 807 IVHRDVKSHNILLDAE-MVPRVADFGLAKALQS--QEGQSDDAMSCVAGSYGYIAPEYA- 862
I+HRD+K NILLD + V ++ DFGLAK L S G+ GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 863 --YTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ SD++S G+ L EL+TG P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 70/186 (37%), Positives = 104/186 (55%), Gaps = 19/186 (10%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VAVK L GT PE F E + + ++RH +V+L CS ++ +V EYM GSL
Sbjct: 33 VAVKTLKPGTMSPEA---FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89
Query: 769 DMLHE-KGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827
D L +G+ L + + AQ A+G+AYL + +HRD+ + NIL+ +V ++
Sbjct: 90 DFLKSGEGKKLRLPQLVDMA-AQ-IAEGMAYLESRNY---IHRDLAARNILVGENLVCKI 144
Query: 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYI---APEYAYTKKVTEKSDVYSFGVVLMELV 884
ADFGLA+ ++ DD + G+ I APE A + T KSDV+SFG++L E+V
Sbjct: 145 ADFGLARLIE------DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198
Query: 885 T-GKRP 889
T G+ P
Sbjct: 199 TYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 683 HLTEQNLIGSGGSCRVYKVKL-----KSGETVAVKRLLGGTHKPETE----TVFRSEIET 733
HL +G G +V + +GE VAVK L E + F EIE
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-----NHSGEEQHRSDFEREIEI 59
Query: 734 LGRVRHGNVVKLLMCCSGQDFNI--LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG 791
L + H N+VK C L+ EY+P+GSL D L + ++ +
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQ 117
Query: 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ---SDDAMS 848
KG+ YL + +HRD+ + NIL+++E + +++DFGLAK L + + S
Sbjct: 118 ICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 849 CVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890
+ + APE T K + SDV+SFGV L EL T P+
Sbjct: 175 PIF----WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 69/212 (32%), Positives = 120/212 (56%), Gaps = 19/212 (8%)
Query: 689 LIGSGGSCRVY-KVKLKSGETVAVK-----RLLGGTHKPETETV---FRSEIETLGRVRH 739
LIG G RVY + + +GE +AVK + G H + + RSEIETL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 740 GNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL 799
N+V+ L + +++ + EY+P GS+ L GR + + + +GLAYL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
H+ I+HRD+K+ N+L+DA+ + +++DFG++K +S + +D + GS ++AP
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAP 179
Query: 860 E--YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E ++Y++ + K D++S G V++E+ G+RP
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 50/281 (17%)
Query: 690 IGSGGSCRVYKVKLKSGET------VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+G G +V+ + E VAVK L + F E E L +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIV 71
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGR-----------SGSLDWSIRFSIAQGA 792
K C+ D I+V+EYM +G L L G G L S IA
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC--- 849
A G+ YL + VHRD+ + N L+ ++V ++ DFG+ S D +
Sbjct: 132 ASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGM----------SRDVYTTDYY 178
Query: 850 -VAGS----YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFG-ENKDIVR 902
V G ++ PE +K T +SDV+SFGVVL E+ T GK+ P +G N++++
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ---PWYGLSNEEVIE 235
Query: 903 WVTEATLSSPERGCCRDLNQLI------DPRMDLSTCDYEE 937
+T+ L R C ++ ++ DP+ ++ D E
Sbjct: 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 79/248 (31%), Positives = 117/248 (47%), Gaps = 44/248 (17%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHG 740
L IG G V + G+ VAVK L K ++ F +E + +RH
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCL-----KDDSTAAQAFLAEASVMTTLRHP 60
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSG-SLDWSIRFSIAQGAAKGLAYL 799
N+V+LL + +V EYM GSL D L +GR+ +L + F++ +G+ YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYL 118
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK-ALQSQEGQSDDAMSCVAGSY--GY 856
VHRD+ + N+L+ ++V +V+DFGLAK A Q Q+ G +
Sbjct: 119 EEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS----------GKLPVKW 165
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-------KDIVRWVTEA-T 908
APE KK + KSDV+SFG++L E+ SFG KD+V V +
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIY--------SFGRVPYPRIPLKDVVPHVEKGYR 217
Query: 909 LSSPERGC 916
+ +PE GC
Sbjct: 218 MEAPE-GC 224
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 6/205 (2%)
Query: 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
+IG G + VY L + E VA+KR+ + + + R E++ + + H NVVK
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL-RKEVQAMSQCNHPNVVKY 64
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
D LV Y+ GSL D++ G LD +I ++ + KGL YLH++
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--- 121
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
+HRD+K+ NILL + ++ADFG++ +L ++ G+ ++APE
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 866 K-VTEKSDVYSFGVVLMELVTGKRP 889
K+D++SFG+ +EL TG P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 74/221 (33%), Positives = 110/221 (49%), Gaps = 31/221 (14%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL-M 747
IG G V+K K ++GETVA+K++ + EI+ L +H VVKLL +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHN 801
G F +LV EYMP L+++L ++ R AQ + KG+AY+H
Sbjct: 68 FPHGSGF-VLVMEYMP-SDLSEVLRDEERP--------LPEAQVKSYMRMLLKGVAYMHA 117
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
+ I+HRD+K N+L+ A+ V ++ADFGLA+ +E S + Y APE
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE---PRLYSHQVATRWYRAPEL 171
Query: 862 AY-TKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKDI 900
Y +K D+++ G + EL+ G P F GEN DI
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGS----PLFPGEN-DI 207
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 76/254 (29%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGG-THKPETETVFRSEIETLGRV 737
H+T+Q +IG+G V++ LK VA+K L G T K + F SE +G+
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD--FLSEASIMGQF 63
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H N+++L + +++ EYM NG+L L + G + +G A G+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMK 121
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
YL + VHRD+ + NIL+++ + +V+DFGL++ L+ DD S G I
Sbjct: 122 YLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE------DDPEGTYTTSGGKI 172
Query: 858 -----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPN-DPSFGENKDIVRWVTEATLS 910
APE +K T SDV+SFG+V+ E+++ G+RP D S N ++++ + +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHEVMKAINDGFRL 229
Query: 911 SPERGCCRDLNQLI 924
C + QL+
Sbjct: 230 PAPMDCPSAVYQLM 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 71/209 (33%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 687 QNLIGSGGSCRVYKVKLKS-GETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVK 744
N IG G V+KV K+ A+K++ L ++ E E E L ++ +++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSSYIIR 63
Query: 745 LLMC-CSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
NI++ EY NG L +L ++GR D RF I GLA+LH+
Sbjct: 64 YYESFLDKGKLNIVM-EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQ--ILLGLAHLHSK 120
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
I+HRD+KS N+ LDA ++ D G+AK L ++ A + V Y Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPY-YLSPELC 173
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPND 891
K EKSDV++ GVVL E TGK P D
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 25/217 (11%)
Query: 684 LTEQNLIGSGGSCRVYKVKL----KSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVR 738
+T + +IG G V + +L K VA+K L G + K + F +E +G+
Sbjct: 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQFD 63
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H N+++L + +++ EYM NGSL L E G + +G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKY 121
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI- 857
L VHRD+ + NIL+++ +V +V+DFGL++ L+ E G G I
Sbjct: 122 LSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-----TKG--GKIP 171
Query: 858 ----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
APE +K T SDV+SFG+V+ E+++ G+RP
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 2e-24
Identities = 86/267 (32%), Positives = 124/267 (46%), Gaps = 43/267 (16%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIET-------LGRVRHGN 741
+G G +V V+ K +G+ A+K L K + + R E+E L R+ H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL----KK--KKIIKRKEVEHTLTERNILSRINHPF 54
Query: 742 VVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLD-WSIRFSIAQGAAKGLAY 798
+VKL + Q LV EY P G L L ++GR RF A+ L Y
Sbjct: 55 IVKLH--YAFQTEEKLYLVLEYAPGGELFSHLSKEGR---FSEERARFYAAE-IVLALEY 108
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC--VAGSYGY 856
LH+ I++RD+K NILLDA+ ++ DFGLAK L S + G+ Y
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKEL------SSEGSRTNTFCGTPEY 159
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KDIVRWVTEATLSSPERG 915
+APE K + D +S GV+L E++TGK P + E+ K+I + + L PE
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP---PFYAEDRKEIYEKILKDPLRFPEFL 216
Query: 916 C--CRDL-NQLI--DPRMDLSTCDYEE 937
RDL + L+ DP L + EE
Sbjct: 217 SPEARDLISGLLQKDPTKRLGSGGAEE 243
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 16/211 (7%)
Query: 689 LIGSGGSCRVY-KVKLKSGETVAVKRLL-------GGTHKPETETVFRSEIETLGRVRHG 740
LIGSG VY + SGE +AVK++ K EI L ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
N+V+ L D + EY+P GS+A +L+ G+ + ++ + + KGL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLH 123
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ--SQEGQSDDAMSCVAGSYGYIA 858
N I+HRD+K NIL+D + +++DFG++K L+ S +++ A + GS ++A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
PE T K+D++S G +++E++TGK P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 14/214 (6%)
Query: 683 HLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVF---RSEIETLGRV 737
+ +G+G Y+ + +K+G +AVK++ E E V R EI + R+
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 738 RHGNVVKLL-MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGL 796
H +++++L C FN+ V E+M GS++ +L + G+ ++ + + +GL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGL 116
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
+YLH + I+HRDVK N+L+D+ R+ADFG A L ++ + + + G+
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
++APE ++ DV+S G V++E+ T K P
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G+G V++ + VAVK L GT P+ F +E + + ++RH +++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD---FLAEAQIMKKLRHPKLIQLYAVC 70
Query: 750 SGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYL--HNDCVPA 806
+ ++ +V E M GSL + L GR+ L I + AQ A+ G+AYL N
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA-AQVAS-GMAYLEAQN----- 123
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
+HRD+ + N+L+ + +VADFGLA+ ++ ++ + + APE A +
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF---PIKWTAPEAALYNR 180
Query: 867 VTEKSDVYSFGVVLMELVT-GKRP 889
+ KSDV+SFG++L E+VT G+ P
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+GSG V++ K+ VA+K L + + F+ E++ L R+RH +++ L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLISLFAVC 71
Query: 750 SGQDFNILVYEYMPNGSLADMLHE-KGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
S + ++ E M GSL L +G+ L + +A A+G+AYL +
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQV--LPVASLIDMACQVAEGMAYLEEQ---NSI 126
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT 868
HRD+ + NIL+ ++V +VADFGLA+ ++ S D Y + APE A +
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI----PYKWTAPEAASHGTFS 182
Query: 869 EKSDVYSFGVVLMELVT-GKRP 889
KSDV+SFG++L E+ T G+ P
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 690 IGSGGSCRVYK-VKLKSGET----VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+GSG VYK V + GE VA+K L T P+ E + V H +VV+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVR 73
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHE-KGRSGS---LDWSIRFSIAQGAAKGLAYLH 800
LL C L+ + MP G L D + K GS L+W ++ AKG++YL
Sbjct: 74 LLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ--SDDAMSCVAGSYGYIA 858
+VHRD+ + N+L+ ++ DFGLAK L E + ++ + ++A
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMA 179
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
E + T KSDV+S+GV + EL+T G +P +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 26/214 (12%)
Query: 688 NLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHGNVVK 744
N IG G +VY V L +GE +AVK + + +T+ E++ L ++H N+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 745 LLMCCSG-----QDFNILVYEYMPNGSLADMLHEKGRSGSLDWS-IRFSIAQGAAKGLAY 798
G + I + EY G+L ++L LD IR Q +GLAY
Sbjct: 64 ----YYGVEVHREKVYIFM-EYCSGGTLEELLEHGR---ILDEHVIRVYTLQ-LLEGLAY 114
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
LH+ IVHRD+K NI LD V ++ DFG A L++ + + +AG+ Y+A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 859 PEYAYTKKVTEK---SDVYSFGVVLMELVTGKRP 889
PE K +D++S G V++E+ TGKRP
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 45/218 (20%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNV 742
IG G +VYK + K+GE VA+K++ + E E T R EI+ L ++RH N+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-----RMENEKEGFPITAIR-EIKLLQKLRHPNI 60
Query: 743 VKLL-MCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ------GAAK 794
V+L + S +I +V+EYM + L +L ++F+ +Q +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSP--------EVKFTESQIKCYMKQLLE 111
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
GL YLH++ I+HRD+K NIL++ + V ++ADFGLA+ ++ + +
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY---TKRNSADYTNRVITL 165
Query: 855 GYIAPEY-----AYTKKVTEKSDVYSFGVVLMELVTGK 887
Y PE Y +V D++S G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 76/235 (32%), Positives = 115/235 (48%), Gaps = 12/235 (5%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G+G V+ VAVK L GT PE+ F E + + ++RH +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQLYAVV 70
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
S + I V EYM GSL D L + G +L +A A G+AY+ +H
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIH 125
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTE 869
RD++S NIL+ +V ++ADFGLA+ ++ E A + APE A + T
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTI 182
Query: 870 KSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924
KSDV+SFG++L ELVT R P N++++ V + C L++L+
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRMPCPQDCPISLHELM 236
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 677 EDDILPHLTEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLG 735
E D IG G S VYK +G+ VA+K++ K E + EI +
Sbjct: 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIIN-EILIMK 70
Query: 736 RVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA-- 793
+H N+V D +V EYM GSL D++ + +R + Q A
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--------FVRMNEPQIAYVC 122
Query: 794 ----KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
+GL YLH+ ++HRD+KS NILL + ++ADFG A A ++E +++
Sbjct: 123 REVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSV-- 176
Query: 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP--NDP 892
V Y ++APE K K D++S G++ +E+ G+ P +P
Sbjct: 177 VGTPY-WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRS---EIETLGRVRHGNVVK 744
L+GSG VY+ + L G+ AVK + + + EI L +++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 745 LL-MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
L + I + E +P GSLA +L + GS + + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFL-ELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHDR- 121
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY-A 862
VHRD+K NIL+D V ++ADFG+AK + A S Y ++APE A
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF----SFAKSFKGSPY-WMAPEVIA 174
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRP 889
+D++S G ++E+ TGK P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 82/218 (37%), Positives = 108/218 (49%), Gaps = 31/218 (14%)
Query: 683 HLTEQNLIGSG--GS---CRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
HL +G G GS CR ++ +GE VAVK+L T E F EIE L +
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSL 62
Query: 738 RHGNVVKLL-MCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
+H N+VK +C S N+ LV EY+P GSL D L +K R LD A KG
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRE-RLDHRKLLLYASQICKG 120
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL-QSQE-------GQSDDAM 847
+ YL + VHRD+ + NIL+++E ++ DFGL K L Q +E G+S
Sbjct: 121 MEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES---- 173
Query: 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885
+ APE K + SDV+SFGVVL EL T
Sbjct: 174 -----PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 69/226 (30%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVK----RLLGGTHKPETETVFRSEIETLGRV-RHGNV 742
+IG G V K K + + A+K R L + + + V E E L R+ H +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--IKEKKVKYVKI-EKEVLTRLNGHPGI 64
Query: 743 VKLLMCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSLDW-SIRFSIAQGAAKGLAYL 799
+KL + QD L V EY PNG L + + GSLD RF A+ L YL
Sbjct: 65 IKLY--YTFQDEENLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAE-ILLALEYL 118
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS-QEGQSDDAMSCVAGSYG--- 855
H+ I+HRD+K NILLD +M ++ DFG AK L +S+ + S
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 856 ------------YIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y++PE K + SD+++ G ++ +++TGK P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G VYK + +GE VA+K++ EI+ L + H N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 749 CSGQDFNILVYEYMPNGSLADMLHE-KGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
+ LV+E+M D+ K R L S+ S +GLA+ H+ I
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
+HRD+K N+L++ E V ++ADFGLA++ S V + Y APE K
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY---VVTRW-YRAPELLLGDKG 175
Query: 868 -TEKSDVYSFGVVLMELVTGK 887
+ D++S G + EL++ +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 68/188 (36%), Positives = 97/188 (51%), Gaps = 21/188 (11%)
Query: 705 SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI--LVYEYM 762
+GE VAVK L + + ++ EI L + H N+VK CCS Q L+ EY+
Sbjct: 32 TGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822
P GSL D L + L+ + AQ +G+AYLH+ +HRD+ + N+LLD +
Sbjct: 91 PLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDND 143
Query: 823 MVPRVADFGLAKALQSQEGQ-----SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFG 877
+ ++ DFGLAKA+ EG +D S V + A E K + SDV+SFG
Sbjct: 144 RLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVF----WYAVECLKENKFSYASDVWSFG 197
Query: 878 VVLMELVT 885
V L EL+T
Sbjct: 198 VTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 75/236 (31%), Positives = 112/236 (47%), Gaps = 12/236 (5%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G G V+ VA+K L GT PE F E + + ++RH +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYAVV 70
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
S + I V E+M GSL D L E G L +A A G+AY+ +H
Sbjct: 71 SEEPIYI-VTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIER---MNYIH 125
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTE 869
RD+++ NIL+ +V ++ADFGLA+ ++ E A + APE A + T
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTI 182
Query: 870 KSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
KSDV+SFG++L ELVT R P N++++ V +GC L++L+
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRMPCPQGCPESLHELMK 237
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 684 LTEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHG 740
+T ++ +G G VY+ V K TVAVK L K +T V F E + ++H
Sbjct: 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHP 62
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
N+V+LL C+ + ++ E+M G+L D L E R ++ + +A + + YL
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 121
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS---YGYI 857
+HRD+ + N L+ + +VADFGL++ + D + AG+ +
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT------GDTYTAHAGAKFPIKWT 172
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVT 885
APE K + KSDV++FGV+L E+ T
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G+G S V KV + +G+ +AVK + ++ + + R E++ L + +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR-ELDILHKCNSPYIVGFYGA 67
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
+ EYM GSL +L K G + I IA KGL YLH I+
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKH--KII 123
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT 868
HRDVK NIL+++ ++ DFG++ L + ++ G+ Y+APE +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF------VGTSSYMAPERIQGNDYS 177
Query: 869 EKSDVYSFGVVLMELVTGKRPNDPS 893
KSD++S G+ L+EL TG+ P P
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPE 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVK--RLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
IG G VYK LK VAVK R T P+ + F E E L + H N+VKL+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRS---TLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
C + +V E +P GSL L +K ++ ++ S+ AA G+ YL +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLESKNC-- 114
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI-----APEY 861
+HRD+ + N L+ V +++DFG+++ + + + V+ I APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR-------EEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTG 886
+ T +SDV+S+G++L E +
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 12/211 (5%)
Query: 685 TEQNLIGSGGSCRVYKVKLKSGETVAVKRL-LGGTHKPETETVFR---SEIETLGRVRHG 740
T+ ++G G VY G+ +AVK++ L ++ E + E++ L ++H
Sbjct: 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
N+V+ L C + + E++P GS++ +L+ R G L + + G+AYLH
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK--ALQSQEGQSDDAMSCVAGSYGYIA 858
N+CV VHRD+K +N++L + ++ DFG A+ A G + + + G+ ++A
Sbjct: 120 NNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
PE KSD++S G + E+ TGK P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 86/270 (31%), Positives = 117/270 (43%), Gaps = 35/270 (12%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G G V+ VA+K L GT PE F E + + ++RH +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 70
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGS-LDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
S + I V EYM GSL D L KG G L +A A G+AY+ V
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 124
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT 868
HRD+++ NIL+ +V +VADFGLA+ ++ E A + APE A + T
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFT 181
Query: 869 EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRM 928
KSDV+SFG++L EL T R P V L ERG RM
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGM---------VNREVLDQVERGY----------RM 222
Query: 929 DLSTCDYEEAEKVLNVALMCTSDFPINRPS 958
C E E + ++ C P RP+
Sbjct: 223 ---PCPPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+GSG V+ K + VA+K + G +E F E + + ++ H N+V+L C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
+ Q +V EYM NG L + L E R G L + + + YL ++ +H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNGF---IH 123
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS---YGYIAPEYAYTKK 866
RD+ + N L+ + V +V+DFGLA+ + DD + G+ + PE +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVL------DDQYTSSQGTKFPVKWAPPEVFDYSR 177
Query: 867 VTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
+ KSDV+SFGV++ E+ + GK P + R+ + S G +L
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYE----------RFSNSEVVESVSAGY-----RLYR 222
Query: 926 PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
P++ +V + C + P +RP+ ++++ L
Sbjct: 223 PKL--------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETE---TVFRSEIETLGRVRHGNVVK 744
L+G G RVY + +G +AVK++ PET+ EI+ L ++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
C + + EYMP GS+ D L G+L ++ + +G+ YLH++
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
IVHRD+K NIL D+ ++ DFG +K LQ+ M V G+ +++PE
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISG 181
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRP 889
+ K+DV+S G ++E++T K P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 74/248 (29%), Positives = 125/248 (50%), Gaps = 22/248 (8%)
Query: 687 QNLIGSGGSCRVYKVKLKSG----ETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGN 741
+ +IG+G V + +LK VA+K L G T K + F SE +G+ H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD--FLSEASIMGQFDHPN 66
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
++ L + +++ E+M NG+L L + G + +G A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA-MSCVAGSYG--YIA 858
VHRD+ + NIL+++ +V +V+DFGL++ L ++ SD S + G + A
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTA 179
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPN-DPSFGENKDIVRWVTEATLSSPERGC 916
PE +K T SDV+S+G+V+ E+++ G+RP D S N+D++ + + P C
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIEQDYRLPPPMDC 236
Query: 917 CRDLNQLI 924
L+QL+
Sbjct: 237 PTALHQLM 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRS---EIETLGRVRHGNVVK 744
+G G VYK + ++G+ VA+K + E + EI L + +VK
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV-------PVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
+V EY GS++D++ K + +L +I KGL YLH++
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSN-- 118
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
+HRD+K+ NILL+ E ++ADFG++ L + + V G+ ++APE
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK----RNTVIGTPFWMAPEVIQE 173
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRPN 890
K+D++S G+ +E+ GK P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 12/213 (5%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+ E + +G G V K +LK+ + + + P+ + E+E + +V
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 744 KLL-MCCSGQDFNI-LVYEYMPNGSLADMLHE-KGRSGSLDWSIRFSIAQGAAKGLAYLH 800
K +I + EY GSL + + K R G + + IA+ KGL+YLH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
+ I+HRD+K NILL + ++ DFG+ S E + A + S+ Y+APE
Sbjct: 123 SR---KIIHRDIKPSNILLTRKGQVKLCDFGV-----SGELVNSLAGTFTGTSF-YMAPE 173
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPS 893
K + SDV+S G+ L+E+ + P P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 689 LIGSGGSCRVYKV-KLKSGETVAVKRLLGGTHKPETE---TVFRSEIETLGRVRHGNVVK 744
L+G G RVY + +G +A K++ PET + EI+ L ++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 745 LLMCCS--GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
C + + EYMP GS+ D L G+L S+ + +G++YLH++
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSN 125
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
IVHRD+K NIL D+ ++ DFG +K LQ+ S + V G+ +++PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI-CMSGTGIRSVTGTPYWMSPEVI 181
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ K+DV+S G ++E++T K P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 76/255 (29%), Positives = 125/255 (49%), Gaps = 38/255 (14%)
Query: 687 QNLIGSGGSCRV----YKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
+ +IG+G V K+ K VA+K L G + + F SE +G+ H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNI 67
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ------GAAKGL 796
+ L + ++V EYM NGSL L + G +F++ Q G A G+
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDG------QFTVIQLVGMLRGIASGM 119
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
YL + VHRD+ + NIL+++ +V +V+DFGL++ L+ DD + G
Sbjct: 120 KYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE------DDPEAAYTTRGGK 170
Query: 857 I-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPN-DPSFGENKDIVRWVTEATL 909
I APE +K T SDV+S+G+V+ E+++ G+RP + S N+D+++ + E
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS---NQDVIKAIEEGYR 227
Query: 910 SSPERGCCRDLNQLI 924
C L+QL+
Sbjct: 228 LPAPMDCPAALHQLM 242
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 72/216 (33%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPET--ETVFRSEIETLGRVRHGNVVKLL 746
+G GG RV VK+KS T A+K + H ET + SE E L H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV-KKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 747 MCCSGQDFNILVY---EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+ +D +Y EY G L +L ++G +++ RF IA YLHN
Sbjct: 60 --RTFKD-KKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFYIAC-VVLAFEYLHNR- 112
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
I++RD+K N+LLD+ ++ DFG AK L+S + + G+ Y+APE
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFC-GTPEYVAPEIIL 165
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
K D +S G++L EL+TG+ P FGE+ +
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPP----FGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 84/287 (29%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG 740
L LT +IG G V + + +G+ VAVK + T F E + ++ H
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHK 59
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSG-SLDWSIRFSIAQGAAKGLAYL 799
N+V+LL I V E M G+L + L +GR+ S+ ++FS+ A+G+ YL
Sbjct: 60 NLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYL 116
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
+ +VHRD+ + NIL+ + V +V+DFGLA+ D++ V + AP
Sbjct: 117 ESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVK----WTAP 166
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919
E KK + KSDV+S+GV+L E+ + R P K++ V + P GC D
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEKGYRMEPPEGCPAD 225
Query: 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ L +++C E E P RPS ++ E L
Sbjct: 226 VYVL------MTSC--WETE-------------PKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 67/308 (21%)
Query: 690 IGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+G G +VYK +L S +VA+K L +P+ + FR E E + ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADML-----HEKGRSG--------SLDWSIRFSIAQ 790
LL C+ + +++EY+ +G L + L H + SLD S IA
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 791 GAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS 848
A G+ YL H+ VHRD+ + N L+ + +++DFGL S++ S D
Sbjct: 132 QIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGL-----SRDIYSADYYR 181
Query: 849 CVAGS---YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFG-ENKDIVRW 903
+ S ++ PE K T +SD++SFGVVL E+ + G +P +G N++++
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY---YGFSNQEVIEM 238
Query: 904 V-TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALM--CTSDFPINRPSMR 960
+ + L PE C R+ ALM C ++ P RP +
Sbjct: 239 IRSRQLLPCPE-DC--------PARV---------------YALMIECWNEIPARRPRFK 274
Query: 961 RVVELLRV 968
+ LR
Sbjct: 275 DIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRL----LGGTHKPETETVFRSEIETLGRVRHGNVVK 744
I G RV+ K KS G+ A+K + + ++ + V +E + L + + VVK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ--VDQVL-TERDILSQAQSPYVVK 57
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSI-RFSIAQGAAKGLAYLHNDC 803
L G+ LV EY+P G LA +L GSLD + R IA+ L YLH++
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAE-IVLALEYLHSN- 112
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKA--LQSQEGQSDDAMSC--VAGSYGYIAP 859
I+HRD+K NIL+D+ ++ DFGL+K ++ Q +DD + G+ YIAP
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E + ++ D +S G +L E + G P
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 37/285 (12%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
LT +GSG V+ K ++ VA+K + G +E F E + + ++ H +V
Sbjct: 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLV 62
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+L C+ Q +V E+M NG L + L + R G L + S+ Q +G+ YL +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERN- 119
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAK-ALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
+ +HRD+ + N L+ + V +V+DFG+ + L + S A V S PE
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS----PPEVF 173
Query: 863 YTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921
K + KSDV+SFGV++ E+ T GK P + N ++V ++
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRG-------------F 218
Query: 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+L P++ T V V C + P RP+ ++ +
Sbjct: 219 RLYRPKLASMT--------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-19
Identities = 70/219 (31%), Positives = 113/219 (51%), Gaps = 25/219 (11%)
Query: 684 LTEQNLIGSGGSCRVYK-VKLKSGETVAVK---RLLGGTHKPETETVFRSEIETLGRVRH 739
L ++GSG VYK + + GETV + ++L T P+ F E + + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 740 GNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHE-KGRSGS---LDWSIRFSIAQGAAKG 795
++V+LL C LV + MP+G L D +HE K GS L+W ++ AKG
Sbjct: 69 PHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKG 121
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ--SDDAMSCVAGS 853
+ YL +VHRD+ + N+L+ + ++ DFGLA+ L+ E + +D +
Sbjct: 122 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK-- 176
Query: 854 YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
++A E + +K T +SDV+S+GV + EL+T G +P D
Sbjct: 177 --WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 23/199 (11%)
Query: 696 CRVYKVKLKSGETVAVKRLLGGTHKPETE----TVFRSEIETLGRVRHGNVVKLL-MCCS 750
CR +GE VAVK L KPE+ + EIE L + H N+VK +C
Sbjct: 23 CRYDPEGDNTGEQVAVKSL-----KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 77
Query: 751 GQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
I L+ E++P+GSL + L +L +++++ KG+ YL + VH
Sbjct: 78 DGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ--ICKGMDYLGSR---QYVH 132
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ---SDDAMSCVAGSYGYIAPEYAYTKK 866
RD+ + N+L+++E ++ DFGL KA+++ + DD S V + APE K
Sbjct: 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYAPECLIQSK 188
Query: 867 VTEKSDVYSFGVVLMELVT 885
SDV+SFGV L EL+T
Sbjct: 189 FYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 20/237 (8%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH--KPETETVFRSEIETLGRVRH 739
H +IG G +V V+ + + + A+K + K V E L + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNH 59
Query: 740 GNVVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
+V + S QD LV + + G L L +K + + ++F I + L
Sbjct: 60 PFLVN--LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS--EEQVKFWICE-IVLALE 114
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
YLH+ I+HRD+K NILLD + + DF +A + + +G+ GY+
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS----TSGTPGYM 166
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVTGKRP-NDPSFGENKDIVRWVTEATLSSPE 913
APE + + D +S GV E + GKRP S I A + P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA 223
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 81/286 (28%), Positives = 120/286 (41%), Gaps = 41/286 (14%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
L IG G V + G VAVK + T F +E + ++RH N+V
Sbjct: 8 LKLLQTIGKGEFGDVM-LGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 744 KLLMCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
+LL + + +V EYM GSL D L +GRS L + + + YL +
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
VHRD+ + N+L+ + V +V+DFGL K S + D V + APE
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVK----WTAPEAL 171
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA-TLSSPERGCCRDLN 921
KK + KSDV+SFG++L E+ + R P KD+V V + + +P+ GC
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPD-GC----- 224
Query: 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
V +V C RPS ++ E L
Sbjct: 225 ----------------PPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G+G V+ VA+K L G+ PE F +E + +++H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRLYAVV 70
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGS-LDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
+ + I + EYM NGSL D L K G L + +A A+G+A++ +
Sbjct: 71 TQEPIYI-ITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT 868
HRD+++ NIL+ + ++ADFGLA+ ++ E + + + APE T
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF---PIKWTAPEAINYGTFT 181
Query: 869 EKSDVYSFGVVLMELVTGKR 888
KSDV+SFG++L E+VT R
Sbjct: 182 IKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
IGSG V+ VA+K + G E F E + + ++ H +V+L C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED---FIEEAQVMMKLSHPKLVQLYGVC 68
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
+ + LV+E+M +G L+D L + + G + +G+AYL + V +H
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSNV---IH 123
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS---YGYIAPEYAYTKK 866
RD+ + N L+ V +V+DFG+ + + DD + G+ + +PE K
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVL------DDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 867 VTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
+ KSDV+SFGV++ E+ + GK P + N ++V T+++ R L
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENR--SNSEVVE-----TINAGFR--------LYK 222
Query: 926 PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
PR+ S YE + C + P +RPS ++ L
Sbjct: 223 PRL-ASQSVYE-------LMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVV--- 743
+IG G +VYK + K+G+ VA+K + + E + E L + H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSNHPNIATFY 69
Query: 744 -----KLLMCCSGQDFNILVYEYMPNGSLADM---LHEKGRSGSLDWSIRFSIAQGAAKG 795
K Q + LV E GS+ D+ L +KG+ +W I + I + +G
Sbjct: 70 GAFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAY-ILRETLRG 125
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
LAYLH + V +HRD+K NILL ++ DFG++ L S G+ + + + Y
Sbjct: 126 LAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN---TFIGTPY- 178
Query: 856 YIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
++APE +SDV+S G+ +EL GK P
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 39/280 (13%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHGNVVKLLM 747
+G+G V+ VAVK T KP + +V F +E + ++H +VKL
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVK-----TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 748 CCSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ + I+ E+M GSL D L ++G L I FS AQ A+G+A++
Sbjct: 69 VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFS-AQ-IAEGMAFIEQR---N 122
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
+HRD+++ NIL+ A +V ++ADFGLA+ ++ E + + + APE
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIKWTAPEAINFGS 179
Query: 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926
T KSDV+SFG++LME+VT R P N +++R + ERG P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIR--------ALERG-------YRMP 223
Query: 927 RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
R + C E++ N+ + C + P RP+ + +L
Sbjct: 224 RPE--NC----PEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 690 IGSG--GSCRVYKVKLKSGE--TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
+G G GS +KSG+ VAVK L + R E + ++ H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR-EASVMAQLDHPCIVRL 61
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ C G+ +LV E P G L L ++ D +A A G+AYL +
Sbjct: 62 IGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESK--- 114
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY--GYIAPEYAY 863
VHRD+ + N+LL +++DFG+++AL + SD + AG + + APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA---GSDYYRATTAGRWPLKWYAPECIN 171
Query: 864 TKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENK--DIVRWVTEAT-LSSPERGCCRD 919
K + KSDV+S+GV L E + G +P +GE K +++ + L PE C ++
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKP----YGEMKGAEVIAMLESGERLPRPE-ECPQE 226
Query: 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969
+ ++ L C P +RP+ + R D
Sbjct: 227 IYSIM---------------------LSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHGNVVKLLM 747
+G+G V+ + VAVK L KP T +V F E + ++H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-----KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 748 CCSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ ++ ++ EYM GSL D L ++G L I FS AQ A+G+AY+
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS-AQ-IAEGMAYIERK---N 123
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
+HRD+++ N+L+ ++ ++ADFGLA+ ++ E + + + APE
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF---PIKWTAPEAINFGS 180
Query: 867 VTEKSDVYSFGVVLMELVT-GKRP 889
T KSDV+SFG++L E+VT GK P
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 35/212 (16%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFR--------SEIETLGRVRHG 740
+G+G RV V+ K SG+ A+K L K + + + +E L +RH
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKIL----SKAK---IVKLKQVEHVLNEKRILQSIRHP 61
Query: 741 NVVKLLMCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
+V + S QD + L V EY+P G L L + GR + RF AQ L Y
Sbjct: 62 FLVN--LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF-PEPVA-RFYAAQVVL-ALEY 116
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS-CVAGSYGYI 857
LH+ IV+RD+K N+LLD++ ++ DFG AK + + C G+ Y+
Sbjct: 117 LHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV------KGRTYTLC--GTPEYL 165
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
APE +K + D ++ G+++ E++ G P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRS---EIETLGRVRHGNVVKL 745
+G G VYK + K+GE VA+K++ E E + + EI L ++H N+VKL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR---LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 746 L--MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
L + + + LV+EY L L ++ S + I+ SI +GLAY H+
Sbjct: 64 LDVIHTERKLY--LVFEYCDM-DLKKYLDKRPGPLSPNL-IK-SIMYQLLRGLAYCHSHR 118
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE--- 860
I+HRD+K NIL++ + V ++ADFGLA+A V + Y APE
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---VVTLW-YRAPEILL 171
Query: 861 --YAYTKKVTEKSDVYSFGVVLMELVTGK 887
Y+ V D++S G + E++TGK
Sbjct: 172 GSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 75/243 (30%), Positives = 113/243 (46%), Gaps = 39/243 (16%)
Query: 659 STSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGG 717
S+S S S +E L N IGSG VYKV + +G A+K ++ G
Sbjct: 57 SSSSSASGSAPSAAKSLSE------LERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYG 109
Query: 718 THKPETETVFRS---EIETLGRVRHGNVVKLL-MCCSGQDFNILVYEYMPNGSLADMLHE 773
H+ +TV R EIE L V H NVVK M + +L+ E+M GSL
Sbjct: 110 NHE---DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSL------ 159
Query: 774 KGRSGSLDWSIRF--SIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831
G+ +F +A+ G+AYLH IVHRD+K N+L+++ ++ADFG
Sbjct: 160 ---EGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEK-----SDVYSFGVVLMELVTG 886
+++ L Q+ D + G+ Y++PE T D++S GV ++E G
Sbjct: 214 VSRIL----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
Query: 887 KRP 889
+ P
Sbjct: 270 RFP 272
|
Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 688 NLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE----TVFRSEIETLGRVRHGNV 742
+G G VYK + ++G VA+K++ G K + T R EI+ L ++H N+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNI 64
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGL 796
+ LL + LV+E+M L ++ +K SI + A + +GL
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIKDK--------SIVLTPADIKSYMLMTLRGL 115
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
YLH++ I+HRD+K +N+L+ ++ V ++ADFGLA++ G + M+ + Y
Sbjct: 116 EYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF----GSPNRKMTHQVVTRWY 168
Query: 857 IAPEYAY-TKKVTEKSDVYSFGVVLMELVTGK 887
APE + + D++S G + EL+
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-17
Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 29/171 (16%)
Query: 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGT 544
+ L G +P I++L LQ + L N G +P +L S+T+L VL+LS N G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 545 IPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQ--FNISHNKLYGEVPSDFDHDLFI 602
IP LG L L L+L+ N L+G +P L L++ FN +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT------------------ 523
Query: 603 SSLLDNPGLCSPDLKPLPPCSKTKPGTIYIVVILSICVILL---VGSLVWF 650
DN GLC + L C I + + V L + ++ W+
Sbjct: 524 ----DNAGLCG--IPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWW 568
|
Length = 623 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 689 LIGSGGSCRVYKV-KLKSGETVAVKRLLGGTHKPETE---TVFRSEIETLGRVRHGNVVK 744
L+G G RVY +G +AVK++ PET EI+ L + H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 745 LLMCCSG-QDFNILVY-EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
C + + ++ E+MP GS+ D L G+L ++ + +G++YLH++
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSN 125
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
IVHRD+K NIL D+ ++ DFG +K LQ+ S M V G+ +++PE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI-CLSGTGMKSVTGTPYWMSPEVI 181
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ K+D++S G ++E++T K P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 28/211 (13%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRS---EIETLGRVRHGNVVK 744
++G G V K + K +GE VA+K+ + E V ++ E++ L ++RH N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKE---SEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH-NDC 803
L + LV+EY+ +L ++L E G ++R I Q + +AY H ++
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELL-EASPGGLPPDAVRSYIWQ-LLQAIAYCHSHN- 120
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE--- 860
I+HRD+K NIL+ V ++ DFG A+AL+++ VA + Y APE
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--PLTDYVATRW-YRAPELLV 174
Query: 861 --YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y K V DV++ G ++ EL+ G P
Sbjct: 175 GDTNYGKPV----DVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VAVK L + + F E E L ++H ++VK C D I+V+EYM +G L
Sbjct: 38 VAVKTLKDASDNARKD--FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 769 DMLHEKGRSG----------SLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818
L G L S IAQ A G+ YL + VHRD+ + N L
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCL 152
Query: 819 LDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGV 878
+ ++ ++ DFG+++ + S + + + ++ PE +K T +SDV+S GV
Sbjct: 153 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSLGV 210
Query: 879 VLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924
VL E+ T GK+P N +++ +T+ + R C +++ L+
Sbjct: 211 VLWEIFTYGKQPWYQL--SNNEVIECITQGRVLQRPRTCPKEVYDLM 255
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 82/301 (27%), Positives = 125/301 (41%), Gaps = 56/301 (18%)
Query: 688 NLIGSGGSCRVYKVKLK------SGET-VAVKRLLGGTHKPETETVFRSEIETLGRVRHG 740
N +GSG VY+ SG VAVK L G E + F E + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHP 59
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLH----EKGRSGSLDWSIRFSIAQGAAKGL 796
N+VKLL C + ++ E M G L L E+ L I AKG
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 797 AYLHNDCVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQS-----QEGQSDDA 846
YL +HRD+ + N L+ DA+ V ++ DFGLA+ + +EG+
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 847 MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVT 905
+ ++APE K T +SDV+SFGV++ E++T G++P P+ N+++++ VT
Sbjct: 177 VR-------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-PAL-NNQEVLQHVT 227
Query: 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965
C + QL+ C + P RP+ R+ E+
Sbjct: 228 AGGRLQKPENCPDKIYQLM---------------------TNCWAQDPSERPTFDRIQEI 266
Query: 966 L 966
L
Sbjct: 267 L 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 728 RSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRS-----GSLDW 782
++E + L + H N+++ ++V EY P G+LA+ + ++ S L +
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106
Query: 783 SIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKALQSQEG 841
++ +A L ++H I+HRD+K+ NILLD +MV ++ DFG++K L S+
Sbjct: 107 FVQILLA------LHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156
Query: 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KDI 900
V G+ YI+PE K +KSD+++ G VL EL + KR + N +
Sbjct: 157 ----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE---AANLPAL 209
Query: 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLST 932
V + T + DL QLI ++L
Sbjct: 210 VLKIMSGTFAPISDRYSPDLRQLILSMLNLDP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 690 IGSGGSCRVY-KVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G S VY + + +G+ VA+K++ +P+ E + +EI + +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELII-NEILVMRENKHPNIVNYLDS 84
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
D +V EY+ GSL D++ E +D ++ + + L +LH++ V +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQV---I 137
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT 868
HRD+KS NILL + ++ DFG + ++ + S + G+ ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWMAPEVVTRKAYG 193
Query: 869 EKSDVYSFGVVLMELVTGKRP 889
K D++S G++ +E+V G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL--- 745
IG G V KV+ KS G+ + K + G + + SE+ L ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 746 LMCCSGQDFNILVYEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
++ S Q I V EY G LA ++ K ++ + I L HN
Sbjct: 68 IIDRSNQTLYI-VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 805 P--AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
P ++HRD+K NI LDA ++ DFGLAK L S A + V Y Y++PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH---DSSFAKTYVGTPY-YMSPEQL 182
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRP 889
EKSD++S G ++ EL P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 21/195 (10%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VAVK L T + F+ E E L ++H ++VK C D I+V+EYM +G L
Sbjct: 38 VAVKALKDPTLAARKD--FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 769 DMLHEKG-------------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
L G G L S IA A G+ YL + VHRD+ +
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATR 152
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYS 875
N L+ A ++ ++ DFG+++ + S + + + ++ PE +K T +SDV+S
Sbjct: 153 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWS 210
Query: 876 FGVVLMELVT-GKRP 889
FGV+L E+ T GK+P
Sbjct: 211 FGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 44/266 (16%)
Query: 690 IGSGGSCRVYKVK---LKSGE---TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
IG G RV++ + L E VAVK L + + F+ E + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIV 71
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADML--------HEKGRSGS-----------LDWSI 784
KLL C+ L++EYM G L + L S S L +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 785 RFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE---G 841
+ IA+ A G+AYL VHRD+ + N L+ MV ++ADFGL++ + S +
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFG-ENKD 899
+DA+ ++ PE + + T +SDV+++GVVL E+ + G + P +G +++
Sbjct: 189 SENDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ---PYYGMAHEE 240
Query: 900 IVRWVTEAT-LSSPERGCCRDLNQLI 924
++ +V + LS P+ C +L L+
Sbjct: 241 VIYYVRDGNVLSCPD-NCPLELYNLM 265
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 7e-17
Identities = 47/139 (33%), Positives = 69/139 (49%), Gaps = 31/139 (22%)
Query: 56 QQSPCNWTGITCETQNQS----VDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGT 111
QQ P W+G C+ + +DG+ L L G PN ++R L+++NLS N G
Sbjct: 400 QQHP--WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN 457
Query: 112 LSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVL 171
+ +G + +L+VLDLS N+F+G IPES G+ L
Sbjct: 458 IP------------------PSLGSIT-------SLEVLDLSYNSFNGSIPESLGQLTSL 492
Query: 172 KVLNLGGNLLSGLIPSFLG 190
++LNL GN LSG +P+ LG
Sbjct: 493 RILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 684 LTEQNLIGSGGSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
LT +G G +V K TVAVK L + + SE+E + +
Sbjct: 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 72
Query: 738 -RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHE---KGRSGSLDWSIR-------- 785
+H N++ LL C+ + +V EY +G+L D L G S D
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 786 --FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843
S A A+G+ +L + +HRD+ + N+L+ + V ++ADFGLA+ +
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI---- 185
Query: 844 DDAMSCVAGS--YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885
D G ++APE + + T +SDV+SFGV+L E+ T
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 685 TEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
T IG G VYK + ++ + VA+K + + E E + + EI+ L + R +
Sbjct: 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-EIQFLSQCRSPYIT 62
Query: 744 KLLMCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
K + ++ EY GS D+L + G LD + I + GL YLH +
Sbjct: 63 KYYGSFLK-GSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
+HRD+K+ NILL E ++ADFG++ Q + + G+ ++APE
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPN 890
EK+D++S G+ +EL G+ P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 20/194 (10%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VAVK L + + F+ E E L ++H ++V+ C+ ++V+EYM +G L
Sbjct: 38 VAVKALKEASESARQD--FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 769 DMLHEKGRS------------GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHN 816
L G G L +IA A G+ YL + VHRD+ + N
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRN 152
Query: 817 ILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSF 876
L+ +V ++ DFG+++ + S + + + ++ PE +K T +SD++SF
Sbjct: 153 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTESDIWSF 210
Query: 877 GVVLMELVT-GKRP 889
GVVL E+ T GK+P
Sbjct: 211 GVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
LT +G+G V K + VA+K + G+ +E F E + + ++ H +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKL 61
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ------GAAKGL 796
V+L C+ Q +V EYM NG L + L E G+ RF +Q +G+
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGM 113
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY-- 854
AYL + +HRD+ + N L+D + +V+DFGL++ + D+ S V +
Sbjct: 114 AYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-----LDDEYTSSVGSKFPV 165
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
+ PE K + KSDV++FGV++ E+ + GK P +
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
L+G G V+K LK VAVK + E + F SE L + H N+VKL+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAI 807
C+ + +V E +P G L +K ++F++ AA G+AYL + +C
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKNC---- 114
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG----SYGYIAPEYAY 863
+HRD+ + N L+ V +++DFG+++ Q DD + +G + APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIKWTAPEALN 167
Query: 864 TKKVTEKSDVYSFGVVLME 882
+ + +SDV+S+G++L E
Sbjct: 168 YGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 684 LTEQNLIGSGGSCRVYK-VKLKSGET----VAVKRLLGGTHKPETETVFRSEIETLGRVR 738
L + L+GSG V+K + + G++ VA+K + + + +T + +G +
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR-QTFQEITDHMLAMGSLD 67
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H +V+LL C G LV + P GSL D H + SLD + AKG+ Y
Sbjct: 68 HAYIVRLLGICPGASLQ-LVTQLSPLGSLLD--HVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
L +VHR++ + NILL ++ + ++ADFG+A L + + S ++A
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY--FYSEHKTPIKWMA 179
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
E + T +SDV+S+GV + E+++ G P
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 73/253 (28%), Positives = 114/253 (45%), Gaps = 24/253 (9%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETET-VFRSEIETLGRVRHGNVVKLLMC 748
IG G ++Y K KS V + + T P E + E+ L +++H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 749 CSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLD----WSIRFSIAQGAAKGLAYLHNDC 803
+V EY G L ++ ++G S D W ++ S+ GL ++H+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDR- 120
Query: 804 VPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
I+HRD+KS NI L MV ++ DFG+A+ L + A +CV Y Y++PE
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---MELAYTCVGTPY-YLSPEIC 174
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KDIVRWVTEATLSSPERGCCRDLN 921
+ K+D++S G VL EL T K P + G N +V + + + RDL
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE---GNNLHQLVLKICQGYFAPISPNFSRDLR 231
Query: 922 QLIDPRMDLSTCD 934
LI +S D
Sbjct: 232 SLISQLFKVSPRD 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 37/204 (18%)
Query: 708 TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767
TVAVK L E + SE L +V H +V+KL CS +L+ EY GSL
Sbjct: 32 TVAVKMLKENASSSELRDLL-SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90
Query: 768 ADMLHEK--------GRSGSLDWSIRF-------------SIAQGAAKGLAYLHNDCVPA 806
L E G G+ + S S A ++G+ YL
Sbjct: 91 RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MK 147
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG-----YIAPEY 861
+VHRD+ + N+L+ +++DFGL++ + ++ S V S G ++A E
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED-------SYVKRSKGRIPVKWMAIES 200
Query: 862 AYTKKVTEKSDVYSFGVVLMELVT 885
+ T +SDV+SFGV+L E+VT
Sbjct: 201 LFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 26/223 (11%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLK-----SGET-VAVKRLLGGTHKPETETV--FRSEIETL 734
+L E +G G V+ K K GET V VK L + FR E++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL---QKTKDENLQSEFRRELDMF 62
Query: 735 GRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML------HEKGRSGSLDWSIRFSI 788
++ H NVV+LL C + + ++ EY G L L EK + L + ++
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE-GQSDDAM 847
A G+ +L N VHRD+ + N L+ ++ +V+ L+K + + E + +A+
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
+ ++APE + KSDV+SFGV++ E+ T G+ P
Sbjct: 180 IPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 18/184 (9%)
Query: 708 TVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPNGS 766
VAVK L H E E + SE++ + + H N+V LL C+ +++ EY G
Sbjct: 67 KVAVKMLKPTAHSSEREALM-SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 767 LADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVP 825
L + L K S L S + AKG+A+L + +C+ HRD+ + N+LL +
Sbjct: 126 LLNFLRRKRES-FLTLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNVLLTHGKIV 180
Query: 826 RVADFGLAKALQSQEGQSDDAMSCVAGS----YGYIAPEYAYTKKVTEKSDVYSFGVVLM 881
++ DFGLA+ + + D+ V G+ ++APE + T +SDV+S+G++L
Sbjct: 181 KICDFGLARDIMN------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 234
Query: 882 ELVT 885
E+ +
Sbjct: 235 EIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 3e-16
Identities = 73/214 (34%), Positives = 112/214 (52%), Gaps = 34/214 (15%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGG----THKPETETVFRSEIETLGRVR-HGNVV 743
+G G V+K + ++ E VA+K++ T T FR EI L + H N+V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT---FR-EIMFLQELGDHPNIV 70
Query: 744 KLLMCCSGQ-DFNI-LVYEYMPNGSLADMLHEKGRSGSL-DWSIRFSIAQGAAKGLAYLH 800
KLL + D +I LV+EYM D LH R+ L D R+ + Q K L Y+H
Sbjct: 71 KLLNVIKAENDKDIYLVFEYME----TD-LHAVIRANILEDVHKRYIMYQ-LLKALKYIH 124
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL-QSQEGQSDDAMS-CVAGSYGYIA 858
+ ++HRD+K NILL+++ ++ADFGLA++L + +E + ++ VA + Y A
Sbjct: 125 SG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW-YRA 180
Query: 859 PE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
PE YTK V D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
IGSG VYK + + +GE VA+K ++ + E + + EI L RH N+V
Sbjct: 8 IQRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEII-QQEISMLKECRHPNIVAY 65
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+D +V EY GSL D+ S I + + + KGLAYLH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-QIAY-VCRETLKGLAYLHETGK- 122
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIAPEYA 862
+HRD+K NILL + ++ADFG++ Q ++ G+ ++APE A
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 863 YTKKV---TEKSDVYSFGVVLMELVTGKRPN 890
++ K D+++ G+ +EL + P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 38/224 (16%)
Query: 684 LTEQN---LIGSGGSCRVYKVKLKSGE-TVAVKRLLGGTHKPETETVF----RSEIETLG 735
E ++G G VY + S + +A+K + PE ++ + EI
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI------PERDSRYVQPLHEEIALHS 60
Query: 736 RVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEK-GRSGSLDWSIRFSIAQGAAK 794
++H N+V+ L S F + E +P GSL+ +L K G + +I F Q +
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-ILE 119
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
GL YLH++ IVHRD+K N+L++ V +++DFG +K L + G+
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPCTETFTGT 172
Query: 854 YGYIAPEYAYTKKVTEK--------SDVYSFGVVLMELVTGKRP 889
Y+APE V +K +D++S G ++E+ TGK P
Sbjct: 173 LQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 66/219 (30%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
L+G G V K K K +G+ VA+K+ L + + EI L ++RH N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
+ LV+E++ + L D+ EK +G LD S +G+ + H+ I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL--EKYPNG-LDESRVRKYLFQILRGIEFCHSH---NI 121
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQS-QEGQSDDAMSCVAGSYGYIAPEY----- 861
+HRD+K NIL+ V ++ DFG A+ L + E +D VA + Y APE
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD----YVATRW-YRAPELLVGDT 176
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900
Y + V D+++ G ++ E++TG +P F + DI
Sbjct: 177 KYGRAV----DIWAVGCLVTEMLTG----EPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 676 NED-DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIET 733
NED + + L G+GGS V KVK + +G +A K + G K E++
Sbjct: 4 NEDLETISDLGA----GNGGS--VSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQI 56
Query: 734 LGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA 793
+ R +V ++ + E+M GSL D +++KG G + I IA
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKG--GPIPVEILGKIAVAVV 113
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
+GL YL+N V I+HRD+K NIL+++ ++ DFG++ L + + G+
Sbjct: 114 EGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT------FVGT 165
Query: 854 YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y++PE K T KSDV+S G+ ++EL GK P
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 7e-16
Identities = 65/202 (32%), Positives = 93/202 (46%), Gaps = 34/202 (16%)
Query: 705 SGETVAVKRLLGGTHKPETETV---FRSEIETLGRVRHGNVVKLLMCCSGQ---DFNILV 758
+G VA+K L T PE E FR E R+ H N+V LL SG+ V
Sbjct: 2 TGHEVAIKLLR--TDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGEAPPGLLFAV 57
Query: 759 YEYMPNGSLADMLHEKG-----RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVK 813
+EY+P +L ++L G +G L + Q LA HN IVHRD+K
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRL-------MLQ-VLDALACAHNQ---GIVHRDLK 106
Query: 814 SHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSC----VAGSYGYIAPEYAYTKK 866
NI++ +V DFG+ L +D A V G+ Y APE +
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP 165
Query: 867 VTEKSDVYSFGVVLMELVTGKR 888
VT SD+Y++G++ +E +TG+R
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 689 LIGSGGSCRVYKV-KLKSGETVAVKRLLGGTHKPETE---TVFRSEIETLGRVRHGNVVK 744
L+G G VY +G +AVK++ ET EI+ L +RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 745 LLMCC---SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
C + +I V EYMP GS+ D L G+L ++ + +G++YLH+
Sbjct: 69 YYGCLRDPEEKKLSIFV-EYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS 124
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
+ IVHRD+K NIL D+ ++ DFG +K +Q+ S + V G+ +++PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-CMSGTGIKSVTGTPYWMSPEV 180
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ K+DV+S ++E++T K P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 688 NLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHG 740
N IG G VY+ + SGE VA+K++ + + E + R EI L +RH
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 741 NVVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA----- 793
N+V+L G+ + LV EY LA +L + FS +Q
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLD--------NMPTPFSESQVKCLMLQL 117
Query: 794 -KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
+GL YLH + I+HRD+K N+LL + ++ADFGLA+ G M+
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY----GLPAKPMTPKVV 170
Query: 853 SYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGK 887
+ Y APE T D+++ G +L EL+ K
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 22/222 (9%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VA+ L G + F +E TLG+ H N+V+L + + ++V EYM NG+L
Sbjct: 36 VAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 769 DML--HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPR 826
L HE G L + G A G+ YL VH+ + +H +L+++++V +
Sbjct: 95 SFLRKHE----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCK 147
Query: 827 VADFGLAKALQSQEGQSDDAMSCVAGSYG--YIAPEYAYTKKVTEKSDVYSFGVVLMELV 884
++ F + QE +S+ + ++G + APE + SDV+SFG+V+ E++
Sbjct: 148 ISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
Query: 885 T-GKRPN-DPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924
+ G+RP D S +D+++ V + R C L+QL+
Sbjct: 203 SYGERPYWDMS---GQDVIKAVEDGFRLPAPRNCPNLLHQLM 241
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 73/229 (31%), Positives = 106/229 (46%), Gaps = 37/229 (16%)
Query: 675 FNEDD---ILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLL-GGTHKPETETVFRS 729
F++DD + L E IG G VY + +++ E VA+K++ G E
Sbjct: 8 FSKDDPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML--HEKGRSGSLDWSIRFS 787
E+ L ++RH N ++ C + LV EY GS +D+L H+K L +
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP----LQEVEIAA 119
Query: 788 IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847
I GA +GLAYLH+ +HRD+K+ NILL ++ADFG A + A
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV-------SPAN 169
Query: 848 SCVAGSYGYIAPEY-------AYTKKVTEKSDVYSFGVVLMELVTGKRP 889
S V Y ++APE Y KV DV+S G+ +EL K P
Sbjct: 170 SFVGTPY-WMAPEVILAMDEGQYDGKV----DVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 691 GSGGSCRVYKVKLKSGET--VAVKRLLGGTHKP-ETETVFRSEIETLGRVRHGNVVKL-- 745
GS G R + G+ VAVK L + K + F E + + H N+++L
Sbjct: 6 GSFGVVRRGEWSTSGGKVIPVAVKCL--KSDKLSDIMDDFLKEAAIMHSLDHENLIRLYG 63
Query: 746 ------LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL 799
LM +V E P GSL D L K G S A A G+ YL
Sbjct: 64 VVLTHPLM---------MVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYL 113
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG---SYGY 856
+ +HRD+ + NILL ++ ++ DFGL +AL Q++D + +
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL----PQNEDHYVMEEHLKVPFAW 166
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
APE T+ + SDV+ FGV L E+ T G+ P
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G S VY + + +G+ VA+K++ +P+ E + +EI + ++ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELII-NEILVMRENKNPNIVNYLDS 84
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
D +V EY+ GSL D++ E +D ++ + + L +LH++ ++
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT 868
HRD+KS NILL + ++ DFG + ++ + S + G+ ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWMAPEVVTRKAYG 193
Query: 869 EKSDVYSFGVVLMELVTGKRP 889
K D++S G++ +E+V G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 3e-15
Identities = 55/206 (26%), Positives = 106/206 (51%), Gaps = 14/206 (6%)
Query: 685 TEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
T IG G S V+ + + +G+ VA+K++ +P+ E + +EI + +++ N+V
Sbjct: 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELII-NEILVMKELKNPNIV 79
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
L D +V EY+ GSL D++ E +D + ++ + + L +LH +
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN- 134
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
++HRD+KS N+LL + ++ DFG + ++ + S + G+ ++APE
Sbjct: 135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWMAPEVVT 188
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRP 889
K K D++S G++ +E+V G+ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
V KL +D+ LV EY+ G A ++ G DW + IA+ G+ LH
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDW-AKQYIAE-VVLGVEDLH 114
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA-LQSQEGQSDDAMSCVAGSYGYIAP 859
I+HRD+K N+L+D ++ DFGL++ L++++ G+ Y+AP
Sbjct: 115 QR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---------FVGTPDYLAP 162
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN--KDIVR----WVTEA-TLSSP 912
E + SD +S G V+ E + G P + +I+ W E SP
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSP 222
Query: 913 ERGCCRDL-NQLI--DPRMDLSTCDYEEAEK 940
E DL N+L+ DP L Y+E +
Sbjct: 223 E---AVDLINRLLCMDPAKRLGANGYQEIKS 250
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+G G VYKVK L + A+K + LG + E E +EI L V H N++
Sbjct: 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIIS 63
Query: 745 LLMCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSL-----DWSIRFSIAQGAAKGLA 797
+ D N L V EY P G L+ + ++ + L W I + +GL
Sbjct: 64 YKE--AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQ 117
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
LH I+HRD+KS NILL A + ++ D G++K L+ G+ Y+
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN------MAKTQIGTPHYM 168
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
APE + + KSD++S G +L E+ T P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 3e-15
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 45/223 (20%)
Query: 687 QNLIGSG--GS-CRVYKVKLKSGETVAVKRLLGGTHKPETET-----VFRSEIETLGRVR 738
IGSG G C + +G VA+K++ + + R EI+ L +R
Sbjct: 5 LKPIGSGAYGVVCSAVDKR--TGRKVAIKKI----SNVFDDLIDAKRILR-EIKLLRHLR 57
Query: 739 HGNVVKL---LMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGS--LDWSIRFSIAQG 791
H N++ L L S +DFN +V E M D LH+ +S D I++ + Q
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELME----TD-LHKVIKSPQPLTDDHIQYFLYQ- 111
Query: 792 AAKGLAYLH--NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
+GL YLH N ++HRD+K NIL+++ ++ DFGLA+ + E +
Sbjct: 112 ILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 850 VAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
V + Y APE YTK + D++S G + EL+T K
Sbjct: 167 VVTRW-YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 684 LTEQNLIGSGGSCRVYK-VKLKSGET----VAVKRLLGGTHKPETETVFRSEIETLGRVR 738
L + ++GSG VYK + + GE VA+K L T P+ E + V
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVG 67
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHE-KGRSGS---LDWSIRFSIAQGAAK 794
V +LL C LV + MP G L D + E K R GS L+W ++ AK
Sbjct: 68 SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AK 120
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ--SDDAMSCVAG 852
G++YL +VHRD+ + N+L+ + ++ DFGLA+ L E + +D +
Sbjct: 121 GMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK- 176
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
++A E ++ T +SDV+S+GV + EL+T G +P D
Sbjct: 177 ---WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 688 NLIGSGGSCRVYKVKLKSGET----VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+IG G VY L + AVK L T E E + I + H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGI-IMKDFSHPNVL 59
Query: 744 KLL-MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
LL +C + ++V YM +G L + + + + ++ I F + AKG+ YL +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ--VAKGMEYLASK 117
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
VHRD+ + N +LD +VADFGLA+ + +E S + ++A E
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 863 YTKKVTEKSDVYSFGVVLMELVT 885
T+K T KSDV+SFGV+L EL+T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-15
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 1/103 (0%)
Query: 236 DSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRL 295
DS F+ L L + L G IP+ S L ++ I L N + G +P SL ++T+L L
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471
Query: 296 DISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNP 337
D+S N+ G++PE++ + SL LNLN N +G +P +L
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-15
Identities = 42/112 (37%), Positives = 62/112 (55%), Gaps = 2/112 (1%)
Query: 230 LIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNL 289
L G IP+ I KL L +++LS N + G IP S + S+E ++L N +G +PESL L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 290 TTLLRLDISQNNLTGNLPETIAAMSLE--SLNLNDNYFTGEIPESLASNPNL 339
T+L L+++ N+L+G +P + L S N DN IP A P+L
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHL 541
|
Length = 623 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 69/230 (30%), Positives = 98/230 (42%), Gaps = 34/230 (14%)
Query: 670 FQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRS 729
F V E D L +E+ + + VAVK L E F
Sbjct: 18 FGEVHLCEADGLQDFSEKAFAENDNADAP--------VLVAVKVLRPDASDNARED-FLK 68
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML--HEKGRSGSLDW--SIR 785
E++ L R+ N+ +LL C+ ++ EYM NG L L H SG S+
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 786 FS----IAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839
FS +A A G+ YL N VHRD+ + N L+ ++ADFG+++ L S
Sbjct: 129 FSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS- 182
Query: 840 EGQSDDAMSCVAGS----YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885
SD V G ++A E K T KSDV++FGV L E++T
Sbjct: 183 ---SD--YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 47/221 (21%)
Query: 686 EQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE-----TVFRSEIETLGRVR- 738
E IG G VYK + L +G VA+K++ P +E + R EI L ++
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLR-EIALLKQLES 57
Query: 739 --HGNVVKLLMCCSGQDFN-----ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG 791
H N+V+LL C G + LV+E++ + LA L + + G +I+ + Q
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ- 115
Query: 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM---S 848
+G+ +LH+ IVHRD+K NIL+ ++ ++ADFGLA+ M S
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY-------SFEMALTS 165
Query: 849 CVAGSYGYIAPE------YAYTKKVTEKSDVYSFGVVLMEL 883
V + Y APE YA D++S G + EL
Sbjct: 166 VVVTLW-YRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 689 LIGSGGSCRVYK-VKLKSGET----VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
++GSG VYK + + GE VA+K L T P+ E + V + +V
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVC 72
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHE-KGRSGS---LDWSIRFSIAQGAAKGLAYL 799
+LL C L+ + MP G L D + E K GS L+W ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG--QSDDAMSCVAGSYGYI 857
+VHRD+ + N+L+ ++ DFGLAK L + E ++ + ++
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK----WM 178
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
A E + T +SDV+S+GV + EL+T G +P D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G S VY + + +G+ VA+ R + +P+ E + +EI + ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAI-RQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDS 85
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
D +V EY+ GSL D++ E +D ++ + + L +LH++ ++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT 868
HRD+KS NILL + ++ DFG + ++ + + G+ ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPYWMAPEVVTRKAYG 194
Query: 869 EKSDVYSFGVVLMELVTGKRP 889
K D++S G++ +E++ G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 14/167 (8%)
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILV--YEYMPNGSLADML-HEKGRSGSLDWSIRF 786
EI L ++H N++ D N L+ EY G+L D + +KG+ + + +
Sbjct: 49 EIVILSLLQHPNIIAYYN--HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 787 SIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA 846
+A ++Y+H I+HRD+K+ NI L + ++ DFG++K L S+ A
Sbjct: 107 LFQIVSA--VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM---A 158
Query: 847 MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPS 893
+ V Y Y++PE K KSD+++ G VL EL+T KR D +
Sbjct: 159 ETVVGTPY-YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 684 LTEQNLIGSGGSCRVYK--VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHG 740
+ +++IG G +V + +K + A ++L F E+E L ++ H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLH-------------EKGRSGSLDWSIRFS 787
N++ LL C + + + EY P G+L D L E G + +L
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 788 IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847
A A G+ YL +HRD+ + N+L+ + ++ADFGL++ +E M
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRG---EEVYVKKTM 177
Query: 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885
+ ++A E T KSDV+SFGV+L E+V+
Sbjct: 178 GRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 687 QNLIGSGGSCRVYKVKLKSG---ETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNV 742
Q++IG G +V K ++K A+KR+ K + F E+E L ++ H N+
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNI 70
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA--------- 793
+ LL C + + L EY P+G+L D L +S L+ F+IA A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLR---KSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 794 -------KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA 846
+G+ YL +HRD+ + NIL+ V ++ADFGL++ QE
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKT 181
Query: 847 MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885
M + ++A E T SDV+S+GV+L E+V+
Sbjct: 182 MGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 65/227 (28%), Positives = 90/227 (39%), Gaps = 42/227 (18%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG- 740
L + IG G V K+ K SG +AVKR+ + E + +++ + R
Sbjct: 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR-LLMDLDVVMRSSDCP 63
Query: 741 NVVKL---------------LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR 785
+VK LM S F VYE K + I
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-----------VLKSV---IPEEIL 109
Query: 786 FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845
IA K L YL + I+HRDVK NILLD ++ DFG++ L ++ D
Sbjct: 110 GKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD 167
Query: 846 AMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRP 889
A G Y+APE +SDV+S G+ L E+ TGK P
Sbjct: 168 A-----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G V+K + + +G+ VA+K+ + P + + EI L +++H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH-NDCVPAI 807
+ LV+EY + L ++ EK G + I+ I Q + + + H ++C+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQ-TLQAVNFCHKHNCI--- 122
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY-----A 862
HRDVK NIL+ + ++ DFG A+ L G DD VA + Y APE
Sbjct: 123 -HRDVKPENILITKQGQIKLCDFGFARILT---GPGDDYTDYVATRW-YRAPELLVGDTQ 177
Query: 863 YTKKVTEKSDVYSFGVVLMELVTG 886
Y V DV++ G V EL+TG
Sbjct: 178 YGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 29/278 (10%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLL 746
++G GG V +++ +G+ A K+L K + E + +E + L +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+D LV M G L ++ G G + F A+ GL LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDLHRE---R 122
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
IV+RD+K NILLD R++D GL A++ EG++ + G+ GY+APE ++
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGL--AVEIPEGET---IRGRVGTVGYMAPEVVKNER 177
Query: 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW------VTEAT------LSSPER 914
T D + G ++ E++ GK P F + K+ V+ V E S R
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSP----FRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233
Query: 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDF 952
CR L DP L C E AE+V T++F
Sbjct: 234 SICRQLLTK-DPGFRLG-CRGEGAEEVKAHPFFRTANF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE----TVFRSEIETLGRVRHGNVVK 744
IG G VYK + +GE VA+K++ T ETE T R EI L + H N+VK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIR-EISLLKELNHPNIVK 63
Query: 745 LLMCCSGQDFNILVYEYMPNGSLA---DMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
LL ++ LV+E++ + L D G L S F + QG LA+ H+
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG----LAFCHS 118
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
V +HRD+K N+L++ E ++ADFGLA+A G + + Y APE
Sbjct: 119 HRV---LHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEI 171
Query: 862 AY-TKKVTEKSDVYSFGVVLMELVTGK 887
K + D++S G + E+VT +
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 64/198 (32%), Positives = 88/198 (44%), Gaps = 31/198 (15%)
Query: 704 KSGETVAVKRLLGG--THKPETETVFRSE---IETLGRVRHGNVVKLLMCCSGQDFNILV 758
K+GE A+K L G + E E++ E ET RH +V L C +D V
Sbjct: 22 KTGELYAIKALKKGDIIARDEVESL-MCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80
Query: 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG---AAK---GLAYLHNDCVPAIVHRDV 812
EY G L +H FS + AA GL YLH + IV+RD+
Sbjct: 81 MEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDL 127
Query: 813 KSHNILLDAEMVPRVADFGLAKALQSQEGQS-DDAMSCVAGSYGYIAPEYAYTKKVTEKS 871
K N+LLD E ++ADFGL K EG D S G+ ++APE T
Sbjct: 128 KLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182
Query: 872 DVYSFGVVLMELVTGKRP 889
D + GV++ E++ G+ P
Sbjct: 183 DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 688 NLIGSGGSCRVYKVKLKSG--ETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVK 744
++IG G +V K ++K A + + + F E+E L ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLH-------------EKGRSGSLDWSIRFSIAQG 791
LL C + + L EY P+G+L D L + +L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851
A+G+ YL +HRD+ + NIL+ V ++ADFGL++ QE M +
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRL- 173
Query: 852 GSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885
++A E T SDV+S+GV+L E+V+
Sbjct: 174 -PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 689 LIGSGGSCRVYKVKLKSGET-VAVKRLLGGTHKPE------TETVFRSEIETLGRVRHGN 741
+G+G RV+ V+ + E A+K + PE + V +E L V H
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVM----AIPEVIRLKQEQHV-HNEKRVLKEVSHPF 62
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+++L Q F ++ EY+P G L L GR + + F ++ L YLH+
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS--TGLFYASE-IVCALEYLHS 119
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
IV+RD+K NILLD E ++ DFG AK L+ D + G+ Y+APE
Sbjct: 120 K---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------DRTWTLCGTPEYLAPEV 169
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGKRP--NDPSFG 895
+K + D ++ G+++ E++ G P +D FG
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G G +VYK + K A +++ + E E F EI+ L +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVGLYEAY 71
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
++ ++ E+ G+L ++ E R G + IR+ + + + L +LH+ ++H
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTE 869
RD+K+ NILL + ++ADFG++ A Q D G+ ++APE + +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQKRDTF---IGTPYWMAPEVVACETFKD 182
Query: 870 -----KSDVYSFGVVLMELVTGKRPN 890
K+D++S G+ L+EL + P+
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPH 208
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 690 IGSG--GSCR--VYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
+GSG G + VYK++ K + VA+K L K + + R E E + ++ + +V++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID-VAIKVLKNENEKSVRDEMMR-EAEIMHQLDNPYIVRM 60
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ C + +LV E G L L G+ + S + + G+ YL
Sbjct: 61 IGVCEAEAL-MLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGK--- 114
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG-----YIAPE 860
VHRD+ + N+LL + +++DFGL+KAL +DD+ A S G + APE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKAL-----GADDSYY-KARSAGKWPLKWYAPE 168
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
+K + +SDV+S+G+ + E + G++P
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 13/229 (5%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G GG V ++K +G+ A K+L K + E + +E + L +V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
+D LV M G L ++ G G + F AQ GL +LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---RI 116
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
V+RD+K N+LLD R++D GLA L+ + + AG+ GY+APE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----KIKGRAGTPGYMAPEVLQGEVY 171
Query: 868 TEKSDVYSFGVVLMELVTGKRP--NDPSFGENKDIVRWVTEATLSSPER 914
D ++ G L E++ G+ P E +++ R E + P++
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G + VK K G+ +K + P+ R E+ L ++H N+V+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGS-------LDWSIRFSIAQGAAKGLAYLHN 801
+V +Y G L ++ + G LDW ++ +A L ++H+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKIN--AQRGVLFPEDQILDWFVQICLA------LKHVHD 119
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
I+HRD+KS NI L + ++ DFG+A+ L S + A +C+ Y Y++PE
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS---TVELARTCIGTPY-YLSPEI 172
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGK 887
+ KSD+++ G VL E+ T K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 68/238 (28%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 670 FQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP-ETET 725
F R N+ ++ + +GSG +V +G VA+K+L +P ++
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAI 56
Query: 726 ----VFRSEIETLGRVRHGNVVKLLMC----CSGQDFN--ILVYEYMPNGSLADMLHEKG 775
+R E+ L + H NV+ LL S +DF LV M AD L+
Sbjct: 57 HAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG----AD-LNNIV 110
Query: 776 RSGSL-DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834
+ L D I+F + Q +GL Y+H+ I+HRD+K NI ++ + ++ DFGLA+
Sbjct: 111 KCQKLSDDHIQFLVYQ-ILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
Query: 835 ALQSQEGQSDDAMSCVAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
+DD M+ + Y APE Y + V D++S G ++ EL+TGK
Sbjct: 167 -------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 690 IGSGGSCRVYKVKLKSGET-VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G V+ +L++ T VAVK T P+ + F E L + H N+V+L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
C+ + +V E + G L +G + I+ + + AA G+ YL + +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ--MVENAAAGMEYLESKHC---I 116
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI-----APEYAY 863
HRD+ + N L+ + V +++DFG+++ + +D + G I APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-------EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 864 TKKVTEKSDVYSFGVVLME 882
+ + +SDV+SFG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 689 LIGSGGSCRVYKVKLKSG-------ETVAVKRLLGGTHKPETETVFRSEIETLG----RV 737
+GSG VYKV+ K+ + + V G K E + + + ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADM---LHEKGRSGSLD--WSIRFSIAQGA 792
RH N+V+ D +V + + L + L EK + + + W+I +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
L YLH + IVHRD+ +NI+L + + DFGLAK Q Q + ++ V G
Sbjct: 126 ---LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQP---ESKLTSVVG 175
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ Y PE + EK+DV++FG +L ++ T + P
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G V V+ ++ G+ +K+L E + L +++H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 749 CSGQDFNI-LVYEYMPNGSLADMLHE-KGR----SGSLDWSIRFSIAQGAAKGLAYLHND 802
G+D + +V + G L L E KG+ + ++W ++ ++A L YLH
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLHEK 121
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
I+HRD+K+ N+ L + +V D G+A+ L++Q D S + G+ Y++PE
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ----CDMASTLIGTPYYMSPELF 174
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGK 887
K KSDV++ G + E+ T K
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 23/222 (10%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIE 732
F +DD ++ IG G VY + +++ E VA+K++ G E E+
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 733 TLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML--HEKGRSGSLDWSIRFSIAQ 790
L ++RH N ++ C + LV EY GS +D+L H+K L ++
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAVTH 122
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV 850
GA +GLAYLH+ ++HRDVK+ NILL + ++ DFG A + A V
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFV 172
Query: 851 AGSYGYIAPEYAYTKKVTE---KSDVYSFGVVLMELVTGKRP 889
Y ++APE + K DV+S G+ +EL K P
Sbjct: 173 GTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG---NVVK 744
LIG G VY+ + +G VA+K + T + + R E+ L ++R N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR-EVALLSQLRQSQPPNITK 66
Query: 745 LLMC-CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
G I + EY GS+ ++ ++G + I + L Y+H
Sbjct: 67 YYGSYLKGPRLWI-IMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKV- 120
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
++HRD+K+ NIL+ ++ DFG+A L + S G+ ++APE
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR----STFVGTPYWMAPEVIT 174
Query: 864 TKKVTE-KSDVYSFGVVLMELVTGKRP 889
K + K+D++S G+ + E+ TG P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLL 746
++G GG V +++ +G+ A K+L K + E++ +E + L +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+D LV M G L ++ G +G + F A+ GL LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC-GLEDLHQE---R 122
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
IV+RD+K NILLD R++D GLA + EGQ+ + G+ GY+APE ++
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQT---IKGRVGTVGYMAPEVVKNER 177
Query: 867 VTEKSDVYSFGVVLMELVTGKRP 889
T D ++ G +L E++ G+ P
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G VYK + + +GE VA+K + + T R EI + ++H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
++ +LV+EYM + L + G G+LD + S KG+A+ H + ++
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT 868
HRD+K N+L++ ++ADFGLA+A G + S + Y AP+ +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAF----GIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 869 EKS-DVYSFGVVLMELVTGK 887
S D++S G ++ E++TG+
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G+G V KV+ K + ++L+ KP E++ L +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
+ E+M GSL +L E R + I ++ +GLAYL I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREK--HQIMH 127
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS-CVAGSYGYIAPEYAYTKKVT 868
RDVK NIL+++ ++ DFG++ GQ D+M+ G+ Y++PE +
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANSFVGTRSYMSPERLQGTHYS 180
Query: 869 EKSDVYSFGVVLMELVTGKRPNDP 892
+SD++S G+ L+EL G+ P P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-13
Identities = 76/259 (29%), Positives = 119/259 (45%), Gaps = 12/259 (4%)
Query: 88 FPNGFCRIRTLRNLNLSDN-YFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFAN 146
P+ R+ +L L+ S +G+ + +L P L + E N
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSL----DLNLNRLRSNISELLELTN 117
Query: 147 LQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLK 206
L LDL NN + P LK L+L N + +PS L NL L + +L +N L
Sbjct: 118 LTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
Query: 207 SSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLA 266
LP + NLS L NL N I ++P I L+ L LDLS+N + ++ S S L
Sbjct: 177 D--LPKLLSNLSNLNNL-DLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLK 232
Query: 267 SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFT 326
++ +EL +N+L +LPES+ NL+ L LD+S N ++ ++ + +L L+L+ N +
Sbjct: 233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLS 290
Query: 327 GEIPESLASNPNLVQLKLF 345
+P L L
Sbjct: 291 NALPLIALLLLLLELLLNL 309
|
Length = 394 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-13
Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 24/194 (12%)
Query: 708 TVAVKRLLG-GTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPNG 765
TVAVK L T K ++ V SE+E + + +H N++ LL C+ ++ EY G
Sbjct: 46 TVAVKMLKDDATDKDLSDLV--SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 766 SLADMLHEKGRSGSLDWSIR--------------FSIAQGAAKGLAYLHNDCVPAIVHRD 811
+L + L + R +D+S S A A+G+ YL + +HRD
Sbjct: 104 NLREYLRAR-RPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRD 159
Query: 812 VKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKS 871
+ + N+L+ + V ++ADFGLA+ + + + + ++APE + + T +S
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQS 217
Query: 872 DVYSFGVVLMELVT 885
DV+SFGV+L E+ T
Sbjct: 218 DVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 684 LTEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
T+ IG G VYK + ++ E VA+K + + E E + + EI L + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYI 64
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
+ ++ EY+ GS D+L + G L+ + +I + KGL YLH++
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE 120
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
+HRD+K+ N+LL + ++ADFG+A L + + + G+ ++APE
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVI 173
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPN 890
K+D++S G+ +EL G+ PN
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 23/222 (10%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIE 732
F ++D T+ IG G VY + +++ E VA+K++ G E E++
Sbjct: 18 FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 733 TLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML--HEKGRSGSLDWSIRFSIAQ 790
L R++H N ++ C + LV EY GS +D+L H+K L +I
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAITH 132
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV 850
GA +GLAYLH+ ++HRD+K+ NILL ++ADFG A A S V
Sbjct: 133 GALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFV 182
Query: 851 AGSYGYIAPEYAYTKKVTE---KSDVYSFGVVLMELVTGKRP 889
Y ++APE + K DV+S G+ +EL K P
Sbjct: 183 GTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 26/195 (13%)
Query: 708 TVAVKRLL-GGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPNG 765
TVAVK L T K + + SE+E + + +H N++ LL C+ + ++ EY G
Sbjct: 46 TVAVKMLKDNATDKDLADLI--SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKG 103
Query: 766 SLADMLHE-------------KGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDV 812
+L + L K L + S A A+G+ YL + +HRD+
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDL 160
Query: 813 KSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY--GYIAPEYAYTKKVTEK 870
+ N+L+ + V ++ADFGLA+ + D G ++APE + + T +
Sbjct: 161 AARNVLVTEDNVMKIADFGLARGVH----DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216
Query: 871 SDVYSFGVVLMELVT 885
SDV+SFG+++ E+ T
Sbjct: 217 SDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 74/254 (29%), Positives = 112/254 (44%), Gaps = 35/254 (13%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLL-- 746
IG G +VYKV K ++A ++L + E +E L + H NVVK
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE--IEAEYNILQSLPNHPNVVKFYGM 87
Query: 747 -----MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS-LDWSIRFSIAQGAAKGLAYLH 800
GQ + LV E GS+ +++ G LD ++ I GA GL +LH
Sbjct: 88 FYKADKLVGGQLW--LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
N+ I+HRDVK +NILL E ++ DFG++ L S + + ++ G+ ++APE
Sbjct: 146 NN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMAPE 198
Query: 861 Y-----AYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI-----VRWVTEATLS 910
Y + DV+S G+ +EL G DP + + + TL
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDG----DPPLFDMHPVKTLFKIPRNPPPTLL 254
Query: 911 SPERGCCRDLNQLI 924
PE+ CR N I
Sbjct: 255 HPEK-WCRSFNHFI 267
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 684 LTEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
T+ IG G V+K + ++ + VA+K + + E E + + EI L + V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 64
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIA---QGAAKGLAYL 799
K ++ EY+ GS D+L R+G D F IA + KGL YL
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYL 117
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
H++ +HRD+K+ N+LL + ++ADFG+A L + + + G+ ++AP
Sbjct: 118 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAP 170
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890
E K+D++S G+ +EL G+ PN
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 9e-13
Identities = 65/231 (28%), Positives = 94/231 (40%), Gaps = 39/231 (16%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLL 746
+IG G V+ V+ K +G+ A+K L K R+E + L +VKL
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 747 MCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSLDWSI-RFSIAQGAAKGLAYLHNDC 803
S QD L V EYMP G L ++L K RF IA+ L +H
Sbjct: 68 --YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEETARFYIAELVL-ALDSVHK-- 119
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA----------------- 846
+HRD+K NIL+DA+ ++ADFGL K + + +
Sbjct: 120 -LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 847 -------MSC-VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ G+ YIAPE + D +S GV+L E++ G P
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 40/219 (18%)
Query: 685 TEQNLIGSGGSCRV-YKVKLKSGETVAVKRLLGGTHKPETETVFRS----EIETLGRVRH 739
T +GSG V + ++GE VA+K+L +P +F E+ L ++H
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 740 GNVVKLL----MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA 793
NV+ LL SG +F LV YM D+ G S D +++ + Q
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYM----QTDLQKIMGHPLSED-KVQYLVYQ-ML 127
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
GL Y+H+ I+HRD+K N+ ++ + ++ DFGLA+ +D M+ +
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVT 177
Query: 854 YGYIAPEYA-----YTKKVTEKSDVYSFGVVLMELVTGK 887
Y APE Y + V D++S G ++ E++TGK
Sbjct: 178 RWYRAPEVILNWMHYNQTV----DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 690 IGSGGSCRVY-KVKLKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IG G VY + E VAVK++ G E E++ L +++H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 748 CCSGQDFNILVYEYMPNGSLADML--HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
C + LV EY GS +D+L H+K L +I GA +GLAYLH+
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
++HRD+K+ NILL ++ADFG A +S A S V Y ++APE
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSAS-------KSSPANSFVGTPY-WMAPEVILAM 192
Query: 866 KVTE---KSDVYSFGVVLMELVTGKRP 889
+ K DV+S G+ +EL K P
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-12
Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 728 RSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRS---------G 778
RSE+ L H +VK D +L+ EY G L + ++ + G
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 779 SLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838
L + I ++ + +H+ ++HRD+KS NI L + ++ DFG +K Q
Sbjct: 173 LLFYQIVLALDE--------VHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK--QY 219
Query: 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP-NDPSFGEN 897
+ S D S G+ Y+APE K+ ++K+D++S GV+L EL+T RP PS
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---Q 276
Query: 898 KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALM 947
++I++ V + L+DP + + +++L+ +
Sbjct: 277 REIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 48/146 (32%), Positives = 74/146 (50%), Gaps = 14/146 (9%)
Query: 747 MCCSGQ--DFNILVYEYMPNGSLADMLHEKGRSGSLDWS-IRFSIAQGAAKGLAYLHNDC 803
+ C+ Q + V EY+ G D++ SG D + RF A+ GL +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAE-IICGLQFLHKK- 115
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
I++RD+K N+LLD + ++ADFG+ K + + S G+ YIAPE
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCK----ENMNGEGKASTFCGTPDYIAPEILK 169
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRP 889
+K E D +SFGV+L E++ G+ P
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 62/247 (25%), Positives = 98/247 (39%), Gaps = 62/247 (25%)
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRS--------GSLDWSIRFSIAQGA 792
+VV+LL S ++V E M G L L + R G +A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE-----GQSDDAM 847
A G+AYL VHRD+ + N ++ ++ ++ DFG+ + + + G+ +
Sbjct: 129 ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK---GL 182
Query: 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-------NKDI 900
V ++APE T KSDV+SFGVVL E+ T E N+++
Sbjct: 183 LPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT--------LAEQPYQGLSNEEV 230
Query: 901 VRWVTEA-TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM 959
+++V + L PE C D K+L + MC P RP+
Sbjct: 231 LKFVIDGGHLDLPE--NCPD--------------------KLLELMRMCWQYNPKMRPTF 268
Query: 960 RRVVELL 966
+V L
Sbjct: 269 LEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLL 746
++G GG V +++ +G+ A KRL K + E++ +E + L +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+D LV M G L ++ G G + F A+ GL LH +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC-GLEDLHRE---N 122
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
V+RD+K NILLD R++D GL A++ EG +++ G+ GY+APE ++
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGL--AVKIPEG---ESIRGRVGTVGYMAPEVLNNQR 177
Query: 867 VTEKSDVYSFGVVLMELVTGKRP 889
T D + G ++ E++ G+ P
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 70/222 (31%), Positives = 109/222 (49%), Gaps = 47/222 (21%)
Query: 687 QNL--IGSG--GS-CRVYKVKLKSGETVAVKRLLGGTHKP-----ETETVFRSEIETLGR 736
QNL +GSG GS C Y +L+ + VAVK+L +P +R E+ L
Sbjct: 18 QNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKL----SRPFQSLIHARRTYR-ELRLLKH 70
Query: 737 VRHGNVVKLL----MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ 790
++H NV+ LL S ++FN LV M L +++ + S D ++F I Q
Sbjct: 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLS---DEHVQFLIYQ 126
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV 850
+GL Y+H+ I+HRD+K N+ ++ + R+ DFGLA+ Q+DD M+
Sbjct: 127 -LLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR-------QADDEMTGY 175
Query: 851 AGSYGYIAPEYA-----YTKKVTEKSDVYSFGVVLMELVTGK 887
+ Y APE Y + V D++S G ++ EL+ GK
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 700 KVKLKSGETVAVKRLL-GGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757
K K K TVAVK L T K ++ V SE+E + + +H N++ LL C+ +
Sbjct: 41 KDKPKEAVTVAVKMLKDDATEKDLSDLV--SEMEMMKMIGKHKNIINLLGACTQDGPLYV 98
Query: 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRF--------------SIAQGAAKGLAYLHNDC 803
+ EY G+L + L + R +++S S A+G+ YL +
Sbjct: 99 IVEYASKGNLREYLRAR-RPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ- 156
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
+HRD+ + N+L+ V ++ADFGLA+ + + + + ++APE +
Sbjct: 157 --KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP--VKWMAPEALF 212
Query: 864 TKKVTEKSDVYSFGVVLMELVT 885
+ T +SDV+SFGV++ E+ T
Sbjct: 213 DRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 36/212 (16%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLM 747
+G G VY ++GE VA+K++ + E R E+++L ++ H N+VKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLKE 65
Query: 748 CCSGQDFNILVYEYMPNGSLAD-MLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
D V+EYM G+L M KG+ S IR SI +GLA++H
Sbjct: 66 VFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSES-VIR-SIIYQILQGLAHIHKH---G 119
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI------APE 860
HRD+K N+L+ V ++ADFGLA+ ++S+ +D Y+ APE
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-----------YVSTRWYRAPE 168
Query: 861 Y-----AYTKKVTEKSDVYSFGVVLMELVTGK 887
+Y+ V D+++ G ++ EL T +
Sbjct: 169 ILLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 40/291 (13%)
Query: 690 IGSGGSCRVYKVKLKSGETVA--VKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IG+G +V + G + A V + L + P+ + +F E++ + H NV++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 748 CCSGQDFNILVYEYMPNGSLADMLH-EKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
C +LV E+ P G L + L +G + + +A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG--QSDDAMSCVAGSYGYIAPEYA- 862
+H D+ N L A++ ++ D+GLA Q E + D C A ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKD---CHAVPLRWLAPELVE 175
Query: 863 ------YTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915
K T+KS+++S GV + EL T +P P ++ +++ V
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDL-SDEQVLKQVVRE-------- 225
Query: 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+D+ +L P++DL +++ V C D P RP+ V ELL
Sbjct: 226 --QDI-KLPKPQLDLKY-----SDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G G +VYK K K +A +++ + E E + EIE L H +VKLL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YMVEIEILATCNHPYIVKLLGAF 78
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
++ E+ P G++ ++ E R G + I+ I + + L YLH+ I+H
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQ-VICRQMLEALQYLHSM---KIIH 133
Query: 810 RDVKSHNILLDAEMVPRVADFGLA----KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
RD+K+ N+LL + ++ADFG++ K LQ ++ S + Y ++APE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD-------SFIGTPY-WMAPEVVMCE 185
Query: 866 KVTE-----KSDVYSFGVVLMELVTGKRPN 890
+ + K+D++S G+ L+E+ + P+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPH 215
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 690 IGSGGSCRV-YKVKLKSGETVAVKRLLGGTHKPETETVFRS----EIETLGRVRHGNVVK 744
+GSG V + ++G VA+K+L ++P +F E+ L ++H NV+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL----YRPFQSELFAKRAYRELRLLKHMKHENVIG 78
Query: 745 LLMCCSGQ----DFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
LL + F+ LV +M M HEK I+F + Q KGL Y
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR----IQFLVYQ-MLKGLKY 133
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
+H I+HRD+K N+ ++ + ++ DFGLA+ Q+D M+ + Y A
Sbjct: 134 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWYRA 183
Query: 859 PEYAYT-KKVTEKSDVYSFGVVLMELVTGK 887
PE T+ D++S G ++ E++TGK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 54/164 (32%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSI-RFSIAQGAAKGL 796
+H + +L C +D V EY+ G L M H + RSG D RF A+ GL
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQ-RSGRFDEPRARFYAAE-IVLGL 109
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG-QSDDAMSCVAGSYG 855
+LH I++RD+K N+LLD+E ++ADFG+ K EG S G+
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPD 161
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
YIAPE + D ++ GV+L E++ G+ P + G+++D
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 15/186 (8%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VAVK L K F EI+ + R+++ N+++LL C D ++ EYM NG L
Sbjct: 47 VAVKMLRADVTK-TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 769 DMLHEK---------GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819
L ++ S+ + +A A G+ YL + VHRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLV 162
Query: 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVV 879
++ADFG+++ L S + + + ++A E K T SDV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVL--PIRWMAWESILLGKFTTASDVWAFGVT 220
Query: 880 LMELVT 885
L E+ T
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 43/131 (32%), Positives = 70/131 (53%), Gaps = 13/131 (9%)
Query: 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819
E+M GSL +L + GR + +I I+ +GL YL I+HRDVK NIL+
Sbjct: 79 EHMDGGSLDQVLKKAGR---IPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 820 DAEMVPRVADFGLAKALQSQEGQSDDAMS-CVAGSYGYIAPEYAYTKKVTEKSDVYSFGV 878
++ ++ DFG++ GQ D+M+ G+ Y++PE T +SD++S G+
Sbjct: 134 NSRGEIKLCDFGVS-------GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGL 186
Query: 879 VLMELVTGKRP 889
L+E+ G+ P
Sbjct: 187 SLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHK---PETETVFRSEIETLGRVRHGNVVKL 745
+G G VYK ++K+G VA+K++L K P T R EI+ L +++H NVV L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT--ALR-EIKILKKLKHPNVVPL 72
Query: 746 L-MCC--SGQDFNI-----LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK--- 794
+ M + +V YM + L+ +L S++ + +Q K
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP--------SVKLTESQ--IKCYM 121
Query: 795 -----GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA-------KALQSQEGQ 842
G+ YLH + I+HRD+K+ NIL+D + + ++ADFGLA + G
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 843 SD-DAMSCVAGSYGYIAPEY-AYTKKVTEKSDVYSFGVVLMELVTGK 887
+ V + Y PE ++ T D++ G V E+ T +
Sbjct: 179 GTRKYTNLVVTRW-YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IGSG +VYK++ K+G +AVK++ +K E + + L V + ++
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD----LDVVLKSHDCPYIV 77
Query: 748 CCSG---QDFNILV-YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL---H 800
C G D ++ + E M + D L K G + I + K L YL H
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKL-LKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL-QSQEGQSDDAMSCVAGSYGYIAP 859
++HRDVK NILLDA ++ DFG++ L S+ A + AG Y+AP
Sbjct: 135 G-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK------AKTRSAGCAAYMAP 183
Query: 860 EYAYTKKVTEK----SDVYSFGVVLMELVTGKRP 889
E K +DV+S G+ L+EL TG+ P
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VAVK L + + E+ F E + + H N+V+L+ + ++ E M G L
Sbjct: 39 VAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLK 97
Query: 769 DMLHE----KGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD---A 821
L E R SL A+ AKG YL + +HRD+ + N LL
Sbjct: 98 SFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGP 154
Query: 822 EMVPRVADFGLAKALQSQE--GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVV 879
V ++ADFG+A+ + + AM + ++ PE T K+DV+SFGV+
Sbjct: 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIK----WMPPEAFLDGIFTSKTDVWSFGVL 210
Query: 880 LMELVTGKRPNDPSFG-------ENKDIVRWVTEATLSSPERGC 916
L E+ S G N++++ +VT P +GC
Sbjct: 211 LWEIF--------SLGYMPYPGRTNQEVMEFVTGGGRLDPPKGC 246
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 28/212 (13%)
Query: 690 IGSG--GSCR--VYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
+GSG G+ + +YK+K KS +TVAVK L + P + E + ++ + +V++
Sbjct: 3 LGSGNFGTVKKGMYKMK-KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL--HNDC 803
+ C + + +LV E G L L +K + + + +I + Q + G+ YL N
Sbjct: 62 IGICEAESW-MLVMELAELGPLNKFL-QKNKHVT-EKNITELVHQ-VSMGMKYLEETN-- 115
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG-----YIA 858
VHRD+ + N+LL + +++DFGL+KAL + E A ++G + A
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK------AKTHGKWPVKWYA 166
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
PE K + KSDV+SFGV++ E + G++P
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 15/217 (6%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLL 746
++G GG V +++ +G+ A K+L K + E + +E L +V VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+D LV M G L ++ G G + F A+ GL L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC-GLEDLQRE---R 122
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
IV+RD+K NILLD R++D GL A+Q EG++ + G+ GY+APE +K
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGL--AVQIPEGET---VRGRVGTVGYMAPEVINNEK 177
Query: 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903
T D + G ++ E++ G+ P F + K+ V+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSP----FRKRKERVKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 679 DILPHLTEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
D+ P + IG G V +G VA+K++ H+ + R EI+ L R
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRF 60
Query: 738 RHGNVVKLL---MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSL-DWSIRFSIAQG 791
+H N++ +L S + FN +V E M L++ ++ L + I++ + Q
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQ- 114
Query: 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851
+GL Y+H+ V +HRD+K N+LL+ ++ DFGLA+ + + VA
Sbjct: 115 ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 852 GSYGYIAPEYAYTKKVTEKS-DVYSFGVVLMELVTGK 887
+ Y APE K K+ D++S G +L E+++ +
Sbjct: 172 TRW-YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VAVK L +K F EI+ + R++ N+++LL C D ++ EYM NG L
Sbjct: 49 VAVKMLREDANK-NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 769 DML--HE------KGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD 820
L HE K ++ +S +A A G+ YL + VHRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVG 164
Query: 821 AEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVL 880
++ADFG+++ L S + + + +++ E K T SDV++FGV L
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVL--PIRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 881 MELVT 885
E++T
Sbjct: 223 WEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 70/245 (28%), Positives = 106/245 (43%), Gaps = 32/245 (13%)
Query: 689 LIGSGGSCRVYKVKLKSGET----VAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVV 743
++G G V + +L + VAVK + L E E F SE + H NV+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE-FLSEAACMKDFDHPNVM 64
Query: 744 KLL-MCCSGQDFN-----ILVYEYMPNGSL-----ADMLHEKGRSGSLDWSIRFSIAQGA 792
KL+ +C +++ +M +G L L L ++F +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE--GQSDDAMSCV 850
A G+ YL N +HRD+ + N +L +M VADFGL+K + S + Q A V
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 851 AGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEAT- 908
+IA E + T KSDV++FGV + E+ T R P G EN +I ++
Sbjct: 180 K----WIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYLRHGNR 233
Query: 909 LSSPE 913
L PE
Sbjct: 234 LKQPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 16/217 (7%)
Query: 677 EDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
+DD ++E +G+G V+KV K + ++L+ KP E++ L
Sbjct: 3 KDDDFEKISE---LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE 59
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGL 796
+V + E+M GSL +L + GR + I ++ KGL
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 116
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS-CVAGSYG 855
YL I+HRDVK NIL+++ ++ DFG++ GQ D+M+ G+
Sbjct: 117 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANSFVGTRS 167
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDP 892
Y++PE + +SD++S G+ L+E+ G+ P P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 708 TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767
T+ KR+L KP T S +T+ R+ V EY+ G L
Sbjct: 47 TMVEKRVLALPGKPPFLTQLHSCFQTMDRL------------------YFVMEYVNGGDL 88
Query: 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827
M H + + G A A GL +LH+ I++RD+K N++LDAE ++
Sbjct: 89 --MYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKI 142
Query: 828 ADFGLAKALQSQEGQSDDAMSCV-AGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTG 886
ADFG+ K E + G+ YIAPE + + D ++FGV+L E++ G
Sbjct: 143 ADFGMCK-----ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
Query: 887 KRPNDPSFGENKD-IVRWVTEATLSSPE 913
+ P D GE++D + + + E +S P+
Sbjct: 198 QPPFD---GEDEDELFQSIMEHNVSYPK 222
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH-------- 739
++G+G +VYK + +K+G+ A+K ++ T E E + EI L + H
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEE--IKLEINMLKKYSHHRNIATYY 79
Query: 740 GNVVKLLMCCSGQDFNI-LVYEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLA 797
G +K G D + LV E+ GS+ D++ + KG + DW I + I + +GLA
Sbjct: 80 GAFIK--KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-IAY-ICREILRGLA 135
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
+LH ++HRD+K N+LL ++ DFG++ L G+ + + G+ ++
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTPYWM 188
Query: 858 APEYAYTKKVTE-----KSDVYSFGVVLMELVTGKRP 889
APE + + +SD++S G+ +E+ G P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 689 LIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
++G G +V+ V+ +G+ A+K L T K + E + L V H +VK
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
L + L+ +++ G L L ++ D ++F +A+ A L +LH+
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLAE-LALALDHLHS--- 116
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
I++RD+K NILLD E ++ DFGL+K +S + + C G+ Y+APE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFC--GTVEYMAPEVVNR 172
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRP 889
+ T+ +D +SFGV++ E++TG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 684 LTEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
T+ IG G V+K + ++ + VA+K + + E E + + EI L + V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 64
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
K ++ EY+ GS D+L G LD + +I + KGL YLH++
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE 120
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
+HRD+K+ N+LL ++ADFG+A L + + + G+ ++APE
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVI 173
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPN 890
K+D++S G+ +EL G+ P+
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPH 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-12
Identities = 73/213 (34%), Positives = 113/213 (53%), Gaps = 10/213 (4%)
Query: 146 NLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205
L LDL+ N +I E L L+L N ++ + P + L +L N +
Sbjct: 94 PLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI 152
Query: 206 KSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGL 265
+S LPS + NL L+NL + N + ++P + L+ L+NLDLS N +S +P L
Sbjct: 153 ES--LPSPLRNLPNLKNLDLSF-NDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL 208
Query: 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNY 324
+++E+++L +N + EL SLSNL L L++S N L +LPE+I + +LE+L+L++N
Sbjct: 209 SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN- 265
Query: 325 FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL 357
SL S NL +L L NS S LP
Sbjct: 266 -QISSISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 37/86 (43%), Positives = 54/86 (62%), Gaps = 2/86 (2%)
Query: 275 DNQ-LSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPES 332
DNQ L G +P +S L L +++S N++ GN+P ++ ++ SLE L+L+ N F G IPES
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 333 LASNPNLVQLKLFNNSFSGKLPDDLG 358
L +L L L NS SG++P LG
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 83/329 (25%), Positives = 135/329 (41%), Gaps = 36/329 (10%)
Query: 263 SGLASIEQIELFDNQL--SGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNL 320
S L+ + ++L S + E+L NL L LD++ N L N+ E + +L SL+L
Sbjct: 64 SSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDL 123
Query: 321 NDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRF 380
++N T P NL +L L +N LP L NL+ D+S ND +
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS------ 176
Query: 381 LCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEM 440
+P+ LN L GN++ +LP + L ++ ++
Sbjct: 177 -------------------DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216
Query: 441 YNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTC 500
NN + S+SN L+G+ ++ N ++P I L L+ +DLS N+ S +
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS--ISS 272
Query: 501 ITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDL 560
+ L L++L+L N + LP L L +L L EL ++L + ++
Sbjct: 273 LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL---KALELKLNSILLNNNI 329
Query: 561 SSNLLTGEIPLELTKLKLNQFNISHNKLY 589
SN T LN N L
Sbjct: 330 LSNGETSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 41/104 (39%), Positives = 61/104 (58%), Gaps = 8/104 (7%)
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
++HRD+KS NILL + + ++ DFG +K + SDD G+ Y+APE K
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT--VSDDVGRTFCGTPYYVAPEIWRRKP 221
Query: 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910
++K+D++S GV+L EL+T KRP D GEN + V TL+
Sbjct: 222 YSKKADMFSLGVLLYELLTLKRPFD---GEN---MEEVMHKTLA 259
|
Length = 496 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 684 LTEQNLIGSGGS---CRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG 740
L IG G + C +G VAVK++ K + + +E+ + +H
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKS--TGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHP 76
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
N+V++ D +V E++ G+L D++ ++ ++ K L++LH
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLH 132
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM----SCVAGSYGY 856
++HRD+KS +ILL ++ +++DFG Q + S V Y +
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-------AQVSKEVPRRKSLVGTPY-W 181
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP--NDPSFGENKDI 900
+APE + D++S G++++E+V G+ P N+P K I
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 35/116 (30%), Positives = 50/116 (43%), Gaps = 25/116 (21%)
Query: 150 LDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSP 209
L L G IP + L+ +NL GN + G IP LG++T L +L YN
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN--- 479
Query: 210 LPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGL 265
G IP+S+G+L L L+L+ N LSG++P + G
Sbjct: 480 ----------------------GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 28/195 (14%)
Query: 709 VAVKRLLG-GTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPNGS 766
VAVK L T K ++ + SE+E + + +H N++ LL C+ ++ EY G+
Sbjct: 53 VAVKMLKSDATEKDLSDLI--SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 767 LADMLHEKGRSGSLDWSIR--------------FSIAQGAAKGLAYLHNDCVPAIVHRDV 812
L + L + R +++ S A A+G+ YL + +HRD+
Sbjct: 111 LREYLRAR-RPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDL 166
Query: 813 KSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY--GYIAPEYAYTKKVTEK 870
+ N+L+ + V ++ADFGLA+ + D G ++APE + + T +
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIH----HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 222
Query: 871 SDVYSFGVVLMELVT 885
SDV+SFGV+L E+ T
Sbjct: 223 SDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 35/190 (18%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE----TVFRSEIETLGRVRHGNVVK 744
IG G V+K + K+ + VA+K++L E E T R EI+ L ++H NVV
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALR-EIKILQLLKHENVVN 75
Query: 745 LLMCCS--GQDFN------ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQ 790
L+ C +N LV+E+ + LA +L K +++F+ + +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK--------NVKFTLSEIKKVMK 126
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV 850
GL Y+H + I+HRD+K+ NIL+ + + ++ADFGLA+A + + +
Sbjct: 127 MLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 851 AGSYGYIAPE 860
+ Y PE
Sbjct: 184 VVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 67/287 (23%), Positives = 122/287 (42%), Gaps = 48/287 (16%)
Query: 698 VYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757
+Y + + VA+K L + P+ F+ E + + H N+V LL + + +
Sbjct: 26 LYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84
Query: 758 VYEYMPNGSLADML------HEKGRSGSLDWSIRFSIAQG--------AAKGLAYLHNDC 803
++EY+ G L + L + G S D +++ S+ G A G+ YL +
Sbjct: 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH- 143
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
VH+D+ + NIL+ ++ +++D GL++ + S + S + ++ PE
Sbjct: 144 --FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL--PIRWMPPEAIM 199
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEATLSSPERGCCRDLNQ 922
K + SD++SFGVVL E+ + P +G N++++ V + L C
Sbjct: 200 YGKFSSDSDIWSFGVVLWEIFSFGL--QPYYGFSNQEVIEMVRKRQLLPCSEDC------ 251
Query: 923 LIDPRMDLSTCDYEEAEKVLNVALM--CTSDFPINRPSMRRVVELLR 967
PRM +LM C + P RP + + LR
Sbjct: 252 --PPRM---------------YSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 687 QNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
Q ++G G VYK L + +AVK + E + SE+E L + ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGF 64
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
++ + E+M GSL D+ + + IA KGL YL +
Sbjct: 65 YGAFFVENRISICTEFMDGGSL-DVY------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
I+HRDVK N+L++ ++ DFG++ L + ++ G+ Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT------YVGTNAYMAPERISGE 168
Query: 866 KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK 898
+ SDV+S G+ MEL G+ P P +N+
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPY-PQIQKNQ 200
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 690 IGSGGSCRVYKV-KLKSGETVAVK--RLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
+GSG VYK L +GE AVK +L G + ++ + EI + +H N+V
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
++ + EY GSL D+ H G L + + + +GLAYLH+
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYLHSK---G 126
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
+HRD+K NILL ++ADFG+A + + + + G+ ++APE A +K
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI----GTPYWMAPEVAAVEK 182
Query: 867 ---VTEKSDVYSFGVVLMELVTGKRP 889
+ D+++ G+ +EL + P
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 47/191 (24%), Positives = 95/191 (49%), Gaps = 17/191 (8%)
Query: 705 SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764
+G+ VAVK++ K + + +E+ + H NVV + D +V E++
Sbjct: 46 TGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103
Query: 765 GSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823
G+L D++ H + + ++ + L+YLHN ++HRD+KS +ILL ++
Sbjct: 104 GALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDG 155
Query: 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMEL 883
+++DFG +Q + + G+ ++APE + D++S G++++E+
Sbjct: 156 RIKLSDFGFC----AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 884 VTGKRP--NDP 892
+ G+ P N+P
Sbjct: 212 IDGEPPYFNEP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 27/228 (11%)
Query: 684 LTEQNLIGSGGSCRVYK--VKLKSGE--TVAVKRLLGGTHKPETETV----FRSEIETLG 735
+T IG G VY+ E VAVK T K T F E +
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK-----TCKNCTSPSVREKFLQEAYIMR 62
Query: 736 RVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
+ H ++VKL+ + I V E P G L L + SLD + + +
Sbjct: 63 QFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTA 119
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
LAYL + VHRD+ + N+L+ + ++ DFGL++ L E +S S
Sbjct: 120 LAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIK 173
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLME-LVTGKRPNDPSFG-ENKDIV 901
++APE ++ T SDV+ FGV + E L+ G + P G +N D++
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVK---PFQGVKNNDVI 218
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 51/202 (25%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G + V + K SG VAVK + K + + +E+ + +H NVV++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 749 -CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
G++ +L+ E++ G+L D++ + L+ ++ + + L YLH+ +
Sbjct: 87 YLVGEELWVLM-EFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GV 138
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
+HRD+KS +ILL + +++DFG +Q + + G+ ++APE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFC----AQISKDVPKRKSLVGTPYWMAPEVISRTPY 194
Query: 868 TEKSDVYSFGVVLMELVTGKRP 889
+ D++S G++++E+V G+ P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV-AGS 853
GL +LH+ IV+RD+K NILLD + ++ADFG+ K E DA +C G+
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGT 159
Query: 854 YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
YIAPE +K D +SFGV+L E++ G+ P
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 29/191 (15%)
Query: 705 SGETVAVKRLLGGTHKPETETV-----FRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759
+G+ VA+K+++ KP + V +R E++ L +RH N++ L D I
Sbjct: 34 TGQNVAIKKIM----KPFSTPVLAKRTYR-ELKLLKHLRHENIISL------SDIFISPL 82
Query: 760 E--YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNI 817
E Y L LH S L+ +GL Y+H+ +VHRD+K NI
Sbjct: 83 EDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNI 139
Query: 818 LLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSF 876
L++ ++ DFGLA+ Q M+ + Y APE T +K + D++S
Sbjct: 140 LINENCDLKICDFGLARIQDPQ-------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192
Query: 877 GVVLMELVTGK 887
G + E++ GK
Sbjct: 193 GCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 27/77 (35%), Positives = 43/77 (55%)
Query: 210 LPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIE 269
+P+ + L L+++ + ++ G IP S+G + L LDLS N +G IP S L S+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 270 QIELFDNQLSGELPESL 286
+ L N LSG +P +L
Sbjct: 494 ILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 25/180 (13%)
Query: 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRD 811
++ V E++ G L + +KGR D A GL +LH+ I++RD
Sbjct: 68 KEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSK---GIIYRD 121
Query: 812 VKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKS 871
+K N++LD + ++ADFG+ K + D+ S G+ YIAPE K T
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 872 DVYSFGVVLMELVTGKRPNDPSFGENKDIV------------RWVTEATLSSPERGCCRD 919
D +SFGV+L E++ G+ P G+++D + RW+T+ + E+ RD
Sbjct: 178 DWWSFGVLLYEMLIGQ---SPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVK--RLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
IGSG VYK + + +GE A+K +L G E V + EI + +H N+V
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+D + E+ GSL D+ H +G L S +++ +GL YLH+
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSK---G 126
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
+HRD+K NILL ++ADFG++ + + + + G+ ++APE A ++
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI----GTPYWMAPEVAAVER 182
Query: 867 ---VTEKSDVYSFGVVLMELVTGKRP 889
+ D+++ G+ +EL + P
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G GG +V+ K K +GE VA+KR+ K +E + L + +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 748 CCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSL-DWSIRFSIAQGAAKGLAYLHNDCV 804
+ QD L EY+P G +L+ G L + RF +A+ + LH
Sbjct: 69 --AFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFE-AVDALHE--- 119
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
+HRD+K N L+DA ++ DFGL+K + + A S V GS Y+APE
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ANSVV-GSPDYMAPEVLRG 172
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRP 889
K D +S G +L E + G P
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 40/164 (24%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNV 742
IG G VYK + +GE VA+K++ + ETE T R EI L + H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-----RLETEDEGVPSTAIR-EISLLKELNHPNI 60
Query: 743 VKLLMCCSGQDFNILVYEYM-----------PNGSLADMLHEKGRSGSLDWSIRFSIAQG 791
V+LL ++ LV+E++ P L L I+ + Q
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL------------IKSYLYQ- 107
Query: 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835
+G+AY H+ ++HRD+K N+L+D E ++ADFGLA+A
Sbjct: 108 LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 698 VYKVK-LKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNVVKL--LMC 748
VY+ + K+GE VA+K+L K E E T R EI L +++H N+V + ++
Sbjct: 21 VYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVV 74
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
S D +V EY+ + L ++ S + G+A+LH++ I+
Sbjct: 75 GSNLDKIYMVMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDN---WIL 128
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-TKKV 867
HRD+K+ N+LL+ + ++ DFGLA+ + G + + + Y APE K+
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAR----EYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184
Query: 868 TEKSDVYSFGVVLMELVTGK 887
+ D++S G + EL+T K
Sbjct: 185 STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 126 LALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLI 185
L LD G +P+ + +LQ ++LS N+ G+IP S G L+VL+L N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 186 PSFLGNLTELTHFELGYNPLKSSPLPSSVG 215
P LG LT L L N L S +P+++G
Sbjct: 483 PESLGQLTSLRILNLNGNSL-SGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G G +VYK + K +A +++ + E E + EI+ L H N+VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED-YMVEIDILASCDHPNIVKLLDAF 71
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
++ ++ E+ G++ ++ E R + + IR Q + L YLH + I+H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLT-EPQIRVVCKQ-TLEALNYLHEN---KIIH 126
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTE 869
RD+K+ NIL + ++ADFG++ A ++ Q D+ G+ ++APE + +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSF---IGTPYWMAPEVVMCETSKD 182
Query: 870 -----KSDVYSFGVVLMELVTGKRPN 890
K+DV+S G+ L+E+ + P+
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH 208
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
L+G+G +VYK + +K+G+ A+K ++ T E E + EI L + H +
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEE--IKQEINMLKKYSHHRNIATYY 69
Query: 748 CC------SGQDFNI-LVYEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYL 799
G D + LV E+ GS+ D++ + KG + +W I + I + +GL++L
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAY-ICREILRGLSHL 127
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
H ++HRD+K N+LL ++ DFG++ L G+ + + G+ ++AP
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTPYWMAP 180
Query: 860 EYAYTKKVTE-----KSDVYSFGVVLMELVTGKRP 889
E + + KSD++S G+ +E+ G P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 44/203 (21%)
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL- 767
VAVK L +K F E++ L R++ N+++LL C +D ++ EYM NG L
Sbjct: 49 VAVKILRPDANK-NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 768 ----ADMLHEKGRSGS-----------LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDV 812
+ L +K +G+ + +S +A A G+ YL + VHRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164
Query: 813 KSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY-----------GYIAPEY 861
+ N L+ + ++ADFG+++ L AG Y ++A E
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNL-------------YAGDYYRIQGRAVLPIRWMAWEC 211
Query: 862 AYTKKVTEKSDVYSFGVVLMELV 884
K T SDV++FGV L E++
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVK--RLLGGTHKPETETVFRSEIETLGRVR---HGNVV 743
IG G VYK + SG VA+K R+ TV E+ L R+ H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV--REVALLKRLEAFDHPNIV 65
Query: 744 KLLMCC----SGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
+L+ C + ++ + LV+E++ + L L + G +I+ + + +GL +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK-DLMRQFLRGLDF 123
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
LH +C IVHRD+K NIL+ + ++ADFGLA+ Q A++ V + Y A
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM-----ALTPVVVTLWYRA 175
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
PE D++S G + E+ K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 295 LDISQNNLTGNLPETIAAMS-LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKL 353
L + L G +P I+ + L+S+NL+ N G IP SL S +L L L NSF+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 354 PDDLGKYSNLEYFDVSTNDFTGELP 378
P+ LG+ ++L +++ N +G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 788 IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847
IA K L YLH+ +++HRDVK N+L++ ++ DFG++ G D++
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDSV 158
Query: 848 SCV--AGSYGYIAPEY----AYTKKVTEKSDVYSFGVVLMELVTGKRPND 891
+ AG Y+APE K KSDV+S G+ ++EL TG+ P D
Sbjct: 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 687 QNLIGSGGSCRVYKV---KLKSGETVAV-KRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
Q +G G VY V K + E + V K + G P E + L ++ H +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS-------LDWSIRFSIAQGAAKG 795
VK +D ++ EY L L E +G +W I+ + G
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------G 118
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
+ Y+H I+HRD+K+ NI L ++ ++ DFG+++ L S D + G+
Sbjct: 119 VHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG----SCDLATTFTGTPY 170
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMEL 883
Y++PE + KSD++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 62/242 (25%), Positives = 94/242 (38%), Gaps = 42/242 (17%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETV-FRSEIETLGRVRHGNVVKLL 746
L+G G RV+ V+LK +G+ A+K L + +E E L + H + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ + LV +Y P G L +L + + RF A+ L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLL---G 123
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKAL-----------------QSQEGQSDDAMSC 849
IV+RD+K NILL ++DF L+K S + S
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 850 VA--------GSYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN 897
G+ YIAPE + V D ++ G++L E++ G P G N
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGT---TPFKGSN 236
Query: 898 KD 899
+D
Sbjct: 237 RD 238
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+ IG G VYK L G VA+K++ + + EI+ L ++ H NV+K
Sbjct: 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIK 66
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADML-HEKGRSGSLD----WSIRFSIAQGAAKGLAYL 799
L + +V E G L+ M+ H K + + W + L ++
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHM 122
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
H+ I+HRD+K N+ + A V ++ D GL + S ++ A S V Y Y++P
Sbjct: 123 HSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPY-YMSP 175
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E + KSD++S G +L E+ + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVK--RLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
++G G R V+ S + A+K RL + E R E L +++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS---RKEAVLLAKMKHPNIVAF 63
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLH-EKGR----SGSLDWSIRFSIAQGAAKGLAYLH 800
+V EY G L + ++G+ L W ++ + G+ ++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV-AGSYGYIAP 859
V +HRD+KS NI L ++ DFG A+ L S A +C G+ Y+ P
Sbjct: 118 EKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-----AYACTYVGTPYYVPP 169
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E KSD++S G +L EL T K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 691 GSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS 750
GS G + VK SG+ VAVK++ K + + +E+ + +H NVV++
Sbjct: 31 GSTGIVCIATVK-SSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 751 GQDFNILVYEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
D +V E++ G+L D++ H + + ++ K L+ LH ++H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQ---GVIH 139
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTE 869
RD+KS +ILL + +++DFG A S+E ++ G+ ++APE
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKSL---VGTPYWMAPELISRLPYGP 195
Query: 870 KSDVYSFGVVLMELVTGKRP--NDPSFGENKDI 900
+ D++S G++++E+V G+ P N+P K I
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPET-ETVFRSEIETLGRVRHGNVVKLLM 747
+G GG V V++K +G+ A K+L K ++ E + E E L +V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
+ LV M G L ++ G G + AQ G+ +LH+ I
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ-ITCGILHLHS---MDI 116
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
V+RD+K N+LLD + R++D GL A++ ++G++ ++ AG+ GY+APE +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKT---ITQRAGTNGYMAPEILKEEPY 171
Query: 868 TEKSDVYSFGVVLMELVTGKRP 889
+ D ++ G + E+V G+ P
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 34/208 (16%)
Query: 708 TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767
T+ KR+L + KP T S +T+ R+ V EY+ G
Sbjct: 47 TMVEKRVLALSGKPPFLTQLHSCFQTMDRL------------------YFVMEYVNGG-- 86
Query: 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827
D++++ + G A A GL +LH+ I++RD+K N++LD+E ++
Sbjct: 87 -DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI 142
Query: 828 ADFGLAKALQSQEGQSDDAMS-CVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTG 886
ADFG+ K E D + G+ YIAPE + + D ++FGV+L E++ G
Sbjct: 143 ADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
Query: 887 KRPNDPSFGENKD-IVRWVTEATLSSPE 913
+ P + GE++D + + + E ++ P+
Sbjct: 198 QAPFE---GEDEDELFQSIMEHNVAYPK 222
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRV-RHGNVVKL 745
+IG G +V V+LK E + +++ + E + ++E + H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
C + V EY+ G L M H + + + RF A+ + L YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLHER--- 115
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG-QSDDAMSCVAGSYGYIAPEYAYT 864
I++RD+K N+LLD+E ++ D+G+ K EG + D S G+ YIAPE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRPND 891
+ D ++ GV++ E++ G+ P D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 708 TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767
T+ KR+L KP T S +T+ R+ V EY+ G
Sbjct: 47 TMVEKRVLALQDKPPFLTQLHSCFQTVDRL------------------YFVMEYVNGG-- 86
Query: 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827
D+++ + G A + GL +LH I++RD+K N++LD+E ++
Sbjct: 87 -DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKI 142
Query: 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
ADFG+ K +G + G+ YIAPE + + D +++GV+L E++ G+
Sbjct: 143 ADFGMCKE-HMVDGVTTRTF---CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
Query: 888 RPNDPSFGENKD-IVRWVTEATLSSPE 913
P D GE++D + + + E +S P+
Sbjct: 199 PPFD---GEDEDELFQSIMEHNVSYPK 222
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 27/159 (16%)
Query: 734 LGRVRHGNVVKL--------LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR 785
L V H +V+++ + C ++ +Y Y+ RS L
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK-----------RSRPLPIDQA 159
Query: 786 FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845
I + +GL YLH I+HRDVK+ NI ++ + D G A Q
Sbjct: 160 LIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA-----QFPVVAP 211
Query: 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELV 884
A +AG+ APE K K+D++S G+VL E++
Sbjct: 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 45/236 (19%)
Query: 690 IGSGGSCRVYKVKLKSGET---VAVKRLLGGTHKPETETVFRS---EIETLGRVRHGNVV 743
IG G RVYK K K+G+ A+K+ G K + + +S EI L ++H NVV
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKG--DKEQYTGISQSACREIALLRELKHENVV 65
Query: 744 KLL-MCCSGQDFNI-LVYEYMPNGSLADML-----HEKGRSGSLDWSIRFSIAQGAAKGL 796
L+ + D ++ L+++Y + D+ H + + S+ S+ S+ G+
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPR----VADFGLAKALQS--QEGQSDDAMSCV 850
YLH++ ++HRD+K NIL+ E R + D GLA+ + + D V
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP---V 175
Query: 851 AGSYGYIAPEYA-----YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKDI 900
+ Y APE YTK + D+++ G + EL+T + P F G I
Sbjct: 176 VVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLE----PIFKGREAKI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-10
Identities = 74/228 (32%), Positives = 98/228 (42%), Gaps = 12/228 (5%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155
L+ L+LSDN L +L+ L L +N + +LP +NL LDLS N
Sbjct: 140 SNLKELDLSDNKI--ESLPSPLRNLPNLKNLDLSFND-LSDLPKLLSNLSNLNNLDLSGN 196
Query: 156 NFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVG 215
S D+P L+ L+L N + + S L NL L+ EL N L+ LP S+G
Sbjct: 197 KIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED--LPESIG 252
Query: 216 NLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275
NLS LE L N I I S+G L L LDLS N LS +P L +E +
Sbjct: 253 NLSNLETL-DLSNNQISSI-SSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLL 310
Query: 276 NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDN 323
L + S L +I N T + SL +L DN
Sbjct: 311 LTLKALELKLNSILLN---NNILSNGETSSPEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
++G G V K + K + E VA+K+ E + E++ L ++ N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
+ LV+EY+ L L E+ +G +R I Q K + + H + I
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ-LIKAIHWCHKN---DI 121
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
VHRD+K N+L+ V ++ DFG A+ L EG + + VA + Y +PE
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYTEYVATRW-YRSPELLLGAPY 178
Query: 868 TEKSDVYSFGVVLMELVTGK 887
+ D++S G +L EL G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 48/222 (21%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEI-ETLGRVRHGNVVKLLM 747
IG G +VY+V+ K + A+K L + E V + E+ T+G +L+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGER------NILV 48
Query: 748 CCS--------GQDFNI-------LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGA 792
G F+ LV +YM G L L ++GR + +F IA+
Sbjct: 49 RTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS--EDRAKFYIAE-L 105
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
L +LH IV+RD+K NILLDA + DFGL+KA + + + G
Sbjct: 106 VLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT----DNKTTNTFCG 158
Query: 853 SYGYIAPEY-----AYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ Y+APE YTK V D +S GV++ E+ G P
Sbjct: 159 TTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 50/242 (20%)
Query: 688 NLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETE-------------TVFRSEIET 733
+G G +V K +G+ VA+K++ + T R E++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELKI 73
Query: 734 LGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA 793
+ ++H N++ L+ DF LV + M L ++ K IR + +Q
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK---------IRLTESQVKC 123
Query: 794 ------KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA----------KALQ 837
GL LH +HRD+ NI ++++ + ++ADFGLA +
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 838 SQEGQSDDAMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-G 895
+ Q + M+ + Y APE +K D++S G + EL+TGK P F G
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK----PLFPG 236
Query: 896 EN 897
EN
Sbjct: 237 EN 238
|
Length = 335 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 30/92 (32%), Positives = 46/92 (50%)
Query: 342 LKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKI 401
L L N G +P+D+ K +L+ ++S N G +P L L+ + + N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 402 PESYGECKTLNYLRFGGNELQGELPSKFWGLP 433
PES G+ +L L GN L G +P+ G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 689 LIGSGGSCRVYKVKLKSGETV----AVKRLLGGTHKPETETVFRSEIETLGRVRHGN-VV 743
+IG G +V V+LK + + VK+ L H E ++E + +V
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--VHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
L C LV EY+ G L M H + + + RF A+ L +LH
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAE-ICIALNFLHER- 115
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG-QSDDAMSCVAGSYGYIAPEYA 862
I++RD+K N+LLDA+ ++ D+G+ K EG D S G+ YIAPE
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPND 891
++ D ++ GV++ E++ G+ P D
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 690 IGSGGSCRVYKVK-LKSG-ETVAVKRLLGGTHKPETETVFRSEIETLGRVR------HGN 741
IG G +V+K + LK+G VA+KR+ T E + S I + +R H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 742 VVKLLMCCSGQDFN-----ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGL 796
VV+L C+ + LV+E++ + L L + G +I+ + Q +GL
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGL 123
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
+LH+ +VHRD+K NIL+ + ++ADFGLA+ Q A++ V + Y
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-----ALTSVVVTLWY 175
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900
APE D++S G + E+ K P F + D+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 65/249 (26%), Positives = 102/249 (40%), Gaps = 66/249 (26%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
+IG G V V+ K +G A+K+L K + V R+E + L + VVK
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHV-RAERDILAEADNPWVVK- 65
Query: 746 LMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+ S QD N L+ EY+P G + +L +K + + + + RF IA+
Sbjct: 66 -LYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEET-RFYIAE------------T 110
Query: 804 VPAI--------VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD---------- 845
+ AI +HRD+K N+LLDA+ +++DFGL L+
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 846 -------------------------AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVL 880
A S V G+ YIAPE ++ D +S GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTV-GTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 881 MELVTGKRP 889
E++ G P
Sbjct: 230 YEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 689 LIGSGGSCRVYKVKLKSGETV-AVKRLLGGTHKPETETVFRSEIETLGRVR----HGN-- 741
+IG G V V+ KS + V A+K L + E + RS+ R H N
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLL------SKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 742 -VVKLLMCCSGQD--FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
+V+L + QD + +V EYMP G L +++ W+ RF A+ L
Sbjct: 104 WIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWA-RFYTAE-VVLALDA 157
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ--SDDAMSCVAGSYGY 856
+H+ +HRDVK N+LLD ++ADFG + + G D A+ G+ Y
Sbjct: 158 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAV----GTPDY 209
Query: 857 IAPEYAYTKKVT----EKSDVYSFGVVLMELVTGKRP 889
I+PE ++ + D +S GV L E++ G P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
IG G +VYK + K +GE VA+K++ K EI+ L ++ H N+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 747 MCCSGQ----DFN------ILVYEYMPNGSLADMLHEKGRSGSLDWS---IRFSIAQGAA 793
+ + DF LV+EYM + L +L SG + +S I+ S +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLE----SGLVHFSEDHIK-SFMKQLL 126
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
+GL Y H +HRD+K NILL+ + ++ADFGLA+ S+E + + +
Sbjct: 127 EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR---PYTNKVIT 180
Query: 854 YGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRP 889
Y PE ++ DV+S G +L EL T K+P
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
+G+G RV K K +GE A+K L + EI + +V+H K +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLK------------KREILKMKQVQHVAQEKSI 71
Query: 747 -----------MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA 793
M CS QD N + E++ G L L + GR + D + +F A+
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-DVA-KFYHAE-LV 128
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
YLH+ I++RD+K N+LLD + +V DFG AK + D + G+
Sbjct: 129 LAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-------DRTFTLCGT 178
Query: 854 YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y+APE +K + D ++ GV+L E + G P
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 26/234 (11%)
Query: 727 FRSEIETLGRVRHGNVVKLLMCC------SGQDFNILVYEYMPNGSLADMLHEKGRSGS- 779
F SE + H NV++L+ C G +++ +M +G L L R G
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDC 105
Query: 780 ---LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836
L + A G+ YL + + +HRD+ + N +L+ M VADFGL+K +
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
Query: 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG- 895
+ + ++ + +IA E + T KSDV+SFGV + E+ T R P G
Sbjct: 163 YNGDYYRQGRIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--RGQTPYPGV 218
Query: 896 ENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCD-------YEEAEKVL 942
EN +I ++ + C L L+ L+ D E EK L
Sbjct: 219 ENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFR-SEIETLGRVRHGNVVKLL 746
L+G G +V V+ K SG+ A+K L + E +E L RH + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+D V EY+ G L L + R S D + RF A+ L YLH+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRT-RFYGAE-IVSALDYLHSG---K 115
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA-MSCVAGSYGYIAPEYAYTK 865
IV+RD+K N++LD + ++ DFGL K EG +D A M G+ Y+APE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKTFCGTPEYLAPEVLEDN 170
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP 889
D + GVV+ E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IG G VYK + + + ET+A+K++ L + T R EI L ++HGN+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS-----IRFSIAQGAAKGLAYLHND 802
+ LV+EY+ D+ +K S D++ I+ + Q +G+AY H+
Sbjct: 69 VVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQ-ILRGIAYCHSH 121
Query: 803 CVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
++HRD+K N+L+D ++ADFGLA+A G + + Y APE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF----GIPVRTFTHEVVTLWYRAPEI 174
Query: 862 AY-TKKVTEKSDVYSFGVVLMELVTGKR--PNDPSFGENKDIVR 902
++ + D++S G + E+V K P D E I R
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR 218
|
Length = 294 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 29/91 (31%), Positives = 46/91 (50%)
Query: 435 VDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFS 494
+D + N G I IS L I ++GN+ G +P + ++ L+ +DLS N F+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 495 GHLPTCITQLNKLQQLELQENMFTGELPRNL 525
G +P + QL L+ L L N +G +P L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 63/234 (26%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLM 747
IG G V K + K+G+ A+K + E R EI+ L R+ H N+++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 748 CCSGQDFNILVYEYMPNGSLA------DM-LHE--KGRSGSL-DWSIRFSIAQGAAKGLA 797
+++ G LA DM L+E KGR L + ++ + Q K L
Sbjct: 66 V---------LFD-RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQ-LLKSLD 114
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
++H + I HRD+K NIL+ +++ ++ADFG + + S+ ++ YI
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTE-----------YI 159
Query: 858 ------APE-------YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GEN 897
APE Y K D+++ G V E+++ P F G N
Sbjct: 160 STRWYRAPECLLTDGYYGP------KMDIWAVGCVFFEILSLF----PLFPGTN 203
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 67/236 (28%), Positives = 115/236 (48%), Gaps = 39/236 (16%)
Query: 687 QNL--IGSG--GS-CRVYKVKLKSGETVAVKRLLGGTHKP-----ETETVFRSEIETLGR 736
QNL +GSG GS C + K +G VAVK+L +P + +R E+ L
Sbjct: 20 QNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKL----SRPFQSIIHAKRTYR-ELRLLKH 72
Query: 737 VRHGNVVKLL----MCCSGQDFN-ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG 791
++H NV+ LL S ++FN + + ++ L +++ + + D ++F I Q
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---DDHVQFLIYQ- 128
Query: 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851
+GL Y+H+ I+HRD+K N+ ++ + ++ DFGLA+ +DD M+
Sbjct: 129 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYV 178
Query: 852 GSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKR--PNDPSFGENKDIVRWV 904
+ Y APE + D++S G ++ EL+TG+ P + K I+R V
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMC 748
IG G +V+KV K + A ++L H + E +E L + H NVVK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE--IEAEYNILKALSDHPNVVKFYGM 83
Query: 749 CSGQDFNI-----LVYEYMPNGSLADMLHEKG---RSGSLDWSIRFSIAQGAAKGLAYLH 800
+D LV E GS+ D++ KG R ++ I I A GL +LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
+ +HRDVK +NILL E ++ DFG++ L S + + ++ G+ ++APE
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMAPE 194
Query: 861 YAYTKK-----VTEKSDVYSFGVVLMELVTGKRP 889
++ + DV+S G+ +EL G P
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 9/122 (7%)
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
GL +LH I++RD+K N+LLD + R++D GLA L ++GQS AG+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSK--TKGYAGTP 161
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP--NDPSFGENKDIVRWVTEATLSSP 912
G++APE ++ D ++ GV L E++ + P ENK++ + + +++ P
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP 221
Query: 913 ER 914
++
Sbjct: 222 DK 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 725 TVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS- 783
T+ I L +H + L C +D V EY+ G D++ + RS D
Sbjct: 42 TMTEKRILALAA-KHPFLTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPR 97
Query: 784 IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843
RF A+ L +LH +++RD+K NILLDAE ++ADFG+ K EG
Sbjct: 98 SRFYAAE-VTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-----EGIL 148
Query: 844 DDAM-SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ + G+ YIAPE + D ++ GV++ E++ G+ P
Sbjct: 149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 57/227 (25%), Positives = 84/227 (37%), Gaps = 45/227 (19%)
Query: 709 VAVKRLLGGTHKPETETVF------RSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762
V VK + GG P E R+ I + R + V ++M Y+
Sbjct: 122 VIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM---------PKYKC- 170
Query: 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822
D+ RSG L +I + + LAYLH I+HRDVK+ NI LD
Sbjct: 171 ------DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEP 221
Query: 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI------APEYAYTKKVTEKSDVYSF 876
+ DFG A + D C YG+ +PE K+D++S
Sbjct: 222 ENAVLGDFGAA----CKLDAHPDTPQC----YGWSGTLETNSPELLALDPYCAKTDIWSA 273
Query: 877 GVVLMELVTGKRP-----NDPSFGENKDIVRWVTEATLSSPERGCCR 918
G+VL E+ S + + I+R + L P+ G
Sbjct: 274 GLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320
|
Length = 392 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 64/261 (24%), Positives = 98/261 (37%), Gaps = 56/261 (21%)
Query: 689 LIGSGGSCRVY-KVKLKSGETVAVKRL---LGGTHKPETETVFRSEIETLGRVRHGNVVK 744
LIG GG VY VA+K++ L P + F E + + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN--PLLKKRFLREAKIAADLIHPGIVP 66
Query: 745 LLMCCSGQDFNILVYEYMP----------------NGSLADMLHEKGRSGSLDWSIRFSI 788
+ CS D VY MP SL+ L EK G+ SI
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-----LSI 118
Query: 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD--AEMVPRVADFGLAKALQSQEGQSDDA 846
+ Y+H+ ++HRD+K NILL E+V + D+G A + +E D
Sbjct: 119 FHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV--ILDWGAAIFKKLEEEDLLDI 173
Query: 847 --------------MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDP 892
+ G+ Y+APE +E +D+Y+ GV+L +++T P
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-- 231
Query: 893 SFGENKDIVRWVTEATLSSPE 913
K + + SP
Sbjct: 232 ---RRKKGRKISYRDVILSPI 249
|
Length = 932 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 684 LTEQNLIGSG--GSCRVYKVKLK--SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH 739
T ++G G GS R ++K + S + VAVK L F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 740 GNVVKL----LMCCSGQDFNI--LVYEYMPNGSL-----ADMLHEKGRSGSLDWSIRFSI 788
NV+KL L + I ++ +M +G L + E+ + L +RF I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS 848
A G+ YL + +HRD+ + N +L+ M VADFGL+K + S + S
Sbjct: 121 --DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 849 CVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWV 904
+ ++A E T SDV++FGV + E++T R P G EN +I ++
Sbjct: 176 KL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 20/142 (14%)
Query: 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL---HNDCVPAIVHRDVKSHN 816
EYM GSL + + + + I KGL +L HN I+HRDVK N
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-----IIHRDVKPTN 133
Query: 817 ILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTE------K 870
+L++ ++ DFG++ L + +++ G Y+APE + + +
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTN------IGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 871 SDVYSFGVVLMELVTGKRPNDP 892
SDV+S G+ ++E+ G+ P P
Sbjct: 188 SDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 689 LIGSGGSCRVYKVKLKS-GETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
+IG G +V K KS G AVK L T K E + L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ V +Y+ G L H + L+ RF A+ A + YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---L 115
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG-QSDDAMSCVAGSYGYIAPEYAYT 864
I++RD+K NILLD++ + DFGL K EG + ++ S G+ Y+APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRP 889
+ D + G VL E++ G P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETE---TVFRSEIETLGRVRHGNVVK 744
++G G +V +LK SG AVK L + + T+ I +L R H + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
L C D V E++ G L M H +K R + RF A+ L +LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARA-RFYAAE-ITSALMFLHDK- 115
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM-SCVAGSYGYIAPEYA 862
I++RD+K N+LLD E ++ADFG+ K EG + S G+ YIAPE
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
D ++ GV+L E++ G P + EN+D
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 38/238 (15%)
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLH-----EKGRSGSLDWSIRFSIAQGA--A 793
+VV+LL S ++V E M +G L L + G +++ I A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
G+AYL+ VHRD+ + N ++ + ++ DFG+ + + + +
Sbjct: 130 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 854 YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTE-ATLSS 911
+ +APE T SD++SFGVVL E+ + P G N+ ++++V + L
Sbjct: 187 W--MAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFVMDGGYLDQ 242
Query: 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969
P+ C E+V ++ MC P RP+ +V LL+ D
Sbjct: 243 PD------------------NCP----ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 15/204 (7%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTH---KPETETVFRSEIETLGRVRHGNVVKLL 746
IG G +V K K+ ++L K E + + L V+H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
D V +Y+ G L H + + RF A+ A L YLH+
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---LN 116
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG-QSDDAMSCVAGSYGYIAPEYAYTK 865
I++RD+K NILLD++ + DFGL K EG + S G+ Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-----EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP 889
D + G VL E++ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 27/169 (15%)
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS-IRFSIAQGAAKGLA 797
+ N +KL + ++L+ +Y+ +G L D+L ++G+ L + ++ I Q + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQ-LVEALN 123
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVP-RVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
LH I+H D+K N+L D + D+GL K G SC G+ Y
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI----IGTP----SCYDGTLDY 172
Query: 857 IAPEYAYTKKVTEKSDVYSF-----GVVLMELVTGKRPNDPSFGENKDI 900
+PE K+ + SF GV+ EL+TGK P E D+
Sbjct: 173 FSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 9e-09
Identities = 61/242 (25%), Positives = 108/242 (44%), Gaps = 39/242 (16%)
Query: 730 EIETLGRVRHGNVVKLL---MCCSGQDFNILVYEYMPNGSLADMLHEKGRS-GSLDWSIR 785
E+ + ++H N+V+ + + + Q IL+ E+ G L+ + + + G ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 786 FSIAQGAAKGLAYLHN----DCVPAIVHRDVKSHNILL-----------------DAEMV 824
I + LAY HN ++HRD+K NI L + +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY--TKKVTEKSDVYSFGVVLME 882
++ DFGL+K + G A SCV Y Y +PE TK +KSD+++ G ++ E
Sbjct: 181 AKIGDFGLSKNI----GIESMAHSCVGTPY-YWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 883 LVTGKRPNDPSFGENKDIVRWVTEATLSS--PERGCCRDLNQLIDPRMDLSTCDYEEAEK 940
L +GK P F + + + ++E P +G ++LN LI ++LS + A +
Sbjct: 236 LCSGKTP----FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQ 291
Query: 941 VL 942
L
Sbjct: 292 CL 293
|
Length = 1021 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 689 LIGSGGSCRVYKV-KLKSGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGN---VV 743
+IG GG VY K +G+ A+K L K + ET+ +E L V G+ +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+ D + + M G L L + G + +RF + GL ++HN
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKE--MRFYATE-IILGLEHMHNRF 117
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
V V+RD+K NILLD R++D GLA ++ + G++GY+APE
Sbjct: 118 V---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTHGYMAPEVLQ 168
Query: 864 TKKVTEKS-DVYSFGVVLMELVTGKRP 889
+ S D +S G +L +L+ G P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-----RHGNVV 743
+IG G +V V+LK + +++ + E + ++T V H +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDI--DWVQTEKHVFETASNHPFLV 59
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
L C + V E++ G L M H + + + RF A+ + L +LH
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNFLHER- 115
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD-DAMSCVAGSYGYIAPEYA 862
I++RD+K N+LLDAE ++ D+G+ K EG D S G+ YIAPE
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-----EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPND 891
+ D ++ GV++ E++ G+ P D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 51/162 (31%), Positives = 72/162 (44%), Gaps = 12/162 (7%)
Query: 729 SEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSI 788
+E L RH + L D V EY G L L + R S D + RF
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRA-RFYG 101
Query: 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD-DAM 847
A+ L YLH+ +V+RD+K N++LD + ++ DFGL K EG SD M
Sbjct: 102 AE-IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATM 152
Query: 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
G+ Y+APE D + GVV+ E++ G+ P
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 55/294 (18%)
Query: 697 RVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS 750
+VYK L + + VA+K L P E F+ E R++H N+V LL +
Sbjct: 20 KVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE-FKHEAMMRSRLQHPNIVCLLGVVT 78
Query: 751 GQDFNILVYEYMPNGSLADML-----HEKGRSGSLDWSIR--------FSIAQGAAKGLA 797
+ +++ Y + L + L H S D +++ I A G+
Sbjct: 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGME 138
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY--- 854
+L + V VH+D+ + N+L+ ++ +++D GL + E + D + S
Sbjct: 139 FLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFR-----EVYAADYYKLMGNSLLPI 190
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPE 913
+++PE K + SD++S+GVVL E+ + G +P N+D++
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSNQDVI------------ 236
Query: 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
++I R L C + V + L C ++FP RP + + LR
Sbjct: 237 --------EMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNV 742
IG G VYK + K+G+ VA+K++ + E+E T R EI L ++H N+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIR-EISLLKELQHPNI 61
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V L + L++E++ + L L + +D + S +G+ + H+
Sbjct: 62 VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY- 861
++HRD+K N+L+D + V ++ADFGLA+A G + + Y APE
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF----GIPVRVYTHEVVTLWYRAPEVL 173
Query: 862 ----AYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y+ V D++S G + E+ T K+P
Sbjct: 174 LGSPRYSTPV----DIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTH--KPETETVFRSEIETLGRVRHGNVVKLL 746
+IG G V V+ KS V +LL K F E + + VV+L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ +V EYMP G L +++ W+ RF A+ L +H+
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WA-RFYTAE-VVLALDAIHS---MG 162
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG--QSDDAMSCVAGSYGYIAPEYAYT 864
+HRDVK N+LLD ++ADFG + ++EG + D A+ G+ YI+PE +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAV----GTPDYISPEVLKS 217
Query: 865 KK----VTEKSDVYSFGVVLMELVTGKRP 889
+ + D +S GV L E++ G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IG G V+K K + + E VA+KR+ L + + R EI L ++H N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
LV+EY + L G +D I S KGLA+ H+ +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
+HRD+K N+L++ ++ADFGLA+A G S + Y P+ + K+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 868 TEKS-DVYSFGVVLMELVTGKRP 889
S D++S G + EL RP
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 31/196 (15%)
Query: 705 SGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKL---LMCCSGQDFN--ILV 758
+ E VA+K++ ++ + + R EI+ L + H NV+ + + + FN +V
Sbjct: 29 TNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87
Query: 759 YEYMPNGSLADMLHEKGRSGSL--DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHN 816
YE M LH+ RS D ++ + Q +GL Y+H+ ++HRD+K N
Sbjct: 88 YELMDTD-----LHQIIRSSQTLSDDHCQYFLYQ-LLRGLKYIHS---ANVLHRDLKPSN 138
Query: 817 ILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY-----AYTKKVTEKS 871
+LL+A ++ DFGLA+ + D M+ + Y APE YT +
Sbjct: 139 LLLNANCDLKICDFGLART----TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAI---- 190
Query: 872 DVYSFGVVLMELVTGK 887
DV+S G + EL+ K
Sbjct: 191 DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 25/194 (12%)
Query: 699 YKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758
+ E V ++LG H+ ++ F + + ++ H ++VKL C + NI+V
Sbjct: 22 LDIVGPGQEVSVVLKVLGSDHR-DSLAFFET-ASLMSQLSHKHLVKLYGVCVRDE-NIMV 78
Query: 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818
EY+ G L LH + + SL W + +A+ A L YL + +VH +V NIL
Sbjct: 79 EEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNIL 133
Query: 819 L-----DAEMVP--RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY--TKKVTE 869
+ + VP +++D G+ + S+E + + +IAPE +T
Sbjct: 134 VARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------PWIAPECIRNGQASLTI 185
Query: 870 KSDVYSFGVVLMEL 883
+D +SFG L+E+
Sbjct: 186 AADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRS---EIETLGRVRHGNVVKL 745
IGSG V + +SG+ VA+K++ H + T+ + E++ L +H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI---PHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 746 L--MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSG---SLDWSIRFSIAQGAAKGLAY 798
+ G DF +V + M + LH S + + IR+ + Q +GL Y
Sbjct: 70 RDILRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEE-HIRYFLYQ-LLRGLKY 122
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
+H+ V +HRD+K N+L++ + R+ DFG+A+ L S + M+ + Y A
Sbjct: 123 IHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 859 PE-----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
PE YT + D++S G + E++ G+R
Sbjct: 180 PELLLSLPEYTTAI----DMWSVGCIFAEML-GRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFR-SEIETLGRVRHGNVVKLL 746
L+G G +V V+ K +G A+K L + E +E L RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
D V EY G L L + R + + + RF A+ L YLH+ V
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERA-RFYGAE-IVSALEYLHSRDV-- 116
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA-MSCVAGSYGYIAPEYAYTK 865
V+RD+K N++LD + ++ DFGL K EG SD A M G+ Y+APE
Sbjct: 117 -VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP 889
D + GVV+ E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 727 FRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH-----EKGRSGSLD 781
F +E + +VV+LL S +++ E M G L L +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 782 WSIR--FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839
S++ +A A G+AYL+ + VHRD+ + N ++ + ++ DFG+ + +
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172
Query: 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENK 898
+ + +++PE T SDV+SFGVVL E+ T P G N+
Sbjct: 173 DYYRKGGKGLL--PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQGMSNE 228
Query: 899 DIVRWVTEATLSSPERGCCRDLNQLI------DPRM 928
++R+V E L C L +L+ +P+M
Sbjct: 229 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKM 264
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 689 LIGSGGSCRVYKVKLKSGETV-AVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
+IG G +V + K+ E AVK L K E + + L V+H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
D V +Y+ G L H + L+ RF A+ A L YLH+
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---L 115
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
IV+RD+K NILLD++ + DFGL K + + + S G+ Y+APE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP 889
D + G VL E++ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 44/197 (22%)
Query: 779 SLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837
+LD S + AKG+++L + +C+ HRD+ + NILL + ++ DFGLA+ ++
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIR 265
Query: 838 SQEGQSDDAMSCVAGS----YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPS 893
+ D+ V G+ ++APE + T +SDV+S+G++L E+ S
Sbjct: 266 N------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF--------S 311
Query: 894 FGENKDIVRWVTEATLSSPERGCCRD--LNQLIDP--RMDLSTCDYEEAEKVLNVALMCT 949
G SSP G D ++I RM C E ++ C
Sbjct: 312 LG--------------SSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK---SCW 354
Query: 950 SDFPINRPSMRRVVELL 966
P+ RP+ +++V+L+
Sbjct: 355 DADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 36/179 (20%)
Query: 793 AKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG--QSDDAMSC 849
A+G+ +L + C+ HRD+ + NILL V ++ DFGLA+ + + DA
Sbjct: 183 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT 908
+ ++APE + K T +SDV+SFGV+L E+ + G P P +++ R + E T
Sbjct: 239 LK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQIDEEFCRRLKEGT 293
Query: 909 -LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ +PE Y E + ++ L C + P +RP+ +VE+L
Sbjct: 294 RMRAPE---------------------YATPE-IYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 51/216 (23%)
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLH 800
VVKL +D V +Y+P G + +L G L RF IA+ + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESVH 118
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGL---------AKALQSQEGQSDDAMS--- 848
+HRD+K NIL+D + ++ DFGL +K Q + D+M
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 849 -----------------------CVA----GSYGYIAPEYAYTKKVTEKSDVYSFGVVLM 881
C+A G+ YIAPE T+ D +S GV+L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 882 ELVTGKRP-NDPSFGENK-DIVRWVTEATLSSPERG 915
E++ G+ P + E + ++ W E TL P +
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINW--ETTLHIPSQA 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 682 PHLTEQNLIGSGGSCRVYK-----VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
+T +L+ G R++ K E V VK + T+ E L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYG 64
Query: 737 VRHGNVVKLL-MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IA 789
+ H N++ +L +C + ++Y YM G+L L ++ R G + S +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQLVHMA 123
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS--DDAM 847
A G++YLH ++H+D+ + N ++D E+ ++ D L++ L + D+
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
V ++A E K+ + SDV+SFGV+L EL+T G+ P
Sbjct: 181 RPVK----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 689 LIGSGGSCRVYKVKLKSGE------TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
++G+G +V+ V+ +G + V + K +T R+E L VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 743 VKLLMCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+ L + + L+ +Y+ G + L++ R + +RF + L +LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGE-IILALEHLHK 123
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
IV+RD+K NILLD+E + DFGL+K S+E + + G+ Y+APE
Sbjct: 124 ---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF---CGTIEYMAPEI 177
Query: 862 AYTKKVTEKS-DVYSFGVVLMELVTGKRP 889
K K+ D +S G+++ EL+TG P
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 48/290 (16%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IG G VY+ L G VA+K++ + + EI+ L ++ H NV+K
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 748 CCSGQDFNILVYEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ +V E G L+ M+ H K + + + L ++H+
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
++HRD+K N+ + A V ++ D GL + S ++ A S V Y Y++PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPY-YMSPERIHENG 182
Query: 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926
KSD++S G +L E+ + P +G+ ++ C+ + Q
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQ---SPFYGDKMNLY-------------SLCKKIEQ---- 222
Query: 927 RMDLSTCDY---------EEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
CDY EE +++N MC + P RP + V ++ +
Sbjct: 223 ------CDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 41/219 (18%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKR-LLGGTHKPETETVFRSEIETLGRVRHGN-VVKLL 746
IG G +VYK + +G+ VA+K+ L + T R EI L + +V+LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRLL 67
Query: 747 MC-----CSGQDFNILVYEYMPNGSLADM-LHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
+G+ LV+EY+ + M + +G L S KG+A+ H
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 801 NDCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG---- 855
++HRD+K N+L+D + + ++AD GL +A S SY
Sbjct: 128 KH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-----------SIPVKSYTHEIV 173
Query: 856 ---YIAPEY-----AYTKKVTEKSDVYSFGVVLMELVTG 886
Y APE Y+ V D++S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 46/140 (32%), Positives = 71/140 (50%), Gaps = 21/140 (15%)
Query: 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHN 816
L+ +Y+ G L L+++ + +R IA+ L +LH I++RD+K N
Sbjct: 82 LILDYVNGGELFTHLYQREHFT--ESEVRVYIAE-IVLALDHLHQ---LGIIYRDIKLEN 135
Query: 817 ILLDAEMVPRVADFGLAKALQSQEGQSDDAMS-CVAGSYGYIAPEY------AYTKKVTE 869
ILLD+E + DFGL+K ++E + A S C G+ Y+APE + K V
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEE--ERAYSFC--GTIEYMAPEVIRGGSGGHDKAV-- 189
Query: 870 KSDVYSFGVVLMELVTGKRP 889
D +S GV+ EL+TG P
Sbjct: 190 --DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 63/204 (30%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFR-SEIETLGRVRHGNVVKLL 746
L+G G +V VK K +G A+K L + E +E L RH + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
D V EY G L L + R S D + RF A+ L YLH++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRA-RFYGAE-IVSALDYLHSE--KN 116
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA-MSCVAGSYGYIAPEYAYTK 865
+V+RD+K N++LD + ++ DFGL K EG D A M G+ Y+APE
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP 889
D + GVV+ E++ G+ P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHGNVVKL- 745
LI +YK + + V + R HK + +EI+ L R+ N++K+
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVII-RTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84
Query: 746 ---LMCCSGQDFNILVYEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+ L+ EY G L ++L EK L + + +A KGL L+
Sbjct: 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYK 140
Query: 802 -DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
P ++++ S + L+ ++ GL K L S ++ + M V SY +
Sbjct: 141 YTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM--VYFSYKMLNDI 195
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
++ + T K D+YS GVVL E+ TGK P
Sbjct: 196 FS---EYTIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTH--KPETETVFRSEIETLGRVRHGNVVKLL 746
+IG G V V+ KS + V +LL K F E + + VV+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ +V EYMP G L +++ W+ +F A+ L +H+
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WA-KFYTAE-VVLALDAIHS---MG 162
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLA-KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
++HRDVK N+LLD ++ADFG K ++ + D A+ G+ YI+PE ++
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV----GTPDYISPEVLKSQ 218
Query: 866 K----VTEKSDVYSFGVVLMELVTGKRP 889
+ D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 687 QNLIGSGGSCRV-YKVKLKSGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVK 744
Q +IG G V + +GE VA+K++ H + + R EI+ L +RH ++V+
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 745 ---LLMCCSGQDFN--ILVYEYMPNGSLADMLHE--KGRSGSLDWSIRFSIAQGAAKGLA 797
+++ S ++F +V+E M + LH+ K +F + Q + L
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQ-LLRALK 117
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
Y+H V HRD+K NIL +A+ ++ DFGLA+ + + VA + Y
Sbjct: 118 YIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-YR 173
Query: 858 APEY--AYTKKVTEKSDVYSFGVVLMELVTGK 887
APE ++ K T D++S G + E++TGK
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 39/112 (34%), Positives = 60/112 (53%), Gaps = 17/112 (15%)
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
GL Y+H+ V +HRD+K N+L++A+ ++ DFGLA+ G++ M+ +
Sbjct: 117 GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 855 GYIAPEY-----AYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIV 901
Y APE +YTK + DV+S G +L EL+ K P F + KD V
Sbjct: 174 WYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK----PVF-KGKDYV 216
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 44/286 (15%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKLL- 746
IG G VY+ L + VA+K++ + + EI+ L ++ H NV+K L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 747 MCCSGQDFNILVYEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ NI V E G L+ M+ + K + + + + ++H+
Sbjct: 70 SFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--- 125
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
++HRD+K N+ + A V ++ D GL + S ++ A S V Y Y++PE +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPY-YMSPERIHEN 181
Query: 866 KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
KSD++S G +L E+ A L SP G D L
Sbjct: 182 GYNFKSDIWSLGCLLYEM-----------------------AALQSPFYG---DKMNLFS 215
Query: 926 PRMDLSTCDY------EEAEKVLNVALMCTSDFPINRPSMRRVVEL 965
+ CDY +EK+ + MC P RP + V ++
Sbjct: 216 LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 38/180 (21%)
Query: 793 AKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851
A+G+ +L + C+ HRD+ + NILL V ++ DFGLA+ + D
Sbjct: 184 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYK------DPDYVRK 233
Query: 852 GS----YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTE 906
GS ++APE + K T +SDV+SFGV+L E+ + G P P N++ + + +
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQINEEFCQRLKD 292
Query: 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
T RM + E + + L C P RP+ +VE+L
Sbjct: 293 GT------------------RM--RAPENATPE-IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 66/298 (22%)
Query: 690 IGSGGSCRVYKVKLK------------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
+G G ++Y L E + ++L +H+ + F + +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQV 61
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H ++V L C NI+V E++ G L +H K + W +F +A+ A L+
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALS 119
Query: 798 YLHNDCVPAIVHRDVKSHNILL-----DAEMVP--RVADFGLAKALQSQEGQSDDAMSCV 850
YL + +VH +V + NILL D E P +++D G+ + S++ CV
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-------ECV 169
Query: 851 AGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELV-TGKRPNDPSFGENKDIVRWVTEAT 908
+IAPE +K ++ +D +SFG L E+ G+ P + + T
Sbjct: 170 E-RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP--------------LKDKT 214
Query: 909 LSSPER---GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVV 963
L+ ER G C L T +E ++ C + P RP R ++
Sbjct: 215 LAEKERFYEGQCM-----------LVTPSCKELADLMT---HCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 46/206 (22%), Positives = 85/206 (41%), Gaps = 14/206 (6%)
Query: 691 GSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC-C 749
+ K K + VAVK++ + E + + EI T +++H N++ +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
+ +V M GS D+L G + +I F I + L Y+H+ +H
Sbjct: 70 VDSEL-YVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSK---GFIH 124
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC----VAGSYGYIAPEYAYT- 864
R VK+ +ILL + ++ + ++ G+ + + +++PE
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKH-GKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183
Query: 865 -KKVTEKSDVYSFGVVLMELVTGKRP 889
+ EKSD+YS G+ EL G P
Sbjct: 184 LQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIE-------TLGRVRHGNV 742
IG G +V +V+ + + + + + H V RSE+ L +V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-----IVSRSEVTHTLAERTVLAQVNCPFI 55
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS-IRFSIAQGAAKGLAYLHN 801
V L + LV ++ G L H R G D S RF A+ L LH
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAE-LLCALENLHK 111
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE- 860
V ++RD+K NILLD + + DFGL K DD + G+ Y+APE
Sbjct: 112 FNV---IYRDLKPENILLDYQGHIALCDFGLCKLNMKD----DDKTNTFCGTPEYLAPEL 164
Query: 861 ---YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ YTK V D ++ GV+L E++TG P
Sbjct: 165 LLGHGYTKAV----DWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 689 LIGSGGSCRVYKVKL----KSGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNV 742
++G+G +V+ V+ SG+ A+K L T K +T R+E + L +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 743 VKLLMCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+ L D + L+ +Y+ G L L ++ R + I L +LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG---EIVLALEHLHK 123
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
I++RD+K NILLD+ + DFGL+K E + A S G+ Y+AP+
Sbjct: 124 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE--VERAYS-FCGTIEYMAPDI 177
Query: 862 ------AYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ K V D +S GV++ EL+TG P
Sbjct: 178 VRGGDGGHDKAV----DWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 680 ILPHLTEQNLIGSGGS---CRVYKVKLKSGETVAVKRLLGG-THKPETETVFRSEIETLG 735
+L + IGSG C + L G VAVK+L ++ + +R E+ L
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLK 75
Query: 736 RVRHGNVVKLLMCCSGQ----DFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIA 789
V H N++ LL + Q +F LV E M + +L ++H + LD +
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME-----LDHERMSYLL 129
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
G+ +LH+ I+HRD+K NI++ ++ ++ DFGLA+ ++ M+
Sbjct: 130 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-----ACTNFMMTP 181
Query: 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTG 886
+ Y APE E D++S G ++ ELV G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-07
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 45/221 (20%)
Query: 687 QNL--IGSGGS---CRVYKVKLKSGETVAVKRL----LGGTHKPETETVFRSEIETLGRV 737
QNL IGSG C Y G+ VA+K+L TH +R E+ + V
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRA---YR-ELVLMKLV 72
Query: 738 RHGNVVKLLMCCSGQ----DFN--ILVYEYMPNGSLA-----DMLHEKGRSGSLDWSIRF 786
H N++ LL + Q +F LV E M + +L D+ HE+ + +
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHER---------MSY 122
Query: 787 SIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA 846
+ Q G+ +LH+ I+HRD+K NI++ ++ ++ DFGLA+ G S
Sbjct: 123 LLYQMLC-GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMM 174
Query: 847 MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
V Y Y APE E D++S G ++ E++ G
Sbjct: 175 TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 42/222 (18%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL--L 746
+G G + V+ V + VAVK+++ T + R EI+ + R+ H N+VK+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVL-TDPQSVKHALR-EIKIIRRLDHDNIVKVYEV 70
Query: 747 MCCSGQDFN------------ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK 794
+ SG D +V EYM LA++L E+G R + Q +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLSEE--HARLFMYQ-LLR 125
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQ---SQEGQSDDAMSCV 850
GL Y+H+ V +HRD+K N+ ++ E +V ++ DFGLA+ + S +G + +
Sbjct: 126 GLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-- 180
Query: 851 AGSYGYIAPEYA-----YTKKVTEKSDVYSFGVVLMELVTGK 887
+ Y +P YTK + D+++ G + E++TGK
Sbjct: 181 --TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 687 QNLIGSGGSCRVYKVKLK-SGETVAVKRLL-GGTHKPETETVFRSEIETLGRVRHGNVVK 744
++L+G G V V+ K +G+ A+K + ET + F E + L + +
Sbjct: 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS-IRFSIAQGAAKGLAYLHNDC 803
L +D LV EY P G L +L+ D +F +A+ +H+
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLA----IHSVH 119
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
VHRD+K N+L+D ++ADFG A L + + ++ V G+ YIAPE
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN--KMVNSKLPV-GTPDYIAPEVLT 176
Query: 864 TKKVTEKS------DVYSFGVVLMELVTGKRP 889
T K D +S GV+ E++ G+ P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
+IG G +V K K G+ AVK L ++ E + + L V+H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ V +++ G L H + + RF A+ A L YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---I 115
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
IV+RD+K NILLD++ + DFGL K +Q D + G+ Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----DTTTTFCGTPEYLAPEVIRKQ 171
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP 889
D + G VL E++ G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 689 LIGSGGSCRVYKV-KLKSGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGN---VV 743
+IG GG VY K +G+ A+K L K + ET+ +E L V G+ +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+ D + + M G L L + G + +RF A+ GL ++HN
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE--MRFYAAE-IILGLEHMHNRF 117
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
V V+RD+K NILLD R++D GLA ++ + G++GY+APE
Sbjct: 118 V---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTHGYMAPE-VL 167
Query: 864 TKKVTEKS--DVYSFGVVLMELVTGKRP 889
K V S D +S G +L +L+ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 42/132 (31%), Positives = 69/132 (52%), Gaps = 22/132 (16%)
Query: 768 ADMLHEKGRSGS----LDWSIRFSIAQGAAKGLAYL-HNDCVPAIVHRDVKSHNILLDAE 822
+D E+ S LD +RFS A+G+ +L +C+ HRDV + N+LL
Sbjct: 195 SDSKDEEDTEDSWPLDLDDLLRFSSQ--VAQGMDFLASKNCI----HRDVAARNVLLTDG 248
Query: 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGS----YGYIAPEYAYTKKVTEKSDVYSFGV 878
V ++ DFGLA+ + +D+ V G+ ++APE + T +SDV+S+G+
Sbjct: 249 RVAKICDFGLARDIM------NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302
Query: 879 VLMELVT-GKRP 889
+L E+ + GK P
Sbjct: 303 LLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 34/178 (19%)
Query: 793 AKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG--QSDDAMSC 849
AKG+ +L + C+ HRD+ + NILL V ++ DFGLA+ + + DA
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT 908
+ ++APE + + T +SDV+SFGV+L E+ + G P P +++ R + E T
Sbjct: 245 LK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEFCRRLKEGT 299
Query: 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
RM DY E + L C P RP+ +VE L
Sbjct: 300 ------------------RM--RAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 689 LIGSGGSCRVYKVKL----KSGETVAVKRLLGGT----HKPETETVFRSEIETLGRVRHG 740
++G GG +V++V+ +G+ A+K L T K T ++E L V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT--KAERNILEAVKHP 60
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
+V L+ L+ EY+ G L L +G ++ + F +++ + L +LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIF--MEDTACFYLSE-ISLALEHLH 117
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
I++RD+K NILLDA+ ++ DFGL K +S + C G+ Y+APE
Sbjct: 118 QQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFC--GTIEYMAPE 170
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ D +S G ++ +++TG P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G VYK + +G+ VA+K + T + T R E L ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
++ V+EYM M+ G G +++R + Q +GLAY+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLRGLAYIHGQ---HIL 125
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-TKKV 867
HRD+K N+L+ ++ADFGLA+A +S Q+ S + Y P+
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARA-KSIPSQT---YSSEVVTLWYRPPDVLLGATDY 181
Query: 868 TEKSDVYSFGVVLMELVTGK 887
+ D++ G + +E++ G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-07
Identities = 63/232 (27%), Positives = 89/232 (38%), Gaps = 29/232 (12%)
Query: 133 FIGELPDFSREFANLQVLDLSRNNFSGDIP---ESFGRFPVLKVLNLGGNLLSGLIPSFL 189
+ L + LQ LDLS N D ES R L+ L L N L L
Sbjct: 69 GLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL 128
Query: 190 GN-LTELTH----FELGYNPLKSSPLPSSVGNLS---KLENLWAAKANLIGE-IPDSIGK 240
L +L LG N L+ + + L L+ L A + I
Sbjct: 129 AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188
Query: 241 LAFLSNL---DLSDNFL----SGKIPHSFSGLASIEQIELFDNQLSGE-----LPESLSN 288
L NL DL++N L + + + + L S+E + L DN L+ LS
Sbjct: 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSP 248
Query: 289 LTTLLRLDISQNNLT----GNLPETIAAM-SLESLNLNDNYFTGEIPESLAS 335
+LL L +S N++T +L E +A SL L+L N F E + LA
Sbjct: 249 NISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGG---THKPETETVFRSEIETLGRVRHGNVVKL 745
+IG G V VK+K E + ++L + ET FR E L + L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAET-ACFREERNVLVNGDCQWITTL 66
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG--AAKGLAYLHNDC 803
+++ LV +Y G L +L + D + RF IA+ A + LH
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYIAEMVLAIHSIHQLH--- 122
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFG-LAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
VHRD+K N+LLD R+ADFG K Q QS S G+ YI+PE
Sbjct: 123 ---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS----SVAVGTPDYISPEIL 175
Query: 863 YTK-----KVTEKSDVYSFGVVLMELVTGKRP 889
K + D +S GV + E++ G+ P
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G G VYK + K + + + + H+ E+ L ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
+ LV+EY+ + L L + G S ++ +++ + Q +GL Y H ++H
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFLFQ-LLRGLNYCHRR---KVLH 127
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-TKKVT 868
RD+K N+L++ ++ADFGLA+A + S + Y P+ + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 869 EKSDVYSFGVVLMELVTGKRPNDP 892
+ D++ G + E+ TG RP P
Sbjct: 184 TQIDMWGVGCIFYEMSTG-RPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 23/60 (38%), Positives = 30/60 (50%)
Query: 146 NLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205
NL+ LDLS N + +F P LKVL+L GN L+ + P L L +L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 688 NLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL- 745
N+IG+G VY+ + + + E VA+K++L P+ + E+ + + H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQYKN---RELLIMKNLNHINIIFLK 125
Query: 746 ----LMCCSGQDFNI---LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
C + NI +V E++P M H + +L + + + LAY
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
+H+ I HRD+K N+L+D ++ DFG AK L + GQ + C S Y
Sbjct: 186 IHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA--GQRSVSYIC---SRFYR 237
Query: 858 APEYAY-TKKVTEKSDVYSFGVVLMELVTG 886
APE T D++S G ++ E++ G
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 689 LIGSGGSCRVYKVKLKSGET-VAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
LI +G VY V+ K A+K++ + + + VF E + L + VV +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ +V EY+ G A +L G + +D + R A+ L YLHN
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMA-RMYFAE-TVLALEYLHN---Y 120
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAK-ALQSQ-----EGQSD-------DAMSCVAG 852
IVHRD+K N+L+ + ++ DFGL+K L S EG + D C G
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC--G 178
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE 896
+ YIAPE + + D ++ G++L E + G P FG+
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV---PFFGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 55/233 (23%)
Query: 728 RSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSI-RF 786
++E + L + VVKL +D V +Y+P G DM+ R + RF
Sbjct: 49 KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG---DMMSLLIRMEVFPEVLARF 105
Query: 787 SIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ-------SQ 839
IA+ + +H +HRD+K NIL+D + ++ DFGL + Q
Sbjct: 106 YIAE-LTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161
Query: 840 EGQS------------DDAMSC------------------------VAGSYGYIAPEYAY 863
+G DD +C + G+ YIAPE
Sbjct: 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRPN-DPSFGENK-DIVRWVTEATLSSPER 914
K T+ D +S GV+L E++ G+ P P+ E + ++ W E TL P +
Sbjct: 222 RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW--ENTLHIPPQ 272
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 15/99 (15%)
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
+GL YLH+ I+HRD+K N+L+++ V ++ DFGLA+ ++ + +S V
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPD-ESKHMTQEVVTQ 168
Query: 854 YGYIAPEYA-----YTKKVTEKSDVYSFGVVLMELVTGK 887
Y Y APE YT V D++S G + EL+ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 55/225 (24%)
Query: 728 RSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSI-RF 786
++E + L + VV+L +D V +Y+P G DM+ R G + RF
Sbjct: 49 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG---DMMSLLIRMGIFPEDLARF 105
Query: 787 SIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL---------AKALQ 837
IA+ + +H +HRD+K NIL+D + ++ DFGL +K Q
Sbjct: 106 YIAELTC-AVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 838 SQEGQSDDAMS------------------------------CVA----GSYGYIAPEYAY 863
S + D+M C+A G+ YIAPE
Sbjct: 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRP---NDPSFGENKDIVRWVT 905
T+ D +S GV+L E++ G+ P P + K ++ W T
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMK-VINWQT 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 33/128 (25%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNI 817
Y+ + + ++L + G G L S A+G+ +L + +CV HRD+ + N+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEG-LTTLDLLSFTYQVARGMEFLASKNCV----HRDLAARNV 268
Query: 818 LLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFG 877
LL + ++ DFGLA+ + + + ++APE + T SDV+S+G
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 878 VVLMELVT 885
++L E+ +
Sbjct: 327 ILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-06
Identities = 36/171 (21%), Positives = 74/171 (43%), Gaps = 33/171 (19%)
Query: 729 SEIETLGRVRHGNVVKLLMCCSGQDFNILV--------YEYMPNGSLADMLHEKGRSGSL 780
+EI LGR+ H N++K+ + ++ Y +M + + + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265
Query: 781 DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840
R +I + + Y+H+ ++HRD+K NI L+ + + DFG A + +
Sbjct: 266 LKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 841 GQSDDAMSCVAGSYGYI------APEYAYTKKVTEKSDVYSFGVVLMELVT 885
A YG++ +PE E +D++S G++L+++++
Sbjct: 322 ---------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTH--KPETETVFRSEIETLGRVRHGNVVKLL 746
+IG G V VKLK+ + V ++L K FR E + L V N
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDNQWITT 65
Query: 747 MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG--AAKGLAYLHND 802
+ + QD N LV +Y G L +L + D + RF +A+ A + LH
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYLAEMVIAIDSVHQLH-- 122
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFG-LAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
VHRD+K NIL+D R+ADFG K ++ QS S G+ YI+PE
Sbjct: 123 ----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS----SVAVGTPDYISPEI 174
Query: 862 AYTK-----KVTEKSDVYSFGVVLMELVTGKRP 889
K + D +S GV + E++ G+ P
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 690 IGSGGSCRVYKVKLKSGE--TVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
+G+G RV K+ + VA+KR + + + VF SE + L + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ + LV E++ G L R + + A YL +
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---DVGCFYAAQIVLIFEYLQS---L 150
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
IV+RD+K N+LLD + ++ DFG AK + ++ + G+ YIAPE
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-------TYTLCGTPEYIAPEILLNV 203
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP---NDP 892
+ +D ++ G+ + E++ G P N+P
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G G V+K + K E + + + H+ E+ L ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
+ LV+EY+ + L L G S+ +++ + Q +GL+Y H I+H
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMH-NVKIFMFQ-LLRGLSYCHKR---KILH 126
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQ-SQEGQSDDAMS-------CVAGSYGYIAPEY 861
RD+K N+L++ + ++ADFGLA+A + S++ ++ + GS Y P
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP-- 184
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGKRPNDP 892
D++ G +L E+ TG RP P
Sbjct: 185 ---------IDMWGVGCILYEMATG-RPMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 6/146 (4%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC 749
+G G V+K + K E + + + H+ E+ L ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
LV+EY+ + L + + G S+ +++ + Q +GLAY H ++H
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIFLYQ-ILRGLAYCHRR---KVLH 127
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKA 835
RD+K N+L++ ++ADFGLA+A
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARA 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 56/235 (23%), Positives = 95/235 (40%), Gaps = 41/235 (17%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHGNVVKLL 746
+IG G V V+ K + ++L E E V R+E + L VVK+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ L+ E++P G + +L +K + + +F IA+ + +H
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS--EEATQFYIAE-TVLAIDAIHQ---LG 121
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQS---------------------------- 838
+HRD+K N+LLDA+ +++DFGL L+
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 839 ----QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
++ + A S V G+ YIAPE + D +S GV++ E++ G P
Sbjct: 182 AETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 687 QNL--IGSGGS---CRVYKVKLKSGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHG 740
QNL IGSG C Y L VA+K+L ++ + +R E+ + V H
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 76
Query: 741 NVVKLLMCCSGQ----DFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK 794
N++ LL + Q +F LV E M + +L ++ + LD +
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME-----LDHERMSYLLYQMLC 130
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
G+ +LH+ I+HRD+K NI++ ++ ++ DFGLA+ G S V Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRY 183
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
Y APE E D++S G ++ E+V K
Sbjct: 184 -YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G VYK K K +G+ VA+K + + T R E L ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808
++ LV+EY+ M +K G +++ + Q +GL+Y+H I+
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYIHQR---YIL 125
Query: 809 HRDVKSHNILLDAEMVPRVADFGLAKA 835
HRD+K N+L+ ++ADFGLA+A
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-05
Identities = 17/42 (40%), Positives = 23/42 (54%), Gaps = 1/42 (2%)
Query: 26 LHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITC 67
L+ D + L+ KS DP+ L W S PC+WTG+TC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWN-PSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 45/237 (18%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHGNVVKLL 746
+IG G V V+ K V ++L E E V R+E + L VVK+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 747 MCCSGQD-FNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
S QD N+ L+ E++P G + +L +K + +F IA+ + +H
Sbjct: 68 Y--SFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAE-TVLAIDSIHQ--- 119
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS-------------------------- 838
+HRD+K N+LLD++ +++DFGL L+
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 839 ------QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ + A S V G+ YIAPE + D +S GV++ E++ G P
Sbjct: 180 RKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
G+ +LH+ I+HRD+K NI++ ++ ++ DFGLA+ G S V Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRY 190
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
Y APE E D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 22/84 (26%), Positives = 40/84 (47%)
Query: 394 NNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSI 453
N G IP + + L + GN ++G +P + ++ ++ N F GSI S+
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 454 SNAPKLTGILINGNNFTGEVPSQI 477
L + +NGN+ +G VP+ +
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVK--RLLGGTHKPETETVFRS--EIETLGRVRHGNVVK 744
+G G VYK + K +G+ VA+K RL + E F + E L ++H N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRL-----EHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
L + LV+EY+ + L + + G S+ ++R + Q +GLAY H
Sbjct: 68 LHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH-NVRLFLFQ-LLRGLAYCHQR-- 122
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835
++HRD+K N+L+ ++ADFGLA+A
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 70/281 (24%), Positives = 109/281 (38%), Gaps = 73/281 (25%)
Query: 689 LIGSGGSCRVYKV-KLKSGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLL 746
+IG G V V K +G+ A+K LL K + ++E + L VV L
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ L+ E++P G L ML K + S D + RF +A+ CV A
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTML-IKYDTFSEDVT-RFYMAE------------CVLA 113
Query: 807 I--------VHRDVKSHNILLDAEMVPRVADFGLA-------------KALQSQEGQSDD 845
I +HRD+K NIL+D +++DFGL+ K LQ + ++
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 846 -------------------------------AMSCVAGSYGYIAPEYAYTKKVTEKSDVY 874
A S V G+ YIAPE + ++ D +
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV-GTPDYIAPEIFLQQGYGQECDWW 232
Query: 875 SFGVVLMELVTGKRP--NDPSFGENKDIVRWVTEATLSSPE 913
S G ++ E + G P ++ S + I+ W TL P+
Sbjct: 233 SLGAIMFECLIGWPPFCSENSHETYRKIINW--RETLYFPD 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPE----TETV-FRSEIETLGRVRHGN-- 741
+IG G V VK+K+ V ++L +K E ET FR E + L +G+
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKIL---NKWEMLKRAETACFREERDVL---VNGDRR 61
Query: 742 -VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG--AAKGLAY 798
+ L ++ LV +Y G L +L + D + RF +A+ A +
Sbjct: 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYLAEMVLAIDSVHQ 120
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA-GSYGYI 857
L VHRD+K N+LLD R+ADFG L + S VA G+ YI
Sbjct: 121 LG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA----DGTVQSNVAVGTPDYI 170
Query: 858 APEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRP 889
+PE + + D +S GV + E++ G+ P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 793 AKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851
A G+ +L + +CV HRD+ + N+L+ + ++ DFGLA+ + D+
Sbjct: 249 ANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMR------DSNYISK 298
Query: 852 GS----YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885
GS ++APE + T SDV+SFG++L E+ T
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 40/189 (21%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 707 ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGS 766
+T + ++L +H+ +E+ F + + ++ H ++V C D +I+V EY+ GS
Sbjct: 27 KTEVLLKVLDKSHRNYSESFFEAA-SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGS 85
Query: 767 LADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL-----DA 821
L L + ++ W + +A+ A L +L + + H +V + N+LL
Sbjct: 86 LDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRK 140
Query: 822 EMVP---RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-YAYTKKVTEKSDVYSFG 877
P +++D G++ + +E + ++ PE + ++ +D +SFG
Sbjct: 141 TGNPPFIKLSDPGISITVLPKEILLE--------RIPWVPPECIENPQNLSLAADKWSFG 192
Query: 878 VVLMELVTG 886
L E+ +G
Sbjct: 193 TTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 24/59 (40%), Positives = 37/59 (62%)
Query: 244 LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNL 302
L +LDLS+N L+ +F GL +++ ++L N L+ PE+ S L +L LD+S NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 690 IGSGGSCRVYKVKLKSGETVA--VKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IG+G +V ++ SG T A V + L + + + F E + ++H N+++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSL--DWSIRFSIAQGAAKGLAYLHNDCVP 805
C+ +LV E+ P G L L ++ + D + +A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLA--KALQSQEGQSDDAMSCVAGSYGYIAPEYA- 862
+H D+ N LL A++ ++ D+GL+ K + D + +IAPE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPELVD 175
Query: 863 ------YTKKVTEKSDVYSFGVVLMEL 883
T++S+V+S GV + EL
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 690 IGSGGSCRVYKVKLKSGE---TVAVKRLLG-GTHKPETETVFRSEIETLGRVRHGNVVKL 745
+G G VYK K K G+ A+K++ G G EI L ++H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-----EIALLRELKHPNVIAL 63
Query: 746 L-MCCSGQDFNI-LVYEYMPNGSLADMLH---------EKGRSGSLDWSIRFSIAQGAAK 794
+ S D + L+++Y + D+ H + L S+ S+
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPR----VADFGLAKALQSQEGQSDDAMSCV 850
G+ YLH + V +HRD+K NIL+ E R +AD G A+ S D + V
Sbjct: 120 GIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDPV 175
Query: 851 AGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGK 887
++ Y APE + T+ D+++ G + EL+T +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 690 IGSGGSCRVYKVKLKSGET---VAVKRLLG-GTHKPETETVFRSEIETLGRVRHGNVVKL 745
+G G VYK K K G+ A+K++ G G EI L ++H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-----EIALLRELKHPNVISL 63
Query: 746 L-MCCSGQDFNI-LVYEYMPNGSLADMLHE-KGRSGSLDWSIRFSIAQGAAK-------- 794
+ S D + L+++Y + D+ H K S + +G K
Sbjct: 64 QKVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPR----VADFGLAKALQSQEGQSDDAMSCV 850
G+ YLH + V +HRD+K NIL+ E R +AD G A+ S D + V
Sbjct: 120 GIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDPV 175
Query: 851 AGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGK 887
++ Y APE + T+ D+++ G + EL+T +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 36/135 (26%), Positives = 53/135 (39%), Gaps = 23/135 (17%)
Query: 235 PDSIGKLAFLSNLDLSDNFLSGKIPHSFSGL---ASIEQIELFDNQLSGE--------LP 283
+ K L LDLSDN L L +S+++++L +N L L
Sbjct: 74 LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK 133
Query: 284 ESLSNLTTLLRLDISQNNLTGNLPETIAAM-----SLESLNLNDNYFTGE----IPESLA 334
+ L +L + +N L G E +A L+ LNL +N + E L
Sbjct: 134 DLPPALE---KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLK 190
Query: 335 SNPNLVQLKLFNNSF 349
+N NL L L NN
Sbjct: 191 ANCNLEVLDLNNNGL 205
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-04
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 757 LVYEYMPNGSLADMLHEKGRSGSLDWSI-RFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
LV EY+ G + +LH G D + I++ A L YLH I+HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLH---IYGYFDEEMAVKYISE-VALALDYLHRH---GIIHRDLKPD 133
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
N+L+ E ++ DFGL+K ++E D ++
Sbjct: 134 NMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 27/102 (26%), Positives = 45/102 (44%), Gaps = 6/102 (5%)
Query: 786 FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845
+I + + + YLH + I+HRD+K+ NI ++ + DFG A + +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG---AACFPVDINAN 238
Query: 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
AG+ APE D++S G+VL E+ T
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 34/148 (22%), Positives = 62/148 (41%), Gaps = 19/148 (12%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV--RHGNVV-KL 745
L+ G + RVY + K + +K E E+ L ++ R G V K+
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKI----NPSREKGADREREVAIL-QLLARKGLPVPKV 58
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
L ++ L+ E++ +L ++ E+ + IA+ A+ LA LH +
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEE----------KEDIAEQLAELLAKLHQLPLL 108
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLA 833
+ H D+ NIL+D + + D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 33/127 (25%), Positives = 48/127 (37%), Gaps = 26/127 (20%)
Query: 765 GSLADMLHEKGRSGSLD--WSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822
SLAD+L +GR + + W++ L LH R KS NILL +
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQ----CLGALRELH---------RQAKSGNILLTWD 47
Query: 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLME 882
+ G S + APE + TEK+D+YS G+ L E
Sbjct: 48 G--LLKLDGSV-------AFKTPEQSRPDPYFM--APEVIQGQSYTEKADIYSLGITLYE 96
Query: 883 LVTGKRP 889
+ + P
Sbjct: 97 ALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 12/93 (12%)
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ-EGQSDDAMSCVAGSY 854
L LH + IV RD+ +NILLD ++ F ++ +G++ + M C
Sbjct: 98 LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC----- 149
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
APE + TE D +S G +L EL+TGK
Sbjct: 150 ---APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.05 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.95 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.93 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.92 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-117 Score=1125.75 Aligned_cols=916 Identities=37% Similarity=0.639 Sum_probs=786.7
Q ss_pred HhhhccchhhHHHHHHHhhhccCCCCCccCCccCCCCCCCCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccc
Q 039922 20 FSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLR 99 (973)
Q Consensus 20 ~~~~~~~~~~~~~l~~~k~~~~~d~~~~~~sw~~~~~~~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~ 99 (973)
+..+.+-+.|+.||++||+++ .||.+.+++|.. ..+||.|.||+|++. .+|+.|+|++++++|.+|++|..+++|+
T Consensus 21 ~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~w~~--~~~~c~w~gv~c~~~-~~v~~L~L~~~~i~~~~~~~~~~l~~L~ 96 (968)
T PLN00113 21 LNFSMLHAEELELLLSFKSSI-NDPLKYLSNWNS--SADVCLWQGITCNNS-SRVVSIDLSGKNISGKISSAIFRLPYIQ 96 (968)
T ss_pred HHccCCCHHHHHHHHHHHHhC-CCCcccCCCCCC--CCCCCcCcceecCCC-CcEEEEEecCCCccccCChHHhCCCCCC
Confidence 333444557888999999997 688888999963 457999999999864 5899999999999999999999999999
Q ss_pred eeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCc
Q 039922 100 NLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179 (973)
Q Consensus 100 ~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 179 (973)
+|+|++|++.|.+|...+..+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|
T Consensus 97 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n 174 (968)
T PLN00113 97 TINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174 (968)
T ss_pred EEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccC
Confidence 9999999999999988888999999999999999998886 56899999999999999999999999999999999999
Q ss_pred ccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCC
Q 039922 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP 259 (973)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 259 (973)
.+.+.+|..++++++|++|+|++|.+... +|..++++++|++|++++|++.+.+|..++++++|++|++++|.+++.+|
T Consensus 175 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 253 (968)
T PLN00113 175 VLVGKIPNSLTNLTSLEFLTLASNQLVGQ-IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253 (968)
T ss_pred cccccCChhhhhCcCCCeeeccCCCCcCc-CChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence 99999999999999999999999998653 78999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcc-cCcEEEccCCcCCCCCCccccCCCc
Q 039922 260 HSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPN 338 (973)
Q Consensus 260 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~ 338 (973)
..|+++++|++|++++|++.+.+|..+.++++|+.|++++|.+++.+|..+... +|+.|++++|.+++.+|..+..+++
T Consensus 254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~ 333 (968)
T PLN00113 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333 (968)
T ss_pred hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC
Confidence 999999999999999999999999999999999999999999999999887665 7999999999999999999999999
Q ss_pred cceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccC
Q 039922 339 LVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGG 418 (973)
Q Consensus 339 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 418 (973)
|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..++.+.+|+.|++++|++.+.+|..++.+++|+.|++++
T Consensus 334 L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~ 413 (968)
T PLN00113 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413 (968)
T ss_pred CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCc
Q 039922 419 NELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLP 498 (973)
Q Consensus 419 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 498 (973)
|++++..|..|..+++|+.|++++|++.+.++..+..+++|+.|++++|++.+.+|..+. .++|+.|++++|++++.+|
T Consensus 414 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~ 492 (968)
T PLN00113 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVP 492 (968)
T ss_pred CEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccC
Confidence 999999999999999999999999999999999999999999999999999999888664 5899999999999999999
Q ss_pred cccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-c
Q 039922 499 TCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-K 577 (973)
Q Consensus 499 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~ 577 (973)
..+.++++|+.|+|++|++++.+|..+..+++|++|+|++|+++|.+|..|..+++|+.|||++|+++|.+|..+..+ .
T Consensus 493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 572 (968)
T PLN00113 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572 (968)
T ss_pred hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999999 8
Q ss_pred ccceeccCCcCcccCCCCCc-ccccccccCCCCCCCCCCC-CCCCCCCCCCC--Cc-eeehhhHHHHHHHHHH-Hhhhee
Q 039922 578 LNQFNISHNKLYGEVPSDFD-HDLFISSLLDNPGLCSPDL-KPLPPCSKTKP--GT-IYIVVILSICVILLVG-SLVWFF 651 (973)
Q Consensus 578 l~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~n~~~c~~~l-~~~~~c~~~~~--~~-~~i~~~~~~~~~l~~~-~~~~~~ 651 (973)
|+.+++++|++.|.+|.... ..+...++.+|+.+|+++. ...++|..... .+ ++++++++++++++++ ++++++
T Consensus 573 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (968)
T PLN00113 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI 652 (968)
T ss_pred cCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999997532 3466778999999999754 33567854311 11 2222233322222222 222222
Q ss_pred ecccCcc----ccCCCCCceeeeee---eccccccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchh
Q 039922 652 KVKSGFF----STSKSPWKVVTFQR---VSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPET 723 (973)
Q Consensus 652 ~~k~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~ 723 (973)
++|+... ......|....+.. .....+++...++..++||+|+||.||+|+.. +|+.||||++.....
T Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---- 728 (968)
T PLN00113 653 RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---- 728 (968)
T ss_pred HhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----
Confidence 2222110 11111122111111 01122344566788899999999999999974 789999999843221
Q ss_pred HHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 039922 724 ETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803 (973)
Q Consensus 724 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 803 (973)
...+|++.+++++|||||+++++|.+++..|+||||+++|+|.++++. ++|.++.+|+.|||+|++|||..+
T Consensus 729 --~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~ 800 (968)
T PLN00113 729 --IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRC 800 (968)
T ss_pred --ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCC
Confidence 123468889999999999999999999999999999999999999953 789999999999999999999766
Q ss_pred CCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHH
Q 039922 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMEL 883 (973)
Q Consensus 804 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 883 (973)
.++|+|||+||+||+++.++.+++. ||........ ....++..|+|||++.+..++.++|||||||++|||
T Consensus 801 ~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 871 (968)
T PLN00113 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871 (968)
T ss_pred CCCeecCCCCHHhEEECCCCceEEE-eccccccccC--------CCccccccccCcccccCCCCCcccchhhHHHHHHHH
Confidence 6699999999999999999988875 5554332111 123678999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 039922 884 VTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLS-TCDYEEAEKVLNVALMCTSDFPINRPSMRRV 962 (973)
Q Consensus 884 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 962 (973)
+||+.||+...+......+|....... .....++|+.+... ....++..++.+++.+|+++||++||+|.||
T Consensus 872 ~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev 944 (968)
T PLN00113 872 LTGKSPADAEFGVHGSIVEWARYCYSD-------CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944 (968)
T ss_pred HhCCCCCCcccCCCCcHHHHHHHhcCc-------cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHH
Confidence 999999977666666777887654322 22344555554322 2345667789999999999999999999999
Q ss_pred HHHHhhccc
Q 039922 963 VELLRVDKS 971 (973)
Q Consensus 963 l~~L~~~~~ 971 (973)
+++|++...
T Consensus 945 l~~L~~~~~ 953 (968)
T PLN00113 945 LKTLESASR 953 (968)
T ss_pred HHHHHHhhc
Confidence 999998643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-61 Score=614.01 Aligned_cols=513 Identities=35% Similarity=0.595 Sum_probs=484.9
Q ss_pred ceeEeecCCCccCCCCCCCcc-CccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEE
Q 039922 73 SVDGIDLSGFDLSGGFPNGFC-RIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLD 151 (973)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~ 151 (973)
.+..|+|+++.++|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++|.+.+.+|..++.+++|++|+
T Consensus 94 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 170 (968)
T PLN00113 94 YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170 (968)
T ss_pred CCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence 578899999999999998765 999999999999999988875 4688999999999999999999999999999999
Q ss_pred CcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCccc
Q 039922 152 LSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLI 231 (973)
Q Consensus 152 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~ 231 (973)
|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|.+.. .+|..++++++|++|++++|++.
T Consensus 171 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~ 249 (968)
T PLN00113 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG-EIPYEIGGLTSLNHLDLVYNNLT 249 (968)
T ss_pred CccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC-cCChhHhcCCCCCEEECcCceec
Confidence 99999999999999999999999999999999999999999999999999999875 37889999999999999999999
Q ss_pred ccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhh
Q 039922 232 GEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIA 311 (973)
Q Consensus 232 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 311 (973)
+.+|..++++++|++|+|++|.+++.+|..+.++++|++|++++|++.+.+|..+.++++|+.|++++|.+++..|..+.
T Consensus 250 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 329 (968)
T PLN00113 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329 (968)
T ss_pred cccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988876
Q ss_pred cc-cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhh
Q 039922 312 AM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCI 390 (973)
Q Consensus 312 ~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 390 (973)
.. +|+.|++++|.+++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|
T Consensus 330 ~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L 409 (968)
T PLN00113 330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRV 409 (968)
T ss_pred cCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEE
Confidence 65 79999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCC
Q 039922 391 IIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT 470 (973)
Q Consensus 391 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~ 470 (973)
++++|++++..|..+..+++|++|++++|.+++..+..++.+++|+.|++++|++.+.+|..+ ..++|+.|++++|+++
T Consensus 410 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~ 488 (968)
T PLN00113 410 RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFS 488 (968)
T ss_pred ECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccC
Confidence 999999999999999999999999999999999999999999999999999999998888766 4589999999999999
Q ss_pred CCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcccc
Q 039922 471 GEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELG 550 (973)
Q Consensus 471 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 550 (973)
+.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|||++|+++|.+|..+.
T Consensus 489 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 568 (968)
T PLN00113 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG 568 (968)
T ss_pred CccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccEEecCCCcCccccChhhhcccccceeccCCc-Ccc
Q 039922 551 NLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNK-LYG 590 (973)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~-l~g 590 (973)
.++.|+.|++++|+++|.+|..-.-..+....+.+|. ++|
T Consensus 569 ~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 609 (968)
T PLN00113 569 NVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG 609 (968)
T ss_pred cCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccC
Confidence 9999999999999999999976332255556667776 444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=434.42 Aligned_cols=287 Identities=46% Similarity=0.738 Sum_probs=247.4
Q ss_pred eeeecccc-ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeE
Q 039922 670 FQRVSFNE-DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748 (973)
Q Consensus 670 ~~~~~~~~-~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 748 (973)
...+++.+ ..+++.|...++||+|+||.||+|...+|+.||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 44567777 88899999999999999999999999999999999885433222 4559999999999999999999999
Q ss_pred EecCC-eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 749 CSGQD-FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 749 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
|.+.+ +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.|.|+||||||+|||+|+++++||
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 99988 599999999999999999886544 7899999999999999999999999889999999999999999999999
Q ss_pred eccCcchhccccCCCcccccccc-ccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCC-CCchhHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCV-AGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKDIVRWVT 905 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~-~~~~~~~~~~~ 905 (973)
+|||+++...... ...... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... .+...+++|+.
T Consensus 219 sDFGLa~~~~~~~----~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 219 SDFGLAKLGPEGD----TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred cCccCcccCCccc----cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 9999996554311 111112 79999999999999999999999999999999999999888654 33445899986
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDY-EEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
..... ..+.+++|+.+....+.. ....++..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 295 ~~~~~-------~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLEE-------GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHC-------cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 66655 478999999987444443 68888999999999999999999999999997643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=390.86 Aligned_cols=258 Identities=37% Similarity=0.551 Sum_probs=214.4
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-eeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD-FNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 761 (973)
.....+.+|+|+||+||+|.+.....||||++..........+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34556679999999999999984344999999766555555778999999999999999999999999887 79999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEEeCCCCCCEEeCCCC-ceEEeccCcchhcccc
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA-IVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQ 839 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 839 (973)
|++|+|.++++.. ....+++..+++|+.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999875 334799999999999999999999999 7 99999999999999998 9999999999876543
Q ss_pred CCCccccccccccccCcccccccc--CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY--TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
. ..++...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .+....+..........
T Consensus 198 ~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~Rp~~p--- 268 (362)
T KOG0192|consen 198 K----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLRPPIP--- 268 (362)
T ss_pred c----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCCCCCC---
Confidence 2 2244478999999999999 56999999999999999999999999986432 34444333322221111
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+..++.+||+.||++||++.|++..|+.+.
T Consensus 269 -----------------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 269 -----------------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred -----------------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 113467888899999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=366.28 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=212.6
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-eeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD-FNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 759 (973)
.+.+..+.||+|..|+||+++++ +++.+|+|++. ....+...+++.+|+++++..+||+||+++++|...+ ..+++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 35667889999999999999987 78899999993 3345566788999999999999999999999999988 599999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||++|||++++...+ .+++...-+|+.+|++||.|||+ + +||||||||+|||++..|+|||+|||.+..+..
T Consensus 158 EYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999998654 58999999999999999999996 6 999999999999999999999999999987754
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. ....++||..|||||-+.+..|+.++||||||++++|+.+|+.|+-+..+......+.+.......++.
T Consensus 232 S------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~---- 301 (364)
T KOG0581|consen 232 S------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR---- 301 (364)
T ss_pred h------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC----
Confidence 3 234578999999999999999999999999999999999999999875332333333333332222211
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
+... ....++..++..|+++||.+||++.|+++|=
T Consensus 302 ---------lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 302 ---------LPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred ---------CCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1111 2346788999999999999999999998763
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=367.66 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=212.1
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCch-----hHHHHHHHHHHHhcCCCCCeeeEEeEEecCC
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE-----TETVFRSEIETLGRVRHGNVVKLLMCCSGQD 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 753 (973)
+.+.|.+.+.+|+|+||.|-+|..+ +|+.||||++.+...... .....++|+++|++++||+||++.++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567888999999999999999765 899999999965432221 2233579999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC---CceEEecc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE---MVPRVADF 830 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df 830 (973)
..|+|||||+||+|.+.+..++. +.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999987653 67777788999999999999999 99999999999999765 78999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCC---CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV---TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
|+|+..... ..+.+..||+.|.|||++.++.+ ..++|+||+||++|-+++|..||..... ...+.+.+.++
T Consensus 324 GlAK~~g~~-----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-~~sl~eQI~~G 397 (475)
T KOG0615|consen 324 GLAKVSGEG-----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-DPSLKEQILKG 397 (475)
T ss_pred chhhccccc-----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-CccHHHHHhcC
Confidence 999987532 34677899999999999987653 3478999999999999999999986432 23355555555
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.....+ ....+..++.++++.+|+..||++|||++|++++=
T Consensus 398 ~y~f~p------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 398 RYAFGP------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred cccccC------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 433211 12245677889999999999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=363.47 Aligned_cols=269 Identities=29% Similarity=0.436 Sum_probs=212.3
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
..++|...+.||+|+||+||+|+.+ ++..||||.+.++.......+.+..|+++++.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3567888889999999999999976 789999999976655666777889999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC------CceEEeccCc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE------MVPRVADFGL 832 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGl 832 (973)
||||.+|+|.+|++..+ .+++..+...+.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999999865 589999999999999999999999 99999999999999765 4689999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
|+.+.... ......|++-|||||++...+|+.|+|+||+|+++|||++|+.||+.. ...++..++++.....+
T Consensus 162 AR~L~~~~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~--t~~eL~~~~~k~~~~~~ 234 (429)
T KOG0595|consen 162 ARFLQPGS-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE--TPKELLLYIKKGNEIVP 234 (429)
T ss_pred hhhCCchh-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc--CHHHHHHHHhccccccC
Confidence 99986432 245578999999999999999999999999999999999999999864 44555555554443322
Q ss_pred --CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039922 913 --ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVV 963 (973)
Q Consensus 913 --~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 963 (973)
+........+++-+.+.... .+.......+...++..+|.+|+.+.++-
T Consensus 235 ~~~~~~s~~~~~Ll~~ll~~~~--~~~~~~~~~~~~~~l~~~p~~~~~~~~~~ 285 (429)
T KOG0595|consen 235 VLPAELSNPLRELLISLLQRNP--KDRISFEDFFDHPFLAANPQDRADAFELE 285 (429)
T ss_pred chhhhccCchhhhhhHHHhcCc--cccCchHHhhhhhhcccCcccccCccccc
Confidence 11111222222222221110 11122334455677777787777665543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=378.55 Aligned_cols=254 Identities=32% Similarity=0.496 Sum_probs=217.5
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
.++..+.||+|.||.||.|.+.....||+|.++.. ....+.|.+|+++|++++|++||+++++|..++..|||||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 35667899999999999999997779999999543 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
+.|+|.+|++.. ....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+++.+.++..
T Consensus 284 ~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y- 358 (468)
T KOG0197|consen 284 PKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY- 358 (468)
T ss_pred ccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce-
Confidence 999999999872 334688999999999999999999999 999999999999999999999999999995443322
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.......-.+.|.|||.+..++++.|+|||||||++|||+| |+.||... ...++++.+.++.+-..|.+||
T Consensus 359 --~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~ev~~~le~GyRlp~P~~CP---- 430 (468)
T KOG0197|consen 359 --TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEEVLELLERGYRLPRPEGCP---- 430 (468)
T ss_pred --eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--CHHHHHHHHhccCcCCCCCCCC----
Confidence 11222234578999999999999999999999999999999 77776653 5677888888887776666553
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
..+.+++..||+.+|++|||++.+...++..
T Consensus 431 -----------------~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 431 -----------------DEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -----------------HHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 4577889999999999999999999888774
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=374.47 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=213.8
Q ss_pred CCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+|...++||+|||+.+|+++. .+|+.||+|++.++. ......+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 789999999996643 34455677889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
|+|++++|.++++.. .++++.+++.+++||+.|+.|||+. +|+|||||..|+++++++++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999998743 3699999999999999999999999 9999999999999999999999999999988654
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. ...+..||+.|.|||++....++..+||||+||++|-|+.|++||+.. .-.+...-++......|
T Consensus 172 ~E----rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--~vkety~~Ik~~~Y~~P------- 238 (592)
T KOG0575|consen 172 GE----RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--TVKETYNKIKLNEYSMP------- 238 (592)
T ss_pred cc----ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--hHHHHHHHHHhcCcccc-------
Confidence 32 234578999999999999999999999999999999999999999753 22333333333222211
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....+..++|..+++++|.+|||+++|+.+
T Consensus 239 ---------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 ---------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1223567889999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=348.35 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=214.2
Q ss_pred cCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEe-EEecCCe-eEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM-CCSGQDF-NIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~l 757 (973)
...|.+.++||+|+||+||++.. .+|..||.|.+.........++...+|+.++++++|||||++++ .+.++.+ .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34688999999999999999985 48999999999766666777788899999999999999999998 4545444 899
Q ss_pred EEeccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 758 VYEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVP-AIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
|||+|++|+|.+.++..+. ...+++..+++++.|++.||+++|..... -|.||||||.||+++.+|.|||+|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999875433 34589999999999999999999994331 288999999999999999999999999999
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
+.... ......+||+.||+||.+...+|+.|+||||+||++|||+.-++||.+. ..-.+.+.+.++...
T Consensus 178 l~s~~----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~----- 246 (375)
T KOG0591|consen 178 LSSKT----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYP----- 246 (375)
T ss_pred hcchh----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCC-----
Confidence 86543 2345689999999999999999999999999999999999999999863 333344444333211
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
. -.+.-+...+..++..|+.+||+.||+...+++.+.
T Consensus 247 ------~---------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 247 ------P---------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ------C---------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 0 011456788999999999999999998655555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=351.56 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=204.2
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCch-hHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE-TETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..++||+|+||+||.++.+ +++.+|+|+++++..... ..+...+|..++.+++||+||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 567999999999999999999876 688999999976654433 456788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
+||+.||.|...+...+ .+++..+.-.+.+|+.||.|||+. +|||||+||+|||+|++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998765 488888888889999999999999 999999999999999999999999999985433
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. .+...++||+.|||||++.+..|+.++|+||+|+++|||++|.+||... +.....+.+.......++.
T Consensus 178 ~~----~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--~~~~~~~~I~~~k~~~~p~---- 247 (357)
T KOG0598|consen 178 DG----DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--DVKKMYDKILKGKLPLPPG---- 247 (357)
T ss_pred CC----CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--cHHHHHHHHhcCcCCCCCc----
Confidence 32 2234479999999999999999999999999999999999999999763 3333344333332111111
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP 957 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 957 (973)
-...+..+++.+.++.||++|.
T Consensus 248 -----------------~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 -----------------YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----------------cCCHHHHHHHHHHhccCHHHhc
Confidence 1235567888899999999996
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=373.99 Aligned_cols=449 Identities=29% Similarity=0.428 Sum_probs=214.4
Q ss_pred EeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCC
Q 039922 76 GIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155 (973)
Q Consensus 76 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n 155 (973)
.+.++++++.. +.+.+.++..|..|++++|++. .+|+ +++.+..++.|+.++|.++ ++|..++.+.+|..|+.++|
T Consensus 49 ~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~-aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n 124 (565)
T KOG0472|consen 49 KLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPA-AIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSN 124 (565)
T ss_pred hhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCH-HHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccc
Confidence 34455554442 2333445555555555555554 3332 3445555555555555543 34445555555555555555
Q ss_pred cCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCC
Q 039922 156 NFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIP 235 (973)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p 235 (973)
.+. .+|++++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++. +|...-+++.|++|+...| +.+.+|
T Consensus 125 ~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~--l~~~~i~m~~L~~ld~~~N-~L~tlP 199 (565)
T KOG0472|consen 125 ELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA--LPENHIAMKRLKHLDCNSN-LLETLP 199 (565)
T ss_pred cee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh--CCHHHHHHHHHHhcccchh-hhhcCC
Confidence 554 34444555555555555555555 234444555555555555555544 2333333555555544332 233444
Q ss_pred ccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhcc-CCCccceeeccccccCCCChhhhhccc
Q 039922 236 DSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLS-NLTTLLRLDISQNNLTGNLPETIAAMS 314 (973)
Q Consensus 236 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 314 (973)
+.++.+.+|..|+|..|+|. ..| +|.+++.|.+|++..|+|+ .+|.+.. ++.++..|||..|+++
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk----------- 265 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK----------- 265 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-----------
Confidence 45555555555555555554 333 4555555555555555554 3333322 4455555555555554
Q ss_pred CcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeeccccccc------------------
Q 039922 315 LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE------------------ 376 (973)
Q Consensus 315 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~------------------ 376 (973)
..|+.++-+.+|.+||+|+|.++ ..|..++++ .|+.|-+.+|.+...
T Consensus 266 -------------e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs 330 (565)
T KOG0472|consen 266 -------------EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS 330 (565)
T ss_pred -------------cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH
Confidence 44444444444444444444444 344444444 444444444444311
Q ss_pred -------------------CCcc----ccccCCchhhhcccCccCCCCCCccCCcc--eeeEEEccCCccccccCcccCC
Q 039922 377 -------------------LPRF----LCFRNKLQCIIIFNNRFSGKIPESYGECK--TLNYLRFGGNELQGELPSKFWG 431 (973)
Q Consensus 377 -------------------~~~~----~~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~ 431 (973)
.|.+ .....+.+.|+++.-+++....+.|..-. -....++++|++. +.|..+..
T Consensus 331 ~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~ 409 (565)
T KOG0472|consen 331 KIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVE 409 (565)
T ss_pred hhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHH
Confidence 0000 11223444455555555422222222111 2455555555554 34444444
Q ss_pred CCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceee
Q 039922 432 LPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLE 511 (973)
Q Consensus 432 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 511 (973)
+..+...-+.+|+..+.+|..++.+++|+.|+|++|.+. .+|..++.+..|+.||+|+|+|. .+|.++..+..|+.+-
T Consensus 410 lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtll 487 (565)
T KOG0472|consen 410 LKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLL 487 (565)
T ss_pred HHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHH
Confidence 443333222223333344555555555555555555554 55555555555555555555555 5555555555555555
Q ss_pred ccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCc
Q 039922 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 512 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
.++|++....|+.+.+|.+|..|||.+|.|. .+|+.+++|++|+.|+|++|++.
T Consensus 488 as~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 488 ASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 5555555444444555555555555555555 45555555555555555555554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=334.84 Aligned_cols=272 Identities=21% Similarity=0.303 Sum_probs=209.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+.|+...++|+|+||+||+++.+ +|+.||||++......+..++...+|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45778889999999999999987 69999999997777677778889999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
||+..-|++ +..... -++...+.+++.|++.|+.|+|++ +++||||||+|||++.++.+||||||+|+.+...
T Consensus 82 ~~dhTvL~e-Le~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHH-HHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 997654443 444333 378889999999999999999999 9999999999999999999999999999988632
Q ss_pred CCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc-----
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER----- 914 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 914 (973)
...++.++.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+.|-+. .+.+++.. +....-...+.
T Consensus 155 ---gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~-SDiDQLy~-I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 155 ---GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR-SDIDQLYL-IRKTLGNLIPRHQSIF 229 (396)
T ss_pred ---cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc-chHHHHHH-HHHHHcccCHHHHHHh
Confidence 233566889999999999987 78999999999999999999999877543 22233322 22211111100
Q ss_pred cccCcccccccCCCCCC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLS----TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....+..+.-|..+.. .--+.....++++++.|++.||++|++-+|++.+
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00000111111111100 0002234478999999999999999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=376.04 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=216.1
Q ss_pred CCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
+....+.||+|.||+||+|+.. +...||||.++.+ .....+++|++|++++..++|||||+++|+|.+++..|
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 4556788999999999999754 3457999999543 33447789999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCce
Q 039922 757 LVYEYMPNGSLADMLHEKGR-----------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP 825 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 825 (973)
+|+|||..|+|.+||+.... ..+++..+.+.||.|||.||+||-++ .+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999975421 12377889999999999999999999 99999999999999999999
Q ss_pred EEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHH
Q 039922 826 RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 826 kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 904 (973)
||+|||+++.+-..+.+.. .....-.++|||||.+..+++|+++|||||||++||+++ |+.||.+- ..+++++.+
T Consensus 643 KIsDfGLsRdiYssDYYk~--~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl--Sn~EVIe~i 718 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKV--RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL--SNQEVIECI 718 (774)
T ss_pred Eecccccchhhhhhhhhcc--cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc--chHHHHHHH
Confidence 9999999998765543221 112234579999999999999999999999999999999 88898864 566777777
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.++..-..+. +.+.+++.|+..||+..|.+||+++||-..|+..
T Consensus 719 ~~g~lL~~Pe---------------------~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 719 RAGQLLSCPE---------------------NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HcCCcccCCC---------------------CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 6665432222 3356788999999999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.78 Aligned_cols=271 Identities=24% Similarity=0.340 Sum_probs=212.1
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCC-eeE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQD-FNI 756 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 756 (973)
+-++|+..++||.|.||.||+|+.+ +|+.||||+++++... ..+..-.+|+..++++. |||||++.+++.+.+ ..|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3467899999999999999999865 7999999999877655 33444578999999998 999999999999888 999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||| ..+|.+.++.. ...+++..++.|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+|+.+
T Consensus 87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999999 58999999876 44799999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCCCccccccccccccCcccccccc-CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.+. .+++.++.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++.|-+. .+.+++.... + +...|...
T Consensus 161 ~Sk-----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~-sE~Dqi~KIc-~-VLGtP~~~ 232 (538)
T KOG0661|consen 161 RSK-----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA-SEIDQIYKIC-E-VLGTPDKD 232 (538)
T ss_pred ccC-----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC-cHHHHHHHHH-H-HhCCCccc
Confidence 544 3466789999999999876 567899999999999999999998877542 2222222211 1 11111111
Q ss_pred cc---CcccccccCCC------CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CC---RDLNQLIDPRM------DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~---~~l~~~~d~~l------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ..+...+.-.+ .....-+....+..+++.+|+++||.+|||+.|++++
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11 11111221111 0111112345688999999999999999999999876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=318.75 Aligned_cols=271 Identities=24% Similarity=0.333 Sum_probs=215.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|...+++|+|.||.||+|++. +|+.||||+++.............+|++.++.++|+||+.++++|...+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999865 89999999997665555555678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
||+ .+|...++.... .+....+..++.++++|++|+|++ .|+|||+||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 699999887543 688899999999999999999999 99999999999999999999999999999886554
Q ss_pred CCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. ....+.|.+|.|||.+.+. .|+..+||||.||++.||+-|.+-| +...+-+++..... ....|....+.+
T Consensus 156 ~~----~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f-pG~sDidQL~~If~--~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 156 RI----QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF-PGDSDIDQLSKIFR--ALGTPTPDQWPE 228 (318)
T ss_pred cc----cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC-CCCchHHHHHHHHH--HcCCCCcccCcc
Confidence 32 2334789999999999875 6899999999999999999887544 43334344333222 223333333344
Q ss_pred cccccc-------CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLID-------PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d-------~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.++.| |.......-........+++..|+.+||.+|++++|++++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 444444 1111111223345566999999999999999999999876
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=350.10 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=211.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCch-hHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE-TETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
..+|...+.||.|+|++|++|+.+ +++.||||++.+.....+ ..+-+..|.+.|.+| .||.|++++..|.++...|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 456888999999999999999876 799999999966543333 234567899999999 79999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|+||+++|+|.+++++.+ .+++...+..+.+|+.|++|||+. |||||||||+|||+|+||+++|+|||.|+.+.
T Consensus 152 vLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999875 589999999999999999999999 99999999999999999999999999999886
Q ss_pred ccCCC-----cc--cc--ccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 838 SQEGQ-----SD--DA--MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 838 ~~~~~-----~~--~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
+.... .. .. ...++||..|.+||++..+..+..+|+|+|||++|+|+.|++||... .+-.+.+.|....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~--NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA--NEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc--cHHHHHHHHHHhc
Confidence 54322 11 11 24589999999999999999999999999999999999999999853 2122223333322
Q ss_pred ccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 909 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
...+ +.-...+.+|+.+.+..||.+|+|..+|.+|-
T Consensus 304 y~fp----------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 304 YEFP----------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ccCC----------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 2211 11125677888999999999999999988763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.16 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=211.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+.|+..++||.|..++||+|+.. .++.||||++.-+..... .+.+++|+..|+.++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999864 789999999954443333 577899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
.||.+||+.+.++..... -+++..+..|.+++++||.|||++ |.||||||+.|||++++|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999876543 389999999999999999999999 9999999999999999999999999998776554
Q ss_pred CCCccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.......+...+||++|||||++.+ ..|+.|+||||||++..|+.+|..||..- +..+-+...+......
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~-pPmkvLl~tLqn~pp~------- 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY-PPMKVLLLTLQNDPPT------- 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC-ChHHHHHHHhcCCCCC-------
Confidence 3221222266799999999999543 47899999999999999999999999742 2222222222211111
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......+.. ........+.+++..|+++||++|||+++++++
T Consensus 252 -~~t~~~~~d-----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 -LLTSGLDKD-----EDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -cccccCChH-----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 001111111 112234478999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=344.48 Aligned_cols=258 Identities=30% Similarity=0.436 Sum_probs=205.6
Q ss_pred CCCCccccccccCCeeEEEEEECC-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC--eeEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD--FNILV 758 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 758 (973)
.+|...+.||+|+||+||.+...+ |+..|||.+... .....+.+.+|+.++++++|||||+.+|.....+ .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 357778999999999999999874 899999998544 2222667899999999999999999999855544 68999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccCcchhcc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKALQ 837 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~ 837 (973)
|||+++|+|.+++...+. .+++..+...++||++||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999987653 589999999999999999999999 9999999999999999 7999999999998776
Q ss_pred ccCCCccccccccccccCccccccccCCC-CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKK-VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
. ............||+.|||||++.++. ...++||||+||++.||+||+.||..- .+...++........
T Consensus 170 ~-~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~---- 240 (313)
T KOG0198|consen 170 S-KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDS---- 240 (313)
T ss_pred c-ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCC----
Confidence 4 122223344578999999999998643 345999999999999999999999742 122222222222210
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
..++. .....+..+++++|++.+|++||||.+++++...
T Consensus 241 ---~P~ip----------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 241 ---LPEIP----------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ---CCCCC----------cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 00111 1234677889999999999999999999988643
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=364.64 Aligned_cols=431 Identities=29% Similarity=0.421 Sum_probs=303.4
Q ss_pred cCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhH
Q 039922 142 REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLE 221 (973)
Q Consensus 142 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 221 (973)
.++..|.+|++++|+++ ..|++++.+..++.|+.++|+++ .+|+.++.+.+|..|+.++|.+.. +|+.++.+..|+
T Consensus 65 ~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~e--l~~~i~~~~~l~ 140 (565)
T KOG0472|consen 65 KNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKE--LPDSIGRLLDLE 140 (565)
T ss_pred hcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccceee--cCchHHHHhhhh
Confidence 33444444444444444 33444444444444444444444 334444444444444444444433 344444444444
Q ss_pred HHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccc
Q 039922 222 NLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNN 301 (973)
Q Consensus 222 ~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 301 (973)
.|+..+|+++ ..|..++++.+|..|++.+|+++...|+.+. ++.|++|+...|-+. .+|..++.+.+|..|+|.+|+
T Consensus 141 dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nk 217 (565)
T KOG0472|consen 141 DLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNK 217 (565)
T ss_pred hhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcc
Confidence 4444444433 2344555555555566666666544443333 566666666666555 556666666666666666666
Q ss_pred cCCCChhhhhcccCcEEEccCCcCCCCCCccc-cCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCcc
Q 039922 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESL-ASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRF 380 (973)
Q Consensus 302 l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 380 (973)
+. .+|+.-+...|.+|+++.|+|. .+|... .+++++..|||..|+++ +.|+.+.-+.+|++||+|+|.|+ .+|..
T Consensus 218 i~-~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~s 293 (565)
T KOG0472|consen 218 IR-FLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYS 293 (565)
T ss_pred cc-cCCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcc
Confidence 65 3443333334666666666666 555554 48899999999999999 89999999999999999999999 56777
Q ss_pred ccccCCchhhhcccCccCCC--------------------------------------CCCc---cCCcceeeEEEccCC
Q 039922 381 LCFRNKLQCIIIFNNRFSGK--------------------------------------IPES---YGECKTLNYLRFGGN 419 (973)
Q Consensus 381 ~~~l~~L~~L~L~~n~l~~~--------------------------------------~p~~---~~~l~~L~~L~L~~N 419 (973)
++++ .|+.|.+.+|.+... .+.. .....+.+.|++++-
T Consensus 294 Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ 372 (565)
T KOG0472|consen 294 LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDK 372 (565)
T ss_pred cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccc
Confidence 8888 899999999987410 0000 112346788889988
Q ss_pred ccccccCcccCCCCC---ccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCC
Q 039922 420 ELQGELPSKFWGLPE---VDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGH 496 (973)
Q Consensus 420 ~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 496 (973)
+++ .+|+..+...+ ....+++.|++. .+|..+..+..+.+..+..|+..+.+|..++.+++|..|+|++|-+. .
T Consensus 373 qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~ 449 (565)
T KOG0472|consen 373 QLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-D 449 (565)
T ss_pred ccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-h
Confidence 888 55666555544 888999999998 56777777776655444445555589999999999999999999998 7
Q ss_pred CccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc
Q 039922 497 LPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL 576 (973)
Q Consensus 497 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 576 (973)
+|..++.+..|+.||+|.|++. .+|..+-.+..|+.+-.++|++....|..+.+|.+|.+|||.+|.+. .||+.++++
T Consensus 450 LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgnm 527 (565)
T KOG0472|consen 450 LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNM 527 (565)
T ss_pred cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccc
Confidence 9999999999999999999999 89999999999999999999998655556999999999999999999 999999999
Q ss_pred -cccceeccCCcCc
Q 039922 577 -KLNQFNISHNKLY 589 (973)
Q Consensus 577 -~l~~l~l~~N~l~ 589 (973)
+|+.|.+++|++.
T Consensus 528 tnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 528 TNLRHLELDGNPFR 541 (565)
T ss_pred cceeEEEecCCccC
Confidence 9999999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=361.19 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=222.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-C---CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-S---GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
...++.++||.|.||.||+|+++ . ...||||.++. ...+..+.+|..|..+|.+.+||||+++.|+.......+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 34567889999999999999987 2 34699999963 3456777889999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|.|||++|+|+.||+.+. +++++.+...|+++||.||.||-+. ++|||||.++||||+.+..+|++|||+++.+.
T Consensus 708 iTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999999875 3699999999999999999999999 99999999999999999999999999999775
Q ss_pred ccCCCcccccccccc--ccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 838 SQEGQSDDAMSCVAG--SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 838 ~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
++... .++...| .++|.|||.+..+++|.++||||||+++||.++ |..||... ..+++..-++++.+-.+|.
T Consensus 783 dd~~~---~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--SNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 783 DDPEA---AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred cCCCc---cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--chHHHHHHHHhccCCCCCC
Confidence 55422 2222222 469999999999999999999999999999998 89999764 5678888888888776666
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
+| +..+.+|+..||++|-.+||.+.+|+.+|..
T Consensus 858 DC---------------------P~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 858 DC---------------------PAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred CC---------------------cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 55 4567899999999999999999999999976
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.88 Aligned_cols=273 Identities=25% Similarity=0.299 Sum_probs=210.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--CeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 757 (973)
.+.|+..++||+|.||.||+|++. +|+.||+|++.-....++......+|+.+|+++.||||+++.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 346788899999999999999865 799999999976665566667788999999999999999999998776 78999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|+|||+ -+|.-++....- .+++.++..++.|++.||+|+|.+ +|+|||||.+|||+|.+|.+||+|||+|+++.
T Consensus 196 VFeYMd-hDL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEeccc-chhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999996 478777765332 589999999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.... ..++..+.|.+|.|||.+.+. .|+.++|+||.|||+.||++|++.+.+.. +.+++ +.|-+..-...+..+
T Consensus 270 ~~~~---~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t-EveQl-~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 270 PSGS---APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT-EVEQL-HKIFKLCGSPTEDYW 344 (560)
T ss_pred CCCC---cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc-HHHHH-HHHHHHhCCCChhcc
Confidence 5543 336678899999999999875 69999999999999999999998887542 22222 222222222222221
Q ss_pred c-Cccc--ccccCCCCCCCCCHH----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039922 917 C-RDLN--QLIDPRMDLSTCDYE----EAEKVLNVALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 917 ~-~~l~--~~~d~~l~~~~~~~~----~~~~l~~l~~~cl~~dP~~Rps~~evl~ 964 (973)
+ ..+. ..+.+.......-.+ -....++++..++..||.+|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 0111 111111111111111 1346688999999999999999998875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.02 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=210.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+-...|+...+||+|+.|.||.++.. +++.||||++.... ...++-+.+|+.+|+..+|+|||++++.|..+++.|+
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 44557888899999999999999865 78899999995333 3445567899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|||||++|+|.+.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.
T Consensus 348 VMEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EEeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999988654 489999999999999999999999 99999999999999999999999999998876
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... .....+||+.|||||+.....|+.|+||||||++++||+.|.+||-.. ..-+.+......+...
T Consensus 421 ~~~~----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-~PlrAlyLIa~ng~P~------- 488 (550)
T KOG0578|consen 421 EEQS----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPK------- 488 (550)
T ss_pred cccC----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-ChHHHHHHHhhcCCCC-------
Confidence 5543 234578999999999999999999999999999999999999999742 1222222222222211
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. ........+.+++.+|++.||++|+++.|+++|
T Consensus 489 ----------lk---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 ----------LK---NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----------cC---CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11 012235678899999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.09 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=211.6
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.+.+...+.||+|.||+||+|++. -.||||++.-.....+..+.|++|+..+++-+|.||+=+.|||...+. .||+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 456678899999999999999986 379999998777777888999999999999999999999999988777 99999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
||+|-+|+.++|.... .++..+.+.||+|||+||.|||.+ +|||||||+.||++.+++.|||+|||++..-..-.
T Consensus 468 wCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 9999999999997653 689999999999999999999999 99999999999999999999999999986543221
Q ss_pred CCccccccccccccCccccccccC---CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
. ........|...|||||++.. .+|+..+||||||+++|||+||..||.. ...+++.-.+..+...
T Consensus 543 g--~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi--~~~dqIifmVGrG~l~------- 611 (678)
T KOG0193|consen 543 G--EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI--QNRDQIIFMVGRGYLM------- 611 (678)
T ss_pred c--ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC--CChhheEEEecccccC-------
Confidence 1 122334567889999999874 4689999999999999999999999973 2222222222222111
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.|.. ........++.+|+..||.+++++||.+.+|+..|+..
T Consensus 612 ------pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 612 ------PDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ------ccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 1111 11123456889999999999999999999999987763
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.56 Aligned_cols=390 Identities=23% Similarity=0.264 Sum_probs=308.7
Q ss_pred CCEEECcCCcCCCCCCcccCCC--CcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHh
Q 039922 147 LQVLDLSRNNFSGDIPESFGRF--PVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLW 224 (973)
Q Consensus 147 L~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 224 (973)
-..||.+.+.+...--..+.++ +.-++|++++|+++.+.+..|.++++|+++++.+|.++.
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~----------------- 116 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR----------------- 116 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-----------------
Confidence 3567777777763211112111 233457777777776666666666666666666665543
Q ss_pred hccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCC
Q 039922 225 AAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTG 304 (973)
Q Consensus 225 l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 304 (973)
+|..-....+|+.|+|.+|.|+.+-.++++.++.|+.||||.|.|+.
T Consensus 117 ---------------------------------IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~ 163 (873)
T KOG4194|consen 117 ---------------------------------IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISE 163 (873)
T ss_pred ---------------------------------cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhc
Confidence 33322223345555555555555555667777788888888888876
Q ss_pred CChhhhhc-ccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccc
Q 039922 305 NLPETIAA-MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCF 383 (973)
Q Consensus 305 ~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 383 (973)
..-..|.. .++++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-.--..|.+
T Consensus 164 i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqg 243 (873)
T KOG4194|consen 164 IPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQG 243 (873)
T ss_pred ccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcC
Confidence 55555554 57888888888888877788888889999999999999666667888999999999999987443456788
Q ss_pred cCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEe
Q 039922 384 RNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGIL 463 (973)
Q Consensus 384 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~ 463 (973)
+++|+.|.|..|.+.......|-.+.++++|+|+.|+++..-.+++.+++.|+.|+|++|.|..+-+++....++|++|+
T Consensus 244 L~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~Ld 323 (873)
T KOG4194|consen 244 LPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELD 323 (873)
T ss_pred chhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEe
Confidence 99999999999999888888899999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCc---ccCccccceeeeeccCc
Q 039922 464 INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPR---NLNSLTALIVLNLSTNQ 540 (973)
Q Consensus 464 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~ 540 (973)
|++|+|+...+..|..+..|++|.|++|+++..--.+|..+++|+.|||++|.|+..+-+ .|.+|++|+.|+|.+|+
T Consensus 324 Ls~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 324 LSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred ccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 999999988888999999999999999999876677899999999999999999977653 57889999999999999
Q ss_pred ccCCCCccccccccccEEecCCCcCccccChhhhcccccceeccCC
Q 039922 541 LTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHN 586 (973)
Q Consensus 541 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N 586 (973)
|......+|.+++.|+.|||.+|.+-..-|..+..+.|+.|.+..-
T Consensus 404 lk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSs 449 (873)
T KOG4194|consen 404 LKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSS 449 (873)
T ss_pred eeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhccc
Confidence 9955556899999999999999999988888888887777766443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.33 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=213.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|...+.||+|+||+||||+.+ +.+.||+|.+.+....+...+.+++|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788899999999999999877 78899999998777777777889999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+.+ +|.+++...+ .++++.+..|+.+++.||.|||+. +|.|||+||+||+++..+.+|++|||+++.+....
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9965 9999998755 599999999999999999999999 99999999999999999999999999999875432
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.....+.||+-|||||...++.|+..+|.||+||++||+++|++||... ...++++.|......
T Consensus 155 ----~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v~---------- 218 (808)
T KOG0597|consen 155 ----SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPVK---------- 218 (808)
T ss_pred ----eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCCC----------
Confidence 3345678999999999999999999999999999999999999999752 222333332221111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.......+.+++...+++||.+|.+-.+++.|
T Consensus 219 ------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 ------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 112345678899999999999999999988765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=350.23 Aligned_cols=365 Identities=22% Similarity=0.258 Sum_probs=191.2
Q ss_pred EecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCC
Q 039922 126 LALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205 (973)
Q Consensus 126 L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 205 (973)
|++++|.++..-+..|.++++|+.+++..|.++ .||...+...+|+.|+|.+|.|+.+..+.+..++.|+.||||.|.|
T Consensus 83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~i 161 (873)
T KOG4194|consen 83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLI 161 (873)
T ss_pred eeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchh
Confidence 444444444444445555555555555555555 4454333444455555555555555555555555555555555555
Q ss_pred CCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchh
Q 039922 206 KSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPES 285 (973)
Q Consensus 206 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 285 (973)
+.++.| .|..-.++++|+|++|+|+..--..|.++.+|..|.|++|+++...+..
T Consensus 162 s~i~~~-------------------------sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~ 216 (873)
T KOG4194|consen 162 SEIPKP-------------------------SFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRS 216 (873)
T ss_pred hcccCC-------------------------CCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHH
Confidence 443321 1222234555555555555555555555555555556666555444445
Q ss_pred ccCCCccceeeccccccCCCChhhhhcc-cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCcc
Q 039922 286 LSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLE 364 (973)
Q Consensus 286 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 364 (973)
|.++++|+.|+|..|+|...---.|... +|+.|.|..|.+...-...|..+.++++|+|+.|+++..--.++.+++.|+
T Consensus 217 Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~ 296 (873)
T KOG4194|consen 217 FKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLE 296 (873)
T ss_pred hhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhh
Confidence 5555666666665555542222222222 344444444444444444455555555555555555544444455555555
Q ss_pred ceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCc
Q 039922 365 YFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNR 444 (973)
Q Consensus 365 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 444 (973)
.|+||+|.|...-++.+...++|++|+|++|+++...+.+|..+..|++|+|++|.+...-...|.++.+|+.|||.+|.
T Consensus 297 ~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ 376 (873)
T KOG4194|consen 297 QLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNE 376 (873)
T ss_pred hhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCe
Confidence 55555555554444444444444444444444444444455555555555555555554444445555555555555555
Q ss_pred ccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcc
Q 039922 445 FEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN 524 (973)
Q Consensus 445 l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 524 (973)
+.+.+.+ -...|..+++|+.|+|.+|+|+.+...+|.++.+|+.|||.+|.|...-|.+
T Consensus 377 ls~~IED---------------------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nA 435 (873)
T KOG4194|consen 377 LSWCIED---------------------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNA 435 (873)
T ss_pred EEEEEec---------------------chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccc
Confidence 4433321 1123555666666666666666444466777777777777777777666777
Q ss_pred cCccccceeeeecc
Q 039922 525 LNSLTALIVLNLST 538 (973)
Q Consensus 525 ~~~l~~L~~L~Ls~ 538 (973)
|..| .|+.|.++.
T Consensus 436 Fe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 436 FEPM-ELKELVMNS 448 (873)
T ss_pred cccc-hhhhhhhcc
Confidence 7766 666666543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=312.78 Aligned_cols=239 Identities=26% Similarity=0.312 Sum_probs=200.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.+|.|+||+|..++.+ +|..+|+|++.+... ...+.+...+|..+++.+.||+++++++.|.+.+..|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 457888999999999999999977 788999999965432 223445677899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||++||-|..++++.+ +++++.++-+|.||+.|++|||+. +|++||+||+|||+|++|++||+|||+|+.+..
T Consensus 123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999998765 489999999999999999999999 999999999999999999999999999998743
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. ..+..||+.|+|||++..+.+..++|.|||||++|||+.|.+||.... ...+.+.+.++....|.
T Consensus 197 r-------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--~~~iY~KI~~~~v~fP~----- 262 (355)
T KOG0616|consen 197 R-------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--PIQIYEKILEGKVKFPS----- 262 (355)
T ss_pred c-------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--hHHHHHHHHhCcccCCc-----
Confidence 2 345789999999999999999999999999999999999999998642 24444444444332111
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCC
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINR 956 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R 956 (973)
--..++.+++...++.|-.+|
T Consensus 263 -----------------~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 -----------------YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----------------ccCHHHHHHHHHHHhhhhHhh
Confidence 012345677778888887777
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=344.62 Aligned_cols=254 Identities=28% Similarity=0.397 Sum_probs=208.9
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC---chhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCC
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK---PETETVFRSEIETLGRVR-HGNVVKLLMCCSGQD 753 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 753 (973)
...+.|...+.||+|+||.|+.|... +|+.||+|++.+.... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999765 7899999977554211 133456778999999999 999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-CceEEeccCc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGL 832 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl 832 (973)
..|+||||+.+|+|.+++...+ ++.+..+..+++|++.|++|+|++ +|+||||||+||++|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998743 588899999999999999999999 99999999999999999 9999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCC-CC-CCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK-VT-EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+..... .........||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.. ....+...+..+...
T Consensus 168 s~~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--~~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 168 SAISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--NVPNLYRKIRKGEFK 241 (370)
T ss_pred ccccCC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--cHHHHHHHHhcCCcc
Confidence 987641 123456678999999999999877 75 7899999999999999999999852 223333333222211
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+ . .+ . ..++..++.+|+..+|.+|+++.||+++
T Consensus 242 ~p-----~----~~----------~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 242 IP-----S----YL----------L--SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CC-----C----Cc----------C--CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 00 1 01 0 4678899999999999999999999854
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.22 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=206.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|...++||+|+||.||.|+.+ +|+.+|+|++++... ...+.+.++.|..+|....++.||+++..|.+.+..|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 567999999999999999999876 799999999976543 234456688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||++||++...|...+ .+++..+...+.+++.|++.+|+. |+|||||||+|+|||..|++||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999998754 588888888999999999999999 999999999999999999999999999843321
Q ss_pred cC--------------------CCcc------c-----------------cccccccccCccccccccCCCCCCCCChhh
Q 039922 839 QE--------------------GQSD------D-----------------AMSCVAGSYGYIAPEYAYTKKVTEKSDVYS 875 (973)
Q Consensus 839 ~~--------------------~~~~------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 875 (973)
.. .... . .....+||+-|+|||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 0000 0 012248999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCC--chhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCC
Q 039922 876 FGVVLMELVTGKRPNDPSFGE--NKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFP 953 (973)
Q Consensus 876 lG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP 953 (973)
+|||+|||+.|.+||....+. .+.++.|......... .....+..++|.+|+. ||
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~----------------------~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE----------------------VDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc----------------------CcccHHHHHHHHHHhc-CH
Confidence 999999999999999875432 2344555433322210 1122667888899999 99
Q ss_pred CCCCC---HHHHHHH
Q 039922 954 INRPS---MRRVVEL 965 (973)
Q Consensus 954 ~~Rps---~~evl~~ 965 (973)
++|.. +.||.+|
T Consensus 431 ~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKH 445 (550)
T ss_pred HHhcCcccHHHHhcC
Confidence 99984 6666543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=373.79 Aligned_cols=483 Identities=27% Similarity=0.344 Sum_probs=387.6
Q ss_pred eecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCc
Q 039922 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156 (973)
Q Consensus 77 l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~ 156 (973)
+|.+.+.+. .||..+..-..++.|+++.|.+- ..|.+...++-+|+.|++++|+++ ..|..+..+.+|+.|+++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 344555544 46666666666889999999876 455666777778999999999875 678888899999999999999
Q ss_pred CCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCc
Q 039922 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD 236 (973)
Q Consensus 157 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~ 236 (973)
|. ..|.+.+++.+|++|+|.+|.+. ..|..+..+++|++|++|+|.+.. +|..+..++.++.+..++|..+...+.
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~--~Pl~i~~lt~~~~~~~s~N~~~~~lg~ 155 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGP--IPLVIEVLTAEEELAASNNEKIQRLGQ 155 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCC--CchhHHhhhHHHHHhhhcchhhhhhcc
Confidence 98 67888999999999999999988 678999999999999999999876 678889999999999988844443332
Q ss_pred cccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCc
Q 039922 237 SIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLE 316 (973)
Q Consensus 237 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~ 316 (973)
.. .+.++|..|.+.+.++..+..++. .|+|.+|.+. . ..+..+.+|+.|....|++... .....+|+
T Consensus 156 ----~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l---~~~g~~l~ 222 (1081)
T KOG0618|consen 156 ----TS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL---EISGPSLT 222 (1081)
T ss_pred ----cc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE---EecCcchh
Confidence 22 788899999998888888888777 7999999987 2 3467788899999999988732 23445789
Q ss_pred EEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCc
Q 039922 317 SLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNR 396 (973)
Q Consensus 317 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 396 (973)
.|+.++|.++...+... -.+|+++++++|+++ .+|++++.+.+|+.++..+|+++ .+|..+....+|+.|.+..|.
T Consensus 223 ~L~a~~n~l~~~~~~p~--p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~ne 298 (1081)
T KOG0618|consen 223 ALYADHNPLTTLDVHPV--PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNE 298 (1081)
T ss_pred eeeeccCcceeeccccc--cccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhh
Confidence 99999999884433322 257899999999998 66789999999999999999996 778888888899999999999
Q ss_pred cCCCCCCccCCcceeeEEEccCCccccccCcccCCCCC-ccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCch
Q 039922 397 FSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPE-VDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPS 475 (973)
Q Consensus 397 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~ 475 (973)
+. .+|.....++.|++|+|..|+|....+..|.-+.. |+.|+.+.|++.......=..++.|+.|.+.+|.++...-.
T Consensus 299 l~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p 377 (1081)
T KOG0618|consen 299 LE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFP 377 (1081)
T ss_pred hh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchh
Confidence 98 67778888999999999999998555544444444 78888888888766544445566788899999999888777
Q ss_pred hhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccc
Q 039922 476 QICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVL 555 (973)
Q Consensus 476 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 555 (973)
.+.++..|+.|+|++|++.......+.++..|++|+||||+|+ .+|+.+..+..|++|...+|+|. ..| .+..++.|
T Consensus 378 ~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL 454 (1081)
T KOG0618|consen 378 VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQL 454 (1081)
T ss_pred hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcc
Confidence 8888889999999999988444456778889999999999998 88888899999999999999997 677 88889999
Q ss_pred cEEecCCCcCccc-cChhhhcccccceeccCCc
Q 039922 556 TSLDLSSNLLTGE-IPLELTKLKLNQFNISHNK 587 (973)
Q Consensus 556 ~~L~Ls~N~l~~~-~p~~l~~l~l~~l~l~~N~ 587 (973)
+.+|||.|+|+-. +|......+|++||+++|.
T Consensus 455 ~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 455 KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred eEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 9999999998743 4444443588899999887
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.37 Aligned_cols=261 Identities=27% Similarity=0.415 Sum_probs=202.7
Q ss_pred CCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC-C
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ-D 753 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 753 (973)
++|+..++||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++... +
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 5688899999999999999974 245789999985332 233456788999999999 899999999988764 4
Q ss_pred eeEEEEeccCCCChhhhhhccCC---------------------------------------------------------
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR--------------------------------------------------------- 776 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 776 (973)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 67899999999999999875321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcccccccccccc
Q 039922 777 --SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854 (973)
Q Consensus 777 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~ 854 (973)
...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........ .......++.
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~ 240 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSARLPL 240 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCCCCCc
Confidence 12377888899999999999999999 9999999999999999999999999999865432211 1112234567
Q ss_pred CccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCC
Q 039922 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTC 933 (973)
Q Consensus 855 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 933 (973)
.|+|||++.+..++.++|||||||++|||++ |..||..... .......+...... ..
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~~----------------~~----- 298 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-NEEFCQRLKDGTRM----------------RA----- 298 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHhcCCCC----------------CC-----
Confidence 8999999999999999999999999999997 9999865321 22222222211100 00
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 934 DYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 934 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.......+.+++.+|++.||++|||+.||++.|+...
T Consensus 299 ~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 299 PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0112356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=344.64 Aligned_cols=257 Identities=28% Similarity=0.379 Sum_probs=210.9
Q ss_pred CCCCccccccccCCeeEEEEEECC--C--CE-EEEEEecCC-CCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS--G--ET-VAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~--~--~~-vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
++....++||+|+||.||+|+++. + .. ||||..+.+ ....+..++|.+|.++|+.++|||||++||++..+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 345556899999999999998763 2 23 899998653 35667788999999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++|||+|+||+|.+++...+. .++..++..++.++|+||+|||+. +++||||.++|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999998654 589999999999999999999999 999999999999999999999999999875
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHH-HhccCCC
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTE-ATLSSPE 913 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 913 (973)
-.... .... ...-..+|+|||.+..+.++.++|||||||++||+++ |..||.+. ...++..++.. ..+-..+
T Consensus 312 ~~~~~---~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 312 GSQYV---MKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--KNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred Cccee---eccc-cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--CHHHHHHHHHhcCccCCCC
Confidence 43111 0110 1134579999999999999999999999999999999 78888753 34456666633 3222111
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
...+..+..++.+|+..+|+.||+|.++.+.++...
T Consensus 386 ---------------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 386 ---------------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred ---------------------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 123456777788999999999999999999998753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=340.06 Aligned_cols=252 Identities=26% Similarity=0.342 Sum_probs=216.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCC-CCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.+-|+..+.||+|+.|.|-.|+.. +|+.+|||++.+. .........+.+|+-+|+.+.|||++++|++|+...++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 455778899999999999999865 8999999999765 33444556789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
.||+++|-|.+|+..++ .+++.++.+.++||+.|+.|.|.. +|+|||+||+|+|+|..+++||+|||+|..-.+
T Consensus 91 lEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999998765 588999999999999999999999 999999999999999999999999999976433
Q ss_pred cCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
+ .-..+.+|++.|.|||++.+.+| +.++||||+|||+|.++||+.||+. +..+.+...+..+..+.|.
T Consensus 165 g-----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--dNir~LLlKV~~G~f~MPs---- 233 (786)
T KOG0588|consen 165 G-----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--DNIRVLLLKVQRGVFEMPS---- 233 (786)
T ss_pred C-----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--ccHHHHHHHHHcCcccCCC----
Confidence 2 33456789999999999999988 5799999999999999999999984 3455666666666554221
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
....+..+++++|+..||++|.|++||.+|--
T Consensus 234 ------------------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 234 ------------------NISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ------------------cCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 22456789999999999999999999999853
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.73 Aligned_cols=260 Identities=28% Similarity=0.392 Sum_probs=202.5
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhc--CCCCCeeeEEeEEecCC----ee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR--VRHGNVVKLLMCCSGQD----FN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~ 755 (973)
......++||+|.||.||||++. ++.||||++ ..+.++.|.+|..+.+. ++|+||++++++-...+ ++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKif-----p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIF-----PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEec-----CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 44667789999999999999997 699999999 34566777777776665 58999999999876655 88
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC------VPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
++|+||.+.|+|.+|+..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||..|+++.|+|
T Consensus 284 wLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999999875 5899999999999999999999863 57899999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCCCCC------CCCChhhHHHHHHHHHcCCCCCCCC-CCC------
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT------EKSDVYSFGVVLMELVTGKRPNDPS-FGE------ 896 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~------~~~Dv~slG~~l~elltg~~p~~~~-~~~------ 896 (973)
||+|..+....... .....+||.+|||||++.+..-- .+.||||+|.|+|||+++..-.++. .++
T Consensus 360 FGLAl~~~p~~~~~--d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKPQG--DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCCCc--chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 99999887655432 23347999999999999875322 3689999999999999976544321 111
Q ss_pred --------chhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 897 --------NKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 897 --------~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
-+++...+.... -.|.+....-.-..+..+.+.+..||..||+.|.|+.=|-+.+.+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK---------------~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKK---------------QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhc---------------cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 111112211111 112222222223456788999999999999999999888777755
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.03 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=202.5
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+.+...+-+|+|+.|.||.|+++ ++.||||+++ +.-+.+++-+++++|+||+.+.|+|.....+||||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~---------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVR---------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc-CceehhHHHh---------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 34556788999999999999998 8999999882 1123478899999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
|..|-|.+.++... .+.......|..+||.||.|||.+ .|||||||+-||||+.+..|||+|||-++.....
T Consensus 194 Ca~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred cccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 99999999998654 588888999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.+...+.||+.|||||++.+...+.|+||||||||+|||+||..||..... .. |..++-. ...
T Consensus 266 ---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds--sA----IIwGVGs--------NsL 328 (904)
T KOG4721|consen 266 ---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS--SA----IIWGVGS--------NSL 328 (904)
T ss_pred ---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch--he----eEEeccC--------Ccc
Confidence 234558999999999999999999999999999999999999999964210 00 0001100 000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.+. .....+..+.-+++.||+..|..||++++++.||+..+
T Consensus 329 ~Lp--------vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 329 HLP--------VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccc--------CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 011 11233456778899999999999999999999998654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=332.90 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=201.1
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCc-hhHHHHHHHHHHHhcCCCCCeeeEEeEEec----CCeeEEEEec
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKP-ETETVFRSEIETLGRVRHGNVVKLLMCCSG----QDFNILVYEY 761 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 761 (973)
...||+|++|.||+|++ +|+.||||++....... ...+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999998 58999999996443322 224678899999999999999999999876 3467899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.++++... .+++..+.+++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999997643 5889999999999999999999732 78899999999999999999999999988653321
Q ss_pred CccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....+.......
T Consensus 178 ------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~-------- 241 (283)
T PHA02988 178 ------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--TTKEIYDLIINKNNSL-------- 241 (283)
T ss_pred ------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcCCCC--------
Confidence 22467899999999876 68999999999999999999999999753 2233333332211110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
.+. ......+.+++.+||+.||++|||++|+++.|++.++
T Consensus 242 -------~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 -------KLP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -------CCC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000 1224568899999999999999999999999998653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=320.29 Aligned_cols=276 Identities=24% Similarity=0.303 Sum_probs=211.9
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-----
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG----- 751 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----- 751 (973)
.++...|...+.||+|+||.|+++..+ +|+.||+|++..........++..+|+++++.++|+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 455667777899999999999999876 79999999997777777788889999999999999999999999865
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
-...|+|+|+| +.+|.+.++... .++...+..++.|+++|+.|+|+. +|+|||+||+|++++.+..+||+|||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 35679999999 579999998654 388899999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCcccccccc-CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+|+..... .....++..+.|.+|.|||++. ...|+.+.||||.||++.||++|+..|-+. +..+-.+.+......
T Consensus 171 LAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~--d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 171 LARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK--DYVHQLQLILELLGT 246 (359)
T ss_pred ceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC--chHHHHHHHHHhcCC
Confidence 99988655 2234567889999999999876 468999999999999999999999988643 111111111111111
Q ss_pred CCCccc-----cCccccccc-----CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGC-----CRDLNQLID-----PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~-----~~~l~~~~d-----~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.... +......+. +.......-+......++++.+|+..||.+|+|++|.++|
T Consensus 247 -P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 247 -PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred -CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 000000000 0000000001223467889999999999999999999876
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.88 Aligned_cols=262 Identities=25% Similarity=0.314 Sum_probs=209.1
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC------------chhHHHHHHHHHHHhcCCCCCeee
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK------------PETETVFRSEIETLGRVRHGNVVK 744 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~niv~ 744 (973)
....++|++.+.||+|.||.|-+|+.. +++.||+|++.+.... ....+..++|+.+|++++|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 556789999999999999999999876 7999999999653211 111246889999999999999999
Q ss_pred EEeEEec--CCeeEEEEeccCCCChhhhhhccCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC
Q 039922 745 LLMCCSG--QDFNILVYEYMPNGSLADMLHEKGRSGS-LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA 821 (973)
Q Consensus 745 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 821 (973)
++++..+ .+..|+|+|||..|.+...=. .+. ++..++++++++++.||+|||.+ +|+||||||+|+|+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 9999876 568899999999887754322 223 88999999999999999999999 9999999999999999
Q ss_pred CCceEEeccCcchhccccCC-CccccccccccccCccccccccCCC----CCCCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 039922 822 EMVPRVADFGLAKALQSQEG-QSDDAMSCVAGSYGYIAPEYAYTKK----VTEKSDVYSFGVVLMELVTGKRPNDPSFGE 896 (973)
Q Consensus 822 ~~~~kl~DfGl~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~elltg~~p~~~~~~~ 896 (973)
+|+|||+|||.+........ .........+||+.|+|||...++. .+.+.||||+||++|-++.|+.||... .
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--~ 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--F 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--h
Confidence 99999999999876633321 1223345578999999999987743 356889999999999999999999753 2
Q ss_pred chhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 897 NKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
..++.+.|.......+. .++..+.+.+++.+|+.+||++|.+..||..|...
T Consensus 324 ~~~l~~KIvn~pL~fP~--------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPE--------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHHHHHHhcCcccCCC--------------------cccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 33444444443333221 13456788999999999999999999999887643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=362.83 Aligned_cols=258 Identities=29% Similarity=0.435 Sum_probs=210.4
Q ss_pred CCCccccccccCCeeEEEEEEC--CCC----EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK--SGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
..+..+.||+|.||.||+|... +|. .||+|.+.+. ...+...+|.+|..+|+.++|||||+++|+|-+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3456778999999999999876 343 4999998543 34566788999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 757 LVYEYMPNGSLADMLHEKGR----SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
+++|||++|+|..|+++... ...+.....+.++.|||+|+.|||++ ++|||||..+|+|+++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987621 33588999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHH-HHHHHhcc
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVR-WVTEATLS 910 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~-~~~~~~~~ 910 (973)
|+.+...+.... .....-...|||||.+..+.++.|+|||||||++||++| |..||.. . ...++.. +...+ +-
T Consensus 849 ArDiy~~~yyr~--~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~-~-~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 849 ARDIYDKDYYRK--HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS-R-SNFEVLLDVLEGG-RL 923 (1025)
T ss_pred hHhhhhchheec--cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC-c-chHHHHHHHHhCC-cc
Confidence 996544332111 111123468999999999999999999999999999999 5666643 3 3444444 55444 44
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.++..|+ ..+.+++..||+.+|++||++..|++.+..+.
T Consensus 924 ~~P~~CP---------------------~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 924 DPPSYCP---------------------EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCCCCCC---------------------hHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 4555543 45679999999999999999999999887653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=319.64 Aligned_cols=271 Identities=26% Similarity=0.320 Sum_probs=212.9
Q ss_pred ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHh--cCCCCCeeeEEeEEecC---
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLG--RVRHGNVVKLLMCCSGQ--- 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~--- 752 (973)
..+..+...++.||+|.||.||+|++. |+.||||+|.. .+++...+|.++.+ -++|+||..+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 345567888999999999999999998 99999999931 12233444555554 46999999999886543
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEeCCCCCCEEeCCCCceE
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND-----CVPAIVHRDVKSHNILLDAEMVPR 826 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~k 826 (973)
...++|.+|.+.|||.+|+... +++....++++..+|.||++||.+ ..|.|.|||||++||||.+++.+.
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 2678999999999999999864 589999999999999999999965 468999999999999999999999
Q ss_pred EeccCcchhccccCCCccccccccccccCccccccccCCC----C--CCCCChhhHHHHHHHHHcC----------CCCC
Q 039922 827 VADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK----V--TEKSDVYSFGVVLMELVTG----------KRPN 890 (973)
Q Consensus 827 l~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~slG~~l~elltg----------~~p~ 890 (973)
|+|+|+|............+....+||.+|||||++.... + -..+||||||.|+||+..+ +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999888777665566677789999999999986532 2 2368999999999999863 3455
Q ss_pred CCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 891 DPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+...+.+..+.+..+ ....+-+.|.+.....+.+....+.++++.||..+|..|.|+-.|.+.|.+..
T Consensus 437 yd~Vp~DPs~eeMrk------------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRK------------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ccCCCCCCCHHHHhc------------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 543333332222110 01122334566667777888999999999999999999999999999887654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=314.10 Aligned_cols=274 Identities=22% Similarity=0.288 Sum_probs=210.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCC-eeeEEeEEecCC-----
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN-VVKLLMCCSGQD----- 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 753 (973)
...|...++||+|+||+||+|+.+ +|+.||+|++.-....+.......+|+.++++++|+| ||++.+++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777889999999999999876 7999999999655443344455789999999999999 999999998877
Q ss_pred -eeEEEEeccCCCChhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 754 -FNILVYEYMPNGSLADMLHEKGRS-GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 754 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
..++||||+ .-+|.++++..... .-.+...+..++.||+.|++|+|++ +|+||||||+||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 789999999 57999999876532 2366688999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+|+...-. ...+...++|.+|+|||++.+. .|+...||||+||+++||++++..|.+..+ .+++ ..+-... .
T Consensus 166 lAra~~ip----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql-~~If~~l-G 238 (323)
T KOG0594|consen 166 LARAFSIP----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQL-FRIFRLL-G 238 (323)
T ss_pred hHHHhcCC----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHH-HHHHHHc-C
Confidence 99865422 2346667899999999999887 789999999999999999999988876432 2222 2222221 2
Q ss_pred CCCccccCcccccccCCCCCCCC------CH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTC------DY---EEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~------~~---~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.|....+.....+.+........ .. .......+++.+|++++|.+|.|+.++++|
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 22222222233333322111111 11 112478899999999999999999999887
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=307.53 Aligned_cols=273 Identities=23% Similarity=0.260 Sum_probs=208.0
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCeeE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDFNI 756 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 756 (973)
-.+.|+..+.|++|+||.||+|+++ +++.||+|+++.+.....-.-...+|+.++.+.+|||||.+-.+... -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3457889999999999999999987 78999999996555444444556899999999999999999988765 45789
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+|||||+ -+|...++.... ++...++..++.|+++|++|||.. .|+|||||++|+|++..|.+||+|||+|+.+
T Consensus 154 ~VMe~~E-hDLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHH-hhHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999997 489999987763 688899999999999999999999 8999999999999999999999999999988
Q ss_pred cccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.+.. .+++..+.|.+|.|||.+.+. .|+++.|+||+|||+.||+++++.|.+.. +..++. .+-... ..|...
T Consensus 228 gsp~----k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~-~If~ll-GtPte~ 300 (419)
T KOG0663|consen 228 GSPL----KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLD-KIFKLL-GTPSEA 300 (419)
T ss_pred cCCc----ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHH-HHHHHh-CCCccc
Confidence 6553 346678899999999999875 58999999999999999999998886542 222222 111111 111111
Q ss_pred ccCcccccc---cCCCCCCCC--------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLI---DPRMDLSTC--------DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~---d~~l~~~~~--------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+..+.++. .-.+....+ .......-++++...+.+||.+|.|+.|.+++
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111111 000000000 00023566788999999999999999998865
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.48 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=219.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe-eEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF-NILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 758 (973)
.++|...+++|+|+||.++.++.+ +++.|++|++.-.......++...+|+.++++++|||||.+.+.|..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357888999999999999999876 78899999997666666666788999999999999999999999999888 9999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|+|++||++.+.+.... ...++++++..++.|++.|+.|||+. +|+|||||+.||+++.++.|||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998765 34689999999999999999999988 999999999999999999999999999998866
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
... ....++||+.|+.||++.+.+|..|+||||+||++|||++-+++|... +...++..+......
T Consensus 159 ~~~----~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~--~m~~Li~ki~~~~~~-------- 224 (426)
T KOG0589|consen 159 EDS----LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS--NMSELILKINRGLYS-------- 224 (426)
T ss_pred chh----hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc--chHHHHHHHhhccCC--------
Confidence 542 245578999999999999999999999999999999999999999763 344444444333322
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....+..++..++..|++.+|+.||++.+++.+
T Consensus 225 -------------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 -------------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -------------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1123456788899999999999999999999876
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=307.36 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=213.5
Q ss_pred ccCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+.+.|+..+.||+|.|+.||++.. .+|+.+|+|.+.-+.-.....+.+.+|+.+-+.++|||||++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788999999999999999765 4899999998865544455677899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCceEEeccCcchh
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVPRVADFGLAKA 835 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl~~~ 835 (973)
+|+|.|++|..-+-.. ...++..+-..++||++++.|.|.+ +|||||+||+|+++.+ ...+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997655432 2366777888999999999999999 9999999999999953 45699999999988
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
+... .....++||++|||||++...+|+..+|||+.||++|-++.|..||.. ++..++.+.+..+....+.+.
T Consensus 163 l~~g-----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 163 VNDG-----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred eCCc-----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--ccHHHHHHHHhccccCCCCcc
Confidence 7622 345668999999999999999999999999999999999999999985 355667777766654433221
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
+ +...+...+++++|+..||.+|.|+.|.++|=
T Consensus 236 w------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 236 W------------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred c------------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 1 22345678999999999999999999998763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=331.90 Aligned_cols=253 Identities=25% Similarity=0.309 Sum_probs=201.3
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
|+..+.||+|+||.||+|... +|+.||+|++..... .......+.+|+.++++++|++|+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999875 799999999854322 223345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999998876432 22588999999999999999999999 99999999999999999999999999987653222
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.........
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~-------- 222 (285)
T cd05631 157 ----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VKREEVDRRVKEDQE-------- 222 (285)
T ss_pred ----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHHhhcccc--------
Confidence 123356899999999999999999999999999999999999999764221 111111111111000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
.........+.+++.+|+++||++||+ ++|++++
T Consensus 223 ----------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 ----------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ----------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 001122456789999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.28 Aligned_cols=265 Identities=25% Similarity=0.364 Sum_probs=203.7
Q ss_pred CCCCccccccccCCeeEEEEEECC-----------------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS-----------------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 744 (973)
++|+..++||+|+||.||+|.+.+ +..||+|.+.... .......+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 468888999999999999997542 3369999885432 3344567899999999999999999
Q ss_pred EEeEEecCCeeEEEEeccCCCChhhhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 039922 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGR----------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808 (973)
Q Consensus 745 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 808 (973)
+++++...+..++||||+++|+|.+++..... ...+++..+.+++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998864321 12467888999999999999999999 999
Q ss_pred EeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc--C
Q 039922 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT--G 886 (973)
Q Consensus 809 H~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g 886 (973)
||||||+||++++++.+||+|||+++.+...... .......++..|+|||+..++.++.++||||||+++|||++ +
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCcee--EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999765433211 11222345788999999988899999999999999999987 5
Q ss_pred CCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 887 KRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 887 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
..||... ...+....+.......... . ....+ ......+.+++.+|++.||++||||.||.+.|
T Consensus 239 ~~p~~~~--~~~~~~~~~~~~~~~~~~~-----~-~~~~~--------~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 239 EQPYGEL--TDEQVIENAGEFFRDQGRQ-----V-YLFRP--------PPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred CCCCCcC--CHHHHHHHHHHHhhhcccc-----c-cccCC--------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 5666542 2333333333322110000 0 00000 12235788999999999999999999999998
Q ss_pred hh
Q 039922 967 RV 968 (973)
Q Consensus 967 ~~ 968 (973)
++
T Consensus 303 ~~ 304 (304)
T cd05096 303 TE 304 (304)
T ss_pred hC
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=337.65 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=204.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 757 (973)
.++|...++||+|+||+|+.+..+ +++.+|||++++.... ....+..+.|.+++.... ||+++.++.+|.+.++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457888999999999999999987 6889999999876543 344566778888888775 9999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+.||++..+.+. +.+++..+.-++..|+.||+|||++ +|||||||-+|||+|.+|++||+|||+++.--
T Consensus 447 vmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999995444332 2589999999999999999999999 99999999999999999999999999997543
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.. ....+++.||+.|||||++.+..|+.++|+|||||++|||+.|+.||.+. +++++.+-+......
T Consensus 520 ~~----g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~d~~~------- 586 (694)
T KOG0694|consen 520 GQ----GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVNDEVR------- 586 (694)
T ss_pred CC----CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCC-------
Confidence 21 23456689999999999999999999999999999999999999999863 555666655443222
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM 959 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 959 (973)
+..-...+..+++++++.++|++|.-+
T Consensus 587 ---------------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 ---------------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 112235677899999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=335.62 Aligned_cols=248 Identities=25% Similarity=0.311 Sum_probs=203.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999986 789999999853321 2234456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997643 478899999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||... ......+.+......
T Consensus 155 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~--------- 216 (291)
T cd05612 155 -------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD--NPFGIYEKILAGKLE--------- 216 (291)
T ss_pred -------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCcC---------
Confidence 12346899999999999989999999999999999999999999753 222333332222111
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVELL 966 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~L 966 (973)
+. ......+.+++.+|++.||.+||+ +.|++++-
T Consensus 217 --------~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 217 --------FP-----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred --------CC-----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 00 111346789999999999999995 88888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=302.91 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=209.1
Q ss_pred CCCCccccccccCCeeEEEEE-ECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----Cee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ-----DFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 755 (973)
++|++++.+|+|||+.||.++ ..+++.||+|++ .....+..+..++|++..++++|||+++++++...+ .+.
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI--~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKI--LCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhhee--eccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 478999999999999999998 457889999998 444456777889999999999999999999886543 358
Q ss_pred EEEEeccCCCChhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 756 ILVYEYMPNGSLADMLHEKGRS-GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
|++++|...|+|.+.+...... ..+++.+++.|+.+|++||++||+. .|+++||||||.||++++++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999765443 3799999999999999999999997 3469999999999999999999999999987
Q ss_pred hccccCCCccc-----cccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHH
Q 039922 835 ALQSQEGQSDD-----AMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 835 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 906 (973)
...-.-..... .......|..|+|||... +...++++|||||||++|+|+.|..||+...+....+.--+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv-- 255 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV-- 255 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee--
Confidence 65432211111 123345789999999875 45678999999999999999999999986433222111111
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
..+.+..... ....+.+.+++.+|++.||.+||++.+++.++...
T Consensus 256 -----------------~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 256 -----------------QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------------eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111111 22578899999999999999999999999998754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=314.34 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=217.5
Q ss_pred ccCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
...+|++.+.+|+|.||.|-++.. +.|+.||||.+++... .+.+.-.+++|+++|+.++||||+.++++|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345788899999999999999986 6899999999876543 33444567899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||..+|.|.+|+...+ .+++..+.++++||..|+.|.|++ +++|||+|.+|||+|+++++||+|||++-.+.
T Consensus 131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999998755 589999999999999999999999 99999999999999999999999999998775
Q ss_pred ccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.. ...+.+.|++-|.+||+..+..| ++.+|-||+||++|-+..|..||++ .+...+++.+..+....++
T Consensus 205 ~~-----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG--~Dhk~lvrQIs~GaYrEP~--- 274 (668)
T KOG0611|consen 205 DK-----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG--RDHKRLVRQISRGAYREPE--- 274 (668)
T ss_pred cc-----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC--chHHHHHHHhhcccccCCC---
Confidence 43 33567899999999999999887 4789999999999999999999986 3566777777776655332
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+-...-+|++|+..+|++|.|+.+|..|-
T Consensus 275 --------------------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 --------------------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------------------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 223456789999999999999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.56 Aligned_cols=272 Identities=20% Similarity=0.237 Sum_probs=203.7
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+|+.+ +++.||+|++..........+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 6888999999999999999986 688999999965544445556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
++++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 82 VEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 998776654432 22588899999999999999999999 999999999999999999999999999987643221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc-----c
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG-----C 916 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 916 (973)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+.......+... .
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 156 ---ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES--EIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ---ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 11233568999999999999899999999999999999999999997532 1111111111110000000 0
Q ss_pred cCcccccccCCCCCC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLS-----TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.........+..... .........+.+++.+|+++||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 0001124568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.05 Aligned_cols=246 Identities=27% Similarity=0.358 Sum_probs=205.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
..|+..+.||+|+||.||+|.+. +++.||+|++.-.. .....+.+++|+.++..++++||.++|+.|..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 35777899999999999999875 78999999995332 23445678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
||.+|++.+.++... .+++..+.-|++++..|+.|||.+ +.+|||||+.||++..+|.+|++|||.+..+....
T Consensus 92 y~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999987643 347777788999999999999999 99999999999999999999999999997765543
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.. ...++||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+....+. +.
T Consensus 166 ~r----r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------------rv 219 (467)
T KOG0201|consen 166 KR----RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------------RV 219 (467)
T ss_pred hc----cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------------eE
Confidence 22 25689999999999999999999999999999999999999999753220 01
Q ss_pred ccccc----CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLID----PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d----~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.-+|. |.+. ......+.+++..|+++||+.||+|.+++++
T Consensus 220 lflIpk~~PP~L~-----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 220 LFLIPKSAPPRLD-----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred EEeccCCCCCccc-----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11111 1112 1335668999999999999999999999876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=337.76 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=198.1
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
+.||+|+||.||+|+.+ +|+.||+|++.+... .......+.+|+.++++++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 789999999864322 2233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccc
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 845 (973)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----~ 150 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----A 150 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----C
Confidence 9999887543 588999999999999999999999 99999999999999999999999999987532211 1
Q ss_pred cccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccccc
Q 039922 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925 (973)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 925 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... +.......+......
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~~~~~~~~--------------- 213 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEIR--------------- 213 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC--CHHHHHHHHHcCCCC---------------
Confidence 233457999999999999999999999999999999999999999752 222233322211100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 926 PRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 926 ~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
+. .....++.+++.+|++.||++|| ++.+++++
T Consensus 214 --~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 --FP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --CC-----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 00 11235678899999999999999 79998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=339.98 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=205.1
Q ss_pred CCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 754 (973)
++|+..+.||+|+||.||+|+. .++..||||++.... .....+.+.+|+.+++.+ +||||++++++|..++.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 4688899999999999999964 246689999985333 233456788999999999 89999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC----------------------------------------------------------
Q 039922 755 NILVYEYMPNGSLADMLHEKGR---------------------------------------------------------- 776 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 776 (973)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 777 --------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 777 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
...+++..+.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12468888999999999999999999 9999999999999999999999999999766433211
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.......++..|+|||++.+..++.++|||||||++|||++ |..||... .......+++.......
T Consensus 271 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~~~---------- 337 (375)
T cd05104 271 --VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSKFYKMIKEGYRML---------- 337 (375)
T ss_pred --cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC-CchHHHHHHHHhCccCC----------
Confidence 11112335678999999999999999999999999999998 78888643 22233344333322110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+ .....++.+++.+|++.||++||+|.||+++|++.
T Consensus 338 ---~~--------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 ---SP--------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CC--------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00 01134688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=327.46 Aligned_cols=264 Identities=28% Similarity=0.375 Sum_probs=212.6
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
...+.++||+|.||.|..+....+..||||+++... ......+|.+|+++|.+++|||||+++++|..++..++|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 456788999999999999999888999999996443 3445688999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++|+|.+|+.++... ....+...+|+.|||.||+||.+. ++||||+.++|+|+|+++++||+|||+++.+-..+.
T Consensus 618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y- 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY- 692 (807)
T ss_pred hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc-
Confidence 999999999876432 245566788999999999999999 999999999999999999999999999987654432
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc--CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT--GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.+.....+-.++|||||.+..+++++++|||+||+++||+++ ...||... .++++++...........
T Consensus 693 -y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l--t~e~vven~~~~~~~~~~------- 762 (807)
T KOG1094|consen 693 -YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL--TDEQVVENAGEFFRDQGR------- 762 (807)
T ss_pred -eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh--hHHHHHHhhhhhcCCCCc-------
Confidence 122233455689999999999999999999999999999986 77788754 234444433322211100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
+.+-.+ .+....++.+++.+||+.+-++||+++++...|++.
T Consensus 763 -~~~l~~------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 -QVVLSR------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -ceeccC------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 011111 122356788999999999999999999999999864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=338.77 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=202.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|...+.||+|+||.||+|+.+ +++.||+|++.+.. ......+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 356888999999999999999986 68999999985432 1223345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999987643 478888899999999999999999 999999999999999999999999999876532
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ......+.+......
T Consensus 171 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~-------- 233 (329)
T PTZ00263 171 R-------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--TPFRIYEKILAGRLK-------- 233 (329)
T ss_pred C-------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCcC--------
Confidence 2 12356899999999999999999999999999999999999999652 222222222221110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
+.. .....+.+++.+|++.||++||+ +.|+++|
T Consensus 234 -~p~-------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 -FPN-------------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCC-------------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 000 01245779999999999999996 6888765
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=322.64 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=203.5
Q ss_pred CCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.+|++.+.||+|+||.||+|.++ .+..||+|.+.... .......+.+|+..+++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 45788899999999999999764 45689999986432 23445678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999987643 3588999999999999999999999 99999999999999999999999999876532
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.... .......++..|+|||+..++.++.++|||||||++||+++ |..||... ...+..+.+.......
T Consensus 159 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~--~~~~~~~~~~~~~~~~----- 228 (266)
T cd05064 159 SEAI---YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM--SGQDVIKAVEDGFRLP----- 228 (266)
T ss_pred ccch---hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCCCCC-----
Confidence 2111 11112335678999999999999999999999999999875 99998653 2233333332211110
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
........+.+++.+|++++|++||++.||.+.|+.
T Consensus 229 ----------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 ----------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 001224568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.96 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=203.8
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||.||+++.+++..+|+|.+.... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 3577788999999999999999888899999884332 2345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.++++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 81 MENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999987543 2588999999999999999999999 999999999999999999999999999876543221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||+..+..++.++||||||+++|||++ |+.||... ...+....+......
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--~~~~~~~~i~~~~~~---------- 220 (256)
T cd05114 156 T---SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRGFRL---------- 220 (256)
T ss_pred e---ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCCC----------
Confidence 1 1112345678999999988889999999999999999999 88888643 233333333322111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
..+. .....+.+++.+|++++|++||++.|+++.|.
T Consensus 221 ---~~~~--------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 ---YRPK--------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCC--------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0010 11346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.39 Aligned_cols=267 Identities=27% Similarity=0.357 Sum_probs=199.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-----eeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD-----FNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 756 (973)
.|...+++|.|+||.||+|+.. +++.||||++..... .-.+|.++|+.++|||||++..+|.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4677889999999999999876 578999999843321 1246999999999999999999886532 235
Q ss_pred EEEeccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-CceEEeccCcch
Q 039922 757 LVYEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAK 834 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~~ 834 (973)
+|||||+ .+|.++++.... ...++...+.-+..||.+|++|||+. +|+||||||+|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 8999997 589988875321 22467777788999999999999998 99999999999999976 999999999999
Q ss_pred hccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.+...+. ...+..|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+. ....+++..++-.......
T Consensus 175 ~L~~~ep-----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 175 VLVKGEP-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred eeccCCC-----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHH
Confidence 8866543 2346788999999999875 6899999999999999999999888763 2334444443322211110
Q ss_pred c--cccCcccccccCCCCCCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 R--GCCRDLNQLIDPRMDLST----CDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~--~~~~~l~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .......+.-.+.+.... .......+..+++.++++++|.+|.++.|++++
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 000111122223332222 223456688999999999999999999998765
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.27 Aligned_cols=271 Identities=20% Similarity=0.251 Sum_probs=202.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..++||+|+||.||+|+.+ +++.||+|++..... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46888999999999999999876 789999999854322 2234467789999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|++ |+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLD-SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCC-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 996 599998865432 478889999999999999999999 99999999999999999999999999987543222
Q ss_pred CCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC-
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR- 918 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 918 (973)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||... ...+....+.......+...++.
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 ----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS--TVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred ----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCChHHhhcc
Confidence 12233567899999998865 56889999999999999999999999753 22222222222221111111110
Q ss_pred ----cccccccCCCCCCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 ----DLNQLIDPRMDLSTC---DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ----~l~~~~d~~l~~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+...+....... ......+..+++.+|+++||.+|||+.|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111111111100000 01123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=321.66 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=210.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ........+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 56888999999999999999875 78999999885432 23344567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988864322 23578889999999999999999999 999999999999999999999999999876543
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
... ......|+..|+|||...+..++.++||||+|+++|||++|+.||.............+......
T Consensus 159 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd08228 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP-------- 226 (267)
T ss_pred hhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC--------
Confidence 221 12234678899999999888899999999999999999999999975332222222222211100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.. ........+.+++.+|++.+|++||++.+|++.+++.+
T Consensus 227 --------~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 --------PL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --------CC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 01223467889999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.41 Aligned_cols=271 Identities=24% Similarity=0.289 Sum_probs=200.2
Q ss_pred CCCCccccccccCCeeEEEEEEC--CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC---CCCCeeeEEeEEe-----c
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK--SGETVAVKRLLGGTHKPETETVFRSEIETLGRV---RHGNVVKLLMCCS-----G 751 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~ 751 (973)
++|+..+.||+|+||.||+|+.. +++.||+|++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999873 468899999865443333344566677776665 6999999999885 2
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 799998875432 2478999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+++..... .......|+..|+|||++.+..++.++||||+||++|||++|+.||... ...+....+.......
T Consensus 156 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~--~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 156 LARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIGLP 228 (290)
T ss_pred ceEeccCC-----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCC
Confidence 98765332 1123456899999999998889999999999999999999999999763 2233333333322211
Q ss_pred CCccccCcccccccCCCCCC------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PERGCCRDLNQLIDPRMDLS------TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+..++... .+....+... ...+.....+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 229 GEEDWPRDV-ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred Chhhchhhh-cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 111111111 0111111000 0001224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=332.13 Aligned_cols=270 Identities=23% Similarity=0.325 Sum_probs=206.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||.||+++.+ +|..||+|.+.... .......+.+|++++++++|+||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 57889999999999999999987 68889999885432 23445678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... .+++..+..++.|++.|++|||+.. +|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999997643 4788999999999999999999851 69999999999999999999999999987653221
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||... +..++...+........ .......
T Consensus 159 ------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (331)
T cd06649 159 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP--DAKELEAIFGRPVVDGE-EGEPHSI 229 (331)
T ss_pred ------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhcccccccc-cCCcccc
Confidence 22356899999999999999999999999999999999999999653 22222222111110000 0000000
Q ss_pred ------------------------ccccc---CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 921 ------------------------NQLID---PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 921 ------------------------~~~~d---~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.++.+ ..............++.+++.+|+++||++|||+.|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000 00000000112345789999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=335.72 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=204.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+|+..+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+++++.++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888999999999999999987 589999999854322 12334567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999997543 478899999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
......||+.|+|||++.+..++.++||||+||++|||++|..||... ...+....+.........
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~------- 219 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS--TPNETWENLKYWKETLQR------- 219 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC--CHHHHHHHHHhccccccC-------
Confidence 123356899999999999999999999999999999999999999753 222222222211110000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....++ ......++.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~-------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDP-------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCcc-------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000 01234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=299.46 Aligned_cols=257 Identities=27% Similarity=0.386 Sum_probs=209.6
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC------CchhHHHHHHHHHHHhcCC-CCCeeeEEeEE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH------KPETETVFRSEIETLGRVR-HGNVVKLLMCC 749 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 749 (973)
......|...+.+|.|..++|.++..+ +|.++|+|++.-... ..+..++-.+|+.+++++. ||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 445667888999999999999887654 789999998853221 1222345577999999985 99999999999
Q ss_pred ecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 750 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
+.+...++|+|.|+.|.|.+|+...- .++++...+|++|+.+|++|||.. +|||||+||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999997643 589999999999999999999999 999999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCcccccccc------CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY------TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 903 (973)
||++..+.+.. ......||++|.|||.+. ...|+..+|+||+||++|-++.|.+||..- ..--+.+.
T Consensus 167 FGFa~~l~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~ 239 (411)
T KOG0599|consen 167 FGFACQLEPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRM 239 (411)
T ss_pred cceeeccCCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHH
Confidence 99999876543 345678999999999885 346888999999999999999999999731 12223444
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.++..+... | .+ .+......+++.+|++.||++|.|+.|+++|
T Consensus 240 ImeGkyqF~s------------p-----eW-adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKYQFRS------------P-----EW-ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhcccccCC------------c-----ch-hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 4444433111 1 11 3445678899999999999999999999876
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=339.13 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=203.1
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 754 (973)
++|+..+.||+|+||.||+|+.. ++..||+|++..... ......+.+|+.+++.+ +|+|||+++++|...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 46888999999999999998742 345799999954332 33456688999999999 89999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC----------------------------------------------------------
Q 039922 755 NILVYEYMPNGSLADMLHEKGR---------------------------------------------------------- 776 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 776 (973)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccc
Q 039922 777 ---------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 777 ---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
...+++.++.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........ ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~ 271 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVK 271 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--eec
Confidence 12467888999999999999999999 9999999999999999999999999998765432211 111
Q ss_pred cccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccC
Q 039922 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 926 (973)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .......+.... .. ..+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-~~~~~~~~~~~~-~~------------~~~ 337 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-NSKFYKMVKRGY-QM------------SRP 337 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-cHHHHHHHHccc-Cc------------cCC
Confidence 22335678999999998999999999999999999997 9999865321 122222211110 10 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 927 RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 927 ~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.....++.+++.+|++.||++||++.||++.|++.
T Consensus 338 --------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 --------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred --------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01135688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=324.51 Aligned_cols=258 Identities=28% Similarity=0.491 Sum_probs=207.6
Q ss_pred CCCCccccccccCCeeEEEEEECC------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
++|+..+.||+|+||.||+|.... ...||+|.+.... .......+.+|+..+++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468889999999999999998652 2579999885332 334456789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 756 ILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
+++|||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999975421 13578889999999999999999999 99999999999999999
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIV 901 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 901 (973)
+.++|+|||+++........ .......++..|+|||++.++.++.++|||||||++|||++ |..||... ...++.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~--~~~~~~ 236 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYY--RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF--SNQEVI 236 (283)
T ss_pred CcEEECCCcceeeccccccc--cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHH
Confidence 99999999998765433211 11223456788999999998899999999999999999998 99998753 223344
Q ss_pred HHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 902 RWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
+.+....... .....+.++.+++.+|++.||++||++.||+++|+.
T Consensus 237 ~~i~~~~~~~---------------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMIRSRQLLP---------------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcCC---------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 4433322110 011234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.97 Aligned_cols=251 Identities=34% Similarity=0.508 Sum_probs=195.6
Q ss_pred ccccccccCCeeEEEEEEC-----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 686 EQNLIGSGGSCRVYKVKLK-----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
..+.||.|.||.||+|.+. .+..|+||.+.. .......+.+.+|++.+++++||||+++++++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 356899999943 2344457789999999999999999999999998888999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.++++... ...+++..+.+|+.||++||+|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999998762 23589999999999999999999999 99999999999999999999999999987663222
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. .......+...|+|||.+....++.++||||||+++|||++ |+.||... ...++...+.+......+
T Consensus 158 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~------ 227 (259)
T PF07714_consen 158 KY--KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKLKQGQRLPIP------ 227 (259)
T ss_dssp SE--EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHHHTTEETTSB------
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccceec------
Confidence 11 11222346678999999999999999999999999999999 67887542 334444444333222111
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
......+.+++.+||+.+|++||+|.++++.|
T Consensus 228 ---------------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 ---------------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---------------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---------------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11235688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=320.23 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=206.7
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3568889999999999999999888899999988432 2335678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.++++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 82 YMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred cCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999987542 33578899999999999999999999 99999999999999999999999999998764322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. ......++..|+|||+..++.++.++|||||||++|||++ |..||... .......++......
T Consensus 158 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~--------- 223 (261)
T cd05072 158 YT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--SNSDVMSALQRGYRM--------- 223 (261)
T ss_pred ee---ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC--CHHHHHHHHHcCCCC---------
Confidence 11 1122345678999999988889999999999999999998 88888642 222333333221110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
+.. .....++.+++.+|++++|++||+++++.+.|+.
T Consensus 224 ------~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ------PRM------ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ------CCC------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 1123568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=328.55 Aligned_cols=273 Identities=23% Similarity=0.276 Sum_probs=200.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|...+.||+|+||.||+|+.+ +++.||+|++..... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 357889999999999999999987 789999999854322 223345678999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred ECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 9995 78888876542 2578889999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. .......++..|+|||++.+ ..++.++||||+||++|||++|+.||.... +.......+............+.
T Consensus 157 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 S----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK-DIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred C----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc-cHHHHHHHHHHHhCCCChhhccc
Confidence 1 12233567899999998765 457889999999999999999999997532 22222222211111100000000
Q ss_pred --cccccccCCCCC-CCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 --DLNQLIDPRMDL-STCD-------YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 --~l~~~~d~~l~~-~~~~-------~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.........+.. .... ......+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000000 0000 0112457789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=331.53 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=196.7
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
+.||+|+||.||+++.. +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 789999999854322 2233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccc
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 845 (973)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----~ 150 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----A 150 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC----C
Confidence 9998886543 588999999999999999999999 99999999999999999999999999987532221 1
Q ss_pred cccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccccc
Q 039922 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925 (973)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 925 (973)
......||+.|+|||++.++.++.++|||||||++|||++|+.||... +.....+.+......
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~~~~~~~~--------------- 213 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIR--------------- 213 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCC---------------
Confidence 223457899999999999999999999999999999999999999753 222222222111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 926 PRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 926 ~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
+. ......+.+++.+|+++||++|| ++.+++++
T Consensus 214 --~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 --FP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CC-----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 00 11235678999999999999998 89888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=329.90 Aligned_cols=242 Identities=23% Similarity=0.291 Sum_probs=194.3
Q ss_pred ccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
||+|+||.||+|+.. +++.||+|++.+.. ........+.+|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999986 68899999985432 2233445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccc
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~~ 150 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD----KT 150 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC----cc
Confidence 99987643 488999999999999999999999 999999999999999999999999999875432221 12
Q ss_pred cccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCC
Q 039922 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPR 927 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 927 (973)
....||+.|+|||++.+..++.++||||+||++|||++|+.||... ......+.+......
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--~~~~~~~~~~~~~~~----------------- 211 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--NVNEMYRKILQEPLR----------------- 211 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC--CHHHHHHHHHcCCCC-----------------
Confidence 3456899999999999999999999999999999999999999752 222222211111000
Q ss_pred CCCCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 039922 928 MDLSTCDYEEAEKVLNVALMCTSDFPINRPS---MRRVVEL 965 (973)
Q Consensus 928 l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~ 965 (973)
+ .......+.+++.+|+++||++||+ +.|++++
T Consensus 212 ~-----~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 212 F-----PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred C-----CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 0 0112356788999999999999974 6777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=331.35 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=197.5
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
++||+|+||.||+++.. +|+.||+|++.+... .......+.+|+.+++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999876 689999999964422 2334456788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccc
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 845 (973)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----~ 150 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----A 150 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----c
Confidence 9998886543 588999999999999999999999 99999999999999999999999999987532211 1
Q ss_pred cccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccccc
Q 039922 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925 (973)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 925 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... +.......+......
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~--~~~~~~~~~~~~~~~--------------- 213 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEDIK--------------- 213 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC--CHHHHHHHhccCCcc---------------
Confidence 223457899999999999999999999999999999999999999753 222222221111000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 926 PRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 926 ~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
+. .....++.+++.+|+++||++|| ++.|++++
T Consensus 214 --~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 --FP-----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00 11235678899999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=334.60 Aligned_cols=248 Identities=23% Similarity=0.266 Sum_probs=201.4
Q ss_pred cCCCCccccccccCCeeEEEEEECC--CCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKS--GETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.++|+..+.||+|+||.||+|+.+. +..||+|++..... .....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578889999999999999998653 36899999853321 22344567889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997643 488999999999999999999999 99999999999999999999999999997653
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.. .....||+.|+|||++.+..++.++||||+||++|||++|..||... +.....+.+......
T Consensus 183 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--~~~~~~~~i~~~~~~------- 246 (340)
T PTZ00426 183 TR-------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN--EPLLIYQKILEGIIY------- 246 (340)
T ss_pred CC-------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCC-------
Confidence 21 12357899999999999988999999999999999999999999753 222222222211100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
+. ......+.+++.+|++.||++|+ +++|++++
T Consensus 247 ------~p---------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 ------FP---------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CC---------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 01124567899999999999995 89998876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.13 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=207.2
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.+.|+..+.||+|.-|+||.++.+ ++..+|+|++.+.... .....+...|.++|+.++||.++.+|..|+.++..|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 456788899999999999999987 4589999999655432 33345677799999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||||+||+|....+.+. ...+++..++-.+.+|+.||+|||.. |||+|||||+||||-++|++-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999887764 34688888888999999999999999 999999999999999999999999999754321
Q ss_pred cC-------------------------------CCc---------------------cccccccccccCccccccccCCC
Q 039922 839 QE-------------------------------GQS---------------------DDAMSCVAGSYGYIAPEYAYTKK 866 (973)
Q Consensus 839 ~~-------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 866 (973)
.. ... ......++||-.|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 000 01123357999999999999999
Q ss_pred CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHH
Q 039922 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVAL 946 (973)
Q Consensus 867 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~ 946 (973)
.+.++|+|+|||++|||+.|..||.+.. ..+.+...+.+ .+..... ++....+.++|+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~-~~~Tl~NIv~~--------------------~l~Fp~~-~~vs~~akDLIr 369 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSN-NKETLRNIVGQ--------------------PLKFPEE-PEVSSAAKDLIR 369 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCC-chhhHHHHhcC--------------------CCcCCCC-CcchhHHHHHHH
Confidence 9999999999999999999999998742 22222222211 1111111 245678899999
Q ss_pred hccCCCCCCCCC----HHHHHHH
Q 039922 947 MCTSDFPINRPS----MRRVVEL 965 (973)
Q Consensus 947 ~cl~~dP~~Rps----~~evl~~ 965 (973)
+.+.+||.+|.. +.||.+|
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHhccChhhhhccccchHHhhcC
Confidence 999999999997 8888765
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.06 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=205.7
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35688889999999999999998888899999985332 235668899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997643 23589999999999999999999999 99999999999999999999999999998765221
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. ........+..|+|||+..+..++.++||||||+++|||++ |+.||... ........+......
T Consensus 158 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~--------- 223 (261)
T cd05068 158 Y---EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM--TNAEVLQQVDQGYRM--------- 223 (261)
T ss_pred c---cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC---------
Confidence 1 11111223468999999998899999999999999999999 88888642 222222222211100
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
. ........+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 -----~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -----P-------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----C-------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 001223568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.07 Aligned_cols=258 Identities=29% Similarity=0.455 Sum_probs=207.3
Q ss_pred CCCCccccccccCCeeEEEEEECC------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
++|...+.||+|+||.||+|+..+ ++.||+|++.... ..+..+.+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457888999999999999998643 4789999985332 233567899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc
Q 039922 756 ILVYEYMPNGSLADMLHEKGR-----------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV 824 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 824 (973)
++||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975431 23478889999999999999999999 9999999999999999999
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHH
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 903 (973)
++|+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||++ |..||... ......+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~--~~~~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL--SNEEVIEC 236 (280)
T ss_pred EEECCcccceecccCcce--ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHH
Confidence 999999998765332211 11122345688999999999999999999999999999998 99998653 23334444
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
+........+ ......+.+++.+|++.+|++||++.||++.|++
T Consensus 237 ~~~~~~~~~~---------------------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ITQGRLLQRP---------------------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHcCCcCCCC---------------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 3322211000 1123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.89 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=207.0
Q ss_pred CCCCccccccccCCeeEEEEEECC----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
++|+..+.||+|+||.||+|.++. ...||+|.+.... .......+.+|+..+++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 468889999999999999998752 4579999885432 34455678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++..... .+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999976432 588999999999999999999999 99999999999999999999999999998775
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
...... ......++..|+|||...+..++.++||||||+++|||++ |..||... ......+.+........
T Consensus 158 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~---- 229 (266)
T cd05033 158 DSEATY--TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM--SNQDVIKAVEDGYRLPP---- 229 (266)
T ss_pred ccccce--eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHcCCCCCC----
Confidence 222111 1112234678999999998999999999999999999998 99898642 23333333332211100
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.......+.+++.+|++.+|++||++.||+++|+..
T Consensus 230 -----------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 -----------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=359.53 Aligned_cols=486 Identities=25% Similarity=0.296 Sum_probs=401.1
Q ss_pred ceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEEC
Q 039922 73 SVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDL 152 (973)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L 152 (973)
++..|+++.+.+-...-+...+.-+|+.||||+|.+. .+|. .+..+.+|+.|+++.|.|. .+|.....+.+|++|.|
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~-~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL 98 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPI-QITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNL 98 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCc-hhhhHHHHhhcccchhhHh-hCchhhhhhhcchhhee
Confidence 3677888877654322233334445999999999987 6654 5788899999999999886 57789999999999999
Q ss_pred cCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccc
Q 039922 153 SRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIG 232 (973)
Q Consensus 153 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 232 (973)
.+|.+. ..|.++..+.+|++|+++.|++. .+|..+..++.++.+..++| .+. ..++... .+++++..|.+.+
T Consensus 99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N-~~~----~~lg~~~-ik~~~l~~n~l~~ 170 (1081)
T KOG0618|consen 99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNN-EKI----QRLGQTS-IKKLDLRLNVLGG 170 (1081)
T ss_pred ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcc-hhh----hhhcccc-chhhhhhhhhccc
Confidence 999998 78999999999999999999998 67999999999999999999 221 2233333 8899999999999
Q ss_pred cCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhc
Q 039922 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAA 312 (973)
Q Consensus 233 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 312 (973)
.++..+.+++. .|||.+|.+. --.+..+.+|+.|....|+++... -..++|+.|+.++|.++ .....+..
T Consensus 171 ~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~-~~~~~p~p 240 (1081)
T KOG0618|consen 171 SFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLT-TLDVHPVP 240 (1081)
T ss_pred chhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcce-eecccccc
Confidence 99999888877 7999999987 235778889999999999998431 23478999999999999 44444555
Q ss_pred ccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhc
Q 039922 313 MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIII 392 (973)
Q Consensus 313 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 392 (973)
.+|+.+++++|+++ .+|+++..+.+|+.++..+|+++ .+|..+...++|++|++.+|+++ -+|.....++.|+.|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 68999999999999 56699999999999999999997 89999999999999999999998 67778888999999999
Q ss_pred ccCccCCCCCCccCCcce-eeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCC
Q 039922 393 FNNRFSGKIPESYGECKT-LNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTG 471 (973)
Q Consensus 393 ~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~ 471 (973)
..|++....+..+.-... |+.|..+.|++....-..=..++.|+.|++.+|.++...-+.+.++..|+.|+|++|++..
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 999998544444444443 8899999999985553334457889999999999999999999999999999999999995
Q ss_pred CCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCC-CCcccc
Q 039922 472 EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGT-IPPELG 550 (973)
Q Consensus 472 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~ 550 (973)
.....+.++..|+.|+||+|+++ .+|.++..+..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+.. +|....
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC
Confidence 55567889999999999999999 89999999999999999999999 788 899999999999999999843 343333
Q ss_pred ccccccEEecCCCcCccccChhhhcc-cccceeccCC
Q 039922 551 NLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHN 586 (973)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N 586 (973)
-++|++|||++|.-.-.--..+..+ .+..+++.-|
T Consensus 475 -~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 475 -SPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred -CcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 2899999999998432222333344 4555555555
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=315.21 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=211.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888999999999999999987 89999999885432 22334667889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998865322 23578999999999999999999999 999999999999999999999999999876543
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.... .....++..|+|||+..+..++.++||||||+++|||++|+.||........+..+.+......
T Consensus 159 ~~~~----~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd08224 159 KTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-------- 226 (267)
T ss_pred CCcc----cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--------
Confidence 2211 1234578899999999988899999999999999999999999965332222222222111100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.. ........+.+++.+|++++|++||++.+|+++|++..
T Consensus 227 --------~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 --------PL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------CC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 01133457889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.80 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=203.5
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||.||.|+..++..||+|.+.... ...+.+.+|+..+++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 3577788999999999999998877789999885332 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.+++..... .+++..++.++.||+.|++|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 81 ~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 81 MSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999876432 589999999999999999999999 999999999999999999999999999876543221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.......++..|+|||+..+..++.++||||||+++|||++ |..||... ...+....+........
T Consensus 156 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~-------- 222 (256)
T cd05113 156 ---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF--NNSETVEKVSQGLRLYR-------- 222 (256)
T ss_pred ---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHhcCCCCCC--------
Confidence 11112345678999999988889999999999999999999 88888642 22233333322211100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
+ ......+.+++.+|++++|++||++.++++.|+
T Consensus 223 -----~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -----P--------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----C--------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 012467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=291.55 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=211.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|.+.+.+|+|-||.||.|+.+ ++..||+|++.++.. ....+.++++|+++.+.++||||.+++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 567899999999999999999876 678899999865432 234456789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
+||.++|.+...+.... ...+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..|++|||.+..-..
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999998532 34588888889999999999999999 999999999999999999999999999865431
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.......||.-|.|||...+..++.++|+|++|++.||++.|.+||.... ..+..+.+.+....
T Consensus 177 ------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~-------- 240 (281)
T KOG0580|consen 177 ------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLK-------- 240 (281)
T ss_pred ------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHcccc--------
Confidence 12345789999999999999999999999999999999999999998643 44444444433222
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
+| ........+++.+|+.++|.+|.+..||+++-.
T Consensus 241 ------~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 241 ------FP--------STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ------CC--------cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11 122456778999999999999999999998743
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.36 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=204.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|+..+.||+|+||.||+|... .++.||+|++.... .......+.+|+.+++.++|+||+++++++..++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 457889999999999999998753 35679999884332 23345668899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 755 NILVYEYMPNGSLADMLHEKGR-------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
.++||||+++|+|.+++..... ....++..+..++.|++.|++|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999875321 12367888999999999999999999 9999999999999999999999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 906 (973)
+|||+++......... ......++..|+|||++.++.++.++|||||||++|||++ |..||... ......+.+..
T Consensus 161 ~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--SNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCcceee--cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHc
Confidence 9999987654332211 1112345678999999998899999999999999999999 67787642 22333333322
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
......+ ......+.+++.+|++.+|++||++.|++++|++
T Consensus 237 ~~~~~~~---------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLDKP---------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCCCC---------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2111000 1123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=333.39 Aligned_cols=273 Identities=21% Similarity=0.236 Sum_probs=199.3
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----CeeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ-----DFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 756 (973)
+|+..++||+|+||.||+|+.. +|+.||+|++............+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999876 789999999864433334455688999999999999999999987543 2479
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||++ ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 78998886543 488999999999999999999999 9999999999999999999999999999765
Q ss_pred cccCCCccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
...... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.......+..
T Consensus 154 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHHhCCCCHH
Confidence 332211 112234578999999999865 678999999999999999999999996532 111122221111110000
Q ss_pred cc----cCcccccc---cCCCCCC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GC----CRDLNQLI---DPRMDLS--TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~----~~~l~~~~---d~~l~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. .....+.+ .+..... ..-+.....+.+++.+|++.||++||++.|++++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 00000000 0000000 0001123467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=332.03 Aligned_cols=250 Identities=28% Similarity=0.396 Sum_probs=195.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|+++++.++|+||+++++++..++..++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 346777889999999999999876 78999999985332 3344567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999986532 245677889999999999999999 9999999999999999999999999998765432
Q ss_pred CCCccccccccccccCccccccccC-----CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT-----KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.. ......||..|+|||++.. ...+.++|||||||++|||++|+.||.... ..+....+.........
T Consensus 222 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~- 294 (353)
T PLN00034 222 MD----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR--QGDWASLMCAICMSQPP- 294 (353)
T ss_pred cc----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CccHHHHHHHHhccCCC-
Confidence 21 1233578999999998743 234568999999999999999999997422 11211111111111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .......++.+++.+|++.||++||++.|++++
T Consensus 295 ------------~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ------------E-----APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------------C-----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001224568899999999999999999999987
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=333.83 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=204.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 753 (973)
.++|.+.++||+|+||.||+|+.. .+..||||++.... .....+.+.+|+++++++. ||||+++++++.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356888999999999999999853 23479999985432 3344567899999999996 999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCC---------------------------------------------------------
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR--------------------------------------------------------- 776 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 776 (973)
..|+||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864311
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC
Q 039922 777 ------------------------------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD 820 (973)
Q Consensus 777 ------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 820 (973)
...+++..+..++.|++.|++|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 12367788899999999999999999 999999999999999
Q ss_pred CCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchh
Q 039922 821 AEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKD 899 (973)
Q Consensus 821 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~ 899 (973)
+++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-~~~ 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-DST 348 (400)
T ss_pred CCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch-hHH
Confidence 9999999999998765432211 11222346788999999998899999999999999999997 8888865321 122
Q ss_pred HHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 900 IVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
....+...... . ........+.+++.+|++.+|++||++.+|.++|++.-
T Consensus 349 ~~~~~~~~~~~----------------~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGYRM----------------A-----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCCCC----------------C-----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 22222211100 0 00122457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.76 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=215.4
Q ss_pred CCCccccccccCCeeEEEEEECC-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++++.++||-|.||.||.|.|+. .-.||||.++. +....++|.+|..+|+.++|||+|+++++|..+..+|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 45677899999999999999873 55799999842 334567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
|..|+|.+|++...+. .++....+.|+.||+.||+||..+ ++|||||..+|+||.++..||++|||+++.+..+..
T Consensus 345 M~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999987543 567777899999999999999999 999999999999999999999999999999865432
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.+.....-.+.|.|||.+....++.|+|||+|||++||+.| |..||-+ .+..+++...+++.+-.-+.+|
T Consensus 421 ---TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG--idlSqVY~LLEkgyRM~~PeGC---- 491 (1157)
T KOG4278|consen 421 ---TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYGLLEKGYRMDGPEGC---- 491 (1157)
T ss_pred ---ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC--ccHHHHHHHHhccccccCCCCC----
Confidence 12222334578999999999999999999999999999999 6667643 2455666666666665555544
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
+.+++++++.||+++|..||+++|+-+.+|...+
T Consensus 492 -----------------PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 492 -----------------PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -----------------CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 4567899999999999999999999999887544
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=342.36 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=203.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-C-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-S-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
..|...+.||+|+||.||+|... + ++.||+|.+. .........+++|+.+++.++|||||++++++..++..|+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~--~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVM--LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcc--cCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34888999999999999999865 3 6788888763 223344566788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||+++|+|.++++... ....+++..+..++.||+.||+|+|+. +|+||||||+||++++++.+||+|||+++.+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999999886432 233578889999999999999999999 999999999999999999999999999986643
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+....+........
T Consensus 222 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~--~~~~~~~~~~~~~~~~~------ 291 (478)
T PTZ00267 222 SVS--LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP--SQREIMQQVLYGKYDPF------ 291 (478)
T ss_pred ccc--cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC------
Confidence 221 11223456899999999999999999999999999999999999999652 22333333222211100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.......+.+++.+|++.||++||++.+++++
T Consensus 292 ---------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 ---------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---------------CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01123568899999999999999999999754
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.53 Aligned_cols=272 Identities=28% Similarity=0.395 Sum_probs=204.1
Q ss_pred CCC-CccccccccCCeeEEEEEE-----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--C
Q 039922 682 PHL-TEQNLIGSGGSCRVYKVKL-----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--D 753 (973)
Q Consensus 682 ~~~-~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 753 (973)
++| +..+.||+|+||+||.+.. .+++.||+|.+.... .....+.+.+|++.+++++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 344 7889999999999988653 367889999985432 223456788999999999999999999987653 4
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..++||||+++++|.+++... .+++..++.++.|++.|++|||+. +++||||||+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 678999999999999998653 489999999999999999999999 9999999999999999999999999998
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+......... .......++..|+|||+..+..++.++||||||+++|||++|..|+........+...+...
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~------- 226 (283)
T cd05080 155 KAVPEGHEYY-RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG------- 226 (283)
T ss_pred cccCCcchhh-ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc-------
Confidence 8664332111 11112345667999999988899999999999999999999999986532211111111000
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+.+.++..... .........+.+++.+|++++|++||++++|++.|+..+
T Consensus 227 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 227 QMTVVRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccchhhhhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00001111122211111 011223467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.22 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=203.7
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.|...+.||+|+||.||+|..+ .++.||+|++... ......+.+|++.+++++|+||+++++++..++..++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 4677889999999999999876 5889999988432 23456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999987543 23588999999999999999999999 999999999999999999999999999877643221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||+..+..++.++|||||||++|||++ |..||... ...+..+.+......
T Consensus 160 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~~---------- 224 (263)
T cd05052 160 T---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKGYRM---------- 224 (263)
T ss_pred e---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCCC----------
Confidence 1 1112234568999999998999999999999999999998 88888642 222222222211100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.. .......+.+++.+|++.+|++||++.|+++.|+..
T Consensus 225 ------~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ------ER-----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------CC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00 011235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=343.87 Aligned_cols=259 Identities=23% Similarity=0.303 Sum_probs=206.7
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD---- 753 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 753 (973)
...++|.+.+.||+|+||+||+|+.. +|+.||+|++............+.+|+..+..++|+|++++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34468999999999999999999865 7999999999655555556677889999999999999999988775432
Q ss_pred ----eeEEEEeccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe
Q 039922 754 ----FNILVYEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828 (973)
Q Consensus 754 ----~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 828 (973)
..++||||+++|+|.++++.... ...+++..+..++.|++.||+|+|+. +|+||||||+||++++++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 36799999999999999875432 33588999999999999999999999 99999999999999999999999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+....
T Consensus 186 DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--~~~~~~~~~~~~~ 261 (496)
T PTZ00283 186 DFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--NMEEVMHKTLAGR 261 (496)
T ss_pred ecccCeeccccccc--cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHhcCC
Confidence 99999766433211 1223457999999999999999999999999999999999999999752 2222222211111
Q ss_pred ccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 909 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. + .......++.+++.+|++.+|++||++.+++++
T Consensus 262 ~~---------------~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YD---------------P------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC---------------C------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 0 001223568899999999999999999999875
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.73 Aligned_cols=259 Identities=28% Similarity=0.433 Sum_probs=205.7
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
.+|.+.+.||+|+||.||++... ++..||+|.+.. ........+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC--cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 45788899999999999999752 345689998843 2334556789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCce
Q 039922 756 ILVYEYMPNGSLADMLHEKG----------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP 825 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 825 (973)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999987543 123489999999999999999999999 99999999999999999999
Q ss_pred EEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHH
Q 039922 826 RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 826 kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 904 (973)
+|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||... ...+....+
T Consensus 160 kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~--~~~~~~~~i 235 (288)
T cd05093 160 KIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECI 235 (288)
T ss_pred EeccCCccccccCCcee--ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHH
Confidence 99999998765433211 11222345778999999998899999999999999999998 88888643 222233322
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
...... ... ......+.+++.+|++.+|.+|||+.||.+.|+...
T Consensus 236 ~~~~~~-----------~~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 TQGRVL-----------QRP----------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HcCCcC-----------CCC----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 221111 000 012346899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.92 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=208.3
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.+|+..++||+|+||.||+|..++++.+|+|.+... .......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 468889999999999999999988999999998433 233455688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999997643 34589999999999999999999999 999999999999999999999999999976643221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. .....++..|+|||...++.++.++||||||+++|+|++ |+.||... ...+..+.+........
T Consensus 160 ~----~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~-------- 225 (261)
T cd05148 160 L----SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM--NNHEVYDQITAGYRMPC-------- 225 (261)
T ss_pred c----ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC--CHHHHHHHHHhCCcCCC--------
Confidence 1 112345678999999988899999999999999999998 88888643 23333443332211100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.......+.+++.+|++.||++|||+.++++.|+.
T Consensus 226 -------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 -------------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01223567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.34 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=206.2
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
.+|...+.||+|+||.||+|+.. ++..+++|.+. .......+.+.+|++.+++++|+||+++++++..++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecC--CccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 35677889999999999999753 35568999883 33344456789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 756 ILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
++||||+++++|.+++..... ...+++..++.++.||+.|++|||++ +++||||||+||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999975421 23478999999999999999999999 99999999999999999
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIV 901 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 901 (973)
+.++|+|||++......... .......++..|+|||+..+..++.++||||||+++|||++ |+.||... ......
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~ 235 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--SNTEVI 235 (291)
T ss_pred CcEEECCCCcccccCCCcee--ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHH
Confidence 99999999998765433211 11223456788999999999999999999999999999999 99998653 222233
Q ss_pred HHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 902 RWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+.+...... +. ....+..+.+++.+|++++|++||++.+|++.|++..
T Consensus 236 ~~~~~~~~~-----------~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 ECITQGRVL-----------ER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHhCCCCC-----------CC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 322221111 00 0112356889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.05 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=207.3
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|++|.||+|+.+ +++.|++|.+..........+.+.+|++++++++|||++++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999876 689999999865444455667789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.++++... ...+++..++.++.|++.|++|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999997642 23688999999999999999999999 999999999999999999999999999876644322
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......|+..|+|||+..++.++.++||||||+++|||++|+.||... ........+......
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~----------- 219 (256)
T cd08529 157 ----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN--NQGALILKIIRGVFP----------- 219 (256)
T ss_pred ----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCC-----------
Confidence 122346788999999999999999999999999999999999999753 222223322221111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.........+.+++.+|++.+|++||++.+++++
T Consensus 220 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0001234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=325.81 Aligned_cols=200 Identities=27% Similarity=0.411 Sum_probs=174.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||.||++..+ +++.||+|.+.... .......+.+|++++++++|+||++++++|..++..++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 57899999999999999999887 68889999885432 33445678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... .+++..+..++.|++.|++|||+.. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999997643 4788899999999999999999741 69999999999999999999999999987653221
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCC
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPS 893 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 893 (973)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12346889999999999889999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.84 Aligned_cols=257 Identities=20% Similarity=0.289 Sum_probs=197.1
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.|+..+.||+|+||+||+|+.. +++.||+|++.+... .....+.+.+|++++++++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999875 688999999954322 23345678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987643 478888899999999999999999 99999999999999999999999999975432110
Q ss_pred CC-------------------------------------------ccccccccccccCccccccccCCCCCCCCChhhHH
Q 039922 841 GQ-------------------------------------------SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFG 877 (973)
Q Consensus 841 ~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 877 (973)
.. .........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 00001235799999999999988999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHh--ccCCCCCC
Q 039922 878 VVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALM--CTSDFPIN 955 (973)
Q Consensus 878 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~--cl~~dP~~ 955 (973)
|++|||++|+.||..... ......+...... . .+. +. .....++.+++.+ |..++|..
T Consensus 236 ~il~elltG~~Pf~~~~~--~~~~~~i~~~~~~---------~-~~~-~~-------~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP--TETQLKVINWENT---------L-HIP-PQ-------VKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred hHHHHHHhCCCCCcCCCH--HHHHHHHHccccc---------c-CCC-CC-------CCCCHHHHHHHHHHccCcccccC
Confidence 999999999999976321 1111111110000 0 000 00 0112455666766 55667777
Q ss_pred CCCHHHHHHH
Q 039922 956 RPSMRRVVEL 965 (973)
Q Consensus 956 Rps~~evl~~ 965 (973)
||++.|++++
T Consensus 296 R~~~~~~l~h 305 (381)
T cd05626 296 RNGADDIKAH 305 (381)
T ss_pred CCCHHHHhcC
Confidence 9999999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=324.47 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=201.6
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCC----EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.+|+..+.||+|+||.||+|++. +++ .||+|++... ......+.+.+|+.+++.++|+||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 35888999999999999999864 333 4899988532 2334556788999999999999999999998764 577
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+|+||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999986432 578899999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
....... ......++..|+|||++.+..++.++||||||+++|||++ |..||... ...++...+........
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~~--- 232 (316)
T cd05108 160 GADEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQ--- 232 (316)
T ss_pred cCCCcce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhCCCCCCC---
Confidence 5433211 1112234678999999999999999999999999999998 99998642 22233332222111100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
+ ......+.+++.+|++.+|++||++.++++.+...
T Consensus 233 ----------~--------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 233 ----------P--------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ----------C--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 01124578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.06 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=194.8
Q ss_pred ccccccCCeeEEEEEEC----CCCEEEEEEecCCCC--CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 688 NLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTH--KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+.||+|+||.||+++.. +++.||+|++.+... .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 578999999854321 223345577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.+++.... .+.+..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987543 477888889999999999999999 999999999999999999999999999865322211
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... +.......+......
T Consensus 156 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~--~~~~~~~~~~~~~~~----------- 218 (323)
T cd05584 156 ----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE--NRKKTIDKILKGKLN----------- 218 (323)
T ss_pred ----cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC-----------
Confidence 122356899999999999888999999999999999999999999753 222222222111100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
+. ......+.+++.+|++++|++|| ++.+++++
T Consensus 219 --~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 --LP---------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CC---------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 00 11134678999999999999999 78888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=312.66 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=199.3
Q ss_pred cccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 689 LIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
.||+|+||.||+|.++ +++.||+|++..........+.+.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 5788999998655444455677899999999999999999999885 45678999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccc
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 845 (973)
+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~- 153 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK- 153 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee-
Confidence 9999987543 588999999999999999999999 999999999999999999999999999987644332111
Q ss_pred cccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
......++..|+|||......++.++|||||||++|||++ |+.||... ......+.+.......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~i~~~~~~~------------- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--KGNEVTQMIESGERME------------- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCCCC-------------
Confidence 1112234578999999988889999999999999999998 99998753 2233333333221110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.. .....++.+++.+|+++||++||++++|++.|+..
T Consensus 219 ---~~-----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 ---CP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CC-----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 00 11235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=315.60 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=203.1
Q ss_pred CCccccccccCCeeEEEEEECC----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe-----
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF----- 754 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 754 (973)
|.+.+.||+|+||.||+|.... +..||+|++............+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998752 3679999986544444455678999999999999999999998866554
Q ss_pred -eEEEEeccCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 755 -NILVYEYMPNGSLADMLHEKG---RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 755 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 123588999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|+++.+....... ......++..|+|||+..+..++.++|||||||++|||++ |..||... ...+..+++.....
T Consensus 158 g~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV--ENHEIYDYLRHGNR 233 (273)
T ss_pred cceeecccccccc--ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC
Confidence 9998764332211 1112234678999999988899999999999999999999 88887542 23333343332211
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.. . .......+.+++.+|++.||.+||++.||++.|++.
T Consensus 234 ~~-----------~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LK-----------Q----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-----------C----------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0 012245788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.75 Aligned_cols=254 Identities=26% Similarity=0.302 Sum_probs=201.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.|+..++||+|+||+||++... +++.||+|++..... .......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999875 689999999854322 22234557789999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886532 23588999999999999999999999 99999999999999999999999999987653222
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. .....|+..|+|||++.+..++.++||||+||++|||++|+.||.... .....+.+.........
T Consensus 157 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~------- 222 (285)
T cd05605 157 T-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK--EKVKREEVERRVKEDQE------- 222 (285)
T ss_pred c-----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc--hhhHHHHHHHHhhhccc-------
Confidence 1 223468899999999998899999999999999999999999997532 11111112111111000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
.........+.+++.+|+++||++|| ++.+++++
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 -----------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01112345678999999999999999 88898765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.87 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=206.5
Q ss_pred CCCccccccccCCeeEEEEEECCC-CEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeE-Eec------CC
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSG-ETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMC-CSG------QD 753 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~------~~ 753 (973)
++++.+.|.+|||+.||.|.+..+ .+||+|++.. ..+..-+..++|+++|++|+ |+|||.+++. ... .-
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~--~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV--NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec--CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 456788999999999999998866 9999999843 35667778899999999998 9999999993 211 24
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
+++|.||||.+|+|-+++...... .+++.++++|+.|+++|+++||.. .|+|||||||-+|||++.+++.||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 678999999999999999865443 499999999999999999999996 567999999999999999999999999998
Q ss_pred hhccccCCCccc-----cccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH
Q 039922 834 KALQSQEGQSDD-----AMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 834 ~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 905 (973)
............ .-....-|+.|+|||++. +..+++|+||||+||++|-++....||+...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------- 262 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------- 262 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence 654322210000 011234689999999875 6688999999999999999999999998531
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
-..+++..+..... +.+...+.+||+.||++||++||++.+|++.+..+.
T Consensus 263 --------------~laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 263 --------------KLAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred --------------ceeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 01122222222222 567889999999999999999999999999887654
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.97 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=197.8
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGS 766 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 766 (973)
+.||+|+||.||+|+.+ +++.||+|.+... ...+....+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999876 7899999987533 234455678999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcccc
Q 039922 767 LADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA 846 (973)
Q Consensus 767 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 846 (973)
|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ...
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 152 (252)
T cd05084 80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--AST 152 (252)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccc--ccc
Confidence 999987543 2578999999999999999999999 999999999999999999999999999876432211 011
Q ss_pred ccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccccc
Q 039922 847 MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925 (973)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 925 (973)
......+..|+|||.+.++.++.++||||+|+++|||++ |..||... ........+......
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~--~~~~~~~~~~~~~~~--------------- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL--SNQQTREAIEQGVRL--------------- 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc--CHHHHHHHHHcCCCC---------------
Confidence 111223457999999999899999999999999999998 88888642 112222222111000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 926 PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 926 ~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.........+.+++.+|++.+|++||++.||.++|+.
T Consensus 216 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 216 ------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 0001224578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.86 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=201.6
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
+|+..+.||+|+||.||+|+++++..+|+|.+.... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 577889999999999999998878899999985332 23346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++........
T Consensus 82 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 82 ANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999875432 588999999999999999999999 9999999999999999999999999998765432111
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......++..|+|||...+..++.++||||||+++||+++ |..||... ...+....+......
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~----------- 220 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF--SNSEVVESVSAGYRL----------- 220 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHcCCcC-----------
Confidence 1111223467999999998999999999999999999999 78888642 222222222211100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
..+ .....++.+++.+|++.+|++||++.|+++.|.
T Consensus 221 --~~~--------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 --YRP--------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCC--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 000 113457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=316.91 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=203.7
Q ss_pred CCCCccccccccCCeeEEEEEE-----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL-----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
+.|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++|+||+++++++..++..|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4577788999999999999975 256789999985332 2344467889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 757 LVYEYMPNGSLADMLHEKGR--------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
+||||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853221 12478889999999999999999999 99999999999999999
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIV 901 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 901 (973)
+.+||+|||+++........ .......++..|+|||+..+..++.++||||||+++|||++ |..||... ......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~--~~~~~~ 236 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--SNQEVI 236 (283)
T ss_pred CcEEeccccccccccCCcce--ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHH
Confidence 99999999999876433211 11222345678999999988889999999999999999998 88888642 222333
Q ss_pred HHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 902 RWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
+.+....... .......++.+++.+|+++||++||++.+|.++|+.
T Consensus 237 ~~~~~~~~~~---------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQLLP---------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcCC---------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 3332211110 001123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.97 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=209.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..+.||+|+||.||+|... +++.||||.+.... ........+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999864 89999999885432 22334567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998874322 23588999999999999999999999 999999999999999999999999999876543
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
... ......|+..|+|||+..+..++.++||||||+++|||++|..||.....+.....+.+....
T Consensus 159 ~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 224 (267)
T cd08229 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD---------- 224 (267)
T ss_pred CCc----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC----------
Confidence 321 122346888999999999889999999999999999999999999653222222222211110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+... .......+.+++.+|++.+|++||||.+|++.+++.
T Consensus 225 ------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 ------YPPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ------CCCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00000 012345788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=329.89 Aligned_cols=244 Identities=22% Similarity=0.281 Sum_probs=196.5
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
+.||+|+||.||+++.. +|+.||+|++.+... .......+.+|+++++.++|+||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 789999999964322 2233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---- 150 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---- 150 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----
Confidence 9998886543 58899999999999999999997 6 99999999999999999999999999987532221
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~--~~~~~~~~i~~~~~~-------------- 214 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEIR-------------- 214 (325)
T ss_pred cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC--CHHHHHHHHhcCCCC--------------
Confidence 1223456899999999999999999999999999999999999999753 222222222111100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
+. .....++.+++.+|+++||++|+ ++.+++++
T Consensus 215 ---~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 ---FP-----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CC-----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00 11234678899999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=326.69 Aligned_cols=261 Identities=28% Similarity=0.404 Sum_probs=203.1
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec-CC
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG-QD 753 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~ 753 (973)
++|++.++||+|+||.||+|... +++.||+|++.... .....+.+.+|+.+++++ +|+||++++++|.. +.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 47889999999999999998643 35789999985332 223345677899999999 79999999998865 45
Q ss_pred eeEEEEeccCCCChhhhhhccCC---------------------------------------------------------
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR--------------------------------------------------------- 776 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 776 (973)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998864321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccC
Q 039922 777 -SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855 (973)
Q Consensus 777 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~ 855 (973)
...+++..+..++.||+.|++|||+. +|+||||||+||++++++.++|+|||+++.+...... .......++..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~~ 240 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDARLPLK 240 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--hhccCCCCCcc
Confidence 12578999999999999999999999 9999999999999999999999999999876433211 11222455678
Q ss_pred ccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCC
Q 039922 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCD 934 (973)
Q Consensus 856 y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 934 (973)
|+|||++.+..++.++||||+||++|||++ |..||.... ..+.....+...... .. +
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~------------~~-~-------- 298 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-IDEEFCRRLKEGTRM------------RA-P-------- 298 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC-ccHHHHHHHhccCCC------------CC-C--------
Confidence 999999999999999999999999999998 999986532 222222222221111 00 0
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 935 YEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 935 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.....++.+++.+|++.+|++||++.||+++|+...
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.00 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=194.8
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHH---hcCCCCCeeeEEeEEecCCeeEEE
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETL---GRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
|++.+.||+|+||.||+|... +|+.||+|++.+... .....+.+.+|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999876 689999999964321 122334556665554 567899999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|..+++.. .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999887542 589999999999999999999999 999999999999999999999999999865322
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||... +..+....+......
T Consensus 154 ~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~--~~~~~~~~i~~~~~~-------- 219 (324)
T cd05589 154 FG----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD--DEEEVFDSIVNDEVR-------- 219 (324)
T ss_pred CC----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC--------
Confidence 11 1223467899999999999999999999999999999999999999753 222222222221111
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
+. ......+.+++.+|++.||.+|| ++.+++++
T Consensus 220 ---------~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 ---------YP-----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---------CC-----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 00 11235577899999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=326.03 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=195.6
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|+.+ +++.||+|++.+... .....+.+.+|..++.++ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 688999999965432 223445677888888776 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|..++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---- 150 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---- 150 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----
Confidence 99998886543 588999999999999999999999 99999999999999999999999999987532221
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC---CchhHHHHHHHHhccCCCccccCccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG---ENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... .......++.........
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------- 222 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------- 222 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------
Confidence 112345789999999999999999999999999999999999999963211 111222233222222000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS------MRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~evl~~ 965 (973)
.+. ......+.+++.+|+++||++||+ +.|++++
T Consensus 223 -----~~p-----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 -----RIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -----CCC-----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 000 112356789999999999999998 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=334.73 Aligned_cols=257 Identities=25% Similarity=0.320 Sum_probs=204.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|...+.||+|+||+||+|+.. +|+.||+|++..... .......+.+|++++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999987 789999999964322 2244567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 3588999999999999999999999 9999999999999999999999999999766443
Q ss_pred CC-------------------------CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCC
Q 039922 840 EG-------------------------QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF 894 (973)
Q Consensus 840 ~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 894 (973)
.. ..........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 20 00011234568999999999999999999999999999999999999997532
Q ss_pred CCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 039922 895 GENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-MRRVVEL 965 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~ 965 (973)
.......+...... ..-+. .......+.+++.+|++ ||++||+ +.|++++
T Consensus 235 --~~~~~~~i~~~~~~------------~~~p~------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 --LQETYNKIINWKES------------LRFPP------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred --HHHHHHHHhccCCc------------ccCCC------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111110000 00000 00134667889999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.04 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=194.3
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
++||+|+||.||+|+.+ +++.||+|++.+... .....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999976 688999999854321 223345567788888776 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---- 150 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---- 150 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----
Confidence 99999887543 488999999999999999999999 99999999999999999999999999987532211
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... ......+.+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--~~~~~~~~i~~~~~~-------------- 214 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDEVV-------------- 214 (320)
T ss_pred CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCCC--------------
Confidence 1223457899999999999989999999999999999999999999753 223333332221100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM------RRVVEL 965 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 965 (973)
.+ ......+.+++.+|++.||++||++ .+++++
T Consensus 215 ~~--------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 YP--------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CC--------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 00 0123467889999999999999998 666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=330.18 Aligned_cols=240 Identities=26% Similarity=0.336 Sum_probs=193.5
Q ss_pred ccccccCCeeEEEEEE----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccC
Q 039922 688 NLIGSGGSCRVYKVKL----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
+.||+|+||.||+++. .+|+.||+|++............+.+|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 368899999996443333344567789999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc
Q 039922 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843 (973)
Q Consensus 764 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 843 (973)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999999986543 488999999999999999999999 999999999999999999999999999876533221
Q ss_pred cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 923 (973)
......|++.|+|||++.+..++.++|||||||++|||++|+.||... +.......+...... +
T Consensus 154 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--~~~~~~~~i~~~~~~---------~--- 217 (318)
T cd05582 154 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK--DRKETMTMILKAKLG---------M--- 217 (318)
T ss_pred --ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC--CHHHHHHHHHcCCCC---------C---
Confidence 123457899999999999888999999999999999999999999753 222222222211100 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 039922 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRR 961 (973)
Q Consensus 924 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 961 (973)
. ......+.+++.+|+++||++||++.+
T Consensus 218 -p---------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 -P---------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -C---------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 112356788999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=330.52 Aligned_cols=266 Identities=18% Similarity=0.198 Sum_probs=199.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
..+|+..+.||+|+||.||++.+. +++.||+|+.. ...+.+|++++++++||||+++++++..++..++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 357999999999999999999875 78899999652 234678999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
|++. ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9994 78888886543 478999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-----chhHHHHHHHHhccCCCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-----NKDIVRWVTEATLSSPER 914 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 914 (973)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.|+...... .......+...... ++.
T Consensus 236 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~-~p~ 311 (391)
T PHA03212 236 NA---NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT-HPN 311 (391)
T ss_pred cc---cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC-Chh
Confidence 11 1233457999999999999999999999999999999999999887543211 11111111111100 000
Q ss_pred ccc----Ccccccc----c---CCCCCC-CC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCC----RDLNQLI----D---PRMDLS-TC--DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~----~~l~~~~----d---~~l~~~-~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+ ..+.+.. . ...... .. ......++.+++.+|++.||++|||+.|++++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 0000000 0 000000 00 01234578899999999999999999999865
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.84 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=195.9
Q ss_pred ccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
||+|+||+||++..+ +|+.||+|++.+.... ....+.+..|++++++++|+||+++.+++..++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999876 7899999998543221 22335677899999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcccc
Q 039922 768 ADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA 846 (973)
Q Consensus 768 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 846 (973)
.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++..+..... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----~ 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----K 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc----c
Confidence 98875432 234589999999999999999999999 999999999999999999999999999876543321 1
Q ss_pred ccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccC
Q 039922 847 MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926 (973)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 926 (973)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...+.......
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~-~~~~~~~~~~~--------------- 216 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-E-NKELKQRILND--------------- 216 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-h-HHHHHHhhccc---------------
Confidence 223568999999999999999999999999999999999999997532111 1 11111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 927 RMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 927 ~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
... ........+.+++.+|++.||++|| ++++++++
T Consensus 217 ~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 217 SVT---YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCC---CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 000 0112345678999999999999999 77888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.61 Aligned_cols=257 Identities=25% Similarity=0.327 Sum_probs=199.6
Q ss_pred CccccccccCCeeEEEEEECCC-C--EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC------Cee
Q 039922 685 TEQNLIGSGGSCRVYKVKLKSG-E--TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------DFN 755 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 755 (973)
.+.+.||+|+||.||+|++.+. + .||+|.+..........+.+.+|++.++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999987643 3 689998865544455567788999999999999999999987432 246
Q ss_pred EEEEeccCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 756 ILVYEYMPNGSLADMLHEKG---RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
++||||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874322 223478999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
++.+...... .......+++.|+|||+..+..++.++||||||+++|||++ |+.||... ......+.+.......
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 159 SKKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENSEIYDYLRQGNRLK 234 (272)
T ss_pred ccccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCCC
Confidence 9876433211 11122345678999999999999999999999999999999 78888542 2233333332211100
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
. .......+.+++.+|++++|++|||+.|+++.|+..
T Consensus 235 -------------~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 235 -------------Q--------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------------C--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=327.15 Aligned_cols=272 Identities=23% Similarity=0.225 Sum_probs=201.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD---- 753 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 753 (973)
.+.++|+..+.||+|+||.||+++.. +|+.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45678999999999999999999875 6899999999655444555667889999999999999999999986543
Q ss_pred --eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 754 --FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 754 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
..|+||||++ +++.+.++. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 4699999996 566666543 377888899999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH-------
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV------- 904 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~------- 904 (973)
+++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||..... .......+
T Consensus 169 ~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~ 242 (359)
T cd07876 169 LARTACTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNKVIEQLGTPS 242 (359)
T ss_pred CccccccCc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCc
Confidence 987543221 12335689999999999999999999999999999999999999975321 11110000
Q ss_pred -----------HHHhccCCCccccCcccccccCC-CC-CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 905 -----------TEATLSSPERGCCRDLNQLIDPR-MD-LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 905 -----------~~~~~~~~~~~~~~~l~~~~d~~-l~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
...... .+........+....- .. ...........+.+++.+|++.||++|||+.|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 243 AEFMNRLQPTVRNYVEN-RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHHHhh-CCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000 0000000001111000 00 0001112245688999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.71 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=200.6
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..+.||+|+||.||+|+.. +|+.||||++..... .......+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999986 689999999954321 2234456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987643 488999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCcc----------------------------------ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc
Q 039922 840 EGQSD----------------------------------DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885 (973)
Q Consensus 840 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt 885 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11000 00112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHH
Q 039922 886 GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS---MRRV 962 (973)
Q Consensus 886 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ev 962 (973)
|..||.... .......+...... + ...+ . ......+.+++.+|+. +|.+|++ +.|+
T Consensus 235 G~~Pf~~~~--~~~~~~~i~~~~~~---------~-~~~~-~-------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 235 GYPPFCSDN--PQETYRKIINWKET---------L-QFPD-E-------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred CCCCCCCCC--HHHHHHHHHcCCCc---------c-CCCC-C-------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 999997532 22222222111100 0 0000 0 0113456788888996 8999998 9998
Q ss_pred HHH
Q 039922 963 VEL 965 (973)
Q Consensus 963 l~~ 965 (973)
+++
T Consensus 294 l~h 296 (364)
T cd05599 294 KSH 296 (364)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.17 Aligned_cols=254 Identities=25% Similarity=0.304 Sum_probs=198.1
Q ss_pred CCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCC--CchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCee
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTH--KPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 755 (973)
+|+..+.||+|+||.||+++.. +++.||+|++.+... .....+.+.+|+.+++.++ |++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 3778899999999999998763 688999999854321 2233456788999999995 89999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 488999999999999999999999 999999999999999999999999999876
Q ss_pred ccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||....... . ...+.......
T Consensus 155 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~-~~~~~~~~~~~--- 226 (332)
T cd05614 155 FLSEEKE---RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-T-QSEVSRRILKC--- 226 (332)
T ss_pred ccccCCC---ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-C-HHHHHHHHhcC---
Confidence 5332221 12235789999999998765 47889999999999999999999997532111 1 11111111110
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
++.+. ......+.+++.+|++.||++|| ++++++++
T Consensus 227 ----------~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 ----------DPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----------CCCCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00010 11235678899999999999999 78888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=347.11 Aligned_cols=263 Identities=23% Similarity=0.301 Sum_probs=203.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|++.++||+|+||.||+|... +|+.||+|++..... .....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999876 689999999964432 2334567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 760 EYMPNGSLADMLHEKGR--------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
||+++|+|.+++..... ....++..+++++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 12356778899999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCC--------------ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCc
Q 039922 832 LAKALQSQEGQ--------------SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN 897 (973)
Q Consensus 832 l~~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 897 (973)
+++........ .........||+.|+|||++.+..++.++||||+||++|||+||+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 99866211100 00112235699999999999999999999999999999999999999975321
Q ss_pred hhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhh
Q 039922 898 KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-SMRRVVELLRV 968 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~ 968 (973)
..... ......+. .. . ...+.+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus 237 ~ki~~---~~~i~~P~-----~~----~-------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 237 RKISY---RDVILSPI-----EV----A-------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhhh---hhhccChh-----hc----c-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 00000000 00 0 0012345678899999999999996 67777777765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=330.57 Aligned_cols=205 Identities=25% Similarity=0.354 Sum_probs=175.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..+.||+|+||+||+|+.. +++.||+|++.+... .......+.+|+.++.+++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999876 689999999954321 2233456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999987643 588999999999999999999999 9999999999999999999999999998765321
Q ss_pred CCCc-------------------------------cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCC
Q 039922 840 EGQS-------------------------------DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKR 888 (973)
Q Consensus 840 ~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~ 888 (973)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 001123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 039922 889 PNDP 892 (973)
Q Consensus 889 p~~~ 892 (973)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=312.50 Aligned_cols=254 Identities=30% Similarity=0.448 Sum_probs=203.6
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|++++++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 346888999999999999999988888999999854332 3456889999999999999999999875 456889999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.++++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+..+....
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 81 YMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999987542 23578999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. ......++..|+|||+..+..++.++||||||+++|||++ |..||... ...+..+.+......
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~--------- 222 (260)
T cd05070 157 YT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--NNREVLEQVERGYRM--------- 222 (260)
T ss_pred cc---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC---------
Confidence 11 1112235678999999988899999999999999999999 88888642 223333332221100
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.........+.+++.+|++++|++|||++++.+.|++
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001224568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=326.04 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=197.6
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCC-CCeeeEEeEEecCCeeEEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRH-GNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 759 (973)
+|+..+.||+|+||.||+|+.+ +++.||+|++.+... .....+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999876 578999999864322 22344567789999999976 46888999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887543 478899999999999999999999 9999999999999999999999999998643211
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......||..|+|||++.+..++.++||||+||++|||++|+.||... +..+....+......
T Consensus 155 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--~~~~~~~~i~~~~~~--------- 219 (324)
T cd05587 155 G----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQSIMEHNVS--------- 219 (324)
T ss_pred C----CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCC---------
Confidence 1 1223456899999999999999999999999999999999999999753 223333332221110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM-----RRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 965 (973)
+. .....++.+++.+|+++||.+|++. .++.++
T Consensus 220 --------~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 --------YP-----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --------CC-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 1123467889999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=325.97 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=195.4
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
++||+|+||.||+|+.+ +++.||+|++.+... .....+.+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 578999999854321 223345567788888866 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 150 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---- 150 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC----
Confidence 99998887543 478899999999999999999999 99999999999999999999999999987542221
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... ......+.+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~--~~~~~~~~i~~~~~~-------------- 214 (321)
T cd05591 151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD--NEDDLFESILHDDVL-------------- 214 (321)
T ss_pred ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC--------------
Confidence 1123356899999999999999999999999999999999999999753 223333332221110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-------SMRRVVEL 965 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-------s~~evl~~ 965 (973)
.+ .....++.+++.+|++.||++|| ++.+++++
T Consensus 215 ~p--------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YP--------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC--------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00 01134678899999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=324.09 Aligned_cols=243 Identities=24% Similarity=0.322 Sum_probs=192.1
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
++||+|+||.||+|+.+ +|+.||+|++.+... .....+....|..++... +|++|+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 688999999964321 122334556677777654 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----
Confidence 99999887543 478899999999999999999999 99999999999999999999999999986432211
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||..|+|||++.+..++.++||||+||++|||++|+.||... +.....+.+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~--~~~~~~~~~~~~~~~-------------- 214 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVDTPH-------------- 214 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC--------------
Confidence 1233457899999999999999999999999999999999999999753 223333322221110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR-RVVE 964 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 964 (973)
+. .....++.+++.+|++.||++||++. ++.+
T Consensus 215 ---~~-----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 215 ---YP-----RWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred ---CC-----CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 00 01234677899999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=323.35 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=196.6
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
++||+|+||.||+|+.+ +++.||+|++.+... .....+.+.+|..+++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999876 688999999965432 223345678899999888 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---- 150 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---- 150 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC----
Confidence 99998886543 589999999999999999999999 99999999999999999999999999986432211
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC---chhHHHHHHHHhccCCCccccCccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE---NKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.......||..|+|||++.+..++.++||||+||++|||++|+.||...... .....++...........
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------- 223 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-------
Confidence 1223457899999999999999999999999999999999999999642111 111222322222221000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS------MRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~evl~~ 965 (973)
+. ......+.+++.+|+++||++||+ +.|++++
T Consensus 224 ------~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 ------IP-----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ------CC-----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 00 112346788999999999999997 6787754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=322.58 Aligned_cols=243 Identities=24% Similarity=0.339 Sum_probs=190.1
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhc-CCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGR-VRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|..++.. .+||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 688999999864322 12233445556666664 4799999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---- 150 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----
Confidence 99999887543 488899999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+...... +
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~-------------~ 215 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE--DEDELFDSILNDRPH-------------F 215 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCC-------------C
Confidence 1223456899999999999989999999999999999999999999753 222222222111000 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR-RVVE 964 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 964 (973)
. .....++.+++.+|++.+|++||++. ++.+
T Consensus 216 ~---------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 P---------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C---------CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0 11234567899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=323.75 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=197.5
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 759 (973)
+|...+.||+|+||.||+|+.+ +++.||+|++.+... .....+.+..|..++..+ +|++|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3677889999999999999876 678999999864422 222334566777887777 5899999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 488999999999999999999999 9999999999999999999999999998753221
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+......
T Consensus 155 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~--~~~~~~~~i~~~~~~--------- 219 (323)
T cd05616 155 G----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVA--------- 219 (323)
T ss_pred C----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC---------
Confidence 1 1223456899999999999999999999999999999999999999753 233333333322111
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM-----RRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 965 (973)
+ ......++.+++.+|+++||++|++. .++.++
T Consensus 220 --------~-----p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 --------Y-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --------C-----CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0 01123567889999999999999974 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.83 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=199.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCC----EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
++|+..+.||+|+||.||+|++. +++ .|++|++... .......++..|+..+++++||||+++++++. ++..+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 45778899999999999999875 454 4777776322 12233456778888999999999999999875 45578
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+++||+++|+|.+++..... .+++..+..++.||+.|++|||+. +++||||||+||++++++.+||+|||.++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 89999999999999976432 589999999999999999999999 9999999999999999999999999999866
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
...... .......++..|+|||+..++.++.++||||||+++||+++ |..||... ......+.+.......
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~---- 231 (279)
T cd05111 160 YPDDKK--YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM--RPHEVPDLLEKGERLA---- 231 (279)
T ss_pred cCCCcc--cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCcCC----
Confidence 433221 11233456788999999998899999999999999999998 99898653 2233334333221110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+. .....+.+++.+|+..+|++||++.|+++.|+..
T Consensus 232 ---------~~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 232 ---------QPQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred ---------CCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 000 0123567889999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=322.62 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=192.2
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhc-CCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGR-VRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999976 578999999864321 12233445667777775 4899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----
Confidence 99999987542 478899999999999999999999 99999999999999999999999999986432211
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||..|+|||++.+..++.++||||+||++|||++|+.||... +..+..+.+...... +
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~i~~~~~~-------------~ 215 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--DEEELFQSIRMDNPC-------------Y 215 (316)
T ss_pred CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC-------------C
Confidence 1123356899999999999999999999999999999999999999753 223333333221110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR-RVVE 964 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 964 (973)
. ......+.+++.+|++.||++||++. ++.+
T Consensus 216 ~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 P---------RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred C---------ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0 01234578899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=316.16 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=202.8
Q ss_pred CCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.|...+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4677889999999999999864 35789999985332 2234566889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 757 LVYEYMPNGSLADMLHEKG-------------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
+++||+++++|.+++.... ....+++..+..++.|++.||+|+|+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 122478888999999999999999999 999999999999999999
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHH
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVR 902 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 902 (973)
.+||+|||+++........ .......+++.|+|||.+.++.++.++||||+||++|||++ |..||... ...+..+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVIE 237 (283)
T ss_pred ceEecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHH
Confidence 9999999998765433211 11223445788999999988899999999999999999998 77777542 2233333
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.+....... ........+.+++.+|++++|++||++.+|++.|+.
T Consensus 238 ~i~~~~~~~---------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVLP---------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcCC---------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 333221110 001223557899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=330.59 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=200.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.+.. ......+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 356888999999999999999876 68899999985432 1223345578899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998653 367888889999999999999999 999999999999999999999999999876543
Q ss_pred cCCCccccccccccccCccccccccCC----CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTK----KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+......
T Consensus 195 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~---- 265 (370)
T cd05596 195 NGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMDHKNS---- 265 (370)
T ss_pred CCc---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--HHHHHHHHHcCCCc----
Confidence 221 112335789999999998653 47889999999999999999999997532 12222222111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN--RPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~ 965 (973)
+ .+. ........+.+++.+|++.+|.+ ||++.|++++
T Consensus 266 --------~---~~~---~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --------L---TFP---DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------C---CCC---CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 000 00123467788999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.25 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=201.0
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+|...+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5888899999999999999876 789999999964432 23345668899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 82 YQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999997652 2588999999999999999999999 99999999999999999999999999997664332
Q ss_pred CCccccccccccccCcccccccc------CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAY------TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+......
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~~~~---- 227 (330)
T cd05601 157 MV---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--SAKTYNNIMNFQRF---- 227 (330)
T ss_pred ce---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--HHHHHHHHHcCCCc----
Confidence 21 122346899999999986 4567899999999999999999999997532 11111111111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....+ .......+.+++..|++ +|.+||++.+++++
T Consensus 228 ------~~~~~--------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 ------LKFPE--------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ------cCCCC--------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00000 01123567788899998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.80 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=204.2
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.+.|+..++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+|++++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34688889999999999999999899999999985332 23456889999999999999999999874 567899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999987543 33688999999999999999999999 99999999999999999999999999987654222
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......++..|+|||+.....++.++||||||+++||+++ |+.||... ...+....+.......
T Consensus 157 ~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~-------- 223 (260)
T cd05067 157 Y---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM--TNPEVIQNLERGYRMP-------- 223 (260)
T ss_pred c---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHcCCCCC--------
Confidence 1 11112345678999999998899999999999999999999 99998643 2233333332211110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.......++.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 -------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001123568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.61 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=200.2
Q ss_pred ccccccCCeeEEEEEEC--C--CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccC
Q 039922 688 NLIGSGGSCRVYKVKLK--S--GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
++||+|+||.||+|++. + +..||+|.+...... ...+.+.+|+.+++++.|+|++++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 47999999999999764 2 268999998544332 45667899999999999999999999876 456799999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc
Q 039922 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843 (973)
Q Consensus 764 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 843 (973)
+|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999997654 588999999999999999999999 99999999999999999999999999998765433211
Q ss_pred cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
.......++..|+|||...+..++.++||||||+++|||++ |+.||... +..+...++.......
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--~~~~~~~~~~~~~~~~----------- 218 (257)
T cd05060 153 -RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLESGERLP----------- 218 (257)
T ss_pred -ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCCcCC-----------
Confidence 11111224568999999998999999999999999999998 99998653 3344444443321110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
. .......+.+++.+|++.+|++||++.++++.|+.+.
T Consensus 219 --~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 --R--------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --C--------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 0112357889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.59 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=204.6
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 754 (973)
++|+..+.||+|+||.||++... ....||+|.+.... .......+.+|+++++++ +|+||+++++++..++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 46788899999999999999864 23679999885432 233445688999999999 79999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC
Q 039922 755 NILVYEYMPNGSLADMLHEKG-------------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA 821 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 821 (973)
.++||||+++|+|.++++... ....+++..++.++.|++.|++|||+. +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 999999999999999986431 223588999999999999999999999 9999999999999999
Q ss_pred CCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhH
Q 039922 822 EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDI 900 (973)
Q Consensus 822 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~ 900 (973)
++.+||+|||.++.+...... .......++..|+|||+..+..++.++|||||||++||+++ |..||... ...+.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~ 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYY--RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEEL 243 (293)
T ss_pred CCeEEeCccccccccccccce--eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC--CHHHH
Confidence 999999999999876433211 11112234678999999988899999999999999999998 88888642 22233
Q ss_pred HHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+.+...... . ........+.+++.+|++++|++||||.|+++.|+.+
T Consensus 244 ~~~~~~~~~~--------------~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKLLKEGYRM--------------E-------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHcCCcC--------------C-------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 3322221110 0 0011235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.57 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=194.0
Q ss_pred ccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
||+|+||.||+++.+ +|+.||+|++...... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999876 6899999998543222 22344566799999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccc
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~ 151 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----TI 151 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----ee
Confidence 988865432 2478899999999999999999999 99999999999999999999999999987654322 12
Q ss_pred cccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCC
Q 039922 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPR 927 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 927 (973)
....|+..|+|||++.+..++.++||||+||++|||++|+.||..... .............. . +.
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~--------~----~~-- 216 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE-KVAKEELKRRTLED--------E----VK-- 216 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHHHhhcc--------c----cc--
Confidence 234688999999999988899999999999999999999999964221 11111111111110 0 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 928 MDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 928 l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.. ......++.+++.+|+++||++||++.|+++..
T Consensus 217 ~~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 217 FE----HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cc----cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 00 011235678999999999999999997665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=325.00 Aligned_cols=239 Identities=25% Similarity=0.285 Sum_probs=188.3
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHH-HHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEI-ETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
++||+|+||+||+|+.+ +|+.||+|++.+... .......+.+|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 789999999854321 112223344444 456889999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---- 150 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----
Confidence 99999887543 578899999999999999999999 99999999999999999999999999986532221
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+..+.+...... +
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~-------------~ 215 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DTAEMYDNILNKPLR-------------L 215 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC--CHHHHHHHHHcCCCC-------------C
Confidence 1223456899999999999999999999999999999999999999753 222222222111100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 960 (973)
. ......+.+++.+|++.||++||++.
T Consensus 216 ~---------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 K---------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C---------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0 11245678999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=323.58 Aligned_cols=244 Identities=24% Similarity=0.334 Sum_probs=195.3
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|+.+ +++.||+|++.+... .......+.+|.++++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 588999999864321 223345567888888887 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 150 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---- 150 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----
Confidence 99998887543 589999999999999999999999 99999999999999999999999999986532221
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||... +.......+...... +
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~--~~~~~~~~i~~~~~~-------------~ 215 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD--DEDELFQSILEDEVR-------------Y 215 (318)
T ss_pred CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCC-------------C
Confidence 1122346899999999999999999999999999999999999999753 222222222211100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM-----RRVVEL 965 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 965 (973)
. ......+.+++.+|++.||.+||++ .+++++
T Consensus 216 ~---------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 P---------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred C---------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0 1123567899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.12 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=196.8
Q ss_pred cccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 689 LIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
.||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999764 35579999885432 3344567899999999999999999999886 45779999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccc
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 845 (973)
+|.+++.... ..+++..+.+++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......... .
T Consensus 80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~ 153 (257)
T cd05115 80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-K 153 (257)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce-e
Confidence 9999987532 3589999999999999999999999 99999999999999999999999999997654433211 1
Q ss_pred cccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
......++..|+|||+..++.++.++||||||+++||+++ |+.||... ...+....+.......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~------------- 218 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--KGPEVMSFIEQGKRLD------------- 218 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCCCCC-------------
Confidence 1112233578999999988889999999999999999996 99998753 2223333332221110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.......++.+++.+|++++|++||++.+|.+.|+..
T Consensus 219 --------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 --------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0012246778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.27 Aligned_cols=254 Identities=30% Similarity=0.430 Sum_probs=202.2
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..++||+|+||.||+|++.++..||+|++.... ...+.+.+|++++++++|+||+++++++. .+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 4688899999999999999998877789999985322 23456889999999999999999999875 4567999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.+++.... ...+++..+..++.|++.||+|+|+. +++||||||+||++++++.++|+|||.++.+.....
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999997542 23578999999999999999999999 999999999999999999999999999976643321
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||+..++.++.++||||||+++|||++ |..||.... .....+.+......
T Consensus 158 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~~~~~~~---------- 222 (262)
T cd05071 158 T---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYRM---------- 222 (262)
T ss_pred c---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHHhcCCCC----------
Confidence 1 1122346678999999988899999999999999999999 777776432 12222211110000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.........+.+++.+|++++|++||++.++++.|+..
T Consensus 223 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00123346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=331.99 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=197.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..+.||+|+||.||+++.+ +|+.||+|++.+... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36788899999999999999875 789999999854321 2233456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987543 478888999999999999999999 9999999999999999999999999998643211
Q ss_pred CCC-----------cc--------------------------------ccccccccccCccccccccCCCCCCCCChhhH
Q 039922 840 EGQ-----------SD--------------------------------DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSF 876 (973)
Q Consensus 840 ~~~-----------~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 876 (973)
... .. .......||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00 00012469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCC
Q 039922 877 GVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINR 956 (973)
Q Consensus 877 G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R 956 (973)
||++|||++|..||.... ..+....+...... ..+.+. ......+.+++.+|++ +|.+|
T Consensus 235 Gvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~----------~~~p~~--------~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN--SHETYRKIINWRET----------LYFPDD--------IHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred chhhhhhhcCCCCCCCCC--HHHHHHHHHccCCc----------cCCCCC--------CCCCHHHHHHHHHHhc-CHhhc
Confidence 999999999999997532 12222211111000 000000 0123457788889997 66665
Q ss_pred ---CCHHHHHHH
Q 039922 957 ---PSMRRVVEL 965 (973)
Q Consensus 957 ---ps~~evl~~ 965 (973)
+++.|++++
T Consensus 294 ~~r~~~~~~l~h 305 (377)
T cd05629 294 LGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHhcC
Confidence 599999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.38 Aligned_cols=253 Identities=30% Similarity=0.433 Sum_probs=202.3
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|...+.||+|++|.||+|....+..||+|++.... ...+.+.+|+.++++++|+|++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4577888999999999999998877889999874332 23456888999999999999999998875 4568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.++++... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999997642 23578999999999999999999999 999999999999999999999999999976543221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||...++.++.++||||||+++|||++ |..||... ...+..+++......
T Consensus 158 ~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~---------- 222 (260)
T cd05069 158 T---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--VNREVLEQVERGYRM---------- 222 (260)
T ss_pred c---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC----------
Confidence 1 1122345678999999998899999999999999999999 88888653 222333332221100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
. ........+.+++.+|++++|++||++++|++.|+.
T Consensus 223 ------~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ------P-----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ------C-----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 001234678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=327.64 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=198.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+++.+ +++.||+|++.+.. ......+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 457889999999999999999986 68899999985422 2223445678899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999998653 378888999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCccccccccccccCccccccccCC----CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTK----KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+.......
T Consensus 195 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~--- 266 (370)
T cd05621 195 TGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--LVGTYSKIMDHKNSL--- 266 (370)
T ss_pred CCc---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCccc---
Confidence 221 112345799999999998754 37889999999999999999999997532 122222111111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN--RPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~ 965 (973)
.+ . ........+.+++..|++.+|.+ |+++.|++++
T Consensus 267 -------~~-----p---~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 -------NF-----P---EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------CC-----C---CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 0 00122455678888899765544 8999999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.26 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=207.4
Q ss_pred CCCCccccccccCCeeEEEEEECC-----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-CCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS-----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-QDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 755 (973)
++|...++||+|+||.||+|...+ +..||+|++... ......+.+.+|+..+++++|+||+++++++.. +...
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 467888999999999999999875 688999988532 334456778899999999999999999998766 5778
Q ss_pred EEEEeccCCCChhhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 756 ILVYEYMPNGSLADMLHEKGRS-----GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
++++||+++++|.+++...... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764322 3588999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|+++.+...... .......++..|+|||+..+..++.++||||||+++||+++ |+.||... ...++..++.....
T Consensus 162 g~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~ 237 (280)
T cd05043 162 ALSRDLFPMDYH--CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYLKDGYR 237 (280)
T ss_pred CCcccccCCceE--EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHHHcCCC
Confidence 999866433211 11122345678999999988899999999999999999999 99998652 22333333332110
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
. .. .......+.+++.+|++.||++|||+.|+++.|+...
T Consensus 238 ~-------------~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 238 L-------------AQ--------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C-------------CC--------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 00 0112356789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.82 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=198.5
Q ss_pred ccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
++||+|+||.||+|...+++.||+|.+.... .......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4689999999999998889999999885432 334455688999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccc
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
.+++.... ..+++..+..++.|++.|+.|+|+. +++||||||+||++++++.+||+|||++......... ..
T Consensus 80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~---~~ 151 (250)
T cd05085 80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS---SS 151 (250)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc---cC
Confidence 99986543 2578999999999999999999999 9999999999999999999999999998754322111 11
Q ss_pred cccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccC
Q 039922 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 926 (973)
....++..|+|||+..++.++.++||||||+++||+++ |..||... ........+...... ..
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~--~~~~~~~~~~~~~~~-----------~~--- 215 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM--TNQQAREQVEKGYRM-----------SC--- 215 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCCCC-----------CC---
Confidence 11234567999999998899999999999999999998 88898643 222222222111100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 927 RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 927 ~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
.......+.+++.+|++.+|++||++.|+++.|+
T Consensus 216 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 -------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0112457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.43 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=207.6
Q ss_pred CCCccccccccCCeeEEEEEEC--CCC--EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK--SGE--TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+++..++||+|+||.|++|.|+ +|+ .||||.+....... ....|.+|+.+|-+|+|+|++|+||+..+ ....+|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 4566789999999999999886 343 68999996443332 56789999999999999999999999877 677899
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||.++.|+|.+.+++ .....+-......++.|||.||.||..+ ++||||+..+|+++-....|||+|||+++-+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999998 3344678888899999999999999999 999999999999999999999999999998877
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.+..+.. .....-.+.|+|||.+...+++.++|||+|||++|||+| |..||.+- ...++.+.+.++.+-..+
T Consensus 265 ned~Yvm-~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g~qIL~~iD~~erLpRP---- 337 (1039)
T KOG0199|consen 265 NEDMYVM-APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RGIQILKNIDAGERLPRP---- 337 (1039)
T ss_pred CCcceEe-cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--CHHHHHHhccccccCCCC----
Confidence 6654321 112334578999999999999999999999999999999 67788652 334455555433332222
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
+...++++++++.||..+|++|||+.+|.+.+
T Consensus 338 -----------------k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 338 -----------------KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -----------------CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 23467899999999999999999999997544
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.73 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=200.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCC--EEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGE--TVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
++|++.++||+|+||.||+|..+ ++. .+++|.++. .......+.+.+|++++.++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57888999999999999999876 333 478887742 22334456788999999999 79999999999999999999
Q ss_pred EEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc
Q 039922 758 VYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV 824 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 824 (973)
||||+++|+|.++++.... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999965321 12478899999999999999999999 9999999999999999999
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHH
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 903 (973)
+||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |..||... ...+....
T Consensus 158 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~--~~~~~~~~ 230 (297)
T cd05089 158 SKIADFGLSRGEEVYVK-----KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM--TCAELYEK 230 (297)
T ss_pred EEECCcCCCccccceec-----cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHH
Confidence 99999999864321110 111223457999999988889999999999999999997 99998653 22222222
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+...... ... ......+.+++.+|++.+|.+||++.++++.|+...
T Consensus 231 ~~~~~~~----------------~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 LPQGYRM----------------EKP-----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HhcCCCC----------------CCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111000 000 112356789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.86 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=214.2
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDF 754 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 754 (973)
..+.+.|+..+.||+|.||.||+++.+ +|+.+|+|.+.+.... ......+.+|+.+|++++ |||||.+.++|++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 455677889999999999999999987 4999999999655432 234567899999999998 9999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC----CceEEecc
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE----MVPRVADF 830 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Df 830 (973)
.++|||++.+|.|.+.+... .+++..+..++.|++.+++|+|+. ||+|||+||+|+|+... +.+|++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999998775 288999999999999999999999 99999999999999543 57999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
|++..... .......+||+.|+|||++....|+.++||||+|+++|.|++|..||.... .......+..+...
T Consensus 184 Gla~~~~~-----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~--~~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 184 GLAKFIKP-----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET--EFEIFLAILRGDFD 256 (382)
T ss_pred CCceEccC-----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC--hhHHHHHHHcCCCC
Confidence 99988755 233566899999999999999999999999999999999999999998642 22222222222211
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
+....+ +.....+.++++.|+..||.+|+|+.++++|-
T Consensus 257 -----------------f~~~~w-~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 257 -----------------FTSEPW-DDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred -----------------CCCCCc-cccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 111111 34467889999999999999999999999973
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.80 Aligned_cols=266 Identities=25% Similarity=0.342 Sum_probs=205.5
Q ss_pred cCCCCccccccccCCeeEEEEEECC-----------------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCee
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKS-----------------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 743 (973)
.++|+..+.||+|+||.||+|+..+ +..||+|++.... .....+.+.+|++++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578899999999999999987652 2468999885433 234566789999999999999999
Q ss_pred eEEeEEecCCeeEEEEeccCCCChhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCC
Q 039922 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGR--------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815 (973)
Q Consensus 744 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 815 (973)
++++++..++..++||||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999876431 12578999999999999999999999 9999999999
Q ss_pred CEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc--CCCCCCCC
Q 039922 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT--GKRPNDPS 893 (973)
Q Consensus 816 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~ 893 (973)
||++++++.++|+|||+++........ .......++..|+|||+..++.++.++|||||||++|||++ |..||...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred ceeecCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999998765432211 11223446778999999988899999999999999999998 66677542
Q ss_pred CCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 894 FGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
...+..+.+....... ....... .......++.+++.+|+++||++||++.||++.|++
T Consensus 238 --~~~~~~~~~~~~~~~~-------~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 --TDQQVIENAGHFFRDD-------GRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --ChHHHHHHHHhccccc-------cccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 2233333332221110 0000000 001123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=332.63 Aligned_cols=204 Identities=23% Similarity=0.334 Sum_probs=172.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.|+..++||+|+||.||+|+.. +++.||+|++.+... .......+.+|+.++++++|+||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999875 688999999854321 22344568889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987543 478888899999999999999999 99999999999999999999999999975321100
Q ss_pred C-------------------------------------------CccccccccccccCccccccccCCCCCCCCChhhHH
Q 039922 841 G-------------------------------------------QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFG 877 (973)
Q Consensus 841 ~-------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 877 (973)
. ..........||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 000011234689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCC
Q 039922 878 VVLMELVTGKRPNDP 892 (973)
Q Consensus 878 ~~l~elltg~~p~~~ 892 (973)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.26 Aligned_cols=271 Identities=26% Similarity=0.310 Sum_probs=196.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC---CCCCeeeEEeEEec-----CC
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV---RHGNVVKLLMCCSG-----QD 753 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 753 (973)
+|+..+.||+|+||.||+|+.+ +|+.||+|.+............+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 688999999864433333334455677766665 69999999998764 34
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 589888875432 3488999999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+....... .....|+..|+|||++.+..++.++||||+||++|||++|+.||.... ....+.. +.........
T Consensus 156 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~-~~~~~~~-~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQMA-----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGK-IFDLIGLPPE 228 (288)
T ss_pred ccccCccc-----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC-HHHHHHH-HHHHhCCCCh
Confidence 76543221 223567899999999999899999999999999999999999986532 1112222 1111111000
Q ss_pred ccccCcc---cccccCCC--CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDL---NQLIDPRM--DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l---~~~~d~~l--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+... ...+.+.. ......++....+.+++.+|+++||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 00000000 0000111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.79 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=203.8
Q ss_pred cCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+..+++++|+||+++++++...+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 467889999999999999998754 24589999885332 23344567889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 755 NILVYEYMPNGSLADMLHEKGR-------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
.++||||+++|+|.+++..... ....++..+..++.|++.|++|||+. +|+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 12356778899999999999999999 9999999999999999999999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 906 (973)
+|||+++........ .......++..|+|||...++.++.++|||||||++|||++ |..||... ..++..+.+..
T Consensus 161 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQVLKFVMD 236 (288)
T ss_pred CcCCccccccccccc--cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHc
Confidence 999998765433221 11122345678999999998899999999999999999999 77788642 22233332221
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.... . . .......+.+++.+|++++|++||++.|+++.++..
T Consensus 237 ~~~~-----------~-----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 GGYL-----------D-----Q-----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCC-----------C-----C-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1100 0 0 011235789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=329.51 Aligned_cols=271 Identities=21% Similarity=0.252 Sum_probs=199.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-----eeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD-----FNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 756 (973)
+|+..++||+|+||.||+++.. +|+.||+|++..........+.+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3677899999999999999975 7999999998654444445567889999999999999999999998776 789
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 68888775432 588999999999999999999999 9999999999999999999999999998765
Q ss_pred cccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
..... .......++..|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....+...........
T Consensus 154 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDES---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS--PIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCcc---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHcCCCCHHH
Confidence 33221 122334678999999998764 47899999999999999999999997532 1111111111100000000
Q ss_pred cc---Ccccc-ccc-----CCCC-CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CC---RDLNQ-LID-----PRMD-LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~---~~l~~-~~d-----~~l~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ..... +.. +... ..........++.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 00000 000 0000 000011124568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.45 Aligned_cols=272 Identities=22% Similarity=0.280 Sum_probs=201.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|++|.||+|+.. +++.||+|++............+.+|+.++++++|+|++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3677889999999999999876 689999999864433334456788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
++ ++|.+++........+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 78988887654445689999999999999999999999 99999999999999999999999999987553221
Q ss_pred CccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.......++..|+|||++.+. .++.++||||+||++|||++|+.||..... ............. +........
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~ 229 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE-IDQLFRIFRILGT--PTEDVWPGV 229 (285)
T ss_pred ---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCC--CChhhhhcc
Confidence 112234568899999987654 578899999999999999999999975321 1111111111110 000000000
Q ss_pred cccccC-----CCCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDP-----RMDLS---TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~-----~l~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....+. ..... ........++.+++.+|++.||++|||+.+|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00000 0001124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=323.90 Aligned_cols=242 Identities=25% Similarity=0.270 Sum_probs=189.1
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHH-HHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSE-IETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|+.+ +++.||+|++.+... .......+.+| ..+++.++|+||+++++++..++..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 678899999854321 11222333334 4457888999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+.+..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---- 150 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---- 150 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----
Confidence 99999987643 467888888999999999999999 99999999999999999999999999987543221
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... ......+.+...... +
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~-------------~ 215 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKPLQ-------------L 215 (325)
T ss_pred CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC--CHHHHHHHHHhCCcC-------------C
Confidence 1223457899999999999999999999999999999999999999752 222333332221111 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVV 963 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 963 (973)
. ......+.+++.+|+++||.+||++.+.+
T Consensus 216 ~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 K---------PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred C---------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0 11235678899999999999999876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.18 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=206.5
Q ss_pred CCCccccccccCCeeEEEEEECC---CC--EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKS---GE--TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..+..++||.|.||.||+|.+.+ |+ .||||.-+.... .+..+.|..|..+|+.++|||||+++|+|++. ..++
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 34567899999999999998753 33 488888765443 44577899999999999999999999999854 5689
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|||.++-|-|..|++..+. .++.......+.||+.||+|||+. .+|||||..+||||.....|||+|||+++++.
T Consensus 468 vmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999987654 588888899999999999999999 99999999999999999999999999999987
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.+..... +...-.+.|||||.+.-+.++.++|||.|||.+||++. |..||....+ .++.-.++++.+.+.+.
T Consensus 543 d~~yYka---S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN--sDVI~~iEnGeRlP~P~-- 615 (974)
T KOG4257|consen 543 DDAYYKA---SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN--SDVIGHIENGERLPCPP-- 615 (974)
T ss_pred ccchhhc---cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc--cceEEEecCCCCCCCCC--
Confidence 6553221 12234578999999999999999999999999999998 9999986432 23333333333332222
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
..+..+..++.+||+++|.+||.+.|+...|+.
T Consensus 616 -------------------nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 616 -------------------NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred -------------------CCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 335567889999999999999999999888865
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.10 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=202.5
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
.+|...++||+|+||.||++... ++..+|+|.+. .........+.+|++.+++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecC--cCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45777899999999999999642 45689999874 23344556789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 756 ILVYEYMPNGSLADMLHEKGR------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
++||||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 999999999999999875431 12478899999999999999999999 999999999999999999
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHH
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVR 902 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 902 (973)
.+||+|||++......... .......+++.|+|||+..+..++.++|||||||++|||++ |..||... ...+...
T Consensus 160 ~~kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~ 235 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL--SNTEAIE 235 (280)
T ss_pred CEEECCCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC--CHHHHHH
Confidence 9999999998755432211 11122335678999999999999999999999999999998 88888642 2222222
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.+....... . .......+.+++.+|++.||++||++.||.+.|+.
T Consensus 236 ~~~~~~~~~-------------~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQGRELE-------------R--------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCccCC-------------C--------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 222211100 0 01123567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.89 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=202.3
Q ss_pred CCCCccccccccCCeeEEEEEECC---------------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS---------------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 746 (973)
++|++.+.||+|+||.||.++... ...||+|++.... .......+.+|++++++++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 478889999999999999987642 2358999885432 334456789999999999999999999
Q ss_pred eEEecCCeeEEEEeccCCCChhhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCE
Q 039922 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGR---------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNI 817 (973)
Q Consensus 747 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 817 (973)
+++...+..++||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864321 12368889999999999999999999 999999999999
Q ss_pred EeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc--CCCCCCCCCC
Q 039922 818 LLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT--GKRPNDPSFG 895 (973)
Q Consensus 818 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~ 895 (973)
++++++.+||+|||++........ ........++..|+|||+..++.++.++|||||||++|||++ |..||...
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~-- 236 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL-- 236 (295)
T ss_pred EEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc--
Confidence 999999999999999876543221 111122345678999999998999999999999999999998 55666542
Q ss_pred CchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 896 ENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
...+....+....... . ...... ........+.+++.+|++++|++||++++|++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~-------~-~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 237 SDEQVIENTGEFFRNQ-------G-RQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ChHHHHHHHHHhhhhc-------c-ccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2223332222211110 0 000000 001123579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.31 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=204.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CC---CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SG---ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..|+..+.||+|+||.||+|+.+ ++ ..+|+|++.... .....+.+.+|++++++++|+|++++.+++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 45777899999999999999876 33 379999885332 23445678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999987543 3588999999999999999999999 99999999999999999999999999987664
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
...... ........+..|+|||+..++.++.++|||||||++|||++ |+.||... ...+....+...... +
T Consensus 159 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~--~~~~~~~~i~~~~~~-~---- 230 (268)
T cd05063 159 DDPEGT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM--SNHEVMKAINDGFRL-P---- 230 (268)
T ss_pred cccccc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC--CHHHHHHHHhcCCCC-C----
Confidence 332211 11111223457999999988899999999999999999998 99998653 222333333221100 0
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
........+.+++.+|++.+|++||++.+|++.|++.
T Consensus 231 ----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011235678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.24 Aligned_cols=258 Identities=26% Similarity=0.368 Sum_probs=205.8
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
++|+..+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.+++.++|+||+++++++...+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46788899999999999999875 24689999984332 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe
Q 039922 756 ILVYEYMPNGSLADMLHEKGR-------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 828 (973)
++||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999865321 22478889999999999999999999 99999999999999999999999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 907 (973)
|||+++.+...... .......++..|+|||...++.++.++|||||||++||+++ |..||... .......++...
T Consensus 162 dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFVIDG 237 (277)
T ss_pred CcccchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHHhcC
Confidence 99998766443221 11223446788999999988899999999999999999998 88888642 333344443321
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.... .. ......+.+++.+|++++|++|||+.|+++.|+.
T Consensus 238 ~~~~-----------~~----------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLD-----------LP----------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCC-----------CC----------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1110 00 0114578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.19 Aligned_cols=271 Identities=19% Similarity=0.250 Sum_probs=200.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|...+.||+|+||.||+|+.+ +++.||+|++..... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56888999999999999999876 688999999854332 2233457789999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 85 YLD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 996 58888876543 2478889999999999999999999 99999999999999999999999999987543222
Q ss_pred CCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC-
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR- 918 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 918 (973)
. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+...........++.
T Consensus 159 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 159 K----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST--VEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred c----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhh
Confidence 1 1223467899999998865 468899999999999999999999997532 2222222222111111100000
Q ss_pred -ccccccc---CCCCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 -DLNQLID---PRMDLS---TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 -~l~~~~d---~~l~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+..+ +..... ........++.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 000000 0001224567899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.20 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=202.2
Q ss_pred cCCCCccccccccCCeeEEEEEECC------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKS------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|...+.||+|+||.||+|...+ +..||+|.+... .....+..+.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3568888999999999999998763 567899987422 223445668899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC---ceEE
Q 039922 755 NILVYEYMPNGSLADMLHEKGR----SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM---VPRV 827 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 827 (973)
.++||||+++++|.++++.... ...+++..+++++.||+.|++|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999876432 12588999999999999999999999 999999999999998754 5999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 906 (973)
+|||+++.+...... ........+..|+|||+..+..++.++|||||||++|||++ |..||... ........+..
T Consensus 161 ~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~--~~~~~~~~~~~ 236 (277)
T cd05036 161 ADFGMARDIYRASYY--RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR--TNQEVMEFVTG 236 (277)
T ss_pred ccCccccccCCccce--ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHc
Confidence 999999876322211 11112233568999999999999999999999999999997 88888643 22233332221
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
..... . .......+.+++.+|++.+|++||++.+|+++|+.
T Consensus 237 ~~~~~----------------~-----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 GGRLD----------------P-----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCcCC----------------C-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11000 0 01123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.52 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=204.1
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.+...+|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++|+|++++++++..++..|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 344567889999999999999999865 78999999985433 234466889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 999999999999998643 478889999999999999999999 9999999999999999999999999998765
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ......|++.|+|||...+..++.++|||||||++|||++|+.||...... .....+. ....+.
T Consensus 167 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-~~~~~~~---~~~~~~--- 235 (296)
T cd06654 167 TPEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIA---TNGTPE--- 235 (296)
T ss_pred ccccc----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-HhHHHHh---cCCCCC---
Confidence 33221 122346888999999998888999999999999999999999999753221 1111111 101000
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ........+.+++.+|+.++|++||++.|++++
T Consensus 236 -----------~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 -----------LQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -----------CC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 011234567889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=311.11 Aligned_cols=273 Identities=29% Similarity=0.381 Sum_probs=200.5
Q ss_pred CCCccccccccCCeeEEEEEEC-----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCee
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDFN 755 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 755 (973)
.|+..+.||+|+||.||++..+ +++.||+|++.. ......+.+.+|++++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH--STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 5778899999999999998743 588999999843 334445678999999999999999999998754 3467
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 89999999999999987543 2589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
........ .......++..|+|||+..++.++.++||||||+++|||++|..|+.... ....+.+...... ..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~~~~~---~~ 230 (284)
T cd05081 158 LPQDKEYY-KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP---AEFMRMMGNDKQG---QM 230 (284)
T ss_pred ccCCCcce-eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc---hhhhhhccccccc---cc
Confidence 64332211 00111223456999999998899999999999999999999887764321 1110000000000 00
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
....+.+.+...... .........+.+++.+|++++|++||||.||++.|+.++
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 231 IVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred chHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000000111100000 001122457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=331.68 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=196.1
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|++++++++|+||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5888999999999999999876 689999999853221 12334567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999997643 478888899999999999999999 99999999999999999999999999975321000
Q ss_pred C---------------------------------------CccccccccccccCccccccccCCCCCCCCChhhHHHHHH
Q 039922 841 G---------------------------------------QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLM 881 (973)
Q Consensus 841 ~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 881 (973)
. ..........||+.|+|||++.+..++.++||||+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 0000112357999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC---C
Q 039922 882 ELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP---S 958 (973)
Q Consensus 882 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---s 958 (973)
||++|+.||.... ..+....+...... ...+. .......+.+++.+|+ .+|++|+ +
T Consensus 236 ell~G~~Pf~~~~--~~~~~~~i~~~~~~------------~~~~~------~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 236 EMLVGQPPFLADT--PAETQLKVINWETT------------LHIPS------QAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred ehhhCCCCCCCCC--HHHHHHHHhccCcc------------ccCCC------CCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 9999999997532 11111111110000 00000 0112344566777765 4999999 8
Q ss_pred HHHHHHH
Q 039922 959 MRRVVEL 965 (973)
Q Consensus 959 ~~evl~~ 965 (973)
+.|++++
T Consensus 295 ~~ell~h 301 (376)
T cd05598 295 ADEIKAH 301 (376)
T ss_pred HHHHhCC
Confidence 9999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.09 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=202.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCC----EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.+|+..++||+|+||+||+|++. +|+ .||+|++... ........+.+|+.+++.++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 46778899999999999999854 454 4899988533 233445678899999999999999999999875 4578
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
++|||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999999987643 2588999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
...... .......++..|+|||...+..++.++|||||||++|||++ |..||... ....+..++........+
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~~~-- 233 (279)
T cd05109 160 DIDETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDLLEKGERLPQP-- 233 (279)
T ss_pred ccccce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCcCCCC--
Confidence 432211 11112234678999999998899999999999999999998 88888642 233344444332111000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+.+++.+|++.||++||++.|+++.|+...
T Consensus 234 -------------------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 234 -------------------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112356789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=306.09 Aligned_cols=248 Identities=30% Similarity=0.412 Sum_probs=199.6
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe-cCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS-GQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 760 (973)
++|+..+.||+|+||.||++... |+.||+|.+... ...+.+.+|+.++++++|++++++++++. .++..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 36788899999999999999876 888999988422 23456889999999999999999999764 5567899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999876432 3478999999999999999999999 99999999999999999999999999987543221
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
....++..|+|||+..+..++.++|||||||++|||++ |+.||... ...+...++......
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~--------- 218 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKM--------- 218 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCC---------
Confidence 12234568999999998899999999999999999998 88888542 223333333221110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.. .......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 --~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 --DA----------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 00 01224578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.53 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=205.1
Q ss_pred CCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.+|++.+.||+|+||.||+|... .+..||+|.+.... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778899999999999999864 23479999885433 23445678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+..+.
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999997643 2578999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
...... .......++..|+|||+..++.++.++||||||+++||+++ |..||... ...+....+...... +
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~--~~~~~~~~~~~~~~~--~--- 229 (267)
T cd05066 158 DDPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM--SNQDVIKAIEEGYRL--P--- 229 (267)
T ss_pred ccccee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC--CHHHHHHHHhCCCcC--C---
Confidence 432211 11111223568999999998899999999999999999887 99998653 223333333322110 0
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
. ....+..+.+++.+|++++|++||+|.++++.|+..
T Consensus 230 ----------~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 ----------A------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----------C------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 011235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=324.54 Aligned_cols=271 Identities=21% Similarity=0.213 Sum_probs=201.6
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ----- 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 752 (973)
.+.++|+..+.||+|+||.||++... .++.||||++..........+.+.+|+.+++.++|+||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 35678999999999999999999875 688999999965544455566788999999999999999999987543
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
...|+||||++ +++.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999996 577777643 377888999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 172 ~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~ 244 (364)
T cd07875 172 LARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLGTP 244 (364)
T ss_pred CccccCCCC-----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCC
Confidence 997653321 1233568999999999999999999999999999999999999996532 111111111110000
Q ss_pred CC------------------ccccCcccccccCC-CC-CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PE------------------RGCCRDLNQLIDPR-MD-LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~------------------~~~~~~l~~~~d~~-l~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+ ........+..... .. ...........+.+++.+|++.||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000000000 00 000111124577899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.51 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=198.5
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..++||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 5778899999999999999864 78899999985432 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999997542 367888889999999999999999 99999999999999999999999999987653221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchh--HHHHHHHHhccCCCccccCc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD--IVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 919 (973)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||......... ...+........
T Consensus 150 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 216 (279)
T cd06619 150 -----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------- 216 (279)
T ss_pred -----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------
Confidence 22356889999999999989999999999999999999999999753221111 111111111000
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+.+. ......++.+++.+|++++|++||++.|++++-
T Consensus 217 -----~~~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 217 -----PPVLP----VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred -----CCCCC----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 00000 011235678999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.84 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=200.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++... .......+++|+.++++++|+||+++++++..++..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 356889999999999999999975 7889999998533 2234456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.++++... .+++..+..++.|++.|++|||+. +|+|||++|+||++++++.++|+|||++..+...
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 86 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999999887542 578999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.. ......|+..|+|||.+. ...++.++||||+||++|||++|+.||...... .....+. ...
T Consensus 160 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~-~~~-------- 225 (267)
T cd06646 160 IA----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMS-KSN-------- 225 (267)
T ss_pred cc----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeee-cCC--------
Confidence 21 122346888999999874 445788999999999999999999998643211 1111000 000
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
...+.... .......+.+++.+|++.+|++||+++++++++
T Consensus 226 ------~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 ------FQPPKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ------CCCCCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000100 012245788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=315.41 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=204.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC--------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK--------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 751 (973)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... .....+.+.+|+..++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 346778899999999999999742 34579999885332 234456788999999999 79999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEE
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 818 (973)
.+..++||||+++|+|.+++..... ...+++.++..++.||+.|++|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999975421 12478889999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCc
Q 039922 819 LDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGEN 897 (973)
Q Consensus 819 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 897 (973)
+++++.+||+|||.++.+...... .......++..|+|||+..+..++.++||||||+++|||++ |..||... ..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PV 245 (304)
T ss_pred EcCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CH
Confidence 999999999999999876433221 11122345678999999998899999999999999999998 77777542 22
Q ss_pred hhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 898 KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.+....+...... + ........+.+++.+|++.+|++||+|.||++.|+++.
T Consensus 246 ~~~~~~~~~~~~~--------------~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 246 EELFKLLKEGHRM--------------D-------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHHHcCCcC--------------C-------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 2233322211100 0 00122467888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=325.20 Aligned_cols=271 Identities=23% Similarity=0.224 Sum_probs=201.2
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ----- 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 752 (973)
...++|+..+.||+|+||.||++... .++.||+|++..........+.+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999875 688999999965554455566788899999999999999999988643
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
...|+||||++ +++.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 35699999996 567766643 378888999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 165 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~ 237 (355)
T cd07874 165 LARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTP 237 (355)
T ss_pred ccccCCCcc-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCC
Confidence 997653321 1233578999999999999899999999999999999999999997531 111111111100000
Q ss_pred C------------------CccccCcccccc-cCCCCC-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 P------------------ERGCCRDLNQLI-DPRMDL-STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~------------------~~~~~~~l~~~~-d~~l~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. +......+.... +..... ..........+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 000000000000 000000 01111234577899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.57 Aligned_cols=259 Identities=28% Similarity=0.476 Sum_probs=204.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|+..+.||+|+||.||+|... ++..||+|++.... .......+.+|+..+++++|+||+++++++..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 346888899999999999999864 46789999885332 33445678899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCC
Q 039922 755 NILVYEYMPNGSLADMLHEKGR-------------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 815 (973)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999974321 12467888999999999999999999 9999999999
Q ss_pred CEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCC
Q 039922 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSF 894 (973)
Q Consensus 816 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~ 894 (973)
||++++++.++|+|||++..+...... ........+..|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~- 236 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY--KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM- 236 (288)
T ss_pred heEecCCCceEECccccceecccCccc--cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 999999999999999998765433211 11112234567999999998899999999999999999998 77888642
Q ss_pred CCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 895 GENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
...+....+...... . .......++.+++.+|++.+|++||++.|+++.|++
T Consensus 237 -~~~~~~~~~~~~~~~-----------~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 -AHEEVIYYVRDGNVL-----------S----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -CHHHHHHHHhcCCCC-----------C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 222333332221110 0 001123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=322.37 Aligned_cols=239 Identities=24% Similarity=0.272 Sum_probs=187.2
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHH-HHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEI-ETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
++||+|+||.||+|+.. +|+.||+|++.+... .......+.+|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 688999999854321 122233444444 467889999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---- 150 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----
Confidence 99998886533 478888899999999999999999 99999999999999999999999999987532221
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... +.....+.+......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~-------------- 214 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DVSQMYDNILHKPLQ-------------- 214 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC--CHHHHHHHHhcCCCC--------------
Confidence 1223456899999999999889999999999999999999999999753 222222222111000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 960 (973)
........+.+++.+|++.||.+||++.
T Consensus 215 --------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 --------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0011235678999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.01 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=206.1
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|++.+.||+|+||.||+|..++++.||+|.+.... ...+.+.+|+..+++++|+||+++++++..+...++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45788899999999999999998888899999985332 334668899999999999999999999999899999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++++|||.+..+....
T Consensus 82 ~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999997643 23589999999999999999999999 99999999999999999999999999987664321
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......++..|+|||...+..++.++||||+|+++||+++ |+.||... ......+.+.......
T Consensus 158 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~~-------- 224 (261)
T cd05034 158 Y---TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--TNREVLEQVERGYRMP-------- 224 (261)
T ss_pred h---hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCC--------
Confidence 1 11112234568999999998899999999999999999999 89888542 2222333222211100
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
. .......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 225 -----~--------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 -----R--------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----C--------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 01113568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=311.35 Aligned_cols=260 Identities=27% Similarity=0.357 Sum_probs=203.6
Q ss_pred CCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
+|+..+.||+|+||.||+|... ....+|+|.+.... .......+.+|+..++.++||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3677899999999999999863 23568888875332 2334467889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCC
Q 039922 757 LVYEYMPNGSLADMLHEKGR---------------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 815 (973)
+||||+++|+|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 99999999999998864211 12478899999999999999999999 9999999999
Q ss_pred CEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCC
Q 039922 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSF 894 (973)
Q Consensus 816 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~ 894 (973)
||++++++.+||+|||+++......... ......++..|+|||+..+..++.++||||||+++|||++ |..||...
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~- 233 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYV--KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI- 233 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchh--cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-
Confidence 9999999999999999987654332211 1112335678999999988889999999999999999999 88888642
Q ss_pred CCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 895 GENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
..+.+..++...... ... ......+.+++.+|++++|++||++.|+++.|++...
T Consensus 234 -~~~~~~~~~~~~~~~----------------~~~-----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 -APERLFNLLKTGYRM----------------ERP-----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -CHHHHHHHHhCCCCC----------------CCC-----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 233333333221111 000 1123568899999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.34 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=199.8
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
|+..++||+|+||.||++... +++.||+|.+...... ....+.+.+|+.++++++|++++++++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 567788999999999999876 7899999998544322 22345577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999998865432 3588999999999999999999999 999999999999999999999999999875432221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch-hHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK-DIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||........ ............ .
T Consensus 158 -----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~- 223 (285)
T cd05630 158 -----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE--------E- 223 (285)
T ss_pred -----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh--------h-
Confidence 2234689999999999999999999999999999999999999975322111 111111000000 0
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
. .......+.+++.+|++.||++||| +.|++++
T Consensus 224 ---~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 ---Y---------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---c---------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0 0112345789999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.73 Aligned_cols=255 Identities=29% Similarity=0.371 Sum_probs=194.0
Q ss_pred ccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe-cCCeeEEEEecc
Q 039922 688 NLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS-GQDFNILVYEYM 762 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 762 (973)
+.||+|+||.||+|... ++..||+|++... ......+.+.+|+.+++.++|||++++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999864 2457999987422 22344567888999999999999999999775 455689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
.+|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.+......
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999975432 467788899999999999999999 9999999999999999999999999998765432211
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
.........++..|+|||+..+..++.++|||||||++|||++|+.|+.... ...+....+...... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~~~~~~~~---~-------- 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQGRRL---L-------- 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcCCCC---C--------
Confidence 1111122345678999999988899999999999999999999665543321 222333332211100 0
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.+ ...+..+.+++.+|++.+|++||++.||++.|+..-
T Consensus 223 --~~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 --QP--------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CC--------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 011346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.80 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=202.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc---hhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP---ETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+.|+..+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999875 68999999985432221 223568889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987543 478888999999999999999999 99999999999999999999999999987654
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
..... ........++..|+|||++.+..++.++||||+|+++|||++|+.||... +..............
T Consensus 156 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~------- 225 (263)
T cd06625 156 TICSS-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF--EAMAAIFKIATQPTN------- 225 (263)
T ss_pred ccccc-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc--chHHHHHHHhccCCC-------
Confidence 32211 11112345788999999999988999999999999999999999998643 111111111110000
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+ .......+.+++.+|++++|++||++.|++++
T Consensus 226 --------~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 --------PQL-----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------CCC-----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000 01223567889999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.91 Aligned_cols=246 Identities=27% Similarity=0.429 Sum_probs=199.7
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGS 766 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 766 (973)
-++|+|.||+||.|++. +...+|||.+. .......+-+.+|+..-++++|+|||+++|.+.+++..-+.||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIp--ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIP--EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecc--cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 37999999999999987 45679999984 3333445567889999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC-CCCceEEeccCcchhccccCCCc
Q 039922 767 LADMLHEKGRSGSL--DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD-AEMVPRVADFGLAKALQSQEGQS 843 (973)
Q Consensus 767 L~~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGl~~~~~~~~~~~ 843 (973)
|.+.++..= +++ .+.++--..+||++||.|||+. .|||||||-+||||+ -.|.+||+|||-++++..-..
T Consensus 659 LSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 659 LSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred HHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 999998642 344 6778888999999999999999 999999999999996 489999999999988754322
Q ss_pred cccccccccccCccccccccCC--CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYTK--KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
....+.||..|||||++.++ .|+.++|||||||++.||.||++||.........+.+ -+...
T Consensus 732 --~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyK----------- 795 (1226)
T KOG4279|consen 732 --CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYK----------- 795 (1226)
T ss_pred --cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hccee-----------
Confidence 23457899999999999865 5889999999999999999999999864322222221 11111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..|. ...+...+...++.+|+.+||..||++.++++.
T Consensus 796 --vHP~-----iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 796 --VHPP-----IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred --cCCC-----CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 1111 224567889999999999999999999998753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=312.96 Aligned_cols=255 Identities=33% Similarity=0.474 Sum_probs=201.4
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|+..+.||+|+||+||+++.. +++.||+|++..............+|+..+++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999987 5668999999655433333334456999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---- 150 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---- 150 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS----
T ss_pred ccccccccccccc---cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc----
Confidence 9999999998332 589999999999999999999999 999999999999999999999999999875411
Q ss_pred ccccccccccccCcccccccc-CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.........++..|+|||+.. +..++.++||||+|+++|+|++|..||... ...+....+........
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~--------- 219 (260)
T PF00069_consen 151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILKRPL--------- 219 (260)
T ss_dssp TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTHH---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhcccccc---------
Confidence 112334467889999999998 888999999999999999999999999853 11121221111111100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... .. ........+.+++.+|++.||++||++.+++++
T Consensus 220 --~~~-~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 220 --PSS-SQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --HHH-TT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --ccc-cc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00 000113789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=314.84 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=203.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC--------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK--------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 751 (973)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... .......+.+|+++++++ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 356888999999999999998753 23579999985432 234456688899999999 79999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEE
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 818 (973)
++..|+||||+++|+|.+++..... ...+++.++.+++.|++.|++|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999976421 12478899999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCc
Q 039922 819 LDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGEN 897 (973)
Q Consensus 819 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 897 (973)
+++++.+||+|||.++......... ......++..|+|||+..++.++.++||||+||++|||++ |..||... ..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--~~ 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PV 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhh--ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--CH
Confidence 9999999999999987654322111 0111234568999999998899999999999999999998 77887542 22
Q ss_pred hhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 898 KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+..+.+...... +. ......++.+++.+|++.+|++||+|.||++.|+.+
T Consensus 249 ~~~~~~~~~~~~~-----------~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 249 EELFKLLKEGHRM-----------DK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHHHHHHcCCCC-----------CC----------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 2333322211100 00 011235778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.00 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=200.6
Q ss_pred ccccccCCeeEEEEEECC--C--CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccC
Q 039922 688 NLIGSGGSCRVYKVKLKS--G--ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
++||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|+..+++++|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998753 3 36999998544332 556788999999999999999999999988 88999999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc
Q 039922 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843 (973)
Q Consensus 764 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 843 (973)
+++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++.+.......
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999976542 4689999999999999999999999 99999999999999999999999999998775433211
Q ss_pred cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
.. .....++..|+|||+..+..++.++|||||||++|||++ |..||... ...+....+......
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~------------ 219 (257)
T cd05040 155 VM-EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEGER------------ 219 (257)
T ss_pred ec-ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCc------------
Confidence 11 112456788999999998899999999999999999999 99998643 222333332221100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
... ....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LER--------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCC--------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000 0112457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=327.93 Aligned_cols=371 Identities=26% Similarity=0.363 Sum_probs=279.7
Q ss_pred CCCCCEEECcCCcCC-CCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHH
Q 039922 144 FANLQVLDLSRNNFS-GDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLEN 222 (973)
Q Consensus 144 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 222 (973)
|+-.+-.|+|+|.++ +..|.....+++++.|.|...++. .+|+.++.|.+|++|.+++|++.+ +-..+..|+.|+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~--vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS--VHGELSDLPRLRS 82 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh--hhhhhccchhhHH
Confidence 445667788888888 557888888888888888888887 568888888888888888888866 4567777888888
Q ss_pred HhhccCccc-ccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccc
Q 039922 223 LWAAKANLI-GEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNN 301 (973)
Q Consensus 223 L~l~~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 301 (973)
+.+..|++. .-+|+.+..+..|++||||+|+++ ..|..+..-+++-.|+|++|+|..+....+.+++.|-.||||+|+
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence 888888774 447888888888888999999888 678888888888888888888885544556778888888888888
Q ss_pred cCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeecccccc-CCCCCCccCCCCccceeeecccccccCCcc
Q 039922 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFS-GKLPDDLGKYSNLEYFDVSTNDFTGELPRF 380 (973)
Q Consensus 302 l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 380 (973)
+....|..-....|+.|.|++|.+.-.--..+..+++|+.|++++.+=+ ..+|..+..+.+|..+|||.|.+.
T Consensus 162 Le~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp------ 235 (1255)
T KOG0444|consen 162 LEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP------ 235 (1255)
T ss_pred hhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC------
Confidence 8754444434446777777777664332333444556666666664322 345556666666666666666554
Q ss_pred ccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcc
Q 039922 381 LCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLT 460 (973)
Q Consensus 381 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~ 460 (973)
..|+.+-++.+|+.|+|++|+|+.. ........+|+
T Consensus 236 -------------------~vPecly~l~~LrrLNLS~N~iteL-------------------------~~~~~~W~~lE 271 (1255)
T KOG0444|consen 236 -------------------IVPECLYKLRNLRRLNLSGNKITEL-------------------------NMTEGEWENLE 271 (1255)
T ss_pred -------------------cchHHHhhhhhhheeccCcCceeee-------------------------eccHHHHhhhh
Confidence 4556666666666666666666521 23345566777
Q ss_pred eEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccC-CCccccccccccceeeccccccccccCcccCccccceeeeeccC
Q 039922 461 GILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSG-HLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTN 539 (973)
Q Consensus 461 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (973)
+|++|.|+++ .+|..++.+++|+.|.+.+|+++- -+|..++++.+|+.+..++|.+. ..|+.++.+.+|+.|.|++|
T Consensus 272 tLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~N 349 (1255)
T KOG0444|consen 272 TLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHN 349 (1255)
T ss_pred hhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccc
Confidence 8888888887 889999999999999999998762 47899999999999999999998 99999999999999999999
Q ss_pred cccCCCCccccccccccEEecCCCcCccccChh
Q 039922 540 QLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLE 572 (973)
Q Consensus 540 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 572 (973)
++- ++|+.+.-|+.|+.|||..|.=- .+|+-
T Consensus 350 rLi-TLPeaIHlL~~l~vLDlreNpnL-VMPPK 380 (1255)
T KOG0444|consen 350 RLI-TLPEAIHLLPDLKVLDLRENPNL-VMPPK 380 (1255)
T ss_pred cee-echhhhhhcCCcceeeccCCcCc-cCCCC
Confidence 998 79999999999999999999765 44443
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=306.13 Aligned_cols=249 Identities=31% Similarity=0.451 Sum_probs=204.1
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 46788899999999999999876 89999999953322 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 82 MAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999976432 2589999999999999999999999 999999999999999999999999999986632211
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
...++..|+|||+..++.++.++||||||+++||+++ |..||... ...++...+......
T Consensus 158 -------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~---------- 218 (256)
T cd05039 158 -------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVEKGYRM---------- 218 (256)
T ss_pred -------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCC----------
Confidence 2234568999999988899999999999999999997 99888642 223333322221100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
+. ....+..+.+++.+|++.+|++||++.|++++|+.
T Consensus 219 -~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 -EA----------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CC----------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00 01124678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.80 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=199.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCC--EEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGE--TVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
++|+..+.||+|+||.||+|.++ ++. .+|+|.+... ........+.+|++++.++ +|+||+++++++..++..|+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46788899999999999999875 454 4577776422 2334456788999999999 89999999999999999999
Q ss_pred EEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc
Q 039922 758 VYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV 824 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 824 (973)
||||+++|+|.++++.... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975431 12578899999999999999999999 9999999999999999999
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHH
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 903 (973)
+||+|||++........ .....++..|+|||+..+..++.++|||||||++|||+| |..||... ...+....
T Consensus 163 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~ 235 (303)
T cd05088 163 AKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEK 235 (303)
T ss_pred EEeCccccCcccchhhh-----cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC--ChHHHHHH
Confidence 99999999863221110 111234567999999988889999999999999999998 99998643 22222222
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
+...... ... ......+.+++.+|++.+|++||++.+++++++++
T Consensus 236 ~~~~~~~----------------~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 LPQGYRL----------------EKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HhcCCcC----------------CCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2111000 000 01234578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.00 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=202.6
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.+|+..+.||+|+||.||++.+.+++.+|+|.+.... .....+.+|++++++++|++++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 3577788999999999999998878899999885332 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 81 MEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999987543 2578999999999999999999999 999999999999999999999999999876533211
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.......++.+|+|||...++.++.++||||+|+++|||++ |..||... ......+.+.....
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~----------- 219 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR--SNSEVVETINAGFR----------- 219 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC--CHHHHHHHHhCCCC-----------
Confidence 11112335678999999998899999999999999999998 88888642 22333332221110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
...+.. ....+.+++.+|++.+|++||++.||+++|.
T Consensus 220 --~~~~~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 --LYKPRL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 011111 1356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=306.64 Aligned_cols=251 Identities=30% Similarity=0.445 Sum_probs=204.3
Q ss_pred ccccccCCeeEEEEEECC----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccC
Q 039922 688 NLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
+.||+|+||.||+|.... +..||+|.+....... ..+.+.+|++.++.++|+|++++++++..++..++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 479999999999998864 7899999986443322 46778999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 764 NGSLADMLHEKGR------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 764 ~gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
+++|.+++..... ...+++..++.++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999987521 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.... ........++..|+|||......++.++||||+|+++|||++ |..||... ...+..+.+......
T Consensus 157 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~------ 226 (262)
T cd00192 157 DDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLRKGYRL------ 226 (262)
T ss_pred cccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC------
Confidence 4332 111233457789999999988899999999999999999999 58888653 333333333321110
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
. .......++.+++.+|++.+|++||++.|++++|+
T Consensus 227 -------~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -------P--------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------C--------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 00112467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=306.28 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=204.7
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++|+||+++.+++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3568889999999999999999888889999988432 2345678899999999999999999999877 77899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... ....++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999997643 33578899999999999999999999 99999999999999999999999999987654322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......++..|+|||++..+.++.++|||||||++||+++ |..||... +..+..+++......
T Consensus 157 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~--------- 222 (260)
T cd05073 157 Y---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGYRM--------- 222 (260)
T ss_pred c---ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhCCCCC---------
Confidence 1 11122345678999999998889999999999999999999 88888642 233333333221100
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
. ........+.+++.+|++++|++||++.++.+.|+.
T Consensus 223 --~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --P----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --C----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 001224568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.76 Aligned_cols=250 Identities=24% Similarity=0.308 Sum_probs=195.1
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|+.++.++ +|++|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 678999999965432 223445678899999888 599999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 150 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---- 150 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----
Confidence 99998886543 589999999999999999999999 99999999999999999999999999987532211
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-chhHHHHHHHHhccCCCccccCccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-NKDIVRWVTEATLSSPERGCCRDLNQL 923 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~ 923 (973)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+++.......+.. .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~--- 222 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-----I--- 222 (327)
T ss_pred CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-----C---
Confidence 1123457899999999999999999999999999999999999999643211 111122222222111100 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 039922 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM------RRVVEL 965 (973)
Q Consensus 924 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 965 (973)
. ......+.+++.+|+++||++|+++ .+++++
T Consensus 223 -----p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 -----P-----RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -----C-----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 0 1123557889999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=305.03 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=202.7
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-CCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-QDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 760 (973)
.|+..+.||+|++|.||+++.+ +++.||+|++..........+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999876 57899999986544444556678899999999999999999998764 446789999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999987642 23589999999999999999999999 99999999999999999999999999987664322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||+..++.++.++||||+|+++|||++|+.||... +.......+......
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--~~~~~~~~~~~~~~~---------- 220 (257)
T cd08223 157 D----MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--DMNSLVYRIIEGKLP---------- 220 (257)
T ss_pred C----ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcCCC----------
Confidence 1 123356789999999999999999999999999999999999998642 212221111111100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.........+.+++.+|++.+|++||++.|++++
T Consensus 221 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 -----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0012234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=304.61 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=206.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||.++.. +++.|++|++............+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998865 689999999865544455567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997643 33588999999999999999999999 999999999999999999999999999876543321
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......++..|+|||+..+..++.++||||+|+++|||++|..||... ...+....+......
T Consensus 157 ----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~~~~~~~~~~~~~~~----------- 219 (256)
T cd08221 157 ----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--NPLNLVVKIVQGNYT----------- 219 (256)
T ss_pred ----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCC-----------
Confidence 123356889999999998888899999999999999999999998653 222222222111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
........++.+++.+|++.+|++||++.|+++++
T Consensus 220 ----------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ----------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00012245688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=322.65 Aligned_cols=240 Identities=25% Similarity=0.280 Sum_probs=189.0
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHH-HHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIE-TLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|+.+ +|+.||+|++.+... .......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999876 789999999854321 1223344455544 57789999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 150 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---- 150 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----
Confidence 99998886543 588999999999999999999999 99999999999999999999999999987532221
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.......||..|+|||++.+..++.++||||+||++|||++|+.||... +..+..+.+...... +
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~~~~~~~~-------------~ 215 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--DVAEMYDNILHKPLV-------------L 215 (325)
T ss_pred CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC--CHHHHHHHHHcCCcc-------------C
Confidence 1223456899999999999999999999999999999999999999753 222222222111100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRR 961 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 961 (973)
. +.....+.+++.+|++.+|++||++.+
T Consensus 216 ~---------~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 R---------PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred C---------CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 0 112356778999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=321.96 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=202.7
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 754 (973)
++|...++||+|+||.||+|++. .++.||+|++.... .....+.+.+|++++.++. |||||++++++...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 45778899999999999999864 34689999996432 2233456889999999997 9999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC----------------------------------------------------------
Q 039922 755 NILVYEYMPNGSLADMLHEKGR---------------------------------------------------------- 776 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 776 (973)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe
Q 039922 777 -------------------------------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819 (973)
Q Consensus 777 -------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 819 (973)
...+++..+..++.|++.|++|||+. +++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 11356778889999999999999998 99999999999999
Q ss_pred CCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCch
Q 039922 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENK 898 (973)
Q Consensus 820 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 898 (973)
++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~-~~~ 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP-MNE 349 (401)
T ss_pred eCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-chH
Confidence 99999999999999765332211 11122356788999999998889999999999999999998 888886421 112
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.....+...... ..+ .....++.+++.+|++.+|++||+++||++.|++.
T Consensus 350 ~~~~~~~~~~~~-------------~~p--------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 QFYNAIKRGYRM-------------AKP--------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHcCCCC-------------CCC--------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 122211111000 000 11235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=318.61 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=193.1
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEe
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 760 (973)
|...+.||+|+||.||+|+.+ +|+.||+|++.+... .....+.+..|..+++.+. |++|+++.+++...+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 567789999999999999876 689999999854321 2233455777888888886 5778889999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999887543 488999999999999999999999 99999999999999999999999999987542221
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... ......+.+.......+
T Consensus 156 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--~~~~~~~~i~~~~~~~p-------- 221 (323)
T cd05615 156 ----VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE--DEDELFQSIMEHNVSYP-------- 221 (323)
T ss_pred ----ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC--------
Confidence 1123356899999999999989999999999999999999999999753 22333333332211100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM 959 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 959 (973)
......+.+++.+|++++|.+|++.
T Consensus 222 --------------~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 --------------KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --------------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1123457889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=311.04 Aligned_cols=253 Identities=26% Similarity=0.330 Sum_probs=199.8
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
|+..+.||+|+||+||+|... +++.||+|.+...... ......+.+|++++++++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 7899999998543222 22344577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998886543 23589999999999999999999999 99999999999999999999999999987543221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......|+..|+|||++.+..++.++||||+|+++|||++|..||.... .......+.........
T Consensus 157 ----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~--~~~~~~~~~~~~~~~~~-------- 222 (285)
T cd05632 157 ----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK--EKVKREEVDRRVLETEE-------- 222 (285)
T ss_pred ----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhhhcccc--------
Confidence 1223568999999999998899999999999999999999999997531 11111112221111000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
.+ .......+.+++..|++.||++||+ +.+++++
T Consensus 223 -~~---------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -VY---------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -cc---------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00 0112346788999999999999999 6777665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=310.37 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=203.0
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.|++.++||+||.+.||++...+.+.||+|++.....+......|..|+..|.+++ |.+||++++|-..++..|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 58899999999999999999998999999988666666777788999999999996 99999999999999999999996
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
= ..+|.+++...... ..+| .++.+..|++.|+.++|++ ||||.||||.|+++ -.|.+||+|||+|..+..+..
T Consensus 442 G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 442 G-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred c-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence 4 68999999876432 3345 6677889999999999999 99999999999887 356899999999998876543
Q ss_pred CccccccccccccCccccccccCC-----------CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTK-----------KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.. .....+||+.||+||.+... +.++++||||+|||+|+|+.|+.||.. ... .|.
T Consensus 515 sI--~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----~~n--~~a------ 580 (677)
T KOG0596|consen 515 SI--VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----IIN--QIA------ 580 (677)
T ss_pred ce--eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH----HHH--HHH------
Confidence 22 22346899999999987532 356899999999999999999999963 111 111
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+..+.||..+..........++.++++.|++.||.+||+..|++++
T Consensus 581 --------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 --------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12233444332222222222338999999999999999999999875
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.61 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=205.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
..|...+.||.|+||.||.+++. +.+.||||++..... ..+.-.++.+|+..+++++|||++.+-++|-.+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34777889999999999999876 778899999965543 3344567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||| -||-.+.+.-..+ ++.+..+..|..+.+.||+|||+. +.||||||.-|||+++.|.|||+|||.+..+.+.
T Consensus 106 EYC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 999 5788888876554 588889999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..++||+.|||||++. .+.|+-++||||+|++..|+...++|.... +....++....+..
T Consensus 180 --------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNes-------- 242 (948)
T KOG0577|consen 180 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNES-------- 242 (948)
T ss_pred --------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCC--------
Confidence 3479999999999986 578999999999999999999999998642 22222222221111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
|.+. ..+....+.+++..|+++-|.+|||..+++++-
T Consensus 243 ---------PtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 243 ---------PTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ---------CCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1111 245567899999999999999999999998863
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=311.29 Aligned_cols=265 Identities=25% Similarity=0.355 Sum_probs=201.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-----------------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-----------------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 744 (973)
++|+..+.||+|+||.||++... ++..||+|++... ........+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 46888999999999999998543 2346899988533 23344567899999999999999999
Q ss_pred EEeEEecCCeeEEEEeccCCCChhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCC
Q 039922 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGR--------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHN 816 (973)
Q Consensus 745 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 816 (973)
+++++..++..++||||+++|+|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999876431 12467889999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc--CCCCCCCCC
Q 039922 817 ILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT--GKRPNDPSF 894 (973)
Q Consensus 817 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~ 894 (973)
|++++++.++|+|||+++.+...... .......++..|+|||+..++.++.++|||||||++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~- 237 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL- 237 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc-
Confidence 99999999999999998765433211 11112234678999999888899999999999999999998 67787542
Q ss_pred CCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 895 GENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
...+............ . .....+.. ......+.+++.+|++.||++||++.||++.|++
T Consensus 238 -~~~~~~~~~~~~~~~~-------~-~~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 -SDEQVIENTGEFFRDQ-------G-RQVYLPKP------ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -ChHHHHHHHHHHHhhc-------c-ccccCCCC------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2222222111111110 0 00000000 1123678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=341.89 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=201.6
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDF 754 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 754 (973)
+...++|.+.+.||+|+||+||+|+.. +++.||+|.+............+..|+.++++++|||||+++++|.. .+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445678999999999999999999976 57789999886554445556778999999999999999999998854 457
Q ss_pred eEEEEeccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEEeCCCCCCEEeCC--------
Q 039922 755 NILVYEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCV----PAIVHRDVKSHNILLDA-------- 821 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dlkp~NIll~~-------- 821 (973)
.|+||||+++|+|.+++..... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999999875322 2358999999999999999999998521 25999999999999964
Q ss_pred ---------CCceEEeccCcchhccccCCCccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCC
Q 039922 822 ---------EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPN 890 (973)
Q Consensus 822 ---------~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~ 890 (973)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM-----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc-----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23489999999976533221 223568999999999854 45889999999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 891 DPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... . ....+...... + .+.. ......+.+++..||+.+|++||++.|++++
T Consensus 244 ~~~~-~---~~qli~~lk~~-p--------------~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKAN-N---FSQLISELKRG-P--------------DLPI----KGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCC-c---HHHHHHHHhcC-C--------------CCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 6431 1 11222211111 0 0000 1123568899999999999999999999853
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.38 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=204.5
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 754 (973)
++|...+.||+|+||.||++... ++..||+|++.... .....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 46788899999999999998742 35579999885432 234456789999999999 79999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.++||||+++|+|.++++... ...+++.++..++.|++.|++|||+. +++|+||||+||++++++.++++|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999997543 22479999999999999999999999 99999999999999999999999999987
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
........ .......++..|+|||.+.++.++.++||||+||++|||++ |..||.... ........+......
T Consensus 190 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~--- 263 (302)
T cd05055 190 DIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP-VDSKFYKLIKEGYRM--- 263 (302)
T ss_pred cccCCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC-chHHHHHHHHcCCcC---
Confidence 65433211 11122345678999999999999999999999999999998 888886432 222222222211100
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.. ......++.+++.+|++++|++||++.||++.|++.
T Consensus 264 ----------~~--------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 ----------AQ--------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------CC--------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 011235688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.66 Aligned_cols=272 Identities=24% Similarity=0.262 Sum_probs=203.5
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-C-----CCeeeEEeEEe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-H-----GNVVKLLMCCS 750 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~ 750 (973)
+.+-.+|.+.++||+|+||.|.+|.+. +++.||||+++... .-..+...|+.+|..++ | -|+|+++++|.
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 334447899999999999999999865 69999999995332 33344567999999986 4 39999999999
Q ss_pred cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC--CCceEEe
Q 039922 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA--EMVPRVA 828 (973)
Q Consensus 751 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~ 828 (973)
..++.|+|+|.+ ..+|.++++..... .++...++.|+.||+.||.+||+. +|||+||||+|||+.+ ...+||+
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEE
Confidence 999999999999 57999999877544 488999999999999999999999 9999999999999965 3479999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
|||.|...... ...+.-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|-++ .+.+++.. |.+..
T Consensus 334 DFGSSc~~~q~-------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~-ne~DQl~~-I~e~l 404 (586)
T KOG0667|consen 334 DFGSSCFESQR-------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD-NEYDQLAR-IIEVL 404 (586)
T ss_pred ecccccccCCc-------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC-CHHHHHHH-HHHHh
Confidence 99999865322 22456788999999999999999999999999999999997666442 22333322 22111
Q ss_pred ccCCC--------------c--cccC--cccc-----------------cccCCCC-C-----CCCCHHHHHHHHHHHHh
Q 039922 909 LSSPE--------------R--GCCR--DLNQ-----------------LIDPRMD-L-----STCDYEEAEKVLNVALM 947 (973)
Q Consensus 909 ~~~~~--------------~--~~~~--~l~~-----------------~~d~~l~-~-----~~~~~~~~~~l~~l~~~ 947 (973)
-..+. . +.+. ...+ ..+.... . ......+...+.+++++
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 11010 0 0000 0000 0000000 0 01112456688999999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 039922 948 CTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 948 cl~~dP~~Rps~~evl~~L 966 (973)
|+..||.+|+|+.|.++|=
T Consensus 485 ~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHP 503 (586)
T ss_pred HhccCchhcCCHHHHhcCc
Confidence 9999999999999998863
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.00 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=204.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CC---CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SG---ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..|+..+.||+|+||.||+|..+ ++ ..||+|.+.... .....+.+..|+..+++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 34677889999999999999875 33 369999885432 34456679999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||++++++.+|++|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 83 ITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999987643 3588999999999999999999999 99999999999999999999999999987654
Q ss_pred ccCCCccccccccc--cccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 838 SQEGQSDDAMSCVA--GSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 838 ~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
...... ....... .+..|+|||+..+..++.++||||+||++||+++ |..||... ...+...++........
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~--~~~~~~~~i~~~~~~~~-- 232 (269)
T cd05065 158 DDTSDP-TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVINAIEQDYRLPP-- 232 (269)
T ss_pred cCcccc-ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCCcCCC--
Confidence 332211 1011111 2457999999998999999999999999999987 99998653 23344444422111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
..+.+..+.+++.+|++++|++||++.+|++.|+..
T Consensus 233 -------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 -------------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=330.34 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=192.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-------
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------- 752 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 752 (973)
..+|+..++||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 356889999999999999999875 68999999884321 2245799999999999999999876432
Q ss_pred -CeeEEEEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEec
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVAD 829 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 829 (973)
...++||||++ +++.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 24679999997 57777765322 233588999999999999999999999 999999999999999765 699999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
||+++.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|..||.... ....+...+....
T Consensus 215 FGla~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~~ 288 (440)
T PTZ00036 215 FGSAKNLLAGQR-----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS-SVDQLVRIIQVLG 288 (440)
T ss_pred cccchhccCCCC-----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhC
Confidence 999987643321 2235689999999988654 68999999999999999999999997532 1222222221110
Q ss_pred ccCCCcc----ccCcccccccCCCCCCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 909 LSSPERG----CCRDLNQLIDPRMDLST----CDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 909 ~~~~~~~----~~~~l~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. +... ......++--+...... .......++.+++.+|+++||++|||+.|++++
T Consensus 289 -~-p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 -T-PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred -C-CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000 00000000000000000 001123578899999999999999999999865
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=309.24 Aligned_cols=262 Identities=26% Similarity=0.374 Sum_probs=202.8
Q ss_pred CCCccccccccCCeeEEEEEE-----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--Cee
Q 039922 683 HLTEQNLIGSGGSCRVYKVKL-----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFN 755 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 755 (973)
.|+..+.||+|+||.||.++. .+++.||+|.+.... .......+.+|++++++++|+|++++.+++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 467889999999999999974 357899999985332 234456789999999999999999999998775 567
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999865432 579999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC----------chhHHHHHH
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE----------NKDIVRWVT 905 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~----------~~~~~~~~~ 905 (973)
+....... .......++..|+|||+..++.++.++||||||+++|||++++.|....... ......++.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 159 IETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65433211 1122345677899999998889999999999999999999988765432110 001111111
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
...... ... ........+.+++.+|++.+|++||++.|+++.++.+
T Consensus 238 ~~~~~~---------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK---------------RLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc---------------cCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 110000 000 0012346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=313.01 Aligned_cols=272 Identities=20% Similarity=0.254 Sum_probs=201.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|...+.||+|+||.||+|+.+ +++.||+|.+..... ......+.+|+.++++++|+||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 356888999999999999999876 688999999853322 223345778999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||++ ++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 84 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9996 689988875432 578899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. .......++..|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....+...........+..
T Consensus 158 ~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 158 T----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST--VEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred C----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCChhhchh
Confidence 2 112234568899999987654 57889999999999999999999997532 2222222222211111111100
Q ss_pred ccc--cccc---CCCCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLN--QLID---PRMDLS---TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~--~~~d---~~l~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+. +... +..... .........+.+++.+|++.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0000 000000 0001123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=317.37 Aligned_cols=275 Identities=20% Similarity=0.246 Sum_probs=198.3
Q ss_pred cccccccc--CCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 686 EQNLIGSG--GSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 686 ~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
..++||+| +||+||+++.+ +|+.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 68899999875 7899999999655444455567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865422 2478999999999999999999999 9999999999999999999999999865443211110
Q ss_pred ---ccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc--
Q 039922 843 ---SDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG-- 915 (973)
Q Consensus 843 ---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 915 (973)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ....................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP-ATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHHhcCCccccccccch
Confidence 0011122356778999999876 458899999999999999999999997532 11111111110000000000
Q ss_pred ccCc-------------ccccc-----cC---CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRD-------------LNQLI-----DP---RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~-------------l~~~~-----d~---~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+ ..+.. .+ ..............+.+++.+|+++||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 00000 00 000001122335678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=305.30 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=201.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+++.. +++.||+|.+.... .....+.+.+|+.+++.++|+|++++++++.+++..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 3677899999999999999876 68899999985332 233456778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 80 CDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999886532 23578899999999999999999999 999999999999999999999999999876533221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......|+..|+|||+..+..++.++||||||+++|+|++|+.||... +.......+...... .
T Consensus 156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~--------~-- 219 (255)
T cd08219 156 ----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--SWKNLILKVCQGSYK--------P-- 219 (255)
T ss_pred ----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC--CHHHHHHHHhcCCCC--------C--
Confidence 122356888999999999888999999999999999999999999752 222222211111111 0
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+ .......+.+++.+|++.||++||++.|++..
T Consensus 220 --~---------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 --L---------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --C---------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 01123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.13 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=203.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+++.. +|+.||+|++..........+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 689999999864433344556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999887542 22478899999999999999999999 999999999999999999999999999876543221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......|+..|+|||+..++.++.++|||||||++|||++|+.||... +..+....+ .....+
T Consensus 157 ----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~~~~~~~~~---~~~~~~-------- 219 (256)
T cd08218 157 ----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLVLKI---IRGSYP-------- 219 (256)
T ss_pred ----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--CHHHHHHHH---hcCCCC--------
Confidence 112345788999999999889999999999999999999999998642 222222211 111000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ........+.+++.+|++.+|++||+|.||+++
T Consensus 220 -----~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -----P-----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -----C-----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 001224568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.49 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=202.8
Q ss_pred CCCCccccccccCCeeEEEEEEC--------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK--------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ 752 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 752 (973)
++|.+.+.||+|+||.||+|+.. ....||+|.+.... .......+.+|+.+++++ +|+||+++++++..+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 46788899999999999999752 24578999885432 234456688899999999 699999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 819 (973)
+..++||||+++|+|.+++..... ...+++.++.+++.|++.|++|||+. +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999975321 13478899999999999999999999 99999999999999
Q ss_pred CCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCch
Q 039922 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENK 898 (973)
Q Consensus 820 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 898 (973)
++++.+||+|||.++......... ......++..|+|||++.++.++.++||||||+++|||++ |..||... ...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--~~~ 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYK--KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PVE 243 (314)
T ss_pred cCCCcEEEcccccccccccccccc--ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC--CHH
Confidence 999999999999998664322111 1111234467999999999899999999999999999999 88888542 222
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+....+...... +. ......++.+++.+|++.+|++||++.|+++.|++..
T Consensus 244 ~~~~~~~~~~~~-----------~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 ELFKLLREGHRM-----------DK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHcCCCC-----------CC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 333332221100 00 0112346778999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.71 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=202.3
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCC----chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK----PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+|+..+.||+|+||.||+|...+|+.+|+|.+...... ......+.+|++.+++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788899999999999999888999999988543221 12235688899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997543 478899999999999999999999 999999999999999999999999999876532
Q ss_pred cCC--CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 839 QEG--QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 839 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... ..........|+..|+|||+..+..++.++||||+|+++|||++|+.||.... .......+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~------ 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD--RLAAMFYIGAHRGL------ 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC--hHHHHHHhhhccCC------
Confidence 211 11112233568899999999998889999999999999999999999996431 11111111111000
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+. ......+.+++.+|++.+|++||++.|++++
T Consensus 227 --------~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 --------MPRLP-----DSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --------CCCCC-----CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00010 1234567899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=305.59 Aligned_cols=253 Identities=26% Similarity=0.314 Sum_probs=204.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.|+.-++||+||||.||-++.+ +|+.||.|++.++.. ....+....+|..++++++.++||.+-.+|++.+..|+|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 4677789999999999998866 799999999865543 23445567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
.|.||+|.-++...+. .-+++..++-.+.+|+.||++||++ +||.||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 266 lMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred eecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999988877664 3588999999999999999999999 99999999999999999999999999999876554
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ....+||.+|||||++.++.|+...|+||+||++|||+.|+.||..-.+. .-.+-+...+...+.
T Consensus 342 ~-----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--vk~eEvdrr~~~~~~------- 407 (591)
T KOG0986|consen 342 P-----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--VKREEVDRRTLEDPE------- 407 (591)
T ss_pred c-----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--hhHHHHHHHHhcchh-------
Confidence 3 34468999999999999999999999999999999999999999752111 111112222222110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVE 964 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~ 964 (973)
.+...-.++...+.+..+++||++|. .++||.+
T Consensus 408 -----------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 408 -----------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred -----------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 11122345677888899999999997 4445544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=323.23 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=198.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.+.. ......+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999987 68899999985322 1223345678899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 122 ~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 122 MEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 9999999999998653 377888889999999999999999 999999999999999999999999999976543
Q ss_pred cCCCccccccccccccCccccccccCC----CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTK----KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||... +.......+......
T Consensus 195 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~---- 265 (371)
T cd05622 195 EGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNS---- 265 (371)
T ss_pred CCc---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCc----
Confidence 221 112345799999999998754 3788999999999999999999999753 212222211111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN--RPSMRRVVELL 966 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 966 (973)
..+.+ .......+.+++.+|++..+.+ |+++.|++++.
T Consensus 266 ------~~~~~--------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 ------LTFPD--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ------ccCCC--------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00000 0123456778889999844433 78999998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=309.62 Aligned_cols=263 Identities=29% Similarity=0.406 Sum_probs=204.9
Q ss_pred CCCCccccccccCCeeEEEEEEC-----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 754 (973)
+.|+..+.||+|+||.||+|+.. +++.||+|++...... ...+.+.+|++.++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 35677889999999999999854 4688999999544332 356779999999999999999999999877 567
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 8999999999999999976532 589999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchh----------HHHHH
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD----------IVRWV 904 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~----------~~~~~ 904 (973)
......... .......++..|+|||...+..++.++||||||+++|||++|+.|+......... ...+.
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDYY-YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccccCCcce-eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 765322211 1111234456799999998889999999999999999999999998653221100 11111
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.... . .... ........++.+++.+|++++|++||+|.||+++|+.+
T Consensus 237 ~~~~-~----------------~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLK-E----------------GERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHH-c----------------CCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1100 0 0000 00012236788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.14 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=207.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||+||+|... ++..+|+|++....... ..+.+.+|++.++.++|+|++++++.+..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 36888999999999999999865 68899999985443332 55678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
++++++|.++++.......+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999997643334689999999999999999999999 99999999999999999999999999988765443
Q ss_pred CCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
...........|+..|+|||++... .++.++|+||||+++|||++|+.||..... .....+.... . ++
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~---~-~~------ 225 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQN---D-PP------ 225 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcC---C-CC------
Confidence 3211122335688999999998876 788999999999999999999999975321 1112221111 0 00
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+............+.+++.+|++.||++||++.|++++
T Consensus 226 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 -------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000011334678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=295.28 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=205.3
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|.++.++|+|+||.||++..+ +|+.+|+|++. .....+++.+|+.+|++.+.+++|++||.|......++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP----V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP----VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecC----ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 677889999999999999865 79999999882 3455677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
..|+..+.++...+ ++.+.++..+++..+.||+|||.. .-+|||||.-|||++.+|.+||+|||.+-.+.....
T Consensus 111 GAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 111 GAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 99999999987543 799999999999999999999998 889999999999999999999999999865533221
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
....+.||+.|||||++..-.|..++||||+|++..||..|++||..-.+... +. ...-.++
T Consensus 185 ---KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-IF-----MIPT~PP--------- 246 (502)
T KOG0574|consen 185 ---KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-IF-----MIPTKPP--------- 246 (502)
T ss_pred ---hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-eE-----eccCCCC---------
Confidence 12347899999999999999999999999999999999999999975321100 00 0000011
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
|.++ ...+...++-++++.|+-+.|++|.|+.++++|-
T Consensus 247 ---PTF~---KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 247 ---PTFK---KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred ---CCCC---ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 1111 1123466899999999999999999999998863
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=321.81 Aligned_cols=270 Identities=20% Similarity=0.234 Sum_probs=198.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ----- 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 752 (973)
++.++|+..+.||+|+||.||+|... +++.||||++..........+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999875 788999999865443334455677899999999999999999887543
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
...|+++|++ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 78998877532 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+++..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||.... ....+..+. .....
T Consensus 164 ~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~-~~~~~ 234 (343)
T cd07878 164 LARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND-YIDQLKRIM-EVVGT 234 (343)
T ss_pred cceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHH-HHhCC
Confidence 98765322 223568999999999876 568899999999999999999999996431 111122211 11111
Q ss_pred CCCccc----cCcccccccC--CCCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGC----CRDLNQLIDP--RMDLS---TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~----~~~l~~~~d~--~l~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+... .......+.. ..... ..-......+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000 00000 0000112357899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=324.28 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=196.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.|+..+.||+|+||.||+|+.+ +++.||+|++.... ........+.+|+.++..++|++|+++++++.+++..|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5788899999999999999876 68999999985332 122344567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 82 FLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999987543 488999999999999999999999 99999999999999999999999999987543211
Q ss_pred CC-------------------------------ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCC
Q 039922 841 GQ-------------------------------SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889 (973)
Q Consensus 841 ~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 889 (973)
.. .........||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 00011235799999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 039922 890 NDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS---MRRVVEL 965 (973)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~ 965 (973)
|.... .......+...... + .+.+. .....++.+++.+|+ .||++|++ +.|+++|
T Consensus 236 f~~~~--~~~~~~~i~~~~~~---------~--~~p~~-------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSET--PQETYRKVMNWKET---------L--VFPPE-------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCC--HHHHHHHHHcCCCc---------e--ecCCC-------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 97532 12221111110000 0 00000 012345667777766 49999984 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.43 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=197.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++.+.....||+|+||.||+|++. +++.||+|.+... .....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 445556678999999999999865 6788999988433 3345567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~~ 838 (973)
||+++++|.+++.........++..+..++.||+.|++|||+. +|+||||||+||+++. ++.++|+|||.+.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999997643221237888899999999999999999 9999999999999986 67999999999876543
Q ss_pred cCCCccccccccccccCccccccccCCC--CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKK--VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... ......|+..|+|||+..+.. ++.++||||+|+++|||++|+.||..... .....+.......
T Consensus 162 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~--~~~~~~~~~~~~~------ 229 (268)
T cd06624 162 INP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE--PQAAMFKVGMFKI------ 229 (268)
T ss_pred CCC----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC--hhhhHhhhhhhcc------
Confidence 221 122345789999999986543 78899999999999999999999864321 1111111110000
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+ ......++.+++.+|++.+|++||++.|++++
T Consensus 230 --------~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 --------HPEI-----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------CCCC-----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000 11234567899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=316.84 Aligned_cols=257 Identities=21% Similarity=0.249 Sum_probs=195.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..+.||+|+||.||+++.. +++.||+|++.+.. ......+.+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999976 68999999985321 12233456888999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997532 2578899999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCccccccccccccCccccccccC-----CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT-----KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
... ......||+.|+|||++.. +.++.++||||+||++|||++|+.||... ...+....+......
T Consensus 156 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~--~~~~~~~~i~~~~~~---- 226 (331)
T cd05597 156 GTV---QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEH---- 226 (331)
T ss_pred CCc---cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCc----
Confidence 211 1122468999999999863 45788999999999999999999999742 111111111110000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSD--FPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~--dP~~Rps~~evl~~ 965 (973)
..+.+ ........+.+++.+|+.. ++..||++.+++++
T Consensus 227 ------~~~~~-------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 ------FQFPP-------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------ccCCC-------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00000 0011234567777777654 33448899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=305.60 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=191.5
Q ss_pred ccccccCCeeEEEEEECC---CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLKS---GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|...+ +..+|+|++..... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999998653 45799998854332 23445788899999999999999999999999999999999999
Q ss_pred CChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 765 GSLADMLHEKGR--SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 765 gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
|+|.+++..... ....++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975432 22456778889999999999999999 9999999999999999999999999998754322211
Q ss_pred ccccccccccccCccccccccCC-------CCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTK-------KVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.......++..|+|||++.+. .++.++||||||+++|||++ |..||.... ..+...........
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~---- 228 (269)
T cd05087 157 --VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS--DEQVLTYTVREQQL---- 228 (269)
T ss_pred --ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHhhcccC----
Confidence 112234567889999988642 35789999999999999996 999996532 22222221111100
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
...++.+. ......+.+++..|+ .+|++|||++||++.|+
T Consensus 229 -------~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 -------KLPKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -------CCCCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 112345677888998 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.45 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=194.4
Q ss_pred ccccccCCeeEEEEEEC-CCC--EEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEeccC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGE--TVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
++||+|+||.||+|+.+ ++. .+|+|.+... ......+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 46899999999999976 343 4688877422 2334456788999999999 79999999999999999999999999
Q ss_pred CCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 764 NGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 764 ~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
+|+|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999875421 12478899999999999999999998 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|++........ ......+..|+|||+.....++.++||||||+++|||++ |..||... ...+..+.+.....
T Consensus 157 gl~~~~~~~~~-----~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~--~~~~~~~~~~~~~~ 229 (270)
T cd05047 157 GLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGYR 229 (270)
T ss_pred CCccccchhhh-----ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc--CHHHHHHHHhCCCC
Confidence 99853221110 111223567999999988889999999999999999997 99998642 22222222211100
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
. + .. ......+.+++.+|++.+|.+||++.|+++.|+++
T Consensus 230 ~--------------~--~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 230 L--------------E--KP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred C--------------C--CC-----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0 0 00 11234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.83 Aligned_cols=271 Identities=23% Similarity=0.285 Sum_probs=201.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+|+.. +|+.||+|++............+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999986 789999999865433333445678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
++ ++|.+++.... ..+++..+..++.||++||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 68888776532 3589999999999999999999999 999999999999999999999999999876543221
Q ss_pred CccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
......++..|+|||++.+. .++.++||||+||++|||++|+.|+..... .....+.+............ ...
T Consensus 155 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~ 228 (284)
T cd07839 155 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEESW-PGV 228 (284)
T ss_pred ----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC-HHHHHHHHHHHhCCCChHHh-HHh
Confidence 12334578899999988764 468899999999999999999999765322 22222222221111100000 000
Q ss_pred cccccC----CCCC----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDP----RMDL----STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~----~l~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+..+. .... ....+....++.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 011110 0000 00111234577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.80 Aligned_cols=272 Identities=21% Similarity=0.281 Sum_probs=202.9
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|++|.||+|+.+ +|+.||+|++..........+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35788899999999999999987 68999999986444333445668899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|++++.+..+..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988887765432 489999999999999999999999 99999999999999999999999999998764432
Q ss_pred CCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc-----
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER----- 914 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 914 (973)
. ......++..|+|||+..+ ..++.++||||||+++|||++|+.||..... ....... ..........
T Consensus 155 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-VDQLYLI-RKTLGDLIPRHQQIF 228 (286)
T ss_pred c----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH-HHHhCCCChHHhhhc
Confidence 1 1223457889999999875 4578899999999999999999999975322 1122111 1111000000
Q ss_pred cccCcccccccCCCCCC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLS----TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...........+..... .........+.+++.+|++++|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000100000 0001124678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.33 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=201.1
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc-------hhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP-------ETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
+|...+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999875 68899999885443221 123567889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997643 478889999999999999999999 99999999999999999999999999988
Q ss_pred hccccCCC--ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 835 ALQSQEGQ--SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 835 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
........ .........|+..|+|||...+..++.++||||+|+++|||++|+.||.... .......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~---- 228 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT--QLQAIFKIGENA---- 228 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc--HHHHHHHHhccC----
Confidence 76532111 0111123457889999999998889999999999999999999999997531 111111111100
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+. ......+.+++.+|++.||.+||++.||+++
T Consensus 229 ------------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 ------------SPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------------CCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00010 1234677899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=304.51 Aligned_cols=240 Identities=25% Similarity=0.367 Sum_probs=186.6
Q ss_pred ccccccCCeeEEEEEECC-------------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 688 NLIGSGGSCRVYKVKLKS-------------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
+.||+|+||.||+|+..+ ...||+|.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999998532 235888887432 23445578889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc-------eEE
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV-------PRV 827 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl 827 (973)
.++||||+++|+|..+++... ..+++..+++++.||++|++|||+. +|+||||||+||+++.++. +++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999998886543 2588999999999999999999999 9999999999999987664 899
Q ss_pred eccCcchhccccCCCccccccccccccCcccccccc-CCCCCCCCChhhHHHHHHHHH-cCCCCCCCCCCCchhHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELV-TGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~~~~~~~ 905 (973)
+|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+..... .+.. ...
T Consensus 154 ~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~-~~~ 222 (262)
T cd05077 154 SDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--AEKE-RFY 222 (262)
T ss_pred CCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--hHHH-HHH
Confidence 999998654322 1245778899999886 567899999999999999998 57777654211 1111 110
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
.... ... ......+.+++.+|++.||++||++.+|++++.
T Consensus 223 ~~~~------------~~~----------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC------------MLV----------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc------------cCC----------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1000 000 011346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=316.70 Aligned_cols=261 Identities=27% Similarity=0.383 Sum_probs=200.1
Q ss_pred CCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec-CC
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG-QD 753 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~ 753 (973)
++|+..++||+|+||.||+|++ .+++.||||++.... .......+.+|+.++.++ +|+||+++++++.. +.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 4788999999999999999974 357899999995432 233445688899999999 68999999998865 45
Q ss_pred eeEEEEeccCCCChhhhhhccCC---------------------------------------------------------
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR--------------------------------------------------------- 776 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 776 (973)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864310
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccc
Q 039922 777 -------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849 (973)
Q Consensus 777 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~ 849 (973)
...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~ 240 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGD 240 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch--hhcCC
Confidence 01367788899999999999999999 9999999999999999999999999998765332211 11112
Q ss_pred cccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCC
Q 039922 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRM 928 (973)
Q Consensus 850 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 928 (973)
..++..|+|||...+..++.++||||||+++|||++ |..||.... ........+....... . +.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~--------~-----~~- 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEGTRMR--------A-----PD- 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc-ccHHHHHHHhccCCCC--------C-----CC-
Confidence 345678999999988899999999999999999997 888886432 1122222221111100 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 929 DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 929 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
....++.+++.+|++.+|++||++.||+++|+...
T Consensus 306 -------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 306 -------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred -------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01245789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.21 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=197.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC-----
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ----- 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----- 752 (973)
+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4567888999999999999999876 68899999985332 3345678899999998 699999999998652
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
+..|+||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+|+|++|+||++++++.++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 46799999999999999987642 23588999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHH
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 906 (973)
++........ ......|+..|+|||++. +..++.++||||+||++|||++|+.||..... .......
T Consensus 157 ~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~~~ 228 (272)
T cd06637 157 VSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLI 228 (272)
T ss_pred Cceecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHHHH
Confidence 9876533221 123356889999999986 34578899999999999999999999964321 1111111
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. . . .....+ ......+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~-~-~-------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 PR-N-P-------APRLKS---------KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred hc-C-C-------CCCCCC---------CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0 0 000011 1123467899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=310.62 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=203.3
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.+...+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++|+|++++++++..++..+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 345578999999999999999999874 79999999985332 234466889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred EeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 999999999999998643 478889999999999999999999 9999999999999999999999999998765
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ......+++.|+|||...+..++.++|||||||++|++++|+.||...... ..... +... ..
T Consensus 166 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-~~~~~-~~~~--~~----- 232 (297)
T cd06656 166 TPEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYL-IATN--GT----- 232 (297)
T ss_pred cCCcc----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-hheee-eccC--CC-----
Confidence 33221 112346788999999999888999999999999999999999999753211 11000 0000 00
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+... ........+.+++.+|++.+|++||++.+|+++
T Consensus 233 ---------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 ---------PELQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---------CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011223557889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=314.41 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=160.7
Q ss_pred cccccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCeeEEEEec
Q 039922 687 QNLIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDFNILVYEY 761 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 761 (973)
.++||+|+||+||+|+.+ +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999865 56789999984332 23346789999999999999999998854 4567899999
Q ss_pred cCCCChhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe----CCCCceEEeccC
Q 039922 762 MPNGSLADMLHEKG------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL----DAEMVPRVADFG 831 (973)
Q Consensus 762 ~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG 831 (973)
++ ++|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 95 68887775321 122478889999999999999999999 99999999999999 456789999999
Q ss_pred cchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPS 893 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~ 893 (973)
+++........ ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 158 ~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99876433211 122334678999999999876 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.08 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=213.6
Q ss_pred cccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 677 EDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 677 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
+..+.+-|...+.||+|.|+.|-.++.. +|+.||||++.+.....-....+.+|+..|+.++|||||++|++...+...
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 4566778999999999999999988754 899999999987766666677788999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe-CCCCceEEeccCcch
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL-DAEMVPRVADFGLAK 834 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGl~~ 834 (973)
|+|.|.=++|+|.+|+-++.. -+.+..+.+++.||+.|+.|.|+. .+||||+||+||.+ .+-|-|||.|||++-
T Consensus 93 yLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccc
Confidence 999999999999999987655 388889999999999999999999 99999999999766 567899999999997
Q ss_pred hccccCCCccccccccccccCccccccccCCCCC-CCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT-EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.+.+.. ......|+..|-|||++.+..|+ +++||||+|||+|-+.+|+.||...- +.
T Consensus 168 kf~PG~-----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN--DS--------------- 225 (864)
T KOG4717|consen 168 KFQPGK-----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN--DS--------------- 225 (864)
T ss_pred cCCCcc-----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc--ch---------------
Confidence 765443 34557899999999999998886 58899999999999999999997532 11
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+..++|=.+. .......+..++|..|+..||.+|.+.+||+..
T Consensus 226 ----ETLTmImDCKYt---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 226 ----ETLTMIMDCKYT---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----hhhhhhhccccc---CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 112222321111 113456788999999999999999999999754
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.31 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=198.9
Q ss_pred ccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
++||+|+||.||++...+++.||+|++...... ...+.+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999877999999988544332 4556789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccc
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
.+++..... .+++..+..++.+++.|++|||+. +++||||+|+||+++.++.++|+|||.+......... ...
T Consensus 80 ~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~ 152 (251)
T cd05041 80 LTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--VSD 152 (251)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcce--ecc
Confidence 999875432 578899999999999999999999 9999999999999999999999999998765422111 000
Q ss_pred cccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccC
Q 039922 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 926 (973)
....++..|+|||...++.++.++||||||+++|||++ |..||.... .......+...... .
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--~~~~~~~~~~~~~~-------------~-- 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--NQQTRERIESGYRM-------------P-- 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--HHHHHHHHhcCCCC-------------C--
Confidence 11233567999999988899999999999999999999 777775431 22222222211100 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 927 RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 927 ~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
........+.+++.+|++.+|++||++.||++.|+.
T Consensus 216 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 216 ------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 001124578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.20 Aligned_cols=260 Identities=26% Similarity=0.387 Sum_probs=202.9
Q ss_pred CCCCccccccccCCeeEEEEEEC--------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK--------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ 752 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 752 (973)
.+|++.+.||+|+||.||+|... .+..||+|.+... ......+.+.+|+.+++++ +|+||+++++++..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35788999999999999999753 1236899987532 2334456788999999999 799999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe
Q 039922 753 DFNILVYEYMPNGSLADMLHEKG-------------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 819 (973)
+..+++|||+++|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 99999999999999999987532 122478899999999999999999999 99999999999999
Q ss_pred CCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCch
Q 039922 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENK 898 (973)
Q Consensus 820 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 898 (973)
++++.+||+|||+++........ .......++..|+|||+..+..++.++||||||+++|||++ |..||... ...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~ 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVE 243 (334)
T ss_pred cCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--CHH
Confidence 99999999999998765432211 11112234567999999999999999999999999999998 77887542 222
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+....+...... .. .......+.+++.+|++.+|++||+|.|+++.|+...
T Consensus 244 ~~~~~~~~~~~~-----------~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLKEGHRM-----------DK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHcCCCC-----------CC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 222222211100 00 0112356889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.05 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=199.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 357888899999999999999875 6889999998533 2233456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++.... .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999987543 588999999999999999999999 9999999999999999999999999998765332
Q ss_pred CCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.. ......|+..|+|||++. .+.++.++||||+||++|||++|+.||..... .......... ... +
T Consensus 160 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-~~~~~~~~~~-~~~-~---- 228 (267)
T cd06645 160 IA----KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-MRALFLMTKS-NFQ-P---- 228 (267)
T ss_pred cc----ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-hhhHHhhhcc-CCC-C----
Confidence 21 122356889999999874 45688899999999999999999999864321 1111111100 000 0
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.... .......+.+++.+|++.+|++||++++|+++
T Consensus 229 ---------~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 ---------PKLKD---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---------Ccccc---cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000 00123467899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=303.34 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=202.5
Q ss_pred CCCCccccccccCCeeEEEEEECC-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||.||+|+..+ ++.||+|.+... ...+.+.+|++++++++|+||+++++++..++..|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 468889999999999999999874 889999998432 226678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 79 YCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999986543 3589999999999999999999999 99999999999999999999999999988764332
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+ ....
T Consensus 154 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~--~~~~~~~--~~~~---------- 215 (256)
T cd06612 154 A----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP--MRAIFMI--PNKP---------- 215 (256)
T ss_pred c----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch--hhhhhhh--ccCC----------
Confidence 1 12234578899999999988999999999999999999999999975321 1111100 0000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+. ........+.+++.+|++.+|++||++.||+++
T Consensus 216 ----~~~~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 216 ----PPTLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred ----CCCCC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00000 112234578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.95 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=198.0
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|+..+.||+|+||.||+|... ++..+|+|.+.. ......+.+.+|+++++.++|+|++++++++..++..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC--CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 567789999999999999986 577889998842 23345567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++++|..++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++........
T Consensus 85 ~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 85 AGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999998876532 2589999999999999999999999 999999999999999999999999999876533221
Q ss_pred ccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
......++..|+|||++. +..++.++||||+||++|||++|+.||.... ..+..... ......
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~-~~~~~~------- 226 (282)
T cd06643 159 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKI-AKSEPP------- 226 (282)
T ss_pred ---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHH-hhcCCC-------
Confidence 122346889999999874 4457789999999999999999999986421 11111111 111000
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
....+ ......+.+++.+|++.+|++||++.+++++-
T Consensus 227 ----~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 227 ----TLAQP--------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ----CCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00000 11235688999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=310.54 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=202.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
...+|+..+.||.|++|.||+|... +|+.||+|.+... .....+.+.+|++.++.++|+|++++++++..++..++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 3456888999999999999999864 7899999998533 233456788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999988643 478999999999999999999999 999999999999999999999999999876543
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.... .....++..|+|||...+..++.++|||||||++|+|++|+.||..... ... ...+...... .
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-~~~-~~~~~~~~~~--~----- 234 (296)
T cd06655 168 EQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRA-LYLIATNGTP--E----- 234 (296)
T ss_pred cccc----CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHH-HHHHHhcCCc--c-----
Confidence 3211 1234678899999999988899999999999999999999999975321 111 1111111100 0
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... .......+.+++.+|++.||++||++.+++++
T Consensus 235 ----~~~--------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 ----LQN--------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ----cCC--------cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 01123467889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.05 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=203.6
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCC----EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.+|+..+.||+|+||.||+|..+ +|+ .||+|.+.... .......+.+|+..+++++|+||+++++++.. +..+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 46778899999999999999865 333 58999875332 23455678899999999999999999999987 7889
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999976433 488999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
....... ......++..|+|||......++.++||||||+++||+++ |+.||... ...++.+.+........
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~~--- 232 (279)
T cd05057 160 DVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--PAVEIPDLLEKGERLPQ--- 232 (279)
T ss_pred cCcccce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhCCCCCCC---
Confidence 5332211 1112224568999999988899999999999999999999 99998753 23334443332211100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
+ ......+.+++.+|+..+|.+||++.++++.|++.
T Consensus 233 ----------~--------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 233 ----------P--------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ----------C--------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 01124578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.49 Aligned_cols=271 Identities=27% Similarity=0.335 Sum_probs=205.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999975 789999999965544445567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+ +++|.+++.... ..+++.+++.++.||+.||+|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987543 3589999999999999999999999 999999999999999999999999999887643321
Q ss_pred CccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.......++..|+|||+..+. .++.++||||+|+++|||++|..||... .......++............ ..+
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~ 228 (286)
T cd07832 155 ---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE--NDIEQLAIVFRTLGTPNEETW-PGL 228 (286)
T ss_pred ---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC--CHHHHHHHHHHHcCCCChHHH-hhc
Confidence 123345688999999988654 4688999999999999999997777542 122222222221111110000 001
Q ss_pred ccccc------C---CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLID------P---RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d------~---~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.++.+ + ........++....+.+++.+|++++|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11100 0 000000011234788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.82 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=203.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||++... +++.+|+|++............+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 788999999865544455567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-CceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~~~~~~~~ 840 (973)
+++++|.+++.... ...+++..+..++.|++.|++|||++ +++|+||+|+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 23578999999999999999999999 99999999999999865 468999999998764332
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. .....++..|+|||...+..++.++||||||+++|+|++|+.||... +.......+......
T Consensus 157 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~--~~~~~~~~~~~~~~~---------- 219 (256)
T cd08220 157 K-----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA--NLPALVLKIMSGTFA---------- 219 (256)
T ss_pred c-----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC--chHHHHHHHHhcCCC----------
Confidence 1 12346788999999999888999999999999999999999998653 222222222221111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+. ......+.+++.+|++++|++|||+.|++++
T Consensus 220 -~~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 -PIS----------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCC----------CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000 1123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=316.62 Aligned_cols=257 Identities=21% Similarity=0.239 Sum_probs=197.0
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|...+.||+|+||.||+++.+ +++.||+|++.+.. ........+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 68899999985322 12233455788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997632 2578889999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCccccccccccccCccccccccC-----CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT-----KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.. .......||+.|+|||++.+ +.++.++||||+||++|||++|+.||... +..+....+......
T Consensus 156 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~~~---- 226 (331)
T cd05624 156 GT---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHEER---- 226 (331)
T ss_pred Cc---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC--CHHHHHHHHHcCCCc----
Confidence 21 11223568999999999875 56788999999999999999999999752 212222111111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN--RPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~ 965 (973)
+............+.+++.+|+..++.+ |+++++++++
T Consensus 227 -------------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 -------------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -------------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000000112356778888888865544 5688888776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.90 Aligned_cols=241 Identities=21% Similarity=0.323 Sum_probs=186.8
Q ss_pred ccccccCCeeEEEEEECC--------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 688 NLIGSGGSCRVYKVKLKS--------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
+.||+|+||.||+|.... ...||+|.+.. ......+.+.+|+.+++.++|||++++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc--hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999997642 23488887732 22334456888999999999999999999999989999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc--------eEEeccC
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV--------PRVADFG 831 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG 831 (973)
||+++|+|.++++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999976533 578999999999999999999999 9999999999999987765 5999999
Q ss_pred cchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.+...... ....++..|+|||++.+ ..++.++||||||+++|||++|..++..... ........ .....
T Consensus 154 ~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~~~~-~~~~~ 223 (258)
T cd05078 154 ISITVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQFY-EDRHQ 223 (258)
T ss_pred cccccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHHHHH-Hcccc
Confidence 88654321 22457889999999876 4578999999999999999999644332211 11111111 10000
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
+. .....++.+++.+|++.+|++|||++++++.|+
T Consensus 224 -----------------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 -----------------LP-----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------------CC-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 011246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.09 Aligned_cols=257 Identities=28% Similarity=0.407 Sum_probs=204.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+|... +++.||+|.+..........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 789999999865544445667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999987643 478889999999999999999999 999999999999999999999999999887654433
Q ss_pred CccccccccccccCccccccccCCC---CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKK---VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
..........++..|+|||++.+.. ++.++||||||+++||+++|+.||.... ........+... .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-~~~~~~~~~~~~--~-------- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-NEFQIMFHVGAG--H-------- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-chHHHHHHHhcC--C--------
Confidence 2222122356788999999988766 8899999999999999999999997532 111111111110 0
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+. ........+.+++.+|++.+|++||++.|++++
T Consensus 224 ------~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 ------KPPIP---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ------CCCCC---cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 001124556789999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.65 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=203.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+.+.+|++++++++|+||+++++++..++..|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 46888899999999999999875 6789999998533 22355678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 81 YCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999999887642 2588999999999999999999999 99999999999999999999999999987654322
Q ss_pred CCccccccccccccCccccccccCC---CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTK---KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
. ......++..|+|||...+. .++.++||||||+++|||++|+.||..... ...... +......
T Consensus 156 ~----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-~~~~~~-~~~~~~~------- 222 (262)
T cd06613 156 A----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-MRALFL-ISKSNFP------- 222 (262)
T ss_pred h----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHH-HHhccCC-------
Confidence 1 12234678899999998776 788999999999999999999999975321 111111 1111000
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+ .........+.+++.+|++.+|++||++.+|+++
T Consensus 223 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 223 -------PPKL---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -------Cccc---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.03 Aligned_cols=239 Identities=23% Similarity=0.357 Sum_probs=185.5
Q ss_pred cccccCCeeEEEEEECC-------------------------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCee
Q 039922 689 LIGSGGSCRVYKVKLKS-------------------------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 743 (973)
.||+|+||.||+|.... ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 69999999999987421 135888888422 233445688899999999999999
Q ss_pred eEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 744 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
++++++..++..++||||+++|+|..++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 99999999999999999999999999986532 2578899999999999999999999 999999999999997643
Q ss_pred -------ceEEeccCcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHH-cCCCCCCCCC
Q 039922 824 -------VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELV-TGKRPNDPSF 894 (973)
Q Consensus 824 -------~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~ 894 (973)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3799999987543221 12356788999998865 56899999999999999995 6888886532
Q ss_pred CCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 895 GENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
. .....+..... . +. ......+.+++.+|++.+|++||++.+|++.|+
T Consensus 227 ~--~~~~~~~~~~~-~-----------------~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 P--SEKERFYEKKH-R-----------------LP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred h--HHHHHHHHhcc-C-----------------CC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 22222211110 0 00 001235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=316.04 Aligned_cols=257 Identities=22% Similarity=0.231 Sum_probs=195.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|+..++||+|+||.||+++.+ +++.||+|++.+.. ........+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999976 57889999984321 12223445788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976432 578889999999999999999999 9999999999999999999999999998755332
Q ss_pred CCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.. .......||+.|+|||++. .+.++.++|||||||++|||++|+.||... +.......+.......
T Consensus 156 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~--- 227 (332)
T cd05623 156 GT---VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERF--- 227 (332)
T ss_pred Cc---ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC--CHHHHHHHHhCCCccc---
Confidence 21 1122356899999999986 346789999999999999999999999753 2122222111110000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPI--NRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~--~Rps~~evl~~ 965 (973)
.+ ..........+.+++.+|+..+|. .|+++.|++++
T Consensus 228 -------~~-------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 -------QF-------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -------cC-------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 000011235567788887755444 47899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=324.29 Aligned_cols=269 Identities=22% Similarity=0.265 Sum_probs=199.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..+|.+.+.||+|+||.||++... .++.||+|.+... ....+|++++++++|+||+++++++...+..|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 456889999999999999998754 4578999987422 234679999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|||++. ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 164 v~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999995 7888888433 3589999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-chhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-NKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......+.......+....
T Consensus 237 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 237 AHPDT--PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred ccccc--ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 33221 1223457999999999999999999999999999999999999999764221 11111111111111000000
Q ss_pred cC---cc----ccc---ccCCCCCCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CR---DL----NQL---IDPRMDLSTC--DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~---~l----~~~---~d~~l~~~~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. .+ .+. ..+....... .......+.+++.+|++.||++||++.|++.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00 000 0000000000 00123467889999999999999999999876
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.74 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=205.2
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCeeEEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDFNILVY 759 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 759 (973)
+|+..+.||+|+||.||++... +++.||+|++..........+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3677889999999999999865 78899999986555555566778899999999999999999998754 45679999
Q ss_pred eccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 760 EYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLH-----NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
||+++++|.+++.... ....+++..++.++.|++.|++||| +. +++|+||+|+||++++++.+|++|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999987542 2346899999999999999999999 66 9999999999999999999999999998
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
......... .....++..|+|||...+..++.++||||||+++|+|++|+.||... +.....+.+......
T Consensus 158 ~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~--- 228 (265)
T cd08217 158 KILGHDSSF----AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR--NQLQLASKIKEGKFR--- 228 (265)
T ss_pred ccccCCccc----ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc--CHHHHHHHHhcCCCC---
Confidence 876443321 12346889999999999888999999999999999999999999753 233333333222111
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.........+.+++.+|++.+|++||++.+|+++
T Consensus 229 ------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0112234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=334.47 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=193.7
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC------
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------ 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 752 (973)
...+|++.++||+||||.||+++.+ ||+.||||++.-.. .......+.+|+..+.+++|||||+++..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 4556888999999999999999998 99999999996555 444556678899999999999999997332100
Q ss_pred --------------------------------------------------------------------------------
Q 039922 753 -------------------------------------------------------------------------------- 752 (973)
Q Consensus 753 -------------------------------------------------------------------------------- 752 (973)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 039922 753 ---------------------------------DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL 799 (973)
Q Consensus 753 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL 799 (973)
-..||-||||+...++++++.+... -.....++++++|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 1237889999888888888765431 14667899999999999999
Q ss_pred hhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc------c--------cCCCccccccccccccCccccccccCC
Q 039922 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ------S--------QEGQSDDAMSCVAGSYGYIAPEYAYTK 865 (973)
Q Consensus 800 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~------~--------~~~~~~~~~~~~~gt~~y~aPE~~~~~ 865 (973)
|++ |+|||||||.||++|+++.|||+|||++.... . ..+......+..+||.-|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998732 0 011122244667899999999998764
Q ss_pred ---CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHH
Q 039922 866 ---KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVL 942 (973)
Q Consensus 866 ---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~ 942 (973)
+|+.|+|+||+|||++||+. ||...++ ........+.+... .+ ..+. .+....=.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-Ra~iL~~LR~g~iP-------~~-~~f~----------~~~~~~e~ 848 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-RASILTNLRKGSIP-------EP-ADFF----------DPEHPEEA 848 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHH-HHHHHHhcccCCCC-------CC-cccc----------cccchHHH
Confidence 49999999999999999984 5654321 11122222221111 11 1122 23344557
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 039922 943 NVALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 943 ~l~~~cl~~dP~~Rps~~evl~ 964 (973)
+++++|++.||.+||||.|++.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 8899999999999999999975
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.78 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=199.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+.|++.+.||+|+||.||+|+.. +++.||+|.+.. ......+.+.+|+.+++.++|+|++++++++..++..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 56889999999999999999986 588999999843 334455678889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|..++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 90 ~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 90 FCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred cCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999888765432 588999999999999999999999 99999999999999999999999999886543221
Q ss_pred CCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
. ......++..|+|||++. ...++.++|||||||++|||++|..||.... .... +........+.
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~----~~~~~~~~~~~- 234 (292)
T cd06644 165 Q----RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRV----LLKIAKSEPPT- 234 (292)
T ss_pred c----ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHH----HHHHhcCCCcc-
Confidence 1 122346788999999884 3456789999999999999999999986421 1111 11111110000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+ ......++.+++.+|++.+|++||++.|++++
T Consensus 235 -------~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 -------LSQ--------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CCC--------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 01223567889999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.68 Aligned_cols=256 Identities=25% Similarity=0.320 Sum_probs=201.8
Q ss_pred CCCCccccccccCCeeEEEEEECCC----CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSG----ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
++|...+.||+|+||.||+|...+. ..||+|...... .....+.+.+|+.++++++|+||+++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3577889999999999999987532 468999884332 23455678999999999999999999998875 55789
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976432 589999999999999999999999 99999999999999999999999999987654
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ......++..|+|||.+....++.++||||||+++||+++ |..||.... ..+...++........
T Consensus 159 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~~~~~~~~~---- 229 (270)
T cd05056 159 DESYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK--NNDVIGRIENGERLPM---- 229 (270)
T ss_pred cccce---ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCcCCC----
Confidence 33211 1112234568999999988889999999999999999996 999996532 2233333322111100
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
. ......+.+++.+|+.++|++|||+.++++.|+..+
T Consensus 230 ------------~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 230 ------------P-----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ------------C-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 112356888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.03 Aligned_cols=256 Identities=26% Similarity=0.373 Sum_probs=205.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||+||++... +|+.||+|++.... .....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46888899999999999999876 68899999885432 23456678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++...+ .+++..+..++.+++.|+.|||+.. +++||||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999887643 5889999999999999999999731 89999999999999999999999999986542211
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC------chhHHHHHHHHhccCCCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE------NKDIVRWVTEATLSSPER 914 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~ 914 (973)
.....|+..|+|||++.++.++.++|||||||++||+++|+.||...... ......++........+
T Consensus 159 ------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (284)
T cd06620 159 ------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP- 231 (284)
T ss_pred ------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC-
Confidence 12346889999999998889999999999999999999999999754221 11122333322221110
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+. ..+....+.+++.+|+++||++||++.||+++.
T Consensus 232 ------------~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 ------------RLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ------------CCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 012345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.36 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=201.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34677889999999999999875 67899999885332 23345678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++++|||++..+....
T Consensus 83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999988642 478899999999999999999999 99999999999999999999999999987654322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||+..+..++.++||||||+++|||++|+.|+..... .....++....
T Consensus 156 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~~~------------ 217 (277)
T cd06642 156 I----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--MRVLFLIPKNS------------ 217 (277)
T ss_pred h----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch--hhHHhhhhcCC------------
Confidence 1 12234578899999999988999999999999999999999999864321 11111111100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+.+ .......+.+++.+|++.+|++||+|.||+++-
T Consensus 218 ----~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 218 ----PPTL-----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ----CCCC-----CcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0001 112345688999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.63 Aligned_cols=254 Identities=28% Similarity=0.406 Sum_probs=206.0
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|++|.||++..+ +++.||+|++..... ....+.+.+|++.+++++|+||+++++++..++..++|+||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5778889999999999999887 689999999864432 34556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997653 368889999999999999999999 8 99999999999999999999999999987653322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ....++..|+|||+..+..++.++||||+|+++|+|++|+.||...........+.+........+
T Consensus 156 ~------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 222 (265)
T cd06605 156 A------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP------- 222 (265)
T ss_pred h------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-------
Confidence 1 115678899999999999999999999999999999999999975432223333333222211100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+. .......+.+++.+|+..+|++||++.|++++
T Consensus 223 ------~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 ------RLP----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ------CCC----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 01134568899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.74 Aligned_cols=262 Identities=26% Similarity=0.328 Sum_probs=201.1
Q ss_pred cccc-ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEe
Q 039922 674 SFNE-DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCS 750 (973)
Q Consensus 674 ~~~~-~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 750 (973)
.++. .++.++|+..+.||+|+||.||+|+.+ +++.||+|++... ......+.+|+.+++++ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3443 567889999999999999999999876 6889999987422 22345678899999999 6999999999874
Q ss_pred -----cCCeeEEEEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc
Q 039922 751 -----GQDFNILVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV 824 (973)
Q Consensus 751 -----~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 824 (973)
.++..++||||+++++|.++++... ....+++..+..++.|++.|+.|||+. +++||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 3457899999999999999876432 233578899999999999999999999 9999999999999999999
Q ss_pred eEEeccCcchhccccCCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchh
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~ 899 (973)
++|+|||+++.+..... ......|+..|+|||++. +..++.++||||+||++|||++|+.||..... ...
T Consensus 163 ~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~ 237 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRA 237 (286)
T ss_pred EEEccCCceeecccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHH
Confidence 99999999876543221 122346889999999875 34578899999999999999999999865311 111
Q ss_pred HHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 900 IVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.... .....+ ...++. .....+.+++.+|++.||++||++.|++++.
T Consensus 238 ~~~~----~~~~~~--------~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LFKI----PRNPPP--------TLHQPE--------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hhhc----cccCCC--------cccCCC--------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1110 000000 001110 1134688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=308.11 Aligned_cols=270 Identities=22% Similarity=0.319 Sum_probs=203.0
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+++.. +++.||+|.+.... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 5888899999999999999876 67889999885332 233455688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.++++... .+++..+..++.|++.||+|||+.. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999999997643 5788999999999999999999732 89999999999999999999999999986543221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc----
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC---- 917 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 917 (973)
.....|+..|+|||+..+..++.++||||||+++|||++|+.||.... ......+..............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCccccc
Confidence 123568899999999988889999999999999999999999986432 222222221111000000000
Q ss_pred ---------CcccccccCCCC---CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 ---------RDLNQLIDPRMD---LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ---------~~l~~~~d~~l~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
....+..+.... ..........++.+++.+|++.+|++||++.||+++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000000 0000011345688999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.09 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=198.0
Q ss_pred ccccccCCeeEEEEEECC-------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 688 NLIGSGGSCRVYKVKLKS-------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+.||+|+||.||+|+.++ ++.||+|.+.... .......+.+|+..++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998752 2579999885332 22445678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-----ceEEeccC
Q 039922 761 YMPNGSLADMLHEKGR----SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-----VPRVADFG 831 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG 831 (973)
|+++++|.+++..... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999975321 22478899999999999999999999 999999999999999887 89999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+++........ .......++..|+|||++.++.++.++|||||||++|||++ |+.||... ...+....+......
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~~ 232 (269)
T cd05044 157 LARDIYKSDYY--RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--NNQEVLQHVTAGGRL 232 (269)
T ss_pred ccccccccccc--ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc--CHHHHHHHHhcCCcc
Confidence 98765433211 11122345678999999999999999999999999999998 99998642 222333322211000
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
. ........+.+++.+|++.+|.+||++++|.+.|+.
T Consensus 233 ------------------~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 ------------------Q---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------------------C---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 001224578899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.92 Aligned_cols=258 Identities=24% Similarity=0.423 Sum_probs=203.0
Q ss_pred CCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCC----chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHK----PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+|+..+.||+|++|.||+|+. .+++.||+|++...... ....+.+.+|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367788999999999999986 47899999998543321 1234678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcchhc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKAL 836 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~ 836 (973)
||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999987543 578899999999999999999999 999999999999998776 5999999998776
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
...............++..|+|||...+..++.++||||+|+++|++++|..||..... ......+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~---- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALIFKIASATT---- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHHHHHhccCC----
Confidence 54322111222335688999999999888899999999999999999999999964321 111121111111100
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ..........+.+++.+|++.+|++||++.|++++
T Consensus 229 --------~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 --------A-----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --------C-----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0 01112344678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=323.03 Aligned_cols=268 Identities=20% Similarity=0.199 Sum_probs=198.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
..|.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++..++..++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46888999999999999999876 57899999642 1235689999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
++ .++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 241 ~~-~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KY-RSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 99 478988886543 2589999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC------chhHHHHHHHHhccC--C
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE------NKDIVRWVTEATLSS--P 912 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~--~ 912 (973)
. ........||..|+|||++.+..++.++|||||||++|||++|..|+...... ...+.+.+....... .
T Consensus 315 ~--~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 315 S--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred c--cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 1 11122356999999999999999999999999999999999988766432111 122333333322110 0
Q ss_pred CccccCccccc--------ccCCCCCCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQL--------IDPRMDLSTCD--YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~--------~d~~l~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+......+... ..+......+. ......+.+++.+|++.||.+|||+.|++++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000 00000000000 0112367889999999999999999999986
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=318.66 Aligned_cols=243 Identities=25% Similarity=0.274 Sum_probs=187.0
Q ss_pred ccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC---CCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV---RHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
||+|+||+||+|+.+ +|+.||+|++.+... .......+..|..++.+. +||+|+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 689999999853321 112223344566666655 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 150 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---- 150 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----
Confidence 99999887543 588999999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 923 (973)
.......||..|+|||++.+. .++.++||||+||++|||++|+.||... ...+....+...... +
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~------------~ 216 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE--DTQQMYRNIAFGKVR------------F 216 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC--CHHHHHHHHHcCCCC------------C
Confidence 112345689999999998754 4789999999999999999999999753 222222222111110 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHH
Q 039922 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP----SMRRVVEL 965 (973)
Q Consensus 924 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~evl~~ 965 (973)
.. ......+.+++.+|+++||.+|| ++.|++++
T Consensus 217 ~~---------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 217 PK---------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CC---------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 00 01234667899999999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.13 Aligned_cols=280 Identities=22% Similarity=0.270 Sum_probs=202.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC---
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD--- 753 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 753 (973)
.+..++|+..+.||+|+||.||+|+.. +++.||+|++............+.+|++++++++||||+++++++...+
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 344567999999999999999999876 6899999998644433334445678999999999999999999987654
Q ss_pred -----eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe
Q 039922 754 -----FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828 (973)
Q Consensus 754 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 828 (973)
..++||||++ +++.+++.... ..+++.++..++.|++.|++|||+. +++|+||||+||++++++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence 3499999996 58888776532 2589999999999999999999999 99999999999999999999999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
|||++..+...............++..|+|||+..+. .++.++||||||+++|||++|..||.... .......+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~--~~~~~~~~~~~ 239 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT--EQHQLTLISQL 239 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHH
Confidence 9999987654332222223345678899999987654 46889999999999999999999987532 22222222222
Q ss_pred hccCCCccccCcc-cccccC-CCCCC--------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 908 TLSSPERGCCRDL-NQLIDP-RMDLS--------TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 908 ~~~~~~~~~~~~l-~~~~d~-~l~~~--------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....++...+... .+..+. .+... .........+.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1111110000000 000000 00000 0000112456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.23 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=193.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHH-HhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIET-LGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+|+..+.||+|+||.||+|+.+ +|+.||+|++....... ....+..|... ++..+|+||+++++++..++..|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5788899999999999999886 69999999986443322 23344455554 666789999999999999999999999
Q ss_pred ccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 761 YMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
|++ |+|.+++.... ....+++..+..++.|++.|++|||+++ +++||||||+||++++++.+||+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 78888876432 2346899999999999999999999853 7999999999999999999999999998765322
Q ss_pred CCCccccccccccccCccccccccC----CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT----KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
. ......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||.......+.+...+ .....
T Consensus 158 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~----- 226 (283)
T cd06617 158 V-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSP----- 226 (283)
T ss_pred c-----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCC-----
Confidence 1 1122467889999998864 4568899999999999999999999964322222222211 11100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+. .......+.+++.+|++.+|++||++.+++++
T Consensus 227 -----------~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 -----------QLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -----------CCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01123568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=317.43 Aligned_cols=192 Identities=24% Similarity=0.293 Sum_probs=164.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
..|+..+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++..++..++|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 36889999999999999999986 5778999975321 13468899999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
++ .++|.+++.... ..+++..+..|+.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 138 ~~-~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HY-SSDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cc-CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 99 478888886543 3589999999999999999999999 99999999999999999999999999987532211
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCC
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDP 892 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~ 892 (973)
......||..|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 212 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 212 -----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred -----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 12335689999999999999999999999999999999997666543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=328.47 Aligned_cols=267 Identities=19% Similarity=0.226 Sum_probs=191.4
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC------CCeeeEEeEEecC
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH------GNVVKLLMCCSGQ 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~ 752 (973)
..++|++.++||+|+||+||+|... .++.||||++.... .....+..|+.+++.++| .+++++++++..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3567999999999999999999875 67889999984321 223345556666666654 4689999988764
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCC-------
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEM------- 823 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~------- 823 (973)
+..|+|||++ +++|.+++.... .+++..+..|+.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccc
Confidence 5788999988 678888886543 58899999999999999999997 5 899999999999998765
Q ss_pred ---------ceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCC
Q 039922 824 ---------VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF 894 (973)
Q Consensus 824 ---------~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 894 (973)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999875421 11234678999999999999999999999999999999999999997532
Q ss_pred CCchhHHHHHHHHhccCCCc---cc-cCccccccc------CCCC---------CC-CCCHHHHHHHHHHHHhccCCCCC
Q 039922 895 GENKDIVRWVTEATLSSPER---GC-CRDLNQLID------PRMD---------LS-TCDYEEAEKVLNVALMCTSDFPI 954 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~---~~-~~~l~~~~d------~~l~---------~~-~~~~~~~~~l~~l~~~cl~~dP~ 954 (973)
..+....+.......+.. .+ ..+..++++ +... .. .........+.+++.+|+++||+
T Consensus 350 --~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 350 --NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred --hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 222222222211110000 00 000000000 0000 00 00011235678999999999999
Q ss_pred CCCCHHHHHHH
Q 039922 955 NRPSMRRVVEL 965 (973)
Q Consensus 955 ~Rps~~evl~~ 965 (973)
+|||+.|+++|
T Consensus 428 ~R~ta~e~L~H 438 (467)
T PTZ00284 428 KRLNARQMTTH 438 (467)
T ss_pred hCCCHHHHhcC
Confidence 99999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.08 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=203.5
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+... ......+.+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 46788899999999999999864 3467999987432 2222456789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 756 ILVYEYMPNGSLADMLHEKGRS------GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
++||||+++|+|.+++...... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999765422 1588999999999999999999999 999999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHh
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
||++........ .......++..|+|||.+.++.++.++||||||+++|||++ |..||... ........+....
T Consensus 161 ~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~--~~~~~~~~~~~~~ 235 (275)
T cd05046 161 LSLSKDVYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL--SDEEVLNRLQAGK 235 (275)
T ss_pred cccccccCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--chHHHHHHHHcCC
Confidence 999875432221 12223456778999999988889999999999999999999 77787542 2233333332211
Q ss_pred ccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 909 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
...+ . .......+.+++.+|++.+|++||++.|++++|+
T Consensus 236 ~~~~-----------~---------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELP-----------V---------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCC-----------C---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1100 0 0112357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.46 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=203.0
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||.|++|.||+|+.. +++.||+|++.... .......+.+|+.+++.++|+|++++++++.++...|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 35788899999999999999876 68899999985433 23445668899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.++.+....
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999999998754 588999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||+..+..++.++||||||+++|||++|+.||.... .......+.....
T Consensus 153 ~----~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~----------- 215 (274)
T cd06609 153 S----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--PMRVLFLIPKNNP----------- 215 (274)
T ss_pred c----ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--hHHHHHHhhhcCC-----------
Confidence 1 1223467889999999998889999999999999999999999996532 1111111111100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+.. ......+.+++.+|++.+|++||++++++++
T Consensus 216 -----~~~~~----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 -----PSLEG----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----CCCcc----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00000 0134567889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=302.65 Aligned_cols=258 Identities=26% Similarity=0.358 Sum_probs=201.2
Q ss_pred CCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC------
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD------ 753 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 753 (973)
|.+.+.||+|+||.||+|.++ +++.||+|++..........+.+.+|+..+++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 4688999999655555556677889999999999999999999886532
Q ss_pred eeEEEEeccCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 754 FNILVYEYMPNGSLADMLHEKG---RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
..++++||+++|+|.+++.... ....+++.....++.|++.|++|||+. +|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875322 122478889999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|.++........ .......++..|++||...++.++.++||||||+++|||++ |+.||... .......++.....
T Consensus 158 g~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~ 233 (273)
T cd05074 158 GLSKKIYSGDYY--RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV--ENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccCCcce--ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC--CHHHHHHHHHcCCc
Confidence 998865432211 11112345678999999998899999999999999999999 77887542 22333333322110
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
. .. .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 234 ~----------------~~-----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 L----------------KQ-----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C----------------CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 011235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.09 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=189.0
Q ss_pred ccccccCCeeEEEEEECC---CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLKS---GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|...+ ...+|+|.+... ........+.+|++.++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 358999999999997543 346888877432 2334456788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 765 GSLADMLHEKGR--SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 765 gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
|+|.+++..... ....++.....++.||+.|++|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999976432 12356788899999999999999999 9999999999999999999999999998654322111
Q ss_pred ccccccccccccCccccccccC-------CCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYT-------KKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.......++..|+|||+... ..++.++|||||||++|||++ |..||... ...+....+......
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~~~---- 228 (269)
T cd05042 157 --ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL--SDEQVLKQVVREQDI---- 228 (269)
T ss_pred --eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC--CHHHHHHHHhhccCc----
Confidence 11123345678999998642 456789999999999999999 67777542 112222211111110
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
.+.++.+ .......+.+++..|+ .||++||+++||++.|.
T Consensus 229 -------~~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 -------KLPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -------cCCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0111111 1123355667788888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.64 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=201.0
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||.||+|+.. +|+.||+|.+.... .......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 35788899999999999999986 78999999885332 23344678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.++++.......+++..+..++.|++.|++|||+.. +++|+||||+||+++.++.++|+|||.+..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999998876433336899999999999999999999632 89999999999999999999999999987653221
Q ss_pred CCccccccccccccCccccccccCCC------CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKK------VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.....++..|+|||...+.. ++.++||||+||++|||++|+.||.... .......+.......++
T Consensus 158 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~- 228 (286)
T cd06622 158 ------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--YANIFAQLSAIVDGDPP- 228 (286)
T ss_pred ------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc--hhhHHHHHHHHhhcCCC-
Confidence 12245788999999986543 4789999999999999999999996531 12222211111111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ........+.+++.+|++.+|++||++.+++.+
T Consensus 229 ------------~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 ------------T-----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------------C-----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 111234667889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.82 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=200.5
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|++.+.||+|+||.||+|+.. +++.||+|.+.. ......+.+.+|++++++++|+|++++++++..++..|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 56888999999999999999875 688999999842 334455678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++..... .+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 83 FCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred ccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999999876432 588999999999999999999999 99999999999999999999999999886653322
Q ss_pred CCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
. ......++..|+|||++. ...++.++||||+|+++|||++|+.||.... ..... .......++
T Consensus 158 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--~~~~~---~~~~~~~~~-- 226 (280)
T cd06611 158 Q----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--PMRVL---LKILKSEPP-- 226 (280)
T ss_pred c----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--HHHHH---HHHhcCCCC--
Confidence 1 122346889999999875 3456789999999999999999999997531 11111 111111000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+. ........+.+++.+|++.+|++||++.+++++
T Consensus 227 -----------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 -----------TLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----------CcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 001123467889999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.93 Aligned_cols=247 Identities=29% Similarity=0.419 Sum_probs=197.5
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||.||++.. +++.||+|.+... .....+.+|+.++++++|+|++++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4578889999999999999875 5889999988432 2345688999999999999999999998654 47999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 80 MSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999997643 23578999999999999999999999 99999999999999999999999999987543211
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.....+..|+|||++.++.++.++||||||+++|||++ |+.||... ........+......
T Consensus 155 ------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~---------- 216 (254)
T cd05083 155 ------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM--SLKEVKECVEKGYRM---------- 216 (254)
T ss_pred ------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC--CHHHHHHHHhCCCCC----------
Confidence 11234567999999988899999999999999999998 88888643 222222222211100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
++ ....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 217 ----~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 ----EP-------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CC-------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00 01224567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.69 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=203.4
Q ss_pred CccccccccCCeeEEEEEEC-CCCEEEEEE--ecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe--eEEEE
Q 039922 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKR--LLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF--NILVY 759 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~--~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 759 (973)
+...+||+|+|-+||+|.+. +|..||=-. +..-...+...++|..|+.+++.|+|+||++++++|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999876 566665322 22223445556889999999999999999999999987654 67999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~~ 838 (973)
|.|..|+|.+|.++.++ .+.+...+|++||++||.|||++ .|+|+|||||-+||+|+. .|.|||+|.|+|+.+..
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999988764 88899999999999999999998 568999999999999986 58999999999987643
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. ...++||+.|||||+.. ..|...+||||||+.++||.|+..||..- ....++++.+..+.+. .
T Consensus 199 s~------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-~n~AQIYKKV~SGiKP-------~ 263 (632)
T KOG0584|consen 199 SH------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-TNPAQIYKKVTSGIKP-------A 263 (632)
T ss_pred cc------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-CCHHHHHHHHHcCCCH-------H
Confidence 22 23378999999999765 89999999999999999999999999753 3455666666665544 3
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+..+-| .++.++|.+|+.. .++|||+.|++++
T Consensus 264 sl~kV~d-------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 264 ALSKVKD-------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HhhccCC-------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3444444 4567899999999 9999999999864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.85 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=200.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCC----EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+.... ......++.+|+.+++.++|+||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 35778889999999999999864 444 47888874332 233345688999999999999999999998754 467
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999876432 578899999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||... ......+++.......
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~---- 231 (303)
T cd05110 160 EGDEKEY--NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKGERLP---- 231 (303)
T ss_pred cCccccc--ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCCCC----
Confidence 4332211 1112345678999999998899999999999999999998 88888642 2233444433221110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+ ......+.+++.+|+..+|++||++.|+++.++..
T Consensus 232 ---------~~--------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 ---------QP--------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---------CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 01134678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.02 Aligned_cols=271 Identities=25% Similarity=0.332 Sum_probs=201.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC---chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK---PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+|+..+.||+|+||.||+|... +|+.||+|++...... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999876 6899999999654433 33345677899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||+. +++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997643 2589999999999999999999999 999999999999999999999999999977644
Q ss_pred cCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||.... +...+ ..+............+
T Consensus 155 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PNR----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQL-GKIFEALGTPTEENWP 228 (298)
T ss_pred CCc----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHH-HHHHHHcCCCchhhhh
Confidence 321 1223356788999998864 457889999999999999999977765422 21211 1111111110000000
Q ss_pred C--ccccccc----CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 R--DLNQLID----PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~--~l~~~~d----~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .+..... +..............+.+++.+|++++|++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0000000 0000011112335678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.35 Aligned_cols=272 Identities=22% Similarity=0.302 Sum_probs=204.2
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+|..+ +++.||+|++..........+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999876 688999999865544445567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
++++.+..+.... ..+++..+..++.||+.|++|||+. +++|+|++|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9887676655432 2478999999999999999999999 999999999999999999999999999887654332
Q ss_pred CccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc----
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC---- 916 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 916 (973)
.......++..|+|||+..+. .++.++||||||+++|||++|+.||.... ..+............++...
T Consensus 156 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 ---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS--DIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHhhhcc
Confidence 122335678899999999887 88999999999999999999999986431 11211111111111000000
Q ss_pred ------cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 ------CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ------~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+.+..++......+......++.+++++|++.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000000000000111225778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=311.38 Aligned_cols=198 Identities=25% Similarity=0.347 Sum_probs=160.0
Q ss_pred cccccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCeeEEEEec
Q 039922 687 QNLIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDFNILVYEY 761 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 761 (973)
..+||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 357999999999999875 45789999885332 23357789999999999999999998853 5677999999
Q ss_pred cCCCChhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe----CCCCceEEeccC
Q 039922 762 MPNGSLADMLHEKG------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL----DAEMVPRVADFG 831 (973)
Q Consensus 762 ~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG 831 (973)
++ ++|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||++ ++++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 86 57777764321 123478889999999999999999999 99999999999999 566789999999
Q ss_pred cchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPS 893 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~ 893 (973)
+++........ ........||..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 158 ~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99876433221 112234578999999999876 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.67 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=195.3
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC---chhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCeeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK---PETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 756 (973)
.|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|+.++++++|+||+++++++.. ++..+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5788899999999999999875 6899999988543222 2234568889999999999999999998865 46778
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||+++..
T Consensus 83 l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999987543 478888999999999999999999 9999999999999999999999999998765
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
...... ........++..|+|||++.+..++.++||||+||++||+++|+.||.... ... .+.......
T Consensus 157 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-~~~----~~~~~~~~~----- 225 (266)
T cd06651 157 QTICMS-GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-AMA----AIFKIATQP----- 225 (266)
T ss_pred cccccc-CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-hHH----HHHHHhcCC-----
Confidence 432111 111223457889999999998889999999999999999999999997431 111 111111110
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.+. ......+..++ +|+..+|++||+|.||+++
T Consensus 226 -------~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 -------TNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -------CCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 001110 11234455666 6888999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=300.85 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=202.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
..|+..+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 35778889999999999999876 68899999885332 23445678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++... .+++.....++.|++.|++|+|+. +++|+||+|+||++++++.++++|||++.......
T Consensus 83 ~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 83 YLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999988642 478888999999999999999999 99999999999999999999999999987654322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. ..
T Consensus 156 ~----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~---~~--------- 217 (277)
T cd06640 156 I----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--MRVLFLIPK---NN--------- 217 (277)
T ss_pred c----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--HhHhhhhhc---CC---------
Confidence 1 12234678899999999888899999999999999999999999875321 111111100 00
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+ .........+.+++.+|++.+|++||++.|++++
T Consensus 218 ----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 ----PP-----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----CC-----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00 1112345678899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=299.54 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=201.4
Q ss_pred CCCccccccccCCeeEEEEEECC--CCEEEEEEecCCC--------CCchhHHHHHHHHHHHhc-CCCCCeeeEEeEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKS--GETVAVKRLLGGT--------HKPETETVFRSEIETLGR-VRHGNVVKLLMCCSG 751 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 751 (973)
.|+..+.||+|+||.||+|..+. ++.+|+|.+.... ........+.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999999874 6889999875321 122233456678887765 799999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
++..++||||+++++|.+++.... ....+++..+++++.|++.|++|||+ . +++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999885422 23358889999999999999999996 5 899999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
||.+....... ......|+..|+|||+..++.++.++||||||+++|||++|+.||... ........+.....
T Consensus 158 fg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~ 230 (269)
T cd08528 158 FGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--NMLSLATKIVEAVY 230 (269)
T ss_pred ccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc--CHHHHHHHHhhccC
Confidence 99987654332 223456889999999999888999999999999999999999998643 22222222221111
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
. +. . .......+.+++.+|++.||++||++.||.++++.
T Consensus 231 ~---------------~~-~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 E---------------PL-P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred C---------------cC-C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1 00 0 01123568889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=304.98 Aligned_cols=273 Identities=21% Similarity=0.224 Sum_probs=197.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+.|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++|+||+++.+++..++..|+||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457888999999999999999875 689999999854432 233345678999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||++ +++.+++.... ..+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 77877765432 2467888889999999999999999 9999999999999999999999999998754322
Q ss_pred CCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC-----
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE----- 913 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 913 (973)
.. ......++..|+|||+..+. .++.++||||||+++|||++|+.||.......+.+.+.. .......+
T Consensus 157 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 231 (291)
T cd07870 157 SQ----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW-TVLGVPTEDTWPG 231 (291)
T ss_pred CC----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHH-HHcCCCChhhhhh
Confidence 11 12234568899999998754 578899999999999999999999975322212111111 10000000
Q ss_pred -----ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 -----RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 -----~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
............+.+............+.+++.+|++.||++|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000000001124567889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=304.41 Aligned_cols=253 Identities=27% Similarity=0.374 Sum_probs=200.2
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
.+....|...+.||+|+||.||+|+.. +|+.||+|++.... ......+.+.+|+++++.++|||++++.+++..++..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 344566889999999999999999876 68999999985433 2334446788999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
|+||||++ |++.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++..
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 99999996 67777775433 2589999999999999999999999 999999999999999999999999999865
Q ss_pred ccccCCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.... ....++..|+|||++. .+.++.++||||||+++|||++|+.||... +.......+. ....
T Consensus 165 ~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~--~~~~~~~~~~---~~~~ 231 (307)
T cd06607 165 VSPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIA---QNDS 231 (307)
T ss_pred cCCC--------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc--cHHHHHHHHh---cCCC
Confidence 4322 1245788999999874 456888999999999999999999998642 1111111111 1100
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
+ .+ ........+.+++.+|++.+|++||++.+|+++.
T Consensus 232 ~-------------~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 P-------------TL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred C-------------CC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 00 0112345789999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=300.10 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=187.8
Q ss_pred ccccccCCeeEEEEEECCC---CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLKSG---ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+++..++ ..+++|.+.... .....+.+.+|+..++.++||||+++++++......|+||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999976543 345667664322 234456789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc
Q 039922 765 GSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843 (973)
Q Consensus 765 gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 843 (973)
|+|.++++.... ....++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh--
Confidence 999999976432 23466777889999999999999999 999999999999999999999999998754322111
Q ss_pred cccccccccccCccccccccC-------CCCCCCCChhhHHHHHHHHHcC-CCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYT-------KKVTEKSDVYSFGVVLMELVTG-KRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
........++..|+|||+... ..++.++||||||+++|||+++ ..||... ...+....+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~~------ 226 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--SDREVLNHVIKDQQ------ 226 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhhcc------
Confidence 011123457889999998753 2457899999999999999975 5566432 22222222211111
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
..+.++.+.. .....+.+++..|+ .+|++||++.||++.|.
T Consensus 227 -----~~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 -----VKLFKPQLEL-----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -----cccCCCccCC-----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1122222221 12346777888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.47 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=200.5
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC---CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH---KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+|+..+.||+|++|.||+|... +++.||+|.+..... ..+..+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999987 799999998854321 233456788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999987543 478999999999999999999999 999999999999999999999999999876533
Q ss_pred cCCCccccccccccccCccccccccCCC-CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKK-VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.. ......|+..|+|||...... ++.++|+||||+++|+|++|+.||.... .......+ ....
T Consensus 155 ~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~----~~~~------ 218 (258)
T cd06632 155 FS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKI----GRSK------ 218 (258)
T ss_pred cc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHH----Hhcc------
Confidence 22 122356788999999987766 8999999999999999999999997532 11111111 1100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... + .......+.+++.+|++.+|++||++.+++++
T Consensus 219 -~~~~-~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 -ELPP-I---------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -cCCC-c---------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000 0 01123567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.29 Aligned_cols=272 Identities=24% Similarity=0.317 Sum_probs=202.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35778899999999999999986 58999999986544444455678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|++++++.++..... .+++..+..++.|++.|++|||+. +++|||++|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999988888765432 489999999999999999999999 99999999999999999999999999987654332
Q ss_pred CCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc----
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG---- 915 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 915 (973)
. ......++..|+|||+..+ ..++.++||||||+++|||++|+.||.... ..+....+...........
T Consensus 155 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E----VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS--DIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c----ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1233467889999998875 457889999999999999999998886432 1111111111100000000
Q ss_pred ccC-cccccccCCCCCC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCR-DLNQLIDPRMDLS----TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~-~l~~~~d~~l~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... .......+..... ...+.....+.+++.+|++++|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 0000000000000 0011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=308.17 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=202.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc-hhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP-ETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+|+..+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|++.++.++|+||+++++.+..++..|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5778899999999999999887 58999999996543322 345668899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999987532 23688999999999999999999999 99999999999999999999999999987653321
Q ss_pred CCcc-------------------------ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC
Q 039922 841 GQSD-------------------------DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG 895 (973)
Q Consensus 841 ~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 895 (973)
.... .......|+..|+|||+..+..++.++||||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~- 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN- 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc-
Confidence 1100 01113468889999999998889999999999999999999999997532
Q ss_pred CchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHHH
Q 039922 896 ENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS----MRRVVEL 965 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps----~~evl~~ 965 (973)
.......+...... ... .......+.+++.+|++.+|++||+ +.|++++
T Consensus 237 -~~~~~~~~~~~~~~-------------------~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 -RDETFSNILKKEVT-------------------FPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred -hHHHHHHHhcCCcc-------------------CCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11111111110000 000 0114567899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=316.79 Aligned_cols=253 Identities=28% Similarity=0.391 Sum_probs=210.8
Q ss_pred CCccccccccCCeeEEEEEEC-CCC----EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.+..++||+|+||+||+|.+- .|+ +||+|++.. ....+...++.+|+..|.+++|||++|++++|.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 345789999999999999864 443 689998853 344556678999999999999999999999998766 7899
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
++||+.|+|.+|++.++. .+-....+.|..|||+||.|||.+ ++|||||..+||||.+-.++|+.|||+++....
T Consensus 776 tq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999998654 588889999999999999999999 999999999999999999999999999998877
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
++....... ..-.+.|||-|.+....|+.++|||||||++||++| |..|++.. ..+++.+.++.+.+-..+..
T Consensus 851 d~~ey~~~~--gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--~~~eI~dlle~geRLsqPpi-- 924 (1177)
T KOG1025|consen 851 DEKEYSAPG--GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--PAEEIPDLLEKGERLSQPPI-- 924 (1177)
T ss_pred ccccccccc--cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC--CHHHhhHHHhccccCCCCCC--
Confidence 665433222 223578999999999999999999999999999999 99999863 45566666666554333322
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
...++..++.+||..|+..||+++++...+.+
T Consensus 925 -------------------CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 925 -------------------CTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -------------------ccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 34567888999999999999999999888765
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.49 Aligned_cols=238 Identities=25% Similarity=0.395 Sum_probs=188.3
Q ss_pred ccccccCCeeEEEEEECCCC-----------EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 688 NLIGSGGSCRVYKVKLKSGE-----------TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
+.||+|+||.||+|..++.. .|++|.+.... .....+.+|+.++++++|+||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999987433 47778763222 125778899999999999999999999988 7789
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-------ceEEec
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-------VPRVAD 829 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~D 829 (973)
+||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999999986543 588999999999999999999999 999999999999999888 799999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCC--CCCCCCChhhHHHHHHHHHcC-CCCCCCCCCCchhHHHHHHH
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK--KVTEKSDVYSFGVVLMELVTG-KRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~ 906 (973)
||++...... ....++..|+|||++.+. .++.++||||||+++||+++| ..|+.... ......+...
T Consensus 152 fg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~~~~~~~~ 221 (259)
T cd05037 152 PGIPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSEKERFYQD 221 (259)
T ss_pred CCcccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chhHHHHHhc
Confidence 9998765431 123466789999998876 789999999999999999994 66665432 1111221110
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
. .. .. ......+.+++.+|++.+|++||++.||++.|+
T Consensus 222 ---~-------~~--------~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 ---Q-------HR--------LP-----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---C-------CC--------CC-----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 00 001167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=304.58 Aligned_cols=269 Identities=23% Similarity=0.291 Sum_probs=201.6
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.|+..+.||+|++|.||+|+.+ +|+.||+|++............+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3778899999999999999876 789999999865444444556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+. ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 68988886543 23588999999999999999999999 999999999999999999999999999876543221
Q ss_pred CccccccccccccCccccccccCCC-CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC--
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKK-VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR-- 918 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 918 (973)
......++..|+|||+..+.. ++.++||||||+++|||+||+.||.... +.....+.+...... ......
T Consensus 156 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~ 228 (284)
T cd07860 156 ----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQLFRIFRTLGTP--DEVVWPGV 228 (284)
T ss_pred ----ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHhCCC--Chhhhhhh
Confidence 122335678999999887644 5889999999999999999999997532 222222222211111 000000
Q ss_pred --------cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 --------DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 --------~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+.....+. ...+.....+.+++.+|++.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFS--KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHH--HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0001123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=339.66 Aligned_cols=257 Identities=26% Similarity=0.334 Sum_probs=208.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
-+|....+||.|.||.||.|... +|+..|+|.+..............+|..++..++|||+|+++|+=...+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 35677889999999999998754 78999999886554444444567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
||++|+|.+.+.... ..++........|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1315 yC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999887532 355666667788999999999999 99999999999999999999999999999987775
Q ss_pred CCccccccccccccCccccccccCC---CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTK---KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
...+.......||+.|||||++.+. ....++||||+|||+.||+||+.||..-. .+-.+...+..+.....|
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-ne~aIMy~V~~gh~Pq~P---- 1463 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-NEWAIMYHVAAGHKPQIP---- 1463 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-chhHHHhHHhccCCCCCc----
Confidence 5555666778999999999999764 45679999999999999999999998643 333333333332222111
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.....+-.+++..|++.||++|.++.|++++=
T Consensus 1464 -----------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1464 -----------------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred -----------------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 11344557888899999999999999998763
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.88 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=200.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+.|.....||+|+||.||++... +++.||+|++.. ......+.+.+|+..++.++|+|++++++.+..++..++||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL--RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec--chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 344555678999999999999875 688999999843 23344566889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++... .+++..+..++.||+.|++|||+. +++||||||+||++++++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 99 EFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred eCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999999987542 478899999999999999999999 9999999999999999999999999998765332
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. ......|+..|+|||+..+..++.++||||||+++|||++|+.||... +.......+......
T Consensus 172 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--~~~~~~~~~~~~~~~--------- 236 (292)
T cd06658 172 VP----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLPP--------- 236 (292)
T ss_pred cc----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCC---------
Confidence 21 122356889999999998888999999999999999999999999753 111211111111100
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.. .......+.+++.+|++.||.+|||+.|++++
T Consensus 237 -------~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 237 -------RVKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -------cccc---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 01223467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=300.97 Aligned_cols=257 Identities=29% Similarity=0.449 Sum_probs=198.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC--------chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK--------PETETVFRSEIETLGRVRHGNVVKLLMCCSGQD 753 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 753 (973)
+|...+.||+|+||.||+|... +|+.||+|.+...... ....+.+.+|+..++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999865 6899999988432111 112345788999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..++||||+++++|.++++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999987652 588899999999999999999999 9999999999999999999999999998
Q ss_pred hhccccCCCccccccccccccCccccccccCCC--CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK--VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
......... .......|+..|+|||...... ++.++||||+|+++||+++|..||... .............
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDN--DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EAIAAMFKLGNKR- 228 (272)
T ss_pred ccccccccc--cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc----chHHHHHHhhccc-
Confidence 765332211 1122345788999999987654 789999999999999999999998532 1111111111100
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....+... ........+.+++.+|++++|++||++.||+++
T Consensus 229 --------~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 --------SAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --------cCCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00001111 112234678889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=296.27 Aligned_cols=252 Identities=31% Similarity=0.483 Sum_probs=201.5
Q ss_pred CCccccccccCCeeEEEEEECC-----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKS-----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+++.+.||.|+||.||+++..+ +..||+|++.... .....+.+.+|++.++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999998763 4889999985332 222566789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999876432 1289999999999999999999999 999999999999999999999999999877654
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
....... ...++..|+|||...+..++.++||||+|+++|||++ |..||... ......+.+........
T Consensus 156 ~~~~~~~---~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~----- 225 (258)
T smart00219 156 DDYYKKK---GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLKKGYRLPK----- 225 (258)
T ss_pred ccccccc---cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCC-----
Confidence 3221111 1236789999999988889999999999999999998 77777542 33333443332211100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
......++.+++.+|++.+|++|||+.|+++.|
T Consensus 226 ----------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ----------------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----------------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011345688899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=301.69 Aligned_cols=272 Identities=21% Similarity=0.267 Sum_probs=198.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|++|.||+|+.+ +++.||+|.+...... .....+.+|++++++++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 357888999999999999999976 7899999998543322 22344678999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||++ ++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 83 e~~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 83 EYLD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred ecCC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9997 599998875433 578999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. ......++..|+|||+..+ ..++.++||||+|+++|||++|+.||...... .+....+........+. ...
T Consensus 157 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~ 230 (291)
T cd07844 157 SK----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-EDQLHKIFRVLGTPTEE-TWP 230 (291)
T ss_pred Cc----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHhcCCCChh-hhh
Confidence 11 1122346788999998865 45788999999999999999999999653211 11111111111110000 000
Q ss_pred cccc---ccc--------CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQ---LID--------PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~---~~d--------~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... ... ..+............+.+++.+|++.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 000 0000000001112567899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=301.97 Aligned_cols=257 Identities=28% Similarity=0.338 Sum_probs=199.4
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC---
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ--- 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--- 752 (973)
.++.++|...+.||+|+||.||+|..+ +++.+|+|++... ......+.+|+.+++++ +|+|++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 456788999999999999999999875 6889999998432 22345677899999998 799999999998653
Q ss_pred --CeeEEEEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 753 --DFNILVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 753 --~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
+..++||||+++++|.++++... ....+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence 35899999999999999886432 233588999999999999999999999 999999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCC-----CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-----KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 904 (973)
||.+......... .....|+..|+|||+.... .++.++|||||||++|||++|+.||.... ....+.++.
T Consensus 172 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-~~~~~~~~~ 246 (291)
T cd06639 172 FGVSAQLTSTRLR----RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-PVKTLFKIP 246 (291)
T ss_pred cccchhccccccc----ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHh
Confidence 9998765432211 1224578899999987543 36889999999999999999999997531 111222111
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. . .. ..+.++ ......+.+++.+|++.+|++||++.|++++
T Consensus 247 -~---~-~~-------~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 -R---N-PP-------PTLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -c---C-CC-------CCCCcc--------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 1 00 001111 1223468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.04 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=197.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC---chhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--Cee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK---PETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 755 (973)
..|+..+.||+|+||.||.|... +|+.||+|++...... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999875 6899999988533221 23345788899999999999999999988763 567
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++++|.+++.... .+++..+.+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 478888899999999999999999 999999999999999999999999999876
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
....... ........|+..|+|||...+..++.++||||||+++|||++|+.||.... ..... ........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~----~~~~~~~~--- 226 (265)
T cd06652 156 LQTICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-AMAAI----FKIATQPT--- 226 (265)
T ss_pred ccccccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-hHHHH----HHHhcCCC---
Confidence 5432111 112233568899999999988889999999999999999999999996421 11111 11111100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+ .........+..++.+|+. +|++||+++||+++
T Consensus 227 ---------~~-----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 ---------NP-----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---------CC-----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00 0112334567788889985 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=303.19 Aligned_cols=273 Identities=22% Similarity=0.250 Sum_probs=201.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--CeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 757 (973)
.+.|+..+.||+|+||.||+|+.+ +++.||+|.+............+.+|+.++++++||||+++++++... +..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 356888999999999999999987 688999999964443333444577899999999999999999998877 88999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+....
T Consensus 84 v~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999996 599988875432 589999999999999999999999 99999999999999999999999999988664
Q ss_pred ccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.... ......++..|+|||...+. .++.++||||+|+++|||++|..||..... ......+...........+
T Consensus 158 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 158 SPLK----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred CCcc----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchHHH
Confidence 4321 12234577899999988754 468899999999999999999999975321 1111111111110000000
Q ss_pred c----------CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 C----------RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~----------~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ....+.....+............+.+++.+|++.+|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000000000000000125668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.72 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=206.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|...+.||+|++|.||+|+.. +++.||+|++...... .....+.+|+..+.+++|+|++++++++...+..++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 5778899999999999999987 5999999998544322 4567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999764 358999999999999999999999 8 99999999999999999999999999987664332
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC-CchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. .....++..|+|||...+..++.++||||||+++|||++|+.||..... ...+...++......
T Consensus 155 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 221 (264)
T cd06623 155 DQ----CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP--------- 221 (264)
T ss_pred Cc----ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC---------
Confidence 21 1234578899999999998999999999999999999999999975431 222223322211100
Q ss_pred ccccccCCCCCCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYE-EAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ... ....+.+++.+|++++|++||++.|++++
T Consensus 222 -------~~-----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 -------SL-----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------CC-----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 011 34678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=310.38 Aligned_cols=270 Identities=21% Similarity=0.235 Sum_probs=201.5
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC------
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------ 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 752 (973)
+.++|+..+.||+|+||.||+|+.. +|+.||+|++............+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 5678999999999999999999876 789999999865444444556677899999999999999999988643
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
...|+||||++ ++|.+.+... +++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35699999995 6888877532 78888999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC-
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS- 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 911 (973)
++....... .....++..|+|||...+..++.++||||+||++|+|++|+.||.... .......+.......
T Consensus 165 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD--HIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCCC-----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhcCCCC
Confidence 976533221 223457889999999999999999999999999999999999996431 111111111100000
Q ss_pred -----------------CCccccCcccccccCCCCC---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 -----------------PERGCCRDLNQLIDPRMDL---STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 -----------------~~~~~~~~l~~~~d~~l~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+......+.+.+...... ..........+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000111111111000 00012345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=297.99 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=201.7
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCeeEEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDFNILVY 759 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 759 (973)
+|...+.||.|++|.||+|..+ +++.||+|.+..... ......+.+|++++++++|+||+++++++.. .+..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5778889999999999999986 688999998854322 2455678899999999999999999998865 34689999
Q ss_pred eccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998876422 233578889999999999999999999 999999999999999999999999999865432
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC---CchhHHHHHHHHhccCCCcc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG---ENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~ 915 (973)
.. .....++..|+|||...+..++.++||||+|+++|||++|+.||..... ...+...++......
T Consensus 158 ~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 226 (287)
T cd06621 158 SL------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP----- 226 (287)
T ss_pred cc------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-----
Confidence 21 1124577899999999989999999999999999999999999976422 122233332221100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+ .. .........+.+++.+|++.+|++|||+.|++++
T Consensus 227 ------~~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 ------ELKD-EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ------hhcc-CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0000 00 0001234678899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=304.55 Aligned_cols=250 Identities=20% Similarity=0.336 Sum_probs=199.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
..|.....||+|+||.||++... +++.||+|++.... ....+.+.+|+..++.++|||++++++++..++..++|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34555668999999999999875 78999999985332 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 99 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred cCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999999877542 478999999999999999999999 99999999999999999999999999987554322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......|+..|+|||+..+..++.++|||||||++|||++|+.||... +.......+...... ..
T Consensus 172 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~--------~~ 237 (297)
T cd06659 172 P----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD--SPVQAMKRLRDSPPP--------KL 237 (297)
T ss_pred c----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhccCCC--------Cc
Confidence 1 122356889999999999889999999999999999999999999753 222222222111000 00
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ........+.+++.+|++.+|++||++.|++++
T Consensus 238 --------~---~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 --------K---NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --------c---ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 001123457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=301.91 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=200.7
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+|+..+.||+|+||.||++... +++.||+|++..... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5788899999999999999876 689999999854322 22345668899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999987653 588999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.....+++.|+|||...+...+.++||||||+++|+|++|+.||.... .....+.+......
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~---------- 216 (290)
T cd05580 155 ------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEGKVR---------- 216 (290)
T ss_pred ------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCcc----------
Confidence 123468899999999988888999999999999999999999997532 22222222111100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
+. ......+.+++.+|++.+|.+|+ ++.|++++
T Consensus 217 -------~~-----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 -------FP-----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -------CC-----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 00 11135678899999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.25 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=201.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++|||++++++++...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 467888999999999999999865 6889999998432 2334566889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999998653 368889999999999999999999 9999999999999999999999999988765433
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. ......++..|+|||...++.++.++||||||+++||+++|+.||...... ..+.. +... . .
T Consensus 169 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-~~~~~-~~~~--~-~------- 232 (293)
T cd06647 169 QS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYL-IATN--G-T------- 232 (293)
T ss_pred cc----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-hheee-hhcC--C-C-------
Confidence 21 122346888999999998888999999999999999999999999753211 11110 0000 0 0
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+. ........+.+++.+|++.+|++||++.+++.+
T Consensus 233 ------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 ------PELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ------CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011234568889999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=279.90 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=205.4
Q ss_pred eccccccccCCCCcc-ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEE
Q 039922 673 VSFNEDDILPHLTEQ-NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCC 749 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 749 (973)
..+.+..++++|++. ++||-|-.|.|-.+..+ +|+++|+|++.. ....++|++.--.. .|||||.++++|
T Consensus 52 m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 52 MDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred cchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhh
Confidence 334445677777764 68999999999998766 799999998831 22356777765554 599999999987
Q ss_pred ec----CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---C
Q 039922 750 SG----QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---E 822 (973)
Q Consensus 750 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~ 822 (973)
+. .....+|||.|+||.|...+...+. ..+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.+. +
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCC
Confidence 54 5677899999999999999987653 4689999999999999999999999 9999999999999964 5
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC--chhH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDI 900 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~ 900 (973)
..+||+|||+++..... .......-|+.|.|||++...+|+...|+||+||++|-|++|.+||+...+. ...+
T Consensus 201 a~lKLtDfGFAK~t~~~-----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM 275 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQEP-----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275 (400)
T ss_pred cceEecccccccccCCC-----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH
Confidence 67999999999875432 3345567799999999999999999999999999999999999999875431 1223
Q ss_pred HHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+..+... +.++++ ....+...++++.++..+|++|.|+.|++.+
T Consensus 276 k~rI~~gqy~------------FP~pEW------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 276 KRRIRTGQYE------------FPEPEW------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHhhccCcc------------CCChhH------hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 3333333322 222211 3457788999999999999999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=300.38 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=199.4
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCC----
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQD---- 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~---- 753 (973)
..++|+..+.||+|++|.||+|+.+ +++.||+|++... ....+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4578999999999999999999986 6789999988433 22446789999999999 6999999999996544
Q ss_pred --eeEEEEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 754 --FNILVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 754 --~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
..++||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 5899999999999999886532 234688999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC-----CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-----KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 905 (973)
|.+........ ......|+..|+|||++.. ..++.++||||+|+++|||++|+.||.... ........ .
T Consensus 158 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~-~ 231 (275)
T cd06608 158 GVSAQLDSTLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-PMRALFKI-P 231 (275)
T ss_pred ccceecccchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-hHHHHHHh-h
Confidence 99876533221 1223468889999998753 346789999999999999999999996421 11111111 1
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ... +.+ .........+.+++.+|++.||++|||+.|++++
T Consensus 232 ~---~~~-------------~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 R---NPP-------------PTL---KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c---cCC-------------CCC---CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 000 000 0112245678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=318.98 Aligned_cols=362 Identities=22% Similarity=0.349 Sum_probs=257.9
Q ss_pred cchhHHHhhccCccc-ccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCcccee
Q 039922 217 LSKLENLWAAKANLI-GEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRL 295 (973)
Q Consensus 217 l~~L~~L~l~~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 295 (973)
|+-.+-.++++|.+. +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..++.++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 344455667778777 567777888888888888888777 67888888888888888888877 456677778888888
Q ss_pred eccccccC--CCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCC-CccCCCCccceeeeccc
Q 039922 296 DISQNNLT--GNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPD-DLGKYSNLEYFDVSTND 372 (973)
Q Consensus 296 ~Ls~N~l~--~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~ 372 (973)
++.+|++. |+.++.|....|+.||||+|+++ ..|..+..-+++..|+||+|+|. .||. .|.+++.|-+||||+|+
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccch
Confidence 88888773 45555555557888888888887 67777777777788888888887 4444 45677777788888888
Q ss_pred ccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccc-cccCcccCCCCCccEEEeecCcccCCCCC
Q 039922 373 FTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQ-GELPSKFWGLPEVDFFEMYNNRFEGSISP 451 (973)
Q Consensus 373 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 451 (973)
+. .+|.....+..|+.|.|++|.+...--..+-.+++|++|.+++.+=+ ..+|.++..+.+|..+|++.|.+. ..|+
T Consensus 162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPe 239 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPE 239 (1255)
T ss_pred hh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchH
Confidence 76 56666777777777777777776544445556667777777766532 456667777777777777777776 4567
Q ss_pred CCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeecccccccc-ccCcccCcccc
Q 039922 452 SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG-ELPRNLNSLTA 530 (973)
Q Consensus 452 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~ 530 (973)
.+.++++|+.|+||+|.|+ .+.-..+.-.+|++|+||.|+++ .+|.++.++++|+.|.+.+|+++- -+|..++.+.+
T Consensus 240 cly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~ 317 (1255)
T KOG0444|consen 240 CLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQ 317 (1255)
T ss_pred HHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhh
Confidence 7777777777777777776 44444444556777777777777 677777777777777777777662 36777777777
Q ss_pred ceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcC
Q 039922 531 LIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKL 588 (973)
Q Consensus 531 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l 588 (973)
|+.+..++|.+. ..|+.++.+..|+.|.|+.|+|- .+|..+--+ .|..||+..|.-
T Consensus 318 Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 318 LEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred hHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 777777777776 67777777777777777777776 677776666 677777777653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=297.59 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=202.2
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|...+.||+|+||.||+|..+ +|..||+|.+..........+.+.+|+.+++.++|+|++++++++..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3677889999999999999986 688999999855433334556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~~~~~ 840 (973)
+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999875432 3578999999999999999999999 999999999999999885 46999999987664322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......|+..|+|||+..+..++.++||||||+++|||++|+.||.... ..+++....... .
T Consensus 157 ~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~--------~ 219 (257)
T cd08225 157 E----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGY--------F 219 (257)
T ss_pred c----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhccc--------C
Confidence 1 1222458889999999988889999999999999999999999986421 122222211110 0
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ..+.....+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 AP----------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CC----------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 001223568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.95 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=199.0
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+|...+.||+|+||.||++..+ +++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999876 678999999854422 12334567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999997643 588899999999999999999999 99999999999999999999999999886421110
Q ss_pred CC-----------ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 841 GQ-----------SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 841 ~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
.. .........++..|+|||.+.+..++.++||||||+++|||++|..||... ...+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~~~~~~~~~~~~~ 233 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDDI 233 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccc
Confidence 00 000111245788999999998889999999999999999999999999743 22222222111111
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
.. +. ........+.+++.+|++.+|++||++.++.+.|+
T Consensus 234 ~~--------------~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 234 EW--------------PE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CC--------------CC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 10 00 00122456789999999999999998655555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.74 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=200.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
-|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+..+++++|+||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4677889999999999999875 68899999884332 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++..+.....
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999998642 478999999999999999999999 999999999999999999999999999876543221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......++..|+|||+..+..++.++|||||||++|||++|..||.... .......+.... . .
T Consensus 157 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~---~-----~--- 219 (277)
T cd06641 157 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--PMKVLFLIPKNN---P-----P--- 219 (277)
T ss_pred ----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--hHHHHHHHhcCC---C-----C---
Confidence 1223467889999999988889999999999999999999999986421 112222111100 0 0
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ........+.+++.+|++.+|++||++.+++++
T Consensus 220 -----~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 -----T-----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -----C-----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 011234567889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.02 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=197.7
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG----- 751 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----- 751 (973)
...+.|+..+.||+|+||.||+|+.. +++.||+|++... ......+..|+.+++++ +|+|++++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 44567889999999999999999875 6889999988432 23345678899999998 69999999999853
Q ss_pred -CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 752 -QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 752 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
.+..|++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|+|++|+||++++++.++|+||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 467899999999999999887543 23578888999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 905 (973)
|++........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.||..... ...... +.
T Consensus 166 g~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~~~~-~~ 239 (282)
T cd06636 166 GVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-MRALFL-IP 239 (282)
T ss_pred cchhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-Hhhhhh-Hh
Confidence 99876532221 123356889999999875 35678899999999999999999999964321 111110 00
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. . . .+... .......+.+++.+|++.||++||++.|++++
T Consensus 240 ~---~-~------------~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 R---N-P------------PPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred h---C-C------------CCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 0 0 00000 01234578999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=298.70 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=202.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+.+|++.+++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999986 689999999964432 22456778999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998765 2588999999999999999999999 99999999999999999999999999987654332
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
......|+..|+|||+..+..++.++|+||+|+++|+|++|..||...... ...++.........
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~------- 219 (258)
T cd05578 155 -----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQETADV------- 219 (258)
T ss_pred -----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhccccc-------
Confidence 122356788999999998888999999999999999999999999754221 12222211111000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM--RRVVE 964 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~--~evl~ 964 (973)
.........+.+++.+|++.||.+||++ +|+++
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 -----------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -----------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0001223678899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=296.96 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=206.5
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.+..+.|+..+.||+|++|.||+|..+ +++.||+|++..... ..+.+.+|++.+++++|+|++++++++...+..+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 456677889999999999999999987 789999999953322 4567889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+|+||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 9999999999999998754 3589999999999999999999998 9999999999999999999999999998765
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ......++..|+|||+..+..++.++||||||+++|||++|+.||... ........+......
T Consensus 167 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~--~~~~~~~~~~~~~~~------ 234 (286)
T cd06614 167 TKEKS----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE--PPLRALFLITTKGIP------ 234 (286)
T ss_pred ccchh----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCC------
Confidence 43221 112345788999999998888999999999999999999999998642 111111111111000
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
... ........+.+++.+|++.+|.+||++.+++++-
T Consensus 235 -----~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 235 -----PLK--------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred -----CCc--------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 000 0011245688999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=297.74 Aligned_cols=249 Identities=20% Similarity=0.328 Sum_probs=199.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.|...+.||+|++|.||++... +++.||+|++.. ......+.+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL--RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec--cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 4556689999999999999865 788999998842 2334455688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 98 LEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999999876 2478899999999999999999999 999999999999999999999999998875533221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......|+..|+|||...+..++.++||||||+++|||++|+.||.... .......+.. ..++
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~~~~~~---~~~~-------- 233 (285)
T cd06648 171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAMKRIRD---NLPP-------- 233 (285)
T ss_pred ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHh---cCCC--------
Confidence 1223468899999999988889999999999999999999999986421 1111111111 1000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... ........+.+++.+|++++|++||++.+++++
T Consensus 234 -----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 234 -----KLK---NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -----CCc---ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 000 001123578999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.47 Aligned_cols=273 Identities=25% Similarity=0.292 Sum_probs=200.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--CeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 757 (973)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++............+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999986 689999999864433333334567899999999999999999998754 56899
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||++ ++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 58888887543 3589999999999999999999999 99999999999999999999999999988764
Q ss_pred ccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||... +..+....+........ ...
T Consensus 160 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~--~~~~~~~~~~~~~~~~~-~~~ 232 (309)
T cd07845 160 LPAK----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK--SEIEQLDLIIQLLGTPN-ESI 232 (309)
T ss_pred CccC----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCC-hhh
Confidence 3321 1222345788999998865 55789999999999999999999999753 22222222222111100 000
Q ss_pred cCcccc-----ccc-CCCCCCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 917 CRDLNQ-----LID-PRMDLSTC---DYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 917 ~~~l~~-----~~d-~~l~~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
...+.. .+. +....... .......+.+++.+|++.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000000 000 00000000 011245678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=303.30 Aligned_cols=256 Identities=26% Similarity=0.354 Sum_probs=212.9
Q ss_pred ccccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 676 NEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.+..-+..|.+...||+|.|+.|..++.. ++..||+|.+.+........+.+.+|+++|..+.|||||+++.+.+....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 34555678999999999999999999876 79999999998776666665668999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.|+||||+.+|.+.+|+..+++ ..+..+..++.|+.+|++|+|++ .|||||||++||+++.++.+||+|||++.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccce
Confidence 9999999999999999998765 45578888999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.+... .......|++.|.|||+..+.+| ++.+|+||+|+++|-+..|..||++.. -..+.+.+..+..+.+
T Consensus 204 ~~~~~-----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--lk~Lr~rvl~gk~rIp- 275 (596)
T KOG0586|consen 204 FFDYG-----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--LKELRPRVLRGKYRIP- 275 (596)
T ss_pred eeccc-----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--cccccchheeeeeccc-
Confidence 87533 23456789999999999998776 579999999999999999999998631 1122121111111100
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.-...+..+++++++-.+|.+|++++++.++-
T Consensus 276 ---------------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 276 ---------------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ---------------------ceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 11134567889999999999999999998764
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=300.30 Aligned_cols=250 Identities=27% Similarity=0.371 Sum_probs=198.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
..|...+.||+|+||.||+|+.. +++.||+|++.... ........+.+|++++++++|+|++++++++..++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45778899999999999999875 68899999985432 22344457888999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||++ |++.+.+.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9996 58877775432 2589999999999999999999999 9999999999999999999999999988654321
Q ss_pred CCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||.... .......+.......
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~------ 243 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPT------ 243 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccCCC------
Confidence 2245788999999874 4568899999999999999999999986531 111122221111000
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
. ........+.+++.+|++.+|.+||++.+|+++..
T Consensus 244 -----------~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 -----------L----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -----------C----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 0 00123356889999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.70 Aligned_cols=244 Identities=25% Similarity=0.278 Sum_probs=188.1
Q ss_pred cccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc-hhHHHHHHHHHHHh---cCCCCCeeeEEeEEecCCeeEEEEeccC
Q 039922 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP-ETETVFRSEIETLG---RVRHGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
+||+|+||.||++... +++.||+|.+.+..... .....+.+|..+++ ..+|++++++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 68999999886543222 22233444544433 3479999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc
Q 039922 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843 (973)
Q Consensus 764 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 843 (973)
+|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999887543 589999999999999999999999 99999999999999999999999999986543221
Q ss_pred cccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
.....|+..|+|||...+ ..++.++||||+||++|||++|..||.......... +.......
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~----------- 214 (279)
T cd05633 152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTV----------- 214 (279)
T ss_pred ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhhcC-----------
Confidence 122468999999998864 568899999999999999999999997532222111 11111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
... .......++.+++.+|++.||++|| ++.|++++
T Consensus 215 --~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 --NVE-----LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --CcC-----CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000 0112345788999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.57 Aligned_cols=273 Identities=23% Similarity=0.289 Sum_probs=198.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCe-----
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDF----- 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 754 (973)
++|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35788899999999999999976 6899999988654433334456788999999995 6999999999877665
Q ss_pred eEEEEeccCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccC
Q 039922 755 NILVYEYMPNGSLADMLHEKGR--SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFG 831 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 831 (973)
.|+||||++ +++.+++..... ...+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 799999997 589888865432 23579999999999999999999999 9999999999999998 8999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
++........ ......+++.|+|||++.+ ..++.++||||||+++|||++|..||.... ............ .
T Consensus 157 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-~~~~~~~~~~~~--~ 229 (295)
T cd07837 157 LGRAFSIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS-ELQQLLHIFKLL--G 229 (295)
T ss_pred cceecCCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHh--C
Confidence 9876533221 1222356788999998865 457899999999999999999999996532 111221111110 0
Q ss_pred CCCccccCccccccc----CCC---CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLID----PRM---DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d----~~l---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.........+..+ +.. ......+....++.+++.+|++++|.+||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 010000000000000 000 0000111234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.01 Aligned_cols=270 Identities=26% Similarity=0.332 Sum_probs=200.8
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|+..+.||.|++|.||+|... +|+.||+|++............+.+|++.+++++|+|++++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999875 7999999998654433344456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 789998876542 3589999999999999999999999 999999999999999999999999999876532211
Q ss_pred ccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......++..|+|||++.+. .++.++||||||+++|||++|+.||.... ......+........ .........
T Consensus 155 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~ 228 (283)
T cd07835 155 ---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS-EIDQLFRIFRTLGTP--DEDVWPGVT 228 (283)
T ss_pred ---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCC--ChHHhhhhh
Confidence 12233568899999987654 56889999999999999999999997532 222222222111100 000000000
Q ss_pred cccc-----CCC---CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLID-----PRM---DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d-----~~l---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+ +.. ............+.+++.+|++++|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 000 0001111223578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=308.20 Aligned_cols=276 Identities=19% Similarity=0.239 Sum_probs=203.6
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec----CCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG----QDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 756 (973)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..........+.+.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888899999999999999876 69999999996544434445667789999999999999999988753 35679
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+. |+|.+++.... .+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68988886533 489999999999999999999999 9999999999999999999999999998766
Q ss_pred cccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
...............|+..|+|||++.+ ..++.++||||||+++|||++|+.||.... .......+.......++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~--~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN--YVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC--hHHHHHHHHHHhCCChhHh
Confidence 4433222222334578899999998765 468899999999999999999999996531 1111121111111100000
Q ss_pred ----ccCcccccccCCCCCCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 916 ----CCRDLNQLIDPRMDLST-----CDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 916 ----~~~~l~~~~d~~l~~~~-----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
......+..+....... ..+....++.+++.+|++.+|++||++.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00011111110000000 0122356789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=296.46 Aligned_cols=267 Identities=20% Similarity=0.216 Sum_probs=196.4
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecC--CeeEEEE
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQ--DFNILVY 759 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 759 (973)
|+..+.||+|+||.||+|+.. +++.||+|++........ .....+|+..++++. |+|++++++++.++ +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 566789999999999999875 689999999865433222 233457888888885 99999999999887 8899999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||++ |++.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++ +.+||+|||.++.....
T Consensus 80 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 80 ELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred ecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9996 68888876533 3589999999999999999999999 9999999999999999 99999999999766432
Q ss_pred CCCccccccccccccCcccccccc-CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc---
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG--- 915 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 915 (973)
.. .....++..|+|||+.. ++.++.++||||+||++|||++|..||... +..+...++...........
T Consensus 153 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PP-----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT--NELDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CC-----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC--CHHHHHHHHHHHcCCCCHHHHHh
Confidence 21 22345788999999765 456788999999999999999999999653 22333333332221111000
Q ss_pred -ccCcccccccCCCC---CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 -CCRDLNQLIDPRMD---LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 -~~~~l~~~~d~~l~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..........+... ...........+.+++.+|++++|++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 000012336789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=282.73 Aligned_cols=281 Identities=23% Similarity=0.281 Sum_probs=206.7
Q ss_pred ccCCCCccccccccCCeeEEEEEEC---C--CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-CC
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK---S--GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-QD 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 753 (973)
-...|+.+..||+|.||.||+|..+ + ...+|+|+++............-+|+..++.++|+|++.+..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3457889999999999999999654 2 2379999996554433444557789999999999999999998877 78
Q ss_pred eeEEEEeccCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC----CceEE
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR--SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE----MVPRV 827 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl 827 (973)
..++++||.+. +|.+.++.... ...++...+.+|+.||+.|+.|||++ =|+|||+||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 89999999974 88888865432 34688899999999999999999999 69999999999999877 89999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch-------h
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK-------D 899 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-------~ 899 (973)
+|+|+++.+...-.. -.....++.|++|.|||.+.+. .||.+.||||.||++.||+|-.+.|.....+.. +
T Consensus 178 aDlGlaR~~~~plkp-l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKP-LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred ecccHHHHhhccccc-cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 999999987654321 1223457789999999999875 589999999999999999999988865321111 1
Q ss_pred HHHHHHHHhccCCCccccCcccccccC-----CCCCCCCCHH-----------HHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039922 900 IVRWVTEATLSSPERGCCRDLNQLIDP-----RMDLSTCDYE-----------EAEKVLNVALMCTSDFPINRPSMRRVV 963 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~l~~~~d~-----~l~~~~~~~~-----------~~~~l~~l~~~cl~~dP~~Rps~~evl 963 (973)
-.+.+-+ ....|....+..+..+.+. .++...++.. .....++++.+++++||.+|.|+.+.+
T Consensus 257 Ql~rIf~-vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 257 QLDRIFE-VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHH-HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 1111111 1222333333333333332 1111111110 112367899999999999999999998
Q ss_pred HHH
Q 039922 964 ELL 966 (973)
Q Consensus 964 ~~L 966 (973)
++.
T Consensus 336 eh~ 338 (438)
T KOG0666|consen 336 EHP 338 (438)
T ss_pred ccc
Confidence 763
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=295.50 Aligned_cols=271 Identities=24% Similarity=0.327 Sum_probs=201.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|++|.||+|+.. +|+.||+|++..... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4778899999999999999986 689999999864432 23345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
++ ++|.+++........+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.+........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 97 58988887655444689999999999999999999999 999999999999999999999999999876543221
Q ss_pred CccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.... ..+....+........... ...+
T Consensus 156 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~ 228 (284)
T cd07836 156 ----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN--NEDQLLKIFRIMGTPTEST-WPGI 228 (284)
T ss_pred ----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCChhh-HHHH
Confidence 1223456889999998765 456889999999999999999999997542 2222222211111100000 0000
Q ss_pred cccc--cCCCCC-C-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLI--DPRMDL-S-----TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~--d~~l~~-~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... ...... . ...+.....+.+++.+|++.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 000000 0 0001224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.44 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=205.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--CeeEEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFNILVY 759 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 759 (973)
+|...+.||+|++|.||+|... +++.|++|++..........+.+.+|++.+++++|+||+++++.+... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999987 789999999865544445667889999999999999999999999988 8999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+|++|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987654 589999999999999999999998 9999999999999999999999999998876544
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
... .......++..|+|||...+...+.++||||||+++|+|++|..||.... .....+...... ..
T Consensus 155 ~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-------~~ 221 (260)
T cd06606 155 ETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGSS-------GE 221 (260)
T ss_pred ccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhcccc-------CC
Confidence 321 11233567889999999988889999999999999999999999997543 111111111100 00
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+ ........+.+++.+|++.+|++||++.|++++
T Consensus 222 ~~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPE----------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcC----------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 000 011224678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=295.92 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=198.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC---CCCeeeEEeEEecCCeeEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR---HGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 758 (973)
.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+.++++++ |+|++++++++..++..++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 4777889999999999999974 78999999985432 2334456888999999987 99999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.++++.. .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999988653 588999999999999999999999 999999999999999999999999999877644
Q ss_pred cCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... ......|+..|+|||...++ .++.++||||||+++|+|++|..||..... ..++......
T Consensus 154 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~~~~------- 217 (277)
T cd06917 154 NSS----KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMMLIPKS------- 217 (277)
T ss_pred Ccc----ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhccccC-------
Confidence 331 12234688899999988654 568899999999999999999999975311 1111110000
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
..+.+.. .....++.+++.+|++.||++||++.|++++-
T Consensus 218 ------~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 218 ------KPPRLED----NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred ------CCCCCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 0011110 01345688999999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=302.64 Aligned_cols=276 Identities=21% Similarity=0.267 Sum_probs=198.2
Q ss_pred CCCccccccccCCeeEEEEEECC---CCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--CeeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKS---GETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 756 (973)
+|...+.||+|+||.||+|+.+. ++.||+|.+.... ........+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999999764 7899999996532 1223335577899999999999999999999887 8899
Q ss_pred EEEeccCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC----CCceEEecc
Q 039922 757 LVYEYMPNGSLADMLHEKGR--SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA----EMVPRVADF 830 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 830 (973)
+||||++ +++.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++ ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 567776653322 23578899999999999999999999 9999999999999999 999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCc--------hhHH
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN--------KDIV 901 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--------~~~~ 901 (973)
|++......... ........++..|+|||++.+ ..++.++||||||+++|||++|+.||.....+. ..+.
T Consensus 157 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 157 GLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred ccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 998876433221 112233567889999998766 457899999999999999999999997643222 0111
Q ss_pred HHHHHHhccCCCcccc------Cccccc----ccCCCCCCCC----CH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 902 RWVTEATLSSPERGCC------RDLNQL----IDPRMDLSTC----DY--EEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~------~~l~~~----~d~~l~~~~~----~~--~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+...... ..... .+.... .......... .. ....++.+++.+|+++||++|||+.|++++
T Consensus 236 ~~~~~l~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTP--TEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCC--chhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111110000 00000 000000 0000000000 00 233568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=298.28 Aligned_cols=272 Identities=23% Similarity=0.309 Sum_probs=198.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|++|.||+|+.+ +|+.||+|++..........+.+.+|++++++++|+||+++++++..++..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999876 78999999985443333445668889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccCcchhcccc
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~~~ 839 (973)
|++ +++.+++..... ...++..+..++.||+.||+|||+. +++|+||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 688887754332 2367888889999999999999999 9999999999999985 567999999999765332
Q ss_pred CCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.... ....+..... .... +......
T Consensus 157 ~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~-~~~~~~~~~~-~~~~-~~~~~~~ 229 (294)
T PLN00009 157 V----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS-EIDELFKIFR-ILGT-PNEETWP 229 (294)
T ss_pred c----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHH-HhCC-CChhhcc
Confidence 1 112234578899999988664 57889999999999999999999997532 1122221111 1101 0000000
Q ss_pred ccccccc-----CCC---CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLID-----PRM---DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d-----~~l---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....+.+ +.. ......+....++.+++.+|++.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 000 0000011234568899999999999999999999874
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=292.89 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=197.2
Q ss_pred ccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
||+|++|.||+|+.. +++.||+|++.+... .....+.+.+|+.++++++|+||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 589999999865432 234456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccc
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----~~ 149 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KT 149 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----cc
Confidence 99997643 478899999999999999999999 99999999999999999999999999988764332 11
Q ss_pred cccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCC
Q 039922 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPR 927 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 927 (973)
....++..|+|||...+..++.++|+||+|+++|||++|..||.....+.......+...... ..
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------~~ 214 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK---------------LE 214 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC---------------CC
Confidence 224678899999999888899999999999999999999999976432222222211110000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 928 MDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 928 l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
........+.+++.+|++.+|++||+ +.|++++
T Consensus 215 -----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 215 -----FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred -----CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 00111457899999999999999999 7777663
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=279.59 Aligned_cols=243 Identities=23% Similarity=0.280 Sum_probs=202.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCch-hHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE-TETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|...+++|+|.||.|-.++.+ +|+.||+|++++...... ..+.-..|-++++..+||++..+-..|+..+..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 456888899999999999999876 799999999976654332 334456799999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||..||.|.-++.... .+++....-.-..|+.||.|||++ +||.||+|.+|.|+|.||++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999988776543 477777777888999999999999 99999999999999999999999999987532
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
....+...+.||+.|.|||++....|+.++|+|.+||++|||++|+.||... +...+.+.+.......|.
T Consensus 320 ---~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl~ed~kFPr----- 389 (516)
T KOG0690|consen 320 ---KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELILMEDLKFPR----- 389 (516)
T ss_pred ---cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHHhhhccCCc-----
Confidence 2235567789999999999999999999999999999999999999999863 556666666554433211
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP 957 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 957 (973)
....+...++...+.+||.+|.
T Consensus 390 -----------------~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 390 -----------------TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -----------------cCCHHHHHHHHHHhhcChHhhc
Confidence 1234566788899999999997
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=292.84 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=205.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|+||.||+++.+ +++.+|+|++............+.+|++.+++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 3677889999999999999865 788999999865544445566778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
+++++|.+++..... ...+++..++.++.|++.|++|||+. +++|+||+|+||++++++.+|++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999865322 23588999999999999999999999 99999999999999999999999999987764431
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.....++..|+|||...+..++.++|+||+|+++|||++|+.||... +.......+......
T Consensus 158 ------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~---------- 219 (256)
T cd08530 158 ------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR--SMQDLRYKVQRGKYP---------- 219 (256)
T ss_pred ------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCC----------
Confidence 12245788999999999989999999999999999999999999753 222222222211110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
........++.+++.+|++.+|++||++.|++++
T Consensus 220 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 -----------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112334668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=323.34 Aligned_cols=279 Identities=17% Similarity=0.230 Sum_probs=192.1
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC--CCCEEEEEEe--------------cCC-CCCchhHHHHHHHHHHHhcCCCC
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK--SGETVAVKRL--------------LGG-THKPETETVFRSEIETLGRVRHG 740 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~--------------~~~-~~~~~~~~~~~~e~~~l~~l~h~ 740 (973)
..+.++|++.+.||+|+||+||++..+ +++.++.|.+ .+. .........+.+|+.++++++|+
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345678999999999999999998754 2222222211 000 11223345678999999999999
Q ss_pred CeeeEEeEEecCCeeEEEEeccCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEE
Q 039922 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGR--SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818 (973)
Q Consensus 741 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 818 (973)
||+++++++...+..|+|+|++. +++.+++..... ........+..++.|++.||+|||+. +|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999999999999999999984 677777654321 11234566778999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC-C-
Q 039922 819 LDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-E- 896 (973)
Q Consensus 819 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~-~- 896 (973)
++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++..... .
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 99999999999999987643321 112235789999999999999999999999999999999998865433211 1
Q ss_pred chhHHHHHHHHhccCCCccccC---cccccccC-CCCCCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 897 NKDIVRWVTEATLSSPERGCCR---DLNQLIDP-RMDLSTCD-------YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~---~l~~~~d~-~l~~~~~~-------~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+.+.+..... .....+. .+.+.++. .+...... ......+.+++.+|+++||.+|||+.|++++
T Consensus 377 ~~~~~~~~~~~~~--~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 377 GKQLLKIIDSLSV--CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHHhccc--ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1222222211110 0000001 11111110 00000000 0112356778999999999999999999875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=302.29 Aligned_cols=272 Identities=19% Similarity=0.284 Sum_probs=196.7
Q ss_pred cccccc--CCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSG--GSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
..||+| +||+||.++.. +|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 89999999875 799999999865444444557789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
+++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999998876432 2478899999999999999999999 999999999999999999999999986544322111100
Q ss_pred ---ccccccccccCccccccccCC--CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc-c--
Q 039922 845 ---DAMSCVAGSYGYIAPEYAYTK--KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG-C-- 916 (973)
Q Consensus 845 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 916 (973)
.......++..|+|||++.+. .++.++||||+||++|||++|+.||..... .......+........... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR-TQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHhcCCCCCCccccccch
Confidence 001112345679999998763 478999999999999999999999975321 1111111111000000000 0
Q ss_pred ----------------------cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 ----------------------CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ----------------------~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......+.+..+. ..........+.+++++|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000000111111 01123356688999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=294.98 Aligned_cols=270 Identities=25% Similarity=0.332 Sum_probs=201.5
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--CeeEEEEe
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFNILVYE 760 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 760 (973)
|+..+.||+|+||.||+|+.. +|+.||+|++............+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999887 588999999965543344456688899999999999999999999887 89999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|++ ++|.+++.... ..+++..++.++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 58888886542 3589999999999999999999999 99999999999999999999999999988765433
Q ss_pred CCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......++..|+|||...+ ..++.++||||||+++|||++|+.||.... .......+............ ..
T Consensus 155 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~-~~ 228 (287)
T cd07840 155 S---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST--ELEQLEKIFELCGSPTDENW-PG 228 (287)
T ss_pred c---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCchhhc-cc
Confidence 1 11233456788999997764 457899999999999999999999997532 22222222222111111000 00
Q ss_pred cccc-----ccCCCCCC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQL-----IDPRMDLS-----TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~-----~d~~l~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..++ ..+..... .........+.+++.+|++.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1000 00000000 0000125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=306.54 Aligned_cols=270 Identities=21% Similarity=0.287 Sum_probs=198.9
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----C
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ-----D 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 753 (973)
+.++|++.++||+|+||.||+|+.. +|+.||+|++... ........+.+|+.++++++|+||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3567999999999999999999865 7899999998532 2233445678899999999999999999887543 3
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..|+|+||++ +++.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 5799999996 5887777542 588999999999999999999999 9999999999999999999999999998
Q ss_pred hhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
......... ........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||... +.......+........
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~--~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK--DYLHQLNLILGVLGTPS 230 (336)
T ss_pred eeccccccc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHcCCCC
Confidence 765433221 112234568899999998654 56889999999999999999999999642 21121221111111100
Q ss_pred CccccCcccccccC-------------CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQLIDP-------------RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~~d~-------------~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .....+.+. ........+....++.+++.+|++.+|++||++.|++++
T Consensus 231 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 Q----EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred H----HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 011111100 000000001224568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=298.15 Aligned_cols=274 Identities=24% Similarity=0.281 Sum_probs=202.1
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-----
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD----- 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 753 (973)
..++|++.+.||+|+||.||+|..+ +|+.||+|++............+.+|++++++++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567889999999999999999986 6899999998654433444456788999999999999999999987654
Q ss_pred -----eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe
Q 039922 754 -----FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828 (973)
Q Consensus 754 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 828 (973)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 7777766532 2589999999999999999999999 99999999999999999999999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
|||.+........ .......++..|+|||...+ ..++.++||||+||++|||++|+.||... +.......+...
T Consensus 159 dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~--~~~~~~~~~~~~ 233 (302)
T cd07864 159 DFGLARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN--QELAQLELISRL 233 (302)
T ss_pred cccccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHH
Confidence 9999887644332 11223356788999998764 45788999999999999999999999753 222222223332
Q ss_pred hccCCCccccCccccc-----ccCCCCC----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQL-----IDPRMDL----STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~-----~d~~l~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....+... ..+.+. .++.... ..........+.+++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVW-PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhc-ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222111100 000000 0000000 00000124578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=299.03 Aligned_cols=256 Identities=26% Similarity=0.321 Sum_probs=194.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 760 (973)
+|...+.||+|+||.||+++.. +++.||+|++...... .....+.+|+..+.++. |+||+++++++..++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4566789999999999999876 6899999998543322 44567889999999996 9999999999999999999999
Q ss_pred ccCCCChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 761 YMPNGSLADMLHEK--GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 761 ~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|++ +++.++.... .....+++..+..++.|++.|++|||+.. +++||||||+||++++++.++|+|||+++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 4655443211 11235889999999999999999999742 899999999999999999999999999876543
Q ss_pred cCCCccccccccccccCccccccccCC---CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTK---KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
... .....|+..|+|||++.+. .++.++||||+||++|||++|+.||.... .....+.......++
T Consensus 161 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~~-- 229 (288)
T cd06616 161 SIA-----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDPP-- 229 (288)
T ss_pred CCc-----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCCC--
Confidence 221 1223578899999998766 68999999999999999999999996421 111222211111110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.. ........++.+++.+|++++|++||++.||+++
T Consensus 230 -----------~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 -----------ILSN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----------cCCC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0100 0012235678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=292.12 Aligned_cols=270 Identities=25% Similarity=0.305 Sum_probs=199.1
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC---CCCCeeeEEeEEecCCe-----
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV---RHGNVVKLLMCCSGQDF----- 754 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 754 (973)
|++.+.||+|+||.||+|+.+ +++.||+|++............+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999987 589999999965444333344566777776665 59999999999988776
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.+++|||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 589888875432 2589999999999999999999999 99999999999999999999999999987
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
....... .....++..|+|||+..+..++.++|||||||++|||++|..||.... ..+...+............
T Consensus 156 ~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA-----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc-----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHh
Confidence 6643321 122357889999999999999999999999999999999998886532 2222222222111110000
Q ss_pred cccCcc---cccccCCCC--CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDL---NQLIDPRMD--LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l---~~~~d~~l~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+... ......... .....+.....+.+++.+|++.||++||++.|++++
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 -WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred -cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000 000000000 011112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=286.99 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=202.5
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|+..+.||+|++|.||++... +++.|++|++..... ...+.+.+|++.+++++|++++++++++...+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 667789999999999999986 788999999954332 45567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 80 SGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999999987653 3589999999999999999999998 999999999999999999999999999877644321
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
.....++..|+|||+..+..++.++||||||+++|+|++|+.||.... .......... ... ..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~---~~~--------~~ 216 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--PMKALFKIAT---NGP--------PG 216 (253)
T ss_pred ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHh---cCC--------CC
Confidence 223567889999999998889999999999999999999999986431 1111111111 100 00
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... .......+.+++.+|++.||++|||+.|++++
T Consensus 217 ~~~--------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LRN--------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCc--------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 01124678899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=293.60 Aligned_cols=247 Identities=26% Similarity=0.287 Sum_probs=194.1
Q ss_pred ccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
||+|+||+||+|... +|+.||+|.+..... .......+.+|++++++++|||++++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 689999999854322 122344567899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccc
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+....... ..
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~ 151 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----KI 151 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----cc
Confidence 999876543 3588999999999999999999999 99999999999999999999999999987654321 12
Q ss_pred cccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCC
Q 039922 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPR 927 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 927 (973)
....++..|+|||+..++.++.++||||+|+++|+|++|+.||...... .....+.......+ .
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~-----~--------- 215 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK--VEKEELKRRTLEMA-----V--------- 215 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc--ccHHHHHhcccccc-----c---------
Confidence 2346788999999998888999999999999999999999999753221 11111111111100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 928 MDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 928 l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
.........+.+++.+|++.+|++|| ++.+++++
T Consensus 216 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 216 ----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 00011245678999999999999999 77777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.62 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=206.2
Q ss_pred cCCCCccccccccCCeeEEEEEECC-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+.|.++..+|.|+||.||++..++ +-..|.|++ .....+..+.|.-|++++...+||+||++++.|..++..++..
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI--etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI--ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhh--cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 3457788899999999999998774 344566777 4455666778999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
|||+||..+..+-..++ .+++.++..++.|++.||.|||++ +|+|||||+-|||++-+|.++|+|||.+......
T Consensus 109 EFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 99999999988876654 699999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
. .....+.||+.|||||+.. ..+|+.++||||||+++.||..+.+|.+.. ...+.+.+.....|+.
T Consensus 184 ~----qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllKiaKSePPT 254 (1187)
T KOG0579|consen 184 R----QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSEPPT 254 (1187)
T ss_pred H----hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHHHhhcCCCc
Confidence 1 1234478999999999874 567999999999999999999999987642 2233333333333321
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
+..| ......+.+++.+|+.++|..||+++++++|-
T Consensus 255 --------LlqP--------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 255 --------LLQP--------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred --------ccCc--------chhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 1121 22356788999999999999999999998874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=295.38 Aligned_cols=266 Identities=24% Similarity=0.304 Sum_probs=203.5
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|+..+.||+|++|.||+|+.. +++.+|+|++............+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999875 7899999998655544445667888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
+ +++.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred C-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 6 58888887643 3689999999999999999999999 99999999999999999999999999987664432
Q ss_pred ccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.......++..|+|||...+. .++.++||||+|+++|+|++|+.||.... ..+....+...... +.. ....
T Consensus 153 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~--~~~~~~~~~~~~~~-~~~---~~~~ 224 (283)
T cd05118 153 --RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS--EIDQLFKIFRTLGT-PDP---EVWP 224 (283)
T ss_pred --ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCC-Cch---Hhcc
Confidence 112334578899999998776 78999999999999999999999986532 11211111111100 000 1111
Q ss_pred cccc-----------C-CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLID-----------P-RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d-----------~-~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.+ . .............++.+++.+|+++||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111 0 000011112345789999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=299.59 Aligned_cols=277 Identities=23% Similarity=0.275 Sum_probs=198.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-------
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------- 752 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 752 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++............+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 567899999999999999999976 689999999865443333344567899999999999999999887543
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
...++||||++ +++.+.+.... ..+++.++..++.|+++||+|||+. +++|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 34699999996 57777665432 3589999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCc-------cccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH
Q 039922 832 LAKALQSQEGQS-------DDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 832 l~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 903 (973)
++.......... ........++..|+|||...+. .++.++|||||||++|||++|+.||.... .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~--~~~~~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS--DIDQLHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Confidence 997654332211 1112334678889999987654 57899999999999999999999986532 1111111
Q ss_pred HHHHhccCCCcccc--CcccccccCCCCCC-CCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 904 VTEATLSSPERGCC--RDLNQLIDPRMDLS-TCD-----YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 904 ~~~~~~~~~~~~~~--~~l~~~~d~~l~~~-~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+........+...+ ..+....+...... ... ......+.+++.+|++.+|++|||+.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11111111110000 00111110000000 000 1122568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=298.64 Aligned_cols=273 Identities=19% Similarity=0.199 Sum_probs=194.4
Q ss_pred ccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
+.+|.|+++.||+++. +++.||+|++..........+.+.+|++.+++++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344445555555444 699999999965544455667899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC---cc
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ---SD 844 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~---~~ 844 (973)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+..+...... ..
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999976432 2578888999999999999999999 9999999999999999999999999988655432211 11
Q ss_pred ccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC----CccccC
Q 039922 845 DAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP----ERGCCR 918 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 918 (973)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||.... ......+.+........ ......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP-ATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCccccccCchhhhcC
Confidence 11233457788999999875 357889999999999999999999997532 11111111111000000 000000
Q ss_pred cccc----cccCCC---CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 919 DLNQ----LIDPRM---DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 919 ~l~~----~~d~~l---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
...+ ..++.. ...........++.+++.+|+++||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0000 000000 00111223346788999999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=294.86 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=198.0
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|....+||+|+||.||++..+ +|+.||+|++.. ........+.+|+.+++.++|+|++++++++..++..++||||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc--cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 444578999999999999875 789999998842 23345567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~- 171 (292)
T cd06657 100 EGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 171 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence 999999887532 478899999999999999999999 999999999999999999999999998876543221
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
......|+..|+|||+..+..++.++||||+|+++|||++|..||... ........+...... ....
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~--------~~~~ 238 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPP--------KLKN 238 (292)
T ss_pred ---cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhhCCc--------ccCC
Confidence 122356789999999998888999999999999999999999998642 222222222211111 0000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+ ......+.+++.+|++.+|.+||++.|++++
T Consensus 239 -~----------~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 -L----------HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -c----------ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0 1123457788999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=287.39 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=205.8
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|...+.||+|+||.||++... +++.||+|++..........+.+.+|++.++.++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999976 689999999965554446667789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
+++++|.+++.... ....+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 124689999999999999999999999 99999999999999999999999999987654432
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......|+..|+|||...+..++.++||||+|+++|+|++|+.||... +...+.......... .+
T Consensus 158 ~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~--------~~ 223 (258)
T cd08215 158 D----LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE--NLLELALKILKGQYP--------PI 223 (258)
T ss_pred c----eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC--cHHHHHHHHhcCCCC--------CC
Confidence 1 122346788999999998888999999999999999999999998653 222222221111100 00
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ......+.+++.+|++.+|++||++.|++++
T Consensus 224 --------~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 --------P-----SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --------C-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 1123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=287.85 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=203.5
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|+..+.||+|++|.||+++.. +++.||+|.+..........+.+.+|++++++++|+|++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999876 688999999965544445567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998764 3589999999999999999999999 999999999999999999999999999987654332
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
. .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... ......... ... .
T Consensus 155 ~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~~~~~~~~~--~~~-~--------- 216 (254)
T cd06627 155 D----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--PMAALFRIV--QDD-H--------- 216 (254)
T ss_pred c----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHh--ccC-C---------
Confidence 1 223467889999999988888999999999999999999999987432 111111111 000 0
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+ .......+.+++.+|++.+|++||++.|++.+
T Consensus 217 ----~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 217 ----PPL-----PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ----CCC-----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 000 01124567899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=289.31 Aligned_cols=243 Identities=20% Similarity=0.267 Sum_probs=188.9
Q ss_pred CCCCccccc--cccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLI--GSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
+.|++.+.+ |+|+||.||++..+ +++.+|+|.+....... . |......+ +|+|++++++++..++..|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----h--hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 455666665 99999999999875 68889999885332111 1 22222212 69999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcchhc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKAL 836 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~ 836 (973)
||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++ .++|+|||.+...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999997653 589999999999999999999999 999999999999999988 9999999998765
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.... ...++..|+|||++.+..++.++||||+|+++|||++|+.||............+....... .
T Consensus 161 ~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~--- 227 (267)
T PHA03390 161 GTPS--------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK--L--- 227 (267)
T ss_pred CCCc--------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc--C---
Confidence 3221 24578999999999988999999999999999999999999975433222222332221100 0
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-MRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~ 965 (973)
.........+.+++.+|++++|++||+ ++|++++
T Consensus 228 ---------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 228 ---------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000123467889999999999999996 6988864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.56 Aligned_cols=273 Identities=22% Similarity=0.270 Sum_probs=200.7
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----C
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ-----D 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 753 (973)
+..+|...+.||+|+||+||+|+.. +++.||+|++............+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3457889999999999999999875 689999999865443444455677899999999999999999987654 3
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..|+||||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999995 78988886542 589999999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
....... .......++..|+|||...+ ..++.++|||||||++|+|++|+.||... +.......+........
T Consensus 156 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK--DYVHQLKLITELLGSPS 229 (337)
T ss_pred cccCCCc----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHHHHHhCCCC
Confidence 7654322 11233467889999998765 46889999999999999999999999643 11111111111110000
Q ss_pred Ccc----ccCccccccc-----CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERG----CCRDLNQLID-----PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~----~~~~l~~~~d-----~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... ......+.+. +........+....++.+++++|++.+|++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 0000000000 0000000011234678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=290.55 Aligned_cols=244 Identities=24% Similarity=0.268 Sum_probs=187.9
Q ss_pred cccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHH---HHHhcCCCCCeeeEEeEEecCCeeEEEEeccC
Q 039922 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEI---ETLGRVRHGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
+||+|+||.||+|+.. +++.||+|.+.+.... ......+..|. ..++...|++|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 6889999998654322 12222233343 34445579999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc
Q 039922 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843 (973)
Q Consensus 764 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 843 (973)
+|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999886532 589999999999999999999999 99999999999999999999999999987553221
Q ss_pred cccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
.....|+..|+|||+..++ .++.++||||+|+++|||++|+.||..................
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 214 (278)
T cd05606 152 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------------- 214 (278)
T ss_pred ---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------------
Confidence 1234688999999998754 6889999999999999999999999764222111111111100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
++.+. .....++.+++.+|+..+|++|| ++.|++++
T Consensus 215 --~~~~~-----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 --AVELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCCCC-----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00010 11245788999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=302.38 Aligned_cols=277 Identities=24% Similarity=0.302 Sum_probs=202.6
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC--Ce
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ--DF 754 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~ 754 (973)
.+.++|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.+++++ +|+||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45678999999999999999999976 688999999865433344455677899999999 999999999998653 46
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.|+||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||.+.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 799999996 6998888653 478889999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCc-cccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 835 ALQSQEGQS-DDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 835 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
......... ........|+..|+|||++.+ ..++.++||||||+++|||++|+.||..... .+....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~ 233 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST--LNQLEKIIEVIGPPS 233 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCC
Confidence 765433210 122334568899999998754 5578899999999999999999999965321 111111111110000
Q ss_pred Cccc----cCccccccc----CCC-CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGC----CRDLNQLID----PRM-DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~----~~~l~~~~d----~~l-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... .....++++ ... ......+....++.+++.+|++.+|++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 000000010 000 0000001135678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=287.01 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=198.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC---CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--Cee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT---HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 755 (973)
..|...+.||+|+||.||+|+.. +++.||+|++.... ........+.+|++++++++|+||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46788999999999999999875 68999999874322 1233446788999999999999999999998664 467
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++++|.+++.... .+++..+.+++.|++.|++|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 478888999999999999999999 999999999999999999999999999986
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
....... ........++..|+|||+..+..++.++|||||||++||+++|+.||.... ......+ .......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~----~~~~~~~-- 227 (264)
T cd06653 156 IQTICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-AMAAIFK----IATQPTK-- 227 (264)
T ss_pred ccccccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-HHHHHHH----HHcCCCC--
Confidence 5332111 111233568899999999998889999999999999999999999996431 1111111 1111000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. ........+.+++.+|++ +|.+||++.+++.+
T Consensus 228 ----------~~-----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 ----------PM-----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----------CC-----CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00 012234668899999999 47999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.51 Aligned_cols=264 Identities=16% Similarity=0.202 Sum_probs=185.9
Q ss_pred cCCCCccccccccCCeeEEEEEECC----CCEEEEEEecCCCCCchhH---------HHHHHHHHHHhcCCCCCeeeEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETE---------TVFRSEIETLGRVRHGNVVKLLM 747 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~l~~ 747 (973)
-++|++.++||+|+||.||+|...+ +..+|+|+..........+ .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3579999999999999999998764 3456666542221111111 11223344566778999999998
Q ss_pred EEecCC----eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 748 CCSGQD----FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 748 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
++.... ..++++|++. .++.+.+.... ..++..+..|+.|++.|++|||+. +|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 765543 3467888763 46666655432 356788899999999999999999 999999999999999999
Q ss_pred ceEEeccCcchhccccCCCc---cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhH
Q 039922 824 VPRVADFGLAKALQSQEGQS---DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~ 900 (973)
.++|+|||+++.+....... ........||+.|+|||+..+..++.++|||||||++|||++|+.||.... .....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~-~~~~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG-HNGNL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc-cchHH
Confidence 99999999998764322110 111223469999999999999999999999999999999999999997542 22222
Q ss_pred HHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
.......... ++..+.... ......+.+++..|++.+|++||++.++++.++
T Consensus 243 ~~~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIK-----------RLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHH-----------Hhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 2211111100 000000111 112466889999999999999999999998763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=295.12 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=194.4
Q ss_pred cCCCCccccccccCCeeEEEEEECC-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|+..+ ++.||||.+..... ......+.+|+..+.+.. |+||+++++++..+...|+|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4568889999999999999999874 89999999864432 233445666777666665 99999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|||++ +++.++..... ..+++..+..++.|++.|++|||+ . +|+||||+|+||++++++.+||+|||++..+.
T Consensus 93 ~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 57777665432 268899999999999999999997 5 89999999999999999999999999987654
Q ss_pred ccCCCccccccccccccCccccccccCCC----CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKK----VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.... ...+....+......
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~--- 237 (296)
T cd06618 167 DSKA-----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-TEFEVLTKILQEEPP--- 237 (296)
T ss_pred CCCc-----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch-hHHHHHHHHhcCCCC---
Confidence 3221 12235778999999987554 7889999999999999999999996421 111222211111100
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
... .......++.+++.+|++.||++||++.+++++-
T Consensus 238 -------------~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 -------------SLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -------------CCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 000 0001235688999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-33 Score=291.27 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=205.0
Q ss_pred cccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 687 QNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
.+++|+|.||+||-|+.+ +|+.||||++.+-.-....+..+++|+.+++.+.||.||.+-.-|++.+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 579999999999999865 8999999999877666777788999999999999999999999999999999999999 57
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC---CceEEeccCcchhccccCCC
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE---MVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGl~~~~~~~~~~ 842 (973)
+..+++-... .+++++....-++.||+.||.|||.+ +|+|+|+||+|||+.+. -++||+|||+++.+.+..-
T Consensus 648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 7777665433 23688888888999999999999999 99999999999999653 4799999999999876543
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
...++||+.|.|||++.++.|...-|+||.||++|.-++|..||. +++++-+.+.....-.++..+
T Consensus 723 ----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN----EdEdIndQIQNAaFMyPp~PW------ 788 (888)
T KOG4236|consen 723 ----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN----EDEDINDQIQNAAFMYPPNPW------ 788 (888)
T ss_pred ----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC----CccchhHHhhccccccCCCch------
Confidence 234789999999999999999999999999999999999999996 445566666554444333222
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.....+++|...++..=++|.+.++.+.+
T Consensus 789 ------------~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 789 ------------SEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ------------hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 3344566777788888888888888776544
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=287.24 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=187.3
Q ss_pred ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHH-HhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIET-LGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|+.. +|+.||+|++.+.... ......+..|... ....+|+|++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999875 6899999998543221 1222234445444 4455899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999987543 478899999999999999999999 999999999999999999999999998875432
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
.....++..|+|||...+..++.++||||+|+++|||++|..||.... .......+.......+ ..
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~-----~~----- 215 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--PDAVFDNILSRRINWP-----EE----- 215 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccCCC-----Cc-----
Confidence 112457889999999988888999999999999999999999997532 2222222211111000 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
........+.+++.+|++.+|++||++.++.+.+
T Consensus 216 --------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 216 --------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred --------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0012245688999999999999999775444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=294.09 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=197.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
..|+..+.||+|+||.||+|+.. +++.||+|.+.... ........+.+|+++++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999976 67899999885432 22334456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+. |++.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 68887775433 2478999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
....++..|+|||.+. .+.++.++|||||||++|||++|+.||.... .......+..... .
T Consensus 169 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~-~------ 232 (308)
T cd06634 169 --------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNES-P------ 232 (308)
T ss_pred --------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcCC-C------
Confidence 2245788999999874 3567889999999999999999999986421 1111111111100 0
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.. ........+.+++.+|++++|++||++.+++++-..
T Consensus 233 ----------~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 233 ----------AL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ----------Cc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00 011234567899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=267.65 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=195.3
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 760 (973)
.......+|.|+-|.||+++.+ +|..+|||.+.+... .+.-+++...+.++..-. +|+||+.+|||..+...++.||
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3455678999999999999876 689999999965543 334455666666665554 8999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
.|. ...+..++.... ++++...-++...++.||.||-++. +|+|||+||+|||+|+.|++|++|||++-++-+.
T Consensus 172 lMs-~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHH-HHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 994 455666655433 5788778888899999999999874 9999999999999999999999999999776433
Q ss_pred CCccccccccccccCccccccccC---CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.+.+...|.+.|||||-+.- .+|+.++||||||++++|+.||+.||.... .+.+....+.+.. ++
T Consensus 246 ----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-tdFe~ltkvln~e---PP---- 313 (391)
T KOG0983|consen 246 ----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-TDFEVLTKVLNEE---PP---- 313 (391)
T ss_pred ----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-ccHHHHHHHHhcC---CC----
Confidence 23444678899999998863 468889999999999999999999997643 3344444333311 11
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+... ..-...+.+++..|+++|+.+||...+++++
T Consensus 314 ---------~L~~~---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 ---------LLPGH---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---------CCCcc---cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11111 1124578899999999999999999999875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=292.32 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=193.8
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
|...+.||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|+++++.++|+|++++++++.+++..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999875 688999999854332 223345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+. |++.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 67877776433 2588999999999999999999999 999999999999999999999999998754321
Q ss_pred CccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||... +.......+.... .+
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~--~~~~~~~~~~~~~---~~----- 238 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQND---SP----- 238 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcC---CC-----
Confidence 12346888999999974 456888999999999999999999998653 1122222221110 00
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... ......+.+++.+|++++|++||++.+++++
T Consensus 239 ---~~~~---------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 ---TLQS---------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CCCc---------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 1123457889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=301.25 Aligned_cols=273 Identities=26% Similarity=0.346 Sum_probs=203.6
Q ss_pred CCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC------ee
Q 039922 683 HLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD------FN 755 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~ 755 (973)
.|...+.||+|+||.||+|+. ++|+.||||.+.... .....++.-+|++++++++|+|||+++++=++.. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 345678899999999999995 489999999996544 3344556778999999999999999998755433 56
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe--CCCC--ceEEeccC
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL--DAEM--VPRVADFG 831 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfG 831 (973)
.+|||||.+|||...+..-....-+++.+.+.++.+++.||.|||++ +|+||||||.||++ .++| ..||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 89999999999999998765555699999999999999999999999 99999999999998 3444 47999999
Q ss_pred cchhccccCCCccccccccccccCcccccccc-CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch-hHHHHHHHHhc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK-DIVRWVTEATL 909 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~ 909 (973)
.|+.++.+. .....+||..|.+||... ++.|+..+|.|||||++||+.||..||.+-.+... .-..|......
T Consensus 170 ~Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 170 AARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 999886554 466789999999999998 58899999999999999999999999986432211 11222211111
Q ss_pred c-CC-------CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHhh
Q 039922 910 S-SP-------ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP--SMRRVVELLRV 968 (973)
Q Consensus 910 ~-~~-------~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp--s~~evl~~L~~ 968 (973)
. .. .++-..+-..+..+ ....+.....+-..+..++..+|++|. ...++-..+..
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p----~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d 309 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQP----NHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD 309 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCc----ccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence 1 00 11111111111111 122345566677777888899999998 65555544433
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=290.05 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=197.4
Q ss_pred ccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
||+|+||.||+++.. +|+.||+|++..... .....+.+.+|++.+++++|+||+++++.+..++..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 599999999854322 224456788899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc----
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS---- 843 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~---- 843 (973)
.++++... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997643 589999999999999999999999 99999999999999999999999999987653321100
Q ss_pred cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 923 (973)
........++..|+|||...+...+.++||||||+++||+++|..||... ........+....... +.
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~-~~--------- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE--TPEEIFQNILNGKIEW-PE--------- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCcCC-Cc---------
Confidence 01123346788999999998888999999999999999999999999753 2223333322211110 00
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 924 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
.......+.+++.+|++.+|++||++.++.+.|+
T Consensus 223 ----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 ----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0012467789999999999999999955555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=291.06 Aligned_cols=268 Identities=24% Similarity=0.322 Sum_probs=198.2
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
|.+.+.||+|++|+||+|+.. +++.||+|++...... .......+|+..+++++ |+|++++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567789999999999999986 5789999998544332 23334557899999999 99999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+ +|+|.+++.... ...+++..+..++.|++.+++|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 9 789999887653 23589999999999999999999999 999999999999999999999999999876543221
Q ss_pred CccccccccccccCcccccccc-CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc-cc--
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG-CC-- 917 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-- 917 (973)
.....++..|+|||+.. ...++.++||||||+++|||++|+.||.... ..+....+.... ..+... ..
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~ 226 (283)
T cd07830 155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS--EIDQLYKICSVL-GTPTKQDWPEG 226 (283)
T ss_pred -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC--hHHHHHHHHHhc-CCCChhhhhhH
Confidence 22345788999999875 4567899999999999999999999986532 111111111111 100000 00
Q ss_pred CcccccccCCCCCC------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLS------TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+...++..+... .........+.+++++|++.+|++||++.|++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000111010000 0001124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=317.09 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=210.1
Q ss_pred CccccccccCCeeEEEEEEC----C----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCee
Q 039922 685 TEQNLIGSGGSCRVYKVKLK----S----GETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 755 (973)
...+.+|+|.||.||+|... . ...||||.++..... .+.+.+..|+++|+.+ +|+||+.++++|.+++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 45569999999999998743 1 457999999755544 6778899999999999 599999999999999999
Q ss_pred EEEEeccCCCChhhhhhccC---------C--C--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 756 ILVYEYMPNGSLADMLHEKG---------R--S--GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
++|+||+..|+|.++++... . . ..+.....++++.|||.|++||++. ++||||+..+|||++++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCC
Confidence 99999999999999998765 0 0 1378889999999999999999999 99999999999999999
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIV 901 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 901 (973)
..+||+|||+++................ -...|||||.+....++.++|||||||++|||+| |..||.. .....++.
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~~~~~~l~ 532 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-IPPTEELL 532 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-CCcHHHHH
Confidence 9999999999997654433211100001 2456999999999999999999999999999999 6666643 33456667
Q ss_pred HHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 902 RWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
++++.+.+...|..| ..++.++++.||+.+|++||++.|+++.++.
T Consensus 533 ~~l~~G~r~~~P~~c---------------------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHC---------------------SDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHhcCCCCCCCCCC---------------------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 777777665444332 3567899999999999999999999998876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=292.95 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=204.1
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 759 (973)
+|...+.||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|.+++++++ |+||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5788899999999999999876 799999999854322 2344567888999999998 999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++++|||++......
T Consensus 82 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 82 EYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999997643 589999999999999999999999 9999999999999999999999999998766443
Q ss_pred CCCc----------------cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH
Q 039922 840 EGQS----------------DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 840 ~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 903 (973)
.... ........++..|+|||......++.++||||+|++++++++|+.||.... .....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHH
Confidence 2110 122234567889999999988889999999999999999999999997532 1122222
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHHH
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM----RRVVEL 965 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~----~evl~~ 965 (973)
+...... ........+.+++.+|++.+|++||++ .|++++
T Consensus 234 ~~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 234 ILKLEYS----------------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHhcCCC----------------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 2111111 001114568899999999999999999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=295.04 Aligned_cols=277 Identities=23% Similarity=0.268 Sum_probs=199.8
Q ss_pred ccCCCC-ccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCch------------hHHHHHHHHHHHhcCCCCCeeeE
Q 039922 680 ILPHLT-EQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE------------TETVFRSEIETLGRVRHGNVVKL 745 (973)
Q Consensus 680 ~~~~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l 745 (973)
+.++|. ..+.||+|+||.||+|.++ +++.||+|++........ ....+.+|++++++++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 344565 4577999999999999876 789999999854322211 11246789999999999999999
Q ss_pred EeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCce
Q 039922 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP 825 (973)
Q Consensus 746 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 825 (973)
++++..++..++||||++ |+|.+++.... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 999999999999999996 79999886533 488899999999999999999999 99999999999999999999
Q ss_pred EEeccCcchhccccCC----------CccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCC
Q 039922 826 RVADFGLAKALQSQEG----------QSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSF 894 (973)
Q Consensus 826 kl~DfGl~~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~ 894 (973)
+|+|||.+........ ..........++..|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876541110 001112234567889999998764 46889999999999999999999997532
Q ss_pred CCchhHHHHHHHHhccCCCccccCccccc-----ccCCCC--CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 895 GENKDIVRWVTEATLSSPERGCCRDLNQL-----IDPRMD--LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-----~d~~l~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
..+....+............+.. ..+ ..+... ..........++.+++++|++.+|++||++.|++.+-
T Consensus 239 --~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 239 --EIDQLGRIFELLGTPNEDNWPQA-KKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred --HHHHHHHHHHHhCCCchhhCcch-hhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 22222222222211111100000 000 000000 0000012245688999999999999999999998753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=245.65 Aligned_cols=271 Identities=23% Similarity=0.300 Sum_probs=207.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.|...++||+|.||+||+++.. +++.||+|++.-....+.......+|+-+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999866 688999999976666666677789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
| +.+|..|.+... +.++.....+.+.|+++|+.+.|++ ++.|||+||+|.+++.+|..|++|||+++.+.-.
T Consensus 83 c-dqdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-- 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-- 154 (292)
T ss_pred h-hHHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence 9 468988887643 3689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccccccccccCccccccccCCC-CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKK-VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
-+.++..+.|.+|.+|.++.+.+ |++..|+||-||++.|+...+.|..+..+...++.+..... ..+....+..+
T Consensus 155 --vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l--g~p~ed~wps~ 230 (292)
T KOG0662|consen 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL--GTPTEDQWPSM 230 (292)
T ss_pred --eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh--CCCccccCCcc
Confidence 22344557789999999999876 78899999999999999998877766433333433332222 22222223345
Q ss_pred cccccCCC-CCCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRM-DLSTC-------DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l-~~~~~-------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.++.|... ..-.. .+.-...=.++++..+.-+|.+|.++++.+++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 55555221 10000 01111122456666777789999999998875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=298.27 Aligned_cols=274 Identities=22% Similarity=0.233 Sum_probs=195.7
Q ss_pred CCCccccccccCCeeEEEEEEC-C--CCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec----CCe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-S--GETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG----QDF 754 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 754 (973)
+|+..+.||+|+||.||+++.. + +..||+|++..........+.+.+|+++++++ +|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3677889999999999999976 3 77999999864433334456678899999999 49999999987543 245
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.|+++||++ ++|.+++.... .+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||.++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788999985 78998886432 588999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.................|+..|+|||+..+ ..++.++||||+|+++|+|++|+.||.... .......+.......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD--YVDQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC--HHHHHHHHHHHhCCCCH
Confidence 765433221222234578999999998765 468899999999999999999999986531 11111111111100000
Q ss_pred cc----ccCccccc---cc--CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RG----CCRDLNQL---ID--PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~----~~~~l~~~---~d--~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ........ .. +........+.....+.+++.+|++++|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 00000000 00 0000000001124578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=272.45 Aligned_cols=280 Identities=22% Similarity=0.294 Sum_probs=211.7
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec------
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG------ 751 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 751 (973)
+....|....+||+|.||.||+|+.+ .|+.||+|++.-......-.....+|+.++..++|+|++.+++.|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 34567888899999999999999866 67889998764333333333456789999999999999999988753
Q ss_pred --CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 752 --QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 752 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
....|+||++|+ -+|.-.+.... ..++..++.+++.++..||.|+|.. .|+|||+||.|+|++.++.+||+|
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 335799999997 47777776542 2588899999999999999999999 999999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH----
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV---- 904 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~---- 904 (973)
||+++.+...++.....++..+.|.+|.+||.+.+ +.|+++.|||+-||++.||+||.+-+.+..+ .+-...+
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~Lc 245 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQLC 245 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHHHh
Confidence 99998776665554555777888999999998876 5789999999999999999999988876532 2222222
Q ss_pred HHHhccCCCccccCcccccccCC-CCCCCCC--HHHH------HHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 905 TEATLSSPERGCCRDLNQLIDPR-MDLSTCD--YEEA------EKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~-l~~~~~~--~~~~------~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.....+.+|....-++.+-+... +...... ++.. .+..+++..++..||.+|+.+++++.+-
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 23333444444444444444222 1111110 1111 2567888899999999999999998653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=274.08 Aligned_cols=258 Identities=20% Similarity=0.284 Sum_probs=210.1
Q ss_pred CCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-CCee
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-QDFN 755 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 755 (973)
+++...++-+|.||.||+|.+. +.+.|.+|.++... .+.+...+..|...+..+.|||+..+.+++.+ .+..
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 3555667899999999999664 34567888875333 34455678889999999999999999998765 5677
Q ss_pred EEEEeccCCCChhhhhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 756 ILVYEYMPNGSLADMLH-----EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
+++|.++.-|+|+.++. +......++..+...++.|++.|++|||++ ++||.||..+|+++|+..++||+|-
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccc
Confidence 89999999999999997 222233567778899999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
.+++.+.+.+.. .-.....-...||+||.+.+..|+.++|||||||++|||+| |+.|+.. .+..++..+++++.+
T Consensus 441 aLSRDLFP~DYh--cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae--IDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 441 ALSRDLFPGDYH--CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE--IDPFEMEHYLKDGYR 516 (563)
T ss_pred hhccccCccccc--ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc--cCHHHHHHHHhccce
Confidence 999987665421 11112223578999999999999999999999999999999 8888875 466778888888776
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
-..|..| +.+++.++..||+.+|++||+++|++.-|.+.
T Consensus 517 laQP~NC---------------------PDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 517 LAQPFNC---------------------PDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ecCCCCC---------------------cHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 6444433 45678899999999999999999999988763
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=296.69 Aligned_cols=273 Identities=22% Similarity=0.261 Sum_probs=204.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-----eeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD-----FNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 756 (973)
+|+..+.||+|++|.||+|+.. +++.||+|++..........+.+.+|++.++.++|+||+++.+++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999976 5899999999655443455677899999999999999999999987765 789
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888886543 689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
...... ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||.... .......+........+..
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD--YIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHhcCCCChhH
Confidence 543211 1122334678899999999887 78999999999999999999999997532 2222222222111111000
Q ss_pred ----ccCcccccccC---C--CCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 ----CCRDLNQLIDP---R--MDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ----~~~~l~~~~d~---~--l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......+.+.. . .......+.....+.+++.+|++++|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000111110 0 00000011235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=288.75 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=196.1
Q ss_pred CCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCC--CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeE
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTH--KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 756 (973)
|+..+.||+|+||.||.|+.. +|+.||+|++..... .....+.+.+|+.+++++ +|++|+++++++..+...|
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 677889999999999999863 689999999854322 223346678899999999 5899999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999987543 478888999999999999999999 9999999999999999999999999998765
Q ss_pred cccCCCccccccccccccCccccccccCC--CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTK--KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
..... .......|+..|+|||..... .++.++||||||+++|+|++|..||.... ................++
T Consensus 156 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~- 230 (290)
T cd05613 156 HEDEV---ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG-EKNSQAEISRRILKSEPP- 230 (290)
T ss_pred ccccc---cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC-ccccHHHHHHHhhccCCC-
Confidence 43221 112235688999999998753 46789999999999999999999996421 111222222111111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
........+.+++.+|++.+|++|| ++.+++++
T Consensus 231 ------------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 ------------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0011235678999999999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=299.89 Aligned_cols=271 Identities=21% Similarity=0.268 Sum_probs=198.5
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC---
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD--- 753 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 753 (973)
..+.++|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.++++++|+||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999865 7999999998654444444566889999999999999999999987543
Q ss_pred ---eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 754 ---FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 754 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
..++||||+ +++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 67898887542 488999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|++...... .....++..|+|||.+.+ ..++.++||||+|+++|++++|..||..... .......+ ....
T Consensus 163 g~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~-~~~~ 233 (343)
T cd07880 163 GLARQTDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-LDQLMEIM-KVTG 233 (343)
T ss_pred ccccccccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH-HhcC
Confidence 998765322 123457889999998876 4578899999999999999999999975321 11111111 1100
Q ss_pred cCCCc----cccCccccccc--CCCC---CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPER----GCCRDLNQLID--PRMD---LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~----~~~~~l~~~~d--~~l~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.. .........+. +... ...........+.+++.+|++.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000000 0000 000001223467899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=297.19 Aligned_cols=269 Identities=20% Similarity=0.239 Sum_probs=198.0
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC----
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ---- 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 752 (973)
..+.++|...+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 446688999999999999999999864 789999999965443344456678899999999999999999988543
Q ss_pred --CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 753 --DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 753 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
...|++++++ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+||
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecc
Confidence 3467888887 78998877542 488999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|++...... .....++..|+|||+..+ ..++.++||||+||++|||++|+.||.... .......+.....
T Consensus 165 g~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~ 235 (345)
T cd07877 165 GLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVG 235 (345)
T ss_pred ccccccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhC
Confidence 998754221 223467889999998766 567889999999999999999999986421 1111111111111
Q ss_pred cCCCccc-------cCc----ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPERGC-------CRD----LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~~~-------~~~----l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..++... ... +....+..+. .........+.+++.+|++.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFA--NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchh--hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1000000 000 0000000000 0000124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=287.99 Aligned_cols=269 Identities=26% Similarity=0.331 Sum_probs=202.4
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|+..+.||+|++|.||+|+.. +++.||+|++..........+.+..|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456778999999999999987 5899999999655433444566788999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
+ ++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 69999997653 2589999999999999999999999 999999999999999999999999999876543221
Q ss_pred ccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......++..|+|||++.+. .++.++||||||+++||+++|+.||.... .......+........+.. .....
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~ 227 (282)
T cd07829 154 ---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKIFQILGTPTEES-WPGVT 227 (282)
T ss_pred ---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHHHhCCCcHHH-HHhhc
Confidence 12233456789999998776 78999999999999999999999986532 2222222222111111100 00000
Q ss_pred cc--cc---CCCCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QL--ID---PRMDLS---TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~--~d---~~l~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
++ .+ +..... ...+.....+.+++.+|++.+|++||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 11 00 000000 0001124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=269.38 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=197.6
Q ss_pred cccccccCCeeEEEEE-ECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
.+.+|+|+|+.|--++ ..+|..||||++.+ .....+.+..+|++++...+ |+||+.++++|++++.+|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidK--q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDK--QPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhc--CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 4689999999998876 56899999999943 35566778889999999986 99999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC---ceEEeccCcchhccccCC
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM---VPRVADFGLAKALQSQEG 841 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl~~~~~~~~~ 841 (973)
|+|...+++.. -+++.++.++.++||.||.|||.+ ||.|||+||+|||-.... -+||+||.+..-+.....
T Consensus 161 GplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 161 GPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred chHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999998754 388899999999999999999999 999999999999996644 489999988755433221
Q ss_pred ---CccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCc-------------hhH
Q 039922 842 ---QSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-------------KDI 900 (973)
Q Consensus 842 ---~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~-------------~~~ 900 (973)
.........+|+..|||||+.. ...|+.+.|.||+|||+|-|++|..||.+.-+.+ ..+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 1122245568999999999864 2468889999999999999999999997643211 122
Q ss_pred HHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.|.++..+. .|+.+ .....+..+++...+-.||..|.++.+++.+
T Consensus 315 FesIQEGkYeF------------PdkdW------ahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 315 FESIQEGKYEF------------PDKDW------AHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHhccCCcC------------Chhhh------HHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 33333333221 11111 1234566778888888999999999988763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=293.79 Aligned_cols=270 Identities=21% Similarity=0.307 Sum_probs=198.9
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-CCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-QDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 756 (973)
.+.++|+..+.||+|+||.||+|... +++.||+|++.+........+.+.+|++++++++||||+++.+++.. .+..+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45678999999999999999999866 79999999986544444455677889999999999999999999865 56789
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+ +++|.+++... .+++.....++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+...
T Consensus 87 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999999 57898887642 467888889999999999999999 9999999999999999999999999998754
Q ss_pred cccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
... .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||.... .......+.+.....+...
T Consensus 159 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~--~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 159 DPQ-------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD--HVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred CCC-------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHH
Confidence 221 122456789999998765 568899999999999999999999996532 1111111111100000000
Q ss_pred ----ccCcccccccC-----CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 ----CCRDLNQLIDP-----RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ----~~~~l~~~~d~-----~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......+++.. ........+.....+.+++.+|++.+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 000000001124678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=298.30 Aligned_cols=268 Identities=22% Similarity=0.252 Sum_probs=195.2
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC------
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------ 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 752 (973)
+..+|...+.||+|+||.||+|+.. +|+.||+|++.+..........+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3467888999999999999999875 789999999865444444455678999999999999999999998654
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
...++|+||+. .++.++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 34689999995 47766542 2478899999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 164 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~ 234 (342)
T cd07879 164 ARHADAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVP 234 (342)
T ss_pred CcCCCCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCC
Confidence 8754221 223467889999999876 468889999999999999999999997531 111111111111000
Q ss_pred CCccc----cCccccccc--CCCCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PERGC----CRDLNQLID--PRMDLS---TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~~~~----~~~l~~~~d--~~l~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+... .......++ +..... ...+.....+.+++.+|++.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000000000 000000 0001123567899999999999999999999866
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=287.75 Aligned_cols=256 Identities=24% Similarity=0.271 Sum_probs=197.0
Q ss_pred CCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCC--CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeE
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTH--KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 756 (973)
|+..+.||+|++|.||+++.. +++.||+|.+.+... .....+.+.+|+.+++++ +|++|+++++++..++..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 667889999999999998753 578899999854321 123345678899999999 5999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++++|||+++..
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999887532 478889999999999999999999 9999999999999999999999999998765
Q ss_pred cccCCCccccccccccccCccccccccCCC--CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKK--VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
...... ......|+..|+|||...+.. .+.++||||||+++|||++|..||..... ...............
T Consensus 156 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~--- 228 (288)
T cd05583 156 LAEEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSK--- 228 (288)
T ss_pred cccccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHccC---
Confidence 433211 112245788999999987655 78899999999999999999999964211 111111111111110
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
+.. .......+.+++.+|++.+|++|||+.++.+.|+-
T Consensus 229 -----------~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 -----------PPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----------CCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 01123457789999999999999998888766653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=297.58 Aligned_cols=270 Identities=21% Similarity=0.254 Sum_probs=200.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe---
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF--- 754 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 754 (973)
++.++|+..+.||+|++|.||+|+.. +++.||+|++............+.+|+.++++++|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999986 68899999985443334444567789999999999999999988766554
Q ss_pred ---eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 755 ---NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 755 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
.++|+||+ +++|.+++... .+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 67999888642 589999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
++...... .....++..|+|||...+ ..++.++||||+|+++||+++|+.||.... .......+......
T Consensus 164 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~--~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD--HIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCC
Confidence 98765322 223467889999998865 467889999999999999999999996532 12222222221111
Q ss_pred CCCcccc----CcccccccCCCCCC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCC----RDLNQLIDPRMDLS-----TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~----~~l~~~~d~~l~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.++..+. ......+....... ........++.+++.+|++.+|++|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000 00000000000000 0001124678999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=282.72 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=194.9
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCC---CCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGG---THKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+|.+.+.||+|+||.||+++.. .+..+++|.++.. .........+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999876 3445666655322 12223344567799999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 759 YEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886532 234689999999999999999999999 9999999999999975 569999999987654
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... ......|+..|+|||...+..++.++|+||||+++|+|++|..||... .. ...+........
T Consensus 157 ~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--~~---~~~~~~~~~~~~----- 222 (260)
T cd08222 157 GSCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--NF---LSVVLRIVEGPT----- 222 (260)
T ss_pred CCcc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--cH---HHHHHHHHcCCC-----
Confidence 3221 122345788999999998888899999999999999999999998642 11 111111111100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. ........+.+++.+|++.+|++||++.|++++
T Consensus 223 --------~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 --------PS-----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --------CC-----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00 112334678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=295.11 Aligned_cols=271 Identities=21% Similarity=0.304 Sum_probs=193.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-------
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------- 752 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 752 (973)
..+|...+.||.|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 467889999999999999999875 68999999985433 24456688899999999999999999776543
Q ss_pred -------CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCc
Q 039922 753 -------DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMV 824 (973)
Q Consensus 753 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~ 824 (973)
...|+||||++ ++|.+++... .+++..+..++.||+.|++|||+. +++||||||+||+++. ++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 35789999996 6888877532 478999999999999999999999 9999999999999974 567
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 903 (973)
+|++|||.++........ ........++..|+|||+..+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 154 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~~ 231 (342)
T cd07854 154 LKIGDFGLARIVDPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE-LEQMQLI 231 (342)
T ss_pred EEECCcccceecCCcccc-ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 899999998765332211 111122357889999997654 5678899999999999999999999975321 1111111
Q ss_pred HHHHhccCCCccccCcc----cccc-----cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 904 VTEATLSSPERGCCRDL----NQLI-----DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l----~~~~-----d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... .....+. ..... .... .+.............++.+++.+|+++||++||++.|++++
T Consensus 232 ~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 232 LES-VPVVREE-DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHh-cCCCChH-HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 111 0000000 00000 0000 00000000001223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=278.98 Aligned_cols=241 Identities=29% Similarity=0.361 Sum_probs=195.0
Q ss_pred ccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCCh
Q 039922 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSL 767 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 767 (973)
||+|+||.||++... +++.||+|++.+.... ....+.+..|+.++++++|+|++++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 5899999998654322 23456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccc
Q 039922 768 ADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 768 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~ 150 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----SRT 150 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC----Ccc
Confidence 99997653 478999999999999999999998 99999999999999999999999999987654332 112
Q ss_pred cccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCC
Q 039922 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPR 927 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 927 (973)
....++..|+|||...+...+.++|+||||+++||+++|+.||... +.....+.+......
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~----------------- 211 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE--DRKEIYEKILKDPLR----------------- 211 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHhcCCCC-----------------
Confidence 3356788999999998888899999999999999999999999653 222333322221100
Q ss_pred CCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH---HHHHH
Q 039922 928 MDLSTCDYEEAEKVLNVALMCTSDFPINRPSM---RRVVE 964 (973)
Q Consensus 928 l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~---~evl~ 964 (973)
+. ......+.+++.+|+..||++||++ .++.+
T Consensus 212 ~~-----~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 212 FP-----EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CC-----CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 00 1114567889999999999999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=273.58 Aligned_cols=278 Identities=21% Similarity=0.238 Sum_probs=209.6
Q ss_pred eeeecccc-ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CC-----C
Q 039922 670 FQRVSFNE-DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HG-----N 741 (973)
Q Consensus 670 ~~~~~~~~-~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----n 741 (973)
.+.+.|.. +.+..+|.+...+|+|.||.|-++.+. .+..||+|+++. ...-.++.+-|++.++++. +. -
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 44566666 445889999999999999999998765 578999999832 2233445677999999993 22 4
Q ss_pred eeeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC
Q 039922 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA 821 (973)
Q Consensus 742 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 821 (973)
+|.+.+||...++.|+|+|.+ |-|+.+++..+.. .+++..++..|+.|++++++|||+. +++|.||||+||++.+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvs 227 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVS 227 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEec
Confidence 778889999999999999998 5699999987543 3688899999999999999999999 9999999999999831
Q ss_pred --------------------CCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHH
Q 039922 822 --------------------EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLM 881 (973)
Q Consensus 822 --------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 881 (973)
+..++++|||.|++..... ...+.|..|.|||++.+-.++.++||||+|||++
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 3458999999998653332 4578899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCchhHHHHHHHHhccC----------------------CCccccCcccccccCCCCC---CCCCHH
Q 039922 882 ELVTGKRPNDPSFGENKDIVRWVTEATLSS----------------------PERGCCRDLNQLIDPRMDL---STCDYE 936 (973)
Q Consensus 882 elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~~~d~~l~~---~~~~~~ 936 (973)
|+.||...|..-. +.+.+ .. .+..... +......+...+.++.... -.....
T Consensus 301 ElytG~~LFqtHe-n~EHL-aM-MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~ 377 (415)
T KOG0671|consen 301 ELYTGETLFQTHE-NLEHL-AM-MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL 377 (415)
T ss_pred EeeccceecccCC-cHHHH-HH-HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH
Confidence 9999999987532 22222 11 1111111 1111111222233322211 122345
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 937 EAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 937 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+..++++++++|+.+||.+|+|+.|++.+
T Consensus 378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 378 EHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 67789999999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=313.67 Aligned_cols=148 Identities=26% Similarity=0.379 Sum_probs=131.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|.+.++||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357888999999999999999987 789999999964322 233446788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
|||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999987543 478889999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=265.69 Aligned_cols=256 Identities=25% Similarity=0.317 Sum_probs=197.4
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.+....||.|+||+|+|...+ +|+..|||++..... ....+++..|.+...+- ++||||+++|++..++.-|+.||.
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 445678999999999998765 899999999964433 45556777787765554 699999999999888899999999
Q ss_pred cCCCChhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 762 MPNGSLADMLHEKG--RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 762 ~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
| ..|++.+...-. ....+++.-.-+|+.-.+.||.||-... .|+|||+||+|||++..|.+||||||++-.+...
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 9 567766543211 1235788777888888999999999875 8999999999999999999999999998765432
Q ss_pred CCCccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
- +.+.-.|...|||||-+.. ..|+-++||||+|+++||+.||..|+.. ...+.+.+.......++.
T Consensus 222 i-----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~----w~svfeql~~Vv~gdpp~--- 289 (361)
T KOG1006|consen 222 I-----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK----WDSVFEQLCQVVIGDPPI--- 289 (361)
T ss_pred H-----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch----HHHHHHHHHHHHcCCCCe---
Confidence 2 2334568899999998863 3588999999999999999999999974 334555555555443332
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.......+....+..++..|+.+|-..||..+++.++
T Consensus 290 ----------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 ----------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11112223456788999999999999999999988653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=270.28 Aligned_cols=243 Identities=24% Similarity=0.330 Sum_probs=197.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCch-hHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE-TETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
..+|....+||+|+||.|-.+..+ +.+.||||++++...... ..+--..|.+++..- +-|.++.+..+|++-+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 446888899999999999999876 567899999976643332 223334566676665 46899999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+.+|+|--.++..+ .+.+..+.-.|.+||-||-+||++ +|+.||||.+|||+|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999988887665 477888888999999999999999 99999999999999999999999999987422
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
....+...+.||+.|+|||++...+|+.++|+|||||++|||+.|+.||++ +++.++.+.+.+..-.
T Consensus 502 ----~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--eDE~elF~aI~ehnvs------- 568 (683)
T KOG0696|consen 502 ----FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--EDEDELFQAIMEHNVS------- 568 (683)
T ss_pred ----cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHHccCc-------
Confidence 122345568899999999999999999999999999999999999999987 3556666666554422
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP 957 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 957 (973)
+...-..+...+....+.+.|.+|.
T Consensus 569 ---------------yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 ---------------YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---------------CcccccHHHHHHHHHHhhcCCcccc
Confidence 1223345667777888888898886
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=287.70 Aligned_cols=241 Identities=23% Similarity=0.221 Sum_probs=191.5
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
.++.|.....+|.|+|+.|-.+... +++..+||++.+.. ....+|+.++... +|+||+++.+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 3556777778999999999888765 78899999995441 2234466555555 69999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe-CCCCceEEeccCcchhc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL-DAEMVPRVADFGLAKAL 836 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGl~~~~ 836 (973)
|||.+.++-+.+.+..... ....+..|+.+|+.|+.|||++ |+||||+||+|||+ ++.++++|+|||.++..
T Consensus 394 v~e~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eehhccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 9999998887777665432 2267778999999999999999 99999999999999 68999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... .....-|..|.|||+.....++.++||||+|+++|+|++|+.||.....+ .++...+..+
T Consensus 467 ~~~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~--------- 529 (612)
T KOG0603|consen 467 ERS-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMP--------- 529 (612)
T ss_pred chh-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCC---------
Confidence 433 22234578999999999999999999999999999999999999764222 2222211111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..........++++.+|++.||.+||+|.++..+
T Consensus 530 ---------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 ---------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---------------ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1113345678899999999999999999999765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=305.28 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=200.8
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|.+.++||+|+||.|..++.+ +++.||.|++.+-. ......+.|..|..+|..-..+=||.+..+|.++...|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 357899999999999999999987 68889999985421 1223446689999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||||+||+|-..+.... .+++..++-++..|+.||.-+|+. |+|||||||+|||+|..|++||+|||.+-.+..
T Consensus 154 MdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999998764 588888888889999999999999 999999999999999999999999999988865
Q ss_pred cCCCccccccccccccCcccccccc----C-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAY----T-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+.. -.....+|||-|.+||++. + +.|+..+|+||+||++|||+.|..||+.. .++..+.+...-
T Consensus 228 dG~---V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~h--- 296 (1317)
T KOG0612|consen 228 DGT---VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNH--- 296 (1317)
T ss_pred CCc---EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhch---
Confidence 432 2234568999999999986 2 67899999999999999999999999853 222222111110
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS---MRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~ 965 (973)
.+ .+... .+...+....++|.+.+. +|+.|.. +.|+..|
T Consensus 297 ----k~-------~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 297 ----KE-------SLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ----hh-------hcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 00 11111 112245666777776664 4788886 8877665
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=295.99 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=192.0
Q ss_pred CCccccccccCCee-EEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCR-VYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
|...+++|.|+.|+ ||+|... |+.||||++. .+......+|+..++.- +||||||+++.-.++.+.|+..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44456899999874 6999886 8999999983 33445678899999887 499999999998899999999999
Q ss_pred cCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---C--CceEEeccCcchh
Q 039922 762 MPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---E--MVPRVADFGLAKA 835 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfGl~~~ 835 (973)
| ..+|++++..... .........+.+..|++.|+++||+. +||||||||+||||+. + .+++|+|||+++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9 5899999987411 11111134578899999999999998 9999999999999975 3 5789999999999
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcC-CCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTG-KRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
+..+.....+ .....||.+|+|||++.....+.++||||+||++|+.++| .+||......+..+ ..+.
T Consensus 661 l~~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI----l~~~------ 729 (903)
T KOG1027|consen 661 LAGGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI----LTGN------ 729 (903)
T ss_pred cCCCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh----hcCc------
Confidence 9877654444 5567899999999999999989999999999999999996 88887532211111 1111
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+..+-. . .+. +..++|.+|++++|..||++.+|+.|
T Consensus 730 ---~~L~~L~~-------~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 730 ---YTLVHLEP-------L-PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---cceeeecc-------C-chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11111110 0 111 67889999999999999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=286.51 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=205.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEec-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSG----- 751 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~----- 751 (973)
+-.+.|++.+.||+|.+|.||+++.+ +|+.+|+|+.... .+..++.+.|.++++... |||++.++++|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34567889999999999999999865 7899999988433 344556778899998884 9999999999853
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
++..|+|||||.+||..+.++... ...++|..+..|++.++.|+++||.. .++|||||-.|||++.++.||++|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeee
Confidence 678999999999999999998765 56799999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHH
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 906 (973)
.+..+...... ....+||+.|||||++. ...|+..+|+||+|++..||..|.+|+....+. +.+.
T Consensus 169 vSaQldsT~gr----RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-raLF----- 238 (953)
T KOG0587|consen 169 VSAQLDSTVGR----RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-RALF----- 238 (953)
T ss_pred eeeeeeccccc----ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-hhhc-----
Confidence 99877655432 23468999999999985 245778999999999999999999998754321 1110
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+.|++ ... -......++.++|..|+.+|.++||++.+++++
T Consensus 239 ~IpRNPPP--------------kLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 LIPRNPPP--------------KLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cCCCCCCc--------------ccc-chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111111 111 113456789999999999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=270.86 Aligned_cols=219 Identities=23% Similarity=0.175 Sum_probs=173.8
Q ss_pred cCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCChhhhh
Q 039922 693 GGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML 771 (973)
Q Consensus 693 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 771 (973)
|.+|.||+++++ +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999876 78999999985332 1233444455567999999999999999999999999999999998
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccc
Q 039922 772 HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851 (973)
Q Consensus 772 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~ 851 (973)
.... .+++..+..++.|++.|++|+|+. +++||||||+||++++++.++++|||.+....... ....
T Consensus 77 ~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------~~~~ 143 (237)
T cd05576 77 SKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------DGEA 143 (237)
T ss_pred HHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------ccCC
Confidence 7543 488999999999999999999999 99999999999999999999999999876553321 1234
Q ss_pred cccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCC
Q 039922 852 GSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLS 931 (973)
Q Consensus 852 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 931 (973)
++..|+|||...++.++.++||||+|+++|||++|..|+...... . . ....+ .+.
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~---------~--------~~~~~---~~~-- 198 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---I---------N--------THTTL---NIP-- 198 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---c---------c--------ccccc---CCc--
Confidence 567899999998888999999999999999999999886532100 0 0 00000 000
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 039922 932 TCDYEEAEKVLNVALMCTSDFPINRPSM 959 (973)
Q Consensus 932 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 959 (973)
......+.+++.+|++.||++||++
T Consensus 199 ---~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 199 ---EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ---ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 1123567889999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.49 Aligned_cols=262 Identities=26% Similarity=0.282 Sum_probs=197.9
Q ss_pred ccccCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchh-----HHHHHHHHHHHhcCCCCCeeeEEeEEec
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPET-----ETVFRSEIETLGRVRHGNVVKLLMCCSG 751 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~ 751 (973)
..+.++|-...++|+|||+.||++.+ ...+.||||+-.-.....+. .+..-+|..+-+.+.||.||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 44566788899999999999999975 46889999975322222222 2335679999999999999999999864
Q ss_pred -CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC---CCCceEE
Q 039922 752 -QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD---AEMVPRV 827 (973)
Q Consensus 752 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl 827 (973)
.+.+|-|.|||+|.+|+-|++... .++++.+.+|+.||+.||.||.+. .|+|+|-||||.|||+- .-|.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 567899999999999999998764 489999999999999999999986 56899999999999994 3578999
Q ss_pred eccCcchhccccCCCccc---cccccccccCccccccccCC----CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhH
Q 039922 828 ADFGLAKALQSQEGQSDD---AMSCVAGSYGYIAPEYAYTK----KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~ 900 (973)
.|||+++.++.+...... ......||.+|.+||...-+ +++.|+||||.||++|+++.|+.||.... ...++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq-sQQdI 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ-SQQDI 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-hHHHH
Confidence 999999998765432211 23446799999999987533 57889999999999999999999997642 22222
Q ss_pred HHH--HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039922 901 VRW--VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVV 963 (973)
Q Consensus 901 ~~~--~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 963 (973)
.+. +.+..... +. ..+....+...+|++|+++--+.|....++.
T Consensus 694 LqeNTIlkAtEVq----------------FP---~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQENTILKATEVQ----------------FP---PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Hhhhchhcceecc----------------CC---CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 221 11111110 00 1123345667888999998888887766653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=240.21 Aligned_cols=214 Identities=25% Similarity=0.347 Sum_probs=170.3
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhc-CCCCCeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGR-VRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
..-...||+|++|.|-+.++. +|+..|+|++..... ....+...+|+.+..+ ..+|++|.++|.+..+...++.||.
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 344678999999999888765 899999999964433 3444556677776554 5799999999999999999999999
Q ss_pred cCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEK-GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
| ..||+.+-++- .....+++.-.-+|+..+..||.|||++. .++|||+||+|||++.+|++|+||||++-.+.+.-
T Consensus 127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 9 57888766432 23456888889999999999999999986 89999999999999999999999999987664321
Q ss_pred CCccccccccccccCccccccccC----CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHH
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT----KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 906 (973)
+.+-..|...|||||.+.. ..|+-++||||+|+++.||.+++.||+.....-+++.+.+++
T Consensus 204 -----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 204 -----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred -----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 1222467889999998863 478899999999999999999999998654444444444433
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=274.18 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=204.5
Q ss_pred cCCCCccccccccCCeeEEEEEECCCC-EEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGE-TVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
..+++.+..+|.|+||.|-.++.++.+ .+|+|++++... ....++.+..|..+|...+.|+||++|-.|.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 445667788999999999999877443 389998865533 334556678899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||-|-||.+...++..+ .++..+..-++.-+.+|++|||++ +||+|||||+|.++|.+|.+||.|||+++.+..
T Consensus 499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999998765 477777778888899999999999 999999999999999999999999999999865
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
... .-++.||+.|.|||++.++.++.++|.||+|+++||+++|.+||... +.-.....+.++.-..
T Consensus 573 g~K-----TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~--dpmktYn~ILkGid~i------- 638 (732)
T KOG0614|consen 573 GRK-----TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV--DPMKTYNLILKGIDKI------- 638 (732)
T ss_pred CCc-----eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--chHHHHHHHHhhhhhh-------
Confidence 543 23478999999999999999999999999999999999999999864 2223333344433210
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
.+.........+++++.+..+|.+|.. +.||.+|
T Consensus 639 -------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 -------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 011223455678888999999999984 6666555
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=290.54 Aligned_cols=262 Identities=19% Similarity=0.217 Sum_probs=169.3
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-C----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeE------
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-S----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC------ 748 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------ 748 (973)
..++|...++||+|+||.||+|++. + +..||+|++..... . +....| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---V-EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---h-HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4568999999999999999999986 4 68999998843221 1 111111 1122222222222211
Q ss_pred EecCCeeEEEEeccCCCChhhhhhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeC
Q 039922 749 CSGQDFNILVYEYMPNGSLADMLHEKGRS-----------------GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRD 811 (973)
Q Consensus 749 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 811 (973)
...++..++||||+++++|.+++...... .......+..++.|++.||+|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 24567889999999999999988653211 0112334567999999999999999 999999
Q ss_pred CCCCCEEeCC-CCceEEeccCcchhccccCCCccccccccccccCccccccccCC----------------------CCC
Q 039922 812 VKSHNILLDA-EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK----------------------KVT 868 (973)
Q Consensus 812 lkp~NIll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 868 (973)
|||+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+... .++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~---~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccccc---CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 9999999986 579999999999865433221 22346789999999965322 234
Q ss_pred CCCChhhHHHHHHHHHcCCCCCCCCCC--------CchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHH
Q 039922 869 EKSDVYSFGVVLMELVTGKRPNDPSFG--------ENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEK 940 (973)
Q Consensus 869 ~~~Dv~slG~~l~elltg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~ 940 (973)
.++||||+||++|||+++..|++.... ...+...|....... .........+++| .....
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~d----------~~~~~ 425 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR--ASPDLRRGFEVLD----------LDGGA 425 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc--cchhhhhhhhhcc----------ccchH
Confidence 567999999999999997766432100 000111221111000 0000000001111 11234
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 941 VLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 941 l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+++.+|+++||++|||+.|+++|
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCC
Confidence 5689999999999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=261.70 Aligned_cols=240 Identities=29% Similarity=0.424 Sum_probs=194.7
Q ss_pred CCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCChhhhhh
Q 039922 694 GSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH 772 (973)
Q Consensus 694 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 772 (973)
+||.||+|+.. +|+.||+|++........ .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999987 589999999854432221 5788999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcccccccccc
Q 039922 773 EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852 (973)
Q Consensus 773 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~g 852 (973)
... .+++..+..++.+++.+++|||+. +++|+||+|+||++++++.++++|||.+....... ......+
T Consensus 80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~ 148 (244)
T smart00220 80 KRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFVG 148 (244)
T ss_pred hcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----ccccccC
Confidence 643 278899999999999999999999 99999999999999999999999999998765432 1233567
Q ss_pred ccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCC
Q 039922 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLST 932 (973)
Q Consensus 853 t~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 932 (973)
+..|++||...+..++.++||||+|+++|++++|..||... .+.....++..........
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~------------------- 208 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-DQLLELFKKIGKPKPPFPP------------------- 208 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhccCCCCcc-------------------
Confidence 88999999998888999999999999999999999998652 2233333333322211000
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 933 CDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 933 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.......++.+++.+|+..+|++||++.+++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 000034678899999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=248.98 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=195.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
..+|...++||+|+|+.|..++.+ +.+.||+|++++... ..+.....+.|..+..+. +||++|.+..+|.++...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 456888999999999999999876 677899999976533 334556677888888777 59999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|.||+++|+|--.+..+. .++++.+.-....|.-||.|||++ ||+.||+|.+||++|.+|++|+.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999976665543 588888888899999999999999 99999999999999999999999999987532
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCC--CCCchhHHHHHHHHhccCCCcc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPS--FGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.. ....+.+.||+.|.|||++.+..|...+|+|++||+++||+.|+.||+-. ...+..-.++.-+...+...+
T Consensus 403 ~~----gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir- 477 (593)
T KOG0695|consen 403 GP----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR- 477 (593)
T ss_pred CC----CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-
Confidence 22 23456689999999999999999999999999999999999999999753 112222223322222220000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP 957 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 957 (973)
+. +....+.-.+++.-+++||.+|.
T Consensus 478 --------ip---------rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 --------IP---------RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --------cc---------ceeehhhHHHHHHhhcCCcHHhc
Confidence 00 11223455777888999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=277.81 Aligned_cols=261 Identities=19% Similarity=0.211 Sum_probs=179.9
Q ss_pred cCCCCccccccccCCeeEEEEEE-----------------CCCCEEEEEEecCCCCCc------------hhHHHHHHHH
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL-----------------KSGETVAVKRLLGGTHKP------------ETETVFRSEI 731 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~e~ 731 (973)
.++|++.++||+|+||+||+|.+ .+++.||||++....... ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56799999999999999999864 245789999985322110 0112233467
Q ss_pred HHHhcCCCCCe-----eeEEeEEec--------CCeeEEEEeccCCCChhhhhhccCC---------------------C
Q 039922 732 ETLGRVRHGNV-----VKLLMCCSG--------QDFNILVYEYMPNGSLADMLHEKGR---------------------S 777 (973)
Q Consensus 732 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~ 777 (973)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 677777653 3567999999999999999874311 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCcc
Q 039922 778 GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857 (973)
Q Consensus 778 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~ 857 (973)
...++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++..+...... ......+++.|+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~---~~~~g~~tp~Y~ 377 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF---NPLYGMLDPRYS 377 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---CccccCCCccee
Confidence 1346778899999999999999999 9999999999999999999999999999765432211 111233478999
Q ss_pred ccccccCCCC----------------------CCCCChhhHHHHHHHHHcCCC-CCCCCCCC-------chhHHHHHHHH
Q 039922 858 APEYAYTKKV----------------------TEKSDVYSFGVVLMELVTGKR-PNDPSFGE-------NKDIVRWVTEA 907 (973)
Q Consensus 858 aPE~~~~~~~----------------------~~~~Dv~slG~~l~elltg~~-p~~~~~~~-------~~~~~~~~~~~ 907 (973)
|||.+..... ..+.||||+||++|||++|.. |+.....- ..+...|....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 9998754321 134699999999999999875 55421100 01112222111
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFP---INRPSMRRVVEL 965 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rps~~evl~~ 965 (973)
.. ...... .........+++.+|+.++| .+|+|+.|+++|
T Consensus 458 ~~-----------------~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQ-----------------KYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cc-----------------CCCccc-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 000000 11234667888899998766 689999999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=264.75 Aligned_cols=208 Identities=24% Similarity=0.343 Sum_probs=172.7
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
-|..++.||-|+||.|..+... +...||.|.+.++.. ........++|..+|.....+-||++|..|.+.+..|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4677889999999999998755 456789998865432 23344567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc----
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL---- 836 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~---- 836 (973)
|++||++-..|...+ .+.+..++-.+.++.+|+++.|.. |+|||||||+|||||.||++||.|||+++-+
T Consensus 710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999987765 477777777888899999999999 9999999999999999999999999997422
Q ss_pred -----cccCCC-----------------------------ccccccccccccCccccccccCCCCCCCCChhhHHHHHHH
Q 039922 837 -----QSQEGQ-----------------------------SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLME 882 (973)
Q Consensus 837 -----~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 882 (973)
...+-. ........+||..|+|||++....++..+|+||.|||+||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111000 0001122479999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCC
Q 039922 883 LVTGKRPNDPSFGE 896 (973)
Q Consensus 883 lltg~~p~~~~~~~ 896 (973)
|+.|+.||....+.
T Consensus 864 m~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPG 877 (1034)
T ss_pred HhhCCCCccCCCCC
Confidence 99999999876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=252.94 Aligned_cols=133 Identities=26% Similarity=0.328 Sum_probs=111.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-----C---CCeeeEEeEEec
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-----H---GNVVKLLMCCSG 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~ 751 (973)
..+|..+++||.|.|++||.+.+. ..+.||+|+.+.. ..-.+....|++++++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 368999999999999999999875 6788999998422 233455678999999984 2 489999999965
Q ss_pred ----CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC
Q 039922 752 ----QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD 820 (973)
Q Consensus 752 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 820 (973)
+.+.|+|+|++ |.+|..++...... -++...+.+|++||+.||.|||.+| +|+|.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 55889999999 67888888765432 4889999999999999999999998 999999999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=245.16 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=196.3
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----CeeE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ-----DFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 756 (973)
+.+..+.||-|+||.||.+++. +|+.||.|++..-...-...+.+-+|.+++.-.+|.|+...++..... .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455688999999999999876 899999999965555555667788999999999999999988876543 2557
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+++|.|. .+|.+.+-.- ..++...+.-...||++||.|||+. +|.||||||-|.+++.+...||+|||+++..
T Consensus 134 V~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 8999884 6787777543 2477788888999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH----------
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT---------- 905 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~---------- 905 (973)
..++. ..++..+.|..|.|||++.+. .|+.+.||||.||++.|++..+..|....+ .+-.+.+.
T Consensus 207 e~d~~---~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 207 DQRDR---LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred chhhh---hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHH
Confidence 54432 345666788999999999875 689999999999999999998888865321 11111111
Q ss_pred -----HHh----ccCCCc-cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 906 -----EAT----LSSPER-GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 906 -----~~~----~~~~~~-~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
++. .+.... ..-..++.+-.+ .....+...+...++..||++|.+..+.+.++
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~--------~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASP--------DDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCC--------cccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111 110000 000011111111 12233556777889999999999999887765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=241.07 Aligned_cols=267 Identities=22% Similarity=0.268 Sum_probs=201.3
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-----
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD----- 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 753 (973)
...+|...+.+|.|.- .|..+.+. .+++||+|++..+.......++..+|...+..++|+||++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456778889999988 66666544 6899999999777666566677889999999999999999999986543
Q ss_pred -eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 754 -FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 754 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
+.|+|||+| ..+|.+.+.- .++-+++..|..|+++|+.|||+. +|+||||||+||++..++.+||.|||+
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 569999999 5799988873 367788899999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc-C
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS-S 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~ 911 (973)
++.-..+ -.++.++.|..|.|||++.+-.+.+.+||||.||++.||++|+..|.+ ...+-+|.+..... .
T Consensus 165 ar~e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 165 ARTEDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKIIEQLGT 235 (369)
T ss_pred hcccCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHHHHHhcC
Confidence 9864332 235667899999999999988899999999999999999999988853 22233332211111 0
Q ss_pred CC-------------------ccccCcccc-cccCCCCCC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PE-------------------RGCCRDLNQ-LIDPRMDLS-TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~-------------------~~~~~~l~~-~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. ....-...+ +.|-.+... ..++-+......++.+|+-.+|++|.+++++++|
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 000000001 111111111 1112345567888999999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-28 Score=257.18 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=168.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCch--hH----HHHHHHHHHHhcCC---CCCeeeEEeEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE--TE----TVFRSEIETLGRVR---HGNVVKLLMCCSG 751 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~----~~~~~e~~~l~~l~---h~niv~l~~~~~~ 751 (973)
..|+..+.+|.|+||.|+.|.++ +...|++|.+.+.+.-.. .+ -..-.|+.+|..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999987 456788898865432111 00 11346999999997 9999999999999
Q ss_pred CCeeEEEEeccC-CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 752 QDFNILVYEYMP-NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 752 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
++.+|++||-.. +-+|.+++..+. .+++..+..|++||+.|+++||++ +|||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 999999999875 448889988765 489999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCC
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPND 891 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~ 891 (973)
|.+.... ..++..++||+.|.|||++.+.+| +..-|||++|+++|-++....||+
T Consensus 715 gsaa~~k------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTK------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhc------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9988764 344667899999999999998887 567899999999999999888886
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=230.63 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=194.4
Q ss_pred ccccccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeE-Ee
Q 039922 674 SFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMC-CS 750 (973)
Q Consensus 674 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~ 750 (973)
+...-++.+.|.+.+.+|+|.||.+-.+..+ +.+.+++|.+.++ ....++|.+|...--.+. |.||+..|++ |+
T Consensus 16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred cccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 3334566778999999999999999999876 6788999988433 345677999988766664 8999988864 77
Q ss_pred cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe-C-CCCceEEe
Q 039922 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL-D-AEMVPRVA 828 (973)
Q Consensus 751 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~-~~~~~kl~ 828 (973)
..+.+++++||++.|+|.+-+...+ +-+....+++.|+++|+.|||++ ++||||||.+|||| + +..++|++
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred cCceEEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEee
Confidence 8889999999999999998876643 66777889999999999999999 99999999999999 3 45689999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCC-----CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-----KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 903 (973)
|||.++..+.. .....-+-.|.|||..... ...+.+|||.||+++|.++||+.||......+..+.+|
T Consensus 166 DFG~t~k~g~t-------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~ 238 (378)
T KOG1345|consen 166 DFGLTRKVGTT-------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW 238 (378)
T ss_pred ecccccccCce-------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH
Confidence 99998765332 2223344578999976532 24578999999999999999999998766666777777
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....+..+ .+.+.+. .-..+..++.++-+..+|++|=...++.++
T Consensus 239 ~~w~~rk~~------~~P~~F~----------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 239 EQWLKRKNP------ALPKKFN----------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHHhcccCc------cCchhhc----------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 665443321 1111111 113455666677888888888444444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=234.44 Aligned_cols=212 Identities=36% Similarity=0.551 Sum_probs=182.5
Q ss_pred ccccCCeeEEEEEECC-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCChh
Q 039922 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768 (973)
Q Consensus 690 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 768 (973)
||+|++|.||++...+ ++.+++|++....... ..+.+.+|+..++.++|++++++++++...+..+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999864 8999999995433221 4567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccCcchhccccCCCccccc
Q 039922 769 DMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKALQSQEGQSDDAM 847 (973)
Q Consensus 769 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~ 847 (973)
+++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~ 150 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LL 150 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hh
Confidence 9987642 2578999999999999999999999 9999999999999999 89999999999876543321 12
Q ss_pred cccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccC
Q 039922 848 SCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926 (973)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 926 (973)
....+...|++||..... .++.++|+|++|++++++
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 234577889999998877 888999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 927 RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 927 ~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467888999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=223.02 Aligned_cols=261 Identities=19% Similarity=0.244 Sum_probs=198.8
Q ss_pred cCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecC--CeeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQ--DFNI 756 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~ 756 (973)
.++|++.+++|+|.++.||.|.. .++++++||+++ +-..+.+.+|+.+++.+. ||||+++++...+. ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 46789999999999999999974 478899999983 334566899999999998 99999999998764 4567
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccCcchh
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKA 835 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~ 835 (973)
+|+||+.+.+...... .++...+...+.+++.||.|.|+. ||.|||+||.|+++|. .-.++|+|+|+|.+
T Consensus 112 LiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999999888776543 356667788899999999999999 9999999999999986 45699999999999
Q ss_pred ccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH-----------
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW----------- 903 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~----------- 903 (973)
+.+.... .-.+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||........++++.
T Consensus 183 YHp~~eY-----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 183 YHPGKEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred cCCCcee-----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 8765543 23456778889998875 567888999999999999999999998765555555433
Q ss_pred -HHHHhccCCCccccCcccccccC----C---CCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 904 -VTEATLSSPERGCCRDLNQLIDP----R---MDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 904 -~~~~~~~~~~~~~~~~l~~~~d~----~---l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+.....++. ...++.. . +-..+..--...+.++++...+.+|-.+|+|+.|.++|
T Consensus 258 Yl~KY~i~Ldp~-----~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 258 YLNKYQIDLDPQ-----FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHccCCChh-----HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 33332221111 1111110 0 00011111123567888999999999999999998765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=248.78 Aligned_cols=272 Identities=22% Similarity=0.216 Sum_probs=208.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC------CCCeeeEEeEEec
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR------HGNVVKLLMCCSG 751 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~ 751 (973)
.+-.+|.+....|+|-|++|.+|.+. -|..||||++... +...+.=.+|+++|++|. --|+++++-.|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 34457888889999999999999875 5789999999533 233444568999999995 3489999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-CceEEecc
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADF 830 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 830 (973)
.++.|+|+|-+ .-+|.+.++..+..--+...++..++.|+..||..|-.. +|+|.||||+||||++. ..+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence 99999999988 579999999888776788899999999999999999998 99999999999999875 56899999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
|.|......+ .+.+..+..|.|||++.+-.|+...|+||.||.+||+.||+..|-+.. ..++........-.
T Consensus 582 GSA~~~~ene------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T--NN~MLrl~me~KGk 653 (752)
T KOG0670|consen 582 GSASFASENE------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT--NNQMLRLFMELKGK 653 (752)
T ss_pred cccccccccc------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC--cHHHHHHHHHhcCC
Confidence 9998765543 233556788999999999999999999999999999999999986643 22333332222111
Q ss_pred CCC-------------ccccC-------------------------cccccccCCCCCCCCCHHHHHHHHHHHHhccCCC
Q 039922 911 SPE-------------RGCCR-------------------------DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDF 952 (973)
Q Consensus 911 ~~~-------------~~~~~-------------------------~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~d 952 (973)
.|. .-.+. ++...+-........++.....+.+|+..|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 110 00000 0000011111122334455678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 039922 953 PINRPSMRRVVEL 965 (973)
Q Consensus 953 P~~Rps~~evl~~ 965 (973)
|++|.|..+.++|
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=231.24 Aligned_cols=214 Identities=32% Similarity=0.405 Sum_probs=176.5
Q ss_pred CCccccccccCCeeEEEEEECC-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|...+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++...+..++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999999874 899999999543322 25677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++++|.+++..... .+++..+..++.+++.+++|||+. +++|+|++|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 99999999876432 178899999999999999999999 999999999999999999999999999887654321
Q ss_pred ccccccccccccCccccccc-cCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHH
Q 039922 843 SDDAMSCVAGSYGYIAPEYA-YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 906 (973)
.......++..|++||.. ....++.++|||+||++++||++|+.||.........+.+.+..
T Consensus 154 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 154 --ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred --ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 112334677889999998 66777889999999999999999999996422233344444333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-27 Score=254.98 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=203.1
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+-.++|...+.+|+|.||.|||++++ +++..|+|+++ .......+...+|+-+++..+|+|||.+++.+-..+..++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVk--Lep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVK--LEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeee--ccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 33567889999999999999999976 79999999994 4444555667889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
.||||.+|+|++.-+.. +.+++.++....++..+|++|||+. +-+|||||-.||++++.|.+|++|||.+..+.
T Consensus 90 cMEycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999877653 3688999999999999999999999 99999999999999999999999999986653
Q ss_pred ccCCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
..- .....+.||+.|||||+.. .+.|...+|||+.|+...|+-.-+.|.....+ .+....+.+...+.+.
T Consensus 164 ati----~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l~LmTkS~~qpp~- 236 (829)
T KOG0576|consen 164 ATI----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRALFLMTKSGFQPPT- 236 (829)
T ss_pred hhh----hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HHHHHHhhccCCCCCc-
Confidence 322 2234578999999999864 56789999999999999999888877653221 1111222222212111
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 964 (973)
++. .......+-++++.|+.++|.+||++..++.
T Consensus 237 -------------lkD---k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 -------------LKD---KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -------------ccC---CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 110 1223567889999999999999999987765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-26 Score=235.39 Aligned_cols=273 Identities=24% Similarity=0.306 Sum_probs=198.8
Q ss_pred ccCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCe
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDF 754 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 754 (973)
+.+.|..+++||+|+|++||++.+. ..+.||+|.+.... ....+.+|++++..+. +.||+++.+++..++.
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3456888999999999999998754 46789999985333 2345788999999996 8999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccCcc
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLA 833 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~ 833 (973)
.++|+||+++....++... ++...+...++.+..||+++|+. |||||||||.|++.+. .+.-.|.|||++
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 9999999999988888764 56778888999999999999999 9999999999999975 567899999999
Q ss_pred hhccccC------C-------C---------------------------ccccccccccccCccccccccC-CCCCCCCC
Q 039922 834 KALQSQE------G-------Q---------------------------SDDAMSCVAGSYGYIAPEYAYT-KKVTEKSD 872 (973)
Q Consensus 834 ~~~~~~~------~-------~---------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 872 (973)
...+... . . .........||+||.|||++.. ...+++.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7432111 0 0 0001123479999999999875 45688999
Q ss_pred hhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc-------CCCc--ccc-Cc---c-------ccc----ccCC-
Q 039922 873 VYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS-------SPER--GCC-RD---L-------NQL----IDPR- 927 (973)
Q Consensus 873 v~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~--~~~-~~---l-------~~~----~d~~- 927 (973)
|||.||++.-+++++.||.....+-..+.+.+...... .+.. .+. .. . ..+ +-+.
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999987655544443322111100 0000 000 00 0 000 0000
Q ss_pred ---CCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 928 ---MDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 928 ---l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.............+++++.+|+..||.+|.|++|.++|
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00011111123478899999999999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-27 Score=239.94 Aligned_cols=399 Identities=22% Similarity=0.273 Sum_probs=214.8
Q ss_pred CCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccC-cCCCCCCCCccccCcchhHHHhh
Q 039922 147 LQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGY-NPLKSSPLPSSVGNLSKLENLWA 225 (973)
Q Consensus 147 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~~~l~~L~~L~l 225 (973)
-..++|..|.|+.+.|.+|+.+++|+.|||++|+|+.+-|++|.+|.+|..|.+.+ |+|+.++ ...|++|.+|+.|.+
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~-k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLP-KGAFGGLSSLQRLLL 147 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhh-hhHhhhHHHHHHHhc
Confidence 44555666666655555666666666666666666666666666666665555533 6666532 245666667777766
Q ss_pred ccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCc------------ccCchhccCCCccc
Q 039922 226 AKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLS------------GELPESLSNLTTLL 293 (973)
Q Consensus 226 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~------------~~~p~~l~~l~~L~ 293 (973)
..|++.-...+.|..+++|..|.+.+|.+..+-..+|..+.+++.+.+..|.+- ...|..++...-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 666666666677888888888888888888444447888888888888887732 12222333333333
Q ss_pred eeeccccccCCCChhhhhcccCcEE--Ec-cCCcCCCCCC-ccccCCCccceeeeccccccCCCCCCccCCCCccceeee
Q 039922 294 RLDISQNNLTGNLPETIAAMSLESL--NL-NDNYFTGEIP-ESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVS 369 (973)
Q Consensus 294 ~L~Ls~N~l~~~~~~~~~~~~L~~L--~L-~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 369 (973)
...+.++++...-+..+... ++.+ .+ +.+...+.-| ..|..+++|+.|+|++|+++++-+.+|..+..+++|.|.
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~-~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCS-LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred hHHHHHHHhcccchhhhhhh-HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 33344444433323222211 1111 11 1111222222 235555666666666666665555555556666666666
Q ss_pred cccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccC-cccCCCCCccEEEeecCcccCC
Q 039922 370 TNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELP-SKFWGLPEVDFFEMYNNRFEGS 448 (973)
Q Consensus 370 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~ 448 (973)
.|++...-...|.++..|+.|+|.+|+|+...|.+|..+..|.+|.|-.|.+...-- .++.. .|..++..|
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~- 378 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVG- 378 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCC-
Confidence 665554444444444444445555555444444444444444444444444321000 00000 000001000
Q ss_pred CCCCCCCCCCcceEeecCCcCCC---CCchhhh---------cCCcCc-EEeCcCCcccCCCccccccccccceeecccc
Q 039922 449 ISPSISNAPKLTGILINGNNFTG---EVPSQIC---------TLRQLQ-AVDLSQNRFSGHLPTCITQLNKLQQLELQEN 515 (973)
Q Consensus 449 ~~~~~~~~~~L~~L~L~~N~l~~---~~p~~~~---------~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (973)
.+.-.....++.+.++.+.+.. ..|++.+ .++-+. +...|++.++ .+|..+. ..-++|++.+|
T Consensus 379 -~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn 454 (498)
T KOG4237|consen 379 -NPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGN 454 (498)
T ss_pred -CCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccc
Confidence 0111122235555555544321 1222211 122232 2345555555 6666554 35677888888
Q ss_pred ccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCC
Q 039922 516 MFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563 (973)
Q Consensus 516 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (973)
.++ .+|.+ .+.+| .+|||+|+++..-...|.+|++|.+|-||+|
T Consensus 455 ~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 455 AIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 888 77776 66777 8888888888666678888888888888876
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=267.79 Aligned_cols=322 Identities=21% Similarity=0.282 Sum_probs=172.2
Q ss_pred cCCccccCCC-CCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhh
Q 039922 233 EIPDSIGKLA-FLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIA 311 (973)
Q Consensus 233 ~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 311 (973)
.+|..+..++ +|+.|++.++.++ .+|..| .+.+|++|++.+|++. .++..+..+++|+.|+|++|.....+|....
T Consensus 579 ~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~ 655 (1153)
T PLN03210 579 HLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSM 655 (1153)
T ss_pred ecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCcccc
Confidence 4455555543 4777777777776 556665 3567777777777776 4566667777777777777654445555333
Q ss_pred cccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhh
Q 039922 312 AMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCII 391 (973)
Q Consensus 312 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 391 (973)
..+|+.|+|++|.....+|..+..+++|+.|++++|...+.+|..+ ++++|+.|++++|...+.+|.. ..+|+.|+
T Consensus 656 l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~ 731 (1153)
T PLN03210 656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLD 731 (1153)
T ss_pred CCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeee
Confidence 4467777777766555667777777777777777765444566544 5677777777776544444432 23455566
Q ss_pred cccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCC
Q 039922 392 IFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTG 471 (973)
Q Consensus 392 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~ 471 (973)
+++|.+. .+|..+ .+++|++|++.++..... .. .+....+..+...++|+.|++++|...+
T Consensus 732 L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l-~~----------------~~~~l~~~~~~~~~sL~~L~Ls~n~~l~ 792 (1153)
T PLN03210 732 LDETAIE-EFPSNL-RLENLDELILCEMKSEKL-WE----------------RVQPLTPLMTMLSPSLTRLFLSDIPSLV 792 (1153)
T ss_pred cCCCccc-cccccc-cccccccccccccchhhc-cc----------------cccccchhhhhccccchheeCCCCCCcc
Confidence 6666554 344433 345555555554322100 00 0001111112223445555555554444
Q ss_pred CCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccc
Q 039922 472 EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGN 551 (973)
Q Consensus 472 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 551 (973)
.+|..++++++|+.|++++|..-+.+|..+ .+++|+.|+|++|.....+|.. .++|+.|+|++|.++ .+|.++..
T Consensus 793 ~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~ 867 (1153)
T PLN03210 793 ELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEK 867 (1153)
T ss_pred ccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhc
Confidence 555555555555555555543222444443 3455555555554333233332 234555555555554 34555555
Q ss_pred cccccEEecCC-CcCccccChhhhcc-cccceeccCC
Q 039922 552 LAVLTSLDLSS-NLLTGEIPLELTKL-KLNQFNISHN 586 (973)
Q Consensus 552 l~~L~~L~Ls~-N~l~~~~p~~l~~l-~l~~l~l~~N 586 (973)
+++|++|+|++ |+|+ .+|..+..+ .|+.++++++
T Consensus 868 l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 868 FSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 55555555555 3333 344444444 4555555544
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=264.24 Aligned_cols=345 Identities=23% Similarity=0.278 Sum_probs=188.7
Q ss_pred CccccCCCCCCEEECcCCc------CCCCCCcccCCCC-cccEEecCCcccCCcccccccccccccEeeccCcCCCCCCC
Q 039922 138 PDFSREFANLQVLDLSRNN------FSGDIPESFGRFP-VLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPL 210 (973)
Q Consensus 138 ~~~~~~l~~L~~L~Ls~n~------l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~ 210 (973)
+.+|.++++|+.|.+..+. +...+|+.|..++ +|+.|++.++.++ .+|..| ...+|++|+|++|++.. +
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~--L 626 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK--L 626 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc--c
Confidence 3456667777777775543 2234555565553 4777777777665 345555 45677777777776654 2
Q ss_pred CccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCC
Q 039922 211 PSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLT 290 (973)
Q Consensus 211 ~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 290 (973)
+.. +..+++|+.|+|++|.....+| .++.+++|+.|++++|.....+|..+.+++
T Consensus 627 ~~~------------------------~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~ 681 (1153)
T PLN03210 627 WDG------------------------VHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLN 681 (1153)
T ss_pred ccc------------------------cccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccC
Confidence 333 3444455555555443322333 244455555555555543344555555555
Q ss_pred ccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeec
Q 039922 291 TLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVST 370 (973)
Q Consensus 291 ~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 370 (973)
+|+.|++++|...+.+|..+...+|+.|++++|.....+|.. .++|+.|+|++|.+. .+|..+ .+++|++|++.+
T Consensus 682 ~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~ 756 (1153)
T PLN03210 682 KLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCE 756 (1153)
T ss_pred CCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccc
Confidence 555555555443334444333335555555555443344432 245666666666665 445443 455666666655
Q ss_pred ccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCC
Q 039922 371 NDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSIS 450 (973)
Q Consensus 371 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 450 (973)
+.... +... +....+......++|+.|++++|...+.+|..+.++++|+.|++++|..-+.+|
T Consensus 757 ~~~~~-l~~~----------------~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP 819 (1153)
T PLN03210 757 MKSEK-LWER----------------VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819 (1153)
T ss_pred cchhh-cccc----------------ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence 33211 0000 000111112223455566666665555555566666666666666554333444
Q ss_pred CCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccc-cccccccCcccCccc
Q 039922 451 PSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQE-NMFTGELPRNLNSLT 529 (973)
Q Consensus 451 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~ 529 (973)
..+ ++++|+.|++++|.....+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++ |+++ .+|..+..++
T Consensus 820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~ 893 (1153)
T PLN03210 820 TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLK 893 (1153)
T ss_pred CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCccccccc
Confidence 444 5666677777666544444432 356777777777776 5777777777777777777 4455 5666777777
Q ss_pred cceeeeeccC
Q 039922 530 ALIVLNLSTN 539 (973)
Q Consensus 530 ~L~~L~Ls~N 539 (973)
+|+.|+++++
T Consensus 894 ~L~~L~l~~C 903 (1153)
T PLN03210 894 HLETVDFSDC 903 (1153)
T ss_pred CCCeeecCCC
Confidence 7777777765
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-26 Score=234.23 Aligned_cols=407 Identities=19% Similarity=0.192 Sum_probs=244.6
Q ss_pred ceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcC-CcCCCCCCcccCCCCcccEEecC
Q 039922 99 RNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSR-NNFSGDIPESFGRFPVLKVLNLG 177 (973)
Q Consensus 99 ~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~ 177 (973)
..++|..|+|+ .||+.+|+.+.+||.|||++|.|+.+-|++|.++++|..|-+.+ |+|+......|++|..|+.|.+.
T Consensus 70 veirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 70 VEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred eEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 56677777777 77777777777777777777777777777777777776665555 77775555567777777777777
Q ss_pred CcccCCcccccccccccccEeeccCcCCCCCCCCc-cccCcchhHHHhhccCc------------ccccCCccccCCCCC
Q 039922 178 GNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPS-SVGNLSKLENLWAAKAN------------LIGEIPDSIGKLAFL 244 (973)
Q Consensus 178 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~-~~~~l~~L~~L~l~~n~------------l~~~~p~~l~~l~~L 244 (973)
-|++.-+..+.|..|++|..|.+.+|.+..+ +. .+..+..++.+.+..|. .....|..++.....
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i--~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSI--CKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhh--ccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 7777777777777777777777777777653 33 66777777777777665 223334445555555
Q ss_pred CEEEccCCcccccCCcCCCC-CCCCCEEEccCCcCcccCc-hhccCCCccceeeccccccCCCChhhhhcc-cCcEEEcc
Q 039922 245 SNLDLSDNFLSGKIPHSFSG-LASIEQIELFDNQLSGELP-ESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLN 321 (973)
Q Consensus 245 ~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~ 321 (973)
.-..+.++++....+.-|.. +.++..-..+.+...++-| ..|..+++|+.|+|++|+++++-+.+|... .+++|.|.
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 55556666655443333322 2222222223332333333 357777777777777777777777777665 57777777
Q ss_pred CCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeeccccccc-CCccccccCCchhhhcccCccCCC
Q 039922 322 DNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE-LPRFLCFRNKLQCIIIFNNRFSGK 400 (973)
Q Consensus 322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~ 400 (973)
.|+|...-...|.++..|+.|+|.+|+|+..-|..|..+..|..|+|-.|.+.-. --.|+.. .+..+.-.|.
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~~ 379 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVGN 379 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCCC
Confidence 7777766666777777777788888887777777777777777777777766410 0011100 0111111111
Q ss_pred CCCccCCcceeeEEEccCCccccc---cCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcce-EeecCCcCCCCCchh
Q 039922 401 IPESYGECKTLNYLRFGGNELQGE---LPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTG-ILINGNNFTGEVPSQ 476 (973)
Q Consensus 401 ~p~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~-L~L~~N~l~~~~p~~ 476 (973)
.|- +.-..++.+.++++.+... .|.+.+-.+ . +.--...+-+.+ ..-++..++ .+|..
T Consensus 380 ~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s---~~cP~~c~c~~tVvRcSnk~lk-~lp~~ 441 (498)
T KOG4237|consen 380 PRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLT------------S---SPCPPPCTCLDTVVRCSNKLLK-LLPRG 441 (498)
T ss_pred CCC--CCCchhccccchhccccccccCCccccCCCC------------C---CCCCCCcchhhhhHhhcccchh-hcCCC
Confidence 111 1122345555555544321 111111000 0 111111222322 223333333 45544
Q ss_pred hhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccC
Q 039922 477 ICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTN 539 (973)
Q Consensus 477 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (973)
+- ..-.+|++.+|.++ .+|.. .+..| .+|||+|+++..--..|.+|++|.+|-||.|
T Consensus 442 iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 442 IP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 32 24567788888887 67776 56777 8888888888666677888888888888876
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=266.77 Aligned_cols=200 Identities=19% Similarity=0.213 Sum_probs=140.0
Q ss_pred cCCC-CCeeeEEeEE-------ecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 039922 736 RVRH-GNVVKLLMCC-------SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807 (973)
Q Consensus 736 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 807 (973)
.++| +||++++++| ...+..+.++||+ +++|.++++... ..+++.+++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3455 5777788877 2334667889988 679999997532 3589999999999999999999999 99
Q ss_pred EEeCCCCCCEEeCC-------------------CCceEEeccCcchhccccCCC------------ccccccccccccCc
Q 039922 808 VHRDVKSHNILLDA-------------------EMVPRVADFGLAKALQSQEGQ------------SDDAMSCVAGSYGY 856 (973)
Q Consensus 808 vH~Dlkp~NIll~~-------------------~~~~kl~DfGl~~~~~~~~~~------------~~~~~~~~~gt~~y 856 (973)
+||||||+|||++. ++.+|++|||+++........ .........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 445566666666542110000 00001123578899
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHH
Q 039922 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYE 936 (973)
Q Consensus 857 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 936 (973)
+|||++.+..++.++|||||||++|||++|..|+... ....... ...... +.. ..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~-~~~~~~---------------~~~------~~ 236 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSL-RHRVLP---------------PQI------LL 236 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHH-HHhhcC---------------hhh------hh
Confidence 9999999999999999999999999999988876421 1111111 111100 000 01
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 937 EAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 937 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
...+...++.+|++++|.+||+|.||+++-
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 123346788899999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=207.97 Aligned_cols=167 Identities=23% Similarity=0.268 Sum_probs=127.4
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.++++.... .+++..++.|+.||+.||+|||++ + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999976432 589999999999999999999999 6 999999999999999 99987653321
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..++.. .....+..
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~--------- 128 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-MPADDPRD--------- 128 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-hccCCccc---------
Confidence 257899999999999999999999999999999999999997542222222222221 11100000
Q ss_pred cCCCCCCCCCHHHH--HHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 925 DPRMDLSTCDYEEA--EKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 925 d~~l~~~~~~~~~~--~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
........ ..+.+++.+|++.+|++||++.|+++++...
T Consensus 129 ------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 129 ------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00001122 3689999999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=243.87 Aligned_cols=267 Identities=26% Similarity=0.387 Sum_probs=176.7
Q ss_pred CCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccC
Q 039922 243 FLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322 (973)
Q Consensus 243 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 322 (973)
.-..|+|++|.++ .+|..+. ++|+.|++.+|+++ .+|.. +++|++|+|++|+|+. +|.. ..+|+.|++++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l--p~sL~~L~Ls~ 271 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL--PPGLLELSIFS 271 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc--ccccceeeccC
Confidence 4567899999998 5777765 47899999999988 45542 4778888888888884 3432 23688888888
Q ss_pred CcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCC
Q 039922 323 NYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIP 402 (973)
Q Consensus 323 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 402 (973)
|.++ .+|..+ ++|+.|+|++|+++ .+|.. .++|++|+|++|++++ +|.. ...|+.|++++|++.+ +|
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LP 338 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-cc
Confidence 8877 344432 56777888888887 45542 3567788888887774 2321 1234445555555542 22
Q ss_pred CccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCc
Q 039922 403 ESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQ 482 (973)
Q Consensus 403 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 482 (973)
.. . .+|+.|+|++|+|++. |.. ..+|+.|++++|.|+ .+|.. ..+
T Consensus 339 ~l---p------------------------~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~-~LP~l---~~~ 383 (788)
T PRK15387 339 TL---P------------------------SGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLT-SLPAL---PSG 383 (788)
T ss_pred cc---c------------------------cccceEecCCCccCCC-CCC---Ccccceehhhccccc-cCccc---ccc
Confidence 21 1 2344455555544432 221 234556666666666 34532 246
Q ss_pred CcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCC
Q 039922 483 LQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSS 562 (973)
Q Consensus 483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (973)
|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 788888888887 456433 56788888888888 466543 46778888888887 6888888888888888888
Q ss_pred CcCccccChhhhcc
Q 039922 563 NLLTGEIPLELTKL 576 (973)
Q Consensus 563 N~l~~~~p~~l~~l 576 (973)
|+|+|.+|..+..+
T Consensus 455 N~Ls~~~~~~L~~l 468 (788)
T PRK15387 455 NPLSERTLQALREI 468 (788)
T ss_pred CCCCchHHHHHHHH
Confidence 88888888776443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=238.54 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=174.6
Q ss_pred CCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccc
Q 039922 268 IEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNN 347 (973)
Q Consensus 268 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 347 (973)
-..|++++|.|+ .+|..+. ++|+.|++++|+++. +|.. ..+|++|+|++|+|+. +|.. .++|+.|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l--p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL--PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC--CCCCcEEEecCCccCc-ccCc---ccccceeeccCC
Confidence 445666666666 4555443 256666666666653 3321 1245555555555542 2321 234444555555
Q ss_pred cccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCc
Q 039922 348 SFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPS 427 (973)
Q Consensus 348 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 427 (973)
.++ .+|.. . .+|+.|++++|+++ .+|.. .++|++|++++|++++. |.
T Consensus 273 ~L~-~Lp~l---p------------------------~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~L-p~ 319 (788)
T PRK15387 273 PLT-HLPAL---P------------------------SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASL-PA 319 (788)
T ss_pred chh-hhhhc---h------------------------hhcCEEECcCCccc-ccccc---ccccceeECCCCccccC-CC
Confidence 444 22221 1 23444455555554 23332 35678888888887753 33
Q ss_pred ccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCcccccccccc
Q 039922 428 KFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKL 507 (973)
Q Consensus 428 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 507 (973)
. ..+|+.|++++|++++ +|. ...+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|... .+|
T Consensus 320 l---p~~L~~L~Ls~N~L~~-LP~---lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~L 384 (788)
T PRK15387 320 L---PSELCKLWAYNNQLTS-LPT---LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP---SGL 384 (788)
T ss_pred C---cccccccccccCcccc-ccc---cccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCcccc---ccc
Confidence 2 2357778888888875 333 22579999999999994 5643 357889999999999 577643 579
Q ss_pred ceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCC
Q 039922 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHN 586 (973)
Q Consensus 508 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N 586 (973)
+.|+|++|+|+ .+|.. .++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+..+ .|..++|++|
T Consensus 385 ~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 385 KELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 455 (788)
T ss_pred ceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence 99999999999 46654 367999999999999 477643 46889999999999 899999988 8999999999
Q ss_pred cCcccCCCCC
Q 039922 587 KLYGEVPSDF 596 (973)
Q Consensus 587 ~l~g~~p~~~ 596 (973)
+|+|.+|..+
T Consensus 456 ~Ls~~~~~~L 465 (788)
T PRK15387 456 PLSERTLQAL 465 (788)
T ss_pred CCCchHHHHH
Confidence 9999888654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=201.60 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=191.5
Q ss_pred CCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccC
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
.....+|.+...|..|+|+++ |..+++|++.-........+.|..|.-.++...||||.++++.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 334567889999999999998 7788888875444445556779999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe--ccCcchhccccCC
Q 039922 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA--DFGLAKALQSQEG 841 (973)
Q Consensus 764 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DfGl~~~~~~~~~ 841 (973)
.|+|...++... .-..+-.++.+++.+||+|++|||+. +|-|.---+.++.|++|++.+++|+ |--++..
T Consensus 271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 999999999754 33578889999999999999999996 3345555689999999999988874 3222211
Q ss_pred CccccccccccccCccccccccCCCCC---CCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVT---EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
-....-.+.||+||.++.+.-+ .++|+|||.+++||+-|...||..-.+. +.-.....++.+.
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-ecgmkialeglrv-------- 408 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-ECGMKIALEGLRV-------- 408 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-hhhhhhhhccccc--------
Confidence 0112335789999999876543 5899999999999999999999753221 1111112222211
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
-+ .+.....+.+++.-|.++||.+||.++.|+-.||..
T Consensus 409 ----~i---------ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 ----HI---------PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ----cC---------CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11 133456778889999999999999999999998864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=216.07 Aligned_cols=170 Identities=21% Similarity=0.225 Sum_probs=131.0
Q ss_pred cccCCCCccccccccCCeeEEEEEEC--CCCEEEEEEecCCCC---CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK--SGETVAVKRLLGGTH---KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD 753 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 753 (973)
.+.++|...+.||+|+||+||+|..+ +++.||||++..... .....+.+.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 45567999999999999999999875 577889998743211 22345678999999999999999854332 24
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCC-CCCCEEeCCCCceEEeccCc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDV-KSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGl 832 (973)
..|+||||+++++|... .. .. ...++.++++||+|+|+. +|+|||| ||+||+++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 57999999999999632 11 11 146788999999999999 9999999 99999999999999999999
Q ss_pred chhccccCCCcc----ccccccccccCccccccccC
Q 039922 833 AKALQSQEGQSD----DAMSCVAGSYGYIAPEYAYT 864 (973)
Q Consensus 833 ~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~ 864 (973)
++.+........ .......+++.|+|||++..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 987754321111 11235678889999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-20 Score=205.60 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=189.5
Q ss_pred CCCccccccccCCeeEEEEEECCC--CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC----CCeeeEEeEE-ecCCee
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSG--ETVAVKRLLGGTHKPETETVFRSEIETLGRVRH----GNVVKLLMCC-SGQDFN 755 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~ 755 (973)
+|++.+.||+|+||.||.|...+. ..+|+|.-........ ..+..|..++..+.. +++.++++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999997753 4788887643322211 156778888888862 6899999998 578889
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-----CceEEecc
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-----MVPRVADF 830 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df 830 (973)
++||+.+ +.+|.++..... ...++..+..+|+.|++.+|+++|+. |++||||||.|+++... ..+.+.||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9999988 789999876554 45799999999999999999999999 99999999999999764 46899999
Q ss_pred Ccch--hccccCCC---cccc-ccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH
Q 039922 831 GLAK--ALQSQEGQ---SDDA-MSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 831 Gl~~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 904 (973)
|+++ .+....+. .... .....||.+|+++....+...+.+.|+||++.++.|+..|..||...... .......
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~-~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT-DLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc-chHHHHH
Confidence 9998 43323221 1112 23466999999999999999999999999999999999999999653221 1111111
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
....... ... .....+. .+.++...+-..+...+|....+.+.+++
T Consensus 251 ~~~~~~~------------~~~---~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 251 KDPRKLL------------TDR---FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHhhhhc------------ccc---ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 1111110 000 0111123 33444444444788889988888877765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=227.08 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=190.6
Q ss_pred CccccccccCCeeEEEEEEC-CCCEEEEEEec----CCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKRLL----GGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
....++|.|++|.|+.+... ....++.|.+. ...........+..|+.+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988876644 44445555443 11111112222566888888899999988888777777666679
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||++. +|...+.... .+....+..++.|+..|++|+|.. |+.|||+|++|++++.++.+||+|||.+....-.
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99998 9998887642 477888889999999999999999 9999999999999999999999999998776544
Q ss_pred CCCccccccccccccCccccccccCCCCCC-CCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTE-KSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
............|+..|+|||+..+..|.+ ..||||.|+++..|.+|+.||......+....+ .... .
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~~~~-------~ 542 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----NNYS-------D 542 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----hccc-------c
Confidence 332224456678999999999999998875 689999999999999999999876444333200 0000 0
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+......+ .......+.+...++.+|++.+|.+|.|+.+|++.
T Consensus 543 ~~~~~~~~----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 543 QRNIFEGP----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccccCh----HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000000 01112345677899999999999999999999764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.2e-21 Score=224.74 Aligned_cols=265 Identities=28% Similarity=0.434 Sum_probs=175.0
Q ss_pred CCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccC
Q 039922 243 FLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322 (973)
Q Consensus 243 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 322 (973)
+...|+++++.++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+++. +|..+. .+|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~-~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP-DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh-ccccEEECcC
Confidence 4577888888888 4565553 47888888888888 4565554 478888898888884 454433 2688888888
Q ss_pred CcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCC
Q 039922 323 NYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIP 402 (973)
Q Consensus 323 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 402 (973)
|+++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|++++ +|..+. ++|+.|++++|++.. +|
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP 320 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LP 320 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CC
Confidence 8888 5666654 47888999988888 5676554 478888888888874 343332 367777777777763 34
Q ss_pred CccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCc
Q 039922 403 ESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQ 482 (973)
Q Consensus 403 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 482 (973)
..+. ++|++|++++|.+++ +|..+ .++|+.|++++|+|+ .+|..+. ++
T Consensus 321 ~~l~--~sL~~L~Ls~N~Lt~-LP~~l--------------------------~~sL~~L~Ls~N~L~-~LP~~lp--~~ 368 (754)
T PRK15370 321 ETLP--PGLKTLEAGENALTS-LPASL--------------------------PPELQVLDVSKNQIT-VLPETLP--PT 368 (754)
T ss_pred cccc--ccceeccccCCcccc-CChhh--------------------------cCcccEEECCCCCCC-cCChhhc--CC
Confidence 3332 456666666666653 23222 145666666666665 3554442 46
Q ss_pred CcEEeCcCCcccCCCccccccccccceeeccccccccccCccc----CccccceeeeeccCcccCCCCccccccccccEE
Q 039922 483 LQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNL----NSLTALIVLNLSTNQLTGTIPPELGNLAVLTSL 558 (973)
Q Consensus 483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 558 (973)
|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ ..++++..|+|.+|.++. ..+.+|+.|
T Consensus 369 L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L 438 (754)
T PRK15370 369 ITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL 438 (754)
T ss_pred cCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh
Confidence 777777777777 4565554 36777788888777 455443 334677788888888762 345555555
Q ss_pred ecCCCcCccc
Q 039922 559 DLSSNLLTGE 568 (973)
Q Consensus 559 ~Ls~N~l~~~ 568 (973)
++.|.+.|.
T Consensus 439 -l~s~~~~gp 447 (754)
T PRK15370 439 -MSSVGYQGP 447 (754)
T ss_pred -hhcccccCC
Confidence 455655553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.3e-21 Score=225.11 Aligned_cols=266 Identities=24% Similarity=0.425 Sum_probs=179.6
Q ss_pred CCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeecc
Q 039922 267 SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFN 346 (973)
Q Consensus 267 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 346 (973)
+...|++++++++ .+|..+. ++|+.|+|++|+++. +|..+. .+|+.|++++|+++ .+|..+. ++|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~-~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ-GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc-cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 5678888888888 4666553 478888888888884 444333 36888888888877 4555443 3677777777
Q ss_pred ccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccC
Q 039922 347 NSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELP 426 (973)
Q Consensus 347 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 426 (973)
|++. .+|..+. ++|+.|++++|+++ .+|. .+. ++|++|++++|++++ +|
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~------------------------~l~--~sL~~L~Ls~N~Lt~-LP 299 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPE------------------------NLP--EELRYLSVYDNSIRT-LP 299 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-cccc------------------------ccC--CCCcEEECCCCcccc-Cc
Confidence 7777 5565543 46677777777666 2333 221 256666666666663 23
Q ss_pred cccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccc
Q 039922 427 SKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNK 506 (973)
Q Consensus 427 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 506 (973)
..+. ++|+.|++++|+++.. |..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++
T Consensus 300 ~~lp--~sL~~L~Ls~N~Lt~L-P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~ 368 (754)
T PRK15370 300 AHLP--SGITHLNVQSNSLTAL-PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PT 368 (754)
T ss_pred ccch--hhHHHHHhcCCccccC-Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CC
Confidence 2221 3566677777777643 3322 2578888888888884 676654 68999999999998 5777664 68
Q ss_pred cceeeccccccccccCcccCccccceeeeeccCcccCCCCccc----cccccccEEecCCCcCccccChhhhccccccee
Q 039922 507 LQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL----GNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFN 582 (973)
Q Consensus 507 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~ 582 (973)
|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ ..++.+..|+|.+|+++. ..+. .|+.+
T Consensus 369 L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~---~tl~--~L~~L- 438 (754)
T PRK15370 369 ITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE---RTIQ--NMQRL- 438 (754)
T ss_pred cCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH---HHHH--HHHHh-
Confidence 999999999998 5676654 47899999999998 566654 345788999999999873 2222 34444
Q ss_pred ccCCcCcccC
Q 039922 583 ISHNKLYGEV 592 (973)
Q Consensus 583 l~~N~l~g~~ 592 (973)
++.+.+.|++
T Consensus 439 l~s~~~~gp~ 448 (754)
T PRK15370 439 MSSVGYQGPR 448 (754)
T ss_pred hhcccccCCc
Confidence 4556666644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-19 Score=199.64 Aligned_cols=264 Identities=30% Similarity=0.399 Sum_probs=200.7
Q ss_pred CCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCch-hHHHHHHHHHHHhcCCCC-CeeeEEeEEecCCeeEEEEec
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPE-TETVFRSEIETLGRVRHG-NVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 761 (973)
|...+.+|.|+||.||++... ..+|+|.+........ ....+.+|...++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999887 8899999865544433 567789999999999988 799999999877778999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~~~~~ 840 (973)
+.++++.+++........+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997766543112578889999999999999999999 999999999999999988 79999999998554433
Q ss_pred CCcc--ccccccccccCccccccccC---CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC--chhHHHHHHHHhccCCC
Q 039922 841 GQSD--DAMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRWVTEATLSSPE 913 (973)
Q Consensus 841 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 913 (973)
.... .......|+..|+|||...+ ..+....|+||+|++++++++|..|+...... .....+.+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 2111 12456789999999999987 57888999999999999999999997653221 22223322222111
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.......+... ......+.+++..|+..+|..|.++.+....
T Consensus 234 -----~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 2234577888999999999999999877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.7e-20 Score=176.02 Aligned_cols=223 Identities=22% Similarity=0.253 Sum_probs=176.8
Q ss_pred ccccCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC-CCeeeEEeEEecCCee
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH-GNVVKLLMCCSGQDFN 755 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~ 755 (973)
......|..+++||+|+||.+|.|.. .+|+.||+|.=...... ..+..|..+.+.+++ ..|..+..+..+....
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 34456899999999999999999974 58999999976433322 235678888888875 6788888888888999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCceEEeccCc
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVPRVADFGL 832 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl 832 (973)
.+|||.. +-||.+.+.-..+ .++.++++-++-|++.-++|+|.+ +++||||||+|.|..- ...+.++|||+
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence 9999998 7899998876544 588999999999999999999999 9999999999999964 34689999999
Q ss_pred chhccccCCCc---cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC-CchhHHHHHHHHh
Q 039922 833 AKALQSQEGQS---DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEAT 908 (973)
Q Consensus 833 ~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~ 908 (973)
++.+.+..... .+.-....||.+|.+-....+...+.+.|+-|+|.++.+.--|..||..... ...+-.+.+.+..
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 98875443221 1223456799999988887778888999999999999999999999987432 2334444444444
Q ss_pred cc
Q 039922 909 LS 910 (973)
Q Consensus 909 ~~ 910 (973)
..
T Consensus 241 ~s 242 (341)
T KOG1163|consen 241 MS 242 (341)
T ss_pred cC
Confidence 44
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=182.76 Aligned_cols=202 Identities=22% Similarity=0.349 Sum_probs=170.2
Q ss_pred CCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 759 (973)
..|++.++||+|+||.++.|+. -+++.||||.=..+. ..-+++.|....+.+. .++|..++.+-.++-...+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 3688999999999999999974 479999999653222 2334667888888775 689999888888888889999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-----CceEEeccCcch
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-----MVPRVADFGLAK 834 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfGl~~ 834 (973)
|.+ |-||.+..+-.++ .++.+++..+|.|++.-++|+|++ ..|.|||||+|+||..- ..+.++|||+++
T Consensus 104 dLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 998 7899999887665 699999999999999999999999 99999999999999643 358999999999
Q ss_pred hccccCCCcc---ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCC
Q 039922 835 ALQSQEGQSD---DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPS 893 (973)
Q Consensus 835 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 893 (973)
.+.+...... +......||.+||+-....+++.+.+.|.-|+|-++++.+-|..||.+-
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 8765543322 2345568999999999999999999999999999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=182.96 Aligned_cols=141 Identities=18% Similarity=0.160 Sum_probs=108.4
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCchh------------------------HHHHHHHHHHHhcCCCCCe
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPET------------------------ETVFRSEIETLGRVRHGNV 742 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni 742 (973)
...||+|+||.||+|...+|+.||||+++........ .....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999999889999999999654321111 1223459999999988776
Q ss_pred eeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEeCCCCCCEEeCC
Q 039922 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL-HNDCVPAIVHRDVKSHNILLDA 821 (973)
Q Consensus 743 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NIll~~ 821 (973)
.....+.. ...++||||++++++....... ..++......++.|++.+++|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 44333222 2348999999887765443222 2578889999999999999999 688 999999999999998
Q ss_pred CCceEEeccCcchhc
Q 039922 822 EMVPRVADFGLAKAL 836 (973)
Q Consensus 822 ~~~~kl~DfGl~~~~ 836 (973)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=184.00 Aligned_cols=175 Identities=14% Similarity=0.166 Sum_probs=134.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhH-HH------HHHHHHHHhcCCCCCeeeEEeEEe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETE-TV------FRSEIETLGRVRHGNVVKLLMCCS 750 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-~~------~~~e~~~l~~l~h~niv~l~~~~~ 750 (973)
+-+.++|+..+++|.|+||.||.+.. ++..+|+|.+.......+.. .. +++|+..+.+++|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 44567899999999999999999766 57799999996554333221 22 678999999999999999998865
Q ss_pred cC--------CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 751 GQ--------DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 751 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
.. +..++||||++|.+|.++.. .+. ....+++.++..+|+. |++|||++|.||+++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 33 35789999999999988732 222 2456899999999999 99999999999999998
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELV 884 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell 884 (973)
+ ++++|||.......... . ..+.....+..++|+|+||+++....
T Consensus 172 g-i~liDfg~~~~~~e~~a-----~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA-----K-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhh-----H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 99999998765422111 0 11334455667999999999877554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=186.03 Aligned_cols=234 Identities=24% Similarity=0.331 Sum_probs=151.7
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCC-----------CCeeeEEeEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRH-----------GNVVKLLMCC 749 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h-----------~niv~l~~~~ 749 (973)
.+...+.||.|+++.||.+++. +|+++|+|++...... ....+.+++|.-....+.+ +.+++ ++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P-~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP-LDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B----SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee-eEEE
Confidence 3456789999999999999987 5899999988544322 2345667777655555332 22222 2221
Q ss_pred ---------ecC---C-----eeEEEEeccCCCChhhhhhc---cCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 039922 750 ---------SGQ---D-----FNILVYEYMPNGSLADMLHE---KGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIV 808 (973)
Q Consensus 750 ---------~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 808 (973)
... . ..+++|+-+ .++|.+++.. ... ........+..+..|+++.+++||+. |++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 111 1 226788877 5788887653 111 11244566788889999999999999 999
Q ss_pred EeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCC--------CCCCCCChhhHHHHH
Q 039922 809 HRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK--------KVTEKSDVYSFGVVL 880 (973)
Q Consensus 809 H~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~slG~~l 880 (973)
|+||+|+|++++++|.++|+||+.....+.. ......+..|.+||..... .++.+.|.|++|+++
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE-------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce-------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 9999999999999999999999877654322 1113345789999976442 478899999999999
Q ss_pred HHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCC
Q 039922 881 MELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINR 956 (973)
Q Consensus 881 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R 956 (973)
|.|++|..||......... .| ....+. +.++.+..+++.+++++|++|
T Consensus 241 y~lWC~~lPf~~~~~~~~~--~~-------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADP--EW-------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTS--GG-------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccc--cc-------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999864221110 00 122344 677889999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=177.83 Aligned_cols=141 Identities=22% Similarity=0.233 Sum_probs=110.8
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCch------------------------hHHHHHHHHHHHhcCCCCCe
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPE------------------------TETVFRSEIETLGRVRHGNV 742 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~ni 742 (973)
...||+|++|.||+|+..+|+.||||++........ ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999988899999999865422110 02234678999999999987
Q ss_pred eeEEeEEecCCeeEEEEeccCCCChhhh-hhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeC
Q 039922 743 VKLLMCCSGQDFNILVYEYMPNGSLADM-LHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLD 820 (973)
Q Consensus 743 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~ 820 (973)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 544444332 24899999988755433 322 246778889999999999999999 8 999999999999998
Q ss_pred CCCceEEeccCcchhcc
Q 039922 821 AEMVPRVADFGLAKALQ 837 (973)
Q Consensus 821 ~~~~~kl~DfGl~~~~~ 837 (973)
++.++|+|||++..+.
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-19 Score=195.30 Aligned_cols=214 Identities=29% Similarity=0.459 Sum_probs=163.6
Q ss_pred HhcCCCCCeeeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-EEeCC
Q 039922 734 LGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI-VHRDV 812 (973)
Q Consensus 734 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vH~Dl 812 (973)
|+.+.|.|+.+++|.+..+...+.|.+||..|+|.+.+.... ..++|.-...++++|+.||+|+|+. .| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 467899999999999999999999999999999999998733 3689999999999999999999998 55 89999
Q ss_pred CCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCC-------CCCCCChhhHHHHHHHHHc
Q 039922 813 KSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK-------VTEKSDVYSFGVVLMELVT 885 (973)
Q Consensus 813 kp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~ellt 885 (973)
++.|+++|....+|++|||+......... ........-..-|.|||.+.... .+.++||||||++++|+++
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~--~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAE--PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccc--ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999876643111 11111122345699999987631 4678999999999999999
Q ss_pred CCCCCCCCCC--CchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039922 886 GKRPNDPSFG--ENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVV 963 (973)
Q Consensus 886 g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 963 (973)
.+.||+.... +..+++.+++..... .+.|.+.... +....+..++.+||.++|++||++.+|-
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~~~~~------------~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKKGGSN------------PFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccCccccccccCChHHHHHHHHhcCCC------------CcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 9999987432 223455555441111 1112221111 2233688999999999999999999998
Q ss_pred HHHhhc
Q 039922 964 ELLRVD 969 (973)
Q Consensus 964 ~~L~~~ 969 (973)
..++..
T Consensus 219 ~~~~~~ 224 (484)
T KOG1023|consen 219 SKLLTI 224 (484)
T ss_pred hhhhhh
Confidence 887653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=170.72 Aligned_cols=191 Identities=17% Similarity=0.122 Sum_probs=138.8
Q ss_pred CccccccccCCeeEEEEEECCCCEEEEEEecCCCCCch--hHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEec
Q 039922 685 TEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPE--TETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
.....+++|+||+||.+.. .+++++.+.+........ ....+.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 588999888743322111 1235789999999996 5789999886 346899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCC-CCCCEEeCCCCceEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDV-KSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
+.+.+|.+.... ....++.|++.+++++|+. ||+|||| ||+||++++++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 998888654321 1135778999999999999 9999999 7999999999999999999998554322
Q ss_pred CC----cccc-----ccccccccCccccccccC-CCCC-CCCChhhHHHHHHHHHcCCCCCCCC
Q 039922 841 GQ----SDDA-----MSCVAGSYGYIAPEYAYT-KKVT-EKSDVYSFGVVLMELVTGKRPNDPS 893 (973)
Q Consensus 841 ~~----~~~~-----~~~~~gt~~y~aPE~~~~-~~~~-~~~Dv~slG~~l~elltg~~p~~~~ 893 (973)
.. ...- ..-...++.|++|+-..- ...+ .+.+.++-|.-+|.++|++.+...+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 0000 001224667777774332 1222 4668999999999999999988654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-19 Score=206.21 Aligned_cols=254 Identities=22% Similarity=0.207 Sum_probs=180.1
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCC--chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK--PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.+...+.+|++.|=+|.++++..|. |+||++-+.... -....+-.+|++ ...++|||.+++.-+...+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677889999999999999999887 999998654321 122222233444 566689999999888777788889999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc--cc
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL--QS 838 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~--~~ 838 (973)
|.. -+|.+.+... ..+...+.+-|+.|++.|+...|.. ||+|||||.+|||++.=.-+.|+||..-+-. ..
T Consensus 102 yvk-hnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHh-hhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 884 4788877543 2467777788999999999999999 9999999999999999989999999764322 22
Q ss_pred cCCCccccccccccc----cCccccccccCC----------C-CCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHH
Q 039922 839 QEGQSDDAMSCVAGS----YGYIAPEYAYTK----------K-VTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVR 902 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt----~~y~aPE~~~~~----------~-~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 902 (973)
+. +..+..+..| .+|.|||-...+ . .+++-||||+||++.|+++ |++||.. .++..
T Consensus 175 DN---Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~a 246 (1431)
T KOG1240|consen 175 DN---PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLA 246 (1431)
T ss_pred CC---cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHh
Confidence 21 2223333444 379999966431 1 5678899999999999999 5666642 22222
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
+.... . ....+++.+ -+...+.+++..|++.||++|.++++.++.-++...
T Consensus 247 Yr~~~--~-------~~~e~~Le~---------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 247 YRSGN--A-------DDPEQLLEK---------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred HhccC--c-------cCHHHHHHh---------CcCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 21110 0 111111110 011256799999999999999999999998777554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-19 Score=196.46 Aligned_cols=227 Identities=27% Similarity=0.297 Sum_probs=177.4
Q ss_pred cccccCCeeEEEEEE----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEeccC
Q 039922 689 LIGSGGSCRVYKVKL----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
.+|+|.||.|+.++. ..|..+|.|+.++.............|..++...+ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987542 24777899988665433333335566888888887 9999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc
Q 039922 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843 (973)
Q Consensus 764 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 843 (973)
+|.+...+.... ..++.........++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999987776543 355666666777899999999999 999999999999999999999999999987543321
Q ss_pred cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccc
Q 039922 844 DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923 (973)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 923 (973)
..||..|||||+.. ....++|.||||++++||+||..||.. +....+......
T Consensus 153 ------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~~------------- 205 (612)
T KOG0603|consen 153 ------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKAELE------------- 205 (612)
T ss_pred ------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhhccC-------------
Confidence 27899999999987 677899999999999999999999975 333333322211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 039922 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM 959 (973)
Q Consensus 924 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 959 (973)
...+.......++..++..+|..|.-.
T Consensus 206 ---------~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 ---------MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ---------CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 113445566777888888888888744
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.2e-20 Score=204.71 Aligned_cols=274 Identities=23% Similarity=0.315 Sum_probs=160.8
Q ss_pred eeeccccccCC-CChhhhhcc-cCcEEEccCCcCCCC----CCccccCCCccceeeeccccccC------CCCCCccCCC
Q 039922 294 RLDISQNNLTG-NLPETIAAM-SLESLNLNDNYFTGE----IPESLASNPNLVQLKLFNNSFSG------KLPDDLGKYS 361 (973)
Q Consensus 294 ~L~Ls~N~l~~-~~~~~~~~~-~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~------~~p~~l~~l~ 361 (973)
.|+|..+.+++ .....+... .|+.|+++++.+++. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 46777777763 333333332 588888888877532 44455566677777777776652 1223445566
Q ss_pred CccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCcccc----ccCcccCCC-CCcc
Q 039922 362 NLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQG----ELPSKFWGL-PEVD 436 (973)
Q Consensus 362 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l-~~L~ 436 (973)
+|++|++++|.+.+..+..+..+.+ . ++|++|++++|++++ .+...+..+ ++|+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~--------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~ 140 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLR--------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhc--------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCce
Confidence 6666666666665444333332222 1 225555555555542 111223334 5556
Q ss_pred EEEeecCcccCC----CCCCCCCCCCcceEeecCCcCCCC----CchhhhcCCcCcEEeCcCCcccCC----Cccccccc
Q 039922 437 FFEMYNNRFEGS----ISPSISNAPKLTGILINGNNFTGE----VPSQICTLRQLQAVDLSQNRFSGH----LPTCITQL 504 (973)
Q Consensus 437 ~L~L~~N~l~~~----~~~~~~~~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l 504 (973)
.|++++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 666666655521 223345556677777777777642 233445556888888888877643 33445567
Q ss_pred cccceeeccccccccccCcccCc-----cccceeeeeccCcccC----CCCccccccccccEEecCCCcCccc----cCh
Q 039922 505 NKLQQLELQENMFTGELPRNLNS-----LTALIVLNLSTNQLTG----TIPPELGNLAVLTSLDLSSNLLTGE----IPL 571 (973)
Q Consensus 505 ~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 571 (973)
++|++|++++|++++.....+.. .+.|+.|++++|.++. .+...+..+++|+++|+++|.++.. +..
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 300 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence 77888888888887533333322 3688888888888862 2344556667888888888888854 333
Q ss_pred hhhcc--cccceeccCCcC
Q 039922 572 ELTKL--KLNQFNISHNKL 588 (973)
Q Consensus 572 ~l~~l--~l~~l~l~~N~l 588 (973)
.+... .++.+++.+|.+
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 301 SLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhhcCCchhhcccCCCCC
Confidence 33333 577777777753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.8e-20 Score=166.80 Aligned_cols=163 Identities=30% Similarity=0.494 Sum_probs=111.4
Q ss_pred cceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEe
Q 039922 408 CKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVD 487 (973)
Q Consensus 408 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 487 (973)
++.++.|.|++|+++ .+|..+..+.+|+.|++++|+|+ ..|.+++.+++|+.|+++-|++. ..|..|+.++-|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344444555555554 33444445555555555555554 34666777777777777777776 6777777777777777
Q ss_pred CcCCcccC-CCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCc
Q 039922 488 LSQNRFSG-HLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 488 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
|++|++.. .+|..|..++.|+-|+|++|.+. .+|..++.+++|+.|.+..|.+- .+|.+++.|++|+.|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 77777753 56777777777777777777777 77777777777777777777776 57777777777777777777777
Q ss_pred cccChhhhcc
Q 039922 567 GEIPLELTKL 576 (973)
Q Consensus 567 ~~~p~~l~~l 576 (973)
.+|+++..+
T Consensus 187 -vlppel~~l 195 (264)
T KOG0617|consen 187 -VLPPELANL 195 (264)
T ss_pred -ecChhhhhh
Confidence 677776655
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-19 Score=201.30 Aligned_cols=33 Identities=21% Similarity=0.207 Sum_probs=18.7
Q ss_pred eecCCCccCC-CCCCCccCccccceeccCCCccc
Q 039922 77 IDLSGFDLSG-GFPNGFCRIRTLRNLNLSDNYFN 109 (973)
Q Consensus 77 l~l~~~~l~g-~~~~~~~~l~~L~~L~Ls~n~l~ 109 (973)
|+|.++.+++ .....|..+++|+.|++++|.++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~ 36 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLG 36 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCc
Confidence 5566666653 33444555566666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=171.22 Aligned_cols=195 Identities=23% Similarity=0.243 Sum_probs=133.9
Q ss_pred CCCCeeeEEeEEec---------------------------CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHH
Q 039922 738 RHGNVVKLLMCCSG---------------------------QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ 790 (973)
Q Consensus 738 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 790 (973)
+|||||++.++|.+ ....|+||... ..+|++|+.... .+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 69999999877632 23458999887 469999997653 45566677889
Q ss_pred HHHHHHHHHhhcCCCCeEEeCCCCCCEEe--CCCC--ceEEeccCcchhccccCC--CccccccccccccCccccccccC
Q 039922 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILL--DAEM--VPRVADFGLAKALQSQEG--QSDDAMSCVAGSYGYIAPEYAYT 864 (973)
Q Consensus 791 ~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfGl~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~ 864 (973)
|+++|+.|||++ ||.|||+|++||++ |+|+ ...++|||.+---+...- ..........|....||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999999 4443 468899998743222110 01111223457778999998764
Q ss_pred CC------CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHH
Q 039922 865 KK------VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEA 938 (973)
Q Consensus 865 ~~------~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 938 (973)
.. --.|+|.|+.|.+.||+++...||+.-.+..-+...+- +.. + |.+ .....
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-e~q-----------L-----Pal-----p~~vp 483 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-ESQ-----------L-----PAL-----PSRVP 483 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-hhh-----------C-----CCC-----cccCC
Confidence 21 12589999999999999999999986211111111111 111 0 011 12234
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHH
Q 039922 939 EKVLNVALMCTSDFPINRPSMRRV 962 (973)
Q Consensus 939 ~~l~~l~~~cl~~dP~~Rps~~ev 962 (973)
..+.+++...++.||.+|++..=.
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHH
Confidence 567889999999999999986533
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-19 Score=162.80 Aligned_cols=148 Identities=32% Similarity=0.584 Sum_probs=109.6
Q ss_pred CCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccC
Q 039922 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGN 216 (973)
Q Consensus 137 ~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 216 (973)
+|..+..+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+.|||.+|.+..-.+|..|..
T Consensus 48 vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~ 125 (264)
T KOG0617|consen 48 VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFY 125 (264)
T ss_pred cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhH
Confidence 4445667777777777777777 56777777777777777777776 567777777777777777777776667777777
Q ss_pred cchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCC
Q 039922 217 LSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNL 289 (973)
Q Consensus 217 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 289 (973)
++.|+.|++..|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+..|++|++.+|+++ .+|..++++
T Consensus 126 m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 126 MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 777777777776643 56777888888888888888776 56777777777777777777777 556555554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=161.99 Aligned_cols=137 Identities=18% Similarity=0.293 Sum_probs=104.8
Q ss_pred CCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-----CCCCeeeEEeEEecCC---e-
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-----RHGNVVKLLMCCSGQD---F- 754 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~- 754 (973)
+...++||+|+||.||. .-.++.. +||++.... ....+.+.+|+.+++.+ .||||++++++++++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999996 3234444 799885432 23456789999999999 5799999999998863 3
Q ss_pred eEEEEec--cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEEeCCCCCCEEeCC----CCceEE
Q 039922 755 NILVYEY--MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGL-AYLHNDCVPAIVHRDVKSHNILLDA----EMVPRV 827 (973)
Q Consensus 755 ~~lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl 827 (973)
..+|+|| +.+|+|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 3378999 5579999999653 24444 35577788777 999999 9999999999999974 347999
Q ss_pred eccCcc
Q 039922 828 ADFGLA 833 (973)
Q Consensus 828 ~DfGl~ 833 (973)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.2e-17 Score=191.60 Aligned_cols=194 Identities=20% Similarity=0.243 Sum_probs=156.6
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC---CCCeeeEEeEEecCCeeEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR---HGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 758 (973)
+.|.+.+.||+|+||+||+|...+|+.||+|+=+.....+ |.-=.+++.||+ -+-|..+..++...+.-++|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 4577889999999999999998889999999764433221 222223334444 23455566666778888999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC-------CCCceEEeccC
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD-------AEMVPRVADFG 831 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~DfG 831 (973)
+||.+-|+|.+++... +.++|...+.++.|++..++.||.. +||||||||+|.|+. +...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999843 3589999999999999999999999 999999999999994 23468999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKR 888 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~ 888 (973)
-+..+.--.. ...+...++|-.+-.+|+..++.++..+|.|.+..+++-|+.|+.
T Consensus 847 ~siDm~lfp~--~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPD--GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCC--CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9877654332 234667889999999999999999999999999999999999884
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=164.76 Aligned_cols=142 Identities=22% Similarity=0.222 Sum_probs=109.8
Q ss_pred CCccccccccCCeeEEEEE--ECCCCEEEEEEecCCCCCc----------------------hhHHHHHHHHHHHhcCCC
Q 039922 684 LTEQNLIGSGGSCRVYKVK--LKSGETVAVKRLLGGTHKP----------------------ETETVFRSEIETLGRVRH 739 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~h 739 (973)
|.+.+.||+|+||.||+|. ..+|+.||+|++....... .....+..|...++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6677899999999999998 5689999999986432110 012346789999999976
Q ss_pred CC--eeeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEEeCCCCCC
Q 039922 740 GN--VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA-IVHRDVKSHN 816 (973)
Q Consensus 740 ~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp~N 816 (973)
.. +.+++++ ...++||||++++++..+..... .....+...++.|++.+++|||+. + ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 33 3444443 23589999999888876542221 345566788999999999999999 9 9999999999
Q ss_pred EEeCCCCceEEeccCcchhc
Q 039922 817 ILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 817 Ill~~~~~~kl~DfGl~~~~ 836 (973)
|+++ ++.++|+|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999988754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=179.61 Aligned_cols=140 Identities=21% Similarity=0.289 Sum_probs=113.6
Q ss_pred ccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCC-CC-----chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGT-HK-----PETETVFRSEIETLGRVRHGNVVKLLMCCSGQD 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 753 (973)
....|...+.||+|+||.||++.+.. +.+++|+...+. .. ....+.+.+|+++++.++|++++....++...+
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34455778999999999999998764 445555432221 11 122356889999999999999998888877777
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..++||||+++++|.+++. ....++.+++.+++|||+. +++|||+||+||++ +++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999998875 3467899999999999999 99999999999999 6789999999998
Q ss_pred hh
Q 039922 834 KA 835 (973)
Q Consensus 834 ~~ 835 (973)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.8e-16 Score=159.25 Aligned_cols=136 Identities=22% Similarity=0.351 Sum_probs=113.8
Q ss_pred ccccccCCeeEEEEEECCCCEEEEEEecCCCCCch------hHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPE------TETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+.||+|++|.||+|.. .|..|++|+......... ....+.+|++.+..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 588899998753322111 224577899999999999988777777777888999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
+++++|.+++.... + .+..++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886421 2 7889999999999999999 999999999999999 78899999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.3e-16 Score=157.78 Aligned_cols=137 Identities=20% Similarity=0.162 Sum_probs=107.7
Q ss_pred CCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCc--------------------hhHHHHHHHHHHHhcCCCC--C
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKP--------------------ETETVFRSEIETLGRVRHG--N 741 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~--n 741 (973)
|...+.||+|+||.||++..++|+.||||++....... .....+..|...+..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66678999999999999998889999999875432110 1122366788889888877 4
Q ss_pred eeeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC
Q 039922 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA 821 (973)
Q Consensus 742 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 821 (973)
+.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +++||||+|+||++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence 444443 2455899999999998765321 23457889999999999998 9999999999999999
Q ss_pred CCceEEeccCcchhc
Q 039922 822 EMVPRVADFGLAKAL 836 (973)
Q Consensus 822 ~~~~kl~DfGl~~~~ 836 (973)
++.++|+|||.+...
T Consensus 161 ~~~~~liDfg~~~~~ 175 (198)
T cd05144 161 DEKIYIIDWPQMVST 175 (198)
T ss_pred CCcEEEEECCccccC
Confidence 999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=155.44 Aligned_cols=132 Identities=25% Similarity=0.371 Sum_probs=106.9
Q ss_pred cccccCCeeEEEEEECCCCEEEEEEecCCCCC-c-----hhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK-P-----ETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
.||+|+||.||+|.. +|..|++|+....... . .....+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5789999986533211 1 12355778999999999887665555555666779999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++++|.+++.... . .++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 0 7899999999999999 999999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-16 Score=179.41 Aligned_cols=210 Identities=25% Similarity=0.347 Sum_probs=142.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.+|..++.|-.|+||.||.++++ ..+++|.| +.+... ..++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc---cccccCCccee-----------------
Confidence 46788999999999999999887 45677774 421111 0111 33333444444
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+=...++..+ .++.. ++.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 ----gDc~tllk~~g---~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG---PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcccCC---CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 22233333322 23322 27899999999 99999999999999999999999999986543211
Q ss_pred CCc---------cc--cccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 841 GQS---------DD--AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 841 ~~~---------~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
... .. ....+.||+.|.|||++....|+..+|+|++|+++||.+-|+.||..+. .+++...+.....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt--peelfg~visd~i 275 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELFGQVISDDI 275 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC--HHHHHhhhhhhhc
Confidence 000 00 0133589999999999999999999999999999999999999998753 2333333322222
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP 957 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 957 (973)
..++. +.....+...++.+.++.+|..|-
T Consensus 276 ~wpE~-------------------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 EWPEE-------------------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccccc-------------------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 21111 122345667788899999999996
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.1e-16 Score=171.10 Aligned_cols=126 Identities=24% Similarity=0.454 Sum_probs=110.4
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..|+.|++|...+|.+|+.........++.....++.|++.|++| + +.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999876666678899999999999999999 6 8999999999999999999999999998
Q ss_pred hhccccCCC--ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc
Q 039922 834 KALQSQEGQ--SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885 (973)
Q Consensus 834 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt 885 (973)
......... .....+...||..||+||.+.+..|+.++||||+|++++|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 877655411 1112455689999999999999999999999999999999997
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-15 Score=177.31 Aligned_cols=151 Identities=31% Similarity=0.501 Sum_probs=86.5
Q ss_pred CcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCC
Q 039922 483 LQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSS 562 (973)
Q Consensus 483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (973)
++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+++|++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 55666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CcCccccChhhhcccccceeccCCcCcccCCCCCcccccccccCCCCCCCCCCCCCCCCCCCCCCCc--eeehhhHHHHH
Q 039922 563 NLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSKTKPGT--IYIVVILSICV 640 (973)
Q Consensus 563 N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p~~~~~~~~~~~~~~n~~~c~~~l~~~~~c~~~~~~~--~~i~~~~~~~~ 640 (973)
|+++|.+|..+..+. .......+.+|+.+|+.|. .++|....... +.+++++++++
T Consensus 500 N~l~g~iP~~l~~~~--------------------~~~~~l~~~~N~~lc~~p~--l~~C~~~~~~~~~i~~~~~~~~~~ 557 (623)
T PLN03150 500 NSLSGRVPAALGGRL--------------------LHRASFNFTDNAGLCGIPG--LRACGPHLSVGAKIGIAFGVSVAF 557 (623)
T ss_pred CcccccCChHHhhcc--------------------ccCceEEecCCccccCCCC--CCCCcccCCCceEEEEEhHHHHHH
Confidence 666666666554320 0112234567778887543 35675432222 33333333333
Q ss_pred HHHHHHhhheeeccc
Q 039922 641 ILLVGSLVWFFKVKS 655 (973)
Q Consensus 641 ~l~~~~~~~~~~~k~ 655 (973)
+++++.+++++++|+
T Consensus 558 l~~~~~~~~~~~~r~ 572 (623)
T PLN03150 558 LFLVICAMCWWKRRQ 572 (623)
T ss_pred HHHHHHHhhheeehh
Confidence 333334445555544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.3e-15 Score=175.74 Aligned_cols=150 Identities=31% Similarity=0.537 Sum_probs=99.6
Q ss_pred chhhHHHHHHHhhhccCCCCCccCCccCCCCCCC--CccceeEEcCC--C--CceeEeecCCCccCCCCCCCccCccccc
Q 039922 26 LHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSP--CNWTGITCETQ--N--QSVDGIDLSGFDLSGGFPNGFCRIRTLR 99 (973)
Q Consensus 26 ~~~~~~~l~~~k~~~~~d~~~~~~sw~~~~~~~~--C~w~gv~c~~~--~--~~v~~l~l~~~~l~g~~~~~~~~l~~L~ 99 (973)
...|..||+++|+++ .+|.. .+|.+. .|.| |.|.||+|... . .+|+.|+|+++++.|.+|+.++.+++|+
T Consensus 370 ~~~~~~aL~~~k~~~-~~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 370 LLEEVSALQTLKSSL-GLPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred CchHHHHHHHHHHhc-CCccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 456889999999987 45532 489632 1111 27999999632 2 2588999999999999998888888888
Q ss_pred eeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCC-CcccEEecCC
Q 039922 100 NLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRF-PVLKVLNLGG 178 (973)
Q Consensus 100 ~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~L~~ 178 (973)
.|+|++|++.|.+|. .++.+++|+.|+|++|.+++.+|..++.+++|++|+|++|+++|.+|..++.+ .++..+++.+
T Consensus 446 ~L~Ls~N~l~g~iP~-~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~ 524 (623)
T PLN03150 446 SINLSGNSIRGNIPP-SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524 (623)
T ss_pred EEECCCCcccCcCCh-HHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence 888888888776653 35556666666666666655555555555566666666555555555555432 3444555555
Q ss_pred cc
Q 039922 179 NL 180 (973)
Q Consensus 179 n~ 180 (973)
|.
T Consensus 525 N~ 526 (623)
T PLN03150 525 NA 526 (623)
T ss_pred Cc
Confidence 44
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-14 Score=146.86 Aligned_cols=138 Identities=23% Similarity=0.250 Sum_probs=98.9
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHH----------------------HHHHHHHHhcCCCCC--e
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV----------------------FRSEIETLGRVRHGN--V 742 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~n--i 742 (973)
.+.||+|+||+||+|...+|+.||||++............ ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998643222111111 134666666665432 3
Q ss_pred eeEEeEEecCCeeEEEEeccCCCChhh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeC
Q 039922 743 VKLLMCCSGQDFNILVYEYMPNGSLAD-MLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLD 820 (973)
Q Consensus 743 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~ 820 (973)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. . +|+|||+||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444433 24589999999854322 111110 11 5567899999999999999 7 999999999999999
Q ss_pred CCCceEEeccCcchhcc
Q 039922 821 AEMVPRVADFGLAKALQ 837 (973)
Q Consensus 821 ~~~~~kl~DfGl~~~~~ 837 (973)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.5e-14 Score=136.99 Aligned_cols=135 Identities=23% Similarity=0.256 Sum_probs=113.1
Q ss_pred ccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC--CCeeeEEeEEecCCeeEEEEeccC
Q 039922 686 EQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH--GNVVKLLMCCSGQDFNILVYEYMP 763 (973)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~ 763 (973)
+.+.||+|.++.||+++..+ ..+++|....... ...+.+|+..++.++| ..+++++.++..++..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35689999999999999864 7899998843322 4568889999999986 589999998888888999999998
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 764 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++++.++++|||.+..
T Consensus 77 g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8766543 4456677899999999999986444799999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-15 Score=164.86 Aligned_cols=193 Identities=29% Similarity=0.533 Sum_probs=147.8
Q ss_pred CCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEE
Q 039922 360 YSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFE 439 (973)
Q Consensus 360 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 439 (973)
+..-...||+.|++. ++|..++....|+.+.|+.|.+. .+|+.++++..|++|+|+.|+++ ..|..++.+|
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp------ 144 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP------ 144 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc------
Confidence 445567788888887 77888888888888888888887 78888999999999999999988 5555555444
Q ss_pred eecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeecccccccc
Q 039922 440 MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG 519 (973)
Q Consensus 440 L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 519 (973)
|+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++.
T Consensus 145 -------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~- 202 (722)
T KOG0532|consen 145 -------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE- 202 (722)
T ss_pred -------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-
Confidence 455555555555 67777777778888888888887 67888888888888888888888
Q ss_pred ccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-c---ccceeccCC
Q 039922 520 ELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-K---LNQFNISHN 586 (973)
Q Consensus 520 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~---l~~l~l~~N 586 (973)
.+|.++..| .|..||+|+|+++ .+|..|.+|..|++|-|.+|+|+ ..|..+... + .++|+..-+
T Consensus 203 ~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 203 DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 677777755 4888888888888 78888888888888888888888 667776554 2 345555444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-15 Score=177.16 Aligned_cols=258 Identities=23% Similarity=0.309 Sum_probs=193.2
Q ss_pred CCCCccccccccCCeeEEEEEEC--CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK--SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 758 (973)
..|...+.||+|+|+.|-..... ....+|+|.+...............|..+-..+. |+|++++++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35677788999999999887654 3445677766444433444455566777777776 99999999999999999999
Q ss_pred EeccCCCChhhhh-hccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcchh
Q 039922 759 YEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYLH-NDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKA 835 (973)
Q Consensus 759 ~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~ 835 (973)
.+|..++++.+.+ +.... ..+....-....|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||++..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999998877 43321 2344455678899999999999 77 999999999999999999 999999999988
Q ss_pred ccccCCCcccccccccc-ccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 836 LQSQEGQSDDAMSCVAG-SYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+....+. ........| ++.|+|||...+. ......|+||.|+++.-+++|..|++...........|+........
T Consensus 175 ~~~~~g~-~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 252 (601)
T KOG0590|consen 175 YRNKNGA-ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQ- 252 (601)
T ss_pred ccccCCc-ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccccc-
Confidence 7652222 233444567 9999999998884 55778999999999999999999999876666666666655422100
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 964 (973)
... ........++..+++.++|+.|.+.+++..
T Consensus 253 ----~~~--------------~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 253 ----LPW--------------NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----Ccc--------------ccCChhhhhcccccccCCchhccccccccc
Confidence 000 011233456677888899999998887643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=144.03 Aligned_cols=137 Identities=19% Similarity=0.256 Sum_probs=106.1
Q ss_pred ccccc-ccCCeeEEEEEECCCCEEEEEEecCCCC-----------CchhHHHHHHHHHHHhcCCCCCe--eeEEeEEecC
Q 039922 687 QNLIG-SGGSCRVYKVKLKSGETVAVKRLLGGTH-----------KPETETVFRSEIETLGRVRHGNV--VKLLMCCSGQ 752 (973)
Q Consensus 687 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 752 (973)
...|| .||.|+||.+... +..++||++.++.. .......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45787 8999999999886 78999998853211 11334567889999999998875 6677664332
Q ss_pred -Ce---eEEEEeccCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 753 -DF---NILVYEYMPN-GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 753 -~~---~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
.. .++|||++++ .+|.+++... .++.. .+.+++.++++||+. ||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 6898887542 23433 356899999999999 9999999999999999999999
Q ss_pred eccCcchh
Q 039922 828 ADFGLAKA 835 (973)
Q Consensus 828 ~DfGl~~~ 835 (973)
+|||.++.
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.2e-15 Score=160.72 Aligned_cols=172 Identities=28% Similarity=0.497 Sum_probs=145.9
Q ss_pred eeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcC
Q 039922 411 LNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490 (973)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 490 (973)
-...+|+.|++. .+|..++.+..|+.+.|+.|.+. .+|+.+.++..|+.|+|+.|+++ .+|..+|.++ |+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence 334455555555 45555555555555566666655 56788888888888888888888 8899999886 99999999
Q ss_pred CcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccC
Q 039922 491 NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
|+++ .+|..++.+..|..||.+.|++. .+|..++++.+|+.|++..|++. .+|+++..|+ |..||+|.|+++ .||
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iP 227 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLP 227 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecc
Confidence 9998 89999999999999999999999 89999999999999999999998 7899999776 999999999999 999
Q ss_pred hhhhcc-cccceeccCCcCccc
Q 039922 571 LELTKL-KLNQFNISHNKLYGE 591 (973)
Q Consensus 571 ~~l~~l-~l~~l~l~~N~l~g~ 591 (973)
..+.+| .|++|-|.+|.|+.+
T Consensus 228 v~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred hhhhhhhhheeeeeccCCCCCC
Confidence 999999 999999999999954
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.5e-13 Score=137.73 Aligned_cols=210 Identities=21% Similarity=0.310 Sum_probs=142.7
Q ss_pred HHHHhcCCCCCeeeEEeEEecC-----CeeEEEEeccCCCChhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 039922 731 IETLGRVRHGNVVKLLMCCSGQ-----DFNILVYEYMPNGSLADMLHEKGRS-GSLDWSIRFSIAQGAAKGLAYLHNDCV 804 (973)
Q Consensus 731 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~ 804 (973)
+..+-.+-|.|||++..|+.+. ....++.|||..|++.++++...+. ..+..+...+|+.||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445556799999999887543 3568999999999999999865432 346677778999999999999999 57
Q ss_pred CCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHH
Q 039922 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELV 884 (973)
Q Consensus 805 ~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell 884 (973)
|.|+|+++.-+-|++..++-+|++--.-......-............+-++|.|||+-.....+.++|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 79999999999999999998888532211111000000001112234668999999987778888999999999999999
Q ss_pred cCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039922 885 TGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 885 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 964 (973)
.+..-...+. ........+...... +-++. -...+..|++..|..||+|++++.
T Consensus 277 ilEiq~tnse-S~~~~ee~ia~~i~~------------len~l-------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSE-SKVEVEENIANVIIG------------LENGL-------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCc-ceeehhhhhhhheee------------ccCcc-------------ccCcCcccccCCCCCCcchhhhhc
Confidence 8876432211 111111111111111 00100 023456899999999999999987
Q ss_pred HHh
Q 039922 965 LLR 967 (973)
Q Consensus 965 ~L~ 967 (973)
|.-
T Consensus 331 Hpl 333 (458)
T KOG1266|consen 331 HPL 333 (458)
T ss_pred Cce
Confidence 643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.1e-13 Score=148.35 Aligned_cols=252 Identities=21% Similarity=0.223 Sum_probs=185.8
Q ss_pred CCCccccccc--cCCeeEEEEEE---CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeE
Q 039922 683 HLTEQNLIGS--GGSCRVYKVKL---KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 683 ~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 756 (973)
.+...+.+|. |.+|.||.+.. .+++.+|+|+-+.....+.....=.+|+....+++ |++.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556778899 99999999887 37889999986555555555555567777777775 999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEEeCCCCCCEEeCCC-CceEEeccC
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK----GLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFG 831 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 831 (973)
+-.|++ +.++.++.+.... .++....+.+..+..+ |+.++|.. +++|-|+||.||+..++ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 999988 5788888876443 4667777788888888 99999999 99999999999999999 889999999
Q ss_pred cchhccccCCCcc-ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSD-DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+...+....-... .......|...|++||.. ++-++.+.|+|++|.++.+..++..+...... ..|....
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~~~r--- 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWSQLR--- 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC-----CCccccc---
Confidence 9988765542111 111223577889999975 55778899999999999999998887654211 1121111
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 964 (973)
....+ .. +......++...+..|++++|..|++.+.+..
T Consensus 340 -----------~~~ip---~e-~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 -----------QGYIP---LE-FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----------cccCc---hh-hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11110 00 00111223344888999999999999987754
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-13 Score=151.54 Aligned_cols=184 Identities=33% Similarity=0.514 Sum_probs=120.5
Q ss_pred CCccceeeeccccccCCCCCCccCCC-CccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEE
Q 039922 336 NPNLVQLKLFNNSFSGKLPDDLGKYS-NLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYL 414 (973)
Q Consensus 336 l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 414 (973)
++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-------------------------~l~~~~~~l~~L~~L 168 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-------------------------SLPSPLRNLPNLKNL 168 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-------------------------hhhhhhhcccccccc
Confidence 355555666666655 4444444443 5555555555554 222334445555555
Q ss_pred EccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCccc
Q 039922 415 RFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFS 494 (973)
Q Consensus 415 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 494 (973)
++++|++... |...+..++|+.|++++|+++ .+|..+.....|++|++++|++.
T Consensus 169 ~l~~N~l~~l-------------------------~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~ 222 (394)
T COG4886 169 DLSFNDLSDL-------------------------PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII 222 (394)
T ss_pred ccCCchhhhh-------------------------hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce
Confidence 5555555421 222224455556666666665 55655555666888888888654
Q ss_pred CCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhh
Q 039922 495 GHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELT 574 (973)
Q Consensus 495 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 574 (973)
..+..+..+.++..|.+++|++. .++..++.+++++.|++++|+++ .++. ++.+.+|+.||+++|.++...|....
T Consensus 223 -~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 223 -ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred -ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhhc
Confidence 56777888888888888888887 55788888888999999999998 4555 88889999999999999876665544
Q ss_pred c
Q 039922 575 K 575 (973)
Q Consensus 575 ~ 575 (973)
.
T Consensus 299 ~ 299 (394)
T COG4886 299 L 299 (394)
T ss_pred c
Confidence 3
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8e-13 Score=150.68 Aligned_cols=199 Identities=31% Similarity=0.519 Sum_probs=102.7
Q ss_pred eeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCC-ccceeeeccccccCCCCCCccCCCCccceeeeccc
Q 039922 294 RLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNP-NLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTND 372 (973)
Q Consensus 294 ~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 372 (973)
.++++.|.+............++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..++.+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 455555555433333333345666666666666 3444444443 6666666666666 455556666666666666666
Q ss_pred ccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCC
Q 039922 373 FTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPS 452 (973)
Q Consensus 373 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 452 (973)
++ .+|...+..+.|+.|++++|++. .+|........|++|.+++|.+. ..+ ..
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~------------------------~~ 227 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELL------------------------SS 227 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecc------------------------hh
Confidence 66 33333334444555555555554 33433334444555555555322 222 33
Q ss_pred CCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcc
Q 039922 453 ISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN 524 (973)
Q Consensus 453 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 524 (973)
+.++.++..+.+.+|++. .++..+..++++++|++++|.++ .++. ++.+.+++.|++++|.+...+|..
T Consensus 228 ~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 228 LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 333344444444444443 22444555555666666666665 3333 555666666666666666444433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.1e-12 Score=145.28 Aligned_cols=143 Identities=22% Similarity=0.264 Sum_probs=100.5
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCch--------------------------------------hHHHHH
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPE--------------------------------------TETVFR 728 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 728 (973)
.+.||.|++|.||+|++++|+.||||+..+.....- .+-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999854321000 001244
Q ss_pred HHHHHHhcCC----CCCeeeEEeEE-ecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHhhc
Q 039922 729 SEIETLGRVR----HGNVVKLLMCC-SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK-GLAYLHND 802 (973)
Q Consensus 729 ~e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~ 802 (973)
+|...+.+++ |..-+.+-.++ ......++||||++|++|.++...... .. .+.+++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5555555552 32223322222 224557999999999999887653211 12 23456666666 47888988
Q ss_pred CCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 803 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|++|+|++|.||++++++.++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=9e-12 Score=142.69 Aligned_cols=149 Identities=19% Similarity=0.185 Sum_probs=95.9
Q ss_pred cccCCCCccccccccCCeeEEEEEECC-CCEEEEEEecCCCCC----------------------------c----hhH-
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHK----------------------------P----ETE- 724 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------~----~~~- 724 (973)
++...|.. +.||+|++|.||+|+.++ |+.||||+..+.... . +..
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34455666 799999999999999987 999999999644210 0 001
Q ss_pred -----HHHHHHHHHHhcCC----CCCeeeEEeEEec-CCeeEEEEeccCCCChhhhh--hccCC-CCCCCHHHHHHHHHH
Q 039922 725 -----TVFRSEIETLGRVR----HGNVVKLLMCCSG-QDFNILVYEYMPNGSLADML--HEKGR-SGSLDWSIRFSIAQG 791 (973)
Q Consensus 725 -----~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~~ 791 (973)
-.+.+|...+.+++ +...+.+=.++.+ ....++||||++|+.+.++- ...+. ...+.......++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 12344555555553 3333333333322 45678999999999997742 22111 001222222223333
Q ss_pred HHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC----ceEEeccCcchhccc
Q 039922 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM----VPRVADFGLAKALQS 838 (973)
Q Consensus 792 ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGl~~~~~~ 838 (973)
+... |++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 276 -------if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -------VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3345 999999999999999988 999999999877654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.6e-11 Score=131.22 Aligned_cols=166 Identities=19% Similarity=0.237 Sum_probs=127.0
Q ss_pred ECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCH
Q 039922 703 LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDW 782 (973)
Q Consensus 703 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~ 782 (973)
..++.+|.|..++.... +.....++-++.++.++||+|+++++.++.++..|+|+|-+ .-|..+++... .
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------K 103 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------H
Confidence 34788899988854332 45566788899999999999999999999999999999988 46777776543 4
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccc
Q 039922 783 SIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862 (973)
Q Consensus 783 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 862 (973)
....-.+.||+.||.|||+.| +++|+++.-..|+|++.|..||++|.++........ ......--..|..|+.+
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChhhc
Confidence 455567889999999999776 899999999999999999999999988765432211 01111222356677755
Q ss_pred cCCCCCCCCChhhHHHHHHHHHcC
Q 039922 863 YTKKVTEKSDVYSFGVVLMELVTG 886 (973)
Q Consensus 863 ~~~~~~~~~Dv~slG~~l~elltg 886 (973)
.... -..|.|.||++++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 3333 346999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.3e-11 Score=117.37 Aligned_cols=130 Identities=20% Similarity=0.188 Sum_probs=95.0
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCee-eEEeEEecCCeeEEEEeccCCC
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV-KLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 765 (973)
++.++.|.++.||+++.. ++.|++|....... ....+.+|+..++.+.+.+++ +++.+. .+..++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 457889999999999876 78899998743321 123457788888888765554 444433 23457999999988
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC--VPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
++.+. . . ....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~--~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE--D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc--c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 77543 0 0 11245678999999999982 12359999999999999 6689999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.5e-11 Score=133.03 Aligned_cols=249 Identities=20% Similarity=0.163 Sum_probs=179.2
Q ss_pred ccCCCCccccccccCCeeEEEEEEC--CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK--SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 756 (973)
...+|..+..||.|.|+.|+++... ++..|++|..............-..|+.+...+ .|.++++.+..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3557888999999999999997643 678899998866554444443345677766666 4899999988888888888
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-CceEEeccCcchh
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAKA 835 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~~~ 835 (973)
+--||+++++......-. ..++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.+..
T Consensus 343 ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 999999999887655221 2467778899999999999999998 99999999999999886 7889999999864
Q ss_pred ccccCCCccccccccccccCcc--ccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYI--APEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+.-... ....+.+++ +|+......+..++|+||||.-+.|.+++....... ..|.....
T Consensus 417 ~~~~~~-------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------~~~~~i~~----- 477 (524)
T KOG0601|consen 417 LAFSSG-------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------VQSLTIRS----- 477 (524)
T ss_pred cceecc-------cccccccccccchhhccccccccccccccccccccccccCcccCccc-------ccceeeec-----
Confidence 321111 112233444 555555677889999999999999999887543221 11111000
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
..... .+.....+..+...+..+++..||.+.++..+.+-
T Consensus 478 ------------~~~p~---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 478 ------------GDTPN---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ------------ccccC---CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00000 01222566778889999999999999988776544
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.1e-12 Score=131.49 Aligned_cols=91 Identities=24% Similarity=0.356 Sum_probs=50.9
Q ss_pred hhhhcCCcCcEEeCcCCcccCC----CccccccccccceeeccccccccccCcccC-----ccccceeeeeccCcccC--
Q 039922 475 SQICTLRQLQAVDLSQNRFSGH----LPTCITQLNKLQQLELQENMFTGELPRNLN-----SLTALIVLNLSTNQLTG-- 543 (973)
Q Consensus 475 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~-- 543 (973)
..+..++.|++|||.+|-++.. +...+..+++|++|+++++.+......+|. ..++|++|+|.+|.++-
T Consensus 207 eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da 286 (382)
T KOG1909|consen 207 EALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDA 286 (382)
T ss_pred HHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHH
Confidence 3566677777777777776632 334455566666777776666643332221 24556666666666651
Q ss_pred --CCCccccccccccEEecCCCcC
Q 039922 544 --TIPPELGNLAVLTSLDLSSNLL 565 (973)
Q Consensus 544 --~~p~~~~~l~~L~~L~Ls~N~l 565 (973)
.+-..+...+.|+.|+|++|++
T Consensus 287 ~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 287 ALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHHHhcchhhHHhcCCcccc
Confidence 1222334455666666666665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.6e-11 Score=122.99 Aligned_cols=110 Identities=32% Similarity=0.440 Sum_probs=56.8
Q ss_pred CCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccc
Q 039922 452 SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL 531 (973)
Q Consensus 452 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 531 (973)
+..-.|+++.|++++|.|.. + ..+..+++|+.||||+|.++ .+-.+-.++.+.+.|.|++|.|.. -..++.+-+|
T Consensus 302 SvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSL 376 (490)
T KOG1259|consen 302 SVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSL 376 (490)
T ss_pred hhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhh
Confidence 33334444444444444441 1 12455556666666666665 344444455566666666666541 1234445556
Q ss_pred eeeeeccCcccCCC-CccccccccccEEecCCCcCc
Q 039922 532 IVLNLSTNQLTGTI-PPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 532 ~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
..||+++|+|.... -..+++||-|+.+.|.+|++.
T Consensus 377 vnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 377 VNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred eeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 66666666665211 124555666666666666665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.9e-10 Score=109.85 Aligned_cols=137 Identities=15% Similarity=0.143 Sum_probs=97.4
Q ss_pred ccccccCCeeEEEEEECC-------CCEEEEEEecCCC------------C--------CchhHH----HHHHHHHHHhc
Q 039922 688 NLIGSGGSCRVYKVKLKS-------GETVAVKRLLGGT------------H--------KPETET----VFRSEIETLGR 736 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~--------~~~~~~----~~~~e~~~l~~ 736 (973)
..||.|--+.||.|...+ +..+|||+++... . .....+ ..++|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 4799999874210 0 011122 33489999999
Q ss_pred CCC--CCeeeEEeEEecCCeeEEEEeccCCCChhh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEeCC
Q 039922 737 VRH--GNVVKLLMCCSGQDFNILVYEYMPNGSLAD-MLHEKGRSGSLDWSIRFSIAQGAAKGLAYL-HNDCVPAIVHRDV 812 (973)
Q Consensus 737 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dl 812 (973)
+.. -.+.+++++ ...++||||++++.+.. .++.. .++......+..+++.++.++ |+. ++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 864 355566654 45789999997643321 22211 234455667889999999999 788 9999999
Q ss_pred CCCCEEeCCCCceEEeccCcchhc
Q 039922 813 KSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 813 kp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
++.||+++ ++.+.++|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 467999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.5e-11 Score=121.55 Aligned_cols=138 Identities=28% Similarity=0.328 Sum_probs=112.8
Q ss_pred CCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccc
Q 039922 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529 (973)
Q Consensus 450 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 529 (973)
...+..+..|++++|++|.|+ .+.....-++.++.|++|+|.|. .+- .+..+.+|+.||||+|.++ .+-.+-..+.
T Consensus 277 ~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLG 352 (490)
T KOG1259|consen 277 LVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLG 352 (490)
T ss_pred EEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhc
Confidence 344556677999999999998 67778888899999999999998 343 3888999999999999999 7778888899
Q ss_pred cceeeeeccCcccCCCCccccccccccEEecCCCcCccc-cChhhhcc-cccceeccCCcCcccCC
Q 039922 530 ALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE-IPLELTKL-KLNQFNISHNKLYGEVP 593 (973)
Q Consensus 530 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l-~l~~l~l~~N~l~g~~p 593 (973)
+++.|+|+.|.|.. + ..++.|-+|..||+++|++... --..++++ -|+.+.|.+|++.+.+.
T Consensus 353 NIKtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 353 NIKTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred CEeeeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999999999973 2 4577888999999999999732 11334555 58899999999997653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.4e-11 Score=127.22 Aligned_cols=209 Identities=26% Similarity=0.261 Sum_probs=103.8
Q ss_pred CcCCccEEecccccccccCC-ccccCCCCCCEEECcCCcCCCCC--CcccCCCCcccEEecCCcccCCcccccc-ccccc
Q 039922 119 PCFHLQVLALDYNVFIGELP-DFSREFANLQVLDLSRNNFSGDI--PESFGRFPVLKVLNLGGNLLSGLIPSFL-GNLTE 194 (973)
Q Consensus 119 ~l~~L~~L~L~~n~~~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~--p~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~ 194 (973)
++..|+...|++..+..... .....|++++.||||.|-+...- -.-...|++|+.|+|+.|++........ ..++.
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 34445555555444321100 23344555555555555544211 1122345555555555555542222111 13445
Q ss_pred ccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccC-CcCCCCCCCCCEEEc
Q 039922 195 LTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKI-PHSFSGLASIEQIEL 273 (973)
Q Consensus 195 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L 273 (973)
|+.|.|+.|.++.-.+-..+...++|+.|+|..|+...........+..|+.|||++|.+-... -...+.++.|+.|++
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 5555555555543333334445556666666666433333333444556677777766654221 134556667777777
Q ss_pred cCCcCccc-Cchh-----ccCCCccceeeccccccCC--CChhhhhcccCcEEEccCCcCCC
Q 039922 274 FDNQLSGE-LPES-----LSNLTTLLRLDISQNNLTG--NLPETIAAMSLESLNLNDNYFTG 327 (973)
Q Consensus 274 ~~n~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~L~~L~L~~N~l~~ 327 (973)
+.+.+..+ .|+. ....++|+.|+++.|++.. .+-......+|+.|.+..|.++.
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 77766532 2222 3445677777777777742 12222223367777777777763
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-09 Score=103.39 Aligned_cols=133 Identities=27% Similarity=0.393 Sum_probs=103.6
Q ss_pred ccccccCCeeEEEEEECCCCEEEEEEecCCCC-Cch-----hHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTH-KPE-----TETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
..+++|+-+.+|.+.+. |..+++|.-.++.. .++ ......+|..++.+++--.|.-.+-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999776 55677775433322 222 234456799999999876666666667778888899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
+++..|.+++... ...++..+-.-+.-||.. +|+|||+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888654 245677788888999999 999999999999997766 89999999864
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-11 Score=138.40 Aligned_cols=249 Identities=24% Similarity=0.236 Sum_probs=119.0
Q ss_pred CcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEe
Q 039922 119 PCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHF 198 (973)
Q Consensus 119 ~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 198 (973)
.+..++.+.+..|.+.. +-..+..+++|+.|++.+|+|... ...+..+++|++|+|++|+|+.+. .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 44555555565555543 223345556666666666666632 222555666666666666666442 24445555556
Q ss_pred eccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCC-cCCCCCCCCCEEEccCCc
Q 039922 199 ELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP-HSFSGLASIEQIELFDNQ 277 (973)
Q Consensus 199 ~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~ 277 (973)
++++|.|+.+. .+..+..|+.+++++|++...-+ . ...+.+++.+++.+|.
T Consensus 146 ~l~~N~i~~~~---------------------------~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~ 197 (414)
T KOG0531|consen 146 NLSGNLISDIS---------------------------GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNS 197 (414)
T ss_pred eeccCcchhcc---------------------------CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCc
Confidence 66666554421 22335556666666666653322 1 3455556666666666
Q ss_pred CcccCchhccCCCccceeeccccccCCCChhhhhcc--cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCC
Q 039922 278 LSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM--SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPD 355 (973)
Q Consensus 278 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 355 (973)
+... ..+..+..+..+++..|.++..-+- .... .|+.+++++|++. .++..+..++++..|++.+|++... .
T Consensus 198 i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l-~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~ 271 (414)
T KOG0531|consen 198 IREI--EGLDLLKKLVLLSLLDNKISKLEGL-NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--E 271 (414)
T ss_pred hhcc--cchHHHHHHHHhhcccccceeccCc-ccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--c
Confidence 5422 2233334444445555555422111 1111 2445555555554 2223344444555555555555421 1
Q ss_pred CccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCC-ccCCcceeeEEEccCCccccccC
Q 039922 356 DLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPE-SYGECKTLNYLRFGGNELQGELP 426 (973)
Q Consensus 356 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~ 426 (973)
.+.....+..+.+..|.+.... ..... ..+...+++.+.+..|.+....+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 272 GLERLPKLSELWLNDNKLALSE---------------------AISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccccchHHHhccCcchhcchh---------------------hhhccccccccccccccccccCccccccc
Confidence 1223333444444444433110 01111 14555667777777777765443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.1e-11 Score=128.72 Aligned_cols=209 Identities=21% Similarity=0.228 Sum_probs=147.9
Q ss_pred ccCCCCCCEEECcCCcCCCCCC--cccCCCCcccEEecCCcccCCccc--ccccccccccEeeccCcCCCCCCCCccccC
Q 039922 141 SREFANLQVLDLSRNNFSGDIP--ESFGRFPVLKVLNLGGNLLSGLIP--SFLGNLTELTHFELGYNPLKSSPLPSSVGN 216 (973)
Q Consensus 141 ~~~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 216 (973)
=.++.+|+...|.+.... .++ +....+++++.|||+.|-+....| .....|++|+.|+|+.|++....-...-..
T Consensus 117 Qsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 346788899999888776 233 356678999999999998885433 455678999999999998865332233346
Q ss_pred cchhHHHhhccCccccc-CCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCc--hhccCCCccc
Q 039922 217 LSKLENLWAAKANLIGE-IPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELP--ESLSNLTTLL 293 (973)
Q Consensus 217 l~~L~~L~l~~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~ 293 (973)
++.|+.|.++.|+++.. +-..+..+++|+.|+|..|...........-+..|++|+|++|++-. .+ ...+.++.|.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchh
Confidence 78888899999988733 23334567889999999886443445556677889999999998763 33 3467788888
Q ss_pred eeeccccccCCC-Chhh------hhcccCcEEEccCCcCCCC-CCccccCCCccceeeeccccccC
Q 039922 294 RLDISQNNLTGN-LPET------IAAMSLESLNLNDNYFTGE-IPESLASNPNLVQLKLFNNSFSG 351 (973)
Q Consensus 294 ~L~Ls~N~l~~~-~~~~------~~~~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~ 351 (973)
.|+++.+.++.. .|+. ....+|+.|+++.|++..- .-..+..+++|+.|.+..|.++.
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 888888888653 2332 1223799999999988531 12345566788888888888873
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.7e-11 Score=124.68 Aligned_cols=115 Identities=22% Similarity=0.250 Sum_probs=57.3
Q ss_pred CCCCCEEEccCCcccccC----CcCCCCCCCCCEEEccCCcCcc----cCchhccCCCccceeeccccccCCCChhhhhc
Q 039922 241 LAFLSNLDLSDNFLSGKI----PHSFSGLASIEQIELFDNQLSG----ELPESLSNLTTLLRLDISQNNLTGNLPETIAA 312 (973)
Q Consensus 241 l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 312 (973)
-+.|++++.++|++.... ...|...+.|+.+.+..|.|.. .+...+..+++|+.|||..|.++..-..
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~---- 231 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV---- 231 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH----
Confidence 345666666666665321 1223444555555555555431 1122344455555555555554422221
Q ss_pred ccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCc-----cCCCCccceeeeccccc
Q 039922 313 MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL-----GKYSNLEYFDVSTNDFT 374 (973)
Q Consensus 313 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~ 374 (973)
.+...+..+++|+.|++++|.++......+ ...+.|+.|.+.+|.++
T Consensus 232 ---------------~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 232 ---------------ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred ---------------HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 122344555666666666666654433322 22556666666666665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.1e-10 Score=113.67 Aligned_cols=125 Identities=26% Similarity=0.282 Sum_probs=38.0
Q ss_pred cCCccEEecccccccccCCcccc-CCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEe
Q 039922 120 CFHLQVLALDYNVFIGELPDFSR-EFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHF 198 (973)
Q Consensus 120 l~~L~~L~L~~n~~~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 198 (973)
+..+++|+|++|.|..+ ..++ .+.+|+.||||+|.|+.. +.+..++.|++|++++|+|+.+.+.....+++|++|
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 33445555555554421 1233 456677777777777633 236667777777777777775422222356777777
Q ss_pred eccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCc----CCCCCCCCCEEEc
Q 039922 199 ELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPH----SFSGLASIEQIEL 273 (973)
Q Consensus 199 ~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L 273 (973)
+|++|+|....-- ..+..+++|+.|+|.+|.++.. +. .+..+++|+.||-
T Consensus 94 ~L~~N~I~~l~~l------------------------~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 94 YLSNNKISDLNEL------------------------EPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TTS---SCCCC------------------------GGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred ECcCCcCCChHHh------------------------HHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 7777776543210 2234455666666666666532 21 2345666666653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.8e-11 Score=135.45 Aligned_cols=247 Identities=24% Similarity=0.290 Sum_probs=156.6
Q ss_pred cCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhH
Q 039922 142 REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLE 221 (973)
Q Consensus 142 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 221 (973)
..+..++.+++..|.+.. +-..+..+++|+.|++.+|+|..+ ...+..+++|++|++++|.|+.+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~------------ 134 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE------------ 134 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc------------
Confidence 456677777788888874 334477788888888888888854 222677888888888888876532
Q ss_pred HHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCc-hhccCCCccceeecccc
Q 039922 222 NLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELP-ESLSNLTTLLRLDISQN 300 (973)
Q Consensus 222 ~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N 300 (973)
.+..++.|+.|++++|.|+.. ..+..+++|+.+++++|++....+ . +..+.+++.+++..|
T Consensus 135 ---------------~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n 196 (414)
T KOG0531|consen 135 ---------------GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGN 196 (414)
T ss_pred ---------------chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCC
Confidence 234455588888888988733 345568888888888888885544 2 467778888888888
Q ss_pred ccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCc--cceeeeccccccCCCCCCccCCCCccceeeecccccccCC
Q 039922 301 NLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPN--LVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELP 378 (973)
Q Consensus 301 ~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 378 (973)
.+.... ..-....+..+++..|.++..-+ +..++. |+.+++++|++. ..+..+..+.++..+++++|++...
T Consensus 197 ~i~~i~-~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~-- 270 (414)
T KOG0531|consen 197 SIREIE-GLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL-- 270 (414)
T ss_pred chhccc-chHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--
Confidence 876322 22222234455777777763321 222222 677777777776 4434555666666666666666521
Q ss_pred ccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccc---cCc-ccCCCCCccEEEeecCcccCCCC
Q 039922 379 RFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGE---LPS-KFWGLPEVDFFEMYNNRFEGSIS 450 (973)
Q Consensus 379 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~-~~~~l~~L~~L~L~~N~l~~~~~ 450 (973)
..+.....+..+....|.+... ... .....+.++...+..|.+....+
T Consensus 271 ------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 271 ------------------------EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ------------------------ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 2233344555555666655421 111 25567888888998888875443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.9e-09 Score=111.10 Aligned_cols=143 Identities=25% Similarity=0.286 Sum_probs=108.7
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCC--eeeEEeEEecC---CeeEEEEec
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN--VVKLLMCCSGQ---DFNILVYEY 761 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~---~~~~lv~e~ 761 (973)
.+.++.|.++.||++...+|+.+++|........ .....+.+|.++++.+++.+ +.+++.+.... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3578999999999998877789999987433221 23446788999999997643 56677776553 366899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC-------------------------------------- 803 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 803 (973)
+++.++.+.+.. ..++...+..++.++++++++||+..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888775532 13667777788888888888888521
Q ss_pred ---------------CCCeEEeCCCCCCEEeCC--CCceEEeccCcch
Q 039922 804 ---------------VPAIVHRDVKSHNILLDA--EMVPRVADFGLAK 834 (973)
Q Consensus 804 ---------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGl~~ 834 (973)
...++|+|++|.||+++. ++.+.++||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 246899999999999998 6678999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.7e-10 Score=140.07 Aligned_cols=127 Identities=29% Similarity=0.391 Sum_probs=76.0
Q ss_pred cccceeccCCCcccCcCCcCcCCCcCCccEEeccccc--ccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccE
Q 039922 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNV--FIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKV 173 (973)
Q Consensus 96 ~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~--~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 173 (973)
...+...+-+|.+. .++ .-..++.|++|-+..|. +......+|..++.|++||||+|.=-+.+|.+++.|-+|++
T Consensus 523 ~~~rr~s~~~~~~~-~~~--~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIA--GSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchh-hcc--CCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 45555555566554 222 12344467777777765 44444445666777777777776655567777777777777
Q ss_pred EecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhcc
Q 039922 174 LNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAK 227 (973)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~ 227 (973)
|+|+++.++ .+|..+++|.+|.+|++..+.-... +|.....|++|++|.+..
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~-~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLES-IPGILLELQSLRVLRLPR 651 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheecccccccccc-ccchhhhcccccEEEeec
Confidence 777777777 5577777777777777766653222 133444455555554443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.3e-09 Score=99.41 Aligned_cols=145 Identities=21% Similarity=0.302 Sum_probs=107.0
Q ss_pred ccccccccCCeeEEEEEECCCCEEEEEEecCCCC-Cc-----hhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 686 EQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTH-KP-----ETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
...++-||+-+.|+++.+. |+.+.||.-..+.. .+ -..++..+|.+.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678899999999999887 88888885433321 11 23456678999999887555555555566666677999
Q ss_pred eccCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC---ceEEeccCcchh
Q 039922 760 EYMPN-GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM---VPRVADFGLAKA 835 (973)
Q Consensus 760 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl~~~ 835 (973)
||+++ -++.+++........ ........++.|-+.+.-||.. +++||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99965 378888876543322 2223367889999999999999 999999999999996544 358999999753
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5e-10 Score=81.73 Aligned_cols=42 Identities=33% Similarity=0.847 Sum_probs=30.7
Q ss_pred hhhHHHHHHHhhhccCCCCCccCCccCCCCCCCCccceeEEc
Q 039922 27 HGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCE 68 (973)
Q Consensus 27 ~~~~~~l~~~k~~~~~d~~~~~~sw~~~~~~~~C~w~gv~c~ 68 (973)
+.|++||++||+++..||.+.+++|..+...+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 468999999999997788899999986533689999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.8e-10 Score=132.73 Aligned_cols=253 Identities=21% Similarity=0.227 Sum_probs=168.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc-hhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP-ETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.+.+.+.+-+-+|.++.++-++-. .|...+.|......... .+.+..+.+..+.-..+||.+++....+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345666778889999999876543 34444444432111111 1122233333333334567777666666667888999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
++|..+++|...++..+. .+.......+..+..+.+|||.. .+.|+|++|.|.+...+++.+++|||.......
T Consensus 883 ~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999998887652 44444455566688999999998 799999999999999999999999984322211
Q ss_pred c---------------------CCC------ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCC
Q 039922 839 Q---------------------EGQ------SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPND 891 (973)
Q Consensus 839 ~---------------------~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 891 (973)
. ... .........||+.|.+||...+.....++|+|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 000 0011234578999999999999999999999999999999999999998
Q ss_pred CCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 039922 892 PSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 960 (973)
... .++..+.+.......+ .-..+......+++.+.+..+|.+|..|.
T Consensus 1037 a~t--pq~~f~ni~~~~~~~p-------------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AET--PQQIFENILNRDIPWP-------------------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccc--hhhhhhccccCCCCCC-------------------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 643 2333333222221111 11112234456667778888888887665
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.6e-10 Score=136.27 Aligned_cols=108 Identities=30% Similarity=0.328 Sum_probs=96.0
Q ss_pred ccccceeccCCCc--ccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCccc
Q 039922 95 IRTLRNLNLSDNY--FNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLK 172 (973)
Q Consensus 95 l~~L~~L~Ls~n~--l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 172 (973)
.+.|+.|-+.+|. +. .++.+.|..++.|+.|||++|.-.+.+|..++.|-+|++|+|++..++ .+|..+++|..|.
T Consensus 544 ~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~ 621 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLI 621 (889)
T ss_pred CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhh
Confidence 3468899999986 44 777778999999999999999888899999999999999999999999 7999999999999
Q ss_pred EEecCCcccCCcccccccccccccEeeccCcC
Q 039922 173 VLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204 (973)
Q Consensus 173 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~ 204 (973)
+||+..+.-...+|..+..|++|++|.+-.-.
T Consensus 622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred eeccccccccccccchhhhcccccEEEeeccc
Confidence 99999998776778888889999999996554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.7e-10 Score=108.09 Aligned_cols=109 Identities=28% Similarity=0.440 Sum_probs=37.1
Q ss_pred CCCCCCcceEeecCCcCCCCCchhhh-cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCccc-Ccccc
Q 039922 453 ISNAPKLTGILINGNNFTGEVPSQIC-TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNL-NSLTA 530 (973)
Q Consensus 453 ~~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 530 (973)
+.+..++++|+|++|.|+. + +.++ .+.+|+.|||++|.|+ .++ .+..+++|+.|++++|+|+ .+++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 3444567777777777773 2 3444 4677888888888887 343 4677888888888888888 444444 35788
Q ss_pred ceeeeeccCcccCCC-CccccccccccEEecCCCcCc
Q 039922 531 LIVLNLSTNQLTGTI-PPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 531 L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
|+.|+|++|+|...- -..+..+++|+.|+|.+|+++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 888888888887421 135567888888888888887
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.7e-09 Score=85.26 Aligned_cols=60 Identities=40% Similarity=0.531 Sum_probs=37.4
Q ss_pred ccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcC
Q 039922 506 KLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLL 565 (973)
Q Consensus 506 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 565 (973)
+|++|++++|+|+...+..|.++++|++|++++|++++..|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456666666666644445666666666666666666655555666666666666666654
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.5e-08 Score=97.85 Aligned_cols=127 Identities=26% Similarity=0.278 Sum_probs=83.1
Q ss_pred eEEEEEECCCCEEEEEEecCCC------------------------CCchhHHHHHHHHHHHhcCCCC--CeeeEEeEEe
Q 039922 697 RVYKVKLKSGETVAVKRLLGGT------------------------HKPETETVFRSEIETLGRVRHG--NVVKLLMCCS 750 (973)
Q Consensus 697 ~Vy~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 750 (973)
-||.|...+|..+|+|..+... .........++|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999999999999874210 0011235577899999999866 455666442
Q ss_pred cCCeeEEEEeccC--CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 751 GQDFNILVYEYMP--NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL-HNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 751 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
..++||||++ +..+....... ++......++.+++..+..+ |.. |++|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 4579999998 54454433221 11334556777888866664 677 99999999999999888 8999
Q ss_pred eccCcchhc
Q 039922 828 ADFGLAKAL 836 (973)
Q Consensus 828 ~DfGl~~~~ 836 (973)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.4e-09 Score=84.08 Aligned_cols=61 Identities=38% Similarity=0.595 Sum_probs=43.5
Q ss_pred CCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCC
Q 039922 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205 (973)
Q Consensus 145 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 205 (973)
++|++|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3567777777777755556677777777777777777766667777777777777777754
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.7e-08 Score=102.51 Aligned_cols=142 Identities=17% Similarity=0.160 Sum_probs=98.7
Q ss_pred ccccccCCeeEEEEEECCCCEEEEEEecCCCCCc---------hhHHHHHHHHHHHhcCCCCCe--eeEEeEEec-----
Q 039922 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKP---------ETETVFRSEIETLGRVRHGNV--VKLLMCCSG----- 751 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~----- 751 (973)
+.+-......|+++.. +|+.|.||+........ .....+.+|...+.++...+| .+++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455667665 47899999774322110 111136788888888853333 344555432
Q ss_pred CCeeEEEEeccCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-------CC
Q 039922 752 QDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-------EM 823 (973)
Q Consensus 752 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~ 823 (973)
....++|+|++++. +|.+++.... ....+...+..++.+++..++-||.. ||+|+|++++|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23468999999875 7988875321 12345667788999999999999999 9999999999999975 56
Q ss_pred ceEEeccCcch
Q 039922 824 VPRVADFGLAK 834 (973)
Q Consensus 824 ~~kl~DfGl~~ 834 (973)
.+.++||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999775
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.3e-08 Score=98.00 Aligned_cols=134 Identities=26% Similarity=0.229 Sum_probs=97.0
Q ss_pred CccccccccCCeeEEEEEECCCCEEEEEEecCC-----------------CC---CchhHHHHHHHHHHHhcCCCC--Ce
Q 039922 685 TEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGG-----------------TH---KPETETVFRSEIETLGRVRHG--NV 742 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------~~---~~~~~~~~~~e~~~l~~l~h~--ni 742 (973)
.+.++||.|--+.||.|..++|.++|||.=... .. ........++|+++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 356899999999999999999999999932110 00 112344567899999999755 66
Q ss_pred eeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 743 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
.+.+++ +...+|||++++--|...- ++.+..-.++..|++-+...-.. |+||||+.+-||++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 666644 5668999999875554321 12333344555666666666666 99999999999999999
Q ss_pred CceEEeccCcc
Q 039922 823 MVPRVADFGLA 833 (973)
Q Consensus 823 ~~~kl~DfGl~ 833 (973)
|.+.++||--+
T Consensus 239 g~~~vIDwPQ~ 249 (304)
T COG0478 239 GDIVVIDWPQA 249 (304)
T ss_pred CCEEEEeCccc
Confidence 99999999644
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.8e-07 Score=97.07 Aligned_cols=169 Identities=22% Similarity=0.346 Sum_probs=125.9
Q ss_pred CeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec----CCeeEEEEeccCC-CChh
Q 039922 695 SCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG----QDFNILVYEYMPN-GSLA 768 (973)
Q Consensus 695 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 768 (973)
..+.|++... ||..|++|++.........+ ...-+++++++.|.|+|++.+++.. +...++||+|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk--~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK--DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc--chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3678998755 89999999994433221111 2345788999999999999998863 4467899999985 4676
Q ss_pred hhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 769 DMLHEKG------------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 769 ~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
++.-... .....++...|.++.|++.||.++|+. |...+-+.+++|+++.+.+++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 5442211 112367788999999999999999999 9999999999999999999999988887665
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCC
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 889 (973)
..+.. |-+.+ -++-|.=.+|.+++.+.||..-
T Consensus 444 ~~d~~------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 44331 00111 2356888999999999999743
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.1e-06 Score=91.29 Aligned_cols=193 Identities=14% Similarity=0.196 Sum_probs=128.6
Q ss_pred CccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeE----E---ecCCeeE
Q 039922 685 TEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMC----C---SGQDFNI 756 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~----~---~~~~~~~ 756 (973)
.....+|+|+-+.+|-.-. -+..+.|++....... +.. -++.|... .||-+-.=+.+ . ..+....
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~--~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAA--QAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchH--HHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 4567899999999997422 2334667775433221 111 22333333 46543321111 1 1122245
Q ss_pred EEEeccCCC-ChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 757 LVYEYMPNG-SLADMLHEKG---RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 757 lv~e~~~~g-sL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
+.|+.+++. -...+..... .....+|.-.++.++.+|.+.+.||.. |.+-||+.++|+||++++.|.|.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 777777543 2222222111 112478999999999999999999999 999999999999999999999998654
Q ss_pred chhccccCCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcC-CCCCCC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTG-KRPNDP 892 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg-~~p~~~ 892 (973)
-... .....+.+.+|...|.+||... +..-+...|-|.+|+++++++.| ++||.+
T Consensus 164 fqi~-----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 164 FQIN-----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eeec-----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 3322 2234467788999999999765 33456788999999999999987 899975
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.1e-08 Score=113.33 Aligned_cols=155 Identities=18% Similarity=0.249 Sum_probs=103.6
Q ss_pred HHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc-----cccccccccccCcccccccc
Q 039922 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS-----DDAMSCVAGSYGYIAPEYAY 863 (973)
Q Consensus 789 ~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 863 (973)
+.+++.|+.|+|... ++||++|.|++|.++..+.+||+.|+++.......... ........-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999884 89999999999999999999999999876554422211 11111122345799999999
Q ss_pred CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHH
Q 039922 864 TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLN 943 (973)
Q Consensus 864 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~ 943 (973)
+...+.++|+||+|+++|-+..|+.+.....+....... ...... . ....+..+.+.++.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--~~~~~~---------~--------~~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--SRNLLN---------A--------GAFGYSNNLPSELRE 243 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--hhcccc---------c--------ccccccccCcHHHHH
Confidence 988899999999999999999555444322211111110 000000 0 001122344566777
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 039922 944 VALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 944 l~~~cl~~dP~~Rps~~evl~ 964 (973)
=+.+++..++..||++.++..
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHhcCCcccCcchhhhhc
Confidence 778899999999998877643
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1e-08 Score=91.53 Aligned_cols=132 Identities=23% Similarity=0.313 Sum_probs=98.7
Q ss_pred cceEeecCCcCCCCCchhhh---cCCcCcEEeCcCCcccCCCccccc-cccccceeeccccccccccCcccCccccceee
Q 039922 459 LTGILINGNNFTGEVPSQIC---TLRQLQAVDLSQNRFSGHLPTCIT-QLNKLQQLELQENMFTGELPRNLNSLTALIVL 534 (973)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 534 (973)
+..++|+++++- .+++... ....|...+|++|.+. ..|+.|. ..+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 444556655554 3444433 3455677799999998 4555555 4568899999999999 888889999999999
Q ss_pred eeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCCCC
Q 039922 535 NLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSD 595 (973)
Q Consensus 535 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~ 595 (973)
|++.|.|. ..|..+..|.+|-.||.-+|.+. +||..+... .....++.++.+.+..|..
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 99999998 78888888999999999999987 788775444 4445566777777776654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.2e-09 Score=118.67 Aligned_cols=207 Identities=26% Similarity=0.255 Sum_probs=137.6
Q ss_pred CCCCCEEECcCCcCCCCC-CcccCCCCcccEEecCCcccCCccccccccc-ccccEeeccCcCCCCCCCCccccCcchhH
Q 039922 144 FANLQVLDLSRNNFSGDI-PESFGRFPVLKVLNLGGNLLSGLIPSFLGNL-TELTHFELGYNPLKSSPLPSSVGNLSKLE 221 (973)
Q Consensus 144 l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 221 (973)
+++++.|.+-.-.=.+.- |-.+..+.+|++|.|.++.|+.. ..+..+ ..|++|... ..+..|+
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~-------------~Sl~Al~ 147 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLICH-------------NSLDALR 147 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhhh-------------ccHHHHH
Confidence 344555554443222222 55677888889999888887731 111111 123333221 2344566
Q ss_pred HHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccc
Q 039922 222 NLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNN 301 (973)
Q Consensus 222 ~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 301 (973)
++.-+. .|.+..++.. ..|.+.+.++|.+. ....++.-++.|+.|+|++|+++.. +.+..+++|+.|||++|.
T Consensus 148 ~v~asc---ggd~~ns~~W-n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~ 220 (1096)
T KOG1859|consen 148 HVFASC---GGDISNSPVW-NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNC 220 (1096)
T ss_pred HHHHHh---ccccccchhh-hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccch
Confidence 664333 2333222221 15778899999998 6777888899999999999999854 378899999999999999
Q ss_pred cCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCC-CCCCccCCCCccceeeeccccc
Q 039922 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGK-LPDDLGKYSNLEYFDVSTNDFT 374 (973)
Q Consensus 302 l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~ 374 (973)
++...--......|..|.+++|.++.. ..+.++.+|+.|||++|-|.+. .-.-+..+..|+.|.|.+|.+.
T Consensus 221 L~~vp~l~~~gc~L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 221 LRHVPQLSMVGCKLQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hccccccchhhhhheeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 984322222333699999999998743 3567888999999999998753 1123566788899999999886
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.2e-09 Score=119.86 Aligned_cols=179 Identities=28% Similarity=0.340 Sum_probs=120.4
Q ss_pred CCccCCcceeeEEEccCCccccccCcccCCC-CCccEEEeecCccc---CCCC---CCCCC---CCCcceEeecCCcCCC
Q 039922 402 PESYGECKTLNYLRFGGNELQGELPSKFWGL-PEVDFFEMYNNRFE---GSIS---PSISN---APKLTGILINGNNFTG 471 (973)
Q Consensus 402 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~---~~~~---~~~~~---~~~L~~L~L~~N~l~~ 471 (973)
|-.+..++.|++|.+.++.|... ..+..+ ..|+.|.- .|.++ ..+. ..+.+ .-+|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 55666777888888888877631 111111 12222211 11111 0000 11222 235778888889888
Q ss_pred CCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCc-ccCccccceeeeeccCcccCCCCcccc
Q 039922 472 EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPR-NLNSLTALIVLNLSTNQLTGTIPPELG 550 (973)
Q Consensus 472 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 550 (973)
.+...+.-++.|+.|||++|+++..- .+..+++|+.|||++|+|. .+|. ...++. |+.|+|++|.++.. ..+.
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHH
Confidence 67777888899999999999998432 7888999999999999999 5553 344455 99999999999832 4578
Q ss_pred ccccccEEecCCCcCccccCh-hhhcc-cccceeccCCcCcc
Q 039922 551 NLAVLTSLDLSSNLLTGEIPL-ELTKL-KLNQFNISHNKLYG 590 (973)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~~~p~-~l~~l-~l~~l~l~~N~l~g 590 (973)
+|.+|+-|||++|-|++.--- .+..+ .|..|+|.+|++.+
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 899999999999999864221 12233 78889999999875
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.4e-08 Score=98.17 Aligned_cols=178 Identities=25% Similarity=0.335 Sum_probs=115.8
Q ss_pred CcCCccEEeccccccc--ccCCccccCCCCCCEEECcCCcCCCCCCccc-CCCCcccEEecCCcccCCc-cccccccccc
Q 039922 119 PCFHLQVLALDYNVFI--GELPDFSREFANLQVLDLSRNNFSGDIPESF-GRFPVLKVLNLGGNLLSGL-IPSFLGNLTE 194 (973)
Q Consensus 119 ~l~~L~~L~L~~n~~~--~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~ 194 (973)
.++.++.|||.+|.|+ .++-..+.+++.|+.|+|+.|++...|- ++ ..+.+|++|.|.+..+.-. ....+..++.
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~-~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~ 147 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIK-SLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPK 147 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccc-cCcccccceEEEEEcCCCCChhhhhhhhhcchh
Confidence 4556667777777665 4566677889999999999999884432 23 4667899999999887632 3355677888
Q ss_pred ccEeeccCcCCCCCCC--------C---ccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccC-CcCC
Q 039922 195 LTHFELGYNPLKSSPL--------P---SSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKI-PHSF 262 (973)
Q Consensus 195 L~~L~Ls~n~l~~~~~--------~---~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~ 262 (973)
+++|.+|.|.+....+ . ..+..++.+..+|+..|++....| ++..+-+..|.+.... -..+
T Consensus 148 vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fp-------nv~sv~v~e~PlK~~s~ek~s 220 (418)
T KOG2982|consen 148 VTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFP-------NVNSVFVCEGPLKTESSEKGS 220 (418)
T ss_pred hhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcc-------cchheeeecCcccchhhcccC
Confidence 8888888885432211 1 123344556666766666665443 5666777777665322 2345
Q ss_pred CCCCCCCEEEccCCcCcc-cCchhccCCCccceeeccccccCC
Q 039922 263 SGLASIEQIELFDNQLSG-ELPESLSNLTTLLRLDISQNNLTG 304 (973)
Q Consensus 263 ~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~ 304 (973)
..++.+..|+|+.|+|.. .--+++.++++|..|.+++|.+..
T Consensus 221 e~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 221 EPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred CCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 556666677788777752 122456677777777777777764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.3e-06 Score=86.95 Aligned_cols=139 Identities=18% Similarity=0.170 Sum_probs=102.5
Q ss_pred cccCCeeEEEEEECCCCEEEEEEecCC----CCCchhHHHHHHHHHHHhcCCCC--CeeeEEeEEe-c----CCeeEEEE
Q 039922 691 GSGGSCRVYKVKLKSGETVAVKRLLGG----THKPETETVFRSEIETLGRVRHG--NVVKLLMCCS-G----QDFNILVY 759 (973)
Q Consensus 691 g~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~----~~~~~lv~ 759 (973)
|+||-+.|++.... |..+-+|+-... -..+..+..|.+|+..+.++... .+.+++ ++. . .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888899998766 557999976311 11134677899999999999632 244444 332 1 12347999
Q ss_pred eccCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc--eEEeccCcchh
Q 039922 760 EYMPN-GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV--PRVADFGLAKA 835 (973)
Q Consensus 760 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGl~~~ 835 (973)
|-+++ -+|.+++..... .+.+...+..++.+++..++-||+. |+.|+|+.++||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 488888765322 2467777889999999999999999 9999999999999986666 99999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.2e-07 Score=90.43 Aligned_cols=125 Identities=25% Similarity=0.290 Sum_probs=89.6
Q ss_pred CCCEEEEEEecCCCC-----CchhHHHHHHHHHHHhcCCCC--CeeeEEeEEecC----CeeEEEEeccCCC-Chhhhhh
Q 039922 705 SGETVAVKRLLGGTH-----KPETETVFRSEIETLGRVRHG--NVVKLLMCCSGQ----DFNILVYEYMPNG-SLADMLH 772 (973)
Q Consensus 705 ~~~~vavK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~ 772 (973)
.++.+.+|....... .........+|...+.++... ...+.+++.+.. ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 355666665422211 112344577788888777543 334555555442 2448999999874 7998887
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC---ceEEeccCcchh
Q 039922 773 EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM---VPRVADFGLAKA 835 (973)
Q Consensus 773 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl~~~ 835 (973)
.... .+......++.+++..++-||.. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQ---LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcc---cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 6332 55667788999999999999999 999999999999999887 899999997664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 973 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-49 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-43 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-28 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 8e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 8e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 8e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 480 bits (1239), Expect = e-157
Identities = 168/562 (29%), Positives = 273/562 (48%), Gaps = 28/562 (4%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+D+S + S G P L++L++S N +G S ++S C L++L + N F+G
Sbjct: 205 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR-AISTCTELKLLNISSNQFVGP 262
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPES-FGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL 195
+P +LQ L L+ N F+G+IP+ G L L+L GN G +P F G+ + L
Sbjct: 263 IPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320
Query: 196 THFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAF-LSNLDLSDNFL 254
L N ++ + L+ L + GE+P+S+ L+ L LDLS N
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 255 SGKIPHSF--SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAA 312
SG I + + +++++ L +N +G++P +LSN + L+ L +S N L+G +P ++ +
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440
Query: 313 MS-LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTN 371
+S L L L N GEIP+ L L L L N +G++P L +NL + +S N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 372 DFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWG 431
TGE+P+++ L + + NN FSG IP G+C++L +L N G +P+ +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 432 LPEVDFFEMYNNRFEGSISPSISNAPKLTGILI--NGNNFTGEVPSQICTLRQLQAVDLS 489
++ N G I N N F G Q+ L +++
Sbjct: 561 QS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 490 QNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL 549
+ GH + L++ NM +G +P+ + S+ L +LNL N ++G+IP E+
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
Query: 550 GNLAVLTSLDLSSNLLTGEIPLELTKLK-LNQFNISHNKLYGEVPSD-----FDHDLFIS 603
G+L L LDLSSN L G IP ++ L L + ++S+N L G +P F +
Sbjct: 677 GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFP----PA 732
Query: 604 SLLDNPGLCSPDLKPLPPCSKT 625
L+NPGLC PLP C +
Sbjct: 733 KFLNNPGLCGY---PLPRCDPS 751
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 446 bits (1149), Expect = e-144
Identities = 182/619 (29%), Positives = 288/619 (46%), Gaps = 56/619 (9%)
Query: 20 FSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDL 79
S + SL+ + LI K L D N L DW +PC + G+TC + V IDL
Sbjct: 4 ASPSQSLYREIHQLISFKD-VLPDKNL-LPDWSSNK--NPCTFDGVTCR--DDKVTSIDL 57
Query: 80 SGFDLSGGFPN--------------------------GFCRIRTLRNLNLSDNYFNGTLS 113
S L+ GF GF +L +L+LS N +G ++
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVT 117
Query: 114 S-QSLSPCFHLQVLALDYNVFIGELPD-FSREFANLQVLDLSRNNFSGDIPESF---GRF 168
+ SL C L+ L + N + +L+VLDLS N+ SG +
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177
Query: 169 PVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKA 228
LK L + GN +SG + + L ++ N S+ +P +G+ S L++L +
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNF-STGIPF-LGDCSALQHLDISGN 233
Query: 229 NLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLS- 287
L G+ +I L L++S N G IP L S++ + L +N+ +GE+P+ LS
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 288 NLTTLLRLDISQNNLTGNLPETIAAMS-LESLNLNDNYFTGEIP-ESLASNPNLVQLKLF 345
TL LD+S N+ G +P + S LESL L+ N F+GE+P ++L L L L
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 346 NNSFSGKLPDDLGKYS-NLEYFDVSTNDFTGELPRFLC--FRNKLQCIIIFNNRFSGKIP 402
N FSG+LP+ L S +L D+S+N+F+G + LC +N LQ + + NN F+GKIP
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 403 ESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGI 462
+ C L L N L G +PS L ++ +++ N EG I + L +
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471
Query: 463 LINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELP 522
+++ N+ TGE+PS + L + LS NR +G +P I +L L L+L N F+G +P
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531
Query: 523 RNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQF- 581
L +LI L+L+TN GTIP + S +++N + G+ + + + +
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKEC 587
Query: 582 --NISHNKLYGEVPSDFDH 598
+ + G +
Sbjct: 588 HGAGNLLEFQGIRSEQLNR 606
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-13
Identities = 35/131 (26%), Positives = 51/131 (38%), Gaps = 36/131 (27%)
Query: 72 QSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYN 131
S+ +D+S LSG P + L LNL N +G++ +
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE---------------- 675
Query: 132 VFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIP----- 186
+G+L L +LDLS N G IP++ +L ++L N LSG IP
Sbjct: 676 --VGDLR-------GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 726
Query: 187 ------SFLGN 191
FL N
Sbjct: 727 ETFPPAKFLNN 737
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-108
Identities = 117/293 (39%), Positives = 163/293 (55%), Gaps = 26/293 (8%)
Query: 686 EQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVK 744
+N++G GG +VYK +L G VAVKRL + E + F++E+E + H N+++
Sbjct: 34 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLR 91
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS-LDWSIRFSIAQGAAKGLAYLHNDC 803
L C +LVY YM NGS+A L E+ S LDW R IA G+A+GLAYLH+ C
Sbjct: 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS----CVAGSYGYIAP 859
P I+HRDVK+ NILLD E V DFGLAK + D + V G+ G+IAP
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-------DYKDTHVTTAVRGTIGHIAP 204
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD---IVRWVTEATLSSPERGC 916
EY T K +EK+DV+ +GV+L+EL+TG+R D + N D ++ WV
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE------ 258
Query: 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969
+ L L+D + EE E+++ VAL+CT P+ RP M VV +L D
Sbjct: 259 -KKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-104
Identities = 105/283 (37%), Positives = 149/283 (52%), Gaps = 17/283 (6%)
Query: 686 EQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
+ LIG G +VYK L+ G VA+KR + + E F +EIETL RH ++V L
Sbjct: 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE--FETEIETLSFCRHPHLVSL 100
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
+ C ++ IL+Y+YM NG+L L+ + S+ W R I GAA+GL YLH
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA- 159
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
I+HRDVKS NILLD VP++ DFG++K ++ Q+ + V G+ GYI PEY
Sbjct: 160 --IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTH-LSTVVKGTLGYIDPEYFIK 215
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD-IVRWVTEATLSSPERGCCRDLNQL 923
++TEKSDVYSFGVVL E++ + S + W + S G L Q+
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA----VESHNNG---QLEQI 268
Query: 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+DP + E K + A+ C + +RPSM V+ L
Sbjct: 269 VDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-100
Identities = 101/303 (33%), Positives = 152/303 (50%), Gaps = 27/303 (8%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKP----ETETVFRSE 730
F+E P N +G GG VYK + TVAVK+L + + F E
Sbjct: 27 FDER---PISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQ--FDQE 80
Query: 731 IETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ 790
I+ + + +H N+V+LL S D LVY YMPNGSL D L + L W +R IAQ
Sbjct: 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 140
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS-C 849
GAA G+ +LH + +HRD+KS NILLD +++DFGLA+ + Q+ M+
Sbjct: 141 GAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQT--VMTSR 194
Query: 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909
+ G+ Y+APE ++T KSD+YSFGVVL+E++TG D ++ E
Sbjct: 195 IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEE-IE 251
Query: 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969
+ + ID + ++ D E + +VA C + RP +++V +LL+
Sbjct: 252 DEE-----KTIEDYIDKK--MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 970 KSS 972
+S
Sbjct: 305 TAS 307
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 6e-88
Identities = 123/575 (21%), Positives = 209/575 (36%), Gaps = 38/575 (6%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+D+ +S P ++ L+ LNL N + LS ++ + C +L L L N
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKI 112
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLG--NLTE 194
+ + NL LDLS N S + + L+ L L N + L L +
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
Query: 195 LTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSN---LDLSD 251
L EL N +K P + +L L+ L + + + ++ L LS+
Sbjct: 173 LKKLELSSNQIKEFS-PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 252 NFLSGKIPHSFSGLA--SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPET 309
+ LS +F GL ++ ++L N L+ +S + L L + NN+ +
Sbjct: 232 SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
Query: 310 IAAM-SLESLNLNDNYFTGEI---------PESLASNPNLVQLKLFNNSFSGKLPDDLGK 359
+ + ++ LNL ++ I S L L + +N G +
Sbjct: 292 LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
Query: 360 YSNLEYFDVSTNDFTGELPRFLCFRN----KLQCIIIFNNRFSGKIPESYGECKTLNYLR 415
NL+Y +S + + F + L + + N+ S +++ L L
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 416 FGGNELQGELPSK-FWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTG--E 472
G NE+ EL + + GL + + N++ S + P L +++
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 473 VPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFT--------GELPRN 524
PS LR L +DLS N + + L KL+ L+LQ N G
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 525 LNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNI 583
L L+ L +LNL +N +L L +DL N L L N+
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNL 591
Query: 584 SHNKLYGEVPSDFDHDLFISSLLD---NPGLCSPD 615
N + F + LD NP C+ +
Sbjct: 592 QKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-81
Identities = 109/539 (20%), Positives = 188/539 (34%), Gaps = 41/539 (7%)
Query: 67 CETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVL 126
C ++ D S L+ P+ + LNL+ N L + + + L L
Sbjct: 2 CTVSHEVAD---CSHLKLTQ-VPDDLPT--NITVLNLTHNQLRR-LPAANFTRYSQLTSL 54
Query: 127 ALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIP 186
+ +N P+ ++ L+VL+L N S ++F L L+L N + +
Sbjct: 55 DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 187 SFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD---SIGKLAF 243
+ L +L +N L S+ + L L+ L + N I + I +
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTK-LGTQVQLENLQELLLSN-NKIQALKSEELDIFANSS 172
Query: 244 LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLS---NLTTLLRLDISQN 300
L L+LS N + P F + + + L + QL L E L T++ L +S +
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232
Query: 301 NLTGNLPETIAAM---SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL 357
L+ T + +L L+L+ N +S A P L L N+ L
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 358 GKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFG 417
N+ Y ++ + I S+ K L +L
Sbjct: 293 HGLFNVRYLNLKRS---------------FTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 418 GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSIS----NAPKLTGILINGNNFTGEV 473
N++ G + F GL + + + N+ + + L + + N +
Sbjct: 338 DNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397
Query: 474 PSQICTLRQLQAVDLSQNRFSGHLP-TCITQLNKLQQLELQENMFTGELPRNLNSLTALI 532
L L+ +DL N L L + ++ L N + + + +L
Sbjct: 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 533 VLNLSTNQLTG--TIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKL 588
L L L + P L LT LDLS+N + L L KL ++ HN L
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 2e-66
Identities = 93/476 (19%), Positives = 170/476 (35%), Gaps = 51/476 (10%)
Query: 146 NLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205
+ +V D S + +P+ + VLNL N L L + ++LT ++G+N
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTN--ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN-- 59
Query: 206 KSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGL 265
+ P+ KL L L+L N LS +F+
Sbjct: 60 -----------------------TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNY 324
++ ++ L N + L+ LD+S N L+ T + +L+ L L++N
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 325 FTGEIPESLA--SNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLC 382
E L +N +L +L+L +N P L ++ L LC
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216
Query: 383 FR---NKLQCIIIFNNRFSGKIPESYGECK--TLNYLRFGGNELQGELPSKFWGLPEVDF 437
++ + + N++ S ++ K L L N L F LP++++
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276
Query: 438 FEMYNNRFEGSISPSISNAPKLT---------GILINGNNFTGEVPSQICTLRQLQAVDL 488
F + N + S S+ + I+ + L+ L+ +++
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336
Query: 489 SQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLN----SLTALIVLNLSTNQLTGT 544
N G T L L+ L L + + N + + L +LNL+ N+++
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396
Query: 545 IPPELGNLAVLTSLDLSSNLLTGEIP-LELTKL-KLNQFNISHNKLYGEVPSDFDH 598
L L LDL N + E+ E L + + +S+NK + F
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-66
Identities = 91/537 (16%), Positives = 180/537 (33%), Gaps = 47/537 (8%)
Query: 77 IDLSGFDLSGGFPNGF--CRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFI 134
+ LS + +L+ L LS N S L L L+
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLG 208
Query: 135 GELPDFSREFAN---LQVLDLSRNNFSGDIPESFG--RFPVLKVLNLGGNLLSGLIPSFL 189
L + ++ L LS + S +F ++ L +L+L N L+ +
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
Query: 190 GNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLW---------AAKANLIGEIPDSIGK 240
L +L +F L YN ++ S+ L + L + A+L S
Sbjct: 269 AWLPQLEYFFLEYNNIQHLF-SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327
Query: 241 LAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGE--LPESLSNL--TTLLRLD 296
L L +L++ DN + G + F+GL +++ + L ++ S E+ +L + L L+
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387
Query: 297 ISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIP-ESLASNPNLVQLKLFNNSFSGKLP 354
+++N ++ + + + LE L+L N E+ + N+ ++ L N +
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 355 DDLGKYSNLEYFDVSTNDFTGELPRFLCFRN--KLQCIIIFNNRFSGKIPESYGECKTLN 412
+ +L+ + F+ L + + NN + + + L
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 413 YLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE 472
L N L ++ + G + L + + N F
Sbjct: 508 ILDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 473 VPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNL-NSLTAL 531
L +L+ +DL N + + L+ L LQ+N+ T + + L
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 532 IVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEI----PLELTKLKLNQFNIS 584
L++ N T + + + L+ P + F+ S
Sbjct: 612 TELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-26
Identities = 35/200 (17%), Positives = 64/200 (32%), Gaps = 3/200 (1%)
Query: 409 KTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNN 468
+ L N+L+ + F ++ ++ N P L + + N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 469 FTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSL 528
+ L + L N + L L+L N + L
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 529 TALIVLNLSTNQLTGTIPPELGNLA--VLTSLDLSSNLLTGEIPLELTKL-KLNQFNISH 585
L L LS N++ EL A L L+LSSN + P + +L +++
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 586 NKLYGEVPSDFDHDLFISSL 605
+L + +L +S+
Sbjct: 205 VQLGPSLTEKLCLELANTSI 224
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 2e-87
Identities = 89/589 (15%), Positives = 173/589 (29%), Gaps = 76/589 (12%)
Query: 47 KLGDWVRTSQQSPCNWT---GITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNL 103
+W + W G++ N V G+ L GF SG P+ ++ L L L
Sbjct: 56 PGANW--NFNKELDMWGAQPGVSL-NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLAL 112
Query: 104 SDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPE 163
+ + + R ++ +
Sbjct: 113 GSHGEKVNERLFGPKGISANM---------------------SDEQKQKMRMHYQKTFVD 151
Query: 164 SFGR--FPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLE 221
R F L + + I + T N + + +V L+KL
Sbjct: 152 YDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF--VSKAVMRLTKLR 209
Query: 222 NLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGE 281
+ + + E + + + L + +E+++ +
Sbjct: 210 QFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 282 LPESLSNLTTLLRLDISQNNLTG---------NLPETIAAMSLESLNLNDNYF-TGEIPE 331
LP L L + ++++ N L + ++ + + N T +
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
Query: 332 SLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCII 391
SL L L+ N G G L +++ N T F F +++ +
Sbjct: 325 SLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLS 383
Query: 392 IFNNRFSGKIPESY--GECKTLNYLRFGGNELQGELPSKFWGLPE-------VDFFEMYN 442
+N+ IP + ++ + F NE+ F L V + N
Sbjct: 384 FAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442
Query: 443 NRFEGSISPSISNAPKLTGILINGNNFTG-------EVPSQICTLRQLQAVDLSQNRFSG 495
N+ S L+ I + GN T + L ++DL N+ +
Sbjct: 443 NQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
Query: 496 HLPTCI--TQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTN------QLTGTIPP 547
L T L L ++L N F+ P + + L + + P
Sbjct: 503 -LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 548 ELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDF 596
+ LT L + SN + + ++T ++ +I N S
Sbjct: 561 GITLCPSLTQLQIGSNDIRK-VNEKITP-NISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 1e-71
Identities = 73/524 (13%), Positives = 146/524 (27%), Gaps = 78/524 (14%)
Query: 78 DLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL 137
++ + N N T S+++ L+ + + F+ E
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSN--NITFVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 138 PDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTH 197
+ + + L + + +P+FL L E+
Sbjct: 223 I-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 198 FELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDN-FLSG 256
+ N S + + + N +
Sbjct: 278 INVACNRGISGEQLKDDWQ-----------------ALADAPVGEKIQIIYIGYNNLKTF 320
Query: 257 KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM--S 314
+ S + + +E NQL G + + L L+++ N +T +P
Sbjct: 321 PVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQ 378
Query: 315 LESLNLNDNYFTGEIPESLA--SNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTND 372
+E+L+ N IP S + + N +
Sbjct: 379 VENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF--------------- 422
Query: 373 FTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGL 432
L + I + NN+ S E + L+ + GN L +
Sbjct: 423 --DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480
Query: 433 PEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPS-QICTLRQLQAVDLSQN 491
E + N LT I + N T + TL L +DLS N
Sbjct: 481 NE-----------------NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYN 523
Query: 492 RFSGHLPTCITQLNKLQQLELQE------NMFTGELPRNLNSLTALIVLNLSTNQLTGTI 545
FS PT + L+ ++ N E P + +L L + +N + +
Sbjct: 524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KV 581
Query: 546 PPELGNLAVLTSLDLSSNLLTGEIPLELTK-LKLNQFNISHNKL 588
++ ++ LD+ N + ++ + + ++K
Sbjct: 582 NEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 2e-68
Identities = 69/493 (13%), Positives = 143/493 (29%), Gaps = 83/493 (16%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
I +++ R+ LR + ++ F + C + +Y
Sbjct: 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVA------ENICEAWENENSEYAQQYKT 240
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL--------IPSF 188
+L +++ +P P ++++N+ N +
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300
Query: 189 LGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLD 248
++ +GYN LK+ P+ +S+ + KL L N + + G L++L+
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY-NQLEGKLPAFGSEIKLASLN 359
Query: 249 LSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLS--NLTTLLRLDISQNNLTG-- 304
L+ N ++ + +E + N+L +P +++ + +D S N +
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD 418
Query: 305 -----NLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSG------- 351
L T ++ S+NL++N + E ++ L + L N +
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 352 KLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRN--KLQCIIIFNNRFSGKIPESYGECK 409
++ L D+ N T L L I + N FS P
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536
Query: 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNF 469
TL GN
Sbjct: 537 TLKGFGIRNQ------------------------------------------RDAQGNRT 554
Query: 470 TGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529
E P I L + + N + I + L++++N +
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYI 611
Query: 530 ALIVLNLSTNQLT 542
+ L ++
Sbjct: 612 EAGMYMLFYDKTQ 624
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-83
Identities = 108/577 (18%), Positives = 200/577 (34%), Gaps = 39/577 (6%)
Query: 66 TCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQV 125
N + ++L+ + + P + +NL+LS N L S S LQV
Sbjct: 4 VEVVPNITYQCMELNFYKIPDNLPF------STKNLDLSFNPLRH-LGSYSFFSFPELQV 56
Query: 126 LALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLI 185
L L + ++L L L+ N +F L+ L L+ L
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 186 PSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLS 245
+G+L L + +N ++S LP NL+ LE+L + + + L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 246 N----LDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPE-SLSNLTTL--LRLDIS 298
LDLS N ++ P +F + + ++ L +N S + + + L L RL +
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 299 QNNLTGNLPETIAAM--SLESLNLNDN------YFTGEIPESLASNPNLVQLKLFNNSFS 350
+ GNL + + L +L + + Y+ +I + N+ L + +
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 351 GKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKT 410
D ++ ++ F L +L G S + +
Sbjct: 296 R--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPS 348
Query: 411 LNYLRFGGNELQ--GELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNN 468
L +L N L G +G + + ++ N +S + +L + +N
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSN 407
Query: 469 FTGEVPSQI-CTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN-LN 526
+ +LR L +D+S L+ L+ L++ N F +
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 527 SLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLK-LNQFNISH 585
L L L+LS QL P +L+ L L++S N L L + S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 586 NKLYGEVPSDFDHDLFISSLLD---NPGLCSPDLKPL 619
N + + H + L+ N C+ + +
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 1e-80
Identities = 115/555 (20%), Positives = 190/555 (34%), Gaps = 35/555 (6%)
Query: 78 DLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL 137
DLS L F L+ L+LS + + HL L L N
Sbjct: 34 DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLA 92
Query: 138 PDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGNLTELT 196
++LQ L N + G LK LN+ NL+ +P + NLT L
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 197 HFELGYNPLKSSPLPSSVGNLSKLENLWAA---KANLIGEIPDSIGKLAFLSNLDLSDNF 253
H +L N ++S + + L ++ L + N + I K L L L +NF
Sbjct: 153 HLDLSSNKIQSIY-CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211
Query: 254 LSGKIP-HSFSGLASIEQIELFDNQLSGEL------PESLSNLTTL--LRLDISQNNLTG 304
S + GLA +E L + E +L L L ++ +
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 305 N-LPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSN 362
+ + + + ++ S +L + + N L+L N F L
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329
Query: 363 LEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNR--FSGKIPESYGECKTLNYLRFGGNE 420
L + G L+ + + N F G +S +L YL N
Sbjct: 330 LTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 421 LQGELPSKFWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQICT 479
+ + S F GL +++ + ++ + S+ + L + I+ +
Sbjct: 385 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 480 LRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLST 538
L L+ + ++ N F + I T+L L L+L + P NSL++L VLN+S
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 539 NQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL--KLNQFNISHNKLYGEVPSDF 596
N L L LD S N + EL L N++ N
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC----TC 559
Query: 597 DHDLFISSLLDNPGL 611
+H F+ + D L
Sbjct: 560 EHQSFLQWIKDQRQL 574
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 2e-69
Identities = 102/529 (19%), Positives = 183/529 (34%), Gaps = 30/529 (5%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIG- 135
+ L+G + F + +L+ L + L + + L+ L + +N+
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSF 139
Query: 136 ELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKV----LNLGGNLLSGLIPSFLGN 191
+LP++ NL+ LDLS N + + L+L N ++ + P
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 192 LTELTHFELGYNPLKSSPLPSSVGNLSKLE--NLWAAKANLIGEIPD-SIGKLAFLSNLD 248
+ L L N + + + + L+ LE L + G + L L NL
Sbjct: 200 I-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 249 LSDNFLS------GKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNL 302
+ + L+ I F+ L ++ L + + S L++
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKF 316
Query: 303 TGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNN--SFSGKLPDDLGKY 360
+ SL+ L N G S P+L L L N SF G
Sbjct: 317 GQFPTLKLK--SLKRLTFTSN--KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 361 SNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESY-GECKTLNYLRFGGN 419
++L+Y D+S N FL L+ + ++ S + L YL
Sbjct: 373 TSLKYLDLSFNGVITMSSNFLGLEQ-LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 420 ELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQIC 478
+ F GL ++ +M N F+ + P I + LT + ++ P+
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 479 TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSL-TALIVLNLS 537
+L LQ +++S N F LN LQ L+ N + L ++L LNL+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 538 TNQLTGTIPPE--LGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNIS 584
N T + L + L + + P + + + NI+
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-29
Identities = 41/220 (18%), Positives = 80/220 (36%), Gaps = 5/220 (2%)
Query: 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNF 469
+ L N L+ F+ PE+ ++ + + + L+ +++ GN
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 470 TGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG-ELPRNLNSL 528
L LQ + + + I L L++L + N+ +LP ++L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 529 TALIVLNLSTNQLTGTIPPELGNLAVLT----SLDLSSNLLTGEIPLELTKLKLNQFNIS 584
T L L+LS+N++ +L L + SLDLS N + P +++L++ +
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 585 HNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSK 624
+N V L + + L K
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 3e-78
Identities = 97/613 (15%), Positives = 196/613 (31%), Gaps = 72/613 (11%)
Query: 29 DAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNW------------TGITCETQNQSVDG 76
D + L + LD N + + NW G+ N V G
Sbjct: 270 DYKALKAIWE-ALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL-DNNGRVTG 327
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+ L+GF G P+ ++ L+ L+ + + + + +
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 137 LPDFSREFANLQVLDLSRNNFSGD---IPESFGRFPVLKVLNLGG--NLLSGLIPSFLGN 191
F L + DL ++ + + P LK +G N ++ I +
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQR 446
Query: 192 LTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSD 251
LT+L +P + + + S L L++++L +
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYA------KQYENEELSWSNLKDLTDVELYN 500
Query: 252 NFLSGKIPHSFSGLASIEQIELFDNQLSG---------ELPESLSNLTTLLRLDISQNNL 302
++P L ++ + + N+ L + + + NNL
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560
Query: 303 TGNLPE--TIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGK 359
P ++ M L L+ N E+ +N L LKL N +P+D
Sbjct: 561 EE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCA 616
Query: 360 Y-SNLEYFDVSTNDFTGELPRFLCFRN--KLQCIIIFNNRFSGKIPE-----SYGECKTL 411
+ +E S N +P ++ + + N+ + +
Sbjct: 617 FTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675
Query: 412 NYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFE-------GSISPSISNAPKLTGILI 464
+ + NE+Q F + + NN + N LT I +
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 465 NGNNFTGEVPSQI--CTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQE------NM 516
N T + TL L +D+S N FS PT ++L+ ++ N
Sbjct: 736 RFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNR 793
Query: 517 FTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN-LLTGEIPLELTK 575
+ P + + +LI L + +N + + +L L LD++ N ++ ++
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPY 850
Query: 576 LKLNQFNISHNKL 588
++ + + ++K
Sbjct: 851 IEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-59
Identities = 71/485 (14%), Positives = 139/485 (28%), Gaps = 86/485 (17%)
Query: 86 GGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFA 145
R+ L+ + +++ F + + DY
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTY------DNIAVDWEDANSDYAKQYENEELSWSNLK 491
Query: 146 NLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL---------IPSFLGNLTELT 196
+L ++L +P+ P L+ LN+ N + ++
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 197 HFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG 256
F +GYN L+ P +S+ + KL L N + + + G L++L L N +
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVH-NKVRHLE-AFGTNVKLTDLKLDYNQIEE 609
Query: 257 KIPHS-FSGLASIEQIELFDNQLSGELPE--SLSNLTTLLRLDISQNNLTGNLPETIAAM 313
IP + +E + N+L +P + ++ + +D S N + +M
Sbjct: 610 -IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 314 ------SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFS-------GKLPDDLGKY 360
+ ++ L+ N E A+ + + L NN + +
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727
Query: 361 SNLEYFDVSTNDFTGELPRFLCFRN--KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGG 418
L D+ N T L L + + N FS P L
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785
Query: 419 NELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQIC 478
GN + P+ I
Sbjct: 786 Q------------------------------------------RDAEGNRILRQWPTGIT 803
Query: 479 TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQEN-MFTGELPRNLNSLTA-LIVLNL 536
T L + + N + + +L L++ +N + ++ + A + VL
Sbjct: 804 TCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860
Query: 537 STNQL 541
Q
Sbjct: 861 DKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-58
Identities = 72/516 (13%), Positives = 166/516 (32%), Gaps = 65/516 (12%)
Query: 99 RNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFS 158
L+ + + + ++ + +++ + + L L+
Sbjct: 279 EALDGKNWRYYSGTINNTIHSL--NWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAK 336
Query: 159 GDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLS 218
G +P++ G+ LKVL+ G + + F E + ++ +
Sbjct: 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQ 396
Query: 219 KLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQL 278
+L + + I P+ + + S + L D QI N++
Sbjct: 397 RLNLSDLLQ-DAINRNPE-MKPIKKDSRISLKDT-----------------QIGNLTNRI 437
Query: 279 SGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPN 338
+ + +++ LT L + + + T + E N + S ++ +
Sbjct: 438 TF-ISKAIQRLTKLQIIYFANSPFTYDNIAV----DWEDANSDYAKQYENEELSWSNLKD 492
Query: 339 LVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFS 398
L ++L+N +LPD L L+ +++ N
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS---------------AAQLKADW 537
Query: 399 GKIPESYGECKTLNYLRFGGNELQGELPS--KFWGLPEVDFFEMYNNRFEGSISPSISNA 456
++ + + G N L+ E P+ + ++ + +N+ +
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTN 594
Query: 457 PKLTGILINGNNFTGEVPSQICT-LRQLQAVDLSQNRFSGHLPTC--ITQLNKLQQLELQ 513
KLT + ++ N E+P C Q++ + S N+ +P + + ++
Sbjct: 595 VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFS 652
Query: 514 ENMFTGELPRNLNSLTA-----LIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT-- 566
N E S+ + LS N++ + ++++ LS+NL+T
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
Query: 567 -----GEIPLELTKL-KLNQFNISHNKLYGEVPSDF 596
L ++ NKL + DF
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDF 747
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-47
Identities = 71/467 (15%), Positives = 144/467 (30%), Gaps = 50/467 (10%)
Query: 150 LDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSP 209
+ + + I + + + L+ + + F + P
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQP 315
Query: 210 LPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIE 269
+ N ++ L A G +PD+IG+L L L + + + +
Sbjct: 316 -GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374
Query: 270 QIELFDNQLSGELPE-SLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGE 328
E +++ + L L D+ Q+ + N PE ++L D
Sbjct: 375 MSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN-PEMKPIKKDSRISLKDT----- 428
Query: 329 IPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQ 388
Q+ N + + + + + L+ + + FT +
Sbjct: 429 ------------QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD 475
Query: 389 CIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEG- 447
+ S+ K L + +LP + LPE+ + NR
Sbjct: 476 -----YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 448 --------SISPSISNAPKLTGILINGNNFTG-EVPSQICTLRQLQAVDLSQNRFSGHLP 498
++ PK+ + NN + + + +L +D N+ HL
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE 589
Query: 499 TCITQLNKLQQLELQENMFTGELPRNL-NSLTALIVLNLSTNQLTGTIPP--ELGNLAVL 555
KL L+L N E+P + + L S N+L IP ++ V+
Sbjct: 590 A-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646
Query: 556 TSLDLSSNLLTGEIP------LELTKLKLNQFNISHNKLYGEVPSDF 596
S+D S N + E + + + +S+N++ F
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 3e-21
Identities = 38/247 (15%), Positives = 71/247 (28%), Gaps = 47/247 (19%)
Query: 78 DLSGFDLSG----GFPN--GFCRIRTLRNLNLSDNYFNG----TLSSQSLSPCFHLQVLA 127
+ G S PN + + +++ S N S + +
Sbjct: 620 QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679
Query: 128 LDYNVFIGELPDFSREFANLQVLDLSRNNFS-------GDIPESFGRFPVLKVLNLGGNL 180
L YN + + + + LS N + ++ +L ++L N
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739
Query: 181 LSGLIPSF-LGNLTELTHFELGYNPLKSSPLPSSVGNLSKLE------NLWAAKANLIGE 233
L+ L F L L++ ++ YN S P+ N S+L+ A ++ +
Sbjct: 740 LTSLSDDFRATTLPYLSNMDVSYNCFSS--FPTQPLNSSQLKAFGIRHQRDAEGNRILRQ 797
Query: 234 IPDSIGKLAFL---------------------SNLDLSDNFLSGKIPHSFSGLASIEQIE 272
P I L LD++DN S
Sbjct: 798 WPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYV 857
Query: 273 LFDNQLS 279
L ++
Sbjct: 858 LLYDKTQ 864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-74
Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 31/302 (10%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L + G V+K +L E VAVK + E+ +L ++H N+
Sbjct: 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENI 80
Query: 743 VKLLMCCSGQDFN----ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
++ + L+ + GSL+D L + W+ IA+ A+GLAY
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAY 136
Query: 799 LHNDCV-------PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851
LH D PAI HRD+KS N+LL + +ADFGLA ++ G+S
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA--GKSAGDTHGQV 194
Query: 852 GSYGYIAPEYA-----YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906
G+ Y+APE + + + D+Y+ G+VL EL + D G + + E
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD---GPVDEYMLPFEE 251
Query: 907 ATLSSPERGCCRDL--NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964
P +++ ++ P + + + C R S V E
Sbjct: 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
Query: 965 LL 966
+
Sbjct: 312 RI 313
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 5e-73
Identities = 113/574 (19%), Positives = 191/574 (33%), Gaps = 32/574 (5%)
Query: 66 TCETQNQSVDGIDLSGFDLS---GGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFH 122
+ N++ + L+ G PN + L S N T+ + + S +
Sbjct: 9 IEKEVNKTYN---CENLGLNEIPGTLPN------STECLEFSFNVLP-TIQNTTFSRLIN 58
Query: 123 LQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS 182
L L L D + L L L+ N + LK L +S
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 183 GLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLA 242
+ L N L LG N + S LP KL+ L + + + L
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKG-FPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177
Query: 243 FLSN--LDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSN--LTTLLRLDIS 298
+N L+L+ N ++G I A + + Q + + L N + +L
Sbjct: 178 QATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFE 236
Query: 299 QNNLTGNLPETIA---AMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPD 355
+ P MS+ES+NL +YF + L +L L S +LP
Sbjct: 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295
Query: 356 DLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKI-PESYGECKTLNYL 414
L S L+ +S N F L + I N ++ + L L
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355
Query: 415 RFGGNELQ--GELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTG- 471
++++ + L + + N + + P+L + +
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415
Query: 472 EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG---ELPRNLNSL 528
+ S L L+ ++LS + L LQ L LQ N F + +L +L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
Query: 529 TALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKL 588
L +L LS L+ +L ++ +DLS N LT L+ LK N++ N +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535
Query: 589 YGEVPSDFDHDLFISSLL--DNPGLCSPDLKPLP 620
+PS ++ NP C+
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTCSNIYFL 569
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-18
Identities = 31/187 (16%), Positives = 59/187 (31%), Gaps = 3/187 (1%)
Query: 440 MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT 499
N + + S LT + + + +L + L+ N T
Sbjct: 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET 99
Query: 500 CITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLD 559
++ L+ L + + L++ L L L +N ++ P+ L LD
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159
Query: 560 LSSNLLTGEIPLE---LTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDL 616
+N + + L + N++ N + G P FD +F S
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIF 219
Query: 617 KPLPPCS 623
K L +
Sbjct: 220 KGLKNST 226
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-71
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 5/273 (1%)
Query: 150 LDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSG--LIPSFLGNLTELTHFELGYNPLKS 207
D + G + ++ + + L+L G L IPS L NL L +G
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 208 SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLAS 267
P+P ++ L++L L+ N+ G IPD + ++ L LD S N LSG +P S S L +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 268 IEQIELFDNQLSGELPESLSNLTTLLR-LDISQNNLTGNLPETIAAMSLESLNLNDNYFT 326
+ I N++SG +P+S + + L + IS+N LTG +P T A ++L ++L+ N
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210
Query: 327 GEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNK 386
G+ S+ N ++ L NS + L +G NL D+ N G LP+ L
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
Query: 387 LQCIIIFNNRFSGKIPESYGECKTLNYLRFGGN 419
L + + N G+IP+ G + + + N
Sbjct: 270 LHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-69
Identities = 78/301 (25%), Positives = 136/301 (45%), Gaps = 12/301 (3%)
Query: 29 DAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITC--ETQNQSVDGIDLSGFDLSG 86
D + L+++K L +P L W+ T+ W G+ C +TQ V+ +DLSG +L
Sbjct: 7 DKQALLQIKK-DLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 87 GF--PNGFCRIRTLRNLNLSD-NYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSRE 143
+ P+ + L L + N G + +++ L L + + G +PDF +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPP-AIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL-THFELGY 202
L LD S N SG +P S P L + GN +SG IP G+ ++L T +
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 203 NPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSF 262
N L + +P + NL+ L + ++ L G+ G + L+ N L+ +
Sbjct: 184 NRL-TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KV 240
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322
++ ++L +N++ G LP+ L+ L L L++S NNL G +P+ + +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN 300
Query: 323 N 323
N
Sbjct: 301 N 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 7e-67
Identities = 89/399 (22%), Positives = 138/399 (34%), Gaps = 106/399 (26%)
Query: 233 EIPDSIGKLAFLSN----LDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGE--LPESL 286
+I +G LS+ D + G + + + + ++L L +P SL
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 287 SNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFN 346
+NL L L I N G IP ++A L L + +
Sbjct: 73 ANLPYLNFLYIG----------------------GINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 347 NSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYG 406
+ SG +PD L + L D S N SG +P S
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFS------------------------YNALSGTLPPSIS 146
Query: 407 ECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILING 466
L + F NR G+I S + KL +
Sbjct: 147 SLPNLVGITF------------------------DGNRISGAIPDSYGSFSKLFTSM--- 179
Query: 467 NNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLN 526
+S+NR +G +P LN L ++L NM G+
Sbjct: 180 --------------------TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFG 218
Query: 527 SLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLK-LNQFNISH 585
S ++L+ N L + ++G L LDL +N + G +P LT+LK L+ N+S
Sbjct: 219 SDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 586 NKLYGEVPSDFD-HDLFISSLLDNPGLCSPDLKPLPPCS 623
N L GE+P + +S+ +N LC PLP C+
Sbjct: 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGS---PLPACT 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-66
Identities = 88/287 (30%), Positives = 137/287 (47%), Gaps = 34/287 (11%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
L + IG+G V++ + G VAVK L+ E F E+ + R+RH N+V
Sbjct: 39 LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+ + +V EY+ GSL +LH+ G LD R S+A AKG+ YLHN
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
P IVHR++KS N+L+D + +V DFGL++ + + + AG+ ++APE
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL----KASTFLSSKSAAGTPEWMAPEVLR 212
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRWVTEATLSSPERGCCRDLN 921
+ EKSDVYSFGV+L EL T ++P +G +V V
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP----WGNLNPAQVVAAVGFKCK------------ 256
Query: 922 QLIDPRMDL-STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
R+++ + +V + C ++ P RPS +++LLR
Sbjct: 257 -----RLEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 6e-66
Identities = 102/547 (18%), Positives = 182/547 (33%), Gaps = 35/547 (6%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANLQVLDLSR 154
+ +N++LS N L S S S LQ L L I + D + +L L L+
Sbjct: 32 SSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRC-EIETIEDKAWHGLHHLSNLILTG 89
Query: 155 NNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSV 214
N P SF L+ L L+ L +G L L + +N + S LP+
Sbjct: 90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF 149
Query: 215 GNLSKLENLWAAKANLIGEIPDSI-----GKLAFLSNLDLSDNFLSGKIPHSFSGLASIE 269
NL+ L ++ + N I I + +LD+S N + +F G+ +
Sbjct: 150 SNLTNLVHVDLSY-NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLH 207
Query: 270 QIELFDNQLSGELPE-SLSNLTTLLRLDISQNNLTGN---------LPETIAAMSLESLN 319
++ L N S + + L NL L + + E + ++++
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 320 LNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPR 379
L + N+ + L S +D+ K+ + +
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTL 325
Query: 380 FLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFW--GLPEVDF 437
L L+ + + N+ S I +L+YL N L + G +
Sbjct: 326 DL---PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 438 FEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVP-SQICTLRQLQAVDLSQNRFSGH 496
++ N +S + +L + + S +L +L +D+S
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 497 LPTCITQLNKLQQLELQENMFTGELPRN-LNSLTALIVLNLSTNQLTGTIPPELGNLAVL 555
L L L++ N F N + T L L+LS QL L L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 556 TSLDLSSNLLTGEIPLELTKLK-LNQFNISHNKLYGEVPSDFDHDLFISSLL--DNPGLC 612
L++S N L +L L+ + S N++ ++ +N C
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559
Query: 613 SPDLKPL 619
+ +
Sbjct: 560 ICEHQKF 566
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-31
Identities = 44/229 (19%), Positives = 76/229 (33%), Gaps = 5/229 (2%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNG-TLSSQSLSPCFHLQVLALDYNVFIG 135
+ L+ S F +L L+LS N + S S L+ L L +N
Sbjct: 333 LTLTMNKGSISFKKVALP--SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN-GAI 389
Query: 136 ELPDFSREFANLQVLDLSRNNFSGDIPES-FGRFPVLKVLNLGGNLLSGLIPSFLGNLTE 194
+ LQ LD + S F L L++ LT
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 195 LTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL 254
L ++ N K + L + N + L L +K L L L L++S N L
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 255 SGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT 303
++ L S+ ++ N++ +L +++ N++
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 40/220 (18%), Positives = 80/220 (36%), Gaps = 8/220 (3%)
Query: 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNF 469
+ + N L+ F E+ + ++ E + L+ +++ GN
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 470 TGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG-ELPRNLNSL 528
P L L+ + + + + I QL L++L + N +LP ++L
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 529 TALIVLNLSTNQLTGTIPPELGNL----AVLTSLDLSSNLLTGEIPLELTKLKLNQFNIS 584
T L+ ++LS N + +L L V SLD+S N + +KL++ +
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 585 HNKLYGEVPSDFDHDLF---ISSLLDNPGLCSPDLKPLPP 621
N + +L + L+ +L+ P
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-19
Identities = 25/133 (18%), Positives = 42/133 (31%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+D+S + F F + +L L ++ N F S + +L L L
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELT 196
LQ+L++S NN + + L L+ N + L
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548
Query: 197 HFELGYNPLKSSP 209
F L N +
Sbjct: 549 FFNLTNNSVACIC 561
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-64
Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 38/286 (13%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+ + ++G G V K K + + VA+K++ F E+ L RV H N+V
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIV 64
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
KL C LV EY GSL ++LH + S ++G+AYLH+
Sbjct: 65 KLYGACL-NPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 804 VPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
A++HRD+K N+LL A V ++ DFG A +Q+ M+ GS ++APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-------MTNNKGSAAWMAPEVF 175
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE-ATLSSPERGCCRDLN 921
+EK DV+S+G++L E++T ++P D G I+ V + + +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK-NLPKPIE 234
Query: 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
L+ C S P RPSM +V+++
Sbjct: 235 SLMT---------------------RCWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 6e-63
Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 49/298 (16%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETV--FRSEIETLGRVRHG 740
LT + +IG GG +VY+ G+ VAVK + ++T+ R E + ++H
Sbjct: 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
N++ L C + LV E+ G L +L K + I + A A+G+ YLH
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLH 122
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPR--------VADFGLAKALQSQEGQSDDAMSCVAG 852
++ + I+HRD+KS NIL+ ++ + DFGLA+ AG
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------WHRTTKMSAAG 176
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG--ENKDIVRWVTEATLS 910
+Y ++APE ++ SDV+S+GV+L EL+TG+ P F + + V L
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRGIDGLAVAYGVAMNKL- 231
Query: 911 SPERGCCRDLNQLIDPRMDL-STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
+ + STC E + C + P +RPS +++ L
Sbjct: 232 ----------------ALPIPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-62
Identities = 87/327 (26%), Positives = 139/327 (42%), Gaps = 61/327 (18%)
Query: 659 STSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGG 717
+ S + ++ NE + + IG GG V+K +L VA+K L+ G
Sbjct: 2 AMGGSEFPKSRLPTLADNE------IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILG 55
Query: 718 THKPETETV-----FRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH 772
+ ETE + F+ E+ + + H N+VKL + V E++P G L L
Sbjct: 56 DSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-NPPRM-VMEFVPCGDLYHRLL 113
Query: 773 EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD-----AEMVPRV 827
+K + WS++ + A G+ Y+ N P IVHRD++S NI L A + +V
Sbjct: 114 DKAHP--IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170
Query: 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE--YAYTKKVTEKSDVYSFGVVLMELVT 885
ADFGL++ QS ++S + G++ ++APE A + TEK+D YSF ++L ++T
Sbjct: 171 ADFGLSQ-------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223
Query: 886 GKRPNDPSFGENKDIVRWVTEATLSSPER-----GCCRDLNQLIDPRMDLSTCDYEEAEK 940
G+ P F E R C L +I+
Sbjct: 224 GEGP----FDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIE--------------- 264
Query: 941 VLNVALMCTSDFPINRPSMRRVVELLR 967
+C S P RP +V+ L
Sbjct: 265 ------LCWSGDPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-61
Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 47/293 (16%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
L + S ++K + + G + VK L F E L H NV+
Sbjct: 12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 744 KLLMCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+L C + +MP GSL ++LH +G + +D S A A+G+A+LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE- 860
P I + S ++++D +M R++ + + Q + ++APE
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---------SPGRMYAPAWVAPEA 179
Query: 861 --YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRWVTEATLSSPE--R 914
+D++SF V+L ELVT + P F + N +I V L P
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP----FADLSNMEIGMKVALEGL-RPTIPP 234
Query: 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
G +++L+ +C ++ P RP +V +L
Sbjct: 235 GISPHVSKLMK---------------------ICMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-60
Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 35/289 (12%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+T IGSG VYK K VAVK L P+ F++E+ L + RH N++
Sbjct: 26 ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+ + I V ++ SL LH + IA+ A+G+ YLH
Sbjct: 84 LFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA-- 138
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE--- 860
+I+HRD+KS+NI L + ++ DFGLA G ++GS ++APE
Sbjct: 139 -KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG--SHQFEQLSGSILWMAPEVIR 195
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRWVTEATLSSPERGCCR 918
+ + +SDVY+FG+VL EL+TG+ P + N+D + + SP+ R
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
S C +++ + C RPS R++ +
Sbjct: 252 ------------SNCP----KRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-59
Identities = 70/329 (21%), Positives = 112/329 (34%), Gaps = 70/329 (21%)
Query: 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIE--TLGRVR 738
L +L LIG G VYK L VAVK F +E + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF-----SFANRQNFINEKNIYRVPLME 65
Query: 739 HGNVVKLLMCCSGQDFNI-----LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA 793
H N+ + ++ + LV EY PNGSL L + DW +A
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVT 121
Query: 794 KGLAYLHND------CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS----QEGQS 843
+GLAYLH + PAI HRD+ S N+L+ + ++DFGL+ L + G+
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 844 DDAMSCVAGSYGYIAPEYA-------YTKKVTEKSDVYSFGVVLMELVTGKR-------- 888
D+A G+ Y+APE + ++ D+Y+ G++ E+
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 889 -----------PNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEE 937
N P+F + + +V +
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLV--------------SREKQRPKFPEAWK---ENSLA 284
Query: 938 AEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ C R + + E +
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERM 313
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 8e-59
Identities = 64/320 (20%), Positives = 122/320 (38%), Gaps = 45/320 (14%)
Query: 661 SKSPWKVVTFQRVSFNEDDILPH-LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTH 719
++S + + + E DI L LIG G +VY + VA++ +
Sbjct: 11 ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD 68
Query: 720 KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS 779
+ F+ E+ + RH NVV + C ++ +L ++ +
Sbjct: 69 NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--V 126
Query: 780 LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ-S 838
LD + IAQ KG+ YLH I+H+D+KS N+ D + DFGL
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182
Query: 839 QEGQSDDAMSCVAGSYGYIAPE---------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Q G+ +D + G ++APE ++ SDV++ G + EL + P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 890 NDPSFGENKDIVRWVTEATL--SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALM 947
+ + + W + + + G ++++ ++ L
Sbjct: 243 FK---TQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL---------------------LF 278
Query: 948 CTSDFPINRPSMRRVVELLR 967
C + RP+ +++++L
Sbjct: 279 CWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-57
Identities = 80/321 (24%), Positives = 121/321 (37%), Gaps = 61/321 (19%)
Query: 680 ILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH 739
I + IG G V+ K + GE VAVK E +EI +RH
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRH 90
Query: 740 GNVVKLLMCCSGQDFNI----LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
N++ + + L+ +Y NGSL D L +LD +A + G
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSG 146
Query: 796 LAYLHND-----CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV 850
L +LH + PAI HRD+KS NIL+ +AD GLA S + D +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 851 AGSYGYIAPE------YAYTKKVTEKSDVYSFGVVLMELVTGKR---------------- 888
G+ Y+ PE + +D+YSFG++L E+
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
Query: 889 PNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALM- 947
P+DPS+ + ++IV C + L R C + + LM
Sbjct: 267 PSDPSYEDMREIV--------------CIKKLRPSFPNRWSSDECLRQMGK------LMT 306
Query: 948 -CTSDFPINRPSMRRVVELLR 967
C + P +R + RV + L
Sbjct: 307 ECWAHNPASRLTALRVKKTLA 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-56
Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 43/297 (14%)
Query: 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L ++G G + KV + +GE + +K L+ ET+ F E++ + + H NV
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNV 69
Query: 743 VKLL-MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+K + + + N + EY+ G+L ++ WS R S A+ A G+AYLH+
Sbjct: 70 LKFIGVLYKDKRLNF-ITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS 126
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA----------MSCVA 851
I+HRD+ SHN L+ VADFGLA+ + ++ Q + V
Sbjct: 127 MN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 852 GSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911
G+ ++APE + EK DV+SFG+VL E++ DP + L
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLNVRGFL-- 240
Query: 912 PERGCCRDLNQLIDPRMDL-STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
C + + C P RPS ++ L
Sbjct: 241 ---------------DRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-56
Identities = 79/318 (24%), Positives = 114/318 (35%), Gaps = 65/318 (20%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIE--TLGRVRHGN 741
+T +G G V++ + GE VAVK E + E E +RH N
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQ-GENVAVKIF-----SSRDEKSWFRETELYNTVMLRHEN 63
Query: 742 VVKLLMCCSGQDFNI----LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
++ + + L+ Y GSL D L +LD I A GLA
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLA 119
Query: 798 YLHNDCV-----PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
+LH + PAI HRD+KS NIL+ +AD GLA Q D + G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 853 SYGYIAPE------YAYTKKVTEKSDVYSFGVVLMELVTGKR----------------PN 890
+ Y+APE ++ D+++FG+VL E+ PN
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 891 DPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALM--C 948
DPSF + + +V C I R A+ LM C
Sbjct: 240 DPSFEDMRKVV--------------CVDQQRPNIPNRWFSDPTLTSLAK------LMKEC 279
Query: 949 TSDFPINRPSMRRVVELL 966
P R + R+ + L
Sbjct: 280 WYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 80/328 (24%), Positives = 123/328 (37%), Gaps = 65/328 (19%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIE-- 732
+ I + Q IG G V++ K + GE VAVK E + E E
Sbjct: 35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF-----SSREERSWFREAEIY 88
Query: 733 TLGRVRHGNVVKLLMCCSGQDFNI----LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSI 788
+RH N++ + + + LV +Y +GSL D L+ ++ +
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKL 144
Query: 789 AQGAAKGLAYLHNDCV-----PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843
A A GLA+LH + V PAI HRD+KS NIL+ +AD GLA S
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 844 DDAMSCVAGSYGYIAPE------YAYTKKVTEKSDVYSFGVVLMELVTGKR--------- 888
D A + G+ Y+APE + +++D+Y+ G+V E+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 889 -------PNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKV 941
P+DPS E + +V C + L I R A+
Sbjct: 265 LPYYDLVPSDPSVEEMRKVV--------------CEQKLRPNIPNRWQSCEALRVMAK-- 308
Query: 942 LNVALM--CTSDFPINRPSMRRVVELLR 967
+M C R + R+ + L
Sbjct: 309 ----IMRECWYANGAARLTALRIKKTLS 332
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-54
Identities = 122/608 (20%), Positives = 212/608 (34%), Gaps = 54/608 (8%)
Query: 66 TCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQV 125
+C + +L+ + T L LS NY T+++ S LQ+
Sbjct: 1 SCSFDGRIAF---YRFCNLTQVPQV----LNTTERLLLSFNYIR-TVTASSFPFLEQLQL 52
Query: 126 LALDYNVFIGELPDFS-REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS-- 182
L L + + R NL++LDL + P++F L L L LS
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 183 GLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGK-- 240
L + NL LT +L N ++S L S G L+ L+++ + +N I + + +
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS-SNQIFLVCEHELEPL 171
Query: 241 -LAFLSNLDLSDNFLSGKIPHSFSGLA------------------SIEQIELFDNQLSGE 281
LS L+ N L ++ + +++ F N +S
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 282 LPESLSNLTTLLRLDISQNNLTGNLPETIAAM---SLESLNLNDNYFTGEIPESLASNPN 338
SL ++ +N+ T A + S+ L+L+ + + +
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 339 LVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFS 398
L L L N + + NL+ ++S N K+ I + N +
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 399 GKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPK 458
+++ + L L N L + +P + + N+ +++
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINLT---- 402
Query: 459 LTGILINGNNFTG-EVPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENM 516
I ++ N ++ + + LQ + L+QNRFS ++ L+QL L ENM
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 517 FTGELPRNLNS-----LTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPL 571
L L+ L VL L+ N L P +L L L L+SN LT +
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH 521
Query: 572 ELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSKTKPGTIY 631
L +IS N+L D L + + N +C +L TI
Sbjct: 522 NDLPANLEILDISRNQLL-APNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIA 580
Query: 632 IVVILSIC 639
C
Sbjct: 581 GPPADIYC 588
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-52
Identities = 105/517 (20%), Positives = 197/517 (38%), Gaps = 38/517 (7%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANLQVLDLSR 154
+ +NL+LS N L S S LQVL L I + D + + ++L L L+
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRC-EIQTIEDGAYQSLSHLSTLILTG 85
Query: 155 NNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSV 214
N +F L+ L L+ L +G+L L + +N ++S LP
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 215 GNLSKLENLWAAKANLIGEIPDSIGKLAFLSN----LDLSDNFLSGKIPHSFSGLASIEQ 270
NL+ LE+L + + + L + LDLS N ++ P +F + + +
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHK 204
Query: 271 IELFDNQLSGELPE----SLSNLTTL---LRLDISQNNLTG---NLPETIAAMSLESLNL 320
+ L +N S + + L+ L L ++ NL + E + +++E L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 321 N-DNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYS--NLEYFDVSTNDFTGEL 377
+Y+ +I + N+ L + + ++ D + +LE + F
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFP--- 320
Query: 378 PRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQ--GELPSKFWGLPEV 435
L ++ L+ + +N+ E + +L +L N L G +G +
Sbjct: 321 --TLKLKS-LKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 436 DFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTG-EVPSQICTLRQLQAVDLSQNRFS 494
+ ++ N ++S + +L + +N S +LR L +D+S
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 495 GHLPTCITQLNKLQQLELQENMFTGELPRN-LNSLTALIVLNLSTNQLTGTIPPE-LGNL 552
L+ L+ L++ N F + L L L+LS QL + P +L
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSL 493
Query: 553 AVLTSLDLSSNLLTGEIPLELTKLK-LNQFNISHNKL 588
+ L L+++SN L +L L + + N
Sbjct: 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-47
Identities = 108/511 (21%), Positives = 188/511 (36%), Gaps = 31/511 (6%)
Query: 73 SVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNV 132
S +DLS L F L+ L+LS T+ + HL L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 133 FIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGN 191
++LQ L N + G LK LN+ NL+ +P + N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 192 LTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAA---KANLIGEIPDSIGKLAFLSNLD 248
LT L H +L N ++S + + L ++ L + N + I K L L
Sbjct: 148 LTNLEHLDLSSNKIQSIY-CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 249 LSDNFLSGKIPH-SFSGLASIEQIELF------DNQLSGELPESLSNLT--TLLRLDISQ 299
L +NF S + GLA +E L + L +L L T+ ++
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 300 NNLTGNLPETI--AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL 357
+ + + ++ S +L + + N L+L N F L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 358 GKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNR--FSGKIPESYGECKTLNYLR 415
+L+ ++N + + L+ + + N F G +S +L YL
Sbjct: 325 ---KSLKRLTFTSNKGG-NAFSEVDLPS-LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 416 FGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVP 474
N + + S F GL +++ + ++ + S+ + L + I+ +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 475 SQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNLNSLTALIV 533
L L+ + ++ N F + I T+L L L+L + P NSL++L V
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 534 LNLSTNQLTGTIPPE-LGNLAVLTSLDLSSN 563
LN+++NQL ++P L L + L +N
Sbjct: 499 LNMASNQLK-SVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-18
Identities = 41/220 (18%), Positives = 82/220 (37%), Gaps = 8/220 (3%)
Query: 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNF 469
+ L N L+ F+ PE+ ++ + + + L+ +++ GN
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 470 TGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFT-GELPRNLNSL 528
L LQ + + + I L L++L + N+ +LP ++L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 529 TALIVLNLSTNQLTGTIPPELGNLAVLT----SLDLSSNLLTGEIPLELTKLKLNQFNIS 584
T L L+LS+N++ +L L + SLDLS N + P +++L++ +
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 585 HNKLYGEVPSDFDHDLF---ISSLLDNPGLCSPDLKPLPP 621
+N V L + L+ +L+
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 33/115 (28%), Positives = 46/115 (40%), Gaps = 2/115 (1%)
Query: 92 FCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL-PDFSREFANLQVL 150
F +R L L++S + + + L+VL + N F PD E NL L
Sbjct: 417 FLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 151 DLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205
DLS+ P +F L+VLN+ N L + LT L L NP
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-52
Identities = 104/498 (20%), Positives = 182/498 (36%), Gaps = 39/498 (7%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156
L + ++ + + + L + + + + + L R
Sbjct: 2 PLGSATITQD--TPINQIFTDTALAEKMKTVLGKT-NVTDTVSQT-DLDQVTTLQADRLG 57
Query: 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGN 216
+ L +N N L+ + P L NLT+L + N + + + N
Sbjct: 58 IK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD---ITPLAN 110
Query: 217 LSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDN 276
L+ L L N I +I + L L+ L+LS N +S + SGL S++Q+ N
Sbjct: 111 LTNLTGLTLFN-NQITDID-PLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GN 165
Query: 277 QLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLAS 335
Q++ + L+NLTTL RLDIS N ++ +A + +LESL +N + P L
Sbjct: 166 QVTD--LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGI 219
Query: 336 NPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNN 395
NL +L L N L +NL D++ N + P L KL + + N
Sbjct: 220 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275
Query: 396 RFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISN 455
+ S L L N+L+ S L + + +Y N +S+
Sbjct: 276 QISN--ISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI--SPVSS 329
Query: 456 APKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQEN 515
KL + N + S + L + + N+ S P + L ++ QL L +
Sbjct: 330 LTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 385
Query: 516 MFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTK 575
+T +++ + T L P + + T D++ NL + + T
Sbjct: 386 AWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTF 443
Query: 576 LKLNQFNISHNKLYGEVP 593
+ G V
Sbjct: 444 SQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-44
Identities = 92/449 (20%), Positives = 160/449 (35%), Gaps = 35/449 (7%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+ + +G + L +N S+N L L + ++ N I +
Sbjct: 51 LQADRLGIKS--IDGVEYLNNLTQINFSNNQLT---DITPLKNLTKLVDILMNNN-QIAD 104
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELT 196
+ + NL L L N + + L L L N +S + L LT L
Sbjct: 105 ITPLA-NLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQ 159
Query: 197 HFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG 256
G PL NL+ LE L + N + +I + KL L +L ++N +S
Sbjct: 160 QLSFGNQVTDLKPL----ANLTTLERLDISS-NKVSDIS-VLAKLTNLESLIATNNQISD 213
Query: 257 KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLE 316
P L +++++ L NQL +L++LT L LD++ N ++ NL L
Sbjct: 214 ITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS-NLAPLSGLTKLT 268
Query: 317 SLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE 376
L L N + P LA L L+L N + NL Y + N+ +
Sbjct: 269 ELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI 324
Query: 377 LPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVD 436
P + KLQ + +NN+ S S +N+L G N++ P L +
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 378
Query: 437 FFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGH 496
+ + + + + + + N P+ I D++ N S
Sbjct: 379 QLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSY- 435
Query: 497 LPTCITQLNKLQQLELQENMFTGELPRNL 525
++ + F+G + + L
Sbjct: 436 TNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-12
Identities = 23/174 (13%), Positives = 47/174 (27%), Gaps = 11/174 (6%)
Query: 91 GFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVL 150
++ L L L N + +S LQ L N + ++ + N+ L
Sbjct: 304 PISNLKNLTYLTLYFNNIS---DISPVSSLTKLQRLFFYNN-KVSDVSSLA-NLTNINWL 358
Query: 151 DLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPL 210
N S P + L L + ++ N++ N +
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP---NTVKNVTGALIA 413
Query: 211 PSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
P+++ + NL + + + SG +
Sbjct: 414 PATISDGGSYTEPD-ITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-49
Identities = 103/505 (20%), Positives = 185/505 (36%), Gaps = 26/505 (5%)
Query: 122 HLQVLALDYNVFIGELP--DFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179
++ L L +N I + D ANLQVL L + + ++F L+ L+L N
Sbjct: 27 AMKSLDLSFN-KITYIGHGDLRA-CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIP-DSI 238
LS L S+ G L+ L + L NP ++ + S NL+ L+ L EI
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 239 GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDIS 298
L L+ L++ L S + I + L ++ + L L+++ L++
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204
Query: 299 QNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLG 358
NL + + S + F G + + N L L+ + D
Sbjct: 205 DTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD--C 261
Query: 359 KYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGG 418
+ L F+ S +D EL + ++ + I + Y + + +
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVT--IRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319
Query: 419 NELQGELPSKFWGLPEVDFFEMYNNRFEGSISPS---ISNAPKLTGILINGNNFT--GEV 473
+++ S L ++F ++ N + P L ++++ N+ +
Sbjct: 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379
Query: 474 PSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIV 533
+ TL+ L ++D+S+N F +P K++ L L + + L V
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEV 435
Query: 534 LNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVP 593
L++S N L + L L L +S N L +P L IS N+L
Sbjct: 436 LDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPD 490
Query: 594 SDFDHDLFISSLL--DNPGLCSPDL 616
FD + + NP CS
Sbjct: 491 GIFDRLTSLQKIWLHTNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-44
Identities = 95/497 (19%), Positives = 169/497 (34%), Gaps = 44/497 (8%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANLQVLDLSR 154
+++L+LS N + L C +LQVL L + I + + +L+ LDLS
Sbjct: 26 AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSS-RINTIEGDAFYSLGSLEHLDLSD 83
Query: 155 NNFSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGNLTELTHFELGYNPLKSSPLPSS 213
N+ S FG LK LNL GN L + S NLT L +G S
Sbjct: 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143
Query: 214 VGNLSKLENLWAAKANLIGEIPD-SIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIE 272
L+ L L + S+ + + +L L + + + L+S+ +E
Sbjct: 144 FAGLTSLNELEIKA-LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 273 LFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM--------SLESLNLNDNY 324
L D L+ L + + E+ + L + +D
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
Query: 325 FTG---------EIPESLAS--NPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
G ++ L + +L + L ++ V +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 374 TGELPRFLCFRNK-LQCIIIFNNRFSGKIPES---YGECKTLNYLRFGGNELQ--GELPS 427
+P K L+ + + N + ++ G +L L N L+ +
Sbjct: 323 F-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 428 KFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVD 487
L + ++ N F + S K+ + ++ V + C + L+ +D
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLD 437
Query: 488 LSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPP 547
+S N L +LQ+L + N LP L+V+ +S NQL ++P
Sbjct: 438 VSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLK-SVPD 490
Query: 548 E-LGNLAVLTSLDLSSN 563
L L + L +N
Sbjct: 491 GIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-41
Identities = 93/510 (18%), Positives = 163/510 (31%), Gaps = 51/510 (10%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
L+ L L + ++ ++ + F +L+
Sbjct: 43 HGDLRACANLQVLILKSS-----------------RINTIEGDAFYS--------LGSLE 77
Query: 149 VLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGNLTELTHFELGYNPLKS 207
LDLS N+ S FG LK LNL GN L + S NLT L +G S
Sbjct: 78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 208 SPLPSSVGNLSKLENLWAAKANLIGEIPD-SIGKLAFLSNLDLSDNFLSGKIPHSFSGLA 266
L+ L L + S+ + + +L L + + + L+
Sbjct: 138 EIRRIDFAGLTSLNELEIKA-LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 267 SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFT 326
S+ +EL D L+ L + + G++ + L L
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPM--KKLAFRGSVLTDESFNELLKLLRYIL--- 251
Query: 327 GEIPESLASNPNLVQLKLFNNSFSGKLPDDLG-KYSNLEYFDVSTNDFTGELPRFLCFRN 385
E+ E + L L FN S S + + + + + +L
Sbjct: 252 -ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE 310
Query: 386 KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGEL---PSKFWGLPEVDFFEMYN 442
K++ I + N++ K+L +L N + E + P + +
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 443 NRFE--GSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTC 500
N + LT + I+ N F +P +++ ++LS + TC
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTC 428
Query: 501 ITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDL 560
I L+ L++ N L L L +S N+L T+P VL + +
Sbjct: 429 I--PQTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPDA-SLFPVLLVMKI 480
Query: 561 SSNLLTGEIPLELTKLK-LNQFNISHNKLY 589
S N L +L L + + N
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 53/355 (14%), Positives = 99/355 (27%), Gaps = 66/355 (18%)
Query: 79 LSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNG---------TLSSQSLSPCFHLQVLALD 129
L + + R L+D FN LS C + +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 130 YNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFL 189
+ E ++ L + + D+ + +K + + + + + SF
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFS 330
Query: 190 GNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDL 249
+L L +L N + L +S G L L L
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSA----------------------CKGAWPSLQTLVL 368
Query: 250 SDNFLS--GKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLP 307
S N L K L ++ +++ N +P+S + L++S + +
Sbjct: 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVK 426
Query: 308 ETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFD 367
I +LE L++++N L P L +L + N LPD
Sbjct: 427 TCIPQ-TLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPDAS---------- 470
Query: 368 VSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQ 422
L + I N+ + +L + N
Sbjct: 471 ---------------LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-47
Identities = 74/464 (15%), Positives = 150/464 (32%), Gaps = 25/464 (5%)
Query: 123 LQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS 182
++ + + L + N++ LDLS N S F L++LNL N+L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 183 GLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLA 242
+ L +L+ L +L N + + +E L AA N I + S
Sbjct: 72 ETLD--LESLSTLRTLDLNNNYV------QELLVGPSIETLHAAN-NNISRVSCSR--GQ 120
Query: 243 FLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSG-ELPESLSNLTTLLRLDISQNN 301
N+ L++N ++ + ++ ++L N++ E ++ TL L++ N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYS 361
+ ++ + L++L+L+ N + S + + L NN + L
Sbjct: 181 IY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 362 NLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNEL 421
NLE+FD+ N F R F + + ++ EC +G
Sbjct: 238 NLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 422 QGELPSKFWGLPEVDFFEMYNNRFEGS----ISPSISNAPKLTGILINGNNFTGEVPSQI 477
+ L + E +GS + N + I + +
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVT 356
Query: 478 CTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLS 537
+ ++ + + +L Q EL + L +L
Sbjct: 357 LRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV-GQIELQHATEEQSPLQLLRAI 415
Query: 538 TNQLT-GTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQ 580
+ + + + D+ + T L +L +
Sbjct: 416 VKRYEEMYVEQQSVQNNAIRDWDMYQHKET---QLAEENARLKK 456
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-38
Identities = 80/493 (16%), Positives = 143/493 (29%), Gaps = 47/493 (9%)
Query: 78 DLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL 137
DLSG LS L LNLS N TL +SLS L+ L L+ N ++ EL
Sbjct: 40 DLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLS---TLRTLDLNNN-YVQEL 95
Query: 138 PDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTH 197
+++ L + NN S + R K + L N ++ L G + + +
Sbjct: 96 LVGP----SIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 198 FELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGK 257
+L N + + + LE+L N I ++ + A L LDLS N L+
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQY-NFIYDVKGQVV-FAKLKTLDLSSNKLA-F 205
Query: 258 IPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLES 317
+ F A + I L +N+L + ++L L D+ N + +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 318 LNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGEL 377
+ ++ + L+ + + G
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 378 PRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDF 437
++ + + + +
Sbjct: 325 TE--------------------RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKIT 364
Query: 438 FEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHL 497
E + +S +L G L E+ LQ + R+
Sbjct: 365 LEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYE--- 420
Query: 498 PTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL-GNLAVLT 556
+ + +N + + T L N +L G L A L
Sbjct: 421 -------EMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQ 473
Query: 557 SLDLSSNLLTGEI 569
L + L ++
Sbjct: 474 ELVVREQNLASQL 486
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-29
Identities = 50/337 (14%), Positives = 99/337 (29%), Gaps = 41/337 (12%)
Query: 282 LPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLV 340
+ E N ++ ++L L + +++ L+L+ N + LA L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 341 QLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGK 400
L L +N DL S L D++ N EL
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL---------------------- 96
Query: 401 IPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLT 460
++ L N + S+ G + + NN+ ++
Sbjct: 97 ------VGPSIETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQ 147
Query: 461 GILINGNNFTG-EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG 519
+ + N + L+ ++L N + + KL+ L+L N
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA- 204
Query: 520 ELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLN 579
+ S + ++L N+L I L L DL N +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 580 QFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDL 616
++ + ++ + + + +L C DL
Sbjct: 264 VQTVAKQTV-KKLTGQNEEECTVPTLGHYGAYCCEDL 299
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 27/141 (19%), Positives = 57/141 (40%), Gaps = 9/141 (6%)
Query: 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKL 507
+I N + + ++ + S + ++ +DLS N S + KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567
+ L L N+ E +L SL+ L L+L+ N + EL + +L ++N ++
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 568 EIPLELTKLKLNQFNISHNKL 588
+ + +++NK+
Sbjct: 113 RVSCSRGQ-GKKNIYLANNKI 132
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-46
Identities = 112/501 (22%), Positives = 182/501 (36%), Gaps = 76/501 (15%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
P +++ + + + + +P + + + + L D
Sbjct: 27 PVEAENVKSKTEYYNAWSEW------ERNAPPGNGEQREMAVS----RLRDCLDR--QAH 74
Query: 149 VLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSS 208
L+L+ S +PE L+ L N L+ L P +L L L
Sbjct: 75 ELELNNLGLS-SLPELPPH---LESLVASCNSLTEL-PELPQSLKSLLVDNNNLKALSDL 129
Query: 209 PLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASI 268
P LE L + N + ++P+ + +FL +D+ +N L K+P S+
Sbjct: 130 P--------PLLEYLGVSN-NQLEKLPE-LQNSSFLKIIDVDNNSLK-KLP---DLPPSL 175
Query: 269 EQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGE 328
E I +NQL ELPE L NL L + N+L LP+ SLES+ +N E
Sbjct: 176 EFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPL--SLESIVAGNNILE-E 229
Query: 329 IPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQ 388
+PE L + P L + NN LPD +LE +V N T +LP L
Sbjct: 230 LPE-LQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQ---SLT 280
Query: 389 CIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGS 448
+ + N FS + E L YL NE++ L L E++ + NN+
Sbjct: 281 FLDVSENIFS-GLSEL---PPNLYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLI-E 331
Query: 449 ISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQ 508
+ L ++ + N+ EVP L+QL + N P + L+
Sbjct: 332 LPALPPR---LERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLR 383
Query: 509 QLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE 568
N E+P +L L++ TN L P ++ L ++S +
Sbjct: 384 M-----NSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPESV---EDLRMNSERVVDP 431
Query: 569 IPLELTKL-KLNQFNISHNKL 588
KL H+
Sbjct: 432 YEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-45
Identities = 77/469 (16%), Positives = 147/469 (31%), Gaps = 78/469 (16%)
Query: 146 NLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205
LQ +N + ++P + P G E+ L
Sbjct: 12 FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD 70
Query: 206 KS-----------SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL 254
+ S LP +L L N + E+P+ L L + + L
Sbjct: 71 RQAHELELNNLGLSSLPELPPHLESL-VAS---CNSLTELPELPQSLKSLLVDNNNLKAL 126
Query: 255 SGKIPH---------------SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQ 299
S P + ++ I++ +N L +LP+ +L +
Sbjct: 127 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF---IAAGN 182
Query: 300 NNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGK 359
N L LPE L ++ ++N ++P+ +L + NN +L
Sbjct: 183 NQLE-ELPELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNILE--ELPELQN 235
Query: 360 YSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGN 419
L N LP L+ + + +N + +PE L+ +
Sbjct: 236 LPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFS 290
Query: 420 ELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICT 479
L P+ + + +N S+ + L + ++ N E+P+
Sbjct: 291 GLSELPPN-------LYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLI-ELPALPPR 338
Query: 480 LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTN 539
L +L S N + +P L+QL ++ N E P S+ L + +
Sbjct: 339 LERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLA- 389
Query: 540 QLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKL 588
+P N L L + +N L E P ++ ++ ++
Sbjct: 390 ----EVPELPQN---LKQLHVETNPLR-EFPDIPESVE--DLRMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 83/407 (20%), Positives = 148/407 (36%), Gaps = 59/407 (14%)
Query: 88 FPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANL 147
P +++L N + + L+ L + N + +LP+ + L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPL--------LEYLGVSNN-QLEKLPELQN-SSFL 155
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207
+++D+ N+ +P+ L+ + G N L L L NL LT N LK
Sbjct: 156 KIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLKK 209
Query: 208 SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLAS 267
LP +L + A N++ E+P+ + L FL+ + +N L +P L
Sbjct: 210 --LPDLPLSLESIV----AGNNILEELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSL-- 259
Query: 268 IEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTG 327
E + + DN L+ +LPE +LT LD+S+N + L E +L LN + N
Sbjct: 260 -EALNVRDNYLT-DLPELPQSLT---FLDVSENIFS-GLSELPP--NLYYLNASSNEIR- 310
Query: 328 EIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKL 387
+ + P+L +L + NN +LP LE S N E+P L
Sbjct: 311 SLCDLP---PSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQ---NL 359
Query: 388 QCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEG 447
+ + + N + P+ + L N E+P L ++ + N
Sbjct: 360 KQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNLKQLH---VETNPLR- 409
Query: 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFS 494
+ + + +N T +L+ +
Sbjct: 410 EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 72/339 (21%), Positives = 124/339 (36%), Gaps = 52/339 (15%)
Query: 264 GLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM---------- 313
+++ + L+ E+P N+ + + + N P
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 314 ----SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVS 369
L LN+ + +PE P+L L NS + +LP+ +L + +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 370 TNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKF 429
+ +LP L+ + + NN+ K+PE L + N L+ +LP
Sbjct: 123 LKALS-DLP------PLLEYLGVSNNQLE-KLPEL-QNSSFLKIIDVDNNSLK-KLPDLP 172
Query: 430 WGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLS 489
L + NN+ E + P + N P LT I + N+ ++P +L +
Sbjct: 173 PSLEFIA---AGNNQLE-EL-PELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAG 223
Query: 490 QNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL 549
N LP + L L + N+ LP SL AL N+ N LT +P
Sbjct: 224 NNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPELP 276
Query: 550 GNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKL 588
+ LT LD+S N+ + + L N S N++
Sbjct: 277 QS---LTFLDVSENIFS-GLSELPPNLY--YLNASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 57/308 (18%), Positives = 102/308 (33%), Gaps = 42/308 (13%)
Query: 282 LPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLV 340
+ + T L +NLT +P + S + + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 341 QLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGK 400
+L + +++ + LP L+ ++ N + +
Sbjct: 62 VSRLRDCLD-----------RQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-E 105
Query: 401 IPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLT 460
+PE K+L L P L + + NN+ E + P + N+ L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPL----LEYLG---VSNNQLE-KL-PELQNSSFLK 156
Query: 461 GILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGE 520
I ++ N+ ++P +L + N+ LP + L L + N +
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-K 209
Query: 521 LPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQ 580
LP SL + N L PEL NL LT++ +NLL +P L+
Sbjct: 210 LPDLPLSLE---SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE--A 261
Query: 581 FNISHNKL 588
N+ N L
Sbjct: 262 LNVRDNYL 269
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 79/420 (18%), Positives = 150/420 (35%), Gaps = 78/420 (18%)
Query: 171 LKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANL 230
L ++ + P +L E L + + L + L A
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD---VVTQEELESITKLVVAG-EK 55
Query: 231 IGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLT 290
+ I I L L L+L+ N ++ P S L + + + N+++ +L NLT
Sbjct: 56 VASIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 291 TLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSF 349
L L ++++N++ +A + + SLNL N+ L++ L L + +
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167
Query: 350 SGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECK 409
+ ++L ++ N+++ I +
Sbjct: 168 KD--VTPIANLTDLYSLSLN--------------YNQIEDISPLAS------------LT 199
Query: 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNF 469
+L+Y N++ ++N +L + I N
Sbjct: 200 SLHYFTAYVNQITD--------------------------ITPVANMTRLNSLKIGNNKI 233
Query: 470 TGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529
T S + L QL +++ N+ S + L KL+ L + N + LN+L+
Sbjct: 234 TD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLS 287
Query: 530 ALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLE-LTKLKLNQFNISHNKL 588
L L L+ NQL +G L LT+L LS N +T PL L+K+ + ++ +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMD--SADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-42
Identities = 76/421 (18%), Positives = 147/421 (34%), Gaps = 77/421 (18%)
Query: 147 LQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLK 206
L + I L ++ ++ L +T + +
Sbjct: 2 AATLATLPAPIN-QI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 207 SSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLA 266
S + L+ LE L N I +I + L L+NL + N ++ + L
Sbjct: 58 S---IQGIEYLTNLEYLNLNG-NQITDIS-PLSNLVKLTNLYIGTNKIT--DISALQNLT 110
Query: 267 SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYF 325
++ ++ L ++ +S L+NLT + L++ N+ + ++ M L L + ++
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKV 167
Query: 326 TGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRN 385
P +A+ +L L L N L ++L YF N
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAY--------------VN 209
Query: 386 KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRF 445
++ I N LN L+ G N++
Sbjct: 210 QITDITPVAN------------MTRLNSLKIGNNKITD---------------------- 235
Query: 446 EGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLN 505
++N +LT + I N + + + L +L+ +++ N+ S + + L+
Sbjct: 236 ----LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLS 287
Query: 506 KLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLL 565
+L L L N E + LT L L LS N +T P L +L+ + S D ++ ++
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
Query: 566 T 566
Sbjct: 346 K 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 75/377 (19%), Positives = 139/377 (36%), Gaps = 37/377 (9%)
Query: 123 LQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS 182
LA I ++ + + A L + + + + + L + G ++
Sbjct: 2 AATLATLPAP-INQIFPDA-DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 183 GLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLA 242
+ + LT L + L N + + NL KL NL+ N I +I ++ L
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITDIS---PLSNLVKLTNLYIGT-NKITDIS-ALQNLT 110
Query: 243 FLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNL 302
L L L+++ +S P + L + + L N LSN+T L L ++++ +
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167
Query: 303 T-----GNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL 357
NL L SL+LN N P LAS +L + N + +
Sbjct: 168 KDVTPIANLT------DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPV 217
Query: 358 GKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFG 417
+ L + N T P L ++L + I N+ S + + L L G
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVG 273
Query: 418 GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQI 477
N++ S L +++ + NN+ I LT + ++ N+ T P +
Sbjct: 274 SNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--L 329
Query: 478 CTLRQLQAVDLSQNRFS 494
+L ++ + D +
Sbjct: 330 ASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-38
Identities = 63/296 (21%), Positives = 124/296 (41%), Gaps = 24/296 (8%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
++L+G ++ + + L NL + N +L +L+ L L+ + I +
Sbjct: 71 LNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT---DISALQNLTNLRELYLNED-NISD 124
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELT 196
+ + + L+L N+ D+ L L + + + + P + NLT+L
Sbjct: 125 ISPLA-NLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLY 180
Query: 197 HFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG 256
L YN ++ S + +L+ L A N I +I + + L++L + +N ++
Sbjct: 181 SLSLNYNQIEDI---SPLASLTSLHYFTAYV-NQITDIT-PVANMTRLNSLKIGNNKITD 235
Query: 257 KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SL 315
P + L+ + +E+ NQ+S ++ +LT L L++ N ++ + + L
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289
Query: 316 ESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTN 371
SL LN+N E E + NL L L N + P L S ++ D +
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 65/351 (18%), Positives = 119/351 (33%), Gaps = 58/351 (16%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+ ++G ++ G + L LNL+ N I +
Sbjct: 49 LVVAGEKVAS--IQGIEYLTNLEYLNLNGNQ--------------------------ITD 80
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELT 196
+ S L L + N + + L+ L L + +S + P L NLT++
Sbjct: 81 ISPLSN-LVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMY 135
Query: 197 HFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG 256
LG N S S + N++ L L + + + ++ I L L +L L+ N +
Sbjct: 136 SLNLGANHNLS--DLSPLSNMTGLNYLTVTE-SKVKDVT-PIANLTDLYSLSLNYNQIED 191
Query: 257 KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT-----GNLPETIA 311
P + L S+ + NQ++ ++N+T L L I N +T NL
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPLANLS---- 243
Query: 312 AMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTN 371
L L + N + ++ L L + +N S L S L ++ N
Sbjct: 244 --QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNN 297
Query: 372 DFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQ 422
E + L + + N + P ++ F ++
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-41
Identities = 60/367 (16%), Positives = 116/367 (31%), Gaps = 52/367 (14%)
Query: 213 SVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIE 272
+ S ENL+ + + D + + N D + + + +S + QIE
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----NNPQIE 61
Query: 273 LFDNQLSGELPESLSNLT--TLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEI 329
+ + L + T + L++ L P+ + L+ + ++ E+
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 330 PESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQC 389
P+++ L L L N LP + + L + ELP L
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA------- 171
Query: 390 IIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSI 449
S + L LR ++ LP+
Sbjct: 172 --------STDASGEHQGLVNLQSLRLEWTGIR-SLPA---------------------- 200
Query: 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQ 509
SI+N L + I + + + I L +L+ +DL + P L++
Sbjct: 201 --SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257
Query: 510 LELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEI 569
L L++ LP +++ LT L L+L +P + L + + +L
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317
Query: 570 PLELTKL 576
Sbjct: 318 QHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 59/398 (14%), Positives = 108/398 (27%), Gaps = 71/398 (17%)
Query: 134 IGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLT 193
+G + + L + + ++ + N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56
Query: 194 ELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNF 253
LK++ L + + PD +L+ L ++ +
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRS-VPLPQFPDQAFRLSHLQHMTIDAAG 115
Query: 254 LSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM 313
L ++P + A +E + L N L LP S+++L L L I LPE +A+
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
NL L+L LP + NL+ + +
Sbjct: 174 DA--------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218
Query: 374 TGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLP 433
+ L + KL+ + + P +G L L
Sbjct: 219 S-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL------------------- 258
Query: 434 EVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRF 493
IL + +N +P I L QL+ +DL
Sbjct: 259 ----------------------------ILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVN 289
Query: 494 SGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL 531
LP+ I QL + + ++ + A
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 61/263 (23%), Positives = 100/263 (38%), Gaps = 26/263 (9%)
Query: 91 GFCRIRTLRNLNLSDNYFNGTLSS--QSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
L L L HLQ + +D + ELPD ++FA L+
Sbjct: 76 EDATQPGRVALELRSVP----LPQFPDQAFRLSHLQHMTIDAA-GLMELPDTMQQFAGLE 130
Query: 149 VLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGN---------LTELTHFE 199
L L+RN +P S L+ L++ +P L + L L
Sbjct: 131 TLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLR 189
Query: 200 LGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP 259
L + ++S LP+S+ NL L++L + + + +I L L LDL P
Sbjct: 190 LEWTGIRS--LPASIANLQNLKSLKIRN-SPLSALGPAIHHLPKLEELDLRGCTALRNYP 246
Query: 260 HSFSGLASIEQIELFD-NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLES 317
F G A ++++ L D + L LP + LT L +LD+ LP IA + +
Sbjct: 247 PIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
Query: 318 LNLNDNYFTG---EIPESLASNP 337
+ + + P + + P
Sbjct: 306 ILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 49/341 (14%), Positives = 94/341 (27%), Gaps = 75/341 (21%)
Query: 259 PHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESL 318
H + E + + + LS D ++ + + +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQI 60
Query: 319 NLNDNYFTGEIPESL--ASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE 376
+ L A+ P V L+L + + PD + S+L++ +
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-- 117
Query: 377 LPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVD 436
++P++ + L L N L+ LP
Sbjct: 118 -----------------------ELPDTMQQFAGLETLTLARNPLR-ALP---------- 143
Query: 437 FFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGH 496
SI++ +L + I E+P + +
Sbjct: 144 --------------ASIASLNRLRELSIRACPELTELPEPLASTD--------------- 174
Query: 497 LPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLT 556
L LQ L L+ LP ++ +L L L + + L+ + P + +L L
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232
Query: 557 SLDLSSNLLTGEIPLELTKLK-LNQFNISHNKLYGEVPSDF 596
LDL P L + + +P D
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 64/308 (20%), Positives = 119/308 (38%), Gaps = 17/308 (5%)
Query: 123 LQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS 182
++ + + L + N++ LDLS N S F L++LNL N+L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 183 GLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLA 242
+ L +L+ L +L N + + +E L AA N I + S G+
Sbjct: 72 ETLD--LESLSTLRTLDLNNNYV------QELLVGPSIETLHAAN-NNISRVSCSRGQG- 121
Query: 243 FLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSG-ELPESLSNLTTLLRLDISQNN 301
N+ L++N ++ + ++ ++L N++ E ++ TL L++ N
Sbjct: 122 -KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYS 361
+ ++ + L++L+L+ N + S + + L NN + L
Sbjct: 181 IY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 362 NLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNEL 421
NLE+FD+ N F R F + + K+ E T+ L G
Sbjct: 238 NLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYC 295
Query: 422 QGELPSKF 429
+LP+ F
Sbjct: 296 CEDLPAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 54/313 (17%), Positives = 104/313 (33%), Gaps = 30/313 (9%)
Query: 78 DLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL 137
++ L + ++ L+LS N + +S+ L+P L++L L N + E
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSN-VLYET 73
Query: 138 PDFSREFANLQVLDLSRNNFSGDIPE-----------------SFGRFPVLKVLNLGGNL 180
D + L+ LDL+ N ++ S R K + L N
Sbjct: 74 LDLES-LSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNK 131
Query: 181 LSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGK 240
++ L G + + + +L N + + + LE+L N I ++ +
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY-NFIYDVKGQVV- 189
Query: 241 LAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQN 300
A L LDLS N L+ + F A + I L +N+L + ++L L D+ N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 301 NLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKY 360
+ + + ++ + L + LP
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA-- 304
Query: 361 SNLEYFDVSTNDF 373
+ +
Sbjct: 305 --DRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 51/337 (15%), Positives = 100/337 (29%), Gaps = 41/337 (12%)
Query: 282 LPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLV 340
+ E N ++ ++L L + +++ L+L+ N + LA L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 341 QLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGK 400
L L +N DL S L D++ N +Q +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLN--------------NNYVQEL---------- 95
Query: 401 IPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLT 460
++ L N + S+ G + + NN+ ++
Sbjct: 96 -----LVGPSIETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQ 147
Query: 461 GILINGNNFTG-EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG 519
+ + N + L+ ++L N + + KL+ L+L N
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA- 204
Query: 520 ELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLN 579
+ S + ++L N+L I L L DL N L K
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQ 262
Query: 580 QFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDL 616
+ + ++ + + + +L C DL
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 28/145 (19%), Positives = 57/145 (39%), Gaps = 17/145 (11%)
Query: 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKL 507
+I N + + ++ + S + ++ +DLS N S + KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567
+ L L N+ E +L SL+ L L+L+ N + EL + +L ++N ++
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 568 EIPLE----LTKLKLNQFNISHNKL 588
+ + L ++NK+
Sbjct: 113 RVSCSRGQGKKNIYL-----ANNKI 132
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-39
Identities = 85/401 (21%), Positives = 140/401 (34%), Gaps = 48/401 (11%)
Query: 120 CFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179
VL + + + LPD A++ L + NN + +P L+ L + GN
Sbjct: 39 NNGNAVLNVGES-GLTTLPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIG 239
L+ L P L EL+ F L + P S L LW N + +P
Sbjct: 92 QLTSL-PVLPPGLLELSIFSNPLTHLPALP--------SGLCKLWIFG-NQLTSLPVLPP 141
Query: 240 KLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQ 299
L L +SDN L+ +P S L ++ ++NQL+ LP S L L +S
Sbjct: 142 G---LQELSVSDNQLA-SLPALPSEL---CKLWAYNNQLT-SLPMLPSGLQE---LSVSD 190
Query: 300 NNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGK 359
N L +LP + L L +N T +P L +L + N + LP
Sbjct: 191 NQLA-SLPTLPS--ELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLPS- 241
Query: 360 YSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGN 419
L+ VS N T LP L + ++ N+ + ++PES + + GN
Sbjct: 242 --ELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 420 ELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICT 479
L + + RF+ + + + L L + +
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAADWLVPAREGEPAP 352
Query: 480 LRQLQAVDLSQN--RFSGHLPTCITQLNKLQQLELQENMFT 518
+ N FS L N ++ + + +
Sbjct: 353 ADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISS 393
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 5e-33
Identities = 76/372 (20%), Positives = 129/372 (34%), Gaps = 74/372 (19%)
Query: 244 LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT 303
+ L++ ++ L+ +P A I + + DN L+ LP L TL ++S N LT
Sbjct: 42 NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT 94
Query: 304 GNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSN 362
+LP + L + +P L +L +F N + LP
Sbjct: 95 -SLPVLPPGLLELSIFSNPLT----HLPALP---SGLCKLWIFGNQLT-SLPVLPP---G 142
Query: 363 LEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQ 422
L+ VS N LP +L + +NN+ + +P L L N+L
Sbjct: 143 LQELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLA 194
Query: 423 GELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQ 482
S+ S L + N T +P+ L++
Sbjct: 195 -------------------------SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLKE 225
Query: 483 LQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLT 542
L +S NR + LP ++L ++L + N T LP + L L++ NQLT
Sbjct: 226 L---IVSGNRLT-SLPVLPSEL---KELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT 274
Query: 543 GTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKL-----NQFNISHNKLYGEVPSDFD 597
+P L +L+ T+++L N L+ L ++
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA 333
Query: 598 HDLFISSLLDNP 609
L + L
Sbjct: 334 LHLAAADWLVPA 345
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 64/258 (24%), Positives = 99/258 (38%), Gaps = 42/258 (16%)
Query: 95 IRTLRNLNLSDNYFNGTLSS--QSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDL 152
LR L +S N L+S L + + + LP L L +
Sbjct: 80 PPELRTLEVSGNQ----LTSLPVLPPGLLELSIFSNPLT-HLPALPS------GLCKLWI 128
Query: 153 SRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPS 212
N + +P L+ L++ N L+ L P+ L +L N L S LP
Sbjct: 129 FGNQLT-SLPVLPPG---LQELSVSDNQLASL-PALPSELCKLW---AYNNQLTS--LPM 178
Query: 213 SVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIE 272
L +L N + +P + L L +N L+ +P SGL +++
Sbjct: 179 LPSGLQELS----VSDNQLASLPTLPSE---LYKLWAYNNRLT-SLPALPSGL---KELI 227
Query: 273 LFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPES 332
+ N+L+ LP S L L +S N LT +LP + L SL++ N T +PES
Sbjct: 228 VSGNRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLPS--GLLSLSVYRNQLT-RLPES 279
Query: 333 LASNPNLVQLKLFNNSFS 350
L + + L N S
Sbjct: 280 LIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 68/347 (19%), Positives = 114/347 (32%), Gaps = 56/347 (16%)
Query: 88 FPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANL 147
P + L + + S L L + N +L L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPALPSG--------LCKLWIFGN----QLTSLPVLPPGL 143
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207
Q L +S N + +P L L N L+ L P L EL+ + N L S
Sbjct: 144 QELSVSDNQLA-SLPALPSE---LCKLWAYNNQLTSL-PMLPSGLQELS---VSDNQLAS 195
Query: 208 SPLPSSVGNLSKL-----------------ENLWAAKANLIGEIPDSIGKLAFLSNLDLS 250
LP+ L KL + L + N + +P +L L +S
Sbjct: 196 --LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSG-NRLTSLPVLPSEL---KELMVS 249
Query: 251 DNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETI 310
N L+ +P SGL + ++ NQL+ LPESL +L++ +++ N L+
Sbjct: 250 GNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQA 303
Query: 311 AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVST 370
+ S + AS P + L + +P G+ + + + +
Sbjct: 304 -LREITSAPGYSGPII-RFDMAGASAPRETRA-LHLAAADWLVPAREGEPAPADRWHMFG 360
Query: 371 NDFTGELPRFLCFRNKLQCIIIFNNR--FSGKIPESYGECKTLNYLR 415
+ F F ++L F F +I + LR
Sbjct: 361 QE--DNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEALR 405
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 18/61 (29%), Positives = 29/61 (47%), Gaps = 6/61 (9%)
Query: 528 LTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNK 587
VLN+ + LT T+P L +T+L + N LT +P +L+ +S N+
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPALPPELR--TLEVSGNQ 92
Query: 588 L 588
L
Sbjct: 93 L 93
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IG G VYK + ++ VA L F+ E E L ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 748 C----CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
G+ +LV E M +G+L L R + + S + KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 804 VPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
P I+HRD+K NI + ++ D GLA ++ ++ V G+ ++APE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA------VIGTPEFMAPEM- 201
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y +K E DVY+FG+ ++E+ T + P
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLL 746
+G GG VY + VA+K + K ET F E+ ++ H N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
D LV EY+ +L++ + G L + G+ + H+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---R 131
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
IVHRD+K NIL+D+ ++ DFG+AKAL + V G+ Y +PE A +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH---VLGTVQYFSPEQAKGEA 188
Query: 867 VTEKSDVYSFGVVLMELVTGKRP 889
E +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLL 746
++G GG V+ + L+ VAVK L P FR E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 747 MCCSGQDFNI------LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
+G+ +V EY+ +L D++H +G + + A + L + H
Sbjct: 79 D--TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
+ I+HRDVK NI++ A +V DFG+A+A+ + G S + V G+ Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTAQYLSPE 189
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
A V +SDVYS G VL E++TG+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-37
Identities = 88/463 (19%), Positives = 156/463 (33%), Gaps = 46/463 (9%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
+L++S+N S L++L + N + L S EL + +L +N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDS--IGKLAFLSNLDLSDNFLSGKIPHSF 262
L L++L + N +P G ++ L L LS L
Sbjct: 81 LVKISC----HPTVNLKHLDLS-FNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 263 SGLASIE-QIELFDNQLSGELPESLSNLTTL-LRLDISQNNLTGNLPETIAAMSLE---- 316
+ L + + L + E PE L + T L + N + +
Sbjct: 136 AHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 317 ----SLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGK---YSNLEYFDVS 369
L N + I L +NP L L L N + + + ++ + YF +S
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 370 TNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKF 429
G S K L+ + + +
Sbjct: 256 NVKLQG-------------------QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 430 WGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLS 489
++ + S + + N T V L +L+ + L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 490 QNRFS--GHLPTCITQLNKLQQLELQENMFTGELPRNL-NSLTALIVLNLSTNQLTGTIP 546
N+ + TQ+ LQQL++ +N + + + + +L+ LN+S+N LT TI
Sbjct: 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 547 PELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKL 588
L + LDL SN + IP ++ KL L + N++ N+L
Sbjct: 417 RCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-32
Identities = 78/503 (15%), Positives = 168/503 (33%), Gaps = 58/503 (11%)
Query: 73 SVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNV 132
+++S +S + + + LR L +S N L L+ L L +N
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN- 79
Query: 133 FIGELPDFSREFANLQVLDLSRNNFSGDIPES--FGRFPVLKVLNLGGNLLSGLIPSFLG 190
+ ++ NL+ LDLS N F +P FG LK L L L +
Sbjct: 80 KLVKIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 191 NLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLS 250
+L + P L + I ++ + +L
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEG---LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 251 DNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETI 310
+ + + F + L+ + TL ++ + N+ + + +
Sbjct: 194 --------LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLV 244
Query: 311 AAMSLESLNLNDNYFTGEIPESLASNPN-----LVQLKLFNNSFSGKLPDDLGKYSNLEY 365
++ ++++ G++ L ++ ++ F +SN+
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 366 FDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGEL 425
+ + + + LC +L F N L +
Sbjct: 305 KNFTVSGTR--MVHMLCPSK----------------------ISPFLHLDFSNNLLTDTV 340
Query: 426 PSKFWGLPEVDFFEMYNNRFEGSISPSIS---NAPKLTGILINGNNFTGEVPSQICT-LR 481
L E++ + N+ + +S L + I+ N+ + + C+ +
Sbjct: 341 FENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 482 QLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQL 541
L ++++S N + + C+ +++ L+L N +P+ + L AL LN+++NQL
Sbjct: 400 SLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
Query: 542 TGTIPPE-LGNLAVLTSLDLSSN 563
++P L L + L +N
Sbjct: 457 K-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 48/280 (17%), Positives = 105/280 (37%), Gaps = 14/280 (5%)
Query: 54 TSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLS 113
+ S + N +++ I+ + T+ ++S+ G L
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ--LVWHTTVWYFSISNVKLQGQLD 264
Query: 114 SQSLSPCFH----LQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFP 169
+ L + + +VF F+N+ + + + + +
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 170 VLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSV-GNLSKLENLWAAKA 228
L+ NLL+ + G+LTEL L N LK + + + L+ L ++
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384
Query: 229 NLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLS 287
++ + L +L++S N L+ I I+ ++L N++ +P+ +
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVV 441
Query: 288 NLTTLLRLDISQNNLTGNLPETIAA--MSLESLNLNDNYF 325
L L L+++ N L ++P+ I SL+ + L+ N +
Sbjct: 442 KLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN--VVKL 745
IGSGGS +V++V + + A+K + +T +R+EI L +++ + +++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ +V E N L L +K +D R S + + + +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE----- 860
IVH D+K N L+ M+ ++ DFG+A +Q G+ Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 203
Query: 861 ------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
K++ KSDV+S G +L + GK P
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-37
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN--VVKL 745
IGSGGS +V++V + + A+K + +T +R+EI L +++ + +++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ +V E N L L +K +D R S + + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE----- 860
IVH D+K N L+ M+ ++ DFG+A +Q G+ Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184
Query: 861 ------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
K++ KSDV+S G +L + GK P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-37
Identities = 70/296 (23%), Positives = 119/296 (40%), Gaps = 47/296 (15%)
Query: 681 LPH--LTEQNLIGSGGSCRVYKVKLKSGET-VAVKRLLGGTHKPETETVFRSEIETLGRV 737
L H L IG G V+ +L++ T VAVK F E L +
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQY 169
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H N+V+L+ C+ + +V E + G L +G + ++ AA G+
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM--VGDAAAGME 227
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
YL + C +HRD+ + N L+ + V +++DFG+++ D + +G +
Sbjct: 228 YLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREE-------ADGVYAASGGLRQV 277
Query: 858 -----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-LS 910
APE + + +SDV+SFG++L E + G P P+ N+ +V + L
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY-PNL-SNQQTREFVEKGGRLP 335
Query: 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
PE C + +L+ C + P RPS + + L
Sbjct: 336 CPE-LCPDAVFRLM---------------------EQCWAYEPGQRPSFSTIYQEL 369
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN--VVKL 745
IGSGGS +V++V + + A+K + +T +R+EI L +++ + +++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ +V E N L L +K +D R S + + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE----- 860
IVH D+K N L+ M+ ++ DFG+A +Q G+ Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231
Query: 861 ------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
K++ KSDV+S G +L + GK P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-36
Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 43/289 (14%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L + +G+G V+ VAVK + G+ E F +E + ++H +
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKL 245
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
VKL + + I + E+M GSL D L S + A+G+A++
Sbjct: 246 VKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI---AP 859
+HRD+++ NIL+ A +V ++ADFGLA+ ++ D+ + G+ I AP
Sbjct: 304 N---YIHRDLRAANILVSASLVCKIADFGLARVIE------DNEYTAREGAKFPIKWTAP 354
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA-TLSSPERGCC 917
E T KSDV+SFG++LME+VT G+ P P N +++R + + PE C
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGM-SNPEVIRALERGYRMPRPE-NCP 411
Query: 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+L + M + C + P RP+ + +L
Sbjct: 412 EELYNI----M-----------------MRCWKNRPEERPTFEYIQSVL 439
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-36
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 37/287 (12%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGET-VAVKRLLGGTHKPETETVFRSEIETLGRVRHGN 741
+T ++ +G G VY+ K VAVK L T + E F E + ++H N
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPN 277
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+V+LL C+ + ++ E+M G+L D L E R + + +A + + YL
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEK 336
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
+HR++ + N L+ + +VADFGL++ + + + APE
Sbjct: 337 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPES 390
Query: 862 AYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA-TLSSPERGCCRD 919
K + KSDV++FGV+L E+ T G P P + + + + + PE GC
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGI-DLSQVYELLEKDYRMERPE-GCPEK 447
Query: 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ +L M C P +RPS + +
Sbjct: 448 VYEL----M-----------------RACWQWNPSDRPSFAEIHQAF 473
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETETVFRSEIETLGRVRHGNVVKLL 746
L+G GG VY+ + VA+K + + P T + E T GR++ +VV +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 747 MCCSGQDFNI--LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
G+ + + LA ML +G L +I + L H
Sbjct: 101 D--FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
HRDVK NIL+ A+ + DFG+A A + E + G+ Y+APE
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGN--TVGTLYYMAPERFSE 209
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRP 889
T ++D+Y+ VL E +TG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 47/291 (16%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
LT IGSG V+ + + VA+K + G E F E E + ++ H +
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---FIEEAEVMMKLSHPKL 65
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL--H 800
V+L C Q LV E+M +G L+D L + + G + +G+AYL
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI--- 857
++HRD+ + N L+ V +V+DFG+ + + DD + G+ +
Sbjct: 124 C-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL------DDQYTSSTGTKFPVKWA 172
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-LSSPERG 915
+PE + + KSDV+SFGV++ E+ + GK P + N ++V ++ L P
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENR-SNSEVVEDISTGFRLYKPR-L 229
Query: 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ Q+ M C + P +RP+ R++ L
Sbjct: 230 ASTHVYQI----M-----------------NHCWRERPEDRPAFSRLLRQL 259
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 31/227 (13%)
Query: 683 HLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN 741
H +G GG V V+ L G A+KR+L H+ + + E + H N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPN 87
Query: 742 VVKLLMCCSGQDFN----ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQG 791
+++L+ C + L+ + G+L + + G+ + + G
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN-----FLTEDQILWLLLG 142
Query: 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851
+GL +H HRD+K NILL E P + D G S A++
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 852 -----GSYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ Y APE ++ + E++DV+S G VL ++ G+ P
Sbjct: 200 WAAQRCTISYRAPELFSVQSH-CVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 82/286 (28%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L + +G G V+ VA+K L GT PE F E + + ++RH +
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKL 241
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V+L S + I V EYM GSL D L + L +A A G+AY+
Sbjct: 242 VQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM 299
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
VHRD+++ NIL+ +V +VADFGLA+ ++ E + + APE A
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWTAPEAA 353
Query: 863 YTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA-TLSSPERGCCRDL 920
+ T KSDV+SFG++L EL T G+ P P N++++ V + P C L
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPY-PGM-VNREVLDQVERGYRMPCPP-ECPESL 410
Query: 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ L M C P RP+ + L
Sbjct: 411 HDL----M-----------------CQCWRKEPEERPTFEYLQAFL 435
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 62/302 (20%)
Query: 683 HLTEQNLIGSG--GSCRVYKVKLKSGE-----TVAVKRLLGGTHKPETETVFRSEIETLG 735
+ ++GSG G+ VYK VA+K L T + E +
Sbjct: 16 EFKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMA 72
Query: 736 RVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
V + +V +LL C + + + MP G L D + E ++ + AKG
Sbjct: 73 SVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKG 129
Query: 796 LAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
+ YL +VHRD+ + N+L+ ++ DFGLAK L ++E
Sbjct: 130 MNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-------KEYHAE 177
Query: 854 YGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE--NKDIVRWVT 905
G + A E + T +SDV+S+GV + EL+T G +P + +I +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILE 233
Query: 906 EAT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964
+ L P C D+ + M C +RP R ++
Sbjct: 234 KGERLPQPP-ICTIDVYMI----M-----------------RKCWMIDADSRPKFRELII 271
Query: 965 LL 966
Sbjct: 272 EF 273
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 21/232 (9%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLK-----SGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
L +G G +V + +GE VAVK L + EIE L +
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNL 80
Query: 738 RHGNVVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
H N+VK C+ N L+ E++P+GSL + L ++ + A KG
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG---QSDDAMSCVAG 852
+ YL + VHRD+ + N+L+++E ++ DFGL KA+++ + DD S V
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRW 903
+ APE K SDV+SFGV L EL+T + P K I
Sbjct: 195 ---WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-35
Identities = 79/292 (27%), Positives = 120/292 (41%), Gaps = 53/292 (18%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L IG G V + G VAVK + T F +E + ++RH N+
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNL 248
Query: 743 VKLLMCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
V+LL + + +V EYM GSL D L +GRS L + + + YL
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEG 307
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI---- 857
+ VHRD+ + N+L+ + V +V+DFGL K S G +
Sbjct: 308 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS------------TQDTGKLPVKW 352
Query: 858 -APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-LSSPER 914
APE KK + KSDV+SFG++L E+ + G+ P P KD+V V + + +P+
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRI-PLKDVVPRVEKGYKMDAPD- 409
Query: 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
GC + + M C RP+ ++ E L
Sbjct: 410 GCPPAVYDV----M-----------------KNCWHLDAATRPTFLQLREQL 440
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 72/229 (31%), Positives = 103/229 (44%), Gaps = 22/229 (9%)
Query: 683 HLTEQNLIGSG--GS---CRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
HL +G G GS CR ++ +GE VAVK+L T + + F EIE L +
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSL 68
Query: 738 RHGNVVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
+H N+VK C L+ EY+P GSL D L + +D KG
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKG 126
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ---SDDAMSCVAG 852
+ YL +HRD+ + NIL++ E ++ DFGL K L + + S +
Sbjct: 127 MEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF- 182
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDI 900
+ APE K + SDV+SFGVVL EL T ++ P + I
Sbjct: 183 ---WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 5e-35
Identities = 69/287 (24%), Positives = 109/287 (37%), Gaps = 27/287 (9%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL-- 746
+G+GG V + +GE VA+K+ E EI+ + ++ H NVV
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREV 80
Query: 747 ----MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
+ D +L EY G L L++ L ++ + L YLH +
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 803 CVPAIVHRDVKSHNILLDAE---MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
I+HRD+K NI+L ++ ++ D G AK L + + G+ Y+AP
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-----GELCTEFVGTLQYLAP 192
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP----NDPSFGENKDIVRWVTEATLSSPERG 915
E KK T D +SFG + E +TG RP P K + + G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRV 962
+ + L P LS + E+ L M R + +
Sbjct: 253 AVKFSSVLPTPN-HLSGILAGKLERWL--QCMLMWH-QRQRGTDPQN 295
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
+ + +IGSG S V +L+ VA+K L G + + F SE +G+
Sbjct: 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFD 108
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H N+++L + ++V EYM NGSL L + G + +G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 799 L--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
L VHRD+ + N+L+D+ +V +V+DFGL++ L+ DD + + G
Sbjct: 167 LSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE------DDPDAAYTTTGGK 215
Query: 857 I-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE--NKDIVRWVTEAT 908
I APE + + SDV+SFGVV+ E++ G+RP + N+D++ V E
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP----YWNMTNRDVISSVEEGY 271
Query: 909 -LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
L +P GC L+QL M L C RP ++V +L
Sbjct: 272 RLPAPM-GCPHALHQL----M-----------------LDCWHKDRAQRPRFSQIVSVL 308
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 81/294 (27%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L IG G V + G VAVK + T F +E + ++RH N+
Sbjct: 22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNL 76
Query: 743 VKLLMCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL-- 799
V+LL + + +V EYM GSL D L +GRS L + + + YL
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEG 135
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI-- 857
+N VHRD+ + N+L+ + V +V+DFGL K S G +
Sbjct: 136 NN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS------------TQDTGKLPV 178
Query: 858 ---APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-LSSP 912
APE KK + KSDV+SFG++L E+ + G+ P P KD+V V + + +P
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRI-PLKDVVPRVEKGYKMDAP 236
Query: 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ GC + ++ M C RPS ++ E L
Sbjct: 237 D-GCPPAVYEV----M-----------------KNCWHLDAAMRPSFLQLREQL 268
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L +G+G V+ VAVK L G+ P+ F +E + +++H +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRL 70
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL--H 800
V+L + + I + EYM NGSL D L L + +A A+G+A++
Sbjct: 71 VRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEER 128
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI--- 857
N +HRD+++ NIL+ + ++ADFGLA+ ++ D+ + G+ I
Sbjct: 129 N-----YIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEYTAREGAKFPIKWT 177
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
APE T KSDV+SFG++L E+VT G+ P
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 685 TEQNLIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
T Q +G G V++ ++G AVK++ E E+ + +V
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIV 113
Query: 744 KLL-MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS-IRFSIAQGAAKGLAYLHN 801
L G NI E + GSL ++ + G L + + Q A +GL YLH
Sbjct: 114 PLYGAVREGPWVNI-FMELLEGGSLGQLIKQMGC---LPEDRALYYLGQ-ALEGLEYLHT 168
Query: 802 DCVPAIVHRDVKSHNILLDAEMVP-RVADFGLAKALQ-SQEGQSDDAMSCVAGSYGYIAP 859
I+H DVK+ N+LL ++ + DFG A LQ G+S + G+ ++AP
Sbjct: 169 RR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E K K D++S +++ ++ G P
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 47/292 (16%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGET-VAVKRLLGGTHKPETETVFRSEIETLGRVRHGN 741
+T ++ +G G VY+ K VAVK L T + E F E + ++H N
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPN 70
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL-- 799
+V+LL C+ + ++ E+M G+L D L E R + + +A + + YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 129
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS---YGY 856
N +HRD+ + N L+ + +VADFGL++ + D + AG+ +
Sbjct: 130 KN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT------GDTYTAHAGAKFPIKW 178
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-LSSPER 914
APE K + KSDV++FGV+L E+ T G P P + + + + + PE
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGI-DLSQVYELLEKDYRMERPE- 235
Query: 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
GC + +L M C P +RPS + +
Sbjct: 236 GCPEKVYEL----M-----------------RACWQWNPSDRPSFAEIHQAF 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 73/231 (31%), Positives = 100/231 (43%), Gaps = 26/231 (11%)
Query: 683 HLTEQNLIGSG--GS---CRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
HL +G G GS CR ++ +GE VAVK+L T + + F EIE L +
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSL 99
Query: 738 RHGNVVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
+H N+VK C L+ EY+P GSL D L + +D KG
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKG 157
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
+ YL +HRD+ + NIL++ E ++ DFGL K L D G
Sbjct: 158 MEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP------QDKEYYKVKEPG 208
Query: 856 YI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDI 900
APE K + SDV+SFGVVL EL T ++ P + I
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 70/291 (24%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
+T +GSG V K K VAVK + G+ + F E +T+ ++ H +
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE---FFQEAQTMMKLSHPKL 65
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL--H 800
VK CS + +V EY+ NG L + L G+ + +G+A+L H
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFLESH 123
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI--- 857
+HRD+ + N L+D ++ +V+DFG+ + + DD G+ +
Sbjct: 124 Q-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL------DDQYVSSVGTKFPVKWS 172
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-LSSPERG 915
APE + K + KSDV++FG+++ E+ + GK P + N ++V V++ L P
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY-DLY-TNSEVVLKVSQGHRLYRPH-L 229
Query: 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ Q+ M C + P RP+ ++++ +
Sbjct: 230 ASDTIYQI----M-----------------YSCWHELPEKRPTFQQLLSSI 259
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 82/286 (28%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L + +G G V+ VA+K L GT PE F E + + ++RH +
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKL 324
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V+L S + I V EYM GSL D L + L +A A G+AY+
Sbjct: 325 VQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM 382
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
VHRD+++ NIL+ +V +VADFGLA+ ++ E + + APE A
Sbjct: 383 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWTAPEAA 436
Query: 863 YTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA-TLSSPERGCCRDL 920
+ T KSDV+SFG++L EL T G+ P P N++++ V + P C L
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPY-PGM-VNREVLDQVERGYRMPCPP-ECPESL 493
Query: 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ L M C P RP+ + L
Sbjct: 494 HDL----M-----------------CQCWRKEPEERPTFEYLQAFL 518
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 72/224 (32%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 683 HLTEQNLIGSG--GS---CRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
HL + +G G GS CR + +G VAVK+L P+ + F+ EI+ L +
Sbjct: 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKAL 81
Query: 738 RHGNVVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
+VK G LV EY+P+G L D L + LD S + KG
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKG 139
Query: 796 LAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ---SDDAMSCV 850
+ YL VHRD+ + NIL+++E ++ADFGLAK L + + S +
Sbjct: 140 MEYLGSRR-----CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 851 AGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPS 893
+ APE + +SDV+SFGVVL EL T + PS
Sbjct: 195 F----WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 65/259 (25%), Positives = 112/259 (43%), Gaps = 26/259 (10%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
++G G + V++ + K +G+ A+K + + R E E L ++ H N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 748 C--CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ +L+ E+ P GSL +L E + L S + + G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 806 AIVHRDVKSHNILL----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE- 860
IVHR++K NI+ D + V ++ DFG A+ L+ D+ + G+ Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----DEQFVSLYGTEEYLHPDM 186
Query: 861 -------YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG--ENKDIVRWVTEATLSS 911
+ KK D++S GV TG P P G NK+++ + S
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 912 PERGCCRDLNQLIDPRMDL 930
G + N ID D+
Sbjct: 247 AISGVQKAENGPIDWSGDM 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 66/294 (22%), Positives = 119/294 (40%), Gaps = 59/294 (20%)
Query: 690 IGSG--GSCRVYKVKLKSGE---TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+G G GS V + + + VA+K L GT + E + + ++ + +V+
Sbjct: 18 LGCGNFGS--VRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVR 74
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL--HND 802
L+ C + + V E G L L G+ + S + + G+ YL N
Sbjct: 75 LIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI----- 857
VHRD+ + N+LL +++DFGL+KAL + + A S G
Sbjct: 131 ----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY------TARSAGKWPLKWY 180
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE--NKDIVRWVTEAT-LSSPE 913
APE +K + +SDV+S+GV + E ++ G++P + + +++ ++ + + P
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGKRMECPP 236
Query: 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
C +L L M C +RP V + +R
Sbjct: 237 -ECPPELYAL----M-----------------SDCWIYKWEDRPDFLTVEQRMR 268
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 62/291 (21%), Positives = 115/291 (39%), Gaps = 47/291 (16%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
LT +G+G V K + VA+K + G+ + F E + + + H +
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLSHEKL 81
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL--H 800
V+L C+ Q ++ EYM NG L + L + + + + + YL
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI--- 857
+HRD+ + N L++ + V +V+DFGL++ + DD + GS +
Sbjct: 140 Q-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL------DDEYTSSVGSKFPVRWS 188
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-LSSPERG 915
PE K + KSD+++FGV++ E+ + GK P F N + + + L P
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-ERF-TNSETAEHIAQGLRLYRPH-L 245
Query: 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
+ + M C + RP+ + ++ +
Sbjct: 246 ASEKVYTI----M-----------------YSCWHEKADERPTFKILLSNI 275
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-34
Identities = 65/372 (17%), Positives = 133/372 (35%), Gaps = 48/372 (12%)
Query: 146 NLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205
N +++ + F +++LNL + + + +G+N +
Sbjct: 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 105
Query: 206 KSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHSFSG 264
+ P P N+ L L + N + +P I L+ L +S+N L +F
Sbjct: 106 RYLP-PHVFQNVPLLTVLVLER-NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163
Query: 265 LASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNY 324
S++ ++L N+L+ + LS + +L ++S N L+ L I ++E L+ + N
Sbjct: 164 TTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPI---AVEELDASHNS 216
Query: 325 FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFR 384
+ + N L LKL +N+ + L Y L D+S N+
Sbjct: 217 IN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE---------- 261
Query: 385 NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNR 444
I + F + L L N L L +P + ++ +N
Sbjct: 262 ------KIMYHPFVK--------MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 445 FEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQL 504
+ + +L + ++ N+ + T L+ + LS N + + L
Sbjct: 307 LL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWD---CNSLRAL 359
Query: 505 -NKLQQLELQEN 515
+ + + +
Sbjct: 360 FRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-33
Identities = 69/347 (19%), Positives = 131/347 (37%), Gaps = 23/347 (6%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
ID+ D+ GF + + + + ++ L + L +++L L+ I E
Sbjct: 28 IDMQTQDVYFGFED--ITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL-QIEE 83
Query: 137 LPDFS-REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL 195
+ ++ +Q L + N P F P+L VL L N LS L N +L
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 143
Query: 196 THFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLS 255
T + N L+ + + L+NL + N + + S+ + L + ++S N LS
Sbjct: 144 TTLSMSNNNLERIE-DDTFQATTSLQNLQLSS-NRLTHVDLSL--IPSLFHANVSYNLLS 199
Query: 256 GKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSL 315
+ + ++E+++ N ++ LT L + NNLT + + L
Sbjct: 200 -----TLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT-DTAWLLNYPGL 250
Query: 316 ESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTG 375
++L+ N + L +L + NN L L+ D+S N
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL- 308
Query: 376 ELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQ 422
+ R ++L+ + + +N + S TL L N+
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 64/387 (16%), Positives = 128/387 (33%), Gaps = 26/387 (6%)
Query: 234 IPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLL 293
I ++ ++ + L + + + ++ + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 294 RLDISQNNLTGNLPETI--AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSG 351
L+++ + + A +++ L + N P + P L L L N S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 352 KLPDDL-GKYSNLEYFDVSTNDFTGELPRFLCFRN--KLQCIIIFNNRFSGKIPESYGEC 408
LP + L +S N+ + F+ LQ + + +NR + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIED-DTFQATTSLQNLQLSSNRLT-HVDL--SLI 185
Query: 409 KTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNN 468
+L + N L S V+ + +N + ++ +LT + + NN
Sbjct: 186 PSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNN 237
Query: 469 FTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSL 528
T + + L VDLS N + ++ +L++L + N L +
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 529 TALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKL 588
L VL+LS N L + L +L L N + + L L +SHN
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH-TLKNLTLSHNDW 351
Query: 589 YGEVPSDFDHDLFISSLLDNPGLCSPD 615
++ ++ D C D
Sbjct: 352 DCNSLRALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 69/341 (20%), Positives = 116/341 (34%), Gaps = 30/341 (8%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANL 147
R + LNL+D + + + + +Q L + +N I LP + L
Sbjct: 62 AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN-AIRYLPPHVFQNVPLL 119
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207
VL L RN+ S F P L L++ N L + T L + +L N L
Sbjct: 120 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179
Query: 208 SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLAS 267
L + L + N+ + ++ + LD S N ++ L
Sbjct: 180 VDL----SLIPSLFHA-----NVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVEL-- 228
Query: 268 IEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFT 326
++L N L+ + L N L+ +D+S N L + M LE L +++N
Sbjct: 229 -TILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
Query: 327 GEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT-------GELPR 379
+ P L L L +N + + ++ LE + N L
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKN 343
Query: 380 FLCFRNKLQCI---IIFNNRFSGKIPESYGECKTLNYLRFG 417
N C +F N + ++ CK L G
Sbjct: 344 LTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHG 384
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-30
Identities = 78/449 (17%), Positives = 131/449 (29%), Gaps = 71/449 (15%)
Query: 154 RNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSS 213
R I + V +++ L + ++ P +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP-AAL 64
Query: 214 VGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIE 272
+ + ++E L I EI + L + N + PH F + + +
Sbjct: 65 LDSFRQVELLNLND-LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123
Query: 273 LFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPE 331
L N LS N L L +S NNL +T A SL++L L+ N T +
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL 182
Query: 332 SLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCII 391
SL P+L + N S L +E D S N
Sbjct: 183 SL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN----------------- 218
Query: 392 IFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISP 451
+ L L+ N L + P + ++ N E I
Sbjct: 219 --------VVRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMY 265
Query: 452 SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLE 511
F +++L+ + +S NR L + L+ L+
Sbjct: 266 HP---------------FVK--------MQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 301
Query: 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPL 571
L N + RN L L L N + T+ L +L LS N L
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD-CNSL 356
Query: 572 ELTKLKLNQFNISHNKLYGEVPSDFDHDL 600
+ + + + ++ +H L
Sbjct: 357 RALFRNVARPAVDDADQHCKIDYQLEHGL 385
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 59/294 (20%)
Query: 690 IGSG--GSCRVYKVKLKSGE---TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+GSG G+ V K + + TVAVK L + P + +E + ++ + +V+
Sbjct: 25 LGSGNFGT--VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL--HND 802
++ C + + + V E G L L + + + + G+ YL N
Sbjct: 83 MIGICEAESWML-VMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN- 137
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI----- 857
VHRD+ + N+LL + +++DFGL+KAL++ E A ++G
Sbjct: 138 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------KAQTHGKWPVKWY 187
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE--NKDIVRWVTEAT-LSSPE 913
APE K + KSDV+SFGV++ E + G++P + ++ + + + P
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKGERMGCPA 243
Query: 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
GC R++ L M +C + NRP V LR
Sbjct: 244 -GCPREMYDL----M-----------------NLCWTYDVENRPGFAAVELRLR 275
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-34
Identities = 85/443 (19%), Positives = 156/443 (35%), Gaps = 29/443 (6%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
+ L LS+N+ S L+VL L N + L +L + ++ +N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDS--IGKLAFLSNLDLSDNFLSGKIPHSF 262
L++ + ++ L +L + N +P G L L+ L LS
Sbjct: 112 LQN--ISC--CPMASLRHLDLSF-NDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV 166
Query: 263 SGLA-SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLN 321
+ L S ++L + G ESL T + + N ++ ++ +L L L+
Sbjct: 167 AHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLS 226
Query: 322 DNYFTGEIPESLAS-------NPNLVQLKLFNNSFSGKLPDDLGKY---SNLEYFDVSTN 371
+ E + L + P L+ + L + + K L ++ +EY ++
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286
Query: 372 DFTG-----ELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELP 426
T E L + N F Y +N ++
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 427 SKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT--GEVPSQICTLRQLQ 484
F N F S+ S +L +++ N +V + L+
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406
Query: 485 AVDLSQNRFSGHLPTCITQL-NKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTG 543
+D+S N + H + L L NM TG + R L + VL+L N++
Sbjct: 407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM- 463
Query: 544 TIPPELGNLAVLTSLDLSSNLLT 566
+IP ++ +L L L+++SN L
Sbjct: 464 SIPKDVTHLQALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 85/499 (17%), Positives = 164/499 (32%), Gaps = 76/499 (15%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYN--------VF--------------- 133
+ L+LS N + L +S L+VL L +N VF
Sbjct: 53 RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 134 IGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLT 193
+ + A+L+ LDLS N+F +P F GNLT
Sbjct: 112 LQNIS--CCPMASLRHLDLSFNDFD-VLPVC-KEF---------------------GNLT 146
Query: 194 ELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNF 253
+LT L + L V +L L + I ++ + L L +
Sbjct: 147 KLTFLGLSAAKFRQLDL-LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205
Query: 254 LSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM 313
S + ++ ++L + +L+ E + L + L + N+T
Sbjct: 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT---------- 255
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSN-----LEYFDV 368
L+ + + L ++N + + ++ + YS L V
Sbjct: 256 -LQHIETTWKCSVKLF--QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV 312
Query: 369 STNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSK 428
F ++ ++ + + +L F N +
Sbjct: 313 KNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372
Query: 429 FWGLPEVDFFEMYNNRFE--GSISPSISNAPKLTGILINGNNFTGEVPSQICTL-RQLQA 485
L + + N + ++ N L + ++ N+ + C +
Sbjct: 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 486 VDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTI 545
++LS N +G + C+ K++ L+L N +P+++ L AL LN+++NQL ++
Sbjct: 433 LNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488
Query: 546 PPE-LGNLAVLTSLDLSSN 563
P L L + L N
Sbjct: 489 PDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 41/261 (15%), Positives = 88/261 (33%), Gaps = 14/261 (5%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYN--VFIGELPDFSREFANLQVLDLSR 154
TL+++ + P +L + L + E +L + +
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 155 NNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSV 214
F + F + + L + + + + T N S
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV-FQGC 373
Query: 215 GNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL----SGKIPHSFSGLASIEQ 270
L +L+ L + N + +S+L+ D L S + + SI
Sbjct: 374 STLKRLQTLILQR-NGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 271 IELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEI 329
+ L N L+G + L + LD+ N + ++P+ + + +L+ LN+ N +
Sbjct: 433 LNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488
Query: 330 PESLASN-PNLVQLKLFNNSF 349
P+ + +L + L +N +
Sbjct: 489 PDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 33/142 (23%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 454 SNAPKLTGIL-INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLE 511
+ P T L ++ N+ + I L +L+ + LS NR L + L+ L+
Sbjct: 48 KDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLD 106
Query: 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPP--ELGNLAVLTSLDLSSNLLTGEI 569
+ N + + +L L+LS N +P E GNL LT L LS+
Sbjct: 107 VSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 570 PLELTKLKLNQFNISHNKLYGE 591
L + L L+ + + +
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIK 184
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 29/120 (24%), Positives = 40/120 (33%), Gaps = 28/120 (23%)
Query: 85 SGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREF 144
S + ++ LNLS N L +VF LP
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNM--------------------LTGSVFRC-LP------ 449
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
++VLDL N IP+ L+ LN+ N L + LT L + L NP
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-34
Identities = 50/245 (20%), Positives = 90/245 (36%), Gaps = 39/245 (15%)
Query: 689 LIGSGGSCRVYK---VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
I GG +Y + +G V +K L+ + E + + +E + L V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVH-SGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 746 L-----MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
G +V EY+ SL +K + +I L+YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL---PVAEAIA--YLLEILPALSYLH 199
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
+ +V+ D+K NI+L E + ++ D G + ++ + G+ G+ APE
Sbjct: 200 SI---GLVYNDLKPENIMLTEEQL-KLIDLGAVSRI--------NSFGYLYGTPGFQAPE 247
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRPND-----------PSFGENKDIVRWVTEATL 909
T +D+Y+ G L L + P R + A
Sbjct: 248 IV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAID 306
Query: 910 SSPER 914
P +
Sbjct: 307 PDPRQ 311
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-34
Identities = 75/452 (16%), Positives = 140/452 (30%), Gaps = 75/452 (16%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
N + S + L L+ + ++ + + + LT LT N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
+ + L + L L N + + + L L+ L+ N L+ S
Sbjct: 76 ITTLDL----SQNTNLTYLACDS-NKLTNLD--VTPLTKLTYLNCDTNKLT---KLDVSQ 125
Query: 265 LASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNY 324
+ + N L+ E+ +S+ T L LD N + L +L+ + N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNK 181
Query: 325 FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFR 384
T E+ ++ N L +L N+ + DL + L + D S+N T +
Sbjct: 182 IT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-----IDVT 230
Query: 385 N--KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYN 442
+L N + ++ S L L +L E+
Sbjct: 231 PLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID---------------- 270
Query: 443 NRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCIT 502
+++ +L G E+ + QL +D + L ++
Sbjct: 271 ----------LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LS 315
Query: 503 QLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSS 562
Q KL L L T EL ++ T L L+ + +G + L + +
Sbjct: 316 QNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAE 370
Query: 563 NLLTGEIPLELTKLKL------NQFNISHNKL 588
LT L + + N +
Sbjct: 371 GQTITMPKETLTNNSLTIAVSPDLLDQFGNPM 402
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 78/499 (15%), Positives = 145/499 (29%), Gaps = 101/499 (20%)
Query: 79 LSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELP 138
+ F++ ++ TL +L+ ++ + L L N I L
Sbjct: 25 AAAFEMQATDTISEEQLATLTSLDCHNSSIT---DMTGIEKLTGLTKLICTSN-NITTLD 80
Query: 139 DFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHF 198
NL L N + ++ L LN N L+ L S LT+
Sbjct: 81 LSQ--NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVS---QNPLLTYL 132
Query: 199 ELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKI 258
N L + + ++L L I ++ + L+ LD S N ++ ++
Sbjct: 133 NCARNTLTEIDV----SHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-EL 185
Query: 259 PHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT----GNLPETIAAMS 314
S + ++ N ++ +L L+ L LD S N LT L
Sbjct: 186 D--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEIDVTPLT------Q 234
Query: 315 LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT 374
L + + N T E+ S + L L DL + L YF
Sbjct: 235 LTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGC--- 285
Query: 375 GELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPE 434
K++ + + +N L L +
Sbjct: 286 ----------RKIKELDVTHN-------------TQLYLLDCQAAGIT------------ 310
Query: 435 VDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFS 494
+S PKL + +N T E+ + +L+++
Sbjct: 311 ---------------ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
Query: 495 GHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTG---TIPPELGN 551
+ ++ L E L + + I ++ G I P G
Sbjct: 353 D-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGG 410
Query: 552 LAVLTSLDLSSNLLTGEIP 570
+ + ++ L+ + P
Sbjct: 411 VYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 38/236 (16%), Positives = 77/236 (32%), Gaps = 44/236 (18%)
Query: 98 LRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNF 157
L L+ S N L+ ++P L N + EL + + L L + +
Sbjct: 214 LTFLDCSSNK----LTEIDVTPLTQLTYFDCSVN-PLTELDVST--LSKLTTLHCIQTDL 266
Query: 158 SGDIPES--------------------FGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTH 197
+I + L +L+ ++ L L +L +
Sbjct: 267 L-EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVY 322
Query: 198 FELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGK 257
L L L V + +KL++L I + S+GK+ L+N ++
Sbjct: 323 LYLNNTELTE--LD--VSHNTKLKSLSCVN-AHIQDFS-SVGKIPALNNNFEAEGQTITM 376
Query: 258 IPHSFSGL-----ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPE 308
+ + S + ++ F N ++ + + I+ NL+ + P
Sbjct: 377 PKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 31/222 (13%)
Query: 683 HLTEQNLIGSG--GSCRVYKVKLKSGET----VAVKRL-LGGTHKPETETVFRSEIETLG 735
L +G G G V + + + VAVK L +PE F E+ +
Sbjct: 19 DLRLLEKLGDGSFGV--VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 736 RVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
+ H N+++L + V E P GSL D L + G A A+G
Sbjct: 77 SLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEG 133
Query: 796 LAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
+ YL +HRD+ + N+LL + ++ DFGL +AL + V
Sbjct: 134 MGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY------VMQE 182
Query: 854 YGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
+ + APE T+ + SD + FGV L E+ T G+ P
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 74/297 (24%), Positives = 113/297 (38%), Gaps = 51/297 (17%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRH 739
+IG G VY + A+K L T + E F E + + H
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGLNH 81
Query: 740 GNVVKLLMCCSGQDFNIL-VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
NV+ L+ + + YM +G L + R+ ++ I F A+G+ Y
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEY 139
Query: 799 L--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
L VHRD+ + N +LD +VADFGLA+ + + S +
Sbjct: 140 LAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILD-----REYYSVQQHRHAR 189
Query: 857 I-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-L 909
+ A E T + T KSDV+SFGV+L EL+T G P + D+ ++ + L
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY-RHI-DPFDLTHFLAQGRRL 247
Query: 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
PE C L Q+ M C P RP+ R +V +
Sbjct: 248 PQPE-YCPDSLYQV----M-----------------QQCWEADPAVRPTFRVLVGEV 282
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 87/529 (16%), Positives = 161/529 (30%), Gaps = 62/529 (11%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
ID+ D+ GF + + + + ++ L + L +++L L+ I E
Sbjct: 34 IDMQTQDVYFGFED--ITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL-QIEE 89
Query: 137 LPDFS-REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL 195
+ ++ +Q L + N P F P+L VL L N LS L N +L
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 149
Query: 196 THFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD-----------------SI 238
T + N L+ + + L+NL + N + + ++
Sbjct: 150 TTLSMSNNNLERIE-DDTFQATTSLQNLQLSS-NRLTHVDLSLIPSLFHANVSYNLLSTL 207
Query: 239 GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDIS 298
+ LD S N ++ L ++L N L+ + L N L+ +D+S
Sbjct: 208 AIPIAVEELDASHNSINVVRGPVNVEL---TILKLQHNNLT-DTA-WLLNYPGLVEVDLS 262
Query: 299 QNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL 357
N L + M LE L +++N + P L L L +N + +
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 320
Query: 358 GKYSNLEYFDVSTNDFT-------GELPRFLCFRNKLQCI---IIFNNRFSGKIPESYGE 407
++ LE + N L N C +F N + ++
Sbjct: 321 PQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
Query: 408 CKTLNYLRFG---GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILI 464
CK L G + L + E + N+ + I
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYI 440
Query: 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN 524
L+ + ++ N ++ +L ++Q+ L
Sbjct: 441 TQQGGV--------PLQGNEQLEAEVNELR-------AEVQQLTNEQIQQEQLLQGLHAE 485
Query: 525 LNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLEL 573
++ T L L + L + L T E
Sbjct: 486 ID--TNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEA 532
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 689 LIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL- 746
IG+G R K++ KS G+ + K L G+ + + SE+ L ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 747 --MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS-------LDWSIRFSIAQGAAKGLA 797
+ + I V EY G LA ++ + + L + Q L
Sbjct: 73 RIIDRTNTTLYI-VMEYCEGGDLASVITKGTKERQYLDEEFVLRV-----MTQ-LTLALK 125
Query: 798 YLH--NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
H +D ++HRD+K N+ LD + ++ DFGLA+ L + A + V G+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DTSFAKTFV-GTPY 181
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y++PE EKSD++S G +L EL P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
+++ ++G+G V +LK +VA+K L G + + F E +G+
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFD 104
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H N+++L + ++V EYM NGSL L + + +G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 799 L--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
L VHRD+ + NIL+++ +V +V+DFGL + L+ DD + G
Sbjct: 163 LSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLE------DDPEAAYTTRGGK 211
Query: 857 I-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE--NKDIVRWVTEAT 908
I +PE +K T SDV+S+G+VL E+++ G+RP + E N+D+++ V E
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVIKAVDEGY 267
Query: 909 -LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
L P C L QL M L C NRP ++V +L
Sbjct: 268 RLPPPM-DCPAALYQL----M-----------------LDCWQKDRNNRPKFEQIVSIL 304
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 80/297 (26%), Positives = 115/297 (38%), Gaps = 51/297 (17%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRH 739
+ +IG G VY L + AVK L T E F +E + H
Sbjct: 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSH 85
Query: 740 GNVVKLLMCCSGQDFNIL-VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
NV+ LL C + + L V YM +G L + + + + AKG+ Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKY 143
Query: 799 L--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
L VHRD+ + N +LD + +VADFGLA+ + + S +
Sbjct: 144 LASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----KEYYSVHNKTGAK 193
Query: 857 I-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT-L 909
+ A E T+K T KSDV+SFGV+L EL+T G P P DI ++ + L
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-PDV-NTFDITVYLLQGRRL 251
Query: 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
PE C L ++ M L C RPS +V +
Sbjct: 252 LQPE-YCPDPLYEV----M-----------------LKCWHPKAEMRPSFSELVSRI 286
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-33
Identities = 77/363 (21%), Positives = 139/363 (38%), Gaps = 42/363 (11%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
++LDL +N + F FP L+ L L N++S + P NL L L N
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 204 PLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHS 261
LK +P V LS L L + N I + D + L L +L++ DN L +
Sbjct: 91 RLKL--IPLGVFTGLSNLTKLDIS-ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147
Query: 262 FSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS-LESLNL 320
FSGL S+EQ+ L L+ E+LS+L L+ L + N+ + + L+ L +
Sbjct: 148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEI 207
Query: 321 NDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDD-LGKYSNLEYFDVSTNDFTGELPR 379
+ + + + NL L + + + + +P + L + ++S N +
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS----- 261
Query: 380 FLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSK-FWGLPEVDFF 438
I + L ++ G +L + F GL +
Sbjct: 262 -----------TIEGSMLHE--------LLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVL 301
Query: 439 EMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHL 497
+ N+ ++ S+ + L ++++ N + C L + + F+
Sbjct: 302 NVSGNQLT-TLEESVFHSVGNLETLILDSNPLACD-----CRLLWVFR-RRWRLNFNRQQ 354
Query: 498 PTC 500
PTC
Sbjct: 355 PTC 357
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 60/299 (20%), Positives = 99/299 (33%), Gaps = 27/299 (9%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+DL + + F L L L++N + + + F+L+ L L N +
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN-RLKL 94
Query: 137 LPDFS-REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL 195
+P +NL LD+S N + F LK L +G N L + L L
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSL 154
Query: 196 THFELGYNPLKS------SPLPS-----------------SVGNLSKLENLWAAKANLIG 232
L L S S L S L +L+ L + +
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTL 292
+ + L++L ++ L+ + L + + L N +S L L L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274
Query: 293 LRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFS 350
+ + L P + L LN++ N T S NL L L +N +
Sbjct: 275 QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 70/362 (19%), Positives = 123/362 (33%), Gaps = 60/362 (16%)
Query: 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTL 292
+P+ I LDL N + F+ +E++EL +N +S P + +NL L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 293 LRLDISQNNLTGNLPETI--AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFS 350
L + N L +P + +L L++++N + NL L++ +N
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 351 GKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKT 410
+S F+G L L+ + + + E+
Sbjct: 142 ----------------YISHRAFSG-LNS-------LEQLTLEKCNLTSIPTEALSHLHG 177
Query: 411 LNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT 470
L LR + F L + E+ + + +++P+ LT + I N T
Sbjct: 178 LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
Query: 471 GEVPSQICT-LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529
VP L L+ ++LS N S ++ +M L
Sbjct: 238 -AVPYLAVRHLVYLRFLNLSYNPIS----------------TIEGSMLHE--------LL 272
Query: 530 ALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLTGEIPLELTK--LKLNQFNISHN 586
L + L QL + P L L L++S N LT + + L + N
Sbjct: 273 RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSN 330
Query: 587 KL 588
L
Sbjct: 331 PL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 48/277 (17%), Positives = 94/277 (33%), Gaps = 36/277 (12%)
Query: 317 SLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE 376
++ + F +PE + L L N D+ + +LE +++ N +
Sbjct: 15 AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-- 69
Query: 377 LPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSK-FWGLPEV 435
+ F+ L L N L+ +P F GL +
Sbjct: 70 --------------AVEPGAFNN--------LFNLRTLGLRSNRLK-LIPLGVFTGLSNL 106
Query: 436 DFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQI-CTLRQLQAVDLSQNRF 493
++ N+ + + + L + + N+ + + L L+ + L +
Sbjct: 107 TKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL 164
Query: 494 SGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLA 553
+ ++ L+ L L L+ + L L VL +S T+ P
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224
Query: 554 VLTSLDLSSNLLTGEIPLE-LTKLK-LNQFNISHNKL 588
LTSL ++ LT +P + L L N+S+N +
Sbjct: 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 78/299 (26%), Positives = 125/299 (41%), Gaps = 38/299 (12%)
Query: 683 HLTEQNLIGSG--GS---CRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
+L + +G G G +GE VAVK L P+ + ++ EI+ L +
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTL 90
Query: 738 RHGNVVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
H +++K CC LV EY+P GSL D L S+ + AQ +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG---QSDDAMSCVAG 852
+AYLH +HRD+ + N+LLD + + ++ DFGLAKA+ +D S V
Sbjct: 147 MAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912
+ APE K SDV+SFGV L EL+T ++ +
Sbjct: 203 ---WYAPECLKEYKFYYASDVWSFGVTLYELLT--------HCDSSQSPPTKFLELIGIA 251
Query: 913 ERG-CCRDLNQLIDP--RMDL-STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
+ L +L++ R+ C +V ++ C RP+ ++ +L+
Sbjct: 252 QGQMTVLRLTELLERGERLPRPDKC----PAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 65/259 (25%), Positives = 112/259 (43%), Gaps = 26/259 (10%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
++G G + V++ + K +G+ A+K + + R E E L ++ H N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 748 C--CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ +L+ E+ P GSL +L E + L S + + G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 806 AIVHRDVKSHNILL----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE- 860
IVHR++K NI+ D + V ++ DFG A+ L+ D+ + G+ Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----DEQFVSLYGTEEYLHPDM 186
Query: 861 -------YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG--ENKDIVRWVTEATLSS 911
+ KK D++S GV TG P P G NK+++ + S
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 912 PERGCCRDLNQLIDPRMDL 930
G + N ID D+
Sbjct: 247 AISGVQKAENGPIDWSGDM 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 27/220 (12%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE-----TVAVKRLLGGTHKPETETVFRSEIETLGRV 737
+T Q +IG+G VYK LK+ VA+K L G + + F E +G+
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQF 103
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H N+++L S +++ EYM NG+L L + + G + +G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 798 YL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
YL N VHRD+ + NIL+++ +V +V+DFGL++ L+ DD + S G
Sbjct: 162 YLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLE------DDPEATYTTSGG 210
Query: 856 YI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
I APE +K T SDV+SFG+V+ E++T G+RP
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 57/242 (23%), Positives = 97/242 (40%), Gaps = 38/242 (15%)
Query: 685 TEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
E ++G G +V K + A+K++ H E + SE+ L + H VV
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 744 KLLMCCSGQDFNI-------------LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ 790
+ + + + EY NG+L D++H + + D R Q
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-FRQ 124
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS----------QE 840
+ L+Y+H+ I+HRD+K NI +D ++ DFGLAK +
Sbjct: 125 -ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 841 GQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
S D ++ G+ Y+A E EK D+YS G++ E++ S G +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGMERV 235
Query: 900 IV 901
+
Sbjct: 236 NI 237
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 685 TEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
E LIGSGG +V+K K G+T +KR+ K E R E++ L ++ H N+V
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAER-EVKALAKLDHVNIV 67
Query: 744 KLLMCCSGQDFNI----------------LVYEYMPNGSLADMLHEKGRSGSLDWSIRFS 787
C G D++ + E+ G+L + ++ R LD +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALE 126
Query: 788 IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847
+ + KG+ Y+H+ +++RD+K NI L ++ DFGL +L ++D
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-----KNDGKR 178
Query: 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ G+ Y++PE ++ ++ D+Y+ G++L EL+
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 71/300 (23%), Positives = 109/300 (36%), Gaps = 58/300 (19%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
+ IG G V++ S E VA+K T E F E T+ +
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFD 74
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
H ++VKL+ + I + E G L L + R SLD + A + LAY
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 799 L--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
L VHRD+ + N+L+ + ++ DFGL++ ++ S G
Sbjct: 132 LESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--------YYKASKGK 178
Query: 857 I-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE--NKDIVRWVTEA- 907
+ APE ++ T SDV+ FGV + E++ G +P F N D++ +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGE 234
Query: 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
L P C L L M C + P RP + L
Sbjct: 235 RLPMPP-NCPPTLYSL----M-----------------TKCWAYDPSRRPRFTELKAQLS 272
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-33
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 683 HLTEQNLIGSG--GSCRVYKVKLKSGE-----TVAVKRLLGGTHKPETETVFRSEIETLG 735
+ ++GSG G+ VYK VA+K L T + E +
Sbjct: 16 EFKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMA 72
Query: 736 RVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
V + +V +LL C + + + MP G L D + E ++ + AKG
Sbjct: 73 SVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKG 129
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
+ YL + +VHRD+ + N+L+ ++ DFGLAK L ++E G
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-------KEYHAEGG 179
Query: 856 YI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
+ A E + T +SDV+S+GV + EL+T G +P
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-33
Identities = 79/298 (26%), Positives = 115/298 (38%), Gaps = 51/298 (17%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVR 738
+ +IG G VY L + AVK L T E F +E +
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFS 148
Query: 739 HGNVVKLLMCCSGQDFNIL-VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H NV+ LL C + + L V YM +G L + + + + AKG+
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMK 206
Query: 798 YL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
+L VHRD+ + N +LD + +VADFGLA+ + + S +
Sbjct: 207 FLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----KEFDSVHNKTGA 256
Query: 856 YI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEAT- 908
+ A E T+K T KSDV+SFGV+L EL+T G P P DI ++ +
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-PDV-NTFDITVYLLQGRR 314
Query: 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
L PE C L ++ M L C RPS +V +
Sbjct: 315 LLQPE-YCPDPLYEV----M-----------------LKCWHPKAEMRPSFSELVSRI 350
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 47/223 (21%), Positives = 92/223 (41%), Gaps = 27/223 (12%)
Query: 685 TEQNLIGSGGSCRVYKVKLKS-GETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNV 742
+G GG V++ K K A+KR+ L + E++ L ++ H +
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV--MREVKALAKLEHPGI 65
Query: 743 VKLLMCCSGQD---------FNILVY---EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQ 790
V+ ++ + +Y + +L D ++ + + S+ I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE--------GQ 842
A+ + +LH+ ++HRD+K NI + V +V DFGL A+ E
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT 885
+ + G+ Y++PE + + K D++S G++L EL+
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 683 HLTEQNLIGSG--GS-CR-VYKVKLKSGET-VAVKRLLGGTHKPETETVFRSEIETLGRV 737
L + ++GSG G+ + V+ + +S + V +K + + ++ + +G +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSL 72
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H ++V+LL C G + V +Y+P GSL D + + G+L + + AKG+
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMY 129
Query: 798 YL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
YL H +VHR++ + N+LL + +VADFG+A L + Q + S
Sbjct: 130 YLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-------LLYSEA 177
Query: 856 YI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
A E + K T +SDV+S+GV + EL+T G P
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKL 745
++++G G + + VAVKR+L PE + E++ L H NV++
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRESDEHPNVIRY 83
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ F + E +L + + +K + ++ Q GLA+LH+
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL--EPITLLQQTTSGLAHLHSL--- 137
Query: 806 AIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
IVHRD+K HNIL+ ++ ++DFGL K L S S V G+ G+IAPE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-HSFSRRSGVPGTEGWIAPE 196
Query: 861 Y---AYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
+ T D++S G V +++ P FG++
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--P-FGKSLQ 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVK 744
IG G + VK + G +K + + E E R E+ L ++H N+V+
Sbjct: 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQ 87
Query: 745 LLMCC-SGQDFNILVYEYMPNGSLADMLHEKGRSGSLD----WSIRFSIAQGAAKGLAYL 799
I V +Y G L + + Q L ++
Sbjct: 88 YRESFEENGSLYI-VMDYCEGGDLFKRI-NAQKGVLFQEDQILDW---FVQ-ICLALKHV 141
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
H+ I+HRD+KS NI L + ++ DFG+A+ L S + A +C+ G+ Y++P
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS---TVELARACI-GTPYYLSP 194
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E K KSD+++ G VL EL T K
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 685 TEQNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNV 742
+ IG G VY+ L G VA+K++ + + EI+ L ++ H NV
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 743 VKLLMCC-SGQDFNILVYEYMPNGSLADMLHEKGRSGSL--DWSIRFSIAQGAAKGLAYL 799
+K + NI V E G L+ M+ + L + ++ Q L ++
Sbjct: 95 IKYYASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ-LCSALEHM 152
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
H+ ++HRD+K N+ + A V ++ D GL + S ++ A S V G+ Y++P
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLV-GTPYYMSP 205
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E + KSD++S G +L E+ + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 47/232 (20%)
Query: 683 HLTEQNLIGSG-------GSCRVYKVKLKSGET-VAVKRLLGGTHKPETETVFRSEIETL 734
L +G G G R + ET V +K L F +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMM 66
Query: 735 GRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK 794
++ H ++V C D NILV E++ GSL L + ++ W + +A+ A
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAA 124
Query: 795 GLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPR--------VADFGLAKALQSQEGQSD 844
+ +L + ++H +V + NILL E + ++D G++ + ++
Sbjct: 125 AMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175
Query: 845 DAMSCVAGSYGYI-----APE-YAYTKKVTEKSDVYSFGVVLMELVT-GKRP 889
PE K + +D +SFG L E+ + G +P
Sbjct: 176 ---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-32
Identities = 61/249 (24%), Positives = 108/249 (43%), Gaps = 34/249 (13%)
Query: 654 KSGFFSTSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSG--GSCRVYKVKLKSGE---T 708
S F S P ++ +++ D++L +G G GS V + + +
Sbjct: 312 TSVFESPFSDPEELKD-KKLFLKRDNLL---IADIELGCGNFGS--VRQGVYRMRKKQID 365
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
VA+K L GT + E + + ++ + +V+L+ C + + V E G L
Sbjct: 366 VAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLH 423
Query: 769 DMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPR 826
L K + S + + G+ YL N VHR++ + N+LL +
Sbjct: 424 KFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAK 476
Query: 827 VADFGLAKALQSQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLM 881
++DFGL+KAL + + A S G APE +K + +SDV+S+GV +
Sbjct: 477 ISDFGLSKALGADDSYY------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 882 ELVT-GKRP 889
E ++ G++P
Sbjct: 531 EALSYGQKP 539
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 62/302 (20%)
Query: 683 HLTEQNLIGSG--GSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGR 736
+ ++G G G VY+ + + VAVK + + F SE +
Sbjct: 13 DVVLNRILGEGFFGE--VYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKN 69
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGL 796
+ H ++VKL+ + I + E P G L L S + + + + K +
Sbjct: 70 LDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAM 126
Query: 797 AYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
AYL N VHRD+ NIL+ + ++ DFGL++ ++ ++ S
Sbjct: 127 AYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED--------YYKASV 173
Query: 855 GYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE--NKDIVRWVTE 906
+ +PE ++ T SDV+ F V + E+++ GK+P F NKD++ + +
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP----FFWLENKDVIGVLEK 229
Query: 907 AT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965
L P+ C L L M C P +RP +V
Sbjct: 230 GDRLPKPD-LCPPVLYTL----M-----------------TRCWDYDPSDRPRFTELVCS 267
Query: 966 LR 967
L
Sbjct: 268 LS 269
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVK-----RLLGGTHKPETETVFRSEIETLGRVRHGNV 742
+G GG + +++ + E A K LL KP EI + H +V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL----KPHQREKMSMEISIHRSLAHQHV 77
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLD-WSIRFSIAQGAAKGLAYLHN 801
V DF +V E SL ++ + L R+ + Q G YLH
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQ-IVLGCQYLHR 133
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
+ V +HRD+K N+ L+ ++ ++ DFGLA +G+ + C G+ YIAPE
Sbjct: 134 NRV---IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVL-C--GTPNYIAPEV 186
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGKRP 889
K + + DV+S G ++ L+ GK P
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 74/306 (24%), Positives = 125/306 (40%), Gaps = 66/306 (21%)
Query: 690 IGSGGSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+G G +V+ K VAVK L T + F+ E E L ++H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIV 80
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR-------------FSIAQ 790
K C D I+V+EYM +G L L G + + IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 791 GAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS 848
A G+ YL + VHRD+ + N L+ A ++ ++ DFG+++ + S +
Sbjct: 141 QIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-------Y 188
Query: 849 CVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVR 902
G + + PE +K T +SDV+SFGV+L E+ T GK+P N +++
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQL-SNTEVIE 246
Query: 903 WVTEA-TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRR 961
+T+ L P C +++ + M L C P R +++
Sbjct: 247 CITQGRVLERPR-VCPKEVYDV----M-----------------LGCWQREPQQRLNIKE 284
Query: 962 VVELLR 967
+ ++L
Sbjct: 285 IYKILH 290
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
++G G VY L + +A+K + EI ++H N+V+ L
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 748 CCSGQDFNILVYEYMPNGSLADML-HEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
S F + E +P GSL+ +L + G + +I F Q +GL YLH++
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-ILEGLKYLHDNQ--- 142
Query: 807 IVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE--YAY 863
IVHRD+K N+L++ V +++DFG +K L G + + G+ Y+APE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFT-GTLQYMAPEIIDKG 198
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRP 889
+ + +D++S G ++E+ TGK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 7e-32
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVK-----RLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L+G G VY+ + + +G VA+K + K ++E++ +++H ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY----KAGMVQRVQNEVKIHCQLKHPSI 73
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
++L ++ LV E NG + L + + S + + F + Q G+ YLH+
Sbjct: 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF-MHQ-IITGMLYLHSH 131
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
+ +HRD+ N+LL M ++ADFGLA + + C G+ YI+PE A
Sbjct: 132 GI---LHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTL-C--GTPNYISPEIA 184
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRP 889
+SDV+S G + L+ G+ P
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 23/227 (10%)
Query: 683 HLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HG 740
L + ++ GG VY+ + + SG A+KRLL +++ E E+ + ++ H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 741 NVVKLLMCCS-------GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA 793
N+V+ S L+ + G L + L + G L I
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA-- 851
+ + ++H P I+HRD+K N+LL + ++ DFG A + S A
Sbjct: 147 RAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 852 ------GSYGYIAPE--YAYTKK-VTEKSDVYSFGVVLMELVTGKRP 889
+ Y PE Y+ + EK D+++ G +L L + P
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVK-----RLLGGTHKPETETVFRSEIETLGRVRHGNV 742
+G GG + +++ + E A K LL KP EI + H +V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL----KPHQREKMSMEISIHRSLAHQHV 103
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLD-WSIRFSIAQGAAKGLAYLHN 801
V DF +V E SL ++ + L R+ + Q G YLH
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQ-IVLGCQYLHR 159
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM---SCVAGSYGYIA 858
+ V +HRD+K N+ L+ ++ ++ DFGLA + + D C G+ YIA
Sbjct: 160 NRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLC--GTPNYIA 209
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
PE K + + DV+S G ++ L+ GK P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 67/313 (21%), Positives = 119/313 (38%), Gaps = 65/313 (20%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE------TVAVKRLLGGTHKPETETVFRSEIETLGR 736
+ +G +VYK L VA+K L P E FR E R
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRAR 68
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR----------- 785
++H NVV LL + +++ Y +G L + L + + +
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 786 --FSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841
+ A G+ YL H+ +VH+D+ + N+L+ ++ +++D GL + + + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD- 182
Query: 842 QSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFG 895
+ APE K + SD++S+GVVL E+ + G +P +
Sbjct: 183 ------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGY- 234
Query: 896 ENKDIVRWVTEAT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPI 954
N+D+V + L P+ C + L M + C ++FP
Sbjct: 235 SNQDVVEMIRNRQVLPCPD-DCPAWVYAL----M-----------------IECWNEFPS 272
Query: 955 NRPSMRRVVELLR 967
RP + + LR
Sbjct: 273 RRPRFKDIHSRLR 285
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-31
Identities = 72/310 (23%), Positives = 120/310 (38%), Gaps = 66/310 (21%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE---TVAVKRLLGGTHKPETETVFRSEIETLGRV-R 738
+ Q++IG G +V K ++K A+KR+ K + F E+E L ++
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGH 84
Query: 739 HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRF------------ 786
H N++ LL C + + L EY P+G+L D L + +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 787 -SIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843
A A+G+ YL +HRD+ + NIL+ V ++ADFGL++
Sbjct: 145 LHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--------G 191
Query: 844 DDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGEN 897
+ V + G + A E T SDV+S+GV+L E+V+ G P
Sbjct: 192 QEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-CGM-TC 247
Query: 898 KDIVRWVTEAT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINR 956
++ + + L P C ++ L M C + P R
Sbjct: 248 AELYEKLPQGYRLEKPL-NCDDEVYDL----M-----------------RQCWREKPYER 285
Query: 957 PSMRRVVELL 966
PS +++ L
Sbjct: 286 PSFAQILVSL 295
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-31
Identities = 82/451 (18%), Positives = 132/451 (29%), Gaps = 85/451 (18%)
Query: 122 HLQVLALDYNVFIGELPDFS-REFANLQVLDLSRNNFSGDIPE-SFGRFPVLKVLNLGGN 179
H+ + L N I EL + S +LQ L + + I +F L +L L N
Sbjct: 31 HVNYVDLSLN-SIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIG 239
L L L L L + L + L +
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNF--FKPLTS----------------- 130
Query: 240 KLAFLSNLDLSDNFLSGKIPHS-FSGLASIEQIELFDNQLSGELPESLSNLT--TLLRLD 296
L L L DN + P S F + ++L N++ E L N L
Sbjct: 131 ----LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 297 ISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDD 356
+S L ++N+ + E + N ++ L L N F +
Sbjct: 187 LSSITL---------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR 231
Query: 357 LGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRF 416
+ + + N F G E +
Sbjct: 232 FFDAIAGTKIQSLILSNSYNMGSSFGH-TNFKDPD--NFTFKGL------EASGVKTCDL 282
Query: 417 GGNELQGELPSK-FWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPS 475
+++ L F +++ + N I + F G
Sbjct: 283 SKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNA---------------FWG---- 321
Query: 476 QICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNL-NSLTALIV 533
L L ++LSQN + + + L+KL+ L+L N L L L
Sbjct: 322 ----LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKE 375
Query: 534 LNLSTNQLTGTIPPE-LGNLAVLTSLDLSSN 563
L L TNQL ++P L L + L +N
Sbjct: 376 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 83/396 (20%), Positives = 135/396 (34%), Gaps = 50/396 (12%)
Query: 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM--SLESLNLNDN 323
A + ++L N ++ S S L L L + Q + SL L L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 324 YFTGEIPESLASN-PNLVQLKLFNNSF-SGKLPDDL-GKYSNLEYFDVSTNDFTGELPRF 380
F ++ + NL L L + L + ++LE + N+ P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 381 L-----------CFRNKLQCI--IIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPS 427
NK++ I N TL + L E
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN--EYWLGWEKCG 206
Query: 428 KFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGIL-----INGNNFTGEVPSQICTLRQ 482
+ + ++ N F+ S++ +A T I + N + +
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266
Query: 483 ----------LQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRN-LNSLTA 530
++ DLS+++ L + + L+QL L +N ++ N LT
Sbjct: 267 FTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTH 324
Query: 531 LIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLTGEIPLEL-TKL-KLNQFNISHNK 587
L+ LNLS N L +I + NL L LDLS N + + + L L + + N+
Sbjct: 325 LLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQ 382
Query: 588 LYGEVPSD-FDH--DLFISSLLDNPGLCS-PDLKPL 619
L VP FD L L NP CS P + L
Sbjct: 383 LK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 417
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 56/260 (21%), Positives = 96/260 (36%), Gaps = 32/260 (12%)
Query: 92 FCRIRTLRNLNLSDNYF----NGTLSSQSLSPCFHL-----QVLALDYNVFIGELPDFSR 142
F +R L+L+ N L + L + ++ E
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 143 EFANLQVLDLSRNNFSGDIPESF-GRFPVLKVLNLGGNLLSGLIPSFLGN---------- 191
+ ++ LDLS N F + + F K+ +L + + SF
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 192 ----LTELTHFELGYNPLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLS 245
+ + +L + + + L SV + + LE L A+ N I +I D+ L L
Sbjct: 270 KGLEASGVKTCDLSKSKIFA--LLKSVFSHFTDLEQLTLAQ-NEINKIDDNAFWGLTHLL 326
Query: 246 NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGN 305
L+LS NFL F L +E ++L N + +S L L L + N L +
Sbjct: 327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 306 LPETIAA--MSLESLNLNDN 323
+P+ I SL+ + L+ N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 45/228 (19%), Positives = 86/228 (37%), Gaps = 17/228 (7%)
Query: 78 DLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL 137
D++ + L + ++ L+LS N F +++ + ++ +L +
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 138 PDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTH 197
F D F G +K +L + + L+ S + T+L
Sbjct: 254 SSFGH----TNFKDPDNFTFKGLEASG------VKTCDLSKSKIFALLKSVFSHFTDLEQ 303
Query: 198 FELGYNPLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLS 255
L N + + + L+ L L ++ N +G I + L L LDLS N +
Sbjct: 304 LTLAQNEINK--IDDNAFWGLTHLLKLNLSQ-NFLGSIDSRMFENLDKLEVLDLSYNHIR 360
Query: 256 GKIPH-SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNL 302
+ SF GL +++++ L NQL LT+L ++ + N
Sbjct: 361 A-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 38/130 (29%), Positives = 49/130 (37%), Gaps = 3/130 (2%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
DLS + + F L L L+ N N + + HL L L N F+G
Sbjct: 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN-FLGS 337
Query: 137 LPDFS-REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL 195
+ L+VLDLS N+ +SF P LK L L N L + LT L
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSL 397
Query: 196 THFELGYNPL 205
L NP
Sbjct: 398 QKIWLHTNPW 407
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 72/312 (23%), Positives = 123/312 (39%), Gaps = 65/312 (20%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE------TVAVKRLLGGTHKPETETVFRSEIETLGR 736
+ + +G G +V+ + + VAVK L + + F+ E E L
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTM 99
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML------------HEKGRSGSLDWSI 784
++H ++V+ C+ ++V+EYM +G L L E G L
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 785 RFSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842
++A A G+ YL + VHRD+ + N L+ +V ++ DFG+++ + S +
Sbjct: 160 LLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-- 212
Query: 843 SDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGE 896
G + PE +K T +SDV+SFGVVL E+ T GK+P
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW-YQL-S 265
Query: 897 NKDIVRWVTEA-TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN 955
N + + +T+ L P C ++ + M C P
Sbjct: 266 NTEAIDCITQGRELERPR-ACPPEVYAI----M-----------------RGCWQREPQQ 303
Query: 956 RPSMRRVVELLR 967
R S++ V L+
Sbjct: 304 RHSIKDVHARLQ 315
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 72/312 (23%), Positives = 125/312 (40%), Gaps = 67/312 (21%)
Query: 684 LTEQNLIGSG--GSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLG 735
L +G+G G +V + K + VAVK L H E E SE++ +
Sbjct: 48 LQFGKTLGAGAFG--KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMS 104
Query: 736 RV-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR--------- 785
+ +H N+V LL C+ +++ EY G L + L K R D +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 786 --FSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841
+ A+G+A+L N +HRDV + N+LL V ++ DFGLA+ +
Sbjct: 165 DLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDI----- 214
Query: 842 QSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFG 895
+D + + APE + T +SDV+S+G++L E+ + G P P
Sbjct: 215 MNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-PGIL 271
Query: 896 ENKDIVRWVTEAT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPI 954
N + V + ++ P +++ + M C + P
Sbjct: 272 VNSKFYKLVKDGYQMAQPA-FAPKNIYSI----M-----------------QACWALEPT 309
Query: 955 NRPSMRRVVELL 966
+RP+ +++ L
Sbjct: 310 HRPTFQQICSFL 321
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 72/304 (23%), Positives = 116/304 (38%), Gaps = 57/304 (18%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRH 739
L ++G G V + LK + VAVK + F SE + H
Sbjct: 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 740 GNVVKLLMCCS-----GQDFNILVYEYMPNGSLADML-HEKGRSGSLDWSIR--FSIAQG 791
NV++LL C G +++ +M G L L + + +G ++
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 792 AAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
A G+ YL N +HRD+ + N +L +M VADFGL+K + S +
Sbjct: 156 IALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR------ 204
Query: 850 VAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRW 903
G + A E + T KSDV++FGV + E+ T G P P +N ++ +
Sbjct: 205 -QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-PGV-QNHEMYDY 261
Query: 904 VTEAT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRV 962
+ L PE C +L ++ M C P++RP+ +
Sbjct: 262 LLHGHRLKQPE-DCLDELYEI----M-----------------YSCWRTDPLDRPTFSVL 299
Query: 963 VELL 966
L
Sbjct: 300 RLQL 303
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 24/259 (9%), Positives = 59/259 (22%), Gaps = 45/259 (17%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
+ G V+ V+ ++ E A+K +G + R+ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 747 MCC----------------------SGQDFNI----LVYEYMPNGSLADMLHEKGR---- 776
D+ + L+ + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 777 SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836
G + + A L + +VH N+ + + + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKK--VTEKSDVYSFGVVLMELVTGKRPNDPSF 894
+ Y E+ T + + G+ + + P
Sbjct: 245 -------GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 895 GENKDIVRWVTEATLSSPE 913
K + + +
Sbjct: 298 PGIKGSWKRPSLRVPGTDS 316
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 67/315 (21%)
Query: 683 HLTEQNLIGSGGSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
L+ +G+G +V + +K + TVAVK L H E E SE++ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSY 82
Query: 737 V-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR---------- 785
+ H N+V LL C+ +++ EY G L + L K S +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 786 -----FSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838
S + AKG+A+L N +HRD+ + NILL + ++ DFGLA+ +++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 839 QEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDP 892
D V + APE + T +SDV+S+G+ L EL + G P P
Sbjct: 198 -----DSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-P 249
Query: 893 SFGENKDIVRWVTEA-TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSD 951
+ + + E + SPE ++ + M C
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPE-HAPAEMYDI----M-----------------KTCWDA 287
Query: 952 FPINRPSMRRVVELL 966
P+ RP+ +++V+L+
Sbjct: 288 DPLKRPTFKQIVQLI 302
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 27/233 (11%)
Query: 671 QRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRS 729
+ +DD + + +G+G V+KV K SG +A K + KP
Sbjct: 26 KVGELKDDD----FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIR 80
Query: 730 EIETLGRVRHGNVVKLLMCCSG---QDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIR 785
E++ L +V G D I + E+M GSL +L + GR + I
Sbjct: 81 ELQVLHECNSPYIVG----FYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQIL 133
Query: 786 FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845
++ KGL YL I+HRDVK NIL+++ ++ DFG++ GQ D
Sbjct: 134 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLID 184
Query: 846 AMS-CVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN 897
+M+ G+ Y++PE + +SD++S G+ L+E+ G+ P P +
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 69/305 (22%), Positives = 106/305 (34%), Gaps = 58/305 (19%)
Query: 684 LTEQNLIGSGGSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRH 739
T ++G G V + +LK + VAVK L F E + H
Sbjct: 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 740 GNVVKLLMCCS------GQDFNILVYEYMPNGSLADMLHE---KGRSGSLDWSIRFSIAQ 790
+V KL+ +++ +M +G L L +L
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 791 GAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS 848
A G+ YL N +HRD+ + N +L +M VADFGL++ + S +
Sbjct: 145 DIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-------Y 192
Query: 849 CVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVR 902
G + A E T SDV++FGV + E++T G+ P EN +I
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-AGI-ENAEIYN 250
Query: 903 WVTE-ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRR 961
++ L P C ++ L M C S P RPS
Sbjct: 251 YLIGGNRLKQPP-ECMEEVYDL----M-----------------YQCWSADPKQRPSFTC 288
Query: 962 VVELL 966
+ L
Sbjct: 289 LRMEL 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-30
Identities = 35/246 (14%), Positives = 68/246 (27%), Gaps = 49/246 (19%)
Query: 684 LTEQNLIGSGGSCRVYKVK-LKSGETVAVK-----------------------RLLGGTH 719
L ++G + ++GE+ V RLL G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 720 KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD-------FNILVYEYMPNGSLADMLH 772
+ V I V+ K++ + F + + ++L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 773 EKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831
SL R + + LA LH+ +VH ++ +I+LD + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 832 LAKALQSQEGQSDDAMSCVAGSYG---YIAPEYAY-----TKKVTEKSDVYSFGVVLMEL 883
A+S + + A +T D ++ G+ + +
Sbjct: 257 HLVRDG------ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
Query: 884 VTGKRP 889
P
Sbjct: 311 WCADLP 316
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 79/316 (25%), Positives = 122/316 (38%), Gaps = 70/316 (22%)
Query: 683 HLTEQNLIGSG--GSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETL 734
L +G G G +V + K + TVAVK L G E SE++ L
Sbjct: 28 RLKLGKPLGRGAFG--QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKIL 84
Query: 735 GRV-RHGNVVKLLMCCSGQDFNILV-YEYMPNGSLADML-------------HEKGRSGS 779
+ H NVV LL C+ ++V E+ G+L+ L E
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 780 LDWSIRFSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837
L + AKG+ +L +HRD+ + NILL + V ++ DFGLA+ +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 838 SQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
D V + APE + + T +SDV+SFGV+L E+ + G P
Sbjct: 200 K-----DPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY- 251
Query: 892 PSFGENKDIVRWVTEA-TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTS 950
P +++ R + E + +P+ ++ Q M L C
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPD-YTTPEMYQT----M-----------------LDCWH 289
Query: 951 DFPINRPSMRRVVELL 966
P RP+ +VE L
Sbjct: 290 GEPSQRPTFSELVEHL 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-29
Identities = 72/302 (23%), Positives = 110/302 (36%), Gaps = 62/302 (20%)
Query: 683 HLTEQNLIGSG--GSCRVYKVKLKSGE----TVAVKRLLGGTHKPETETVFRSEIETLGR 736
+ IG G G V++ S E VA+K T E F E T+ +
Sbjct: 391 RIELGRCIGEGQFGD--VHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQ 447
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGL 796
H ++VKL+ + I + E G L L R SLD + A + L
Sbjct: 448 FDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTAL 504
Query: 797 AYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
AYL VHRD+ + N+L+ + ++ DFGL++ ++ S
Sbjct: 505 AYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--------YYKASK 551
Query: 855 GYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFG--ENKDIVRWVTE 906
G + APE ++ T SDV+ FGV + E++ G +P F +N D++ +
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIEN 607
Query: 907 AT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965
L P C L L M C + P RP +
Sbjct: 608 GERLPMPP-NCPPTLYSL----M-----------------TKCWAYDPSRRPRFTELKAQ 645
Query: 966 LR 967
L
Sbjct: 646 LS 647
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 58/248 (23%), Positives = 100/248 (40%), Gaps = 37/248 (14%)
Query: 677 EDDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
E + + + ++G G S V G VAVKR+L + + EI+ L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTE 64
Query: 737 V-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIA----QG 791
H NV++ + F + E N +L D++ K S + +
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 792 AAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPR-------------VADFGLAKALQS 838
A G+A+LH+ I+HRD+K NIL+ ++DFGL K L S
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 839 QEGQSDDAMSCVAGSYGYIAPE-------YAYTKKVTEKSDVYSFGVVLMELVTGKRPND 891
+ ++ +G+ G+ APE +++T D++S G V +++ +
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-- 238
Query: 892 PSFGENKD 899
P FG+
Sbjct: 239 P-FGDKYS 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 688 NLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETV-----FRSEIETLGRVRHGN 741
+G G VY + +S +A+K L K + E R E+E +RH N
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+++L L+ EY P G++ L + + + I + A L+Y H+
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITE-LANALSYCHS 127
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
++HRD+K N+LL + ++ADFG + S C G+ Y+ PE
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LC--GTLDYLPPEM 178
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ EK D++S GV+ E + GK P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 72/320 (22%), Positives = 115/320 (35%), Gaps = 72/320 (22%)
Query: 683 HLTEQNLIGSGGSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
+L ++GSG +V K VAVK L E E SE++ + +
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQ 104
Query: 737 V-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR---------- 785
+ H N+V LL C+ L++EY G L + L K S D
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 786 ----------FSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833
A AKG+ +L + VHRD+ + N+L+ V ++ DFGLA
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 834 KALQSQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GK 887
+ + S D V + APE + T KSDV+S+G++L E+ + G
Sbjct: 220 RDIMS-----DSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272
Query: 888 RPNDPSFGENKDIVRWVTEAT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVAL 946
P P + + + + + P ++ + M
Sbjct: 273 NPY-PGIPVDANFYKLIQNGFKMDQPF-YATEEIYII----M-----------------Q 309
Query: 947 MCTSDFPINRPSMRRVVELL 966
C + RPS + L
Sbjct: 310 SCWAFDSRKRPSFPNLTSFL 329
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-29
Identities = 75/447 (16%), Positives = 137/447 (30%), Gaps = 80/447 (17%)
Query: 100 NLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSG 159
N +LS N F T+S + ++ + +RN
Sbjct: 10 NFSLSQNSFYNTISGTY------------------ADYFSAWDKWEKQALPGENRNEAVS 51
Query: 160 DIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSK 219
+ E L L LS L + +T L E+ N L S LP +L
Sbjct: 52 LLKECL--INQFSELQLNRLNLSSLPDNLPPQITVL---EITQNALIS--LPELPASLEY 104
Query: 220 LENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLS 279
L+ A N + +P+ L +LD+ +N L+ +P + L E I +NQL+
Sbjct: 105 LD----ACDNRLSTLPELPAS---LKHLDVDNNQLT-MLPELPALL---EYINADNNQLT 153
Query: 280 GELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNL 339
LPE ++L L + N LT LPE SLE+L+++ N +P N +
Sbjct: 154 -MLPELPTSLE---VLSVRNNQLTF-LPELPE--SLEALDVSTNLLE-SLPAVPVRNHHS 205
Query: 340 ----VQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNN 395
+ + N + +P+++ + N + R + Q
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPR 263
Query: 396 RFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISN 455
+ + + F + +S
Sbjct: 264 -------------------------IYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQ 298
Query: 456 APKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQEN 515
+ N F+ ++ + + + + + +L+ +L Q
Sbjct: 299 IWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQ----VAAWLEKLSASAELRQQSF 353
Query: 516 MFTGELPRNLNSLTALIVLNLSTNQLT 542
+ + AL NL L
Sbjct: 354 AVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 52/237 (21%), Positives = 90/237 (37%), Gaps = 35/237 (14%)
Query: 93 CRIRTLRNLNLSDNYFNGTLSSQSLSPCF--HLQVLALDYNVFIGELPDFSREFANLQVL 150
C I L L+ SL + VL + N + LP+ A+L+ L
Sbjct: 56 CLINQFSELQLNRLNL------SSLPDNLPPQITVLEITQNA-LISLPE---LPASLEYL 105
Query: 151 DLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPL 210
D N S +PE LK L++ N L+ L P L + N L L
Sbjct: 106 DACDNRLS-TLPELPAS---LKHLDVDNNQLTML-PELPALLEYI---NADNNQLTM--L 155
Query: 211 PSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQ 270
P +L L + N + +P+ L LD+S N L +P E+
Sbjct: 156 PELPTSLEVLS----VRNNQLTFLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEE 207
Query: 271 IELF----DNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDN 323
E+F +N+++ +PE++ +L + + N L+ + E+++ + +
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-25
Identities = 54/311 (17%), Positives = 111/311 (35%), Gaps = 35/311 (11%)
Query: 273 LFDNQLSG---ELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEI 329
F N +SG + + ++N L E + L LN + +
Sbjct: 17 SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN-QFSELQLNRLNLS-SL 74
Query: 330 PESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQC 389
P++L P + L++ N+ LP+ +LEY D N + LP L+
Sbjct: 75 PDNLP--PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPA---SLKH 124
Query: 390 IIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSI 449
+ + NN+ + +PE L Y+ N+L LP L + + NN+ +
Sbjct: 125 LDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSLEVLS---VRNNQLT-FL 175
Query: 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAV----DLSQNRFSGHLPTCITQLN 505
+ L + ++ N +P+ + +NR + H+P I L+
Sbjct: 176 PELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLD 230
Query: 506 KLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLL 565
+ L++N + + +L+ TA + + + + N D +
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWF 288
Query: 566 TGEIPLELTKL 576
+++++
Sbjct: 289 PENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 1e-20
Identities = 53/267 (19%), Positives = 90/267 (33%), Gaps = 30/267 (11%)
Query: 95 IRTLRNLNLSDNYFNGTLSSQSLSPCF-HLQVLALDYNVFIGELPDFSREFANLQVLDLS 153
+L L+ DN +L L+ L +D N LP+ A L+ ++
Sbjct: 99 PASLEYLDACDNRL------STLPELPASLKHLDVDNNQLT-MLPE---LPALLEYINAD 148
Query: 154 RNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSS 213
N + +PE L+VL++ N L+ L P +L L ++ N L+S LP+
Sbjct: 149 NNQLT-MLPELPTS---LEVLSVRNNQLTFL-PELPESLEAL---DVSTNLLES--LPAV 198
Query: 214 VGNLSKLENLWAA---KANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQ 270
E + N I IP++I L + L DN LS +I S S +
Sbjct: 199 PVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPD 258
Query: 271 IELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM--SLESLNLNDNYFTGE 328
S + N D N ++ + + E + +
Sbjct: 259 YHGPRIYFSM--SDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS--A 314
Query: 329 IPESLASNPNLVQLKLFNNSFSGKLPD 355
+ L+ + F + L
Sbjct: 315 FLDRLSDTVSARNTSGFREQVAAWLEK 341
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-29
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 9/232 (3%)
Query: 122 HLQVLALDYNVFIGELP--DFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179
+ ++L L N I + F +L++L LSRN+ +F L L L N
Sbjct: 65 NTRLLNLHEN-QIQIIKVNSFKH-LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI- 238
L+ + L++L L NP++S P + + L L + + I +
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIP-SYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 239 GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDIS 298
L+ L L+L+ L +IP+ + L +++++L N LS P S L L +L +
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239
Query: 299 QNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSF 349
Q+ + + SL +NL N T + +L ++ L +N +
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 7/231 (3%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
N ++L+L N SF L++L L N + + L L EL N
Sbjct: 63 STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSD-NFLSGKIPHS 261
L + P + LSKL+ LW N I IP ++ L LDL + LS +
Sbjct: 123 RLTTIP-NGAFVYLSKLKELWLRN-NPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 262 FSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNL 320
F GL+++ + L L E+P +L+ L L LD+S N+L+ P + + L+ L +
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 321 NDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTN 371
+ + + +LV++ L +N+ + D +LE + N
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 34/251 (13%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
++L + N F +R L L LS N+ T+ + + +L L L N +
Sbjct: 69 LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN-RLTT 126
Query: 137 LPDFS-REFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGG-NLLSGLIPSFLGNLTE 194
+P+ + + L+ L L N +F R P L+ L+LG LS + L+
Sbjct: 127 IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN 186
Query: 195 LTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL 254
L + L L + NL+ L L LDLS N L
Sbjct: 187 LRYLNLAMCNL------REIPNLTPLIK---------------------LDELDLSGNHL 219
Query: 255 SGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM- 313
S P SF GL ++++ + +Q+ + NL +L+ ++++ NNLT LP +
Sbjct: 220 SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPL 278
Query: 314 -SLESLNLNDN 323
LE ++L+ N
Sbjct: 279 HHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 48/216 (22%), Positives = 76/216 (35%), Gaps = 31/216 (14%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANL 147
F + L L L DN T+ + + L+ L L N I +P ++ +L
Sbjct: 105 IGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNN-PIESIPSYAFNRIPSL 162
Query: 148 QVLDLSRNNFSGDIPE-SFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLK 206
+ LDL I E +F L+ LNL L IP+ L +L +L N L
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLT-PLIKLDELDLSGNHLS 220
Query: 207 SSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLA 266
+ P S L L L + + + ++F L
Sbjct: 221 AIR-------------------------PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255
Query: 267 SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNL 302
S+ +I L N L+ + + L L R+ + N
Sbjct: 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 50/254 (19%), Positives = 92/254 (36%), Gaps = 12/254 (4%)
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
+ E+P+ + + N L L N + +LE +S N
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 374 TGELPRFLCFRN--KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWG 431
+ F L + +F+NR + ++ L L N ++ F
Sbjct: 101 R-TIEIG-AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 432 LPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490
+P + ++ + IS L + + N E+P+ + L +L +DLS
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSG 216
Query: 491 NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPE-L 549
N S P L LQ+L + ++ ++L +L+ +NL+ N LT +P +
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLF 275
Query: 550 GNLAVLTSLDLSSN 563
L L + L N
Sbjct: 276 TPLHHLERIHLHHN 289
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 53/215 (24%), Positives = 81/215 (37%), Gaps = 16/215 (7%)
Query: 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNV 742
+ +G G V+KV+ K G AVKR + P+ +E+ + +V +H
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V+L L E SL G S + + LA+LH+
Sbjct: 120 VRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEA-QVWGYLRD-TLLALAHLHSQ 176
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
+VH DVK NI L ++ DFGL L + + G Y+APE
Sbjct: 177 ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT----AGAGEVQE-GDPRYMAPE-L 227
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN 897
+DV+S G+ ++E+ P GE
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL--PHGGEG 260
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 52/232 (22%), Positives = 92/232 (39%), Gaps = 9/232 (3%)
Query: 122 HLQVLALDYNVFIGELP--DFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179
+ + L L N I + F +L+VL L RN+ +F L L L N
Sbjct: 76 NTRYLNLMEN-NIQMIQADTFRH-LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI- 238
L+ + L++L L NP++S P + + L L + + I +
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIP-SYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 239 GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDIS 298
L L L+L + +P+ + L +E++E+ N P S L++L +L +
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250
Query: 299 QNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSF 349
+ ++ + SL LNL N + + LV+L L +N +
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 9/232 (3%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
+N + L+L NN ++F L+VL LG N + + L L EL N
Sbjct: 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133
Query: 204 PLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSD-NFLSGKIPH 260
L +PS LSKL LW N I IP ++ L LDL + L
Sbjct: 134 WLTV--IPSGAFEYLSKLRELWLRN-NPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 261 SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLN 319
+F GL +++ + L + ++P +L+ L L L++S N+ P + + SL+ L
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248
Query: 320 LNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTN 371
+ ++ + + +LV+L L +N+ S D L + N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 9/217 (4%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANL 147
+ F + L L L N + + + L L L N ++ +P + + L
Sbjct: 92 ADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN-WLTVIPSGAFEYLSKL 149
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGG-NLLSGLIPSFLGNLTELTHFELGYNPLK 206
+ L L N +F R P L L+LG L + L L + LG +K
Sbjct: 150 RELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209
Query: 207 SSPLPSSVGNLSKLENLWAAKANLIGEIP-DSIGKLAFLSNLDLSDNFLSGKIPHSFSGL 265
P ++ L LE L + N EI S L+ L L + ++ +S ++F GL
Sbjct: 210 DMP---NLTPLVGLEELEMSG-NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL 265
Query: 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNL 302
AS+ ++ L N LS + + L L+ L + N
Sbjct: 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 46/254 (18%), Positives = 93/254 (36%), Gaps = 12/254 (4%)
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
+ + E+P+ + N L L N+ D +LE + N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 374 TGELPRFLCFRN--KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWG 431
++ F L + +F+N + ++ L L N ++ F
Sbjct: 112 R-QIEVG-AFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 432 LPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490
+P + ++ + IS L + + N ++P+ + L L+ +++S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 491 NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPE-L 549
N F P L+ L++L + + + + L +L+ LNL+ N L+ ++P +
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286
Query: 550 GNLAVLTSLDLSSN 563
L L L L N
Sbjct: 287 TPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-15
Identities = 65/312 (20%), Positives = 106/312 (33%), Gaps = 80/312 (25%)
Query: 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTL 292
E+P I + L+L +N + +F L +E ++L N + + + L +L
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 293 LRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASN-PNLVQLKLFNNSFS 350
L++ N LT + L L L +N IP + P+L++L
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRL-------- 176
Query: 351 GKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKT 410
DLG+ LEY +S F G L
Sbjct: 177 -----DLGELKKLEY--ISEGAFEG-LFN------------------------------- 197
Query: 411 LNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT 470
L YL G ++ ++P+ L ++ EM N F I P +F
Sbjct: 198 LKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRP---------------GSFH 239
Query: 471 GEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN-LNSLT 529
G L L+ + + ++ S L L +L L N + LP + L
Sbjct: 240 G--------LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLR 290
Query: 530 ALIVLNLSTNQL 541
L+ L+L N
Sbjct: 291 YLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 52/243 (21%), Positives = 79/243 (32%), Gaps = 38/243 (15%)
Query: 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNN 468
YL N +Q F L ++ ++ N I + L + + N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134
Query: 469 FTGEVPSQICT-LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN-LN 526
T +PS L +L+ + L N ++ L +L+L E +
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 527 SLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP-------LELTKLKLN 579
L L LNL + P L L L L++S N EI L KL +
Sbjct: 194 GLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVM 250
Query: 580 Q----------F---------NISHNKLYGEVPSD-FDHDLFISSLL--DNPGLCSPDLK 617
F N++HN L +P D F ++ L NP C D+
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHNPWNCDCDIL 309
Query: 618 PLP 620
L
Sbjct: 310 WLA 312
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 66/306 (21%), Positives = 114/306 (37%), Gaps = 59/306 (19%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE------TVAVKRLLGGTHKPETETVFRSEIETLGR 736
++T +G G VY+ ++ VAVK L + E F E + +
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISK 89
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML----HEKGRSGSLDWSIRFSIAQGA 792
H N+V+ + ++ E M G L L + SL +A+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 793 AKGLAYL--HNDCVPAIVHRDVKSHNILLDAE---MVPRVADFGLAKALQSQEGQSDDAM 847
A G YL ++ +HRD+ + N LL V ++ DFG+A+ +
Sbjct: 150 ACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS------- 197
Query: 848 SCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIV 901
G + PE T K+D +SFGV+L E+ + G P PS N++++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSK-SNQEVL 255
Query: 902 RWVTE-ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960
+VT + P+ C + ++ M C P +RP+
Sbjct: 256 EFVTSGGRMDPPK-NCPGPVYRI----M-----------------TQCWQHQPEDRPNFA 293
Query: 961 RVVELL 966
++E +
Sbjct: 294 IILERI 299
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 63/302 (20%)
Query: 690 IGSG--GSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN 741
+G G G VY+ VK + VA+K + E F +E + +
Sbjct: 33 LGQGSFG--MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHH 89
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR-------FSIAQGAAK 794
VV+LL S +++ E M G L L + + + + +A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 795 GLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
G+AYL + VHRD+ + N ++ + ++ DFG+ + + + G
Sbjct: 150 GMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-------YYRKG 197
Query: 853 SYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTE 906
G + +PE T SDV+SFGVVL E+ T ++P N+ ++R+V E
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGL-SNEQVLRFVME 255
Query: 907 -ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965
L P+ C L +L M MC P RPS ++
Sbjct: 256 GGLLDKPD-NCPDMLFEL----M-----------------RMCWQYNPKMRPSFLEIISS 293
Query: 966 LR 967
++
Sbjct: 294 IK 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 73/316 (23%), Positives = 125/316 (39%), Gaps = 72/316 (22%)
Query: 684 LTEQNLIGSG--GSCRVYK--------VKLKSGETVAVKRLLGGTHKPETETVFRSEIET 733
LT +G G G +V K K TVAVK L + + SE+E
Sbjct: 83 LTLGKPLGEGCFG--QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEM 139
Query: 734 LGRV-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML-------------HEKGRSGS 779
+ + +H N++ LL C+ ++ EY G+L + L +
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 780 LDWSIRFSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837
+ + S A+G+ YL +HRD+ + N+L+ V ++ADFGLA+ +
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 838 SQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
+ + + G + APE + + T +SDV+SFGV++ E+ T G P
Sbjct: 255 NID-------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY- 306
Query: 892 PSFGENKDIVRWVTE-ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTS 950
P +++ + + E + P C +L + M C
Sbjct: 307 PGI-PVEELFKLLKEGHRMDKPA-NCTNELYMM----M-----------------RDCWH 343
Query: 951 DFPINRPSMRRVVELL 966
P RP+ +++VE L
Sbjct: 344 AVPSQRPTFKQLVEDL 359
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 73/316 (23%), Positives = 125/316 (39%), Gaps = 72/316 (22%)
Query: 684 LTEQNLIGSG--GSCRVYK--------VKLKSGETVAVKRLLGGTHKPETETVFRSEIET 733
LT +G G G +V K K TVAVK L + + SE+E
Sbjct: 37 LTLGKPLGEGAFG--QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEM 93
Query: 734 LGRV-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML-------------HEKGRSGS 779
+ + +H N++ LL C+ ++ EY G+L + L +
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 780 LDWSIRFSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837
+ + S A+G+ YL +HRD+ + N+L+ V ++ADFGLA+ +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 838 SQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
+ + + G + APE + + T +SDV+SFGV++ E+ T G P
Sbjct: 209 NID-------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY- 260
Query: 892 PSFGENKDIVRWVTE-ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTS 950
P +++ + + E + P C +L + M C
Sbjct: 261 PGI-PVEELFKLLKEGHRMDKPA-NCTNELYMM----M-----------------RDCWH 297
Query: 951 DFPINRPSMRRVVELL 966
P RP+ +++VE L
Sbjct: 298 AVPSQRPTFKQLVEDL 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 71/339 (20%), Positives = 126/339 (37%), Gaps = 61/339 (17%)
Query: 652 KVKSGFFSTSKSPWKVVTFQRVSFNEDDILPH--LTEQNLIGSGGSCRVYKVKLKSGE-- 707
K+++ T +P + S ++ +P +T +G G VY+ ++
Sbjct: 39 KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 98
Query: 708 ----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMP 763
VAVK L + E F E + + H N+V+ + ++ E M
Sbjct: 99 PSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 157
Query: 764 NGSLADML----HEKGRSGSLDWSIRFSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNI 817
G L L + SL +A+ A G YL ++ +HRD+ + N
Sbjct: 158 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNC 212
Query: 818 LLDAE---MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTE 869
LL V ++ DFG+A+ + G + PE T
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAG-------YYRKGGCAMLPVKWMPPEAFMEGIFTS 265
Query: 870 KSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA-TLSSPERGCCRDLNQLIDPR 927
K+D +SFGV+L E+ + G P PS N++++ +VT + P+ C + ++
Sbjct: 266 KTDTWSFGVLLWEIFSLGYMPY-PSK-SNQEVLEFVTSGGRMDPPK-NCPGPVYRI---- 318
Query: 928 MDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
M C P +RP+ ++E +
Sbjct: 319 M-----------------TQCWQHQPEDRPNFAIILERI 340
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 51/246 (20%), Positives = 83/246 (33%), Gaps = 50/246 (20%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVK----RLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
IG G V + A+K + + + E + E+ + ++ H N+ +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLHHPNIAR 92
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG------------- 791
L + + LV E G L D L+ + ++ Q
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 792 -----------------AAK-------GLAYLHNDCVPAIVHRDVKSHNILL--DAEMVP 825
+ L YLHN I HRD+K N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 826 RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE--YAYTKKVTEKSDVYSFGVVLMEL 883
++ DFGL+K M+ AG+ ++APE + K D +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 884 VTGKRP 889
+ G P
Sbjct: 270 LMGAVP 275
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 55/271 (20%), Positives = 100/271 (36%), Gaps = 23/271 (8%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
+ F ++ L L L +N + + ++ SP LQ L + N + E+P ++L
Sbjct: 71 KDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKN-HLVEIPPNL--PSSLV 126
Query: 149 VLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLL--SGLIPSFLGNLTELTHFELGYNPLK 206
L + N F + + +GGN L SG P L L + + L
Sbjct: 127 ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT 185
Query: 207 SSPLPSSVGNLSKLENLWAAKANLIGEIPD-SIGKLAFLSNLDLSDNFLSGKIPHSFSGL 265
P L L N I I + + + L L L N + S S L
Sbjct: 186 GIP----KDLPETLNELHLDH-NKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240
Query: 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT-------GNLPETIAAMSLESL 318
++ ++ L +N+LS +P L +L L + + NN+T + + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 319 NLNDNYFT-GEIPESLASN-PNLVQLKLFNN 347
+L +N E+ + + + ++ N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 54/287 (18%), Positives = 103/287 (35%), Gaps = 42/287 (14%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
+ +LDL N+ S + F L L L N +S + L +L + N
Sbjct: 53 SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKI--PH 260
L +P ++ S L L N I ++P + L ++ +++ N L P
Sbjct: 113 HLVE--IPPNL--PSSLVELRIH-DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 261 SFSGL--------------------ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQN 300
+F GL ++ ++ L N++ E L + L RL + N
Sbjct: 168 AFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227
Query: 301 NLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDD--- 356
+ +++ + +L L+L++N + +P L L + L N+ + K+ +
Sbjct: 228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFC 285
Query: 357 ----LGKYSNLEYFDVSTNDFT-GELPR--FLCFRNKLQCIIIFNNR 396
K + + N E+ F C + I N +
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD-RLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 65/341 (19%), Positives = 112/341 (32%), Gaps = 87/341 (25%)
Query: 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTL 292
+P I + LDL +N +S F GL + + L +N++S ++ S L L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 293 LRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGK 352
+L IS+N+L +P + + SL L ++DN + N+ +++ N
Sbjct: 105 QKLYISKNHLV-EIPPNLPS-SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN----- 157
Query: 353 LPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLN 412
LE F G KL + I + + IP+ +TLN
Sbjct: 158 ---------PLENSGFEPGAFDG---------LKLNYLRISEAKLT-GIPK--DLPETLN 196
Query: 413 YLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE 472
L N++Q I +
Sbjct: 197 ELHLDHNKIQ----------------------------------------AIELEDLLR- 215
Query: 473 VPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALI 532
+L + L N+ ++ L L++L L N + +P L L L
Sbjct: 216 -------YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ 267
Query: 533 VLNLSTNQLTGTIPPE-------LGNLAVLTSLDLSSNLLT 566
V+ L TN +T + A + L +N +
Sbjct: 268 VVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 31/149 (20%), Positives = 58/149 (38%), Gaps = 8/149 (5%)
Query: 442 NNRFEGSISP-SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTC 500
NN + L +++ N + LR+LQ + +S+N +P
Sbjct: 63 NNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP- 119
Query: 501 ITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGT-IPPELGNLAVLTSLD 559
+ L +L + +N + L + + + N L + P + L L
Sbjct: 120 -NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178
Query: 560 LSSNLLTGEIPLELTKLKLNQFNISHNKL 588
+S LT IP +L + LN+ ++ HNK+
Sbjct: 179 ISEAKLT-GIPKDLPE-TLNELHLDHNKI 205
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 34/149 (22%), Positives = 45/149 (30%), Gaps = 30/149 (20%)
Query: 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN 524
+ VP +I +DL N S L L L L N + +
Sbjct: 41 SDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA 97
Query: 525 LNSLTALIVLNLSTNQLTGTIPPEL----------------------GNLAVLTSLDLSS 562
+ L L L +S N L IPP L L + +++
Sbjct: 98 FSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 563 NLLTGEIPLE---LTKLKLNQFNISHNKL 588
N L E LKLN IS KL
Sbjct: 157 NPLE-NSGFEPGAFDGLKLNYLRISEAKL 184
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 73/316 (23%), Positives = 122/316 (38%), Gaps = 72/316 (22%)
Query: 684 LTEQNLIGSG--GSCRVYK--------VKLKSGETVAVKRLLGGTHKPETETVFRSEIET 733
L +G G G +V K VAVK L + + SE+E
Sbjct: 71 LVLGKPLGEGAFG--QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEM 127
Query: 734 LGRV-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR------- 785
+ + +H N++ LL C+ ++ EY G+L + L + G
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 786 ------FSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837
S A A+G+ YL +HRD+ + N+L+ + V ++ADFGLA+ +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 838 SQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891
+ + G + APE + + T +SDV+SFGV+L E+ T G P
Sbjct: 243 HID-------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY- 294
Query: 892 PSFGENKDIVRWVTEA-TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTS 950
P +++ + + E + P C +L + M C
Sbjct: 295 PGV-PVEELFKLLKEGHRMDKPS-NCTNELYMM----M-----------------RDCWH 331
Query: 951 DFPINRPSMRRVVELL 966
P RP+ +++VE L
Sbjct: 332 AVPSQRPTFKQLVEDL 347
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETV-----FRSEIETLGRVRHGNV 742
+G G VY + ++ +A+K L K + E R EIE +RH N+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVL----FKSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
+++ + L+ E+ P G L L + GR + + + A L Y H
Sbjct: 77 LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD--EQRSATFMEE-LADALHYCHER 133
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
V +HRD+K N+L+ + ++ADFG + S ++ C G+ Y+ PE
Sbjct: 134 KV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MC--GTLDYLPPEMI 184
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRP 889
K EK D++ GV+ E + G P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 41/223 (18%), Positives = 87/223 (39%), Gaps = 33/223 (14%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRL---------------LGGTHKPETETVFRSEIETL 734
+ G ++ + K + A+K+ F++E++ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 735 GRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------I 788
+++ + + D ++YEYM N S+ +++ I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL-DKNYTCFIPIQVIKCI 156
Query: 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS 848
+ +Y+HN+ I HRDVK NIL+D +++DFG ++ + ++ + S
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG----S 210
Query: 849 CVAGSYGYIAPEYAYTKKVT--EKSDVYSFGVVLMELVTGKRP 889
G+Y ++ PE+ + K D++S G+ L + P
Sbjct: 211 R--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 79/324 (24%), Positives = 118/324 (36%), Gaps = 81/324 (25%)
Query: 683 HLTEQNLIGSG--GSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETL 734
+L +G G G +V K TVAVK L E SE L
Sbjct: 24 NLVLGKTLGEGEFG--KVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVL 80
Query: 735 GRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADML---------------------HE 773
+V H +V+KL CS +L+ EY GSL L +
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 774 KGRSGSLDWSIRFSIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831
+L S A ++G+ YL +VHRD+ + NIL+ +++DFG
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFG 195
Query: 832 LAKALQSQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT- 885
L++ + +D+ V S G I A E + T +SDV+SFGV+L E+VT
Sbjct: 196 LSRDV-----YEEDSY--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 886 GKRPNDPSFGENKDIVRWVTEA-TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNV 944
G P P + + + + P+ C ++ Y
Sbjct: 249 GGNPY-PGI-PPERLFNLLKTGHRMERPD-NCSEEM--------------YR-------- 283
Query: 945 ALM--CTSDFPINRPSMRRVVELL 966
LM C P RP + + L
Sbjct: 284 -LMLQCWKQEPDKRPVFADISKDL 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 22/283 (7%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+DL ++ F ++ L L L +N + +S + +P L+ L L N + E
Sbjct: 57 LDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKN-QLKE 114
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLL--SGLIPSFLGNLTE 194
LP+ LQ L + N + F + V+ LG N L SG+ + +
Sbjct: 115 LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172
Query: 195 LTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD-SIGKLAFLSNLDLSDNF 253
L++ + + + +P G L L N I ++ S+ L L+ L LS N
Sbjct: 173 LSYIRIADTNITT--IPQ--GLPPSLTELHLDG-NKITKVDAASLKGLNNLAKLGLSFNS 227
Query: 254 LSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM 313
+S S + + ++ L +N+L ++P L++ + + + NN++
Sbjct: 228 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 286
Query: 314 -------SLESLNLNDNYFT-GEIPESLASN-PNLVQLKLFNN 347
S ++L N EI S ++L N
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 61/287 (21%), Positives = 104/287 (36%), Gaps = 41/287 (14%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
+ +LDL N + F L L L N +S + P L +L L N
Sbjct: 51 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKI--PH 260
LK LP + L+ L N I ++ S+ L + ++L N L
Sbjct: 111 QLKE--LPEKM--PKTLQELRVH-ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 261 SFSGLASIEQIELFDNQLSG----------EL-----------PESLSNLTTLLRLDISQ 299
+F G+ + I + D ++ EL SL L L +L +S
Sbjct: 166 AFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 300 NNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSG------K 352
N+++ ++A L L+LN+N ++P LA + + + L NN+ S
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 353 LPDDLGKYSNLEYFDVSTNDFT-GELPR--FLCFRNKLQCIIIFNNR 396
P K ++ + +N E+ F C + + N +
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV-RAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 65/335 (19%), Positives = 127/335 (37%), Gaps = 54/335 (16%)
Query: 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTL 292
++P + + LDL +N ++ F L ++ + L +N++S P + + L L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 293 LRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGK 352
RL +S+N L LPE + +L+ L +++N T ++ ++L N
Sbjct: 103 ERLYLSKNQLK-ELPEKMPK-TLQELRVHENEITKVRKSVFNGLNQMIVVELGTN----- 155
Query: 353 LPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLN 412
L+ + F G + + L I I + + IP+ G +L
Sbjct: 156 ---------PLKSSGIENGAFQG-MKK-------LSYIRIADTNIT-TIPQ--GLPPSLT 195
Query: 413 YLRFGGNELQGELPSK-FWGLPEVDFFEMYNNRFEGSISP-SISNAPKLTGILINGNNFT 470
L GN++ ++ + GL + + N ++ S++N P L + +N N
Sbjct: 196 ELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253
Query: 471 GEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTA 530
+VP + + +Q V L N S + N F P +
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNIS----------------AIGSNDFCP--PGYNTKKAS 294
Query: 531 LIVLNLSTNQLTGT-IPPEL-GNLAVLTSLDLSSN 563
++L +N + I P + V ++ L +
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 26/295 (8%)
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
L + +D ++P+ L P+ L L NN + D NL + N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 374 TGELPRFLCFRN--KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWG 431
+ P F KL+ + + N+ ++PE KTL LR NE+ S F G
Sbjct: 89 SKISPG--AFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNG 143
Query: 432 LPEVDFFEMYNNRF-EGSISPSI-SNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLS 489
L ++ E+ N I KL+ I I N T +P L + L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLD 200
Query: 490 QNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN-LNSLTALIVLNLSTNQLTGTIPPE 548
N+ + + LN L +L L N + + L + L L+L+ N+L +P
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGG 258
Query: 549 LGNLAVLTSLDLSSNLLTG------EIPLELTKL-KLNQFNISHNKL-YGEVPSD 595
L + + + L +N ++ P TK + ++ N + Y E+
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 78/322 (24%), Positives = 125/322 (38%), Gaps = 77/322 (23%)
Query: 684 LTEQNLIGSG--GSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLG 735
+ IG G G RV++ + + VAVK L F+ E +
Sbjct: 49 IEYVRDIGEGAFG--RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMA 105
Query: 736 RVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRF--------- 786
+ N+VKLL C+ L++EYM G L + L S
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 787 ------------SIAQGAAKGLAYL--HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832
IA+ A G+AYL VHRD+ + N L+ MV ++ADFGL
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGL 220
Query: 833 AKALQSQEGQSDDAMSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-G 886
++ + S + A I PE + + T +SDV+++GVVL E+ + G
Sbjct: 221 SRNIYSAD-------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273
Query: 887 KRPNDPSFGENKDIVRWVTE-ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVA 945
+P +++++ +V + L+ PE C +L L M
Sbjct: 274 LQPY-YGM-AHEEVIYYVRDGNILACPE-NCPLELYNL----M----------------- 309
Query: 946 LMCTSDFPINRPSMRRVVELLR 967
+C S P +RPS + +L+
Sbjct: 310 RLCWSKLPADRPSFCSIHRILQ 331
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 16/232 (6%)
Query: 661 SKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTH 719
P + + +G G VYK ++G+ VA+K++
Sbjct: 8 RNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV----- 62
Query: 720 KPETE-TVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSG 778
E++ EI + + +VVK +V EY GS++D++ + R+
Sbjct: 63 PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNK 120
Query: 779 SLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838
+L +I Q KGL YLH +HRD+K+ NILL+ E ++ADFG+A L
Sbjct: 121 TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177
Query: 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890
+ + V G+ ++APE +D++S G+ +E+ GK P
Sbjct: 178 TMAKRNT----VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 14/239 (5%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS--GLIPSFLGNLTELTHFELG 201
++ L+L N F + L L+L N LS G T L + +L
Sbjct: 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 202 YNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDS--IGKLAFLSNLDLSDNFLSGKIP 259
+N + + + S+ L +LE+L + + ++ + L L LD+S
Sbjct: 87 FNGVIT--MSSNFLGLEQLEHLDFQH-SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143
Query: 260 HSFSGLASIEQIELFDNQ-LSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM--SLE 316
F+GL+S+E +++ N LP+ + L L LD+SQ L L T SL+
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQ 202
Query: 317 SLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL--GKYSNLEYFDVSTNDF 373
LN++ N F +L L N S+L + +++ NDF
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 52/252 (20%), Positives = 82/252 (32%), Gaps = 31/252 (12%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFN-GTLSSQSLSPCFHLQVLALDYNVFIG 135
++L L F ++ L L+LS N + SQS L+ L L +N +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN-GVI 91
Query: 136 ELPDFSREFANLQVLDLSRNNFSGDIPES-FGRFPVLKVLNLGGNLLSGLIPSFLGNLTE 194
+ L+ LD +N S F L L++ L+
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151
Query: 195 LTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL 254
L ++ N + + LP L L LDLS L
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLT------------------------FLDLSQCQL 187
Query: 255 SGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETI---A 311
P +F+ L+S++ + + N L +L LD S N++ +
Sbjct: 188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHF 246
Query: 312 AMSLESLNLNDN 323
SL LNL N
Sbjct: 247 PSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 56/282 (19%), Positives = 99/282 (35%), Gaps = 36/282 (12%)
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
S + N T +P + + +L+L +N K + L +S
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLS---- 60
Query: 374 TGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLP 433
N L + G +L YL N + + S F GL
Sbjct: 61 ----------SNGLSFKGCCSQSDFG--------TTSLKYLDLSFNGVI-TMSSNFLGLE 101
Query: 434 EVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQICT-LRQLQAVDLSQN 491
+++ + ++ + S+ + L + I+ + + I L L+ + ++ N
Sbjct: 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGN 160
Query: 492 RFSGHLPTCI-TQLNKLQQLELQENMFTGELPRN-LNSLTALIVLNLSTNQLTGTIPPE- 548
F + I T+L L L+L + +L NSL++L VLN+S N ++
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP 218
Query: 549 LGNLAVLTSLDLSSNLLTGEIPLELTKL--KLNQFNISHNKL 588
L L LD S N + EL L N++ N
Sbjct: 219 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 3/119 (2%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANL 147
F + +L L ++ N F + +L L L + +L + ++L
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC-QLEQLSPTAFNSLSSL 201
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNL-TELTHFELGYNPL 205
QVL++S NNF + L+VL+ N + L + + L L N
Sbjct: 202 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 22/95 (23%), Positives = 38/95 (40%), Gaps = 9/95 (9%)
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPP-ELGNLAVLTSLDLSSNLLT 566
++ T +P + ++ L L +N+L ++P L LT L LSSN L+
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 567 --GEIPLELTKL-KLNQFNISHNKLYGEVPSDFDH 598
G L ++S N + + S+F
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLG 99
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 12/212 (5%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
+ + LDLS N SF FP L+VL+L + + +L+ L+ L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 204 PLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFL-SGKIPH 260
P++S L LS L+ L A + + + + G L L L+++ N + S K+P
Sbjct: 87 PIQS--LALGAFSGLSSLQKLVAVE-TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 261 SFSGLASIEQIELFDNQLSGELPE----SLSNLTTL-LRLDISQNNLTGNLPETIAAMSL 315
FS L ++E ++L N++ + L + L L LD+S N + P + L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 316 ESLNLNDNYFTGEIPESLASNPNLVQLKLFNN 347
+ L L+ N +L ++ L N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 18/223 (8%)
Query: 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNN 468
+ L N L+ F+ PE+ ++ + +I + L+ +++ GN
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 469 FTGEVPSQICT-LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG-ELPRNLN 526
+ + L LQ + + + I L L++L + N+ +LP +
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 527 SLTALIVLNLSTNQLTGTIPPE----LGNLAVLT-SLDLSSNLLTGEIPLEL-TKLKLNQ 580
+LT L L+LS+N++ +I L + +L SLDLS N + I +++L +
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204
Query: 581 FNISHNKLYGEVPSD-FDH--DLFISSLLDNPGLCS-PDLKPL 619
+ N+L VP FD L L NP CS P + L
Sbjct: 205 LALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 246
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 44/238 (18%), Positives = 74/238 (31%), Gaps = 42/238 (17%)
Query: 337 PNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCI--IIFN 394
+ L L N + L+ D+S R ++Q I +
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS--------------RCEIQTIEDGAYQ 73
Query: 395 NRFSGKIPESYGECKTLNYLRFGGNELQGELPSK-FWGLPEVDFFEMYNNRFEGSISPSI 453
+ L+ L GN +Q L F GL + S+
Sbjct: 74 SLSH------------LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFP 119
Query: 454 -SNAPKLTGILINGNNFTG-EVPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQ-- 508
+ L + + N ++P L L+ +DLS N+ + L+++
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL 178
Query: 509 --QLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSN 563
L+L N + L L L TNQL ++P L L + L +N
Sbjct: 179 NLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 34/225 (15%), Positives = 72/225 (32%), Gaps = 32/225 (14%)
Query: 687 QNLIGSGGSCRVYKVK------LKSGETVAVKRLLGGTHKPETET---VFRSEIETLGRV 737
+L+G G +VY+ K+ + +K KP + +E L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-----KPANPWEFYIGTQLMERLKPS 124
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGR--SGSLDWSIRFSIAQGAAKG 795
+K Q+ ++LV E G+L + ++ + + S A
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVP-----------RVADFGLAKALQSQEGQSD 844
+ +H+ I+H D+K N +L + + D G + ++
Sbjct: 185 IEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF--PKG 239
Query: 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ + G+ E K + D + + ++ G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 41/277 (14%), Positives = 77/277 (27%), Gaps = 62/277 (22%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVK-----------------------RLLGGTHKPETE 724
++G + ++GE+ V RLL G +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 725 TVFRSEIETLGRVRHGNVVKLLMCCSGQD----FNILVYEYMPNGSLADMLHE----KGR 776
V I V+ K++ + + +L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 777 SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836
SL R + + LA LH+ +VH ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 255
Query: 837 QSQEGQSDDAMSCVAGSYGYIAPEY-----------AYTKKVTEKSDVYSFGVVLMELVT 885
D A + S G+ PE +T D ++ G+V+ +
Sbjct: 256 -------DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 886 GKRPNDPSFGEN--KDIVRWVTEATLSSPERGCCRDL 920
P ++ W+ + + P+ R L
Sbjct: 309 ADLP----ITKDAALGGSEWIFRSCKNIPQP--VRAL 339
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 676 NEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIET 733
+ D T IG G S VY + +G+ VA++++ L +P+ E + EI
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIIN-EILV 70
Query: 734 LGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA 793
+ ++ N+V L D +V EY+ GSL D++ E +D ++ +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECL 126
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
+ L +LH++ ++HRD+KS NILL + ++ DFG + ++ + + G+
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGT 179
Query: 854 YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890
++APE K K D++S G++ +E++ G+ P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 48/233 (20%), Positives = 85/233 (36%), Gaps = 44/233 (18%)
Query: 685 TEQNLIGSGGSCRVYKV-KLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNV 742
E IGSG V+K K G A+KR E E+ + +H +V
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSL--DWSIRFSIAQGAAKGLAYLH 800
V+ + D ++ EY GSLAD + E R S + ++ + Q +GL Y+H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ-VGRGLRYIH 132
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVP-------------------RVADFGLAKALQSQEG 841
+ ++VH D+K NI + +P ++ D G
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT------- 182
Query: 842 QSDDAMSCVAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ S ++A E Y + K+D+++ + ++ +
Sbjct: 183 RISSPQVEEGDSR-FLANEVLQENYTHLP----KADIFALALTVVCAAGAEPL 230
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 685 TEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
T+ IG G V+K ++ + VA+K + + E E + + EI L + V
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVT 83
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
K ++ EY+ GS D+L G LD + +I + KGL YLH++
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE- 138
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
+HRD+K+ N+LL ++ADFG+A L + + + G+ ++APE
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT----FVGTPFWMAPEVIK 192
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRPN 890
K+D++S G+ +EL G+ P+
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPH 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 690 IGSGGSCRVYKVKL----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
IG G KVKL +G VA+K + P + E+ + + H N+VKL
Sbjct: 23 IGKGNFA---KVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ L+ EY G + D L GR + S + + Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR-- 134
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
IVHRD+K+ N+LLDA+M ++ADFG S E + G+ Y APE K
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGF-----SNEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 866 KVT-EKSDVYSFGVVLMELVTGKRP 889
K + DV+S GV+L LV+G P
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 67/312 (21%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVK----RLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
IG G V + + G+ AVK + TE + R E ++H ++V+
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR-EASICHMLKHPHIVE 90
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAY 798
LL S +V+E+M L + ++ +G +S A + + L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-----VYSEAVASHYMRQILEALRY 145
Query: 799 LH-NDCVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
H N+ I+HRDVK H +LL A + ++ FG+A L +S G
Sbjct: 146 CHDNN----IIHRDVKPHCVLLASKENSAPV--KLGGFGVAIQLG----ESGLVAGGRVG 195
Query: 853 SYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKDIVRWVTEA 907
+ ++APE Y K V DV+ GV+L L++G P F G + + + +
Sbjct: 196 TPHFMAPEVVKREPYGKPV----DVWGCGVILFILLSGCLP----FYGTKERLFEGIIKG 247
Query: 908 TLS---------SPERGCCRDL-NQL--IDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN 955
S +DL ++ +DP ++ + LN + D
Sbjct: 248 KYKMNPRQWSHISES---AKDLVRRMLMLDPAERIT------VYEALNHPWLKERDRYAY 298
Query: 956 RPSMRRVVELLR 967
+ + VE LR
Sbjct: 299 KIHLPETVEQLR 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 28/227 (12%)
Query: 673 VSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEI 731
++ + + +GSG V + K + A+K + + + + E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 732 ETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQG 791
L + H N++KL + LV E G L D + + +F+
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM---------KFNEVDA 138
Query: 792 AA------KGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQ 842
A G+ YLH IVHRD+K N+LL + + + ++ DFGL+ +
Sbjct: 139 AVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-----E 190
Query: 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ M G+ YIAPE KK EK DV+S GV+L L+ G P
Sbjct: 191 NQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 5/209 (2%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
A Q + L N S SF L +L L N+L+ + + L L +L N
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIP-HS 261
S P++ L +L L + + E+ + LA L L L DN L +P +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDR-CGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148
Query: 262 FSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNL 320
F L ++ + L N++S + L +L RL + QN + P + L +L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 321 NDNYFTGEIPESLASNPNLVQLKLFNNSF 349
N + E+LA L L+L +N +
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 57/243 (23%), Positives = 82/243 (33%), Gaps = 36/243 (14%)
Query: 63 TGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFH 122
GI +Q I L G +S F R L L L N + + + +
Sbjct: 28 VGIPAASQR-----IFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81
Query: 123 LQVLALDYNVFIGELPD--FSREFANLQVLDLSRNNFSGDIPE-SFGRFPVLKVLNLGGN 179
L+ L L N + + F L L L R ++ F L+ L L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHG-LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIG 239
L L +L LTH L N + S +P L +L
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISS--VPE--RAFRGLHSLD--------------- 180
Query: 240 KLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQ 299
L L N ++ PH+F L + + LF N LS E+L+ L L L ++
Sbjct: 181 ------RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
Query: 300 NNL 302
N
Sbjct: 235 NPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 45/221 (20%), Positives = 77/221 (34%), Gaps = 16/221 (7%)
Query: 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNN 468
+ GN + + F + +++N I + + L + ++ N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNA 91
Query: 469 FTGEVPSQICT-LRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRN-L 525
V L +L + L + L + L LQ L LQ+N LP +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 526 NSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLTGEIPLE-LTKL-KLNQFN 582
L L L L N+++ ++P L L L L N + + L +L
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 583 ISHNKLYGEVPSD-FDH--DLFISSLLDNPGLCSPDLKPLP 620
+ N L +P++ L L DNP +C +PL
Sbjct: 208 LFANNL-SALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 52/276 (18%), Positives = 82/276 (29%), Gaps = 59/276 (21%)
Query: 293 LRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGK 352
+ Q L +P I A + + + L+ N + S + NL L L +N +
Sbjct: 14 VTTSCPQQGLQ-AVPVGIPA-ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-- 69
Query: 353 LPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLN 412
+ FTG L L
Sbjct: 70 --------------RIDAAAFTG-LAL-------------------------------LE 83
Query: 413 YLRFGGNELQGELPSK-FWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFT 470
L N + F GL + + + + P + L + + N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 471 GEVPSQICT-LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN-LNSL 528
+P L L + L NR S L+ L +L L +N + + L
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDL 200
Query: 529 TALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSN 563
L+ L L N L+ +P E L L L L L+ N
Sbjct: 201 GRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 29/127 (22%), Positives = 37/127 (29%), Gaps = 7/127 (5%)
Query: 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN 524
VP I Q + L NR S L L L N+
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 525 LNSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLTGEIPLE-LTKL-KLNQF 581
L L L+LS N ++ P L L +L L L E+ L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 582 NISHNKL 588
+ N L
Sbjct: 135 YLQDNAL 141
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 63/270 (23%), Positives = 103/270 (38%), Gaps = 23/270 (8%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
++ LDLS N + R L+ L L N ++ + +L L H +L YN
Sbjct: 51 TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 204 PLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI--GKLAFLSNLDLSDNFLSGKIPH 260
L + L SS LS L L N + ++ L L L + + KI
Sbjct: 111 YLSN--LSSSWFKPLSSLTFLNLL-GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 261 -SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM--SLES 317
F+GL +E++E+ + L P+SL ++ + L + L E + S+E
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVEC 226
Query: 318 LNLNDNYFTG----EIPE----SLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVS 369
L L D E+ SL +K+ + S ++ L + S L + S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285
Query: 370 TNDFTGELPRFLCFRN--KLQCIIIFNNRF 397
N +P + F LQ I + N +
Sbjct: 286 RNQLKS-VPDGI-FDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 59/297 (19%), Positives = 99/297 (33%), Gaps = 41/297 (13%)
Query: 63 TGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFH 122
+G+T ++ +DLS ++ + R L+ L L+ N
Sbjct: 48 SGLTEAVKS-----LDLSNNRITYISNSDLQRCVNLQALVLTSN---------------- 86
Query: 123 LQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS 182
+ ++ + F +L+ LDLS N S F L LNL GN
Sbjct: 87 -GINTIEEDSFSS--------LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK 137
Query: 183 GLIP-SFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD-SIGK 240
L S +LT+L +G + L+ LE L A+ + S+
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID-ASDLQSYEPKSLKS 196
Query: 241 LAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSG----ELPE----SLSNLTTL 292
+ +S+L L + +S+E +EL D L EL SL T
Sbjct: 197 IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
Query: 293 LRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSF 349
+ I+ +L + L L + N +L ++ L N +
Sbjct: 257 RNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 35/208 (16%), Positives = 71/208 (34%), Gaps = 21/208 (10%)
Query: 98 LRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD--FSREFANLQVLDLSRN 155
L LNL N + + S LQ+L + ++ F+ L+ L++ +
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG-LTFLEELEIDAS 184
Query: 156 NFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVG 215
+ P+S + L L L+ F+ + + EL L +
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE--- 241
Query: 216 NLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275
L +S+ K N+ ++D L ++ + ++ + ++E
Sbjct: 242 --------------LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 276 NQLSGELPESLSNLTTLLRLDISQNNLT 303
NQL LT+L ++ + N
Sbjct: 287 NQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 54/318 (16%), Positives = 102/318 (32%), Gaps = 44/318 (13%)
Query: 317 SLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE 376
+ IP L + L L NN + DL + NL+ +++N
Sbjct: 35 ICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-T 90
Query: 377 LPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSK-FWGLPEV 435
+ + FS +L +L N L L S F L +
Sbjct: 91 IE---------------EDSFSS--------LGSLEHLDLSYNYLS-NLSSSWFKPLSSL 126
Query: 436 DFFEMYNNRFEGSISPSI--SNAPKLTGILINGNNFTGEVPSQI-CTLRQLQAVDLSQNR 492
F + N ++ ++ + S+ KL + + + ++ + L L+ +++ +
Sbjct: 127 TFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 493 FSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL--- 549
+ P + + + L L L ++ +++ L L L EL
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245
Query: 550 -----GNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDH--DLFI 602
++ ++ L + L L + S N+L FD L
Sbjct: 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQK 305
Query: 603 SSLLDNPGLCS-PDLKPL 619
L NP CS P + L
Sbjct: 306 IWLHTNPWDCSCPRIDYL 323
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/264 (23%), Positives = 105/264 (39%), Gaps = 32/264 (12%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIET 733
DD L +G G V K++ SG+ +AVKR+ T + + +++
Sbjct: 4 VKADD----LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDI 58
Query: 734 LGR-VRHGNVVKLLMCCSGQDFN----ILVYEYMPNGSLADML-HEKGRSGSLDWSIRFS 787
R V V G F + E M + SL + ++ I
Sbjct: 59 SMRTVDCPFTVT----FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK 113
Query: 788 IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM 847
IA K L +LH+ +++HRDVK N+L++A ++ DFG++ G D +
Sbjct: 114 IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS-------GYLVDDV 164
Query: 848 SC--VAGSYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIV 901
+ AG Y+APE K + KSD++S G+ ++EL + P D + +
Sbjct: 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 224
Query: 902 RWVTEATLSSPERGCCRDLNQLID 925
+ V E + P +
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTS 248
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G V K K + + + AVK + + K + + E+E L ++ H N++KL
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHND 802
+V E G L D + ++ RFS A G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKH 140
Query: 803 CVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
IVHRD+K NILL + + ++ DFGL+ Q + M G+ YIAP
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYYIAP 192
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E EK DV+S GV+L L++G P
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 50/216 (23%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 676 NEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETL 734
++ D L IG G + V + SG VAVK + K + + +E+ +
Sbjct: 39 DQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIM 96
Query: 735 GRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK 794
+H NVV++ + ++ E++ G+L D++ + L+ ++ + +
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQ 152
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
LAYLH ++HRD+KS +ILL + +++DFG + + + G+
Sbjct: 153 ALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS----LVGTP 205
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890
++APE + D++S G++++E+V G+ P
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 23/231 (9%)
Query: 671 QRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRS 729
Q F +D L + IG G V K+ K SG+ +AVKR+ + E + +
Sbjct: 15 QHWDFTAED----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM- 69
Query: 730 EIETLGR-VRHGNVVKLL-MCCSGQDFNILVYEYMPNGSLADMLHE--KGRSGSLDWSIR 785
+++ + R +V+ D I E M + S + I
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWI-CMELM-STSFDKFYKYVYSVLDDVIPEEIL 127
Query: 786 FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845
I K L +L + I+HRD+K NILLD ++ DFG++ L ++ D
Sbjct: 128 GKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD 185
Query: 846 AMSCVAGSYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDP 892
AG Y+APE A + +SDV+S G+ L EL TG+ P
Sbjct: 186 -----AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 24/217 (11%)
Query: 687 QNLIGSGGS--CRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNV 742
+IG G V + +GE V V+R+ L + E+ H N+
Sbjct: 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG-ELHVSKLFNHPNI 88
Query: 743 VKLLMC-CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
V + + + V +M GS D++ G + +I + I QG K L Y+H+
Sbjct: 89 VPYRATFIADNELWV-VTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGVLKALDYIHH 146
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG---YIA 858
VHR VK+ +IL+ + ++ ++ S + S +++
Sbjct: 147 M---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 859 PE------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
PE Y KSD+YS G+ EL G P
Sbjct: 204 PEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVK-----RLLGGTHKPETETVFRSEIETLGRVRHG-- 740
L+GSGG VY +++ VA+K R+ P V E+ L +V G
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFS 108
Query: 741 NVVKLLMCCSGQDFNILVYEY-MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL 799
V++LL D +L+ E P L D + E+G L + S + + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 165
Query: 800 HNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
HN V +HRD+K NIL+D ++ DFG AL ++ D G+ Y
Sbjct: 166 HNCGV---LHRDIKDENILIDLNRGELKLIDFGSG-ALL-KDTVYTD--FD--GTRVYSP 216
Query: 859 PEYAYTKKVT-EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV-TEATLSSPERGC 916
PE+ + + V+S G++L ++V G P F +++I+R S E
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQRVSSE--- 269
Query: 917 CRDL 920
C+ L
Sbjct: 270 CQHL 273
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-25
Identities = 77/306 (25%), Positives = 124/306 (40%), Gaps = 59/306 (19%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLL-GGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G G V K K +G+ AVK + + + E++ L ++ H N++KL
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHN 801
+ + LV E G L D + + RFS A G+ Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMHK 144
Query: 802 DCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
+ IVHRD+K N+LL + R+ DFGL+ ++ M G+ YIA
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-----EASKKMKDKIGTAYYIA 196
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GEN-KDIVRWVTEATLS------ 910
PE EK DV+S GV+L L++G P F G N DI++ V + +
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSGCPP----FNGANEYDILKKVEKGKYTFELPQW 251
Query: 911 ---SPERGCCRDL-NQLI--DPRMDLSTCDYEEAEKVLN---VALMCTSDFPINRPSMRR 961
S +DL +++ P M +S A L+ + ++ PS+
Sbjct: 252 KKVSES---AKDLIRKMLTYVPSMRIS------ARDALDHEWIQTYTKEQISVDVPSLDN 302
Query: 962 VVELLR 967
+ +R
Sbjct: 303 AILNIR 308
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 63/258 (24%), Positives = 99/258 (38%), Gaps = 47/258 (18%)
Query: 661 SKSPWKVVTFQRVSFNEDDILPHLTEQ--------NLIGSGGSCRVYKVKLK-SGETVAV 711
S + + FQ ++ N + + +GSG V K K A+
Sbjct: 7 HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66
Query: 712 KRL-----------LGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760
K + + + +EI L + H N++KL + + LV E
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHNDCVPAIVHRDVKS 814
+ G L + + + + F A G+ YLH IVHRD+K
Sbjct: 127 FYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKH---NIVHRDIKP 174
Query: 815 HNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKS 871
NILL ++ + ++ DFGL+ D + G+ YIAPE KK EK
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSK-----DYKLRDRLGTAYYIAPE-VLKKKYNEKC 228
Query: 872 DVYSFGVVLMELVTGKRP 889
DV+S GV++ L+ G P
Sbjct: 229 DVWSCGVIMYILLCGYPP 246
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G V K K + + AVK + + K + + E+E L ++ H N++KL
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQGAAKGLAYLHND 802
+V E G L D + ++ RFS I + G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKH 140
Query: 803 CVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
IVHRD+K NILL + + ++ DFGL+ Q + M G+ YIAP
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYYIAP 192
Query: 860 E---YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E Y +K DV+S GV+L L++G P
Sbjct: 193 EVLRGTYDEKC----DVWSAGVILYILLSGTPP 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 34/235 (14%)
Query: 671 QRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRS 729
QR +D L +GSG +V+K++ + +G +AVK++ +K E + +
Sbjct: 18 QRYQAEIND----LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM- 72
Query: 730 EIETLGR-VRHGNVVKLLMCCSG---QDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSI 784
+++ + + +V+ C G + ++ + E M + +G + I
Sbjct: 73 DLDVVLKSHDCPYIVQ----CFGTFITNTDVFIAMELMGTCAEKLKKRMQGP---IPERI 125
Query: 785 RFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844
+ K L YL ++HRDVK NILLD ++ DFG++ G+
Sbjct: 126 LGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS-------GRLV 176
Query: 845 DAMSC--VAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDP 892
D + AG Y+APE ++DV+S G+ L+EL TG+ P
Sbjct: 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 49/321 (15%), Positives = 102/321 (31%), Gaps = 49/321 (15%)
Query: 665 WKVVTFQRVSFNEDDI------LPHLTEQNLIGSGGS----CRVYKVKLKSGETVAVKRL 714
K + + + L L ++ + + + +
Sbjct: 36 IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDEST 95
Query: 715 LGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEK 774
P +I + N V L S + + + + +L D ++ +
Sbjct: 96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 775 GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834
+ + I A+ + +LH+ ++HRD+K NI + V +V DFGL
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 835 ALQSQEGQSD--------DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTG 886
A+ E + + G+ Y++PE + + K D++S G++L EL+
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
Query: 887 KRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVAL 946
ER + + + + L E ++ V
Sbjct: 273 FSTQM---------------------ERVRI--ITDVRNLKFPLLFTQKYPQEHMM-VQD 308
Query: 947 MCTSDFPINRPSMRRVVELLR 967
M + P RP +++
Sbjct: 309 MLSPS-PTERPEAT---DIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 20/105 (19%), Positives = 34/105 (32%), Gaps = 2/105 (1%)
Query: 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+G GG V++ K K A+KR+ + E V R E++ L ++ H +V
Sbjct: 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR-EVKALAKLEHPGIV 67
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSI 788
+ E + S S + I
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/225 (24%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIET 733
+ D +G G +VYK K ++G A K ++ + E E EIE
Sbjct: 12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAK-VIETKSEEELEDYIV-EIEI 69
Query: 734 LGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA 793
L H +VKLL ++ E+ P G++ ++ E R + I+ + +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-IQV-VCRQML 127
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CV 850
+ L +LH+ I+HRD+K+ N+L+ E R+ADFG++ ++ +
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS-------AKNLKTLQKRDSF 177
Query: 851 AGSYGYIAPEYAYTKKVTE-----KSDVYSFGVVLMELVTGKRPN 890
G+ ++APE + + + K+D++S G+ L+E+ + P+
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 18/211 (8%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G G V + E VAVK + E + + EI + H NVVK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRF---SIAQGAAKGLAYLHNDCV 804
+ L EY G L D + + RF +A G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMA-----GVVYLHGI-- 124
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
I HRD+K N+LLD +++DFGLA + + C G+ Y+APE
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKR 181
Query: 865 KKVT-EKSDVYSFGVVLMELVTGKRP-NDPS 893
++ E DV+S G+VL ++ G+ P + PS
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVK 744
L+G+G +VYK + +K+G+ A+K + + E + EI L + H N+
Sbjct: 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 745 -----LLMCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
+ G D + LV E+ GS+ D++ + +L I + +GL++
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSH 144
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
LH V +HRD+K N+LL ++ DFG++ L G+ + + + G+ ++A
Sbjct: 145 LHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---TFI-GTPYWMA 197
Query: 859 PEYAYTKKVTE-----KSDVYSFGVVLMELVTGKRPN 890
PE + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 18/211 (8%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G G V + E VAVK + E + + EI + H NVVK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRF---SIAQGAAKGLAYLHNDCV 804
+ L EY G L D + + RF +A G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMA-----GVVYLHGI-- 124
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
I HRD+K N+LLD +++DFGLA + + C G+ Y+APE
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKR 181
Query: 865 KKVT-EKSDVYSFGVVLMELVTGKRP-NDPS 893
++ E DV+S G+VL ++ G+ P + PS
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G V + K+ G A K + E +++H N+V+L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHND 802
+ F+ LV++ + G L + + + +S A + + +AY H++
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSN 124
Query: 803 CVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
IVHR++K N+LL A + ++ADFGLA + E A AG+ GY+
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAV--KLADFGLAIEVNDSE-----AWHGFAGTPGYL 174
Query: 858 APE----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+PE Y+K V D+++ GV+L L+ G P
Sbjct: 175 SPEVLKKDPYSKPV----DIWACGVILYILLVGYPP 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIE 732
F +DD ++ IG G VY + +++ E VA+K++ G E E+
Sbjct: 47 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 733 TLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGA 792
L ++RH N ++ C + LV EY GS +D+L + L ++ GA
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGA 163
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
+GLAYLH+ ++HRDVK+ NILL + ++ DFG A A S V
Sbjct: 164 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGT 213
Query: 853 SYGYIAPEYAYTKKVTE---KSDVYSFGVVLMELVTGKRPN 890
Y ++APE + K DV+S G+ +EL K P
Sbjct: 214 PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
Q +IGSG + V E VA+KR+ + + + EI+ + + H N+V
Sbjct: 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL-LKEIQAMSQCHHPNIVSY 78
Query: 746 LMCCSGQDFNI-LVYEYMPNGSLADML-----HEKGRSGSLDWSIRFSIAQGAAKGLAYL 799
+ LV + + GS+ D++ + +SG LD S +I + +GL YL
Sbjct: 79 Y-TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM-SCVAGSYGYIA 858
H + +HRDVK+ NILL + ++ADFG++ L + + + + G+ ++A
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 859 PE-----YAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890
PE Y K D++SFG+ +EL TG P
Sbjct: 195 PEVMEQVRGYDFKA----DIWSFGITAIELATGAAPY 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 31/232 (13%)
Query: 671 QRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRS 729
+ + + I + +GSG V+ V+ + SG +K + + E +
Sbjct: 11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA- 69
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS-- 787
EIE L + H N++K+ +V E G L + + G S
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEG 124
Query: 788 ----IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQE 840
+ + LAY H+ +VH+D+K NIL ++ DFGLA+
Sbjct: 125 YVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---- 177
Query: 841 GQSDDAMSCVAGSYGYIAPE---YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+SD+ + AG+ Y+APE T K D++S GVV+ L+TG P
Sbjct: 178 -KSDEHSTNAAGTALYMAPEVFKRDVTFKC----DIWSAGVVMYFLLTGCLP 224
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 38/221 (17%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVK-------RLLGGTHKPETETVFRSEIETLGRV-RHG 740
+G G S V + K + AVK E E++ L +V H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 741 NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQGAAK 794
N+++L F LV++ M G L D L EK S I + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLE 135
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
+ LH IVHRD+K NILLD +M ++ DFG + L + + V G+
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPGEKLREVCGTP 187
Query: 855 GYIAPE------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y+APE ++ D++S GV++ L+ G P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 25/205 (12%), Positives = 51/205 (24%), Gaps = 45/205 (21%)
Query: 689 LIGSGGSCRVYK---VKLKSGETVAVKRLLGGTHKPETETV-FRSEIETLGRVRHGNVVK 744
G + ++ L VA+ + P+ S L R+ V +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
+L + ++V E++ GSL ++ S Q A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD-----TSPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
+ + + + +A +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPA------------------------TMPD----- 178
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRP 889
+ D+ G L L+ + P
Sbjct: 179 --ANPQDDIRGIGASLYALLVNRWP 201
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 53/228 (23%), Positives = 85/228 (37%), Gaps = 36/228 (15%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIET 733
+ DI + T +N IG G V K + A K++ + E F+ EIE
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--KYFVEDVDRFKQEIEI 59
Query: 734 LGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------ 787
+ + H N+++L LV E G L + + K F
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---------FRESDAAR 110
Query: 788 IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSD 844
I + +AY H + HRD+K N L + ++ DFGLA +
Sbjct: 111 IMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-----KPG 162
Query: 845 DAMSCVAGSYGYIAPE---YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
M G+ Y++P+ Y + D +S GV++ L+ G P
Sbjct: 163 KMMRTKVGTPYYVSPQVLEGLYGPEC----DEWSAGVMMYVLLCGYPP 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 60/259 (23%), Positives = 101/259 (38%), Gaps = 50/259 (19%)
Query: 659 STSKSPWKVVTFQRVSFNEDDILPHLTEQN-----LIGSGGSCRVYKVKLKS-GETVAVK 712
+ S S KV F ++ ++ + P +GSG V + + VA++
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 713 ----RLLGGTHKPETETV--FRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGS 766
R E + +EIE L ++ H ++K+ +D+ +V E M G
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGE 225
Query: 767 LADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHNDCVPAIVHRDVKSHNILL- 819
L D + R A + YLH + I+HRD+K N+LL
Sbjct: 226 LFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS 273
Query: 820 --DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-------YAYTKKVTEK 870
+ + + ++ DFG +K L M + G+ Y+APE Y + V
Sbjct: 274 SQEEDCLIKITDFGHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAV--- 325
Query: 871 SDVYSFGVVLMELVTGKRP 889
D +S GV+L ++G P
Sbjct: 326 -DCWSLGVILFICLSGYPP 343
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 66/252 (26%), Positives = 104/252 (41%), Gaps = 46/252 (18%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVK-----RLLGGTHKPETETVFRSEIETLGRVR---- 738
L+G GG V+ +L VA+K R+LG + ++ T E+ L +V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 739 HGNVVKLLMCCSGQDFNILVYEY-MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H V++LL Q+ +LV E +P L D + EKG L +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQ 153
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
+ H+ V VHRD+K NIL+D ++ DFG AL + D G+ Y
Sbjct: 154 HCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSG-ALL-HDEPYTD--FD--GTRVY 204
Query: 857 IAPEYAYTKKVT-EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR-------WVTEAT 908
PE+ + + V+S G++L ++V G P F +++I+ V
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIP----FERDQEILEAELHFPAHV---- 256
Query: 909 LSSPERGCCRDL 920
SP+ C L
Sbjct: 257 --SPD---CCAL 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 43/217 (19%)
Query: 689 LIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G G + VY+ K K + A+K L K + + R+EI L R+ H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGA------AKGLAYLHN 801
LV E + G L D + EKG +S A + +AYLH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHE 166
Query: 802 DCVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
+ IVHRD+K N+L DA + +ADFGL+K ++ Q M V G+ GY
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLK--IADFGLSKIVEHQV-----LMKTVCGTPGY 216
Query: 857 IAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
APE AY +V D++S G++ L+ G P
Sbjct: 217 CAPEILRGCAYGPEV----DMWSVGIITYILLCGFEP 249
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 54/216 (25%), Positives = 84/216 (38%), Gaps = 29/216 (13%)
Query: 700 KVKL----KSGETVAVK-----RLL--GGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
V + + V VK ++L P+ V EI L RV H N++K+L
Sbjct: 39 FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHANIIKVLDI 97
Query: 749 CSGQDFNILVYEYMPNGS-LADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
Q F LV E +G L + R LD + I + + YL I
Sbjct: 98 FENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKD---I 151
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
+HRD+K NI++ + ++ DFG + + G+ Y APE
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGS-----AAYLERGKLFYTFCGTIEYCAPEVLMGNPY 206
Query: 868 T-EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR 902
+ +++S GV L LV + P F E ++ V
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENP----FCELEETVE 238
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 28/237 (11%)
Query: 143 EFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGY 202
AN + ++N + + + L+ G ++ + + L L EL
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 203 NPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSF 262
N + + + NL+K+ L + N + + +I L + LDL+ ++ P
Sbjct: 73 NQITD---LAPLKNLTKITELELSG-NPLKNV-SAIAGLQSIKTLDLTSTQITDVTP--L 125
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT-----GNLPETIAAMSLES 317
+GL++++ + L NQ++ + L+ LT L L I ++ NL L +
Sbjct: 126 AGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTPLANLS------KLTT 177
Query: 318 LNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT 374
L +DN + +I LAS PNL+++ L NN S P L SNL ++ T
Sbjct: 178 LKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 50/229 (21%), Positives = 98/229 (42%), Gaps = 18/229 (7%)
Query: 122 HLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLL 181
+ +A + + + + + + L + I E L L L N +
Sbjct: 20 NAIKIAAGKS-NVTDTVTQA-DLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQI 75
Query: 182 SGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKL 241
+ L P L NLT++T EL NPLK+ S++ L ++ L I ++ + L
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLKN---VSAIAGLQSIKTLDLTS-TQITDVTP-LAGL 128
Query: 242 AFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNN 301
+ L L L N ++ I +GL +++ + + + Q+S L+NL+ L L N
Sbjct: 129 SNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNK 184
Query: 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFS 350
++ ++ + +L ++L +N + LA+ NL + L N + +
Sbjct: 185 IS-DISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 53/266 (19%), Positives = 94/266 (35%), Gaps = 26/266 (9%)
Query: 91 GFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVL 150
G + L L L DN L + L L N + + + +++ L
Sbjct: 58 GVQYLNNLIGLELKDNQIT---DLAPLKNLTKITELELSGN-PLKNVSAIA-GLQSIKTL 112
Query: 151 DLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPL 210
DL+ + D+ L+VL L N ++ + P L LT L + +G +
Sbjct: 113 DLTSTQIT-DV-TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-- 166
Query: 211 PSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQ 270
+ + NLSKL L A N I +I + L L + L +N +S P + +++
Sbjct: 167 -TPLANLSKLTTLKADD-NKISDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 271 IELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIP 330
+ L + ++ + +NL + P TI ++ T +
Sbjct: 222 VTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATI----SDNGTYASPNLTWNLT 275
Query: 331 ESLASNP----NLVQLKLFNNSFSGK 352
+ + V K FSG
Sbjct: 276 SFINNVSYTFNQSVTFKNTTVPFSGT 301
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 53/314 (16%), Positives = 111/314 (35%), Gaps = 73/314 (23%)
Query: 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNY 324
SI Q ++ P L +++ ++N+T T A + + +L+
Sbjct: 1 GSITQ----PTAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTG 52
Query: 325 FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFR 384
T I E + NL+ L+L +N + L + + ++S
Sbjct: 53 VT-TI-EGVQYLNNLIGLELKDNQITD--LAPLKNLTKITELELS--------------G 94
Query: 385 NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNR 444
N L+ + +++ L ++
Sbjct: 95 NPLKNVSAIAG------------LQSIKTLDLTSTQIT---------------------- 120
Query: 445 FEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQL 504
++P ++ L + ++ N T P + L LQ + + + S P + L
Sbjct: 121 ---DVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANL 172
Query: 505 NKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNL 564
+KL L+ +N + ++ L SL LI ++L NQ++ + P L N + L + L++
Sbjct: 173 SKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQT 228
Query: 565 LTGEIPLELTKLKL 578
+T + L +
Sbjct: 229 ITNQPVFYNNNLVV 242
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G V + K+ G A K + E +++H N+V+L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHND 802
+ F+ LV++ + G L + + + +S A + + +AY H++
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSN 147
Query: 803 CVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
IVHR++K N+LL ++ADFGLA + E A AG+ GY++P
Sbjct: 148 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----AWHGFAGTPGYLSP 199
Query: 860 E----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E Y+K V D+++ GV+L L+ G P
Sbjct: 200 EVLKKDPYSKPV----DIWACGVILYILLVGYPP 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 61/251 (24%), Positives = 99/251 (39%), Gaps = 46/251 (18%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLL 746
++G G RV + L + + AVK + + E+E L + + H NV++L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQGAAKGLAYLH 800
+D LV+E M GS+ +H++ F+ + Q A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLH 128
Query: 801 NDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSD---DAMSCVAGSY 854
N I HRD+K NIL + ++ DF L ++ S + GS
Sbjct: 129 N---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 855 GYIAPE---------YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKDIVRWV 904
Y+APE Y K+ D++S GV+L L++G P F G W
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRC----DLWSLGVILYILLSGYPP----FVGRCGSDCGWD 237
Query: 905 TEATLSSPERG 915
+ +
Sbjct: 238 RGEACPACQNM 248
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVK------RLLGGTHKPETETVFRSEIETLGRVR-HGN 741
IG G S V + ++ G AVK L E R E L +V H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQGAAKG 795
++ L+ F LV++ M G L D L EK S I + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---------LSEKETRSIMRSLLEA 212
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
+++LH + IVHRD+K NILLD M R++DFG + L + + + + G+ G
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL-----EPGEKLRELCGTPG 264
Query: 856 YIAPE------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y+APE ++ D+++ GV+L L+ G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-23
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 42/208 (20%)
Query: 689 LIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
++GSG V+ VK + G+ A+K + ++ +EI L +++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQGAAKGLAYLHN 801
LV + + G L D + E+G ++ + Q + YLH
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHE 124
Query: 802 DCVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
+ IVHRD+K N+L +++++ + DFGL+K Q + MS G+ GY
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIM--ITDFGLSKMEQ------NGIMSTACGTPGY 173
Query: 857 IAPE----YAYTKKVTEKSDVYSFGVVL 880
+APE Y+K V D +S GV+
Sbjct: 174 VAPEVLAQKPYSKAV----DCWSIGVIT 197
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPE--TETVFRSEIETLGRVRHGNVVKL 745
+G G +V + +G VAVK L + + R EI+ L RH +++KL
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL 76
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
S +V EY+ G L D + + GR + R Q + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRV-EEMEARRL--FQQILSAVDYCHRHM-- 131
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
+VHRD+K N+LLDA M ++ADFGL+ + S SC GS Y APE +
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLR--TSC--GSPNYAAPEVISGR 185
Query: 866 KVT-EKSDVYSFGVVLMELVTGKRPND 891
+ D++S GV+L L+ G P D
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 40/217 (18%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLL-GGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G G V + G+ A + + + + R E ++H N+V+L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER-EARICRLLKHPNIVRLHD 77
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHN 801
S + + L+++ + G L + + + +S A + + + + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQ 128
Query: 802 DCVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
+VHR++K N+LL A + +ADFGLA ++ A AG+ GY
Sbjct: 129 M---GVVHRNLKPENLLLASKLKGAAVK--LADFGLAIEVEG----EQQAWFGFAGTPGY 179
Query: 857 IAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
++PE Y K V D+++ GV+L L+ G P
Sbjct: 180 LSPEVLRKDPYGKPV----DLWACGVILYILLVGYPP 212
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 2e-22
Identities = 51/263 (19%), Positives = 98/263 (37%), Gaps = 20/263 (7%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
FA +L + + + + + + + + + + L +T L N
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGN 75
Query: 204 PLKS-SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSF 262
L PL NL L L+ + N I ++ S+ L L +L L N +S I
Sbjct: 76 KLTDIKPL----TNLKNLGWLFLDE-NKIKDL-SSLKDLKKLKSLSLEHNGIS-DING-L 127
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322
L +E + L +N+++ LS LT L L + N ++ ++ L++L L+
Sbjct: 128 VHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSK 184
Query: 323 NYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLC 382
N+ + ++ +LA NL L+LF+ K + V D + P +
Sbjct: 185 NHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT--VKNTDGSLVTPEIIS 240
Query: 383 FRNKLQCIIIFNNRFSGKIPESY 405
+ + + S+
Sbjct: 241 DDGDYEKPNVKWHLPEFTNEVSF 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 5e-19
Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 18/242 (7%)
Query: 98 LRNLNLSDNYFNGTLSS-QSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156
+ L L+ N L+ + L+ +L L LD N I +L + L+ L L N
Sbjct: 67 VTKLFLNGNK----LTDIKPLTNLKNLGWLFLDENK-IKDLSSLK-DLKKLKSLSLEHNG 120
Query: 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGN 216
S DI P L+ L LG N ++ + + L LT+L L N + +
Sbjct: 121 IS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI---VPLAG 173
Query: 217 LSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDN 276
L+KL+NL+ +K N I ++ ++ L L L+L K + S L ++ D
Sbjct: 174 LTKLQNLYLSK-NHISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
Query: 277 QLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASN 336
L PE +S+ + ++ + + ++ F G + + L
Sbjct: 232 SLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEV 289
Query: 337 PN 338
Sbjct: 290 YT 291
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 5e-14
Identities = 51/323 (15%), Positives = 103/323 (31%), Gaps = 70/323 (21%)
Query: 284 ESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQL 342
++ ++ + ++T T + S++ + N++ + + + PN+ +L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70
Query: 343 KLFNNSFSGKLPD--DLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGK 400
L N KL D L NL + + NK++ + +
Sbjct: 71 FLNGN----KLTDIKPLTNLKNLGWLFLD--------------ENKIKDLSSLKD----- 107
Query: 401 IPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLT 460
K L L N + I+ + + P+L
Sbjct: 108 -------LKKLKSLSLEHNGIS-------------------------DING-LVHLPQLE 134
Query: 461 GILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGE 520
+ + N T + + L +L + L N+ S + + L KLQ L L +N + +
Sbjct: 135 SLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-D 189
Query: 521 LPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQ 580
L L L L VL L + + NL V ++ + L + +
Sbjct: 190 LR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-DDGDYEK 247
Query: 581 FNISHNKLYGEVPSDFDHDLFIS 603
N+ + F ++
Sbjct: 248 PNVKWHLPEFTNEVSFIFYQPVT 270
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 7e-11
Identities = 54/295 (18%), Positives = 110/295 (37%), Gaps = 19/295 (6%)
Query: 386 KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRF 445
+ + + + ++ E +++ + ++++ + LP V + N+
Sbjct: 22 ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL 77
Query: 446 EGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLN 505
I P ++N L + ++ N S + L++L+++ L N S + L
Sbjct: 78 T-DIKP-LTNLKNLGWLFLDENKIK--DLSSLKDLKKLKSLSLEHNGIS--DINGLVHLP 131
Query: 506 KLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLL 565
+L+ L L N T L+ LT L L+L NQ++ I P L L L +L LS N +
Sbjct: 132 QLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI 187
Query: 566 TGEIPLE-LTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCSK 624
+ L L L + + + + + + +++ + G
Sbjct: 188 SDLRALAGLKNLD--VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDY 245
Query: 625 TKPGTIYIVVILSICVILLVGSLVWFFKVKSGFFSTSKSPWKVVTFQRVSFNEDD 679
KP + + + V + V K K+ F P + VS++ D
Sbjct: 246 EKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQP--LKEVYTVSYDVDG 298
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 38/220 (17%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVK-----RLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L+G G +V +V ++ AVK +L P E + EI+ L R+RH NV
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR---RIPNGEANVKKEIQLLRRLRHKNV 68
Query: 743 VKL---LMCCSGQDFNILVYEYMPNGS--LADMLHEKGRSGSLDWSIRFSIAQGAAK--- 794
++L L Q +V EY G + D + EK RF + Q
Sbjct: 69 IQLVDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEK----------RFPVCQAHGYFCQ 117
Query: 795 ---GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVA 851
GL YLH+ IVH+D+K N+LL +++ G+A+AL +DD
Sbjct: 118 LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL--HPFAADDTCRTSQ 172
Query: 852 GSYGYIAPEYAYTKKVTE--KSDVYSFGVVLMELVTGKRP 889
GS + PE A K D++S GV L + TG P
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 45/214 (21%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVK----RLLGGTHKPETETV--FRSEIETLGRVRHGNV 742
+GSG V + + VA+K R E + +EIE L ++ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGL 796
+K+ +D+ +V E M G L D + R A +
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAV 127
Query: 797 AYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
YLH + I+HRD+K N+LL + + + ++ DFG +K L M + G+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-----LMRTLCGT 179
Query: 854 YGYIAPE-------YAYTKKVTEKSDVYSFGVVL 880
Y+APE Y + V D +S GV+L
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 57/242 (23%), Positives = 98/242 (40%), Gaps = 37/242 (15%)
Query: 673 VSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKS-GETVAVK----RLLGGTHKPETETVF 727
+F + + +GSG V K + KS G A K R + +
Sbjct: 3 ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 728 RSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS 787
E+ L +V H N++ L + +L+ E + G L D L +K S
Sbjct: 63 EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---------LS 113
Query: 788 IAQGAA------KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP----RVADFGLAKALQ 837
+ + G+ YLH I H D+K NI+L + +P ++ DFGLA ++
Sbjct: 114 EEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GE 896
+ G+ ++APE + + ++D++S GV+ L++G P F G+
Sbjct: 171 DGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD 221
Query: 897 NK 898
K
Sbjct: 222 TK 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 41/221 (18%)
Query: 685 TEQNLIGSG--GSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN 741
T+ +IG+G G VY+ KL SGE VA+K++L + R E++ + ++ H N
Sbjct: 57 TDTKVIGNGSFGV--VYQAKLCDSGELVAIKKVL-----QDKRFKNR-ELQIMRKLDHCN 108
Query: 742 VVKLL--MCCSGQDFNI----LVYEYMPNGSLADMLHEKGRSGSL--DWSIRFSIAQGAA 793
+V+L SG+ + LV +Y+P ++ + R+ ++ + Q
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ-LF 166
Query: 794 KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP-RVADFGLAKALQSQEGQSDDAM-SCVA 851
+ LAY+H+ I HRD+K N+LLD + ++ DFG AK L E S +
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-----PNVSYIC 218
Query: 852 GSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
Y Y APE YT + DV+S G VL EL+ G+
Sbjct: 219 SRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 41/231 (17%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVK-----RLLGGTHKPETETVFRS------------- 729
IG G V A+K +L+ P +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 730 ------EIETLGRVRHGNVVKLL--MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLD 781
EI L ++ H NVVKL+ + +D +V+E + G + ++ S D
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPL-SED 137
Query: 782 WSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841
+ + Q KG+ YLH I+HRD+K N+L+ + ++ADFG++ +
Sbjct: 138 QARFY--FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-- 190
Query: 842 QSDDAMSCVAGSYGYIAPE--YAYTKKVT-EKSDVYSFGVVLMELVTGKRP 889
D +S G+ ++APE K + + DV++ GV L V G+ P
Sbjct: 191 --DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 37/225 (16%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVK----RLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+GSG V K + KS G A K R + + + E+ L +V H NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAY 798
L + +L+ E + G L D L +K S + + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKES---------LSEEEATSFIKQILDGVNY 130
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVP----RVADFGLAKALQSQEGQSDDAMSCVAGSY 854
LH I H D+K NI+L + +P ++ DFGLA ++ + G+
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTP 182
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENK 898
++APE + + ++D++S GV+ L++G P F G+ K
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-22
Identities = 64/251 (25%), Positives = 100/251 (39%), Gaps = 42/251 (16%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IGSG ++ + E VAVK + G E V R EI +RH N+V+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQR-EIINHRSLRHPNIVRFKE 83
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK------GLAYLHN 801
++ EY G L + + GR FS + G++Y H+
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHS 134
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPR--VADFGLAKALQSQEGQSDDAM---SCVAGSYGY 856
+ HRD+K N LLD PR + DFG +K+ + + G+ Y
Sbjct: 135 MQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTV--GTPAY 183
Query: 857 IAPEYAYTKKVT-EKSDVYSFGVVLMELVTGKRP-NDPSFGEN-KDIVRWVTEATLSSPE 913
IAPE ++ + +DV+S GV L ++ G P DP + + ++ + S P+
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 914 RGC----CRDL 920
C L
Sbjct: 244 DIRISPECCHL 254
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 37/226 (16%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVK----RLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+GSG V K + K G+ A K R L + + + E+ L +RH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAY 798
L + +L+ E + G L D L EK + + G+ Y
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES---------LTEDEATQFLKQILDGVHY 123
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVP----RVADFGLAKALQSQEGQSDDAMSCVAGSY 854
LH+ I H D+K NI+L + VP ++ DFG+A +++ + G+
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-----EFKNIFGTP 175
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKD 899
++APE + + ++D++S GV+ L++G P F GE K
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGETKQ 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 67/252 (26%), Positives = 115/252 (45%), Gaps = 20/252 (7%)
Query: 652 KVKSGFFSTSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKS-GETVA 710
V S + + WK Q V D +L H +G+G V++V ++ G A
Sbjct: 127 TVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFA 186
Query: 711 VKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADM 770
K ++ T + R EI+T+ +RH +V L + +++YE+M G L +
Sbjct: 187 AKFVM--TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 771 LHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV--A 828
+ ++ S D ++ + + Q KGL ++H + VH D+K NI+ + +
Sbjct: 245 VADEHNKMSEDEAVEY-MRQ-VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLI 299
Query: 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKR 888
DFGL L ++ ++ G+ + APE A K V +D++S GV+ L++G
Sbjct: 300 DFGLTAHLDPKQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
Query: 889 PNDPSF-GENKD 899
P F GEN D
Sbjct: 355 P----FGGENDD 362
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFR--SEIETLGRVRHGN 741
+ + G G V K K +G +VA+K+++ + R ++ L + H N
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVLHHPN 80
Query: 742 VVKLL---MCCSGQDFN----ILVYEYMPNGSLADMLHEKGRSGSL------DWSIRFSI 788
+V+L +D +V EY+P D LH R+ I+ +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQSQEGQSDDAM 847
Q + + LH V + HRD+K HN+L++ ++ DFG AK L E +
Sbjct: 136 FQ-LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE----PNV 189
Query: 848 SCVAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
+ + Y Y APE YT V D++S G + E++ G+
Sbjct: 190 AYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 37/226 (16%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVK----RLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+GSG V K + KS G A K R + + + E+ L ++H NV+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAY 798
L + IL+ E + G L D L EK + + G+ Y
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYY 129
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVP----RVADFGLAKALQSQEGQSDDAMSCVAGSY 854
LH+ I H D+K NI+L VP ++ DFGLA + + G+
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTP 181
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKD 899
++APE + + ++D++S GV+ L++G P F G+ K
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQ 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 41/222 (18%), Positives = 88/222 (39%), Gaps = 37/222 (16%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
+G G V++ S +T K + K + + + EI L RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHND 802
+ ++++E++ + + ++ + + + + L +LH+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFE--------LNEREIVSYVHQVCEALQFLHSH 121
Query: 803 CVPAIVHRDVKSHNILL----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
I H D++ NI+ + + ++ +FG A+ L + D + + Y A
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTI--KIIEFGQARQL-----KPGDNFRLLFTAPEYYA 171
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKD 899
PE V+ +D++S G ++ L++G P F E
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQ 209
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPE--TETVFRSEIETLGRVRHGNVVKL 745
+G G +V K+ + VA+K + K V R EI L +RH +++KL
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL 74
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ ++V EY G L D + EK R + D RF Q + Y H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRM-TEDEGRRF--FQQIICAIEYCHRHK-- 128
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
IVHRD+K N+LLD + ++ADFGL+ + + SC GS Y APE K
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLK--TSC--GSPNYAAPEVINGK 182
Query: 866 KVT-EKSDVYSFGVVLMELVTGKRPND 891
+ DV+S G+VL ++ G+ P D
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 57/243 (23%), Positives = 83/243 (34%), Gaps = 44/243 (18%)
Query: 670 FQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVF 727
+ + T Q I SG V G VA+KR+ T +
Sbjct: 8 AAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNIL 67
Query: 728 RS---------EIETLGRVRHGNVVKLL---MCCSGQDFN--ILVYEYMPNGSLADMLHE 773
EI L H N++ L + + LV E M D L +
Sbjct: 68 SDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TD-LAQ 122
Query: 774 KGRSGSLDWS---IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830
+ S I++ + GL LH +VHRD+ NILL + DF
Sbjct: 123 VIHDQRIVISPQHIQYFMYH-ILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDF 178
Query: 831 GLAKALQSQEGQSDDAMSC-VAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELV 884
LA+ +D + V + Y APE +TK V D++S G V+ E+
Sbjct: 179 NLARED-----TADANKTHYVTHRW-YRAPELVMQFKGFTKLV----DMWSAGCVMAEMF 228
Query: 885 TGK 887
K
Sbjct: 229 NRK 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 15/231 (6%)
Query: 662 KSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHK 720
+ WK Q V + + + +GSG V++ K+ G K + T
Sbjct: 31 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPY 88
Query: 721 PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSL 780
P + ++EI + ++ H ++ L + +L+ E++ G L D + + S
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE 148
Query: 781 DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV--ADFGLAKALQS 838
I + + Q A +GL ++H +IVH D+K NI+ + + V DFGLA L
Sbjct: 149 AEVINY-MRQ-ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E + + + APE + V +D+++ GV+ L++G P
Sbjct: 204 DE-----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 53/208 (25%), Positives = 81/208 (38%), Gaps = 44/208 (21%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR-VRHGNVVKLLM 747
IG G + + + AVK + P EIE L R +H N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP------TEEIEILLRYGQHPNIITLKD 83
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQGAAKGLAYLHN 801
+ +V E M G L D + + FS + K + YLH
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHA 134
Query: 802 DCVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
+VHRD+K NIL + E + R+ DFG AK L+++ G + + +
Sbjct: 135 Q---GVVHRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAENG----LLMTPCYTANF 186
Query: 857 IAPE----YAYTKKVTEKSDVYSFGVVL 880
+APE Y D++S GV+L
Sbjct: 187 VAPEVLERQGYDAAC----DIWSLGVLL 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 69/210 (32%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPE--TETVFRSEIETLGRVRHGNVVKL 745
+G G +V K +G VAVK L + + R EI+ L RH +++KL
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL 81
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
S +V EY+ G L D + + GR S R Q G+ Y H V
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRL-DEKESRRL--FQQILSGVDYCHRHMV- 137
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAM---SCVAGSYGYIAPEYA 862
VHRD+K N+LLDA M ++ADFGL+ + SD SC GS Y APE
Sbjct: 138 --VHRDLKPENVLLDAHMNAKIADFGLS-NM-----MSDGEFLRTSC--GSPNYAAPEVI 187
Query: 863 YTKKVT-EKSDVYSFGVVLMELVTGKRPND 891
+ + D++S GV+L L+ G P D
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 56/253 (22%), Positives = 116/253 (45%), Gaps = 22/253 (8%)
Query: 652 KVKSGFFSTSKSPWKVVTFQRVSFNEDDILPH--LTEQNLIGSGGSCRVYKVKLKS-GET 708
K S +P + V+ + + +++ ++G G +V+K + + G
Sbjct: 57 KRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLK 116
Query: 709 VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLA 768
+A K + T + + ++EI + ++ H N+++L ++ +LV EY+ G L
Sbjct: 117 LAAKIIK--TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 769 DMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV- 827
D + ++ + + +I F + Q +G+ ++H I+H D+K NIL ++
Sbjct: 175 DRIIDESYNLTELDTILF-MKQ-ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIK 229
Query: 828 -ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTG 886
DFGLA+ + + + G+ ++APE V+ +D++S GV+ L++G
Sbjct: 230 IIDFGLARRYKP-----REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
Query: 887 KRPNDPSF-GENK 898
P F G+N
Sbjct: 285 LSP----FLGDND 293
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 48/184 (26%), Positives = 74/184 (40%), Gaps = 12/184 (6%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
+ +L LS N + + L LNL L+ L G L L +L +N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHN 87
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHS- 261
L+S LP L L L + N + +P L L L L N L +P
Sbjct: 88 QLQS--LPLLGQTLPALTVLDVSF-NRLTSLPLGALRGLGELQELYLKGNELK-TLPPGL 143
Query: 262 FSGLASIEQIELFDNQLSGELPESL-SNLTTLLRLDISQNNLTGNLPETI-AAMSLESLN 319
+ +E++ L +N L+ ELP L + L L L + +N+L +P+ + L
Sbjct: 144 LTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 320 LNDN 323
L+ N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 57/182 (31%), Positives = 73/182 (40%), Gaps = 10/182 (5%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156
L+LS+N T S +L P L L LD + +L L LDLS N
Sbjct: 32 DTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAE-LTKLQVDGT-LPVLGTLDLSHNQ 88
Query: 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSV-G 215
+P P L VL++ N L+ L L L EL L N LK+ LP +
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT--LPPGLLT 145
Query: 216 NLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELF 274
KLE L A N + E+P + L L L L +N L IP F G + L
Sbjct: 146 PTPKLEKLSLAN-NNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLH 203
Query: 275 DN 276
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 60/281 (21%), Positives = 84/281 (29%), Gaps = 82/281 (29%)
Query: 285 SLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKL 344
+S + + L ++ + NLT LP + L+L++N +L L QL L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK-DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 345 FNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPES 404
+ L+
Sbjct: 63 DRAEL-----------TKLQVDGTLPV--------------------------------- 78
Query: 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILI 464
L L N+LQ LP LP + ++ NR S+
Sbjct: 79 ------LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA----------- 119
Query: 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPR 523
G L +LQ + L N LP + T KL++L L N T ELP
Sbjct: 120 ----LRG--------LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPA 165
Query: 524 NL-NSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563
L N L L L L N L TIP +L L N
Sbjct: 166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 48/195 (24%), Positives = 73/195 (37%), Gaps = 34/195 (17%)
Query: 454 SNAPKLTGIL-INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLEL 512
+ PK T IL ++ N + + +L ++L + + L L L L+L
Sbjct: 27 PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDL 84
Query: 513 QENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLTGEIPL 571
N LP +L AL VL++S N+LT ++P L L L L N L +P
Sbjct: 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPP 141
Query: 572 -------ELTKL-------------------KLNQFNISHNKLYGEVPSDFD-HDLFISS 604
+L KL L+ + N LY F H L +
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAF 201
Query: 605 LLDNPGLCSPDLKPL 619
L NP LC+ ++
Sbjct: 202 LHGNPWLCNCEILYF 216
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 29/137 (21%), Positives = 39/137 (28%), Gaps = 29/137 (21%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
P + L L++S N SL R LQ
Sbjct: 93 PLLGQTLPALTVLDVSFNRL------TSLPL-----------GAL--------RGLGELQ 127
Query: 149 VLDLSRNNFSGDIPES-FGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207
L L N +P P L+ L+L N L+ L L L L L N L +
Sbjct: 128 ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT 186
Query: 208 SPLPSSVGNLSKLENLW 224
+P L +
Sbjct: 187 --IPKGFFGSHLLPFAF 201
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 32/107 (29%), Positives = 43/107 (40%), Gaps = 7/107 (6%)
Query: 483 LQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLT 542
V+ + + LP + L L EN+ L T L LNL +L
Sbjct: 12 HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL- 67
Query: 543 GTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKL 588
T G L VL +LDLS N L +PL L L ++S N+L
Sbjct: 68 -TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL 112
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 671 QRVSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRS 729
+ V D+ P T + IG G V + VA+K++ H+ + R
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR- 74
Query: 730 EIETLGRVRHGNVVKLL---MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSL-DWS 783
EI+ L R RH N++ + + + +V + M D L++ ++ L +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLSNDH 129
Query: 784 IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843
I + + Q +GL Y+H+ ++HRD+K N+LL+ ++ DFGLA+ +
Sbjct: 130 ICYFLYQ-ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 844 DDAMSCVAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
VA + Y APE YTK + D++S G +L E+++ +
Sbjct: 186 GFLTEYVATRW-YRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 44/217 (20%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLM 747
+G G K V KS + AVK + K + EI L H N+VKL
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKII----SKRMEANTQK-EITALKLCEGHPNIVKLHE 73
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQGAAKGLAYLHN 801
Q LV E + G L + + +K FS I + ++++H+
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKH---------FSETEASYIMRKLVSAVSHMHD 124
Query: 802 DCVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
+VHRD+K N+L + E+ ++ DFG A+ + + + Y
Sbjct: 125 V---GVVHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPD----NQPLKTPCFTLHY 175
Query: 857 IAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
APE Y + D++S GV+L +++G+ P
Sbjct: 176 AAPELLNQNGYDESC----DLWSLGVILYTMLSGQVP 208
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC- 748
IG+G V++ KL + VA+K++L + R E++ + V+H NVV L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNR-ELQIMRIVKHPNVVDLKAFF 101
Query: 749 ---CSGQDFNI--LVYEYMPNGSLADMLHEKGRSGSLDWS-IRFSIAQGAAKGLAYLHND 802
+D LV EY+P H ++ I+ + Q + LAY+H+
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAYIHSI 160
Query: 803 CVPAIVHRDVKSHNILLDAEMVP-RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE- 860
I HRD+K N+LLD ++ DFG AK L + E +S + Y Y APE
Sbjct: 161 ---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE----PNVSYICSRY-YRAPEL 212
Query: 861 ----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
YT + D++S G V+ EL+ G+
Sbjct: 213 IFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP------ETETVFRSEIETLGRVRHGN 741
++G G V + + A+K L K + V E + + R+ H
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKIL----EKRHIIKENKVPYV-TRERDVMSRLDHPF 91
Query: 742 VVKLLMCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSLDWSI-RFSIAQGAAKGLAY 798
VKL + QD L Y NG L + + GS D + RF A+ L Y
Sbjct: 92 FVKLY--FTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAE-IVSALEY 145
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
LH I+HRD+K NILL+ +M ++ DFG AK L + Q+ G+ Y++
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV--GTAQYVS 200
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
PE K + SD+++ G ++ +LV G P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-20
Identities = 48/216 (22%), Positives = 89/216 (41%), Gaps = 38/216 (17%)
Query: 689 LIGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLL 746
++G G + +V + ++G+ A+K L R E++ + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCIL 88
Query: 747 ----MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGA------AKGL 796
G+ +++ E M G L + E+G F+ + A +
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAI 141
Query: 797 AYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGS 853
+LH+ I HRDVK N+L + + V ++ DFG AK + +
Sbjct: 142 QFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA------LQTPCYT 192
Query: 854 YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y+APE +K + D++S GV++ L+ G P
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 10/185 (5%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
A+ + LDL N S ++F R L++L L N L L L L + N
Sbjct: 36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDN 95
Query: 204 PLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPH- 260
L++ LP V L L L + N + +P + L L+ L L N L +P
Sbjct: 96 KLQA--LPIGVFDQLVNLAELRLDR-NQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKG 151
Query: 261 SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAA--MSLESL 318
F L S++++ L++NQL + LT L L + N L +PE L+ L
Sbjct: 152 VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210
Query: 319 NLNDN 323
L +N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 52/191 (27%), Positives = 78/191 (40%), Gaps = 32/191 (16%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
F R+ LR L L+DN ++ L +F NL+
Sbjct: 54 SKAFHRLTKLRLLYLNDN-----------------KLQTLPAGIFKE--------LKNLE 88
Query: 149 VLDLSRNNFSGDIPES-FGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207
L ++ N +P F + L L L N L L P +LT+LT+ LGYN L+S
Sbjct: 89 TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS 147
Query: 208 SPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHSFSGL 265
LP V L+ L+ L N + +P+ KL L L L +N L +F L
Sbjct: 148 --LPKGVFDKLTSLKELRLYN-NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 266 ASIEQIELFDN 276
++ ++L +N
Sbjct: 205 EKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 10/158 (6%)
Query: 411 LNYLRFGGNELQGELPSK-FWGLPEVDFFEMYNNRFEGSISPSISNAP-KLTGILINGNN 468
L L N+LQ LP+ F L ++ + +N+ + ++ + + L + ++ N
Sbjct: 63 LRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQ 120
Query: 469 FTGEVPSQICT-LRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNL- 525
+P ++ L +L + L N LP + +L L++L L N +P
Sbjct: 121 LK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAF 177
Query: 526 NSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563
+ LT L L L NQL +L L L L N
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 37/131 (28%), Positives = 59/131 (45%), Gaps = 13/131 (9%)
Query: 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPR 523
N + L +L+ + L+ N+ LP I +L L+ L + +N LP
Sbjct: 45 QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPI 102
Query: 524 NL-NSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLTGEIPL----ELTKLK 577
+ + L L L L NQL ++PP + +L LT L L N L +P +LT LK
Sbjct: 103 GVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK 160
Query: 578 LNQFNISHNKL 588
+ + +N+L
Sbjct: 161 --ELRLYNNQL 169
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 29/127 (22%), Positives = 56/127 (44%), Gaps = 11/127 (8%)
Query: 467 NNFTGEVPSQICT-LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNL 525
N + +C+ +VD S + + +P+ I ++L+LQ N + +
Sbjct: 1 NEALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNI--PADTKKLDLQSNKLSSLPSKAF 57
Query: 526 NSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLT---GEIPLELTKLKLNQF 581
+ LT L +L L+ N+L T+P + L L +L ++ N L + +L L +
Sbjct: 58 HRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLA--EL 114
Query: 582 NISHNKL 588
+ N+L
Sbjct: 115 RLDRNQL 121
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 35/124 (28%), Positives = 49/124 (39%), Gaps = 16/124 (12%)
Query: 89 PNG-FCRIRTLRNLNLSDNYFNGTLSSQSLSP-CFH----LQVLALDYNVFIGELPD--F 140
P G F ++ L L L N +SL P F L L+L YN + LP F
Sbjct: 101 PIGVFDQLVNLAELRLDRNQL------KSLPPRVFDSLTKLTYLSLGYNE-LQSLPKGVF 153
Query: 141 SREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFEL 200
+ +L+ L L N +F + LK L L N L + +L +L +L
Sbjct: 154 DK-LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 201 GYNP 204
NP
Sbjct: 213 QENP 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 31/221 (14%)
Query: 690 IGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG-NVVKLLM 747
+G G V + KS G+ A K L + EI L + V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLAYLHN 801
IL+ EY G + + + S +G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYYLHQ 149
Query: 802 DCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
+ IVH D+K NILL ++ DFG+++ + + + G+ Y+A
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-----ELREIMGTPEYLA 201
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENK 898
PE +T +D+++ G++ L+T P F GE+
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSP----FVGEDN 238
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 25/228 (10%)
Query: 670 FQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETET 725
F V + +L IGSG V VA+K+L ++ +
Sbjct: 11 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR 70
Query: 726 VFRSEIETLGRVRHGNVVKLL----MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGS 779
+R E+ + V H N++ LL S ++F +V E M A+ L + +
Sbjct: 71 AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQVIQMEL 124
Query: 780 LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839
+ + + Q G+ +LH+ I+HRD+K NI++ ++ ++ DFGLA+ +
Sbjct: 125 DHERMSYLLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
+ V Y Y APE E D++S G ++ E++ G
Sbjct: 181 FMMTPY----VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 54/249 (21%), Positives = 102/249 (40%), Gaps = 17/249 (6%)
Query: 117 LSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNL 176
L + + + E ++ + + ++ + + P + L L
Sbjct: 20 DDAFAETIKDNLKKK-SVTDAVTQN-ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 177 GGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD 236
GN L+ + P L NL L L N +K SS+ +L KL++L N I +I +
Sbjct: 76 NGNKLTDIKP--LANLKNLGWLFLDENKVKDL---SSLKDLKKLKSLSLEH-NGISDI-N 128
Query: 237 SIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLD 296
+ L L +L L +N ++ I S L ++ + L DNQ+S ++ L+ LT L L
Sbjct: 129 GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLY 184
Query: 297 ISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSG-KLPD 355
+S+N+++ +L +L+ L L + ++ +K + S ++
Sbjct: 185 LSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
Query: 356 DLGKYSNLE 364
D G Y
Sbjct: 244 DDGDYEKPN 252
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 53/244 (21%), Positives = 100/244 (40%), Gaps = 26/244 (10%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156
++ + +++ S Q + ++ L L+ N + ++ + NL L L N
Sbjct: 47 SIDQIIANNSDIK---SVQGIQYLPNVTKLFLNGN-KLTDIKPLA-NLKNLGWLFLDENK 101
Query: 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGN 216
D+ S LK L+L N +S + + L +L +L LG N + + +
Sbjct: 102 VK-DL-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD---ITVLSR 154
Query: 217 LSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDN 276
L+KL+ L N I +I + L L NL LS N +S + + +GL +++ +ELF
Sbjct: 155 LTKLDTLSLED-NQISDIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQ 210
Query: 277 QLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASN 336
+ + SNL + + +L + E ++ + +Y + L
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSLV----------TPEIISDDGDYEKPNVKWHLPEF 260
Query: 337 PNLV 340
N V
Sbjct: 261 TNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 49/286 (17%), Positives = 102/286 (35%), Gaps = 47/286 (16%)
Query: 284 ESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQL 342
S ++ ++ + ++T T + S++ + N++ + + + PN+ +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 343 KLFNNSFSGKLPD--DLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGK 400
L N KL D L NL + + NK++ + +
Sbjct: 74 FLNGN----KLTDIKPLANLKNLGWLFLD--------------ENKVKDLSSLKD----- 110
Query: 401 IPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLT 460
K L L N + ++ LP+++ + NN+ I+ +S KL
Sbjct: 111 -------LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLD 159
Query: 461 GILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGE 520
+ + N + VP + L +LQ + LS+N S + L L LEL +
Sbjct: 160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNK 215
Query: 521 LPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT 566
+ ++L + + L P + + ++ +L
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 55/300 (18%), Positives = 88/300 (29%), Gaps = 39/300 (13%)
Query: 281 ELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLA---SNP 337
EL +L LL+ + G + I ++SL+ L + I
Sbjct: 37 ELYGGGRSLEYLLKR-VDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGIS 95
Query: 338 NLVQLKLFNNSFSGKLPDDLGKYS--NLEYFDVSTNDFTGELPRFLCFRNK----LQCII 391
L +L L N +G P L + + +L ++ + + L+ +
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 392 IFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISP 451
I E L+ L N GE P
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP------------------ 197
Query: 452 SISNAPKLTGILINGNNFT---GEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQ-LNKL 507
P L + + G + QLQ +DLS N ++L
Sbjct: 198 --LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567
L L ++P+ L L VL+LS N+L P L + +L L N
Sbjct: 256 NSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 49/247 (19%), Positives = 82/247 (33%), Gaps = 22/247 (8%)
Query: 146 NLQVLDLSRNNFSGDIPESFGRF---PVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGY 202
+L+ L + I R L+ L L ++G P L T L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 203 NPLKSSPLPSSVGNLS-----KLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGK 257
+ + + + L L+ L A+A+ + + + LS LDLSDN G+
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 258 IPHSFS----GLASIEQIELFDNQ---LSGELPESLSNLTTLLRLDISQNNLTGNLPETI 310
+ +++ + L + SG + L LD+S N+L
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 311 AAM--SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDV 368
L SLNL+ ++P+ L L L L N P + + +
Sbjct: 249 CDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NP-SPDELPQVGNLSL 303
Query: 369 STNDFTG 375
N F
Sbjct: 304 KGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 53/341 (15%), Positives = 97/341 (28%), Gaps = 59/341 (17%)
Query: 216 NLSKLENLWAAKANLIGEIPDSI--GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIEL 273
N S + W++ N +G + G + L D S++++ +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 274 FDNQLSGELPESLS---NLTTLLRLDISQNNLTGNLPETIAAM---SLESLNLNDNYFTG 327
++ + ++ L L + +TG P + L LNL + +
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 328 EIPESLA----SNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCF 383
P L L + + + + L D+S N GE
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG----- 190
Query: 384 RNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNN 443
+ + K P TL L +
Sbjct: 191 --------LISALCPLKFP-------TLQVLALRNAGM---------------------E 214
Query: 444 RFEGSISPSISNAPKLTGILINGNNFTGEVPSQICT-LRQLQAVDLSQNRFSGHLPTCIT 502
G S + +L G+ ++ N+ + C QL +++LS +P +
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273
Query: 503 QLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTG 543
KL L+L N P L + L+L N
Sbjct: 274 A--KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 49/215 (22%), Positives = 81/215 (37%), Gaps = 17/215 (7%)
Query: 78 DLSGFDLSGGFPN--GFCRIRTLRNLNLSDNYFNGTLSSQSLSPCF---HLQVLALDYNV 132
L +++G P L LNL + + + + + L+VL++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 133 FIGELPDFSREFANLQVLDLSRNNFSGDIPES----FGRFPVLKVLNLGGNL---LSGLI 185
+ + R F L LDLS N G+ +FP L+VL L SG+
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 186 PSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLS 245
+ +L +L +N L+ + S S+L +L + + ++P + LS
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF-TGLKQVPKGLPAK--LS 277
Query: 246 NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSG 280
LDLS N L P S L + + L N
Sbjct: 278 VLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 35/197 (17%), Positives = 60/197 (30%), Gaps = 18/197 (9%)
Query: 410 TLNYLRFGGNELQGELPS---KFWGLPEVDFFEMYNNRFEGSISPSISNA--PKLTGILI 464
+L L + + + G+ + + N G+ P + A P L + +
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 465 NGNNFTGEVPS----QICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGE 520
++ Q L+ + ++Q + L L+L +N GE
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 521 L-------PRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLEL 573
P +L L + N +G L LDLS N L
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 574 TKL--KLNQFNISHNKL 588
+LN N+S L
Sbjct: 249 CDWPSQLNSLNLSFTGL 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 36/151 (23%), Positives = 50/151 (33%), Gaps = 10/151 (6%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLS---SQSLSPCFHLQVLALDYNVF 133
+ ++ L L+LSDN G + LQVLAL
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 134 ---IGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPV-LKVLNLGGNLLSGLIPSFL 189
G + LQ LDLS N+ +P L LNL L +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP 273
Query: 190 GNLTELTHFELGYNPLKSSPLPSSVGNLSKL 220
L+ L +L YN L +P P + + L
Sbjct: 274 AKLSVL---DLSYNRLDRNPSPDELPQVGNL 301
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 4e-19
Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 24/237 (10%)
Query: 659 STSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGG 717
S SK + + + V + +L IGSG V VA+K+L
Sbjct: 40 SKSKVDNQFYSVE-VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 718 -THKPETETVFRSEIETLGRVRHGNVVKLL----MCCSGQDFN--ILVYEYMPNGSLADM 770
++ + +R E+ + V H N++ LL + ++F LV E M A+
Sbjct: 99 FQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN- 152
Query: 771 LHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830
L + + + + + Q G+ +LH+ + +HRD+K NI++ ++ ++ DF
Sbjct: 153 LCQVIQMELDHERMSYLLYQ-MLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDF 208
Query: 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
GLA+ + + V Y Y APE E D++S G ++ E+V K
Sbjct: 209 GLARTAGTSFMMTPY----VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 55/250 (22%), Positives = 100/250 (40%), Gaps = 67/250 (26%)
Query: 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
+ +G+G V +V SG+ A+K++L + R E++ + + H N++
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNR-ELDIMKVLDHVNII 63
Query: 744 KLLMC------------------------------------CSGQDFNI--LVYEYMPNG 765
KL+ + ++ EY+P+
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD- 122
Query: 766 SLADMLHEKGRSGSL--DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823
+L +L RSG I I Q + + ++H+ I HRD+K N+L++++
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 824 VP-RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-----YAYTKKVTEKSDVYSFG 877
++ DFG AK L E +++ + + Y APE YT + D++S G
Sbjct: 179 NTLKLCDFGSAKKLIPSE----PSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIG 229
Query: 878 VVLMELVTGK 887
V EL+ GK
Sbjct: 230 CVFGELILGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 57/241 (23%), Positives = 102/241 (42%), Gaps = 41/241 (17%)
Query: 669 TFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVF 727
+ F D+ + +G GG+ V+ + VA+K+++ T +
Sbjct: 1 SMNIHGF---DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-TDPQSVKHAL 56
Query: 728 RSEIETLGRVRHGNVVKLL------------MCCSGQDFN--ILVYEYMPNGSLADMLHE 773
R EI+ + R+ H N+VK+ S + N +V EYM D L
Sbjct: 57 R-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LAN 110
Query: 774 KGRSGSL-DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFG 831
G L + R + Q +GL Y+H+ ++HRD+K N+ ++ E +V ++ DFG
Sbjct: 111 VLEQGPLLEEHARLFMYQ-LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFG 166
Query: 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTG 886
LA+ + + + Y +P YTK + D+++ G + E++TG
Sbjct: 167 LARIMDPHYSHKGHLSEGLVTKW-YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTG 221
Query: 887 K 887
K
Sbjct: 222 K 222
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLL- 746
+G G + +V ++ K + E A+K L + R E+E R + ++V+++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKML------QDCPKARR-EVELHWRASQCPHIVRIVD 122
Query: 747 ---MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFS------IAQGAAKGLA 797
+G+ ++V E + G L + ++G F+ I + + +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQ 175
Query: 798 YLHNDCVPAIVHRDVKSHNILL-----DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
YLH+ I HRDVK N+L +A + ++ DFG AK S ++
Sbjct: 176 YLHSI---NIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTSHNS-----LTTPCY 225
Query: 853 SYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ Y+APE Y K D++S GV++ L+ G P
Sbjct: 226 TPYYVAPEVLGPEKYDKSC----DMWSLGVIMYILLCGYPP 262
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 70/269 (26%), Positives = 113/269 (42%), Gaps = 28/269 (10%)
Query: 653 VKSGFFSTSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAV 711
+ S +F+ WK + Q V+ N ++G GG V +++ +G+ A
Sbjct: 162 LDSIYFNR-FLQWKWLERQPVTKNTFRQY------RVLGKGGFGEVCACQVRATGKMYAC 214
Query: 712 KRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADM 770
K+L K + E + +E + L +V VV L +D LV M G L
Sbjct: 215 KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 274
Query: 771 LHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830
++ G++G + F A+ GL LH + IV+RD+K NILLD R++D
Sbjct: 275 IYHMGQAGFPEARAVFYAAE-ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330
Query: 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTG 886
GLA + G+ GY+APE YT D ++ G +L E++ G
Sbjct: 331 GLAV-----HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAG 381
Query: 887 KRP--NDPSFGENKDIVRWVTEATLSSPE 913
+ P + +++ R V E E
Sbjct: 382 QSPFQQRKKKIKREEVERLVKEVPEEYSE 410
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 38/234 (16%)
Query: 670 FQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETET 725
F + N+ ++ +GSG V +SGE VA+K+L + +
Sbjct: 10 FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR 69
Query: 726 VFRSEIETLGRVRHGNVVKLL----MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGS 779
+R E+ L ++H NV+ LL S ++F LV +M D L +
Sbjct: 70 AYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKF 123
Query: 780 LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839
+ I++ + Q KGL Y+H+ +VHRD+K N+ ++ + ++ DFGLA+
Sbjct: 124 SEEKIQYLVYQ-MLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR----- 174
Query: 840 EGQSDDAMSC-VAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
+D M+ V + Y APE Y + V D++S G ++ E++TGK
Sbjct: 175 --HADAEMTGYVVTRW-YRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 221
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 28/178 (15%), Positives = 65/178 (36%), Gaps = 10/178 (5%)
Query: 174 LNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGE 233
LG + + + + + LT+ L + + + +++L
Sbjct: 28 GLLGQSSTANITEA---QMNSLTYITLANINVTDL---TGIEYAHNIKDLTINN-IHATN 80
Query: 234 IPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLL 293
+ I L+ L L + ++ + SGL S+ +++ + + ++ L +
Sbjct: 81 Y-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
Query: 294 RLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSG 351
+D+S N ++ L+SLN+ + + P L QL F+ + G
Sbjct: 140 SIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 24/162 (14%), Positives = 58/162 (35%), Gaps = 8/162 (4%)
Query: 143 EFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGY 202
+ +L + L+ N + D+ +K L + + + + L+ L +
Sbjct: 42 QMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMG 97
Query: 203 NPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSF 262
+ S + ++ L+ L L + + I I L ++++DLS N I
Sbjct: 98 KDVTSDKI-PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PL 155
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTG 304
L ++ + + + + + + L +L + G
Sbjct: 156 KTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 27/142 (19%), Positives = 54/142 (38%), Gaps = 7/142 (4%)
Query: 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKL 507
++ I A + + IN + T + I L L+ + + + ++ L L
Sbjct: 58 DLTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567
L++ + + +N+L + ++LS N I P L L L SL++ + +
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD 173
Query: 568 EIPLE-LTKLKLNQFNISHNKL 588
+E KL Q +
Sbjct: 174 YRGIEDFPKLN--QLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 31/138 (22%), Positives = 60/138 (43%), Gaps = 6/138 (4%)
Query: 452 SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLE 511
+ + LT I + N T I ++ + ++ + I+ L+ L++L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLR 94
Query: 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPL 571
+ T + NL+ LT+L +L++S + +I ++ L + S+DLS N +I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM- 153
Query: 572 ELTKLK-LNQFNISHNKL 588
L L L NI + +
Sbjct: 154 PLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 28/190 (14%), Positives = 71/190 (37%), Gaps = 21/190 (11%)
Query: 216 NLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275
N + + I + ++ L+ + L++ ++ + +I+ + + +
Sbjct: 21 TFKAYLNGLLGQ-SSTANI--TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 276 NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLA 334
+ +S L+ L RL I ++T + ++ + SL L+++ + I +
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 335 SNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTN---DFTG--ELPRFLCFRNKLQC 389
+ P + + L N + L L+ ++ + D+ G + P KL
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFP-------KLNQ 185
Query: 390 IIIFNNRFSG 399
+ F+ G
Sbjct: 186 LYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 22/160 (13%), Positives = 57/160 (35%), Gaps = 9/160 (5%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156
+L + L++ + +++ L ++ S +NL+ L + +
Sbjct: 45 SLTYITLANINVT---DLTGIEYAHNIKDLTINNI-HATNYNPIS-GLSNLERLRIMGKD 99
Query: 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGN 216
+ D + L +L++ + I + + L ++ +L YN + +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD--IMPLKT 157
Query: 217 LSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG 256
L +L++L + + + I L+ L + G
Sbjct: 158 LPELKSLNIQF-DGVHDY-RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 32/209 (15%), Positives = 70/209 (33%), Gaps = 21/209 (10%)
Query: 221 ENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSG 280
E + IPDS N L + + + + + S+ I L + ++
Sbjct: 4 EQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT- 57
Query: 281 ELPESLSNLTTLLRLDISQNNLT-----GNLPETIAAMSLESLNLNDNYFTGEIPESLAS 335
+L + + L I+ + T L +LE L + T + +L+
Sbjct: 58 DL-TGIEYAHNIKDLTINNIHATNYNPISGLS------NLERLRIMGKDVTSDKIPNLSG 110
Query: 336 NPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNN 395
+L L + +++ + + + D+S N ++ L +L+ + I +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFD 169
Query: 396 RFSGKIPESYGECKTLNYLRFGGNELQGE 424
+ LN L + G+
Sbjct: 170 GVH-DY-RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 23/137 (16%), Positives = 50/137 (36%), Gaps = 8/137 (5%)
Query: 98 LRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNF 157
+++L +++ + + +S +L+ L + + +L +LD+S +
Sbjct: 68 IKDLTINNIHAT---NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 158 SGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNL 217
I P + ++L N I L L EL + ++ + + +
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY---RGIEDF 180
Query: 218 SKLENLWAAKANLIGEI 234
KL L+A IG
Sbjct: 181 PKLNQLYAFS-QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 24/161 (14%), Positives = 51/161 (31%), Gaps = 29/161 (18%)
Query: 408 CKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGN 467
+ L + GL ++ + P++S LT + I+ +
Sbjct: 65 AHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 468 NFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNS 527
+ ++I TL ++ ++DLS N + + L +
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYN-------------GAITDIM------------PLKT 157
Query: 528 LTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE 568
L L LN+ + + + + L L S + G+
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 21/131 (16%), Positives = 40/131 (30%), Gaps = 28/131 (21%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+ + G D++ + +L L++S + L+ I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSA----HDDSILTK--------------INT 134
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELT 196
LP + +DLS N DI P LK LN+ + + + + +L
Sbjct: 135 LP-------KVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLN 184
Query: 197 HFELGYNPLKS 207
+
Sbjct: 185 QLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 18/117 (15%), Positives = 36/117 (30%), Gaps = 22/117 (18%)
Query: 502 TQLNKLQQLELQENMFTGELPRNLNSLTA-------------------LIVLNLSTNQLT 542
+ L ++ +NSLT + L ++ T
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHAT 79
Query: 543 GTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFDH 598
P + L+ L L + +T + L+ L L +ISH+ + + +
Sbjct: 80 NYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 31/201 (15%)
Query: 698 VYKVKLKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNVVKLLMCCSG 751
VYK K G VA+KR+ + + E T R EI L + H N+V L+
Sbjct: 37 VYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHS 90
Query: 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRD 811
+ LV+E+M L +L L S +G+A+ H I+HRD
Sbjct: 91 ERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRD 144
Query: 812 VKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY-----AYTKK 866
+K N+L++++ ++ADFGLA+A G + + + Y AP+ Y+
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAF----GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 867 VTEKSDVYSFGVVLMELVTGK 887
V D++S G + E++TGK
Sbjct: 201 V----DIWSIGCIFAEMITGK 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-18
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 46/236 (19%)
Query: 671 QRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP------ET 723
+ V+F+ +IL IG G +V V+ + + A+K + +K E
Sbjct: 10 EDVNFDHFEIL------RAIGKGSFGKVCIVQKNDTKKMYAMKYM----NKQKCVERNEV 59
Query: 724 ETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSLD 781
VF+ E++ + + H +V L S QD + V + + G L H + ++
Sbjct: 60 RNVFK-ELQIMQGLEHPFLVNLW--YSFQDEEDMFMVVDLLLGGDL--RYHLQ-QNVHFK 113
Query: 782 -WSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840
+++ I + L YL N I+HRD+K NILLD + DF +A
Sbjct: 114 EETVKLFICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA-----M 164
Query: 841 GQSDDAMSCVAGSYGYIAPE-------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ ++ +AG+ Y+APE Y+ V D +S GV EL+ G+RP
Sbjct: 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 37/234 (15%)
Query: 670 FQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETET 725
F R + ++ + +GSG V ++G VA+K+L + +
Sbjct: 11 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70
Query: 726 VFRSEIETLGRVRHGNVVKLL----MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGS 779
+R E+ L +RH NV+ LL + DF LV +M D L + +
Sbjct: 71 AYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LGKLMKHEK 124
Query: 780 LDWS-IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838
L I+F + Q KGL Y+H I+HRD+K N+ ++ + ++ DFGLA+
Sbjct: 125 LGEDRIQFLVYQ-MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---- 176
Query: 839 QEGQSDDAMSCVAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
+ V + Y APE YT+ V D++S G ++ E++TGK
Sbjct: 177 --QADSEMTGYVVTRW-YRAPEVILNWMRYTQTV----DIWSVGCIMAEMITGK 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 690 IGSGGSCRVYK-VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG-NVVKLL- 746
+G G V++ + + + E V VK L KP + + EI+ L +R G N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 747 MCCSGQDFN-ILVYEYMPNGSLADMLHEKGRSGSL-DWSIRFSIAQGAAKGLAYLHNDCV 804
+ LV+E++ N + +L D+ IRF + + K L Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYE-ILKALDYCHSM-- 149
Query: 805 PAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSC-VAGSYGYIAPE-- 860
I+HRDVK HN+++D E R+ D+GLA+ + VA Y + PE
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF-----YHPGQEYNVRVASRY-FKGPELL 202
Query: 861 ---YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y + D++S G +L ++ K P
Sbjct: 203 VDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
+IG G V VK+K +G+ A+K + + E FR E + L + +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQL 126
Query: 746 LMCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+ QD N L V EY G L +L + G + + RF +A+ + +H
Sbjct: 127 --HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAE-IVMAIDSVHRL- 181
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE--- 860
VHRD+K NILLD R+ADFG L++ +G ++ G+ Y++PE
Sbjct: 182 --GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA-DGTVRSLVAV--GTPDYLSPEILQ 236
Query: 861 --------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+Y + D ++ GV E+ G+ P
Sbjct: 237 AVGGGPGTGSYGPEC----DWWALGVFAYEMFYGQTP 269
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 698 VYKVK-LKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNVVKLLMCCS 750
V+K K ++ E VA+KR+ + + + + R EI L ++H N+V+L
Sbjct: 18 VFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLH 71
Query: 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHR 810
LV+E+ L G LD I S KGL + H+ ++HR
Sbjct: 72 SDKKLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHR 125
Query: 811 DVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY-----AYTK 865
D+K N+L++ ++A+FGLA+A G S + Y P+ Y+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 866 KVTEKSDVYSFGVVLMELVTGKRP 889
+ D++S G + EL RP
Sbjct: 182 SI----DMWSAGCIFAELANAGRP 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 24/198 (12%)
Query: 698 VYKVK-LKSGETVAVKRLLGGTHKPETE-TVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755
V+K + +G+ VA+K+ L P + R EI L +++H N+V LL +
Sbjct: 19 VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRL 77
Query: 756 ILVYEYMPNGSLADMLHE-KGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKS 814
LV+EY + +LHE + + SI + + + H +HRDVK
Sbjct: 78 HLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKP 130
Query: 815 HNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-----YAYTKKVTE 869
NIL+ V ++ DFG A+ L D + Y +PE Y V
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTGP----SDYYDDEVATRWYRSPELLVGDTQYGPPV-- 184
Query: 870 KSDVYSFGVVLMELVTGK 887
DV++ G V EL++G
Sbjct: 185 --DVWAIGCVFAELLSGV 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 39/236 (16%)
Query: 669 TFQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETE 724
TF R N+ ++ + +GSG V K+G VAVK+L +
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 725 TVFRSEIETLGRVRHGNVVKLL----MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSG 778
+R E+ L ++H NV+ LL S ++FN LV M AD L+ +
Sbjct: 74 RTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNNIVKCQ 127
Query: 779 SL-DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837
L D ++F I Q +GL Y+H+ I+HRD+K N+ ++ + ++ DFGLA+
Sbjct: 128 KLTDDHVQFLIYQ-ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 180
Query: 838 SQEGQSDDAMSC-VAGSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
+ D M+ VA + Y APE Y + V D++S G ++ EL+TG+
Sbjct: 181 ----HTADEMTGYVATRW-YRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGR 227
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 31/201 (15%)
Query: 698 VYKVKLKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNVVKLLMCCSG 751
VYK + GET A+K++ + E E T R EI L ++H N+VKL
Sbjct: 18 VYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHT 71
Query: 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRD 811
+ +LV+E++ L +L G L+ S G+AY H+ ++HRD
Sbjct: 72 KKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125
Query: 812 VKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-----YAYTKK 866
+K N+L++ E ++ADFGLA+A G + + Y AP+ Y+
Sbjct: 126 LKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 867 VTEKSDVYSFGVVLMELVTGK 887
+ D++S G + E+V G
Sbjct: 182 I----DIWSVGCIFAEMVNGT 198
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 47/215 (21%), Positives = 71/215 (33%), Gaps = 16/215 (7%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIP----SFLGNLTELTHFE 199
N L +F F L+ + + N + +I S L L E+
Sbjct: 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI-- 86
Query: 200 LGYNPLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGK 257
N L + NL L+ L + I +PD LD+ DN
Sbjct: 87 EKANNLLY--INPEAFQNLPNLQYLLISN-TGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 258 IPH-SFSGLAS-IEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETI--AAM 313
I SF GL+ + L N + E+ S N T L L++S NN LP + A
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNS 348
L+++ L + L +N
Sbjct: 203 GPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 37/216 (17%), Positives = 77/216 (35%), Gaps = 10/216 (4%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELP-DFSREFANL 147
F L + +S N + + S L + ++ + + + + NL
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIP--SFLGNLTELTHFELGYNPL 205
Q L +S +L++ N+ I SF+G E L N +
Sbjct: 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 206 KSSPLPSSVGNLSKLENLWAAKANLIGEIP-DSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
+ + +S N ++L+ L + N + E+P D + LD+S + +
Sbjct: 167 QE--IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224
Query: 265 LASIEQIELFDNQLSGELPESLSNLTTLLRLDISQN 300
L + ++ + +LP +L L L+ ++
Sbjct: 225 LKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 42/233 (18%), Positives = 75/233 (32%), Gaps = 9/233 (3%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANLQVLDLSR 154
R L + + S L+ + + N + + L + + +
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 155 NNFSGDIPES-FGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP-LKSSPLPS 212
N I F P L+ L + + L + + ++ N + + S
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 213 SVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP-HSFSGLASIEQI 271
VG + LW K N I EI +S L L+LSDN ++P F G + +
Sbjct: 149 FVGLSFESVILWLNK-NGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207
Query: 272 ELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNY 324
++ ++ L NL L LP ++L +L
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 54/278 (19%), Positives = 97/278 (34%), Gaps = 36/278 (12%)
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
S ++ T EIP L N ++L+ + +LE ++S ND
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 374 TGELPRFLCFRN--KLQCIIIFN-NRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFW 430
+ + F N KL I I N PE++ L YL ++
Sbjct: 67 LEVIEADV-FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 431 GLPEVDFFEMYNNRFEGSISP-SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLS 489
+ ++ +N +I S + IL N E+ + QL ++LS
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 490 QNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPE- 548
N N L+ EL ++F G + ++L++S ++ ++P
Sbjct: 186 DN-------------NNLE--ELPNDVFHG--------ASGPVILDISRTRIH-SLPSYG 221
Query: 549 LGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHN 586
L NL L + NL +L L ++++
Sbjct: 222 LENLKKLRARST-YNLKKLPTLEKLVALMEA--SLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 30/167 (17%), Positives = 56/167 (33%), Gaps = 8/167 (4%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD--FSREFAN 146
P F + L+ L +S+ L +L + N+ I + F
Sbjct: 97 PEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 155
Query: 147 LQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLK 206
+L L++N +F + ++ N L L + ++ +
Sbjct: 156 SVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
Query: 207 SSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNF 253
S LPS L L+ L A + ++P ++ KL L L+
Sbjct: 216 S--LPS--YGLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 23/145 (15%), Positives = 47/145 (32%), Gaps = 13/145 (8%)
Query: 474 PSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIV 533
+IC + +++ + +P+ + +L + L
Sbjct: 3 HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 534 LNLSTNQLTGTIPPE-LGNLAVLTSLDLS-SNLLTGEIPLE-LTKL-KLNQFNISHNKLY 589
+ +S N + I + NL L + + +N L I E L L IS+ +
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI- 116
Query: 590 GEVPSD-FDH--DLFISSLLDNPGL 611
+P H + + DN +
Sbjct: 117 KHLPDVHKIHSLQKVLLDIQDNINI 141
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 698 VYKVK-LKSGETVAVKRLLGGTHKPETE-----TVFRSEIETLGRVRHGNVVKLLMCCSG 751
VYK +G VA+K + K ++E T R EI + ++H N+V+L
Sbjct: 21 VYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIR-EISLMKELKHENIVRLYDVIHT 74
Query: 752 QDFNILVYEYMPN--GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVH 809
++ LV+E+M N D L+ ++ +GLA+ H + I+H
Sbjct: 75 ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILH 131
Query: 810 RDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY-----AYT 864
RD+K N+L++ ++ DFGLA+A S + Y AP+ Y+
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPVN----TFSSEVVTLWYRAPDVLMGSRTYS 187
Query: 865 KKVTEKSDVYSFGVVLMELVTGK 887
+ D++S G +L E++TGK
Sbjct: 188 TSI----DIWSCGCILAEMITGK 206
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 37/209 (17%), Positives = 75/209 (35%), Gaps = 11/209 (5%)
Query: 123 LQVLALDYNVFIGELPDFS-REFANLQVLDLSRNNFSGDIPE-SFGRFPVLKVLNLGGN- 179
Q L L + +P + N+ + +S + + SF + + +
Sbjct: 33 TQTLKLIET-HLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI- 238
L+ + P L L L + LK P + V + L + IP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 239 -GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPE-SLSNLTTLLR-L 295
G L L +N + ++F+G ++ + L N+ + + + + + L
Sbjct: 152 QGLCNETLTLKLYNNGFTSVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 296 DISQNNLTGNLPETIAAMSLESLNLNDNY 324
D+SQ ++T LP L+ L + +
Sbjct: 211 DVSQTSVT-ALPSKGLE-HLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 38/233 (16%), Positives = 72/233 (30%), Gaps = 36/233 (15%)
Query: 337 PNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRN--KLQCIIIFN 394
P+ LKL N+ VS + +L F N K+ I I N
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS-FYNLSKVTHIEIRN 89
Query: 395 NRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISP--S 452
R I P LP + F ++N +
Sbjct: 90 TRNLTYID-----------------------PDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 453 ISNAPKLTGILINGNNFTGEVPSQICT--LRQLQAVDLSQNRFSGHLPTCITQLNKLQQL 510
+ + + I N + +P + + L N F+ + KL +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 511 ELQENMFTGELPRNL--NSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDL 560
L +N + + ++ + +L++S +T +P + L +L L + +
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 42/230 (18%), Positives = 82/230 (35%), Gaps = 19/230 (8%)
Query: 361 SNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNE 420
E F V+ D +P Q + + ++ ++ + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 421 LQGELPSK-FWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVP--SQ 476
+L S F+ L +V E+ N R I P P L + I P ++
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 477 ICTLRQLQAVDLSQNRFSGHLPTCITQ--LNKLQQLELQENMFTGELPRNLNSLTALIVL 534
+ + ++++ N + +P Q N+ L+L N FT + + T L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 535 NLSTNQLTGTIPPEL--GNLAVLTSLDLSSNLLTGEIPLE----LTKLKL 578
L+ N+ I + G + + LD+S +T +P + L +L
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 21/143 (14%), Positives = 51/143 (35%), Gaps = 12/143 (8%)
Query: 459 LTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFT 518
+ + +PS + + L L + + L + ++ + ++
Sbjct: 13 EEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDVTL 68
Query: 519 GELPRNL-NSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLTGEIPLELTKL 576
+L + +L+ + + + + I P+ L L +L L + + L P +LTK+
Sbjct: 69 QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP-DLTKV 126
Query: 577 ----KLNQFNISHNKLYGEVPSD 595
I+ N +P +
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVN 149
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 28/162 (17%), Positives = 60/162 (37%), Gaps = 12/162 (7%)
Query: 244 LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT 303
+ ++ + +IP S S + ++L + L + SNL + R+ +S +
Sbjct: 13 EEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTL 68
Query: 304 GNLPETIAA--MSLESLNLNDNYFTGEIP-ESLASNPNLVQLKLFNNSFSGKLPDD--LG 358
L + + + + I ++L P L L +FN PD +
Sbjct: 69 QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127
Query: 359 KYSNLEYFDVSTNDFTGELPR--FLCFRNKLQCIIIFNNRFS 398
+++ N + +P F N+ + ++NN F+
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 53/214 (24%)
Query: 698 VYKVK-LKSGETVAVKRLLGGTHKPETE----TVFRSEIETLGRVRHGNVVKLLMCCSGQ 752
VYK + + + VA+K++ G + T R EI+ L + H N++ LL +
Sbjct: 26 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHK 84
Query: 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDV 812
LV+++M L ++ K S L S + +GL YLH I+HRD+
Sbjct: 85 SNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDL 138
Query: 813 KSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG--------------YIA 858
K +N+LLD V ++ADFGLAK+ +G Y A
Sbjct: 139 KPNNLLLDENGVLKLADFGLAKS------------------FGSPNRAYTHQVVTRWYRA 180
Query: 859 PEY-----AYTKKVTEKSDVYSFGVVLMELVTGK 887
PE Y V D+++ G +L EL+
Sbjct: 181 PELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 698 VYKVK-LKSGETVAVKRLLGGTHKPETE-TVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755
V K + +G VA+K+ L + R EI+ L ++RH N+V LL C +
Sbjct: 41 VMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRW 99
Query: 756 ILVYEYMPNGSLADMLHE-KGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKS 814
LV+E++ + +L + + LD+ + G+ + H+ I+HRD+K
Sbjct: 100 YLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKP 152
Query: 815 HNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-----YAYTKKVTE 869
NIL+ V ++ DFG A+ L + + + Y APE Y K V
Sbjct: 153 ENILVSQSGVVKLCDFGFARTLAAP----GEVYDDEVATRWYRAPELLVGDVKYGKAV-- 206
Query: 870 KSDVYSFGVVLMELVTGK 887
DV++ G ++ E+ G+
Sbjct: 207 --DVWAIGCLVTEMFMGE 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-17
Identities = 59/247 (23%), Positives = 96/247 (38%), Gaps = 31/247 (12%)
Query: 653 VKSGFFSTSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAV 711
+ S +F WK + Q + + ++G GG V+ ++K +G+ A
Sbjct: 163 LDSLYF-LRFLQWKWLEAQPMGEDWFLDF------RVLGRGGFGEVFACQMKATGKLYAC 215
Query: 712 KRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADM 770
K+L K + E + L +V +V L + LV M G +
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI--R 273
Query: 771 LH---EKGRSGSLDWS-IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPR 826
H + F AQ GL +LH I++RD+K N+LLD + R
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329
Query: 827 VADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE----YAYTKKVTEKSDVYSFGVVLME 882
++D GLA + AG+ G++APE Y V D ++ GV L E
Sbjct: 330 ISDLGLAV----ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYE 381
Query: 883 LVTGKRP 889
++ + P
Sbjct: 382 MIAARGP 388
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 48/224 (21%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNV 742
IG G V+K + K+G+ VA+K++ E E T R EI+ L ++H NV
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALR-EIKILQLLKHENV 78
Query: 743 VKLL-MCCSGQDFNI-------LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA- 793
V L+ +C + LV+++ + LA +L ++F++++
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--------VKFTLSEIKRV 129
Query: 794 -----KGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS 848
GL Y+H + I+HRD+K+ N+L+ + V ++ADFGLA+A + + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 849 CVAGSYGYIAPEY-----AYTKKVTEKSDVYSFGVVLMELVTGK 887
+ Y PE Y + D++ G ++ E+ T
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 690 IGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRS---EIETLGRVRHGNVV 743
+G G VYK K K + A+K++ E + S EI L ++H NV+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI-------EGTGISMSACREIALLRELKHPNVI 81
Query: 744 KLL-MCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KG 795
L + S D + L+++Y + L ++ S + ++ + G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPR----VADFGLAKALQSQEGQSDDAMSCVA 851
+ YLH + ++HRD+K NIL+ E R +AD G A+ S D V
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 852 GSYGYIAPE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
++ Y APE YTK + D+++ G + EL+T +
Sbjct: 198 -TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 679 DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
+I ++L+G G V +GE VA+K++ R EI+ L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHF 66
Query: 738 RHGNVVKLL---MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSL-DWSIRFSIAQG 791
+H N++ + S ++FN ++ E M D LH + L D I++ I Q
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQ----TD-LHRVISTQMLSDDHIQYFIYQ- 120
Query: 792 AAKGLAYLHNDCVPA-IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCV 850
+ + LH + ++HRD+K N+L+++ +V DFGLA+ + + +
Sbjct: 121 TLRAVKVLHG----SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 851 AGSYGYI------APE-----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
+G ++ APE Y++ + DV+S G +L EL +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-17
Identities = 93/497 (18%), Positives = 151/497 (30%), Gaps = 110/497 (22%)
Query: 146 NLQVLDLSRNNFSGD-IPESFGRFPVLKVLNLGGNLLS----GLIPSFLGNLTELTHFEL 200
++Q LD+ S E +V+ L L+ I S L L L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 201 GYNPLK-------SSPLPSSVGNLSKLENLWAAKANLIGE-----IPDSIGKLAFLSNLD 248
N L L + + KL +L + + + ++ L L L
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKL-SL---QNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 249 LSDNFLSGK-IPHSFSGLAS----IEQIELFDNQLSGE----LPESLSNLTTLLRLDISQ 299
LSDN L + GL +E+++L LS L L L +S
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 300 NNLTGNLPETIAAM------SLESLNLNDNYFTGE----IPESLASNPNLVQLKLFNNSF 349
N++ + LE+L L T + + +AS +L +L L +N
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 350 SGKLPDDLGKY-----SNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPES 404
+L S L + T + LC
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC--------------------RV 279
Query: 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNA-PKLTGIL 463
++L L GNEL E G + ++ +L +
Sbjct: 280 LRAKESLKELSLAGNELGDE------GAR--------------LLCETLLEPGCQLESLW 319
Query: 464 INGNNFT-------GEVPSQICTLRQLQAVDLSQNRFSG----HLPTCITQLN-KLQQLE 511
+ +FT V +Q L +L +S NR L + Q L+ L
Sbjct: 320 VKSCSFTAACCSHFSSVLAQNRFLLEL---QISNNRLEDAGVRELCQGLGQPGSVLRVLW 376
Query: 512 LQENMFTGE----LPRNLNSLTALIVLNLSTNQLTGTIPPELG-----NLAVLTSLDLSS 562
L + + L L + +L L+LS N L +L +L L L
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 436
Query: 563 NLLTGEIPLELTKLKLN 579
+ E+ L L+ +
Sbjct: 437 IYWSEEMEDRLQALEKD 453
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 57/313 (18%), Positives = 93/313 (29%), Gaps = 64/313 (20%)
Query: 92 FCRIRTLRNLNLSDNYFNGT----LSSQSLSPCFHLQVLALDYNVFIGE--LPDFSREFA 145
+ TL+ L+LSDN L L P L+ L L+Y + +
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC-SLSAASCEPLASVLR 167
Query: 146 ---NLQVLDLSRNNFSGD----IPESFGRFPV-LKVLNLGGNLLS----GLIPSFLGNLT 193
+ + L +S N+ + + + P L+ L L ++ + + +
Sbjct: 168 AKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKA 227
Query: 194 ELTHFELGYNPLK-------SSPLPSSVGNLSKLENLWAAKANLIGE-----IPDSIGKL 241
L LG N L L L L +W I + +
Sbjct: 228 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL-WIWE---CGITAKGCGDLCRVLRAK 283
Query: 242 AFLSNLDLSDNFLSG----------KIPHSFSGLASIEQIELFDNQLSGE----LPESLS 287
L L L+ N L P +E + + + L+
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGC-----QLESLWVKSCSFTAACCSHFSSVLA 338
Query: 288 NLTTLLRLDISQNNLTGNLPETIAAM------SLESLNLNDNYFTGE----IPESLASNP 337
LL L IS N L + L L L D + + +L +N
Sbjct: 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398
Query: 338 NLVQLKLFNNSFS 350
+L +L L NN
Sbjct: 399 SLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-14
Identities = 63/334 (18%), Positives = 99/334 (29%), Gaps = 57/334 (17%)
Query: 96 RTLRNLNLSDNYFNG----TLSSQSLSPCFHLQVLALDYNVF----IGELPDFSREFANL 147
L LNL N + +P +Q L+L G L R L
Sbjct: 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 115
Query: 148 QVLDLSRNNFSGDIPESFGRF-----PVLKVLNLGGNLLS----GLIPSFLGNLTELTHF 198
Q L LS N + L+ L L LS + S L +
Sbjct: 116 QELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKEL 175
Query: 199 ELGYNPLK-------SSPLPSSVGNLSKLENLWAAKANLIGE-----IPDSIGKLAFLSN 246
+ N + L S L L L + + + + A L
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEAL-KLE---SCGVTSDNCRDLCGIVASKASLRE 231
Query: 247 LDLSDNFLSGK-----IPHSFSGLASIEQIELFDNQLSGE----LPESLSNLTTLLRLDI 297
L L N L P + + + +++ ++ + L L +L L +
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 298 SQNNLTGNLPETIAAM------SLESLNLNDNYFTGE----IPESLASNPNLVQLKLFNN 347
+ N L + LESL + FT LA N L++L++ NN
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN 351
Query: 348 SFSGK----LPDDLGKY-SNLEYFDVSTNDFTGE 376
L LG+ S L ++ D +
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-14
Identities = 51/319 (15%), Positives = 100/319 (31%), Gaps = 62/319 (19%)
Query: 71 NQSVDGIDLSGFDLSGGFPNGFCR-IRTLRNLNLSDNYFNGTLSSQSLSPCF----HLQV 125
+ + +D+ +LS ++ + + L D + +S L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL-TEARCKDISSALRVNPALAE 60
Query: 126 LALDYNVFIGE------LPDFSREFANLQVLDLSRNNFS----GDIPESFGRFPVLKVLN 175
L L N +G+ L +Q L L + G + + P L+ L+
Sbjct: 61 LNLRSN-ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 176 LGGNLLSG-----LIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANL 230
L NLL L L L +L Y L +S L+ +
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS----AASCEPLASV---------- 165
Query: 231 IGEIPDSIGKLAFLSNLDLSDNFLSGK-IPHSFSGL----ASIEQIELFDNQLSGE---- 281
+ L +S+N ++ + GL +E ++L ++ +
Sbjct: 166 -------LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRD 218
Query: 282 LPESLSNLTTLLRLDISQNNLTGNLPETIAAM------SLESLNLNDNYFTGE----IPE 331
L +++ +L L + N L + L +L + + T + +
Sbjct: 219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278
Query: 332 SLASNPNLVQLKLFNNSFS 350
L + +L +L L N
Sbjct: 279 VLRAKESLKELSLAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 39/257 (15%), Positives = 79/257 (30%), Gaps = 49/257 (19%)
Query: 361 SNLEYFDVSTNDFTGELPRFLCFRNK-LQCIIIFNNRFSGK----IPESYGECKTLNYLR 415
+++ D+ + + L + Q + + + + I + L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 416 FGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVP 474
NEL G+ + + + + K+ + + TG
Sbjct: 63 LRSNELGDV------GVH--------------CVLQGLQTPSCKIQKLSLQNCCLTGAGC 102
Query: 475 SQIC----TLRQLQAVDLSQNRFSG----HLPTCITQLN-KLQQLELQENMFTGE----L 521
+ TL LQ + LS N L + +L++L+L+ + L
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162
Query: 522 PRNLNSLTALIVLNLSTNQLTGTIPPELG-----NLAVLTSLDLSSNLLTGE----IPLE 572
L + L +S N + L + L +L L S +T + +
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 573 LTKLK-LNQFNISHNKL 588
+ L + + NKL
Sbjct: 223 VASKASLRELALGSNKL 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-17
Identities = 66/254 (25%), Positives = 101/254 (39%), Gaps = 42/254 (16%)
Query: 652 KVKSGFFSTSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVA 710
K F S K + R+ + +++ +IG G V V+ K + + A
Sbjct: 45 KNIDNFLSRYKDTINKIRDLRMKAEDYEVV------KVIGRGAFGEVQLVRHKSTRKVYA 98
Query: 711 VKRLLGGTHKPET-----ETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL--VYEYMP 763
+K L K E F E + + VV+L + QD L V EYMP
Sbjct: 99 MKLL----SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF--YAFQDDRYLYMVMEYMP 152
Query: 764 NGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823
G L + W+ RF A+ L +H+ +HRDVK N+LLD
Sbjct: 153 GGDL--VNLMSNYDVPEKWA-RFYTAEVVL-ALDAIHSM---GFIHRDVKPDNMLLDKSG 205
Query: 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE--------YAYTKKVTEKSDVYS 875
++ADFG + ++EG + G+ YI+PE Y ++ D +S
Sbjct: 206 HLKLADFGTCMKM-NKEGMVRCDTAV--GTPDYISPEVLKSQGGDGYYGREC----DWWS 258
Query: 876 FGVVLMELVTGKRP 889
GV L E++ G P
Sbjct: 259 VGVFLYEMLVGDTP 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 67/220 (30%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
L+G G +V VK K +G A+K L K E +E L RH + L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTAL 213
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
D V EY G L H + R S D + RF A+ L YLH++
Sbjct: 214 KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRA-RFYGAE-IVSALDYLHSEK- 268
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA-MSCVAGSYGYIAPE--- 860
+V+RD+K N++LD + ++ DFGL K EG D A M G+ Y+APE
Sbjct: 269 -NVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 861 -YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
Y + V D + GVV+ E++ G R P + ++ +
Sbjct: 323 DNDYGRAV----DWWGLGVVMYEMMCG-RL--PFYNQDHE 355
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE----TETV-FRSEIETLGRVRHGNV 742
+IG G V VKLK + + A+K L +K E ET FR E + L +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 743 VKLLMCCSGQDFNIL--VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH 800
L + QD N L V +Y G L +L + + + RF +A+ + +H
Sbjct: 137 TTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAE-MVIAIDSVH 192
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
VHRD+K NIL+D R+ADFG L ++G +++ G+ YI+PE
Sbjct: 193 QL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAV--GTPDYISPE 246
Query: 861 ---------YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y + D +S GV + E++ G+ P
Sbjct: 247 ILQAMEGGKGRYGPEC----DWWSLGVCMYEMLYGETP 280
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETE-----TVFRSEIETLGRVRHGNVV 743
+G G VYK K K + VA+K + + E E T R E+ L ++H N+V
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIR-EVSLLKDLKHANIV 63
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
L + LV+EY+ L L + G ++ +GLAY H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY-- 861
++HRD+K N+L++ ++ADFGLA+A + Y P+
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAK----SIPTKTYDNEVVTLWYRPPDILL 173
Query: 862 ---AYTKKVTEKSDVYSFGVVLMELVTGK 887
Y+ ++ D++ G + E+ TG+
Sbjct: 174 GSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 5e-16
Identities = 56/265 (21%), Positives = 99/265 (37%), Gaps = 55/265 (20%)
Query: 673 VSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETETVFRSE 730
++ I ++LIG+G V + VA+K++L + + + R E
Sbjct: 44 RPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-E 102
Query: 731 IETLGRVRHGNVVKLL---MCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSL--DWS 783
I L R+ H +VVK+L + + F+ +V E +D + R+ +
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SD-FKKLFRTPVYLTELH 157
Query: 784 IRFSIAQGAAKGLAYLH--NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841
I+ + G+ Y+H I+HRD+K N L++ + +V DFGLA+ + E
Sbjct: 158 IKTLLYN-LLVGVKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 842 QSDDAMSCVAGSYG-----------------------YIAPE-----YAYTKKVTEKSDV 873
+ Y APE YT+ + DV
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DV 267
Query: 874 YSFGVVLMELVTGKRPNDPSFGENK 898
+S G + EL+ + N +
Sbjct: 268 WSIGCIFAELLNMIKENVAYHADRG 292
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 38/207 (18%)
Query: 698 VYKVK-LKSGETVAVKRLLGGTHKPETE------TVFRSEIETLGRVRHGNVVKLLMCCS 750
VYK + ETVA+KR+ + E E T R E+ L ++H N+++L
Sbjct: 50 VYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIH 103
Query: 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHR 810
L++EY N L + ++ + + S G+ + H+ +HR
Sbjct: 104 HNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHR 156
Query: 811 DVKSHNILLDAEMVPR-----VADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY---- 861
D+K N+LL + DFGLA+A + + Y PE
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR----QFTHEIITLWYRPPEILLGS 212
Query: 862 -AYTKKVTEKSDVYSFGVVLMELVTGK 887
Y+ V D++S + E++
Sbjct: 213 RHYSTSV----DIWSIACIWAEMLMKT 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 9e-16
Identities = 63/238 (26%), Positives = 94/238 (39%), Gaps = 33/238 (13%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGN---V 742
+IG GG VY + +G+ A+K L K +E L V G+ +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFI 254
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V + D + + M G L L + G S RF A+ GL ++HN
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADM-RFYAAE-IILGLEHMHNR 311
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-- 860
+V+RD+K NILLD R++D GLA + + V G++GY+APE
Sbjct: 312 ---FVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASV-GTHGYMAPEVL 362
Query: 861 ---YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKDIVRWVTEATLSSPER 914
AY D +S G +L +L+ G P F + TL+
Sbjct: 363 QKGVAYDSSA----DWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVE 412
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 62/236 (26%), Positives = 95/236 (40%), Gaps = 39/236 (16%)
Query: 665 WKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP-- 721
W+ + ++ D + +G+G RV VK K SG A+K L K
Sbjct: 30 WETPSQNTAQLDQFDRI------KTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKV 79
Query: 722 ----ETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRS 777
+ E +E L V +VKL +V EY+ G + L GR
Sbjct: 80 VKLKQIEHT-LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 778 GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837
S + RF AQ YLH+ +++RD+K N+L+D + +V DFG AK +
Sbjct: 139 -SEPHA-RFYAAQ-IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 838 SQEGQSDDAMSCVAGSYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ G+ +APE Y K V D ++ GV++ E+ G P
Sbjct: 192 ------KGRTWTLCGTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 51/264 (19%), Positives = 96/264 (36%), Gaps = 50/264 (18%)
Query: 669 TFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETETV 726
+ + ++LIG G VY + + VA+K++ + + +
Sbjct: 13 NLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI 72
Query: 727 FRSEIETLGRVRHGNVVKLLMCC---SGQDFN--ILVYEYMPNGSLADMLHEKGRSGSL- 780
R EI L R++ +++L F+ +V E +D L + ++
Sbjct: 73 LR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFL 126
Query: 781 -DWSIRFSIAQGAAKGLAYLH--NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837
+ I+ + G ++H I+HRD+K N LL+ + +V DFGLA+ +
Sbjct: 127 TEEHIKTILYN-LLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 838 SQEGQSDDAMSCVAGSYG------------------YIAPE-----YAYTKKVTEKSDVY 874
S++ + G Y APE YTK + D++
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIW 236
Query: 875 SFGVVLMELVTGKRPNDPSFGENK 898
S G + EL+ + +
Sbjct: 237 STGCIFAELLNMLQSHINDPTNRF 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 40/168 (23%), Positives = 62/168 (36%), Gaps = 12/168 (7%)
Query: 144 FANLQVLDLSRNNFSGDIPE-SFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGY 202
+ +LDLS NN S E + R L L L N L+ + + L + +L
Sbjct: 38 PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97
Query: 203 NPLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPH 260
N L + L + +L LE L N I + + +A L L LS N +S
Sbjct: 98 NHLHT--LDEFLFSDLQALEVLLLYN-NHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154
Query: 261 SFSG---LASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGN 305
L + ++L N+L L L ++ + L N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY---LHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 49/211 (23%), Positives = 76/211 (36%), Gaps = 35/211 (16%)
Query: 146 NLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIP-SFLGNLTELTHFELGYNP 204
+L S+ ++P+S +L+L N LS L LT L L +N
Sbjct: 19 ASNILSCSKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
L + S + NL LDLS N L FS
Sbjct: 76 LNF--ISSEA--FVPVPNL---------------------RYLDLSSNHLHTLDEFLFSD 110
Query: 265 LASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS----LESLNL 320
L ++E + L++N + + ++ L +L +SQN ++ E I + L L+L
Sbjct: 111 LQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDL 170
Query: 321 NDNYFTGEIPESLASNPNLVQ--LKLFNNSF 349
+ N L P V+ L L NN
Sbjct: 171 SSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 43/190 (22%), Positives = 65/190 (34%), Gaps = 34/190 (17%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155
L+LS N L + L NL L LS N
Sbjct: 39 SYTALLDLSHNNL------SRLRAEWTPTRL------------------TNLHSLLLSHN 74
Query: 156 NFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSV- 214
+ + E+F P L+ L+L N L L +L L L N + + +
Sbjct: 75 HLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV--VDRNAF 132
Query: 215 GNLSKLENLWAAKANLIGEIP----DSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASI-- 268
++++L+ L+ ++ N I P KL L LDLS N L L +
Sbjct: 133 EDMAQLQKLYLSQ-NQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
Query: 269 EQIELFDNQL 278
+ L +N L
Sbjct: 192 NGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 46/180 (25%), Positives = 71/180 (39%), Gaps = 18/180 (10%)
Query: 454 SNAPKLTGIL-INGNNFTGEVPSQICT-LRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQL 510
+ P T +L ++ NN + T L L ++ LS N + + + + L+ L
Sbjct: 35 QSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93
Query: 511 ELQENMFTGELPRN-LNSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLTGE 568
+L N L + L AL VL L N + + ++A L L LS N ++
Sbjct: 94 DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-R 150
Query: 569 IPLE----LTKL-KLNQFNISHNKLYGEVPSDFDH----DLFISSLLDNPGLCSPDLKPL 619
P+E KL KL ++S NKL +D L +NP C L L
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQL 210
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 34/162 (20%), Positives = 64/162 (39%), Gaps = 16/162 (9%)
Query: 413 YLRFGGNELQGELPSK--FWGLPEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNF 469
L N L L ++ L + + +N IS P L + ++ N+
Sbjct: 43 LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL 100
Query: 470 TGEVPSQICT-LRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELP----R 523
+ + + L+ L+ + L N + + +LQ+L L +N + P +
Sbjct: 101 H-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 524 NLNSLTALIVLNLSTNQLTGTIPPELGNLAVLT--SLDLSSN 563
+ N L L++L+LS+N+L +L L L L +N
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 38/124 (30%), Positives = 51/124 (41%), Gaps = 10/124 (8%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFS-REFANL 147
F + LR L+LS N+ + TL S L+VL L N I + + + A L
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNH-IVVVDRNAFEDMAQL 138
Query: 148 QVLDLSRNNFSGDIPE----SFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTH--FELG 201
Q L LS+N S P + P L +L+L N L L + L L L
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 202 YNPL 205
NPL
Sbjct: 198 NNPL 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKL 745
L+G G +V V+ K +G A+K L K E +E L RH + L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTAL 70
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
D V EY G L H + R + + + RF A+ L YLH+
Sbjct: 71 KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERA-RFYGAE-IVSALEYLHSR-- 124
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIAPE- 860
+V+RD+K N++LD + ++ DFGL K EG SD A C G+ Y+APE
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFC--GTPEYLAPEV 176
Query: 861 ---YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y + V D + GVV+ E++ G+ P
Sbjct: 177 LEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 67/246 (27%), Positives = 108/246 (43%), Gaps = 49/246 (19%)
Query: 672 RVSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGG-THKPETETVFRS 729
RV + +L +G G V+K ++GE VAVK++ + + + FR
Sbjct: 2 RVDRH---VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR- 57
Query: 730 EIETLGRVR-HGNVVKLLMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSL-DWSIR 785
EI L + H N+V LL + LV++YM D LH R+ L +
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME----TD-LHAVIRANILEPVHKQ 112
Query: 786 FSIAQGAAKGLAYLH--NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843
+ + Q K + YLH ++HRD+K NILL+AE +VADFGL+++ + +
Sbjct: 113 YVVYQ-LIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 844 DDAMSCVAGSYG-----------------YIAPE-----YAYTKKVTEKSDVYSFGVVLM 881
++ + + Y APE YTK + D++S G +L
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG 222
Query: 882 ELVTGK 887
E++ GK
Sbjct: 223 EILCGK 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 30/206 (14%)
Query: 698 VYKVK-LKSGETVAVKRLLGGTHKPETETVFRS---EIETL---GRVRHGNVVKLLMCCS 750
VYK + SG VA+K + + S E+ L H NVV+L+ C+
Sbjct: 25 VYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84
Query: 751 GQDFNI-----LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ LV+E++ L L + G +I+ + Q +GL +LH +C
Sbjct: 85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ-FLRGLDFLHANC-- 140
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY---- 861
IVHRD+K NIL+ + ++ADFGLA+ Q A++ V + Y APE
Sbjct: 141 -IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQS 194
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGK 887
Y V D++S G + E+ K
Sbjct: 195 TYATPV----DMWSVGCIFAEMFRRK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 4e-15
Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 40/187 (21%)
Query: 787 SIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDA 846
+ AKG+ +L + +HRD+ + NILL + V ++ DFGLA+ +
Sbjct: 197 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP------ 247
Query: 847 MSCVAGSYGYI-----APEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDI 900
V + APE + + T +SDV+SFGV+L E+ + G P P +++
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEF 305
Query: 901 VRWVTEAT-LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM 959
R + E T + +P+ ++ Q M L C P RP+
Sbjct: 306 CRRLKEGTRMRAPD-YTTPEMYQT----M-----------------LDCWHGEPSQRPTF 343
Query: 960 RRVVELL 966
+VE L
Sbjct: 344 SELVEHL 350
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 37/168 (22%), Positives = 58/168 (34%), Gaps = 19/168 (11%)
Query: 690 IGSGGSCRVYK------VKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNV 742
+G G +V + K + TVAVK L G E SE++ L + H NV
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIHIGHHLNV 88
Query: 743 VKLLMCCSGQDFNILV-YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
V LL C+ ++V E+ G+L+ L K R KG +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK----------RNEFVPYKTKGARFRQG 138
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
+ D+K + + + F K+L E +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 48/263 (18%), Positives = 91/263 (34%), Gaps = 28/263 (10%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
AN +L + + + D+ S ++ N + + L + + T L L +N
Sbjct: 18 LANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHN 73
Query: 204 PLKS-SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSF 262
+ SPL +L+KLE L + N + + + A LS L L +N L S
Sbjct: 74 QISDLSPL----KDLTKLEELSVNR-NRLKNL--NGIPSACLSRLFLDNNELRD--TDSL 124
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322
L ++E + + +N+L + L L+ L LD+ N +T N + ++L
Sbjct: 125 IHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTG 181
Query: 323 NYFTGEIPESLASNPNLVQLKLFNNSFSGKLPD----DLGKYSNLEYFDVSTNDFTGELP 378
E + P L + + + G Y + +
Sbjct: 182 QKCV---NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCV----LWELPVYTD 234
Query: 379 RFLCFRNKLQCIIIFNNRFSGKI 401
++ + F G +
Sbjct: 235 EVSYKFSEYINVGETEAIFDGTV 257
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 52/258 (20%), Positives = 79/258 (30%), Gaps = 25/258 (9%)
Query: 98 LRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNF 157
NL S +Q D + I L F NL+ L LS N
Sbjct: 21 AVKQNLGKQSVT---DLVSQKELSGVQNFNGDNS-NIQSLAGMQ-FFTNLKELHLSHNQI 75
Query: 158 SGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNL 217
S D+ L+ L++ N L L L+ L L N L+ S+ +L
Sbjct: 76 S-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD---TDSLIHL 127
Query: 218 SKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQ 277
LE L N + I +G L+ L LDL N ++ + L + I+L +
Sbjct: 128 KNLEILSIRN-NKLKSI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK 183
Query: 278 LSGELPESLSNLTTLLRLDISQNNLTGNL--PETIA-AMSLESLNLNDNYFTGEIPESLA 334
E + L + + G P I+ S + E
Sbjct: 184 CVNEPVKYQPELYITNTV----KDPDGRWISPYYISNGGSYVDGCVLWELPV-YTDEVSY 238
Query: 335 SNPNLVQLKLFNNSFSGK 352
+ + F G
Sbjct: 239 KFSEYINVGETEAIFDGT 256
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 42/205 (20%), Positives = 82/205 (40%), Gaps = 21/205 (10%)
Query: 408 CKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGN 467
G + + K L V F N+ + S++ + L + ++ N
Sbjct: 18 LANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHN 73
Query: 468 NFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLN--KLQQLELQENMFTGELPRNL 525
+ S + L +L+ + +++NR + + L +L L N +L
Sbjct: 74 QIS--DLSPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRD--TDSL 124
Query: 526 NSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLE-LTKLKLNQFNIS 584
L L +L++ N+L +I LG L+ L LDL N +T L L K+ +++
Sbjct: 125 IHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLTRLKKVN--WIDLT 180
Query: 585 HNKLYGEVPSDFDHDLFISSLLDNP 609
K P + +L+I++ + +P
Sbjct: 181 GQKCV-NEPVKYQPELYITNTVKDP 204
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 30/142 (21%), Positives = 53/142 (37%), Gaps = 13/142 (9%)
Query: 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKL 507
+ P + + T V L +Q + + L + L
Sbjct: 11 QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNL 65
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567
++L L N + +L L LT L L+++ N+L + + + L+ L L +N L
Sbjct: 66 KELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNG-IPSAC-LSRLFLDNNELRD 120
Query: 568 EIPLE-LTKLKLNQFNISHNKL 588
L L L+ +I +NKL
Sbjct: 121 TDSLIHLKNLE--ILSIRNNKL 140
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 52/275 (18%), Positives = 93/275 (33%), Gaps = 34/275 (12%)
Query: 229 NLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSN 288
I ++ LA +L ++ + S L+ ++ ++ + +
Sbjct: 7 TPINQV-FPDPGLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQS--LAGMQF 61
Query: 289 LTTLLRLDISQNNLT-----GNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLK 343
T L L +S N ++ +L LE L++N N + + L +L
Sbjct: 62 FTNLKELHLSHNQISDLSPLKDLT------KLEELSVNRNRLK-NLNGI--PSACLSRLF 112
Query: 344 LFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPE 403
L NN D L NLE + N + L F +KL+ + + N +
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNT--G 166
Query: 404 SYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPS-ISNAPKLTG- 461
K +N++ G + E L + + + R ISP ISN
Sbjct: 167 GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR---WISPYYISNGGSYVDG 223
Query: 462 -ILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSG 495
+L +T EV + V ++ F G
Sbjct: 224 CVLWELPVYTDEV---SYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 41/285 (14%), Positives = 86/285 (30%), Gaps = 68/285 (23%)
Query: 284 ESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQL 342
L ++ ++ + ++T + + +++ N +++ + + NL +L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 343 KLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIP 402
L +N S L L + LE V+ RN+L+ +
Sbjct: 69 HLSHNQIS-DL-SPLKDLTKLEELSVN--------------RNRLKNL------------ 100
Query: 403 ESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGI 462
+ L+ L NEL+ + + L +
Sbjct: 101 -NGIPSACLSRLFLDNNELR-------------------------DTDS-LIHLKNLEIL 133
Query: 463 LINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELP 522
I N + L +L+ +DL N + +T+L K+ ++L E
Sbjct: 134 SIRNNKLK--SIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNE-- 187
Query: 523 RNLNSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLT 566
+ L + N + I P + N + L
Sbjct: 188 -PVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 28/169 (16%), Positives = 58/169 (34%), Gaps = 21/169 (12%)
Query: 97 TLRNLNLSDNYFNGTLSS-QSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155
L L L +N L SL +L++L++ N + + + L+VLDL N
Sbjct: 107 CLSRLFLDNNE----LRDTDSLIHLKNLEILSIRNN-KLKSIVMLG-FLSKLEVLDLHGN 160
Query: 156 NFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVG 215
+ + R + ++L G + L +P P +
Sbjct: 161 EIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITN---TVKDPDGRWISPYYIS 215
Query: 216 NLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
N + ++ E+P ++++ + ++ G+ F G
Sbjct: 216 NGGSYVDG-----CVLWELPVYTDEVSYKFSEYIN----VGETEAIFDG 255
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)
Query: 698 VYKVK--LKSGETVAVKRLLGGTHKPETE------TVFRSEIETL---GRVRHGNVVKLL 746
V+K + G VA+KR+ + +T + R E+ L H NVV+L
Sbjct: 27 VFKARDLKNGGRFVALKRV-----RVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLF 80
Query: 747 MCCSGQDFNI-----LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
C+ + LV+E++ L L + G +I+ + Q +GL +LH+
Sbjct: 81 DVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDFLHS 138
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
+VHRD+K NIL+ + ++ADFGLA+ Q A++ V + Y APE
Sbjct: 139 HR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEV 190
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGK 887
D++S G + E+ K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 689 LIGSGGSCRVYKVKLK----SGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNV 742
++G G +V+ VK + + A+K L T + T + E + L V H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPFI 88
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
VKL + L+ +++ G L K + + +F +A+ A L +LH+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHS 144
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIA 858
I++RD+K NILLD E ++ DFGL+K E + + C G+ Y+A
Sbjct: 145 L---GIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFC--GTVEYMA 194
Query: 859 PE----YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
PE +T+ D +SFGV++ E++TG P G+++
Sbjct: 195 PEVVNRRGHTQSA----DWWSFGVLMFEMLTG-TL--PFQGKDRK 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP------ETETVFRSEIETLGRVRHGN 741
+G+G RV+ ++ + +G A+K L K + E E L V H
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHT-NDERLMLSIVTHPF 67
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSI-RFSIAQGAAKGLAYLH 800
++++ ++ +Y+ G L + +S + +F A+ L YLH
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLR-KSQRFPNPVAKFYAAE-VCLALEYLH 123
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
+ I++RD+K NILLD ++ DFG AK D + G+ YIAPE
Sbjct: 124 SK---DIIYRDLKPENILLDKNGHIKITDFGFAK-------YVPDVTYTLCGTPDYIAPE 173
Query: 861 ----YAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
Y K + D +SFG+++ E++ G P
Sbjct: 174 VVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 36/134 (26%), Positives = 54/134 (40%), Gaps = 5/134 (3%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
+ + L +N P +F + L+ ++L N +S L P L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 205 LKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHSF 262
+ LP S+ L L+ L AN I + L L+ L L DN L +F
Sbjct: 92 ITE--LPKSLFEGLFSLQLLLLN-ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148
Query: 263 SGLASIEQIELFDN 276
S L +I+ + L N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 26/153 (16%), Positives = 55/153 (35%), Gaps = 26/153 (16%)
Query: 172 KVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLI 231
+ L N + + P +L +L N + L L +L
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE--LAPDA--FQGLRSL-------- 82
Query: 232 GEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTT 291
++L L N ++ F GL S++ + L N+++ ++ +L
Sbjct: 83 -------------NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 292 LLRLDISQNNLTGNLPETIAAM-SLESLNLNDN 323
L L + N L T + + ++++++L N
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 6/125 (4%)
Query: 229 NLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESL- 286
N I IP L +DLS+N +S P +F GL S+ + L+ N+++ ELP+SL
Sbjct: 42 NTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLF 100
Query: 287 SNLTTLLRLDISQNNLTGNLPETI--AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKL 344
L +L L ++ N + L +L L+L DN + + + + L
Sbjct: 101 EGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHL 159
Query: 345 FNNSF 349
N F
Sbjct: 160 AQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 6/90 (6%)
Query: 480 LRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNL-NSLTALIVLNLS 537
++L+ +DLS N+ S L L L L L N T ELP++L L +L +L L+
Sbjct: 55 YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112
Query: 538 TNQLTGTIPPEL-GNLAVLTSLDLSSNLLT 566
N++ + + +L L L L N L
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 15/110 (13%)
Query: 508 QQLELQENMFTGELPRN-LNSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLL 565
++ L++N +P + L ++LS NQ++ + P+ L L SL L N +
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 566 TGEIPLE----LTKLKLNQFNISHNKLYGEVPSD-FD--HDLFISSLLDN 608
T E+P L L+ ++ NK+ + D F H+L + SL DN
Sbjct: 93 T-ELPKSLFEGLFSLQ--LLLLNANKI-NCLRVDAFQDLHNLNLLSLYDN 138
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 32/119 (26%), Positives = 49/119 (41%), Gaps = 5/119 (4%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD--FSREFAN 146
P F + LR ++LS+N + L+ + L L L N I ELP F +
Sbjct: 49 PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK-ITELPKSLFEG-LFS 105
Query: 147 LQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205
LQ+L L+ N + ++F L +L+L N L + L + L NP
Sbjct: 106 LQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 34/128 (26%), Positives = 52/128 (40%), Gaps = 10/128 (7%)
Query: 441 YNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQICT-LRQLQAVDLSQNRFSGHLP 498
N + I P S KL I ++ N + E+ LR L ++ L N+ + LP
Sbjct: 40 EQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELP 96
Query: 499 TCI-TQLNKLQQLELQENMFTGELPRNL-NSLTALIVLNLSTNQLTGTIPPE-LGNLAVL 555
+ L LQ L L N L + L L +L+L N+L TI L +
Sbjct: 97 KSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAI 154
Query: 556 TSLDLSSN 563
++ L+ N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 30/133 (22%), Positives = 44/133 (33%), Gaps = 5/133 (3%)
Query: 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETI--AAMSLESLNLNDN 323
+I +I L N + P + S L R+D+S N ++ L SL SL L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 324 YFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL-GKYSNLEYFDVSTNDFTGELPRFLC 382
T +L L L N + L D NL + N
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 383 FRNKLQCIIIFNN 395
+Q + + N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 29/151 (19%)
Query: 757 LVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
V E++ G L M H +K R + RF A+ L +LH+ I++RD+K
Sbjct: 101 FVMEFVNGGDL--MFHIQKSRRFDEARA-RFYAAE-IISALMFLHDK---GIIYRDLKLD 153
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIAPE----YAYTKKVT 868
N+LLD E ++ADFG+ K EG + + C G+ YIAPE Y V
Sbjct: 154 NVLLDHEGHCKLADFGMCK-----EGICNGVTTATFC--GTPDYIAPEILQEMLYGPAV- 205
Query: 869 EKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
D ++ GV+L E++ G P EN+D
Sbjct: 206 ---DWWAMGVLLYEMLCG-HA--PFEAENED 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 29/151 (19%)
Query: 757 LVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
V +Y+ G L H ++ R + RF A+ A L YLH+ IV+RD+K
Sbjct: 116 FVLDYINGGEL--FYHLQRERCFLEPRA-RFYAAE-IASALGYLHSL---NIVYRDLKPE 168
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIAPE----YAYTKKVT 868
NILLD++ + DFGL K E ++ + C G+ Y+APE Y + V
Sbjct: 169 NILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFC--GTPEYLAPEVLHKQPYDRTV- 220
Query: 869 EKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
D + G VL E++ G P P + N
Sbjct: 221 ---DWWCLGAVLYEMLYG-LP--PFYSRNTA 245
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 21/140 (15%)
Query: 757 LVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
L+ +Y+ G L H + + + + + L +LH I++RD+K
Sbjct: 136 LILDYINGGEL--FTHLSQRERFTEHEV-QIYVGE-IVLALEHLHKL---GIIYRDIKLE 188
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE------YAYTKKVTE 869
NILLD+ + DFGL+K + E + C G+ Y+AP+ + K V
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDF-C--GTIEYMAPDIVRGGDSGHDKAV-- 243
Query: 870 KSDVYSFGVVLMELVTGKRP 889
D +S GV++ EL+TG P
Sbjct: 244 --DWWSLGVLMYELLTGASP 261
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 27/138 (19%), Positives = 53/138 (38%), Gaps = 8/138 (5%)
Query: 145 ANLQVLDLSRNNFSGDIPE-SFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
L L+ N F+ F + P L+ +N N ++ + + + L N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 204 PLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPH- 260
L++ + + L L+ L +N I + + L+ + L L DN ++ +
Sbjct: 92 RLEN--VQHKMFKGLESLKTLMLR-SNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
Query: 261 SFSGLASIEQIELFDNQL 278
+F L S+ + L N
Sbjct: 148 AFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 28/133 (21%), Positives = 52/133 (39%), Gaps = 3/133 (2%)
Query: 193 TELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSD 251
L N L +L + + N I +I + + ++ + L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSN-NKITDIEEGAFEGASGVNEILLTS 90
Query: 252 NFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIA 311
N L F GL S++ + L N+++ +S L+++ L + N +T P
Sbjct: 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150
Query: 312 AM-SLESLNLNDN 323
+ SL +LNL N
Sbjct: 151 TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 23/131 (17%), Positives = 46/131 (35%), Gaps = 7/131 (5%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD--FSREFANLQVLDLSR 154
L L++N F ++ L+ + N I ++ + F + + + L+
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN-KITDIEEGAFEG-ASGVNEILLTS 90
Query: 155 NNFSGDIPES-FGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSS 213
N ++ F LK L L N ++ + L+ + L N + + P +
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA-PGA 148
Query: 214 VGNLSKLENLW 224
L L L
Sbjct: 149 FDTLHSLSTLN 159
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 9/127 (7%)
Query: 229 NLIGEIP--DSIGKLAFLSNLDLSDNFLSGKIPH-SFSGLASIEQIELFDNQLSGELPES 285
N + KL L ++ S+N ++ I +F G + + +I L N+L +
Sbjct: 42 NEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHK 99
Query: 286 L-SNLTTLLRLDISQNNLTGNLPETI--AAMSLESLNLNDNYFTGEIPESLASNPNLVQL 342
+ L +L L + N +T + S+ L+L DN T P + + +L L
Sbjct: 100 MFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL 158
Query: 343 KLFNNSF 349
L N F
Sbjct: 159 NLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 18/89 (20%), Positives = 38/89 (42%), Gaps = 4/89 (4%)
Query: 480 LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNL-NSLTALIVLNLST 538
L QL+ ++ S N+ + + + ++ L N + + L +L L L +
Sbjct: 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRS 114
Query: 539 NQLTGTIPPEL-GNLAVLTSLDLSSNLLT 566
N++T + + L+ + L L N +T
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 734 LGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGA 792
L V+H +V L+ L+ EY+ G L + E+ D + F +A+
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTA-CFYLAE-I 130
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---C 849
+ L +LH I++RD+K NI+L+ + ++ DFGL K E D ++ C
Sbjct: 131 SMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHTFC 182
Query: 850 VAGSYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
G+ Y+APE + + V D +S G ++ +++TG P P GEN+
Sbjct: 183 --GTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTG-AP--PFTGENRK 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 46/229 (20%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIE-TLG--RV-----RH 739
++G G +V + K + E AVK L K + ++E T+ RV +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL----KKDVV--IQDDDVECTMVEKRVLALPGKP 401
Query: 740 GNVVKLLMCCSGQDFNILVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAY 798
+ +L C D V EY+ G L M H ++ + F A+ A GL +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHA-VFYAAE-IAIGLFF 457
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYG 855
L + I++RD+K N++LD+E ++ADFG+ K E D + C G+
Sbjct: 458 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFC--GTPD 507
Query: 856 YIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF-GENKD 899
YIAPE Y K V D ++FGV+L E++ G+ P F GE++D
Sbjct: 508 YIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP----FEGEDED 548
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 31/152 (20%)
Query: 757 LVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
V EY+ G L M H ++ + F A+ A GL +L + I++RD+K
Sbjct: 98 FVMEYVNGGDL--MYHIQQVGRFKEPHA-VFYAAE-IAIGLFFLQSK---GIIYRDLKLD 150
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIAPE----YAYTKKVT 868
N++LD+E ++ADFG+ K E D + C G+ YIAPE Y K V
Sbjct: 151 NVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFC--GTPDYIAPEIIAYQPYGKSV- 202
Query: 869 EKSDVYSFGVVLMELVTGKRPNDPSF-GENKD 899
D ++FGV+L E++ G+ P F GE++D
Sbjct: 203 ---DWWAFGVLLYEMLAGQAP----FEGEDED 227
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 32/159 (20%)
Query: 757 LVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
V EY+ G L M H ++ R + + RF A+ + L YLH I++RD+K
Sbjct: 87 FVIEYVNGGDL--MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLD 139
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIAPE----YAYTKKVT 868
N+LLD+E ++ D+G+ K EG + C G+ YIAPE Y V
Sbjct: 140 NVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFC--GTPNYIAPEILRGEDYGFSV- 191
Query: 869 EKSDVYSFGVVLMELVTGKRP------NDPSFGENKDIV 901
D ++ GV++ E++ G+ P +D +D +
Sbjct: 192 ---DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-13
Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 29/151 (19%)
Query: 757 LVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
V EY+ G L M H + L + F A+ GL +LH+ IV+RD+K
Sbjct: 95 FVMEYLNGGDL--MYHIQSCHKFDLSRA-TFYAAE-IILGLQFLHSK---GIVYRDLKLD 147
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIAPE----YAYTKKVT 868
NILLD + ++ADFG+ K E DA + C G+ YIAPE Y V
Sbjct: 148 NILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFC--GTPDYIAPEILLGQKYNHSV- 199
Query: 869 EKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
D +SFGV+L E++ G + P G++++
Sbjct: 200 ---DWWSFGVLLYEMLIG-QS--PFHGQDEE 224
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 48/317 (15%), Positives = 100/317 (31%), Gaps = 64/317 (20%)
Query: 95 IRTLRNLNLSDNYFN--GTLS-SQSLSPCFHLQVLALDYNVFIGE-----LPDFSREFAN 146
++ +L + S L ++ + L N IG L + +
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGN-TIGTEAARWLSENIASKKD 61
Query: 147 LQVLDLSRNNFSGDIP-----------ESFGRFPVLKVLNLGGNLLSG----LIPSFLGN 191
L++ + S + F+G + ++ + P L + L N + FL
Sbjct: 62 LEIAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 192 LTELTHFELGYNP------------LKSSPLPSSVGNLSKLENLWAAKANLIGE-----I 234
T L H L N L+ + N L ++ + N +
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR-NRLENGSMKEW 179
Query: 235 PDSIGKLAFLSNLDLSDNFLSGK-----IPHSFSGLASIEQIELFDNQLSGE----LPES 285
+ L + + N + + + + ++ ++L DN + L +
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 286 LSNLTTLLRLDISQNNLTGNLPETIAAM-------SLESLNLNDNYFTGE----IPESLA 334
L + L L ++ L+ + L++L L N + + +
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299
Query: 335 SN-PNLVQLKLFNNSFS 350
P+L+ L+L N FS
Sbjct: 300 EKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 54/375 (14%), Positives = 122/375 (32%), Gaps = 94/375 (25%)
Query: 244 LSNLDLSDNFLSGK----IPHSFSGLASIEQIELFDNQLSGE----LPESLSNLTTLLRL 295
+ L + ++ + + S+++I L N + E L E++++ L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 296 DISQNNLTGNLPETIAAM-----------SLESLNLNDNYFTGE----IPESLASNPNLV 340
+ S E A+ L ++ L+DN F + + L+ + L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 341 QLKLFNNSFSGK----LPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNR 396
L L NN + + L + + + + L +C RN+L+ N
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP-----LRSIICGRNRLE------NG 174
Query: 397 FSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNA 456
+ +++ + L+ ++ N ++ E G E + ++
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPE------G-------------IEHLLLEGLAYC 215
Query: 457 PKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENM 516
+L + + N FT + L+ + L++L L + +
Sbjct: 216 QELKVLDLQDNTFTHLG-----------SSALAI---------ALKSWPNLRELGLNDCL 255
Query: 517 FTGE--------LPRNLNSLTALIVLNLSTNQLTGTIPPELG-----NLAVLTSLDLSSN 563
+ + N L L L N++ L + L L+L+ N
Sbjct: 256 LSARGAAAVVDAFSKLEN--IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313
Query: 564 LLT--GEIPLELTKL 576
+ ++ E+ ++
Sbjct: 314 RFSEEDDVVDEIREV 328
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 58/328 (17%), Positives = 104/328 (31%), Gaps = 69/328 (21%)
Query: 123 LQVLALDYNVFIGE-----LPDFSREFANLQVLDLSRNNFSGD----IPESFGRFPVLKV 173
++ +L + I + E +++ + LS N + + E+ L++
Sbjct: 6 IEGKSLKLD-AITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 174 LNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGE 233
+ L L L P L + L N G
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQ-ALLKCP-----------KLHTV-RLS---DNAFGP 108
Query: 234 -----IPDSIGKLAFLSNLDLSDNFLS-------------GKIPHSFSGLASIEQIELFD 275
+ D + K L +L L +N L + + I
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 276 NQLSGE----LPESLSNLTTLLRLDISQNNLT-----GNLPETIAAM-SLESLNLNDNYF 325
N+L ++ + L + + QN + L E +A L+ L+L DN F
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 326 TGE----IPESLASNPNLVQLKLFNNSFSGK----LPDDLGKYSN--LEYFDVSTNDFTG 375
T + +L S PNL +L L + S + + D K N L+ + N+
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 376 E----LPRFLCFRNK-LQCIIIFNNRFS 398
+ L + + L + + NRFS
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 49/287 (17%), Positives = 83/287 (28%), Gaps = 78/287 (27%)
Query: 96 RTLRNLNLSDNYF--NGTLS-SQSLSPCFHLQVLALDYN-------VFIGE------LPD 139
L + LSDN F LS L+ L L N I +
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153
Query: 140 FSREFANLQVLDLSRNNFSGD----IPESFGRFPVLKVLNLGGNLL-----SGLIPSFLG 190
++ L+ + RN ++F +L + + N + L+ L
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 191 NLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLS 250
EL +L N + A + ++ L L L+
Sbjct: 214 YCQELKVLDLQDNTFTHL----------------GSSA-----LAIALKSWPNLRELGLN 252
Query: 251 DNFLSGKIPHSFSGLASI-EQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPET 309
D LS + G A++ + +N L L + N + + T
Sbjct: 253 DCLLSAR------GAAAVVDAFSKLEN-------------IGLQTLRLQYNEIELDAVRT 293
Query: 310 IAAM------SLESLNLNDNYFT------GEIPESLASNPNLVQLKL 344
+ + L L LN N F+ EI E ++ +L
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDEL 340
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 46/296 (15%), Positives = 88/296 (29%), Gaps = 82/296 (27%)
Query: 314 SLESLNLNDNYFTGE----IPESLASNPNLVQLKLFNNSFSGK----LPDDLGKYSNLEY 365
S+E +L + T E + L + ++ ++ L N+ + L +++ +LE
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 366 FDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYG-------ECKTLNYLRFGG 418
+ S F R +IPE+ +C L+ +R
Sbjct: 65 AEFSDI---------------------FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103
Query: 419 NELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE------ 472
N G + + +S L + ++ N +
Sbjct: 104 NAF---------GPTAQE-----------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 473 -------VPSQICTLRQLQAVDLSQNRFSG----HLPTCITQLNKLQQLELQENMFTGE- 520
V + L+++ +NR L +++ +N E
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 521 ----LPRNLNSLTALIVLNLSTNQLTGT----IPPELGNLAVLTSLDLSSNLLTGE 568
L L L VL+L N T + L + L L L+ LL+
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 32/157 (20%)
Query: 757 LVYEYMPNGSLADMLH-EKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSH 815
V EY+ G L M H ++ R + + RF A+ + L YLH I++RD+K
Sbjct: 130 FVIEYVNGGDL--MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLD 182
Query: 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMS---CVAGSYGYIAPE----YAYTKKVT 868
N+LLD+E ++ D+G+ K EG + C G+ YIAPE Y V
Sbjct: 183 NVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFC--GTPNYIAPEILRGEDYGFSV- 234
Query: 869 EKSDVYSFGVVLMELVTGKRP------NDPSFGENKD 899
D ++ GV++ E++ G+ P +D +D
Sbjct: 235 ---DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 49/135 (36%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
N Q+L L N + P F LK L LG N L L +LT+LT +LG N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 205 LKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPH-SF 262
L LPS+V L L+ L+ N + E+P I +L L++L L N L IPH +F
Sbjct: 100 LTV--LPSAVFDRLVHLKELFMCC-NKLTELPRGIERLTHLTHLALDQNQLK-SIPHGAF 155
Query: 263 SGLASIEQIELFDNQ 277
L+S+ LF N
Sbjct: 156 DRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 32/114 (28%), Positives = 47/114 (41%), Gaps = 4/114 (3%)
Query: 454 SNAPKLTGIL-INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLE 511
+ P IL ++ N T P +L L+ + L N+ LP + L +L L+
Sbjct: 36 AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLD 94
Query: 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLL 565
L N T + L L L + N+LT +P + L LT L L N L
Sbjct: 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 246 NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESL-SNLTTLLRLDISQNNLTG 304
L L DN ++ P F L +++++ L NQL LP + +LT L LD+ N LT
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 305 NLPETI--AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNN 347
LP + + L+ L + N T E+P + +L L L N
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 37/152 (24%), Positives = 56/152 (36%), Gaps = 27/152 (17%)
Query: 413 YLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE 472
L N++ P F L + + +N+ ++
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVG-------------------- 82
Query: 473 VPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNLNSLTAL 531
V L QL +DL N+ + LP+ + +L L++L + N T ELPR + LT L
Sbjct: 83 VFDS---LTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHL 137
Query: 532 IVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563
L L NQL L+ LT L N
Sbjct: 138 THLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 44/215 (20%), Positives = 83/215 (38%), Gaps = 58/215 (26%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLL- 746
+G G + +V ++ K + E A+K L + R E+E R + ++V+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 78
Query: 747 ---MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAA------KGLA 797
+G+ ++V E + G L + ++G F+ + + + +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQ 131
Query: 798 YLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
YLH+ I HRDVK N+L + ++ DFG AK Y
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------GEKY 175
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ D++S GV++ L+ G P
Sbjct: 176 D-------------KSCDMWSLGVIMYILLCGYPP 197
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 7/159 (4%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
A+ + LDL + +F L LNL N L L +LTEL L N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 205 LKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPHS- 261
L S LP V +L++L+ L+ N + +P + +L L L L+ N L IP
Sbjct: 95 LAS--LPLGVFDHLTQLDKLYLGG-NQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 262 FSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQN 300
F L +++ + L NQL + L L + + N
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 51/157 (32%), Positives = 63/157 (40%), Gaps = 7/157 (4%)
Query: 124 QVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSG 183
+ L L R L L+L N F L L L N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 184 LIPSFLGNLTELTHFELGYNPLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKL 241
L +LT+L LG N LKS LPS V L+KL+ L N + IP KL
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKS--LPSGVFDRLTKLKELRLNT-NQLQSIPAGAFDKL 154
Query: 242 AFLSNLDLSDNFLSGKIPH-SFSGLASIEQIELFDNQ 277
L L LS N L +PH +F L ++ I LF NQ
Sbjct: 155 TNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 43/169 (25%), Positives = 64/169 (37%), Gaps = 14/169 (8%)
Query: 454 SNAPKLTGIL-INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLE 511
S P T L + + L +L ++L N+ L + L +L L
Sbjct: 31 SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLG 89
Query: 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLTGEIP 570
L N + LT L L L NQL ++P + L L L L++N L IP
Sbjct: 90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIP 147
Query: 571 L----ELTKLKLNQFNISHNKLYGEVPSDFDHDLFISS--LLDNPGLCS 613
+LT L+ ++S N+L FD + + L N CS
Sbjct: 148 AGAFDKLTNLQ--TLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 36/122 (29%), Positives = 51/122 (41%), Gaps = 13/122 (10%)
Query: 473 VPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNL-NSLTAL 531
VPS I + +DL + L KL L L N L + + LT L
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTEL 85
Query: 532 IVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLTGEIPL----ELTKLKLNQFNISHN 586
L L+ NQL ++P + +L L L L N L +P LTKLK + ++ N
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK--ELRLNTN 141
Query: 587 KL 588
+L
Sbjct: 142 QL 143
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 8/154 (5%)
Query: 414 LRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAP-KLTGILINGNNFTGE 472
L L + F GL ++ + + N+ + ++S + + +L + + N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 473 VPSQICT-LRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNL-NSLT 529
+P + L QL + L N+ LP+ + +L KL++L L N +P + LT
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 530 ALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563
L L+LSTNQL L L ++ L N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 7e-11
Identities = 50/275 (18%), Positives = 84/275 (30%), Gaps = 52/275 (18%)
Query: 50 DWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFN 109
D S + D + L LS
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE--K 360
Query: 110 GTLSSQSLSPCFHLQVLALDYNVFIGELPDFSRE-------------FANLQVLD----- 151
T+ L C LQ L + + + R F+ L+ +D
Sbjct: 361 STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420
Query: 152 ---LSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSS 208
R+ F + + ++VL+L L+ L L L +TH +L +N L++
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRA- 477
Query: 209 PLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASI 268
LP ++ L LE L A+ N + + + L L L L +N L
Sbjct: 478 -LPPALAALRCLEVLQASD-NALENVDG-VANLPRLQELLLCNNRLQ-----------QS 523
Query: 269 EQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT 303
I+ L + L+ L++ N+L
Sbjct: 524 AAIQ------------PLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 31/155 (20%), Positives = 53/155 (34%), Gaps = 17/155 (10%)
Query: 452 SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLE 511
++ L + P + L L++ L +N + L+
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH------ 447
Query: 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPL 571
L T L +L L + L+LS N+L +PP L L L L S N L +
Sbjct: 448 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD- 502
Query: 572 ELTKL-KLNQFNISHNKLYGEVPSDFDHDLFISSL 605
+ L +L + + +N+L + S
Sbjct: 503 GVANLPRLQELLLCNNRL-----QQSAAIQPLVSC 532
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 48/258 (18%), Positives = 80/258 (31%), Gaps = 28/258 (10%)
Query: 138 PDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS----GLIPSFLGNLT 193
PD +++ + DL + + +P+ R + +L
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDE 349
Query: 194 ELTHFELGYNPLKSSP-LPSSVGNLSKLE--NLWAAKANL-----IGEIPDSIGKLAFLS 245
+L EL S L +LE N W + + + L + S
Sbjct: 350 QLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS 409
Query: 246 NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGEL---------PESLSNLTTLLRLD 296
L D + + S + + L L L + LD
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLD 469
Query: 297 ISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPD 355
+S N L LP +AA+ LE L +DN + +A+ P L +L L NN +
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAA 525
Query: 356 --DLGKYSNLEYFDVSTN 371
L L ++ N
Sbjct: 526 IQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 43/260 (16%), Positives = 76/260 (29%), Gaps = 29/260 (11%)
Query: 305 NLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLE 364
N P + L + +LND + + + L + D L
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLF 352
Query: 365 YFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQG- 423
++S T L L +LQ + N I L Y +
Sbjct: 353 RCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL 411
Query: 424 --------------------ELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGIL 463
E +V + + + + +T +
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLD 469
Query: 464 INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG-ELP 522
++ N +P + LR L+ + S N ++ + L +LQ+L L N
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAI 526
Query: 523 RNLNSLTALIVLNLSTNQLT 542
+ L S L++LNL N L
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC 546
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 8e-11
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 1/95 (1%)
Query: 233 EIPDSIGKLAFLSNLDLSDNFLSGKIP-HSFSGLASIEQIELFDNQLSGELPESLSNLTT 291
+ + L+ L + + + GL + + + + L P++
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 292 LLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFT 326
L RL++S N L +T+ +SL+ L L+ N
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 21/108 (19%), Positives = 39/108 (36%), Gaps = 3/108 (2%)
Query: 460 TGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT-CITQLNKLQQLELQENMFT 518
+G+ + + + L + + + HL + L +L+ L + ++
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 519 GELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT 566
P + L LNLS N L ++ + L L LS N L
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 15/80 (18%), Positives = 25/80 (31%), Gaps = 3/80 (3%)
Query: 146 NLQVLDLSRNNFSGDIP-ESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
NL L + + L+ L + + L + P L+ L +N
Sbjct: 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91
Query: 205 LKSSPLPSSVGNLSKLENLW 224
L+S L L+ L
Sbjct: 92 LES--LSWKTVQGLSLQELV 109
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 23/95 (24%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 185 IPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEI-PDSIGKLAF 243
L LT + + L +L NL K + + + PD+
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK-SGLRFVAPDAFHFTPR 81
Query: 244 LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQL 278
LS L+LS N L + GL S++++ L N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 17/101 (16%), Positives = 33/101 (32%), Gaps = 3/101 (2%)
Query: 276 NQLSGELPESLSNLTTLLRLDISQNNLTGNLP-ETIAAM-SLESLNLNDNYFTGEIPESL 333
+ + L L L I +L + + L +L + + P++
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 334 ASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT 374
P L +L L N+ L + +L+ +S N
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 25/117 (21%), Positives = 37/117 (31%), Gaps = 25/117 (21%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQ 148
+ L L + + Q L L+ G L L+
Sbjct: 24 LHHLPGAENLTELYIENQ--------QHLQ--------HLELRDLRG-LG-------ELR 59
Query: 149 VLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPL 205
L + ++ P++F P L LNL N L L + L+ L L NPL
Sbjct: 60 NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 1e-10
Identities = 100/543 (18%), Positives = 172/543 (31%), Gaps = 135/543 (24%)
Query: 121 FHLQVLALDYN----VFIGELPDFSREFANLQVLDLSRNNFSG----DIPESFGRFPVLK 172
F Y VF F F V D+ ++ S I S + V
Sbjct: 9 FETGEHQYQYKDILSVF---EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMS--KDAVSG 63
Query: 173 VLNLGGNLLS---GLIPSFLGNLTELTHFELGYNPLKSSPL-PSSVGNL--SKLENLWA- 225
L L LLS ++ F+ + +++ +P+K+ PS + + + + L+
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLR-INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 226 ----AKANLIGEIPDSIGKL-AFLSNLDLSDNFL------SGKIPHSFSGLASIEQIELF 274
AK N+ KL L L + N L SGK + +A
Sbjct: 123 NQVFAKYNV--SRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-----TWVAL------- 168
Query: 275 DNQLSGELPESLSNLTTLLRLD-----ISQNNLTGNLPETIAAMSLESLNLNDNYFTGEI 329
+ + ++D ++ N N PET+ M L+ L
Sbjct: 169 ---------DVCLSYKVQCKMDFKIFWLNLKNC--NSPETVLEM-LQKLLYQ-------- 208
Query: 330 PESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQC 389
+PN ++S + KL + EL R L + C
Sbjct: 209 -----IDPNWTSRS--DHSSNIKLR---------------IHSIQAELRRLLKSKPYENC 246
Query: 390 IIIFNNRFSGKIPESYG-ECKTL------NYLRFGGNELQGELPSKF--WGLPE---VDF 437
+++ N + K ++ CK L F + L
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 438 FEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGE-VPSQICTLRQLQAVDLSQNRFSG 495
Y + + + + P+ I+ E + + T + V+ +
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSII-------AESIRDGLATWDNWKHVNCDK----- 354
Query: 496 HLPTCITQ-LNKLQQLELQENMFT--GELPRNLNSLTALIVLNLSTNQLTGTIPPELGNL 552
L T I LN L+ E ++ MF P + + + I+L+L + + + N
Sbjct: 355 -LTTIIESSLNVLEPAEYRK-MFDRLSVFPPSAH-IPT-ILLSLIWFDVIKSDVMVVVNK 410
Query: 553 AVLTSL-DLSSNLLTGEIP---LELTKLKLNQFNISHNKL---YGEVPSDFDHDLFISSL 605
SL + T IP LEL N++ + H + Y +P FD D I
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHY-NIPKTFDSDDLIPPY 468
Query: 606 LDN 608
LD
Sbjct: 469 LDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 4e-05
Identities = 67/438 (15%), Positives = 125/438 (28%), Gaps = 155/438 (35%)
Query: 6 AKSLIALLFSFLLCFSLAISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGI 65
++++ +L L + D I+++ + R+L S+
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL----LKSKPYE------ 244
Query: 66 TC-----ETQNQSVDGIDLSGFDLSGGFPNGFCRI-RTLRNLNLSDNYFNGT---LSSQS 116
C QN + F+LS C+I T R ++D T +S
Sbjct: 245 NCLLVLLNVQNAKA----WNAFNLS-------CKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 117 LSPCFH----LQVLALDYNVFIGELP---------------DFSREFAN----------- 146
S +L + +LP + R+
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 147 ---------LQVLD--LSRNNFSGDIPESFGRFP--------VLKVL------NLGGNLL 181
L VL+ R F + FP +L ++ + ++
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMF-----DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV 408
Query: 182 SGLIPSFL-----------------------GNLTELTHFEL--GYNPLKSSPLPSSVGN 216
+ L L N L H + YN K+ +
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDS----DD 463
Query: 217 LSK--LENLWAAKANLIG---EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQI 271
L L+ + + IG + + ++ + L FL KI H + +
Sbjct: 464 LIPPYLDQYFY---SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA---- 516
Query: 272 ELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND-NYFTGEIP 330
S+ N TL +L + + N P+ E L +N F +I
Sbjct: 517 -----------SGSILN--TLQQLKFYKPYICDNDPK------YERL-VNAILDFLPKIE 556
Query: 331 ESLASNP--NLVQLKLFN 346
E+L + +L+++ L
Sbjct: 557 ENLICSKYTDLLRIALMA 574
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 56/231 (24%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG------- 740
+G G V+ K + + VA+K + K TE EI+ L RV
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAA-EDEIKLLQRVNDADNTKEDS 82
Query: 741 ----NVVKLLMCCSGQDFNI---------LVYEYMPNGSLADMLHEKGRSG-SLDWSIRF 786
+++KLL FN +V+E + +L ++ + G L ++
Sbjct: 83 MGANHILKLL-----DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLI-YVK- 134
Query: 787 SIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP------RVADFGLAKALQSQE 840
I++ GL Y+H C I+H D+K N+L++ P ++AD G A E
Sbjct: 135 QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDE 190
Query: 841 GQSDDAMSCVAGSYGYIAPE----YAYTKKVTEKSDVYSFGVVLMELVTGK 887
++ + Y +PE + D++S ++ EL+TG
Sbjct: 191 HYTNSIQTRE-----YRSPEVLLGAPWGCGA----DIWSTACLIFELITGD 232
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 19/218 (8%)
Query: 63 TGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFH 122
ET +L ++ + ++ + +++ Q L +
Sbjct: 15 DDAFAETIK-----ANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLP---N 64
Query: 123 LQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLS 182
++ LAL N + ++ NL L L+ N F + LK L L N L
Sbjct: 65 VRYLALGGNK-LHDISALKE-LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ 122
Query: 183 GLIPSFLGNLTELTHFELGYNPLKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GK 240
L LT LT+ L +N L+S LP V L+ L L + N + +P+ + K
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQS--LPKGVFDKLTNLTELDLS-YNQLQSLPEGVFDK 179
Query: 241 LAFLSNLDLSDNFLSGKIPH-SFSGLASIEQIELFDNQ 277
L L +L L N L +P F L S++ I L DN
Sbjct: 180 LTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 43/187 (22%), Positives = 77/187 (41%), Gaps = 28/187 (14%)
Query: 172 KVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLI 231
NL ++ + L + + +KS + L + L L
Sbjct: 22 IKANLKKKSVTDA-VTQNE-LNSIDQIIANNSDIKSVQ---GIQYLPNVRYLALGGNKL- 75
Query: 232 GEIPDSIG---KLAFLSNLDLSDNFLSGKIPHS-FSGLASIEQIELFDNQLSGELPESLS 287
I +L L+ L L+ N L +P+ F L +++++ L +NQL LP+ +
Sbjct: 76 ----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVF 129
Query: 288 N-LTTLLRLDISQNNLTGNLPETI--AAMSLESLNLNDNYFTGEIPE----SLASNPNLV 340
+ LT L L+++ N L +LP+ + +L L+L+ N +PE L L
Sbjct: 130 DKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLT---QLK 184
Query: 341 QLKLFNN 347
L+L+ N
Sbjct: 185 DLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 36/144 (25%), Positives = 63/144 (43%), Gaps = 15/144 (10%)
Query: 451 PSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQL 510
+ + + I+ N ++ I L ++ + L N+ + +L L L
Sbjct: 35 VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD-ISAL-KELTNLTYL 90
Query: 511 ELQENMFTGELPRNL-NSLTALIVLNLSTNQLTGTIPPELGN-LAVLTSLDLSSNLLTGE 568
L N LP + + LT L L L NQL ++P + + L LT L+L+ N L
Sbjct: 91 ILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-S 147
Query: 569 IPL----ELTKLKLNQFNISHNKL 588
+P +LT L + ++S+N+L
Sbjct: 148 LPKGVFDKLTNLT--ELDLSYNQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 6/111 (5%)
Query: 458 KLTGILINGNNFTGEVPSQI-CTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQEN 515
LT +++ GN +P+ + L L+ + L +N+ LP + +L L L L N
Sbjct: 86 NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHN 143
Query: 516 MFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLL 565
+ LT L L+LS NQL ++P + L L L L N L
Sbjct: 144 QLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 46/136 (33%), Positives = 60/136 (44%), Gaps = 7/136 (5%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
A LDL N+ F L L LGGN L L LT LT+ L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 205 LKSSPLPSSV-GNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSDNFLSGKIPH-S 261
L+S LP+ V L++L+ L N + +PD + KL L +L L N L +P
Sbjct: 88 LQS--LPNGVFDKLTQLKELALNT-NQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGV 143
Query: 262 FSGLASIEQIELFDNQ 277
F L S++ I L DN
Sbjct: 144 FDRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 33/116 (28%), Positives = 46/116 (39%), Gaps = 7/116 (6%)
Query: 454 SNAPKLTGIL-INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLE 511
+ P T L + N+ L L + L N+ LP + +L L L
Sbjct: 24 TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLN 82
Query: 512 LQENMFTGELPRNL-NSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLL 565
L N LP + + LT L L L+TNQL ++P + L L L L N L
Sbjct: 83 LSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 37/159 (23%), Positives = 58/159 (36%), Gaps = 31/159 (19%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG-NVVKLLM 747
IG G + K L + E VA+K + P E ++ G + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP----QLHLEYRFYKQLGSGDGIPQVYY 72
Query: 748 CCSGQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFS------IAQGAAKGLAYLH 800
+N +V E + G SL D+ R FS IA + Y+H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVH 122
Query: 801 NDCVPAIVHRDVKSHNILLDAEMVPR-----VADFGLAK 834
+ +++RDVK N L+ + DF LAK
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 58/269 (21%), Positives = 86/269 (31%), Gaps = 74/269 (27%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN------- 741
+G G V+ ++ + VA+K + H ET EI L VR+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA---LDEIRLLKSVRNSDPNDPNRE 101
Query: 742 -VVKLLMCCSGQDFNI---------LVYEYMPNG-SLADMLHEKGRSGSLDWSIRFSIAQ 790
VV+LL DF I +V+E + G L + K L I Q
Sbjct: 102 MVVQLL-----DDFKISGVNGTHICMVFEVL--GHHLLKWI-IKSNYQGLPLPCVKKIIQ 153
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE---------------------------- 822
+GL YLH C I+H D+K NILL
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 823 ------MVPRVADFGLAKALQSQEGQSDDAMSCVAGSY--------GYIAPEYAYTKKVT 868
V A + + +D +C + Y + E
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 869 EKSDVYSFGVVLMELVTGKRPNDPSFGEN 897
+D++S + EL TG +P GE
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 9/123 (7%)
Query: 101 LNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGD 160
+ L+ + + + L L I + + +D S N
Sbjct: 2 VKLT---AELIEQAAQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR-K 56
Query: 161 IPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKL 220
+ + F LK L + N + + L +LT L N L + L+ L
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE---LGDLDPLASL 112
Query: 221 ENL 223
++L
Sbjct: 113 KSL 115
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 26/132 (19%), Positives = 44/132 (33%), Gaps = 25/132 (18%)
Query: 216 NLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275
N + L I I + L +D SDN + K+ F L ++ + + +
Sbjct: 17 NAVRDRELDLRG-YKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73
Query: 276 NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLAS 335
N++ L L L ++ N+L L L + LAS
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLV----------ELGDL------------DPLAS 111
Query: 336 NPNLVQLKLFNN 347
+L L + N
Sbjct: 112 LKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 15/84 (17%), Positives = 27/84 (32%), Gaps = 6/84 (7%)
Query: 98 LRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNF 157
++ SDN L+ L ++ N + +L L L+ N+
Sbjct: 44 FDAIDFSDNEIR---KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
Query: 158 S--GDIPESFGRFPVLKVLNLGGN 179
GD+ + L L + N
Sbjct: 101 VELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 21/118 (17%), Positives = 39/118 (33%), Gaps = 13/118 (11%)
Query: 284 ESLSNLTTLLRLDISQNNLT--GNLPETIAAMSLESLNLNDNYFTGEIP--ESLASNPNL 339
+N LD+ + NL T+ ++++ +DN EI + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLD--QFDAIDFSDN----EIRKLDGFPLLRRL 66
Query: 340 VQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT--GELPRFLCFRNKLQCIIIFNN 395
L + NN +L ++ N G+L ++ L + I N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS-LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 24/115 (20%), Positives = 44/115 (38%), Gaps = 7/115 (6%)
Query: 475 SQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVL 534
+Q + + +DL + + L++ ++ +N +L L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 535 NLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT--GEIPLELTKLK-LNQFNISHN 586
++ N++ L LT L L++N L G++ L LK L I N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 19/153 (12%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG-NVVKLLM 747
IG G +++ L + + VA+K + P R E T + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIPNVYY 73
Query: 748 CCSGQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
N+LV + + G SL D+L GR S+ A+ + +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKS--- 126
Query: 807 IVHRDVKSHNILLDAEMVPR-----VADFGLAK 834
+V+RD+K N L+ V DFG+ K
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 29/135 (21%), Positives = 52/135 (38%), Gaps = 28/135 (20%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
++ L L N F+ +P+ + L +++L N +S L N+T+L L YN
Sbjct: 31 RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPH-SFS 263
L+ +P L L L L N +S +P +F+
Sbjct: 90 LRC--IPPRT-----------------------FDGLKSLRLLSLHGNDIS-VVPEGAFN 123
Query: 264 GLASIEQIELFDNQL 278
L+++ + + N L
Sbjct: 124 DLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 8/76 (10%)
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLT 566
+L L N FT +P+ L++ L +++LS N+++ T+ + N+ L +L LS N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 567 GEIPL----ELTKLKL 578
IP L L+L
Sbjct: 92 -CIPPRTFDGLKSLRL 106
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 454 SNAPKLTGIL-INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLEL 512
P+ L ++GN FT VP ++ + L +DLS NR S + + +L L L
Sbjct: 27 KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL 85
Query: 513 QENMFTGELPRNL-NSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSN 563
N +P + L +L +L+L N ++ +P +L+ L+ L + +N
Sbjct: 86 SYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 31/109 (28%), Positives = 48/109 (44%), Gaps = 14/109 (12%)
Query: 246 NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESL-SNLTTLLRLDISQNNLTG 304
L L N + +P S + I+L +N++S L SN+T LL L +S N L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 305 NLPETI--AAMSLESLNLNDNYFTGEIPE----SLASNPNLVQLKLFNN 347
+P SL L+L+ N + +PE L++ L L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSA---LSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 19/75 (25%), Positives = 34/75 (45%), Gaps = 2/75 (2%)
Query: 229 NLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESL-S 287
N +P + L+ +DLS+N +S SFS + + + L N+L +P
Sbjct: 41 NQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFD 99
Query: 288 NLTTLLRLDISQNNL 302
L +L L + N++
Sbjct: 100 GLKSLRLLSLHGNDI 114
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 29/170 (17%)
Query: 191 NLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLS 250
TE EL + +++ L ++L + N I +I S+ + L L L
Sbjct: 21 VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALST-NNIEKI-SSLSGMENLRILSLG 78
Query: 251 DNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT------- 303
N + KI + + ++E++ + NQ++ L + L L L +S N +T
Sbjct: 79 RNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK 135
Query: 304 -GNLPETIAAMSLESLNLNDNYFTGEIPES----------LASNPNLVQL 342
L LE L L N + E+ + PNL +L
Sbjct: 136 LAALD------KLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 27/127 (21%), Positives = 45/127 (35%), Gaps = 8/127 (6%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156
+ L +LS + LAL N I ++ S NL++L L RN
Sbjct: 24 EAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNN-IEKISSLS-GMENLRILSLGRNL 81
Query: 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGN 216
I L+ L + N ++ L S + L L + N + + +
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITN---WGEIDK 135
Query: 217 LSKLENL 223
L+ L+ L
Sbjct: 136 LAALDKL 142
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 3/83 (3%)
Query: 506 KLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLL 565
+ +L ++ L++L A L LSTN + I L + L L L NL+
Sbjct: 26 EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLI 82
Query: 566 TGEIPLELTKLKLNQFNISHNKL 588
L+ L + IS+N++
Sbjct: 83 KKIENLDAVADTLEELWISYNQI 105
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 29/140 (20%), Positives = 57/140 (40%), Gaps = 17/140 (12%)
Query: 463 LINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLE---LQENMFT- 518
L ++ + + TL+ + + LS N I+ L+ ++ L L N+
Sbjct: 30 LHGMIPPIEKMDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIKK 84
Query: 519 -GELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLE-LTKL 576
L ++L L +S NQ+ ++ + L L L +S+N +T ++ L L
Sbjct: 85 IENLDAVADTLE---ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAAL 139
Query: 577 K-LNQFNISHNKLYGEVPSD 595
L ++ N LY + +
Sbjct: 140 DKLEDLLLAGNPLYNDYKEN 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 19/152 (12%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG-NVVKLLM 747
IGSG +Y + +GE VA+K T P E + ++ G + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRW 72
Query: 748 CCSGQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
C + D+N++V E + G SL D+ + R SL + +A + Y+H+
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIHSKN--- 125
Query: 807 IVHRDVKSHNILL----DAEMVPRVADFGLAK 834
+HRDVK N L+ +V + DFGLAK
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 58/225 (25%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG------N 741
+IG G +V K K + VA+K + ++ EI L +R N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV---RNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 742 VVKLL--------MCCSGQDFNILVYEYMPNGSLADML---HEKGRSGSLDWSIRFSIAQ 790
V+ +L +C + +E + + +L +++ +G S L +R A
Sbjct: 161 VIHMLENFTFRNHIC--------MTFELL-SMNLYELIKKNKFQGFSLPL---VR-KFAH 207
Query: 791 GAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP--RVADFGLAKALQSQEGQSDDAMS 848
+ L LH I+H D+K NILL + +V DFG + E Q
Sbjct: 208 SILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQR----- 255
Query: 849 CVAGSYGYI------APEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
Y YI APE + D++S G +L EL+TG
Sbjct: 256 ----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 54/316 (17%), Positives = 100/316 (31%), Gaps = 72/316 (22%)
Query: 114 SQSLSPCFHLQVLALDYN-------VFIGELPDFSREFANLQVLDLSRNNFSGDIPESFG 166
+ S + L L N V + + F+ A++ L+LS N+ +
Sbjct: 15 EEFTSIPHGVTSLDLSLNNLYSISTVELIQA--FANTPASVTSLNLSGNSLGFKNSDELV 72
Query: 167 RF-----PVLKVLNLGGNLLS-----GLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGN 216
+ + LNL GN LS L+ + +T +LG+N S
Sbjct: 73 QILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS----SKSSSE 128
Query: 217 LSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLA--------SI 268
+P S +++L+L N L K S L ++
Sbjct: 129 F----------KQAFSNLPAS------ITSLNLRGNDLGIK---SSDELIQILAAIPANV 169
Query: 269 EQIELFDNQLSGE----LPESLSNL-TTLLRLDISQNNLTGNLPETIAAM------SLES 317
+ L N L+ + L + L+++ ++ LD+S N L +A + + S
Sbjct: 170 NSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVS 229
Query: 318 LNLNDNYFTGE----IPESLASNPNLVQLKLFNNSFSGKLPDD-------LGKYSNLEYF 366
LNL N G + S +L + L + + +
Sbjct: 230 LNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILV 289
Query: 367 DVSTNDFTGELPRFLC 382
D + + +
Sbjct: 290 DKNGKEIHPSHSIPIS 305
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 59/383 (15%), Positives = 108/383 (28%), Gaps = 88/383 (22%)
Query: 273 LFDNQLSGE----LPESLSNLTTLLRLDISQNNLTGNLPETIAAM------SLESLNLND 322
+ + E S + LD+S NNL + S+ SLNL+
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 323 NYFTGEIPESLAS-----NPNLVQLKLFNNSFSGKLPDDLGK-----YSNLEYFDVSTND 372
N + + L N+ L L N S K D+L K + D+ ND
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 373 FTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGE-------- 424
F+ + Q ++ L GN+L +
Sbjct: 121 FSSKSSSEFK-----QAFSNLP--------------ASITSLNLRGNDLGIKSSDELIQI 161
Query: 425 LPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484
L + + ++ + N + N +L L + ++ L
Sbjct: 162 LAAIPANVNSLN---LRGNNL------ASKNCAELAKFLASIP----------ASVTSL- 201
Query: 485 AVDLSQNRFS----GHLPTCITQLN-KLQQLELQENMFTGE----LPRNLNSLTALIVLN 535
DLS N L + + + L L N G L +SL L +
Sbjct: 202 --DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259
Query: 536 LSTNQLTGTIPPE--------LGNLAVLTSLDLSSNLLTGEIPLELTK-LKLNQFNISHN 586
L + + + E N+ + +D + + + ++ ++
Sbjct: 260 LDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVP 318
Query: 587 KLYGEVPSDFDHDLFISSLLDNP 609
L + L+ P
Sbjct: 319 SLLNQCLIFAQKHQTNIEDLNIP 341
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 59/344 (17%), Positives = 113/344 (32%), Gaps = 74/344 (21%)
Query: 69 TQNQSVDGIDLSGFDLSGGFPNGFCRI--------RTLRNLNLSDNYFNGT----LSSQS 116
+ V +DLS +L + ++ +LNLS N L
Sbjct: 19 SIPHGVTSLDLSLNNLY---SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQIL 75
Query: 117 LSPCFHLQVLALDYNVF-------IGELPDFSREFANLQVLDLSRNNFSGD----IPESF 165
+ ++ L L N + + + + VLDL N+FS ++F
Sbjct: 76 AAIPANVTSLNLSGNFLSYKSSDELVKT--LAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133
Query: 166 GRFPV-LKVLNLGGNLLS-----GLIPSFLGNLTELTHFELGYNPLK-------SSPLPS 212
P + LNL GN L LI + L N L + L S
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193
Query: 213 SVGNLSKLENLWAAKANLIGEIPDSIGKLA--------FLSNLDLSDNFLSGK----IPH 260
+++ L +L A NL+G S +LA + +L+L N L G +
Sbjct: 194 IPASVTSL-DLSA---NLLG--LKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKL 247
Query: 261 SFSGLASIEQIELFDNQLSG-------ELPESLSNLTTLLRLDISQNNLTGNLPETIAAM 313
L ++ + L + + L + N+ ++ +D + + + I+ +
Sbjct: 248 LKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNL 307
Query: 314 ------SLESLNLNDN--YFTGEIPESLASNPNLVQLKLFNNSF 349
+ +L + F + ++ +L+ +
Sbjct: 308 IRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTC 351
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 64/405 (15%), Positives = 116/405 (28%), Gaps = 88/405 (21%)
Query: 174 LNLGGNLLSG--LIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLI 231
+N L G + F +T +L N L S+
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNL------YSIS--------TVELIQAF 46
Query: 232 GEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGL-----ASIEQIELFDNQLSGE----L 282
P S +++L+LS N L K + A++ + L N LS + L
Sbjct: 47 ANTPAS------VTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100
Query: 283 PESL-SNLTTLLRLDISQNNLTGNLPETIAAM------SLESLNLNDNYFTGEIPESLAS 335
++L + T+ LD+ N+ + S+ SLNL N + + L
Sbjct: 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160
Query: 336 -----NPNLVQLKLFNNSFSGKLPDDLGKY-----SNLEYFDVSTNDFTGELPRFLC--- 382
N+ L L N+ + K +L K+ +++ D+S N + L
Sbjct: 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIF 220
Query: 383 --FRNKLQCIIIFNNRFSGK----IPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVD 436
N + + + N G + K L + + ++ +
Sbjct: 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCK------ 274
Query: 437 FFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGH 496
++ + N K+ + NG I L + +
Sbjct: 275 -----------ALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323
Query: 497 LPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQL 541
C+ K Q LN L + L
Sbjct: 324 ---CLIFAQKHQTNIED-----------LNIPDELRESIQTCKPL 354
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 2e-08
Identities = 32/192 (16%), Positives = 49/192 (25%), Gaps = 52/192 (27%)
Query: 690 IGSGGSCRVYKVKLKSGETVAVKRL------LGGTHKPETETVFRSEIETL--------- 734
IG G V++ VA+K + L +T EI
Sbjct: 28 IGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 735 GRVRHGNVVKLL--MCCSG----------------------------QDFNILVYEYMPN 764
R + L C G D +V E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV 824
G + + K S + SI LA HRD+ N+LL +
Sbjct: 147 GIDLEQMRTKLSS----LATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSL 200
Query: 825 PRVADFGLAKAL 836
++ K+
Sbjct: 201 KKLHYTLNGKSS 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 44/220 (20%)
Query: 688 NLIGSGGSCRVYKVK-LKSGETVAVK--RLLGGTHKPETETVFRSEIETLGRVRH----- 739
+LIG G +V K E VA+K + +K + E+ L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 740 -GNVVKLL--------MCCSGQDFNILVYEYMPNGSLADMLHEKGRSG-SLDWSIRFSIA 789
+V L +C LV+E + + +L D+L G SL+ R A
Sbjct: 115 KYYIVHLKRHFMFRNHLC--------LVFEML-SYNLYDLLRNTNFRGVSLN-LTR-KFA 163
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP--RVADFGLAKALQSQEGQSDDAM 847
Q L +L + +I+H D+K NILL ++ DFG + Q +
Sbjct: 164 QQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS-------CQLGQRI 215
Query: 848 SCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGK 887
S Y +PE D++S G +L+E+ TG+
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 24/114 (21%), Positives = 42/114 (36%), Gaps = 3/114 (2%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156
++ L L ++ N L+ L+ + + + + L+ L+LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV-GLTSIANLPK-LNKLKKLELSDNR 75
Query: 157 FSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGNLTELTHFELGYNPLKSSP 209
SG + + P L LNL GN + L L L L +L + +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 28/133 (21%), Positives = 48/133 (36%), Gaps = 25/133 (18%)
Query: 216 NLSKLENLW-AAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELF 274
S ++ L + G++ + L L + L+ I + L ++++EL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 275 DNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLA 334
DN++SG L L L++S N + L ++ E L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK----------DLSTI------------EPLK 110
Query: 335 SNPNLVQLKLFNN 347
NL L LFN
Sbjct: 111 KLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 25/115 (21%), Positives = 44/115 (38%), Gaps = 5/115 (4%)
Query: 191 NLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLS 250
+++ L + L +LE L + I + + KL L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTIN-VGLTSIAN-LPKLNKLKKLELS 72
Query: 251 DNFLSGKIPHSFSGLASIEQIELFDNQLS--GELPESLSNLTTLLRLDISQNNLT 303
DN +SG + ++ + L N++ + E L L L LD+ +T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 28/111 (25%), Positives = 49/111 (44%), Gaps = 6/111 (5%)
Query: 478 CTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLS 537
+++L +D S++ G L + +L+ L T + NL L L L LS
Sbjct: 17 SDVKELV-LDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 538 TNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLE-LTKLK-LNQFNISHN 586
N+++G + LT L+LS N + +E L KL+ L ++ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 27/111 (24%), Positives = 45/111 (40%), Gaps = 7/111 (6%)
Query: 265 LASIEQIELFDNQLS-GELPESLSNLTTLLRLDISQNNLT--GNLPETIAAMSLESLNLN 321
+ ++++ L +++ + G+L L L LT NLP+ L+ L L+
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLN---KLKKLELS 72
Query: 322 DNYFTGEIPESLASNPNLVQLKLFNNSFSG-KLPDDLGKYSNLEYFDVSTN 371
DN +G + PNL L L N + L K NL+ D+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 17/151 (11%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG-NVVKLLM 747
IGSG +Y +++ E VA+K T P E + ++ G + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRW 70
Query: 748 CCSGQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
D+N+LV + + G SL D+ + R SL + +A + ++H+
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM--LADQMINRVEFVHSKS--- 123
Query: 807 IVHRDVKSHNILLDAEMVPR---VADFGLAK 834
+HRD+K N L+ + DFGLAK
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 28/90 (31%), Positives = 39/90 (43%), Gaps = 5/90 (5%)
Query: 134 IGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLT 193
G++ + EF NL+ L L + + + P LK L L N + G + L
Sbjct: 38 DGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLP 95
Query: 194 ELTHFELGYNPLKSSPLPSSVGNLSKLENL 223
LTH L N LK S++ L KLE L
Sbjct: 96 NLTHLNLSGNKLKD---ISTLEPLKKLECL 122
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 24/119 (20%)
Query: 229 NLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSN 288
+ G+I + L L L + L + + L ++++EL +N++ G L
Sbjct: 36 SNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFGGLDMLAEK 93
Query: 289 LTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNN 347
L L L++S N L + +L E L L L LFN
Sbjct: 94 LPNLTHLNLSGNKLK----------DISTL------------EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 23/94 (24%), Positives = 33/94 (35%), Gaps = 8/94 (8%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSS-QSLSPCFHLQVLALDYNVFIGELPDFSREFANL 147
L L+L + L S +L L+ L L N G L + + NL
Sbjct: 42 EGLTAEFVNLEFLSLINVG----LISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL 97
Query: 148 QVLDLSRNNFS--GDIPESFGRFPVLKVLNLGGN 179
L+LS N + E + LK L+L
Sbjct: 98 THLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 30/111 (27%), Positives = 47/111 (42%), Gaps = 6/111 (5%)
Query: 478 CTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLS 537
+R+L +D ++ G + + L+ L L + NL L L L LS
Sbjct: 24 AAVRELV-LDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 538 TNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLE-LTKLK-LNQFNISHN 586
N++ G + L LT L+LS N L LE L KL+ L ++ +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 30/135 (22%), Positives = 52/135 (38%), Gaps = 9/135 (6%)
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322
SG + ++ +L P ++ L LD ++N T ++LE L+L +
Sbjct: 3 SGSSGMDMKRRIHLELRNRTPAAVRELV----LDNCKSNDGKIEGLTAEFVNLEFLSLIN 58
Query: 323 NYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT--GELPRF 380
+ +L P L +L+L N G L K NL + ++S N L
Sbjct: 59 VGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116
Query: 381 LCFRNKLQCIIIFNN 395
L+ + +FN
Sbjct: 117 KKLEC-LKSLDLFNC 130
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 34/134 (25%), Positives = 48/134 (35%), Gaps = 27/134 (20%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
++ L+L N F + L L+L N + L LT+LT L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPH-SFS 263
L+S LP+ V + KL L L L N L +P F
Sbjct: 88 LQS--LPNGVFD-----------------------KLTQLKELALDTNQLK-SVPDGIFD 121
Query: 264 GLASIEQIELFDNQ 277
L S+++I L N
Sbjct: 122 RLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 473 VPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALI 532
VP+ I + ++L N+ +L +L +L L +N + LT L
Sbjct: 22 VPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 533 VLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLL 565
+L L N+L ++P + L L L L +N L
Sbjct: 80 ILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 9/86 (10%)
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLT 566
+LEL+ N + LT L L+LS NQ+ ++P + L LT L L N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 567 GEIPL----ELTKLKLNQFNISHNKL 588
+P +LT+LK + + N+L
Sbjct: 90 -SLPNGVFDKLTQLK--ELALDTNQL 112
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 3e-07
Identities = 36/225 (16%), Positives = 76/225 (33%), Gaps = 35/225 (15%)
Query: 129 DYNVFIGELPDFSREFANLQVLDLSRNNFS---------GDIPESFGRFPVLKVLNLGGN 179
D + + + +FA+ + L +F D+ P+L L + G
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 180 LLSGLIPSFLGNLTELTHFELGYNP------LKSSPLPSSVGNLSKLENLWAAKANLIGE 233
+ NL L G P + S LP NL KL L+ + +
Sbjct: 183 NNLSIGKKPRPNLKSLE-IISGGLPDSVVEDILGSDLP----NLEKLV-LYVGVEDYGFD 236
Query: 234 IPDSI-------GKLAFLSNLDLSDNFLSGKIPHSFSG---LASIEQIELFDNQLSGE-- 281
++ + L L + D + F L +E +++ L+ E
Sbjct: 237 GDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296
Query: 282 --LPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNY 324
L + + + L +++ N L+ + + + ++++D+
Sbjct: 297 RLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 4e-05
Identities = 23/153 (15%), Positives = 50/153 (32%), Gaps = 18/153 (11%)
Query: 457 PKLTGILINGNNFTGEVPSQICT-----LRQLQAVDLSQNRFSGHLPTCI------TQLN 505
P L + I V I L +L ++ +
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252
Query: 506 KLQQLELQENMFTGELPRNL---NSLTALIVLNLSTNQLTGT----IPPELGNLAVLTSL 558
L+ L + + + + L L +++S LT + + + L +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312
Query: 559 DLSSNLLTGEIPLELTKLKLNQFNISHNKLYGE 591
++ N L+ E+ EL K + ++S ++ Y +
Sbjct: 313 NMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDD 345
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 5e-05
Identities = 23/161 (14%), Positives = 58/161 (36%), Gaps = 19/161 (11%)
Query: 241 LAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESL--SNLTTLLRLDI- 297
L + L+ + + +++ +E+ L + E + S+L L +L +
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 298 --SQNNLTGNLPETIAAM-------SLESLNLNDNYFTGEIPESLASNPNLVQLK---LF 345
++ + +L+ L + D + E + L QL+ +
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 346 NNSFSGK----LPDDLGKYSNLEYFDVSTNDFTGELPRFLC 382
+ + L D + K +L++ ++ N + E+ + L
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 32/183 (17%), Positives = 67/183 (36%), Gaps = 30/183 (16%)
Query: 243 FLSNLDLSDNFLSGKIPHSFSGLA--------SIEQIELFDNQLSGELPESLSN-LTTLL 293
L L+L+ ++ P + +A +++++ L QL +L
Sbjct: 73 SLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR 129
Query: 294 RLDISQNNLTGNLPETIAAM------SLESLNLNDNYFTGE----IPESLASNPNLVQLK 343
+L + N+L + + + + +L L++N T + E LA N ++ L
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLS 189
Query: 344 LFNNSFSGK----LPDDLGKYSNLEYFDVSTNDFTGE----LPRFLCFRNKLQCIIIFNN 395
L + + L L + L+ +V+ N L R L+ + ++ N
Sbjct: 190 LLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFN 249
Query: 396 RFS 398
S
Sbjct: 250 ELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 46/285 (16%), Positives = 82/285 (28%), Gaps = 67/285 (23%)
Query: 97 TLRNLNLSDNYFNGTLSSQSLSPCF-HLQVLALDYNVF-------IGELPDFSREFANLQ 148
L +NL+ ++L P F + L L N + +L + +
Sbjct: 102 ALDEVNLASCQL-DPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL--LLHDQCQIT 158
Query: 149 VLDLSRNNFSGD----IPESFGRFPVLKVLNLGGNLLS----GLIPSFLGNLTELTHFEL 200
L LS N + + E + L+L L L+ + L +L +
Sbjct: 159 TLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNV 218
Query: 201 GYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLS----- 255
YN ++ L++ AA+ + L L L N LS
Sbjct: 219 AYNGAG----DTAALALAR-----AAREH------------PSLELLHLYFNELSSEGRQ 257
Query: 256 --GKIPHSFSGLASIEQIELFDNQLSGE----LPESLSNLTTLLRLDISQNNLTGNLPET 309
+ + G A + +S L E NL + R + ++
Sbjct: 258 VLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRH--------- 308
Query: 310 IAAMSLESLNLNDNYFTGE----IPESLASNPNLVQLKLFNNSFS 350
+ L +L D+ + L + L S
Sbjct: 309 ---LELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 32/174 (18%), Positives = 60/174 (34%), Gaps = 41/174 (23%)
Query: 689 LIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM- 747
IG GG +Y + S E+V +P +E++ R ++ +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 748 ------------------CCSGQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFS- 787
+G+ + ++ + G L + + RFS
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK--------RFSR 151
Query: 788 -----IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV--ADFGLAK 834
++ L Y+H VH D+K+ N+LL+ + +V D+GLA
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 31/134 (23%), Positives = 49/134 (36%), Gaps = 28/134 (20%)
Query: 145 ANLQVLDLSRNNFSGDIPE-SFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
+ L L+ N + FGR P L L L N L+G+ P+ + + +LG N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPH-SF 262
+K + + + L L L+L DN +S + SF
Sbjct: 89 KIKE--ISNKM-----------------------FLGLHQLKTLNLYDNQISC-VMPGSF 122
Query: 263 SGLASIEQIELFDN 276
L S+ + L N
Sbjct: 123 EHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 22/96 (22%), Positives = 39/96 (40%), Gaps = 5/96 (5%)
Query: 473 VPSQICTLRQLQAVDLSQNRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNLNSLTAL 531
+P I + L+ N + +L L +LEL+ N TG P + +
Sbjct: 23 IPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 532 IVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLT 566
L L N++ I ++ L L +L+L N ++
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 26/106 (24%), Positives = 44/106 (41%), Gaps = 9/106 (8%)
Query: 193 TELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI-GKLAFLSNLDLSD 251
T L N L G L L L + N + I + + + L L +
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKR-NQLTGIEPNAFEGASHIQELQLGE 87
Query: 252 NFLSGKIPH-SFSGLASIEQIELFDNQLSGELPE----SLSNLTTL 292
N + +I + F GL ++ + L+DNQ+S + L++LT+L
Sbjct: 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSL 131
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 20/74 (27%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 284 ESLSNLTTLLRLDISQNNLTGNLPETIAAM-----SLESLNLNDNYFTGE----IPESLA 334
E+L T + + I + +A M +L+SLN+ N+ +G + E+L
Sbjct: 59 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQ 118
Query: 335 SNPNLVQLKLFNNS 348
SN +L++L++ N S
Sbjct: 119 SNTSLIELRIDNQS 132
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 33/177 (18%), Positives = 56/177 (31%), Gaps = 50/177 (28%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAV--------------------KRLLGGTHKPETETVF 727
IGSGG +Y E A +R+ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 728 RSEIETLGRVRH-GNVVKLLMCCSGQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIR 785
+ + + G L G+ + +V E + G L + + G
Sbjct: 104 QLDYLGIPLFYGSG-----LTEFKGRSYRFMVMERL--GIDLQKISGQNGT--------- 147
Query: 786 FS------IAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV--ADFGLAK 834
F + L Y+H + VH D+K+ N+LL + +V AD+GL+
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 42/273 (15%), Positives = 82/273 (30%), Gaps = 23/273 (8%)
Query: 69 TQNQSVDGIDLSGFDLSGGFPNGFCRI----RTLRNLNLSDNYF-NGTLSSQSLSPCFHL 123
+L + G I R L++++ + L + + L
Sbjct: 81 KGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDL 140
Query: 124 QVLALDYNVFIGE--LPDFSREFANLQVLDLSRNNFSGDIPESFGRF----PVLKVLNLG 177
+ L LD L ++ L + ++FS + L+VLN
Sbjct: 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY 200
Query: 178 GNLLSGL----IPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGE 233
+ + + + N L ++G + L + LE N
Sbjct: 201 MTEFAKISPKDLETIARNCRSLVSVKVGDFEILE--LVGFFKAAANLEEFCGGSLNEDIG 258
Query: 234 IPDSIGKLAFLSNLDLSDNFLSGK--IPHSFSGLASIEQIEL-FDNQLSGELPESLSNLT 290
+P+ L F L G +P F A I +++L + + + +
Sbjct: 259 MPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP 318
Query: 291 TLLRLDISQNNLTGNLPETIAAM--SLESLNLN 321
L L+ N + E +A L+ L +
Sbjct: 319 NLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIE 350
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 50/317 (15%), Positives = 99/317 (31%), Gaps = 45/317 (14%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSP----CFHLQVLALDYNVFIGELPDFSREFANLQVLD 151
+L LN F +S + L C L + + + EL F + ANL+
Sbjct: 192 TSLEVLNFYMTEFAK-ISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFC 249
Query: 152 LSRNNFSGDIPESFGRFPVLKVLNLGG--NLLSGLIPSFLGNLTELTHFELGYNPLKSSP 209
N +PE + + L G + +P ++ +L Y L++
Sbjct: 250 GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETED 309
Query: 210 LPSSVGNLSKLENLWAAKANLIGEIPD-SIGKLAF----LSNLDLSDNFLSGKIPHSFS- 263
+ + LE L I D + LA L L + +
Sbjct: 310 HCTLIQKCPNLEVLE-----TRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGL 364
Query: 264 ----GLASI-------EQIELFDNQLSGE----LPESLSNLTTLLRLDISQNNLTGNLP- 307
GL ++ E + ++ + ++ E + L NL + + + +LP
Sbjct: 365 VSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPL 424
Query: 308 -ETIAAM-----SLESLNLNDNY--FTGEIPESLASN-PNLVQLKLFNNSFSGKLPDDLG 358
+ ++ L T + PN+ + L S + +
Sbjct: 425 DNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFS 484
Query: 359 KY-SNLEYFDVSTNDFT 374
+ NL+ ++ F+
Sbjct: 485 RGCPNLQKLEMRGCCFS 501
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 28/80 (35%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
QVL L N + P F R L L+L N L+ L LT+LT L N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89
Query: 205 LKSSPLPSSVGNLSKLENLW 224
LKS P + NL L ++W
Sbjct: 90 LKSIP-RGAFDNLKSLTHIW 108
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 24/83 (28%), Positives = 35/83 (42%), Gaps = 7/83 (8%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
+ Q L L+ N + P F L+ L N L+ + LT+LT +L N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92
Query: 205 LKSSPLPSSVG---NLSKLENLW 224
LKS P G NL L +++
Sbjct: 93 LKSIPR----GAFDNLKSLTHIY 111
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 41/265 (15%), Positives = 77/265 (29%), Gaps = 40/265 (15%)
Query: 98 LRNLNLSDNYFNGTLSSQSLSP----CFHLQVLALDYNVFIGE--LPDFSREFANLQVLD 151
L + L ++ L + +VL L L + NL+ LD
Sbjct: 107 LEEIRLK----RMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELD 162
Query: 152 LSRNNFSGDIPESFGRF----PVLKVLNLGG---NLLSGLIPSFLGNLTELTHFELGYNP 204
L ++ F L LN+ + + + L +L
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
L + + +LE +L + + + SG
Sbjct: 223 PLEK-LATLLQRAPQLE------------------ELGTGGYTAEVRPDVYSGLSVALSG 263
Query: 265 LASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM--SLESLNLND 322
+ + F + + LP S + L L++S + + L+ L + D
Sbjct: 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLD 323
Query: 323 NYFTGEIPESLASN-PNLVQLKLFN 346
E LAS +L +L++F
Sbjct: 324 Y-IEDAGLEVLASTCKDLRELRVFP 347
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 60/404 (14%), Positives = 129/404 (31%), Gaps = 69/404 (17%)
Query: 77 IDLSGFDLSGGFPNGFCRI----RTLRNLNLSDNYFNGTLSS-QSLSP-CFHLQVLALDY 130
+DL D+ + +L +LN+S + S+ + L C +L+ L L+
Sbjct: 161 LDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR 220
Query: 131 NVFIGELPDFSREFANLQVLDLSRNNFSGD------IPESFGRFPVLKVLNLGGNLLSGL 184
V + +L + L+ L + + L+ L+ + +
Sbjct: 221 AVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAY 280
Query: 185 IPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLA-- 242
+P+ + LT L Y ++S L + KL+ LW + I + + LA
Sbjct: 281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLW--VLDYIED--AGLEVLAST 336
Query: 243 --FLSNLDLSDNFLSGKIPHS----------FSGLASIEQIELFDNQLSGE----LPESL 286
L L + + P+ G +E + F Q++ + +
Sbjct: 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNR 396
Query: 287 SNLT---------------TLLRLDISQNNLTGNLP-------------ETIAAMS---- 314
N+T TL LDI + + + +
Sbjct: 397 PNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAK 456
Query: 315 -LESLNLNDNYFTGEIPESLASN-PNLVQLKLFNNSFSGK-LPDDLGKYSNLEYFDVSTN 371
+E L++ + + S +L +L++ + F K L + K + +S+
Sbjct: 457 KMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC 516
Query: 372 DFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLR 415
+ + L + + + + R + + + R
Sbjct: 517 SVSFGACKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVFIYR 560
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 15/79 (18%), Positives = 31/79 (39%), Gaps = 9/79 (11%)
Query: 281 ELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-----SLESLNLNDNYFTGE----IPE 331
L E+ N + + ++ ++ + + + SL LN+ N+ T E +
Sbjct: 61 SLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120
Query: 332 SLASNPNLVQLKLFNNSFS 350
S ++V+ K N S
Sbjct: 121 STLVTQSIVEFKADNQRQS 139
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 46/261 (17%), Positives = 89/261 (34%), Gaps = 14/261 (5%)
Query: 89 PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDY-NVFIGELPDFSREFANL 147
P+ R+ + + F +Q + L + + L + + L
Sbjct: 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGG--NLLSGLIPSFLGNLTELTHFELGYNPL 205
Q L L S I + + L LNL G + + L + + L L +
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180
Query: 206 KSSP-----LPSSVGNLSKLENLWAAKANLIGEIPDSIGK-LAFLSNLDLSD-NFLSGKI 258
+ + +++L NL + NL ++ + L +LDLSD L
Sbjct: 181 FTEKHVQVAVAHVSETITQL-NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 239
Query: 259 PHSFSGLASIEQIELFD-NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLES 317
F L ++ + L + E L + TL L + + + + +L
Sbjct: 240 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF-GIVPDGTLQLLKE-ALPH 297
Query: 318 LNLNDNYFTGEIPESLASNPN 338
L +N ++FT ++ + N
Sbjct: 298 LQINCSHFTTIARPTIGNKKN 318
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 50/248 (20%), Positives = 82/248 (33%), Gaps = 82/248 (33%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRS----------EIETLGRV 737
+G G RV + + + + AVK V R+ E + L ++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK-------------VVRNIKKYTRSAKIEADILKKI 88
Query: 738 RHG-----NVVKLL--------MCCSGQDFNILVYEYMPNGSLADMLHEKGRSG-SLDWS 783
++ N+VK MC L++E + SL +++ +G ++
Sbjct: 89 QNDDINNNNIVKYHGKFMYYDHMC--------LIFEPL-GPSLYEIITRNNYNGFHIE-D 138
Query: 784 IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843
I+ K L YL ++ H D+K NILLD + +
Sbjct: 139 IK-LYCIEILKALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 844 DDAMSCVA----GS--------YGYI------APE------YAYTKKVTEKSDVYSFGVV 879
+ + G I APE + SD++SFG V
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDV------SSDMWSFGCV 248
Query: 880 LMELVTGK 887
L EL TG
Sbjct: 249 LAELYTGS 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 21/93 (22%)
Query: 751 GQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFS------IAQGAAKGLAYLHNDC 803
+ LV + G SL L + S +A L +LH +
Sbjct: 129 QDKYRFLVLPSL--GRSLQSALDVSPKH-------VLSERSVLQVACRLLDALEFLHENE 179
Query: 804 VPAIVHRDVKSHNILLDAEMVPRV--ADFGLAK 834
VH +V + NI +D E +V A +G A
Sbjct: 180 ---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.01 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.9 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.89 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.44 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.41 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.39 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.15 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.65 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.61 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.48 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.42 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.2 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.91 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.77 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.77 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.69 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.68 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.59 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.42 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.3 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.81 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.87 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.86 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.89 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.35 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.4 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.56 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-82 Score=779.71 Aligned_cols=590 Identities=34% Similarity=0.550 Sum_probs=481.0
Q ss_pred hccchhhHHHHHHHhhhccCCCCCccCCccCCCCCCCCccceeEEcCCCCceeEeecCCCccCCC---CC----------
Q 039922 23 AISLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGG---FP---------- 89 (973)
Q Consensus 23 ~~~~~~~~~~l~~~k~~~~~d~~~~~~sw~~~~~~~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~---~~---------- 89 (973)
+.+.+.|++||++||+++. ||. .++||.. +.+||.|+||+|+ +++|+.|+|++.++.|. +|
T Consensus 7 ~~~~~~~~~all~~k~~~~-~~~-~l~~W~~--~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLP-DKN-LLPDWSS--NKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCS-CTT-SSTTCCT--TSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred ccCCHHHHHHHHHHHhhCC-Ccc-cccCCCC--CCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 3446789999999999985 888 9999963 5689999999998 57999999999998886 33
Q ss_pred -------------CCccCccccceeccCCCcccCcCCc-CcCCCcCCccEEecccccccccCCccc-cCCCCCCEEECc-
Q 039922 90 -------------NGFCRIRTLRNLNLSDNYFNGTLSS-QSLSPCFHLQVLALDYNVFIGELPDFS-REFANLQVLDLS- 153 (973)
Q Consensus 90 -------------~~~~~l~~L~~L~Ls~n~l~~~~~~-~~l~~l~~L~~L~L~~n~~~~~~~~~~-~~l~~L~~L~Ls- 153 (973)
+.|+++++|++|||++|.+.|.+|. ..++.+++|++|+|++|.+.+.+|..+ ..+++|++|||+
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 5778888999999999988877664 257777777777777777766655443 334444444444
Q ss_pred ------------------------------------------------CCcCCCCCCcccCCCCcccEEecCCcccCCcc
Q 039922 154 ------------------------------------------------RNNFSGDIPESFGRFPVLKVLNLGGNLLSGLI 185 (973)
Q Consensus 154 ------------------------------------------------~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 185 (973)
+|.+++.+|. ++++++|++|+|++|++++.+
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~ 239 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF 239 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCH
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcc
Confidence 4444433333 555555555555555555555
Q ss_pred cccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCC-CCCCEEEccCCcccccCCcCCCC
Q 039922 186 PSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKL-AFLSNLDLSDNFLSGKIPHSFSG 264 (973)
Q Consensus 186 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~ 264 (973)
|..|+++++|++|+|++|.+... +|.. .+++|++|++++|.+.+.+|..+..+ ++|++|+|++|.+++.+|..|++
T Consensus 240 ~~~l~~l~~L~~L~Ls~n~l~~~-~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~ 316 (768)
T 3rgz_A 240 SRAISTCTELKLLNISSNQFVGP-IPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316 (768)
T ss_dssp HHHTTTCSSCCEEECCSSCCEES-CCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGG
T ss_pred cHHHhcCCCCCEEECCCCcccCc-cCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhc
Confidence 55555555555555555555431 2222 55666666666666666777777664 77888888888887777777888
Q ss_pred CCCCCEEEccCCcCcccCchh-ccCCCccceeeccccccCCCChhhhhcc--cCcEEEccCCcCCCCCCccccC--CCcc
Q 039922 265 LASIEQIELFDNQLSGELPES-LSNLTTLLRLDISQNNLTGNLPETIAAM--SLESLNLNDNYFTGEIPESLAS--NPNL 339 (973)
Q Consensus 265 l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~~~~~--l~~L 339 (973)
+++|++|++++|+++|.+|.. +.++++|++|++++|++++.+|..+... +|+.|++++|++++.+|..+.. +++|
T Consensus 317 l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp CTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred CCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 888888888888887777765 7778888888888888877777766543 6888888888888777777766 7889
Q ss_pred ceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCC
Q 039922 340 VQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGN 419 (973)
Q Consensus 340 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 419 (973)
++|++++|++++.+|..+.++++|++|+|++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|++|++++|
T Consensus 397 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 476 (768)
T 3rgz_A 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476 (768)
T ss_dssp CEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCC
Confidence 99999999999899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCcc
Q 039922 420 ELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT 499 (973)
Q Consensus 420 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 499 (973)
++++..|..+.++++|+.|++++|++++.+|..+..+++|++|++++|++++.+|..++.+++|++|++++|+++|.+|.
T Consensus 477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~ 556 (768)
T 3rgz_A 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCG
T ss_pred cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCCh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988876
Q ss_pred ccc----------------------------------------------------------------------cccccce
Q 039922 500 CIT----------------------------------------------------------------------QLNKLQQ 509 (973)
Q Consensus 500 ~~~----------------------------------------------------------------------~l~~L~~ 509 (973)
++. .+++|+.
T Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~ 636 (768)
T 3rgz_A 557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636 (768)
T ss_dssp GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE
T ss_pred HHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE
Confidence 543 3577999
Q ss_pred eeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcC
Q 039922 510 LELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKL 588 (973)
Q Consensus 510 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l 588 (973)
|||++|+++|.+|.+++++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.||..+..+ .|+.|++++|+|
T Consensus 637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999 899999999999
Q ss_pred cccCCCCC-cccccccccCCCCCCCCCCCCCCCCCCCC
Q 039922 589 YGEVPSDF-DHDLFISSLLDNPGLCSPDLKPLPPCSKT 625 (973)
Q Consensus 589 ~g~~p~~~-~~~~~~~~~~~n~~~c~~~l~~~~~c~~~ 625 (973)
+|.||.+. ...+...+|.|||++||+|++ +|...
T Consensus 717 ~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~---~C~~~ 751 (768)
T 3rgz_A 717 SGPIPEMGQFETFPPAKFLNNPGLCGYPLP---RCDPS 751 (768)
T ss_dssp EEECCSSSSGGGSCGGGGCSCTEEESTTSC---CCCSC
T ss_pred cccCCCchhhccCCHHHhcCCchhcCCCCc---CCCCC
Confidence 99999864 345777889999999998764 78653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-65 Score=630.35 Aligned_cols=514 Identities=31% Similarity=0.501 Sum_probs=464.1
Q ss_pred ceeEeecCCCccCCCCCCCc-cCccccceeccCCCcccCcCCcC------------------------cCCCcCCccEEe
Q 039922 73 SVDGIDLSGFDLSGGFPNGF-CRIRTLRNLNLSDNYFNGTLSSQ------------------------SLSPCFHLQVLA 127 (973)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~------------------------~l~~l~~L~~L~ 127 (973)
+...|+|+++.+.+.+|..+ .++++|++|||++|++++..+.. .+..+++|++|+
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~ 206 (768)
T 3rgz_A 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLD 206 (768)
T ss_dssp TCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEE
T ss_pred CCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEE
Confidence 46778888888877777654 56666666666666665433211 236788889999
Q ss_pred cccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCC
Q 039922 128 LDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207 (973)
Q Consensus 128 L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 207 (973)
|++|.+.+.+|. ++.+++|++|+|++|.+++.+|..++.+++|++|+|++|++++.+|.. .+++|++|+|++|+++.
T Consensus 207 Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~ 283 (768)
T 3rgz_A 207 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283 (768)
T ss_dssp CCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEE
T ss_pred CcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCC
Confidence 999998888887 999999999999999999999999999999999999999999888775 89999999999999874
Q ss_pred CCCCccccCc-chhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcC-CCCCCCCCEEEccCCcCcccCchh
Q 039922 208 SPLPSSVGNL-SKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHS-FSGLASIEQIELFDNQLSGELPES 285 (973)
Q Consensus 208 ~~~~~~~~~l-~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~p~~ 285 (973)
.+|..+..+ ++|++|++++|++.+.+|..++++++|++|+|++|.+++.+|.. |.++++|++|++++|++++.+|..
T Consensus 284 -~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~ 362 (768)
T 3rgz_A 284 -EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362 (768)
T ss_dssp -SCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTT
T ss_pred -ccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHH
Confidence 367777765 99999999999999999999999999999999999999888876 999999999999999999999999
Q ss_pred ccCCC-ccceeeccccccCCCChhhhhc---ccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCC
Q 039922 286 LSNLT-TLLRLDISQNNLTGNLPETIAA---MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYS 361 (973)
Q Consensus 286 l~~l~-~L~~L~Ls~N~l~~~~~~~~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 361 (973)
+.+++ +|+.|++++|++++.+|..+.. .+|++|++++|++++.+|..+.++++|++|+|++|++++.+|..++.++
T Consensus 363 l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 442 (768)
T 3rgz_A 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442 (768)
T ss_dssp HHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred HHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCC
Confidence 99987 9999999999999888777654 3799999999999999999999999999999999999999999999999
Q ss_pred CccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEee
Q 039922 362 NLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMY 441 (973)
Q Consensus 362 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 441 (973)
+|++|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|++|++++|++++.+|.+|+.+++|+.|+++
T Consensus 443 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 522 (768)
T 3rgz_A 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhh-------------------------------------------
Q 039922 442 NNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQIC------------------------------------------- 478 (973)
Q Consensus 442 ~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~------------------------------------------- 478 (973)
+|++++.+|..+..+++|+.|++++|+++|.+|..+.
T Consensus 523 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (768)
T 3rgz_A 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602 (768)
T ss_dssp SSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGG
T ss_pred CCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccch
Confidence 9999999999999999999999999999988886543
Q ss_pred ---------------------------cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccc
Q 039922 479 ---------------------------TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL 531 (973)
Q Consensus 479 ---------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 531 (973)
.+++|++|||++|+++|.+|.+++++++|+.|+|++|+++|.+|..++++++|
T Consensus 603 ~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L 682 (768)
T 3rgz_A 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682 (768)
T ss_dssp GGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred hhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCC
Confidence 35679999999999999999999999999999999999999999999999999
Q ss_pred eeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcccccceeccCCc-Ccc
Q 039922 532 IVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNK-LYG 590 (973)
Q Consensus 532 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~-l~g 590 (973)
+.||||+|+++|.+|..+.++++|++|||++|+|+|.||..-.-..+....+.+|. |+|
T Consensus 683 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp CEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcC
Confidence 99999999999999999999999999999999999999976332266677777885 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=574.87 Aligned_cols=543 Identities=21% Similarity=0.219 Sum_probs=475.7
Q ss_pred CceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEE
Q 039922 72 QSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLD 151 (973)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~ 151 (973)
.+++.|+|+++.+++..+..|.++++|++|+|++|.+++ +++.+|+++++|++|+|++|.+.+..+..|+.+++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCC-CCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCc-cCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 468999999999999888889999999999999999985 5557899999999999999999977777899999999999
Q ss_pred CcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccc--cCcchhHHHhhccCc
Q 039922 152 LSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSV--GNLSKLENLWAAKAN 229 (973)
Q Consensus 152 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~--~~l~~L~~L~l~~n~ 229 (973)
|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|.++..+ +..+ ..+++|++|++++|.
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~~~~~~L~~L~L~~n~ 182 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK-SEELDIFANSSLKKLELSSNQ 182 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC-HHHHGGGTTCEESEEECTTCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC-HHHhhccccccccEEECCCCc
Confidence 9999999888889999999999999999999999999999999999999999997642 3333 356899999999999
Q ss_pred ccccCCccccCC---------------------------CCCCEEEccCCcccccCCcCCCCCCC--CCEEEccCCcCcc
Q 039922 230 LIGEIPDSIGKL---------------------------AFLSNLDLSDNFLSGKIPHSFSGLAS--IEQIELFDNQLSG 280 (973)
Q Consensus 230 l~~~~p~~l~~l---------------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~n~l~~ 280 (973)
+.+..|..++.+ ++|+.|++++|.+++..|..|.+++. |++|++++|++++
T Consensus 183 l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~ 262 (680)
T 1ziw_A 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262 (680)
T ss_dssp CCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCE
T ss_pred ccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCc
Confidence 998888776654 56788889999999888999988865 9999999999998
Q ss_pred cCchhccCCCccceeeccccccCCCChhhhhcc-cCcEEEccCCcCCC-----CCCc----cccCCCccceeeecccccc
Q 039922 281 ELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTG-----EIPE----SLASNPNLVQLKLFNNSFS 350 (973)
Q Consensus 281 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~-----~~p~----~~~~l~~L~~L~L~~N~l~ 350 (973)
..|..+..+++|+.|++++|++++..|..+... +|+.|++++|...+ .+|. .|..+++|++|++++|+++
T Consensus 263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~ 342 (680)
T 1ziw_A 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence 888999999999999999999998888777665 79999999887654 2333 6788999999999999999
Q ss_pred CCCCCCccCCCCccceeeecccccc--cCCcccccc--CCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccC
Q 039922 351 GKLPDDLGKYSNLEYFDVSTNDFTG--ELPRFLCFR--NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELP 426 (973)
Q Consensus 351 ~~~p~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 426 (973)
+..+..|..+++|++|++++|.+.. .....+..+ ++|+.|++++|++.+..|..+..+++|++|++++|.+.+.+|
T Consensus 343 ~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 422 (680)
T 1ziw_A 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422 (680)
T ss_dssp CCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC
T ss_pred CCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC
Confidence 9888899999999999999998643 223334333 589999999999999999999999999999999999987665
Q ss_pred -cccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCC--CCCchhhhcCCcCcEEeCcCCcccCCCcccccc
Q 039922 427 -SKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT--GEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQ 503 (973)
Q Consensus 427 -~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 503 (973)
..|.++++|+.|++++|++.+..+..+..+++|+.|++++|.+. +.+|..+..+++|++|+|++|++++..|..|.+
T Consensus 423 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~ 502 (680)
T 1ziw_A 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502 (680)
T ss_dssp SGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcc
Confidence 78999999999999999999999999999999999999999987 578999999999999999999999888888999
Q ss_pred ccccceeeccccccccccC--------cccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhc
Q 039922 504 LNKLQQLELQENMFTGELP--------RNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTK 575 (973)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 575 (973)
+++|++|+|++|++++..+ ..|.++++|+.|+|++|+++...+..|.++++|+.|||++|++++..|..+..
T Consensus 503 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~ 582 (680)
T 1ziw_A 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582 (680)
T ss_dssp CTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCC
Confidence 9999999999999996532 34789999999999999999544457999999999999999999655555677
Q ss_pred c-cccceeccCCcCcccCCCCCc---ccccccccCCCCCCCCCCC
Q 039922 576 L-KLNQFNISHNKLYGEVPSDFD---HDLFISSLLDNPGLCSPDL 616 (973)
Q Consensus 576 l-~l~~l~l~~N~l~g~~p~~~~---~~~~~~~~~~n~~~c~~~l 616 (973)
+ .|+.|++++|++++..|..+. .......+.+||+.|+++.
T Consensus 583 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 7 999999999999998776543 3456677899999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=551.02 Aligned_cols=526 Identities=21% Similarity=0.195 Sum_probs=435.9
Q ss_pred CCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCC
Q 039922 80 SGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSG 159 (973)
Q Consensus 80 ~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 159 (973)
++.+++ .+|..+. +++++|||++|+++ .+++.+|.++++|++|+|++|.+.+..|..|+.+++|++|+|++|++++
T Consensus 20 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~ 95 (606)
T 3t6q_A 20 ENLGLN-EIPGTLP--NSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF 95 (606)
T ss_dssp TTSCCS-SCCTTSC--TTCCEEECTTCCCS-EECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSE
T ss_pred CCCCcc-cCcCCCC--CcCcEEEccCCccC-cCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccc
Confidence 333443 3455444 36899999999998 5666789999999999999999999999999999999999999999998
Q ss_pred CCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCcccc
Q 039922 160 DIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIG 239 (973)
Q Consensus 160 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~ 239 (973)
..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++.++.|..++ +++|++|++++|.+.+..|..++
T Consensus 96 ~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~ 174 (606)
T 3t6q_A 96 MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNAIHYLSKEDMS 174 (606)
T ss_dssp ECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEECCSSCCCEECHHHHH
T ss_pred cChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccC-CcccCEEEcccCcccccChhhhh
Confidence 88999999999999999999999888889999999999999999999876666665 99999999999999999899999
Q ss_pred CCCCCC--EEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccC-----CCChhhhh-
Q 039922 240 KLAFLS--NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT-----GNLPETIA- 311 (973)
Q Consensus 240 ~l~~L~--~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-----~~~~~~~~- 311 (973)
.+++|+ .|++++|.+++..|..|.. .+|++|++++|.. .+..+..+.++....+..+.+. ...+..+.
T Consensus 175 ~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~ 250 (606)
T 3t6q_A 175 SLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250 (606)
T ss_dssp TTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred hhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhccccccccChhHhch
Confidence 999999 8999999999888877765 6899999999872 3444555554444333322221 12222222
Q ss_pred --cccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchh
Q 039922 312 --AMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQC 389 (973)
Q Consensus 312 --~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 389 (973)
..+|+.|++++|.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|+.
T Consensus 251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 329 (606)
T 3t6q_A 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329 (606)
T ss_dssp GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence 236888999999998888888888899999999999888 77888888899999999999988888888888899999
Q ss_pred hhcccCccCCCCCC-ccCCcceeeEEEccCCcccccc--CcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecC
Q 039922 390 IIIFNNRFSGKIPE-SYGECKTLNYLRFGGNELQGEL--PSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILING 466 (973)
Q Consensus 390 L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~ 466 (973)
|++++|.+.+.+|. .+..+++|++|++++|.+++.. +..+..+++|+.|++++|++.+..+..+..+++|+.|++++
T Consensus 330 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 409 (606)
T 3t6q_A 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409 (606)
T ss_dssp EECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTT
T ss_pred EECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCC
Confidence 99999988866654 4888889999999999988776 77888889999999999998888888888889999999999
Q ss_pred CcCCCCCchh-hhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccc---cCcccCccccceeeeeccCccc
Q 039922 467 NNFTGEVPSQ-ICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGE---LPRNLNSLTALIVLNLSTNQLT 542 (973)
Q Consensus 467 N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~ 542 (973)
|.+++..|.. +..+++|++|++++|.+++..|..++.+++|++|+|++|++++. .+..+..+++|+.|+|++|+++
T Consensus 410 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~ 489 (606)
T 3t6q_A 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489 (606)
T ss_dssp CCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCC
T ss_pred CcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccC
Confidence 9888776544 78888999999999999888888888889999999999988863 3366888899999999999998
Q ss_pred CCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCCCCCc--ccccccccCCCCCCCCCCC
Q 039922 543 GTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFD--HDLFISSLLDNPGLCSPDL 616 (973)
Q Consensus 543 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~~~--~~~~~~~~~~n~~~c~~~l 616 (973)
+..|..|..+++|+.|+|++|++++.+|..+..+ .| .|++++|++++.+|..+. .......+.+||+.|.++.
T Consensus 490 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred ccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 8888888889999999999999998888888888 78 899999999887776543 2355667888888887754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-57 Score=550.80 Aligned_cols=521 Identities=21% Similarity=0.223 Sum_probs=463.6
Q ss_pred CceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEE
Q 039922 72 QSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLD 151 (973)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~ 151 (973)
.+++.|+|+++.+++..|.+|.++++|++|+|++|+++ .++...|+++++|++|+|++|.+.+..|..|+.+++|++|+
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEE
Confidence 35889999999999999999999999999999999998 67878899999999999999999988889999999999999
Q ss_pred CcCCcCCCCCCcccCCCCcccEEecCCcccCCccccccc--ccccccEeeccCcCCCCCCCCccccCc------------
Q 039922 152 LSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLG--NLTELTHFELGYNPLKSSPLPSSVGNL------------ 217 (973)
Q Consensus 152 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~~l------------ 217 (973)
|++|.+++..|..++++++|++|+|++|++++..+..+. .+++|++|++++|.++..+ |..+..+
T Consensus 128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~~~ 206 (680)
T 1ziw_A 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS-PGCFHAIGRLFGLFLNNVQ 206 (680)
T ss_dssp CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBC-TTGGGGSSEECEEECTTCC
T ss_pred CCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccC-hhhhhhhhhhhhhhccccc
Confidence 999999999999999999999999999999988887765 4589999999999997653 4444443
Q ss_pred ---------------chhHHHhhccCcccccCCccccCCCC--CCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcc
Q 039922 218 ---------------SKLENLWAAKANLIGEIPDSIGKLAF--LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSG 280 (973)
Q Consensus 218 ---------------~~L~~L~l~~n~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 280 (973)
++|++|++++|.+.+..|..+.+++. |++|+|++|++++..|..|+.+++|++|++++|++++
T Consensus 207 l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 286 (680)
T 1ziw_A 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286 (680)
T ss_dssp CHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSE
T ss_pred cChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCc
Confidence 45777888889999999999988865 9999999999999999999999999999999999999
Q ss_pred cCchhccCCCccceeeccccccCCC-----Chh----hhhc-ccCcEEEccCCcCCCCCCccccCCCccceeeecccccc
Q 039922 281 ELPESLSNLTTLLRLDISQNNLTGN-----LPE----TIAA-MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFS 350 (973)
Q Consensus 281 ~~p~~l~~l~~L~~L~Ls~N~l~~~-----~~~----~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 350 (973)
..|..+.++++|+.|++++|...+. +|. .+.. .+|++|++++|++++..+..|..+++|++|++++|.++
T Consensus 287 ~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~ 366 (680)
T 1ziw_A 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366 (680)
T ss_dssp ECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSC
T ss_pred cChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchh
Confidence 9999999999999999998876542 222 3333 47999999999999999999999999999999999865
Q ss_pred CCC--CCCccCC--CCccceeeecccccccCCccccccCCchhhhcccCccCCCCC-CccCCcceeeEEEccCCcccccc
Q 039922 351 GKL--PDDLGKY--SNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIP-ESYGECKTLNYLRFGGNELQGEL 425 (973)
Q Consensus 351 ~~~--p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~ 425 (973)
+.. ...+..+ ++|+.|++++|++++..|..+..+++|+.|++++|++.+.+| ..+..+++|++|++++|++.+..
T Consensus 367 ~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 446 (680)
T 1ziw_A 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446 (680)
T ss_dssp CCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECC
T ss_pred hhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeC
Confidence 432 2234333 689999999999999999999999999999999999987665 78999999999999999999999
Q ss_pred CcccCCCCCccEEEeecCccc--CCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCC------
Q 039922 426 PSKFWGLPEVDFFEMYNNRFE--GSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHL------ 497 (973)
Q Consensus 426 ~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~------ 497 (973)
+..|..+++|+.|++++|++. +.+|..+..+++|+.|++++|++++..+..|..+++|++|+|++|++++..
T Consensus 447 ~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 526 (680)
T 1ziw_A 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPG 526 (680)
T ss_dssp TTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTT
T ss_pred hhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccC
Confidence 999999999999999999987 577899999999999999999999888888999999999999999998542
Q ss_pred --ccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhh-
Q 039922 498 --PTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELT- 574 (973)
Q Consensus 498 --p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~- 574 (973)
+..|.++++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..+.
T Consensus 527 ~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 606 (680)
T 1ziw_A 527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606 (680)
T ss_dssp SCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHH
T ss_pred CcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcc
Confidence 23478999999999999999955556799999999999999999977777789999999999999999987777776
Q ss_pred cc-cccceeccCCcCcccCCC
Q 039922 575 KL-KLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 575 ~l-~l~~l~l~~N~l~g~~p~ 594 (973)
.+ .|+.+++++|++.+..+.
T Consensus 607 ~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 607 AFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHTTCSEEECTTCCCCBCCCC
T ss_pred cccccCEEEccCCCcccCCcc
Confidence 55 899999999999998774
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-57 Score=544.83 Aligned_cols=525 Identities=20% Similarity=0.191 Sum_probs=445.9
Q ss_pred eecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCc
Q 039922 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156 (973)
Q Consensus 77 l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~ 156 (973)
++.++.+++. +|..+. ++|++|+|++|+++ .+++..|.++++|++|+|++|.+.+..|..|+.+++|++|+|++|.
T Consensus 16 ~~c~~~~l~~-ip~~~~--~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 16 YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EECTTSCCSS-CCTTSC--TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEccCCCccc-CCCCCC--CCcCEEECCCCCcC-EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 5566666653 555444 78999999999998 5666789999999999999999999899999999999999999999
Q ss_pred CCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCc
Q 039922 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD 236 (973)
Q Consensus 157 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~ 236 (973)
+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.++.+.+|..++++++|++|++++|++.+..|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 99888999999999999999999999888889999999999999999999878899999999999999999999999888
Q ss_pred cccCCCCCC----EEEccCCcccccCCcCCCCCCCCCEEEccCCcCc-ccCchhccCCCccceeeccccccCC------C
Q 039922 237 SIGKLAFLS----NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLS-GELPESLSNLTTLLRLDISQNNLTG------N 305 (973)
Q Consensus 237 ~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~------~ 305 (973)
.++.+.+|+ +|++++|.+++..+..+... +|++|++++|.++ +..|..+.+++.|+.+++..+.+.+ .
T Consensus 172 ~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~ 250 (606)
T 3vq2_A 172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250 (606)
T ss_dssp TTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred hhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence 888877765 89999999997777777665 8999999999987 5678889999999999887665432 1
Q ss_pred Chh---hhhcccCcEEEc-cCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccc
Q 039922 306 LPE---TIAAMSLESLNL-NDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFL 381 (973)
Q Consensus 306 ~~~---~~~~~~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 381 (973)
.+. .+...+++.+++ ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|++|++++|++ +.+|..
T Consensus 251 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp~~- 325 (606)
T 3vq2_A 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFPTL- 325 (606)
T ss_dssp CGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCCCC-
T ss_pred ChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccccC-
Confidence 112 222336778888 77888888777 888899999999999987 556 788889999999999999 577744
Q ss_pred cccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCcccccc--CcccCCCCCccEEEeecCcccCCCCCCCCCCCCc
Q 039922 382 CFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGEL--PSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKL 459 (973)
Q Consensus 382 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L 459 (973)
.+++|+.|++++|+..+.. .+..+++|++|++++|.+++.. +..+..+++|+.|++++|++++ +|..+..+++|
T Consensus 326 -~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L 401 (606)
T 3vq2_A 326 -DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEEL 401 (606)
T ss_dssp -CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTC
T ss_pred -CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCC
Confidence 8889999999999665433 6778899999999999988763 7888899999999999999886 45888889999
Q ss_pred ceEeecCCcCCCCCc-hhhhcCCcCcEEeCcCCcccCCCccccccccccceeecccccccc-ccCcccCccccceeeeec
Q 039922 460 TGILINGNNFTGEVP-SQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG-ELPRNLNSLTALIVLNLS 537 (973)
Q Consensus 460 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls 537 (973)
+.|++++|++.+..| ..+..+++|++|++++|++++..|..++.+++|++|++++|++++ .+|..+..+++|+.|+|+
T Consensus 402 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls 481 (606)
T 3vq2_A 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481 (606)
T ss_dssp CEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred CeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECC
Confidence 999999999988777 678889999999999999998888889999999999999999987 478889999999999999
Q ss_pred cCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCCCCCcc---cccccccCCCCCCCC
Q 039922 538 TNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFDH---DLFISSLLDNPGLCS 613 (973)
Q Consensus 538 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~~~~---~~~~~~~~~n~~~c~ 613 (973)
+|++++..|..|..+++|++|+|++|++++.+|..+..+ .|+.|++++|+++ .+|..+.. ......+.+||+.|+
T Consensus 482 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccC
Confidence 999998888889999999999999999998889888888 8999999999998 56665432 255567888999998
Q ss_pred CCC
Q 039922 614 PDL 616 (973)
Q Consensus 614 ~~l 616 (973)
++.
T Consensus 561 c~~ 563 (606)
T 3vq2_A 561 CEH 563 (606)
T ss_dssp STT
T ss_pred Ccc
Confidence 865
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=556.94 Aligned_cols=518 Identities=22% Similarity=0.233 Sum_probs=291.1
Q ss_pred CccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCc
Q 039922 60 CNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD 139 (973)
Q Consensus 60 C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~ 139 (973)
|+|.+|.+ ...+++.|||+++.+++..|..|.++++|++|||++|.+.+.+++.+|.++++|++|+|++|.+.+..|+
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56666665 2345677777777777666777777777777777777666666666777777777777777777776677
Q ss_pred cccCCCCCCEEECcCCcCCCCCCcc--cCCCCcccEEecCCcccCCccc-ccccccccccEeeccCcCCCCCCCCccccC
Q 039922 140 FSREFANLQVLDLSRNNFSGDIPES--FGRFPVLKVLNLGGNLLSGLIP-SFLGNLTELTHFELGYNPLKSSPLPSSVGN 216 (973)
Q Consensus 140 ~~~~l~~L~~L~Ls~n~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 216 (973)
.|+.+++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.++.. .+..+..
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~-~~~~l~~ 170 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV-CEHELEP 170 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC-CSGGGHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee-CHHHccc
Confidence 7777777777777777777655544 6777777777777777766544 4567777777777777776543 3455555
Q ss_pred c--chhHHHhhccCcccccCCccccCCCC------CCEEEccCCcccccCCcCCCCC---CCCCEEEccCC---------
Q 039922 217 L--SKLENLWAAKANLIGEIPDSIGKLAF------LSNLDLSDNFLSGKIPHSFSGL---ASIEQIELFDN--------- 276 (973)
Q Consensus 217 l--~~L~~L~l~~n~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~n--------- 276 (973)
+ ++|+.|+++.|.+.+..|..++.+.+ |+.|++++|.+++..+..+... .+++.|.++.+
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 5 55666666666666666655555444 6666666666665555544332 34555555422
Q ss_pred cCcccCchhccCC--CccceeeccccccCCCChhhhhcc-cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCC
Q 039922 277 QLSGELPESLSNL--TTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKL 353 (973)
Q Consensus 277 ~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 353 (973)
.+.+..+..+..+ ++|+.|++++|.+++..+..+... +|+.|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 330 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence 2222222233332 445555555555554444444333 4555555555555555555555555555555555555444
Q ss_pred CCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCC
Q 039922 354 PDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLP 433 (973)
Q Consensus 354 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 433 (973)
|..+..+++|++|++++|++++..+..+..+++|+.|++++|.+++. ..+++|+.|++++|+++. +|.. ..
T Consensus 331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~~-l~~~---~~ 401 (844)
T 3j0a_A 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLVT-LPKI---NL 401 (844)
T ss_dssp SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCCC-CCCC---CT
T ss_pred HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCccc-cccc---cc
Confidence 55555555555555555555555555555555555555555555421 124455555555555552 2221 23
Q ss_pred CccEEEeecCcccCCCC-CCCCCCCCcceEeecCCcCCCCCch-hhhcCCcCcEEeCcCCccc-----CCCccccccccc
Q 039922 434 EVDFFEMYNNRFEGSIS-PSISNAPKLTGILINGNNFTGEVPS-QICTLRQLQAVDLSQNRFS-----GHLPTCITQLNK 506 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~ 506 (973)
+++.|++++|++++... ..+..+++|+.|++++|++++..+. .+..+++|+.|+|++|.++ +..|..|..+++
T Consensus 402 ~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~ 481 (844)
T 3j0a_A 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481 (844)
T ss_dssp TCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCC
T ss_pred ccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccc
Confidence 45555555555554321 1133455555555555555543222 2333455555555555554 233344555555
Q ss_pred cceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcccccceeccCC
Q 039922 507 LQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHN 586 (973)
Q Consensus 507 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N 586 (973)
|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|..+. .|+.+++++|
T Consensus 482 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~--~L~~l~l~~N 557 (844)
T 3j0a_A 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV--SLSVLDITHN 557 (844)
T ss_dssp EECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS--SCCEEEEEEE
T ss_pred ccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC--CcCEEEecCC
Confidence 55555555555555555555555555555555555544444433 5555555555555555554432 3455555555
Q ss_pred cCcccCC
Q 039922 587 KLYGEVP 593 (973)
Q Consensus 587 ~l~g~~p 593 (973)
++.+..+
T Consensus 558 p~~C~c~ 564 (844)
T 3j0a_A 558 KFICECE 564 (844)
T ss_dssp CCCCSSS
T ss_pred Ccccccc
Confidence 5555444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-58 Score=550.80 Aligned_cols=514 Identities=18% Similarity=0.256 Sum_probs=347.3
Q ss_pred hhHHHHHHHhhhccCCCCC-------ccCCccCCCCCCCCcc---ceeEEcCCCCceeEeecCCCccCCCCCCCccCccc
Q 039922 28 GDAEILIRVKSDQLDDPNR-------KLGDWVRTSQQSPCNW---TGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRT 97 (973)
Q Consensus 28 ~~~~~l~~~k~~~~~d~~~-------~~~sw~~~~~~~~C~w---~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~ 97 (973)
.|++||.+||++.-.+.+. ..++|.. +.+||.| +||+|+.. +||+.|+|++++++|.+|++|++|++
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~--~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF--NKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCC--SSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC--CCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence 5899999999997443333 2348964 4689999 99999875 79999999999999999999999999
Q ss_pred cceeccCCCcc------cC------cCCcCcCCCcCCccEEecccccccccCCccccC-CCCCCEEECcCCcCCCCCCcc
Q 039922 98 LRNLNLSDNYF------NG------TLSSQSLSPCFHLQVLALDYNVFIGELPDFSRE-FANLQVLDLSRNNFSGDIPES 164 (973)
Q Consensus 98 L~~L~Ls~n~l------~~------~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~p~~ 164 (973)
|++|||++|.+ .| .+|.. .+..|+ +++++|.+.+.+|..+.. +..+..+++....+..
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~---~~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~----- 177 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDE---QKQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK----- 177 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHH---HHHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC-----
T ss_pred ceEEECcCCccccCCccccccccccCchHH---HHHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc-----
Confidence 99999999987 22 22221 144566 677777766666655542 2233334444333321
Q ss_pred cCCCCcccEEecC--CcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCcccc--C
Q 039922 165 FGRFPVLKVLNLG--GNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIG--K 240 (973)
Q Consensus 165 ~~~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~--~ 240 (973)
.....++.+.+. +|++++ +|..|+++++|++|+|++|.++...++.... + ...+...+.+|+.++ +
T Consensus 178 -~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~--~------~~~~~~~~~ip~~l~~~~ 247 (636)
T 4eco_A 178 -SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE--N------ENSEYAQQYKTEDLKWDN 247 (636)
T ss_dssp -CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS--C------TTSHHHHHHTTSCCCGGG
T ss_pred -ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccc--c------cccchhcccCchhhhhcc
Confidence 112233333343 578888 7888999999999999999876521111000 0 011122345888888 9
Q ss_pred CCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCc-Ccc-cCchhccCC------CccceeeccccccCCCChh--hh
Q 039922 241 LAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQ-LSG-ELPESLSNL------TTLLRLDISQNNLTGNLPE--TI 310 (973)
Q Consensus 241 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~~~~--~~ 310 (973)
+++|++|+|++|.+.+.+|..|+++++|++|++++|+ ++| .+|..++.+ ++|+.|++++|+++ .+|. .+
T Consensus 248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l 326 (636)
T 4eco_A 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL 326 (636)
T ss_dssp CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH
T ss_pred cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh
Confidence 9999999999999999999999999999999999998 888 788888776 88888888888888 6665 55
Q ss_pred hcc-cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCC-ccceeeecccccccCCccccccC--C
Q 039922 311 AAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSN-LEYFDVSTNDFTGELPRFLCFRN--K 386 (973)
Q Consensus 311 ~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~--~ 386 (973)
... +|+.|++++|+++|.+| .+..+++|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+.... +
T Consensus 327 ~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~ 403 (636)
T 4eco_A 327 QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV 403 (636)
T ss_dssp TTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSC
T ss_pred ccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCc
Confidence 544 68888888888887777 7788888888888888888 77777888888 888888888887 6666666544 6
Q ss_pred chhhhcccCccCCCCCCccC-------CcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCC--
Q 039922 387 LQCIIIFNNRFSGKIPESYG-------ECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAP-- 457 (973)
Q Consensus 387 L~~L~L~~n~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-- 457 (973)
|+.|++++|++.+..|..+. .+++|++|++++|++++..+..+..+++|+.|+|++|+++...+..+....
T Consensus 404 L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~ 483 (636)
T 4eco_A 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483 (636)
T ss_dssp EEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEE
T ss_pred cCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccccc
Confidence 77777777777777777776 666777777777777754444555677777777777777733222222222
Q ss_pred -----CcceEeecCCcCCCCCchhhh--cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCcccc
Q 039922 458 -----KLTGILINGNNFTGEVPSQIC--TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTA 530 (973)
Q Consensus 458 -----~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 530 (973)
+|+.|++++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+
T Consensus 484 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~-------------- 547 (636)
T 4eco_A 484 FKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR-------------- 547 (636)
T ss_dssp CTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB--------------
T ss_pred ccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc--------------
Confidence 5666666666666 4555554 56666666666666664 55556666666666663221
Q ss_pred ceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcccccceeccCCcCc
Q 039922 531 LIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLY 589 (973)
Q Consensus 531 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~l~ 589 (973)
++++|++.+.+|..+.++++|++|+|++|++ +.+|..+. -.|+.|++++|++.
T Consensus 548 ----~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 548 ----DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNI 600 (636)
T ss_dssp ----CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTC
T ss_pred ----ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCc
Confidence 1134444445555555555555555555555 34554433 24555555555444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=538.38 Aligned_cols=499 Identities=20% Similarity=0.204 Sum_probs=417.1
Q ss_pred eeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCc
Q 039922 100 NLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179 (973)
Q Consensus 100 ~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 179 (973)
.++.++..++ .+|.. +. .++++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 16 ~~~c~~~~l~-~iP~~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGT-LP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp EEECTTSCCS-SCCTT-SC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEECCCCCcc-cCcCC-CC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 4677777776 56643 33 26899999999999999999999999999999999999988999999999999999999
Q ss_pred ccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCC
Q 039922 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP 259 (973)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 259 (973)
++++..|..|+++++|++|+|++|+++.++ |..++++++|++|++++|.+.+..++.+..+++|++|++++|.+++..|
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSID-FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGG-GSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred cccccChhhhcccccccEeeccccCcccCC-cchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence 999999999999999999999999998742 4567788888888888888777544444457888888888888887777
Q ss_pred cCCCCCCCCC--EEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcc---cCcEEEccCC---cCCCCCCc
Q 039922 260 HSFSGLASIE--QIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM---SLESLNLNDN---YFTGEIPE 331 (973)
Q Consensus 260 ~~~~~l~~L~--~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~---~L~~L~L~~N---~l~~~~p~ 331 (973)
..|+.+++|+ .|++++|++++..|..+.. .+|+.|++++|. ..+..+... .++.+.+... ......+.
T Consensus 171 ~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~ 246 (606)
T 3t6q_A 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246 (606)
T ss_dssp HHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGG
T ss_pred hhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChh
Confidence 7777888887 7888888888766665544 578888888776 223333222 3344443321 11122233
Q ss_pred cccCCC--ccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcc
Q 039922 332 SLASNP--NLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECK 409 (973)
Q Consensus 332 ~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 409 (973)
.+..+. +|+.|++++|.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++.+..|..+..++
T Consensus 247 ~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 325 (606)
T 3t6q_A 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325 (606)
T ss_dssp GGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCT
T ss_pred HhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccC
Confidence 444443 7999999999999888888999999999999999999 7888899999999999999999988899999999
Q ss_pred eeeEEEccCCccccccCc-ccCCCCCccEEEeecCcccCCC--CCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEE
Q 039922 410 TLNYLRFGGNELQGELPS-KFWGLPEVDFFEMYNNRFEGSI--SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAV 486 (973)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 486 (973)
+|++|++++|.+.+..+. .+..+++|+.|++++|++++.. +..+..+++|++|++++|.+.+..|..+..+++|++|
T Consensus 326 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 405 (606)
T 3t6q_A 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405 (606)
T ss_dssp TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEE
T ss_pred cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeE
Confidence 999999999999866654 5999999999999999999876 7889999999999999999999999999999999999
Q ss_pred eCcCCcccCCCccc-cccccccceeeccccccccccCcccCccccceeeeeccCcccCC---CCccccccccccEEecCC
Q 039922 487 DLSQNRFSGHLPTC-ITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGT---IPPELGNLAVLTSLDLSS 562 (973)
Q Consensus 487 ~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~ 562 (973)
++++|++++..|.. +..+++|+.|++++|++++..|..+..+++|+.|+|++|++++. .+..+..+++|++|+|++
T Consensus 406 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~ 485 (606)
T 3t6q_A 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485 (606)
T ss_dssp ECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTT
T ss_pred ECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCC
Confidence 99999999876654 89999999999999999999999999999999999999999873 346799999999999999
Q ss_pred CcCccccChhhhcc-cccceeccCCcCcccCCCCCcc--cccccccCCCC
Q 039922 563 NLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFDH--DLFISSLLDNP 609 (973)
Q Consensus 563 N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~~~~--~~~~~~~~~n~ 609 (973)
|++++..|..+..+ .|+.|++++|++++.+|..+.. .. ...+.+|.
T Consensus 486 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~ 534 (606)
T 3t6q_A 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSC
T ss_pred CccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCc
Confidence 99999999999998 9999999999999998876642 23 34445554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=545.35 Aligned_cols=498 Identities=21% Similarity=0.257 Sum_probs=293.3
Q ss_pred hhhHHHHHHHhhhccCCCCCccCCccCCC---CCCC--Ccc------------ceeEEcCCCCceeEeecCCCccCCCCC
Q 039922 27 HGDAEILIRVKSDQLDDPNRKLGDWVRTS---QQSP--CNW------------TGITCETQNQSVDGIDLSGFDLSGGFP 89 (973)
Q Consensus 27 ~~~~~~l~~~k~~~~~d~~~~~~sw~~~~---~~~~--C~w------------~gv~c~~~~~~v~~l~l~~~~l~g~~~ 89 (973)
..|++||++||+++ .|| +|..+. ..+| |.| +||+|+. .+||+.|+|++++++|.+|
T Consensus 268 ~~d~~ALl~~k~~l-~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip 340 (876)
T 4ecn_A 268 IKDYKALKAIWEAL-DGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVP 340 (876)
T ss_dssp HHHHHHHHHHHHHT-TGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEEC
T ss_pred hHHHHHHHHHHHHc-CCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCc
Confidence 45899999999997 666 797543 2355 999 9999987 5799999999999999999
Q ss_pred CCccCccccceecc-CCCcccCcCCcCcCCC---cCC--ccEEecc----------ccccccc-----------CCcccc
Q 039922 90 NGFCRIRTLRNLNL-SDNYFNGTLSSQSLSP---CFH--LQVLALD----------YNVFIGE-----------LPDFSR 142 (973)
Q Consensus 90 ~~~~~l~~L~~L~L-s~n~l~~~~~~~~l~~---l~~--L~~L~L~----------~n~~~~~-----------~~~~~~ 142 (973)
++|++|++|++||| ++|.+.|..+...... +.. ++.+... ...+.+. .+....
T Consensus 341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 99999999999999 9999887744321111 000 0000000 0000000 000001
Q ss_pred CCCCCCEEECcC--CcCCCCCCcccCCCCcccEEecCCcccCC-----------------ccccccc--ccccccEeecc
Q 039922 143 EFANLQVLDLSR--NNFSGDIPESFGRFPVLKVLNLGGNLLSG-----------------LIPSFLG--NLTELTHFELG 201 (973)
Q Consensus 143 ~l~~L~~L~Ls~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~L~Ls 201 (973)
....++.+.+.. |++++ +|..|+++++|++|+|++|++++ .+|..++ ++++|++|+|+
T Consensus 421 ~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred cccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 112222222222 44444 45555555555555555555554 2555555 66666666665
Q ss_pred CcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCc-ccc-cCCcCCC-------CCCCCCEEE
Q 039922 202 YNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNF-LSG-KIPHSFS-------GLASIEQIE 272 (973)
Q Consensus 202 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~~-------~l~~L~~L~ 272 (973)
+|.+.. .+|..++++++|++|+|++|+ +++ .+|..++ .+++|++|+
T Consensus 500 ~N~l~~-------------------------~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~ 554 (876)
T 4ecn_A 500 NCPNMT-------------------------QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554 (876)
T ss_dssp SCTTCC-------------------------SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEE
T ss_pred CCCCCc-------------------------cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEE
Confidence 554422 233334444444444444443 433 3333222 222444455
Q ss_pred ccCCcCcccCch--hccCCCccceeeccccccCCCChhhhhc-ccCcEEEccCCcCCCCCCccccCCCc-cceeeecccc
Q 039922 273 LFDNQLSGELPE--SLSNLTTLLRLDISQNNLTGNLPETIAA-MSLESLNLNDNYFTGEIPESLASNPN-LVQLKLFNNS 348 (973)
Q Consensus 273 L~~n~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~ 348 (973)
+++|+++ .+|. .+.++++|+.|+|++|.++ .+| .+.. .+|+.|+|++|+++ .+|..+..+++ |+.|+|++|+
T Consensus 555 Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 630 (876)
T 4ecn_A 555 MGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK 630 (876)
T ss_dssp CCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred eeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCC
Confidence 5555444 4444 4445555555555555444 333 2221 23444444555554 45555666666 6666666666
Q ss_pred ccCCCCCCccCCCC--ccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccC--CcceeeEEEccCCccccc
Q 039922 349 FSGKLPDDLGKYSN--LEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYG--ECKTLNYLRFGGNELQGE 424 (973)
Q Consensus 349 l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~ 424 (973)
++ .+|..+..++. |+.|+|++|++++.+|... ..+. .+.+|++|+|++|+++..
T Consensus 631 L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~---------------------~~l~~~~~~~L~~L~Ls~N~L~~l 688 (876)
T 4ecn_A 631 LK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS---------------------CSMDDYKGINASTVTLSYNEIQKF 688 (876)
T ss_dssp CC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCS---------------------SCTTTCCCCCEEEEECCSSCCCSC
T ss_pred CC-cCchhhhccccCCCCEEECcCCcCCCccccch---------------------hhhccccCCCcCEEEccCCcCCcc
Confidence 66 55665555443 6666666666665544321 1111 223566666666666633
Q ss_pred cCcccCCCCCccEEEeecCcccCCCCCCCC--------CCCCcceEeecCCcCCCCCchhhh--cCCcCcEEeCcCCccc
Q 039922 425 LPSKFWGLPEVDFFEMYNNRFEGSISPSIS--------NAPKLTGILINGNNFTGEVPSQIC--TLRQLQAVDLSQNRFS 494 (973)
Q Consensus 425 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--------~~~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~ 494 (973)
.+..+..+++|+.|+|++|+++. +|..+. ++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|+
T Consensus 689 p~~~~~~l~~L~~L~Ls~N~L~~-ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~ 766 (876)
T 4ecn_A 689 PTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS 766 (876)
T ss_dssp CHHHHHTTCCCSEEECCSCCCSC-CCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCS
T ss_pred CHHHHccCCCCCEEECCCCcCCc-cChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCC
Confidence 33333466666666666666663 333322 2237777788877777 6677776 7778888888888887
Q ss_pred CCCccccccccccceeeccc------cccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccc
Q 039922 495 GHLPTCITQLNKLQQLELQE------NMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 495 ~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
+ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+.|||++|++...
T Consensus 767 ~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i 842 (876)
T 4ecn_A 767 S-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISI 842 (876)
T ss_dssp S-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEE
T ss_pred c-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCcc
Confidence 5 677777888888887765 777777888888888888888888888 57777765 5788888888887755
Q ss_pred cChhhhcc-cccceeccCCcCc
Q 039922 569 IPLELTKL-KLNQFNISHNKLY 589 (973)
Q Consensus 569 ~p~~l~~l-~l~~l~l~~N~l~ 589 (973)
-+..+... .+..+.+++|++.
T Consensus 843 ~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 843 DVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp ECGGGHHHHHTTCCEEECCTTS
T ss_pred ChHHccccccchheeecCCCcc
Confidence 55555444 5666666666554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=554.99 Aligned_cols=524 Identities=23% Similarity=0.221 Sum_probs=455.5
Q ss_pred eecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccC-CccccCCCCCCEEECcCC
Q 039922 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL-PDFSREFANLQVLDLSRN 155 (973)
Q Consensus 77 l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~-~~~~~~l~~L~~L~Ls~n 155 (973)
.|.++++++. +|. -.++|++|||++|.++ .+++.+|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|
T Consensus 9 ~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~-~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 9 AFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEESCCCSSC-CCS---SCTTCCEEEEESCCCC-EECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEccCCCCCC-CCC---CCCCcCEEECCCCcCC-ccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 3445566664 454 4578999999999998 555678999999999999999666555 889999999999999999
Q ss_pred cCCCCCCcccCCCCcccEEecCCcccCCccccc--ccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCccccc
Q 039922 156 NFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSF--LGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGE 233 (973)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 233 (973)
.+++..|..|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.++....+..++++++|++|++++|.+.+.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999999999999876655 999999999999999999877778899999999999999999999
Q ss_pred CCccccCC--CCCCEEEccCCcccccCCcCCCCCCC------CCEEEccCCcCcccCchhccCC---Cccceeecccc--
Q 039922 234 IPDSIGKL--AFLSNLDLSDNFLSGKIPHSFSGLAS------IEQIELFDNQLSGELPESLSNL---TTLLRLDISQN-- 300 (973)
Q Consensus 234 ~p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~------L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~Ls~N-- 300 (973)
.|..++.+ ++|+.|++++|.+.+..|..+..+.+ |+.|++++|++++..+..+... .+++.|+++.+
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 99999888 89999999999999988888777665 9999999999998888776653 57788887733
Q ss_pred -------ccCCCChhhhhc---ccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeec
Q 039922 301 -------NLTGNLPETIAA---MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVST 370 (973)
Q Consensus 301 -------~l~~~~~~~~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 370 (973)
.+.+..+..+.. .+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++
T Consensus 244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 323 (844)
T 3j0a_A 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323 (844)
T ss_dssp BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEES
T ss_pred cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCC
Confidence 333333333333 3799999999999999999999999999999999999998899999999999999999
Q ss_pred ccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCC
Q 039922 371 NDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSIS 450 (973)
Q Consensus 371 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 450 (973)
|++++..|..+..+++|+.|++++|++.+..+..|..+++|++|+|++|.+++. ..+++|+.|++++|+++.. |
T Consensus 324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~~l-~ 397 (844)
T 3j0a_A 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLVTL-P 397 (844)
T ss_dssp CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCCCC-C
T ss_pred CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcccc-c
Confidence 999999999999999999999999999988888999999999999999999853 3388999999999999844 3
Q ss_pred CCCCCCCCcceEeecCCcCCCCC-chhhhcCCcCcEEeCcCCcccCCCcc-ccccccccceeeccccccc-----cccCc
Q 039922 451 PSISNAPKLTGILINGNNFTGEV-PSQICTLRQLQAVDLSQNRFSGHLPT-CITQLNKLQQLELQENMFT-----GELPR 523 (973)
Q Consensus 451 ~~~~~~~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~ 523 (973)
.. ..+++.|++++|++++.. +..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..|.
T Consensus 398 ~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~ 474 (844)
T 3j0a_A 398 KI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474 (844)
T ss_dssp CC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred cc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence 32 567999999999999643 33466899999999999999965443 4567899999999999997 45567
Q ss_pred ccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcccccceeccCCcCcccCCCCCccccccc
Q 039922 524 NLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFIS 603 (973)
Q Consensus 524 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p~~~~~~~~~~ 603 (973)
.|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ..|+.|++++|+|+|.+|..|. .+...
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~~-~L~~l 552 (844)
T 3j0a_A 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVFV-SLSVL 552 (844)
T ss_dssp CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCCS-SCCEE
T ss_pred hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHhC-CcCEE
Confidence 799999999999999999998899999999999999999999976665554 5899999999999999998774 46667
Q ss_pred ccCCCCCCCCCCC
Q 039922 604 SLLDNPGLCSPDL 616 (973)
Q Consensus 604 ~~~~n~~~c~~~l 616 (973)
.+.+||+.|++++
T Consensus 553 ~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 553 DITHNKFICECEL 565 (844)
T ss_dssp EEEEECCCCSSSC
T ss_pred EecCCCccccccc
Confidence 7889999997765
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=532.12 Aligned_cols=510 Identities=19% Similarity=0.200 Sum_probs=451.8
Q ss_pred CceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEE
Q 039922 72 QSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLD 151 (973)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~ 151 (973)
.+++.|+|+++.+++..+.+|.++++|++|+|++|+++ .+++.+|.++++|++|+|++|.+.+..|..|+.+++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCccc-ccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 46899999999999988889999999999999999998 56667899999999999999999999999999999999999
Q ss_pred CcCCcCCCCCCcccCCCCcccEEecCCcccCC-cccccccccccccEeeccCcCCCCCCCCccccCcchhH----HHhhc
Q 039922 152 LSRNNFSGDIPESFGRFPVLKVLNLGGNLLSG-LIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLE----NLWAA 226 (973)
Q Consensus 152 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~----~L~l~ 226 (973)
|++|.+++..|..++++++|++|+|++|++++ .+|..|+++++|++|+|++|+++.+ .|..++.+++|+ .|+++
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~~l~~L~l~ 189 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI-TVNDLQFLRENPQVNLSLDMS 189 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE-CTTTTHHHHHCTTCCCEEECT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec-Chhhhhhhhccccccceeecc
Confidence 99999998888899999999999999999987 5699999999999999999999875 366788888876 69999
Q ss_pred cCcccccCCccccCCCCCCEEEccCCccc-ccCCcCCCCCCCCCEEEccCCcCcc------c---CchhccCCCccceee
Q 039922 227 KANLIGEIPDSIGKLAFLSNLDLSDNFLS-GKIPHSFSGLASIEQIELFDNQLSG------E---LPESLSNLTTLLRLD 296 (973)
Q Consensus 227 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~------~---~p~~l~~l~~L~~L~ 296 (973)
+|.+.+..+..+... +|+.|++++|.++ +..|..+.++++|+.+++..+.+.+ . .+..+..+ +++.++
T Consensus 190 ~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l-~l~~l~ 267 (606)
T 3vq2_A 190 LNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV-TIDEFR 267 (606)
T ss_dssp TCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGS-EEEEEE
T ss_pred CCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhc-cHhhee
Confidence 999987766666555 8999999999997 4677889999999999886655432 1 12223333 466777
Q ss_pred c-cccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccc
Q 039922 297 I-SQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTG 375 (973)
Q Consensus 297 L-s~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 375 (973)
+ ..|.+++..|......+|+.|++++|.++ .+| .+..+++|+.|++++|++ +.+| .+ .+++|++|++++|+..+
T Consensus 268 l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~ 342 (606)
T 3vq2_A 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSI 342 (606)
T ss_dssp ECCCTTCCGGGGSCGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCE
T ss_pred ccccccccccccccccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCcc
Confidence 7 77888888887334458999999999997 456 888999999999999999 5888 45 99999999999997665
Q ss_pred cCCccccccCCchhhhcccCccCCC--CCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCC-CC
Q 039922 376 ELPRFLCFRNKLQCIIIFNNRFSGK--IPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSIS-PS 452 (973)
Q Consensus 376 ~~~~~~~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~ 452 (973)
.. .+..+++|+.|++++|++++. .|..+..+++|++|++++|.+++ .|..|..+++|+.|++++|++.+..+ ..
T Consensus 343 ~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 419 (606)
T 3vq2_A 343 SF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSA 419 (606)
T ss_dssp EC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTT
T ss_pred ch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhh
Confidence 44 567899999999999999876 37889999999999999999986 55889999999999999999999888 78
Q ss_pred CCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccC-CCccccccccccceeeccccccccccCcccCccccc
Q 039922 453 ISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSG-HLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL 531 (973)
Q Consensus 453 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 531 (973)
+..+++|+.|++++|.+++..|..+..+++|++|++++|++++ .+|..|+.+++|+.|+|++|++++..|..+..+++|
T Consensus 420 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 499 (606)
T 3vq2_A 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499 (606)
T ss_dssp TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccC
Confidence 9999999999999999999999999999999999999999997 479999999999999999999999999999999999
Q ss_pred eeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc--cccceeccCCcCcccCCC
Q 039922 532 IVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL--KLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 532 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l--~l~~l~l~~N~l~g~~p~ 594 (973)
+.|+|++|++++.+|..|.++++|++|||++|+++ .+|..+..+ .|+.+++++|++.+..+.
T Consensus 500 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999999988999999999999999999999 788888887 499999999999997774
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=501.32 Aligned_cols=496 Identities=20% Similarity=0.229 Sum_probs=434.3
Q ss_pred CCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCC
Q 039922 88 FPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGR 167 (973)
Q Consensus 88 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~ 167 (973)
+|..+. +++++|||++|+++ .+++.+|.++++|++|+|++|.+.+..+..|+.+++|++|+|++|.+++..|..|++
T Consensus 22 ip~~l~--~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (570)
T 2z63_A 22 IPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (570)
T ss_dssp CCSSSC--SSCCEEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred cCCCcc--ccccEEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence 454443 47899999999998 556678999999999999999998888889999999999999999999888889999
Q ss_pred CCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCC---
Q 039922 168 FPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFL--- 244 (973)
Q Consensus 168 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L--- 244 (973)
+++|++|+|++|++++..+..|+++++|++|+|++|.++.+.+|..++++++|++|++++|.+.+..|..++.+++|
T Consensus 99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~ 178 (570)
T 2z63_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (570)
T ss_dssp CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTC
T ss_pred ccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchh
Confidence 99999999999999987766799999999999999999887788999999999999999999998888889888888
Q ss_pred -CEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcc-cCchhccCCCccceeeccccccCC------CC---hhhhhcc
Q 039922 245 -SNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSG-ELPESLSNLTTLLRLDISQNNLTG------NL---PETIAAM 313 (973)
Q Consensus 245 -~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~------~~---~~~~~~~ 313 (973)
+.|++++|.+++..|..|... +|+.|++++|.... .++..+..++.++.+++..+.+.. .. .......
T Consensus 179 ~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l 257 (570)
T 2z63_A 179 NLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257 (570)
T ss_dssp CCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGS
T ss_pred hhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccccc
Confidence 899999999998888888776 89999999986542 456677788888777665443321 11 1222333
Q ss_pred cCcEEEccCC-cCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhc
Q 039922 314 SLESLNLNDN-YFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIII 392 (973)
Q Consensus 314 ~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 392 (973)
.++.+++++| .+.+.+|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|+.|++
T Consensus 258 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l 332 (570)
T 2z63_A 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTF 332 (570)
T ss_dssp EEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEE
T ss_pred chhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeC
Confidence 6889999998 888899999999999999999999998 688888888 9999999999998 5555 47889999999
Q ss_pred ccCccCCCCCCccCCcceeeEEEccCCcccccc--CcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCC
Q 039922 393 FNNRFSGKIPESYGECKTLNYLRFGGNELQGEL--PSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT 470 (973)
Q Consensus 393 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~ 470 (973)
++|.+.+..+. ..+++|++|++++|.+++.. +..+.++++|+.|++++|++.+..+. +..+++|+.|++++|.+.
T Consensus 333 ~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~ 409 (570)
T 2z63_A 333 TSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLK 409 (570)
T ss_dssp ESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEE
T ss_pred cCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccc
Confidence 99999877665 78999999999999998765 77899999999999999999976555 999999999999999999
Q ss_pred CCCc-hhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccc-cccCcccCccccceeeeeccCcccCCCCcc
Q 039922 471 GEVP-SQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFT-GELPRNLNSLTALIVLNLSTNQLTGTIPPE 548 (973)
Q Consensus 471 ~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 548 (973)
+..| ..+..+++|++|++++|++++..|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++..|..
T Consensus 410 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 489 (570)
T 2z63_A 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489 (570)
T ss_dssp SCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred cccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhh
Confidence 8766 57889999999999999999999999999999999999999998 689999999999999999999999888999
Q ss_pred ccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCCCC
Q 039922 549 LGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSD 595 (973)
Q Consensus 549 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~ 595 (973)
|..+++|++|+|++|++++..|..+..+ .|+.|++++|+++|.+|..
T Consensus 490 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 9999999999999999998888888888 8999999999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=491.67 Aligned_cols=485 Identities=22% Similarity=0.287 Sum_probs=278.0
Q ss_pred CCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCC
Q 039922 59 PCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELP 138 (973)
Q Consensus 59 ~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~ 138 (973)
.|.|.|| |+... ++++ .+|+.+. ++|++|+|++|+++ .+++..|.++++|++|+|++|.+.+..|
T Consensus 3 ~C~~~~~-c~~~~----------~~l~-~ip~~~~--~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 67 (549)
T 2z81_A 3 SCDASGV-CDGRS----------RSFT-SIPSGLT--AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEG 67 (549)
T ss_dssp EECTTSE-EECTT----------SCCS-SCCSCCC--TTCCEEECCSSCCC-EECSSTTSSCTTCCEEECTTSCCCEECT
T ss_pred cCCCCce-EECCC----------Cccc-cccccCC--CCccEEECcCCccC-ccChhhhhcCCcccEEECCCCCcCccCh
Confidence 4999999 96543 3333 3555543 68888888888887 3444567888888888888888877777
Q ss_pred ccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCc-ccccccccccccEeeccCcCCCCCCCCccccCc
Q 039922 139 DFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGNLTELTHFELGYNPLKSSPLPSSVGNL 217 (973)
Q Consensus 139 ~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l 217 (973)
+.|+.+++|++|+|++|.+++..|..|+++++|++|+|++|++++. .|..++++++|++|++++|.+.....+..+.
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~-- 145 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA-- 145 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT--
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhh--
Confidence 7788888888888888888776666677888888888888887753 4567777777888887777632211123444
Q ss_pred chhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeec
Q 039922 218 SKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDI 297 (973)
Q Consensus 218 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 297 (973)
++++|++|++++|.+++..|..++.+++|++|+++.|.+.......+..+++|+.|++
T Consensus 146 ----------------------~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 203 (549)
T 2z81_A 146 ----------------------GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203 (549)
T ss_dssp ----------------------TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEE
T ss_pred ----------------------cccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEc
Confidence 4445555555555555444555555555555555555444221112233445555555
Q ss_pred cccccCCCC--hhhh--hcccCcEEEccCCcCCCCCC----ccccCCCccceeeeccccccCCC------CCCccCCCCc
Q 039922 298 SQNNLTGNL--PETI--AAMSLESLNLNDNYFTGEIP----ESLASNPNLVQLKLFNNSFSGKL------PDDLGKYSNL 363 (973)
Q Consensus 298 s~N~l~~~~--~~~~--~~~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~------p~~l~~l~~L 363 (973)
++|++++.. +..+ ...+|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+.. ...+..+.+|
T Consensus 204 ~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L 283 (549)
T 2z81_A 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283 (549)
T ss_dssp ESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTC
T ss_pred cCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccc
Confidence 555554321 1011 11245555555555443222 22234455555555555554321 1123445555
Q ss_pred cceeeeccccccc-----CCccccccCCchhhhcccCccCCCCCCcc-CCcceeeEEEccCCccccccC---cccCCCCC
Q 039922 364 EYFDVSTNDFTGE-----LPRFLCFRNKLQCIIIFNNRFSGKIPESY-GECKTLNYLRFGGNELQGELP---SKFWGLPE 434 (973)
Q Consensus 364 ~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~ 434 (973)
+.|+++++.+... ++..+....+|+.|++++|++. .+|..+ ..+++|++|++++|++++..| ..+..+++
T Consensus 284 ~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~ 362 (549)
T 2z81_A 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362 (549)
T ss_dssp CEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTT
T ss_pred ccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhcccc
Confidence 5555555544321 1122233345556666666654 344433 355666666666666655442 23455666
Q ss_pred ccEEEeecCcccCCCC--CCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeec
Q 039922 435 VDFFEMYNNRFEGSIS--PSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLEL 512 (973)
Q Consensus 435 L~~L~L~~N~l~~~~~--~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (973)
|+.|++++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+. ++|+.|+|
T Consensus 363 L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~L 438 (549)
T 2z81_A 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDV 438 (549)
T ss_dssp CCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEEC
T ss_pred CcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEEC
Confidence 6666666666654322 33555666666666666666 45555666666666666666665 3444332 45666666
Q ss_pred cccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCccc
Q 039922 513 QENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGE 591 (973)
Q Consensus 513 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~ 591 (973)
++|+|++.+ ..+++|++|+|++|+|+ .+|. ...+++|++|||++|++++.+|..+..+ .|+.|++++|+++|.
T Consensus 439 s~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 439 SNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred CCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 666666432 35566666666666666 4554 3456666666666666666555556665 666666666666665
Q ss_pred CC
Q 039922 592 VP 593 (973)
Q Consensus 592 ~p 593 (973)
+|
T Consensus 513 ~~ 514 (549)
T 2z81_A 513 CP 514 (549)
T ss_dssp HH
T ss_pred Cc
Confidence 55
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=482.88 Aligned_cols=490 Identities=21% Similarity=0.237 Sum_probs=426.0
Q ss_pred CceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEE
Q 039922 72 QSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLD 151 (973)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~ 151 (973)
.+++.|+|+++.+++..+.+|.++++|++|||++|+++ .+++.+|.++++|++|+|++|.+.+..|..|+.+++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCC-ccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 46889999999999988889999999999999999998 56778899999999999999999998899999999999999
Q ss_pred CcCCcCCCCCCcccCCCCcccEEecCCcccCCc-ccccccccccccEeeccCcCCCCCCCCccccCcchh----HHHhhc
Q 039922 152 LSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKL----ENLWAA 226 (973)
Q Consensus 152 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L----~~L~l~ 226 (973)
+++|++++..+..++++++|++|+|++|.+++. +|..|+++++|++|++++|+++.. .+..++.+++| +.|+++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI-YCTDLRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE-CGGGGHHHHTCTTCCCEEECT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee-cHHHccchhccchhhhhcccC
Confidence 999999977666799999999999999999974 699999999999999999999764 35678888888 788999
Q ss_pred cCcccccCCccccCCCCCCEEEccCCcccc-cCCcCCCCCCCCCEEEccCCcC------cccCchhccCCC--ccceeec
Q 039922 227 KANLIGEIPDSIGKLAFLSNLDLSDNFLSG-KIPHSFSGLASIEQIELFDNQL------SGELPESLSNLT--TLLRLDI 297 (973)
Q Consensus 227 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l------~~~~p~~l~~l~--~L~~L~L 297 (973)
+|.+.+..|..+... +|+.|++++|.... .++..+.++++++.+.+..+.+ .......+..+. .++.+++
T Consensus 186 ~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 264 (570)
T 2z63_A 186 LNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264 (570)
T ss_dssp TCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred CCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence 999999888888766 89999999986442 3455667777777766543322 212222333333 3577788
Q ss_pred ccc-ccCCCChhhhhcc-cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccc
Q 039922 298 SQN-NLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTG 375 (973)
Q Consensus 298 s~N-~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 375 (973)
++| .+.+..|..+... +|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|++|++++|.+.+
T Consensus 265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~ 339 (570)
T 2z63_A 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGN 339 (570)
T ss_dssp EETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCC
T ss_pred hcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccc
Confidence 877 7777777777664 7999999999998 678888888 9999999999998 5665 578899999999999887
Q ss_pred cCCccccccCCchhhhcccCccCCCC--CCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCC-CC
Q 039922 376 ELPRFLCFRNKLQCIIIFNNRFSGKI--PESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSIS-PS 452 (973)
Q Consensus 376 ~~~~~~~~l~~L~~L~L~~n~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~ 452 (973)
..+. ..+++|+.|++++|++.+.. |..+..+++|++|++++|.+.+..+. +..+++|+.|++++|++.+..+ ..
T Consensus 340 ~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~ 416 (570)
T 2z63_A 340 AFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSV 416 (570)
T ss_dssp BCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCT
T ss_pred cccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhh
Confidence 7665 77899999999999998654 67788999999999999999976665 9999999999999999998776 57
Q ss_pred CCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCccc-CCCccccccccccceeeccccccccccCcccCccccc
Q 039922 453 ISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFS-GHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL 531 (973)
Q Consensus 453 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 531 (973)
+..+++|++|++++|.+.+..|..+..+++|++|++++|+++ +.+|..+..+++|+.|+|++|++++..|..|..+++|
T Consensus 417 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 496 (570)
T 2z63_A 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496 (570)
T ss_dssp TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCC
Confidence 899999999999999999999999999999999999999998 5799999999999999999999999989999999999
Q ss_pred eeeeeccCcccCCCCccccccccccEEecCCCcCccccChh
Q 039922 532 IVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLE 572 (973)
Q Consensus 532 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 572 (973)
+.|+|++|++++..|..|.++++|+.|++++|++++..|..
T Consensus 497 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999999999888888999999999999999999988853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=436.36 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=214.7
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
++|...+.||+|+||+||+|++. +++.||||++.. ......++|.+|++++++++|||||+++++|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 45778899999999999999864 477899999953 3455667899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCce
Q 039922 756 ILVYEYMPNGSLADMLHEKG----------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVP 825 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 825 (973)
|+|||||++|+|.++++... ....++|.++++|+.|||+||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997642 234689999999999999999999999 99999999999999999999
Q ss_pred EEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHH
Q 039922 826 RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 826 kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 904 (973)
||+|||+|+........ .......||+.|||||++.++.++.++|||||||++|||+| |+.||... ...++...+
T Consensus 168 Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i 243 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECI 243 (299)
T ss_dssp EECCCSCHHHHTGGGCE--EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHH
T ss_pred EECCcccceecCCCCce--eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHH
Confidence 99999999876544321 22234568999999999999999999999999999999999 89999753 344555555
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
..+.....+. ..+.++.+++.+||+.||++||||+||.+.|+...
T Consensus 244 ~~~~~~~~p~---------------------~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 244 TQGRVLQRPR---------------------TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHTCCCCCCT---------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCc---------------------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 5543221111 12356889999999999999999999999998753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=486.65 Aligned_cols=453 Identities=18% Similarity=0.280 Sum_probs=349.9
Q ss_pred CCccEEecccccccccCCccccCCCCCCEEECcCCcC------CC------CCCcccCCCCcccEEecCCcccCCccccc
Q 039922 121 FHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNF------SG------DIPESFGRFPVLKVLNLGGNLLSGLIPSF 188 (973)
Q Consensus 121 ~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l------~~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 188 (973)
.+++.|+|++|.+.|.+|..++.|++|++|||++|.+ .+ .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4788999999999999999999999999999999976 22 334433 56778 888899998888877
Q ss_pred ccc-cccccEeeccCcCCCCCCCCccccCcchhHHHhhc--cCcccccCCccccCCCCCCEEEccCCccccc--------
Q 039922 189 LGN-LTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAA--KANLIGEIPDSIGKLAFLSNLDLSDNFLSGK-------- 257 (973)
Q Consensus 189 ~~~-l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~--~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-------- 257 (973)
+.. +.++..+++....+... ....++.+++. .|++++ +|..++++++|++|+|++|.+++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~~-------~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 229 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKKS-------SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCCC-------CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred HHHHHHHHhhcCccccccccc-------cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence 764 45566666665554321 12233334443 578888 999999999999999999999986
Q ss_pred ---------CCcCCC--CCCCCCEEEccCCcCcccCchhccCCCccceeeccccc-cCC-CChhhhhc-------ccCcE
Q 039922 258 ---------IPHSFS--GLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNN-LTG-NLPETIAA-------MSLES 317 (973)
Q Consensus 258 ---------~~~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~~~-------~~L~~ 317 (973)
+|..++ ++++|++|++++|++.+.+|..++++++|+.|++++|+ +++ .+|..+.. .+|++
T Consensus 230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~ 309 (636)
T 4eco_A 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309 (636)
T ss_dssp TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence 899998 99999999999999999999999999999999999998 887 78877665 57888
Q ss_pred EEccCCcCCCCCCc--cccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCC-chhhhccc
Q 039922 318 LNLNDNYFTGEIPE--SLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNK-LQCIIIFN 394 (973)
Q Consensus 318 L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~ 394 (973)
|++++|+++ .+|. .+.++++|++|++++|+++|.+| .++.+++|++|+|++|+++ .+|..+..+++ |+.|++++
T Consensus 310 L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~ 386 (636)
T 4eco_A 310 IYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAH 386 (636)
T ss_dssp EECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCS
T ss_pred EECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccC
Confidence 888888888 7777 78888888888888888887788 7888888888888888877 55555555555 55555555
Q ss_pred CccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCC-------CCCCcceEeecCC
Q 039922 395 NRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSIS-------NAPKLTGILINGN 467 (973)
Q Consensus 395 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------~~~~L~~L~L~~N 467 (973)
|+++ .+|..+..++ +++|+.|++++|++.+.+|..+. .+++|+.|++++|
T Consensus 387 N~l~-~lp~~~~~~~----------------------l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N 443 (636)
T 4eco_A 387 NKLK-YIPNIFDAKS----------------------VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443 (636)
T ss_dssp SCCS-SCCSCCCTTC----------------------SSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSS
T ss_pred CcCc-ccchhhhhcc----------------------cCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCC
Confidence 5555 4444444433 11444444444444444455454 5667777778888
Q ss_pred cCCCCCchhhhcCCcCcEEeCcCCcccCCCcccccc-c-------cccceeeccccccccccCcccC--ccccceeeeec
Q 039922 468 NFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQ-L-------NKLQQLELQENMFTGELPRNLN--SLTALIVLNLS 537 (973)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls 537 (973)
++++..+..+..+++|++|+|++|+++ .+|..+.. . ++|+.|+|++|+++ .+|..+. .+++|+.|+|+
T Consensus 444 ~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls 521 (636)
T 4eco_A 444 QISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLS 521 (636)
T ss_dssp CCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECC
T ss_pred ccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECC
Confidence 777433334556888888888888888 55554332 2 38999999999998 7888886 89999999999
Q ss_pred cCcccCCCCccccccccccEEec------CCCcCccccChhhhcc-cccceeccCCcCcccCCCCCcccccccccCCCCC
Q 039922 538 TNQLTGTIPPELGNLAVLTSLDL------SSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPG 610 (973)
Q Consensus 538 ~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~~~~~~~~~~~~~n~~ 610 (973)
+|+|++ +|..+.++++|+.|+| ++|++.+.+|..+..+ .|+.|++++|++ +.+|..+........+.+|+.
T Consensus 522 ~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l 599 (636)
T 4eco_A 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPN 599 (636)
T ss_dssp SSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTT
T ss_pred CCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCC
Confidence 999986 8888999999999999 6788999999999999 999999999999 889988776677778889988
Q ss_pred CCCC
Q 039922 611 LCSP 614 (973)
Q Consensus 611 ~c~~ 614 (973)
.|-.
T Consensus 600 ~~~~ 603 (636)
T 4eco_A 600 ISID 603 (636)
T ss_dssp CEEE
T ss_pred cccc
Confidence 7743
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=437.18 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=214.1
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
..++..+.||+|+||+||+|++. +++.||||++.... .....++|.+|+.++++++|||||+++++|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34566788999999999999863 56789999996443 334567899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 756 ILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
++|||||++|+|.+++..... ...++|..+++|+.|||+||+|||++ +||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 999999999999999965321 13589999999999999999999999 99999999999999999
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIV 901 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 901 (973)
+.+||+|||+++.+...... .......||++|||||++.++.++.++|||||||++|||+| |+.||... ...++.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~~~~~~ 257 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYY--KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVV 257 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCB--CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--CHHHHH
T ss_pred CCEEECCcccceeccCCCce--eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CHHHHH
Confidence 99999999999876544321 22344679999999999999999999999999999999999 88999753 344555
Q ss_pred HHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 902 RWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+.+..+.....+. ..+..+.+++.+||+.||++||||.||+++|+...
T Consensus 258 ~~i~~~~~~~~p~---------------------~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 EMIRNRQVLPCPD---------------------DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHTTCCCCCCT---------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHcCCCCCCcc---------------------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 5554433221111 12356889999999999999999999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=438.79 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=208.1
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
++|...++||+|+||+||+|+++ +++.||||++.. ......++|.+|++++++++|||||+++++|.+++..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34667789999999999999864 478899999953 3455667899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 756 ILVYEYMPNGSLADMLHEKGR------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
|+|||||++|+|.++++.... ...++|.++++|+.|||+||+|||+. +|+||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 999999999999999976432 23589999999999999999999999 999999999999999999
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHH
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVR 902 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 902 (973)
.+||+|||+++.+...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||... ...++..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~ 271 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAID 271 (329)
T ss_dssp EEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--CHHHHHH
T ss_pred cEEEcccccceeccCCCcc--eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--CHHHHHH
Confidence 9999999999876543321 22334679999999999999999999999999999999999 89999753 3445555
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.+..+.....+. ..+.++.+++.+||+.||++||||+||+++|+.+.
T Consensus 272 ~i~~g~~~~~p~---------------------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 272 CITQGRELERPR---------------------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHTCCCCCCT---------------------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHcCCCCCCcc---------------------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 555443221111 12356789999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=430.16 Aligned_cols=262 Identities=29% Similarity=0.416 Sum_probs=206.7
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++++..+.||+|+||+||+|+++ ..||||+++.........+.|.+|++++++++|||||++++++.+ +..|+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 456788899999999999999875 369999996555556667889999999999999999999998865 56899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
||++|+|.++++... ..+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999997643 3599999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccccccccccCccccccccC---CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
. ........||+.|||||++.+ +.|+.++|||||||++|||+||+.||.... ....+...+...... +.
T Consensus 187 ~--~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-~~~~~~~~~~~~~~~-p~---- 258 (307)
T 3omv_A 187 G--SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-NRDQIIFMVGRGYAS-PD---- 258 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHTTCCC-CC----
T ss_pred c--ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcCCCC-CC----
Confidence 2 122345689999999999864 468999999999999999999999997532 222222222222111 10
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.. ......+..+.+++.+||+.||++||||.||+++|+..+
T Consensus 259 --~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 259 --LS----------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp --ST----------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred --cc----------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 00 011123457889999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=434.33 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=208.8
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.+........+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999976 7999999999766656666778999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
|||++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999997643 23578999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||... ...++...+........
T Consensus 179 ~----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~~~------- 245 (350)
T 4b9d_A 179 V----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--SMKNLVLKIISGSFPPV------- 245 (350)
T ss_dssp H----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCCCC-------
T ss_pred c----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCCC-------
Confidence 1 1233467999999999999999999999999999999999999999753 33344444433221100
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......++.+++.+|+++||++|||+.|++++
T Consensus 246 --------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 --------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123568899999999999999999999875
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=469.52 Aligned_cols=481 Identities=17% Similarity=0.165 Sum_probs=364.1
Q ss_pred CccceeEEcCC--CCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccC
Q 039922 60 CNWTGITCETQ--NQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL 137 (973)
Q Consensus 60 C~w~gv~c~~~--~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~ 137 (973)
|++.+++.-+. ..+++.|+|+++.+++..|.+|.++++|++|+|++|+++ .+++.+|.++++|++|+|++|.+.+..
T Consensus 12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 90 (549)
T 2z81_A 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLS 90 (549)
T ss_dssp CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCSCC
T ss_pred CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcC-ccChhhccccccCCEEECCCCccCccC
Confidence 56777776443 247999999999999988999999999999999999999 456678999999999999999999988
Q ss_pred CccccCCCCCCEEECcCCcCCC-CCCcccCCCCcccEEecCCcccCCcc-cccccccccccEeeccCcCCCCCCCCcccc
Q 039922 138 PDFSREFANLQVLDLSRNNFSG-DIPESFGRFPVLKVLNLGGNLLSGLI-PSFLGNLTELTHFELGYNPLKSSPLPSSVG 215 (973)
Q Consensus 138 ~~~~~~l~~L~~L~Ls~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 215 (973)
|..++.+++|++|+|++|.+++ ..|..++++++|++|+|++|++.+.+ +..|+++++|++|++++|.++.. .|..++
T Consensus 91 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~ 169 (549)
T 2z81_A 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY-QSQSLK 169 (549)
T ss_dssp HHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE-CTTTTT
T ss_pred HHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc-Chhhhh
Confidence 8889999999999999999996 36788999999999999999954444 47899999999999999998753 467777
Q ss_pred CcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccC--C-cCCCCCCCCCEEEccCCcCcccCch----hccC
Q 039922 216 NLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKI--P-HSFSGLASIEQIELFDNQLSGELPE----SLSN 288 (973)
Q Consensus 216 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--~-~~~~~l~~L~~L~L~~n~l~~~~p~----~l~~ 288 (973)
.+++|++|++..|......+..+..+++|++|++++|++++.. | .....+++|+.|++++|++++..+. .+..
T Consensus 170 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~ 249 (549)
T 2z81_A 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249 (549)
T ss_dssp TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence 7777777777777654332222355777777777777777542 1 1233456777777777777654333 2344
Q ss_pred CCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCC-----CCCCccCCCCc
Q 039922 289 LTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGK-----LPDDLGKYSNL 363 (973)
Q Consensus 289 l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L 363 (973)
+++|+.+++++|.+.+...-. ......+..+++|+.|++.++.+... ++..+....+|
T Consensus 250 ~~~L~~l~l~~~~~~~~~~~~-----------------~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L 312 (549)
T 2z81_A 250 ILELSEVEFDDCTLNGLGDFN-----------------PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312 (549)
T ss_dssp CTTCCEEEEESCEEECCSCCC-----------------CCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTC
T ss_pred hcccccccccccccccccccc-----------------ccchhhhhhhcccccccccccccchhhhcccchhhhhhcccc
Confidence 566666666666665421100 00112234445566666666554421 11112234566
Q ss_pred cceeeecccccccCCccc-cccCCchhhhcccCccCCCCC---CccCCcceeeEEEccCCccccccC--cccCCCCCccE
Q 039922 364 EYFDVSTNDFTGELPRFL-CFRNKLQCIIIFNNRFSGKIP---ESYGECKTLNYLRFGGNELQGELP--SKFWGLPEVDF 437 (973)
Q Consensus 364 ~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~ 437 (973)
+.|++++|+++ .+|..+ ..+++|+.|++++|++.+.+| ..++.+++|++|++++|++++..+ ..+..+++|+.
T Consensus 313 ~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~ 391 (549)
T 2z81_A 313 KRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391 (549)
T ss_dssp CEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCE
T ss_pred eEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCE
Confidence 77777777765 444443 456777777777777766543 346788889999999999886543 56888999999
Q ss_pred EEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeecccccc
Q 039922 438 FEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMF 517 (973)
Q Consensus 438 L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 517 (973)
|++++|+++ .+|..+..+++|++|++++|.++ .+|..+ .++|++|+|++|++++.+ ..+++|++|+|++|+|
T Consensus 392 L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l 463 (549)
T 2z81_A 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKL 463 (549)
T ss_dssp EECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCC
T ss_pred EECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCcc
Confidence 999999998 56788888999999999999998 445443 368999999999999643 5789999999999999
Q ss_pred ccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccC
Q 039922 518 TGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 518 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
+ .+|. ...+++|+.|+|++|+|++.+|..|..+++|+.|+|++|++++..|
T Consensus 464 ~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 464 K-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp S-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred C-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9 7776 5679999999999999999888899999999999999999999887
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=466.41 Aligned_cols=452 Identities=21% Similarity=0.216 Sum_probs=246.9
Q ss_pred EeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCC
Q 039922 76 GIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155 (973)
Q Consensus 76 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n 155 (973)
.||+++++++ .+|..+. ++|++|+|++|+++ .+++..|.++++|++|+|++|.+.+..|..|+.+++|++|||++|
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 4677777777 3666555 67777777777776 344456777777777777777777766777777777777777777
Q ss_pred cCCCCCCcccCCCCcccEEecCCcccCC-cccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccC
Q 039922 156 NFSGDIPESFGRFPVLKVLNLGGNLLSG-LIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEI 234 (973)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 234 (973)
+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|.++. ..
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~--------------------- 131 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SS--------------------- 131 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GG---------------------
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch----hh---------------------
Confidence 777 45544 67777777777777776 356677777777777777776643 12
Q ss_pred CccccCCCCC--CEEEccCCcc--cccCCcCCCCCC-CCCEEEccCCcCcccCch-hccCCCccceeeccccc-------
Q 039922 235 PDSIGKLAFL--SNLDLSDNFL--SGKIPHSFSGLA-SIEQIELFDNQLSGELPE-SLSNLTTLLRLDISQNN------- 301 (973)
Q Consensus 235 p~~l~~l~~L--~~L~Ls~N~l--~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~Ls~N~------- 301 (973)
+..+++| ++|++++|.+ .+..|..+..+. +...+++++|++.+.++. .+.++++|+.|++++|.
T Consensus 132 ---~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 208 (520)
T 2z7x_B 132 ---VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208 (520)
T ss_dssp ---GGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH
T ss_pred ---ccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce
Confidence 3334444 6666666665 555555555544 233445555555543332 34555666666666655
Q ss_pred cCCCChhhhhcccCcEEEccCCcCCCCCCcccc---CCCccceeeeccccccCCCCCCc-----cCCCCccceeeecccc
Q 039922 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESLA---SNPNLVQLKLFNNSFSGKLPDDL-----GKYSNLEYFDVSTNDF 373 (973)
Q Consensus 302 l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l 373 (973)
+.+.+|......+|+.|++++|.+++..+..+. ..++|++|++++|+++|.+|..+ +.+++|+.+++++|.+
T Consensus 209 ~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~ 288 (520)
T 2z7x_B 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288 (520)
T ss_dssp HHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC
T ss_pred eecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce
Confidence 333333222223455555555555432111111 12466666666666666666666 6666666677766666
Q ss_pred cccCC-cccccc---CCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCC
Q 039922 374 TGELP-RFLCFR---NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSI 449 (973)
Q Consensus 374 ~~~~~-~~~~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 449 (973)
.+| ..+..+ .+|+.|++++|++.+.. .+..+++|++|++++|++++..|..+..+++|+.|++++|++++..
T Consensus 289 --~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 364 (520)
T 2z7x_B 289 --GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364 (520)
T ss_dssp --CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHH
T ss_pred --ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccc
Confidence 333 333322 34455555555443211 1134455555555555555444444444444444444444444310
Q ss_pred CCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCcc-ccccccccceeeccccccccccCcccCcc
Q 039922 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT-CITQLNKLQQLELQENMFTGELPRNLNSL 528 (973)
Q Consensus 450 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 528 (973)
.+|..+..+++|++|++++|++++.+|. .+..+++|+.|+|++|++++.+|..+.
T Consensus 365 ----------------------~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-- 420 (520)
T 2z7x_B 365 ----------------------KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-- 420 (520)
T ss_dssp ----------------------HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--
T ss_pred ----------------------cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--
Confidence 2334445555555555555555543333 244455555555555555544444433
Q ss_pred ccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChh-hhcc-cccceeccCCcCcccC
Q 039922 529 TALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLE-LTKL-KLNQFNISHNKLYGEV 592 (973)
Q Consensus 529 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l-~l~~l~l~~N~l~g~~ 592 (973)
++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ .+|.. +..+ .|+.|++++|+++|..
T Consensus 421 ~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccC
Confidence 45555555555555 44554445555555555555555 34443 4444 4555555555555443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=462.51 Aligned_cols=555 Identities=19% Similarity=0.198 Sum_probs=408.0
Q ss_pred CCCCccCCccCCCCCCCCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCC
Q 039922 43 DPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFH 122 (973)
Q Consensus 43 d~~~~~~sw~~~~~~~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~ 122 (973)
|+...+++|... -|..|..-.|.....+ .+=++.+++ .+|+.+- +++++|||++|+|+ .+++.+|.++++
T Consensus 8 ~~~~~~~~~~~~---~p~~~~~c~~~~~~~~---~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~-~l~~~~f~~l~~ 77 (635)
T 4g8a_A 8 DDDDKLAAANSS---IPESWEPCVEVVPNIT---YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPE 77 (635)
T ss_dssp --------------------CCSEEEETTTE---EECTTSCCS-SCCSSSC--TTCCEEECTTSCCC-EECTTTTTTCTT
T ss_pred CCcchhhcccCC---CCCCCCCccccCCCCE---EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCC-CCCHHHHhCCCC
Confidence 445567777532 2344544444332222 233344454 3555442 47899999999998 778889999999
Q ss_pred ccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccC
Q 039922 123 LQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGY 202 (973)
Q Consensus 123 L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 202 (973)
|++|+|++|.|++..|++|.++++|++|+|++|+|++..+..|+++++|++|+|++|+++++.+..|+++++|++|+|++
T Consensus 78 L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~ 157 (635)
T 4g8a_A 78 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 157 (635)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecccc
Confidence 99999999999998899999999999999999999987778899999999999999999988888899999999999999
Q ss_pred cCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCC----EEEccCCcccccCCcCCCCCCCCCEEEccCCcC
Q 039922 203 NPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLS----NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQL 278 (973)
Q Consensus 203 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 278 (973)
|.++.+..|..++.+++|++|++++|++.+..|..+..+.+++ .++++.|.++...+..+. ...++.+++.+|..
T Consensus 158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~ 236 (635)
T 4g8a_A 158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFD 236 (635)
T ss_dssp SCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCS
T ss_pred CccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhcccc
Confidence 9999888899999999999999999999999888887766544 789999999966555554 45678899998876
Q ss_pred cc-cCchhccCCCccceeeccccccC------CCChhhhhcc-cCcEEEccCCcCCC---CCCccccCCCccceeeeccc
Q 039922 279 SG-ELPESLSNLTTLLRLDISQNNLT------GNLPETIAAM-SLESLNLNDNYFTG---EIPESLASNPNLVQLKLFNN 347 (973)
Q Consensus 279 ~~-~~p~~l~~l~~L~~L~Ls~N~l~------~~~~~~~~~~-~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~L~~N 347 (973)
.. ..+..+..+..++...+..+... ......+... .+..+.+..+.... ..+..+..+.+++.+++.+|
T Consensus 237 ~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~ 316 (635)
T 4g8a_A 237 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSV 316 (635)
T ss_dssp SHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESC
T ss_pred cccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccc
Confidence 53 33455677777777666544322 2222222222 45555555443322 23344566678888888888
Q ss_pred cccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCcccc--cc
Q 039922 348 SFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQG--EL 425 (973)
Q Consensus 348 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~ 425 (973)
.+.... .+.....|+.|++++|.+.+..+. .+..|+.+.+..|.+... .....+++|++|++++|.+.. ..
T Consensus 317 ~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~ 389 (635)
T 4g8a_A 317 TIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCC 389 (635)
T ss_dssp EEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEEC
T ss_pred cccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhcccccccccc
Confidence 876432 355667888888888887755443 345677777887776533 345577888888888888753 34
Q ss_pred CcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCc-hhhhcCCcCcEEeCcCCcccCCCccccccc
Q 039922 426 PSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVP-SQICTLRQLQAVDLSQNRFSGHLPTCITQL 504 (973)
Q Consensus 426 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 504 (973)
+..+..+.+|+.+++..|.+.. .+..+..+++|+.+++++|+.....+ ..+..+++++.++++.|.+++..|..+..+
T Consensus 390 ~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~ 468 (635)
T 4g8a_A 390 SQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 468 (635)
T ss_dssp CHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTC
T ss_pred ccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccc
Confidence 5666778888888888888764 35567778888888888877765544 356778888888888888888888888888
Q ss_pred cccceeecccccc-ccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-ccccee
Q 039922 505 NKLQQLELQENMF-TGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFN 582 (973)
Q Consensus 505 ~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~ 582 (973)
++|+.|+|++|++ .+.+|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+ +|+.|+
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 8888888888874 44577888888888888888888888788888888888888888888887777778877 788888
Q ss_pred ccCCcCcccCCCCCcc---cccccccCCCCCCCCCCC
Q 039922 583 ISHNKLYGEVPSDFDH---DLFISSLLDNPGLCSPDL 616 (973)
Q Consensus 583 l~~N~l~g~~p~~~~~---~~~~~~~~~n~~~c~~~l 616 (973)
+++|+|++..|..+.. ......+.+||+.|+|.+
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 8888888888876642 345566788888888754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=465.87 Aligned_cols=432 Identities=22% Similarity=0.239 Sum_probs=314.6
Q ss_pred CCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHh
Q 039922 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLW 224 (973)
Q Consensus 145 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 224 (973)
++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++.+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l---------------- 84 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI---------------- 84 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEE----------------
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeec----------------
Confidence 4555555555555544444555555555555555555555555555555555555555554321
Q ss_pred hccCcccccCCccccCCCCCCEEEccCCcccc-cCCcCCCCCCCCCEEEccCCcCcccCchhccCCCcc--ceeeccccc
Q 039922 225 AAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG-KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTL--LRLDISQNN 301 (973)
Q Consensus 225 l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~Ls~N~ 301 (973)
|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..+..+++| +.|++++|.
T Consensus 85 ----------p~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~ 149 (520)
T 2z7x_B 85 ----------SCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGE 149 (520)
T ss_dssp ----------ECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECT
T ss_pred ----------Ccc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccc
Confidence 111 34445555555555544 234555555555555555555543 234444444 666666666
Q ss_pred c--CCCChhhhhcc--cCcEEEccCCcCCCCCCc-cccCCCccceeeecccc-------ccCCCCCCccCCCCccceeee
Q 039922 302 L--TGNLPETIAAM--SLESLNLNDNYFTGEIPE-SLASNPNLVQLKLFNNS-------FSGKLPDDLGKYSNLEYFDVS 369 (973)
Q Consensus 302 l--~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~Ls 369 (973)
+ ++..|..+... ....+++++|.+.+.++. .+..+++|+.|++++|. +.+.+| .++.+++|+.|+++
T Consensus 150 l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~ 228 (520)
T 2z7x_B 150 TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLN 228 (520)
T ss_dssp TTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEE
T ss_pred ccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccc
Confidence 6 55555554443 244566777777665544 56788899999999987 666666 78889999999999
Q ss_pred cccccccCCcccc---ccCCchhhhcccCccCCCCCCcc-----CCcceeeEEEccCCccccccC-cccCCC---CCccE
Q 039922 370 TNDFTGELPRFLC---FRNKLQCIIIFNNRFSGKIPESY-----GECKTLNYLRFGGNELQGELP-SKFWGL---PEVDF 437 (973)
Q Consensus 370 ~N~l~~~~~~~~~---~l~~L~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~ 437 (973)
+|.+++..+..+. ..++|+.|++++|++.+.+|..+ +.+++|+.+++++|.+ .+| ..+..+ ++|+.
T Consensus 229 ~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~ 306 (520)
T 2z7x_B 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKN 306 (520)
T ss_dssp EEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSE
T ss_pred ccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeE
Confidence 9988764332221 24589999999999998899988 9999999999999999 444 455544 68999
Q ss_pred EEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccC--CCccccccccccceeecccc
Q 039922 438 FEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSG--HLPTCITQLNKLQQLELQEN 515 (973)
Q Consensus 438 L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N 515 (973)
|++++|++.... .+..+++|++|++++|++++.+|..++.+++|++|+|++|++++ .+|..++.+++|++|+|++|
T Consensus 307 L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N 384 (520)
T 2z7x_B 307 FTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384 (520)
T ss_dssp EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSS
T ss_pred EEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCC
Confidence 999999987432 12788999999999999999999999999999999999999996 56688999999999999999
Q ss_pred ccccccCc-ccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCC
Q 039922 516 MFTGELPR-NLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVP 593 (973)
Q Consensus 516 ~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p 593 (973)
++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|+.|||++|+++ .+|..+..+ .|+.|++++|+++ .+|
T Consensus 385 ~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~ 460 (520)
T 2z7x_B 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP 460 (520)
T ss_dssp CCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCC
T ss_pred cCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccC
Confidence 99985665 488999999999999999988887765 79999999999999 899988888 9999999999999 566
Q ss_pred CC-Cc--ccccccccCCCCCCCCCCC
Q 039922 594 SD-FD--HDLFISSLLDNPGLCSPDL 616 (973)
Q Consensus 594 ~~-~~--~~~~~~~~~~n~~~c~~~l 616 (973)
.. +. .......+.+|+..|.++.
T Consensus 461 ~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 461 DGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred HHHhccCCcccEEECcCCCCcccCCc
Confidence 65 43 2355667899999998765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=426.82 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=209.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+.|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||+++++|.+++..|+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456888899999999999999986 79999999995432 233456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
|||++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999998753 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... ...+....+.......
T Consensus 224 ~~----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~-------- 289 (346)
T 4fih_A 224 VP----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPR-------- 289 (346)
T ss_dssp SC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCCC--------
T ss_pred CC----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCC--------
Confidence 22 234578999999999999999999999999999999999999999753 3333344333321110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. .......++.+++.+|+++||++|||+.|+++|
T Consensus 290 --------~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 --------LK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --------CS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------CC---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 001123567899999999999999999999886
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=422.92 Aligned_cols=269 Identities=26% Similarity=0.298 Sum_probs=203.9
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC----eeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD----FNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 757 (973)
++|...+.||+|+||+||+|++. |+.||||++... ......+++|+..+.+++|||||++++++.+++ ..|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 45777889999999999999985 899999999422 222333455677778899999999999997653 5799
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC-----VPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
|||||++|+|.++++.. .++|..+.+++.|++.||+|||+++ .++|+||||||+|||+++++.+||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999999764 4899999999999999999999762 45899999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCC------CCCCCCChhhHHHHHHHHHcCCCCCCCCCC----------C
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK------KVTEKSDVYSFGVVLMELVTGKRPNDPSFG----------E 896 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg~~p~~~~~~----------~ 896 (973)
++.................||+.|||||++.+. .++.++|||||||++|||+||+.|+..... .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 987765443222233456799999999998754 467799999999999999999877643211 1
Q ss_pred chhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 897 NKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
....... ...... +..+|.+.......+....+.+++.+||+.||++||||.||+++|+++.
T Consensus 235 ~~~~~~~-~~~~~~-----------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 235 DPSVEEM-RKVVCE-----------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SCCHHHH-HHHHTT-----------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchHHHH-HHHHhc-----------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111111 111111 1122222222233456778999999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=416.33 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=201.2
Q ss_pred CccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec----CCeeEEEE
Q 039922 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG----QDFNILVY 759 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 759 (973)
+..++||+|+||+||+|++. +++.||+|++..........+.|.+|++++++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999976 68999999997665556667789999999999999999999999864 35679999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEeCCCCCCEEeCC-CCceEEeccCcchhc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA--IVHRDVKSHNILLDA-EMVPRVADFGLAKAL 836 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~ 836 (973)
|||++|+|.++++... .+++..+..++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999998654 589999999999999999999998 6 999999999999984 799999999999754
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.. .......||+.|||||++.+ +|+.++|||||||++|||+||+.||.... ....+...+...... .
T Consensus 183 ~~------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~~i~~~~~~---~-- 249 (290)
T 3fpq_A 183 RA------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKP---A-- 249 (290)
T ss_dssp CT------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCC---G--
T ss_pred CC------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-cHHHHHHHHHcCCCC---C--
Confidence 22 12345689999999998865 69999999999999999999999996432 223333332221111 0
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. +++ ....++.+++.+||++||++|||+.|+++|
T Consensus 250 --~----~~~---------~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 --S----FDK---------VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --G----GGG---------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --C----CCc---------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 111 112457889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=423.24 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=204.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+.|+..++||+|+||+||+|+++ +|+.||||++..... ..+|+.++++++|||||++++++.+++..|+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345778889999999999999986 799999999964322 246999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~~~ 838 (973)
|||++|+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+.+..
T Consensus 130 Ey~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999998654 589999999999999999999999 999999999999999987 699999999987754
Q ss_pred cCCCc-cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQS-DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
..... ........||+.|||||++.+..|+.++||||+||++|||++|+.||.... ...+...+......
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~~------- 274 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF--RGPLCLKIASEPPP------- 274 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC--CSCCHHHHHHSCCG-------
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHHcCCCC-------
Confidence 33211 112234679999999999999999999999999999999999999997642 22233333222110
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
..++ .+.....+.+++.+|+++||++|||+.|++++|..
T Consensus 275 --~~~~----------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 275 --IREI----------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp --GGGS----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --chhc----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 0000 01223567889999999999999999999998865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=419.08 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=210.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||+||+|+.+ +|+.||+|++.+.. ......+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356899999999999999999976 79999999995432 1223456789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999998654 589999999999999999999999 999999999999999999999999999987754
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..++.+.+.......+
T Consensus 185 ~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~p------ 254 (311)
T 4aw0_A 185 ESK--QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIFAKIIKLEYDFP------ 254 (311)
T ss_dssp TTT--CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCC------
T ss_pred CCC--cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCC------
Confidence 332 12234578999999999999999999999999999999999999999753 34444444444322110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVV 963 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 963 (973)
.....++.+++.+|+++||++|||+.|+.
T Consensus 255 ----------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 ----------------EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----------------cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 01124678999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=407.55 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=195.1
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|++.+.||+|+||+||+|+.+ +|+.||+|++.+... .....+.+.+|++++++++|||||++++++.+++..|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999975 799999999965532 23445678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+ +|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 91 vmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99999 689999997653 589999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... ......||+.|||||++.+..+ +.++||||+||++|||++|+.||... ....+.+.+.......+
T Consensus 164 ~~~-----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~~~~i~~~~~~~p---- 232 (275)
T 3hyh_A 164 DGN-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVLFKNISNGVYTLP---- 232 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCC----
T ss_pred CCC-----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCC----
Confidence 332 2334689999999999998876 57999999999999999999999752 33444444443322110
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....++.+++.+|+++||++|||++|++++
T Consensus 233 ------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 233 ------------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0113567889999999999999999999985
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=468.72 Aligned_cols=369 Identities=18% Similarity=0.257 Sum_probs=326.8
Q ss_pred chhHHHhhcc--CcccccCCccccCCCCCCEEEccCCcccc-----------------cCCcCCC--CCCCCCEEEccCC
Q 039922 218 SKLENLWAAK--ANLIGEIPDSIGKLAFLSNLDLSDNFLSG-----------------KIPHSFS--GLASIEQIELFDN 276 (973)
Q Consensus 218 ~~L~~L~l~~--n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-----------------~~~~~~~--~l~~L~~L~L~~n 276 (973)
..++.+.+.. |++.+ +|..++++++|++|+|++|.+++ .+|..++ ++++|++|+|++|
T Consensus 423 l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred cchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 3455555544 78888 89999999999999999999998 3899988 9999999999999
Q ss_pred cCcccCchhccCCCccceeeccccc-cCC-CChhhhhcc--------cCcEEEccCCcCCCCCCc--cccCCCccceeee
Q 039922 277 QLSGELPESLSNLTTLLRLDISQNN-LTG-NLPETIAAM--------SLESLNLNDNYFTGEIPE--SLASNPNLVQLKL 344 (973)
Q Consensus 277 ~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~~~~--------~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L 344 (973)
++.+.+|..+.++++|+.|+|++|+ +++ .+|..+... +|+.|+|++|+++ .+|. .+.++++|+.|+|
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~L 580 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDC 580 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEEC
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEEC
Confidence 9999999999999999999999998 888 788766543 7999999999999 8888 9999999999999
Q ss_pred ccccccCCCCCCccCCCCccceeeecccccccCCccccccCC-chhhhcccCccCCCCCCccCCcce--eeEEEccCCcc
Q 039922 345 FNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNK-LQCIIIFNNRFSGKIPESYGECKT--LNYLRFGGNEL 421 (973)
Q Consensus 345 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~p~~~~~l~~--L~~L~L~~N~l 421 (973)
++|+++ .+| .++.+++|+.|+|++|+++ .+|..+..+++ |+.|++++|++. .+|..+..++. |++|++++|++
T Consensus 581 s~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l 656 (876)
T 4ecn_A 581 VHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI 656 (876)
T ss_dssp TTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCT
T ss_pred CCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcC
Confidence 999999 888 8999999999999999999 88988999999 999999999999 78888887765 99999999999
Q ss_pred ccccCccc---C--CCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcC--------CcCcEEeC
Q 039922 422 QGELPSKF---W--GLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTL--------RQLQAVDL 488 (973)
Q Consensus 422 ~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l--------~~L~~L~L 488 (973)
.+.+|... . .+++|+.|+|++|+++...+..+..+++|+.|+|++|+++ .+|..+... ++|+.|+|
T Consensus 657 ~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~L 735 (876)
T 4ecn_A 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDL 735 (876)
T ss_dssp TTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEEC
T ss_pred CCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEEC
Confidence 98776433 2 4558999999999999544444558999999999999999 667655443 39999999
Q ss_pred cCCcccCCCccccc--cccccceeeccccccccccCcccCccccceeeeecc------CcccCCCCccccccccccEEec
Q 039922 489 SQNRFSGHLPTCIT--QLNKLQQLELQENMFTGELPRNLNSLTALIVLNLST------NQLTGTIPPELGNLAVLTSLDL 560 (973)
Q Consensus 489 s~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~L 560 (973)
++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|.++++|+.|+|
T Consensus 736 s~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~L 813 (876)
T 4ecn_A 736 RFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813 (876)
T ss_dssp CSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEEC
T ss_pred CCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEEC
Confidence 999999 7898887 99999999999999997 899999999999999976 8899999999999999999999
Q ss_pred CCCcCccccChhhhcccccceeccCCcCcccCCCCCc
Q 039922 561 SSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFD 597 (973)
Q Consensus 561 s~N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p~~~~ 597 (973)
++|++ +.+|..+.. .|+.|+|++|++...-+..+.
T Consensus 814 s~N~L-~~Ip~~l~~-~L~~LdLs~N~l~~i~~~~~~ 848 (876)
T 4ecn_A 814 GSNDI-RKVDEKLTP-QLYILDIADNPNISIDVTSVC 848 (876)
T ss_dssp CSSCC-CBCCSCCCS-SSCEEECCSCTTCEEECGGGH
T ss_pred CCCCC-CccCHhhcC-CCCEEECCCCCCCccChHHcc
Confidence 99999 799998664 899999999999876665553
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=428.39 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=211.0
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+..+.|+..+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+++..|+
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 34567999999999999999999986 79999999996443 2334568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|||||++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 226 VmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999998753 489999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... ...+....+......
T Consensus 299 ~~~~----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~------- 365 (423)
T 4fie_A 299 KEVP----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPP------- 365 (423)
T ss_dssp SSCC----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCC-------
T ss_pred CCCc----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCC-------
Confidence 4322 234578999999999999999999999999999999999999999752 333334433332111
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.. .......+.+++.+||++||++|||+.|+++|
T Consensus 366 ---------~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 366 ---------RLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ---------CCSC---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------CCcc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 01123567899999999999999999999886
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=423.02 Aligned_cols=261 Identities=27% Similarity=0.369 Sum_probs=213.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC-CCeeeEEeEEec-C
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH-GNVVKLLMCCSG-Q 752 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~-~ 752 (973)
.++|+..+.||+|+||+||+|++. .++.||||++.... .....+.|.+|++++++++| ||||+++++|.+ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 457888999999999999999865 23579999996433 34456779999999999976 899999999976 4
Q ss_pred CeeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 819 (973)
+..|+|||||++|+|.++++.... ...+++..++.++.|||+||+|||++ +||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence 578999999999999999975321 23589999999999999999999999 99999999999999
Q ss_pred CCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCch
Q 039922 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENK 898 (973)
Q Consensus 820 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 898 (973)
++++.+||+|||+|+.+...... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||.... ...
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~-~~~ 295 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDE 295 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-CSH
T ss_pred CCCCCEEECcchhhhhcccCCCc--eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC-HHH
Confidence 99999999999999876544321 22344678999999999999999999999999999999998 899997532 334
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+...+..+.....+. ....++.+++.+||+.||++||||.||+++|+..
T Consensus 296 ~~~~~i~~g~~~~~p~---------------------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 296 EFCRRLKEGTRMRAPD---------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHTCCCCCCT---------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCc---------------------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 4555555443221111 1134678899999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=414.00 Aligned_cols=251 Identities=25% Similarity=0.318 Sum_probs=201.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.++|++.+.||+|+||+||+|+.. +++.||+|++.+..........+.+|++++++++|||||++++++.+++..|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 357999999999999999999863 4789999999654433334456888999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+|||||++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999998754 589999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ......||+.|||||++.+..|+.++||||+||++|||+||+.||... +..++...+.......+
T Consensus 177 ~~~~~----~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~~p---- 246 (304)
T 3ubd_A 177 IDHEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMILKAKLGMP---- 246 (304)
T ss_dssp ----C----CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC----
T ss_pred cCCCc----cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--CHHHHHHHHHcCCCCCC----
Confidence 43322 234468999999999999999999999999999999999999999753 33444444433221110
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
.....++.+++.+|+++||++||| ++|+++|
T Consensus 247 ------------------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 247 ------------------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ------------------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ------------------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 011356789999999999999998 4677764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=447.40 Aligned_cols=508 Identities=22% Similarity=0.215 Sum_probs=331.7
Q ss_pred ceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEEC
Q 039922 73 SVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDL 152 (973)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L 152 (973)
.++.|||+++.+++..+.+|.++++|++|||++|+|+ .+++.+|.++++|++|+|++|++.+..+..|.++++|++|+|
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 5889999999999888889999999999999999998 677889999999999999999999888889999999999999
Q ss_pred cCCcCCCCCCcccCCCCcccEEecCCcccCCc-ccccccccccccEeeccCcCCCCCCCCccccCcchhHH----Hhhcc
Q 039922 153 SRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLEN----LWAAK 227 (973)
Q Consensus 153 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~----L~l~~ 227 (973)
++|++++..+..|+++++|++|+|++|++++. .|..++++++|++|+|++|+++.+ .+..+..+.+++. ++++.
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI-YCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE-CGGGGHHHHTCTTCCCEEECTT
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccc-ccccccchhhhhhhhhhhhccc
Confidence 99999988788899999999999999999864 688999999999999999999875 3556666665553 45666
Q ss_pred CcccccCCccccCCCCCCEEEccCCcccc-cCCcCCCCCCCCCEEEccCCc------CcccCchhccCCCccceeecccc
Q 039922 228 ANLIGEIPDSIGKLAFLSNLDLSDNFLSG-KIPHSFSGLASIEQIELFDNQ------LSGELPESLSNLTTLLRLDISQN 300 (973)
Q Consensus 228 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~------l~~~~p~~l~~l~~L~~L~Ls~N 300 (973)
|.+....+.. .....++.+++++|.... ..+..+.++..++...+..+. +.......+..+..+...++..+
T Consensus 211 n~l~~i~~~~-~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 211 NPMNFIQPGA-FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp CCCCEECTTT-TTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred CcccccCccc-ccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 6666554443 344567788888886653 233455666666665553322 22223334444445555554444
Q ss_pred ccCCCCh---hhhh-cccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeeccccccc
Q 039922 301 NLTGNLP---ETIA-AMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE 376 (973)
Q Consensus 301 ~l~~~~~---~~~~-~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 376 (973)
....... ..+. ..+++.+.+.+|.+.... .+....+|+.|++.+|.+.+..+ ..+..|+.++++.|.+...
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~ 364 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA 364 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB
T ss_pred hhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC
Confidence 3322111 1111 124666666666554322 23344556666666666653322 2344555666666655432
Q ss_pred CCccccccCCchhhhcccCccCC--CCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCC-CCC
Q 039922 377 LPRFLCFRNKLQCIIIFNNRFSG--KIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSIS-PSI 453 (973)
Q Consensus 377 ~~~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~ 453 (973)
. ....+++|+.+++++|.+.. ..+..+..+.+|+++++..|.+.. .+..+..+++|+.+++..|......+ ..+
T Consensus 365 ~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~ 441 (635)
T 4g8a_A 365 F--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 441 (635)
T ss_dssp C--CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTT
T ss_pred c--ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccc
Confidence 2 23345566666666665542 233344455566666666666553 33445566666666666555544333 345
Q ss_pred CCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcc-cCCCccccccccccceeeccccccccccCcccCccccce
Q 039922 454 SNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRF-SGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALI 532 (973)
Q Consensus 454 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 532 (973)
..+++++.++++.|.+.+..+..+..+++|+.|+|++|++ .+.+|..|..+++|++|+|++|+|++..|..|.++++|+
T Consensus 442 ~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~ 521 (635)
T 4g8a_A 442 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 521 (635)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCC
Confidence 5566666666666666666666666666666666666653 234555666666666666666666666666666666666
Q ss_pred eeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc--cccceeccCCcCccc
Q 039922 533 VLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL--KLNQFNISHNKLYGE 591 (973)
Q Consensus 533 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l--~l~~l~l~~N~l~g~ 591 (973)
+|+|++|+|++..|..|.++++|++|||++|+|++..|..+..+ +|+.|++++|++++.
T Consensus 522 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 522 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 66666666665555566666666666666666666666666554 466666666666553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=404.68 Aligned_cols=255 Identities=21% Similarity=0.325 Sum_probs=192.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-------
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD------- 753 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 753 (973)
++|+..+.||+|+||+||+|+.+ +|+.||||++.... .....+.+.+|++++++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45788899999999999999976 79999999996443 3445567899999999999999999999986543
Q ss_pred -----eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe
Q 039922 754 -----FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828 (973)
Q Consensus 754 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 828 (973)
..|+|||||++|+|.+++.........++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999998765444566777899999999999999999 99999999999999999999999
Q ss_pred ccCcchhccccCCCc--------cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhH
Q 039922 829 DFGLAKALQSQEGQS--------DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900 (973)
Q Consensus 829 DfGl~~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~ 900 (973)
|||+|+.+....... .......+||+.|||||++.+..|+.++||||+||++|||++ ||.. ..+.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~----~~~~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST----QMER 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS----HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC----ccHH
Confidence 999998875443211 112234679999999999999999999999999999999996 7653 1222
Q ss_pred HHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+........+. ..........+++.+|+++||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~p~------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTLTDVRNLKFPP------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHTTCCCH------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhcCCCCC------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22222211110000 002233456789999999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=441.81 Aligned_cols=456 Identities=19% Similarity=0.222 Sum_probs=267.4
Q ss_pred eEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcC
Q 039922 75 DGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSR 154 (973)
Q Consensus 75 ~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~ 154 (973)
..+|++++++++ +|..+. ++|++|+|++|+++ .+++.+|.++++|++|+|++|.+++..|+.|..+++|++|||++
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCC-CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCcc-ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 568999999986 776654 89999999999998 56667899999999999999999988899999999999999999
Q ss_pred CcCCCCCCcccCCCCcccEEecCCcccCCc-ccccccccccccEeeccCcCCCCCCCCccccCcchh--HHHhhccCcc-
Q 039922 155 NNFSGDIPESFGRFPVLKVLNLGGNLLSGL-IPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKL--ENLWAAKANL- 230 (973)
Q Consensus 155 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L--~~L~l~~n~l- 230 (973)
|+++ .+|.. .+++|++|+|++|++++. +|..|+++++|++|+|++|+++.. .+..+++| ++|++++|.+
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL----DLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT----TTGGGTTSCEEEEEEEESSCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC----chhhhhhceeeEEEeeccccc
Confidence 9998 56665 799999999999999874 468899999999999999988652 23333333 5555555555
Q ss_pred -cccCCccccCCC--CCCEEEccCCcccccCCc-CCCCCCCCCEEEccCCcCc----ccCchhccCCCccceeecccccc
Q 039922 231 -IGEIPDSIGKLA--FLSNLDLSDNFLSGKIPH-SFSGLASIEQIELFDNQLS----GELPESLSNLTTLLRLDISQNNL 302 (973)
Q Consensus 231 -~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~Ls~N~l 302 (973)
.+..|..+..+. .+ .+++++|.+.+.++. .+..+++|+.|++++|+.. ...+..+..+++|+.|+++++.+
T Consensus 183 ~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l 261 (562)
T 3a79_B 183 IKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261 (562)
T ss_dssp CCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEE
T ss_pred ccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcC
Confidence 444444444432 11 334444444433322 2334444444444444310 01112233344444444443333
Q ss_pred CCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCc-----cCCCCccceeeecccccccC
Q 039922 303 TGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL-----GKYSNLEYFDVSTNDFTGEL 377 (973)
Q Consensus 303 ~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~ 377 (973)
++. .+.+ ++..+ ..++|++|++++|+++|.+|..+ .+++.|+.++++.|.+ .+
T Consensus 262 ~~~------------------~~~~-~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~ 319 (562)
T 3a79_B 262 TWK------------------CSVK-LFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LF 319 (562)
T ss_dssp CHH------------------HHHH-HHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SS
T ss_pred cHH------------------HHHH-HHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ec
Confidence 221 1110 11111 12366666666666666666655 5555555555555555 22
Q ss_pred C-ccccc---cCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCC--CC
Q 039922 378 P-RFLCF---RNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSI--SP 451 (973)
Q Consensus 378 ~-~~~~~---l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~ 451 (973)
| ..+.. ..+|+.|++++|.+.... ....+++|++|++++|++++..|..|.++++|+.|++++|++++.. |.
T Consensus 320 p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 397 (562)
T 3a79_B 320 SKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397 (562)
T ss_dssp CHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHH
T ss_pred ChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchh
Confidence 3 22211 134555555555543211 1145556666666666666555555556666666666666555422 23
Q ss_pred CCCCCCCcceEeecCCcCCCCCch-hhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCcccc
Q 039922 452 SISNAPKLTGILINGNNFTGEVPS-QICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTA 530 (973)
Q Consensus 452 ~~~~~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 530 (973)
.+..+++|+.|++++|++++.+|. .+..+++|++|++++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++
T Consensus 398 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~ 474 (562)
T 3a79_B 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQA 474 (562)
T ss_dssp TTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCC
T ss_pred hhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCC
Confidence 455555555555555555543333 344555555555555555554444443 45555555555555 45554445555
Q ss_pred ceeeeeccCcccCCCCcc-ccccccccEEecCCCcCccccC
Q 039922 531 LIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 531 L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
|+.|+|++|+|+ .+|.. |..+++|+.|+|++|++++..|
T Consensus 475 L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 475 LQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 555555555555 34443 5555555556666665555444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=441.21 Aligned_cols=456 Identities=21% Similarity=0.203 Sum_probs=341.2
Q ss_pred ccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEE
Q 039922 95 IRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVL 174 (973)
Q Consensus 95 l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 174 (973)
+...+++|+++|+++ .+|.... ++|++|+|++|.+.+..|..|..+++|++|+|++|++++..|+.|+++++|++|
T Consensus 30 ~~~~~~l~ls~~~L~-~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 105 (562)
T 3a79_B 30 NELESMVDYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYL 105 (562)
T ss_dssp ---CCEEECTTSCCC-SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred cCCCcEEEcCCCCCc-cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEE
Confidence 344478888888887 4664332 677888888888777777777888888888888888877777777888888888
Q ss_pred ecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcc
Q 039922 175 NLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL 254 (973)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 254 (973)
+|++|+++. +|.. .+++|++|+|++|+++.+++ |..++++++|++|++++|++
T Consensus 106 ~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~------------------------p~~~~~l~~L~~L~L~~n~l 158 (562)
T 3a79_B 106 DVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPV------------------------CKEFGNLTKLTFLGLSAAKF 158 (562)
T ss_dssp ECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCC------------------------CGGGGGCTTCCEEEEECSBC
T ss_pred ECCCCcCCc-cCcc--ccccCCEEECCCCCccccCc------------------------hHhhcccCcccEEecCCCcc
Confidence 888888773 4544 67778888888777765433 45566666777777777776
Q ss_pred cccCCcCCCCCCCC--CEEEccCCcC--cccCchhccCCC-ccceeeccccccCCCChhhhhc--ccCcEEEccCCcC--
Q 039922 255 SGKIPHSFSGLASI--EQIELFDNQL--SGELPESLSNLT-TLLRLDISQNNLTGNLPETIAA--MSLESLNLNDNYF-- 325 (973)
Q Consensus 255 ~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~--~~L~~L~L~~N~l-- 325 (973)
++. .+..+++| ++|++++|++ ++..|..+..+. ..-.+++++|.+.+.++..... .+|+.|++++|+.
T Consensus 159 ~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 235 (562)
T 3a79_B 159 RQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235 (562)
T ss_dssp CTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTH
T ss_pred ccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccccccccc
Confidence 643 33444444 7777777777 666666666554 1224566777776655443221 2577777777742
Q ss_pred ---CCCCCccccCCCccceeeeccccccCCC----CCCccCCCCccceeeecccccccCCccc-----cccCCchhhhcc
Q 039922 326 ---TGEIPESLASNPNLVQLKLFNNSFSGKL----PDDLGKYSNLEYFDVSTNDFTGELPRFL-----CFRNKLQCIIIF 393 (973)
Q Consensus 326 ---~~~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~ 393 (973)
.+ ....+..+++|+.|+++++.+++.. +.. ...++|++|++++|+++|.+|..+ ..+..|+.+++.
T Consensus 236 ~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~ 313 (562)
T 3a79_B 236 QRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313 (562)
T ss_dssp HHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEE
T ss_pred chHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhcc
Confidence 21 2235677788888888888776431 111 123589999999999999888887 777778778887
Q ss_pred cCccCCCCC-CccCCc---ceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcC
Q 039922 394 NNRFSGKIP-ESYGEC---KTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNF 469 (973)
Q Consensus 394 ~n~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l 469 (973)
.|.+ .+| ..+..+ .+|++|++++|.+.... ....+++|+.|++++|++++.+|..+..+++|++|++++|++
T Consensus 314 ~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 389 (562)
T 3a79_B 314 NQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389 (562)
T ss_dssp ECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCC
T ss_pred ccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCc
Confidence 7777 344 223222 57999999999986433 226889999999999999999999999999999999999999
Q ss_pred CCC--CchhhhcCCcCcEEeCcCCcccCCCcc-ccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCC
Q 039922 470 TGE--VPSQICTLRQLQAVDLSQNRFSGHLPT-CITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIP 546 (973)
Q Consensus 470 ~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 546 (973)
++. +|..+..+++|++|++++|++++.+|. .+..+++|++|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|
T Consensus 390 ~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip 466 (562)
T 3a79_B 390 KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIP 466 (562)
T ss_dssp CBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCC
T ss_pred CCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccC
Confidence 973 456789999999999999999985554 588999999999999999988887765 78999999999998 788
Q ss_pred ccccccccccEEecCCCcCccccChh-hhcc-cccceeccCCcCcccCCC
Q 039922 547 PELGNLAVLTSLDLSSNLLTGEIPLE-LTKL-KLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 547 ~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l-~l~~l~l~~N~l~g~~p~ 594 (973)
..+..+++|++|+|++|+++ .+|.. +..+ .|+.|++++|+++|.+|.
T Consensus 467 ~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 467 KDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred hhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 88889999999999999999 67777 7777 899999999999987764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=407.52 Aligned_cols=277 Identities=17% Similarity=0.221 Sum_probs=211.0
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec------C
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG------Q 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 752 (973)
+.++|++.+.||+|+||+||+|+++ +|+.||||++..........+.+.+|+++|+.++|||||++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3467999999999999999999986 79999999997666556666788999999999999999999998754 3
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
+..|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 57799999995 78999987643 589999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
++.+..............+||+.|+|||++.+. .++.++||||+||++|||++|+.||... +..+....+.......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~--~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK--NYVHQLQLIMMVLGTP 282 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS--SHHHHHHHHHHHHCCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC--CHHHHHHHHHHhcCCC
Confidence 987754433333345567899999999998775 5689999999999999999999999753 3334444444333221
Q ss_pred CCccccC----cccccccCCCCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PERGCCR----DLNQLIDPRMDLSTCD-----YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~~~~~~----~l~~~~d~~l~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+...... .....+.......... +....++.+++.+|+++||++|||+.|+++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111000 0000000000000000 0113567899999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=390.79 Aligned_cols=204 Identities=25% Similarity=0.378 Sum_probs=172.0
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 752 (973)
..+.++|++.+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+|+++++.+ +|||||++++++.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 345678999999999999999999864 4678999998533 2345578899999998 699999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-CceEEeccC
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFG 831 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 831 (973)
+..|+||||+++|+|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999884 378999999999999999999999 99999999999999877 799999999
Q ss_pred cchhccccCCC------------------------ccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcC
Q 039922 832 LAKALQSQEGQ------------------------SDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTG 886 (973)
Q Consensus 832 l~~~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg 886 (973)
+|+........ ........+||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99765432210 01123446799999999998775 589999999999999999999
Q ss_pred CCCCCCCC
Q 039922 887 KRPNDPSF 894 (973)
Q Consensus 887 ~~p~~~~~ 894 (973)
+.||....
T Consensus 244 ~~Pf~~~~ 251 (361)
T 4f9c_A 244 RYPFYKAS 251 (361)
T ss_dssp CSSSSCCS
T ss_pred CCCCCCCC
Confidence 99997653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=395.71 Aligned_cols=380 Identities=21% Similarity=0.229 Sum_probs=245.1
Q ss_pred cEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcc-cccccccccccEeeccC
Q 039922 124 QVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLI-PSFLGNLTELTHFELGY 202 (973)
Q Consensus 124 ~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~ 202 (973)
+.++.+++.+. .+|. + .++|++|||++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 35666666654 3444 2 267788888888887777777778888888888887776443 45677777777777777
Q ss_pred cCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcC--CCCCCCCCEEEccCCcCcc
Q 039922 203 NPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHS--FSGLASIEQIELFDNQLSG 280 (973)
Q Consensus 203 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~n~l~~ 280 (973)
|+++ +..|..++++++|++|+|++|.+++..+.. |.++++|++|++++|++++
T Consensus 89 n~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 143 (455)
T 3v47_A 89 NQFL-------------------------QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK 143 (455)
T ss_dssp CTTC-------------------------EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCS
T ss_pred CccC-------------------------ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCc
Confidence 7653 344667777888888888888887654444 7788888888888888887
Q ss_pred cCchh-ccCCCccceeeccccccCCCChhhhhc---ccCcEEEccCCcCCCCCCccc--------cCCCccceeeecccc
Q 039922 281 ELPES-LSNLTTLLRLDISQNNLTGNLPETIAA---MSLESLNLNDNYFTGEIPESL--------ASNPNLVQLKLFNNS 348 (973)
Q Consensus 281 ~~p~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~---~~L~~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~ 348 (973)
..|.. +.++++|++|++++|.+++..+..+.. .+|+.|++++|.+.+..+..+ ..+++|++|++++|+
T Consensus 144 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~ 223 (455)
T 3v47_A 144 IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223 (455)
T ss_dssp CCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSC
T ss_pred cCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCc
Confidence 66665 677788888888888877766665543 246666666666664433322 133444444444444
Q ss_pred ccCCCCCCccCC---CCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCcccccc
Q 039922 349 FSGKLPDDLGKY---SNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGEL 425 (973)
Q Consensus 349 l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 425 (973)
+++..|..+... ++|+.|++++|.+.+.. +..+.+.+..
T Consensus 224 l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------------------------------~~~~~~~~~~ 265 (455)
T 3v47_A 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------------------------------FGHTNFKDPD 265 (455)
T ss_dssp CCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------------------------------TTCCSSCCCC
T ss_pred ccccchhhhhccccccceeeEeeccccccccc--------------------------------------cchhhhccCc
Confidence 444433333222 34444444444332210 0111122122
Q ss_pred CcccCC--CCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCcccccc
Q 039922 426 PSKFWG--LPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQ 503 (973)
Q Consensus 426 ~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 503 (973)
+..+.. .++|+.|++++|++.+..|..+..+++|++|++++|.+++..|..|..+++|++|+|++|++++..|..|+.
T Consensus 266 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (455)
T 3v47_A 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345 (455)
T ss_dssp TTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTT
T ss_pred ccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcC
Confidence 222222 245566666666666555666666666777777777776666667777777777777777777666777777
Q ss_pred ccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccC
Q 039922 504 LNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++.+|
T Consensus 346 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 346 LDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 7777777777777777777777777778888888887776555566777788888888888877776
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=397.72 Aligned_cols=386 Identities=25% Similarity=0.309 Sum_probs=206.7
Q ss_pred CcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcc-------------cEEecCCcccCCcc
Q 039922 119 PCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVL-------------KVLNLGGNLLSGLI 185 (973)
Q Consensus 119 ~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~ 185 (973)
..++|++|++++|.+ +.+|..++.+++|++|++++|.+.|.+|.+++.+++| ++|++++|++++.
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l- 86 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL- 86 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-
Confidence 356788888888888 7888888888888888888888888888888888776 6666666666542
Q ss_pred cccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCC
Q 039922 186 PSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGL 265 (973)
Q Consensus 186 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 265 (973)
|.. .++|++|++++|.++. +|.. +++|++|++++|++++ +|.. .
T Consensus 87 p~~---~~~L~~L~l~~n~l~~--------------------------lp~~---~~~L~~L~l~~n~l~~-l~~~---~ 130 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE--------------------------LPEL---PQSLKSLLVDNNNLKA-LSDL---P 130 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS--------------------------CCCC---CTTCCEEECCSSCCSC-CCSC---C
T ss_pred CCC---cCCCCEEEccCCcCCc--------------------------cccc---cCCCcEEECCCCccCc-ccCC---C
Confidence 221 2455666666665544 3322 2456666666666663 2211 1
Q ss_pred CCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeec
Q 039922 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLF 345 (973)
Q Consensus 266 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 345 (973)
++|++|++++|++++ +| .++++++|++|++++|++++ +|... .+|++|++++|++++ +| .+..+++|++|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 466666666666664 45 46666666666666666664 33322 256677777776664 44 46666777777777
Q ss_pred cccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCcccccc
Q 039922 346 NNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGEL 425 (973)
Q Consensus 346 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 425 (973)
+|++++ +|... ++|++|++++|+++ .+|. +..+++|+.|++++|++.+ +|.. .++|++|++++|++++ +
T Consensus 204 ~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l 272 (454)
T 1jl5_A 204 NNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-L 272 (454)
T ss_dssp SSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-c
Confidence 777664 33322 46667777777666 4453 6666667777777776664 3332 3567777777777765 3
Q ss_pred CcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcC-CcCcEEeCcCCcccCCCccccccc
Q 039922 426 PSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTL-RQLQAVDLSQNRFSGHLPTCITQL 504 (973)
Q Consensus 426 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l 504 (973)
|.. .++|+.|++++|++++... -.++|+.|++++|.+++ ++ .+ ++|++|++++|++++ +|.. +
T Consensus 273 ~~~---~~~L~~L~ls~N~l~~l~~----~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~ 336 (454)
T 1jl5_A 273 PEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---P 336 (454)
T ss_dssp CCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---C
T ss_pred Ccc---cCcCCEEECcCCccCcccC----cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---C
Confidence 332 3667777777777765211 12567777777777764 22 22 467777777777774 5544 3
Q ss_pred cccceeeccccccccccCcccCccccceeeeeccCcccC--CCCccccccccccEEecCCCcCccccChhhhccccccee
Q 039922 505 NKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTG--TIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFN 582 (973)
Q Consensus 505 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~ 582 (973)
++|+.|++++|+++ .+|. .+++|+.|+|++|++++ .+|.++..+ +.|++.|.+|..+. +|+.|+
T Consensus 337 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~~~--~L~~L~ 402 (454)
T 1jl5_A 337 PRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPELPQ--NLKQLH 402 (454)
T ss_dssp TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC------------------
T ss_pred CcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccccC--cCCEEE
Confidence 66777777777777 4555 35677777777777776 566665544 22444444443211 344455
Q ss_pred ccCCcCcc
Q 039922 583 ISHNKLYG 590 (973)
Q Consensus 583 l~~N~l~g 590 (973)
+++|+++|
T Consensus 403 ls~N~l~~ 410 (454)
T 1jl5_A 403 VETNPLRE 410 (454)
T ss_dssp --------
T ss_pred CCCCcCCc
Confidence 55555544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=396.67 Aligned_cols=363 Identities=20% Similarity=0.180 Sum_probs=238.9
Q ss_pred cccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccC-CccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEE
Q 039922 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL-PDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVL 174 (973)
Q Consensus 96 ~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 174 (973)
++|++|||++|.+++ +++..|+++++|++|+|++|.+.+.+ +..|..+++|++|+|++|.+++..|..|+++++|++|
T Consensus 30 ~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 108 (455)
T 3v47_A 30 AHVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVL 108 (455)
T ss_dssp TTCCEEECCSSCCCE-ECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEE
T ss_pred CccCEEEecCCccCc-CChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEE
Confidence 567788888887773 44456777888888888888776444 5567778888888888888877777778888888888
Q ss_pred ecCCcccCCccccc--ccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCcc-ccCCCCCCEEEccC
Q 039922 175 NLGGNLLSGLIPSF--LGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDS-IGKLAFLSNLDLSD 251 (973)
Q Consensus 175 ~L~~n~l~~~~p~~--~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~-l~~l~~L~~L~Ls~ 251 (973)
+|++|++++..|.. |+++++|++|+|++|.++... |.. ++++++|++|++++
T Consensus 109 ~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~-------------------------~~~~~~~l~~L~~L~L~~ 163 (455)
T 3v47_A 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ-------------------------PASFFLNMRRFHVLDLTF 163 (455)
T ss_dssp ECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCC-------------------------CCGGGGGCTTCCEEECTT
T ss_pred eCCCCCCCccccCcccccCcccCCEEECCCCccCccC-------------------------cccccCCCCcccEEeCCC
Confidence 88888887654444 777888888888887775431 222 44455555555555
Q ss_pred CcccccCCcCCCCC--CCCCEEEccCCcCcccCchh--------ccCCCccceeeccccccCCCChhhhhc----ccCcE
Q 039922 252 NFLSGKIPHSFSGL--ASIEQIELFDNQLSGELPES--------LSNLTTLLRLDISQNNLTGNLPETIAA----MSLES 317 (973)
Q Consensus 252 N~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~--------l~~l~~L~~L~Ls~N~l~~~~~~~~~~----~~L~~ 317 (973)
|.+++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|+.|++++|++++..|..+.. .+|+.
T Consensus 164 n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~ 243 (455)
T 3v47_A 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243 (455)
T ss_dssp CCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEE
T ss_pred CcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceee
Confidence 55555555555444 45555555555555433222 224456666666666666555554432 35666
Q ss_pred EEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccC--CCCccceeeecccccccCCccccccCCchhhhcccC
Q 039922 318 LNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGK--YSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNN 395 (973)
Q Consensus 318 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 395 (973)
|++++|.+.+... ..+.+.+..+..+.. .++|++|++++|++++.+|..+..+++|+.|++++|
T Consensus 244 L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 309 (455)
T 3v47_A 244 LILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN 309 (455)
T ss_dssp EECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred Eeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCC
Confidence 6666665543211 111122112222222 245556666666666555555666666666666666
Q ss_pred ccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCch
Q 039922 396 RFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPS 475 (973)
Q Consensus 396 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~ 475 (973)
++.+..|..+..+++|++|++++|.+++..+..|.++++|+.|++++|++++..|..+..+++|++|++++|++++..+.
T Consensus 310 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 389 (455)
T 3v47_A 310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDG 389 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHh
Confidence 66666666777777788888888888777777788888888888888888877788888888888888888888876666
Q ss_pred hhhcCCcCcEEeCcCCcccCCCc
Q 039922 476 QICTLRQLQAVDLSQNRFSGHLP 498 (973)
Q Consensus 476 ~~~~l~~L~~L~Ls~N~l~~~~p 498 (973)
.+..+++|++|++++|++++..|
T Consensus 390 ~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 390 IFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTTCTTCCEEECCSSCBCCCTT
T ss_pred HhccCCcccEEEccCCCcccCCC
Confidence 77888888888888888887666
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=392.79 Aligned_cols=418 Identities=23% Similarity=0.311 Sum_probs=214.8
Q ss_pred ceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEEC
Q 039922 73 SVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDL 152 (973)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L 152 (973)
++..|+++++.+ |.+|++++++++|++|++++|.+.|.+|. .++.+.+|+.+++..|.. .++++|++
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~l~l~~c~~-----------~~l~~L~l 78 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPP-GNGEQREMAVSRLRDCLD-----------RQAHELEL 78 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCT-TSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCc-ccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence 455666777766 66777777777777777777776666553 466666665555554432 35688888
Q ss_pred cCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccc
Q 039922 153 SRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIG 232 (973)
Q Consensus 153 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 232 (973)
++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|+++.++ .. .++|++|++++|++.+
T Consensus 79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~--~~---~~~L~~L~L~~n~l~~ 145 (454)
T 1jl5_A 79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALS--DL---PPLLEYLGVSNNQLEK 145 (454)
T ss_dssp TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCC--SC---CTTCCEEECCSSCCSS
T ss_pred cCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCccc--CC---CCCCCEEECcCCCCCC
Confidence 8888885 4442 3678888888888887 5543 378888888888886532 11 1355555555555554
Q ss_pred cCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhc
Q 039922 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAA 312 (973)
Q Consensus 233 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 312 (973)
+| .++++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|+.|++++|.+++ +|...
T Consensus 146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~-- 214 (454)
T 1jl5_A 146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP-- 214 (454)
T ss_dssp -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--
T ss_pred -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--
Confidence 44 35666666666666666653 34332 356666666666654 34 45566666666666666654 22211
Q ss_pred ccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhc
Q 039922 313 MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIII 392 (973)
Q Consensus 313 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 392 (973)
.+|++|++++|+++ .+|. +..+++|++|++++|++++ +|.. +++|++|++++|+++
T Consensus 215 ~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~------------------ 270 (454)
T 1jl5_A 215 LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLT------------------ 270 (454)
T ss_dssp TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCS------------------
T ss_pred CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCccc------------------
Confidence 24555555555555 3442 5555555555555555553 3321 244555555555544
Q ss_pred ccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCC-CCcceEeecCCcCCC
Q 039922 393 FNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNA-PKLTGILINGNNFTG 471 (973)
Q Consensus 393 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-~~L~~L~L~~N~l~~ 471 (973)
+ +|.. .++|++|++++|++++.. . -.++|+.|++++|++++.. .+ ++|+.|++++|++++
T Consensus 271 ------~-l~~~---~~~L~~L~ls~N~l~~l~-~---~~~~L~~L~l~~N~l~~i~-----~~~~~L~~L~Ls~N~l~~ 331 (454)
T 1jl5_A 271 ------D-LPEL---PQSLTFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRSLC-----DLPPSLEELNVSNNKLIE 331 (454)
T ss_dssp ------C-CCCC---CTTCCEEECCSSCCSEES-C---CCTTCCEEECCSSCCSEEC-----CCCTTCCEEECCSSCCSC
T ss_pred ------c-cCcc---cCcCCEEECcCCccCccc-C---cCCcCCEEECcCCcCCccc-----CCcCcCCEEECCCCcccc
Confidence 3 2322 256677777777766521 1 1156777777777776421 22 478888888888885
Q ss_pred CCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeecccccccc--ccCcccCccccceeeeeccCcccCCCCccc
Q 039922 472 EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTG--ELPRNLNSLTALIVLNLSTNQLTGTIPPEL 549 (973)
Q Consensus 472 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 549 (973)
+|.. +++|++|++++|+++ .+|. .+++|+.|+|++|++++ .+|.++.. |+.|.+.|.+|..
T Consensus 332 -lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~- 394 (454)
T 1jl5_A 332 -LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL- 394 (454)
T ss_dssp -CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC---------
T ss_pred -cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc-
Confidence 5543 578999999999998 5676 46889999999999997 67776653 3457777888874
Q ss_pred cccccccEEecCCCcCcc--ccChhhhcccccceeccCCcCcccCCC
Q 039922 550 GNLAVLTSLDLSSNLLTG--EIPLELTKLKLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 550 ~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~l~~l~l~~N~l~g~~p~ 594 (973)
+++|+.||+++|+++| .+|.++ +.|.+.+|.+.+.+|.
T Consensus 395 --~~~L~~L~ls~N~l~~~~~iP~sl-----~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 395 --PQNLKQLHVETNPLREFPDIPESV-----EDLRMNSERVVDPYEF 434 (454)
T ss_dssp -----------------------------------------------
T ss_pred --cCcCCEEECCCCcCCccccchhhH-----hheeCcCcccCCcccc
Confidence 5789999999999998 788765 4567788888887764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=401.36 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=201.2
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC----CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT----HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
.++|++.++||+|+||+||+|+.+ +|+.||+|++.+.. .........+.++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 356889999999999999999987 79999999995432 1111122233456777888999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
|+|||||+||+|.+++...+ .+++..+..++.||+.||+|||++ +||||||||+|||++++|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998754 589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCc-hhHHHHHHHHhccCCC
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KDIVRWVTEATLSSPE 913 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 913 (973)
+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||....... ..+...+.......+
T Consensus 342 ~~~~~------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p- 414 (689)
T 3v5w_A 342 FSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP- 414 (689)
T ss_dssp CSSCC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC-
T ss_pred cCCCC------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC-
Confidence 64332 234689999999999974 579999999999999999999999997532221 122222222111100
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
.....++.+++.+|+++||++|++ +.||++|
T Consensus 415 ---------------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 415 ---------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---------------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---------------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 112356789999999999999998 7888765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=406.31 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=212.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
+.+.++|++.+.||+|+||.||+|+.+ +|+.||+|++... .....+.+.+|+.+|+.++|||||+++++|.+++..|
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 456678999999999999999999986 7999999999543 3445667899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC--CceEEeccCcch
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE--MVPRVADFGLAK 834 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGl~~ 834 (973)
+|||||++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 231 iv~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecccee
Confidence 9999999999999986532 3589999999999999999999999 99999999999999854 899999999998
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.+.... ......||+.|||||++.+..|+.++||||+||++|||++|+.||... ...+....+.......+..
T Consensus 306 ~~~~~~-----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~ 378 (573)
T 3uto_A 306 HLDPKQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDS 378 (573)
T ss_dssp ECCTTS-----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCSG
T ss_pred EccCCC-----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHhCCCCCCcc
Confidence 775432 234567999999999999999999999999999999999999999753 3334444433322111100
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ......+.+++.+||+.||++|||+.|+++|
T Consensus 379 ------------~~------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 ------------AF------SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ------------GG------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------------cc------cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0113567889999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=372.31 Aligned_cols=277 Identities=38% Similarity=0.585 Sum_probs=230.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+...++|+..+.||+|+||.||+|+.++|+.||+|++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 5677899999999999999999999988999999998543 33456778999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 758 VYEYMPNGSLADMLHEKGRS-GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999999765422 3589999999999999999999999 9999999999999999999999999999765
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC-CchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 915 (973)
...... .......||+.|+|||++.++.++.++||||||+++|||++|+.||..... +......|.......
T Consensus 190 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 262 (321)
T 2qkw_B 190 TELDQT--HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN----- 262 (321)
T ss_dssp SSSSCC--CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT-----
T ss_pred cccccc--ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc-----
Confidence 432221 122345689999999999989999999999999999999999999976433 233455555443332
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
..+.+.+++.+.. ....+....+.+++.+|++.||++|||+.||+++|+..
T Consensus 263 --~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 263 --GQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp --TCCCSSSSSSCTT-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccHHHhcChhhcc-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 3344555554432 34477888999999999999999999999999999874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.71 Aligned_cols=295 Identities=27% Similarity=0.521 Sum_probs=192.4
Q ss_pred cchhhHHHHHHHhhhccCCCCCccCCccCCCCCCCCc--cceeEEcCCC--CceeEeecCCCccCC--CCCCCccCcccc
Q 039922 25 SLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCN--WTGITCETQN--QSVDGIDLSGFDLSG--GFPNGFCRIRTL 98 (973)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~d~~~~~~sw~~~~~~~~C~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~~~~l~~L 98 (973)
+.+.|++||++||+++ .||. .+++|.. +.+||. |+||+|+..+ ++|+.|+|++++++| .+|+.|.++++|
T Consensus 3 c~~~~~~aL~~~k~~~-~~~~-~l~~W~~--~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDL-GNPT-TLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp SCHHHHHHHHHHHHHT-TCCG-GGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCHHHHHHHHHHHHhc-CCcc-cccCCCC--CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 4567899999999997 6776 7999964 457898 9999998754 789999999999998 888888888888
Q ss_pred ceeccCC-CcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecC
Q 039922 99 RNLNLSD-NYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLG 177 (973)
Q Consensus 99 ~~L~Ls~-n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 177 (973)
++|+|++ |++.+.+|. .|..+++|++|+|++|.+.+.+|..+..+++|++|+|++|.+++.+|..++.+++|++|+|+
T Consensus 79 ~~L~L~~~n~l~~~~p~-~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPP-AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCG-GGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CeeeCCCCCcccccCCh-hHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 8888884 777655542 34555555555555555555555555555555555555555554445445555555555555
Q ss_pred CcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCC-CCCEEEccCCcccc
Q 039922 178 GNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLA-FLSNLDLSDNFLSG 256 (973)
Q Consensus 178 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~ 256 (973)
+|++++.+|..+ ++++ +|++|++++|++++
T Consensus 158 ~N~l~~~~p~~l-------------------------------------------------~~l~~~L~~L~L~~N~l~~ 188 (313)
T 1ogq_A 158 GNRISGAIPDSY-------------------------------------------------GSFSKLFTSMTISRNRLTG 188 (313)
T ss_dssp SSCCEEECCGGG-------------------------------------------------GCCCTTCCEEECCSSEEEE
T ss_pred CCcccCcCCHHH-------------------------------------------------hhhhhcCcEEECcCCeeec
Confidence 554444444444 4444 45555555555555
Q ss_pred cCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCC
Q 039922 257 KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASN 336 (973)
Q Consensus 257 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l 336 (973)
.+|..|..++ |++|++++|++++..|..+..+++|+.|+|++|.+++.+|......+|++|+|++|++++.+|..+..+
T Consensus 189 ~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 267 (313)
T 1ogq_A 189 KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267 (313)
T ss_dssp ECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGC
T ss_pred cCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcC
Confidence 5555555554 555555555555555555555566666666666655444442222356666666677766777777777
Q ss_pred CccceeeeccccccCCCCCCccCCCCccceeeeccc-ccc
Q 039922 337 PNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTND-FTG 375 (973)
Q Consensus 337 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~ 375 (973)
++|++|+|++|+++|.+|.. ..+++|+.+++++|+ +.|
T Consensus 268 ~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 268 KFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp TTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred cCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 88888888888888777765 777788888888776 443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=373.08 Aligned_cols=289 Identities=40% Similarity=0.671 Sum_probs=235.2
Q ss_pred eeeecccc-ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeE
Q 039922 670 FQRVSFNE-DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748 (973)
Q Consensus 670 ~~~~~~~~-~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 748 (973)
...+++.+ ....++|+..+.||+|+||.||+|+.++|+.||||++..... ......+.+|+++++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34455555 566789999999999999999999988899999999964332 2223358899999999999999999999
Q ss_pred EecCCeeEEEEeccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 749 CSGQDFNILVYEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 749 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
+...+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+.++|+||||||+||++++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999986543 235899999999999999999999987778999999999999999999999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCC---CCCchhHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPS---FGENKDIVRWV 904 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~---~~~~~~~~~~~ 904 (973)
+|||+++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||... ........+|+
T Consensus 176 ~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 176 GDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp CCCSSCEECCSSSS---CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred ccCccccccCcccc---cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99999987643332 2233456999999999999889999999999999999999999999631 22344455665
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
...... ..+..+.+..... ....+....+.+++.+|++.||++|||+.||+++|++..
T Consensus 253 ~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 253 KGLLKE-------KKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTTSS-------CCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHhhc-------hhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 444333 3344455544432 345778899999999999999999999999999998743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.35 Aligned_cols=260 Identities=33% Similarity=0.452 Sum_probs=206.5
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|++.+.||+|+||+||+|+.. |+.||||++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 457889999999999999999874 8999999997665556666789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA--IVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|+++|+|.+++........+++..++.++.|++.||+|||+. + |+||||||+||++++++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999998654323489999999999999999999999 8 99999999999999999999999999976433
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+....+.......
T Consensus 192 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~--~~~~~~~~~~~~~~~~------- 258 (309)
T 3p86_A 192 TF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--NPAQVVAAVGFKCKRL------- 258 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS--CHHHHHHHHHHSCCCC-------
T ss_pred cc----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCC-------
Confidence 22 1123457899999999999999999999999999999999999999753 2233333222211110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.+ .......+.+++.+|++.||++|||+.|+++.|+...
T Consensus 259 --------~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 259 --------EI-----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp --------CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CC-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0112356889999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=365.05 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=212.9
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
....++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+.+|+++++.++||||+++++++...+..|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 345678999999999999999999984 8999999999765555566677889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999997654 489999999999999999999999 9999999999999999999999999999766
Q ss_pred cccCCCccccccccccccCccccccccCCCCC-CCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT-EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.... ......||+.|+|||++.+..+. .++||||+||++|||++|+.||... ........+.......+
T Consensus 165 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~p--- 234 (328)
T 3fe3_A 165 TVGG-----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--NLKELRERVLRGKYRIP--- 234 (328)
T ss_dssp SSSC-----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC---
T ss_pred CCCC-----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC---
Confidence 4322 23446799999999999888765 7899999999999999999999753 33334443333221110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......+.+++.+|++.||++|||+.|++++
T Consensus 235 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 -------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0113567889999999999999999999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=360.91 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=209.8
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..++||+|+||.||+|++. +++.||+|++. .......+.+.+|++++++++||||+++++++.+++..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEES--CCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEec--cCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 356888999999999999999986 68999999984 334566778999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp ECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999986433 589999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCCcc----------ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchh----HHHHHH
Q 039922 840 EGQSD----------DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD----IVRWVT 905 (973)
Q Consensus 840 ~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~----~~~~~~ 905 (973)
..... .......||+.|+|||++.+..++.++||||||+++|||++|..|+......... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 32110 1112457999999999999999999999999999999999999998653222111 111111
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.. .+ ......+.+++.+|++.||++|||+.|+++.|+..+
T Consensus 242 ~~----~~---------------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 242 RY----CP---------------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HT----CC---------------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc----CC---------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 00 011235788999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=357.49 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=208.2
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+..++|+..+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 45578999999999999999999864 79999999985433 2345668899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999764 488999999999999999999999 99999999999999999999999999987664
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+........
T Consensus 168 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~~~----- 236 (297)
T 3fxz_A 168 PEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPEL----- 236 (297)
T ss_dssp STTC----CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHHCSCCC-----
T ss_pred Cccc----ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC-----
Confidence 4322 233467999999999999999999999999999999999999999753 22222222211111100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ........+.+++.+|++.||++|||+.|++++
T Consensus 237 ------~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 ------Q--------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ------S--------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------C--------CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 001223568899999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.59 Aligned_cols=285 Identities=36% Similarity=0.560 Sum_probs=223.2
Q ss_pred eecccc-ccccCCCCcc------ccccccCCeeEEEEEECCCCEEEEEEecCCC--CCchhHHHHHHHHHHHhcCCCCCe
Q 039922 672 RVSFNE-DDILPHLTEQ------NLIGSGGSCRVYKVKLKSGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNV 742 (973)
Q Consensus 672 ~~~~~~-~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni 742 (973)
.+.+.+ ..++..|... +.||+|+||.||+|+. +++.||+|++.... ......+.+.+|+.++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 334333 4455555544 8999999999999987 58999999986432 234456789999999999999999
Q ss_pred eeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 743 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
+++++++...+..++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||+++++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCC
Confidence 999999999999999999999999999997654445689999999999999999999999 99999999999999999
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR 902 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 902 (973)
+.+||+|||+++........ .......||+.|+|||++.+ .++.++||||||+++|||++|..||..... ......
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~ 245 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQT--VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLD 245 (307)
T ss_dssp CCEEECCCTTCEECCSCSSC--EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS-SSBTTH
T ss_pred CcEEEeeccccccccccccc--ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc-hHHHHH
Confidence 99999999998765433221 12234578999999998765 588999999999999999999999976422 222222
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcccC
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKSS 972 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 972 (973)
+........ ..+.+.+++.+. .........+.+++.+|++.||++|||+.||+++|++++.|
T Consensus 246 ~~~~~~~~~------~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 246 IKEEIEDEE------KTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp HHHHHHTTS------CCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred HHHHhhhhh------hhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 222221110 123333444332 34467788999999999999999999999999999998765
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=373.37 Aligned_cols=411 Identities=17% Similarity=0.165 Sum_probs=244.0
Q ss_pred cCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCc
Q 039922 84 LSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPE 163 (973)
Q Consensus 84 l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~ 163 (973)
..+..+.+++++++|++|+|++|.+++. | .++.+++|++|+|++|.+.+. | ++.+++|++|+|++|.+++. |
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C-
T ss_pred cCcccccChhHcCCCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e-
Confidence 3444455677888888888888888753 4 577888888888888887764 3 77888888888888888864 3
Q ss_pred ccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCC
Q 039922 164 SFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAF 243 (973)
Q Consensus 164 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 243 (973)
++.+++|++|+|++|++++. | ++++++|++|++++|+++.++ ++.+++|++|++++|+..+.+ .++.+++
T Consensus 102 -~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l~----l~~l~~L~~L~l~~n~~~~~~--~~~~l~~ 171 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEID----VSHNTQLTELDCHLNKKITKL--DVTPQTQ 171 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCCC----CTTCTTCCEEECTTCSCCCCC--CCTTCTT
T ss_pred -cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccceec----cccCCcCCEEECCCCCccccc--ccccCCc
Confidence 78888888888888888864 3 778888888888888876531 444444444444444433333 2444555
Q ss_pred CCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCC
Q 039922 244 LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDN 323 (973)
Q Consensus 244 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N 323 (973)
|++|++++|++++ +| +..+++|+.|++++|++++. .+..+++ |+.|++++|
T Consensus 172 L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~-----------------------L~~L~Ls~N 222 (457)
T 3bz5_A 172 LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQ-----------------------LTFLDCSSN 222 (457)
T ss_dssp CCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTT-----------------------CSEEECCSS
T ss_pred CCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCC-----------------------CCEEECcCC
Confidence 5555555555553 22 44445555555555555432 1444444 555555555
Q ss_pred cCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCC
Q 039922 324 YFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPE 403 (973)
Q Consensus 324 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~ 403 (973)
++++ +| +..+++|+.|++++|++++.. ++.+++|+.|+++.|+ |+.|++++|.+.+.+|
T Consensus 223 ~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~- 281 (457)
T 3bz5_A 223 KLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ- 281 (457)
T ss_dssp CCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE-
T ss_pred cccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc-
Confidence 5554 33 445555556666666555432 2344555555555442 3345555555555444
Q ss_pred ccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcC
Q 039922 404 SYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQL 483 (973)
Q Consensus 404 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 483 (973)
++.+++|++|++++|...+.+|. ..++|+.|++++ +++|++|++++|++++. + ++.+++|
T Consensus 282 -~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~-------------~~~L~~L~L~~N~l~~l-~--l~~l~~L 341 (457)
T 3bz5_A 282 -AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQ-------------NPKLVYLYLNNTELTEL-D--VSHNTKL 341 (457)
T ss_dssp -CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTT-------------CTTCCEEECTTCCCSCC-C--CTTCTTC
T ss_pred -ccccccCCEEECCCCcccceecc---CCCcceEechhh-------------cccCCEEECCCCccccc-c--cccCCcC
Confidence 34556666666666665555443 223344333333 35677777777777763 2 6777777
Q ss_pred cEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccc-cccccEEecCC
Q 039922 484 QAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGN-LAVLTSLDLSS 562 (973)
Q Consensus 484 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~ 562 (973)
+.|++++|++++ ++.|..|++++|++.|. +.+..|..++|++|+++|.+|..+.. ..++....-+.
T Consensus 342 ~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~~~~~~ 408 (457)
T 3bz5_A 342 KSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGD 408 (457)
T ss_dssp SEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBCTTSCCCEEEESS
T ss_pred cEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhcccCceeeccCCC
Confidence 788888877774 24566677777777765 34566777788888888777765432 23333333333
Q ss_pred CcCcccc---------ChhhhcccccceeccCCcCcccCCCCC
Q 039922 563 NLLTGEI---------PLELTKLKLNQFNISHNKLYGEVPSDF 596 (973)
Q Consensus 563 N~l~~~~---------p~~l~~l~l~~l~l~~N~l~g~~p~~~ 596 (973)
+...... +..... -+..+..++|.++|+|++.+
T Consensus 409 ~~~y~~~~~~i~~k~~~~~~~~-~~y~~~~~~~~fsG~i~~p~ 450 (457)
T 3bz5_A 409 GGVYDQATNTITWENLSTDNPA-VTYTFTSENGAIVGTVTTPF 450 (457)
T ss_dssp SEEEETTTTEEEESSCCTTSCE-ECEEEECTTSSEEEEEEEEB
T ss_pred CccccCCCCeeEEEeccCCCce-EEEEEecCCcEEeeEecccc
Confidence 2221111 111111 12334445788888887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=367.12 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=212.2
Q ss_pred cCCCCccccccccCCeeEEEEEEC--------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK--------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 751 (973)
.++|+..+.||+|+||.||+|+.. ++..||||++... ......+.+.+|+++++++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 457888999999999999999863 4567999999543 2344556789999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEE
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 818 (973)
.+..|+||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999986532 13478999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCc
Q 039922 819 LDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGEN 897 (973)
Q Consensus 819 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 897 (973)
+++++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~--~~ 311 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PV 311 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CG
T ss_pred ECCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC--CH
Confidence 999999999999999866543221 12233457889999999999999999999999999999999 99998753 33
Q ss_pred hhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 898 KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.++...+........+ ......+.+++.+|++.||++||++.|++++|+.+
T Consensus 312 ~~~~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 312 EELFKLLKEGHRMDKP---------------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GGHHHHHHTTCCCCCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCC---------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4444433332211000 11235688999999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=365.04 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=211.7
Q ss_pred cccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc----hhHHHHHHHHHHHhcCCCCCeeeEEeEEec
Q 039922 677 EDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP----ETETVFRSEIETLGRVRHGNVVKLLMCCSG 751 (973)
Q Consensus 677 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 751 (973)
...+.+.|+..+.||+|+||.||+|+.+ +|+.||+|++.+..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 3566778999999999999999999987 69999999996543321 235678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC----ceEE
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM----VPRV 827 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl 827 (973)
.+..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++ .+||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEE
Confidence 999999999999999999997543 589999999999999999999999 999999999999998877 7999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
+|||++....... ......||+.|+|||++.+..++.++||||+||++|||++|..||... ...+....+...
T Consensus 161 ~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~ 233 (361)
T 2yab_A 161 IDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITAV 233 (361)
T ss_dssp CCCSSCEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTT
T ss_pred EecCCceEcCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhc
Confidence 9999998764432 233467999999999999999999999999999999999999999753 333333333222
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....++. .. ......+.+++.+|+++||++|||+.|++++
T Consensus 234 ~~~~~~~--------~~----------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 SYDFDEE--------FF----------SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCCCCHH--------HH----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCch--------hc----------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1110000 00 0123568899999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.66 Aligned_cols=276 Identities=23% Similarity=0.274 Sum_probs=209.8
Q ss_pred ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+.+.++|+..+.||+|+||+||+|+.++|+.||+|++..........+.+.+|++++++++||||+++++++..++..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 56778899999999999999999999899999999996555444556778899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFME-KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCS-EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCC-CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999997 58888887543 2589999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+........+..+
T Consensus 171 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 171 IPV----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT--DDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp SCC----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--TTTHHHHHHHHHCCCCTTTS
T ss_pred CCc----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHHCCCChHHh
Confidence 322 22334578999999999876 568999999999999999999999997642 22333333332222221111
Q ss_pred cC--cccccccCCCCCC-CC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CR--DLNQLIDPRMDLS-TC-----DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~--~l~~~~d~~l~~~-~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. .+....+...... .. ......++.+++.+|+++||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 10 0000001111000 00 01123578899999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.00 Aligned_cols=266 Identities=26% Similarity=0.304 Sum_probs=205.6
Q ss_pred cccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhc--CCCCCeeeEEeEEec----C
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR--VRHGNVVKLLMCCSG----Q 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~ 752 (973)
.+.++|+..+.||+|+||.||+|+. +|+.||||++.. .....+.+|.+++.. ++||||+++++++.. .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 3456899999999999999999988 589999999832 233445556666555 799999999998654 3
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEEeCCCCCCEEeCCCCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH--------NDCVPAIVHRDVKSHNILLDAEMV 824 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~ 824 (973)
+..++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred ceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 5679999999999999999543 5899999999999999999999 77 9999999999999999999
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccCC------CCCCCCChhhHHHHHHHHHcC----------CC
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK------KVTEKSDVYSFGVVLMELVTG----------KR 888 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg----------~~ 888 (973)
+||+|||+++.................||+.|+|||++.+. .++.++|||||||++|||++| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 99999999977654433222223345799999999999876 455789999999999999999 88
Q ss_pred CCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 889 PNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 889 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
||..................... ..+.+............+.+++.+|++.||++|||+.||++.|++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQ------------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSC------------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccC------------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 88654333333322222211110 011111111223567889999999999999999999999999987
Q ss_pred c
Q 039922 969 D 969 (973)
Q Consensus 969 ~ 969 (973)
+
T Consensus 300 i 300 (301)
T 3q4u_A 300 I 300 (301)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.91 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=210.4
Q ss_pred ccCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
..++|++.+.||+|+||.||+|++. .+..||||++.... .....+.+.+|+.++++++||||+++++++..++..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 3467889999999999999999985 34569999995432 345567799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++|+|.++++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999997543 3589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
....... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||... ...+....+........+
T Consensus 201 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~~~~~- 276 (325)
T 3kul_A 201 LEDDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVISSVEEGYRLPAP- 276 (325)
T ss_dssp CC----C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCCCCCC-
T ss_pred cccCccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCCCCCCC-
Confidence 6543221 112233456778999999998999999999999999999999 99999653 333333333322111000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+.+++.+|++.||++||++.||++.|+...
T Consensus 277 --------------------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 277 --------------------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp --------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------------------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 122357889999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=351.49 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=211.8
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4688899999999999999999889999999995432 2345689999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ..+++..++.++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999997643 2589999999999999999999999 999999999999999999999999999986643221
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.......+++.|+|||++.+..++.++||||+|+++|||++ |+.||... ...+....+.......
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~--~~~~~~~~~~~~~~~~--------- 227 (269)
T 4hcu_A 162 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY--------- 227 (269)
T ss_dssp ---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC---------
T ss_pred ---ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhcCccCC---------
Confidence 12233456788999999998999999999999999999999 89998753 2333333332221110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcccC
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKSS 972 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 972 (973)
.+ ......+.+++.+|++.||++||++.|++++|++...+
T Consensus 228 ----~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 228 ----KP--------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CC--------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00 11135688999999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=360.13 Aligned_cols=255 Identities=18% Similarity=0.260 Sum_probs=210.7
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
++.++|+..+.||+|+||.||+|+.+ +++.||+|.+.. .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 45678999999999999999999987 688999999842 23455678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC--CCceEEeccCcchh
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA--EMVPRVADFGLAKA 835 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGl~~~ 835 (973)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999997543 2589999999999999999999999 9999999999999987 78999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
..... ......||+.|+|||++.+..++.++||||+||++|||++|..||... ........+.......+..
T Consensus 154 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~- 225 (321)
T 1tki_A 154 LKPGD-----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEE- 225 (321)
T ss_dssp CCTTC-----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCCHH-
T ss_pred CCCCC-----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC--CHHHHHHHHHcCCCCCChh-
Confidence 64322 233467899999999999888999999999999999999999999753 3333444333322211000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.. .....++.+++.+|+++||++|||+.|++++-
T Consensus 226 -------~~----------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 226 -------AF----------KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp -------HH----------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -------hh----------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 00 01235688999999999999999999999864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=376.68 Aligned_cols=357 Identities=20% Similarity=0.182 Sum_probs=205.1
Q ss_pred cCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccc
Q 039922 116 SLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL 195 (973)
Q Consensus 116 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 195 (973)
.++.+++|++|++++|.+.+. | .++.+++|++|+|++|++++. | ++.+++|++|+|++|++++. | ++++++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcC
Confidence 345555555555555555542 3 355555555555555555542 2 55555555555555555543 2 5555555
Q ss_pred cEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccC
Q 039922 196 THFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275 (973)
Q Consensus 196 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 275 (973)
++|++++|+++.+ | ++++++|++|++++|++++. .++++++|++|++++
T Consensus 109 ~~L~L~~N~l~~l--------------------------~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~ 157 (457)
T 3bz5_A 109 TYLNCDTNKLTKL--------------------------D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHL 157 (457)
T ss_dssp CEEECCSSCCSCC--------------------------C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTT
T ss_pred CEEECCCCcCCee--------------------------c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCC
Confidence 5555555554331 1 44556666666666666653 255666666666666
Q ss_pred CcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCC
Q 039922 276 NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPD 355 (973)
Q Consensus 276 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 355 (973)
|+..+.+ .+..+++|+.|++++|++++. | .....+|+.|++++|++++. .+..+++|+.|++++|++++ +|
T Consensus 158 n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~-l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip- 228 (457)
T 3bz5_A 158 NKKITKL--DVTPQTQLTTLDCSFNKITEL-D-VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID- 228 (457)
T ss_dssp CSCCCCC--CCTTCTTCCEEECCSSCCCCC-C-CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC-
T ss_pred CCccccc--ccccCCcCCEEECCCCcccee-c-cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC-
Confidence 6443333 355556666666666666542 2 11222455555555555543 25555566666666666654 33
Q ss_pred CccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCc
Q 039922 356 DLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEV 435 (973)
Q Consensus 356 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 435 (973)
++.+++|++|++++|++++.. ++.+++|+.|++++|+ |
T Consensus 229 -~~~l~~L~~L~l~~N~l~~~~---------------------------~~~l~~L~~L~l~~n~--------------L 266 (457)
T 3bz5_A 229 -VTPLTQLTYFDCSVNPLTELD---------------------------VSTLSKLTTLHCIQTD--------------L 266 (457)
T ss_dssp -CTTCTTCSEEECCSSCCSCCC---------------------------CTTCTTCCEEECTTCC--------------C
T ss_pred -ccccCCCCEEEeeCCcCCCcC---------------------------HHHCCCCCEEeccCCC--------------C
Confidence 555555666666655555432 2344555555555543 2
Q ss_pred cEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeecccc
Q 039922 436 DFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQEN 515 (973)
Q Consensus 436 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (973)
+.|++++|++.+.+| +..+++|+.|++++|.+.+.+|. ...+|+.|++++| ++|+.|+|++|
T Consensus 267 ~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N 328 (457)
T 3bz5_A 267 LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNT 328 (457)
T ss_dssp SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTC
T ss_pred CEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCC
Confidence 344556665555444 45566777777777776666653 2344555555544 56777777777
Q ss_pred ccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCCC
Q 039922 516 MFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 516 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~ 594 (973)
+|++. + ++.+++|+.|++++|+|++ ++.|+.|++++|.++|. ..+ .+..+++++|+|+|.||.
T Consensus 329 ~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 329 ELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp CCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred ccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 77763 2 7777777777777777775 24556667777777765 133 567778888888888876
Q ss_pred CC
Q 039922 595 DF 596 (973)
Q Consensus 595 ~~ 596 (973)
.+
T Consensus 393 ~~ 394 (457)
T 3bz5_A 393 DL 394 (457)
T ss_dssp TC
T ss_pred hH
Confidence 54
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=363.92 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=212.7
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.+.++|+..+.||+|+||.||+|..+ +|+.||+|++..........+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45567999999999999999999876 68999999997665555666778999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC---CceEEeccCcch
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE---MVPRVADFGLAK 834 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGl~~ 834 (973)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.+ +.+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999887543 589999999999999999999999 99999999999999865 459999999998
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... +.......+.......+..
T Consensus 180 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 180 EVNDSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSP 252 (362)
T ss_dssp CCTTCC-----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTT
T ss_pred EecCCc-----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCcc
Confidence 664322 233467999999999999999999999999999999999999999753 3344444444433221110
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. . ......+.+++.+|+++||++||++.|++++
T Consensus 253 ~------------~------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 E------------W------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp G------------G------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c------------c------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 1123568899999999999999999999876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=371.46 Aligned_cols=257 Identities=18% Similarity=0.245 Sum_probs=212.8
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.+.++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45567899999999999999999875 78999999997665555566778999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC---CCCceEEeccCcch
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD---AEMVPRVADFGLAK 834 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~~ 834 (973)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999987653 489999999999999999999999 999999999999998 46789999999997
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||... +.......+.......+..
T Consensus 162 ~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~ 235 (444)
T 3soa_A 162 EVEGEQ----QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSP 235 (444)
T ss_dssp CCCTTC----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCCCCTT
T ss_pred EecCCC----ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhCCCCCCcc
Confidence 664332 2233467999999999999999999999999999999999999999752 3444445444433221111
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ......+.+++.+|+++||++|||+.|++++
T Consensus 236 ------------~~------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 ------------EW------DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ------------TT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------------cc------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 1123568899999999999999999999885
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.30 Aligned_cols=277 Identities=22% Similarity=0.288 Sum_probs=216.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC--eeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD--FNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 757 (973)
.++|+..++||+|+||.||+|+.. +|+.||||++.... .....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 457889999999999999999987 58999999995332 2233566789999999999999999999988755 7799
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe----CCCCceEEeccCcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL----DAEMVPRVADFGLA 833 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl~ 833 (973)
||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999998765444589999999999999999999999 99999999999999 88888999999999
Q ss_pred hhccccCCCccccccccccccCcccccccc--------CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC--chhHHHH
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAY--------TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRW 903 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~ 903 (973)
+....... .....||..|+|||++. +..++.++|||||||++|||++|+.||...... .......
T Consensus 164 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 164 RELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp EECCTTCC-----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred eecCCCCc-----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 87644322 23456899999999886 578899999999999999999999999753222 2222222
Q ss_pred HHHHhccCCCccccCccccccc------CCC-CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 904 VTEATLSSPERGCCRDLNQLID------PRM-DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d------~~l-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+....... .......... +.+ ............+.+++.+|++.||++|||++|++++..+..
T Consensus 239 ~~~~~p~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSG----AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTT----CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcc----cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 22222111 1111111111 111 112344677888999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=365.70 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=200.9
Q ss_pred ccCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
..++|+..+.||+|+||.||+|+.+ +++.||||++.... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 3457999999999999999999875 57789999995432 345567899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++|+|.++++... ..+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999997643 3589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
........ .......++..|+|||++.++.++.++||||||+++|||++ |+.||... ...+....+........+
T Consensus 197 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--~~~~~~~~i~~~~~~~~~- 272 (373)
T 2qol_A 197 LEDDPEAA-YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--SNQDVIKAVDEGYRLPPP- 272 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--CHHHHHHHHHTTEECCCC-
T ss_pred cccCCccc-eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC-
Confidence 65432211 11222345778999999999999999999999999999998 99999753 333344333322211100
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+|++.||++||++.||++.|+..
T Consensus 273 --------------------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 273 --------------------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp --------------------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 12235688999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=371.26 Aligned_cols=261 Identities=23% Similarity=0.347 Sum_probs=211.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+++ +++.||||++... ......+.+.+|++++++++||||+++++++..++..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 356888899999999999999987 7899999998533 23344567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.++++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999976432 588999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. ........++..|+|||++.++.++.++|||||||++|||++ |..||... ...+..+.+........+
T Consensus 267 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~~~----- 337 (377)
T 3cbl_A 267 VY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--SNQQTREFVEKGGRLPCP----- 337 (377)
T ss_dssp EE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--CHHHHHHHHHTTCCCCCC-----
T ss_pred ce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC-----
Confidence 11 111112335778999999998899999999999999999998 89898653 333344443332211100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcccC
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKSS 972 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 972 (973)
...+..+.+++.+||+.||++|||+.+|++.|+.++..
T Consensus 338 ----------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 338 ----------------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11235678999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.86 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=210.6
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||.||+|+.++++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 35688899999999999999999988899999995332 234568999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++..... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999976532 489999999999999999999999 99999999999999999999999999998664332
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||... ........+.......
T Consensus 159 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~-------- 225 (268)
T 3sxs_A 159 Y---VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY--TNSEVVLKVSQGHRLY-------- 225 (268)
T ss_dssp E---EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCCCC--------
T ss_pred h---hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc--ChHHHHHHHHcCCCCC--------
Confidence 1 12233456778999999998899999999999999999999 99999753 2222222222211110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
.+ ......+.+++.+|++.||++|||+.|++++|+..+.
T Consensus 226 -----~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 -----RP--------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -----CC--------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -----CC--------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 00 0113468899999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=358.25 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=207.7
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+.++|+..+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4578999999999999999999987 799999999854332 23345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999987543 589999999999999999999999 999999999999999999999999999976543
Q ss_pred cCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|........+
T Consensus 158 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 230 (323)
T 3tki_A 158 NNR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----- 230 (323)
T ss_dssp TTE--ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT-----
T ss_pred CCc--ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc-----
Confidence 321 122334679999999999987765 778999999999999999999998654443444443322111100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.......+.+++.+|++.||++|||+.|++++-
T Consensus 231 ----------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 231 ----------------WKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ----------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ----------------cccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 011235678899999999999999999998763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=356.83 Aligned_cols=257 Identities=22% Similarity=0.296 Sum_probs=210.1
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc----hhHHHHHHHHHHHhcCCCCCeeeEEeEEecC
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP----ETETVFRSEIETLGRVRHGNVVKLLMCCSGQ 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 752 (973)
+.+.+.|+..+.||+|+||.||+|+.+ +|+.||+|++....... ...+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 455667899999999999999999986 68999999996543221 2457789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC----ceEEe
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM----VPRVA 828 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 828 (973)
+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++ .+||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 99999999999999999997543 589999999999999999999999 999999999999999887 89999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|..||... ...+....+....
T Consensus 161 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~ 233 (326)
T 2y0a_A 161 DFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVN 233 (326)
T ss_dssp CCTTCEECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHTC
T ss_pred ECCCCeECCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--CHHHHHHHHHhcC
Confidence 999998764332 123457999999999999999999999999999999999999999753 2223333332221
Q ss_pred ccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 909 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+. ... ......+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~--------~~~----------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEFED--------EYF----------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCCH--------HHH----------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCcCc--------ccc----------ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11000 000 0123567899999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=355.41 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=207.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 356888999999999999999986 699999999954321 123345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999997653 488999999999999999999999 999999999999999999999999999975432
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +.....+.+.......
T Consensus 158 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~------- 224 (337)
T 1o6l_A 158 DG----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRF------- 224 (337)
T ss_dssp TT----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCC-------
T ss_pred CC----CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCC-------
Confidence 22 2234467999999999999999999999999999999999999999753 3333333333221110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
. ......+.+++.+|++.||++|| ++.||++|
T Consensus 225 ----------p-----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 ----------P-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----------C-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------C-----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 11235678999999999999999 89999876
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.48 Aligned_cols=272 Identities=23% Similarity=0.291 Sum_probs=210.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||+||+|+.. +|+.||+|++..........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999986 68999999997666555666788999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|++ |++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCD-QDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 997 46666665432 3589999999999999999999999 99999999999999999999999999998664322
Q ss_pred CCccccccccccccCccccccccCCC-CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKK-VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.......||+.|+|||++.+.. ++.++||||+||++|||++|+.|+.... +..+....+.......... ....
T Consensus 156 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-~~~~~~~~i~~~~~~~~~~-~~~~ 229 (292)
T 3o0g_A 156 ----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEE-QWPS 229 (292)
T ss_dssp ----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHHHHHHHHHHHCCCCTT-TCTT
T ss_pred ----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-CHHHHHHHHHHHhCCCChh-hhhh
Confidence 2233457899999999998765 7999999999999999999999976543 2333333333322221111 1111
Q ss_pred ccccccC--------CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDP--------RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~--------~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+..+. ..............+.+++.+|++.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1111110 000011112335678899999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.24 Aligned_cols=267 Identities=25% Similarity=0.300 Sum_probs=207.2
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC----eeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD----FNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 757 (973)
++|+..++||+|+||.||+|+.. ++.||||++.. .......+.+|+.++++++||||+++++++.... ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeec---CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 46889999999999999999887 89999999942 2334455677999999999999999999998744 4699
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------CCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC-------VPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+||++++++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999999764 4899999999999999999999862 238999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCC-----CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch-------
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-----KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK------- 898 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~------- 898 (973)
|+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 176 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 176 GLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp TTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred CcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 999876544321 223345799999999998763 556688999999999999999999976432211
Q ss_pred ----hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 899 ----DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 899 ----~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
....+....... ...+.+............+.+++.+|++.||++|||+.||++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHK------------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CSSCCHHHHHHHHTTS------------CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcc------------cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111111 011111111122345677999999999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=361.69 Aligned_cols=260 Identities=19% Similarity=0.285 Sum_probs=212.1
Q ss_pred ccccccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC
Q 039922 674 SFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ 752 (973)
Q Consensus 674 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 752 (973)
......+.++|+..+.||+|+||.||+|..+ +|+.||+|++... .......+.+|++++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred cccCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 3344566788999999999999999999986 7899999998533 334556789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC--CCceEEecc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA--EMVPRVADF 830 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Df 830 (973)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEec
Confidence 99999999999999999987543 2589999999999999999999999 9999999999999974 578999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|..||... ...+....+......
T Consensus 196 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~i~~~~~~ 268 (387)
T 1kob_A 196 GLATKLNPDE-----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWE 268 (387)
T ss_dssp TTCEECCTTS-----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHCCCC
T ss_pred ccceecCCCc-----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC
Confidence 9998764332 123357899999999999999999999999999999999999999753 223333333332211
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+. ... ......+.+++.+|++.||++|||+.|++++
T Consensus 269 ~~~------------~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 FDE------------DAF------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCS------------STT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCc------------ccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 000 1123568899999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=347.83 Aligned_cols=271 Identities=24% Similarity=0.313 Sum_probs=205.1
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||.||+|+..+|+.||+|++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57888999999999999999998899999999965443334446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CS-EEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 97 59999887543 3588999999999999999999999 99999999999999999999999999998764322
Q ss_pred CccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ...+....+............ ...
T Consensus 155 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~-~~~ 228 (288)
T 1ob3_A 155 ---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV--SEADQLMRIFRILGTPNSKNW-PNV 228 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTTTS-TTG
T ss_pred ---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHHCCCChhhc-hhh
Confidence 12234568999999999876 45899999999999999999999999753 222222222222111111110 111
Q ss_pred ccc--ccCCCCC------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQL--IDPRMDL------STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~--~d~~l~~------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+. .++.+.. ..........+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 110 1111110 00011234577899999999999999999999876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.10 Aligned_cols=249 Identities=20% Similarity=0.329 Sum_probs=205.2
Q ss_pred CCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 556678999999999999987 79999999995433 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 125 ~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 196 (321)
T 2c30_A 125 QGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP- 196 (321)
T ss_dssp CSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-
Confidence 999999998643 489999999999999999999999 999999999999999999999999999877644322
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
......||+.|+|||++.+..++.++||||||+++|||++|+.||... ........+......
T Consensus 197 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~------------ 259 (321)
T 2c30_A 197 ---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD--SPVQAMKRLRDSPPP------------ 259 (321)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCC------------
T ss_pred ---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCC------------
Confidence 123457999999999999999999999999999999999999999753 222333332221111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+. ........+.+++.+|++.||++|||+.|++++-
T Consensus 260 ----~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 260 ----KLK---NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp ----CCT---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ----CcC---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 0011235688999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=347.78 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=207.4
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||.||+++..+++.||+|++.... ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 45788899999999999999999988899999995332 234668999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999976432 589999999999999999999999 99999999999999999999999999998664322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||... ........+........+
T Consensus 175 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~~~~------ 243 (283)
T 3gen_A 175 Y---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLRLYRP------ 243 (283)
T ss_dssp H---HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCCCCCC------
T ss_pred c---ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--ChhHHHHHHhcccCCCCC------
Confidence 1 11233456788999999998899999999999999999998 99999753 222333332222111000
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+|++.||++|||+.|++++|+..
T Consensus 244 ---------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 ---------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ---------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01135688999999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=362.05 Aligned_cols=262 Identities=25% Similarity=0.359 Sum_probs=212.3
Q ss_pred ccCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 753 (973)
..++|+..+.||+|+||.||+|++. +++.||||++... ........+.+|+.++++++||||+++++++...+
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3467889999999999999999853 5678999998532 33455567889999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC---ceE
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR----SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM---VPR 826 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~k 826 (973)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999976532 23588999999999999999999999 999999999999999555 599
Q ss_pred EeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHH
Q 039922 827 VADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 827 l~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 905 (973)
|+|||+++........ .......||+.|+|||++.++.++.++|||||||++|||++ |..||... ...+....+.
T Consensus 225 L~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--~~~~~~~~i~ 300 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYY--RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVT 300 (367)
T ss_dssp ECCCHHHHHHHHHSSC--TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHH
T ss_pred ECCCcccccccccccc--ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHH
Confidence 9999999876443321 22334567899999999999999999999999999999998 99998753 3344444443
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.......+ ......+.+++.+|++.||++||++.||+++|+...
T Consensus 301 ~~~~~~~~---------------------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGRMDPP---------------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCC---------------------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 32211111 112346889999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.85 Aligned_cols=263 Identities=26% Similarity=0.369 Sum_probs=208.0
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.+.++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.++++++||||+++++++..++..|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34568999999999999999999976 789999999855433 3345577899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 88 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999997654 589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.... ... ..........+.
T Consensus 162 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~---~~~~~~~~~~~~-- 231 (294)
T 4eqm_A 162 SETSL---TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--AVS---IAIKHIQDSVPN-- 231 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--HHH---HHHHHHSSCCCC--
T ss_pred ccccc---cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHH---HHHHHhhccCCC--
Confidence 43321 12234568999999999999999999999999999999999999997532 111 111111110000
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhhc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-SMRRVVELLRVD 969 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~ 969 (973)
...- ........+.+++.+|+++||++|| +++++.+.|+..
T Consensus 232 ---~~~~---------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 232 ---VTTD---------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp ---HHHH---------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred ---cchh---------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0000 0012246788999999999999998 999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.05 Aligned_cols=254 Identities=31% Similarity=0.480 Sum_probs=204.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhH-----HHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETE-----TVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++.......... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467889999999999999999985 78999999986544332222 67899999999999999999999987655
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEeCCCCCCEEeCCCCc-----eEE
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA--IVHRDVKSHNILLDAEMV-----PRV 827 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl 827 (973)
++||||+++|+|.+++.... ..+++..++.++.|++.|++|||+. + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 69999999999999886543 3689999999999999999999999 8 999999999999988776 999
Q ss_pred eccCcchhccccCCCccccccccccccCcccccccc--CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY--TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 905 (973)
+|||+++.... ......||+.|+|||++. ...++.++||||+||++|||++|+.||.............+.
T Consensus 171 ~Dfg~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 243 (287)
T 4f0f_A 171 ADFGLSQQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243 (287)
T ss_dssp CCCTTCBCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred CCCCccccccc-------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence 99999874322 233467899999999983 456788999999999999999999999764333332233332
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
...... .+ .......+.+++.+|++.||++|||+.|+++.|++
T Consensus 244 ~~~~~~---------------~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLRP---------------TI-----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCCC---------------CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCCC---------------CC-----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 221110 00 01223578899999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=357.54 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=202.8
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-----
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD----- 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 753 (973)
+.++|+..+.||+|+||.||+|+.+ +|+.||||++.... .....+.+.+|++++++++||||++++++|.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3457888999999999999999987 89999999996443 3445677999999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEeccCCCChhhhhhccCCCCCCC
Q 039922 754 ----------------------------------------------------FNILVYEYMPNGSLADMLHEKGRSGSLD 781 (973)
Q Consensus 754 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~ 781 (973)
..++||||+++|+|.+++.........+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 3799999999999999998766555567
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCc--------cccccccccc
Q 039922 782 WSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS--------DDAMSCVAGS 853 (973)
Q Consensus 782 ~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~--------~~~~~~~~gt 853 (973)
+..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......... ........||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 778999999999999999999 99999999999999999999999999998765442211 1122345799
Q ss_pred cCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCC
Q 039922 854 YGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTC 933 (973)
Q Consensus 854 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 933 (973)
+.|+|||++.+..++.++||||+||++|||++|..|+.. .............+ ..
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~~~~~~------------------~~ 294 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVRNLKFP------------------LL 294 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHHTTCCC------------------HH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhhccCCC------------------cc
Confidence 999999999999999999999999999999998765421 11111111111000 01
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 934 DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 934 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.......+.+++.+|+++||++|||+.|++++
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 12334567899999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.56 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=213.2
Q ss_pred ccCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 753 (973)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.++++++||||+++++++..++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 3467889999999999999999975 34789999996432 3445677999999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCC
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR---------------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDV 812 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 812 (973)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 99999999999999999976421 13689999999999999999999999 9999999
Q ss_pred CCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCC
Q 039922 813 KSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPND 891 (973)
Q Consensus 813 kp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~ 891 (973)
||+||++++++.+||+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccc--cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999876443221 12234567889999999998899999999999999999999 999997
Q ss_pred CCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 892 PSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
.. ...+....+........+ ......+.+++.+|++.||++||++.||+++|++...
T Consensus 279 ~~--~~~~~~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GM--AHEEVIYYVRDGNILACP---------------------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TS--CHHHHHHHHHTTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CC--ChHHHHHHHhCCCcCCCC---------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 53 233333333322111000 1123568899999999999999999999999988643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.56 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=212.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC--------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK--------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 751 (973)
.++|...+.||+|+||.||+|+.. .++.||+|++... ......+.+.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 457888999999999999999863 3457999999544 3344557789999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEE
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 818 (973)
++..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999976532 13589999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCc
Q 039922 819 LDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGEN 897 (973)
Q Consensus 819 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 897 (973)
+++++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||... ..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~--~~ 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PV 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CH
T ss_pred EcCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--CH
Confidence 999999999999999876543221 12233567889999999999999999999999999999999 99998653 33
Q ss_pred hhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 898 KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.++.+.+........+ ......+.+++.+|++.||++|||+.||+++|+..
T Consensus 300 ~~~~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 300 EELFKLLKEGHRMDKP---------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHHHHTTCCCCCC---------------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCC---------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3444433332211110 11235688999999999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.69 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=211.8
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.+.++|+..+.||+|+||.||+|..+ +|+.||+|++..........+.+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 34578999999999999999999876 68999999997655555666778999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc---eEEeccCcch
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV---PRVADFGLAK 834 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl~~ 834 (973)
||||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||.+.
T Consensus 83 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999998887653 489999999999999999999999 9999999999999987655 9999999997
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||... ........+.......+..
T Consensus 157 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~ 229 (284)
T 3kk8_A 157 EVNDSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSP 229 (284)
T ss_dssp ECCSSC-----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTT
T ss_pred EcccCc-----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC--chhHHHHHHHhccccCCch
Confidence 654322 223467899999999999999999999999999999999999999753 3333444333332221110
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ......+.+++.+|+++||++|||+.|++++
T Consensus 230 ------------~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 ------------EW------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ------------TT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------------hh------cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 1123568899999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=360.24 Aligned_cols=259 Identities=19% Similarity=0.241 Sum_probs=207.3
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC---CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT---HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.+.++|+..+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++..++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34467899999999999999999876 78999999984321 112245678999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc---eEEecc
Q 039922 755 NILVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV---PRVADF 830 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 830 (973)
.|+||||+++|+|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999988876432 223588999999999999999999999 9999999999999987654 999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
|+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.. ........+......
T Consensus 178 g~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 178 GVAIQLGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG---TKERLFEGIIKGKYK 250 (351)
T ss_dssp TTCEECCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS---SHHHHHHHHHHTCCC
T ss_pred cceeEecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC---cHHHHHHHHHcCCCC
Confidence 99987644321 12345799999999999999999999999999999999999999975 223333333332211
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.. . ......+.+++.+|++.||++|||+.|++++
T Consensus 251 ~~~~~--------~----------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 MNPRQ--------W----------SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCHHH--------H----------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccc--------c----------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10000 0 0123578899999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.82 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=205.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++.+... .....+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 356888999999999999999986 799999999853321 112345678899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998643 488999999999999999999999 999999999999999999999999999986532
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+
T Consensus 159 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~p------ 223 (318)
T 1fot_A 159 V-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRFP------ 223 (318)
T ss_dssp C-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHCCCCCC------
T ss_pred c-------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC------
Confidence 2 23357999999999999999999999999999999999999999753 22333333322211100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
......+.+++.+|++.||++|| ++.|+++|
T Consensus 224 ----------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 224 ----------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11135678999999999999999 89998865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=357.68 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=202.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
.++|+..++||+|+||.||+|+.+ +|+.||+|++.+... .....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467899999999999999999976 689999999954321 223345678899999988 69999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999997654 489999999999999999999999 99999999999999999999999999997533
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+..+.+.......+
T Consensus 176 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~p----- 244 (353)
T 3txo_A 176 CNG----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDEVVYP----- 244 (353)
T ss_dssp C-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC-----
T ss_pred cCC----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCC-----
Confidence 221 2234467999999999999999999999999999999999999999753 33444444433221100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM------RRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 965 (973)
......+.+++.+|+++||++||++ .|+++|
T Consensus 245 -----------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 245 -----------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -----------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 0123567889999999999999998 777764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=351.01 Aligned_cols=273 Identities=27% Similarity=0.344 Sum_probs=206.2
Q ss_pred ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC--CCCCeeeEEeEEecC---
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV--RHGNVVKLLMCCSGQ--- 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~--- 752 (973)
..+.++|+..+.||+|+||.||+|+.. |+.||||++.. .....+.+|.+++... +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 445678999999999999999999987 89999999832 2233445555555554 899999999999876
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEEeCCCCCCEEeCCCCceE
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC-----VPAIVHRDVKSHNILLDAEMVPR 826 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~k 826 (973)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+||+++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7889999999999999999754 4899999999999999999999762 33899999999999999999999
Q ss_pred EeccCcchhccccCCCccccccccccccCccccccccCCCCCCC------CChhhHHHHHHHHHcC----------CCCC
Q 039922 827 VADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEK------SDVYSFGVVLMELVTG----------KRPN 890 (973)
Q Consensus 827 l~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~~l~elltg----------~~p~ 890 (973)
|+|||+++.................||+.|+|||++.+...+.+ +|||||||++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997765443322222334679999999999988777665 9999999999999999 6666
Q ss_pred CCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 891 DPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.................... ...+.+.......+....+.+++.+|++.||++|||+.||+++|+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIK------------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTS------------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhcCCCCchhhhHHHHhhh------------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 54333322222222221111 011111111112356788999999999999999999999999999865
Q ss_pred cC
Q 039922 971 SS 972 (973)
Q Consensus 971 ~~ 972 (973)
.+
T Consensus 331 ~~ 332 (337)
T 3mdy_A 331 ES 332 (337)
T ss_dssp HT
T ss_pred hh
Confidence 43
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.35 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=205.1
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|+..+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+.+|+.+++.++|||||++++++.+.+..|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567999999999999999999976 68899999985322 112334668899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 93 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999997643 589999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCCccccccccccccCccccccccC---CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-chhHHHHHHHHhccCCC
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-NKDIVRWVTEATLSSPE 913 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 913 (973)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .......+.......+
T Consensus 167 ~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p- 240 (384)
T 4fr4_A 167 RET-----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP- 240 (384)
T ss_dssp TTC-----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC-
T ss_pred CCC-----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC-
Confidence 322 2344679999999999864 45899999999999999999999999754222 2222232222111100
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-MRRVVE 964 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~ 964 (973)
......+.+++.+|++.||++||+ +.+|.+
T Consensus 241 ---------------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 ---------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112356889999999999999998 777765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.30 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=211.3
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 4688899999999999999999889999999995433 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp CTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred CCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 99999999997643 2588999999999999999999999 99999999999999999999999999998654321
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
........++..|+|||++.+..++.++||||+|+++|||++ |+.||... ........+.......
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~i~~~~~~~--------- 225 (267)
T 3t9t_A 159 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY--------- 225 (267)
T ss_dssp --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC---------
T ss_pred --ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC--CHHHHHHHHhcCCcCC---------
Confidence 111223456788999999998899999999999999999999 89898753 2333333332221110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcccC
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKSS 972 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 972 (973)
.+ ......+.+++.+|++.||++||++.|++++|++...+
T Consensus 226 ----~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 226 ----KP--------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CC--------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 11235688999999999999999999999999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.27 Aligned_cols=262 Identities=25% Similarity=0.306 Sum_probs=196.5
Q ss_pred cCCCCccccccccCCeeEEEEEECCC----CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee-
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSG----ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN- 755 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~- 755 (973)
.++|+..+.||+|+||.||+|+.... ..||||++..........+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 45799999999999999999987633 2799999966554556677899999999999999999999999877665
Q ss_pred -----EEEEeccCCCChhhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 756 -----ILVYEYMPNGSLADMLHEKGR---SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 756 -----~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 999999999999999865432 12588999999999999999999999 9999999999999999999999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 906 (973)
+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||... ...+....+..
T Consensus 179 ~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~ 254 (323)
T 3qup_A 179 ADFGLSRKIYSGDYY--RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI--ENAEIYNYLIG 254 (323)
T ss_dssp CCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHT
T ss_pred eeccccccccccccc--cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc--ChHHHHHHHhc
Confidence 999999876443321 12223456788999999999999999999999999999999 89998753 23333333332
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
...... .......+.+++.+|++.||++|||+.|+++.|++..
T Consensus 255 ~~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 255 GNRLKQ---------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp TCCCCC---------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCC---------------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 221100 0112356889999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.82 Aligned_cols=266 Identities=28% Similarity=0.368 Sum_probs=204.4
Q ss_pred cCCCCccccccccCCeeEEEEEE-----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--C
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL-----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--D 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 753 (973)
.++|+..+.||+|+||.||+|++ .+++.||||++. .......+.+.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEES--CCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcc--cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 45788999999999999999984 268899999994 33445567789999999999999999999998653 4
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 58999999999999999976532 489999999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC----------CchhHHHH
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG----------ENKDIVRW 903 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~----------~~~~~~~~ 903 (973)
+........ ........++..|+|||++.+..++.++||||||+++|||++|..|+..... ........
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEF-FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcce-eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 876543321 1122334577889999999999999999999999999999999999864210 00011111
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
+........ ... ........+.+++.+|++.||++|||+.|+++.|+.+..
T Consensus 241 ~~~~~~~~~--------------~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNG--------------RLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTC--------------CCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccC--------------cCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111111100 000 011224678899999999999999999999999988653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.04 Aligned_cols=252 Identities=24% Similarity=0.303 Sum_probs=197.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc------------------------hhHHHHHHHHHHHh
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP------------------------ETETVFRSEIETLG 735 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~ 735 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 567999999999999999999876 68899999986443211 12356889999999
Q ss_pred cCCCCCeeeEEeEEec--CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCC
Q 039922 736 RVRHGNVVKLLMCCSG--QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVK 813 (973)
Q Consensus 736 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 813 (973)
+++||||+++++++.. .+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999986 6788999999999999886543 2589999999999999999999999 99999999
Q ss_pred CCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCC---CCCCCChhhHHHHHHHHHcCCCCC
Q 039922 814 SHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK---VTEKSDVYSFGVVLMELVTGKRPN 890 (973)
Q Consensus 814 p~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~ 890 (973)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999987643321 233457999999999987665 377899999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 891 DPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... ........+.......+ + .......+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~--~~~~~~~~~~~~~~~~~------------~--------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 241 MDE--RIMCLHSKIKSQALEFP------------D--------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCS--SHHHHHHHHHHCCCCCC------------S--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCc--cHHHHHHHHhcccCCCC------------C--------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 752 22222222222111100 0 01123568899999999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.31 Aligned_cols=261 Identities=27% Similarity=0.357 Sum_probs=212.9
Q ss_pred cCCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|...+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|++++++++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 45788899999999999999986 245789999996432 34555778999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCC
Q 039922 755 NILVYEYMPNGSLADMLHEKGR---------------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVK 813 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 813 (973)
.++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999986532 12488999999999999999999999 99999999
Q ss_pred CCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCC
Q 039922 814 SHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDP 892 (973)
Q Consensus 814 p~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~ 892 (973)
|+||++++++.+||+|||+++........ .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSY--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCE--ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hheEEEcCCCCEEEccccccccccccccc--eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999866443321 12233457788999999999899999999999999999999 9999975
Q ss_pred CCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 893 SFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
. ........+........+ ......+.+++.+|++.||++||++.|++++|+.+.
T Consensus 256 ~--~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 256 I--PPERLFNLLKTGHRMERP---------------------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp C--CGGGHHHHHHTTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C--CHHHHHHHhhcCCcCCCC---------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3 233444433332211000 112356889999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.69 Aligned_cols=254 Identities=31% Similarity=0.447 Sum_probs=198.1
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||.||+|+.. ++.||+|++.. ....+.+.+|++++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 46788899999999999999986 78999999842 245567899999999999999999999876 347999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc-eEEeccCcchhccccC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV-PRVADFGLAKALQSQE 840 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGl~~~~~~~~ 840 (973)
+++|+|.+++........+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 999999999986544335788999999999999999999932128999999999999998886 799999999765322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
.....||..|+|||++.+..++.++||||||+++|||++|+.||.............+......
T Consensus 160 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 223 (307)
T 2eva_A 160 ------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP---------- 223 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC----------
T ss_pred ------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC----------
Confidence 2234689999999999999999999999999999999999999975432222222211111110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
... ......+.+++.+|++.||++|||+.|++++|+...
T Consensus 224 -~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 224 -PLI----------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp -CCB----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred -Ccc----------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 000 112356789999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.78 Aligned_cols=256 Identities=26% Similarity=0.366 Sum_probs=201.5
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCE----EEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGET----VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
++|+..++||+|+||+||+|++. +++. ||+|++.... .....+.+.+|+.++++++||||+++++++..++ .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 46888999999999999999865 4443 5888774332 3345577899999999999999999999998765 77
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+|+||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 89999999999999987533 589999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
...... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||... ....+...+........+
T Consensus 168 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~~~~~-- 241 (327)
T 3poz_A 168 GAEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQP-- 241 (327)
T ss_dssp TTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCCCC--
T ss_pred cCCccc--ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC--CHHHHHHHHHcCCCCCCC--
Confidence 544322 12233456889999999999999999999999999999999 99999753 333444443332211100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+|++.||++||++.|++++|+..
T Consensus 242 -------------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 242 -------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -------------------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -------------------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11235688999999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=369.51 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=210.6
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||.||+|++++++.||||++.... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 45678889999999999999999889999999995432 34667999999999999999999999986 567899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999999975421 2478889999999999999999999 99999999999999999999999999998764321
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......++..|+|||++..+.++.++|||||||++|||++ |+.||... ...++.+.+........+
T Consensus 339 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~~~~~------ 407 (454)
T 1qcf_A 339 Y---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGYRMPRP------ 407 (454)
T ss_dssp H---HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHHTCCCCCC------
T ss_pred e---eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC------
Confidence 1 11222346788999999998999999999999999999999 99999753 334444444433221111
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
......+.+++.+|++.||++|||+.+|++.|+....
T Consensus 408 ---------------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 408 ---------------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---------------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1123568899999999999999999999999998643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=341.26 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=208.4
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--CeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 758 (973)
.++|+..+.||+|+||.||+|++. ++.||+|++..........+.+.+|+.++++++||||+++++++... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457889999999999999999986 89999999976655666677899999999999999999999999887 788999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA--IVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + ++||||||+||++++++.++++|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999998643 22589999999999999999999998 8 999999999999999999999999887543
Q ss_pred cccCCCccccccccccccCccccccccCCCCCC---CCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTE---KSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.. ....||+.|+|||++.+..++. ++||||||+++|||++|+.||... ........+......
T Consensus 164 ~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~--- 229 (271)
T 3kmu_A 164 QS---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--SNMEIGMKVALEGLR--- 229 (271)
T ss_dssp SC---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS--CHHHHHHHHHHSCCC---
T ss_pred cc---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--ChHHHHHHHHhcCCC---
Confidence 21 2246789999999998766554 799999999999999999999753 222222222111111
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
+.+. ......+.+++.+|++.||++|||+.|+++.|+..+.
T Consensus 230 ------------~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 ------------PTIP-----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------------CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------------CCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0000 1123568899999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=358.94 Aligned_cols=262 Identities=27% Similarity=0.367 Sum_probs=210.0
Q ss_pred cCCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 753 (973)
.++|+..+.||+|+||.||+|++ .+++.||||++... ......+.+.+|+++++++ +||||+++++++...+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 46789999999999999999974 25678999999543 2344556789999999999 7899999999998755
Q ss_pred -eeEEEEeccCCCChhhhhhccCC--------------------------------------------------------
Q 039922 754 -FNILVYEYMPNGSLADMLHEKGR-------------------------------------------------------- 776 (973)
Q Consensus 754 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 776 (973)
..++||||+++|+|.++++....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999976432
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccc
Q 039922 777 -------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849 (973)
Q Consensus 777 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~ 849 (973)
...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ .....
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~ 254 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGD 254 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC--EEC--
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc--hhccc
Confidence 11288999999999999999999999 9999999999999999999999999999866443321 22334
Q ss_pred cccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCC
Q 039922 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRM 928 (973)
Q Consensus 850 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 928 (973)
..||..|+|||++.+..++.++|||||||++|||++ |+.||.... ........+........+
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~~~~~~~~~~~~--------------- 318 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEGTRMRAP--------------- 318 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-CSHHHHHHHHHTCCCCCC---------------
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc-hhHHHHHHHHcCCCCCCC---------------
Confidence 568899999999999999999999999999999998 999997542 223333333332211110
Q ss_pred CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 929 DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 929 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+.+++.+|+++||++|||+.||+++|+...
T Consensus 319 ------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 319 ------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 012356889999999999999999999999998754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=359.36 Aligned_cols=235 Identities=23% Similarity=0.342 Sum_probs=109.5
Q ss_pred CccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccE
Q 039922 94 RIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKV 173 (973)
Q Consensus 94 ~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 173 (973)
.+++|+.|++++|.+. .++ .+..+++|++|+|++|.+.+..+ +..+++|++|++++|.+++..| ++++++|++
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~--~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HhccccEEecCCCCCc-cCc--chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 3556666666666655 233 24445555555555555444332 4455555555555555543322 455555555
Q ss_pred EecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCc
Q 039922 174 LNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNF 253 (973)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 253 (973)
|+|++|++++..+ +.++++|++|++++|.++.. + .++++++|++|+++ |.
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--------------------------~-~~~~l~~L~~L~l~-~~ 166 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--------------------------S-ALSGLTSLQQLSFG-NQ 166 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC--------------------------G-GGTTCTTCSEEEEE-ES
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCC--------------------------h-hhccCCcccEeecC-Cc
Confidence 5555555544322 44455555555554444321 1 24455556666654 33
Q ss_pred ccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccc
Q 039922 254 LSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESL 333 (973)
Q Consensus 254 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~ 333 (973)
+.+..+ +.++++|++|++++|++++. ..+..+++|+.|++++|.+++..| .....+|+.|++++|++++. ..+
T Consensus 167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l 239 (466)
T 1o6v_A 167 VTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--GTL 239 (466)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--GGG
T ss_pred ccCchh--hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc--hhh
Confidence 332222 55555666666666655532 234555555555555555554333 11122444444444444432 233
Q ss_pred cCCCccceeeeccccccCCCCCCccCCCCccceeeeccccc
Q 039922 334 ASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT 374 (973)
Q Consensus 334 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 374 (973)
..+++|+.|++++|.+++..+ +..+++|++|++++|+++
T Consensus 240 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 278 (466)
T 1o6v_A 240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278 (466)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC
T ss_pred hcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccC
Confidence 444444444444444443222 333444444444444433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.04 Aligned_cols=273 Identities=26% Similarity=0.274 Sum_probs=205.3
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC---CchhHHHHHHHHHHHhcCC---CCCeeeEEeEEecC
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH---KPETETVFRSEIETLGRVR---HGNVVKLLMCCSGQ 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 752 (973)
+.++|+..+.||+|+||+||+|+.. +|+.||+|++..... .......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4568999999999999999999974 789999999853321 1122345667777777665 99999999999775
Q ss_pred C-----eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 753 D-----FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 753 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
. ..++||||++ |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 4 5799999996 699999976542 2489999999999999999999999 9999999999999999999999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+....+...
T Consensus 162 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~i~~~ 234 (308)
T 3g33_A 162 ADFGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN--SEADQLGKIFDL 234 (308)
T ss_dssp CSCSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS--SHHHHHHHHHHH
T ss_pred eeCccccccCCCc-----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHH
Confidence 9999998664332 234467899999999999999999999999999999999999999753 333333434333
Q ss_pred hccCCCccccCcccccccCCCCCCC-C-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLST-C-----DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~-~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....+...++... .+....+.... . .++....+.+++.+|+++||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSC-SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchh-hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 3222222221111 11111110000 0 01224678899999999999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=364.29 Aligned_cols=252 Identities=29% Similarity=0.413 Sum_probs=206.9
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC-eeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD-FNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|++. |+.||||+++... ..+.+.+|+.++++++||||+++++++...+ ..|+||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 456888899999999999999986 7899999995432 3467899999999999999999999987655 789999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999987542 2478999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+....+..+.....+
T Consensus 343 ~-------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~~~~p----- 408 (450)
T 1k9a_A 343 Q-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAP----- 408 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS--CTTTHHHHHHTTCCCCCC-----
T ss_pred c-------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC-----
Confidence 1 12356789999999999999999999999999999998 99999753 233444444332211111
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 409 ----------------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 409 ----------------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1123578899999999999999999999999988653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=352.84 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=202.4
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|.+.+.||+|+||.||+|+.. +|+.||+|++.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4578999999999999999999974 789999999853211 11223568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+ +|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 789999887654 489999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ..
T Consensus 160 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~---------------- 216 (336)
T 3h4j_B 160 DGN-----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP--NL---------------- 216 (336)
T ss_dssp TSB-----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST--TC----------------
T ss_pred CCc-----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH--HH----------------
Confidence 332 2234579999999999988776 68999999999999999999999753211 00
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+....... .......+.+++.+|++.||.+|||+.|++++
T Consensus 217 ---~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 217 ---FKKVNSCVYVM---PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ---BCCCCSSCCCC---CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ---HHHHHcCCCCC---cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00000000000 01123567899999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=350.67 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=197.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..++||+|+||+||+|+.. +|+.||||++..............+|+..+.++ +|+||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 356889999999999999999987 799999999866555555555566666666555 899999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+ +++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6799998876543 589999999999999999999999 999999999999999999999999999876543
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. ......||++|+|||++.+ .++.++|||||||++|||++|..|+... .. ...+.... .+
T Consensus 210 ~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~-~~~~~~~~---~~----- 270 (311)
T 3p1a_A 210 AG-----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EG-WQQLRQGY---LP----- 270 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HH-HHHHTTTC---CC-----
T ss_pred CC-----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cH-HHHHhccC---CC-----
Confidence 32 1233568999999998875 7899999999999999999998776531 11 11111100 00
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.-+. ......+.+++.+|+++||++|||+.|++++
T Consensus 271 ---~~~~---------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 ---PEFT---------AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HHHH---------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cccc---------cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0000 1124678999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=358.72 Aligned_cols=280 Identities=20% Similarity=0.228 Sum_probs=209.1
Q ss_pred cCCCCcccccccc--CCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSG--GSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.++|++.++||+| +||.||+|+.+ +|+.||||++..........+.+.+|+.++++++|||||++++++..++..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578999999999 99999999987 79999999997665555666788999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999997653 23589999999999999999999999 99999999999999999999999999986543
Q ss_pred ccCC---CccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 838 SQEG---QSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 838 ~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.... ..........||..|+|||++.+ ..++.++||||+||++|||++|+.||...... ......+........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKLNGTVPCLL 258 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST-THHHHC---------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHhcCCCCccc
Confidence 2211 11112233578999999999987 67899999999999999999999999763222 222111111100000
Q ss_pred C-cccc--------------Cccccccc---C-----CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 E-RGCC--------------RDLNQLID---P-----RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~-~~~~--------------~~l~~~~d---~-----~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ...+ ....+.+. + ..............+.+++.+|+++||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0000 00000000 0 000001112234578999999999999999999999876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=347.55 Aligned_cols=273 Identities=22% Similarity=0.285 Sum_probs=204.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 467889999999999999999986 5999999999766555556677889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998876543 489999999999999999999999 9999999999999999999999999999776433
Q ss_pred CCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc--
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC-- 916 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 916 (973)
.. ......||..|+|||++.+ ..++.++||||+|+++|||++|+.||... ...+....+........+...
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 SD----YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK--SDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc----ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhcccccccccc
Confidence 21 2234578999999999876 67899999999999999999999999753 222222222222111110000
Q ss_pred ---cCcc--cccccCCCCCC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 ---CRDL--NQLIDPRMDLS--TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ---~~~l--~~~~d~~l~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... ..+.++..... ...+.....+.+++.+|++.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000000000 0001224568899999999999999999999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=347.05 Aligned_cols=273 Identities=21% Similarity=0.319 Sum_probs=194.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++.... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357899999999999999999876 68999999996443 2233456789999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 760 EYMPNGSLADMLHEKG---RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
||++ |+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 69999886542 123588999999999999999999999 9999999999999999999999999999866
Q ss_pred cccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ...+....+...........
T Consensus 159 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 159 GIPV----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT--NDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp TSCC----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCSCCTTT
T ss_pred CCCc----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCChhH
Confidence 4322 12334578999999999876 46899999999999999999999999753 23333333333222111110
Q ss_pred ccCcccccc--cCCCCCC-----------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLI--DPRMDLS-----------TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~--d~~l~~~-----------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ....... .+.+... .........+.+++.+|++.||++|||+.|++++
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 W-PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp C-GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred h-hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000000 0000000 0000123578899999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.75 Aligned_cols=264 Identities=28% Similarity=0.410 Sum_probs=202.6
Q ss_pred cccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
-..++|+..+.||+|+||.||+|+.. ..||+|++..........+.+.+|+.++++++|+||+++++++ ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 33567999999999999999999865 4699999976666666678899999999999999999999965 45668999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999996543 3589999999999999999999999 999999999999999999999999999976543
Q ss_pred cCCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
... ........||+.|+|||++. +..++.++||||+|+++|||++|+.||.... ......+.+.........
T Consensus 173 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~-- 247 (289)
T 3og7_A 173 WSG--SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDL-- 247 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHHHTSCCCCT--
T ss_pred ccc--cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhcccccCcch--
Confidence 222 12234467899999999986 5678889999999999999999999997532 333344444333222110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.. ........+.+++.+|++.||++||++.|+++.|++..
T Consensus 248 -----~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 -----SK----------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -----TS----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----hh----------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00 11122467899999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=354.80 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=202.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
.++|+..++||+|+||.||+|+.+ +++.||+|++.+.... ....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457889999999999999999987 6789999999654322 22334577899998877 89999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998653 489999999999999999999999 99999999999999999999999999997532
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-------chhHHHHHHHHhcc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-------NKDIVRWVTEATLS 910 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~ 910 (973)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.+......
T Consensus 205 ~~~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 280 (396)
T 4dc2_A 205 RPG----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280 (396)
T ss_dssp CTT----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC
T ss_pred cCC----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC
Confidence 221 2234567999999999999999999999999999999999999999643111 11122222221111
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM------RRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 965 (973)
. . ......+.+++.+|++.||++||++ .||+++
T Consensus 281 ~-----------------p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 281 I-----------------P-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp C-----------------C-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred C-----------------C-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0 0 1123567899999999999999985 677654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.19 Aligned_cols=248 Identities=23% Similarity=0.265 Sum_probs=207.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467889999999999999999986 799999999853321 123345688899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998654 489999999999999999999999 999999999999999999999999999986533
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+..+.+.......+
T Consensus 194 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~p------ 258 (350)
T 1rdq_E 194 R-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFP------ 258 (350)
T ss_dssp C-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC------
T ss_pred C-------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC--CHHHHHHHHHcCCCCCC------
Confidence 2 22357999999999999999999999999999999999999999753 33333333333221100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
......+.+++.+|++.||++||+ +.||+++
T Consensus 259 ----------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 ----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 012356889999999999999998 8888765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=357.31 Aligned_cols=342 Identities=23% Similarity=0.354 Sum_probs=206.4
Q ss_pred ceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEEC
Q 039922 73 SVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDL 152 (973)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L 152 (973)
+++.|+++++++.. +| .+..+++|++|+|++|.+++. ++ +..+++|++|++++|.+.+..+ ++.+++|++|+|
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-hh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 46667777776654 33 366777777777777777643 32 6777777777777777765544 777777777777
Q ss_pred cCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccc
Q 039922 153 SRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIG 232 (973)
Q Consensus 153 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 232 (973)
++|.+++..+ ++.+++|++|++++|.+++. + .++++++|++|+++ |.+..
T Consensus 120 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~------------------------- 169 (466)
T 1o6v_A 120 FNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTD------------------------- 169 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCC-------------------------
T ss_pred CCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccC-------------------------
Confidence 7777775432 77777777777777777753 2 36777777777775 33221
Q ss_pred cCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhc
Q 039922 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAA 312 (973)
Q Consensus 233 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 312 (973)
+ ..++++++|++|++++|.+++. ..+..+++|++|++++|++++..| ++.+++|+.|++++|.+++. +.....
T Consensus 170 -~-~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l 242 (466)
T 1o6v_A 170 -L-KPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-GTLASL 242 (466)
T ss_dssp -C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GGGGGC
T ss_pred -c-hhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-hhhhcC
Confidence 0 1255666777777777777643 236677777777777777775544 56677777777777777643 333333
Q ss_pred ccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhc
Q 039922 313 MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIII 392 (973)
Q Consensus 313 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 392 (973)
.+|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-------------- 304 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-------------- 304 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--------------
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--------------
Confidence 467777777777775544 6677777777777777775433 6667777777777776654322
Q ss_pred ccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCC
Q 039922 393 FNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE 472 (973)
Q Consensus 393 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~ 472 (973)
+..+++|++|++++|++++..| +..+++|+.|++++|++++. +.+..+++|+.|++++|++++.
T Consensus 305 ------------~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 368 (466)
T 1o6v_A 305 ------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDL 368 (466)
T ss_dssp ------------GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBC
T ss_pred ------------hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCcc
Confidence 2333344444444444443332 33444444444444444432 2344444455555555555444
Q ss_pred CchhhhcCCcCcEEeCcCCccc
Q 039922 473 VPSQICTLRQLQAVDLSQNRFS 494 (973)
Q Consensus 473 ~p~~~~~l~~L~~L~Ls~N~l~ 494 (973)
.| +..+++|+.|++++|+++
T Consensus 369 ~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 369 TP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp GG--GTTCTTCCEEECCCEEEE
T ss_pred ch--hhcCCCCCEEeccCCccc
Confidence 43 445555555555555555
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.17 Aligned_cols=254 Identities=27% Similarity=0.359 Sum_probs=192.6
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
+.+.++|+..+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 345677999999999999999999987 68899999995332 3456889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCceEEeccCcc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVPRVADFGLA 833 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl~ 833 (973)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 125 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp EEECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999999987543 489999999999999999999999 9999999999999975 889999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+......
T Consensus 199 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~i~~~~~~--- 269 (349)
T 2w4o_A 199 KIVEHQV-----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-DQFMFRRILNCEYY--- 269 (349)
T ss_dssp -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-HHHHHHHHHTTCCC---
T ss_pred cccCccc-----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-cHHHHHHHHhCCCc---
Confidence 8654322 12345789999999999999999999999999999999999999975322 22222222221111
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+ ........+.+++.+|++.||++|||+.|++++
T Consensus 270 ---------~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 ---------FISP------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---------CCTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------cCCc------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 001224578899999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=369.99 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=211.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+++ +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 346788899999999999999987 48899999995432 23567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 296 E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999986432 3588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. .......+++.|+|||++.++.++.++|||||||++|||++ |..||... +..++.+.+........+
T Consensus 372 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~~~----- 441 (495)
T 1opk_A 372 TY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP----- 441 (495)
T ss_dssp CE---ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCCCCC-----
T ss_pred ce---eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC-----
Confidence 21 12223456788999999999999999999999999999999 88888753 333444444332211100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+.+++.+||+.||++|||+.||++.|+...
T Consensus 442 ----------------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 442 ----------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----------------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 112356889999999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=348.59 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=204.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.+... .....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 356888999999999999999986 688999999965432 334456688999999988 89999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999997653 489999999999999999999999 99999999999999999999999999997543
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-------chhHHHHHHHHhcc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-------NKDIVRWVTEATLS 910 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~ 910 (973)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.+......
T Consensus 162 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 237 (345)
T 3a8x_A 162 RPG----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237 (345)
T ss_dssp CTT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC
T ss_pred CCC----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC
Confidence 221 1234467999999999999999999999999999999999999999652111 11112222111110
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM------RRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 965 (973)
+. ......+.+++.+|++.||++||++ .|+++|
T Consensus 238 -----------------~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 -----------------IP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -----------------CC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -----------------CC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 00 1123567899999999999999985 677654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=353.95 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=199.9
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC--CCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH--GNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 758 (973)
-++|++.+.||+|+||.||++...+++.||||++..........+.+.+|+.++++++| +||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 34688999999999999999999999999999997665556666789999999999986 9999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||+ .+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 88 ~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp ECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 995 5789999998643 588999999999999999999999 999999999999997 67899999999987654
Q ss_pred cCCCccccccccccccCccccccccC-----------CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYT-----------KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 160 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---- 233 (343)
T 3dbq_A 160 DTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH----
T ss_pred cccc--ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH----
Confidence 3221 12234579999999999864 678889999999999999999999997532211111111
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
....... .+. ......+.+++.+|++.||++|||+.|++++-
T Consensus 234 ~~~~~~~------------~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 234 IDPNHEI------------EFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HCTTSCC------------CCC-----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hcCCccc------------CCc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1110000 000 01124678999999999999999999998874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=348.03 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=209.6
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc----hhHHHHHHHHHHHhcCCCCCeeeEEeEEecC
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP----ETETVFRSEIETLGRVRHGNVVKLLMCCSGQ 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 752 (973)
..+.++|+..+.||+|+||.||+|+.+ +|+.||+|++....... ...+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 445667999999999999999999986 68999999996543222 2467789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC----ceEEe
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM----VPRVA 828 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 828 (973)
+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999999997543 589999999999999999999999 999999999999999888 79999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
|||++....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||... ...+....+....
T Consensus 162 Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 162 DFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITSVS 234 (321)
T ss_dssp CCTTCEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTC
T ss_pred cCccceecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcc
Confidence 999998764332 123456899999999999999999999999999999999999999753 2222222222211
Q ss_pred ccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 909 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...++ +.. ......+.+++.+|+++||++|||+.|++++
T Consensus 235 ~~~~~--------~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YDFDE--------EFF----------SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCCH--------HHH----------TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccCh--------hhh----------cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11000 000 0123568899999999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.31 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=204.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 756 (973)
..++|...+.||+|+||.||+|+.+ +|+.||+|++.+... .....+.+..|..+++.+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3567899999999999999999986 689999999954321 122345577888888876 8999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999997653 489999999999999999999999 9999999999999999999999999999754
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+..+.+......
T Consensus 169 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~------ 236 (345)
T 1xjd_A 169 MLGD----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPF------ 236 (345)
T ss_dssp CCTT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC------
T ss_pred ccCC----CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhCCCC------
Confidence 3222 1234467999999999999999999999999999999999999999753 333444433332111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR-RVVE 964 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 964 (973)
+. ......+.+++.+|++.||++||++. ||++
T Consensus 237 -----------~p-----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 -----------YP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----------CC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----------CC-----cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 00 01135678999999999999999997 6654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=346.51 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=197.2
Q ss_pred cCCCCccccccccCCeeEEEEEE----CCCCEEEEEEecCCCC--CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL----KSGETVAVKRLLGGTH--KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|+..+.||+|+||.||+|+. .+|+.||+|++.+... .......+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999987 4789999999965432 22334567889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997653 478999999999999999999999 99999999999999999999999999987
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+
T Consensus 170 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~p-- 241 (327)
T 3a62_A 170 ESIHDG----TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--NRKKTIDKILKCKLNLP-- 241 (327)
T ss_dssp -------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCCCC--
T ss_pred ccccCC----ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCC--
Confidence 543222 1223457899999999999999999999999999999999999999753 23333333333211100
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
......+.+++.+|++.||++|| ++.|+++|
T Consensus 242 --------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 242 --------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11235678999999999999999 78888875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=354.70 Aligned_cols=248 Identities=20% Similarity=0.284 Sum_probs=197.5
Q ss_pred ccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 686 EQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
..+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3578999999999999875 7999999999533 334567789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe--CCCCceEEeccCcchhccccCCC
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL--DAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++ ++++.+||+|||+++.......
T Consensus 171 ~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 171 GELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp CEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 99999886542 2588999999999999999999999 99999999999999 6778999999999987643321
Q ss_pred ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 922 (973)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+....+.......+.
T Consensus 245 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~--------- 309 (373)
T 2x4f_A 245 ----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD--NDAETLNNILACRWDLED--------- 309 (373)
T ss_dssp ----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCSCS---------
T ss_pred ----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccCCCCh---------
Confidence 23356999999999999999999999999999999999999999753 222333323222111000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 923 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... ......+.+++.+|+++||++|||+.|++++
T Consensus 310 ---~~~------~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 310 ---EEF------QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ---GGG------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hhh------ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 1123578899999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=350.22 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=202.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CC-------CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SG-------ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ 752 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 752 (973)
.++|+..+.||+|+||.||+|+.. ++ +.||+|++.. ......+.+.+|++++++++||||+++++++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG--GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc--ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 356888999999999999999876 23 4799999843 3345567799999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc--------
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV-------- 824 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------- 824 (973)
+..++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999986432 488999999999999999999999 9999999999999998887
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 903 (973)
+||+|||.+...... ....||..|+|||++.+ ..++.++||||+|+++|||++|+.|+..... .......
T Consensus 160 ~kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~~~~~~ 230 (289)
T 4fvq_A 160 IKLSDPGISITVLPK--------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQF 230 (289)
T ss_dssp EEECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHH
T ss_pred eeeccCcccccccCc--------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-hHHHHHH
Confidence 999999998754221 22457889999999987 7789999999999999999997666654322 1111211
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcccC
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKSS 972 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 972 (973)
. ...... +. .....+.+++.+|+++||++|||+.|++++|++...+
T Consensus 231 ~-~~~~~~-~~---------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 Y-EDRHQL-PA---------------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp H-HTTCCC-CC---------------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred h-hccCCC-CC---------------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1 111110 00 0013467899999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.35 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=198.2
Q ss_pred ccCCCCccccccccCCeeEEEEEECC----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
..++|+..+.||+|+||.||+|++.. +..||+|++... ......+.+.+|+..+++++||||+++++++. ++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34678899999999999999998753 457999988533 23455677899999999999999999999984 5678
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999997643 2589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
....... ......+++.|+|||++.+..++.++||||+|+++|||++ |..||... ...+....+........
T Consensus 166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~--~~~~~~~~i~~~~~~~~-- 238 (281)
T 1mp8_A 166 MEDSTYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERLPM-- 238 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCCC--
T ss_pred cCccccc---ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC--CHHHHHHHHHcCCCCCC--
Confidence 6443221 1223456788999999998899999999999999999997 88999753 23344444332211100
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.......+.+++.+|++.||++|||+.|++++|+.+
T Consensus 239 -------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 239 -------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011235688999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=352.18 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=209.5
Q ss_pred cCCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 753 (973)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 46788999999999999999986 246689999996432 233446788999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCC
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRS--------------------GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVK 813 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 813 (973)
..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999765321 2378999999999999999999999 99999999
Q ss_pred CCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCC
Q 039922 814 SHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDP 892 (973)
Q Consensus 814 p~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~ 892 (973)
|+||+++.++.+||+|||++......... .......||+.|+|||++.++.++.++||||||+++|||++ |..||..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999876544321 22334567889999999999999999999999999999998 9999975
Q ss_pred CCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 893 SFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.. ........+........+ ......+.+++.+|++.||++|||+.|++++|+...
T Consensus 278 ~~-~~~~~~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 278 IP-VDANFYKLIQNGFKMDQP---------------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CC-CSHHHHHHHHTTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC-cHHHHHHHHhcCCCCCCC---------------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 42 223333333222111000 112356889999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=348.87 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=212.5
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG 751 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 751 (973)
+...++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 344567999999999999999999765 36789999995332 33455678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKG-------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV 824 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 824 (973)
.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCe
Confidence 999999999999999999987532 113568999999999999999999999 9999999999999999999
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHH
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 903 (973)
+||+|||+++........ .......+|+.|+|||++.+..++.++||||+|+++|||++ |..||... ...+....
T Consensus 177 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~ 252 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRF 252 (322)
T ss_dssp EEECCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHHH
T ss_pred EEECcCcccccccccccc--ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC--CHHHHHHH
Confidence 999999999866443221 12233456889999999999999999999999999999999 88888652 23333333
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+........ .......+.+++.+|++.||++|||+.|++++|++..
T Consensus 253 ~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 253 VMEGGLLDK---------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHTTCCCCC---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHcCCcCCC---------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 322211100 0112356889999999999999999999999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=349.62 Aligned_cols=279 Identities=21% Similarity=0.270 Sum_probs=212.9
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec------
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG------ 751 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 751 (973)
...++|+..+.||+|+||.||+|+.. +|+.||+|++............+.+|+.++++++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 34578999999999999999999985 79999999996655555555678899999999999999999999876
Q ss_pred --CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 752 --QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 752 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
.+..++||||++ |++.+.+..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 94 RCKGSIYLVFDFCE-HDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp ---CEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred cCCceEEEEEeccC-CCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence 446899999997 578777765432 589999999999999999999999 999999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
||+++.+...............||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ........+....
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLC 245 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHh
Confidence 99998775444333344455678999999998876 45799999999999999999999999763 3334444444433
Q ss_pred ccCCCccccCc-ccccccCC--CCCCCCCH-HH------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 909 LSSPERGCCRD-LNQLIDPR--MDLSTCDY-EE------AEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 909 ~~~~~~~~~~~-l~~~~d~~--l~~~~~~~-~~------~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...++...+.. -.+..+.. ........ +. ...+.+++.+|++.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 33222211110 00111100 00001111 11 2458899999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=350.86 Aligned_cols=268 Identities=26% Similarity=0.308 Sum_probs=211.1
Q ss_pred ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhc--CCCCCeeeEEeEEecCC--
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGR--VRHGNVVKLLMCCSGQD-- 753 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~-- 753 (973)
..+.++|+..+.||+|+||.||+|+.. |+.||+|++. ......+.+|.+++.. ++||||+++++++...+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~-----~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFS-----SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEC-----GGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeC-----chhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 344567999999999999999999985 8999999983 2234567788888877 78999999999998776
Q ss_pred --eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEEeCCCCCCEEeCCCC
Q 039922 754 --FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH--------NDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 754 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||++++++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence 789999999999999999753 4899999999999999999999 77 999999999999999999
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCccccccccCCC------CCCCCChhhHHHHHHHHHcC----------C
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK------VTEKSDVYSFGVVLMELVTG----------K 887 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~elltg----------~ 887 (973)
.+||+|||++..................||+.|+|||++.+.. ++.++|||||||++|||++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876544322111234457999999999987652 33689999999999999999 7
Q ss_pred CCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 039922 888 RPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967 (973)
Q Consensus 888 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 967 (973)
.||............+....... ...+.+.......+....+.+++.+|++.||++|||+.||+++|+
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQ------------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTS------------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHH------------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 78866433333333333322211 011111111122456778999999999999999999999999998
Q ss_pred hcc
Q 039922 968 VDK 970 (973)
Q Consensus 968 ~~~ 970 (973)
.+.
T Consensus 333 ~i~ 335 (342)
T 1b6c_B 333 QLS 335 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.51 Aligned_cols=265 Identities=22% Similarity=0.254 Sum_probs=204.1
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC---CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT---HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD 753 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 753 (973)
.++.++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 345678999999999999999999875 78899999985331 12345567899999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCC-------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR-------------------------------------SGSLDWSIRFSIAQGAAKGL 796 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~~L 796 (973)
..++||||+++|+|.+++..... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999999852110 11235677889999999999
Q ss_pred HHHhhcCCCCeEEeCCCCCCEEeCCCC--ceEEeccCcchhccccCCCccccccccccccCccccccccC--CCCCCCCC
Q 039922 797 AYLHNDCVPAIVHRDVKSHNILLDAEM--VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSD 872 (973)
Q Consensus 797 ~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 872 (973)
+|||+. +|+||||||+||+++.++ .+||+|||+++.+...............||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 89999999998765433322223445679999999999875 67899999
Q ss_pred hhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCC
Q 039922 873 VYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDF 952 (973)
Q Consensus 873 v~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~d 952 (973)
||||||++|||++|+.||... ...+....+.......+. +. .......+.+++.+|+++|
T Consensus 259 iwslG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~------------~~------~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGV--NDADTISQVLNKKLCFEN------------PN------YNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCTTS------------GG------GGGSCHHHHHHHHHHSCSC
T ss_pred HHHHHHHHHHHHHCCCCCCCC--ChHHHHHHHHhcccccCC------------cc------cccCCHHHHHHHHHHcCCC
Confidence 999999999999999999753 222333322222211000 00 0112356889999999999
Q ss_pred CCCCCCHHHHHHH
Q 039922 953 PINRPSMRRVVEL 965 (973)
Q Consensus 953 P~~Rps~~evl~~ 965 (973)
|++||++.|++++
T Consensus 319 p~~Rps~~~~l~h 331 (345)
T 3hko_A 319 VDERFDAMRALQH 331 (345)
T ss_dssp TTTSCCHHHHHHS
T ss_pred hhHCCCHHHHhcC
Confidence 9999999999886
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.57 Aligned_cols=256 Identities=29% Similarity=0.451 Sum_probs=195.0
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCC--chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK--PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|++. |+.||||++...... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457888999999999999999986 899999998544322 23346788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC--------CCceEEecc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA--------EMVPRVADF 830 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Df 830 (973)
|||+++++|.+++... .+++..++.++.|++.|++|||++...+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998642 5899999999999999999999992112999999999999986 778999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
|.++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||... ........+......
T Consensus 161 g~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 161 GLAREWHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--DGLAVAYGVAMNKLA 232 (271)
T ss_dssp CC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--CHHHHHHHHHTSCCC
T ss_pred Cccccccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHhhhcCCCC
Confidence 9998654332 12356899999999999999999999999999999999999999753 222222111111100
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
. .. .......+.+++.+|++.||++|||+.|++++|+.+
T Consensus 233 ~---------------~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 L---------------PI-----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C---------------CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C---------------CC-----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 00 011235688999999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=348.10 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=210.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC--------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK--------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 751 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 357888999999999999999863 56789999995432 344556788999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEE
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 818 (973)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999976532 12478999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCc
Q 039922 819 LDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGEN 897 (973)
Q Consensus 819 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 897 (973)
++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||... ..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~ 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PV 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSE--ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CH
T ss_pred EcCCCCEEEccccccccccccccc--cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC--CH
Confidence 999999999999999866443221 11233456788999999998899999999999999999999 99998653 33
Q ss_pred hhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 898 KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.++...+........+ ......+.+++.+|++.||++||++.|++++|+.+
T Consensus 266 ~~~~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKP---------------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCC---------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3444444333211000 11235688999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.82 Aligned_cols=258 Identities=28% Similarity=0.360 Sum_probs=193.9
Q ss_pred CCccccccccCCeeEEEEEEC--CC--CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-CCeeEEE
Q 039922 684 LTEQNLIGSGGSCRVYKVKLK--SG--ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-QDFNILV 758 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 758 (973)
|...+.||+|+||.||+|+.. ++ ..||+|.+... ......+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 566789999999999999864 22 36899988543 334556789999999999999999999998754 5678999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.++++.... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999976433 578999999999999999999999 999999999999999999999999999987654
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.............+|+.|+|||++.+..++.++|||||||++|||++ |..||... ...+....+........
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~--~~~~~~~~~~~~~~~~~----- 317 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRLLQ----- 317 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CSSCHHHHHHTTCCCCC-----
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC--CHHHHHHHHHcCCCCCC-----
Confidence 33222222334567789999999999999999999999999999999 55566542 22333333333221100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+ ......+.+++.+|++.||++||++.|++++|+.+.
T Consensus 318 --------p--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 318 --------P--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp --------C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------C--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 112356889999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=346.12 Aligned_cols=262 Identities=17% Similarity=0.210 Sum_probs=210.0
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
+.++|+..+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|+++++++ +|+||+++++++..++..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 3467899999999999999999974 789999999854422 23478899999999 89999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc-----eEEeccCc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV-----PRVADFGL 832 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGl 832 (973)
||||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99999 899999998642 3689999999999999999999999 9999999999999999887 99999999
Q ss_pred chhccccCCCcc---ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-chhHHHHHHHHh
Q 039922 833 AKALQSQEGQSD---DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-NKDIVRWVTEAT 908 (973)
Q Consensus 833 ~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~ 908 (973)
++.+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+....+....
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 987654332111 1124567999999999999999999999999999999999999999864322 222233333222
Q ss_pred ccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 909 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
...+.. ... ...+ ++.+++..|++.||.+||++++|.+.|+..
T Consensus 237 ~~~~~~--------~~~---------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 237 RATPIE--------VLC---------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHSCHH--------HHT---------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccCCHH--------HHh---------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 221100 000 0012 789999999999999999999999999763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=350.15 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=206.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++.+... .....+.+.+|..++..+ +||+|+++++++...+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 567899999999999999999987 578999999854321 123345678899999988 79999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999998654 489999999999999999999999 99999999999999999999999999997543
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..++.+.+.......+
T Consensus 173 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~p----- 241 (353)
T 2i0e_A 173 WDG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVAYP----- 241 (353)
T ss_dssp CTT----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC-----
T ss_pred cCC----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC--CHHHHHHHHHhCCCCCC-----
Confidence 221 1234467999999999999999999999999999999999999999753 33344444433221100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
......+.+++.+|++.||++||+ +.|++++
T Consensus 242 -----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 -----------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112356889999999999999995 5777765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=348.74 Aligned_cols=256 Identities=26% Similarity=0.350 Sum_probs=202.9
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCE----EEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGET----VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
++|+..+.||+|+||.||+|++. +++. ||+|.+.... .......+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 46888999999999999999875 4443 7888774332 2223345678999999999999999999986 45688
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999997642 2588999999999999999999999 9999999999999999999999999999887
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
...... .......|+..|+|||++.++.++.++||||||+++|||++ |+.||... ........+........+..
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~ 241 (325)
T 3kex_A 166 PPDDKQ--LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL--RLAEVPDLLEKGERLAQPQI 241 (325)
T ss_dssp CCCTTC--CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CTTHHHHHHHTTCBCCCCTT
T ss_pred Cccccc--ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc--CHHHHHHHHHcCCCCCCCCc
Confidence 544322 22344567889999999999999999999999999999999 99999753 23344444443322211111
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
....+.+++.+|++.||++||++.|++++|+..
T Consensus 242 ---------------------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 242 ---------------------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp ---------------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred ---------------------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112356899999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=339.39 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=206.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
++.++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 45667899999999999999999987 57799999985433 2345678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe---CCCCceEEeccCcch
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAK 834 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~ 834 (973)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999999887653 489999999999999999999999 99999999999999 788999999999997
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
...... ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||... ...+....+.......+..
T Consensus 158 ~~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~ 229 (277)
T 3f3z_A 158 RFKPGK-----MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEK 229 (277)
T ss_dssp ECCTTS-----CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCHH
T ss_pred eccCcc-----chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCch
Confidence 664332 2334578999999998865 4899999999999999999999999753 2333333333322111100
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ......+.+++.+|+++||++|||+.|++++
T Consensus 230 ~~------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 230 DW------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HH------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hh------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0123578899999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.99 Aligned_cols=271 Identities=15% Similarity=0.193 Sum_probs=207.9
Q ss_pred ccCCCCccccccccCCeeEEEEEECC------CCEEEEEEecCCCCCchhH---------HHHHHHHHHHhcCCCCCeee
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLKS------GETVAVKRLLGGTHKPETE---------TVFRSEIETLGRVRHGNVVK 744 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~ 744 (973)
..++|+..+.||+|+||.||+|++.+ ++.||||++.........+ ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999998864 4789999985432111111 12334666778889999999
Q ss_pred EEeEEecC----CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC
Q 039922 745 LLMCCSGQ----DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD 820 (973)
Q Consensus 745 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 820 (973)
+++++... ...|+||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99998764 4579999999 999999997643 3589999999999999999999999 999999999999999
Q ss_pred --CCCceEEeccCcchhccccCCCc---cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC
Q 039922 821 --AEMVPRVADFGLAKALQSQEGQS---DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG 895 (973)
Q Consensus 821 --~~~~~kl~DfGl~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 895 (973)
.++.+||+|||+++.+....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765432211 1122445699999999999999999999999999999999999999985332
Q ss_pred CchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 896 ENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+....... .+.+++++.+.... .+..+.+++..|++.+|++||++.+|++.|+..
T Consensus 267 -~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 -DPKYVRDSKIRYRE--------NIASLMDKCFPAAN----APGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp -CHHHHHHHHHHHHH--------CHHHHHHHHSCTTC----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -CHHHHHHHHHHhhh--------hHHHHHHHhccccc----CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 23333333322211 22333443332111 235788999999999999999999999999763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=345.25 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=212.8
Q ss_pred cCCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 753 (973)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 45788999999999999999985 256789999996432 334557789999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEE
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRS---------------GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNIL 818 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 818 (973)
..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 999999999999999999765321 2488999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCc
Q 039922 819 LDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGEN 897 (973)
Q Consensus 819 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 897 (973)
+++++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~ 254 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-VD 254 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-SS
T ss_pred EcCCCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc-ch
Confidence 999999999999999876544321 12233457789999999999999999999999999999999 999987542 22
Q ss_pred hhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 898 KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+........+ ......+.+++.+|++.||++|||+.|++++|++..
T Consensus 255 ~~~~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 SKFYKMIKEGFRMLSP---------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHHHHTCCCCCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHhccCCCCCCc---------------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 3333333322111000 112356889999999999999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=348.44 Aligned_cols=274 Identities=19% Similarity=0.236 Sum_probs=198.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
....++|+..+.||+|+||+||+|+.. +++.||+|++..........+.+.+|+.++++++||||+++++++..++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 455678999999999999999999876 7899999999655544445567789999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe-----CCCCceEEeccC
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL-----DAEMVPRVADFG 831 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DfG 831 (973)
+||||++ |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++ ++++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999997 69999997654 489999999999999999999999 99999999999999 455669999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+++...... .......||..|+|||++.+. .++.++||||+||++|||++|+.||... ...+....+......
T Consensus 183 ~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 183 LARAFGIPI----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD--SEIDQLFKIFEVLGL 256 (329)
T ss_dssp HHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCC
T ss_pred CccccCCcc----cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC--CHHHHHHHHHHHhCC
Confidence 998764332 123345689999999998874 4899999999999999999999999753 222222222222211
Q ss_pred CCCccccCccccc---ccCCCCCCCCCHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQL---IDPRMDLSTCDYE------EAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~---~d~~l~~~~~~~~------~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...... ...... .+........... ....+.+++.+|+++||++|||+.|++++
T Consensus 257 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTW-PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTS-TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cchhhh-hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 111111 111110 0000000011111 23578899999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=340.92 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=212.5
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
..++|+..+.||+|+||.||+|.++ +++.||+|++... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3457888999999999999999987 5889999999532 33456789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999976432 3589999999999999999999999 999999999999999999999999999987653
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... .......+++.|+|||++.+..++.++||||+|+++|||++ |..||... +.....+.+........+
T Consensus 164 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~--~~~~~~~~~~~~~~~~~~---- 234 (288)
T 3kfa_A 164 DTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP---- 234 (288)
T ss_dssp SSS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCCCCC----
T ss_pred Ccc---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhccCCCCCC----
Confidence 322 22334557789999999998999999999999999999999 88888653 333344433332111000
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+|++.||++|||+.|+++.|+..
T Consensus 235 -----------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 235 -----------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=344.06 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=201.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+.+|+.++++++||||+++++++..++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467899999999999999999975 79999999996432 334556778999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 758 VYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999986532 223588999999999999999999999 9999999999999999999999999998866
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.............+......
T Consensus 187 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 256 (310)
T 2wqm_A 187 SSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------ 256 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC------
T ss_pred cCCCc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC------
Confidence 43321 12335689999999999999999999999999999999999999975432222333222221111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
. ... ......+.+++.+|++.||++||++.||+++|++.+
T Consensus 257 -----~-----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 257 -----P-----LPS----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp -----C-----CCT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----C-----Ccc----cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 000 112356889999999999999999999999998854
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=341.84 Aligned_cols=261 Identities=28% Similarity=0.331 Sum_probs=204.3
Q ss_pred CCCCccccccccCCeeEEEEEECC----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe-cCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS-GQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~ 756 (973)
.+|+..++||+|+||.||+|+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++. .++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 357788999999999999998652 235899988532 33445577899999999999999999999864 566789
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999997643 3578999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
...............+|+.|+|||.+.+..++.++||||+|+++|||++|+.|+.... ...+....+........+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-CTTTHHHHHHTTCCCCCC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhcCCCCCCC---
Confidence 5443222233344567889999999999999999999999999999999655544332 222333333222211110
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+.+++.+|++.||++||++.|+++.|++..
T Consensus 255 ------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 255 ------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp ------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011346889999999999999999999999998854
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.92 Aligned_cols=264 Identities=19% Similarity=0.214 Sum_probs=211.8
Q ss_pred cccCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 756 (973)
.+.++|+..+.||+|+||.||+|+. .+|+.||+|++..... .+.+.+|+..++++ +|++++++++++..+...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 3456799999999999999999997 4789999999854322 23477899999999 7999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc-----eEEeccC
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV-----PRVADFG 831 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG 831 (973)
+||||+ +++|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 83 lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 999999 9999999986532 589999999999999999999999 9999999999999988776 9999999
Q ss_pred cchhccccCCCcc---ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-chhHHHHHHHH
Q 039922 832 LAKALQSQEGQSD---DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-NKDIVRWVTEA 907 (973)
Q Consensus 832 l~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~ 907 (973)
+++.......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9987654432111 1234567999999999999999999999999999999999999999764322 22233333322
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
....+.. +.. ......+.+++.+|++.||++||++++|++.|++.
T Consensus 237 ~~~~~~~-------~~~----------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 237 KQSTPLR-------ELC----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHSCHH-------HHT----------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccCccHH-------HHH----------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 2221100 000 01235788999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.36 Aligned_cols=262 Identities=29% Similarity=0.443 Sum_probs=204.2
Q ss_pred ccccCCCCccccccccCCeeEEEEEECC-----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKS-----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 752 (973)
+...++|+..+.||+|+||.||+|+... +..||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 3345678888999999999999998752 2359999995432 344556789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999997643 3589999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
++......... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+.......
T Consensus 194 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 194 SRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLP 270 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC
T ss_pred chhhccccccc-cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHCCCcCC
Confidence 98765432211 11223346788999999999999999999999999999999 99999653 2333333332221110
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
. .......+.+++.+|++.||++||++.|++++|+..
T Consensus 271 ~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 271 T---------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp C---------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C---------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 011235688999999999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=361.13 Aligned_cols=271 Identities=22% Similarity=0.223 Sum_probs=201.9
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ----- 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 752 (973)
.+.++|+..+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 45678999999999999999999876 689999999976555556677889999999999999999999999654
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
...|+||||+++ ++.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 456999999964 56666643 378999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+.......
T Consensus 210 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~--~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 210 LARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--DYIDQWNKVIEQLGTP 282 (464)
T ss_dssp CC-----CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCSC
T ss_pred eeeecCCCc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCC
Confidence 998764322 234468999999999999999999999999999999999999999753 2222222222211110
Q ss_pred CCcc------------------ccCcccccccCCC-CC-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PERG------------------CCRDLNQLIDPRM-DL-STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~~~------------------~~~~l~~~~d~~l-~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.. ......+.+...+ .. ..........+.+++.+|+++||++|||+.|+++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000001110000 00 00011225678999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=364.72 Aligned_cols=256 Identities=30% Similarity=0.399 Sum_probs=204.0
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||.||+|+++++..||||++.... ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34678889999999999999999988889999995433 234678999999999999999999999876 67899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999997532 12488999999999999999999999 99999999999999999999999999998764332
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......++..|+|||++.++.++.++||||||+++|||++ |+.||... ...+..+.+........+
T Consensus 335 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~~~~~------ 403 (452)
T 1fmk_A 335 Y---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRMPCP------ 403 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCCCC------
T ss_pred e---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC------
Confidence 1 11223456789999999999999999999999999999999 89998653 233344433322111000
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+.+++.+|++.||++|||+.+|++.|+...
T Consensus 404 ---------------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 404 ---------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 112356889999999999999999999999998854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=351.80 Aligned_cols=254 Identities=23% Similarity=0.273 Sum_probs=195.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
..++|+..+.||+|+||+||+++.+ +++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 3567999999999999999999987 799999999964332 235578999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc--eEEeccCcchhc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV--PRVADFGLAKAL 836 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGl~~~~ 836 (973)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 95 MEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999997654 489999999999999999999999 9999999999999987765 999999998743
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCC-CChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEK-SDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.... ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||..... .......+.........
T Consensus 169 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~-- 240 (361)
T 3uc3_A 169 VLHS-----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PRDYRKTIQRILSVKYS-- 240 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-----CCCHHHHHHHHHTTCCC--
T ss_pred cccC-----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc-HHHHHHHHHHHhcCCCC--
Confidence 3221 2234579999999999988887655 8999999999999999999976422 22222222222111000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+ . ......+.+++.+|+++||++|||+.|++++
T Consensus 241 -------~~~-~-------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 -------IPD-D-------IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -------CCT-T-------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -------CCC-c-------CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000 0 0113567899999999999999999999886
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=355.86 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=199.8
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC--CCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR--HGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 759 (973)
..|+..+.||+|+||.||+|...+++.||||++..........+.+.+|+.++++++ |+||+++++++..++..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 358899999999999999999988999999999766555566778999999999997 599999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
| +.+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 55889999998653 578889999999999999999999 999999999999995 588999999999876433
Q ss_pred CCCccccccccccccCccccccccC-----------CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYT-----------KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+ ....
T Consensus 208 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~~~~ 281 (390)
T 2zmd_A 208 TTS--VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAII 281 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHHH
T ss_pred Ccc--ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH----HHHh
Confidence 221 11234579999999999865 468889999999999999999999997532211111 1111
Q ss_pred ccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 909 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
..... ..... .....+.+++.+|++.||++||++.|++++-
T Consensus 282 ~~~~~--------------~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 DPNHE--------------IEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CTTSC--------------CCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Ccccc--------------CCCCc---cchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11000 00000 0135678999999999999999999998763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=357.42 Aligned_cols=276 Identities=22% Similarity=0.301 Sum_probs=214.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC--eeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD--FNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 757 (973)
.++|+..++||+|+||.||+|++. +|+.||||++.... .....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 457889999999999999999987 58999999995332 2233566789999999999999999999998755 6799
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe----CCCCceEEeccCcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL----DAEMVPRVADFGLA 833 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl~ 833 (973)
||||+++|+|.+++........+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999998755444589999999999999999999999 99999999999999 78888999999999
Q ss_pred hhccccCCCccccccccccccCccccccccC--------CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC--chhHHHH
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYT--------KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRW 903 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~ 903 (973)
+...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+....
T Consensus 164 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 164 RELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp EECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred eEccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 8764332 2234579999999999865 56788999999999999999999999753222 2222222
Q ss_pred HHHHhccCCCccccCccccccc-------CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 904 VTEATLSSPERGCCRDLNQLID-------PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d-------~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
+.... ++ ..........+ ...............+.+++.+|++.||++||+++|+++.++.+
T Consensus 239 ~~~~~---p~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 239 IITGK---PS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHSC---CT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCC---Cc-ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 22221 11 11111111111 11111234467788899999999999999999999999998774
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=362.38 Aligned_cols=259 Identities=21% Similarity=0.208 Sum_probs=206.3
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
...++|+..++||+|+||+||+|+.+ +++.||+|++.+... .....+.+.+|..++..++||||++++++|.+++..|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34568999999999999999999987 578999999853211 1112233788999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 151 lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999997632 3589999999999999999999999 9999999999999999999999999999765
Q ss_pred cccCCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc-
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS- 910 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 910 (973)
..... .......||+.|+|||++. .+.++.++||||+||++|||++|+.||... +..+....+......
T Consensus 226 ~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 226 MEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERF 300 (437)
T ss_dssp CTTSC---EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHC
T ss_pred ccCCC---cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--ChhHHHHhhhhccccc
Confidence 43322 1223467999999999987 567899999999999999999999999753 333333333222111
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN--RPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~ 965 (973)
..+.. .......+.+++.+|++.+|++ ||++.|+++|
T Consensus 301 ~~p~~------------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 301 QFPTQ------------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSS------------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cCCcc------------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11100 0012356788999999998888 9999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=340.84 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=210.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe--cCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS--GQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l 757 (973)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++..........+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457889999999999999999986 7899999999766555666778999999999999999999999874 4678899
Q ss_pred EEeccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEEeCCCCCCEEeCCCCceEEeccC
Q 039922 758 VYEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPA-----IVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||++++++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999975432 23489999999999999999999999 7 9999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
.++...... .......|+..|+|||++.+..++.++||||||+++|||++|+.||... ...++...+.......
T Consensus 162 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 162 LARILNHDT----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRR 235 (279)
T ss_dssp HHHHC---C----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCC
T ss_pred hheeecccc----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc--CHHHHHHHHhhccccc
Confidence 998764322 1123356899999999999989999999999999999999999999753 3334444443332210
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
. . ......+.+++.+|++.||++||++.||++++..
T Consensus 236 ~----------------~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 I----------------P-----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C----------------C-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred C----------------C-----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0 0 1123568899999999999999999999998765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.15 Aligned_cols=258 Identities=25% Similarity=0.298 Sum_probs=207.1
Q ss_pred CCccccccccCCeeEEEEEECC-C---CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee-EEE
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKS-G---ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN-ILV 758 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 758 (973)
|...++||+|+||.||+|+..+ + ..||+|++... ......+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5566899999999999998642 2 37999998532 3344567789999999999999999999999876655 999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997643 3588999999999999999999999 999999999999999999999999999986654
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.............++..|+|||...+..++.++||||+|+++|||++|+.|+.... +..+....+........+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~----- 250 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRLPQP----- 250 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCCCCC-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCCCCC-----
Confidence 33222233344578899999999999999999999999999999999777765432 334444444333211110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+|++.||++|||+.|+++.|++.
T Consensus 251 ----------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 251 ----------------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.75 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=207.2
Q ss_pred CCCccc-cccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 683 HLTEQN-LIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 683 ~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+|...+ .||+|+||.||+|.+. +++.||+|++... ......+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 455555 8999999999999864 6788999999643 2345567789999999999999999999999 45668999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999997542 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+........
T Consensus 163 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~i~~~~~~~~----- 234 (287)
T 1u59_A 163 DDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRMEC----- 234 (287)
T ss_dssp CSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CTHHHHHHHHTTCCCCC-----
T ss_pred Ccce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHhcCCcCCC-----
Confidence 3321 112233456889999999988889999999999999999999 99999753 23334444333221100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.......+.+++.+|++.||++||++.|++++|+..
T Consensus 235 ----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 235 ----------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ----------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 012235788999999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=341.26 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=204.8
Q ss_pred CCCCccc-cccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQN-LIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
++|...+ .||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4577777 9999999999999653 468899999965554555567899999999999999999999999 5667889
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999998643 488999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+........
T Consensus 169 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~---- 241 (291)
T 1xbb_A 169 ADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMGC---- 241 (291)
T ss_dssp TTCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCCC----
T ss_pred cCCCc-ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCCC----
Confidence 43321 111223446788999999988889999999999999999999 99999753 23333333332211100
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.......+.+++.+|++.||++||++.||++.|+..
T Consensus 242 -----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 242 -----------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 012235788999999999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=351.40 Aligned_cols=277 Identities=20% Similarity=0.206 Sum_probs=211.7
Q ss_pred eecccc-ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-----CCCeee
Q 039922 672 RVSFNE-DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-----HGNVVK 744 (973)
Q Consensus 672 ~~~~~~-~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 744 (973)
.+++.+ ..+.++|+..++||+|+||.||+|+.. +++.||||++.. .......+..|+.+++.++ ||||++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 455555 456788999999999999999999985 789999999942 2344566788999999986 999999
Q ss_pred EEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---
Q 039922 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA--- 821 (973)
Q Consensus 745 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--- 821 (973)
+++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 999999999999999999 8999999986542 3588999999999999999999999 9999999999999975
Q ss_pred ----------------------CCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHH
Q 039922 822 ----------------------EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVV 879 (973)
Q Consensus 822 ----------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~ 879 (973)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 789999999999764322 223578999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc----Cccccccc-----CCCCCCCCCHH--------------
Q 039922 880 LMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC----RDLNQLID-----PRMDLSTCDYE-------------- 936 (973)
Q Consensus 880 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~~~d-----~~l~~~~~~~~-------------- 936 (973)
+|||++|+.||... ...+....+.......+..... ......++ ..+........
T Consensus 249 l~ell~g~~pf~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 249 LAELYTGSLLFRTH--EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHSSCSCCCS--SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHCCCCCCCC--cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 99999999999753 3333333333322221110000 00000000 00000001111
Q ss_pred -HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 937 -EAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 937 -~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....+.+++.+|++.||++|||+.|++++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 12567899999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=359.93 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=207.1
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|...+.||+|+||.||+|+.. +|+.||||++.+... .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4567999999999999999999986 799999999853221 11234578899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999997543 589999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... ........+.......
T Consensus 168 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~----- 235 (476)
T 2y94_A 168 DGE-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD--HVPTLFKKICDGIFYT----- 235 (476)
T ss_dssp TTC-----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS--SSHHHHHHHHTTCCCC-----
T ss_pred ccc-----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCcCC-----
Confidence 322 1234579999999999988765 67999999999999999999999753 3333333333221110
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+ ......+.+++.+|++.||++|||+.|++++
T Consensus 236 ---------p--------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 236 ---------P--------QYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---------C--------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---------C--------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 0112467899999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.90 Aligned_cols=257 Identities=22% Similarity=0.283 Sum_probs=205.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|+..++||+|+||+||+|+.+ +++.||+|++.+... .....+.+.+|+.+++.++|||||++++++.+++..|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3567999999999999999999987 688999999853211 11122347789999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.++++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||+++...
T Consensus 147 V~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 99999999999998753 478999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCCccccccccccccCccccccccCCC----CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKK----VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||... +.......+.........
T Consensus 220 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~ 294 (410)
T 3v8s_A 220 KEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTF 294 (410)
T ss_dssp TTSE---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCCC
T ss_pred cCCc---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC--ChhhHHHHHHhccccccC
Confidence 3221 1223467999999999998665 789999999999999999999999753 333333333322211000
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN--RPSMRRVVELL 966 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 966 (973)
. + .......+.+++.+|++.+|.+ ||++.||++|-
T Consensus 295 p----------~--------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 295 P----------D--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp C----------T--------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred C----------C--------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0 0 0012356789999999999988 99999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.87 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=197.9
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe-
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF- 754 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 754 (973)
..+.++|+..+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+.++++++||||+++++++...+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 456778999999999999999999974 789999999965433 33445678999999999999999999999876543
Q ss_pred ---eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 755 ---NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 755 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
.|+||||+++|+|.++++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred CcccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 399999999999999997654 589999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+++.+...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||... ...............
T Consensus 162 ~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--~~~~~~~~~~~~~~~- 237 (311)
T 3ork_A 162 IARAIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVREDPI- 237 (311)
T ss_dssp CC-------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCCC-
T ss_pred Ccccccccccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHhcCCCC-
Confidence 99876543221 11223456899999999999999999999999999999999999999753 222221111111100
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
++. .. .......+.+++.+|++.||++||++.+++++
T Consensus 238 ~~~--------~~---------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 238 PPS--------AR---------HEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CHH--------HH---------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred Ccc--------cc---------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 000 00 01123568899999999999999977666543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.37 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=203.7
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|+..+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567889999999999999999876 677999999843221 12234668899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999997653 489999999999999999999999 99999999999999999999999999986543
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... .....|+..|+|||++.+..++.++||||+|+++|||++|..||... ........+.......+
T Consensus 161 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~----- 227 (279)
T 3fdn_A 161 SSR------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVEFTFP----- 227 (279)
T ss_dssp -------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCC-----
T ss_pred ccc------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC--cHHHHHHHHHhCCCCCC-----
Confidence 221 23357899999999999999999999999999999999999999752 22333333322211100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
......+.+++.+|++.||++|||+.|++++-
T Consensus 228 -----------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 228 -----------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp -----------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred -----------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 11235678999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=347.53 Aligned_cols=262 Identities=23% Similarity=0.383 Sum_probs=210.8
Q ss_pred ccCCCCccccccccCCeeEEEEEECC------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLKS------GETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 752 (973)
..++|+..+.||+|+||.||+|.... ++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 34678899999999999999998752 2479999995433 334567789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGR-----------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA 821 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 821 (973)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++++
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence 999999999999999999875321 23578999999999999999999999 9999999999999999
Q ss_pred CCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhH
Q 039922 822 EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDI 900 (973)
Q Consensus 822 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~ 900 (973)
++.+||+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||++ |..||.... .....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~ 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-VNSKF 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-SSHHH
T ss_pred CCeEEECccccccccccccce--eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc-hhHHH
Confidence 999999999999876543321 12233557889999999999999999999999999999999 888987532 22333
Q ss_pred HHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
...+........+ ......+.+++.+|++.||++|||+.||+++|+..
T Consensus 277 ~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 YKLVKDGYQMAQP---------------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCC---------------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 3333332211000 01135688999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=350.13 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=204.3
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc------hhHHHHHHHHHHHhcCCCCCeeeEEeEEe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP------ETETVFRSEIETLGRVRHGNVVKLLMCCS 750 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 750 (973)
.++.++|+..+.||+|+||.||+|+.. +++.||||++....... ...+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456678999999999999999999875 78899999996543221 13345678999999999999999999999
Q ss_pred cCCeeEEEEeccCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 751 GQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 751 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
..+..++||||+..| +|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence 999999999999777 9999987643 489999999999999999999999 999999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ..
T Consensus 174 fg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~-------- 236 (335)
T 3dls_A 174 FGSAAYLERGKL-----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE----ET-------- 236 (335)
T ss_dssp CTTCEECCTTCC-----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG----GG--------
T ss_pred cccceECCCCCc-----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH----HH--------
Confidence 999987643322 234578999999999988776 789999999999999999999996411 00
Q ss_pred ccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 909 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
......+. ......+.+++.+|+++||++|||+.|++++-
T Consensus 237 -----------~~~~~~~~-------~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 -----------VEAAIHPP-------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -----------TTTCCCCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -----------HhhccCCC-------cccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00000000 01235688999999999999999999999873
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=358.53 Aligned_cols=277 Identities=24% Similarity=0.317 Sum_probs=198.6
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCC--
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQD-- 753 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-- 753 (973)
..+.++|+..+.||+|+||.||+|.+. +|+.||+|++..........+.+.+|+.+++++. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 345678999999999999999999875 7999999999766556666777889999999997 999999999997544
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..|+||||++ |+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 6899999997 7999988763 488999999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCCC-----------------ccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCC
Q 039922 834 KALQSQEGQ-----------------SDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFG 895 (973)
Q Consensus 834 ~~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 895 (973)
+.+...... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-- 234 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS-- 234 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC--
Confidence 865431110 1122344679999999999876 67899999999999999999999999753
Q ss_pred CchhHHHHHHHHhccCCCccccCcc-----ccccc---C-----CCCCCCCC-------------HHHHHHHHHHHHhcc
Q 039922 896 ENKDIVRWVTEATLSSPERGCCRDL-----NQLID---P-----RMDLSTCD-------------YEEAEKVLNVALMCT 949 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~l-----~~~~d---~-----~l~~~~~~-------------~~~~~~l~~l~~~cl 949 (973)
+..+....+.... ..+.......+ ...++ . .......- ......+.+++.+|+
T Consensus 235 ~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 235 STMNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SHHHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 2222222222211 11110000000 00000 0 00000000 011356889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 039922 950 SDFPINRPSMRRVVEL 965 (973)
Q Consensus 950 ~~dP~~Rps~~evl~~ 965 (973)
+.||++|||+.|+++|
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=349.09 Aligned_cols=248 Identities=22% Similarity=0.265 Sum_probs=180.5
Q ss_pred cccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 687 QNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
.+.||+|+||.||+|+.+ +|+.||||++.+ .....+.+|+.+++.++ ||||+++++++.+++..|+||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 478999999999999986 689999999842 34566788999999997 99999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC---ceEEeccCcchhccccCC
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM---VPRVADFGLAKALQSQEG 841 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl~~~~~~~~~ 841 (973)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++......
T Consensus 91 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 91 GELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp CBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 99999998653 589999999999999999999999 999999999999997765 89999999997654332
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC--chhHHHHHHHHhccCCCccccCc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.+........
T Consensus 164 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------- 233 (325)
T 3kn6_A 164 ---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------- 233 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------
T ss_pred ---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------
Confidence 1233456899999999999999999999999999999999999999753221 1111222222111100
Q ss_pred ccccccCCCCCCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTC-DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..... .......+.+++.+|+++||++|||+.|++++
T Consensus 234 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 234 ---------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ---------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ---------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00000 01124678899999999999999999999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=353.31 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=195.8
Q ss_pred ccccCCCCcc-ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHH-hcCCCCCeeeEEeEEec---
Q 039922 678 DDILPHLTEQ-NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETL-GRVRHGNVVKLLMCCSG--- 751 (973)
Q Consensus 678 ~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~--- 751 (973)
..+.++|... ++||+|+||+||+|+.+ +|+.||||++.. ...+.+|++++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 4556667765 78999999999999986 689999999842 13466788876 44589999999998865
Q ss_pred -CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCceEE
Q 039922 752 -QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVPRV 827 (973)
Q Consensus 752 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 827 (973)
.+..|+||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEE
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEE
Confidence 567899999999999999997643 23589999999999999999999999 9999999999999998 789999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCc--hhHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN--KDIVRWVT 905 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--~~~~~~~~ 905 (973)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.
T Consensus 206 ~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 206 TDFGFAKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp CCCTTCEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred EecccccccCCCC-----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 9999998654322 2334678999999999999999999999999999999999999997643221 12333333
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
......+. +.. ......+.+++.+|++.||++|||+.|++++-
T Consensus 281 ~~~~~~~~------------~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 281 MGQYEFPN------------PEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HTCCCCCT------------TTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cCcccCCC------------ccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 32221110 000 11235688999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.77 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=200.2
Q ss_pred cCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe--
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF-- 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 754 (973)
.++|...+.||+|+||.||+|+.. +++.||+|++..........+.+.+|+.++++++||||+++++++...+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 456888999999999999999865 34589999996555555666789999999999999999999999987553
Q ss_pred ---eEEEEeccCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe
Q 039922 755 ---NILVYEYMPNGSLADMLHEKG---RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828 (973)
Q Consensus 755 ---~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 828 (973)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEe
Confidence 499999999999999985332 234689999999999999999999999 99999999999999999999999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 907 (973)
|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||... ........+...
T Consensus 190 Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~ 265 (313)
T 3brb_A 190 DFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV--QNHEMYDYLLHG 265 (313)
T ss_dssp SCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTT
T ss_pred ecCcceeccccccc--CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC--CHHHHHHHHHcC
Confidence 99999876443221 12233457789999999999999999999999999999999 88888653 233344433322
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.....+ ......+.+++.+|++.||++||++.+++++|+...
T Consensus 266 ~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 266 HRLKQP---------------------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp CCCCCB---------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCC---------------------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 211000 112356889999999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=344.46 Aligned_cols=261 Identities=24% Similarity=0.309 Sum_probs=199.1
Q ss_pred cccCCCCcc-ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCee
Q 039922 679 DILPHLTEQ-NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 679 ~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 755 (973)
.+.+.|.+. ++||+|+||.||+|+.. +++.||||++... .....+.+.+|++++.++ +||||+++++++..++..
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 345567774 78999999999999865 7999999999644 234456788999999885 799999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc---eEEeccCc
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV---PRVADFGL 832 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl 832 (973)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 99999999999999997653 488999999999999999999999 9999999999999998776 99999999
Q ss_pred chhccccCCC---ccccccccccccCccccccccC-----CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCc-------
Q 039922 833 AKALQSQEGQ---SDDAMSCVAGSYGYIAPEYAYT-----KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN------- 897 (973)
Q Consensus 833 ~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~------- 897 (973)
+......... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 8765432211 1112234569999999999875 568899999999999999999999997643221
Q ss_pred ------hhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 898 ------KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 898 ------~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.+.+.......+ +... ......+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~------------~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFP------------DKDW------AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCC------------HHHH------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhHHHHHHHHHhccCcccC------------chhc------ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111222221111100 0000 0123568899999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.13 Aligned_cols=249 Identities=24% Similarity=0.245 Sum_probs=195.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHH-HhcCCCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIET-LGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.+.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457889999999999999999987 6889999999654322 2333455667666 577899999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997653 478899999999999999999999 99999999999999999999999999998643
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... .......||+.|+|||++.+..++.++||||+||++|||++|..||... +..+..+.+.......
T Consensus 191 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~------ 258 (373)
T 2r5t_A 191 EHN----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKPLQL------ 258 (373)
T ss_dssp CCC----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--BHHHHHHHHHHSCCCC------
T ss_pred cCC----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcccCC------
Confidence 322 1234467999999999999999999999999999999999999999752 3333333333321110
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVV 963 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 963 (973)
. ......+.+++.+|++.||++||++.+..
T Consensus 259 -------~---------~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 259 -------K---------PNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -------C---------SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -------C---------CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 0 11235678999999999999999985433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=349.59 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=201.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.+.|+..+.||+|+||.||+|+.. +|+.||||++...... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 345888899999999999999974 7899999999654332 33446788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||++ |++.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99996 788888865432 589999999999999999999999 999999999999999999999999999976532
Q ss_pred cCCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||... ........+......
T Consensus 207 ~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~--~~~~~~~~~~~~~~~----- 271 (348)
T 1u5q_A 207 A--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNESP----- 271 (348)
T ss_dssp B--------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCC-----
T ss_pred C--------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcCCC-----
Confidence 2 2357899999999984 567899999999999999999999999753 111211111111100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.... ......+.+++.+|++.||++|||+.|++++.
T Consensus 272 -----------~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 272 -----------ALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -----------CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -----------CCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0000 11135678999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.35 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=208.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 457888999999999999999986 789999999854332 234567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999998653 2589999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. ........|+..|+|||++.+..+ +.++||||+|+++|||++|+.||............|.......
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 228 (276)
T 2yex_A 159 NR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------- 228 (276)
T ss_dssp TE--ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--------
T ss_pred cc--hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--------
Confidence 21 112334578999999999987665 7789999999999999999999986543333333332211100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+ .......+.+++.+|++.||++|||+.|++++-
T Consensus 229 ------~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 229 ------NP-------WKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp ------TT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ------Cc-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 00 011235678999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=346.10 Aligned_cols=266 Identities=19% Similarity=0.274 Sum_probs=210.9
Q ss_pred eeecccc-ccccCCCCcc-ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEE
Q 039922 671 QRVSFNE-DDILPHLTEQ-NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLL 746 (973)
Q Consensus 671 ~~~~~~~-~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~ 746 (973)
..+.|.. +.+.++|... +.||+|+||.||+|+.. +|+.||+|++............+.+|+.++++++ ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 3445554 5555667776 89999999999999987 6999999999765555556778899999999995 69999999
Q ss_pred eEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CC
Q 039922 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EM 823 (973)
Q Consensus 747 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~ 823 (973)
+++...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 99999999999999999999999986532 23689999999999999999999999 9999999999999998 78
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 903 (973)
.+||+|||+++....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||... ...+....
T Consensus 172 ~~kL~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~ 244 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE-----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE--DNQETYLN 244 (327)
T ss_dssp CEEECCGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHH
T ss_pred cEEEeeCccccccCCccc-----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CchHHHHH
Confidence 999999999987643321 23357899999999999999999999999999999999999999753 22233222
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.......+.. ........+.+++.+|+++||++|||+.|++++
T Consensus 245 i~~~~~~~~~~------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVNVDYSEE------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTCCCCCTT------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhcccccCch------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 22222111000 001223568899999999999999999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=337.41 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=207.1
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 46788999999999999999999888899999995432 23567899999999999999999999986 456899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+.......
T Consensus 88 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999999997532 11488999999999999999999999 99999999999999999999999999998764332
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......++..|+|||++.++.++.++||||||+++|||++ |+.||... ...+....+.......
T Consensus 164 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~-------- 230 (279)
T 1qpc_A 164 Y---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERGYRMV-------- 230 (279)
T ss_dssp E---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCC--------
T ss_pred c---ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc--CHHHHHHHHhcccCCC--------
Confidence 1 11233456789999999998889999999999999999999 88898653 2233333332221110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
. .......+.+++.+|++.||++|||+.++++.|+..
T Consensus 231 -----~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 231 -----R--------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -----C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C--------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 0 011235788999999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=363.68 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=198.3
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..++||+|+||.||+|+.. +|+.||+|++.... ........+.+|+.+++.++||||+++++++...+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 457889999999999999999976 78999999985432 1223345678899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997653 48999999999999999999998 7 99999999999999999999999999997543
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+.......+
T Consensus 301 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~p----- 369 (446)
T 4ejn_A 301 KDG----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEIRFP----- 369 (446)
T ss_dssp C---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC-----
T ss_pred CCC----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHHhCCCCCC-----
Confidence 222 2234467999999999999999999999999999999999999999753 33334443333221100
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
......+.+++.+|+++||++|| ++.|+++|
T Consensus 370 -----------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 370 -----------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11235678999999999999999 99999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.58 Aligned_cols=258 Identities=26% Similarity=0.354 Sum_probs=201.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCE----EEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGET----VAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
.++|+..++||+|+||.||+|++. +++. ||+|.+.... .....+.+.+|+.++++++||||+++++++..++ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 357899999999999999999875 4543 5777774332 3445677899999999999999999999998765 7
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++|+||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 889999999999999986533 589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
....... .......+|..|+|||++.+..++.++|||||||++|||++ |..||... ....+...+........+
T Consensus 167 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~~~~~- 241 (327)
T 3lzb_A 167 LGAEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQP- 241 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCCCC-
T ss_pred ccCcccc--ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCCCC-
Confidence 6543321 12233456788999999999999999999999999999999 99999753 333444443332211110
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+.+++.+|++.||++||++.|+++.|+...
T Consensus 242 --------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 242 --------------------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112346889999999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=357.03 Aligned_cols=258 Identities=22% Similarity=0.252 Sum_probs=204.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|+..++||+|+||.||+|+.+ +|+.||+|++.+... .....+.+.+|..++..++||||+++++++.+.+..|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4568999999999999999999986 799999999953211 11223347889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||+++...
T Consensus 139 VmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 9999999999999976532 589999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCCccccccccccccCcccccccc-------CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAY-------TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.... .......||+.|+|||++. .+.++.++|||||||++|||++|+.||... ...+....+......
T Consensus 214 ~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 214 ADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVHYKEH 288 (412)
T ss_dssp TTSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHH
T ss_pred CCCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhcccC
Confidence 3322 1123457999999999987 457899999999999999999999999753 233333333221111
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINR---PSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~evl~~ 965 (973)
... +. .......++.+++.+|++ +|++| |++.|+++|
T Consensus 289 ~~~------------p~-----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 289 LSL------------PL-----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CCC------------C---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cCC------------Cc-----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000 00 001123578899999999 99998 589999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=363.44 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=205.0
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
..+.++|+..+.||+|+||+||+|+.+ +++.||+|++.+..........+.+|+.+++.++||||+++++++...+..|
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 445667999999999999999999986 7899999999765544445667899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCceEEeccCcc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVPRVADFGLA 833 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl~ 833 (973)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 113 lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999999887653 488999999999999999999999 9999999999999976 455999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+...... ......||+.|+|||++. +.++.++||||+||++|+|++|..||... ...++...+.......+.
T Consensus 187 ~~~~~~~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 187 AVFENQK-----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ--TDQEILRKVEKGKYTFDS 258 (494)
T ss_dssp EECBTTB-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCS
T ss_pred eECCCCc-----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCc
Confidence 8764332 233467999999999876 56899999999999999999999999753 334444444443322111
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .. ......+.+++.+|+++||++|||+.|++++
T Consensus 259 ~------------~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 P------------EW------KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp G------------GG------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred h------------hc------ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 00 1123568899999999999999999999865
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=346.28 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=202.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC---
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD--- 753 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 753 (973)
.++.++|+..+.||+|+||.||+|+.. +|+.||||++..........+.+.+|+++++.++||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 456678999999999999999999985 7999999999666555566678899999999999999999999997653
Q ss_pred ---eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 754 ---FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 754 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
..|+||||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred cCceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence 459999999 78999998763 488999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||... +..+....+.....
T Consensus 173 g~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 173 GLARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS--DHLDQLKEIMKVTG 243 (367)
T ss_dssp TTCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHC
T ss_pred ecccccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcC
Confidence 999865322 234578999999999877 67999999999999999999999999753 22222222222211
Q ss_pred cCCCccccCc------------ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPERGCCRD------------LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~~~~~~------------l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.. .... +.+.....+ ..........+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 244 TPPAE-FVQRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCHH-HHHTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHH-HHHHhhhHHHHHHHHhCCCCCCCCH--HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 11100 0000 000000000 00011224578899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=339.08 Aligned_cols=257 Identities=25% Similarity=0.321 Sum_probs=201.8
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
..+.++|...+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 455678999999999999999999976 689999999864432 334567899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe---CCCCceEEeccCc
Q 039922 757 LVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGL 832 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl 832 (973)
+||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 9999999999999886432 123589999999999999999999999 99999999999999 4568899999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
+........ .....||+.|+|||++. +.++.++||||+|+++|||++|+.||... ........+........
T Consensus 174 a~~~~~~~~-----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~ 245 (285)
T 3is5_A 174 AELFKSDEH-----STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYA 245 (285)
T ss_dssp CCC---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC
T ss_pred ceecCCccc-----CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC--CHHHHHhhhccCCcccc
Confidence 976543321 23456899999999875 57889999999999999999999999753 22222222222111100
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... ......+.+++.+|+++||++|||+.|++++
T Consensus 246 ---------------~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 246 ---------------VEC----RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ---------------C------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ---------------ccc----CcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0123567899999999999999999999875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=357.25 Aligned_cols=330 Identities=22% Similarity=0.202 Sum_probs=232.4
Q ss_pred CCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccC
Q 039922 243 FLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322 (973)
Q Consensus 243 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 322 (973)
+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------------------ 94 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL------------------ 94 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS------------------
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc------------------
Confidence 45555555555555555555555555555555555555555555555555555555555553
Q ss_pred CcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCC
Q 039922 323 NYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIP 402 (973)
Q Consensus 323 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 402 (973)
..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++.+..+
T Consensus 95 -----~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 95 -----IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp -----CCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred -----cCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 333444555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCc
Q 039922 403 ESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQ 482 (973)
Q Consensus 403 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 482 (973)
..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+.++.......+|+.|++++|++++..+..+..+++
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 249 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTT
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccc
Confidence 56777778888888888888777778888888888888888877777777777778999999999999665578899999
Q ss_pred CcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCC
Q 039922 483 LQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSS 562 (973)
Q Consensus 483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (973)
|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 329 (477)
T 2id5_A 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329 (477)
T ss_dssp CCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCS
T ss_pred cCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccC
Confidence 99999999999988888899999999999999999998899999999999999999999977777889999999999999
Q ss_pred CcCccccChhhhcccccceeccCCcCcccCCCC
Q 039922 563 NLLTGEIPLELTKLKLNQFNISHNKLYGEVPSD 595 (973)
Q Consensus 563 N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p~~ 595 (973)
|++++..+.....-....+++.++...+.-|..
T Consensus 330 N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 330 NPLACDCRLLWVFRRRWRLNFNRQQPTCATPEF 362 (477)
T ss_dssp SCEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred CCccCccchHhHHhhhhccccCccCceeCCchH
Confidence 999875442211112333455555555544543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=365.67 Aligned_cols=254 Identities=26% Similarity=0.338 Sum_probs=207.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..++||+|+||.||+|+.+ +|+.||+|++.+... .......+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888999999999999999986 799999999854321 123345678999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999876432 3489999999999999999999999 999999999999999999999999999987643
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC--chhHHHHHHHHhccCCCccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 916 (973)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.+......
T Consensus 339 ~~-----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~------ 407 (576)
T 2acx_A 339 GQ-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE------ 407 (576)
T ss_dssp TC-----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC------
T ss_pred Cc-----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc------
Confidence 32 223457999999999999999999999999999999999999999864321 12233332221111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
. . ......+.+++.+|+++||++|| ++.||++|
T Consensus 408 ---~--------p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 ---Y--------S-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---C--------C-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---C--------C-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 0 11235688999999999999999 78998875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=335.26 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=205.3
Q ss_pred cCCCCccccccccCCeeEEEEEECC----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.++|+..+.||+|+||.||+|++.. +..||+|++.... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4578889999999999999998652 3369999985442 34456778999999999999999999999865 4568
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999976532 588999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
..... .......++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+........+
T Consensus 164 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~--~~~~~~~~~~~~~~~~~~-- 236 (281)
T 3cc6_A 164 EDEDY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIGVLEKGDRLPKP-- 236 (281)
T ss_dssp ------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CGGGHHHHHHHTCCCCCC--
T ss_pred ccccc---cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC--ChHHHHHHHhcCCCCCCC--
Confidence 44322 11233456789999999998899999999999999999998 99999753 333444444333211110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+|++.||++||++.|++++|+..
T Consensus 237 -------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 237 -------------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01235688999999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.09 Aligned_cols=270 Identities=14% Similarity=0.149 Sum_probs=203.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchh---------HHHHHHHHHHHhcCCCCCeeeEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPET---------ETVFRSEIETLGRVRHGNVVKLLM 747 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~ 747 (973)
.++|+..+.||+|+||.||+|+.. ++..||+|++......... ...+.+|+..++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357899999999999999999986 5788999998644321111 123567888999999999999999
Q ss_pred EEec----CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 748 CCSG----QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 748 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
++.. .+..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9987 77899999999 999999997654 589999999999999999999999 999999999999998887
Q ss_pred --ceEEeccCcchhccccCCC---ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch
Q 039922 824 --VPRVADFGLAKALQSQEGQ---SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK 898 (973)
Q Consensus 824 --~~kl~DfGl~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 898 (973)
.+||+|||+++.+...... .........||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876543221 11222456799999999999999999999999999999999999999965333333
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
............ .+. .+.+... . ......+.+++.+|++.||++||++.+|++.|+...
T Consensus 269 ~~~~~~~~~~~~-~~~----~~~~~~~----~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 269 AVQTAKTNLLDE-LPQ----SVLKWAP----S----GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHT-TTH----HHHHHSC----T----TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHhhccc-ccH----HHHhhcc----c----cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 222222222211 110 0000000 0 012357899999999999999999999999998743
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.76 Aligned_cols=265 Identities=28% Similarity=0.372 Sum_probs=206.8
Q ss_pred ccCCC-CccccccccCCeeEEEEEEC-----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--
Q 039922 680 ILPHL-TEQNLIGSGGSCRVYKVKLK-----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-- 751 (973)
Q Consensus 680 ~~~~~-~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-- 751 (973)
+.++| +..+.||+|+||.||++.+. +++.||||++... ......+.+.+|++++++++||||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 34455 88999999999999988653 6889999999644 334556778999999999999999999999987
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
....++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred CceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence 46789999999999999999764 388999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCc---------hhHHH
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN---------KDIVR 902 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~---------~~~~~ 902 (973)
++......... ........+|..|+|||++.+..++.++||||+|+++|||++|+.||....... .....
T Consensus 180 ~a~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 180 LAKAVPEGHEY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GCEECCTTCSE-EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred ccccccccccc-cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 99876543221 112234567888999999999899999999999999999999999986421100 00000
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.+...... .... .........+.+++.+|++.||++|||+.|+++.|+...
T Consensus 259 ~~~~~~~~----------------~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 259 RLTELLER----------------GERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHHHHHT----------------TCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhc----------------ccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 01111100 0000 001122467899999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=347.32 Aligned_cols=271 Identities=20% Similarity=0.256 Sum_probs=200.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57889999999999999999987 789999999853321 1112234579999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|++ |+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 996 699998876533 588999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.......||..|+|||++.+ ..++.++||||+||++|||++|+.||... ...+....+...........++..
T Consensus 155 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 ----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS--TVEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCChHhchhh
Confidence 22334578999999999876 56899999999999999999999999753 334444444443333222222111
Q ss_pred ccc--ccc---CCCCCCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQ--LID---PRMDLST---CDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~--~~d---~~l~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... ... +...... ........+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 100 000 0000000 001123567899999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=361.24 Aligned_cols=202 Identities=26% Similarity=0.328 Sum_probs=160.6
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-----
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG----- 751 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----- 751 (973)
..+.++|+..++||+|+||+||+|+.+ +|+.||||++..........+.+.+|++++++++|||||++++++..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 345678999999999999999999876 78999999997665566667789999999999999999999999843
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
.+..|+||||+ +|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence 35689999998 579999887543 589999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCc-----------------------cccccccccccCccccccc-cCCCCCCCCChhhHHHHHHHHHcC
Q 039922 832 LAKALQSQEGQS-----------------------DDAMSCVAGSYGYIAPEYA-YTKKVTEKSDVYSFGVVLMELVTG 886 (973)
Q Consensus 832 l~~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg 886 (973)
+++......... .......+||+.|+|||++ .+..++.++||||+||++|||++|
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 998765332110 0123456789999999976 566799999999999999999994
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=369.73 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=200.5
Q ss_pred cccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 689 LIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
.||+|+||.||+|.++ ++..||||+++.. ......+.+.+|++++++++|||||++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 7999999999999874 4667999999644 233456789999999999999999999999976 5689999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccc
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 845 (973)
+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+....... .
T Consensus 421 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~ 494 (613)
T 2ozo_A 421 PLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-T 494 (613)
T ss_dssp BHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred cHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee-e
Confidence 9999997543 3589999999999999999999999 99999999999999999999999999998765433211 1
Q ss_pred cccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccc
Q 039922 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924 (973)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 924 (973)
......+++.|+|||++.++.++.++|||||||++|||++ |+.||... ...++...+........+
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~~~~~~~~p----------- 561 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRMECP----------- 561 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CSHHHHHHHHTTCCCCCC-----------
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCCCC-----------
Confidence 1222345689999999999999999999999999999998 99999763 334445544433221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 925 DPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 925 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+||+.||++||++.+|++.|+..
T Consensus 562 ----------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 562 ----------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ----------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11235788999999999999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=347.15 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=202.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCee
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 755 (973)
..+.++|+..+.||+|+||.||+|+.+ +|+.||+|++.+.... ..+|++++.++ +||||+++++++.+++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 345667999999999999999999986 6889999999644322 34577788777 799999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC----CceEEeccC
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE----MVPRVADFG 831 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG 831 (973)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++.++ +.+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 99999999999999987643 589999999999999999999999 99999999999998543 359999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC-CchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~ 910 (973)
+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...++...+......
T Consensus 166 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 166 FAKQLRAENG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241 (342)
T ss_dssp TCEECBCTTC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred CcccCcCCCC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence 9987644322 22345789999999999888899999999999999999999999975322 223334433332221
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.. ........+.+++.+|++.||++||++.|++++
T Consensus 242 ~~~~------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 LSGG------------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCST------------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCcc------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1000 001223568899999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.43 Aligned_cols=263 Identities=27% Similarity=0.395 Sum_probs=205.2
Q ss_pred CCCCccccccccCCeeEEEEEE-----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC--Ce
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL-----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ--DF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 754 (973)
+.|+..+.||+|+||.||+|++ .+++.||+|++.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4578899999999999999984 368999999996443 233456789999999999999999999999876 66
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999965433 589999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCC----------CCchhHHHHH
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF----------GENKDIVRWV 904 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~----------~~~~~~~~~~ 904 (973)
........ ........||..|+|||++.+..++.++||||+|+++|||++|+.|+.... ..........
T Consensus 175 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 76543321 122334567888999999999999999999999999999999998864311 0111111111
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
....... .. .........+.+++.+|++.||++|||+.|+++.|+..
T Consensus 254 ~~~~~~~---------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 254 NTLKEGK---------------RL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHTTC---------------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccC---------------CC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111110 00 00112346788999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.25 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=203.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC----chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK----PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
++|+..+.||+|+||.||+|+.. +|+.||+|++...... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999987 7999999998654322 124677899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC----ceEEeccCc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM----VPRVADFGL 832 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGl 832 (973)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++ .+||+|||.
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997643 489999999999999999999999 999999999999998877 899999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||... ...+....+.......+
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 159 AHKIEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE--TKQETLTNISAVNYDFD 231 (283)
T ss_dssp CEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCCCC
T ss_pred ceeccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc--chHHHHHHhHhcccCCc
Confidence 97654322 123456899999999999999999999999999999999999999753 22222222211111000
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.. ......+.+++.+|++.||++||++.|++++
T Consensus 232 --------~~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 232 --------EEYF----------SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --------HHHH----------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --------chhc----------ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000 0123568899999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.73 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=208.0
Q ss_pred cccCCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 752 (973)
...++|+..+.||+|+||.||+|+. .+++.||+|++... ........+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 3456899999999999999999984 35789999999533 3345566789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCce
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRS----GSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVP 825 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ 825 (973)
+..|+||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999865321 3488999999999999999999999 9999999999999984 4569
Q ss_pred EEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHH
Q 039922 826 RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 826 kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 904 (973)
||+|||++......... .......|++.|+|||++.+..++.++||||||+++|||++ |..||... ......+.+
T Consensus 183 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~ 258 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYY--RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFV 258 (327)
T ss_dssp EECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHH
T ss_pred EECcccccccccccccc--ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--CHHHHHHHH
Confidence 99999999866443321 12234567899999999998999999999999999999998 88888653 333344443
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
........+ ......+.+++.+|++.||++||++.|++++|+...
T Consensus 259 ~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TSGGRMDPP---------------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HTTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCC---------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 332211100 112356889999999999999999999999998743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=363.35 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=209.2
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
..+.++|++.++||+|+||+||+|+.+ +++.||||++.+..........+.+|++++++++||||+++++++...+..|
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 456678999999999999999999986 7999999998543333344567899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC---CCCceEEeccCcc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD---AEMVPRVADFGLA 833 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~ 833 (973)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999887653 489999999999999999999999 999999999999995 4667999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ...+....+.........
T Consensus 172 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 172 TCFQQNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDL 243 (486)
T ss_dssp TTBCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCSCS
T ss_pred eECCCCC-----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCC
Confidence 8764332 2334579999999999875 5899999999999999999999999753 333444444443222111
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. . ......+.+++.+|+++||++|||+.|++++
T Consensus 244 ~~------------~------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQ------------W------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG------------G------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cc------------c------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 1123567899999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.28 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=201.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec----CCeeEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG----QDFNIL 757 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 757 (973)
.|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4777889999999999999876 68899999997655556667789999999999999999999998865 456899
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEeCCCCCCEEeC-CCCceEEeccCcch
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA--IVHRDVKSHNILLD-AEMVPRVADFGLAK 834 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGl~~ 834 (973)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+||+++ +++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999997643 488999999999999999999999 7 99999999999998 78999999999997
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
..... ......||+.|+|||++. +.++.++||||+|+++|||++|+.||.... ........+...... .
T Consensus 181 ~~~~~------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~---~ 249 (290)
T 1t4h_A 181 LKRAS------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKP---A 249 (290)
T ss_dssp GCCTT------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCC---G
T ss_pred ccccc------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-cHHHHHHHHhccCCc---c
Confidence 54322 123356899999999876 468999999999999999999999997532 222222222111100 0
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+ ......+.+++.+|++.||++|||+.|++++
T Consensus 250 --------~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 --------SFD---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------GGG---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------ccC---------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001 1112468899999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.64 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=205.6
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
.+.++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 45567889999999999999999986 79999999996432 2334568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe---CCCCceEEeccCcch
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAK 834 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~ 834 (973)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999987653 488999999999999999999999 99999999999999 788999999999987
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||... ........+.......+.
T Consensus 158 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~- 228 (304)
T 2jam_A 158 MEQNG------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE--TESKLFEKIKEGYYEFES- 228 (304)
T ss_dssp CCCCB------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHCCCCCCT-
T ss_pred ecCCC------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCc-
Confidence 54321 123356899999999999999999999999999999999999999753 233333333332211000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+ ........+.+++.+|++.||++||++.|++++
T Consensus 229 -----------~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 229 -----------P------FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -----------T------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -----------c------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 001223578899999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=346.58 Aligned_cols=273 Identities=28% Similarity=0.357 Sum_probs=207.8
Q ss_pred CCCCccccccccCCeeEEEEEE-----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe--cCCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL-----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS--GQDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 754 (973)
++|+..+.||+|+||.||+|++ .+++.||+|++.. ......+.+.+|++++++++|+||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 4688899999999999999984 3688999999953 34455677899999999999999999999886 4567
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 8999999999999999976432 589999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
........ ........||..|+|||++.+..++.++||||+|+++|||++|+.||.... ....... .......
T Consensus 176 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~---~~~~~~~---~~~~~~~ 248 (327)
T 3lxl_A 176 LLPLDKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS---AEFLRMM---GCERDVP 248 (327)
T ss_dssp ECCTTCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH---HHHHHHC---C----CC
T ss_pred ecccCCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc---chhhhhc---ccccccc
Confidence 76433221 112233567888999999999899999999999999999999999986421 1100000 0000000
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
....+.+.+...... .........+.+++.+|+++||++|||+.|++++|+...
T Consensus 249 -~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 249 -ALSRLLELLEEGQRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp -HHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred -cHHHHHHHhhcccCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000000000000000 011223467889999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=341.69 Aligned_cols=262 Identities=27% Similarity=0.369 Sum_probs=210.3
Q ss_pred cCCCCccccccccCCeeEEEEEE------CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL------KSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 753 (973)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 46789999999999999999974 356899999996443 334556789999999999 6999999999987654
Q ss_pred -eeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe
Q 039922 754 -FNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819 (973)
Q Consensus 754 -~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 819 (973)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEE
Confidence 58999999999999999976542 12278999999999999999999999 99999999999999
Q ss_pred CCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCch
Q 039922 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENK 898 (973)
Q Consensus 820 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 898 (973)
++++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||.... ...
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~ 258 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDE 258 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-CSH
T ss_pred CCCCCEEECCCccccccccCccc--eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc-hhH
Confidence 99999999999999866443221 22234567889999999999999999999999999999998 999987542 223
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.....+........+ ......+.+++.+|++.||++|||+.||+++|+...
T Consensus 259 ~~~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 259 EFCRRLKEGTRMRAP---------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHHHHTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCccCCCC---------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 333333332211000 012356889999999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.24 Aligned_cols=273 Identities=23% Similarity=0.334 Sum_probs=205.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467899999999999999999987 5899999999766655566677889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999988888765433 489999999999999999999999 9999999999999999999999999999766433
Q ss_pred CCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc--
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC-- 916 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 916 (973)
.. ......||..|+|||++.+. .++.++||||+||++|||++|+.||... ...+....+........+...
T Consensus 178 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 178 GE----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD--SDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCChhhhhH
Confidence 21 22345689999999998875 7899999999999999999999999753 222222222211111000000
Q ss_pred ---cCcccccccCCCCCCCC----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 ---CRDLNQLIDPRMDLSTC----DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ---~~~l~~~~d~~l~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.........+.+..... .+.....+.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000001111110000 01224678999999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.75 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=184.1
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3467889999999999999999974 799999999843211 11224678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||.+....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999997643 3589999999999999999999999 99999999999999999999999999987654
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .... .
T Consensus 164 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~---~----------- 223 (278)
T 3cok_A 164 MPHE----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--NTLN---K----------- 223 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred CCCC----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--HHHH---H-----------
Confidence 3221 122356899999999999989999999999999999999999999753211 1110 0
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+....... .......+.+++.+|++.||++||++.|++++
T Consensus 224 -----~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 224 -----VVLADYEM---PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -----CCSSCCCC---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----HhhcccCC---ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00000000 01123567899999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.30 Aligned_cols=262 Identities=22% Similarity=0.258 Sum_probs=199.5
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
....++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.++++++||||+++++++..++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 344678999999999999999999986 788999999864432 233457789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999998653 589999999999999999999999 999999999999999999999999999876
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
...... .......|+..|+|||++.+..++.++||||||+++|||++|+.||... ........+ ....+.
T Consensus 184 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~----~~~~~~- 253 (309)
T 2h34_A 184 TTDEKL---TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHI----NQAIPR- 253 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC--HHHHHHHHH----HSCCCC-
T ss_pred cccccc---ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc--hHHHHHHHh----ccCCCC-
Confidence 643321 1223456899999999999999999999999999999999999999752 111111111 110000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-SMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~ 969 (973)
. .... ......+.+++.+|++.||++|| ++.++++.|+..
T Consensus 254 ----~-~~~~---------~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 254 ----P-STVR---------PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp ----G-GGTS---------TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred ----c-cccC---------CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 0 0000 11234688999999999999999 999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.30 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=202.8
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
+.++|+..+.||+|+||.||+|+.. +++.||+|++............+.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567889999999999999999987 799999999976655566677888999999999 89999999999999999999
Q ss_pred EEeccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC--------------
Q 039922 758 VYEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-------------- 822 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------- 822 (973)
||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976422 13589999999999999999999999 99999999999999844
Q ss_pred -----CceEEeccCcchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 039922 823 -----MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGE 896 (973)
Q Consensus 823 -----~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~ 896 (973)
..+||+|||.+....... ...||..|+|||++.+. .++.++|||||||++|||++|..|+...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---
T ss_pred ccCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---
Confidence 479999999987654322 23589999999998765 5668999999999999999998776431
Q ss_pred chhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 897 NKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
. ....+...... .+. ......+.+++.+|++.||++|||+.|++++-
T Consensus 235 -~-~~~~~~~~~~~----------------~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 235 -D-QWHEIRQGRLP----------------RIP-----QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp -H-HHHHHHTTCCC----------------CCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred -h-HHHHHHcCCCC----------------CCC-----cccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 1 12212111111 000 01235688999999999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=334.79 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=200.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+.|....+||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 345666779999999999999975 6889999999543 2344567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~~ 838 (973)
||+++++|.+++.........++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||.+.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999998754444567889999999999999999999 9999999999999987 89999999999976543
Q ss_pred cCCCccccccccccccCccccccccCCC--CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKK--VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... ......|+..|+|||++.+.. ++.++||||||+++|||++|+.||........... ........
T Consensus 176 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~---- 244 (295)
T 2clq_A 176 INP----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVH---- 244 (295)
T ss_dssp ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH---HHHHHCCC----
T ss_pred CCC----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH---hhcccccc----
Confidence 221 123456899999999987643 78899999999999999999999964221111111 11111100
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+. ......+.+++.+|++.||++||++.|++++
T Consensus 245 ---------~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 ---------PEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---------CCCC-----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---------cccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 1123567899999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=360.14 Aligned_cols=257 Identities=25% Similarity=0.321 Sum_probs=207.2
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc-----------hhHHHHHHHHHHHhcCCCCCeeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP-----------ETETVFRSEIETLGRVRHGNVVKL 745 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l 745 (973)
..+.++|...++||+|+||+||+|+.+ +++.||+|++....... ...+.+.+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 567788999999999999999999986 68899999996543221 335678899999999999999999
Q ss_pred EeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC--
Q 039922 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-- 823 (973)
Q Consensus 746 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 823 (973)
++++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999999987653 489999999999999999999999 999999999999998776
Q ss_pred -ceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHH
Q 039922 824 -VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR 902 (973)
Q Consensus 824 -~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 902 (973)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|..||... ...+...
T Consensus 186 ~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~ 257 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ--NDQDIIK 257 (504)
T ss_dssp SSEEECCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHH
T ss_pred ccEEEEECCCCEEcCCCC-----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHH
Confidence 69999999998764332 233457999999999886 56899999999999999999999999753 3344444
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+.......+... . ......+.+++.+|+++||.+|||+.|++++-
T Consensus 258 ~i~~~~~~~~~~~------------~------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 258 KVEKGKYYFDFND------------W------KNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp HHHHCCCCCCHHH------------H------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHcCCCCCCccc------------c------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 4443322111000 0 01135688999999999999999999998763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=370.46 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=201.9
Q ss_pred ccccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.||+|+||.||+|.+. .++.||||+++.........+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999996555455567789999999999999999999999975 457899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-Y 526 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-c
Confidence 99999997643 589999999999999999999999 9999999999999999999999999999877544321 1
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 923 (973)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ...++...+........+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~~~~~~~~p---------- 594 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMGCP---------- 594 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCCCC----------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC----------
Confidence 12233456789999999999999999999999999999998 99999753 333444444333221111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 924 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+||+.||++||++.+|++.|+..
T Consensus 595 -----------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 595 -----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp -----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11236788999999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=345.67 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=206.9
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC------chhHHHHHHHHHHHhcC-CCCCeeeEEeEEe
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK------PETETVFRSEIETLGRV-RHGNVVKLLMCCS 750 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 750 (973)
.+.++|...+.||+|+||.||+|+.+ +|+.||||++...... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34567888999999999999999986 7999999998654321 11245678899999999 7999999999999
Q ss_pred cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 751 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
..+..|+||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEec
Confidence 9999999999999999999997643 589999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC------CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT------KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 904 (973)
|++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+
T Consensus 245 G~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--~~~~~~~~i 317 (365)
T 2y7j_A 245 GFSCHLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--RQILMLRMI 317 (365)
T ss_dssp TTCEECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH
T ss_pred CcccccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC--CHHHHHHHH
Confidence 99987654322 234678999999998863 35888999999999999999999999752 233333333
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......... +.. ......+.+++.+|++.||++|||+.|++++
T Consensus 318 ~~~~~~~~~------------~~~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEGQYQFSS------------PEW------DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHTCCCCCH------------HHH------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCCCCCC------------ccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 332211000 000 0113568899999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=361.95 Aligned_cols=257 Identities=26% Similarity=0.341 Sum_probs=211.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
..+.++|+..++||+|+||.||+|+.+ +|+.||||++..... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345567999999999999999999987 799999999965433 234567789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe---CCCCceEEeccCc
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGL 832 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl 832 (973)
|+||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999887643 589999999999999999999999 99999999999999 5678999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ...+....+........
T Consensus 176 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 176 STHFEASK-----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA--NEYDILKKVEKGKYTFE 247 (484)
T ss_dssp HHHBCCCC-----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC
T ss_pred eEEccccc-----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCC
Confidence 98764332 2334579999999999865 6899999999999999999999999753 33444444444332211
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
... . ......+.+++.+|+++||++|||+.|++++-
T Consensus 248 ~~~------------~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 248 LPQ------------W------KKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp SGG------------G------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred Ccc------------c------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 100 0 11235688999999999999999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=360.57 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=206.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|...++||+|+||.||+|+.+ +|+.||+|++.+... .....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999986 699999999953321 112345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 759 YEYMPNGSLADMLHEKGR-SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
|||+++|+|.+++..... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999876432 33589999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC--chhHHHHHHHHhccCCCcc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE--NKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 915 (973)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.+.......
T Consensus 341 ~~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~---- 412 (543)
T 3c4z_A 341 AGQT----KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY---- 412 (543)
T ss_dssp TTCC----CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC----
T ss_pred CCCc----ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC----
Confidence 3322 123357999999999999999999999999999999999999999764221 122333222211110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM-----RRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 965 (973)
.......+.+++.+|+++||++||++ .||+++
T Consensus 413 ------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 413 ------------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ------------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ------------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 01123567889999999999999965 666653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=338.30 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=203.7
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-------
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG------- 751 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 751 (973)
+..+|+..+.||+|+||.||+|+.. +|+.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4457889999999999999999987 79999999995332 246789999999999999999998854
Q ss_pred ---------CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC
Q 039922 752 ---------QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE 822 (973)
Q Consensus 752 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 822 (973)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 445799999999999999997542 23589999999999999999999999 99999999999999999
Q ss_pred CceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHH
Q 039922 823 MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR 902 (973)
Q Consensus 823 ~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 902 (973)
+.+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|||++|..|+.. ...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~----~~~--- 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK-----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----TSK--- 226 (284)
T ss_dssp TEEEECCCTTCEESSCCSC-----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH----HHH---
T ss_pred CCEEECcchhheecccccc-----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh----HHH---
Confidence 9999999999887644321 2335689999999999999999999999999999999999988642 111
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcccC
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKSS 972 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 972 (973)
+....... . +. ......+.+++.+|++.||++||++.|++++|+..+.+
T Consensus 227 ~~~~~~~~--------~----~~---------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 227 FFTDLRDG--------I----IS---------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHTT--------C----CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHhhcc--------c----cc---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111111 0 00 01124578899999999999999999999999886643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=345.12 Aligned_cols=272 Identities=21% Similarity=0.221 Sum_probs=199.4
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD---- 753 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 753 (973)
.+.++|+..+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 45678999999999999999999876 6889999999765555566677889999999999999999999997654
Q ss_pred --eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 754 --FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 754 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
..|+||||++ |+|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999996 678888753 378999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+.......
T Consensus 173 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 173 LARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT--DHIDQWNKVIEQLGTP 245 (371)
T ss_dssp C---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHC-CCCC
T ss_pred ccccccccc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCC
Confidence 998654321 223457899999999999999999999999999999999999999753 2222211111110000
Q ss_pred CC------------------ccccCcccccccCC-CCC-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 912 PE------------------RGCCRDLNQLIDPR-MDL-STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 912 ~~------------------~~~~~~l~~~~d~~-l~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+ ......+.+.+... ... ..........+.+++.+|++.||++|||++|++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 00000000000000 000 000122356899999999999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=333.34 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=207.7
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
...++|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34567889999999999999999987 68899999986443 23445677889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+...
T Consensus 92 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999887643 589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ..+....+......
T Consensus 166 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~------ 233 (294)
T 2rku_A 166 EYDGE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNEYS------ 233 (294)
T ss_dssp CSTTC----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCCC------
T ss_pred ccCcc----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhhccCC------
Confidence 43221 1233568999999999999899999999999999999999999997532 22222211111100
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. ......+.+++.+|++.||++|||+.|++++
T Consensus 234 -----------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 -----------IP-----KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----------CC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----------Cc-----cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0113567889999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=367.22 Aligned_cols=257 Identities=30% Similarity=0.399 Sum_probs=209.1
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||.||+|++.++..||||++.... ...+.|.+|++++++++|+||+++++++.+ +..|+|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 35678889999999999999999988899999995433 234678999999999999999999999876 67899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.++++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999997532 12488999999999999999999999 99999999999999999999999999998764321
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .......++..|+|||++.++.++.++|||||||++|||++ |+.||... ...++.+.+........+
T Consensus 418 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~~~~~------ 486 (535)
T 2h8h_A 418 Y---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRMPCP------ 486 (535)
T ss_dssp H---HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--CHHHHHHHHHTTCCCCCC------
T ss_pred e---ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC------
Confidence 1 11223456788999999999999999999999999999999 89998653 233444433322111000
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 487 ---------------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 487 ---------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1123568899999999999999999999999998643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=344.35 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=204.3
Q ss_pred CCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe----cCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS----GQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~ 756 (973)
++|+..+.||+|+||.||+|+. .+|+.||+|++.. ......+.+.+|++++++++||||+++++++. .....+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 4689999999999999999998 4799999999843 34456677899999999999999999999986 345789
Q ss_pred EEEeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 757 LVYEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999987532 233689999999999999999999999 999999999999999999999999998875
Q ss_pred ccccCCCc-----cccccccccccCccccccccCCC---CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 836 LQSQEGQS-----DDAMSCVAGSYGYIAPEYAYTKK---VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 836 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
........ ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.............+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~- 262 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN- 262 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence 43221110 00112345789999999987544 6889999999999999999999995421111122221111
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
....+ ........+.+++.+|++.||++||++.|++++|+.+..
T Consensus 263 ~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 263 QLSIP--------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp C--CC--------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred cCCCC--------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00000 001123578899999999999999999999999988654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=339.40 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=208.2
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
...++|...+.||+|+||.||+++.. +++.||+|++.... ......+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34567889999999999999999987 58899999986443 23445677899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 118 lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999999887643 589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... ......||..|+|||++.+..++.++||||||+++|||++|+.||... ...+....+......
T Consensus 192 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~------ 259 (335)
T 2owb_A 192 EYDGE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYS------ 259 (335)
T ss_dssp CSTTC----CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCC------
T ss_pred ccCcc----cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC--CHHHHHHHHhcCCCC------
Confidence 43221 123457899999999999999999999999999999999999999753 222222222221111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+ . ......+.+++.+|++.||++||++.|++++
T Consensus 260 ---~--------~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 ---I--------P-----KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---C--------C-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---C--------C-----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 0112467889999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=337.18 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=190.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467889999999999999999985 7899999999655444444455566666788899999999999999999999999
Q ss_pred eccCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEK-GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||++ |+|.+++... .....+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9996 6888877542 12336899999999999999999999853 899999999999999999999999999987644
Q ss_pred cCCCccccccccccccCccccccc----cCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYA----YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
... .....||+.|+|||++ .+..++.++||||+|+++|||++|+.||.............+......
T Consensus 163 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 233 (290)
T 3fme_A 163 DVA-----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ---- 233 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC----
T ss_pred ccc-----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC----
Confidence 322 2234689999999996 566788999999999999999999999975322222222222111111
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... ......+.+++.+|+++||++|||+.|++++
T Consensus 234 -------------~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 234 -------------LPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -------------CCT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -------------ccc----ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 000 1123568899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=341.03 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=202.8
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCE--EEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGET--VAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 756 (973)
.++|+..+.||+|+||.||+|+.. +|+. ||+|++.... .....+.+.+|+++++++ +||||+++++++...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 357889999999999999999876 5664 4999885332 334456688999999999 8999999999999999999
Q ss_pred EEEeccCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 757 LVYEYMPNGSLADMLHEKG-------------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997643 123689999999999999999999999 999999999999999999
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHH
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVR 902 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 902 (973)
.+||+|||+++...... ......++..|+|||++.+..++.++||||+|+++|||++ |+.||... ...+...
T Consensus 180 ~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~ 252 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYE 252 (327)
T ss_dssp CEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHH
T ss_pred eEEEcccCcCccccccc-----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC--cHHHHHH
Confidence 99999999987433221 1223456789999999988889999999999999999998 99999753 2222222
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+...... .. .......+.+++.+|++.||++|||+.|++++|+..
T Consensus 253 ~~~~~~~~----------------~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 253 KLPQGYRL----------------EK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HGGGTCCC----------------CC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCC----------------CC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22111000 00 011235688999999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=355.10 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=195.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC------CchhHHHHHHHHHHHhcCCCCCeeeEEeEEe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH------KPETETVFRSEIETLGRVRHGNVVKLLMCCS 750 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 750 (973)
..+.++|...+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345678999999999999999999876 689999999864321 1122235789999999999999999999986
Q ss_pred cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC---CceEE
Q 039922 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE---MVPRV 827 (973)
Q Consensus 751 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl 827 (973)
. +..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 4 55799999999999999887543 589999999999999999999999 99999999999999754 45999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccC---CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 904 (973)
+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ....+.+.+
T Consensus 284 ~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-TQVSLKDQI 357 (419)
T ss_dssp CCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS-SSCCHHHHH
T ss_pred eecccceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc-chHHHHHHH
Confidence 9999998764322 2334679999999999863 567889999999999999999999997532 223333333
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
........+ +.. ......+.+++.+|++.||++|||+.|++++
T Consensus 358 ~~~~~~~~~--------~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYNFIP--------EVW----------AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCCCCH--------HHH----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCCCc--------hhh----------cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 322211000 000 0124578899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=341.00 Aligned_cols=275 Identities=24% Similarity=0.296 Sum_probs=201.4
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc---hhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP---ETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
...++|+..+.||+|+||.||+|+.. +|+.||+|++....... ...+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999986 68999999985432221 112457889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 87 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFME-TDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCS-EEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCC-CCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999997 48988887543 3588899999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
....... ......||+.|+|||++.+. .++.++||||+||++|||++|..||... ...+....+.........
T Consensus 161 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~--~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 161 SFGSPNR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--SDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTTSCCC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCT
T ss_pred eccCCcc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHHHcCCCCh
Confidence 7643321 23345789999999998764 5789999999999999999999998753 222333333332222111
Q ss_pred ccccCcccccccCCC--CCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRM--DLSTCD-----YEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l--~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
..+ .......+... ...... ......+.+++.+|++.||++|||+.|++++-
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 235 EQW-PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTS-SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhh-hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 111 11111111000 000000 12246789999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=346.40 Aligned_cols=272 Identities=22% Similarity=0.294 Sum_probs=206.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 457889999999999999999987 78999999996442 3455677899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999997654 4889999999999999999999831 7999999999999999999999999999765432
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCc-----
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPER----- 914 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 914 (973)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+..........
T Consensus 186 ~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 186 M------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD--AKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp C----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC--HHHHHHHHC--------------
T ss_pred c------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccccccCCCCCCCc
Confidence 2 223578999999999999999999999999999999999999997532 111111110000000000
Q ss_pred --------------cccCcccccccC---CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 915 --------------GCCRDLNQLIDP---RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 915 --------------~~~~~l~~~~d~---~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.......+.++. ..............+.+++.+|+++||++|||+.|++++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 000000000000 0000000111245788999999999999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=353.06 Aligned_cols=207 Identities=23% Similarity=0.301 Sum_probs=173.0
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC----
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ---- 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 752 (973)
..+.++|+..+.||+|+||.||+|+.. +|+.||||++..........+.+.+|++++++++|+||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 456778999999999999999999976 688999999976655666677899999999999999999999999765
Q ss_pred -CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 753 -DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
+..|+||||++ |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 57899999996 69999987543 589999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCc------------------cccccccccccCccccccc-cCCCCCCCCChhhHHHHHHHHHcCCCCCC
Q 039922 832 LAKALQSQEGQS------------------DDAMSCVAGSYGYIAPEYA-YTKKVTEKSDVYSFGVVLMELVTGKRPND 891 (973)
Q Consensus 832 l~~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~ 891 (973)
+++......... ........||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 998765432110 0123557899999999986 56679999999999999999998655543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=334.70 Aligned_cols=252 Identities=30% Similarity=0.405 Sum_probs=198.9
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-CeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ-DFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. |+.||+|++... ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 457889999999999999999886 899999998532 2456789999999999999999999997654 5789999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++..... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999975421 1378899999999999999999999 9999999999999999999999999998765332
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+......
T Consensus 171 ~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~-------- 233 (278)
T 1byg_A 171 Q-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKM-------- 233 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCCC--------
T ss_pred c-------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCC--------
Confidence 1 22356889999999998999999999999999999998 99998753 233333332221110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
.. .......+.+++.+|++.||++||++.|+++.|+.++.
T Consensus 234 --------~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 234 --------DA-----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp --------CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CC-----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 00 01123578899999999999999999999999988653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.76 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=208.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+..+.|+..+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 34457889999999999999999875 789999999964432 3445678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 98 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999999998642 589999999999999999999999 99999999999999999999999999997764
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||... ........+......
T Consensus 171 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~------- 237 (303)
T 3a7i_A 171 DTQI----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL--HPMKVLFLIPKNNPP------- 237 (303)
T ss_dssp TTBC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCC-------
T ss_pred cccc----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc--CHHHHHHHhhcCCCC-------
Confidence 3321 123457899999999999999999999999999999999999999753 222223322221111
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.+. ......+.+++.+|++.||++|||+.|++++.
T Consensus 238 ---------~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 238 ---------TLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---------CCC-----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---------CCc-----cccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 000 11135688999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.80 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=207.8
Q ss_pred cccCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEE-ecCCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC-SGQDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~ 756 (973)
.+.++|+..+.||+|+||.||+|+. .+|+.||+|++..... .+.+.+|+.+++.++|+++++.+.++ ..++..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 3457899999999999999999997 4799999999854432 23478899999999988766666554 6677889
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC---CCCceEEeccCcc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD---AEMVPRVADFGLA 833 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~ 833 (973)
+||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999999 8999999975432 589999999999999999999999 999999999999994 8899999999999
Q ss_pred hhccccCCCcc---ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC-CchhHHHHHHHHhc
Q 039922 834 KALQSQEGQSD---DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEATL 909 (973)
Q Consensus 834 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~ 909 (973)
+.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 87654432111 112446799999999999999999999999999999999999999976322 22233333333222
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
..+.. ... ......+.+++.+|++.||++||++.||++.|+..
T Consensus 236 ~~~~~--------~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 236 STPIE--------VLC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HSCHH--------HHT---------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred CCchH--------HHH---------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 21110 000 01135688999999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=331.44 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=204.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++++..++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 457889999999999999999986 678899999843211 122346788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999997653 488999999999999999999999 999999999999999999999999999865432
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. .....|+..|+|||++.+..++.++||||+|+++|||++|+.||... ...+....+......
T Consensus 167 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~-------- 230 (284)
T 2vgo_A 167 LR------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP--SHTETHRRIVNVDLK-------- 230 (284)
T ss_dssp SC------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCC--------
T ss_pred cc------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC--CHhHHHHHHhccccC--------
Confidence 21 22356899999999999999999999999999999999999999753 222222222111100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. ......+.+++.+|++.||++||++.|++++
T Consensus 231 ---------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 231 ---------FP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ---------CC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ---------CC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 00 1123567899999999999999999999875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=356.69 Aligned_cols=345 Identities=15% Similarity=0.122 Sum_probs=291.1
Q ss_pred CEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCc
Q 039922 245 SNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNY 324 (973)
Q Consensus 245 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~ 324 (973)
+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++| .
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-----------------------~ 67 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN-----------------------I 67 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTS-----------------------C
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCC-----------------------c
Confidence 45677777766 4454442 45666666666666555555665555555555555 4
Q ss_pred CCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCc
Q 039922 325 FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPES 404 (973)
Q Consensus 325 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 404 (973)
+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|++++|++.+..+..
T Consensus 68 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 147 (477)
T 2id5_A 68 VSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147 (477)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTS
T ss_pred cCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhh
Confidence 44566778889999999999999999776677899999999999999999999999999999999999999999999999
Q ss_pred cCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCc
Q 039922 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 484 (973)
|..+++|++|++++|++++..+..|..+++|+.|++++|++.+..+..+..+++|+.|++++|++.+.+|.......+|+
T Consensus 148 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~ 227 (477)
T 2id5_A 148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227 (477)
T ss_dssp STTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCS
T ss_pred ccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCcccc
Confidence 99999999999999999988888899999999999999999999899999999999999999999988888887788999
Q ss_pred EEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCc
Q 039922 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNL 564 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 564 (973)
+|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+
T Consensus 228 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 307 (477)
T 2id5_A 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307 (477)
T ss_dssp EEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSC
T ss_pred EEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCc
Confidence 99999999996555789999999999999999998888999999999999999999999889999999999999999999
Q ss_pred CccccChhhhcc-cccceeccCCcCcccCCCCCcc-cccccccCCCCCCCCCC
Q 039922 565 LTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFDH-DLFISSLLDNPGLCSPD 615 (973)
Q Consensus 565 l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~~~~-~~~~~~~~~n~~~c~~~ 615 (973)
+++..+..+..+ .|+.|++++|++++..+..+.. ......+.++...|+.|
T Consensus 308 l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 308 LTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp CSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred CceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 997666677777 8999999999999865532211 11223455666667654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.22 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=203.2
Q ss_pred ccCCCCccccccccCCeeEEEEEE-CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEE-ecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCC-SGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 757 (973)
+.++|+..+.||+|+||.||+|+. .+++.||+|++...... ..+.+|+++++.++|++++..+.++ ..++..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 456899999999999999999997 47899999987433222 2477899999999988766666555 66788899
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe---CCCCceEEeccCcch
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLAK 834 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~ 834 (973)
||||+ +++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 99999 8999999975433 589999999999999999999999 99999999999999 789999999999998
Q ss_pred hccccCCCcc---ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC-CchhHHHHHHHHhcc
Q 039922 835 ALQSQEGQSD---DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEATLS 910 (973)
Q Consensus 835 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~ 910 (973)
.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 7654432111 123346789999999999999999999999999999999999999976422 222233332222222
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+... .. ......+.+++.+|++.||++||++.||++.|+..
T Consensus 237 ~~~~~--------~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 237 TPIEV--------LC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp SCHHH--------HT---------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred chhhh--------hh---------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 11000 00 01135788999999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.55 Aligned_cols=270 Identities=19% Similarity=0.257 Sum_probs=191.7
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC----
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ---- 752 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 752 (973)
..+.++|+..+.||+|+||.||+|+.. +|+.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 456789999999999999999999875 789999999976555556677888999999999999999999998654
Q ss_pred --CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 753 --DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 753 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
...|+|||++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp GCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred cCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence 5679999999 6899988865 2589999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|+++..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||... +..+....+.....
T Consensus 177 G~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~l~~i~~~~g 247 (367)
T 2fst_X 177 GLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--DHIDQLKLILRLVG 247 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHC
T ss_pred ccccccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhC
Confidence 999765322 234678999999999877 67899999999999999999999999753 22333333332221
Q ss_pred cCCCccccCcc-----cccccCCCCCCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPERGCCRDL-----NQLIDPRMDLSTCDY-----EEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~~~~~~l-----~~~~d~~l~~~~~~~-----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... .....+ ...+........... .....+.+++.+|++.||++|||+.|++++
T Consensus 248 ~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGA-ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCH-HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCH-HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1100 000000 000000000000011 123568899999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=329.43 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=198.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
..++|+..+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+.+|+..++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3467899999999999999999987 799999999853211 12234578899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999997653 488999999999999999999999 99999999999999999999999999997764
Q ss_pred ccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... ......|++.|+|||++.+..+ +.++||||+|+++|||++|+.||... ......+.+.......
T Consensus 163 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~----- 230 (276)
T 2h6d_A 163 DGE-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--HVPTLFKKIRGGVFYI----- 230 (276)
T ss_dssp C------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCC-----
T ss_pred CCc-----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHhhcCcccC-----
Confidence 322 1233568999999999987765 57999999999999999999999752 2333333333221110
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+ ......+.+++.+|++.||++|||+.|++++
T Consensus 231 ---------~--------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ---------P--------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---------C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------c--------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0113567899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=344.80 Aligned_cols=263 Identities=16% Similarity=0.166 Sum_probs=207.3
Q ss_pred CCCCccccccccCCeeEEEEEECC---------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeee--------
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS---------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVK-------- 744 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------- 744 (973)
++|+..+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 679999999999999999999874 789999998533 34788999999999999887
Q ss_pred -------EEeEEec-CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCC
Q 039922 745 -------LLMCCSG-QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHN 816 (973)
Q Consensus 745 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 816 (973)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5677765 78889999999 999999998642 23589999999999999999999999 99999999999
Q ss_pred EEeCCCC--ceEEeccCcchhccccCCC---ccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCC
Q 039922 817 ILLDAEM--VPRVADFGLAKALQSQEGQ---SDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPND 891 (973)
Q Consensus 817 Ill~~~~--~~kl~DfGl~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 891 (973)
|+++.++ .+||+|||+++.+...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999876543321 1112234579999999999999999999999999999999999999998
Q ss_pred CCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 892 PSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
........+........... ..+.+..... ......+.+++.+|++.||++||++.||++.|++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKP---------GPFVGPCGHW----IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSC---------CCEECTTSCE----ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCCh---------hhhhhhcccc----CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 65434444444433322221 1111111100 01236788999999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=348.13 Aligned_cols=250 Identities=14% Similarity=0.142 Sum_probs=200.5
Q ss_pred cCCCCccccccccCCeeEEEEE------ECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC---CCCeeeEEeEEec
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVK------LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR---HGNVVKLLMCCSG 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 751 (973)
.++|...++||+|+||.||+|. ..+++.||+|++... ....+.+|++++++++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4568899999999999999994 447899999999432 2445777888888776 9999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC--------
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKG--RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-------- 821 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------- 821 (973)
++..|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999997532 233689999999999999999999999 9999999999999998
Q ss_pred ---CCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch
Q 039922 822 ---EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK 898 (973)
Q Consensus 822 ---~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 898 (973)
++.+||+|||+++.+..... ........||++|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 89999999999976543222 2234556799999999999999999999999999999999999999864321100
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHhh
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINR-PSMRRVVELLRV 968 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R-ps~~evl~~L~~ 968 (973)
. ++..+... .....+.+++..|++.+|.+| |++.++.+.|+.
T Consensus 294 --------------------~----~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 294 --------------------K----PEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp --------------------E----ECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred --------------------e----echhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 11111110 124566788889999999998 578888777765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.54 Aligned_cols=279 Identities=25% Similarity=0.325 Sum_probs=197.2
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHH--HHHHHhcCCCCCeeeEEeEEec-----CC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRS--EIETLGRVRHGNVVKLLMCCSG-----QD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~-----~~ 753 (973)
.++|+..+.||+|+||.||+|+. +++.||||++... ....+.. |+..+..++|+||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 46789999999999999999987 5899999998422 2233444 4444556899999999985532 33
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEEeCCCCCCEEeCCCCceEE
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC------VPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
..++||||+++|+|.+++... ..++..+..++.||+.||+|||+.+ .++|+||||||+||+++.++.+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 678999999999999999764 3588999999999999999999873 238999999999999999999999
Q ss_pred eccCcchhccccCCC----ccccccccccccCccccccccC-------CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 039922 828 ADFGLAKALQSQEGQ----SDDAMSCVAGSYGYIAPEYAYT-------KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE 896 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~ 896 (973)
+|||+++.+...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 999999876543211 1122334579999999999876 45667899999999999999998887653221
Q ss_pred chhHHHHHHHHhccCCCccccC--cccccccCCCCC-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 897 NKDIVRWVTEATLSSPERGCCR--DLNQLIDPRMDL-STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~--~l~~~~d~~l~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
......+... ....+...... .......+.+.. ..........+.+++.+|++.||++|||+.|+++.|+++.
T Consensus 242 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTE-VGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHH-HCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcc-cCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1100000000 00000000000 000000011110 1112345678999999999999999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=345.99 Aligned_cols=258 Identities=23% Similarity=0.281 Sum_probs=202.8
Q ss_pred cCCCCccccccccCCeeEEEEEE----CCCCEEEEEEecCCCC--CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL----KSGETVAVKRLLGGTH--KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 753 (973)
.++|+..+.||+|+||.||+|+. .+|+.||||++..... .....+.+.+|+++++++ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46789999999999999999997 3789999999854321 112334567799999999 6999999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997653 488999999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCCCccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 207 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE 282 (355)
T ss_dssp EECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCC
T ss_pred eecccCCC---CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHHHHHHHhccC
Confidence 76543221 12334579999999999985 35788999999999999999999999754221 11222221111110
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHh
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVELLR 967 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L~ 967 (973)
++ ........+.+++.+|++.||++|| ++.|++++..
T Consensus 283 ~~-------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 283 PP-------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CC-------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CC-------------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 00 0011235678999999999999999 9999988753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.54 Aligned_cols=265 Identities=28% Similarity=0.371 Sum_probs=206.6
Q ss_pred cCCCCccccccccCCeeEEEEEE-----CCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC--
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKL-----KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD-- 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 753 (973)
.++|+..+.||+|+||.||+|+. .+|+.||+|++.. ......+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 34688899999999999999984 3688999999953 34455677999999999999999999999987644
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 67999999999999999986532 589999999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC----------CchhHHHH
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG----------ENKDIVRW 903 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~----------~~~~~~~~ 903 (973)
......... ........++..|+|||++.+..++.++||||||+++|||++|..|+..... ........
T Consensus 193 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSE-EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccc-cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 876543221 1112234567789999999988899999999999999999999998863200 00011111
Q ss_pred HHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 904 VTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+........ ... ........+.+++.+|++.||++|||+.||++.|+++.
T Consensus 272 ~~~~~~~~~--------------~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 272 LIELLKNNG--------------RLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHTTC--------------CCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCC--------------CCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111100 000 00122467889999999999999999999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.89 Aligned_cols=261 Identities=21% Similarity=0.245 Sum_probs=202.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEec--CCeeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSG--QDFNI 756 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~ 756 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++.. ...+.+.+|++++++++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 357899999999999999999874 789999999842 23466889999999997 9999999999987 66789
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcchh
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKA 835 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~ 835 (973)
+||||+++++|.+++.. +++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.
T Consensus 110 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 99999999999998853 78889999999999999999999 999999999999999776 899999999986
Q ss_pred ccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHH-----------
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW----------- 903 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~----------- 903 (973)
...... .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||.........+...
T Consensus 181 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 181 YHPGQE-----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp CCTTCC-----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred cCCCCc-----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 643322 234578899999999877 678999999999999999999999997643332222221
Q ss_pred -HHHHhccCCCc-------cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 904 -VTEATLSSPER-------GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 904 -~~~~~~~~~~~-------~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+........+. .......+.... .........+.+++.+|+++||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHS-----ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCT-----TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccccccchhhhhhhccccchhhhccc-----cccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111110000 000000011110 0111235678999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=331.01 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=208.6
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
..+.++|+..+.||+|+||.||+|+.+ +++.||+|++..........+.+.+|++++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 456678999999999999999999986 7999999999655444455677899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC---CceEEeccCcc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE---MVPRVADFGLA 833 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGl~ 833 (973)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999887643 489999999999999999999999 99999999999999764 47999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
........ .....|+..|+|||++.+ .++.++||||+|+++|+|++|..||... ...+....+.......+.
T Consensus 172 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 172 TCFQQNTK-----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDL 243 (287)
T ss_dssp GTBCCCSS-----CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCS
T ss_pred eeecCCCc-----cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCc
Confidence 87643321 223468899999998865 5899999999999999999999999753 333333333332211100
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .. ......+.+++.+|+++||++|||+.|++++
T Consensus 244 ~------------~~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 244 P------------QW------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp G------------GG------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h------------hh------hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 00 1123568899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=344.89 Aligned_cols=201 Identities=23% Similarity=0.273 Sum_probs=173.5
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC------CCCCeeeEEeEEe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV------RHGNVVKLLMCCS 750 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~ 750 (973)
+.+..+|+..++||+|+||.||+|... +++.||||++.. .......+.+|+.+++.+ .|+||+++++++.
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 456678999999999999999999876 588999999943 233445677788887777 5679999999999
Q ss_pred cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc--eEEe
Q 039922 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV--PRVA 828 (973)
Q Consensus 751 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~ 828 (973)
..+..++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEEC
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEe
Confidence 9999999999995 799999876532 3489999999999999999999999 9999999999999999887 9999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCC
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPS 893 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 893 (973)
|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 245 DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 245 DFGSSCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCTTCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99998654322 23357899999999999999999999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.59 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=206.9
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-------chhHHHHHHHHHHHhcCC-CCCeeeEEeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-------PETETVFRSEIETLGRVR-HGNVVKLLMC 748 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~l~~~ 748 (973)
....++|+..+.||+|+||.||+|+.+ +|+.||+|++...... ....+.+.+|+.++++++ ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345678999999999999999999986 6899999999644311 123456788999999996 9999999999
Q ss_pred EecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe
Q 039922 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828 (973)
Q Consensus 749 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 828 (973)
+..++..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999997643 589999999999999999999999 99999999999999999999999
Q ss_pred ccCcchhccccCCCccccccccccccCcccccccc------CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY------TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR 902 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 902 (973)
|||.+....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||... .......
T Consensus 167 dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~ 239 (298)
T 1phk_A 167 DFGFSCQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLR 239 (298)
T ss_dssp CCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHH
T ss_pred cccchhhcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--cHHHHHH
Confidence 999997764332 123456899999999885 456889999999999999999999999753 2333333
Q ss_pred HHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.......+. + ........+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~------------~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGNYQFGS------------P------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTCCCCCT------------T------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCCcccCc------------c------cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 33332211100 0 001224578899999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=339.03 Aligned_cols=269 Identities=21% Similarity=0.250 Sum_probs=204.2
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee-
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN- 755 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~- 755 (973)
..+.++|...+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 456788999999999999999999876 789999999976655556677889999999999999999999999877654
Q ss_pred -----EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 756 -----ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 756 -----~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
++||||++ ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred cceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999996 788887743 388999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||... +..+....+.....
T Consensus 189 g~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 189 GLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--DYLDQLTQILKVTG 259 (371)
T ss_dssp TCC---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHC
T ss_pred CcccccccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhC
Confidence 999765322 233578999999999887 68899999999999999999999999753 22222222222111
Q ss_pred cCCCccccCcc-----cccccCCCCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPERGCCRDL-----NQLIDPRMDLSTCD-----YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~~~~~~l-----~~~~d~~l~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.. ....+ ...+.......... ......+.+++.+|++.||++|||+.|++++
T Consensus 260 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 260 VPGTE-FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCHH-HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcHH-HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 11000 00000 00000000000000 1124678999999999999999999999876
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=334.42 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=200.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++..++..++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 45568999999999999999999987 6899999998533 33445678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999999876433 589999999999999999999999 99999999999999999999999999976542
Q ss_pred ccCCCccccccccccccCccccccc-----cCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYA-----YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
... .......||..|+|||++ .+..++.++||||||+++|||++|+.||... ........+.... .
T Consensus 169 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~---~ 239 (302)
T 2j7t_A 169 KTL----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAKSD---P 239 (302)
T ss_dssp HHH----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSC---C
T ss_pred ccc----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC--CHHHHHHHHhccC---C
Confidence 221 112235689999999988 4667889999999999999999999999753 2222222111111 1
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. .. ........+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~--------~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 240 PT--------LL--------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CC--------CS--------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cc--------cC--------CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 00 001123568899999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=336.85 Aligned_cols=267 Identities=26% Similarity=0.365 Sum_probs=187.1
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 467899999999999999999865 789999998853322 234566889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 760 EYMPNGSLADMLHEK-----GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 760 e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
||+++++|.+++... .....+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998642 1233589999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCc-cccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 835 ALQSQEGQS-DDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 835 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
......... ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.... ................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP--PMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHHHHHTSSCCCT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc--hhhHHHHHhccCCCcc
Confidence 765432111 112234578999999999875 568999999999999999999999997632 2222211111111100
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ....++... ......+.+++.+|++.||++||++.|++++
T Consensus 248 ~-------~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 E-------TGVQDKEML-----KKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp T-------C-----CCC-----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c-------cccccchhh-----hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 001111111 1123568899999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.84 Aligned_cols=246 Identities=14% Similarity=0.119 Sum_probs=190.9
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHH---HHHhcCCCCCeeeEE-------e
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEI---ETLGRVRHGNVVKLL-------M 747 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~ 747 (973)
..++|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+.+|+ +.+++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3467889999999999999999974 79999999996442 3344567789999 555566899999998 6
Q ss_pred EEecCC-----------------eeEEEEeccCCCChhhhhhccCCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 039922 748 CCSGQD-----------------FNILVYEYMPNGSLADMLHEKGRS----GSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806 (973)
Q Consensus 748 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 806 (973)
++...+ ..|+||||+ +|+|.+++...... ..+++..++.|+.||+.||+|||+. +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 665543 278999999 68999999764321 1244688889999999999999999 9
Q ss_pred eEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCC-----------CCCCCCChhh
Q 039922 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-----------KVTEKSDVYS 875 (973)
Q Consensus 807 ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s 875 (973)
|+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999999999999999999975322 2234567 999999999887 8999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCC
Q 039922 876 FGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPIN 955 (973)
Q Consensus 876 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~ 955 (973)
|||++|||++|+.||....... ....+... . ......+.+++.+|+++||++
T Consensus 299 lG~il~elltg~~Pf~~~~~~~---------------------~~~~~~~~-~------~~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALG---------------------GSEWIFRS-C------KNIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHHHHHHHSSCCC------C---------------------CSGGGGSS-C------CCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHCCCCCccccccc---------------------chhhhhhh-c------cCCCHHHHHHHHHHcCCCchh
Confidence 9999999999999996432110 00011110 0 011356889999999999999
Q ss_pred CCCHHHHHHH
Q 039922 956 RPSMRRVVEL 965 (973)
Q Consensus 956 Rps~~evl~~ 965 (973)
|||+.|++++
T Consensus 351 Rpt~~e~l~h 360 (377)
T 3byv_A 351 RLLPLQAMET 360 (377)
T ss_dssp CCCHHHHHTS
T ss_pred CCCHHHHhhC
Confidence 9999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=329.62 Aligned_cols=256 Identities=25% Similarity=0.312 Sum_probs=200.3
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC--CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe--cCCe
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT--HKPETETVFRSEIETLGRVRHGNVVKLLMCCS--GQDF 754 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 754 (973)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+.+|+.++++++|+||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999985 78999999985331 11234567899999999999999999999984 4567
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.++||||++++ +.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999765 777776543 33689999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCccccccccccccCccccccccCCC--CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK--VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
....... ........||..|+|||+..+.. ++.++||||+|+++|||++|+.||... ......+.+.......
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~i~~~~~~~- 232 (305)
T 2wtk_C 158 ALHPFAA--DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--NIYKLFENIGKGSYAI- 232 (305)
T ss_dssp ECCTTCS--SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCCCC-
T ss_pred ccCcccc--ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc--hHHHHHHHHhcCCCCC-
Confidence 7643322 12233456899999999987644 377999999999999999999999752 2233333332221110
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
. ......+.+++.+|++.||++|||+.|++++-
T Consensus 233 ----------------~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 233 ----------------P-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp ----------------C-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred ----------------C-----CccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 0 01235678999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=368.01 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=205.8
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
.++|+..++||+|+||.||+|+.+ +++.||||++.+... .....+.+..|..++..+ +|++|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467889999999999999999976 688999999854311 122345677899999987 69999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999998754 489999999999999999999999 99999999999999999999999999997543
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..++.+.+.......
T Consensus 494 ~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~------ 561 (674)
T 3pfq_A 494 WDG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVAY------ 561 (674)
T ss_dssp CTT----CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHSSCCCC------
T ss_pred cCC----cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC--CHHHHHHHHHhCCCCC------
Confidence 222 2234567999999999999999999999999999999999999999753 3333443333221110
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM-----RRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 965 (973)
......++.+++.+|+++||++||++ .||+++
T Consensus 562 ----------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 562 ----------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 01123568899999999999999997 777654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.19 Aligned_cols=253 Identities=24% Similarity=0.307 Sum_probs=199.5
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
...++|+..+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34567889999999999999999986 68999999995432 23568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999987433 2589999999999999999999999 99999999999999999999999999997664
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||... ........+...... .
T Consensus 177 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~---~--- 244 (314)
T 3com_A 177 DTMA----KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI--HPMRAIFMIPTNPPP---T--- 244 (314)
T ss_dssp TTBS----CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCC---C---
T ss_pred hhcc----ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHhcCCCc---c---
Confidence 3321 123456899999999999999999999999999999999999999753 111111111111100 0
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+. ........+.+++.+|++.||++|||+.|++++
T Consensus 245 ----------~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 245 ----------FR---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----------CS---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----------cC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 001123568899999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=334.16 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=198.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC--CCC--EEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK--SGE--TVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
.++|+..+.||+|+||.||+|++. +++ .||+|++..... .....+.+.+|++++++++||||+++++++..++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357889999999999999999864 333 689998854432 3345677899999999999999999999998765 8
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997643 2588999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
....... ........+|..|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+.......+
T Consensus 171 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~-- 245 (291)
T 1u46_A 171 LPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLP-- 245 (291)
T ss_dssp CCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCCC--
T ss_pred ccccccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC--CHHHHHHHHHccCCCCC--
Confidence 6543321 112233457788999999998889999999999999999999 99999753 22333332222111100
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
........+.+++.+|++.||++||++.+++++|++...
T Consensus 246 ------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 246 ------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 001224678899999999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=338.46 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=199.8
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC------CchhHHHHHHHHHHHhcCCCCCeeeEEeEEec
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH------KPETETVFRSEIETLGRVRHGNVVKLLMCCSG 751 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 751 (973)
.+.++|+..+.||+|+||.||+|+.. +++.||||++..... .......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 44567899999999999999999976 688999999854321 11223457899999999999999999999976
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc---eEEe
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV---PRVA 828 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 828 (973)
++ .|+||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred Cc-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 65 799999999999999887543 589999999999999999999999 9999999999999987654 9999
Q ss_pred ccCcchhccccCCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 905 (973)
|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|..||.... ....+...+.
T Consensus 160 Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGET-----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-TQVSLKDQIT 233 (322)
T ss_dssp CCTTCEECCCC-----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT-CSSCHHHHHH
T ss_pred cCccceecccc-----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc-hHHHHHHHHH
Confidence 99999765322 1123456899999999874 5678899999999999999999999997542 2223344433
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.......+ +.. ......+.+++.+|++.||++||++.|++++
T Consensus 234 ~~~~~~~~--------~~~----------~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKYNFIP--------EVW----------AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCCCCCH--------HHH----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCccccCc--------hhh----------hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 32211000 000 0123578899999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.20 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=198.8
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC--CCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR--HGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|+..+++.||+|++..........+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4569999999999999999999989999999999765555566778999999999997 59999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|| +.+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++ +.+||+|||+++....
T Consensus 107 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred Ee-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 99 55789999998643 588999999999999999999999 9999999999999964 8999999999987644
Q ss_pred cCCCccccccccccccCccccccccC-----------CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYT-----------KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
.... .......|++.|+|||++.+ ..++.++||||||+++|||++|+.||............ .
T Consensus 179 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~----~ 252 (313)
T 3cek_A 179 DTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA----I 252 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH----H
T ss_pred cccc--ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH----H
Confidence 3221 11234568999999999875 46788999999999999999999999753322111111 1
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
...... ..+. ......+.+++.+|++.||++||++.|++++-
T Consensus 253 ~~~~~~------------~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 253 IDPNHE------------IEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HCTTSC------------CCCC-----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Hhcccc------------cCCc-----ccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 111000 0000 01135688999999999999999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.57 Aligned_cols=257 Identities=24% Similarity=0.313 Sum_probs=187.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEe--------c
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCS--------G 751 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~ 751 (973)
.+|+..++||+|+||.||+|++. +|+.||+|++... .....+.+.+|+.+++++. ||||+++++++. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 36888999999999999999975 7899999998432 3455667889999999996 999999999983 3
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEeCCCCCCEEeCCCCceEEec
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA--IVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
....++||||++ |+|.+++........+++..++.++.||+.||+|||+. + |+||||||+||++++++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 456799999995 89999987644445699999999999999999999999 8 99999999999999999999999
Q ss_pred cCcchhccccCCCcc--------ccccccccccCccccccc---cCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch
Q 039922 830 FGLAKALQSQEGQSD--------DAMSCVAGSYGYIAPEYA---YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK 898 (973)
Q Consensus 830 fGl~~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 898 (973)
||+++.......... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||..... .
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~ 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--L 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH--H
Confidence 999987654322110 011234689999999998 566788999999999999999999999964211 1
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
..+...... +. . ......+.+++.+|++.||++||++.|++++|+...
T Consensus 260 ---~~~~~~~~~-~~---------------~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 260 ---RIVNGKYSI-PP---------------H-----DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ---------CCC-CT---------------T-----CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HhhcCcccC-Cc---------------c-----cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111100 00 0 001134678999999999999999999999998753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=343.53 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=208.4
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC-CCeeeEEeEEecCCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH-GNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~ 756 (973)
.+.++|++.++||+|+||.||+|++. +++.||||++...... ..+.+|+++++.++| +++..+..++...+..+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 34578999999999999999999974 7999999988544322 237789999999987 56666667777888999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe---CCCCceEEeccCcc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL---DAEMVPRVADFGLA 833 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~ 833 (973)
+||||+ +++|.+++..... .+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 8999999975433 589999999999999999999999 99999999999999 58899999999999
Q ss_pred hhccccCCCc---cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCC-CchhHHHHHHHHhc
Q 039922 834 KALQSQEGQS---DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFG-ENKDIVRWVTEATL 909 (973)
Q Consensus 834 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~ 909 (973)
+.+....... ........||..|+|||++.+..++.++|||||||++|||++|+.||..... ........+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 8765443221 1122356799999999999999999999999999999999999999976432 22223333322222
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
... ...+.. ....++.+++..|++.+|++||++.+|++.|+..
T Consensus 234 ~~~-------~~~l~~----------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATS-------IEALCR----------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSC-------HHHHHT----------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccc-------HHHHhc----------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 100 000000 1135789999999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=335.07 Aligned_cols=274 Identities=24% Similarity=0.284 Sum_probs=204.5
Q ss_pred ccCCCCccccccccCCeeEEEEEEC--CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC---CCCCeeeEEeEEe----
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK--SGETVAVKRLLGGTHKPETETVFRSEIETLGRV---RHGNVVKLLMCCS---- 750 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 750 (973)
..++|+..+.||+|+||.||+|+.. +|+.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3467999999999999999999983 688999999864333222223455677766665 8999999999987
Q ss_pred -cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEec
Q 039922 751 -GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVAD 829 (973)
Q Consensus 751 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 829 (973)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5667899999997 799999976532 2488999999999999999999999 999999999999999999999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
||+++...... ......||..|+|||++.+..++.++||||||+++|||++|+.||... ...+....+.....
T Consensus 164 fg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHC
T ss_pred CcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHHcC
Confidence 99997654321 233467899999999999999999999999999999999999999753 23333333333222
Q ss_pred cCCCccccCccc---cccc-C-CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPERGCCRDLN---QLID-P-RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~~~~~~l~---~~~d-~-~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.......+.... ..+. . ..............+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 211111110000 0000 0 000001112234678899999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=338.35 Aligned_cols=273 Identities=17% Similarity=0.281 Sum_probs=209.3
Q ss_pred ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCc---------------hhHHHHHHHHHHHhcCCCCCe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKP---------------ETETVFRSEIETLGRVRHGNV 742 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~ni 742 (973)
....++|+..+.||+|+||.||+|+. +|+.||+|++....... ...+.+.+|+.++++++||||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 44567899999999999999999999 89999999985332111 112678999999999999999
Q ss_pred eeEEeEEecCCeeEEEEeccCCCChhhh------hhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCC
Q 039922 743 VKLLMCCSGQDFNILVYEYMPNGSLADM------LHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSH 815 (973)
Q Consensus 743 v~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~ 815 (973)
+++++++...+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ . +|+||||||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~ 181 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS 181 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence 9999999999999999999999999998 5432 13468999999999999999999999 8 9999999999
Q ss_pred CEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCC-CCCC-CCChhhHHHHHHHHHcCCCCCCCC
Q 039922 816 NILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTE-KSDVYSFGVVLMELVTGKRPNDPS 893 (973)
Q Consensus 816 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~elltg~~p~~~~ 893 (973)
||+++.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++||||+|+++|||++|+.||...
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hEEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999765432 23345789999999999877 5666 999999999999999999999764
Q ss_pred CCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 894 FGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ..+..+.+.......+.. ............. ..........+.+++.+|++.||++|||+.|++++
T Consensus 256 ~~-~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 256 IS-LVELFNNIRTKNIEYPLD-RNHFLYPLTNKKS--TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SC-SHHHHHHHTSCCCCCCCS-SSSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred Cc-HHHHHHHHhccCcCCccc-hhhhhcccccccc--ccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22 234444433322221110 0000000000000 00012234678999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.84 Aligned_cols=260 Identities=22% Similarity=0.339 Sum_probs=198.9
Q ss_pred ecccc-ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEE
Q 039922 673 VSFNE-DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCC 749 (973)
Q Consensus 673 ~~~~~-~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 749 (973)
+.+.+ ....++|+..+.||+|+||.||+|+.. +|+.||+|++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 33444 456788999999999999999999985 78999999985432 2345688999999998 799999999999
Q ss_pred ec------CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 750 SG------QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 750 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
.. .+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence 76 568899999999999999997642 23588999999999999999999999 999999999999999999
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK 898 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 898 (973)
.+||+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||... ...
T Consensus 167 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~ 240 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM--HPM 240 (326)
T ss_dssp CEEECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS--CHH
T ss_pred CEEEeeCcCceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC--cHH
Confidence 999999999876643221 123356899999999987 567889999999999999999999999653 122
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....+...... .... ......+.+++.+|++.||++||++.|++++
T Consensus 241 ~~~~~~~~~~~~-----------~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 RALFLIPRNPAP-----------RLKS---------KKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHHSCCC-----------CCSC---------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhcCccc-----------cCCc---------cccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 222222111100 0000 1113578899999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.51 Aligned_cols=271 Identities=21% Similarity=0.259 Sum_probs=207.5
Q ss_pred ccccCCCCccccccccCCeeEEEEEE-C-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCC------CeeeEEeEE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKL-K-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG------NVVKLLMCC 749 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~ 749 (973)
+.+.++|++.+.||+|+||.||+|.. + +++.||+|++.. .....+.+.+|+.+++.++|+ +++++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 34567899999999999999999987 3 688999999942 234456788899999988765 499999999
Q ss_pred ecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC--------
Q 039922 750 SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-------- 821 (973)
Q Consensus 750 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------- 821 (973)
...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccC
Confidence 9999999999999 8999999976532 3588999999999999999999999 9999999999999987
Q ss_pred -----------CCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCC
Q 039922 822 -----------EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890 (973)
Q Consensus 822 -----------~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~ 890 (973)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CccccccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 668999999998764322 22357899999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHhccCCCcccc-------------Cc---------ccccccCCCCCCCCCHHHHHHHHHHHHhc
Q 039922 891 DPSFGENKDIVRWVTEATLSSPERGCC-------------RD---------LNQLIDPRMDLSTCDYEEAEKVLNVALMC 948 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~---------l~~~~d~~l~~~~~~~~~~~~l~~l~~~c 948 (973)
... +..+....+.......+..... .+ ..+...+..............+.+++.+|
T Consensus 235 ~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 235 PTH--DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp CCS--CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCC--ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 753 2222222222222111110000 00 00000000001112235567899999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 039922 949 TSDFPINRPSMRRVVEL 965 (973)
Q Consensus 949 l~~dP~~Rps~~evl~~ 965 (973)
++.||++|||+.|++++
T Consensus 313 L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 313 LEYDPAKRITLREALKH 329 (339)
T ss_dssp TCSSTTTSCCHHHHTTS
T ss_pred hCcCcccccCHHHHhcC
Confidence 99999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=339.42 Aligned_cols=261 Identities=22% Similarity=0.341 Sum_probs=202.1
Q ss_pred ccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
..++|+..+.||+|+||.||+|+... .||+|++..........+.+.+|+.++++++|+||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35678999999999999999998863 5999998655444444456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999997643 2588999999999999999999999 999999999999998 679999999998765322
Q ss_pred CCC-ccccccccccccCccccccccC---------CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 840 EGQ-SDDAMSCVAGSYGYIAPEYAYT---------KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 840 ~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
... .........|+..|+|||++.+ ..++.++||||||+++|||++|+.||... ........+.....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAIIWQMGTGMK 260 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC--CHHHHHHHHHTTCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhccCCC
Confidence 111 1122334568999999999874 35788999999999999999999999753 22222222222111
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.. .... .....+.+++.+|++.||++|||+.|+++.|+...
T Consensus 261 ~~-----------~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 261 PN-----------LSQI---------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp CC-----------CCCS---------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CC-----------CCcC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 10 0000 11235789999999999999999999999998854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=342.94 Aligned_cols=269 Identities=23% Similarity=0.276 Sum_probs=195.2
Q ss_pred ccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC------
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD------ 753 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 753 (973)
...+|+..++||+|+||.||+|+...+..||+|++...... ..+|+++++.++||||+++++++...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34578999999999999999999987778999998543321 236999999999999999999985433
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC-CCCceEEeccCc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD-AEMVPRVADFGL 832 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGl 832 (973)
..++||||++++.+............+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 3789999997644433332222233689999999999999999999999 999999999999999 799999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ....+...+.... ..
T Consensus 189 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g-~p 261 (394)
T 4e7w_A 189 AKILIAGEP-----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES-GIDQLVEIIKVLG-TP 261 (394)
T ss_dssp CEECCTTCC-----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHC-CC
T ss_pred cccccCCCC-----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhC-CC
Confidence 987643322 2345789999999998764 58999999999999999999999997532 1222222222111 00
Q ss_pred CCcc----ccCcccccccCCCCCCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PERG----CCRDLNQLIDPRMDLST----CDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~~~----~~~~l~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... .+......+ +...... ........+.+++.+|+++||++|||+.|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKF-PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CHHHHHHHCGGGSSSCC-CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CHHHHHhhChhhhhhcc-ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 000000000 0000000 001134578999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=338.23 Aligned_cols=269 Identities=20% Similarity=0.243 Sum_probs=195.8
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-------
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG------- 751 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 751 (973)
..++|+..+.||+|+||.||+|+.. +|+.||+|++...... ..+|+++++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3467999999999999999999875 7999999998543221 2369999999999999999999843
Q ss_pred -------------------------------CCeeEEEEeccCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 039922 752 -------------------------------QDFNILVYEYMPNGSLADMLHEK-GRSGSLDWSIRFSIAQGAAKGLAYL 799 (973)
Q Consensus 752 -------------------------------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL 799 (973)
....++||||++ |+|.+.+... .....+++..+..++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334789999997 6887777542 1233689999999999999999999
Q ss_pred hhcCCCCeEEeCCCCCCEEeC-CCCceEEeccCcchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHH
Q 039922 800 HNDCVPAIVHRDVKSHNILLD-AEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFG 877 (973)
Q Consensus 800 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG 877 (973)
|+. +|+||||||+||+++ +++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+|
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-----CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 999 999999999999997 689999999999987643322 2345789999999998765 489999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc---cCcccccccCCCCCCC----CCHHHHHHHHHHHHhccC
Q 039922 878 VVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC---CRDLNQLIDPRMDLST----CDYEEAEKVLNVALMCTS 950 (973)
Q Consensus 878 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~ 950 (973)
|++|||++|+.||.... ....+...+.... ....... .....+..-+...... ........+.+++.+|++
T Consensus 230 ~il~ell~g~~pf~~~~-~~~~~~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 230 CVFGELILGKPLFSGET-SIDQLVRIIQIMG-TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHSSCSSCCSS-HHHHHHHHHHHHC-CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHhCCCCCCCCC-hHHHHHHHHHHhC-CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 99999999999997532 2222222222111 1000000 0000000001110000 001124568899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 039922 951 DFPINRPSMRRVVEL 965 (973)
Q Consensus 951 ~dP~~Rps~~evl~~ 965 (973)
+||++|||+.|++++
T Consensus 308 ~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 308 YEPDLRINPYEAMAH 322 (383)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=345.60 Aligned_cols=255 Identities=11% Similarity=0.014 Sum_probs=182.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHH---HHHhcCCCCCeeeEE-------eEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEI---ETLGRVRHGNVVKLL-------MCC 749 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~ 749 (973)
..|+..+.||+|+||.||+|++. +|+.||+|++..... .....+.+.+|+ ..++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45888999999999999999976 789999999976543 234455677785 45555 699988755 444
Q ss_pred ecC-----------------CeeEEEEeccCCCChhhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 039922 750 SGQ-----------------DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIR------FSIAQGAAKGLAYLHNDCVPA 806 (973)
Q Consensus 750 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~ 806 (973)
... ...|+||||++ |+|.+++..... .+++..+ ..++.||+.||+|||++ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 332 34799999998 899999986432 2455555 78889999999999999 9
Q ss_pred eEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHH
Q 039922 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELV 884 (973)
Q Consensus 807 ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell 884 (973)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 999999999999999999999999999865321 113456799999999987 67999999999999999999
Q ss_pred cCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039922 885 TGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 885 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 964 (973)
+|+.||........... . . ..........+.... .......+.+++.+|+++||++|||+.|+++
T Consensus 288 tg~~Pf~~~~~~~~~~~--------~---~---~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSW--------K---R---PSLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTCC--------C---B---CCTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccch--------h---h---hhhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999976432211100 0 0 000000001111110 0123467889999999999999999999975
Q ss_pred H
Q 039922 965 L 965 (973)
Q Consensus 965 ~ 965 (973)
+
T Consensus 353 h 353 (371)
T 3q60_A 353 T 353 (371)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=335.36 Aligned_cols=269 Identities=22% Similarity=0.265 Sum_probs=203.5
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe--
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF-- 754 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 754 (973)
..+.++|...+.||+|+||.||+|+.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 345678999999999999999999976 78999999997655555566788999999999999999999999987654
Q ss_pred ----eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 755 ----NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 755 ----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
.|+||||++ ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred cceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 499999996 688887743 388999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||... +..+....+.....
T Consensus 171 g~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 171 GLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--DYLDQLTQILKVTG 241 (353)
T ss_dssp TCTTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS--CHHHHHHHHHHHHC
T ss_pred ccccCCCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhC
Confidence 999765322 223578999999999876 67899999999999999999999999753 22222222222111
Q ss_pred cCCCccccCcc---------ccccc-CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPERGCCRDL---------NQLID-PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~~~~~~l---------~~~~d-~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.. ....+ ..+.. +..............+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 242 VPGTE-FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp BCCHH-HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCHH-HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 10000 00000 00000 0000011112335678999999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=346.34 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=190.6
Q ss_pred cccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
.+.+.|...++||+|+||+||.+...+|+.||||++.. ...+.+.+|+.+++++ +||||+++++++.+++..|+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG-----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH-----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 33445666789999999999877777899999999842 2345678899999876 89999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCC----CCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-----------
Q 039922 758 VYEYMPNGSLADMLHEKGRSGS----LDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE----------- 822 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----------- 822 (973)
||||++ |+|.+++........ .++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999995 799999976542211 13345678999999999999999 99999999999999654
Q ss_pred --CceEEeccCcchhccccCCCccccccccccccCccccccccC-------CCCCCCCChhhHHHHHHHHHc-CCCCCCC
Q 039922 823 --MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-------KKVTEKSDVYSFGVVLMELVT-GKRPNDP 892 (973)
Q Consensus 823 --~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ellt-g~~p~~~ 892 (973)
+.+||+|||+++.................||+.|+|||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 489999999998775443222222334679999999999875 678999999999999999999 8999965
Q ss_pred CCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 893 SFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..... .. +.......+ .. ..........++.+++.+|++.||++|||+.||+++
T Consensus 243 ~~~~~---~~-i~~~~~~~~------~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 243 KYSRE---SN-IIRGIFSLD------EM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTTHH---HH-HHHTCCCCC------CC---------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhH---HH-HhcCCCCcc------cc---------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 32211 11 111111100 00 011234567789999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=333.63 Aligned_cols=276 Identities=21% Similarity=0.237 Sum_probs=205.7
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ----- 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 752 (973)
++.++|+..+.||+|+||.||+|+.. +++.||+|++... ......+.+.+|++++++++||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 34468999999999999999999876 7889999999532 2344456788999999999999999999998654
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
...|+||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 36799999996 6999988753 489999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
++........ ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ...+....+.......
T Consensus 175 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 175 ARVADPDHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK--HYLDQLNHILGILGSP 251 (364)
T ss_dssp CEECCGGGCB-CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS--SGGGHHHHHHHHHCSC
T ss_pred eEecCCCCCc-cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC--ChHHHHHHHHHHhCCC
Confidence 9876543321 112344679999999998654 45899999999999999999999999753 2333333332222111
Q ss_pred CCccccCc--------ccccccC-CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 912 PERGCCRD--------LNQLIDP-RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 912 ~~~~~~~~--------l~~~~d~-~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
........ ......+ ..............+.+++.+|+++||++|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 10000000 0000000 0000000011235688999999999999999999998763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.46 Aligned_cols=275 Identities=21% Similarity=0.185 Sum_probs=199.1
Q ss_pred ccccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCC---------chhHHHHHHHHHHHhcCCCCCeeeEEeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK---------PETETVFRSEIETLGRVRHGNVVKLLMC 748 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~l~~~ 748 (973)
..+.++|+..+.||+|+||.||+|...+|+.||||++...... ....+.+.+|++++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 4567889999999999999999999989999999998543221 1223678999999999999999999999
Q ss_pred Eec-----CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC
Q 039922 749 CSG-----QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM 823 (973)
Q Consensus 749 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 823 (973)
+.. ....|+||||++ |+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNN 171 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCC
Confidence 843 346799999997 78888887543 3589999999999999999999999 999999999999999999
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHH
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR 902 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 902 (973)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ...+...
T Consensus 172 ~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~ 244 (362)
T 3pg1_A 172 DITICDFNLAREDTADAN-----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS--TFYNQLN 244 (362)
T ss_dssp CEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHH
T ss_pred CEEEEecCcccccccccc-----cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC--CHHHHHH
Confidence 999999999975433221 234578899999999876 67899999999999999999999999753 2222222
Q ss_pred HHHHHhccCCCccc----cCcccccccCCCCC-CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 903 WVTEATLSSPERGC----CRDLNQLIDPRMDL-ST-----CDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 903 ~~~~~~~~~~~~~~----~~~l~~~~d~~l~~-~~-----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+............ .....+.+...... .. ........+.+++.+|++.||++|||+.|++++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 22222111110000 00000000000000 00 001124568899999999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=338.49 Aligned_cols=351 Identities=20% Similarity=0.159 Sum_probs=182.0
Q ss_pred cCCccCCCCCCCCc-cceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEE
Q 039922 48 LGDWVRTSQQSPCN-WTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVL 126 (973)
Q Consensus 48 ~~sw~~~~~~~~C~-w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L 126 (973)
+++|.. .++||. |.+..|.....++ +-.+. .......-..++++++|++++|.++ .+|...|..+++|++|
T Consensus 3 ~~~~~~--~~~C~~~~~~~~c~~~~~~i---~~~~~--~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L 74 (390)
T 3o6n_A 3 VKPRQP--EYKCIDSNLQYDCVFYDVHI---DMQTQ--DVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 74 (390)
T ss_dssp ----CC--EECBCC------EEEESCEE---CSSCC--CCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEE
T ss_pred cCCCCC--ccceehhhhhhccceeeeee---ecccc--cccccccccccCCceEEEecCCchh-hCChhHhcccccCcEE
Confidence 577864 456664 5555554332222 11111 1111112234567777777777765 4555555666666666
Q ss_pred ecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCC
Q 039922 127 ALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLK 206 (973)
Q Consensus 127 ~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 206 (973)
+|++|.+.+..+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|+++...+..|+++++|++|++++|.++
T Consensus 75 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~ 154 (390)
T 3o6n_A 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154 (390)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccC
Confidence 66666665555556666666666666666666555555566666666666666666444444555555555555555543
Q ss_pred CCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhc
Q 039922 207 SSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESL 286 (973)
Q Consensus 207 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l 286 (973)
. ..|..++++++|++|++++|++++. .+..+++|+.|++++|.+++.
T Consensus 155 ~-------------------------~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~----- 201 (390)
T 3o6n_A 155 R-------------------------IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL----- 201 (390)
T ss_dssp B-------------------------CCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----
T ss_pred c-------------------------cChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----
Confidence 2 2233444555555555555555533 233444555555555555421
Q ss_pred cCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccce
Q 039922 287 SNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYF 366 (973)
Q Consensus 287 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 366 (973)
...++|+.|++++|.++.. |.. ..++|+.|++++|++++. ..+..+++|++|
T Consensus 202 ~~~~~L~~L~l~~n~l~~~------------------------~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 253 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINVV------------------------RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEV 253 (390)
T ss_dssp ECCSSCSEEECCSSCCCEE------------------------ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred CCCCcceEEECCCCeeeec------------------------ccc--ccccccEEECCCCCCccc--HHHcCCCCccEE
Confidence 2223455555555544422 111 123444444444444422 234444444444
Q ss_pred eeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCccc
Q 039922 367 DVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFE 446 (973)
Q Consensus 367 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 446 (973)
++++|++++..|..+..+++|+.|++++|++.+ +|..+..+++|++|++++|+++ .+|..+..+++|+.|++++|+++
T Consensus 254 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~ 331 (390)
T 3o6n_A 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331 (390)
T ss_dssp ECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC
T ss_pred ECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccc
Confidence 444444444444444444444444444444442 3444556667777777777776 34555666777777777777776
Q ss_pred CCCCCCCCCCCCcceEeecCCcCCCC
Q 039922 447 GSISPSISNAPKLTGILINGNNFTGE 472 (973)
Q Consensus 447 ~~~~~~~~~~~~L~~L~L~~N~l~~~ 472 (973)
.. .+..+++|+.|++++|++.+.
T Consensus 332 ~~---~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 332 TL---KLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CC---CCCTTCCCSEEECCSSCEEHH
T ss_pred ee---CchhhccCCEEEcCCCCccch
Confidence 44 266677888888888888753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=333.74 Aligned_cols=273 Identities=22% Similarity=0.233 Sum_probs=206.3
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CC-----CeeeEEeEEe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HG-----NVVKLLMCCS 750 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~ 750 (973)
+.+.++|+..+.||+|+||+||+|+.. +++.||||++.. .......+.+|+.+++.++ |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 556789999999999999999999876 688999999942 2334556778888888875 44 4999999999
Q ss_pred cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC--CCCceEEe
Q 039922 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD--AEMVPRVA 828 (973)
Q Consensus 751 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~ 828 (973)
..+..|+||||++ |+|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999995 699999976532 3589999999999999999999952 11899999999999995 47889999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+....+....
T Consensus 204 DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~--~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 204 DFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA--NEVDQMNKIVEVL 274 (382)
T ss_dssp CCTTCEETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHH
T ss_pred eccCceecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHh
Confidence 99999866322 23357899999999999999999999999999999999999999753 3333333333322
Q ss_pred ccCCCcccc--Cc----cccccc-----------------C-------------------CCCCCCCCHHHHHHHHHHHH
Q 039922 909 LSSPERGCC--RD----LNQLID-----------------P-------------------RMDLSTCDYEEAEKVLNVAL 946 (973)
Q Consensus 909 ~~~~~~~~~--~~----l~~~~d-----------------~-------------------~l~~~~~~~~~~~~l~~l~~ 946 (973)
...+..... .. +.++.+ + ..........+...+.+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 111100000 00 000000 0 00011122345568999999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 039922 947 MCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 947 ~cl~~dP~~Rps~~evl~~ 965 (973)
+|+++||++|||+.|++++
T Consensus 355 ~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTS
T ss_pred HhcCCChhhCCCHHHHhcC
Confidence 9999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=340.91 Aligned_cols=269 Identities=25% Similarity=0.315 Sum_probs=194.5
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC------Ce
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------DF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 754 (973)
.+|+..+.||+|+||.||+|++. +|+.||||++..... ...+|++++++++|+|||++++++... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 36888999999999999999986 699999999854321 234699999999999999999988531 23
Q ss_pred eEEEEeccCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC-CceEEeccCc
Q 039922 755 NILVYEYMPNGSLADMLHEK-GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGL 832 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl 832 (973)
.++||||+++ ++.+.+... .....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 5799999974 666655431 1223689999999999999999999999 99999999999999965 5689999999
Q ss_pred chhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+.+.+.......
T Consensus 204 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 204 AKQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTPT 277 (420)
T ss_dssp CEECCTTCC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCC
T ss_pred hhhcccCCC-----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCC
Confidence 987643322 2345789999999998764 78999999999999999999999997532 2223333332211000
Q ss_pred CC--ccccCcccccccCCCCCCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 912 PE--RGCCRDLNQLIDPRMDLST----CDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 912 ~~--~~~~~~l~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.. ........+..-+.+.... .......++.+++.+|+++||++||++.|+++|-
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 00 0000000111111111100 0112246789999999999999999999998763
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.58 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=192.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--------
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-------- 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 751 (973)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 456888999999999999999975 799999999842 23455678899999999999999999998754
Q ss_pred -----CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceE
Q 039922 752 -----QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPR 826 (973)
Q Consensus 752 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 826 (973)
.+..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 456799999999999999998643 2578889999999999999999999 999999999999999999999
Q ss_pred EeccCcchhccccCCC----------ccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCC
Q 039922 827 VADFGLAKALQSQEGQ----------SDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFG 895 (973)
Q Consensus 827 l~DfGl~~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 895 (973)
|+|||.+......... .........|+..|+|||++.+. .++.++||||+||++|||++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 9999999766432110 01123345689999999998764 68999999999999999998 554211
Q ss_pred CchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 896 ENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.......+...... +.+. ........+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~-------------~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ERVNILKKLRSVSIE-------------FPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHSTTCC-------------CCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhccccccc-------------cCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111112211111111 0001 112234567899999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=358.42 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=205.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.++|+..+.||+|+||.||+|++. .+..||+|++... ......+.+.+|+.++++++||||+++++++. ++..+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 456888999999999999999875 2457999988533 23445577899999999999999999999985 45689
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999997643 2589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||... ...+....+........+
T Consensus 542 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--~~~~~~~~i~~~~~~~~~-- 614 (656)
T 2j0j_A 542 EDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERLPMP-- 614 (656)
T ss_dssp CC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHHTCCCCCC--
T ss_pred CCCcc---eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCCCCC--
Confidence 43321 11223456789999999998999999999999999999997 88898753 333444444433211110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
......+.+++.+|++.||++||++.|+++.|+.+
T Consensus 615 -------------------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 615 -------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=334.24 Aligned_cols=276 Identities=20% Similarity=0.248 Sum_probs=203.6
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ----- 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 752 (973)
.+.++|+..+.||+|+||.||+|+.. +|+.||||++... ........+.+|++++++++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 45678999999999999999999986 6899999999532 3344556788999999999999999999987654
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
...++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 67899999996 7999988753 489999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCcc------ccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH
Q 039922 833 AKALQSQEGQSD------DAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 833 ~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 905 (973)
++.......... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||... +..+....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~ 236 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR--DYRHQLLLIF 236 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHH
Confidence 987653321111 11234578999999998764 67899999999999999999999999753 2222222222
Q ss_pred HHhccCCCccccCc-----ccccccCCCCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 906 EATLSSPERGCCRD-----LNQLIDPRMDLSTCD-----YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 906 ~~~~~~~~~~~~~~-----l~~~~d~~l~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.............. ..+.+.......... ......+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 22111110000000 000000000000000 1224578899999999999999999999885
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.51 Aligned_cols=275 Identities=20% Similarity=0.295 Sum_probs=197.2
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe------
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS------ 750 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~------ 750 (973)
..+.++|+..+.||+|+||.||+|+.. +|+.||+|++.. ......+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 345678999999999999999999987 589999999853 34455677899999999999999999999873
Q ss_pred --------cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC-C
Q 039922 751 --------GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD-A 821 (973)
Q Consensus 751 --------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~ 821 (973)
..+..++||||++ |+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++ +
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE 156 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC
Confidence 3467899999997 7999998642 588999999999999999999999 999999999999997 5
Q ss_pred CCceEEeccCcchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhH
Q 039922 822 EMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900 (973)
Q Consensus 822 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~ 900 (973)
++.+||+|||+++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||... ...+.
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--~~~~~ 233 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSH-KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA--HELEQ 233 (320)
T ss_dssp TTEEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHH
T ss_pred CCeEEEccCccccccCCCccc-ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC--CHHHH
Confidence 779999999999876433211 122334567899999998765 67899999999999999999999999753 22222
Q ss_pred HHHHHHHhccCCCcccc---CcccccccCCCCCCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 901 VRWVTEATLSSPERGCC---RDLNQLIDPRMDLST-----CDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~---~~l~~~~d~~l~~~~-----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+............. ..+...+........ ........+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 22222221110000000 000000000000000 001124678999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.36 Aligned_cols=273 Identities=22% Similarity=0.237 Sum_probs=205.2
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC--------CCCeeeEEeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR--------HGNVVKLLMCC 749 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~ 749 (973)
.+.++|+..++||+|+||+||+|+.. +++.||+|++.. .....+.+.+|+.++++++ |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 34578999999999999999999875 688999999942 2345567889999999986 78899999998
Q ss_pred e----cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC--
Q 039922 750 S----GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-- 823 (973)
Q Consensus 750 ~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 823 (973)
. .....++||||+ ++++.+++.... ...+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 7 566889999999 567776665432 235899999999999999999999963 799999999999999775
Q ss_pred -----------------------------------------------ceEEeccCcchhccccCCCccccccccccccCc
Q 039922 824 -----------------------------------------------VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856 (973)
Q Consensus 824 -----------------------------------------------~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y 856 (973)
.+||+|||.+...... .....||..|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y 259 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGG
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcc
Confidence 7999999999865432 2335789999
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCc----hhHHHHHHHHhccCCCcc------------ccCcc
Q 039922 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN----KDIVRWVTEATLSSPERG------------CCRDL 920 (973)
Q Consensus 857 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~------------~~~~l 920 (973)
+|||++.+..++.++|||||||++|||++|+.||....... .+....+.......+... ....+
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99999999999999999999999999999999997643221 111222222111110000 00000
Q ss_pred cccccCCC--------CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLIDPRM--------DLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d~~l--------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.+... ............+.+++.+|+++||++|||+.|++++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000000 0012345677889999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=336.80 Aligned_cols=274 Identities=19% Similarity=0.224 Sum_probs=189.0
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe--
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF-- 754 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 754 (973)
....++|+..+.||+|+||.||+|+.. +|+.||||++...... ...+.+|+..++.++||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345678999999999999999999986 7899999998543322 2345677888888999999999999865332
Q ss_pred -----eEEEEeccCCCChhhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEEeCCCCCCEEeCC-CCce
Q 039922 755 -----NILVYEYMPNGSLADMLHE-KGRSGSLDWSIRFSIAQGAAKGLAYLH--NDCVPAIVHRDVKSHNILLDA-EMVP 825 (973)
Q Consensus 755 -----~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~ 825 (973)
.++||||+++ ++.+.+.. ......+++..+..++.|++.|++||| +. +|+||||||+||+++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999975 55544432 223346889999999999999999999 88 9999999999999997 8999
Q ss_pred EEeccCcchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH
Q 039922 826 RVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 826 kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 904 (973)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||... ........+
T Consensus 172 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--~~~~~~~~~ 244 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP-----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD--NSAGQLHEI 244 (360)
T ss_dssp EECCCTTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH
T ss_pred EEeeCCCceecCCCCC-----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC--ChHHHHHHH
Confidence 9999999987654322 2345689999999998654 4899999999999999999999999763 222223222
Q ss_pred HHHhccCCCccc----c-Cccccccc-CCCC----CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 905 TEATLSSPERGC----C-RDLNQLID-PRMD----LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 905 ~~~~~~~~~~~~----~-~~l~~~~d-~~l~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.......+.... + ..-....+ .... ...........+.+++.+|+++||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 222111100000 0 00000000 0000 001112245689999999999999999999999876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.23 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=184.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||.||+|+.. +|+.||||++..........+.+.++..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999986 7999999999655444444455566667788899999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||+ ++.+..+..... ..+++..+..++.|++.||+|||+ . +++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 455555554322 358999999999999999999998 6 899999999999999999999999999976543
Q ss_pred cCCCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
... .....|++.|+|||++. ...++.++||||||+++|||++|+.||.... ........+........
T Consensus 178 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~- 250 (318)
T 2dyl_A 178 DKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-TDFEVLTKVLQEEPPLL- 250 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-SHHHHHHHHHHSCCCCC-
T ss_pred Ccc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-ccHHHHHHHhccCCCCC-
Confidence 321 23356899999999984 5568899999999999999999999997532 22222222222111100
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. .......+.+++.+|++.||++||++.|++++
T Consensus 251 ---------------~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 251 ---------------PG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ---------------CS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---------------Cc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 00123568899999999999999999999874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=352.50 Aligned_cols=353 Identities=20% Similarity=0.165 Sum_probs=188.3
Q ss_pred CCCCccCCccCCCCCCCCc----cceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCC
Q 039922 43 DPNRKLGDWVRTSQQSPCN----WTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLS 118 (973)
Q Consensus 43 d~~~~~~sw~~~~~~~~C~----w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~ 118 (973)
+....+++|.. +++||. |.++.|+. ++ +-.+.+... +..-..+++++.|++++|.+. .+|+..|.
T Consensus 4 ~~~~~l~~~~~--~~~C~~~~~~~~c~~~~~---~i---~~~~~~~~~--~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~ 72 (597)
T 3oja_B 4 QQRYNVKPRQP--EYKCIDSNLQYDCVFYDV---HI---DMQTQDVYF--GFEDITLNNQKIVTFKNSTMR-KLPAALLD 72 (597)
T ss_dssp -------CCCS--EECCCCC--CCSEEECSC---EE---CSSCCCCEE--SCSSGGGCCCSEEEESSCEES-EECTHHHH
T ss_pred cccccccCCCC--CCcCcccCcCceeEecCc---ee---ccccccccc--CcccccCCCceEEEeeCCCCC-CcCHHHHc
Confidence 44556889964 455663 66665542 12 111111111 111123556666666666665 45544555
Q ss_pred CcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEe
Q 039922 119 PCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHF 198 (973)
Q Consensus 119 ~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 198 (973)
.+++|++|+|++|.+.+..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|
T Consensus 73 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 73 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 152 (597)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEE
Confidence 55555555555555555555555555555555555555555555555555555555555555554444444555555555
Q ss_pred eccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcC
Q 039922 199 ELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQL 278 (973)
Q Consensus 199 ~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 278 (973)
+|++|.++. ..|..++++++|++|+|++|.+++.. +..+++|+.|++++|.+
T Consensus 153 ~Ls~N~l~~-------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 153 SMSNNNLER-------------------------IEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLL 204 (597)
T ss_dssp ECCSSCCCB-------------------------CCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCC
T ss_pred EeeCCcCCC-------------------------CChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcc
Confidence 555554432 23344555555555555555555431 33345555555555555
Q ss_pred cccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCcc
Q 039922 279 SGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLG 358 (973)
Q Consensus 279 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 358 (973)
++ +...++|+.|++++|.++...+. + .++|+.|+|++|.+++ +..+.
T Consensus 205 ~~-----l~~~~~L~~L~ls~n~l~~~~~~------------------------~--~~~L~~L~L~~n~l~~--~~~l~ 251 (597)
T 3oja_B 205 ST-----LAIPIAVEELDASHNSINVVRGP------------------------V--NVELTILKLQHNNLTD--TAWLL 251 (597)
T ss_dssp SE-----EECCTTCSEEECCSSCCCEEECS------------------------C--CSCCCEEECCSSCCCC--CGGGG
T ss_pred cc-----ccCCchhheeeccCCcccccccc------------------------c--CCCCCEEECCCCCCCC--Chhhc
Confidence 43 12233455555555554422111 1 1344444444444443 23344
Q ss_pred CCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEE
Q 039922 359 KYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFF 438 (973)
Q Consensus 359 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 438 (973)
.+++|++|+|++|.+++.+|..+..+++|+.|+|++|++++ +|..+..+++|++|+|++|.++ .+|..+..+++|+.|
T Consensus 252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L 329 (597)
T 3oja_B 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329 (597)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence 44555555555555554444455555555555555555543 3555566777788888888777 456667777888888
Q ss_pred EeecCcccCCCCCCCCCCCCcceEeecCCcCCCC
Q 039922 439 EMYNNRFEGSISPSISNAPKLTGILINGNNFTGE 472 (973)
Q Consensus 439 ~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~ 472 (973)
+|++|++.+. .+..+++|+.|++++|++.+.
T Consensus 330 ~L~~N~l~~~---~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 330 YLDHNSIVTL---KLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp ECCSSCCCCC---CCCTTCCCSEEECCSSCEEHH
T ss_pred ECCCCCCCCc---ChhhcCCCCEEEeeCCCCCCh
Confidence 8888887754 367778899999999988754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.12 Aligned_cols=270 Identities=19% Similarity=0.216 Sum_probs=205.0
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CC-CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCC------eeeEEeEEe
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SG-ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN------VVKLLMCCS 750 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~ 750 (973)
.+.++|++.+.||+|+||.||+|... ++ +.||+|++.. .....+.+.+|+.++++++|++ ++++++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 45678999999999999999999975 44 6899999942 2345567888999999997765 999999999
Q ss_pred cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe-----------
Q 039922 751 GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL----------- 819 (973)
Q Consensus 751 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----------- 819 (973)
..+..++||||+ ++++.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||++
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred eCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 999999999999 677777776543 23589999999999999999999999 99999999999999
Q ss_pred --------CCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCC
Q 039922 820 --------DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPND 891 (973)
Q Consensus 820 --------~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 891 (973)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999764322 233578999999999999999999999999999999999999997
Q ss_pred CCCCCchhHHHHHHHHhccCCCcccc--Cccccc--------------------ccCCCCCCCCCHHHHHHHHHHHHhcc
Q 039922 892 PSFGENKDIVRWVTEATLSSPERGCC--RDLNQL--------------------IDPRMDLSTCDYEEAEKVLNVALMCT 949 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~--------------------~d~~l~~~~~~~~~~~~l~~l~~~cl 949 (973)
.. ...+....+.......+..... ...... ..+..............+.+++.+|+
T Consensus 241 ~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 241 TH--ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp CS--SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CC--CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 53 2233333333322211110000 000000 00000001122345668999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 039922 950 SDFPINRPSMRRVVEL 965 (973)
Q Consensus 950 ~~dP~~Rps~~evl~~ 965 (973)
+.||++|||+.|++++
T Consensus 319 ~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 319 EFDPAQRITLAEALLH 334 (355)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=342.21 Aligned_cols=277 Identities=21% Similarity=0.278 Sum_probs=187.1
Q ss_pred ccCCCCc-cccccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEe--cCC
Q 039922 680 ILPHLTE-QNLIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCS--GQD 753 (973)
Q Consensus 680 ~~~~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~ 753 (973)
+.+.|.+ .++||+|+||.||+|+.+ +++.||+|++..... ...+.+|+.++++++||||+++++++. .+.
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3444555 558999999999999976 578999999953322 235788999999999999999999995 477
Q ss_pred eeEEEEeccCCCChhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe----CCCC
Q 039922 754 FNILVYEYMPNGSLADMLHEKG------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL----DAEM 823 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~ 823 (973)
..|+||||++ |+|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 8999999996 68888775321 122488999999999999999999999 99999999999999 7789
Q ss_pred ceEEeccCcchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCC------
Q 039922 824 VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGE------ 896 (973)
Q Consensus 824 ~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~------ 896 (973)
.+||+|||+++........ ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.....+
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp CEEECCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred cEEEEECCCceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 9999999999876533211 1223446789999999998874 5899999999999999999999999754321
Q ss_pred -chhHHHHHHHHhccCCCccccCcccccccC-----CCC---CCCCCHH---------HHHHHHHHHHhccCCCCCCCCC
Q 039922 897 -NKDIVRWVTEATLSSPERGCCRDLNQLIDP-----RMD---LSTCDYE---------EAEKVLNVALMCTSDFPINRPS 958 (973)
Q Consensus 897 -~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~-----~l~---~~~~~~~---------~~~~l~~l~~~cl~~dP~~Rps 958 (973)
..+....+...... +.......+..+.+. .+. ....... ....+.+++.+|+++||++|||
T Consensus 249 ~~~~~l~~i~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGF-PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCHHHHHHHHHHHCC-CCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred chHHHHHHHHHhhCC-CChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 11222222222211 111111111111000 000 0000000 1346789999999999999999
Q ss_pred HHHHHHHH
Q 039922 959 MRRVVELL 966 (973)
Q Consensus 959 ~~evl~~L 966 (973)
+.|++++=
T Consensus 328 a~e~L~hp 335 (405)
T 3rgf_A 328 SEQAMQDP 335 (405)
T ss_dssp HHHHHTSG
T ss_pred HHHHhcCh
Confidence 99999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=354.35 Aligned_cols=271 Identities=26% Similarity=0.328 Sum_probs=201.3
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec------
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG------ 751 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 751 (973)
...++|+..+.||+|+||.||+|... +|+.||||++... ......+.+.+|++++++++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 34578999999999999999999875 6899999998543 344556778999999999999999999998765
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc---eEEe
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV---PRVA 828 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 828 (973)
++..++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999998765544688999999999999999999999 9999999999999997665 8999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHh
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 908 (973)
|||.+........ .....||+.|+|||++.+..++.++||||+|+++|||++|..||.... ....|.....
T Consensus 167 DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~ 237 (676)
T 3qa8_A 167 DLGYAKELDQGEL-----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVR 237 (676)
T ss_dssp SCCCCCBTTSCCC-----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC
T ss_pred ccccccccccccc-----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhh
Confidence 9999987643321 234678999999999999999999999999999999999999997531 1122211110
Q ss_pred ccCCCccc-cCcccccc--cCC-CCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 039922 909 LSSPERGC-CRDLNQLI--DPR-MDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRV 962 (973)
Q Consensus 909 ~~~~~~~~-~~~l~~~~--d~~-l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 962 (973)
........ .......+ ... .............+.+++.+|+++||++|||+.|+
T Consensus 238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000 00000000 000 01112334567889999999999999999999774
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=332.18 Aligned_cols=335 Identities=19% Similarity=0.183 Sum_probs=221.7
Q ss_pred CCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcc-cCcEE
Q 039922 240 KLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESL 318 (973)
Q Consensus 240 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L 318 (973)
.+.++++|++++|.++...+..|.++++|++|++++|++++..+..+..+++|++|+|++|.+++..|..+... +|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 45788899999998886655567888889999999998887777788888888888888888887777666544 68888
Q ss_pred EccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccC
Q 039922 319 NLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFS 398 (973)
Q Consensus 319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 398 (973)
+|++|+++...+..|..+++|++|++++|++++..|..+..+++|++|++++|++++.. +..+++|+.|++++|
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n--- 196 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYN--- 196 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSS---
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccc---
Confidence 88888887555555677788888888888887766777777778888888877776431 333444444444444
Q ss_pred CCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhh
Q 039922 399 GKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQIC 478 (973)
Q Consensus 399 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 478 (973)
.+++. ...++|+.|++++|++..... ...++|+.|++++|.+++. ..+.
T Consensus 197 ---------------------~l~~~-----~~~~~L~~L~l~~n~l~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~ 245 (390)
T 3o6n_A 197 ---------------------LLSTL-----AIPIAVEELDASHNSINVVRG---PVNVELTILKLQHNNLTDT--AWLL 245 (390)
T ss_dssp ---------------------CCSEE-----ECCSSCSEEECCSSCCCEEEC---CCCSSCCEEECCSSCCCCC--GGGG
T ss_pred ---------------------ccccc-----CCCCcceEEECCCCeeeeccc---cccccccEEECCCCCCccc--HHHc
Confidence 44421 122345555555555543321 1234566666666666643 4566
Q ss_pred cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEE
Q 039922 479 TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSL 558 (973)
Q Consensus 479 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 558 (973)
.+++|++|++++|++++..|..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|++|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 6677777777777776666666777777777777777776 34555566677777777777776 456666667777777
Q ss_pred ecCCCcCccccChhhhcc-cccceeccCCcCcccCCCCCcccccccccCCCCCCCCCCC
Q 039922 559 DLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDL 616 (973)
Q Consensus 559 ~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~~~~~~~~~~~~~n~~~c~~~l 616 (973)
+|++|++++ +| +..+ .|+.|++++|++++.....+...+....+.+++..|+.+.
T Consensus 324 ~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 324 YLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp ECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCTTC
T ss_pred ECCCCccce-eC--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceecccc
Confidence 777777763 33 3344 6677777777776643322222333444566777777543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.79 Aligned_cols=255 Identities=20% Similarity=0.318 Sum_probs=175.2
Q ss_pred ccccCCCCcc-ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec----
Q 039922 678 DDILPHLTEQ-NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG---- 751 (973)
Q Consensus 678 ~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---- 751 (973)
..+.++|.+. ++||+|+||.||+|+.+ +|+.||+|++... . ....+....++.++|+||+++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4556788885 46999999999999987 7999999998432 1 222233344667799999999999876
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCceEEe
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVPRVA 828 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 828 (973)
+...++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 4558999999999999999986532 3589999999999999999999999 9999999999999976 4559999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch--hHHHHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK--DIVRWVTE 906 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~--~~~~~~~~ 906 (973)
|||+++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||........ .....+..
T Consensus 174 Dfg~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (336)
T 3fhr_A 174 DFGFAKETTQNA------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247 (336)
T ss_dssp CCTTCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred ccccceeccccc------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence 999997654221 2345689999999999888899999999999999999999999975422111 00111111
Q ss_pred HhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
.... ...+.. ......+.+++.+|++.||++|||+.|++++-
T Consensus 248 ~~~~------------~~~~~~------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 248 GQYG------------FPNPEW------SEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ---C------------CCTTTS------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cccc------------cCchhh------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 1000 000000 12245688999999999999999999999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=331.48 Aligned_cols=258 Identities=23% Similarity=0.301 Sum_probs=178.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHH-HHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIE-TLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|+..+.||+|+||.||+|..+ +|+.||||++..... ......+..|.. +++.++||||+++++++..++..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 467889999999999999999986 789999999965433 233344555555 77888999999999999999999999
Q ss_pred EeccCCCChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 759 YEYMPNGSLADMLHEK--GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
|||++ |+|.+++... .....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99997 5888877631 11336899999999999999999999952 7999999999999999999999999999766
Q ss_pred cccCCCccccccccccccCccccccc----cCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYA----YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
..... .....||..|+|||++ .+..++.++||||||+++|||++|+.||...... .+.+......
T Consensus 177 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~-- 245 (327)
T 3aln_A 177 VDSIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----FDQLTQVVKG-- 245 (327)
T ss_dssp ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCS--
T ss_pred ccccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH----HHHHHHHhcC--
Confidence 43321 2234689999999998 4567899999999999999999999999742111 1110000000
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+.+.. .........+.+++.+|++.||++||++.|++++
T Consensus 246 -----------~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 246 -----------DPPQLSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -----------CCCCCCC-CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -----------CCCCCCC-cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000100 0001224578899999999999999999999764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=349.35 Aligned_cols=335 Identities=19% Similarity=0.180 Sum_probs=236.4
Q ss_pred CCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcc-cCcEE
Q 039922 240 KLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESL 318 (973)
Q Consensus 240 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L 318 (973)
.+.+++.|++++|.++...+..|.++++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..|..+... +|+.|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 35678888888888887666677888888888888888888777788888888888888888887766665543 67777
Q ss_pred EccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccC
Q 039922 319 NLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFS 398 (973)
Q Consensus 319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 398 (973)
+|++|.+++..+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------------------- 187 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------------------- 187 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---------------------
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---------------------
Confidence 77777777655555677777777777777777766667777777777777777776432
Q ss_pred CCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhh
Q 039922 399 GKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQIC 478 (973)
Q Consensus 399 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 478 (973)
++.+++|++|++++|.+++. ...++|+.|++++|.+....+.. .++|+.|++++|.+++ +..+.
T Consensus 188 ------~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~ 251 (597)
T 3oja_B 188 ------LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLL 251 (597)
T ss_dssp ------GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGG
T ss_pred ------hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--Chhhc
Confidence 23334455555555555432 22345566666666655433222 2467777777777775 35677
Q ss_pred cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEE
Q 039922 479 TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSL 558 (973)
Q Consensus 479 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 558 (973)
.+++|+.|+|++|.+++.+|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|
T Consensus 252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L 329 (597)
T 3oja_B 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329 (597)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence 77888888888888877777778888888888888888874 5666677788888888888887 577777788888888
Q ss_pred ecCCCcCccccChhhhcc-cccceeccCCcCcccCCCCCcccccccccCCCCCCCCCCC
Q 039922 559 DLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDL 616 (973)
Q Consensus 559 ~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~~~~~~~~~~~~~n~~~c~~~l 616 (973)
+|++|++++. | +..+ .|+.|++++|+++|..+..+...+....+.+++..|+.+.
T Consensus 330 ~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 330 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCTTC
T ss_pred ECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCcch
Confidence 8888888743 3 3344 6778888888887765443333444555678888888643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.78 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=191.3
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc----hhHHHHHHHHHHHhcC----CCCCeeeEEeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP----ETETVFRSEIETLGRV----RHGNVVKLLMC 748 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~~ 748 (973)
+.+.++|+..+.||+|+||.||+|+.. +++.||+|++....... .....+.+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 455678999999999999999999875 78999999996443221 1223456788888888 89999999999
Q ss_pred EecCCeeEEEEec-cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC-CCCceE
Q 039922 749 CSGQDFNILVYEY-MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD-AEMVPR 826 (973)
Q Consensus 749 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~k 826 (973)
+...+..++|||| +.+++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++ +++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 78999999998653 489999999999999999999999 999999999999999 889999
Q ss_pred EeccCcchhccccCCCccccccccccccCccccccccCCCCC-CCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH
Q 039922 827 VADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVT-EKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 827 l~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 905 (973)
|+|||+++...... .....|+..|+|||++.+..+. .++||||+|+++|||++|+.||... ... .
T Consensus 181 l~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~----~ 246 (312)
T 2iwi_A 181 LIDFGSGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QEI----L 246 (312)
T ss_dssp ECCCSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH----H
T ss_pred EEEcchhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HHH----h
Confidence 99999998764322 2345689999999998876664 5899999999999999999999631 111 1
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
..... +. ......+.+++.+|++.||++||++.|++++-
T Consensus 247 ~~~~~-----------------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 247 EAELH-----------------FP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp HTCCC-----------------CC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred hhccC-----------------Cc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 11100 00 11235678999999999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.55 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=199.4
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc----hhHHHHHHHHHHHhcCC--CCCeeeEEeEEe
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP----ETETVFRSEIETLGRVR--HGNVVKLLMCCS 750 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~ 750 (973)
+.+.++|+..+.||+|+||.||+|+.. +++.||||++....... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 445678999999999999999999875 78999999996543221 12244677999999996 599999999999
Q ss_pred cCCeeEEEEeccCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC-CCCceEEe
Q 039922 751 GQDFNILVYEYMPN-GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD-AEMVPRVA 828 (973)
Q Consensus 751 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~ 828 (973)
..+..++|||++.+ ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 89999997643 588999999999999999999999 999999999999999 78999999
Q ss_pred ccCcchhccccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||... ... ...
T Consensus 193 Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~----~~~ 258 (320)
T 3a99_A 193 DFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEI----IRG 258 (320)
T ss_dssp CCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH----HHC
T ss_pred eCcccccccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hhh----hcc
Confidence 999998664321 233568999999999887665 67899999999999999999999641 111 110
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
... .. ......+.+++.+|++.||++|||+.|++++
T Consensus 259 ~~~-------------~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 QVF-------------FR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCC-------------CS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc-------------cc---------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 0113568899999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=335.69 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=186.0
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEEEec
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
+|...++||+|+||+||.....+|+.||||++..... ..+.+|+.+++++ +|||||++++++.+.+..|+||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 5778899999999997766666899999999953321 1256799999999 799999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-----CCceEEeccCcchhc
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-----EMVPRVADFGLAKAL 836 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGl~~~~ 836 (973)
++ |+|.+++..... ...+..+..++.||+.||+|||+. +|+||||||+||+++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 95 799999976543 344455678999999999999999 9999999999999953 336889999999876
Q ss_pred cccCCCccccccccccccCcccccccc---CCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAY---TKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
...... ........||+.|+|||++. ...++.++||||+||++|||++ |..||.... ......+ ... .
T Consensus 174 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~---~~~~~~~---~~~-~ 245 (432)
T 3p23_A 174 AVGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL---QRQANIL---LGA-C 245 (432)
T ss_dssp -------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT---THHHHHH---TTC-C
T ss_pred cCCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh---HHHHHHH---hcc-C
Confidence 543211 12233467999999999997 4567889999999999999999 888885421 1111111 100 0
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .... .........+.+++.+|++.||++|||+.||+++
T Consensus 246 ~-------~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 S-------LDCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp C-------CTTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-------cccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 0000 0112345567899999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.70 Aligned_cols=268 Identities=21% Similarity=0.300 Sum_probs=201.2
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-----------CCCeeeEEeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-----------HGNVVKLLMC 748 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~ 748 (973)
.++|+..+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++ |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 457999999999999999999975 789999999942 2344567888999999886 8899999999
Q ss_pred EecCC----eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC----
Q 039922 749 CSGQD----FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD---- 820 (973)
Q Consensus 749 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---- 820 (973)
+...+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ +|+||||||+||+++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 87644 789999999 8999999976432 35889999999999999999999953 899999999999994
Q ss_pred --CCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC--
Q 039922 821 --AEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-- 896 (973)
Q Consensus 821 --~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-- 896 (973)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CcCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 4458999999999765432 22357899999999999999999999999999999999999999754221
Q ss_pred --chhHHHHHHHHhccCCCc---------------cccCc--------ccccccCCCCCCCCCHHHHHHHHHHHHhccCC
Q 039922 897 --NKDIVRWVTEATLSSPER---------------GCCRD--------LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSD 951 (973)
Q Consensus 897 --~~~~~~~~~~~~~~~~~~---------------~~~~~--------l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~ 951 (973)
..+....+.......+.. +.... +.+..... ..........+.+++.+|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK---YKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT---TCCCHHHHHHHHHHHGGGGCS
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc---ccCCcchHHHHHHHHHHHhcc
Confidence 111111111111111100 00000 00000000 123356778899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 039922 952 FPINRPSMRRVVEL 965 (973)
Q Consensus 952 dP~~Rps~~evl~~ 965 (973)
||++|||+.|++++
T Consensus 321 dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 321 DPRKRADAGGLVNH 334 (373)
T ss_dssp STTTCBCHHHHHTC
T ss_pred CccccCCHHHHhhC
Confidence 99999999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.73 Aligned_cols=272 Identities=20% Similarity=0.266 Sum_probs=209.1
Q ss_pred cchhhHHHHHHHhhhccCCCCCccCCcc--CCCCCCCCccceeEEcC--------CCCceeEeecCCCccCCCCCCCccC
Q 039922 25 SLHGDAEILIRVKSDQLDDPNRKLGDWV--RTSQQSPCNWTGITCET--------QNQSVDGIDLSGFDLSGGFPNGFCR 94 (973)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~d~~~~~~sw~--~~~~~~~C~w~gv~c~~--------~~~~v~~l~l~~~~l~g~~~~~~~~ 94 (973)
....|++||++||+++..||.+.+++|. .....++|.|.|++|+. ...+|+.|+|++++++ .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 4567999999999998889999999995 12245789999999952 3467999999999998 78888999
Q ss_pred ccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCC-------
Q 039922 95 IRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGR------- 167 (973)
Q Consensus 95 l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~------- 167 (973)
+++|++|+|++|.++ .+| ..++.+++|++|+|++|.+. .+|..++.+++|++|+|++|++.+.+|..++.
T Consensus 103 l~~L~~L~L~~n~l~-~lp-~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELP-DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GTTCSEEEEESSCCC-CCC-SCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred CCCCCEEECCCCCcc-chh-HHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 999999999999998 666 46889999999999999988 77888999999999999998888888887764
Q ss_pred --CCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCC
Q 039922 168 --FPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLS 245 (973)
Q Consensus 168 --l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~ 245 (973)
+++|++|+|++|+++ .+|..++++++|++|+|++|+++. +|..++.+++|++|++++|++.+.+|..++++++|+
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~--l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA--LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC--CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc--CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 888888888888888 667788888888888888888875 455566666666666666666666666666666666
Q ss_pred EEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccC
Q 039922 246 NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT 303 (973)
Q Consensus 246 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 303 (973)
+|+|++|.+.+.+|..+.++++|++|++++|++.+.+|..+.++++|+.+++..|.+.
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 6666666665566666666666666666666666666666666666666665555443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.97 Aligned_cols=307 Identities=23% Similarity=0.336 Sum_probs=196.0
Q ss_pred ccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcE
Q 039922 238 IGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLES 317 (973)
Q Consensus 238 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~ 317 (973)
+..+++|++|++++|.++. ++ .+..+++|++|++++|++++..+ +..+++|++|++++|.++. ++......+|++
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~~~~~l~~L~~ 114 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-ISALQNLTNLRE 114 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSE
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-chHHcCCCcCCE
Confidence 4567788888888888874 34 37788888888888888885433 7888888888888888875 343333346888
Q ss_pred EEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCcc
Q 039922 318 LNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRF 397 (973)
Q Consensus 318 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 397 (973)
|++++|.+++..+ +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|++
T Consensus 115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred EECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence 8888888875433 7777888888888886553433 37778888888888887764433 55666666666666666
Q ss_pred CCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhh
Q 039922 398 SGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQI 477 (973)
Q Consensus 398 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~ 477 (973)
.+..+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|++|++++|.+++. ..+
T Consensus 190 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~ 261 (347)
T 4fmz_A 190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAV 261 (347)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGG
T ss_pred ccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhH
Confidence 54332 5666666666666666664443 5556666666666666654333 55556666666666665532 345
Q ss_pred hcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccE
Q 039922 478 CTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTS 557 (973)
Q Consensus 478 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 557 (973)
..+++|++|++++|++++. +.+..+++|+.|++++|++++..|..+..+++|+.|+|++|++++..| +..+++|++
T Consensus 262 ~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 337 (347)
T 4fmz_A 262 KDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337 (347)
T ss_dssp TTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSE
T ss_pred hcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccce
Confidence 5556666666666666532 235555666666666666655555555556666666666666654333 555566666
Q ss_pred EecCCCcCc
Q 039922 558 LDLSSNLLT 566 (973)
Q Consensus 558 L~Ls~N~l~ 566 (973)
||+++|+++
T Consensus 338 L~l~~N~i~ 346 (347)
T 4fmz_A 338 ADFANQVIK 346 (347)
T ss_dssp ESSSCC---
T ss_pred eehhhhccc
Confidence 666666554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=306.74 Aligned_cols=64 Identities=25% Similarity=0.316 Sum_probs=30.9
Q ss_pred hhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCccc
Q 039922 477 ICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLT 542 (973)
Q Consensus 477 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (973)
+..+++|+.|++++|++++..|..++.+++|+.|+|++|++++..| +..+++|+.|++++|.|+
T Consensus 283 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 4444455555555555554444445555555555555555554333 445555555555555543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=312.96 Aligned_cols=244 Identities=31% Similarity=0.465 Sum_probs=133.7
Q ss_pred cCcEEEccCCcCCC--CCCccccCCCccceeeecc-ccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhh
Q 039922 314 SLESLNLNDNYFTG--EIPESLASNPNLVQLKLFN-NSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCI 390 (973)
Q Consensus 314 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 390 (973)
+++.|+|++|.+++ .+|..+.++++|++|+|++ |.+.+.+|..++++++|++|+|++|++++.+|..+..
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~------- 123 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ------- 123 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGG-------
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhC-------
Confidence 46666666666666 5666666666666666663 6666666666666666666666666665544444433
Q ss_pred hcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCC-CcceEeecCCcC
Q 039922 391 IIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAP-KLTGILINGNNF 469 (973)
Q Consensus 391 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-~L~~L~L~~N~l 469 (973)
+++|++|++++|.+++..|..|..+++|+.|++++|++++.+|..+..++ +|+.|++++|.+
T Consensus 124 -----------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 124 -----------------IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp -----------------CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred -----------------CCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence 44444444444444444444444444444444444444433344444443 444444444545
Q ss_pred CCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccc
Q 039922 470 TGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL 549 (973)
Q Consensus 470 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 549 (973)
++.+|..+..++ |++|++++|++++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..|
T Consensus 187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 445555555554 66666666666555555556666666666666666544443 5555666666666666665566666
Q ss_pred cccccccEEecCCCcCccccChhhhcc-cccceecc
Q 039922 550 GNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNIS 584 (973)
Q Consensus 550 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~ 584 (973)
..+++|+.|+|++|+++|.+|.. ..+ .|+.++++
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~ 299 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYA 299 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTC
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhc
Confidence 66666666666666666655554 333 44444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=306.34 Aligned_cols=235 Identities=12% Similarity=0.034 Sum_probs=185.0
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.+.++|++.+.||+|+||.||+|++. +|+.||+|++...... ....+.+.+|+..+++++||||+++++++..++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34578999999999999999999986 5899999999655433 344577899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++++|.++++.. ....++.+|+.|++.||+|||++ +|+||||||+||++++++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999998542 34556888999999999999999 99999999999999999999998543
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
|++ .++.++|||||||++|||++|+.||........ +.
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~--------------- 212 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LA--------------- 212 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SE---------------
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hH---------------
Confidence 233 367899999999999999999999976422110 00
Q ss_pred cCcccccccCCCC-CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 917 CRDLNQLIDPRMD-LSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 917 ~~~l~~~~d~~l~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
.....+..... ...........+.+++.+|++.||++| |+.|+++.|++...
T Consensus 213 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 213 --PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp --ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred --HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00000000000 000001224568899999999999999 99999999987543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=342.69 Aligned_cols=241 Identities=21% Similarity=0.272 Sum_probs=192.8
Q ss_pred cccCCCCccccccccCCeeEEEEEEC--CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe--
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK--SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF-- 754 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 754 (973)
.+.++|++.+.||+|+||.||+|.+. +|+.||||++... ........+.+|+.++++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34578999999999999999999986 6899999998543 234555678999999999999999999999987654
Q ss_pred ---eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 755 ---NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 755 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
.|+||||+++++|.+++.. .+++..++.++.||+.||+|||++ +|+||||||+||+++++ .+||+|||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 6999999999999987654 489999999999999999999999 99999999999999986 89999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+++..... ....||++|+|||++.++. +.++|||||||++|||++|..|+......
T Consensus 227 ~a~~~~~~--------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------- 282 (681)
T 2pzi_A 227 AVSRINSF--------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------- 282 (681)
T ss_dssp TCEETTCC--------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------
T ss_pred cchhcccC--------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------
Confidence 99865332 2357999999999987654 88999999999999999998887642110
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHhh
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-MRRVVELLRV 968 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~L~~ 968 (973)
.+ .. ..........+.+++.+|+++||++||+ +.++...+..
T Consensus 283 -------~~---~~-----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 283 -------GL---PE-----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -------SC---CT-----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------cc---cc-----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 00 0001123457889999999999999995 5556555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=304.12 Aligned_cols=238 Identities=21% Similarity=0.313 Sum_probs=182.3
Q ss_pred cccccccCCCCcc-ccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHH-hcCCCCCeeeEEeEEec
Q 039922 675 FNEDDILPHLTEQ-NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETL-GRVRHGNVVKLLMCCSG 751 (973)
Q Consensus 675 ~~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~ 751 (973)
.....+.++|... ++||+|+||.||+|... +++.||+|++.. ...+.+|++++ +..+||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3345667778777 78999999999999985 789999999842 23466788887 56689999999999876
Q ss_pred ----CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCc
Q 039922 752 ----QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMV 824 (973)
Q Consensus 752 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~ 824 (973)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCc
Confidence 677899999999999999998753 23589999999999999999999999 9999999999999998 789
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 904 (973)
+||+|||++.... +..++.++||||+||++|||++|+.||...... ...
T Consensus 159 ~kl~Dfg~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~--- 207 (299)
T 3m2w_A 159 LKLTDFGFAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AIS--- 207 (299)
T ss_dssp EEECCCTTCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------
T ss_pred EEEeccccccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch--hhh---
Confidence 9999999886431 234677899999999999999999999653211 000
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTC-DYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 966 (973)
. .....+.......... .......+.+++.+|++.||++|||+.|++++-
T Consensus 208 -----~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 208 -----P-------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp -----C-------CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----H-------HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0 0000000000000000 011246789999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=320.94 Aligned_cols=245 Identities=16% Similarity=0.128 Sum_probs=179.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCC-CCe----------e----
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRH-GNV----------V---- 743 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~ni----------v---- 743 (973)
...|+..++||+|+||.||+|++. +|+.||||++.... ......+.+++|+.+++.++| ++. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345778899999999999999965 79999999986332 222335678999999999987 221 1
Q ss_pred -e------EEeEEec-----CCeeEEEEeccCCCChhhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 039922 744 -K------LLMCCSG-----QDFNILVYEYMPNGSLADMLHEK----GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807 (973)
Q Consensus 744 -~------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 807 (973)
. +..++.. ....+++|+++ +++|.++++.. .....+++..++.++.||+.||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1 1111111 22356777766 68999888522 1223578889999999999999999999 99
Q ss_pred EEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccc----------cCCCCCCCCChhhHH
Q 039922 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA----------YTKKVTEKSDVYSFG 877 (973)
Q Consensus 808 vH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slG 877 (973)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 99999999999999999999999998764322 233567 999999999 556688899999999
Q ss_pred HHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 039922 878 VVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP 957 (973)
Q Consensus 878 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 957 (973)
|++|||++|+.||...... . ....++.... .....+.+++.+|+++||++||
T Consensus 305 vil~elltg~~Pf~~~~~~--~-------------------~~~~~~~~~~-------~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAAL--G-------------------GSEWIFRSCK-------NIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGG--S-------------------CSGGGGSSCC-------CCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHCCCCCCCcchh--h-------------------hHHHHHhhcc-------cCCHHHHHHHHHHccCChhhCc
Confidence 9999999999999753210 0 0111111100 1135688999999999999999
Q ss_pred CHHHHHHH
Q 039922 958 SMRRVVEL 965 (973)
Q Consensus 958 s~~evl~~ 965 (973)
++.|++++
T Consensus 357 t~~~~l~~ 364 (413)
T 3dzo_A 357 LPLQAMET 364 (413)
T ss_dssp CHHHHTTS
T ss_pred CHHHHHhC
Confidence 98887553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=297.45 Aligned_cols=286 Identities=23% Similarity=0.258 Sum_probs=163.7
Q ss_pred CccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeecc
Q 039922 122 HLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELG 201 (973)
Q Consensus 122 ~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 201 (973)
+|+.++++++.+. .+|..+ .++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3444444444443 234333 2567777777777776666677777777777777777777767777777777777777
Q ss_pred CcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCc--
Q 039922 202 YNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLS-- 279 (973)
Q Consensus 202 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-- 279 (973)
+|+++.+ |. .+. ++|++|++++|++++..+..|.++++|++|++++|.++
T Consensus 111 ~n~l~~l--~~------------------------~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 162 (332)
T 2ft3_A 111 KNHLVEI--PP------------------------NLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162 (332)
T ss_dssp SSCCCSC--CS------------------------SCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGG
T ss_pred CCcCCcc--Cc------------------------ccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccC
Confidence 7776542 21 111 45677777777776555556677777777777777764
Q ss_pred ccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccC
Q 039922 280 GELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGK 359 (973)
Q Consensus 280 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 359 (973)
+..+..+..+ +|+.|++++|.+++ +|..+. .+|++|++++|++++..+..+..+++|+.|+|++|++++..+..+..
T Consensus 163 ~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~-~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 239 (332)
T 2ft3_A 163 GFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP-ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239 (332)
T ss_dssp GSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC-SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGG
T ss_pred CCCcccccCC-ccCEEECcCCCCCc-cCcccc-CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhC
Confidence 3555666666 67777777777664 232222 35566666666666555555666666666666666666555555666
Q ss_pred CCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCC------cceeeEEEccCCccc--cccCcccCC
Q 039922 360 YSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGE------CKTLNYLRFGGNELQ--GELPSKFWG 431 (973)
Q Consensus 360 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~------l~~L~~L~L~~N~l~--~~~~~~~~~ 431 (973)
+++|++|+|++|+++ .+|..+..+++|+.|++++|++++..+..|.. ...|+.|++++|.+. +..|..|..
T Consensus 240 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~ 318 (332)
T 2ft3_A 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318 (332)
T ss_dssp CTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccc
Confidence 666666666666655 34444444444444444444444333333332 233444555555444 333333444
Q ss_pred CCCccEEEeec
Q 039922 432 LPEVDFFEMYN 442 (973)
Q Consensus 432 l~~L~~L~L~~ 442 (973)
+++|+.+++++
T Consensus 319 l~~L~~l~l~~ 329 (332)
T 2ft3_A 319 VTDRLAIQFGN 329 (332)
T ss_dssp BCCSTTEEC--
T ss_pred cchhhhhhccc
Confidence 44444444433
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=294.73 Aligned_cols=267 Identities=20% Similarity=0.272 Sum_probs=179.3
Q ss_pred cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcc
Q 039922 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIF 393 (973)
Q Consensus 314 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 393 (973)
.++.|+|++|++++..+..|.++++|++|+|++|++++..|..+..+++|++|++++|+++ .+|..+. ++|+.|+++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~ 129 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVH 129 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECC
Confidence 4555555555555554555666666666666666666555666666666666666666665 2333222 456666666
Q ss_pred cCccCCCCCCccCCcceeeEEEccCCcccc--ccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCC
Q 039922 394 NNRFSGKIPESYGECKTLNYLRFGGNELQG--ELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTG 471 (973)
Q Consensus 394 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~ 471 (973)
+|++.+..+..+..+++|++|++++|.+.. ..+..|.++++|+.|++++|+++.. |..+. ++|++|++++|.+++
T Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~l~~ 206 (330)
T 1xku_A 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGLP--PSLTELHLDGNKITK 206 (330)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-CSSCC--TTCSEEECTTSCCCE
T ss_pred CCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC-Ccccc--ccCCEEECCCCcCCc
Confidence 666665555566677777777777777743 5566677777777777777777643 33332 678888888888887
Q ss_pred CCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccc
Q 039922 472 EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGN 551 (973)
Q Consensus 472 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 551 (973)
..|..+..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..
T Consensus 207 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~ 285 (330)
T 1xku_A 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 285 (330)
T ss_dssp ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC
T ss_pred cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCC
Confidence 77777888888888888888888766667888888888888888887 77777888888888888888888665566643
Q ss_pred ------cccccEEecCCCcCcc--ccChhhhcc-cccceeccCCc
Q 039922 552 ------LAVLTSLDLSSNLLTG--EIPLELTKL-KLNQFNISHNK 587 (973)
Q Consensus 552 ------l~~L~~L~Ls~N~l~~--~~p~~l~~l-~l~~l~l~~N~ 587 (973)
.+.|+.|++++|++.. ..|..+..+ .++.+++++|+
T Consensus 286 ~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 3677888888888763 344556656 78888888774
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=296.32 Aligned_cols=288 Identities=19% Similarity=0.299 Sum_probs=149.1
Q ss_pred CCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcc-cCcEEEcc
Q 039922 243 FLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLN 321 (973)
Q Consensus 243 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~ 321 (973)
+++.+++++|.++ .+|..+. ++|+.|++++|++++..|..+.++++|++|++++|.+++..|..+... +|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 5777777777776 4555443 567777777777776666667777777777777777665555544432 45555555
Q ss_pred CCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCC
Q 039922 322 DNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKI 401 (973)
Q Consensus 322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 401 (973)
+|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|+++. .+..
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~ 165 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN----------------------SGFE 165 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG----------------------GGSC
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc----------------------CCCC
Confidence 55555 3333332 455555555555554433445555555555555555532 0122
Q ss_pred CCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCC
Q 039922 402 PESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLR 481 (973)
Q Consensus 402 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~ 481 (973)
+..+..+ +|++|++++|++++ +|..+. ++|+.|++++|++++..+..+..+++|+.|++++|++++..+..+..++
T Consensus 166 ~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 241 (332)
T 2ft3_A 166 PGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP 241 (332)
T ss_dssp TTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCT
T ss_pred cccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCC
Confidence 3333333 44444444444443 222111 3444444444444444444455555555555555555544444555555
Q ss_pred cCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCcc------ccceeeeeccCccc--CCCCccccccc
Q 039922 482 QLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSL------TALIVLNLSTNQLT--GTIPPELGNLA 553 (973)
Q Consensus 482 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~--~~~p~~~~~l~ 553 (973)
+|++|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|..+ .+|+.|++++|.++ +..|..|..++
T Consensus 242 ~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~ 320 (332)
T 2ft3_A 242 TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320 (332)
T ss_dssp TCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBC
T ss_pred CCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccc
Confidence 5555555555555 455555555555555555555554444444332 34455555555554 34444455555
Q ss_pred cccEEecCCC
Q 039922 554 VLTSLDLSSN 563 (973)
Q Consensus 554 ~L~~L~Ls~N 563 (973)
+|+.|+|++|
T Consensus 321 ~L~~l~l~~n 330 (332)
T 2ft3_A 321 DRLAIQFGNY 330 (332)
T ss_dssp CSTTEEC---
T ss_pred hhhhhhcccc
Confidence 5555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-35 Score=345.20 Aligned_cols=135 Identities=21% Similarity=0.237 Sum_probs=68.2
Q ss_pred CCCCEEECcCCcCCCCCCcc-cCCCCcccEEecCCcccCC----cccccccccccccEeeccCcCCCCCCCCccccCcch
Q 039922 145 ANLQVLDLSRNNFSGDIPES-FGRFPVLKVLNLGGNLLSG----LIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSK 219 (973)
Q Consensus 145 ~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~ 219 (973)
++|++|||++|+++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|.+...
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~----------- 71 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV----------- 71 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHH-----------
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChH-----------
Confidence 35666666666665332222 4556666666666666653 2344455556666666666554320
Q ss_pred hHHHhhccCcccccCCccc-cCCC----CCCEEEccCCcccc----cCCcCCCCCCCCCEEEccCCcCcccCchhccC--
Q 039922 220 LENLWAAKANLIGEIPDSI-GKLA----FLSNLDLSDNFLSG----KIPHSFSGLASIEQIELFDNQLSGELPESLSN-- 288 (973)
Q Consensus 220 L~~L~l~~n~l~~~~p~~l-~~l~----~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~-- 288 (973)
.+..+ ..+. +|++|+|++|.++. .++..+..+++|++|++++|.+++..+..+..
T Consensus 72 --------------~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 137 (461)
T 1z7x_W 72 --------------GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGL 137 (461)
T ss_dssp --------------HHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHH
T ss_pred --------------HHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHH
Confidence 01111 1122 46666666666653 33555556666666666666655433332221
Q ss_pred ---CCccceeeccccccCC
Q 039922 289 ---LTTLLRLDISQNNLTG 304 (973)
Q Consensus 289 ---l~~L~~L~Ls~N~l~~ 304 (973)
.++|++|++++|.+++
T Consensus 138 ~~~~~~L~~L~L~~n~l~~ 156 (461)
T 1z7x_W 138 LDPQCRLEKLQLEYCSLSA 156 (461)
T ss_dssp TSTTCCCCEEECTTSCCBG
T ss_pred hcCCCcceEEECCCCCCCH
Confidence 3345555555555554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-33 Score=310.31 Aligned_cols=246 Identities=14% Similarity=0.040 Sum_probs=184.7
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCC------CchhHHHHHHHHHHHhcCC---------CCCeeeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTH------KPETETVFRSEIETLGRVR---------HGNVVKL 745 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~l 745 (973)
.++|+..+.||+|+||+||+|+. +|+.||||++..... .....+.+.+|+.+++.++ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 589999999965432 2233467888988888885 7777777
Q ss_pred EeEEe------------------------------cCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHH
Q 039922 746 LMCCS------------------------------GQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795 (973)
Q Consensus 746 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 795 (973)
.+++. ..+..|+||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 76642 26789999999999977666643 247999999999999999
Q ss_pred HHHHh-hcCCCCeEEeCCCCCCEEeCCCC--------------------ceEEeccCcchhccccCCCcccccccccccc
Q 039922 796 LAYLH-NDCVPAIVHRDVKSHNILLDAEM--------------------VPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854 (973)
Q Consensus 796 L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~ 854 (973)
|+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~ 241 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCD 241 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEee
Confidence 99999 88 999999999999999887 8999999999876421 247899
Q ss_pred CccccccccCCCCCCCCChhhHHHH-HHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCC
Q 039922 855 GYIAPEYAYTKKVTEKSDVYSFGVV-LMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTC 933 (973)
Q Consensus 855 ~y~aPE~~~~~~~~~~~Dv~slG~~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 933 (973)
.|+|||++.+.. +.++||||+|++ .+++++|..||.... ......+.+...... +.......
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~~---------------~~~~~~~~ 304 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQMTF---------------KTKCNTPA 304 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-HHHHHHHHHHHTCCC---------------SSCCCSHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-hhhHHHHhhhhhhcc---------------Ccccchhh
Confidence 999999998766 889999998777 788899998874200 000111111111000 00000011
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHH-HH
Q 039922 934 DYEEAEKVLNVALMCTSDFPINRPSMRRVV-EL 965 (973)
Q Consensus 934 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl-~~ 965 (973)
......++.+++.+|+++| |+.|++ +|
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 1346778999999999976 999998 54
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=292.62 Aligned_cols=291 Identities=18% Similarity=0.284 Sum_probs=192.7
Q ss_pred CCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcc-cCcEEEc
Q 039922 242 AFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNL 320 (973)
Q Consensus 242 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L 320 (973)
.+++.++++++.++ .+|..+. ++++.|++++|++++..+..|.++++|++|+|++|.+++..|..+... +|++|++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 36888899888887 4565553 578888888888887766678888888888888888876656655543 5666666
Q ss_pred cCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCC
Q 039922 321 NDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGK 400 (973)
Q Consensus 321 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 400 (973)
++|+++ .+|..+. ++|++|++++|++++..+..+.++++|++|++++|+++. .+.
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~ 162 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGI 162 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGB
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc----------------------cCc
Confidence 666666 3444333 566666666666665555556666666666666666642 013
Q ss_pred CCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcC
Q 039922 401 IPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTL 480 (973)
Q Consensus 401 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l 480 (973)
.+..+..+++|++|++++|.++. +|..+. ++|+.|++++|++++..+..+..+++|+.|++++|.+++..+..+..+
T Consensus 163 ~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 239 (330)
T 1xku_A 163 ENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239 (330)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred ChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCC
Confidence 34445555555555555555553 222222 566666666666666556666666667777777777766666667777
Q ss_pred CcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCc------cccceeeeeccCcccC--CCCcccccc
Q 039922 481 RQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNS------LTALIVLNLSTNQLTG--TIPPELGNL 552 (973)
Q Consensus 481 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~~l 552 (973)
++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|.. ...|+.|++++|.+.. ..|..|..+
T Consensus 240 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~ 318 (330)
T 1xku_A 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318 (330)
T ss_dssp TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred CCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccc
Confidence 77777777777777 66777777777777777777777665566543 3677888888888753 556788888
Q ss_pred ccccEEecCCCc
Q 039922 553 AVLTSLDLSSNL 564 (973)
Q Consensus 553 ~~L~~L~Ls~N~ 564 (973)
..++.++|++|+
T Consensus 319 ~~l~~l~L~~N~ 330 (330)
T 1xku_A 319 YVRAAVQLGNYK 330 (330)
T ss_dssp CCGGGEEC----
T ss_pred cceeEEEecccC
Confidence 888888888885
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-35 Score=338.72 Aligned_cols=379 Identities=20% Similarity=0.233 Sum_probs=231.7
Q ss_pred cccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccc----cCCccccCCCCCCEEEccCCcccccCCcCC-CCCC
Q 039922 192 LTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIG----EIPDSIGKLAFLSNLDLSDNFLSGKIPHSF-SGLA 266 (973)
Q Consensus 192 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~ 266 (973)
+++|++|+|++|+++.......+..+++|++|++++|++.. .++..+..+++|++|+|++|.+++..+..+ ..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 36789999999998765444446677778888888887764 346667777888888888887765433322 2333
Q ss_pred ----CCCEEEccCCcCcc----cCchhccCCCccceeeccccccCCCChhhhhc------ccCcEEEccCCcCCCCC---
Q 039922 267 ----SIEQIELFDNQLSG----ELPESLSNLTTLLRLDISQNNLTGNLPETIAA------MSLESLNLNDNYFTGEI--- 329 (973)
Q Consensus 267 ----~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~------~~L~~L~L~~N~l~~~~--- 329 (973)
+|++|++++|+++. .++..+..+++|++|++++|.+++..+..+.. .+|++|++++|++++..
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 58888888888773 45677777788888888888776443333322 14777777777666532
Q ss_pred -CccccCCCccceeeeccccccCCCCCCcc-----CCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCC
Q 039922 330 -PESLASNPNLVQLKLFNNSFSGKLPDDLG-----KYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPE 403 (973)
Q Consensus 330 -p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~ 403 (973)
+..+..+++|++|++++|.+++..+..+. ..++|++|++++|.+++.... .++.
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~ 221 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--------------------DLCG 221 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--------------------HHHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH--------------------HHHH
Confidence 44445556666666666666543333332 134566666666655532100 1233
Q ss_pred ccCCcceeeEEEccCCcccccc-----CcccCCCCCccEEEeecCcccCC----CCCCCCCCCCcceEeecCCcCCCCCc
Q 039922 404 SYGECKTLNYLRFGGNELQGEL-----PSKFWGLPEVDFFEMYNNRFEGS----ISPSISNAPKLTGILINGNNFTGEVP 474 (973)
Q Consensus 404 ~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~~~~L~~L~L~~N~l~~~~p 474 (973)
.+..+++|++|++++|.+++.. +..+..+++|+.|++++|+++.. ++..+..+++|++|++++|.+++..+
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 301 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHH
Confidence 4445555666666666555432 22233455666666666665542 34445556667777777776654444
Q ss_pred hhhhcC-----CcCcEEeCcCCcccCC----CccccccccccceeeccccccccccCcccCc-----cccceeeeeccCc
Q 039922 475 SQICTL-----RQLQAVDLSQNRFSGH----LPTCITQLNKLQQLELQENMFTGELPRNLNS-----LTALIVLNLSTNQ 540 (973)
Q Consensus 475 ~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~ 540 (973)
..+... ++|++|++++|.+++. +|..+..+++|++|+|++|++++..+..+.. .++|+.|+|++|+
T Consensus 302 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 444332 5777777777777654 4555666677777777777777655554443 5677777777777
Q ss_pred ccC----CCCccccccccccEEecCCCcCccccChhhh----c-c-cccceeccCCcCcc
Q 039922 541 LTG----TIPPELGNLAVLTSLDLSSNLLTGEIPLELT----K-L-KLNQFNISHNKLYG 590 (973)
Q Consensus 541 l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~----~-l-~l~~l~l~~N~l~g 590 (973)
+++ .+|..+..+++|++|||++|++++.-...+. . . +|+.|++.+|....
T Consensus 382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred CChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 775 5677777777777777777777754222221 1 1 46666666665543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=334.95 Aligned_cols=307 Identities=14% Similarity=0.040 Sum_probs=169.2
Q ss_pred CCCCCCEEEccCCcccc----cCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccC
Q 039922 240 KLAFLSNLDLSDNFLSG----KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSL 315 (973)
Q Consensus 240 ~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L 315 (973)
++++|++|++++|.+++ .++..+.++++|+.|++++|.+.+ +|..+..+++|+.|+++.+......
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~--------- 259 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM--------- 259 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC---------
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch---------
Confidence 44555555555555541 222233344555555555555543 3444555555555555432211000
Q ss_pred cEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCC-ccccccCCchhhhccc
Q 039922 316 ESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELP-RFLCFRNKLQCIIIFN 394 (973)
Q Consensus 316 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~ 394 (973)
+..+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|+.|++++
T Consensus 260 -----------~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~ 327 (592)
T 3ogk_B 260 -----------PEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN 327 (592)
T ss_dssp -----------TTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEG
T ss_pred -----------HHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccC
Confidence 122234444455555555554222 444445555555555555555443222 2234455555555552
Q ss_pred CccCCCCCCccCCcceeeEEEcc-----------CCccccccC-cccCCCCCccEEEeecCcccCCCCCCCCC-CCCcce
Q 039922 395 NRFSGKIPESYGECKTLNYLRFG-----------GNELQGELP-SKFWGLPEVDFFEMYNNRFEGSISPSISN-APKLTG 461 (973)
Q Consensus 395 n~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~~L~~ 461 (973)
+...+.++.....+++|++|+++ .|.+++... ..+..+++|+.|+++.|++++..+..+.. +++|+.
T Consensus 328 ~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~ 407 (592)
T 3ogk_B 328 VIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD 407 (592)
T ss_dssp GGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCE
T ss_pred ccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcE
Confidence 22222222333455667777776 245554322 22344677777777777776555555544 667777
Q ss_pred Eeec----CCcCCCC-----CchhhhcCCcCcEEeCcCC--cccCCCcccccc-ccccceeecccccccc-ccCcccCcc
Q 039922 462 ILIN----GNNFTGE-----VPSQICTLRQLQAVDLSQN--RFSGHLPTCITQ-LNKLQQLELQENMFTG-ELPRNLNSL 528 (973)
Q Consensus 462 L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l 528 (973)
|+++ .|.+++. ++..+..+++|+.|++++| .+++..+..+.. +++|+.|+|++|++++ .++..+..+
T Consensus 408 L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 487 (592)
T 3ogk_B 408 FRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGC 487 (592)
T ss_dssp EEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCC
T ss_pred EEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcC
Confidence 7775 5666653 3344666788888888643 355544444443 6778888888888776 345556777
Q ss_pred ccceeeeeccCcccCC-CCccccccccccEEecCCCcCccc
Q 039922 529 TALIVLNLSTNQLTGT-IPPELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 529 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
++|+.|+|++|.+++. ++..+..+++|++|+|++|++++.
T Consensus 488 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 488 PNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp TTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred cccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 8888888888887644 334445678888888888887755
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-33 Score=333.05 Aligned_cols=483 Identities=14% Similarity=0.073 Sum_probs=297.5
Q ss_pred CCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCccc---CcCCcCcCC------------CcCCc
Q 039922 59 PCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFN---GTLSSQSLS------------PCFHL 123 (973)
Q Consensus 59 ~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~---~~~~~~~l~------------~l~~L 123 (973)
|++|+++.+... ..+.+.++ .....+..+.++++|++|+|+++... |.+|. .++ .+++|
T Consensus 41 ck~W~~~~~~~~----~~l~~~~~-~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 41 CRRWFKIDSETR----EHVTMALC-YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPE-NWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp CHHHHHHHHHHC----CEEEESCG-GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCT-TSCCBCHHHHHHHHHHCTTC
T ss_pred hHHHHHhhhccc----cEEEEeec-cccChHHHHHhCCCCeEEEecCCcchhhcccccc-cccccchHHHHHHHhhCCCC
Confidence 458999964322 12333322 23333445678899999999886431 22321 112 67888
Q ss_pred cEEecccccccccCCccccCC-C-CCCEEECcCCc-CCC-CCCcccCCCCcccEEecCCcccCCc----ccccccccccc
Q 039922 124 QVLALDYNVFIGELPDFSREF-A-NLQVLDLSRNN-FSG-DIPESFGRFPVLKVLNLGGNLLSGL----IPSFLGNLTEL 195 (973)
Q Consensus 124 ~~L~L~~n~~~~~~~~~~~~l-~-~L~~L~Ls~n~-l~~-~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L 195 (973)
++|+|++|.+.+..+..+..+ + +|++|+|++|. ++. .++.....+++|++|+|++|.+++. ++..+.++++|
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L 194 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence 888888888776666666553 3 48888888876 221 1222234678888888888887765 34455677888
Q ss_pred cEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccC
Q 039922 196 THFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275 (973)
Q Consensus 196 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 275 (973)
++|+|++|.++... .+.++..+.++++|++|++++|.+.+ +|..+.++++|++|+++.
T Consensus 195 ~~L~L~~n~~~~~~---------------------~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 195 EVLNFYMTEFAKIS---------------------PKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CEEECTTCCCSSCC---------------------HHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred cEEEeeccCCCccC---------------------HHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 88888888775321 12334445677888888888888885 567788888888888876
Q ss_pred CcCc---ccCchhccCCCccceeeccccccCCCChhhhhc-ccCcEEEccCCcCCCCCC-ccccCCCccceeeecccccc
Q 039922 276 NQLS---GELPESLSNLTTLLRLDISQNNLTGNLPETIAA-MSLESLNLNDNYFTGEIP-ESLASNPNLVQLKLFNNSFS 350 (973)
Q Consensus 276 n~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 350 (973)
+... +..+..+..+++|+.|+++++... .+|..+.. .+|++|+|++|.+++... ..+..+++|+.|+++++...
T Consensus 253 ~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~ 331 (592)
T 3ogk_B 253 LNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGD 331 (592)
T ss_dssp CCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHH
T ss_pred cccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCH
Confidence 4332 234456677778888888775332 44444433 367777777777654332 33566777888887733222
Q ss_pred CCCCCCccCCCCccceeeec-----------ccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCC
Q 039922 351 GKLPDDLGKYSNLEYFDVST-----------NDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGN 419 (973)
Q Consensus 351 ~~~p~~l~~l~~L~~L~Ls~-----------N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 419 (973)
+.++.....+++|++|++++ |.+++.... .....+++|++|+++.|
T Consensus 332 ~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~-----------------------~l~~~~~~L~~L~l~~~ 388 (592)
T 3ogk_B 332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLI-----------------------ALAQGCQELEYMAVYVS 388 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHH-----------------------HHHHHCTTCSEEEEEES
T ss_pred HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHH-----------------------HHHhhCccCeEEEeecC
Confidence 22333335567777777772 444432111 11223556666666666
Q ss_pred ccccccCcccCC-CCCccEEEee----cCcccCC-----CCCCCCCCCCcceEeecCC--cCCCCCchhhhc-CCcCcEE
Q 039922 420 ELQGELPSKFWG-LPEVDFFEMY----NNRFEGS-----ISPSISNAPKLTGILINGN--NFTGEVPSQICT-LRQLQAV 486 (973)
Q Consensus 420 ~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~~~~L~~L~L~~N--~l~~~~p~~~~~-l~~L~~L 486 (973)
.+++..+..+.. +++|+.|+++ .|++++. ++..+..+++|+.|+++++ .+++..+..+.. +++|++|
T Consensus 389 ~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L 468 (592)
T 3ogk_B 389 DITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWM 468 (592)
T ss_dssp CCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEE
T ss_pred CccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEe
Confidence 666555555544 6666777764 5555543 2223556778888888643 366555555544 7889999
Q ss_pred eCcCCcccC-CCccccccccccceeeccccccccc-cCcccCccccceeeeeccCcccCCCCccc-cccccccEEecCCC
Q 039922 487 DLSQNRFSG-HLPTCITQLNKLQQLELQENMFTGE-LPRNLNSLTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSN 563 (973)
Q Consensus 487 ~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N 563 (973)
++++|++++ .++..+..+++|+.|+|++|++++. ++..+..+++|+.|+|++|++++.--..+ ..++.+....+..+
T Consensus 469 ~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 469 LLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp EECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred eccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 999999875 3455567889999999999998765 44455678999999999999986543334 35777777766665
Q ss_pred cCccccChhhhc-c-cccceeccCCcCcccCCC
Q 039922 564 LLTGEIPLELTK-L-KLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 564 ~l~~~~p~~l~~-l-~l~~l~l~~N~l~g~~p~ 594 (973)
+-....|.+-.. . ....+. .++.+.|+.|+
T Consensus 549 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~g~~~~ 580 (592)
T 3ogk_B 549 RVPEVNQQGEIREMEHPAHIL-AYYSLAGQRTD 580 (592)
T ss_dssp ---------------CCCEEE-EEECTTCSCSC
T ss_pred cccccccccCCcCCcchhheE-eeeecCCCccC
Confidence 433222211111 0 233333 35667787764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-30 Score=278.60 Aligned_cols=258 Identities=21% Similarity=0.240 Sum_probs=179.4
Q ss_pred ccceeeeccccccCCCCCCccCCCCccceeeeccccccc--CCccccccCCchhhhcccCccCCCCCCccCCcceeeEEE
Q 039922 338 NLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE--LPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLR 415 (973)
Q Consensus 338 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 415 (973)
+|++|+|++|++++..+..|.++++|++|+|++|+++.. .+..+..+++|++|++++|.+. .+|..+..+++|++|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence 455555555555432222344555555555555554421 2333444455555555555554 3445566677777777
Q ss_pred ccCCccccccC-cccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCC-CCchhhhcCCcCcEEeCcCCcc
Q 039922 416 FGGNELQGELP-SKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTG-EVPSQICTLRQLQAVDLSQNRF 493 (973)
Q Consensus 416 L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l 493 (973)
+++|.+++..+ ..+..+++|+.|++++|++.+..+..+..+++|++|++++|.+++ .+|..+..+++|++|++++|++
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 187 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence 77777775554 567777777777777777777777777778888888888888876 5677788888888888888888
Q ss_pred cCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccc-cccEEecCCCcCccccCh-
Q 039922 494 SGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLA-VLTSLDLSSNLLTGEIPL- 571 (973)
Q Consensus 494 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~- 571 (973)
++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++..+.
T Consensus 188 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~ 267 (306)
T 2z66_A 188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 267 (306)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGH
T ss_pred CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChH
Confidence 877788888888888889988888877777888888999999999999888888888884 899999999999875431
Q ss_pred -hhhcc-cccceeccCCcCcccCCCCC
Q 039922 572 -ELTKL-KLNQFNISHNKLYGEVPSDF 596 (973)
Q Consensus 572 -~l~~l-~l~~l~l~~N~l~g~~p~~~ 596 (973)
....+ ..+.+.+..+.+.+..|..+
T Consensus 268 ~~~~~l~~~~~~~~~~~~~~C~~p~~~ 294 (306)
T 2z66_A 268 SFLQWIKDQRQLLVEVERMECATPSDK 294 (306)
T ss_dssp HHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred HHHHHHHhhhhhhccccccccCCchhh
Confidence 12222 45566677778887777654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=284.29 Aligned_cols=275 Identities=17% Similarity=0.227 Sum_probs=209.3
Q ss_pred ceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeeccc
Q 039922 293 LRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTND 372 (973)
Q Consensus 293 ~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 372 (973)
...++++|.++. +|..+. .+|++|++++|++++..+..+.++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 34 ~~c~~~~~~l~~-iP~~~~-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (353)
T 2z80_A 34 GICKGSSGSLNS-IPSGLT-EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111 (353)
T ss_dssp SEEECCSTTCSS-CCTTCC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred eEeeCCCCCccc-cccccc-ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCc
Confidence 345556666653 333222 257777777777776555677778888888888888887767778888888888888888
Q ss_pred ccccCCccccccCCchhhhcccCccCCCCC-CccCCcceeeEEEccCC-ccccccCcccCCCCCccEEEeecCcccCCCC
Q 039922 373 FTGELPRFLCFRNKLQCIIIFNNRFSGKIP-ESYGECKTLNYLRFGGN-ELQGELPSKFWGLPEVDFFEMYNNRFEGSIS 450 (973)
Q Consensus 373 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 450 (973)
+++..+..+..+++|++|++++|++.+..+ ..+..+++|++|++++| .+.+..+..|.++++|+.|++++|++++..|
T Consensus 112 l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (353)
T 2z80_A 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191 (353)
T ss_dssp CSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred CCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCH
Confidence 876655567778888888888888875444 47888888999999888 5777777888889999999999999988888
Q ss_pred CCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccc---cccccceeecccccccc----ccCc
Q 039922 451 PSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCIT---QLNKLQQLELQENMFTG----ELPR 523 (973)
Q Consensus 451 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~ 523 (973)
..+..+++|++|++++|.++...+..+..+++|++|++++|++++..+..+. ....++.++|++|.+++ .+|.
T Consensus 192 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~ 271 (353)
T 2z80_A 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK 271 (353)
T ss_dssp TTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHH
T ss_pred HHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHH
Confidence 8899999999999999998744333455688999999999999876555443 34567777777777765 4788
Q ss_pred ccCccccceeeeeccCcccCCCCcc-ccccccccEEecCCCcCccccC
Q 039922 524 NLNSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 524 ~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
.+..+++|+.|+|++|+|+ .+|.. |..+++|++|+|++|++++..|
T Consensus 272 ~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 272 LLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred HHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 8888999999999999998 56655 5889999999999999998665
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=283.68 Aligned_cols=288 Identities=22% Similarity=0.300 Sum_probs=208.7
Q ss_pred cCCccCCCCCCCCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEe
Q 039922 48 LGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLA 127 (973)
Q Consensus 48 ~~sw~~~~~~~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~ 127 (973)
...|.. ...+|.|.|+ |+-. +++++ .+|..+. ++|++|+|++|+++ .++...|.++++|++|+
T Consensus 20 ~~~~~~--~~~~C~~~~~-c~~~----------~~~l~-~iP~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~ 82 (353)
T 2z80_A 20 EESSNQ--ASLSCDRNGI-CKGS----------SGSLN-SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALV 82 (353)
T ss_dssp ---------CCEECTTSE-EECC----------STTCS-SCCTTCC--TTCCEEECTTSCCC-EECTTTTTTCTTCCEEE
T ss_pred ccCCCc--cCCCCCCCeE-eeCC----------CCCcc-ccccccc--ccCcEEECCCCcCc-ccCHHHhccCCCCCEEE
Confidence 445642 2346999998 7643 33444 3555544 47888899888887 46666788888888888
Q ss_pred cccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCccc-ccccccccccEeeccCcCCC
Q 039922 128 LDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIP-SFLGNLTELTHFELGYNPLK 206 (973)
Q Consensus 128 L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~ 206 (973)
|++|.+.+..|..|+.+++|++|+|++|.+++..+..|+++++|++|+|++|++++..+ ..|.++++|++|++++|..
T Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~- 161 (353)
T 2z80_A 83 LTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT- 161 (353)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS-
T ss_pred CCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcc-
Confidence 88888877777778888888888888888875555557778888888888888775544 4677777777777777731
Q ss_pred CCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhc
Q 039922 207 SSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESL 286 (973)
Q Consensus 207 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l 286 (973)
+.+..+..++++++|++|++++|.+++..|..|.++++|++|++++|+++...+..+
T Consensus 162 -----------------------~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 218 (353)
T 2z80_A 162 -----------------------FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218 (353)
T ss_dssp -----------------------CCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHH
T ss_pred -----------------------ccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhh
Confidence 122335567788888888888888888888888888888899998888875444445
Q ss_pred cCCCccceeeccccccCCCChhhhhc----ccCcEEEccCCcCCC----CCCccccCCCccceeeeccccccCCCCCC-c
Q 039922 287 SNLTTLLRLDISQNNLTGNLPETIAA----MSLESLNLNDNYFTG----EIPESLASNPNLVQLKLFNNSFSGKLPDD-L 357 (973)
Q Consensus 287 ~~l~~L~~L~Ls~N~l~~~~~~~~~~----~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l 357 (973)
..+++|+.|++++|.+++..+..+.. ..++.++|+++.+++ .+|+.+..+++|+.|+|++|+++ .+|.. |
T Consensus 219 ~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~ 297 (353)
T 2z80_A 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIF 297 (353)
T ss_dssp HHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred hhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHH
Confidence 56888999999999888765544432 257888888888775 46777888899999999999998 55555 5
Q ss_pred cCCCCccceeeecccccccC
Q 039922 358 GKYSNLEYFDVSTNDFTGEL 377 (973)
Q Consensus 358 ~~l~~L~~L~Ls~N~l~~~~ 377 (973)
..+++|++|+|++|++.+..
T Consensus 298 ~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 298 DRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp TTCTTCCEEECCSSCBCCCH
T ss_pred hcCCCCCEEEeeCCCccCcC
Confidence 88999999999999887543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=275.87 Aligned_cols=267 Identities=19% Similarity=0.203 Sum_probs=199.4
Q ss_pred cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCC--CCCCccCCCCccceeeecccccccCCccccccCCchhhh
Q 039922 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGK--LPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCII 391 (973)
Q Consensus 314 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 391 (973)
+|++|+|++|+++...+..|.++++|++|+|++|+++.. .+..+..+++|++|+|++|.++ .+|..+..+++|+.|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence 455555555555533334455666666666666665522 2344455666666666666665 3444456666666666
Q ss_pred cccCccCCCCC-CccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccC-CCCCCCCCCCCcceEeecCCcC
Q 039922 392 IFNNRFSGKIP-ESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEG-SISPSISNAPKLTGILINGNNF 469 (973)
Q Consensus 392 L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~L~~N~l 469 (973)
+++|++.+..+ ..+..+++|++|++++|.+.+..+..|..+++|+.|++++|++.+ ..|..+..+++|++|++++|.+
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 187 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence 66666665444 567888888888888888888888888888888888888888876 5788888999999999999999
Q ss_pred CCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCcc-ccceeeeeccCcccCCCC--
Q 039922 470 TGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSL-TALIVLNLSTNQLTGTIP-- 546 (973)
Q Consensus 470 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p-- 546 (973)
++..|..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|..+..+ ++|+.|+|++|.+++..+
T Consensus 188 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~ 267 (306)
T 2z66_A 188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 267 (306)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGH
T ss_pred CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChH
Confidence 98888889999999999999999997777788999999999999999999999999988 499999999999986532
Q ss_pred ccccccccccEEecCCCcCccccChhhhcccccce
Q 039922 547 PELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQF 581 (973)
Q Consensus 547 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l 581 (973)
....-+...+.+....|.+.+..|..+....+..+
T Consensus 268 ~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~~~~~~ 302 (306)
T 2z66_A 268 SFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 302 (306)
T ss_dssp HHHHHHHHTGGGBSCGGGCBEEESGGGTTCBGGGC
T ss_pred HHHHHHHhhhhhhccccccccCCchhhCCceeeee
Confidence 11233555666778889999999998877655443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-31 Score=311.64 Aligned_cols=233 Identities=18% Similarity=0.148 Sum_probs=178.3
Q ss_pred cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcc
Q 039922 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIF 393 (973)
Q Consensus 314 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 393 (973)
+|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~--------------- 97 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV--------------- 97 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE---------------
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC---------------
Confidence 57777777777777667777777777777777777775554 6777777777777777663221
Q ss_pred cCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCC
Q 039922 394 NNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEV 473 (973)
Q Consensus 394 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 473 (973)
.++|++|++++|.+++..+. .+++|+.|++++|++++..|..+..+++|+.|++++|.+++..
T Consensus 98 --------------~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (487)
T 3oja_A 98 --------------GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (487)
T ss_dssp --------------CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE
T ss_pred --------------CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC
Confidence 15667777777777665543 3467777777777777777778888888888888888888878
Q ss_pred chhhh-cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcccccc
Q 039922 474 PSQIC-TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNL 552 (973)
Q Consensus 474 p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 552 (973)
|..+. .+++|++|+|++|.|++. |. +..+++|+.|+|++|+|++. |..+..+++|+.|+|++|+|++ +|..+..+
T Consensus 161 ~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l 236 (487)
T 3oja_A 161 FAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFS 236 (487)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCC
T ss_pred hHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccC
Confidence 87776 688999999999999865 33 34588999999999999964 4458889999999999999984 78889999
Q ss_pred ccccEEecCCCcCc-cccChhhhcc-cccceecc
Q 039922 553 AVLTSLDLSSNLLT-GEIPLELTKL-KLNQFNIS 584 (973)
Q Consensus 553 ~~L~~L~Ls~N~l~-~~~p~~l~~l-~l~~l~l~ 584 (973)
++|+.|+|++|+++ +.+|..+..+ .++.++++
T Consensus 237 ~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp TTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 99999999999998 6777777776 67777665
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=268.02 Aligned_cols=231 Identities=19% Similarity=0.292 Sum_probs=133.3
Q ss_pred cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcc
Q 039922 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIF 393 (973)
Q Consensus 314 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 393 (973)
.++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..+..+++|++|+++
T Consensus 82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 5777888888877 66667777777888888887777 77777777777777777777776 555555555555555555
Q ss_pred cCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCC
Q 039922 394 NNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEV 473 (973)
Q Consensus 394 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 473 (973)
+|++.+.+|..+... ..+..|.++++ |++|++++|.++ .+
T Consensus 159 ~n~~~~~~p~~~~~~---------------~~~~~~~~l~~------------------------L~~L~L~~n~l~-~l 198 (328)
T 4fcg_A 159 ACPELTELPEPLAST---------------DASGEHQGLVN------------------------LQSLRLEWTGIR-SL 198 (328)
T ss_dssp EETTCCCCCSCSEEE---------------C-CCCEEESTT------------------------CCEEEEEEECCC-CC
T ss_pred CCCCccccChhHhhc---------------cchhhhccCCC------------------------CCEEECcCCCcC-cc
Confidence 555555555443320 01112233444 444444444444 44
Q ss_pred chhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccc
Q 039922 474 PSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLA 553 (973)
Q Consensus 474 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 553 (973)
|..+..+++|++|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+.+++
T Consensus 199 p~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~ 277 (328)
T 4fcg_A 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277 (328)
T ss_dssp CGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCT
T ss_pred hHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCC
Confidence 444555555555555555555 2444455555555555555555555555555555555555555555555555555555
Q ss_pred cccEEecCCCcCccccChhhhcc-cccceeccCCcC
Q 039922 554 VLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKL 588 (973)
Q Consensus 554 ~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l 588 (973)
+|+.|+|++|++.|.+|..+..+ +++.+++..|.+
T Consensus 278 ~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp TCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred CCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 55555555555555555555555 555555554433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=277.38 Aligned_cols=248 Identities=19% Similarity=0.219 Sum_probs=189.4
Q ss_pred cEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccC
Q 039922 316 ESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNN 395 (973)
Q Consensus 316 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 395 (973)
..++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 34444444444 3444333 45666666666666555566666666666666666666665566666666666666666
Q ss_pred ccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeec-CcccCCCCCCCCCCCCcceEeecCCcCCCCCc
Q 039922 396 RFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYN-NRFEGSISPSISNAPKLTGILINGNNFTGEVP 474 (973)
Q Consensus 396 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 474 (973)
++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++ |.+....+..|..+++|++|++++|+++ .+|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 66655566777888888888888888877777888888888888887 4444444557888888888888888888 445
Q ss_pred hhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcccccccc
Q 039922 475 SQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAV 554 (973)
Q Consensus 475 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 554 (973)
.+..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 4788899999999999999888899999999999999999999888899999999999999999999777778889999
Q ss_pred ccEEecCCCcCccc
Q 039922 555 LTSLDLSSNLLTGE 568 (973)
Q Consensus 555 L~~L~Ls~N~l~~~ 568 (973)
|+.|+|++|++...
T Consensus 281 L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 281 LERIHLHHNPWNCN 294 (440)
T ss_dssp CCEEECCSSCEECS
T ss_pred CCEEEcCCCCccCC
Confidence 99999999998753
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=278.73 Aligned_cols=230 Identities=18% Similarity=0.200 Sum_probs=172.3
Q ss_pred CccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEc
Q 039922 337 PNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRF 416 (973)
Q Consensus 337 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 416 (973)
++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 34555555555555444555555555555555555555555555555555555555555555555556777777777777
Q ss_pred cCCccccccCcccCCCCCccEEEeec-CcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccC
Q 039922 417 GGNELQGELPSKFWGLPEVDFFEMYN-NRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSG 495 (973)
Q Consensus 417 ~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 495 (973)
++|++++..+..|.++++|+.|++++ |.+....+..+..+++|+.|++++|++++. | .+..+++|++|+|++|++++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence 77777777677777788888888877 445544455678888888888888888843 4 47788899999999999998
Q ss_pred CCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccc
Q 039922 496 HLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 496 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 8899999999999999999999988899999999999999999999977777888999999999999998754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=263.81 Aligned_cols=236 Identities=19% Similarity=0.184 Sum_probs=133.8
Q ss_pred CccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEc
Q 039922 337 PNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRF 416 (973)
Q Consensus 337 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 416 (973)
++|++|+|++|.+++..+..|..+++|++|+|++|++++..|.. +..+++|++|++
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~------------------------~~~l~~L~~L~l 87 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA------------------------FTGLALLEQLDL 87 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT------------------------TTTCTTCCEEEC
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhh------------------------cCCccCCCEEeC
Confidence 35555555555555444444555555555555555554333333 333334444444
Q ss_pred cCCc-cccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccC
Q 039922 417 GGNE-LQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSG 495 (973)
Q Consensus 417 ~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 495 (973)
++|. +++..+..|..+++|+.|++++|++++..+..+..+++|++|++++|.+++..+..+..+++|++|+|++|++++
T Consensus 88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 167 (285)
T 1ozn_A 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167 (285)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc
Confidence 4443 333334444444444444444444444444555555555555555555554444556666666666666666665
Q ss_pred CCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhc
Q 039922 496 HLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTK 575 (973)
Q Consensus 496 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 575 (973)
..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..-..
T Consensus 168 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~ 247 (285)
T 1ozn_A 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHH
T ss_pred cCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHH
Confidence 44455666777777777777777666777777777777777777777555555777777777777777776554432111
Q ss_pred ccccceeccCCcCcccCCCCC
Q 039922 576 LKLNQFNISHNKLYGEVPSDF 596 (973)
Q Consensus 576 l~l~~l~l~~N~l~g~~p~~~ 596 (973)
-.++.+..+.|.+.+..|..+
T Consensus 248 ~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 248 AWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp HHHHHCCSEECCCBEEESGGG
T ss_pred HHHHhcccccCccccCCchHh
Confidence 134555666677777766544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=261.96 Aligned_cols=209 Identities=21% Similarity=0.253 Sum_probs=186.9
Q ss_pred CchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCc-ccCCCCCCCCCCCCcceEee
Q 039922 386 KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNR-FEGSISPSISNAPKLTGILI 464 (973)
Q Consensus 386 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~L~~L~L 464 (973)
+|+.|++++|++.+..+..|..+++|++|++++|.+++..+..|.++++|+.|++++|+ ++...+..+..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 34444444444444555678889999999999999999989999999999999999998 88877899999999999999
Q ss_pred cCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCC
Q 039922 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGT 544 (973)
Q Consensus 465 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 544 (973)
++|.+++..|..+..+++|++|++++|++++..+..|+.+++|+.|+|++|++++..+..+..+++|+.|+|++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 99999988899999999999999999999977777899999999999999999977777899999999999999999988
Q ss_pred CCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCCC
Q 039922 545 IPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 545 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~ 594 (973)
.|..|..+++|+.|+|++|++++..|..+..+ .|+.|++++|++.+..+.
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence 89999999999999999999997666678888 899999999999986653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=274.65 Aligned_cols=255 Identities=19% Similarity=0.212 Sum_probs=174.2
Q ss_pred hccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCC-CCCCcccc-------CCCccceeeeccccccCCCCCC
Q 039922 285 SLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFT-GEIPESLA-------SNPNLVQLKLFNNSFSGKLPDD 356 (973)
Q Consensus 285 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~ 356 (973)
.++..++|+.|++++|.+ .+|..+... |+.|+|++|.++ ..+|..+. ++++|++|+|++|++++.+|..
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 345667888999999988 556554443 888888888884 45665554 6788888888888888888877
Q ss_pred c--cCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCC
Q 039922 357 L--GKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPE 434 (973)
Q Consensus 357 l--~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 434 (973)
+ ..+++|++|+|++|++++. |..+..+.. ..+++|++|++++|++++..+..|..+++
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~-------------------~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQ-------------------WLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHT-------------------TCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHH-------------------hhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 6 7888888888888888866 555554400 00134444444444444444444444444
Q ss_pred ccEEEeecCcccCC--CCCCC--CCCCCcceEeecCCcCCC--CCc-hhhhcCCcCcEEeCcCCcccCCCc-cccccccc
Q 039922 435 VDFFEMYNNRFEGS--ISPSI--SNAPKLTGILINGNNFTG--EVP-SQICTLRQLQAVDLSQNRFSGHLP-TCITQLNK 506 (973)
Q Consensus 435 L~~L~L~~N~l~~~--~~~~~--~~~~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~ 506 (973)
|+.|++++|++.+. .+..+ ..+++|++|++++|++++ .++ ..+..+++|++|+|++|++++.+| ..+..+++
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 44444444444332 11222 566677777777777763 122 334567888888888888887664 45667788
Q ss_pred cceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCcc
Q 039922 507 LQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567 (973)
Q Consensus 507 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (973)
|+.|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|++|+|++|++++
T Consensus 255 L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 255 LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 888888888888 7777776 8888888888888864 65 8888888888888888875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=275.13 Aligned_cols=249 Identities=18% Similarity=0.193 Sum_probs=196.3
Q ss_pred ccCCCccceeeeccccccCCCCCCccCCCCccceeeeccccc-ccCCcccc-------ccCCchhhhcccCccCCCCCCc
Q 039922 333 LASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT-GELPRFLC-------FRNKLQCIIIFNNRFSGKIPES 404 (973)
Q Consensus 333 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~-------~l~~L~~L~L~~n~l~~~~p~~ 404 (973)
++..++|+.|++++|.+ .+|..+... |+.|+|++|+++ ..+|..+. .+++|++|++++|++.+.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34445556666666665 444444333 566666666662 34444443 4566666666666666667776
Q ss_pred c--CCcceeeEEEccCCccccccCcccCCC-----CCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCC--Cch
Q 039922 405 Y--GECKTLNYLRFGGNELQGELPSKFWGL-----PEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE--VPS 475 (973)
Q Consensus 405 ~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~--~p~ 475 (973)
+ +.+++|++|++++|++++. |..+..+ ++|++|++++|++++..+..+..+++|++|++++|++.+. .|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 8889999999999999877 7777776 9999999999999999999999999999999999998865 344
Q ss_pred hh--hcCCcCcEEeCcCCcccC--CCc-cccccccccceeeccccccccccC-cccCccccceeeeeccCcccCCCCccc
Q 039922 476 QI--CTLRQLQAVDLSQNRFSG--HLP-TCITQLNKLQQLELQENMFTGELP-RNLNSLTALIVLNLSTNQLTGTIPPEL 549 (973)
Q Consensus 476 ~~--~~l~~L~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 549 (973)
.+ ..+++|++|+|++|++++ .++ ..+..+++|+.|+|++|++++.+| ..+..+++|+.|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 55 889999999999999983 122 344577999999999999998876 56777999999999999999 788888
Q ss_pred cccccccEEecCCCcCccccChhhhcc-cccceeccCCcCccc
Q 039922 550 GNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGE 591 (973)
Q Consensus 550 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~ 591 (973)
. ++|++|||++|++++. |. +..+ .|+.|++++|++++.
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 7 8999999999999965 76 7777 899999999999863
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=275.28 Aligned_cols=250 Identities=19% Similarity=0.212 Sum_probs=226.5
Q ss_pred ccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEcc
Q 039922 338 NLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFG 417 (973)
Q Consensus 338 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 417 (973)
....++.+++.++ .+|..+. ++++.|+|++|++++..+..|..+++|+.|+|++|++.+..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4678999999998 7787665 789999999999999999999999999999999999998888999999999999999
Q ss_pred CCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCc-hhhhcCCcCcEEeCcCCcccCC
Q 039922 418 GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVP-SQICTLRQLQAVDLSQNRFSGH 496 (973)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 496 (973)
+|++++..+..|..+++|+.|+|++|+++...+..|..+++|+.|++++|+..+.++ ..|..+++|++|+|++|+++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 999998888899999999999999999998888899999999999999955444444 47899999999999999998 5
Q ss_pred CccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc
Q 039922 497 LPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL 576 (973)
Q Consensus 497 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 576 (973)
+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|||++|++++..+..+..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 66 48899999999999999999889999999999999999999998889999999999999999999997666677777
Q ss_pred -cccceeccCCcCcccC
Q 039922 577 -KLNQFNISHNKLYGEV 592 (973)
Q Consensus 577 -~l~~l~l~~N~l~g~~ 592 (973)
.|+.|++++|++.+..
T Consensus 279 ~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 279 HHLERIHLHHNPWNCNC 295 (440)
T ss_dssp TTCCEEECCSSCEECSS
T ss_pred cCCCEEEcCCCCccCCC
Confidence 8999999999887643
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=287.21 Aligned_cols=291 Identities=24% Similarity=0.331 Sum_probs=175.5
Q ss_pred CCCCCccCCccCCCCCCCCccceeEEc------CCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcC
Q 039922 42 DDPNRKLGDWVRTSQQSPCNWTGITCE------TQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQ 115 (973)
Q Consensus 42 ~d~~~~~~sw~~~~~~~~C~w~gv~c~------~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 115 (973)
.|....+++|.. ..+||.|+|..|. -....++.|++++++++ .+|..+. ++|++|+|++|+++ .+|.
T Consensus 6 ~~~~~~w~~W~~--~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~- 78 (622)
T 3g06_A 6 AEYDAVWSAWRR--AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA- 78 (622)
T ss_dssp ----CHHHHHHH--TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC-
T ss_pred HHHHHHHHHHHh--cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC-
Confidence 345667888975 3468999775421 11123788999999998 6787766 89999999999998 5664
Q ss_pred cCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccc
Q 039922 116 SLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL 195 (973)
Q Consensus 116 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 195 (973)
.+++|++|+|++|.+++ +|. .+++|++|+|++|.+++ +|. .+++|++|+|++|+++++ |.. +++|
T Consensus 79 ---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~l-p~~---l~~L 143 (622)
T 3g06_A 79 ---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSL-PVL---PPGL 143 (622)
T ss_dssp ---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCC-CCC---CTTC
T ss_pred ---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcC-CCC---CCCC
Confidence 57889999999999874 554 67899999999999985 454 578899999999999864 543 4889
Q ss_pred cEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccC
Q 039922 196 THFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275 (973)
Q Consensus 196 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 275 (973)
++|+|++|+++.+ |.. +++|+.|++++|.+.+ +| ..+++|+.|++++|.+++ +|.. +++|+.|++++
T Consensus 144 ~~L~Ls~N~l~~l--~~~---~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~ 210 (622)
T 3g06_A 144 QELSVSDNQLASL--PAL---PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYN 210 (622)
T ss_dssp CEEECCSSCCSCC--CCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred CEEECcCCcCCCc--CCc---cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcC
Confidence 9999999988763 322 2344455555555443 33 234455555555555553 2221 24455555555
Q ss_pred CcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCC
Q 039922 276 NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPD 355 (973)
Q Consensus 276 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 355 (973)
|.++ .+|.. +++|+.|+|++|++++ +|. ...+|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.
T Consensus 211 N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp~--~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~ 278 (622)
T 3g06_A 211 NRLT-SLPAL---PSGLKELIVSGNRLTS-LPV--LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPE 278 (622)
T ss_dssp SCCS-SCCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCG
T ss_pred Cccc-ccCCC---CCCCCEEEccCCccCc-CCC--CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCH
Confidence 5555 22321 2445555555555543 221 1124555555555554 2332 2344555555555554 4444
Q ss_pred CccCCCCccceeeecccccccCCc
Q 039922 356 DLGKYSNLEYFDVSTNDFTGELPR 379 (973)
Q Consensus 356 ~l~~l~~L~~L~Ls~N~l~~~~~~ 379 (973)
.+.++++|+.|+|++|++++..|.
T Consensus 279 ~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 279 SLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp GGGGSCTTCEEECCSCCCCHHHHH
T ss_pred HHhhccccCEEEecCCCCCCcCHH
Confidence 455555555555555555444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=275.73 Aligned_cols=251 Identities=20% Similarity=0.207 Sum_probs=226.8
Q ss_pred ccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEcc
Q 039922 338 NLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFG 417 (973)
Q Consensus 338 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 417 (973)
....++.+++.++ .+|..+. +++++|+|++|++++..+..|..+++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4567888888888 6776654 689999999999999999999999999999999999999989999999999999999
Q ss_pred CCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCc-hhhhcCCcCcEEeCcCCcccCC
Q 039922 418 GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVP-SQICTLRQLQAVDLSQNRFSGH 496 (973)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 496 (973)
+|++++..+..|..+++|+.|+|++|+++...+..+..+++|+.|++++|+..+.++ ..|..+++|++|+|++|++++
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 210 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD- 210 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-
Confidence 999998888889999999999999999998888899999999999999954444444 468999999999999999995
Q ss_pred CccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc
Q 039922 497 LPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL 576 (973)
Q Consensus 497 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 576 (973)
+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+
T Consensus 211 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 211 MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 55 58899999999999999999999999999999999999999998889999999999999999999997666667777
Q ss_pred -cccceeccCCcCcccCC
Q 039922 577 -KLNQFNISHNKLYGEVP 593 (973)
Q Consensus 577 -~l~~l~l~~N~l~g~~p 593 (973)
+|+.|++++|++.+...
T Consensus 290 ~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TTCCEEECCSSCEECSTT
T ss_pred cCCCEEEccCCCcCCCCC
Confidence 89999999999876543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=274.77 Aligned_cols=266 Identities=18% Similarity=0.161 Sum_probs=204.2
Q ss_pred ccceeeccccccCCCChhhhhcc-cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeee
Q 039922 291 TLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVS 369 (973)
Q Consensus 291 ~L~~L~Ls~N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 369 (973)
+++..+++.+.+.......+... +|++|+|++|++++..|..|..+++|++|+|++|++++..+ +..+++|++|+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45566777777764444444433 68888888888887777788888888888888888876554 7778888888888
Q ss_pred cccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCC
Q 039922 370 TNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSI 449 (973)
Q Consensus 370 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 449 (973)
+|++++.. ..++|++|++++|++++..+.. +++|+.|++++|++++..
T Consensus 89 ~n~l~~l~-----------------------------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~ 136 (317)
T 3o53_A 89 NNYVQELL-----------------------------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLR 136 (317)
T ss_dssp SSEEEEEE-----------------------------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGG
T ss_pred CCcccccc-----------------------------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCcc
Confidence 88776322 1245666666666666554433 456777777777777766
Q ss_pred CCCCCCCCCcceEeecCCcCCCCCchhhh-cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCcc
Q 039922 450 SPSISNAPKLTGILINGNNFTGEVPSQIC-TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSL 528 (973)
Q Consensus 450 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 528 (973)
+..+..+++|++|++++|.+++..+..+. .+++|++|+|++|++++. |. ...+++|++|+|++|++++ +|..+..+
T Consensus 137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l 213 (317)
T 3o53_A 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSA 213 (317)
T ss_dssp GBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGG
T ss_pred chhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhccc
Confidence 77778888888888888888877777664 688999999999999854 43 3358999999999999995 55568999
Q ss_pred ccceeeeeccCcccCCCCccccccccccEEecCCCcCc-cccChhhhcc-cccceecc-CCcCcccCCC
Q 039922 529 TALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT-GEIPLELTKL-KLNQFNIS-HNKLYGEVPS 594 (973)
Q Consensus 529 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l-~l~~l~l~-~N~l~g~~p~ 594 (973)
++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+ .|+.++++ .+.++|..|.
T Consensus 214 ~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred CcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 99999999999998 58888999999999999999999 7788888888 89999998 5566766554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-26 Score=273.69 Aligned_cols=268 Identities=26% Similarity=0.351 Sum_probs=195.4
Q ss_pred CCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEcc
Q 039922 242 AFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLN 321 (973)
Q Consensus 242 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~ 321 (973)
.+++.|++++|.++ .+|..+. ++|+.|++++|+++ .+|. .+++|+.|+|++|++++ +|. ...+|++|+|+
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls 109 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV--LPPGLLELSIF 109 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC--CCTTCCEEEEC
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC--CCCCCCEEECc
Confidence 35889999999998 6676665 78999999999988 4554 46788888888888874 443 33467777777
Q ss_pred CCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCC
Q 039922 322 DNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKI 401 (973)
Q Consensus 322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 401 (973)
+|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++. |
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~----------------------- 157 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-P----------------------- 157 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-C-----------------------
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-C-----------------------
Confidence 777774 333 45677777777777773 4443 36677777777766632 2
Q ss_pred CCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCC
Q 039922 402 PESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLR 481 (973)
Q Consensus 402 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~ 481 (973)
. .+.+|+.|++++|.+++ +| ..+++|+.|++++|++++. |. .+++|+.|++++|.++ .+|.. ++
T Consensus 158 -~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~-~l~~~---~~ 221 (622)
T 3g06_A 158 -A---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASL-PT---LPSELYKLWAYNNRLT-SLPAL---PS 221 (622)
T ss_dssp -C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS-SCCCC---CT
T ss_pred -C---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCC-CC---ccchhhEEECcCCccc-ccCCC---CC
Confidence 1 12345566666666654 22 3346666666666666642 22 2367788888888887 44432 47
Q ss_pred cCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecC
Q 039922 482 QLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLS 561 (973)
Q Consensus 482 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 561 (973)
+|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|+
T Consensus 222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 89999999999985 66 45678999999999998 5666 6788999999999999 789999999999999999
Q ss_pred CCcCccccChhhhcc
Q 039922 562 SNLLTGEIPLELTKL 576 (973)
Q Consensus 562 ~N~l~~~~p~~l~~l 576 (973)
+|++++.+|..+..+
T Consensus 293 ~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 293 GNPLSERTLQALREI 307 (622)
T ss_dssp SCCCCHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHhc
Confidence 999999999887765
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-29 Score=272.95 Aligned_cols=269 Identities=18% Similarity=0.210 Sum_probs=205.2
Q ss_pred ccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEec
Q 039922 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNL 176 (973)
Q Consensus 97 ~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 176 (973)
.++.++++.+.+. ..+...+..+++|++|+|++|.+.+..|..+..+++|++|+|++|.+++..| +..+++|++|+|
T Consensus 11 ~l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 11 RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp EEEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred ceeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 3456677777775 3334455666777788888777777766777777778888888777775543 777777777777
Q ss_pred CCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccc
Q 039922 177 GGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG 256 (973)
Q Consensus 177 ~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 256 (973)
++|++++.. ..++|++|++++|+++. ..+. .+++|++|++++|++++
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~-------------------------~~~~---~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISR-------------------------VSCS---RGQGKKNIYLANNKITM 134 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSE-------------------------EEEC---CCSSCEEEECCSSCCCS
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCC-------------------------cCcc---ccCCCCEEECCCCCCCC
Confidence 777777432 33677777777777653 2222 35678899999999988
Q ss_pred cCCcCCCCCCCCCEEEccCCcCcccCchhcc-CCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccC
Q 039922 257 KIPHSFSGLASIEQIELFDNQLSGELPESLS-NLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLAS 335 (973)
Q Consensus 257 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~ 335 (973)
..+..|..+++|++|++++|++++..+..+. .+++|+.|+|++|.+++. +......+|++|+|++|++++ +|..+..
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~ 212 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQS 212 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGG
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCCc-chhhhcc
Confidence 8788888889999999999999877777664 688999999999998854 444445579999999999985 4555888
Q ss_pred CCccceeeeccccccCCCCCCccCCCCccceeeeccccc-ccCCccccccCCchhhhcc-cCccCCCCCCc
Q 039922 336 NPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT-GELPRFLCFRNKLQCIIIF-NNRFSGKIPES 404 (973)
Q Consensus 336 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~-~n~l~~~~p~~ 404 (973)
+++|+.|+|++|+++ .+|..+..+++|+.|++++|++. +.+|.++..+++|+.+++. .+.+.+..|..
T Consensus 213 l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp GTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred cCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 999999999999998 57888899999999999999998 7888888899999999998 44455555443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-31 Score=315.41 Aligned_cols=444 Identities=16% Similarity=0.133 Sum_probs=218.1
Q ss_pred CCccceeEEcCCCCceeEeecCCCccCCCCC-CCccCccccceeccCCCcccCcCC---c-----------CcCCCcCCc
Q 039922 59 PCNWTGITCETQNQSVDGIDLSGFDLSGGFP-NGFCRIRTLRNLNLSDNYFNGTLS---S-----------QSLSPCFHL 123 (973)
Q Consensus 59 ~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~Ls~n~l~~~~~---~-----------~~l~~l~~L 123 (973)
|++|+++.. .....++++++. +..| ..+.++++|++|+|++|.....+. . .....+++|
T Consensus 34 ck~W~~~~~----~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 34 CKSWYEIER----WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp CHHHHHHHH----HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHhhh----hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 568999822 123455665543 2223 245678899999999886322111 0 012345667
Q ss_pred cEEecccccccccCCcccc-CCCCCCEEECcCC-cCCCC-CCcccCCCCcccEEecCCcccCCccccccc----cccccc
Q 039922 124 QVLALDYNVFIGELPDFSR-EFANLQVLDLSRN-NFSGD-IPESFGRFPVLKVLNLGGNLLSGLIPSFLG----NLTELT 196 (973)
Q Consensus 124 ~~L~L~~n~~~~~~~~~~~-~l~~L~~L~Ls~n-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L~ 196 (973)
++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 7777776666655554443 4667777777666 34321 333334566677777776666654433333 445666
Q ss_pred EeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCC-cccccCCcCCCCCCCCCEEEccC
Q 039922 197 HFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDN-FLSGKIPHSFSGLASIEQIELFD 275 (973)
Q Consensus 197 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~ 275 (973)
+|++++|. ..+. .. .++..+.++++|++|++++| .+++ ++..+..+++|++|++..
T Consensus 188 ~L~l~~~~-~~~~-------~~--------------~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~ 244 (594)
T 2p1m_B 188 SLNISCLA-SEVS-------FS--------------ALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGG 244 (594)
T ss_dssp EEECTTCC-SCCC-------HH--------------HHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSB
T ss_pred EEEecccC-CcCC-------HH--------------HHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccccc
Confidence 66666664 1100 00 01111233566667777666 3333 555556666666666443
Q ss_pred C-------cCcccCchhccCCCcccee-eccccccCCCChhhhh-cccCcEEEccCCcCCCCC-CccccCCCccceeeec
Q 039922 276 N-------QLSGELPESLSNLTTLLRL-DISQNNLTGNLPETIA-AMSLESLNLNDNYFTGEI-PESLASNPNLVQLKLF 345 (973)
Q Consensus 276 n-------~l~~~~p~~l~~l~~L~~L-~Ls~N~l~~~~~~~~~-~~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~ 345 (973)
+ .+.+ ++..+.++++|+.| .+...... .++..+. ..+|++|+|++|.+++.. +..+..+++|+.|+++
T Consensus 245 ~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~ 322 (594)
T 2p1m_B 245 YTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322 (594)
T ss_dssp CCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred ccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCc
Confidence 3 2332 33355666666666 33222111 1222221 224555555555544221 1123344555555555
Q ss_pred cccccCC-CCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCcc-CCcceeeEEEccCCcccc
Q 039922 346 NNSFSGK-LPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESY-GECKTLNYLRFGGNELQG 423 (973)
Q Consensus 346 ~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~ 423 (973)
+| +++. ++.....+++|++|+++++.-.| ....+.+++.....+ ..+++|++|.++.|.+++
T Consensus 323 ~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g---------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~ 386 (594)
T 2p1m_B 323 DY-IEDAGLEVLASTCKDLRELRVFPSEPFV---------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN 386 (594)
T ss_dssp GG-GHHHHHHHHHHHCTTCCEEEEECSCTTC---------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCH
T ss_pred Cc-cCHHHHHHHHHhCCCCCEEEEecCcccc---------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCH
Confidence 55 2211 11111224445555543321000 001111111111111 124455555555555544
Q ss_pred ccCcccC-CCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCC-----CCchhhhcCCcCcEEeCcCCcccCCC
Q 039922 424 ELPSKFW-GLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTG-----EVPSQICTLRQLQAVDLSQNRFSGHL 497 (973)
Q Consensus 424 ~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~ 497 (973)
.....+. .+++|+.|+++.|...+ -|++++ .++..+..+++|+.|+|++ .+++..
T Consensus 387 ~~~~~l~~~~~~L~~L~L~~~~~~~------------------~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~ 447 (594)
T 2p1m_B 387 AALITIARNRPNMTRFRLCIIEPKA------------------PDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV 447 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEEESSTTC------------------CCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred HHHHHHHhhCCCcceeEeecccCCC------------------cccccCCchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence 3333332 24444444444111000 023331 1122245567777777766 555444
Q ss_pred cccccc-ccccceeeccccccccccCccc-CccccceeeeeccCcccCCCCc-cccccccccEEecCCCcCccc
Q 039922 498 PTCITQ-LNKLQQLELQENMFTGELPRNL-NSLTALIVLNLSTNQLTGTIPP-ELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 498 p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|+++..
T Consensus 448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~ 521 (594)
T 2p1m_B 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFG 521 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHH
T ss_pred HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHH
Confidence 444544 6777777777777766555444 5577777777777777543333 334577788888888777543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-25 Score=241.51 Aligned_cols=218 Identities=27% Similarity=0.367 Sum_probs=171.8
Q ss_pred CCCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccC
Q 039922 58 SPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL 137 (973)
Q Consensus 58 ~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~ 137 (973)
++|.|.|+.|.-.. .+..+++++++++. +|..+. ++|++|+|++|+++ .+++..|.++++|++|+|++|.+.+..
T Consensus 3 ~~C~~~~~~C~c~~-~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 3 ALCKKDGGVCSCNN-NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCBGGGTCSBEEET-TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred ccCCCCCCCCEeCC-CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 67999999996532 46679999999885 666554 67899999999988 566677888888888888888888766
Q ss_pred CccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCc
Q 039922 138 PDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNL 217 (973)
Q Consensus 138 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l 217 (973)
+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|+++++|++|+|++|.++.++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------- 149 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP-------- 149 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC--------
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC--------
Confidence 677788888888888888888777777888888888888888888887777888888888888888776421
Q ss_pred chhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeec
Q 039922 218 SKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDI 297 (973)
Q Consensus 218 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 297 (973)
+..++.+++|++|+|++|++++..+..|.++++|++|++++|++++..+..+..+++|+.|+|
T Consensus 150 -----------------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 150 -----------------KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp -----------------TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred -----------------HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 234566777888888888888766667778888888888888887666666777778888888
Q ss_pred cccccCCC
Q 039922 298 SQNNLTGN 305 (973)
Q Consensus 298 s~N~l~~~ 305 (973)
++|++...
T Consensus 213 ~~N~~~c~ 220 (270)
T 2o6q_A 213 QENPWDCT 220 (270)
T ss_dssp CSSCBCCS
T ss_pred cCCCeeCC
Confidence 88777643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=279.19 Aligned_cols=187 Identities=19% Similarity=0.141 Sum_probs=131.1
Q ss_pred cccccCCeeEEEEEE-CCCCEEEEEEecCCCCC--------chhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEEE
Q 039922 689 LIGSGGSCRVYKVKL-KSGETVAVKRLLGGTHK--------PETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 689 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 758 (973)
..+.|+.|.+..++. .-|+.||+|++.+.... +...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677776666443 35899999999654211 22345689999999999 699999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||++|++|.+++...+ .++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999998653 35543 5899999999999999 999999999999999999999999999987644
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 889 (973)
... .....+||++|+|||++.+ .+..++|+||+|++.+++.++..+
T Consensus 392 ~~~----~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS----WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C----CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc----cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 322 2345679999999999865 467789999999998887765544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-27 Score=273.86 Aligned_cols=237 Identities=19% Similarity=0.209 Sum_probs=179.2
Q ss_pred CcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEe
Q 039922 119 PCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHF 198 (973)
Q Consensus 119 ~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 198 (973)
.+++|++|+|++|.+.+..|..|+.+++|++|+|++|.+++.+| ++.+++|++|+|++|.|++..+ .++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 44577777777777777767777777777777777777776554 7777777777777777775432 2677777
Q ss_pred eccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcC
Q 039922 199 ELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQL 278 (973)
Q Consensus 199 ~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 278 (973)
++++|.++.. .+. .+++|+.|+|++|.+++..|..|+++++|+.|+|++|.+
T Consensus 105 ~L~~N~l~~~-------------------------~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 156 (487)
T 3oja_A 105 HAANNNISRV-------------------------SCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156 (487)
T ss_dssp ECCSSCCCCE-------------------------EEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCC
T ss_pred ECcCCcCCCC-------------------------Ccc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCC
Confidence 7777776542 222 346788888888888887788888888888888888888
Q ss_pred cccCchhcc-CCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCc
Q 039922 279 SGELPESLS-NLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL 357 (973)
Q Consensus 279 ~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 357 (973)
++..|..+. .+++|+.|+|++|.+++. +......+|+.|+|++|.+++. |..+..+++|+.|+|++|.+++ +|..+
T Consensus 157 ~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 157 DTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp CEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred CCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhh
Confidence 877777775 688888888888888755 3333455788888888888864 4458888899999999999984 77778
Q ss_pred cCCCCccceeeeccccc-ccCCccccccCCchhhhcc
Q 039922 358 GKYSNLEYFDVSTNDFT-GELPRFLCFRNKLQCIIIF 393 (973)
Q Consensus 358 ~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~ 393 (973)
..+++|+.|++++|.+. +.+|.++..++.|+.+++.
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 88899999999999887 6777778888888888776
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-25 Score=239.08 Aligned_cols=225 Identities=21% Similarity=0.228 Sum_probs=165.2
Q ss_pred EEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCcc
Q 039922 318 LNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRF 397 (973)
Q Consensus 318 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 397 (973)
.+..+..++ .+|..+. ++|++|++++|++++..+..+.++++|++|++++|+++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~----------------------- 65 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ----------------------- 65 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-----------------------
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-----------------------
Confidence 444444554 3444332 35666666666666554445566666666666666555
Q ss_pred CCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCC-Cchh
Q 039922 398 SGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE-VPSQ 476 (973)
Q Consensus 398 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~-~p~~ 476 (973)
+..+..+..+++|++|++++|.+++..+..|.++++|+.|++++|++.+..+..+..+++|++|++++|.+++. +|..
T Consensus 66 -~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~ 144 (276)
T 2z62_A 66 -TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144 (276)
T ss_dssp -EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGG
T ss_pred -ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchh
Confidence 33445566777777777777777777777777778888888888877777676788888888888888888763 5888
Q ss_pred hhcCCcCcEEeCcCCcccCCCccccccccccc----eeeccccccccccCcccCccccceeeeeccCcccCCCCcccccc
Q 039922 477 ICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQ----QLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNL 552 (973)
Q Consensus 477 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 552 (973)
+..+++|++|+|++|++++..+..+..+++|+ .|++++|++++..+..+.. .+|+.|+|++|++++..+..|..+
T Consensus 145 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l 223 (276)
T 2z62_A 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRL 223 (276)
T ss_dssp GGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTC
T ss_pred hccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhccc
Confidence 88899999999999999877777888888877 8889999998655555544 479999999999987666667889
Q ss_pred ccccEEecCCCcCccccC
Q 039922 553 AVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 553 ~~L~~L~Ls~N~l~~~~p 570 (973)
++|+.|+|++|++++..|
T Consensus 224 ~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 224 TSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CSCCEEECCSSCBCCCTT
T ss_pred ccccEEEccCCcccccCC
Confidence 999999999999987665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-29 Score=301.29 Aligned_cols=133 Identities=14% Similarity=0.186 Sum_probs=103.8
Q ss_pred CCCcceEeecCCcCCCCCchhhh-cCCcCcEEeCc--C----CcccCC-----CccccccccccceeeccccccccccCc
Q 039922 456 APKLTGILINGNNFTGEVPSQIC-TLRQLQAVDLS--Q----NRFSGH-----LPTCITQLNKLQQLELQENMFTGELPR 523 (973)
Q Consensus 456 ~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 523 (973)
+++|+.|.++.|++++..+..+. .+++|+.|+++ + |.+++. ++..+..+++|+.|+|++ .+++..+.
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 67788888888888766666665 58899999999 4 566632 122366789999999988 78777777
Q ss_pred ccCc-cccceeeeeccCcccCCCCccc-cccccccEEecCCCcCccccChhh-hcc-cccceeccCCcCc
Q 039922 524 NLNS-LTALIVLNLSTNQLTGTIPPEL-GNLAVLTSLDLSSNLLTGEIPLEL-TKL-KLNQFNISHNKLY 589 (973)
Q Consensus 524 ~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~l-~~l-~l~~l~l~~N~l~ 589 (973)
.+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+..+ ..+ +|+.|++++|+++
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 7766 8999999999999986655555 679999999999999976655544 335 8999999999884
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-25 Score=238.07 Aligned_cols=214 Identities=24% Similarity=0.230 Sum_probs=156.5
Q ss_pred CCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCC
Q 039922 88 FPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGR 167 (973)
Q Consensus 88 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~ 167 (973)
+|..+. ++|++|+|++|+++ .++...|.++++|++|+|++|.+.+..+..+..+++|++|+|++|.+++..|..|.+
T Consensus 22 ip~~l~--~~l~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 22 IPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp CCSSSC--TTCCEEECTTCCCC-EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred cCCCCC--CCccEEECCCCccc-ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 444443 47899999999998 556668899999999999999998888888999999999999999999888888999
Q ss_pred CCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCC--
Q 039922 168 FPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLS-- 245 (973)
Q Consensus 168 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~-- 245 (973)
+++|++|++++|++++..+..++++++|++|++++|.++...+|..++++++|++|++++|.+.+..+..+..+.+|+
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence 999999999999999887778999999999999999988766666666666666666666666555555555555554
Q ss_pred --EEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCC
Q 039922 246 --NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGN 305 (973)
Q Consensus 246 --~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 305 (973)
.|++++|.+++..+..+.. .+|++|++++|++++..+..+..+++|+.|++++|+++..
T Consensus 179 ~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp CEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred ceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 5666666666444443333 2566666666666544444455555566666665555543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=235.63 Aligned_cols=203 Identities=20% Similarity=0.240 Sum_probs=164.0
Q ss_pred CCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEee
Q 039922 385 NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILI 464 (973)
Q Consensus 385 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L 464 (973)
++|+.|++++|.+.. ...+..+++|++|++++|.+++. ..+..+++|+.|++++|++++..+..+..+++|++|++
T Consensus 41 ~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 334444444444331 23466677788888888877753 36777888888888888888777777888888888888
Q ss_pred cCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCC
Q 039922 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGT 544 (973)
Q Consensus 465 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 544 (973)
++|++++..+..+..+++|++|++++|++++..|..|+.+++|+.|+|++|++++..+..+..+++|+.|+|++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 88888877777788899999999999999977777788999999999999999987778889999999999999999987
Q ss_pred CCccccccccccEEecCCCcCccccChhhhcccccceeccCCcCcccCCCCCc
Q 039922 545 IPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFD 597 (973)
Q Consensus 545 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p~~~~ 597 (973)
.|..|..+++|+.|+|++|++++..| .++.++++.|+++|.+|..+.
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 197 PDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCTT------TTHHHHHHHHHTGGGBBCTTS
T ss_pred CHHHHhCCcCCCEEEccCCCccccCc------HHHHHHHHHHhCCCcccCccc
Confidence 78788999999999999999997766 467888999999999998653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=225.38 Aligned_cols=206 Identities=18% Similarity=0.246 Sum_probs=152.1
Q ss_pred ccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEcc
Q 039922 338 NLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFG 417 (973)
Q Consensus 338 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 417 (973)
+.+.+++++|.++ .+|..+. +++++|+|++|+++ +..+..|..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~------------------------~~~~~~~~~l~~L~~L~l~ 69 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLS------------------------SLPSKAFHRLTKLRLLYLN 69 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCS------------------------CCCTTSSSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCC------------------------eeCHHHhcCCCCCCEEECC
Confidence 4556666666666 4554433 45556666655555 3344456666777777777
Q ss_pred CCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCC
Q 039922 418 GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHL 497 (973)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 497 (973)
+|.+++..+..|.++++|+.|++++|++++..+..+..+++|++|++++|.+++..+..|..+++|++|+|++|++++..
T Consensus 70 ~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 70 DNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp SSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 77777666666677777777777777777666667777788888888888888777777788888888888888888666
Q ss_pred ccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccC
Q 039922 498 PTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 498 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++..-+
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 6668888888888888888887777778888888888888888886666678888888899999988876543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-25 Score=234.74 Aligned_cols=225 Identities=19% Similarity=0.196 Sum_probs=169.5
Q ss_pred CcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhccc
Q 039922 315 LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFN 394 (973)
Q Consensus 315 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 394 (973)
+..+++..+.+.+. ..+..+++|+.|++++|.++. + ..+..+++|++|++++|++++.
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~------------------ 78 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI------------------ 78 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC------------------
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc------------------
Confidence 44555666655543 234456677777777777652 2 2466666777777766666531
Q ss_pred CccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCc
Q 039922 395 NRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVP 474 (973)
Q Consensus 395 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 474 (973)
..+..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..+..+++|++|++++|++++..+
T Consensus 79 --------~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 150 (272)
T 3rfs_A 79 --------SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPK 150 (272)
T ss_dssp --------GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred --------hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCH
Confidence 245666777777777777777666677777777777777777777767777888888888888888887777
Q ss_pred hhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcccccccc
Q 039922 475 SQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAV 554 (973)
Q Consensus 475 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 554 (973)
..+..+++|++|++++|++++..+..|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++. ++.
T Consensus 151 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~ 223 (272)
T 3rfs_A 151 GVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPG 223 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTT
T ss_pred HHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcH
Confidence 7778888899999999999877777788889999999999999988888888899999999999988754 446
Q ss_pred ccEEecCCCcCccccChhhhcc
Q 039922 555 LTSLDLSSNLLTGEIPLELTKL 576 (973)
Q Consensus 555 L~~L~Ls~N~l~~~~p~~l~~l 576 (973)
|+.|+++.|+++|.+|.++..+
T Consensus 224 l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 224 IRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp THHHHHHHHHTGGGBBCTTSCB
T ss_pred HHHHHHHHHhCCCcccCccccc
Confidence 8889999999999999887665
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-26 Score=252.37 Aligned_cols=265 Identities=18% Similarity=0.279 Sum_probs=188.3
Q ss_pred CCCccceeEEcCCCCceeEeecCCCccCCCCCCCccCc--cccceeccCCCcccCcCCcCcCCCcCCccEEecccccccc
Q 039922 58 SPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRI--RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIG 135 (973)
Q Consensus 58 ~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l--~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~ 135 (973)
-|++|+++.|+.. .+..++++++.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+.+
T Consensus 35 vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 35 VCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCH
Confidence 3568999998743 4788999998876 5567777 8999999999999876553 5679999999999999887
Q ss_pred c-CCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCc-ccCCc-ccccccccccccEeeccCc-CCCCCCCC
Q 039922 136 E-LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN-LLSGL-IPSFLGNLTELTHFELGYN-PLKSSPLP 211 (973)
Q Consensus 136 ~-~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~Ls~n-~l~~~~~~ 211 (973)
. ++..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .++...
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~-- 185 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH-- 185 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHH--
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHH--
Confidence 6 8888999999999999999999888888999999999999999 68753 6777889999999999999 775422
Q ss_pred ccccCcchhHHHhhccCcccccCCccccCCC-CCCEEEccCC--ccc-ccCCcCCCCCCCCCEEEccCCc-CcccCchhc
Q 039922 212 SSVGNLSKLENLWAAKANLIGEIPDSIGKLA-FLSNLDLSDN--FLS-GKIPHSFSGLASIEQIELFDNQ-LSGELPESL 286 (973)
Q Consensus 212 ~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~Ls~N--~l~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~p~~l 286 (973)
++..+..++ +|++|++++| .++ +.++..+..+++|++|++++|. +++..+..+
T Consensus 186 ----------------------~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l 243 (336)
T 2ast_B 186 ----------------------VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF 243 (336)
T ss_dssp ----------------------HHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred ----------------------HHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHH
Confidence 233344555 6666666666 333 3344455556666666666666 555555566
Q ss_pred cCCCccceeeccccccCCCChh---hhh-cccCcEEEccCCcCCCCCCccccCC-CccceeeeccccccCCCCCCccC
Q 039922 287 SNLTTLLRLDISQNNLTGNLPE---TIA-AMSLESLNLNDNYFTGEIPESLASN-PNLVQLKLFNNSFSGKLPDDLGK 359 (973)
Q Consensus 287 ~~l~~L~~L~Ls~N~l~~~~~~---~~~-~~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~ 359 (973)
..+++|+.|++++|. +..+. .+. ..+|+.|++++| ++. +.+..+ .+|..|++++|++++..|..++.
T Consensus 244 ~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 244 FQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp GGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred hCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 666666666666664 12222 122 225666666666 332 123333 23666667777777777766654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-25 Score=255.62 Aligned_cols=190 Identities=17% Similarity=0.186 Sum_probs=147.2
Q ss_pred CccccccccCCeeEEEEEECCCCEEEEEEecCCCCCch------hHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 685 TEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPE------TETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
...++||+|+||.||+++. .++.+|+|+...+..... ..+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567999999999999954 488999998754332211 134578999999999999999666666677788999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+||++++ .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999875 457999999999999999 9999999999999999 999999999987644
Q ss_pred cCCCcc---ccccccccccCccccccccC--CCCCCCCChhhHHHHHHHHHcCCCCCC
Q 039922 839 QEGQSD---DAMSCVAGSYGYIAPEYAYT--KKVTEKSDVYSFGVVLMELVTGKRPND 891 (973)
Q Consensus 839 ~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~ 891 (973)
...... .......||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 321100 01234679999999999986 668888999999999998888877663
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=220.11 Aligned_cols=192 Identities=24% Similarity=0.300 Sum_probs=101.4
Q ss_pred CCCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccC
Q 039922 58 SPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGEL 137 (973)
Q Consensus 58 ~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~ 137 (973)
+||.|.|.+|... ...+++++++++. +|..+. ++++.|+|++|+++ +..
T Consensus 3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~-------------------------~~~ 51 (251)
T 3m19_A 3 TCETVTGCTCNEG---KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLA-------------------------TLS 51 (251)
T ss_dssp -CHHHHSSEEEGG---GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCC-------------------------CCC
T ss_pred cCCCCCceEcCCC---CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcC-------------------------ccC
Confidence 5889999999643 3357777777763 444443 45566666666665 333
Q ss_pred CccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCc
Q 039922 138 PDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNL 217 (973)
Q Consensus 138 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l 217 (973)
+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+..|.++++|++|+|++|+++.+
T Consensus 52 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--------- 122 (251)
T 3m19_A 52 DATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSL--------- 122 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC---------
T ss_pred HhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCc---------
Confidence 33444444455555555555444444445555555555555555544444445555555555555544321
Q ss_pred chhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeec
Q 039922 218 SKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDI 297 (973)
Q Consensus 218 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 297 (973)
.+..+.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|
T Consensus 123 ----------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 186 (251)
T 3m19_A 123 ----------------PSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186 (251)
T ss_dssp ----------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ----------------ChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEe
Confidence 1122334445555555555555444445555555555555555555444445555555555555
Q ss_pred cccccCCC
Q 039922 298 SQNNLTGN 305 (973)
Q Consensus 298 s~N~l~~~ 305 (973)
++|+++..
T Consensus 187 ~~N~~~c~ 194 (251)
T 3m19_A 187 FGNQFDCS 194 (251)
T ss_dssp CSCCBCTT
T ss_pred eCCceeCC
Confidence 55555543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=225.60 Aligned_cols=201 Identities=23% Similarity=0.189 Sum_probs=101.4
Q ss_pred ccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCcc
Q 039922 357 LGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVD 436 (973)
Q Consensus 357 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 436 (973)
+.++++++++++++|.++. +|..+. +.++.|++++|++.+..+..+..+++|++|++++|.+++..+.
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--------- 73 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--------- 73 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC---------
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC---------
Confidence 5567777778887777763 333221 3445555555555544444455555555555555555433221
Q ss_pred EEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccc
Q 039922 437 FFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENM 516 (973)
Q Consensus 437 ~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (973)
..+++|++|++++|.++ .+|..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 74 -----------------~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 74 -----------------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp -----------------SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred -----------------CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 34444455555555444 344444455555555555555554444445555555555555555
Q ss_pred cccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcC
Q 039922 517 FTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKL 588 (973)
Q Consensus 517 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l 588 (973)
|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+... .|+.+++++|++
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 55444444455555555555555555333334445555555555555555 444444443 444444444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=223.36 Aligned_cols=206 Identities=24% Similarity=0.200 Sum_probs=162.2
Q ss_pred cccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCccee
Q 039922 332 SLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTL 411 (973)
Q Consensus 332 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 411 (973)
.+.++++++.+++++|.++ .+|..+. ++++.|+|++|++++..+..+..+++|+.|++++|.+++..+. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 3677899999999999999 6776654 6899999999999999999999999999999999999865443 788999
Q ss_pred eEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCC
Q 039922 412 NYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQN 491 (973)
Q Consensus 412 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 491 (973)
++|++++|+++ .+|..+..+ ++|+.|++++|++++..|..|..+++|++|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l------------------------~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTL------------------------PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTC------------------------TTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccC------------------------CCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 99999999987 344444444 45555555555555455556667777777777777
Q ss_pred cccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccc
Q 039922 492 RFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 492 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++...
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 777666666777788888888888888655566778888888888888888 6788888888899999999988753
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-25 Score=246.57 Aligned_cols=262 Identities=18% Similarity=0.234 Sum_probs=166.7
Q ss_pred eeeccccccCCCChhhhhccc-CcEEEccCCcCCCCCC----ccccCCC-ccceeeeccccccCCCCCCccCC-----CC
Q 039922 294 RLDISQNNLTGNLPETIAAMS-LESLNLNDNYFTGEIP----ESLASNP-NLVQLKLFNNSFSGKLPDDLGKY-----SN 362 (973)
Q Consensus 294 ~L~Ls~N~l~~~~~~~~~~~~-L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l-----~~ 362 (973)
.+++++|.+++.+|....... |++|+|++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 356778888877777666654 8888888888876665 6666777 78888888887776666666554 77
Q ss_pred ccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCc-ceeeEEEccCCccccccCccc----CCC-CCcc
Q 039922 363 LEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGEC-KTLNYLRFGGNELQGELPSKF----WGL-PEVD 436 (973)
Q Consensus 363 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~----~~l-~~L~ 436 (973)
|++|+|++|++++..+..++.. +..+ ++|++|++++|++++..+..+ ..+ ++|+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 141 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKT--------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCC
T ss_pred ccEEECcCCcCChHHHHHHHHH--------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCcee
Confidence 7777777777776555543322 1112 344555555555544333322 221 3555
Q ss_pred EEEeecCcccCCCC----CCCCCCC-CcceEeecCCcCCCCCchhhhc----C-CcCcEEeCcCCcccCC----Cccccc
Q 039922 437 FFEMYNNRFEGSIS----PSISNAP-KLTGILINGNNFTGEVPSQICT----L-RQLQAVDLSQNRFSGH----LPTCIT 502 (973)
Q Consensus 437 ~L~L~~N~l~~~~~----~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~----~p~~~~ 502 (973)
.|+|++|++++... ..+...+ +|++|++++|++++..+..++. + ++|++|||++|+|++. ++..+.
T Consensus 142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 55555555543222 2223333 6777777777777666654443 3 5788888888888752 444555
Q ss_pred c-ccccceeeccccccccccC----cccCccccceeeeeccCcccCC-------CCccccccccccEEecCCCcCccccC
Q 039922 503 Q-LNKLQQLELQENMFTGELP----RNLNSLTALIVLNLSTNQLTGT-------IPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 503 ~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
. .++|++|+|++|++++..+ ..+..+++|+.|+|++|.+++. ++..+..+++|+.|||++|++.+..|
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 4 3478888888888876544 3456678888888888885532 33467778888899999998887766
Q ss_pred hhhhc
Q 039922 571 LELTK 575 (973)
Q Consensus 571 ~~l~~ 575 (973)
..+..
T Consensus 302 ~~~~~ 306 (362)
T 3goz_A 302 IPISN 306 (362)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-25 Score=245.46 Aligned_cols=261 Identities=19% Similarity=0.224 Sum_probs=185.9
Q ss_pred EEEccCCcCcccCchhccCCCccceeeccccccCCCCh----hhhhc-c-cCcEEEccCCcCCCCCCccccCC-----Cc
Q 039922 270 QIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLP----ETIAA-M-SLESLNLNDNYFTGEIPESLASN-----PN 338 (973)
Q Consensus 270 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~-~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 338 (973)
.+.++.|.+++.+|..+...++|+.|+|++|.+++..+ ..+.. . +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888888889999999999998776 44543 3 69999999999998888877775 99
Q ss_pred cceeeeccccccCCCCCCccC----C-CCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCC-cceee
Q 039922 339 LVQLKLFNNSFSGKLPDDLGK----Y-SNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGE-CKTLN 412 (973)
Q Consensus 339 L~~L~L~~N~l~~~~p~~l~~----l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~ 412 (973)
|++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+.. .+.. .++|+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~--------------------~l~~~~~~L~ 141 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ--------------------AFSNLPASIT 141 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH--------------------HHTTSCTTCC
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH--------------------HHHhCCCcee
Confidence 999999999999777765444 3 89999999999998766554432 1122 13455
Q ss_pred EEEccCCccccccC----cccCCCC-CccEEEeecCcccCCCCCCC----CCC-CCcceEeecCCcCCCC----Cchhhh
Q 039922 413 YLRFGGNELQGELP----SKFWGLP-EVDFFEMYNNRFEGSISPSI----SNA-PKLTGILINGNNFTGE----VPSQIC 478 (973)
Q Consensus 413 ~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~----~~~-~~L~~L~L~~N~l~~~----~p~~~~ 478 (973)
+|+|++|.+++..+ ..+..++ +|+.|+|++|++++..+..+ ... ++|++|+|++|.+++. ++..+.
T Consensus 142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 55555555553222 2223333 56666666666655444332 233 4777777777777753 445555
Q ss_pred c-CCcCcEEeCcCCcccCCCc----cccccccccceeecccccccc-------ccCcccCccccceeeeeccCcccCCCC
Q 039922 479 T-LRQLQAVDLSQNRFSGHLP----TCITQLNKLQQLELQENMFTG-------ELPRNLNSLTALIVLNLSTNQLTGTIP 546 (973)
Q Consensus 479 ~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~-------~~p~~~~~l~~L~~L~Ls~N~l~~~~p 546 (973)
. .++|++|+|++|++++..+ ..+..+++|+.|+|++|++.+ .++..+..+++|+.|||++|++.+..+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 5 3588899999998886544 344667889999999998443 344567888999999999999986655
Q ss_pred cccc
Q 039922 547 PELG 550 (973)
Q Consensus 547 ~~~~ 550 (973)
..+.
T Consensus 302 ~~~~ 305 (362)
T 3goz_A 302 IPIS 305 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=214.49 Aligned_cols=201 Identities=17% Similarity=0.188 Sum_probs=152.0
Q ss_pred hhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCc
Q 039922 389 CIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNN 468 (973)
Q Consensus 389 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~ 468 (973)
.++++++.+. .+|..+. +++++|+|++|.+++..+..|.++++|+.|+|++|++++..+..+..+++|++|++++|+
T Consensus 18 ~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 18 EVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp EEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 3444444443 3444333 467888888888888777788888888888888888888778888888888999999999
Q ss_pred CCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcc
Q 039922 469 FTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPE 548 (973)
Q Consensus 469 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 548 (973)
+++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 174 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA 174 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHH
Confidence 88777778888999999999999999777777888999999999999999777778999999999999999999777778
Q ss_pred ccccccccEEecCCCcCcccc------ChhhhcccccceeccCCcCcccC
Q 039922 549 LGNLAVLTSLDLSSNLLTGEI------PLELTKLKLNQFNISHNKLYGEV 592 (973)
Q Consensus 549 ~~~l~~L~~L~Ls~N~l~~~~------p~~l~~l~l~~l~l~~N~l~g~~ 592 (973)
|..+++|+.|+|++|++++.. +..+..-.....+..+|++.+..
T Consensus 175 ~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 224 (251)
T 3m19_A 175 FDRLGKLQTITLFGNQFDCSRCEILYLSQWIRENSNKVKDGTGQNLHESP 224 (251)
T ss_dssp TTTCTTCCEEECCSCCBCTTSTTHHHHHHHHHHSGGGBCC-------CCG
T ss_pred HhCCCCCCEEEeeCCceeCCccccHHHHHHHHhcccceeeccCcccccCC
Confidence 999999999999999998763 23332222333445555555443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=228.79 Aligned_cols=232 Identities=16% Similarity=0.192 Sum_probs=158.9
Q ss_pred hhcccCcEEEccCCcCCCCCCc---cccCCCccceeeeccccccCCCCCCc--cCCCCccceeeecccccccCCcccccc
Q 039922 310 IAAMSLESLNLNDNYFTGEIPE---SLASNPNLVQLKLFNNSFSGKLPDDL--GKYSNLEYFDVSTNDFTGELPRFLCFR 384 (973)
Q Consensus 310 ~~~~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~~~~~~~l 384 (973)
+....++.|.+.++.++...-. .+..+++|++|++++|.+++..|..+ ..+++|++|+|++|++++..+..-
T Consensus 61 ~~~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~--- 137 (310)
T 4glp_A 61 VKALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLA--- 137 (310)
T ss_dssp GSSCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHH---
T ss_pred hhhcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhH---
Confidence 3344677888887776531111 12234568888888888888887777 778888888888888875433110
Q ss_pred CCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccC---CC-CCCCCCCCCcc
Q 039922 385 NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEG---SI-SPSISNAPKLT 460 (973)
Q Consensus 385 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~-~~~~~~~~~L~ 460 (973)
...+..+++|++|++++|++.+..+..|..+++|+.|+|++|++.+ .. +..+..+++|+
T Consensus 138 -----------------~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~ 200 (310)
T 4glp_A 138 -----------------ELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQ 200 (310)
T ss_dssp -----------------HHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCC
T ss_pred -----------------HHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCC
Confidence 0123345666666777776666666666666677777777766543 11 22346777888
Q ss_pred eEeecCCcCCCCCch----hhhcCCcCcEEeCcCCcccCCCccccccc---cccceeeccccccccccCcccCcccccee
Q 039922 461 GILINGNNFTGEVPS----QICTLRQLQAVDLSQNRFSGHLPTCITQL---NKLQQLELQENMFTGELPRNLNSLTALIV 533 (973)
Q Consensus 461 ~L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 533 (973)
+|++++|+++ .++. .+..+++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.
T Consensus 201 ~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~ 276 (310)
T 4glp_A 201 NLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRV 276 (310)
T ss_dssp SCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSC
T ss_pred EEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCE
Confidence 8888888886 3333 24677888888888888887777777766 58888888888888 6677664 78888
Q ss_pred eeeccCcccCCCCccccccccccEEecCCCcCcc
Q 039922 534 LNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567 (973)
Q Consensus 534 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (973)
|||++|+|++ +|. +..+++|+.|+|++|+++.
T Consensus 277 L~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 277 LDLSSNRLNR-APQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp EECCSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred EECCCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence 8888888885 343 6777888888888888763
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-25 Score=253.49 Aligned_cols=115 Identities=18% Similarity=0.265 Sum_probs=53.5
Q ss_pred CCCCcceEeecCCcCCC-----CCchhhhcCCcCcEEeCcCCccc----CCCccccccccccceeeccccccccc----c
Q 039922 455 NAPKLTGILINGNNFTG-----EVPSQICTLRQLQAVDLSQNRFS----GHLPTCITQLNKLQQLELQENMFTGE----L 521 (973)
Q Consensus 455 ~~~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~ 521 (973)
.+++|+.|++++|+++. ..|..+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|++++. +
T Consensus 185 ~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l 264 (386)
T 2ca6_A 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264 (386)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred hCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHH
Confidence 34444444444444441 12224444455555555555553 33444445555555555555555433 3
Q ss_pred Cccc--CccccceeeeeccCcccC----CCCccc-cccccccEEecCCCcCcccc
Q 039922 522 PRNL--NSLTALIVLNLSTNQLTG----TIPPEL-GNLAVLTSLDLSSNLLTGEI 569 (973)
Q Consensus 522 p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~ 569 (973)
|..+ +.+++|+.|+|++|++++ .+|..+ .++++|++|+|++|++++..
T Consensus 265 ~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 3333 224555555555555543 244444 33455555555555555443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=212.85 Aligned_cols=154 Identities=17% Similarity=0.207 Sum_probs=71.0
Q ss_pred ccCCcceeeEEEccC-CccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcc---eEeecCC-cCCCCCchhhh
Q 039922 404 SYGECKTLNYLRFGG-NELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLT---GILINGN-NFTGEVPSQIC 478 (973)
Q Consensus 404 ~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~---~L~L~~N-~l~~~~p~~~~ 478 (973)
.|..+++|++|++++ |++++..+..|.++++|+.|++++|++++ +|. +..+++|+ .|++++| .+++..+..|.
T Consensus 75 ~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~ 152 (239)
T 2xwt_C 75 SFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152 (239)
T ss_dssp TEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTT
T ss_pred HcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCccccc
Confidence 444555555555555 55554444555555555555555555554 222 44444444 4445444 44433333444
Q ss_pred cCCcCc-EEeCcCCcccCCCccccccccccceeeccccc-cccccCcccCcc-ccceeeeeccCcccCCCCccccccccc
Q 039922 479 TLRQLQ-AVDLSQNRFSGHLPTCITQLNKLQQLELQENM-FTGELPRNLNSL-TALIVLNLSTNQLTGTIPPELGNLAVL 555 (973)
Q Consensus 479 ~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L 555 (973)
.+++|+ .|++++|+++ .+|......++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|+|+ .+|.. .+++|
T Consensus 153 ~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L 228 (239)
T 2xwt_C 153 GLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHL 228 (239)
T ss_dssp TTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTC
T ss_pred chhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccC
Confidence 444555 5555555544 222222112444445554442 443334444444 44444444444444 23322 33444
Q ss_pred cEEecCCC
Q 039922 556 TSLDLSSN 563 (973)
Q Consensus 556 ~~L~Ls~N 563 (973)
+.|+++++
T Consensus 229 ~~L~l~~~ 236 (239)
T 2xwt_C 229 KELIARNT 236 (239)
T ss_dssp SEEECTTC
T ss_pred ceeeccCc
Confidence 44444443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.2e-25 Score=247.64 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=186.5
Q ss_pred CCCccccCCCccceeeeccccccCCC----CCCccCCCCccceeeeccc---ccccCCccccccCCchhhhcccCccCCC
Q 039922 328 EIPESLASNPNLVQLKLFNNSFSGKL----PDDLGKYSNLEYFDVSTND---FTGELPRFLCFRNKLQCIIIFNNRFSGK 400 (973)
Q Consensus 328 ~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~Ls~N~---l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 400 (973)
.++..+..+++|++|+|++|++++.. +..+..+++|++|+|++|. +++.+|..+..
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~----------------- 85 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL----------------- 85 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH-----------------
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHH-----------------
Confidence 45667777888899999998888653 3446778888888888864 34444443311
Q ss_pred CCCccCCcceeeEEEccCCcccc----ccCcccCCCCCccEEEeecCcccCCCCCCCC----CC---------CCcceEe
Q 039922 401 IPESYGECKTLNYLRFGGNELQG----ELPSKFWGLPEVDFFEMYNNRFEGSISPSIS----NA---------PKLTGIL 463 (973)
Q Consensus 401 ~p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~~---------~~L~~L~ 463 (973)
+...+..+++|++|+|++|.+++ .++..+..+++|+.|+|++|.++...+..+. .+ ++|++|+
T Consensus 86 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~ 165 (386)
T 2ca6_A 86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165 (386)
T ss_dssp HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence 11223556666666777766665 3455566667777777777766533333332 22 7899999
Q ss_pred ecCCcCC-CCCc---hhhhcCCcCcEEeCcCCccc--C---CCccccccccccceeeccccccc----cccCcccCcccc
Q 039922 464 INGNNFT-GEVP---SQICTLRQLQAVDLSQNRFS--G---HLPTCITQLNKLQQLELQENMFT----GELPRNLNSLTA 530 (973)
Q Consensus 464 L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~ 530 (973)
+++|+++ +.+| ..+..+++|++|+|++|+++ | ..|..+..+++|+.|+|++|+++ +.+|..+..+++
T Consensus 166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~ 245 (386)
T 2ca6_A 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245 (386)
T ss_dssp CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence 9999987 4455 46778999999999999997 3 34558889999999999999997 678999999999
Q ss_pred ceeeeeccCcccCC----CCcccc--ccccccEEecCCCcCcc----ccChhh-hcc-cccceeccCCcCcccC
Q 039922 531 LIVLNLSTNQLTGT----IPPELG--NLAVLTSLDLSSNLLTG----EIPLEL-TKL-KLNQFNISHNKLYGEV 592 (973)
Q Consensus 531 L~~L~Ls~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~l-~~l-~l~~l~l~~N~l~g~~ 592 (973)
|+.|+|++|+|++. +|..+. .+++|+.|+|++|++++ .+|..+ ..+ .|+.|++++|++++..
T Consensus 246 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 99999999999865 566773 49999999999999998 599888 555 8999999999998654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=5e-23 Score=225.27 Aligned_cols=226 Identities=16% Similarity=0.175 Sum_probs=150.2
Q ss_pred CccceeeccccccCCC----ChhhhhcccCcEEEccCCcCCCCCCccc--cCCCccceeeeccccccCCCC----CCccC
Q 039922 290 TTLLRLDISQNNLTGN----LPETIAAMSLESLNLNDNYFTGEIPESL--ASNPNLVQLKLFNNSFSGKLP----DDLGK 359 (973)
Q Consensus 290 ~~L~~L~Ls~N~l~~~----~~~~~~~~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~l~~ 359 (973)
..++.+.+.++.++.. +.......+|++|++++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4577888888777532 1122233469999999999999999988 899999999999999997655 23456
Q ss_pred CCCccceeeecccccccCCccccccCCchhhhcccCccCCC--C--CCccCCcceeeEEEccCCccccccCcccCCCCCc
Q 039922 360 YSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGK--I--PESYGECKTLNYLRFGGNELQGELPSKFWGLPEV 435 (973)
Q Consensus 360 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 435 (973)
+++|++|+|++|++++..+..+..+++|++|++++|++.+. + +..++.+++|++|++++|+++...+.
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~-------- 215 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGV-------- 215 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHH--------
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHH--------
Confidence 88888888888888766655555555555555555554321 1 12223444444444444444311100
Q ss_pred cEEEeecCcccCCCCC-CCCCCCCcceEeecCCcCCCCCchhhhcC---CcCcEEeCcCCcccCCCccccccccccceee
Q 039922 436 DFFEMYNNRFEGSISP-SISNAPKLTGILINGNNFTGEVPSQICTL---RQLQAVDLSQNRFSGHLPTCITQLNKLQQLE 511 (973)
Q Consensus 436 ~~L~L~~N~l~~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 511 (973)
+. .+..+++|++|++++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+
T Consensus 216 --------------~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~ 278 (310)
T 4glp_A 216 --------------CAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLD 278 (310)
T ss_dssp --------------HHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEE
T ss_pred --------------HHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEE
Confidence 00 13455666666666666666656555555 57888888888887 5676664 6788888
Q ss_pred ccccccccccCcccCccccceeeeeccCccc
Q 039922 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLT 542 (973)
Q Consensus 512 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (973)
|++|+|++. |. +..+++|+.|+|++|+|+
T Consensus 279 Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 279 LSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred CCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 888888743 33 567788888888888876
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=210.88 Aligned_cols=195 Identities=17% Similarity=0.207 Sum_probs=161.2
Q ss_pred CchhhhcccCccCCCCCCccCCcceeeEEEccCCc-cccccCcccCCCCCccEEEeec-CcccCCCCCCCCCCCCcceEe
Q 039922 386 KLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNE-LQGELPSKFWGLPEVDFFEMYN-NRFEGSISPSISNAPKLTGIL 463 (973)
Q Consensus 386 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~L~~L~ 463 (973)
+|+.|++++|++++..+..|..+++|++|++++|+ +++..+..|.++++|+.|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 44444455555554555678888999999999997 8888888999999999999998 999988888899999999999
Q ss_pred ecCCcCCCCCchhhhcCCcCc---EEeCcCC-cccCCCccccccccccc-eeeccccccccccCcccCccccceeeeecc
Q 039922 464 INGNNFTGEVPSQICTLRQLQ---AVDLSQN-RFSGHLPTCITQLNKLQ-QLELQENMFTGELPRNLNSLTALIVLNLST 538 (973)
Q Consensus 464 L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 538 (973)
+++|++++ +|. +..+++|+ +|++++| ++++..+..|.++++|+ .|++++|+++ .+|......++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 99999996 665 88888888 9999999 99977777899999999 9999999999 5554433348999999999
Q ss_pred Cc-ccCCCCcccccc-ccccEEecCCCcCccccChhhhcc-cccceeccCC
Q 039922 539 NQ-LTGTIPPELGNL-AVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHN 586 (973)
Q Consensus 539 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N 586 (973)
|+ +++..+..|..+ ++|+.|||++|+++ .+|.. .+ .|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 95 986667789999 99999999999998 56654 34 7888888766
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.7e-24 Score=234.14 Aligned_cols=251 Identities=16% Similarity=0.235 Sum_probs=157.7
Q ss_pred CcEEEccCCcCCCCCCccccCC--CccceeeeccccccCCCCCCccCCCCccceeeeccccccc-CCccccccCCchhhh
Q 039922 315 LESLNLNDNYFTGEIPESLASN--PNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGE-LPRFLCFRNKLQCII 391 (973)
Q Consensus 315 L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~ 391 (973)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+++. ++..+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~---------- 114 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGIL---------- 114 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHH----------
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHH----------
Confidence 445555555544 2334444 5566666666666644443 34566666666666665533 33333
Q ss_pred cccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecC-cccCC-CCCCCCCCCCcceEeecCC-c
Q 039922 392 IFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNN-RFEGS-ISPSISNAPKLTGILINGN-N 468 (973)
Q Consensus 392 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~~~~L~~L~L~~N-~ 468 (973)
..+++|++|++++|.+++..+..+..+++|+.|++++| .+++. ++..+..+++|++|++++| .
T Consensus 115 --------------~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~ 180 (336)
T 2ast_B 115 --------------SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180 (336)
T ss_dssp --------------TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred --------------hhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCC
Confidence 33334444444444444444444444444444444444 33321 2334555666777777777 6
Q ss_pred CCCC-CchhhhcCC-cCcEEeCcCC--ccc-CCCccccccccccceeeccccc-cccccCcccCccccceeeeeccCc-c
Q 039922 469 FTGE-VPSQICTLR-QLQAVDLSQN--RFS-GHLPTCITQLNKLQQLELQENM-FTGELPRNLNSLTALIVLNLSTNQ-L 541 (973)
Q Consensus 469 l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l 541 (973)
+++. ++..+..++ +|++|++++| .++ +.+|..+..+++|+.|+|++|. +++..+..+..+++|+.|+|++|. +
T Consensus 181 l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~ 260 (336)
T 2ast_B 181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI 260 (336)
T ss_dssp CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTC
T ss_pred cChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCC
Confidence 6643 566777888 8888888888 454 3567777888899999999998 777778888889999999999985 3
Q ss_pred cCCCCccccccccccEEecCCCcCccccChhhhcc--cccceeccCCcCcccCCCCCc
Q 039922 542 TGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL--KLNQFNISHNKLYGEVPSDFD 597 (973)
Q Consensus 542 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l--~l~~l~l~~N~l~g~~p~~~~ 597 (973)
+......+.++++|+.|+|++| ++ ...+..+ .+..|++++|+++|..|..+.
T Consensus 261 ~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 261 IPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 2222226788999999999998 33 2234444 488889999999999887653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=218.64 Aligned_cols=207 Identities=22% Similarity=0.333 Sum_probs=126.9
Q ss_pred EccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccC
Q 039922 319 NLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFS 398 (973)
Q Consensus 319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 398 (973)
.+..+.+++.+ .+..+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+
T Consensus 25 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l-------------- 84 (308)
T 1h6u_A 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNL-------------- 84 (308)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTC--------------
T ss_pred HhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccC--------------
Confidence 44455554332 24456778888888888773 44 57777788888888877764332 4444
Q ss_pred CCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhh
Q 039922 399 GKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQIC 478 (973)
Q Consensus 399 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 478 (973)
++|++|++++|++++. ..+..+++|+.|++++|++++.. .+..+++|+.|++++|.+++..+ +.
T Consensus 85 ----------~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~ 148 (308)
T 1h6u_A 85 ----------TKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LA 148 (308)
T ss_dssp ----------CSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GG
T ss_pred ----------CCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--cc
Confidence 4455555555554432 13445555555555555555422 25556666666666666664332 66
Q ss_pred cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEE
Q 039922 479 TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSL 558 (973)
Q Consensus 479 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 558 (973)
.+++|++|++++|++++ ++. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++.. .+..+++|+.|
T Consensus 149 ~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L 222 (308)
T 1h6u_A 149 GLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIV 222 (308)
T ss_dssp GCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEE
T ss_pred CCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEE
Confidence 66777777777777764 333 6667777777777777764433 666777777777777776433 26777777777
Q ss_pred ecCCCcCcc
Q 039922 559 DLSSNLLTG 567 (973)
Q Consensus 559 ~Ls~N~l~~ 567 (973)
+|++|++++
T Consensus 223 ~l~~N~i~~ 231 (308)
T 1h6u_A 223 TLTNQTITN 231 (308)
T ss_dssp EEEEEEEEC
T ss_pred EccCCeeec
Confidence 777777763
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=5.8e-22 Score=216.27 Aligned_cols=213 Identities=16% Similarity=0.290 Sum_probs=146.2
Q ss_pred CccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeee
Q 039922 290 TTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVS 369 (973)
Q Consensus 290 ~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 369 (973)
.++..+.+..+.+++... .....+|++|++++|.++. +| .+..+++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 19 ~~~~~~~l~~~~~~~~~~-~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~ 93 (308)
T 1h6u_A 19 ANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS 93 (308)
T ss_dssp HHHHHHHTTCSSTTSEEC-HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred HHHHHHHhCCCCcCceec-HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEcc
Confidence 345555677777764322 2233489999999999985 44 68899999999999999996544 9999999999999
Q ss_pred cccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCC
Q 039922 370 TNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSI 449 (973)
Q Consensus 370 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 449 (973)
+|++++. + .+. .+++|++|++++|++++.. .+..+++|+.|++++|++++..
T Consensus 94 ~n~l~~~-~-~~~------------------------~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~ 145 (308)
T 1h6u_A 94 GNPLKNV-S-AIA------------------------GLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS 145 (308)
T ss_dssp SCCCSCC-G-GGT------------------------TCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG
T ss_pred CCcCCCc-h-hhc------------------------CCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCc
Confidence 9998742 2 344 4455555555555555432 2555555556666666555433
Q ss_pred CCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccc
Q 039922 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529 (973)
Q Consensus 450 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 529 (973)
+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++. +. +..+++|+.|+|++|++++..| +..++
T Consensus 146 ~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~ 217 (308)
T 1h6u_A 146 P--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHLKNNQISDVSP--LANTS 217 (308)
T ss_dssp G--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECTTSCCCBCGG--GTTCT
T ss_pred c--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEccCCccCcccc--ccCCC
Confidence 2 5666667777777777764333 66777777777777777743 32 6777777777777777775443 67777
Q ss_pred cceeeeeccCcccC
Q 039922 530 ALIVLNLSTNQLTG 543 (973)
Q Consensus 530 ~L~~L~Ls~N~l~~ 543 (973)
+|+.|+|++|++++
T Consensus 218 ~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 218 NLFIVTLTNQTITN 231 (308)
T ss_dssp TCCEEEEEEEEEEC
T ss_pred CCCEEEccCCeeec
Confidence 78888888887774
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=217.38 Aligned_cols=240 Identities=13% Similarity=0.119 Sum_probs=103.1
Q ss_pred ceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCC-CccCCCCccc-eeeec
Q 039922 293 LRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPD-DLGKYSNLEY-FDVST 370 (973)
Q Consensus 293 ~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~-L~Ls~ 370 (973)
++++.++++++ .+|..+ ..++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|. .|.+++++++ +.++.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l-~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TEEEEESTTCC-SCCTTC-CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc-CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 34455555555 233222 12344555555555433333444445555555555544333322 3344444332 23333
Q ss_pred ccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeec-CcccCCC
Q 039922 371 NDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYN-NRFEGSI 449 (973)
Q Consensus 371 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~ 449 (973)
|+++.. .|..|..+++|++|++++|+++...+..+....++..+++.+ |++....
T Consensus 90 N~l~~l------------------------~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 90 NNLLYI------------------------NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp TTCCEE------------------------CTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred Cccccc------------------------CchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 444433 333444444444444444444433333333444444444432 2333333
Q ss_pred CCCCCCCC-CcceEeecCCcCCCCCchhhhcCCcCcEEeCcC-CcccCCCccccccccccceeeccccccccccCcccCc
Q 039922 450 SPSISNAP-KLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ-NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNS 527 (973)
Q Consensus 450 ~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 527 (973)
+..|..+. .++.|++++|+|+ .+|.......+|++|++++ |.++...++.|..+++|++|||++|+|+...+..+.+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~ 224 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred ccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence 33333332 3444555555554 2333333334555555543 3444222234555555555555555555333333444
Q ss_pred cccceeeeeccCcccCCCCccccccccccEEecCCC
Q 039922 528 LTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563 (973)
Q Consensus 528 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (973)
+++|+.+++ +.++ .+| .+.++++|+.++++++
T Consensus 225 L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 225 LKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp CCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred chHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence 444433332 2233 344 2555555555555543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-21 Score=197.26 Aligned_cols=175 Identities=22% Similarity=0.237 Sum_probs=98.9
Q ss_pred CCccceeEEcCCCC---------ceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecc
Q 039922 59 PCNWTGITCETQNQ---------SVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALD 129 (973)
Q Consensus 59 ~C~w~gv~c~~~~~---------~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~ 129 (973)
.|.|++|.|+.... +++.|+|+++.+++..+..|..+++|++|+|++|+++ .++...|..+++|++|+|+
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECC
Confidence 38999999975421 3555566666555544445555666666666666555 3444455555566666666
Q ss_pred cccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCC
Q 039922 130 YNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSP 209 (973)
Q Consensus 130 ~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 209 (973)
+|.+.+..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+.
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~--- 161 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD--- 161 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC---
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee---
Confidence 66555544455555566666666666655544444555566666666666655554445555566666666655442
Q ss_pred CCccccCcchhHHHhhccCcccccCCccccCCC
Q 039922 210 LPSSVGNLSKLENLWAAKANLIGEIPDSIGKLA 242 (973)
Q Consensus 210 ~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~ 242 (973)
+.+++|++|.++.|++.|.+|..++.++
T Consensus 162 -----~~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 162 -----CTCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp -----CCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred -----cCCCCHHHHHHHHHhCCceeeccCcccc
Confidence 2334455555555555555555544443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.3e-22 Score=232.06 Aligned_cols=208 Identities=22% Similarity=0.354 Sum_probs=162.0
Q ss_pred ccCCccCCCCCCCC-----cccee-EEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCc
Q 039922 47 KLGDWVRTSQQSPC-----NWTGI-TCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPC 120 (973)
Q Consensus 47 ~~~sw~~~~~~~~C-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l 120 (973)
.+.+|.. +.++| .|.|+ .|.. .+++.|+|+++++++ +|..+. ++|++|+|++|+|+ .+| ..+
T Consensus 32 ~l~~W~~--~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip----~~l 99 (571)
T 3cvr_A 32 AWDKWEK--QALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP----ELP 99 (571)
T ss_dssp HHHHHHT--TCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC----CCC
T ss_pred HHHHHhc--cCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc----ccc
Confidence 4667864 34577 79999 7874 358899999999988 777664 78999999999998 666 346
Q ss_pred CCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeec
Q 039922 121 FHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFEL 200 (973)
Q Consensus 121 ~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 200 (973)
++|++|+|++|.+++ +|. +.. +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 167 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSV 167 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEEC
Confidence 888899999998887 666 554 88999999998886 565 67888899999888886 454 5778888888
Q ss_pred cCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCC-------CEEEc
Q 039922 201 GYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASI-------EQIEL 273 (973)
Q Consensus 201 s~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------~~L~L 273 (973)
++|+++.+ |. +. ++|+.|+|++|+|+ .+|. |.. +| +.|+|
T Consensus 168 s~N~L~~l--------------------------p~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~L 214 (571)
T 3cvr_A 168 RNNQLTFL--------------------------PE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRC 214 (571)
T ss_dssp CSSCCSCC--------------------------CC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEEC
T ss_pred CCCCCCCc--------------------------ch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEec
Confidence 88887652 33 33 67888888888888 5565 554 66 89999
Q ss_pred cCCcCcccCchhccCCCccceeeccccccCCCChhhhhc
Q 039922 274 FDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAA 312 (973)
Q Consensus 274 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 312 (973)
++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..
T Consensus 215 s~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp CSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred CCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 999998 57888888999999999999998887777654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-21 Score=215.02 Aligned_cols=241 Identities=17% Similarity=0.209 Sum_probs=170.2
Q ss_pred cEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccC
Q 039922 316 ESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNN 395 (973)
Q Consensus 316 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 395 (973)
+.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~----------------- 71 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE----------------- 71 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC-----------------
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC-----------------
Confidence 45566666666 4454442 456666666666664334456666666666666666543222
Q ss_pred ccCCCCCCccCCcceee-EEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecC-CcCCCCC
Q 039922 396 RFSGKIPESYGECKTLN-YLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILING-NNFTGEV 473 (973)
Q Consensus 396 ~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~-N~l~~~~ 473 (973)
+..|.+++++. .+.++.|+++...|..|..+++|+.|++++|+++...+..+....++..+++.+ |++....
T Consensus 72 ------~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 72 ------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp ------TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred ------hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 24567777765 467778999999999999999999999999999988888888888899999865 5676555
Q ss_pred chhhhcCC-cCcEEeCcCCcccCCCccccccccccceeeccc-cccccccCcccCccccceeeeeccCcccCCCCccccc
Q 039922 474 PSQICTLR-QLQAVDLSQNRFSGHLPTCITQLNKLQQLELQE-NMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGN 551 (973)
Q Consensus 474 p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 551 (973)
+..|..+. .++.|+|++|+|+ .+|.......+|+.|++++ |+++...++.|.++++|+.|||++|+|+...+..|.+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~ 224 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred ccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence 55666664 6889999999998 4555555667899999985 6677444467899999999999999999544444555
Q ss_pred cccccEEecCCCcCccccChhhhcc-cccceeccCCc
Q 039922 552 LAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNK 587 (973)
Q Consensus 552 l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~ 587 (973)
|+ .|.+.++.--..+|. +..+ +|+.++++++.
T Consensus 225 L~---~L~~l~~~~l~~lP~-l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 225 LK---KLRARSTYNLKKLPT-LEKLVALMEASLTYPS 257 (350)
T ss_dssp CC---EEECTTCTTCCCCCC-TTTCCSCCEEECSCHH
T ss_pred ch---HhhhccCCCcCcCCC-chhCcChhhCcCCCCc
Confidence 54 444444333347774 6667 78888887654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=210.67 Aligned_cols=147 Identities=16% Similarity=0.085 Sum_probs=117.1
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCc----------------hhHHHHHHHHHHHhcCCCCCeeeEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKP----------------ETETVFRSEIETLGRVRHGNVVKLL 746 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~niv~l~ 746 (973)
.|...+.||+|+||.||+|...+|+.||+|++....... .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 355669999999999999999889999999995432111 13567889999999999 4 6666
Q ss_pred eEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceE
Q 039922 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPR 826 (973)
Q Consensus 747 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 826 (973)
+++.. +..|+||||+++|+|.+ +.. .....++.|++.|++|||+. +|+||||||+||+++ ++.+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEE
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEE
Confidence 65543 55699999999999998 421 12346999999999999999 999999999999999 99999
Q ss_pred EeccCcchhccccCCCccccccccccccCccccccccC
Q 039922 827 VADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864 (973)
Q Consensus 827 l~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 864 (973)
|+|||+++. +..|+|||++..
T Consensus 233 l~DFG~a~~-----------------~~~~~a~e~l~r 253 (282)
T 1zar_A 233 IIDFPQSVE-----------------VGEEGWREILER 253 (282)
T ss_dssp ECCCTTCEE-----------------TTSTTHHHHHHH
T ss_pred EEECCCCeE-----------------CCCCCHHHHHHH
Confidence 999999863 234688998743
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=220.45 Aligned_cols=109 Identities=23% Similarity=0.351 Sum_probs=82.0
Q ss_pred CCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccc---
Q 039922 455 NAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL--- 531 (973)
Q Consensus 455 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--- 531 (973)
.+++|+.|++++|.|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|. +.. +|
T Consensus 138 ~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~ 205 (571)
T 3cvr_A 138 LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHS 205 (571)
T ss_dssp CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------
T ss_pred cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcc
Confidence 34556666666666664 443 45677778888888775 666 55 77888888888887 6666 554 66
Q ss_pred ----eeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc
Q 039922 532 ----IVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL 576 (973)
Q Consensus 532 ----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 576 (973)
+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+
T Consensus 206 ~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp --CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred cccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 99999999998 689988889999999999999999999988776
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-20 Score=191.18 Aligned_cols=160 Identities=18% Similarity=0.175 Sum_probs=85.3
Q ss_pred eeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCc
Q 039922 410 TLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLS 489 (973)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 489 (973)
+|++|++++|++++..+..|..+++|+.|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 34444444444444333444444444444444444444444444555555555555555554444445555566666666
Q ss_pred CCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCcccc
Q 039922 490 QNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEI 569 (973)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 569 (973)
+|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+++. ++.|++|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCcee
Confidence 6666544444455566666666666666644444555566666666666655432 345566666666666666
Q ss_pred Chhhhcc
Q 039922 570 PLELTKL 576 (973)
Q Consensus 570 p~~l~~l 576 (973)
|.++..+
T Consensus 182 p~~~~~l 188 (208)
T 2o6s_A 182 RNSAGSV 188 (208)
T ss_dssp BCTTSSB
T ss_pred eccCccc
Confidence 6655544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-21 Score=233.42 Aligned_cols=239 Identities=20% Similarity=0.222 Sum_probs=111.9
Q ss_pred chhhHHHHHHHhhhccCCCCCccCCccCCCCCCCCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCC
Q 039922 26 LHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSD 105 (973)
Q Consensus 26 ~~~~~~~l~~~k~~~~~d~~~~~~sw~~~~~~~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~ 105 (973)
...++++|+++......+.+..-..|..+ .+..+.|.+++++. .+++.|+|.++++... +. ..|+.++|+.
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~ 200 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGD-STPSGTATNSAVST--PLTPKIELFANGKDEA-NQ-----ALLQHKKLSQ 200 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCC-CCccccCCCceecC--CccceEEeeCCCCCcc-hh-----hHhhcCccCc
Confidence 45688899999887654445555678543 34467899998875 4688999988887762 22 2356667777
Q ss_pred CcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcc
Q 039922 106 NYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLI 185 (973)
Q Consensus 106 n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 185 (973)
|.|. .+++..|.+. ..++.+..+++|++|+|++|.+. .+|..+..+++|++|+|++|.|+ .+
T Consensus 201 ~~i~---------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~l 262 (727)
T 4b8c_D 201 YSID---------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-EL 262 (727)
T ss_dssp -------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CC
T ss_pred cccc---------------Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-cc
Confidence 7665 2234445444 45667777888888888888877 56666777788888888888877 56
Q ss_pred cccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCC
Q 039922 186 PSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGL 265 (973)
Q Consensus 186 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 265 (973)
|..|++|++|++|+|++|.|+. +|..|+++++|++|+|++|.|+ .+|..|+++
T Consensus 263 p~~~~~l~~L~~L~Ls~N~l~~--------------------------lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l 315 (727)
T 4b8c_D 263 PAEIKNLSNLRVLDLSHNRLTS--------------------------LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNL 315 (727)
T ss_dssp CGGGGGGTTCCEEECTTSCCSS--------------------------CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSC
T ss_pred ChhhhCCCCCCEEeCcCCcCCc--------------------------cChhhcCCCCCCEEECCCCCCC-ccChhhhcC
Confidence 7777777777777777777642 3455666777777777777776 566667777
Q ss_pred CCCCEEEccCCcCcccCchhccCCCc-cceeeccccccCCCChhhhhcccCcEEEccCC
Q 039922 266 ASIEQIELFDNQLSGELPESLSNLTT-LLRLDISQNNLTGNLPETIAAMSLESLNLNDN 323 (973)
Q Consensus 266 ~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N 323 (973)
++|+.|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|. .|..|++++|
T Consensus 316 ~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~-----~l~~l~l~~n 369 (727)
T 4b8c_D 316 CNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH-----ERRFIEINTD 369 (727)
T ss_dssp TTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----C---------
T ss_pred CCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc-----ccceeEeecc
Confidence 77777777777777777766654422 23356667776665554 2344445444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.9e-19 Score=182.69 Aligned_cols=156 Identities=20% Similarity=0.228 Sum_probs=112.7
Q ss_pred eEEEccCCccccccCcccCCCCCccEEEeecCcccCCCC-CCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcC
Q 039922 412 NYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSIS-PSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490 (973)
Q Consensus 412 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 490 (973)
+.+++++|.++. +|..+. +.++.|+|++|++++..+ ..|..+++|+.|++++|.|++..+..|..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 356666666663 333332 234566666666665543 3466777777777777777766666777778888888888
Q ss_pred CcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccC
Q 039922 491 NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
|++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 88877667777778888888888888887777788888888888888888887777788888888888888888876654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.5e-19 Score=212.04 Aligned_cols=191 Identities=21% Similarity=0.328 Sum_probs=119.3
Q ss_pred ccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEcc
Q 039922 338 NLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFG 417 (973)
Q Consensus 338 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 417 (973)
.+..+.+..+.+.+..+ +..+++|+.|++++|.+... + .+..+++|++|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-------------------------~-~l~~l~~L~~L~Ls 73 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-------------------------Q-GIQYLPNVTKLFLN 73 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-------------------------T-TGGGCTTCCEEECT
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-------------------------h-HHccCCCCCEEEee
Confidence 45555556555553322 34556666666666655421 2 34555566666666
Q ss_pred CCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCC
Q 039922 418 GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHL 497 (973)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 497 (973)
+|++++..+ +..+++|+.|+|++|++.+ ++.+..+++|+.|+|++|.+.+. ..+..+++|+.|+|++|+|++.
T Consensus 74 ~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~--l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l- 146 (605)
T 1m9s_A 74 GNKLTDIKP--LTNLKNLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI- 146 (605)
T ss_dssp TSCCCCCGG--GGGCTTCCEEECCSSCCCC--CTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-
T ss_pred CCCCCCChh--hccCCCCCEEECcCCCCCC--ChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc-
Confidence 666654443 5566666666666666654 23566666777777777776642 3466677777777777777643
Q ss_pred ccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccc
Q 039922 498 PTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 498 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++ + +.+..+++|+.|+|++|++++.
T Consensus 147 -~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 147 -TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp -GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEECC
T ss_pred -hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcCC
Confidence 456677777777777777775555 6777777777777777764 3 3567777777777777777653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=193.00 Aligned_cols=170 Identities=22% Similarity=0.287 Sum_probs=78.2
Q ss_pred CcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEe
Q 039922 119 PCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHF 198 (973)
Q Consensus 119 ~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 198 (973)
.+++|++|++++|.+... + .+..+++|++|+|++|++++..+ ++.+++|++|+|++|++++. ..+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence 444455555555544332 2 24445555555555555554322 55555555555555555542 225555555555
Q ss_pred eccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcC
Q 039922 199 ELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQL 278 (973)
Q Consensus 199 ~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 278 (973)
+|++|+++.+ ..+..+++|++|++++|.+.+. ..++.+++|++|++++|++++..+ +..+++|++|++++|++
T Consensus 118 ~L~~n~i~~~---~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 118 SLEHNGISDI---NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp ECTTSCCCCC---GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCCC---hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 5555554431 1122222222222222222211 234445555555555555554333 55555555555555555
Q ss_pred cccCchhccCCCccceeeccccccC
Q 039922 279 SGELPESLSNLTTLLRLDISQNNLT 303 (973)
Q Consensus 279 ~~~~p~~l~~l~~L~~L~Ls~N~l~ 303 (973)
++. + .+..+++|+.|++++|+++
T Consensus 191 ~~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 191 SDL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred CCC-h-hhccCCCCCEEECcCCccc
Confidence 532 2 2455555555555555554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-21 Score=226.30 Aligned_cols=203 Identities=18% Similarity=0.155 Sum_probs=122.4
Q ss_pred cCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeE
Q 039922 334 ASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNY 413 (973)
Q Consensus 334 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 413 (973)
...++|+.|+|++|+++ .+|..++++++|+.|++++|......|. .+..+.+.+..|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 45667777777777776 6677777777777777765541100000 00011122333444444444444
Q ss_pred EE-ccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCc
Q 039922 414 LR-FGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNR 492 (973)
Q Consensus 414 L~-L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 492 (973)
|+ ++.|.+. +|..+.+.+|.++...+ ..|+.|++++|.|++ +|. ++.+++|+.|+|++|+
T Consensus 414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 44 3433322 22333344444443221 136666777777764 454 7777777777777777
Q ss_pred ccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCC-CccccccccccEEecCCCcCccccC
Q 039922 493 FSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTI-PPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 493 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..|+.+++|+.|+|++|++++.+|
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 77 667777777777777777777774 55 6777777777777777777655 7777777777777777777775544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=194.21 Aligned_cols=151 Identities=25% Similarity=0.369 Sum_probs=94.4
Q ss_pred cCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCc
Q 039922 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 484 (973)
+..+++|++|++++|++++..+ +..+++|+.|++++|++++. +.+..+++|+.|++++|++++. ..+..+++|+
T Consensus 64 ~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~ 137 (291)
T 1h6t_A 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLE 137 (291)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCC
T ss_pred HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCC
Confidence 4555556666666666654433 55556666666666655542 2356666666666666666642 3566667777
Q ss_pred EEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCc
Q 039922 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNL 564 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 564 (973)
.|++++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|+
T Consensus 138 ~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~ 211 (291)
T 1h6t_A 138 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE 211 (291)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEE
T ss_pred EEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCc
Confidence 777777777643 456667777777777777765444 6667777777777777764 33 36667777777777777
Q ss_pred Ccc
Q 039922 565 LTG 567 (973)
Q Consensus 565 l~~ 567 (973)
++.
T Consensus 212 i~~ 214 (291)
T 1h6t_A 212 CLN 214 (291)
T ss_dssp EEC
T ss_pred ccC
Confidence 663
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.8e-19 Score=180.81 Aligned_cols=154 Identities=20% Similarity=0.232 Sum_probs=119.5
Q ss_pred eEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCC
Q 039922 412 NYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQN 491 (973)
Q Consensus 412 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 491 (973)
+.+++++|.++. +|..+. ++++.|++++|+|++..+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 456667776663 333332 56777777777777666667777778888888888887777788888888888888888
Q ss_pred cccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccc
Q 039922 492 RFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 492 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 88865556678888888888888888887788888888888888888888877777788888888888888888753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.6e-19 Score=181.75 Aligned_cols=155 Identities=19% Similarity=0.228 Sum_probs=140.0
Q ss_pred cEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCc-hhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccc
Q 039922 436 DFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVP-SQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQE 514 (973)
Q Consensus 436 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (973)
+.+++++|.++. +|..+. ..+++|++++|++++..| ..|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 589999999986 455543 457899999999997755 4588999999999999999988788999999999999999
Q ss_pred cccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCC
Q 039922 515 NMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVP 593 (973)
Q Consensus 515 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p 593 (973)
|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..+..+ +|+.|++++|++++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99998888889999999999999999998889999999999999999999998889999988 89999999999998765
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.4e-19 Score=208.54 Aligned_cols=187 Identities=21% Similarity=0.290 Sum_probs=129.6
Q ss_pred eecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCc
Q 039922 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNN 156 (973)
Q Consensus 77 l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~ 156 (973)
+++....+...+ .+..|++|+.|+|++|.+. .++ .+..|++|+.|+|++|.+.+..| +..+++|++|+|++|.
T Consensus 26 l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 26 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCC-CCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred HhccCCCccccc--chhcCCCCCEEECcCCCCC-CCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCC
Confidence 344444443322 2456677777777777776 333 46677777777777777765444 6677777777777777
Q ss_pred CCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCc
Q 039922 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD 236 (973)
Q Consensus 157 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~ 236 (973)
+++ +| .+..+++|++|+|++|++++. ..+..+++|+.|+|++|.++. . .
T Consensus 99 l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-------------------------l--~ 147 (605)
T 1m9s_A 99 IKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-------------------------I--T 147 (605)
T ss_dssp CCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCC-------------------------C--G
T ss_pred CCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCC-------------------------c--h
Confidence 764 33 577777777777777777753 346677777777777776654 2 3
Q ss_pred cccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCC
Q 039922 237 SIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGN 305 (973)
Q Consensus 237 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 305 (973)
.+..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++.
T Consensus 148 ~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 148 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred hhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 46677888888888888887666 78888888888888888854 3578888888888888888754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-18 Score=179.84 Aligned_cols=160 Identities=28% Similarity=0.325 Sum_probs=82.3
Q ss_pred CCCCCccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccc
Q 039922 56 QQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIG 135 (973)
Q Consensus 56 ~~~~C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~ 135 (973)
+.+.|.|.+|.|+... + +.+|..+. ++|++|+|++|++++ +++..|.++++|++|+|++|.+.+
T Consensus 15 ~~~~Cs~~~v~c~~~~--l-----------~~ip~~~~--~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~ 78 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKR--H-----------ASVPAGIP--TNAQILYLHDNQITK-LEPGVFDSLINLKELYLGSNQLGA 78 (229)
T ss_dssp TTCEEETTEEECTTSC--C-----------SSCCSCCC--TTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCEEeCCEeEccCCC--c-----------CccCCCCC--CCCCEEEcCCCccCc-cCHHHhhCccCCcEEECCCCCCCC
Confidence 3467999999997532 1 11222221 445555555555552 223445555555555555555544
Q ss_pred cCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCcccc
Q 039922 136 ELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVG 215 (973)
Q Consensus 136 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 215 (973)
..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+++.++ +..+.
T Consensus 79 i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~-~~~~~ 156 (229)
T 3e6j_A 79 LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIP-HGAFD 156 (229)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCC-TTTTT
T ss_pred cChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccC-HHHHh
Confidence 44444555555555555555555444444555555555555555555 33444555555555555555554421 23445
Q ss_pred CcchhHHHhhccCccccc
Q 039922 216 NLSKLENLWAAKANLIGE 233 (973)
Q Consensus 216 ~l~~L~~L~l~~n~l~~~ 233 (973)
.+++|+.|++.+|.+...
T Consensus 157 ~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 157 RLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp TCTTCCEEECTTSCBCTT
T ss_pred CCCCCCEEEeeCCCccCC
Confidence 555555555555554433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.2e-19 Score=195.96 Aligned_cols=177 Identities=19% Similarity=0.186 Sum_probs=111.2
Q ss_pred hhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccC-CCCCccEEEeecCcccCCCCCCCCCCCCcceEeecC
Q 039922 388 QCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFW-GLPEVDFFEMYNNRFEGSISPSISNAPKLTGILING 466 (973)
Q Consensus 388 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~ 466 (973)
+.+++++|++.. +|..+. ..+++|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 356666676663 454443 3466777777777766666666 677777777777777666666666666666666666
Q ss_pred CcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCccc---CccccceeeeeccCcccC
Q 039922 467 NNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNL---NSLTALIVLNLSTNQLTG 543 (973)
Q Consensus 467 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 543 (973)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|||++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 66665555566666666666666666665556666666666666666666664333333 446666666666666664
Q ss_pred CCCcccccccc--ccEEecCCCcCcc
Q 039922 544 TIPPELGNLAV--LTSLDLSSNLLTG 567 (973)
Q Consensus 544 ~~p~~~~~l~~--L~~L~Ls~N~l~~ 567 (973)
..+..|..++. |+.|+|++|+++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 44445555655 3666666666654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.9e-21 Score=225.37 Aligned_cols=203 Identities=21% Similarity=0.154 Sum_probs=165.1
Q ss_pred cCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccE
Q 039922 358 GKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDF 437 (973)
Q Consensus 358 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 437 (973)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|......|.. +..+.+.+..|..+..+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhccc
Confidence 56788889999999987 67888888888888888666432111110 1122345567778888888888
Q ss_pred EE-eecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccc
Q 039922 438 FE-MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENM 516 (973)
Q Consensus 438 L~-L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (973)
|+ ++.|.+. .|..+.+++|.++.. |. ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+
T Consensus 414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYLD-----------DLRSKFLLENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHHH-----------HHHHHHHHHHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhcccc-----------hhhhhhhhccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 88 6776653 567777788877632 21 259999999999995 776 9999999999999999
Q ss_pred cccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCcccc-Chhhhcc-cccceeccCCcCcccCCC
Q 039922 517 FTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEI-PLELTKL-KLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 517 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l-~l~~l~l~~N~l~g~~p~ 594 (973)
|+ .+|..++.+++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.+ |..+..+ .|+.|++++|++++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 99 889999999999999999999996 77 8999999999999999999887 9999999 999999999999988764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-19 Score=197.07 Aligned_cols=177 Identities=22% Similarity=0.225 Sum_probs=127.3
Q ss_pred eEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCC-CCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcC
Q 039922 412 NYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSIS-NAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490 (973)
Q Consensus 412 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 490 (973)
+.+++++|.++. +|..+. +.++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 567788887774 444332 3577788888888777777776 778888888888888776667777888888888888
Q ss_pred CcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccc---cccccccEEecCCCcCcc
Q 039922 491 NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPEL---GNLAVLTSLDLSSNLLTG 567 (973)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 567 (973)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|||++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 88876666677778888888888888887777778888888888888888875333334 567788888888888875
Q ss_pred ccChhhhcc-c--ccceeccCCcCccc
Q 039922 568 EIPLELTKL-K--LNQFNISHNKLYGE 591 (973)
Q Consensus 568 ~~p~~l~~l-~--l~~l~l~~N~l~g~ 591 (973)
..+..+..+ . ++.|++++|++.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred cCHHHhhhccHhhcceEEecCCCccCC
Confidence 444555555 2 47778888877653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.3e-18 Score=177.76 Aligned_cols=156 Identities=21% Similarity=0.225 Sum_probs=122.1
Q ss_pred eeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcC
Q 039922 411 LNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490 (973)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 490 (973)
.+.++.+++.++. +|..+. ++|+.|+|++|++++..+..+..+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 4567777777763 333332 6777777777777777777778888888888888888766556678888888888888
Q ss_pred CcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccC
Q 039922 491 NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8888766677788888888888888888 778888888888888888888886666778888888999999998887654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=178.75 Aligned_cols=153 Identities=20% Similarity=0.259 Sum_probs=131.1
Q ss_pred cEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeecccc
Q 039922 436 DFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQEN 515 (973)
Q Consensus 436 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (973)
+.+++++|.++.. |..+. ++++.|++++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 5688888888754 44443 68999999999999777778999999999999999999888899999999999999999
Q ss_pred ccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCccc
Q 039922 516 MFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGE 591 (973)
Q Consensus 516 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~ 591 (973)
+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..+ .|+.|++++|++.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9996666778889999999999999998888899999999999999999997777778777 889999988887653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=5e-18 Score=171.14 Aligned_cols=158 Identities=25% Similarity=0.306 Sum_probs=124.1
Q ss_pred CcceEeecCCcCCCCCch-hhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeee
Q 039922 458 KLTGILINGNNFTGEVPS-QICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNL 536 (973)
Q Consensus 458 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 536 (973)
++++|++++|++++..+. .+..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 677888888888766554 4888999999999999999888999999999999999999999888888999999999999
Q ss_pred ccCcccCCCCccccccccccEEecCCCcCccccChhhhcccccceeccCCcCcccCCCCCcccccccccCCCCCCCCCCC
Q 039922 537 STNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDL 616 (973)
Q Consensus 537 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p~~~~~~~~~~~~~~n~~~c~~~l 616 (973)
++|+|++.+|..|..+++|++|+|++|++++..+.......++...+..+...+..|..+.. .....+..+...|.++.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~l~~-~~l~~l~~~~~~C~~~~ 188 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRD-VQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTTT-SBGGGSCTTTCCCCCC-
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChHHcC-CChhhCcHhhcCcCCCC
Confidence 99999988899999999999999999999988764321113444456666677777765533 23344556666676543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.4e-19 Score=215.53 Aligned_cols=196 Identities=16% Similarity=0.200 Sum_probs=87.4
Q ss_pred CccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEc
Q 039922 337 PNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRF 416 (973)
Q Consensus 337 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 416 (973)
+.++.|+|.+|.+.. .+. ..|+.++|+.|.|.+ +++..|++. ..+..+..++.|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chh-----hHhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 446666666666653 222 234455566655542 233344444 45666777777777777
Q ss_pred cCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCC
Q 039922 417 GGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGH 496 (973)
Q Consensus 417 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 496 (973)
++|.+. .+|..++.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.|+ .+|..|+.+++|++|+|++|.|+ .
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence 777776 44444556666666666666666 45566666666666666666666 55666666666666666666665 5
Q ss_pred CccccccccccceeeccccccccccCcccCcccc-ceeeeeccCcccCCCCccccccccccEEecCCC
Q 039922 497 LPTCITQLNKLQQLELQENMFTGELPRNLNSLTA-LIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563 (973)
Q Consensus 497 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (973)
+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.++|.+|.. |+.|++++|
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 5666666666666666666666666666554322 223566666666666543 344455555
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-18 Score=182.40 Aligned_cols=127 Identities=18% Similarity=0.323 Sum_probs=54.1
Q ss_pred cCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCc
Q 039922 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 484 (973)
+..+++|++|++++|++++..+ +..+++|+.|++++|++++..+ +.. ++|+.|++++|++++. + .+..+++|+
T Consensus 59 l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~ 131 (263)
T 1xeu_A 59 MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLE 131 (263)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCC
T ss_pred HhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCc--ccc-CcccEEEccCCccCCC-h-hhcCccccc
Confidence 4444455555555555543332 4444444444444444443211 111 4444444444444421 1 244444444
Q ss_pred EEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCccc
Q 039922 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLT 542 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (973)
+|+|++|++++ +| .+..+++|+.|+|++|++++. ..+..+++|+.|++++|.++
T Consensus 132 ~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 132 ILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp EEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred EEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence 44444444442 22 344444444444444444432 33444444444444444444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=7.2e-18 Score=170.92 Aligned_cols=154 Identities=19% Similarity=0.257 Sum_probs=93.3
Q ss_pred cCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCc
Q 039922 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 484 (973)
.+.+++|++|++++|.++ .+| .+..+++|+.|++++|.++. ++.+..+++|++|++++|.+++..|..++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 355667777777777776 333 46666666666666665542 33555666666666666666655556666666666
Q ss_pred EEeCcCCcccCCCccccccccccceeeccccc-cccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCC
Q 039922 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENM-FTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (973)
+|++++|++++..|..++.+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 66666666665556666666666666666665 43 344 45666666666666666653 33 5566666666666666
Q ss_pred cCc
Q 039922 564 LLT 566 (973)
Q Consensus 564 ~l~ 566 (973)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.7e-18 Score=179.33 Aligned_cols=171 Identities=17% Similarity=0.177 Sum_probs=114.5
Q ss_pred ccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceE
Q 039922 383 FRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGI 462 (973)
Q Consensus 383 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L 462 (973)
.+.++..+++++|.+.+.. .+..+++|++|++++|.++.. + .+..+++|+.|++++|++++..+ +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 3445666666666666432 567788888888888888743 3 57777788888888877776544 6777777777
Q ss_pred eecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCccc
Q 039922 463 LINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLT 542 (973)
Q Consensus 463 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (973)
++++|++++ +|.. .. ++|++|+|++|++++ +| .+..+++|+.|+|++|++++. | .+..+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 777777764 3322 22 667777777777764 33 466677777777777777643 3 5666777777777777776
Q ss_pred CCCCccccccccccEEecCCCcCccc
Q 039922 543 GTIPPELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 543 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
+. ..+..+++|+.|+|++|++++.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 54 5566677777777777776643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=176.94 Aligned_cols=138 Identities=21% Similarity=0.204 Sum_probs=106.2
Q ss_pred CCccccccccCCeeEEEEEE-CCCCE--EEEEEecCCCCCc----------------------hhHHHHHHHHHHHhcCC
Q 039922 684 LTEQNLIGSGGSCRVYKVKL-KSGET--VAVKRLLGGTHKP----------------------ETETVFRSEIETLGRVR 738 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~ 738 (973)
|...+.||+|+||.||+|.. .+|+. ||||++....... .....+.+|+..+++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999998 68999 9999875332110 11246889999999998
Q ss_pred CCCe--eeEEeEEecCCeeEEEEeccCC-C----ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEEe
Q 039922 739 HGNV--VKLLMCCSGQDFNILVYEYMPN-G----SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLH-NDCVPAIVHR 810 (973)
Q Consensus 739 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~ 810 (973)
|+++ ..++++ +..++||||+++ | +|.++... .++..+..++.|++.|++||| +. +|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8754 344432 356899999952 4 66655432 234566789999999999999 88 99999
Q ss_pred CCCCCCEEeCCCCceEEeccCcchhc
Q 039922 811 DVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 811 Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=167.87 Aligned_cols=154 Identities=19% Similarity=0.258 Sum_probs=135.4
Q ss_pred cCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccc
Q 039922 429 FWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQ 508 (973)
Q Consensus 429 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 508 (973)
...+++|+.|++++|+++. ++ .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 3567899999999999994 34 6899999999999999776 345889999999999999999988899999999999
Q ss_pred eeeccccccccccCcccCccccceeeeeccCc-ccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCC
Q 039922 509 QLELQENMFTGELPRNLNSLTALIVLNLSTNQ-LTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHN 586 (973)
Q Consensus 509 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N 586 (973)
+|+|++|++++..|..+..+++|+.|+|++|+ ++ .+| .+..+++|+.|++++|++++ +| .+..+ +|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 99999999999899999999999999999998 65 566 79999999999999999995 55 67777 8999999999
Q ss_pred cCcc
Q 039922 587 KLYG 590 (973)
Q Consensus 587 ~l~g 590 (973)
++.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 9764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-17 Score=167.55 Aligned_cols=154 Identities=21% Similarity=0.289 Sum_probs=128.4
Q ss_pred ceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCcc-ccccccccceeeccccccccccCcccCccccceeeeecc
Q 039922 460 TGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT-CITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLST 538 (973)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 538 (973)
+.+++++|.++ .+|..+.. +|++|++++|+|++..+. .|+.+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67888888886 67766543 899999999999976654 489999999999999999999999999999999999999
Q ss_pred CcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCCCCCccc-ccccccCCCCCCCCCCC
Q 039922 539 NQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVPSDFDHD-LFISSLLDNPGLCSPDL 616 (973)
Q Consensus 539 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p~~~~~~-~~~~~~~~n~~~c~~~l 616 (973)
|+|++..|..|..+++|++|+|++|++++.+|..+..+ .|+.|++++|+++|..+-.+... .....+.++...|+.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 99998888889999999999999999999999999998 99999999999999877432111 11223444555666543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-17 Score=183.15 Aligned_cols=221 Identities=14% Similarity=0.067 Sum_probs=101.4
Q ss_pred CCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCc----cCCCCCCccCCccee
Q 039922 336 NPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNR----FSGKIPESYGECKTL 411 (973)
Q Consensus 336 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~----l~~~~p~~~~~l~~L 411 (973)
+++|+.|+|.+ .++...+.+|.++++|+.+++++|.+....+..|....++..+.+..+. ........|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 66777777766 6665555566667777777777776665555555554444444433311 111223334444444
Q ss_pred e-EEEccCCcc-ccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCc
Q 039922 412 N-YLRFGGNEL-QGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLS 489 (973)
Q Consensus 412 ~-~L~L~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 489 (973)
+ .+.+....- ............+++.+.+.++-...........+++|+.+++++|+++...+..|.++.+|+.|+|+
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 4 333332211 00000001112333444433321100000000113455555555555554444445555555555555
Q ss_pred CCcccCCCccccccccccc-eeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEe
Q 039922 490 QNRFSGHLPTCITQLNKLQ-QLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLD 559 (973)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 559 (973)
+| ++.+.+.+|.++++|+ .+++.+ +++...+.+|.++++|+.|++++|+++...+.+|.++++|+.++
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 54 4434444555555555 555554 44434445555555555555555555543344555555555544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.7e-17 Score=181.26 Aligned_cols=282 Identities=15% Similarity=0.138 Sum_probs=144.2
Q ss_pred cCCccEEecccccccccCCccccC-CCCCCEEECcCCcCC--CCCCcccCCCCcccEEecCCcccCCcccccccc-----
Q 039922 120 CFHLQVLALDYNVFIGELPDFSRE-FANLQVLDLSRNNFS--GDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGN----- 191 (973)
Q Consensus 120 l~~L~~L~L~~n~~~~~~~~~~~~-l~~L~~L~Ls~n~l~--~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~----- 191 (973)
+.+++.|.++++--... ...+.. +++|++|||++|++. ...+ +.++.++.+.+..|.|. +.+|.+
T Consensus 24 ~~~l~~L~l~g~i~~~~-~~~l~~~l~~L~~LdLs~n~i~~~~~~~---~~~~~~~~~~~~~~~I~---~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGKLNAED-FRHLRDEFPSLKVLDISNAEIKMYSGKA---GTYPNGKFYIYMANFVP---AYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEEECHHH-HHHHHHSCTTCCEEEEEEEEECCEEESS---SSSGGGCCEEECTTEEC---TTTTEEEETTE
T ss_pred hCceeEEEEeccccHHH-HHHHHHhhccCeEEecCcceeEEecCcc---ccccccccccccccccC---HHHhccccccc
Confidence 45566676665421111 112222 566777777777666 2111 22233455555555332 344555
Q ss_pred ---cccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCC
Q 039922 192 ---LTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASI 268 (973)
Q Consensus 192 ---l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 268 (973)
+++|+.|+|.. .++ ..-+.+|.++++|+.|++++|.++...+..|.+..++
T Consensus 97 ~~g~~~L~~l~L~~-~i~-------------------------~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l 150 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIK-------------------------NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTA 150 (329)
T ss_dssp EEECTTCCC-CBCT-TCC-------------------------EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCE
T ss_pred ccccCCCcEEECCc-ccc-------------------------chhHHHhhcCcccceEEcCCCCccccchhhhcCCCce
Confidence 56666555554 333 2334567777778888888887776777777777666
Q ss_pred CEEEccCCcC----cccCchhccCCCccc-eeeccccccCCCChhhhh-----cccCcEEEccCCcCCCCCCccccCCCc
Q 039922 269 EQIELFDNQL----SGELPESLSNLTTLL-RLDISQNNLTGNLPETIA-----AMSLESLNLNDNYFTGEIPESLASNPN 338 (973)
Q Consensus 269 ~~L~L~~n~l----~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~-----~~~L~~L~L~~N~l~~~~p~~~~~l~~ 338 (973)
..+.+..+.. .......|.++..|+ .+++... +.++..+. ..++..+.+.++-...........+++
T Consensus 151 ~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~---~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~ 227 (329)
T 3sb4_A 151 IFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAM---GKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPN 227 (329)
T ss_dssp EEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTT---CCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTT
T ss_pred EEecCcchhhhhccccccccccccccccceeEEecCC---CcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCC
Confidence 6666555321 222233455555555 3443322 12222221 124555555544221111111112566
Q ss_pred cceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceee-EEEcc
Q 039922 339 LVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLN-YLRFG 417 (973)
Q Consensus 339 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-~L~L~ 417 (973)
|+.|+|++|+++...+..|.++++|+.++|.+| ++...+. +|.++++|+ .+++.
T Consensus 228 L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~------------------------aF~~~~~L~~~l~l~ 282 (329)
T 3sb4_A 228 LVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQR------------------------VFSNCGRLAGTLELP 282 (329)
T ss_dssp CCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTT------------------------TTTTCTTCCEEEEEC
T ss_pred CeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHH------------------------HhhCChhccEEEEEc
Confidence 777777777666555556666777777777666 5544444 444455554 55554
Q ss_pred CCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEe
Q 039922 418 GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGIL 463 (973)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~ 463 (973)
+ .++.+.+..|.++++|+.++++.|+++...+..|.++++|+.++
T Consensus 283 ~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 283 A-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp T-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred c-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 4 44444445555555555555555555545455555555555543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=155.70 Aligned_cols=135 Identities=23% Similarity=0.252 Sum_probs=68.4
Q ss_pred ceeeEEEccCCccc-cccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEe
Q 039922 409 KTLNYLRFGGNELQ-GELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVD 487 (973)
Q Consensus 409 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 487 (973)
++|++|++++|.++ +.+|..+..+++|+.|++++|++++. ..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--------------------------~~~~~l~~L~~L~ 77 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--------------------------SNLPKLPKLKKLE 77 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--------------------------SSCCCCSSCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--------------------------hhhccCCCCCEEE
Confidence 45555666666555 34444444444444444444444432 3344444555555
Q ss_pred CcCCcccCCCccccccccccceeecccccccccc-CcccCccccceeeeeccCcccCCCC---ccccccccccEEecCCC
Q 039922 488 LSQNRFSGHLPTCITQLNKLQQLELQENMFTGEL-PRNLNSLTALIVLNLSTNQLTGTIP---PELGNLAVLTSLDLSSN 563 (973)
Q Consensus 488 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N 563 (973)
|++|++++.+|..+..+++|+.|+|++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|++|++++|
T Consensus 78 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n 157 (168)
T 2ell_A 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157 (168)
T ss_dssp EESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred CcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence 5555554444444444555555555555554321 1455555556666666666653322 25556666666666666
Q ss_pred cCccccC
Q 039922 564 LLTGEIP 570 (973)
Q Consensus 564 ~l~~~~p 570 (973)
.++ .+|
T Consensus 158 ~~~-~~~ 163 (168)
T 2ell_A 158 EDQ-EAP 163 (168)
T ss_dssp TSC-BCC
T ss_pred Chh-hcc
Confidence 655 344
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=150.51 Aligned_cols=137 Identities=21% Similarity=0.216 Sum_probs=95.3
Q ss_pred cCCchhhhcccCccC-CCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceE
Q 039922 384 RNKLQCIIIFNNRFS-GKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGI 462 (973)
Q Consensus 384 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L 462 (973)
.++|+.|++++|++. +.+|..+..+++|++|++++|.+++. ..|..+++|+.|++++|++++.
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~-------------- 86 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG-------------- 86 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSC--------------
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchH--------------
Confidence 378999999999998 78898899999999999999999976 7787788888777777777654
Q ss_pred eecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCC-ccccccccccceeeccccccccccC---cccCccccceeeeecc
Q 039922 463 LINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHL-PTCITQLNKLQQLELQENMFTGELP---RNLNSLTALIVLNLST 538 (973)
Q Consensus 463 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 538 (973)
+|..+..+++|++|+|++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 87 ----------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 87 ----------LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp ----------CCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred ----------HHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 3444444555666666666655321 1455566666666666666664333 3566666666666666
Q ss_pred CcccCCCCc
Q 039922 539 NQLTGTIPP 547 (973)
Q Consensus 539 N~l~~~~p~ 547 (973)
|.++ .+|.
T Consensus 157 n~~~-~~~~ 164 (168)
T 2ell_A 157 REDQ-EAPD 164 (168)
T ss_dssp TTSC-BCCS
T ss_pred CChh-hccc
Confidence 6665 3443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=153.62 Aligned_cols=128 Identities=25% Similarity=0.392 Sum_probs=86.1
Q ss_pred cEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeecccc
Q 039922 436 DFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQEN 515 (973)
Q Consensus 436 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (973)
+.+++++|+++. +|..+ .++|++|++++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 466777777763 33333 246777777777776 55666777777777777777777666666777777777777777
Q ss_pred ccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCcc
Q 039922 516 MFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567 (973)
Q Consensus 516 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (973)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 7776666667777777777777777765444456667777777777777664
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=151.67 Aligned_cols=130 Identities=23% Similarity=0.335 Sum_probs=106.5
Q ss_pred ceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccC
Q 039922 460 TGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTN 539 (973)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (973)
+.+++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 57888888888 5666543 57888999999888 67788888889999999999998777788888899999999999
Q ss_pred cccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCC
Q 039922 540 QLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVP 593 (973)
Q Consensus 540 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p 593 (973)
+|++..|..|..+++|++|+|++|++++..+..+..+ .|+.|++++|++.+..+
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9987777788888999999999999885555557777 88889999998876543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.1e-16 Score=149.45 Aligned_cols=110 Identities=24% Similarity=0.200 Sum_probs=57.3
Q ss_pred CCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccc-cCcccCcc
Q 039922 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGE-LPRNLNSL 528 (973)
Q Consensus 450 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l 528 (973)
|..+..+++|+.|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|+.|++++|++++. .|..+..+
T Consensus 35 ~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l 112 (149)
T 2je0_A 35 EGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL 112 (149)
T ss_dssp CSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGC
T ss_pred HHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhC
Confidence 33334444444444444444433 3444555555555555555544555555555555555555555542 23555556
Q ss_pred ccceeeeeccCcccCCCC---ccccccccccEEecC
Q 039922 529 TALIVLNLSTNQLTGTIP---PELGNLAVLTSLDLS 561 (973)
Q Consensus 529 ~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls 561 (973)
++|+.|++++|++++..+ ..+..+++|+.||++
T Consensus 113 ~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 113 ENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666666666654333 345566666666654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.8e-15 Score=148.96 Aligned_cols=114 Identities=26% Similarity=0.254 Sum_probs=90.7
Q ss_pred CCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeee
Q 039922 457 PKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNL 536 (973)
Q Consensus 457 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 536 (973)
++|+.|++++|++++..+..+..+++|++|++++|++++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 56777777777777666666777888888888888888666666788888888888888888777777888888888888
Q ss_pred ccCcccCCCCccccccccccEEecCCCcCccccC
Q 039922 537 STNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 537 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
++|+|++..+..|..+++|++|+|++|++++..|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 8888886555567888888888998888887665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.7e-15 Score=149.06 Aligned_cols=132 Identities=23% Similarity=0.278 Sum_probs=114.4
Q ss_pred cceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeecc
Q 039922 459 LTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLST 538 (973)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 538 (973)
.+.+++++|+++ .+|..+ .++|++|++++|++++..+..|+.+++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467788888887 455444 36899999999999977777889999999999999999977778889999999999999
Q ss_pred CcccCCCCccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcccCC
Q 039922 539 NQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYGEVP 593 (973)
Q Consensus 539 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p 593 (973)
|+|++..+..|..+++|++|+|++|++++..+..+..+ .|+.|++++|+++|..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99998777788999999999999999996555556777 89999999999998776
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.9e-15 Score=145.52 Aligned_cols=129 Identities=17% Similarity=0.190 Sum_probs=111.0
Q ss_pred cceeeEEEccCCccc-cccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEE
Q 039922 408 CKTLNYLRFGGNELQ-GELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAV 486 (973)
Q Consensus 408 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 486 (973)
.++|++|++++|.++ +.+|..+..+++|+.|++++|++++. ..+..+++|++|++++|.+++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 367888888888887 67777888888888888888888876 778889999999999999998788888889999999
Q ss_pred eCcCCcccCC-CccccccccccceeeccccccccccC---cccCccccceeeeecc
Q 039922 487 DLSQNRFSGH-LPTCITQLNKLQQLELQENMFTGELP---RNLNSLTALIVLNLST 538 (973)
Q Consensus 487 ~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 538 (973)
++++|++++. .|..++.+++|++|++++|++++..+ ..+..+++|+.||+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999863 34889999999999999999997666 5789999999999874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-15 Score=163.45 Aligned_cols=136 Identities=14% Similarity=0.124 Sum_probs=100.6
Q ss_pred CCccccccccCCeeEEEEEECCCCEEEEEEecCCCCC------------c--------hhHHHHHHHHHHHhcCCCCCee
Q 039922 684 LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK------------P--------ETETVFRSEIETLGRVRHGNVV 743 (973)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~--------~~~~~~~~e~~~l~~l~h~niv 743 (973)
|.+.+.||+|+||.||+|...+|+.||||+++..... . ..+....+|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 7788999999999999999999999999987532100 0 0112234677777777655432
Q ss_pred --eEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC
Q 039922 744 --KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA 821 (973)
Q Consensus 744 --~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 821 (973)
+.+++ ...++||||+++++|.++... .....++.|++.++.|||+. |||||||||.|||+++
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 22322 124799999998888765321 12346789999999999999 9999999999999988
Q ss_pred CC----------ceEEeccCcchh
Q 039922 822 EM----------VPRVADFGLAKA 835 (973)
Q Consensus 822 ~~----------~~kl~DfGl~~~ 835 (973)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999997654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.8e-14 Score=161.98 Aligned_cols=264 Identities=10% Similarity=0.090 Sum_probs=154.0
Q ss_pred CCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeec
Q 039922 266 ASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLF 345 (973)
Q Consensus 266 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 345 (973)
..++.+.+.+ .++.+...+|.+. +|+.+++..| ++......|...+|+.+.+.+ .++...+.+|.++++|+.++++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~ 188 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKADLS 188 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEECT
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeeecC
Confidence 4555666554 3444556667764 6888888766 655555566555677777765 5554555667777777777777
Q ss_pred cccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCcccccc
Q 039922 346 NNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGEL 425 (973)
Q Consensus 346 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 425 (973)
+|+++......|. .++|+.+.|..+ ++.. ...+|.++++|+.+.+..| ++...
T Consensus 189 ~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I------------------------~~~aF~~~~~L~~l~l~~~-l~~I~ 241 (401)
T 4fdw_A 189 KTKITKLPASTFV-YAGIEEVLLPVT-LKEI------------------------GSQAFLKTSQLKTIEIPEN-VSTIG 241 (401)
T ss_dssp TSCCSEECTTTTT-TCCCSEEECCTT-CCEE------------------------CTTTTTTCTTCCCEECCTT-CCEEC
T ss_pred CCcceEechhhEe-ecccCEEEeCCc-hhee------------------------hhhHhhCCCCCCEEecCCC-ccCcc
Confidence 7776643333444 466666666533 4333 3344555555555555543 44444
Q ss_pred CcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCC-----CCCchhhhcCCcCcEEeCcCCcccCCCccc
Q 039922 426 PSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT-----GEVPSQICTLRQLQAVDLSQNRFSGHLPTC 500 (973)
Q Consensus 426 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 500 (973)
...|.+ .+|+.+.+ .+.++......|.++++|+.+.+.+|.+. ...+..|.++++|+.++|.+ .++.....+
T Consensus 242 ~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~a 318 (401)
T 4fdw_A 242 QEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGL 318 (401)
T ss_dssp TTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTT
T ss_pred cccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhh
Confidence 455555 45555555 23344444555555666666666555443 23445566666777777763 355455566
Q ss_pred cccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccc-cccEEecCCCcC
Q 039922 501 ITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLA-VLTSLDLSSNLL 565 (973)
Q Consensus 501 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l 565 (973)
|.++++|+.++|..| ++...+.+|.++ +|+.+++++|.+....+..|.+++ .++.|++..|.+
T Consensus 319 F~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 319 LGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred hcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 666677777777444 554555666666 677777777766655555566553 556666655544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.57 E-value=8.7e-14 Score=157.20 Aligned_cols=333 Identities=11% Similarity=0.037 Sum_probs=169.2
Q ss_pred cCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCccccccc
Q 039922 111 TLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLG 190 (973)
Q Consensus 111 ~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 190 (973)
.|...+|.+|.+|+.+.+..+ +..+-..+|.++++|+.++|.++ ++.....+|.++++|+.+.+..+ +..+...+|.
T Consensus 61 sIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~ 137 (394)
T 4fs7_A 61 SIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFK 137 (394)
T ss_dssp EECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred EhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeee
Confidence 455566777777777777543 44444556666667777766543 44344455666666666665543 3333344454
Q ss_pred ccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCE
Q 039922 191 NLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQ 270 (973)
Q Consensus 191 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 270 (973)
+...+........ ...-..+|.++++|+.+.+.++. .......|.++.+|+.
T Consensus 138 ~~~~~~~~~~~~~---------------------------~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~ 189 (394)
T 4fs7_A 138 GCDFKEITIPEGV---------------------------TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKS 189 (394)
T ss_dssp TCCCSEEECCTTC---------------------------CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCB
T ss_pred cccccccccCccc---------------------------cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceE
Confidence 4432222211111 11112356667777777776543 3355566777777777
Q ss_pred EEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeecccccc
Q 039922 271 IELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFS 350 (973)
Q Consensus 271 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 350 (973)
+.+..| ++.+...+|.++..|+.+.+..+... .....+...+|+.+.+..+ ++......|..+++|+.+.+..+...
T Consensus 190 i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~ 266 (394)
T 4fs7_A 190 IKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR 266 (394)
T ss_dssp CCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE
T ss_pred EEcCCC-ceEeCchhhccccccceeecCCCceE-eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce
Confidence 777665 44355566777777777766554332 1111222234444444322 11122233444444444444433322
Q ss_pred CCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccC
Q 039922 351 GKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFW 430 (973)
Q Consensus 351 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 430 (973)
.....|..+..++.+....+.+ ....|..+.+|+.+.+..+ ++...
T Consensus 267 -i~~~~F~~~~~l~~~~~~~~~i---------------------------~~~~F~~~~~L~~i~l~~~-i~~I~----- 312 (394)
T 4fs7_A 267 -IGGSLFYNCSGLKKVIYGSVIV---------------------------PEKTFYGCSSLTEVKLLDS-VKFIG----- 312 (394)
T ss_dssp -ECSCTTTTCTTCCEEEECSSEE---------------------------CTTTTTTCTTCCEEEECTT-CCEEC-----
T ss_pred -eeccccccccccceeccCceee---------------------------ccccccccccccccccccc-cceec-----
Confidence 2223333333333333322211 1123344444444444332 33233
Q ss_pred CCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCcccccccccccee
Q 039922 431 GLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQL 510 (973)
Q Consensus 431 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 510 (973)
..+|.++.+|+.+.+..+ ++......|.++.+|+.+++..| ++.....+|.++++|+.+
T Consensus 313 -------------------~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 371 (394)
T 4fs7_A 313 -------------------EEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKV 371 (394)
T ss_dssp -------------------TTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEE
T ss_pred -------------------hhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEE
Confidence 344555555555555422 44344456666777777777665 554455677777777777
Q ss_pred eccccccccccCcccCccccceee
Q 039922 511 ELQENMFTGELPRNLNSLTALIVL 534 (973)
Q Consensus 511 ~Ls~N~l~~~~p~~~~~l~~L~~L 534 (973)
++..+ ++ .+..+|.++++|+.+
T Consensus 372 ~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 372 ELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp EEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred EECCC-CE-EhhheecCCCCCcEE
Confidence 77654 33 345567777777654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5.9e-14 Score=157.75 Aligned_cols=249 Identities=14% Similarity=0.133 Sum_probs=161.0
Q ss_pred CccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhccc
Q 039922 235 PDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS 314 (973)
Q Consensus 235 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 314 (973)
..+|.+. +|+.+.+..+ ++.+...+|.+. +|+.+.+.+ .++.+.+.+|.++++|+.++++.|+++......|...+
T Consensus 129 ~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~ 204 (401)
T 4fdw_A 129 KDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAG 204 (401)
T ss_dssp TTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCC
T ss_pred HhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecc
Confidence 3456654 6888888776 766667778774 688888886 66666777888888999999988888866666666667
Q ss_pred CcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhccc
Q 039922 315 LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFN 394 (973)
Q Consensus 315 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 394 (973)
|+.+.|.++ ++.....+|.++++|+.+++.+| ++.....+|.+ .+|+.+.+. +.++.....
T Consensus 205 L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~--------------- 265 (401)
T 4fdw_A 205 IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASR--------------- 265 (401)
T ss_dssp CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTT---------------
T ss_pred cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChh---------------
Confidence 888888744 66566667777888888888764 44344455655 667777773 344434344
Q ss_pred CccCCCCCCccCCcceeeEEEccCCccc-----cccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcC
Q 039922 395 NRFSGKIPESYGECKTLNYLRFGGNELQ-----GELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNF 469 (973)
Q Consensus 395 n~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l 469 (973)
+|.+|++|+.+.+.+|.+. ...+..|.++++|+.+++.+ .++......|.++++|+.+.+..| +
T Consensus 266 ---------aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l 334 (401)
T 4fdw_A 266 ---------AFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-V 334 (401)
T ss_dssp ---------TTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-C
T ss_pred ---------HhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-c
Confidence 4445555555555444443 34455566666666666653 355455556666666666666433 5
Q ss_pred CCCCchhhhcCCcCcEEeCcCCcccCCCcccccccc-ccceeeccccccc
Q 039922 470 TGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLN-KLQQLELQENMFT 518 (973)
Q Consensus 470 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~ 518 (973)
+...+..|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus 335 ~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 335 TQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 54455566666 677777777766655555666663 5667777666654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=6.8e-15 Score=145.93 Aligned_cols=105 Identities=23% Similarity=0.225 Sum_probs=49.7
Q ss_pred CcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCc--ccCccccceeee
Q 039922 458 KLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPR--NLNSLTALIVLN 535 (973)
Q Consensus 458 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~ 535 (973)
+|+.|++++|.+++. ..+..+++|++|+|++|+|++..|..+..+++|+.|+|++|+|+ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 344444444444322 23444445555555555554332233345555555555555553 3333 445555555555
Q ss_pred eccCcccCCCCcc----ccccccccEEecCCCcCc
Q 039922 536 LSTNQLTGTIPPE----LGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 536 Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 566 (973)
+++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 5555554 33442 555555555555555544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-14 Score=144.33 Aligned_cols=133 Identities=21% Similarity=0.223 Sum_probs=113.4
Q ss_pred CCCCCCCCcceEeecCCcCCCCCchhhhcC-CcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccc
Q 039922 451 PSISNAPKLTGILINGNNFTGEVPSQICTL-RQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529 (973)
Q Consensus 451 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 529 (973)
..+.++++|+.|++++|+++. +|. +..+ ++|++|++++|+|++. ..++.+++|+.|+|++|+|++..|..+..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 445667788888888888884 454 4444 4999999999999964 6899999999999999999976556679999
Q ss_pred cceeeeeccCcccCCCCc--cccccccccEEecCCCcCccccChh----hhcc-cccceeccCCcCc
Q 039922 530 ALIVLNLSTNQLTGTIPP--ELGNLAVLTSLDLSSNLLTGEIPLE----LTKL-KLNQFNISHNKLY 589 (973)
Q Consensus 530 ~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l-~l~~l~l~~N~l~ 589 (973)
+|+.|+|++|+|+ .+|. .+..+++|+.|+|++|+++ .+|.. +..+ .|+.|++++|...
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999999999997 5776 8999999999999999998 67775 7777 8999999999875
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-16 Score=161.15 Aligned_cols=115 Identities=21% Similarity=0.280 Sum_probs=70.0
Q ss_pred CCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccc
Q 039922 452 SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL 531 (973)
Q Consensus 452 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 531 (973)
.+..+++|++|++++|.+++ +| .+..+++|++|++++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 45555555566666655554 44 5666666666666666666 456666666666666666666664 33 46666666
Q ss_pred eeeeeccCcccCCCC-ccccccccccEEecCCCcCccccCh
Q 039922 532 IVLNLSTNQLTGTIP-PELGNLAVLTSLDLSSNLLTGEIPL 571 (973)
Q Consensus 532 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~ 571 (973)
+.|+|++|++++..+ ..+..+++|++|++++|++++.+|.
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 666666666663211 3566666666666666666665554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-16 Score=161.11 Aligned_cols=161 Identities=21% Similarity=0.217 Sum_probs=114.3
Q ss_pred cccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcce
Q 039922 382 CFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTG 461 (973)
Q Consensus 382 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~ 461 (973)
.....++.+++..+.+.+..|. ++ .+|..|..+++|+.|++++|++++ +| .+..+++|+.
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~ 74 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRI 74 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCE
T ss_pred HhcccccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCE
Confidence 3445666666666666655544 00 111245555555555555555554 33 6666677777
Q ss_pred EeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccC-cccCccccceeeeeccCc
Q 039922 462 ILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELP-RNLNSLTALIVLNLSTNQ 540 (973)
Q Consensus 462 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~ 540 (973)
|++++|.++ .+|..+..+++|++|++++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.
T Consensus 75 L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp EEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred EECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 777777776 567777778899999999999985 55 68889999999999999985433 578889999999999999
Q ss_pred ccCCCCcc----------ccccccccEEecCCCcCcc
Q 039922 541 LTGTIPPE----------LGNLAVLTSLDLSSNLLTG 567 (973)
Q Consensus 541 l~~~~p~~----------~~~l~~L~~L~Ls~N~l~~ 567 (973)
+++.+|.. +..+++|+.|| +|.++.
T Consensus 152 l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 152 LYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred cccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 98776653 78899999887 777763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.5e-13 Score=149.05 Aligned_cols=315 Identities=11% Similarity=0.057 Sum_probs=203.5
Q ss_pred cCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhc
Q 039922 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAA 312 (973)
Q Consensus 233 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 312 (973)
.-..+|.++.+|+.+.|..+ ++.+...+|.++++|+.+++.++ ++.+...+|.++.+|+.+.+..+ +.......|..
T Consensus 62 Ig~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~ 138 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG 138 (394)
T ss_dssp ECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred hHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence 33456777788888888643 66566677888888888888755 55455667778888887776644 33333444444
Q ss_pred ccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhc
Q 039922 313 MSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIII 392 (973)
Q Consensus 313 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 392 (973)
..+.......+ +......+|.++++|+.+.+.++..+ .....|.++.+|+.+++..| ++......|.....|+.+.+
T Consensus 139 ~~~~~~~~~~~-~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~ 215 (394)
T 4fs7_A 139 CDFKEITIPEG-VTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEF 215 (394)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCC
T ss_pred ccccccccCcc-ccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeec
Confidence 44444333322 22233456778888888888765433 45557778888888888766 55455666777777777777
Q ss_pred ccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCC
Q 039922 393 FNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE 472 (973)
Q Consensus 393 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~ 472 (973)
.++... +........+|+.+.+..+ ++......|.+...++.+.+..+... .....|..+..++.+....+.+.
T Consensus 216 ~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~-- 289 (394)
T 4fs7_A 216 PNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP-- 289 (394)
T ss_dssp CTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC--
T ss_pred CCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec--
Confidence 655432 3334445567777777543 34455667777778888777666433 44566777777777776655432
Q ss_pred CchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcccccc
Q 039922 473 VPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNL 552 (973)
Q Consensus 473 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 552 (973)
...|..+.+|+.+.+..+ ++.+...+|.++++|+.++|.++ ++.....+|.++++|+.+++..| ++..-..+|.++
T Consensus 290 -~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C 365 (394)
T 4fs7_A 290 -EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGC 365 (394)
T ss_dssp -TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTC
T ss_pred -cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCC
Confidence 235666777777777655 54455567777777887777644 65455667777778888777766 554445677777
Q ss_pred ccccEEecCCC
Q 039922 553 AVLTSLDLSSN 563 (973)
Q Consensus 553 ~~L~~L~Ls~N 563 (973)
++|+.+++..|
T Consensus 366 ~~L~~i~lp~~ 376 (394)
T 4fs7_A 366 INLKKVELPKR 376 (394)
T ss_dssp TTCCEEEEEGG
T ss_pred CCCCEEEECCC
Confidence 77777777544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=7.9e-14 Score=137.13 Aligned_cols=109 Identities=27% Similarity=0.293 Sum_probs=89.4
Q ss_pred cceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeecc
Q 039922 459 LTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLST 538 (973)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 538 (973)
.+.+++++|.++ .+|..+ .++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456777777777 466555 37888899999999887788888899999999999999877777788899999999999
Q ss_pred CcccCCCCccccccccccEEecCCCcCccccC
Q 039922 539 NQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 539 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (973)
|+|++..+..|..+++|++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99987666678899999999999999986543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-13 Score=135.57 Aligned_cols=109 Identities=28% Similarity=0.267 Sum_probs=98.4
Q ss_pred cCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecC
Q 039922 482 QLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLS 561 (973)
Q Consensus 482 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 561 (973)
..+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 4679999999999 6787774 899999999999998889999999999999999999998777788999999999999
Q ss_pred CCcCccccChhhhcc-cccceeccCCcCcccCC
Q 039922 562 SNLLTGEIPLELTKL-KLNQFNISHNKLYGEVP 593 (973)
Q Consensus 562 ~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~p 593 (973)
+|+|++..|..+..+ +|+.|++++|++++..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999997666678888 99999999999987665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.8e-13 Score=135.01 Aligned_cols=106 Identities=27% Similarity=0.276 Sum_probs=86.2
Q ss_pred ceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccC
Q 039922 460 TGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTN 539 (973)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (973)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56777777775 5666553 78888889999888877888888889999999999998766667788999999999999
Q ss_pred cccCCCCccccccccccEEecCCCcCccc
Q 039922 540 QLTGTIPPELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 540 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
+|++..+..|..+++|++|+|++|+++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 99865555688899999999999998853
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.5e-13 Score=132.94 Aligned_cols=107 Identities=26% Similarity=0.284 Sum_probs=95.3
Q ss_pred CcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCC
Q 039922 483 LQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSS 562 (973)
Q Consensus 483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (973)
-+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 478999999997 7888775 8999999999999988899999999999999999999976666789999999999999
Q ss_pred CcCccccChhhhcc-cccceeccCCcCcccC
Q 039922 563 NLLTGEIPLELTKL-KLNQFNISHNKLYGEV 592 (973)
Q Consensus 563 N~l~~~~p~~l~~l-~l~~l~l~~N~l~g~~ 592 (973)
|+|++..|..+..+ +|+.|++++|++.+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 99996555558888 8999999999988644
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.6e-10 Score=130.38 Aligned_cols=87 Identities=11% Similarity=0.148 Sum_probs=41.8
Q ss_pred CCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccc
Q 039922 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529 (973)
Q Consensus 450 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 529 (973)
...|.++.+|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++.+-..+|.++++|+.+++.+|.... ..+....
T Consensus 304 ~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~ 378 (394)
T 4gt6_A 304 ESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDS 378 (394)
T ss_dssp TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCC
T ss_pred ceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccC
Confidence 344444555555555432 33333445666666666666543 443445566666667776666665431 3455566
Q ss_pred cceeeeeccCcc
Q 039922 530 ALIVLNLSTNQL 541 (973)
Q Consensus 530 ~L~~L~Ls~N~l 541 (973)
+|+.+.+..|.+
T Consensus 379 ~L~~i~i~~~~~ 390 (394)
T 4gt6_A 379 GLQNLPVAPGSI 390 (394)
T ss_dssp CC----------
T ss_pred CCCEEEeCCCCE
Confidence 677666666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=4.1e-14 Score=157.48 Aligned_cols=166 Identities=17% Similarity=0.135 Sum_probs=97.0
Q ss_pred eeeEEEccCCccccccCcccCCC-----CCccEEEeecCcccCCCCCCC-CCCCCcceEeecCCcCCCCCchhhh-----
Q 039922 410 TLNYLRFGGNELQGELPSKFWGL-----PEVDFFEMYNNRFEGSISPSI-SNAPKLTGILINGNNFTGEVPSQIC----- 478 (973)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~-~~~~~L~~L~L~~N~l~~~~p~~~~----- 478 (973)
.|++|+|++|.++......+... ++|+.|+|++|.++......+ ..+++|+.|+|++|.++......++
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 45555555555554333222211 355555555555542211111 1234566777777776644434432
Q ss_pred cCCcCcEEeCcCCcccC----CCccccccccccceeeccccccccc----cCcccCccccceeeeeccCcccCC----CC
Q 039922 479 TLRQLQAVDLSQNRFSG----HLPTCITQLNKLQQLELQENMFTGE----LPRNLNSLTALIVLNLSTNQLTGT----IP 546 (973)
Q Consensus 479 ~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 546 (973)
..++|++|+|++|.|+. .++..+..+++|++|+|++|+|++. ++..+...++|+.|+|++|.|++. ++
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~ 232 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence 34678888888887763 2344445677788888888887753 355566677788888888888642 33
Q ss_pred ccccccccccEEecCCCcCccccChhhhc
Q 039922 547 PELGNLAVLTSLDLSSNLLTGEIPLELTK 575 (973)
Q Consensus 547 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 575 (973)
..+...++|++|||++|+|+..-...+..
T Consensus 233 ~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 233 RAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 44455677888888888887654444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=4.8e-12 Score=140.39 Aligned_cols=131 Identities=18% Similarity=0.136 Sum_probs=96.8
Q ss_pred eEeecCC-cCCCCCchhhhcCCcCcEEeCcC-CcccCCCccccccccccceeeccccccccccCcccCccccceeeeecc
Q 039922 461 GILINGN-NFTGEVPSQICTLRQLQAVDLSQ-NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLST 538 (973)
Q Consensus 461 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 538 (973)
.++++++ +++ .+|. +..+++|++|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577776 777 4777 88888899999986 889877778888999999999999999988888889999999999999
Q ss_pred CcccCCCCccccccccccEEecCCCcCccccC-hhhhcc-cccceeccCCcCcccCCC
Q 039922 539 NQLTGTIPPELGNLAVLTSLDLSSNLLTGEIP-LELTKL-KLNQFNISHNKLYGEVPS 594 (973)
Q Consensus 539 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l-~l~~l~l~~N~l~g~~p~ 594 (973)
|+|++..|..|..++ |+.|+|++|++...-. ..+... ......+..+.+++..|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 999865556666666 9999999999885432 122222 223333444555555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=6e-12 Score=139.59 Aligned_cols=108 Identities=19% Similarity=0.201 Sum_probs=96.8
Q ss_pred cEEeCcCC-cccCCCccccccccccceeeccc-cccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecC
Q 039922 484 QAVDLSQN-RFSGHLPTCITQLNKLQQLELQE-NMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLS 561 (973)
Q Consensus 484 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 561 (973)
..++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|.+|++|+.|||+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35799998 998 5888 99999999999996 99998888999999999999999999999889999999999999999
Q ss_pred CCcCccccChhhhcccccceeccCCcCcccCC
Q 039922 562 SNLLTGEIPLELTKLKLNQFNISHNKLYGEVP 593 (973)
Q Consensus 562 ~N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p 593 (973)
+|+|++..|..+..+.|+.|++++|++.+..+
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 99999655555655689999999999987543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-13 Score=153.44 Aligned_cols=109 Identities=23% Similarity=0.248 Sum_probs=50.4
Q ss_pred CCCCEEEccCCccccc----CCcCCCCCCCCCEEEccCCcCccc----CchhccCCCccceeeccccccCCCChhhhh--
Q 039922 242 AFLSNLDLSDNFLSGK----IPHSFSGLASIEQIELFDNQLSGE----LPESLSNLTTLLRLDISQNNLTGNLPETIA-- 311 (973)
Q Consensus 242 ~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-- 311 (973)
++|++|+|++|.|+.. ++..+...++|++|+|++|++++. ++..+...++|+.|+|++|.++......+.
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 4455555555555431 222334455555666666655532 234445555666666666666532222221
Q ss_pred ---cccCcEEEccCCcCCCCCCccccCCC-----ccceee--ecccccc
Q 039922 312 ---AMSLESLNLNDNYFTGEIPESLASNP-----NLVQLK--LFNNSFS 350 (973)
Q Consensus 312 ---~~~L~~L~L~~N~l~~~~p~~~~~l~-----~L~~L~--L~~N~l~ 350 (973)
..+|++|+|++|.|++.....+..+. .|+.+. +..|.++
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 13566666666666543333332221 155555 5555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.6e-10 Score=128.64 Aligned_cols=136 Identities=14% Similarity=0.135 Sum_probs=88.9
Q ss_pred ccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCcccccc
Q 039922 424 ELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQ 503 (973)
Q Consensus 424 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 503 (973)
.....|.+...|+.+.+.++.. ......|.++++|+.+.+. +.++......|.++.+|+.+++..+ ++.+...+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 3344455555555555543322 2335566777777777775 4455455668889999999999875 66456778999
Q ss_pred ccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCc
Q 039922 504 LNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
+++|+.+.|..+ ++.....+|.++++|+.+++++|.... ..|.....|+.+.+..|.+.
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 999999999755 665667889999999999999987652 45677788999888877653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.8e-10 Score=122.01 Aligned_cols=143 Identities=15% Similarity=0.073 Sum_probs=109.9
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 759 (973)
.+.|+.....+.|+.+.||++... ++.+++|+...... .....+.+|++.++.+. +..+.++++++...+..|+||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 456777778888888999999765 78999999853211 11234788999998885 667788999998888999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC------------------------------------ 803 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 803 (973)
||++|.++.+.+.. ......++.+++++++.||+..
T Consensus 90 e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999998876321 1123468889999999999810
Q ss_pred --------------------CCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 804 --------------------VPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 804 --------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.+.++|||++|.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1368999999999999876666799998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.1e-08 Score=114.51 Aligned_cols=302 Identities=12% Similarity=0.055 Sum_probs=143.3
Q ss_pred ccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcE
Q 039922 238 IGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLES 317 (973)
Q Consensus 238 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~ 317 (973)
+....+|+.+.+.. .++.+...+|.++.+|+.+.+.++ ++.+-..+|.++ +|+.+.+..+ ++......|...+|+.
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~~L~~ 117 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGTDLDD 117 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTCCCSE
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccCCccc
Confidence 33344555555543 344444556666666666666543 443444455554 4555555432 3323333444445666
Q ss_pred EEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCcc
Q 039922 318 LNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRF 397 (973)
Q Consensus 318 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 397 (973)
+.+.++- +......|.+ .+|+.+.+..+ ++......+..+.+++.+.+..+............ +..
T Consensus 118 i~lp~~~-~~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~-----------~~~ 183 (379)
T 4h09_A 118 FEFPGAT-TEIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLY-----------NKN 183 (379)
T ss_dssp EECCTTC-CEECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEE-----------ETT
T ss_pred ccCCCcc-cccccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccceec-----------ccc
Confidence 6665442 2122233333 24555544433 23234445566666666665544332111000000 000
Q ss_pred CCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhh
Q 039922 398 SGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQI 477 (973)
Q Consensus 398 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~ 477 (973)
......+.....+..+.+..+. .......|....+|+.+.+..+ +.......+.++..|+.+.+..+ ++......|
T Consensus 184 -~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF 259 (379)
T 4h09_A 184 -KTILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLL 259 (379)
T ss_dssp -SSEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTT
T ss_pred -cceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcccc
Confidence 0111222233333333333222 1233344444455555554333 22233444555555555555443 333444455
Q ss_pred hcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccE
Q 039922 478 CTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTS 557 (973)
Q Consensus 478 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 557 (973)
.++.+|+.+.+..+ ++.....+|.++++|+.+.+.++.++.....+|.++.+|+.++|..+ ++..-..+|.++++|+.
T Consensus 260 ~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~ 337 (379)
T 4h09_A 260 QNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALST 337 (379)
T ss_dssp TTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCC
T ss_pred ceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCE
Confidence 55666666666543 33234455666666666666666666455566666666666666543 44333456666666666
Q ss_pred EecCCC
Q 039922 558 LDLSSN 563 (973)
Q Consensus 558 L~Ls~N 563 (973)
+.+..+
T Consensus 338 i~ip~~ 343 (379)
T 4h09_A 338 ISYPKS 343 (379)
T ss_dssp CCCCTT
T ss_pred EEECCc
Confidence 666543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.00 E-value=1.4e-11 Score=128.46 Aligned_cols=175 Identities=18% Similarity=0.158 Sum_probs=117.0
Q ss_pred hhHHHHHHHhhhccCCCCCc--------cCCccCC---CCCCCCccceeEEcCCCCceeEeecCC---CccCCCCCC-Cc
Q 039922 28 GDAEILIRVKSDQLDDPNRK--------LGDWVRT---SQQSPCNWTGITCETQNQSVDGIDLSG---FDLSGGFPN-GF 92 (973)
Q Consensus 28 ~~~~~l~~~k~~~~~d~~~~--------~~sw~~~---~~~~~C~w~gv~c~~~~~~v~~l~l~~---~~l~g~~~~-~~ 92 (973)
.|++-|+++-......|-.. .+.|.-. .....|+|.|+.|+..+.+|..+...+ ..+.|.+++ .+
T Consensus 35 y~k~~ll~~i~~~~~~~f~p~~~~~~~~~~~ffV~~~~~A~~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~ 114 (267)
T 3rw6_A 35 YDKAWLLSMIQSKCSVPFTPIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQV 114 (267)
T ss_dssp SCHHHHHHHHHHTCSSCCCCEEEEEETTEEEEEESCHHHHHHHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHH
T ss_pred cCHHHHHHHHHHhCCCCcEeEEEEEeCCEEEEEeCChHHHHHHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHH
Confidence 46777777666555444221 1222100 112258999999998777786665555 345555543 34
Q ss_pred cCccccceeccCCCcccCcCCcCcCCCcCCccE--Eeccccc---ccccCCccccCCCCCCEEECcCCcCCC--CCCccc
Q 039922 93 CRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQV--LALDYNV---FIGELPDFSREFANLQVLDLSRNNFSG--DIPESF 165 (973)
Q Consensus 93 ~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~--L~L~~n~---~~~~~~~~~~~l~~L~~L~Ls~n~l~~--~~p~~~ 165 (973)
..++. .|....|.-++.+....|...+.|+. ++++.|+ +.+.++.....+++|+.|+|++|+|++ .+|..+
T Consensus 115 ~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~ 192 (267)
T 3rw6_A 115 EQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIV 192 (267)
T ss_dssp HHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHH
T ss_pred HHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHH
Confidence 44443 45556666666666566777777877 7788884 333334444678999999999999997 456777
Q ss_pred CCCCcccEEecCCcccCCcccccccccc--cccEeeccCcCCC
Q 039922 166 GRFPVLKVLNLGGNLLSGLIPSFLGNLT--ELTHFELGYNPLK 206 (973)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~Ls~n~l~ 206 (973)
+.+++|++|+|++|+|++. ..+..+. +|++|+|++|.+.
T Consensus 193 ~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 193 QKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp HHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred hhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence 8899999999999999976 3455555 8999999999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=4e-10 Score=119.28 Aligned_cols=136 Identities=15% Similarity=0.127 Sum_probs=98.8
Q ss_pred CCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCC--eeeEEeEEecCCeeEEEEe
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN--VVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e 760 (973)
.+....+.+.|..+.||++...+|+.+++|..... ....+.+|+..++.+.+.+ +.+++++...++..++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 34443333455669999998777889999987432 1234678888888886544 4568888887788899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC------------------------------------- 803 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 803 (973)
|++|.++. ... .+ ...++.++++.++.||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99988884 211 11 2256777888888888742
Q ss_pred ------------------CCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 804 ------------------VPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 804 ------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.+.++|||++|.||+++++..+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.90 E-value=3.6e-08 Score=110.38 Aligned_cols=295 Identities=10% Similarity=0.027 Sum_probs=178.5
Q ss_pred CccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhccc
Q 039922 235 PDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS 314 (973)
Q Consensus 235 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 314 (973)
..+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++.+...+|.. .+|+.+++..+ ++......+...+
T Consensus 62 ~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~-~~~i~~~~F~~~~ 136 (379)
T 4h09_A 62 EANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGA-TTEIGNYIFYNSS 136 (379)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCc-cccccccccccce
Confidence 457888889999998754 665667788876 6888877654 44344455655 47888888765 3323344555556
Q ss_pred CcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhccc
Q 039922 315 LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFN 394 (973)
Q Consensus 315 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 394 (973)
++.+.+..+ ++......|....+++.+.+..+........ .......... ...+.....+..+.+..
T Consensus 137 l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~ 203 (379)
T 4h09_A 137 VKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAEN-YVLYNKNKTI-----------LESYPAAKTGTEFTIPS 203 (379)
T ss_dssp CCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEET-TEEEETTSSE-----------EEECCTTCCCSEEECCT
T ss_pred eeeeeccce-eeccccchhcccccccccccccccceeeccc-ceecccccce-----------ecccccccccccccccc
Confidence 777776654 4435556777888888887776554311111 1000000000 01111111222222211
Q ss_pred CccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCc
Q 039922 395 NRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVP 474 (973)
Q Consensus 395 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 474 (973)
. ........+..+.+|+.+.+..+ +.......|.+...|+.+.+..+ ++......|.++.+|+.+.+..+ +.....
T Consensus 204 ~-~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~ 279 (379)
T 4h09_A 204 T-VKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPY 279 (379)
T ss_dssp T-CCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECT
T ss_pred c-eeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccc
Confidence 1 11133445566667777777544 44455666777777777777655 55455667777777887777543 443445
Q ss_pred hhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccc
Q 039922 475 SQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLA 553 (973)
Q Consensus 475 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 553 (973)
..|..+.+|+.+.+.++.++.....+|.++.+|+.+.|..+ ++.....+|.++++|+.+.+..+ ++..-..+|.+.+
T Consensus 280 ~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 280 LLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred cccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 56777888888888887777555677888888888888654 66455677888888888888654 5533455666553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.89 E-value=5.7e-10 Score=122.88 Aligned_cols=180 Identities=16% Similarity=0.213 Sum_probs=115.8
Q ss_pred cCCcceeeEEEccCCccc---------cccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCch
Q 039922 405 YGECKTLNYLRFGGNELQ---------GELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPS 475 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~ 475 (973)
...+++|+.|.+..+... +.+...+..+|+|+.|++++|.-. ..+. + .+++|+.|.+..+.+......
T Consensus 135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~ 211 (362)
T 2ra8_A 135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVE 211 (362)
T ss_dssp HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHH
T ss_pred hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHH
Confidence 334556666666544221 123344566788888888877311 1222 3 378899999998887755444
Q ss_pred hhh--cCCcCcEEeCcC--CcccCC-----Ccccc--ccccccceeeccccccccccCcccC---ccccceeeeeccCcc
Q 039922 476 QIC--TLRQLQAVDLSQ--NRFSGH-----LPTCI--TQLNKLQQLELQENMFTGELPRNLN---SLTALIVLNLSTNQL 541 (973)
Q Consensus 476 ~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l 541 (973)
.++ .+++|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+++..+..+. .+++|+.|+|+.|.|
T Consensus 212 ~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 212 DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp HHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred HHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 555 688999999864 222111 11223 2478999999999998865544443 578999999999999
Q ss_pred cCC----CCccccccccccEEecCCCcCccccChhhhcccccceeccCCc
Q 039922 542 TGT----IPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNK 587 (973)
Q Consensus 542 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~ 587 (973)
++. ++..+..+++|+.|+|++|.++...-..+...-...+++++|.
T Consensus 292 ~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 292 TDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp BHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred ChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence 853 4445567899999999999988544333433112457787775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.85 E-value=6.9e-09 Score=115.30 Aligned_cols=143 Identities=17% Similarity=0.216 Sum_probs=105.3
Q ss_pred ccccccccCCeeEEEEEECCCCEEEEEEec--CCCCCchhHHHHHHHHHHHhcCCC--CCeeeEEeEEecC---CeeEEE
Q 039922 686 EQNLIGSGGSCRVYKVKLKSGETVAVKRLL--GGTHKPETETVFRSEIETLGRVRH--GNVVKLLMCCSGQ---DFNILV 758 (973)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv 758 (973)
..+.++.|.++.||++... +..+++|+.. ... .......+.+|+.+++.+.. ..+.+++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3567899999999999876 4688888764 221 11223467889999998873 4578888888766 458999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC----------------------------------- 803 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 803 (973)
|||+++..+.+.. ...++...+..++.+++++|+.||+..
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999987775421 113677888899999999999999731
Q ss_pred --------------------CCCeEEeCCCCCCEEeCCCCc--eEEeccCcchh
Q 039922 804 --------------------VPAIVHRDVKSHNILLDAEMV--PRVADFGLAKA 835 (973)
Q Consensus 804 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGl~~~ 835 (973)
.+.++|||+++.||++++++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.82 E-value=1e-09 Score=120.82 Aligned_cols=136 Identities=15% Similarity=0.242 Sum_probs=69.0
Q ss_pred cceeeEEEccCCccccccCcccC--CCCCccEEEeec--CcccCCCCCCCCCCCCcceEeecCCcCCCCCchhh--hcCC
Q 039922 408 CKTLNYLRFGGNELQGELPSKFW--GLPEVDFFEMYN--NRFEGSISPSISNAPKLTGILINGNNFTGEVPSQI--CTLR 481 (973)
Q Consensus 408 l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~--N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~--~~l~ 481 (973)
+++|++|+|..+.+.......+. .+|+|+.|+|+. |...+.. .+ . .+...+ ..++
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~----------------~-~l~~~l~~~~~p 252 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--DM----------------N-VFRPLFSKDRFP 252 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--CG----------------G-GTGGGSCTTTCT
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--hH----------------H-HHHHHHhcCCCC
Confidence 56777777777776544433333 567777777653 1111100 00 0 000001 1245
Q ss_pred cCcEEeCcCCcccCCCccccc---cccccceeeccccccccc----cCcccCccccceeeeeccCcccCCCCccccc-cc
Q 039922 482 QLQAVDLSQNRFSGHLPTCIT---QLNKLQQLELQENMFTGE----LPRNLNSLTALIVLNLSTNQLTGTIPPELGN-LA 553 (973)
Q Consensus 482 ~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~ 553 (973)
+|++|+|++|.+.+..+..+. .+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-..+.. +
T Consensus 253 ~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al- 331 (362)
T 2ra8_A 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL- 331 (362)
T ss_dssp TCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC-
T ss_pred CcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc-
Confidence 666666666655432222222 356677777777766653 3333445677777777777765322222221 1
Q ss_pred cccEEecCCCc
Q 039922 554 VLTSLDLSSNL 564 (973)
Q Consensus 554 ~L~~L~Ls~N~ 564 (973)
...+++++|+
T Consensus 332 -g~~~~~~~~~ 341 (362)
T 2ra8_A 332 -PMKIDVSDSQ 341 (362)
T ss_dssp -CSEEECCSBC
T ss_pred -CCEEEecCCc
Confidence 2557777776
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=2e-08 Score=108.67 Aligned_cols=189 Identities=19% Similarity=0.252 Sum_probs=120.3
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCC--eeeEEeEEecCC---eeEEEEe
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGN--VVKLLMCCSGQD---FNILVYE 760 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e 760 (973)
.+.++.|.+..||++. +.+++|+.. .......+.+|.+.++.+. +.. +.+++......+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~----~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPK----HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEES----SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecC----CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999863 568898762 2244567889999998873 332 334444433333 3588999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND-------------------------------------- 802 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------- 802 (973)
+++|.++.+.... .++..++..++.+++..++.||+.
T Consensus 97 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred ccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9998887653321 356777788888888888888861
Q ss_pred -----------------CCCCeEEeCCCCCCEEeCC--CCceEEeccCcchhccccCCC----------ccccccccccc
Q 039922 803 -----------------CVPAIVHRDVKSHNILLDA--EMVPRVADFGLAKALQSQEGQ----------SDDAMSCVAGS 853 (973)
Q Consensus 803 -----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGl~~~~~~~~~~----------~~~~~~~~~gt 853 (973)
..+.++|||++|.||++++ +..+.++||+.+..-+..... ...........
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1146899999999999998 456789999987643211000 00000000000
Q ss_pred cCccc-cccccCCCCCCCCChhhHHHHHHHHHcCCCCC
Q 039922 854 YGYIA-PEYAYTKKVTEKSDVYSFGVVLMELVTGKRPN 890 (973)
Q Consensus 854 ~~y~a-PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~ 890 (973)
.++.. |+..... ....+.|++|.++|++.+|..+|
T Consensus 252 Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 11112 2221111 12358999999999999998665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.44 E-value=2.3e-08 Score=104.16 Aligned_cols=65 Identities=28% Similarity=0.361 Sum_probs=31.6
Q ss_pred ccccceeecccccccc--ccCcccCccccceeeeeccCcccCCCCccccccc--cccEEecCCCcCccccC
Q 039922 504 LNKLQQLELQENMFTG--ELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLA--VLTSLDLSSNLLTGEIP 570 (973)
Q Consensus 504 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p 570 (973)
+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|++++.+|
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 3444444444444443 2334444455555555555555532 2233333 56666666666665554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.39 E-value=3.6e-08 Score=97.84 Aligned_cols=113 Identities=21% Similarity=0.268 Sum_probs=61.3
Q ss_pred CCCCCcceEeecCC-cCCCC----CchhhhcCCcCcEEeCcCCcccCC----Cccccccccccceeeccccccccc----
Q 039922 454 SNAPKLTGILINGN-NFTGE----VPSQICTLRQLQAVDLSQNRFSGH----LPTCITQLNKLQQLELQENMFTGE---- 520 (973)
Q Consensus 454 ~~~~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~---- 520 (973)
...++|++|+|++| .+... +...+...++|++|+|++|+|... +...+...++|++|+|++|+|+..
T Consensus 33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~ 112 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 112 (185)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence 33445555555555 54422 223344456666666666666531 223344445666666666666643
Q ss_pred cCcccCccccceeeee--ccCcccCC----CCccccccccccEEecCCCcCc
Q 039922 521 LPRNLNSLTALIVLNL--STNQLTGT----IPPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 521 ~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
+...+...++|++|+| ++|.|+.. +...+...+.|++|+|++|.+.
T Consensus 113 l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 113 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3445555666667777 56666532 2233444466777777777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=1e-08 Score=101.83 Aligned_cols=118 Identities=16% Similarity=0.141 Sum_probs=87.0
Q ss_pred CCCccCccccceeccCCC-cccCc---CCcCcCCCcCCccEEeccccccccc----CCccccCCCCCCEEECcCCcCCCC
Q 039922 89 PNGFCRIRTLRNLNLSDN-YFNGT---LSSQSLSPCFHLQVLALDYNVFIGE----LPDFSREFANLQVLDLSRNNFSGD 160 (973)
Q Consensus 89 ~~~~~~l~~L~~L~Ls~n-~l~~~---~~~~~l~~l~~L~~L~L~~n~~~~~----~~~~~~~l~~L~~L~Ls~n~l~~~ 160 (973)
...+...+.|++|+|++| .+... .-...+...++|++|+|++|.|... +...+...++|++|+|++|.|...
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~ 108 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 108 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence 344567788999999998 77632 1123456678899999999988642 445566678899999999999853
Q ss_pred ----CCcccCCCCcccEEec--CCcccCCc----ccccccccccccEeeccCcCCC
Q 039922 161 ----IPESFGRFPVLKVLNL--GGNLLSGL----IPSFLGNLTELTHFELGYNPLK 206 (973)
Q Consensus 161 ----~p~~~~~l~~L~~L~L--~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~ 206 (973)
+...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 109 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3556777888999999 88998854 2345556688999999999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.5e-06 Score=88.35 Aligned_cols=134 Identities=17% Similarity=0.117 Sum_probs=96.5
Q ss_pred cccccCCe-eEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 689 LIGSGGSC-RVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 689 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
.+..|..| .||+.... +++.+++|+-. ......+.+|...++.+. +--+.+++.++...+..++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~-----~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGK-----GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEE-----THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECC-----CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34456665 68988765 46789999762 234556788999888875 323667888888889999999999988
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND------------------------------------------- 802 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------- 802 (973)
++.+..... ......+..+++..++.||+.
T Consensus 106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 877654321 122335666777777777753
Q ss_pred ------------CCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 803 ------------CVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 803 ------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
..+.++|||+.+.||++++++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01248999999999999987777799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.1e-05 Score=86.81 Aligned_cols=136 Identities=15% Similarity=0.122 Sum_probs=93.4
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCC---CeeeEEeEEe-cCCeeEEEEecc
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG---NVVKLLMCCS-GQDFNILVYEYM 762 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 762 (973)
.+.++.|....||++ |+.+++|+-. .......+.+|.+.++.+.+. .+.+++.+.. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456788888999998 6778888751 233456788999999999753 2456666664 455678999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND---------------------------------------- 802 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------- 802 (973)
+|..+.+.... .++...+..++.++++.++.||+.
T Consensus 96 ~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 96 QGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 98877653211 133444455555555555555542
Q ss_pred -----------------CCCCeEEeCCCCCCEEeCC---CCc-eEEeccCcchh
Q 039922 803 -----------------CVPAIVHRDVKSHNILLDA---EMV-PRVADFGLAKA 835 (973)
Q Consensus 803 -----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGl~~~ 835 (973)
..+.++|+|++|.||++++ ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 47999997653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=1.6e-05 Score=87.90 Aligned_cols=83 Identities=8% Similarity=0.054 Sum_probs=54.2
Q ss_pred cccc-cccCCeeEEEEEEC-------CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCC-C--CCeeeEEeEEecC--
Q 039922 687 QNLI-GSGGSCRVYKVKLK-------SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVR-H--GNVVKLLMCCSGQ-- 752 (973)
Q Consensus 687 ~~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~-- 752 (973)
.+.| +.|....+|++... +++.+++|+...... .......+.+|+..++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999998764 267888987632210 0001134677888888775 3 2466777777654
Q ss_pred -CeeEEEEeccCCCChhh
Q 039922 753 -DFNILVYEYMPNGSLAD 769 (973)
Q Consensus 753 -~~~~lv~e~~~~gsL~~ 769 (973)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999998876654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00018 Score=77.10 Aligned_cols=139 Identities=19% Similarity=0.194 Sum_probs=91.6
Q ss_pred ccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC---CCCeeeEEeEEecCCeeEEEEecc
Q 039922 686 EQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR---HGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
..+.|+.|.+..+|++.. +++.+++|+... .....+..|.+.++.+. ...+.+++.+....+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 456789999999999986 477899998732 23566888988888884 256778888888888899999999
Q ss_pred CCCChhh-----------hhhccCC-C----------C--------CCCHHHHH---HHHH----------------HHH
Q 039922 763 PNGSLAD-----------MLHEKGR-S----------G--------SLDWSIRF---SIAQ----------------GAA 793 (973)
Q Consensus 763 ~~gsL~~-----------~l~~~~~-~----------~--------~l~~~~~~---~i~~----------------~ia 793 (973)
++..+.. .+|.... . + .-+|...+ ++.. .++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9875421 1222211 0 0 12454321 1111 111
Q ss_pred HH-HHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 794 KG-LAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 794 ~~-L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
.. ...|.. ...+.++|+|+.+.|++++.++ +.|.|++
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 123321 2246899999999999999887 8899974
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.65 E-value=5.7e-05 Score=82.85 Aligned_cols=141 Identities=20% Similarity=0.226 Sum_probs=78.4
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC--CCeeeEEe------EEecCCeeEEE
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH--GNVVKLLM------CCSGQDFNILV 758 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv 758 (973)
.+.++.|..+.||++...+| .+++|+... . ...+..|..+++.+.. -.+.+++. +....+..+++
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR---P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECS---C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCC---C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 34566677899999987655 589998843 1 1223345555554431 12233332 12245678999
Q ss_pred EeccCCCChh--------------hhhhccCC----C-------CCCCHHHH----------------------------
Q 039922 759 YEYMPNGSLA--------------DMLHEKGR----S-------GSLDWSIR---------------------------- 785 (973)
Q Consensus 759 ~e~~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~---------------------------- 785 (973)
|||++|..+. ..+|.... . ....|...
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999876442 01121100 0 01123211
Q ss_pred ---HHHHHHHHHHHHHHhh----------cCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 786 ---FSIAQGAAKGLAYLHN----------DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 786 ---~~i~~~ia~~L~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
..+...+..++++|++ ...+.++|||+++.||+++.++.+.++||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666663 123489999999999999888899999999754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00011 Score=82.40 Aligned_cols=77 Identities=18% Similarity=0.200 Sum_probs=48.5
Q ss_pred cccccccCCeeEEEEEEC-CCCEEEEEEecCCCC--C---chhHHHHHHHHHHHhcCCC--CC-eeeEEeEEecCCeeEE
Q 039922 687 QNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH--K---PETETVFRSEIETLGRVRH--GN-VVKLLMCCSGQDFNIL 757 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 757 (973)
.+.+|.|.++.||+++.. +++.|++|....... . ......+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 478999998643211 0 1122346678888877642 33 3355543 3445689
Q ss_pred EEeccCCC
Q 039922 758 VYEYMPNG 765 (973)
Q Consensus 758 v~e~~~~g 765 (973)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.48 E-value=1.8e-05 Score=76.10 Aligned_cols=83 Identities=16% Similarity=0.133 Sum_probs=37.8
Q ss_pred cCcEEeCcCCcccCCCccccccccccceeeccccc-cccccCcccCcc----ccceeeeeccCc-ccCCCCccccccccc
Q 039922 482 QLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENM-FTGELPRNLNSL----TALIVLNLSTNQ-LTGTIPPELGNLAVL 555 (973)
Q Consensus 482 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 555 (973)
+|+.||++++.|+..--..+.++++|+.|+|+++. |++.--..++.+ ++|++|+|+++. ||..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34444444444443333334444455555555542 443333333332 245555555542 543222334455666
Q ss_pred cEEecCCCc
Q 039922 556 TSLDLSSNL 564 (973)
Q Consensus 556 ~~L~Ls~N~ 564 (973)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.45 E-value=5.4e-05 Score=72.86 Aligned_cols=82 Identities=15% Similarity=0.104 Sum_probs=39.5
Q ss_pred CCCEEEccCCcCcccCchhccCCCccceeeccccc-cCCCChhhhhc-----ccCcEEEccCCc-CCCCCCccccCCCcc
Q 039922 267 SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNN-LTGNLPETIAA-----MSLESLNLNDNY-FTGEIPESLASNPNL 339 (973)
Q Consensus 267 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~-----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 339 (973)
+|++|+++++.++..--..+..+++|+.|+|++|. ++..--..+.. .+|++|+|++|. +++.--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555554433445555666666666653 43222222221 135555555542 443322334455556
Q ss_pred ceeeecccc
Q 039922 340 VQLKLFNNS 348 (973)
Q Consensus 340 ~~L~L~~N~ 348 (973)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666555553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00021 Score=76.19 Aligned_cols=76 Identities=24% Similarity=0.339 Sum_probs=53.5
Q ss_pred CccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC--C-CeeeEEeEEecCCeeEEEEec
Q 039922 685 TEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH--G-NVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~lv~e~ 761 (973)
..++.+|.|..+.||+++..||+.|++|+-.... ......|..|...|+.+.- + -+.+++++ +..++||||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 3456789999999999999999999999864332 2223457888888887742 1 23445543 234789999
Q ss_pred cCCCC
Q 039922 762 MPNGS 766 (973)
Q Consensus 762 ~~~gs 766 (973)
++.+.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 97654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0013 Score=74.07 Aligned_cols=76 Identities=13% Similarity=0.120 Sum_probs=45.5
Q ss_pred CCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcccccccccc--ccCccccccccCC---CCCCCCChhhHHHH
Q 039922 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG--SYGYIAPEYAYTK---KVTEKSDVYSFGVV 879 (973)
Q Consensus 805 ~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dv~slG~~ 879 (973)
+.++|||++|.||++++++ ++++||+.+..-..... ...... ...|++|+..... ......++......
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-----la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-----IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-----HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-----HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 3899999999999998876 99999998764321100 000000 1345666654311 11122345577777
Q ss_pred HHHHHcC
Q 039922 880 LMELVTG 886 (973)
Q Consensus 880 l~elltg 886 (973)
+|+.+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7777764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0001 Score=72.26 Aligned_cols=110 Identities=17% Similarity=0.239 Sum_probs=53.3
Q ss_pred CCCcceEeecCC-cCCCC----CchhhhcCCcCcEEeCcCCcccC----CCccccccccccceeeccccccccc----cC
Q 039922 456 APKLTGILINGN-NFTGE----VPSQICTLRQLQAVDLSQNRFSG----HLPTCITQLNKLQQLELQENMFTGE----LP 522 (973)
Q Consensus 456 ~~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p 522 (973)
.+.|++|+|++| +|... +...+..-+.|+.|+|++|+|.. .+...+..-+.|+.|+|++|+|++. +-
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 344555555553 44321 22334445566666666666653 2223333445666666666666543 22
Q ss_pred cccCccccceeeeeccC---cccC----CCCccccccccccEEecCCCcC
Q 039922 523 RNLNSLTALIVLNLSTN---QLTG----TIPPELGNLAVLTSLDLSSNLL 565 (973)
Q Consensus 523 ~~~~~l~~L~~L~Ls~N---~l~~----~~p~~~~~l~~L~~L~Ls~N~l 565 (973)
+.+..-+.|+.|+|++| .+.. .+-..+..-+.|+.|+|+.|..
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 33444455666666543 2221 1222333445566666655543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0018 Score=70.45 Aligned_cols=141 Identities=16% Similarity=0.156 Sum_probs=70.8
Q ss_pred ccccccCCee-EEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCC--CeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCR-VYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHG--NVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
+.++.|.... +|+....+|+.+++|....... ..+..|+.+++.+... .+.+++.+....+ +++||++++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 4565565544 6677654477888876532210 1234456666555322 2445666543333 689999977
Q ss_pred CChhhhhhcc---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHHhh
Q 039922 765 GSLADMLHEK---------------------GRS--GSLDWSIRF-------S-------------IAQGAAKGLAYLHN 801 (973)
Q Consensus 765 gsL~~~l~~~---------------------~~~--~~l~~~~~~-------~-------------i~~~ia~~L~yLH~ 801 (973)
..+.+++... ... ...+..... . ....+...++.+.+
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 6665443211 000 011111000 0 00111122222211
Q ss_pred ---cCCCCeEEeCCCCCCEEeCCC----CceEEeccCcchh
Q 039922 802 ---DCVPAIVHRDVKSHNILLDAE----MVPRVADFGLAKA 835 (973)
Q Consensus 802 ---~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGl~~~ 835 (973)
...+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999875 6789999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0038 Score=67.64 Aligned_cols=141 Identities=15% Similarity=0.128 Sum_probs=79.7
Q ss_pred ccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCC--eeeEEeE-----EecCCeeEEEEe
Q 039922 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN--VVKLLMC-----CSGQDFNILVYE 760 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e 760 (973)
..++ |....||++...+|+.+++|...... .....+..|...++.+.... +.+++.. ...++..+.+||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3466 88889999887778889999984322 12345666777777764222 3344432 122456688999
Q ss_pred ccCCCChhh-----------h---hhcc----CC--CCCCCHHHH----HHH---------------HHHHHHHHHHHhh
Q 039922 761 YMPNGSLAD-----------M---LHEK----GR--SGSLDWSIR----FSI---------------AQGAAKGLAYLHN 801 (973)
Q Consensus 761 ~~~~gsL~~-----------~---l~~~----~~--~~~l~~~~~----~~i---------------~~~ia~~L~yLH~ 801 (973)
|++|..+.. . +|.. .. ....++... ..+ ...+...++.+.+
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998754321 0 1111 00 011222111 001 1111122233322
Q ss_pred c----CCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 802 D----CVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 802 ~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
. ....++|||+++.||+++ + .+.++||+.+.
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1 233688999999999999 4 89999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.00026 Score=69.41 Aligned_cols=66 Identities=20% Similarity=0.217 Sum_probs=37.6
Q ss_pred ccCCCCCCEEEccCC-ccccc----CCcCCCCCCCCCEEEccCCcCccc----CchhccCCCccceeeccccccC
Q 039922 238 IGKLAFLSNLDLSDN-FLSGK----IPHSFSGLASIEQIELFDNQLSGE----LPESLSNLTTLLRLDISQNNLT 303 (973)
Q Consensus 238 l~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 303 (973)
+.+-+.|+.|+|++| .|... +...+..-+.|+.|+|++|++... +.+.+..-+.|+.|+|++|.|.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 345567788888775 66532 233344455667777777766632 2233444456666666666665
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0014 Score=70.13 Aligned_cols=73 Identities=14% Similarity=0.094 Sum_probs=44.0
Q ss_pred CccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCe-eeEEeEEecCCeeEEEEecc-
Q 039922 685 TEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV-VKLLMCCSGQDFNILVYEYM- 762 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~- 762 (973)
.-.+.|+.|....+|++ +.+++|+........ ....+|+..++.+....+ .++++++ .+.-++|+||+
T Consensus 21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CSCEEEESCSSEEEEEE-----TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred cceeEcCCcccccccee-----eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 33678888999999998 568888874321111 112457777766643233 3555443 33457899999
Q ss_pred CCCCh
Q 039922 763 PNGSL 767 (973)
Q Consensus 763 ~~gsL 767 (973)
++.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 55444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0031 Score=69.36 Aligned_cols=141 Identities=14% Similarity=0.122 Sum_probs=81.2
Q ss_pred cccccccCCeeEEEEEEC--------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEE
Q 039922 687 QNLIGSGGSCRVYKVKLK--------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 757 (973)
.+.+..|-...+|++... +++.|++|+... . ......+.+|..+++.+. +.-..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--I-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--c-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 345666888899999875 357899998621 1 122345568888888875 3333566666543 28
Q ss_pred EEeccCCCChhhh-----------------hhccCC--CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 039922 758 VYEYMPNGSLADM-----------------LHEKGR--SGSLD--WSIRFSIAQGAAK-------------------GLA 797 (973)
Q Consensus 758 v~e~~~~gsL~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~ia~-------------------~L~ 797 (973)
||||++|.++..- +|.... ..... +.++.++..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999987554310 111111 11122 3444445443322 223
Q ss_pred HHhh----c-CCCCeEEeCCCCCCEEeCCC----CceEEeccCcch
Q 039922 798 YLHN----D-CVPAIVHRDVKSHNILLDAE----MVPRVADFGLAK 834 (973)
Q Consensus 798 yLH~----~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGl~~ 834 (973)
.|.+ . ....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3322 1 12368999999999999876 789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0028 Score=71.38 Aligned_cols=73 Identities=23% Similarity=0.266 Sum_probs=48.4
Q ss_pred cccccccCCeeEEEEEECC--------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCe-eeEEeEEecCCeeEE
Q 039922 687 QNLIGSGGSCRVYKVKLKS--------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV-VKLLMCCSGQDFNIL 757 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~l 757 (973)
.+.|+.|-...||++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 3567788889999998753 578999988321 111344578888888753333 566665542 28
Q ss_pred EEeccCCCCh
Q 039922 758 VYEYMPNGSL 767 (973)
Q Consensus 758 v~e~~~~gsL 767 (973)
||||+++.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999976443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0018 Score=59.32 Aligned_cols=57 Identities=25% Similarity=0.263 Sum_probs=35.3
Q ss_pred eeeccccccc-cccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCcc
Q 039922 509 QLELQENMFT-GELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567 (973)
Q Consensus 509 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (973)
.++.+++.|+ ..+|..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 4444455443 23333222 346677777777775555667778888888888887763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0023 Score=69.10 Aligned_cols=143 Identities=10% Similarity=0.119 Sum_probs=78.3
Q ss_pred cccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCC--eeeEEeE------EecCCeeEEE
Q 039922 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN--VVKLLMC------CSGQDFNILV 758 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv 758 (973)
.+.|+.|....+|++...+| .+++|...... ....+..|..+++.+.... +.+++.. ....+..+++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 35677788899999987755 68899884321 1223456777766664222 2233321 1224567899
Q ss_pred EeccCCCChhh--------------hhhccCC----CC--C---CCHHHHHH------------HHHHHHHHHHHHhhc-
Q 039922 759 YEYMPNGSLAD--------------MLHEKGR----SG--S---LDWSIRFS------------IAQGAAKGLAYLHND- 802 (973)
Q Consensus 759 ~e~~~~gsL~~--------------~l~~~~~----~~--~---l~~~~~~~------------i~~~ia~~L~yLH~~- 802 (973)
|+|++|..+.. .+|.... .. . ..|...+. +...+...++++++.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99998754321 0121110 00 0 11222110 011234455555532
Q ss_pred ---CCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 803 ---CVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 803 ---~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
...+++|+|+.+.||+++++..+.++||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23479999999999999887666899998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.003 Score=57.75 Aligned_cols=56 Identities=29% Similarity=0.348 Sum_probs=35.7
Q ss_pred EEeCcCCccc-CCCccccccccccceeeccccccccccCcccCccccceeeeeccCccc
Q 039922 485 AVDLSQNRFS-GHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLT 542 (973)
Q Consensus 485 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (973)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666665 23454433 35677777777777555566677777777777777664
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.30 E-value=0.014 Score=65.82 Aligned_cols=74 Identities=18% Similarity=0.082 Sum_probs=46.3
Q ss_pred cccccccCCeeEEEEEECC-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCe-eeEEeEEecCCeeEEEEeccCC
Q 039922 687 QNLIGSGGSCRVYKVKLKS-GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV-VKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 764 (973)
.+.|+.|-...+|++...+ ++.+++|+......... ...+|..+++.+...++ .++++++. + ..||||+++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i---dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII---NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS---CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc---CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4567788889999998874 47888988733211111 12468888888864444 46666663 2 259999986
Q ss_pred CCh
Q 039922 765 GSL 767 (973)
Q Consensus 765 gsL 767 (973)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0046 Score=68.22 Aligned_cols=74 Identities=19% Similarity=0.117 Sum_probs=42.8
Q ss_pred cccccccCCeeEEEEEECC---------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCC-eeeEEeEEecCCeeE
Q 039922 687 QNLIGSGGSCRVYKVKLKS---------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN-VVKLLMCCSGQDFNI 756 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~ 756 (973)
.+.++.|....+|++...+ ++.+++|+..... ........|...++.+...+ ..++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3457778888999998764 2688888773221 11112356777777775333 34666544 2 36
Q ss_pred EEEeccCCCCh
Q 039922 757 LVYEYMPNGSL 767 (973)
Q Consensus 757 lv~e~~~~gsL 767 (973)
+||||+++..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.81 E-value=0.034 Score=60.31 Aligned_cols=31 Identities=19% Similarity=0.303 Sum_probs=27.4
Q ss_pred CCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 805 ~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
..++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.87 E-value=0.056 Score=53.14 Aligned_cols=105 Identities=14% Similarity=0.160 Sum_probs=67.9
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCccc
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 845 (973)
+|.+.|...+. ++++.++|.++.|.+.+|.-.-.+.. . ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 78899887654 79999999999999999877622100 1 1222356889999999988764 1110
Q ss_pred cccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCC
Q 039922 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDP 892 (973)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~ 892 (973)
.....+.|||... ...+.+.=|||+|+++|.-+--+.|-+.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e 138 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE 138 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc
Confidence 0112356888753 3456677899999999999987766543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.89 E-value=0.072 Score=59.27 Aligned_cols=73 Identities=11% Similarity=0.068 Sum_probs=45.0
Q ss_pred ccccccCCeeEEEEEECC--------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEE
Q 039922 688 NLIGSGGSCRVYKVKLKS--------GETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 758 (973)
+.+..|-...+|++...+ ++.|++|+........ ....+|..+++.+. +.-..++++.+. -+.|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~---idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF---YDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC---CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh---cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 456667788999988763 5889999863221111 11346777777774 322345554332 2689
Q ss_pred EeccCCCCh
Q 039922 759 YEYMPNGSL 767 (973)
Q Consensus 759 ~e~~~~gsL 767 (973)
|||++|..+
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999987653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.35 E-value=0.6 Score=51.63 Aligned_cols=29 Identities=28% Similarity=0.418 Sum_probs=24.6
Q ss_pred CeEEeCCCCCCEEe------CCCCceEEeccCcch
Q 039922 806 AIVHRDVKSHNILL------DAEMVPRVADFGLAK 834 (973)
Q Consensus 806 ~ivH~Dlkp~NIll------~~~~~~kl~DfGl~~ 834 (973)
.++|+|+.+.||++ +++..++++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 456789999998775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.40 E-value=2 Score=42.20 Aligned_cols=115 Identities=10% Similarity=0.096 Sum_probs=79.0
Q ss_pred CCCCeeeEEeEEecCCeeEEEEeccCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCC
Q 039922 738 RHGNVVKLLMCCSGQDFNILVYEYMPNG-SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHN 816 (973)
Q Consensus 738 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 816 (973)
.||++++. .+-..++...+.|+.-+.+ ++.. ++ ..+...+++++.+|+...++++.. +|--++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888866 5666677777777754322 2222 22 367889999999999988777766 888999999
Q ss_pred EEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCC
Q 039922 817 ILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPND 891 (973)
Q Consensus 817 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 891 (973)
++++.++.+++.-.|+-..+ +|.- .+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l---------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV---------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB---------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC---------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999877764322 1220 1111112246678888898887774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.56 E-value=3 Score=41.13 Aligned_cols=84 Identities=10% Similarity=-0.021 Sum_probs=62.1
Q ss_pred CCCCeeeEEeEEecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEEeCCCCCC
Q 039922 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA-YLHNDCVPAIVHRDVKSHN 816 (973)
Q Consensus 738 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~ivH~Dlkp~N 816 (973)
.||++ -..+-.+++...+.|+.-+++.=...++ ..+...+++.+.+|+.... +++.. +|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence 57887 3444467788777777654332222232 3678899999999998887 67655 888899999
Q ss_pred EEeCCCCceEEeccCcch
Q 039922 817 ILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 817 Ill~~~~~~kl~DfGl~~ 834 (973)
+++|.++.+++.-.|+-.
T Consensus 115 L~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EEECTTCCEEESCCEETT
T ss_pred EEEeCCCcEEEEEcCCcc
Confidence 999999999998877643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 973 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-14 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-13 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-10 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 6e-63
Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 31/288 (10%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
+T IGSG VYK K VAVK L P+ F++E+ L + RH N+
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
+ + + +V ++ SL LH + IA+ A+G+ YLH
Sbjct: 67 LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
I+HRD+KS+NI L ++ ++ DFGLA G ++GS ++APE
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG--SHQFEQLSGSILWMAPEVI 178
Query: 863 YTKK---VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919
+ + +SDVY+FG+VL EL+TG+ P N+D + ++ SP
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSP------- 229
Query: 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
DLS + + + C RP +++ +
Sbjct: 230 ---------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-61
Identities = 75/298 (25%), Positives = 118/298 (39%), Gaps = 29/298 (9%)
Query: 687 QNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
Q IG G V++ K + GE VAVK + + E +EI +RH N++ +
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 63
Query: 747 MCCSGQDFNI----LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
+ + LV +Y +GSL D L+ + +A A GLA+LH +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHME 119
Query: 803 CV-----PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
V PAI HRD+KS NIL+ +AD GLA S D A + G+ Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 858 APEYAYTK------KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911
APE + +++D+Y+ G+V E+ G ++D + S
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI----GGIHEDYQLPYYDLVPSD 235
Query: 912 PERGCCRD--LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
P R Q + P + E + + C R + R+ + L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 72/294 (24%), Positives = 127/294 (43%), Gaps = 35/294 (11%)
Query: 675 FNEDDILPH--LTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIE 732
+ ++ +P L +G+G V+ VAVK L G+ P+ F +E
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEAN 60
Query: 733 TLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGA 792
+ +++H +V+L + + ++ EYM NGSL D L L + +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQI 118
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
A+G+A++ +HRD+++ NIL+ + ++ADFGLA+ ++ E A
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKF 172
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912
+ APE T KSDV+SFG++L E+VT R P N ++++ +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVR 231
Query: 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
C +L QL+ +C + P +RP+ + +L
Sbjct: 232 PDNCPEELYQLM---------------------RLCWKERPEDRPTFDYLRSVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-58
Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 33/283 (11%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
IG+G R K++ K G+ + K L G+ + + SE+ L ++H N+V+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 747 MCCSGQDFNIL--VYEYMPNGSLADMLHEKGRS-GSLDWSIRFSIAQGAAKGLAYLH--N 801
+ L V EY G LA ++ + + LD + L H +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
D ++HRD+K N+ LD + ++ DFGLA+ L G+ Y++PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF----AKAFVGTPYYMSPEQ 185
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921
EKSD++S G +L EL P K++ + E +LN
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRRIPYRYSDELN 243
Query: 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964
++I + +RPS+ ++E
Sbjct: 244 EII---------------------TRMLNLKDYHRPSVEEILE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 3e-57
Identities = 76/286 (26%), Positives = 114/286 (39%), Gaps = 39/286 (13%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L IG G V + G VAVK + T F +E + ++RH N+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNL 62
Query: 743 VKLLMCCSGQDFNI-LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
V+LL + + +V EYM GSL D L +GRS L + + + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEG 121
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
+ VHRD+ + N+L+ + V +V+DFGL K S + APE
Sbjct: 122 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-------QDTGKLPVKWTAPEA 171
Query: 862 AYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921
KK + KSDV+SFG++L E+ + R P KD+V V + GC +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVY 230
Query: 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
+++ C RPS ++ E L
Sbjct: 231 EVM---------------------KNCWHLDAAMRPSFLQLREQLE 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-57
Identities = 65/285 (22%), Positives = 120/285 (42%), Gaps = 33/285 (11%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
LT IGSG V+ + + VA+K + +E F E E + ++ H +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V+L C Q LV+E+M +G L+D L + + +G+AYL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEEA 120
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
C ++HRD+ + N L+ V +V+DFG+ + + + + + + +PE
Sbjct: 121 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVF 174
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922
+ + KSDV+SFGV++ E+ + + + N ++V ++ +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTG-------------FR 220
Query: 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
L PR + V + C + P +RP+ R++ L
Sbjct: 221 LYKPR--------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 79/284 (27%), Positives = 117/284 (41%), Gaps = 33/284 (11%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
L + +G G V+ VA+K L GT PE F E + + ++RH +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKL 74
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V+L S + I V EYM GSL D L + L +A A G+AY+
Sbjct: 75 VQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
VHRD+++ NIL+ +V +VADFGLA+ ++ E + + APE A
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA---RQGAKFPIKWTAPEAA 186
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922
+ T KSDV+SFG++L EL T R P N++++ V C L+
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECPESLHD 245
Query: 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
L+ C P RP+ + L
Sbjct: 246 LM---------------------CQCWRKEPEERPTFEYLQAFL 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-56
Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 35/286 (12%)
Query: 686 EQNLIGSGGSCRVYKVKL---KSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
E +GSG V K K +TVAVK L + P + +E + ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V+++ C + + +LV E G L L + + + + G+ YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
VHRD+ + N+LL + +++DFGL+KAL++ + A + + APE
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECI 182
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KDIVRWVTEATLSSPERGCCRDLN 921
K + KSDV+SFGV++ E + + P G ++ + + GC R++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240
Query: 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
L+ +C + NRP V LR
Sbjct: 241 DLM---------------------NLCWTYDVENRPGFAAVELRLR 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-56
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 13/211 (6%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
+ +G+G V+KV K SG +A K + KP E++ L +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ E+M GSL +L + GR + I ++ KGL YL
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH--K 125
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
I+HRDVK NIL+++ ++ DFG++ L D + G+ Y++PE
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTH 179
Query: 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGEN 897
+ +SD++S G+ L+E+ G+ P P +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 8e-56
Identities = 77/312 (24%), Positives = 120/312 (38%), Gaps = 35/312 (11%)
Query: 660 TSKSPWKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLL 715
++ +P V Q V ++ H +IG G VY L AVK L
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 716 GGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI-LVYEYMPNGSLADMLHEK 774
T E F +E + H NV+ LL C + + +V YM +G L + + +
Sbjct: 65 RITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 775 GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834
+ ++ I F + + VHRD+ + N +LD + +VADFGLA+
Sbjct: 124 THNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSF 894
+ +E S + ++A E T+K T KSDV+SFGV+L EL+T P P
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 895 GENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPI 954
DI ++ + C + + V L C
Sbjct: 239 -NTFDITVYLLQGRRLLQPEYC---------------------PDPLYEVMLKCWHPKAE 276
Query: 955 NRPSMRRVVELL 966
RPS +V +
Sbjct: 277 MRPSFSELVSRI 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 64/282 (22%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 690 IGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
+G G V + + VA+K L GT K +TE E + + ++ + +V+L+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLI 75
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
C + +LV E G L L G+ + S + + G+ YL
Sbjct: 76 GVCQAEAL-MLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEE---KN 129
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
VHRD+ + N+LL +++DFGL+KAL + + A S + APE +K
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRK 188
Query: 867 VTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
+ +SDV+S+GV + E ++ G++P + +++ ++ + C +L L+
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRMECPPECPPELYALM- 245
Query: 926 PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
C +RP V + +R
Sbjct: 246 --------------------SDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 3e-55
Identities = 72/300 (24%), Positives = 127/300 (42%), Gaps = 35/300 (11%)
Query: 674 SFNEDDILPHLTEQNLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRS 729
F ++ + + + +IG+G V LK VA+K L G + + F S
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLS 76
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIA 789
E +G+ H NV+ L + +++ E+M NGSL L + G +
Sbjct: 77 EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGML 134
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD-AMS 848
+G A G+ YL + VHRD+ + NIL+++ +V +V+DFGL++ L+ +
Sbjct: 135 RGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 849 CVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KDIVRWVTEA 907
+ APE +K T SDV+S+G+V+ E+++ P + +D++ + +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTNQDVINAIEQD 249
Query: 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
P C L+QL+ L C +RP ++V L
Sbjct: 250 YRLPPPMDCPSALHQLM---------------------LDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 8e-55
Identities = 73/308 (23%), Positives = 125/308 (40%), Gaps = 57/308 (18%)
Query: 688 NLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN 741
IG G RV++ + VAVK L + + F+ E + + N
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDNPN 77
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS---------------------L 780
+VKLL C+ L++EYM G L + L L
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 781 DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840
+ + IA+ A G+AYL VHRD+ + N L+ MV ++ADFGL++ + S +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KD 899
A A ++ PE + + T +SDV+++GVVL E+ + P +G ++
Sbjct: 195 YYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMAHEE 250
Query: 900 IVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSM 959
++ +V + + + C +L L+ +C S P +RPS
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLM---------------------RLCWSKLPADRPSF 289
Query: 960 RRVVELLR 967
+ +L+
Sbjct: 290 CSIHRILQ 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 8e-55
Identities = 58/285 (20%), Positives = 111/285 (38%), Gaps = 33/285 (11%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV 742
LT +G+G V K + VA+K + G+ + F E + + + H +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLSHEKL 61
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
V+L C+ Q ++ EYM NG L + L E + + + + YL +
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 803 CVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
+HRD+ + N L++ + V +V+DFGL++ + E S + PE
Sbjct: 120 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS---SVGSKFPVRWSPPEVL 173
Query: 863 YTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922
K + KSD+++FGV++ E+ + + F N + + +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRLYRPHLA------ 226
Query: 923 LIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
+EKV + C + RP+ + ++ +
Sbjct: 227 ---------------SEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (480), Expect = 2e-54
Identities = 70/299 (23%), Positives = 126/299 (42%), Gaps = 34/299 (11%)
Query: 671 QRVSFNEDDILPH-LTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFR 728
++++ ++ +T ++ +G G VY+ K TVAVK L T + E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FL 61
Query: 729 SEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSI 788
E + ++H N+V+LL C+ + ++ E+M G+L D L E R + + +
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYM 120
Query: 789 AQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMS 848
A + + YL +HRD+ + N L+ + +VADFGL++ + G + A +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHA 174
Query: 849 CVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEAT 908
+ APE K + KSDV++FGV+L E+ T P ++
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------- 224
Query: 909 LSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
+ +L++ + EKV + C P +RPS + +
Sbjct: 225 -----------VYELLEKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-54
Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 38/281 (13%)
Query: 690 IGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMC 748
IG G VYK + VA L F+ E E L ++H N+V+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 749 C----SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
G+ +LV E M +G+L L + + S + KGL +LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 805 PAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
P I+HRD+K NI + ++ D GLA ++ ++ V G+ ++APE Y
Sbjct: 134 P-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA------VIGTPEFMAPEM-Y 185
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923
+K E DVY+FG+ ++E+ T + P + R + +S ++ ++ ++
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245
Query: 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964
I C R S++ ++
Sbjct: 246 I---------------------EGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 9e-54
Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 38/279 (13%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
+G G VY + K S +A+K L K E R E+E +RH N+++L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
L+ EY P G++ L + + D + A L+Y H+
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---K 125
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
++HRD+K N+LL + ++ADFG + S + + G+ Y+ PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR------RTTLCGTLDYLPPEMIEGR 179
Query: 866 KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
EK D++S GV+ E + GK P + + ++ + ++ + P+ LI
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVEFTFPDF-VTEGARDLIS 236
Query: 926 PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964
P RP +R V+E
Sbjct: 237 ---------------------RLLKHNPSQRPMLREVLE 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 9e-53
Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKSGE-----TVAVKRLLGGTHKPETETVFRSEIETLGRV 737
+T Q +IG+G VYK LK+ VA+K L G + + F E +G+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQF 66
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H N+++L S +++ EYM NG+L L EK G + +G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMK 124
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
YL N VHRD+ + NIL+++ +V +V+DFGL++ L+ + ++ S +
Sbjct: 125 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIPIRWT 180
Query: 858 APEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917
APE +K T SDV+SFG+V+ E++T N ++++ + +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAIND----------- 228
Query: 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
R+ + + + + C RP +V +L
Sbjct: 229 -------GFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 69/306 (22%), Positives = 121/306 (39%), Gaps = 49/306 (16%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
L+ +G+G +V + + TVAVK L H E E SE++ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSY 82
Query: 737 V-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRS---------------GSL 780
+ H N+V LL C+ +++ EY G L + L K S +L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 781 DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840
D S + AKG+A+L + +HRD+ + NILL + ++ DFGLA+ +++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900
++APE + T +SDV+S+G+ L EL + P +
Sbjct: 200 NYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960
+ + E ++ ++ C P+ RP+ +
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIM---------------------KTCWDADPLKRPTFK 296
Query: 961 RVVELL 966
++V+L+
Sbjct: 297 QIVQLI 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 7e-52
Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 11/239 (4%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
+G G V + + E VAVK + + + EI + H NVVK
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
+ L EY G L D + + G+ YLH
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIG--- 123
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
I HRD+K N+LLD +++DFGLA + + ++ + G+ Y+APE ++
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 867 V-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI 924
E DV+S G+VL ++ G+ P D ++ W + T +P + L+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 8e-52
Identities = 69/316 (21%), Positives = 124/316 (39%), Gaps = 56/316 (17%)
Query: 670 FQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLKSGET---VAVKRLLGGTHKPETETV 726
+ + +N+ + Q++IG G +V K ++K A+KR+ K +
Sbjct: 4 YPVLDWND------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD- 56
Query: 727 FRSEIETLGRV-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEK----------- 774
F E+E L ++ H N++ LL C + + L EY P+G+L D L +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 775 --GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832
+ +L A A+G+ YL +HRD+ + NIL+ V ++ADFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDP 892
++ + + ++A E T SDV+S+GV+L E+V+ P
Sbjct: 174 SRG-----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--P 226
Query: 893 SFGEN-KDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSD 951
G ++ + + C ++ L+ C +
Sbjct: 227 YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLM---------------------RQCWRE 265
Query: 952 FPINRPSMRRVVELLR 967
P RPS +++ L
Sbjct: 266 KPYERPSFAQILVSLN 281
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-51
Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 54/305 (17%)
Query: 689 LIGSGGSCRVYKVKLKS------GETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGN 741
++GSG +V VAVK L E E SE++ + ++ H N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHEN 102
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRS--------------------GSLD 781
+V LL C+ L++EY G L + L K L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 782 WSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841
+ A AKG+ +L + VHRD+ + N+L+ V ++ DFGLA+ + S
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIV 901
++APE + T KSDV+S+G++L E+ + P + +
Sbjct: 220 YV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 902 RWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRR 961
+ + +MD + E++ + C + RPS
Sbjct: 278 KLIQN------------------GFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 962 VVELL 966
+ L
Sbjct: 317 LTSFL 321
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 1e-51
Identities = 64/295 (21%), Positives = 111/295 (37%), Gaps = 41/295 (13%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIE 732
F +DD ++ IG G VY + +++ E VA+K++ G E E+
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 733 TLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGA 792
L ++RH N ++ C + LV EY + + K L ++ GA
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGA 124
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
+GLAYLH+ ++HRDVK+ NILL + ++ DFG A + + G
Sbjct: 125 LQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANSFVG 173
Query: 853 SYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909
+ ++APE + K DV+S G+ +EL K P + + +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNAMSALYHIAQNESP 232
Query: 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964
+ + C P +RP+ +++
Sbjct: 233 ALQSGHWSEYFRNFV---------------------DSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-50
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
+G G +VYK + K + A K + T E + EI+ L H N+VKLL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
++ ++ E+ G++ ++ E R L S + + L YLH+
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NK 130
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-- 864
I+HRD+K+ NIL + ++ADFG++ ++ G+ ++APE
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKN----TRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 865 ---KKVTEKSDVYSFGVVLMELVTGKRP 889
+ K+DV+S G+ L+E+ + P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 9e-50
Identities = 67/284 (23%), Positives = 110/284 (38%), Gaps = 35/284 (12%)
Query: 690 IGSGGSCRVYKVKLKS----GETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVK 744
+G G V + + + +VAVK L +PE F E+ + + H N+++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
L + V E P GSL D L + G A A+G+ YL +
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR- 131
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
+HRD+ + N+LL + ++ DFGL +AL Q + + APE T
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KDIVRWVTEATLSSPERGCCRDLNQL 923
+ + SD + FGV L E+ T + P G N I+ + + P C
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDKEGERLPRPEDC------ 240
Query: 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
+ + NV + C + P +RP+ + + L
Sbjct: 241 --------------PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (441), Expect = 2e-48
Identities = 62/267 (23%), Positives = 110/267 (41%), Gaps = 20/267 (7%)
Query: 665 WKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPET 723
WK Q V D +L H +G+G V++V +G A K ++ T
Sbjct: 9 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESD 66
Query: 724 ETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS 783
+ R EI+T+ +RH +V L + +++YE+M G L + + ++ +
Sbjct: 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSED 124
Query: 784 IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV--ADFGLAKALQSQEG 841
+ KGL ++H + VH D+K NI+ + + DFGL L ++
Sbjct: 125 EAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180
Query: 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIV 901
++ G+ + APE A K V +D++S GV+ L++G P + + +
Sbjct: 181 ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETL 234
Query: 902 RWVTEATLSSPER---GCCRDLNQLID 925
R V + + G D I
Sbjct: 235 RNVKSCDWNMDDSAFSGISEDGKDFIR 261
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-47
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 40/297 (13%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVKLKS-----GETVAVKRLLGGTHKPETETVFRS 729
E + + ++GSG VYK VA+K L T P+
Sbjct: 6 LKETE----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILD 60
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIA 789
E + V + +V +LL C L+ + MP G L D + E + +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG--SQYLLNWC 117
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
AKG+ YL + +VHRD+ + N+L+ ++ DFGLAK L ++E +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--AEG 172
Query: 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909
++A E + T +SDV+S+GV + EL+T +I + +
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGER 231
Query: 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELL 966
C D+ ++ + C +RP R ++
Sbjct: 232 LPQPPICTIDVYMIM---------------------VKCWMIDADSRPKFRELIIEF 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 14/215 (6%)
Query: 676 NEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETL 734
+ D T IG G S VY + +G+ VA++++ + + + +EI +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVM 71
Query: 735 GRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAK 794
++ N+V L D +V EY+ GSL D++ E D ++ + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQ 127
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
L +LH++ ++HRD+KS NILL + ++ DFG + S + G+
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTP 180
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
++APE K K D++S G++ +E++ G+ P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-47
Identities = 63/284 (22%), Positives = 104/284 (36%), Gaps = 38/284 (13%)
Query: 689 LIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVK 744
IG G V++ S VA+K T E F E T+ + H ++VK
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVK 72
Query: 745 LLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCV 804
L+ + ++ ++ E G L L R SLD + A + LAYL +
Sbjct: 73 LIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 805 PAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT 864
VHRD+ + N+L+ + ++ DFGL++ ++ S ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK---ASKGKLPIKWMAPESINF 183
Query: 865 KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGEN-KDIVRWVTEATLSSPERGCCRDLNQL 923
++ T SDV+ FGV + E++ P G D++ + C L L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241
Query: 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
+ C + P RP + L
Sbjct: 242 M---------------------TKCWAYDPSRRPRFTELKAQLS 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-47
Identities = 64/298 (21%), Positives = 108/298 (36%), Gaps = 41/298 (13%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
+T +G G VY+ K VA+K + E F +E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKE 79
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS-------LDWSIRFSIA 789
+VV+LL S +++ E M G L L + + S +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
A G+AYL+ + VHRD+ + N ++ + ++ DFG+ + + E
Sbjct: 140 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 194
Query: 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909
+++PE T SDV+SFGVVL E+ T N+ ++R+V E L
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 253
Query: 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
C + + + MC P RPS ++ ++
Sbjct: 254 LDKPDNC---------------------PDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 59/264 (22%), Positives = 95/264 (35%), Gaps = 19/264 (7%)
Query: 688 NLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
++G G V + L + A+K L K E + + R+ H VKL
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
+ Y NG L + + G D + L YLH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG---K 127
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
I+HRD+K NILL+ +M ++ DFG AK + G+ Y++PE K
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 866 KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLI- 924
+ SD+++ G ++ +LV G P G I + + + PE+ L+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK-FFPKARDLVE 242
Query: 925 -----DPRMDLSTCDYEEAEKVLN 943
D L + E +
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (419), Expect = 2e-45
Identities = 53/267 (19%), Positives = 106/267 (39%), Gaps = 20/267 (7%)
Query: 665 WKVVTFQRVSFNEDDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPET 723
WK Q V + + + +GSG V++ +G K + T P
Sbjct: 12 WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLD 69
Query: 724 ETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS 783
+ ++EI + ++ H ++ L + +L+ E++ G L D + + + +
Sbjct: 70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEA 127
Query: 784 IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV--ADFGLAKALQSQEG 841
+ + A +GL ++H +IVH D+K NI+ + + V DFGLA L
Sbjct: 128 EVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----- 179
Query: 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIV 901
D+ + + + APE + V +D+++ GV+ L++G P ++ + +
Sbjct: 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETL 237
Query: 902 RWVTEATLSSPER---GCCRDLNQLID 925
+ V E + I
Sbjct: 238 QNVKRCDWEFDEDAFSSVSPEAKDFIK 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 67/306 (21%), Positives = 118/306 (38%), Gaps = 50/306 (16%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLKS--------GETVAVKRLLGGTHKPETETVFRSEIETL 734
L +G G +V + VAVK L + + SE+E +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMM 72
Query: 735 GRV-RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGS-------------L 780
+ +H N++ LL C+ ++ EY G+L + L + G L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 781 DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840
S A A+G+ YL + +HRD+ + N+L+ + V ++ADFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HH 187
Query: 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDI 900
+ ++APE + + T +SDV+SFGV+L E+ T P +++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 246
Query: 901 VRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR 960
+ + E C +L ++ C P RP+ +
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMM---------------------RDCWHAVPSQRPTFK 285
Query: 961 RVVELL 966
++VE L
Sbjct: 286 QLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 68/306 (22%), Positives = 112/306 (36%), Gaps = 48/306 (15%)
Query: 683 HLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
L +G G +V + + TVAVK L G E SE++ L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIH 72
Query: 737 VRHGNVVKLLM--CCSGQDFNILVYEYMPNGSLADMLHEKGR-------------SGSLD 781
+ H V L+ C +++ E+ G+L+ L K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 782 WSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841
+ AKG+ +L + +HRD+ + NILL + V ++ DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIV 901
++APE + + T +SDV+SFGV+L E+ + P +++
Sbjct: 190 YV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 902 RWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRR 961
R + E T ++ Q + L C P RP+
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTM---------------------LDCWHGEPSQRPTFSE 286
Query: 962 VVELLR 967
+VE L
Sbjct: 287 LVEHLG 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (397), Expect = 2e-43
Identities = 73/280 (26%), Positives = 119/280 (42%), Gaps = 26/280 (9%)
Query: 683 HLTE----QNLIGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGR 736
HL++ ++G GG V+ + L+ VAVK L P FR E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 737 VRHGNVVKLLMCCSGQD----FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGA 792
+ H +V + + +V EY+ +L D++H +G + + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADA 120
Query: 793 AKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAG 852
+ L + H + I+HRDVK NI++ A +V DFG+A+A+ + G S + V G
Sbjct: 121 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIG 176
Query: 853 SYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP-NDPSFGENKDIVRWVTEATLSS 911
+ Y++PE A V +SDVYS G VL E++TG+ P S S+
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 912 PERGCCRDLNQLI------DPRMDLSTCD--YEEAEKVLN 943
G DL+ ++ +P T + +V N
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 1e-42
Identities = 46/243 (18%), Positives = 95/243 (39%), Gaps = 21/243 (8%)
Query: 689 LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G G V++ S +T K + K + + + EI L RH N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
+ ++++E++ + + ++ L+ S + L +LH+ I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 808 VHRDVKSHNILLDAEMVPRV--ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
H D++ NI+ + +FG A+ L + D + + Y APE
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL-----KPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 866 KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE---RGCCRDLNQ 922
V+ +D++S G ++ L++G P N+ I+ + A + E + +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 923 LID 925
+D
Sbjct: 237 FVD 239
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (394), Expect = 4e-42
Identities = 64/269 (23%), Positives = 101/269 (37%), Gaps = 25/269 (9%)
Query: 687 QNLIGSGGSCRVYKVKLK-SGETVAVKRL-LGGTHKPETETVFRSEIETLGRVR---HGN 741
+IG GG VY + +G+ A+K L + ET+ +E L V
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
+V + D + + M G L L + G + A GL ++HN
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMHN 125
Query: 802 DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEY 861
+V+RD+K NILLD R++D GLA S G++GY+APE
Sbjct: 126 RF---VVYRDLKPANILLDEHGHVRISDLGLACDF------SKKKPHASVGTHGYMAPEV 176
Query: 862 AYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920
+D +S G +L +L+ G P ++K + +T +L
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 921 NQLI------DPRMDLSTCDYEEAEKVLN 943
L+ D L C A++V
Sbjct: 237 RSLLEGLLQRDVNRRL-GCLGRGAQEVKE 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (387), Expect = 5e-42
Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 20/285 (7%)
Query: 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
IG G VYK + GET A+K++ + EI L ++H N+VKL
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
+ +LV+E++ + +G L+ S G+AY H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDRR---V 121
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
+HRD+K N+L++ E ++ADFGLA+A + + +KK
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGI---PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 868 TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPR 927
+ D++S G + E+V G G ++ L +P ++ +L
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFP---GVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 928 MDLSTCDYEEAEKVLNVALMCTSDF--------PINRPSMRRVVE 964
+ + + E L D P R + ++ +E
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 6e-42
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 687 QNLIGSGGSCRVYKVK-LKSGETVAVKRL-------LGGTHKPETETVFRSEIETLGRVR 738
+ ++G G S V + + + AVK + E E++ L +V
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 739 -HGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
H N+++L F LV++ M G L D L EK L I + + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVIC 124
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
LH IVHRD+K NILLD +M ++ DFG + L + + V G+ Y+
Sbjct: 125 ALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPGEKLREVCGTPSYL 176
Query: 858 APEYAYT------KKVTEKSDVYSFGVVLMELVTGKRP 889
APE ++ D++S GV++ L+ G P
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 7e-42
Identities = 58/288 (20%), Positives = 98/288 (34%), Gaps = 36/288 (12%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL- 746
IGSG +Y + +GE VA+K T P+ E + ++ G + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIR 69
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
C + D+N++V E + + +A + Y+H+
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSKN--- 123
Query: 807 IVHRDVKSHNIL---LDAEMVPRVADFGLAKALQSQEGQSDDAM---SCVAGSYGYIAPE 860
+HRDVK N L + + DFGLAK + + G+ Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 861 YAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK-DIVRWVTEATLSSPERGCCRD 919
+ + + D+ S G VLM G P K ++E +S+P C+
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
E LN C S ++P + +L R
Sbjct: 244 YP--------------SEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (386), Expect = 1e-41
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 10/213 (4%)
Query: 678 DDILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGR 736
+DI ++++G+G V + ++ + VA+K + + + + +EI L +
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHK 63
Query: 737 VRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGL 796
++H N+V L L+ + + G L D + EKG + +
Sbjct: 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAV 120
Query: 797 AYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
YLH+ + + LD + ++DFGL+K +S G+ GY
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-----DPGSVLSTACGTPGY 175
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+APE K ++ D +S GV+ L+ G P
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 57/242 (23%), Positives = 97/242 (40%), Gaps = 16/242 (6%)
Query: 687 QNLIGSGGSCRVYKVKLK-SGETVAVKRL-LGGTHKPETETVFRSEIETLGRV-RHGNVV 743
++G G +V+ + K + + A+K L + E L H +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
+ ++ V EY+ G L + + D S A GL +LH+
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG 123
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
IV+RD+K NILLD + ++ADFG+ K D + G+ YIAPE
Sbjct: 124 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENML----GDAKTNTFCGTPDYIAPEILL 176
Query: 864 TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923
+K D +SFGV+L E++ G+ P + +++ + P R ++ L
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPFYP-RWLEKEAKDL 233
Query: 924 ID 925
+
Sbjct: 234 LV 235
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 28/292 (9%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRL---LGGTHKPETETVFRSEIETLGRVRHGNVV 743
+ +G G VYK + K + + VA+K++ K EI+ L + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 744 KLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
LL + LV+++M + L S + +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAY 863
I+HRD+K +N+LLD V ++ADFGLAK+ G + A + + Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSF----GSPNRAYTHQVVTRWYRAPELLF 173
Query: 864 TKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQ 922
++ D+++ G +L EL+ G++ TL +P D+
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLP---GDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 923 LID-------PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
L D P + L + +L++ P R + + L+
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT---QALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 67/290 (23%), Positives = 116/290 (40%), Gaps = 25/290 (8%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
IG G VYK + K +GE VA+K++ T + EI L + H N+VKLL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
++ LV+E++ + + + S +GLA+ H+
Sbjct: 68 DVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE-YAYTK 865
++HRD+K N+L++ E ++ADFGLA+A G + + Y APE K
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 866 KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
+ D++S G + E+VT + G+++ + TL +P+ + + D
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFP---GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 926 PRMDLSTCDYEEAEKVLNVALMCTSDF--------PINRPSMRRVVELLR 967
+ ++ KV+ P R S + L
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK---AALA 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (366), Expect = 3e-39
Identities = 49/290 (16%), Positives = 91/290 (31%), Gaps = 38/290 (13%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGN-VVKLL 746
IG G +++ L + + VA+K + R E T + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
N+LV + + D+L GR A+ + +H
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLE-DLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 807 IVHRDVKSHNILLDAEMVP-----RVADFGLAKALQSQEGQS---DDAMSCVAGSYGYIA 858
+V+RD+K N L+ V DFG+ K + + ++G+ Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 859 PEYAYTKKVTEKSDVYSFGVVLMELVTGK-RPNDPSFGENKDIVRWVTEATLSSPERGCC 917
++ + + D+ + G V M + G NK + E S+P R C
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLR 967
EE K ++ + P + L
Sbjct: 242 AGFP--------------EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-39
Identities = 60/298 (20%), Positives = 112/298 (37%), Gaps = 20/298 (6%)
Query: 679 DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV 737
D+ P T + IG G V + VA+K++ H+ + R EI+ L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRF 63
Query: 738 RHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
RH N++ + + Y+ + L++ ++ L +GL
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYI 857
Y+H+ ++HRD+K N+LL+ ++ DFGLA+ ++ + Y
Sbjct: 124 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH-TGFLTEYVATRWYR 179
Query: 858 APEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916
APE K T+ D++S G +L E+++ + G++ L SP +
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF---PGKHYLDQLNHILGILGSPSQED 236
Query: 917 CRDLNQLIDPRMDLSTCDYEEA----------EKVLNVALMCTSDFPINRPSMRRVVE 964
+ L LS + K L++ + P R + + +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-39
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 675 FNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRL----LGGTHKPETETVFRS 729
F ++++ + +GSG V K + K +G A K + + + +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIA 789
E+ L ++H NV+ L + IL+ E + G L D L EK L
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 119
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPR----VADFGLAKALQSQEGQSDD 845
+ G+ YLH+ I H D+K NI+L VP+ + DFGLA + +
Sbjct: 120 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----DFGN 171
Query: 846 AMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ G+ ++APE + + ++D++S GV+ L++G P
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (367), Expect = 5e-39
Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 18/240 (7%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKL 745
+G+G RV+ ++ + +G A+K L + + E L V H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 746 LMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVP 805
++ +Y+ G L +L + R + +F A+ L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVCL----ALEYLHSK 123
Query: 806 AIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK 865
I++RD+K NILLD ++ DFG AK + D + G+ YIAPE TK
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV-------PDVTYTLCGTPDYIAPEVVSTK 176
Query: 866 KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
+ D +SFG+++ E++ G P S + A L P D+ L+
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRFPPF-FNEDVKDLLS 233
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-38
Identities = 64/245 (26%), Positives = 104/245 (42%), Gaps = 24/245 (9%)
Query: 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV 743
T+ +IG+G VY+ KL SGE VA+K++L + + E++ + ++ H N+V
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCNIV 76
Query: 744 KLLMCCSGQD------FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLA 797
+L + LV +Y+P H +L + LA
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 798 YLHNDCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGY 856
Y+H+ I HRD+K N+LLD + V ++ DFG AK L + + +S + Y
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV----RGEPNVSYICSRYYR 189
Query: 857 IAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916
T DV+S G VL EL+ G+ G++ L +P R
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 917 CRDLN 921
R++N
Sbjct: 247 IREMN 251
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 61/291 (20%), Positives = 104/291 (35%), Gaps = 25/291 (8%)
Query: 688 NLIGSGGSCRVYKVKLK--SGETVAVKRLLGGTHKPETETVFRSEIE---TLGRVRHGNV 742
IG G +V+K + G VA+KR+ T + E+ L H NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 743 VKLLMCCSGQDFNILVYEYMPNGSLA---DMLHEKGRSGSLDWSIRFSIAQGAAKGLAYL 799
V+L C+ + + + +K + + +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 800 HNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
H+ +VHRD+K NIL+ + ++ADFGLA+ Q A++ V + Y AP
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-----MALTSVVVTLWYRAP 184
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919
E D++S G + E+ K S + D + + + E RD
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIGLPGEEDWPRD 242
Query: 920 LNQLIDPRMDLSTCDYEEAEKVLN------VALMCTSDFPINRPSMRRVVE 964
+ S E+ ++ + T + P R S +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN-PAKRISAYSALS 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 58/298 (19%), Positives = 115/298 (38%), Gaps = 30/298 (10%)
Query: 688 NLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
IG G V+K + K+G+ VA+K++L K EI+ L ++H NVV L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 747 MCCSGQDFNI--------LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAY 798
C + LV+++ + + + + S + Q GL Y
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYY 132
Query: 799 LHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIA 858
+H + I+HRD+K+ N+L+ + V ++ADFGLA+A + + + + Y
Sbjct: 133 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 859 PEYAYTKK-VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917
PE ++ D++ G ++ E+ T + + + +++ S
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLCGSITPEVWP 247
Query: 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVAL-----------MCTSDFPINRPSMRRVVE 964
N + +++L + + L + + D P R +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD-PAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 63/289 (21%), Positives = 101/289 (34%), Gaps = 23/289 (7%)
Query: 688 NLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLL 746
IG G V+K K + + E VA+KR+ + EI L ++H N+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 747 MCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA 806
LV+E+ G D I S KGL + H+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 807 IVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK 866
++HRD+K N+L++ ++A+FGLA+A + V + K
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI---PVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 867 VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLIDP 926
+ D++S G + EL RP G + D L +P + +L D
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 927 RMDLSTCDYEEAEKVLNVALMCTSDF--------PINRPSMRRVVELLR 967
+ V+ D P+ R S E L+
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE---EALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 9e-37
Identities = 64/277 (23%), Positives = 105/277 (37%), Gaps = 29/277 (10%)
Query: 672 RVSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRL-LGGTHKPETETVFRS 729
+V+ N+ D L L+G G +V V+ K +G A+K L + +
Sbjct: 1 KVTMNDFDYL------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 730 EIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIA 789
E L RH + L D V EY G L L + + RF A
Sbjct: 55 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--TEERARFYGA 112
Query: 790 QGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSC 849
+ ++ L +V+RD+K N++LD + ++ DFGL K S M
Sbjct: 113 EI----VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----GATMKT 164
Query: 850 VAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909
G+ Y+APE D + GVV+ E++ G+ P +++ + + +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEI 222
Query: 910 SSPERGCCRDLNQLI------DP--RMDLSTCDYEEA 938
P R + L+ DP R+ D +E
Sbjct: 223 RFP-RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 24/224 (10%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRL----LGGTHKPETETVFRSEIETLGRVRHG--N 741
L+GSGG VY + VA+K + + + T E+ L +V G
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 742 VVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN 801
V++LL D +L+ E + G+L + S + + + HN
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN 128
Query: 802 DCVPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPE 860
++HRD+K NIL+D ++ DFG L+ D + G+ Y PE
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTRVYSPPE 179
Query: 861 Y-AYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRW 903
+ Y + + V+S G++L ++V G P F +++I+R
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRG 219
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLL 746
++G G + +V ++ ++ E A+K L + R E+E R + ++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 71
Query: 747 MCC----SGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND 802
+G+ ++V E + G L + ++G + I + + + YLH+
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS- 129
Query: 803 CVPAIVHRDVKSHNILLDAEM---VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAP 859
I HRDVK N+L ++ + ++ DFG AK S ++++ + Y+AP
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-----HNSLTTPCYTPYYVAP 182
Query: 860 EYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
E +K + D++S GV++ L+ G P
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 6e-35
Identities = 57/238 (23%), Positives = 91/238 (38%), Gaps = 18/238 (7%)
Query: 690 IGSGGSCRVYKVK-LKSGETVAVKRL-LGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G+G RV VK +SG A+K L K + +E L V +VKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 748 CCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAI 807
+V EY+ G + L GR A YLH+ +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 808 VHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV 867
++RD+K N+L+D + +V DFG AK + + G+ +APE +K
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWTLCGTPEALAPEIILSKGY 215
Query: 868 TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQLID 925
+ D ++ GV++ E+ G P + I + + P DL L+
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFPSH-FSSDLKDLLR 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-33
Identities = 59/308 (19%), Positives = 111/308 (36%), Gaps = 24/308 (7%)
Query: 670 FQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETV 726
F R + ++ + +GSG V ++G VA+K+L
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 727 FRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEK-GRSGSLDWSIR 785
E+ L +RH NV+ LL + + ++ K + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 786 FSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDD 845
+ KGL Y+H + HRD+K N+ ++ + ++ DFGLA+ Q+D
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR-------QADS 173
Query: 846 AMSCVAGSYGYIAPEYAY-TKKVTEKSDVYSFGVVLMELVTGKRP--NDPSFGENKDIVR 902
M+ + Y APE + T+ D++S G ++ E++TGK + K+I++
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 903 WVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLN------VALMCTSDFPINR 956
+R + + +L D+ + + M D R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD-AEQR 292
Query: 957 PSMRRVVE 964
+ +
Sbjct: 293 VTAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 34/290 (11%)
Query: 671 QRVSFNEDDILPHLTEQNLIGSGGSCRVYKVKL----KSGETVAVKRLLGGT--HKPETE 724
++V ++L ++G+G +V+ V+ +G+ A+K L T K +T
Sbjct: 19 EKVGIENFELL------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 725 TVFRSEIETLGRVRHG-NVVKLLMCCSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWS 783
R+E + L +R +V L + L+ +Y+ G L L ++ R +
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 132
Query: 784 IRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQS 843
I + + L + I++RD+K NILLD+ + DFGL+K + E +
Sbjct: 133 IYV------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 186
Query: 844 DDAMSCVAGSYGYIAPEYAYTKK--VTEKSDVYSFGVVLMELVTGKRP--NDPSFGENKD 899
G+ Y+AP+ + D +S GV++ EL+TG P D +
Sbjct: 187 ---AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243
Query: 900 IVRWVTEATLSSPERGCCRDLNQLI------DPRMDLSTCDYEEAEKVLN 943
I R + ++ P+ LI DP+ L C +A+++
Sbjct: 244 ISRRILKSEPPYPQ-EMSALAKDLIQRLLMKDPKKRLG-CGPRDADEIKE 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (299), Expect = 6e-30
Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 25/221 (11%)
Query: 688 NLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKL 745
+G G V++ + + E V VK L KP + + EI+ L +R N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITL 95
Query: 746 LMCCSGQDFN--ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC 803
LV+E++ N + +L K L Y H+
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG 149
Query: 804 VPAIVHRDVKSHNILLDAE-MVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYA 862
I+HRDVK HN+++D E R+ D+GLA+ + S + PE
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-----GQEYNVRVASRYFKGPELL 201
Query: 863 YT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVR 902
+ D++S G +L ++ K P +VR
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 9e-30
Identities = 52/229 (22%), Positives = 83/229 (36%), Gaps = 23/229 (10%)
Query: 670 FQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETV 726
F V + +L IGSG V VA+K+L
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 727 FRSEIETLGRVRHGNVVKLLMCCSGQDFN------ILVYEYMPNGSLADMLHEKGRSGSL 780
E+ + V H N++ LL + Q LV E M + E
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------ 116
Query: 781 DWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840
D + G+ +LH+ I+HRD+K NI++ ++ ++ DFGLA+
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----- 168
Query: 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP 889
+ M+ + Y APE E D++S G ++ E+V K
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-28
Identities = 59/313 (18%), Positives = 112/313 (35%), Gaps = 29/313 (9%)
Query: 669 TFQRVSFNED--DILPHLTEQNLIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETET 725
TF R N+ ++ + +GSG V K+G VAVK+L
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 726 VFRSEIETLGRVRHGNVVKLLMCC----SGQDFNILVYEYMPNGSLADMLHEKGRSGSLD 781
E+ L ++H NV+ LL S ++FN + G+ + + + + L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LT 119
Query: 782 WSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841
+ +GL Y+H+ + HRD+K N+ ++ + ++ DFGLA+ +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM- 175
Query: 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRP--NDPSFGENKD 899
VA + + D++S G ++ EL+TG+ + K
Sbjct: 176 -----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 900 IVRWVTEATLSSPERGCCRDLNQLID-----PRMDLSTCDYEEAEKVLNVALMCTSDFPI 954
I+R V ++ I P+M+ + +++
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290
Query: 955 NRPSMRRVVELLR 967
R + + L
Sbjct: 291 KRITAA---QALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 3e-28
Identities = 48/225 (21%), Positives = 82/225 (36%), Gaps = 20/225 (8%)
Query: 689 LIGSGGSCRVYKVK-LKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLM 747
+G G V+ K + + VA+K + G E EI+ L RV + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNTKEDS 76
Query: 748 CCSGQDFNILVY--EYMPNGSLADMLHE-----------KGRSGSLDWSIRFSIAQGAAK 794
+ +L + PNG M+ E K + I++
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 795 GLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSY 854
GL Y+H C I+H D+K N+L++ P + A D+ + +
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN-LIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 855 GYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899
Y +PE +D++S ++ EL+TG +P G +
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 109 bits (273), Expect = 9e-27
Identities = 67/306 (21%), Positives = 118/306 (38%), Gaps = 8/306 (2%)
Query: 29 DAEILIRVKSDQLDDPNRKLGDWVRTSQQSPCNWTGITCETQNQS--VDGIDLSGFDLSG 86
D + L+++K L +P L W+ T+ W G+ C+T Q+ V+ +DLSG +L
Sbjct: 7 DKQALLQIKK-DLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 87 GF--PNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREF 144
+ P+ + L L + +++ L L + + G +PDF +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
L LD S N SG +P S P L + GN +SG IP G+ ++L
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
+ +P + NL+ + +
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD--KNTQKIHLAKNSLAFDLGKVGL 242
Query: 265 LASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNY 324
++ ++L +N++ G LP+ L+ L L L++S NNL G +P+ + +N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 325 FTGEIP 330
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 99.8 bits (247), Expect = 3e-23
Identities = 69/292 (23%), Positives = 100/292 (34%), Gaps = 29/292 (9%)
Query: 335 SNPNLVQLKLFNNSFSGK--LPDDLGKYSNLEYFDVSTND-FTGELPRFLCFRNKLQCII 391
+ L L + +P L L + + + G +P + +L +
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 392 IFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISP 451
I + SG IP+ + KTL L F N L G LP LP + NR G+I
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 452 SISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLE 511
S + KL + N L VDLS+N G Q
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN-TQKI 226
Query: 512 LQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPL 571
+ L L+L N++ GT+P L L L SL++S N L GEIP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285
Query: 572 ELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSPDLKPLPPCS 623
+ L+ +S+ +N LC PLP C+
Sbjct: 286 QGGNLQ---------------------RFDVSAYANNKCLCGS---PLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.6 bits (197), Expect = 7e-17
Identities = 64/278 (23%), Positives = 105/278 (37%), Gaps = 3/278 (1%)
Query: 151 DLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGL--IPSFLGNLTELTHFELGYNPLKSS 208
D + G + ++ + + L+L G L IPS L NL L +G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 209 PLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASI 268
P+P ++ L++L L+ N+ G IPD + ++ L LD S N LSG +P S S L ++
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 269 EQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGE 328
I N++SG +P+S + + L N A +
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 329 IPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQ 388
L + Q + +G NL D+ N G LP+ L L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 389 CIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELP 426
+ + N G+IP+ G + + + N+ P
Sbjct: 272 SLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 64.4 bits (155), Expect = 2e-11
Identities = 25/68 (36%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 146 NLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP- 204
NL LDL N G +P+ + L LN+ N L G IP GNL N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303
Query: 205 LKSSPLPS 212
L SPLP+
Sbjct: 304 LCGSPLPA 311
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.2 bits (243), Expect = 2e-22
Identities = 73/388 (18%), Positives = 133/388 (34%), Gaps = 41/388 (10%)
Query: 216 NLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFD 275
L++ K N+ + + L ++ L + I L ++ QI +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 276 NQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPES--- 332
NQL+ P L NLT L+ + ++ N + P N+ + ++
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 333 -------------LASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPR 379
+++ L L+ + L + LE D+S+N +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 380 FLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFE 439
+ +I NN+ S P L+ L GN+L+ L + +
Sbjct: 194 AKLTNL--ESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 440 MYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPT 499
+ NN+ +S KLT + + N + P T N +
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQLEDIS 301
Query: 500 CITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLD 559
I+ L L L L N + P ++SLT L L + N+++ L NL + L
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 560 LSSNLLTGEIPLE-LTKLKLNQFNISHN 586
N ++ PL LT++ Q ++
Sbjct: 358 AGHNQISDLTPLANLTRIT--QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 6e-20
Identities = 70/387 (18%), Positives = 122/387 (31%), Gaps = 59/387 (15%)
Query: 143 EFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGY 202
+ + L R I + L +N N L+ + P L NLT+L +
Sbjct: 42 DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 203 NPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDL------------- 249
N + +++ NL+ L ++ + LS+ +
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 250 -SDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPE 308
+ L ++E++++ N+ L+ LT L L + N ++ P
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISVLAKLTNLESLIATNNQISDITPL 215
Query: 309 TIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDV 368
I +L+ L+LN N +LAS NL L L NN S P L + L +
Sbjct: 216 GI-LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270
Query: 369 STNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSK 428
N + P + N + K L YL N + P
Sbjct: 271 GANQISNISP----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-- 324
Query: 429 FWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDL 488
+S+ KL + N + S + L + +
Sbjct: 325 ------------------------VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 489 SQNRFSGHLPTCITQLNKLQQLELQEN 515
N+ S P + L ++ QL L +
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.1 bits (222), Expect = 1e-19
Identities = 79/420 (18%), Positives = 132/420 (31%), Gaps = 57/420 (13%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
A L + N + + ++ + L + + + L LT N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFS 263
L + NL+KL ++ + P + L + + +
Sbjct: 77 QLTDIT---PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT- 132
Query: 264 GLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDN 323
++ ++EL N +S S L +L T S N +
Sbjct: 133 ---NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 324 YFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCF 383
A NL L NN S P + +NL+ ++ N L
Sbjct: 190 ISVL------AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLAS 239
Query: 384 RNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNN 443
L + + NN+ S P L L+ G N++ P GL + E+ N
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN 295
Query: 444 RFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQ 503
+ E S I L+ L + L N S P ++
Sbjct: 296 QL--------------------------EDISPISNLKNLTYLTLYFNNISDISP--VSS 327
Query: 504 LNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563
L KLQ+L N + +L +LT + L+ NQ++ P L NL +T L L+
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 3e-19
Identities = 57/236 (24%), Positives = 86/236 (36%), Gaps = 16/236 (6%)
Query: 88 FPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANL 147
+ L L D N L+ +L+ L N P NL
Sbjct: 164 QVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NL 221
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207
L L+ N + L L+L N +S L P L LT+LT +LG N + +
Sbjct: 222 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 277
Query: 208 SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLAS 267
+ + L+ LE E I L L+ L L N +S P S L
Sbjct: 278 ISPLAGLTALTNLELNE-----NQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 268 IEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDN 323
++++ +N++S SL+NLT + L N ++ L + L LND
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 1e-17
Identities = 64/370 (17%), Positives = 119/370 (32%), Gaps = 59/370 (15%)
Query: 263 SGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT-----GNLPETIAAMSLES 317
+ LA + L ++ + S ++L + L + + L +L
Sbjct: 19 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSIDGVEYLN------NLTQ 70
Query: 318 LNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGEL 377
+N ++N T P L + LV + + NN + P + L
Sbjct: 71 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128
Query: 378 PRFLCFR------NKLQCIIIFNNRFSGKIPESYGECKTLNYL-------RFGGNELQGE 424
N + I + S + + L L R + +
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188
Query: 425 LPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484
S L ++ NN+ I L + +NGN + +L L
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELP--------------------RN 524
+DL+ N+ S P ++ L KL +L+L N + P
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 525 LNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLK-LNQFNI 583
+++L L L L N ++ P + +L L L ++N ++ L L +N +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 584 SHNKLYGEVP 593
HN++ P
Sbjct: 359 GHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 2e-12
Identities = 29/125 (23%), Positives = 41/125 (32%), Gaps = 6/125 (4%)
Query: 79 LSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELP 138
L+ L + + L L + N +S +L L L +N P
Sbjct: 265 LTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 324
Query: 139 DFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHF 198
LQ L + N S S + L+ G N +S L P L NLT +T
Sbjct: 325 --VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378
Query: 199 ELGYN 203
L
Sbjct: 379 GLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 4e-12
Identities = 63/368 (17%), Positives = 112/368 (30%), Gaps = 50/368 (13%)
Query: 61 NWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPC 120
N T +T V + + +G + L +N S+N L
Sbjct: 33 NVTDTVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP---LKNL 87
Query: 121 FHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNL 180
L + ++ N P + L ++ + + N ++
Sbjct: 88 TKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI 147
Query: 181 LSGLIP------------SFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKA 228
+ + L L LT E S + L+ LE+L A
Sbjct: 148 SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNN 207
Query: 229 NLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSN 288
+ P I L L L+ N L + + L ++ ++L +NQ+S P LS
Sbjct: 208 QISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSG 261
Query: 289 LTTLLRLDISQNNLTGNLP---------------------ETIAAMSLESLNLNDNYFTG 327
LT L L + N ++ P +L L L N +
Sbjct: 262 LTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD 321
Query: 328 EIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKL 387
P ++S L +L NN S L +N+ + N + P L ++
Sbjct: 322 ISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRI 375
Query: 388 QCIIIFNN 395
+ + +
Sbjct: 376 TQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 14/105 (13%), Positives = 38/105 (36%), Gaps = 7/105 (6%)
Query: 51 WVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNG 110
+ + + I+ + +++ + L ++S P + L+ L ++N +
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
Query: 111 TLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155
SL+ ++ L+ +N P + + L L+
Sbjct: 344 V---SSLANLTNINWLSAGHNQISDLTPLAN--LTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.1 bits (222), Expect = 4e-20
Identities = 66/308 (21%), Positives = 110/308 (35%), Gaps = 45/308 (14%)
Query: 145 ANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
+ +LDL N + F L L L N +S + P L +L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG 264
LK +P+ + K L L + +N ++ F+G
Sbjct: 91 LKE--------------------------LPEKMPK--TLQELRVHENEITKVRKSVFNG 122
Query: 265 LASIEQIELFDNQL--SGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322
L + +EL N L SG + + L + I+ N+T +P+ + SL L+L+
Sbjct: 123 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP-SLTELHLDG 180
Query: 323 NYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLC 382
N T SL NL +L L NS S L +L ++ N+ ++P L
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN-NNKLVKVPGGLA 239
Query: 383 FRNKLQCIIIFNNRFSG------KIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVD 436
+Q + + NN S P + + + + N +Q +W +
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ------YWEIQPST 293
Query: 437 FFEMYNNR 444
F +Y
Sbjct: 294 FRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.3 bits (220), Expect = 6e-20
Identities = 52/302 (17%), Positives = 106/302 (35%), Gaps = 25/302 (8%)
Query: 233 EIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTL 292
++P + + LDL +N ++ F L ++ + L +N++S P + + L L
Sbjct: 24 KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 293 LRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFN--NSFS 350
RL +S+N L LPE + + L +++N T ++ ++L S
Sbjct: 82 ERLYLSKNQLK-ELPEKMPKTL-QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 351 GKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKT 410
G L Y ++ + T +P+ L L + + N+ + S
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNN 196
Query: 411 LNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT 470
L L N + P + + NN+ +++ + + ++ NN +
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNIS 255
Query: 471 GEVPSQICTLRQL-QAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529
+ C + S N +Q E+Q + F R +
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFS---------NPVQYWEIQPSTF-----RCVYVRA 301
Query: 530 AL 531
A+
Sbjct: 302 AV 303
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.3 bits (207), Expect = 4e-18
Identities = 56/259 (21%), Positives = 93/259 (35%), Gaps = 14/259 (5%)
Query: 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRN 155
L+L +N + +L L L N P L+ L LS+N
Sbjct: 31 PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 156 NFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSP-LPSSV 214
+ L+V N ++ + S L ++ ELG NPLKSS +
Sbjct: 90 QLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146
Query: 215 GNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELF 274
+ KL + A I IP + L+ L L N ++ S GL ++ ++ L
Sbjct: 147 QGMKKLSYIRIAD-TNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 275 DNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTG------E 328
N +S SL+N L L ++ N L ++ + L++N +
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 329 IPESLASNPNLVQLKLFNN 347
P + + LF+N
Sbjct: 264 PPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.5 bits (205), Expect = 5e-18
Identities = 52/256 (20%), Positives = 90/256 (35%), Gaps = 11/256 (4%)
Query: 122 HLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLL 181
+L L N + NL L L N S P +F L+ L L N L
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 182 SGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKL 241
L L EL E ++ S N + L G + +
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 242 AFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNN 301
LS + ++D ++ IP S+ ++ L N+++ SL L L +L +S N+
Sbjct: 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSG------KLPD 355
++ ++A +N ++P LA + + + L NN+ S P
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 356 DLGKYSNLEYFDVSTN 371
K ++ + +N
Sbjct: 267 YNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 66.2 bits (160), Expect = 3e-12
Identities = 37/213 (17%), Positives = 77/213 (36%), Gaps = 5/213 (2%)
Query: 387 LQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFE 446
+ + NN+ + + K L+ L N++ P F L +++ + N+ +
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 447 GSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNK 506
+ + + + N + + + + + SG + K
Sbjct: 93 -ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 507 LQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT 566
L + + + T +P+ L +L L+L N++T L L L L LS N ++
Sbjct: 152 LSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 567 GEIPLELTKLK-LNQFNISHNKLYGEVPSDFDH 598
L L + ++++NKL DH
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 28/153 (18%), Positives = 48/153 (31%), Gaps = 1/153 (0%)
Query: 457 PKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENM 516
P + + N T L+ L + L N+ S P L KL++L L +N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 517 FTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKL 576
+ +L L V ++ ++ L + V+ E
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 577 KLNQFNISHNKLYGEVPSDFDHDLFISSLLDNP 609
KL+ I+ + +P L L N
Sbjct: 151 KLSYIRIADTNI-TTIPQGLPPSLTELHLDGNK 182
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.5 bits (203), Expect = 2e-18
Identities = 28/207 (13%), Positives = 62/207 (29%), Gaps = 33/207 (15%)
Query: 688 NLIGSGGSCRVYKVKLKSGETVAVKRLLGGT--------HKPETETVFRSEIETLGRVRH 739
L+G G V+ + VK G + + F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 740 GNVVKLLMCCSGQDF----NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKG 795
+ KL + + N ++ E + L + E + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD----------EVLDMILEE 115
Query: 796 LAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYG 855
+A ++ IVH D+ +N+L+ E + DF + + + +
Sbjct: 116 VAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV------ 165
Query: 856 YIAPEYAYTKKVTEKSDVYSFGVVLME 882
Y +++ + D+ S +++
Sbjct: 166 RNIITY-FSRTYRTEKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (202), Expect = 8e-18
Identities = 47/265 (17%), Positives = 88/265 (33%), Gaps = 8/265 (3%)
Query: 281 ELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS-LESLNLNDNYFTGEIPESLASNPNL 339
+P + + R+ + N ++ + A L L L+ N + L
Sbjct: 25 AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 340 VQLKLFNNSFSGKL-PDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFS 398
QL L +N+ + P L + P LQ + + +N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 399 GKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPK 458
+++ + L +L GN + F GL +D ++ NR + + +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 459 LTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFT 518
L + + NN + + LR LQ + L+ N + LQ+ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 519 GELPRNLNSLTALIVLNLSTNQLTG 543
LP+ L + L+ N L G
Sbjct: 262 CSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (192), Expect = 2e-16
Identities = 65/286 (22%), Positives = 102/286 (35%), Gaps = 9/286 (3%)
Query: 67 CETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVL 126
C N+ L P G + + L N + + + S C +L +L
Sbjct: 6 CVCYNEPKVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISH-VPAASFRACRNLTIL 61
Query: 127 ALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDI-PESFGRFPVLKVLNLGGNLLSGLI 185
L NV A L+ LDLS N + P +F L L+L L L
Sbjct: 62 WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121
Query: 186 PSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLS 245
P L L + L N L++ P + +L L +L+ + + L L
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALP-DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 246 NLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGN 305
L L N ++ PH+F L + + LF N LS E+L+ L L L ++ N +
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240
Query: 306 LPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSG 351
L+ + + +P+ LA +L N G
Sbjct: 241 CRARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 4e-15
Identities = 43/269 (15%), Positives = 73/269 (27%), Gaps = 25/269 (9%)
Query: 328 EIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKL 387
+P + ++ L N S NL + +N L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 388 QCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEG 447
+ + + +N + P+ F GL + + +
Sbjct: 83 EQLDLSDNAQLRSVD-----------------------PATFHGLGRLHTLHLDRCGLQE 119
Query: 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKL 507
L + + N L L + L NR S L+ L
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179
Query: 508 QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTG 567
+L L +N P L L+ L L N L+ L L L L L+ N
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
Query: 568 EIPLELTKLKLNQFNISHNKLYGEVPSDF 596
+ L +F S +++ +P
Sbjct: 240 DCRARPLWAWLQKFRGSSSEVPCSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.8 bits (143), Expect = 4e-10
Identities = 40/216 (18%), Positives = 67/216 (31%), Gaps = 4/216 (1%)
Query: 409 KTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNN 468
+ GN + + F + +++N + + + L + ++ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 469 FTGEV-PSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNS 527
V P+ L +L + L + P L LQ L LQ+N
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 528 LTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNK 587
L L L L N+++ L L L L N + P L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 588 LYGEVPSDFDHD---LFISSLLDNPGLCSPDLKPLP 620
+P++ L L DNP +C +PL
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.9 bits (172), Expect = 7e-14
Identities = 31/269 (11%), Positives = 75/269 (27%), Gaps = 15/269 (5%)
Query: 294 RLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGK- 352
LD++ NL ++ + + + + ++ + E S + + L N+
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 353 LPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLN 412
L L + S L+ + + + L + L + + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 413 YLRFGGNELQGELPSKFWGLPEVDFFE---------MYNNRFEGSISPSISNAPKLTGIL 463
+ N + + + L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 464 INGNNFTGEVPSQICTLRQLQAVDLSQ-NRFSGHLPTCITQLNKLQQLELQENMFTGELP 522
+ + + L LQ + LS+ + ++ L+ L++ + G L
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 523 RNLNSLTALIVLNLSTNQLTGTIPPELGN 551
+L L ++ + T P +GN
Sbjct: 243 LLKEALPH---LQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 40/272 (14%), Positives = 83/272 (30%), Gaps = 18/272 (6%)
Query: 196 THFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLS 255
+L L + + + + + ++DLS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRC---PRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 256 GK-IPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMS 314
+ S + ++ + L +LS + +L+ + L+RL++S + S
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 315 LESLNLNDNY---------FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEY 365
L+ + + + L N L + + NL +
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 366 FDVSTND-FTGELPRFLCFRNKLQCIIIFN-NRFSGKIPESYGECKTLNYLRFGGNELQG 423
D+S + + + N LQ + + + GE TL L+ G G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 424 ELPSKFWGLPEVDFFEMYNNRFEGSISPSISN 455
L LP + + F P+I N
Sbjct: 240 TLQLLKEALPHLQI---NCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 43/278 (15%), Positives = 91/278 (32%), Gaps = 19/278 (6%)
Query: 99 RNLNLSDNYFNGTLSSQSLSPCFHLQVLALD-YNVFIGELPDFSREFANLQVLDLSRNNF 157
+ L+L+ L V+A F+ + +Q +DLS +
Sbjct: 3 QTLDLTGK----NLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVI 58
Query: 158 SGD-IPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP-LKSSPLPSSVG 215
+ + L+ L+L G LS I + L + L L L + +
Sbjct: 59 EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118
Query: 216 NLSKLENL---WAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIE 272
+ S+L+ L W ++ L+LS + + + + +
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 273 LFDN----QLSGELPESLSNLTTLLRLDISQ-NNLTGNLPETIAAM-SLESLNLNDNYFT 326
D L + + L L L +S+ ++ + + +L++L +
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238
Query: 327 GEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLE 364
G + + P+ L++ + F+ +G N E
Sbjct: 239 GTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 39/250 (15%), Positives = 83/250 (33%), Gaps = 13/250 (5%)
Query: 71 NQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDY 130
+Q V + F R +++++LS++ + LS C LQ L+L+
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 131 NVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNL--------GGNLLS 182
+ + + +NL L+LS + + ++ L +
Sbjct: 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 140
Query: 183 GLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLA 242
+ +T+L N KS + + + L + +L
Sbjct: 141 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200
Query: 243 FLSNLDLSD-NFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNN 301
+L +L LS + + + +++ +++F G L L L I+ ++
Sbjct: 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSH 257
Query: 302 LTGNLPETIA 311
T TI
Sbjct: 258 FTTIARPTIG 267
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 70.2 bits (170), Expect = 3e-13
Identities = 57/327 (17%), Positives = 93/327 (28%), Gaps = 27/327 (8%)
Query: 267 SIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFT 326
++EL + LS LPE +L +L S N+LT LPE ++ ++ N+
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 327 GEIPESLA------------SNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFT 374
++P L + + L +LE+ N
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 375 GELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPE 434
+ + +P S N + ELQ
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 435 VDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFS 494
+ + N L F + L +L N S
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 495 GHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAV 554
+ + L++L + N ELP L L S N L +P N
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQN--- 325
Query: 555 LTSLDLSSNLLTG--EIPLELTKLKLN 579
L L + N L +IP + L++N
Sbjct: 326 LKQLHVEYNPLREFPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 62.9 bits (151), Expect = 6e-11
Identities = 57/311 (18%), Positives = 92/311 (29%), Gaps = 28/311 (9%)
Query: 292 LLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSG 351
L+++ L+ +LPE LESL + N T E+PE +L L + NN+
Sbjct: 40 AHELELNNLGLS-SLPELPP--HLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA 92
Query: 352 ------KLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESY 405
L + LE N ++ K + + F
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 406 GECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILIN 465
E L L F K + + P + N P LT I +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 466 GNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQ--------QLELQENMF 517
N + + +++ N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 518 TGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLK 577
+ E+ + +L LN+S N+L +P L L S N L E+P LK
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLK 327
Query: 578 LNQFNISHNKL 588
Q ++ +N L
Sbjct: 328 --QLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 7e-08
Identities = 52/331 (15%), Positives = 99/331 (29%), Gaps = 29/331 (8%)
Query: 244 LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLT--TLLRLDISQNN 301
L+L++ LS +P +E + N L+ ELPE +L + ++ +
Sbjct: 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 302 LTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGK--LPDDLGK 359
L E + + + L + + + N +L +L S + L +
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 360 YSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGN 419
L+ T + L I + L + N
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 420 ELQGELPSKFWGLPEVDFFEMYNNRFEG--------SISPSISNAPKLTGILINGNNFTG 471
L+ + E S +L L N +
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274
Query: 472 EVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTAL 531
E+ S L+ +++S N+ LP +L++L N E+P +L
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLK-- 327
Query: 532 IVLNLSTNQLTGTIPPELGNLAVLTSLDLSS 562
L++ N L P + + L ++S
Sbjct: 328 -QLHVEYNPLR-EFPDIPES---VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 20/127 (15%), Positives = 37/127 (29%), Gaps = 12/127 (9%)
Query: 50 DWVRTSQQSPCNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFN 109
D Q + + S + +L LN+S+N
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL- 296
Query: 110 GTLSSQSLSPCF-HLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRF 168
L L+ L +N + E+P+ NL+ L + N P+
Sbjct: 297 -----IELPALPPRLERLIASFN-HLAEVPE---LPQNLKQLHVEYNPLRE-FPDIPESV 346
Query: 169 PVLKVLN 175
L++ +
Sbjct: 347 EDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 23/93 (24%), Positives = 36/93 (38%), Gaps = 10/93 (10%)
Query: 152 LSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLP 211
N S +I P L+ LN+ N L +P+ L L +N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLAE--VP 320
Query: 212 SSVGNLSKLENLWAAKANLIGEIPDSIGKLAFL 244
NL +L ++ + N + E PD + L
Sbjct: 321 ELPQNLKQL-HV---EYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 17/60 (28%), Positives = 25/60 (41%), Gaps = 7/60 (11%)
Query: 531 LIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYG 590
L L+ L+ ++P +L SL S N LT E+P LK + +N L
Sbjct: 40 AHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLK--SLLVDNNNLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 20/90 (22%), Positives = 30/90 (33%), Gaps = 10/90 (11%)
Query: 179 NLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSI 238
N S I S L + N L LP+ L +L A N + E+P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE--LPALPPRLERLI----ASFNHLAEVPELP 323
Query: 239 GKLAFLSNLDLSDNFLSGKIPHSFSGLASI 268
L L + N L + P + +
Sbjct: 324 QN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (157), Expect = 5e-12
Identities = 40/209 (19%), Positives = 70/209 (33%), Gaps = 6/209 (2%)
Query: 285 SLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKL 344
+S + + L ++ + NLT LP + L+L++N +L L QL L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK-DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 345 FNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPES 404
+ D L D+S N L + + NR + +
Sbjct: 63 DRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGA 119
Query: 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILI 464
L L GNEL+ P P+++ + NN + ++ L +L+
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 465 NGNNFTGEVPSQICTLRQLQAVDLSQNRF 493
N+ +P L L N +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 6e-09
Identities = 37/182 (20%), Positives = 60/182 (32%), Gaps = 4/182 (2%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
+ +L LS N + + L LNL G L L + +
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--ELTKLQVDGTLPVLGTLD--LS 85
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFS 263
+ LP L L L + L ++ L L L L N L P +
Sbjct: 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT 145
Query: 264 GLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDN 323
+E++ L +N L+ L+ L L L + +N+L + L L+ N
Sbjct: 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
Query: 324 YF 325
+
Sbjct: 206 PW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 30/182 (16%), Positives = 53/182 (29%), Gaps = 7/182 (3%)
Query: 122 HLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLL 181
+L L N+ + L L+L R L VL
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-----TKLQVDGTLPVLGTLDLSH 86
Query: 182 SGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKL 241
+ L L T L + + + LP K N + +P +
Sbjct: 87 NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 242 AFLSNL-DLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQN 300
L++N L+ +GL +++ + L +N L +P+ L + N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
Query: 301 NL 302
Sbjct: 206 PW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 33/176 (18%), Positives = 44/176 (25%), Gaps = 6/176 (3%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+ LS L L LNL +L L +
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLL 95
Query: 137 LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELT 196
N + + L+ L L GN L L P L +L
Sbjct: 96 GQTLPALTVLDVS----FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151
Query: 197 HFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDN 252
L N L P + L L+ L + N + IP L L N
Sbjct: 152 KLSLANNNLTELP-AGLLNGLENLDTLLLQE-NSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 5e-04
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 498 PTC-ITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLT 556
P C ++++ ++ + T LP +L +L+LS N L L LT
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLT 58
Query: 557 SLDLSSN 563
L+L
Sbjct: 59 QLNLDRA 65
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 60.3 bits (144), Expect = 4e-10
Identities = 39/337 (11%), Positives = 84/337 (24%), Gaps = 38/337 (11%)
Query: 267 SIEQIELFDNQLSGE----LPESLSNLTTLLRLDISQNNLTGNLPETIAAM-----SLES 317
SIE L + ++ E + L ++ + +S N + ++ LE
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 318 LNLNDNY----------FTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFD 367
+D + + ++L P L ++L +N+F + L + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 368 VSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPS 427
L + + N+ + P N L G + +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 428 KFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVD 487
L V + L +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEG--------LAYCQELKVLDLQDNTFTHLGSSAL 235
Query: 488 LSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPP 547
+ +L L + L L L N++
Sbjct: 236 AIALKSWPNLRELGLNDCLLS----ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291
Query: 548 EL-----GNLAVLTSLDLSSNLLT--GEIPLELTKLK 577
L + L L+L+ N + ++ E+ ++
Sbjct: 292 TLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.6 bits (124), Expect = 1e-07
Identities = 48/317 (15%), Positives = 92/317 (29%), Gaps = 36/317 (11%)
Query: 311 AAMSLESLNLNDNYFTGE----IPESLASNPNLVQLKLFNNSFSGK----LPDDLGKYSN 362
A S+E +L + T E + L + ++ ++ L N+ + L +++ +
Sbjct: 1 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 363 LEYFDVSTND---FTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGN 419
LE + S E+P L + + + +
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 420 ELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGE----VPS 475
L GL ++ E +++ NAP L I+ N
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 476 QICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLEL---------QENMFTGELPRNLN 526
+ R L V + QN + EL ++ + L L
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 527 SLTALIVLNLSTNQLTGTIPPELGN------LAVLTSLDLSSNLLTGEIPLELTKL---- 576
S L L L+ L+ + + L +L L N + + L +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 577 --KLNQFNISHNKLYGE 591
L ++ N+ E
Sbjct: 301 MPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 40/364 (10%), Positives = 90/364 (24%), Gaps = 55/364 (15%)
Query: 171 LKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANL 230
LK+ + + L + L N + + AA+
Sbjct: 10 LKLDAITTEDEKSVFAV-LLEDDSVKEIVLSGNTIGTE----------------AARW-- 50
Query: 231 IGEIPDSIGKLAFLSNLDLSDNF---LSGKIPHSFSGLASIEQIELFDNQLSGELPESLS 287
+ ++I L + SD F + +IP + L
Sbjct: 51 ---LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALL--------------KCP 93
Query: 288 NLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNN 347
L T+ D + + +L + L +L +
Sbjct: 94 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 153
Query: 348 SFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGE 407
+ + + N L K+ I + E
Sbjct: 154 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 213
Query: 408 CKTL----NYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNA------P 457
C+ L + L P + + + + ++ +A
Sbjct: 214 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 273
Query: 458 KLTGILINGNNFTGEVPSQICT-----LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLEL 512
L + + N + + T + L ++L+ NRFS + ++ ++
Sbjct: 274 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRG 332
Query: 513 QENM 516
+ +
Sbjct: 333 RGEL 336
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 3e-08
Identities = 21/95 (22%), Positives = 34/95 (35%), Gaps = 14/95 (14%)
Query: 259 PHSFSGLASIEQIELFDNQLSGE----LPESLSNLTTLLRLDISQNNLTGNLPETIAAM- 313
+ + + L D +S L +L +L LD+S N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 314 -----SLESLNLNDNYFTGEIPESLA----SNPNL 339
LE L L D Y++ E+ + L P+L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 4e-08
Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 11/93 (11%)
Query: 244 LSNLDLSDNFLSGK-IPHSFSGLASIEQIELFDNQLSGE----LPESLSNLTTLLRLDIS 298
+ +LD+ LS L + + L D L+ + +L L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 299 QNNLTGNLPETIAAM------SLESLNLNDNYF 325
N L + ++ L+L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 8e-08
Identities = 59/469 (12%), Positives = 117/469 (24%), Gaps = 47/469 (10%)
Query: 146 NLQVLDLSRNNFS-GDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNP 204
++Q LD+ S E +V+ L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK----------------- 45
Query: 205 LKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAF-----LSNLDLSDN----FLS 255
+ S++ L L L + + + L L +
Sbjct: 46 ----DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
Query: 256 GKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSL 315
G + + L +++++ L DN L + L + + + L + L
Sbjct: 102 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161
Query: 316 ESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTG 375
S+ F + N V++ S + L S D +
Sbjct: 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 221
Query: 376 ELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEV 435
+ L + + + P L L + + +
Sbjct: 222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 281
Query: 436 DFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSG 495
+ + A L L+ + + C+ S
Sbjct: 282 KESLKELSLAGNELGDEG--ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 339
Query: 496 HLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGT----IPPELGN 551
+ N + + G + L VL L+ ++ + + L
Sbjct: 340 RFLLELQISNNRLEDAGVRELCQG----LGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 395
Query: 552 LAVLTSLDLSSNLLTGEIPLELTKL------KLNQFNISHNKLYGEVPS 594
L LDLS+N L L+L + L Q + E+
Sbjct: 396 NHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 18/84 (21%), Positives = 31/84 (36%), Gaps = 9/84 (10%)
Query: 505 NKLQQLELQENMFTGE----LPRNLNSLTALIVLNLSTNQLTGTIPPELG-----NLAVL 555
+ L+ L L + + L L + +L L+LS N L +L +L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 556 TSLDLSSNLLTGEIPLELTKLKLN 579
L L + E+ L L+ +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKD 452
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 16/78 (20%), Positives = 27/78 (34%), Gaps = 9/78 (11%)
Query: 313 MSLESLNLNDNYFTGE----IPESLASNPNLVQLKLFNNSFSGKLPDDLGK-----YSNL 363
L L L D + + +L +N +L +L L NN L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 364 EYFDVSTNDFTGELPRFL 381
E + ++ E+ L
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 13/91 (14%), Positives = 29/91 (31%), Gaps = 9/91 (9%)
Query: 98 LRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYN----VFIGELPDFSREFANLQVLDLS 153
+++L++ + ++ L QV+ LD ++ R L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 154 RNNFSGDIPESFGRF-----PVLKVLNLGGN 179
N + ++ L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 8/75 (10%), Positives = 24/75 (32%), Gaps = 5/75 (6%)
Query: 313 MSLESLNLNDNYFTGE-IPESLASNPNLVQLKLFNNSFSGK----LPDDLGKYSNLEYFD 367
+ ++SL++ + E L ++L + + + L L +
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 368 VSTNDFTGELPRFLC 382
+ +N+ +
Sbjct: 62 LRSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 14/80 (17%), Positives = 24/80 (30%), Gaps = 9/80 (11%)
Query: 482 QLQAVDLSQNRFSG----HLPTCITQLNKLQQLELQENMFTGELPRNL-----NSLTALI 532
L+ + L+ S L + + L++L+L N L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 533 VLNLSTNQLTGTIPPELGNL 552
L L + + L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 18/87 (20%), Positives = 25/87 (28%), Gaps = 9/87 (10%)
Query: 117 LSPCFHLQVLALDYNVF----IGELPDFSREFANLQVLDLSRNNFSGDIPESFGRF---- 168
P L+VL L L +L+ LDLS N
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 169 -PVLKVLNLGGNLLSGLIPSFLGNLTE 194
+L+ L L S + L L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 13/83 (15%), Positives = 24/83 (28%), Gaps = 5/83 (6%)
Query: 123 LQVLALDYNVFIGE-LPDFSREFANLQVLDLSRNNFSGD----IPESFGRFPVLKVLNLG 177
+Q L + + QV+ L + I + P L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 178 GNLLSGLIPSFLGNLTELTHFEL 200
N L + + + ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 14/84 (16%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 454 SNAPKLTGILINGNNFTGEVPSQIC----TLRQLQAVDLSQNRFSGHLPTCITQ-----L 504
L + + + + S + L+ +DLS N + +
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 505 NKLQQLELQENMFTGELPRNLNSL 528
L+QL L + ++ E+ L +L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 20/83 (24%), Positives = 31/83 (37%), Gaps = 9/83 (10%)
Query: 216 NLSKLENLWAAKANL----IGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSG-----LA 266
S L LW A ++ + ++ L LDLS+N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 267 SIEQIELFDNQLSGELPESLSNL 289
+EQ+ L+D S E+ + L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 20/85 (23%), Positives = 28/85 (32%), Gaps = 8/85 (9%)
Query: 165 FGRFPVLKVLNLGGNLLSGL----IPSFLGNLTELTHFELGYNPLKSS---PLPSSV-GN 216
VL+VL L +S + + L L +L N L + L SV
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 217 LSKLENLWAAKANLIGEIPDSIGKL 241
LE L E+ D + L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 8e-07
Identities = 28/120 (23%), Positives = 43/120 (35%), Gaps = 8/120 (6%)
Query: 77 IDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGE 136
+ L+ DL+ ++ + +L+LS N + L+ L+VL + E
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA--LAALRCLEVL--QASDNALE 56
Query: 137 LPDFSREFANLQVLDLSRNNF-SGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTEL 195
D LQ L L N + P L +LNL GN L L E+
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 8e-07
Identities = 25/128 (19%), Positives = 43/128 (33%), Gaps = 10/128 (7%)
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207
+VL L+ + + + + ++ L+L N L L P+ L E+ +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL----AALRCLEVLQASDNA 54
Query: 208 SPLPSSVGNLSKLENLWAAKANLIG-EIPDSIGKLAFLSNLDLSDNFLSGK---IPHSFS 263
V NL +L+ L L + L L+L N L +
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 264 GLASIEQI 271
L S+ I
Sbjct: 115 MLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 24/116 (20%), Positives = 42/116 (36%), Gaps = 6/116 (5%)
Query: 464 INGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPR 523
+ + T V + L + +DLS NR P + L L+ L+ +N
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGV 61
Query: 524 NLNSLTALIVLNLSTNQLTGTIPPE-LGNLAVLTSLDLSSNLLTGEIPLELTKLKL 578
L L N+L + + L + L L+L N L E ++ ++
Sbjct: 62 ANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 34/152 (22%), Positives = 57/152 (37%), Gaps = 35/152 (23%)
Query: 172 KVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLI 231
+VL+L L+ L L L +TH +L +N L++ P L+ L L +A+
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALP-----PALAALRCLEVLQASDN 53
Query: 232 GEI-PDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLT 290
D + L L L L +N L + L +
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQ-----------------------QSAAIQPLVSCP 90
Query: 291 TLLRLDISQNNLTG--NLPETIAAM--SLESL 318
L+ L++ N+L + E +A M S+ S+
Sbjct: 91 RLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 27/107 (25%), Positives = 38/107 (35%), Gaps = 5/107 (4%)
Query: 271 IELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIP 330
+ L L+ L L + LD+S N L P A LE L +DN
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE--NV 58
Query: 331 ESLASNPNLVQLKLFNNSF-SGKLPDDLGKYSNLEYFDVSTNDFTGE 376
+ +A+ P L +L L NN L L ++ N E
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 3e-05
Identities = 26/92 (28%), Positives = 35/92 (38%), Gaps = 2/92 (2%)
Query: 533 VLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEV 592
VL+L+ LT + L L ++T LDLS N L P L S N L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 593 PSDFDHDLFISSLLDNPGLCSPDLKPLPPCSK 624
L L +N S ++PL C +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 91
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (109), Expect = 5e-06
Identities = 39/238 (16%), Positives = 63/238 (26%), Gaps = 10/238 (4%)
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
S ++ T EIP L N ++L+ + +LE ++S ND
Sbjct: 9 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 374 TGEL---PRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFW 430
+ + I NN L K
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 431 GLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490
L +V N S + IL N E+ + QL ++LS
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 491 NRFSGHLPTCI-TQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPP 547
N LP + + L++ L +L L + L +P
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 17/93 (18%), Positives = 28/93 (30%), Gaps = 4/93 (4%)
Query: 120 CFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179
F +L L+ N ++ NN + F +L++
Sbjct: 152 SFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPS 212
+ L L NL +L LK LP+
Sbjct: 212 RIHSLPSYGLENLKKLRARST--YNLKK--LPT 240
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 9e-06
Identities = 34/216 (15%), Positives = 73/216 (33%), Gaps = 20/216 (9%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
AN + ++N + + ++ + L+ G ++ + + L L EL N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSD------------ 251
+ ++ +++LE N+ K L++ ++D
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 252 -NFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETI 310
+I + L L+NL+ L L N ++ +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 311 AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFN 346
+ +L ++L +N + P LA+ NL + L N
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 28/226 (12%), Positives = 63/226 (27%), Gaps = 17/226 (7%)
Query: 264 GLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDN 323
LA+ +I + ++ + + ++L + L +T + +L L L DN
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73
Query: 324 YFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCF 383
T P + ++L + + T+ L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 384 RNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNN 443
I + +G Y + L ++ + +N
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL----------TPLANLSKLTTLKADDN 183
Query: 444 RFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLS 489
+ +++ P L + + N + P + L V L+
Sbjct: 184 KISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 39/193 (20%), Positives = 61/193 (31%), Gaps = 20/193 (10%)
Query: 60 CNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSP 119
C T + C + ++ P L L+DN S
Sbjct: 8 CEGTTVDCTGRGLK---------EIPRDIP------LHTTELLLNDNELGRISSDGLFGR 52
Query: 120 CFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN 179
HL L L N G P+ +++Q L L N + F LK LNL N
Sbjct: 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112
Query: 180 LLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIG 239
+S ++P +L LT L NP + + + ++L P +
Sbjct: 113 QISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLN--GGAARCGAPSKVR 170
Query: 240 KLAFLSNLDLSDN 252
+ DL +
Sbjct: 171 DVQI---KDLPHS 180
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 28/175 (16%), Positives = 55/175 (31%), Gaps = 4/175 (2%)
Query: 148 QVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKS 207
+D + +IP L L N L + L +
Sbjct: 11 TTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 208 SPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLAS 267
P++ S ++ L + + L L L+L DN +S +P SF L S
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 268 IEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLND 322
+ + L N + + L + ++ P + + ++ L ++
Sbjct: 128 LTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSE 181
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 5e-04
Identities = 20/145 (13%), Positives = 42/145 (28%), Gaps = 4/145 (2%)
Query: 133 FIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNL 192
I + ++ + LDL I ++ N + L L
Sbjct: 7 LIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLL 62
Query: 193 TELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDN 252
L + N + E + + + D + L L+ L + N
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
Query: 253 FLSGKIPHSFSGLASIEQIELFDNQ 277
++ K + + + Q+ + D Q
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 20/93 (21%), Positives = 33/93 (35%), Gaps = 3/93 (3%)
Query: 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQ 509
+ +NA + + + G + + TL Q A+D S N L +L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 510 LELQENMFTGELPRNLNSLTALIVLNLSTNQLT 542
L + N +L L L L+ N L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 17/130 (13%), Positives = 34/130 (26%), Gaps = 7/130 (5%)
Query: 278 LSGELPE---SLSNLTTLLRLDISQNNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESL 333
L+ EL E +N LD+ + + A + ++++ +DN +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGF 59
Query: 334 ASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIF 393
L L + NN +L ++ N K +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
Query: 394 NNRFSGKIPE 403
Sbjct: 120 LRNPVTNKKH 129
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 31/178 (17%), Positives = 51/178 (28%), Gaps = 14/178 (7%)
Query: 385 NKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNR 444
N + II N+ Y + L GN+L L + + + N+
Sbjct: 46 NSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENK 101
Query: 445 FEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQL 504
+ S + S I L L ++ + +
Sbjct: 102 VKDLSSLKDLKKL-------KSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSR 154
Query: 505 NKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSS 562
E+ ++ L LT L L LS N ++ L L L L+L S
Sbjct: 155 LTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 32/205 (15%), Positives = 67/205 (32%), Gaps = 20/205 (9%)
Query: 144 FANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYN 203
FA +L + + + + ++ + + + + + + L +T L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 204 PLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFS 263
L + + L+ L+NL + S K ++ I
Sbjct: 79 KL------TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 264 GLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT--GNLPETIAAMSLESLNLN 321
+ + L+ L TL D +++ L L++L L+
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLT------KLQNLYLS 186
Query: 322 DNYFTGEIPESLASNPNLVQLKLFN 346
N+ + +LA NL L+LF+
Sbjct: 187 KNHISD--LRALAGLKNLDVLELFS 209
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 22/148 (14%), Positives = 38/148 (25%), Gaps = 3/148 (2%)
Query: 244 LSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELP-ESLSNLTTLLRLDISQNNL 302
S L + + H G ++ ++ + + Q L L L L L I ++ L
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 303 TGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFS-GKLPDDLGKYS 361
P+ S + +L +L L N L ++
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128
Query: 362 NLEYFDVSTNDFTGELPRFLCFRNKLQC 389
V L C
Sbjct: 129 EEGLGGVPEQKLQCHGQGPLAHMPNASC 156
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 25/198 (12%), Positives = 58/198 (29%), Gaps = 15/198 (7%)
Query: 287 SNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFN 346
+ L ++ + + N+T + +T + +L + + + NL Q+ N
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQTDLD-QVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 347 NSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYG 406
N + L + L ++ N N + +
Sbjct: 72 NQLTD--ITPLKNLTKLVDILMNNNQI----ADITPLANLTNLTGLTLFNNQITDIDPLK 125
Query: 407 ECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILING 466
LN L N + ++ + + + ++N L + I+
Sbjct: 126 NLTNLNRLELSSNTISDISALSGL----TSLQQLNFSSNQVTDLKPLANLTTLERLDISS 181
Query: 467 NNFTGEVPSQICTLRQLQ 484
N + S + L L+
Sbjct: 182 NKVSD--ISVLAKLTNLE 197
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 27/197 (13%), Positives = 55/197 (27%), Gaps = 16/197 (8%)
Query: 314 SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDF 373
L T + S + L+ D + +NL + S N
Sbjct: 19 EKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQL 74
Query: 374 TGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLP 433
T L+ + + + G ++
Sbjct: 75 TD--------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126
Query: 434 EVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRF 493
+ + + S ++S L + + N T P + L L+ +D+S N+
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKV 184
Query: 494 SGHLPTCITQLNKLQQL 510
S + + +L L+ L
Sbjct: 185 SD--ISVLAKLTNLESL 199
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 27/155 (17%), Positives = 48/155 (30%), Gaps = 28/155 (18%)
Query: 141 SREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFEL 200
R + Q LDL D+ + VLN ++ + + N+ EL L
Sbjct: 18 KRYDGSQQALDLKGLRSDPDLVA----QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNL 72
Query: 201 GYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPH 260
N L ++ + K L L+LS N L +
Sbjct: 73 SNNRLYRLD-----------------------DMSSIVQKAPNLKILNLSGNELKSEREL 109
Query: 261 SFSGLASIEQIELFDNQLSGELPESLSNLTTLLRL 295
+E++ L N LS + + ++ +
Sbjct: 110 DKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.28 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.45 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.34 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.6 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.17 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.93 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.77 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.8 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=414.65 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=205.0
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..+.||+|+||+||+|++++++.||||++... ....++|.+|++++++++|||||+++++|..++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 467888999999999999999998999999999543 23456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|.+++.... ..+++..++.|+.|||.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred cCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999987643 3588999999999999999999999 999999999999999999999999999987654332
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.......||+.|+|||++.++.++.++|||||||++|||+|++.|+... ....++.+.+........+.
T Consensus 157 ---~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~~~~~~~p~------- 225 (263)
T d1sm2a_ 157 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRLYKPR------- 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCHHHHHHHHHHTCCCCCCT-------
T ss_pred ---eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-CCHHHHHHHHHhcCCCCCcc-------
Confidence 1223457899999999999999999999999999999999976665543 23444555554433221111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
....++.+++.+||++||++||||+||+++|+++..
T Consensus 226 --------------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 --------------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 113567899999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=410.24 Aligned_cols=263 Identities=28% Similarity=0.411 Sum_probs=207.8
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||+||+|+.+ ..||||++..........+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 457889999999999999999865 469999997665566677889999999999999999999998754 56899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++..... .+++..+..++.|||+||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999976433 589999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCccccccccccccCccccccccC---CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
. ........||+.|+|||++.+ +.++.++|||||||++|||+||+.||.... ....+...+........
T Consensus 159 ~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~p~----- 230 (276)
T d1uwha_ 159 G--SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPD----- 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHHTSCCCC-----
T ss_pred C--cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcCCCCCc-----
Confidence 2 122345679999999999864 357889999999999999999999997532 22233333333222110
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
..+ .....+..+.+++.+||+.||++||||+||+++|+.+..
T Consensus 231 --~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 --LSK----------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --GGG----------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --chh----------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 000 011224578899999999999999999999999987653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=410.65 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=205.7
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 457889999999999999999986 799999999964432 233456899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 83 Ey~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999997543 589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+........+
T Consensus 157 ~~--~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~------ 228 (271)
T d1nvra_ 157 NR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------ 228 (271)
T ss_dssp TE--ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT------
T ss_pred Cc--cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc------
Confidence 22 122345689999999999988776 578999999999999999999997643333322222111110000
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......++.+++.+|+++||++|||++|++++
T Consensus 229 ---------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 ---------------WKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01123567789999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=408.40 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=200.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec--CCeeEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG--QDFNILV 758 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 758 (973)
++|++.+.||+|+||+||+|+.+ +|+.||+|++..........+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56889999999999999999976 79999999997665556667789999999999999999999999865 4567999
Q ss_pred EeccCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 759 YEYMPNGSLADMLHEKG-RSGSLDWSIRFSIAQGAAKGLAYLHNDC--VPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||++. ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 2336899999999999999999999971 11399999999999999999999999999988
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||... +..++...+........+
T Consensus 164 ~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--~~~~~~~~i~~~~~~~~~-- 235 (269)
T d2java1 164 LNHDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRRIP-- 235 (269)
T ss_dssp C---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCCCCC--
T ss_pred cccCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCCCCC--
Confidence 754322 233467999999999999999999999999999999999999999752 334444444433222110
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....++.+++.+|++.||++|||++|++++
T Consensus 236 -------------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 236 -------------------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------------------cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0123568899999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=403.30 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=207.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.. ......+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56888999999999999999986 78999999985332 12234567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998654 489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+....+.......
T Consensus 160 ~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~-------- 223 (263)
T d2j4za1 160 R------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVEFTF-------- 223 (263)
T ss_dssp C------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCCC--------
T ss_pred c------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCC--------
Confidence 2 23467999999999999999999999999999999999999999752 3333333332221110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .....++.+++.+|+++||++|||++|+++|
T Consensus 224 ---------p-----~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 ---------P-----DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---------C-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------C-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0 0123567889999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-47 Score=411.09 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=201.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCC---EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGE---TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
.++|+..++||+|+||+||+|+++ +|+ .||||++.... .....+.|.+|++++++++|||||++++++..++..+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 456888899999999999999876 332 58899885332 3455677999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+|||||++|+|.+++.... ..+++.++..++.|||+||+|||++ +|+||||||+|||+++++.+||+|||+++.+
T Consensus 104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999887643 3589999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCCCc-cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCc
Q 039922 837 QSQEGQS-DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPER 914 (973)
Q Consensus 837 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
....... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||... ...++...+........+
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--~~~~~~~~i~~~~~~~~~- 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--TNQDVINAIEQDYRLPPP- 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCCCC-
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC-
Confidence 5443221 112233467899999999999999999999999999999998 89998753 334455544433221111
Q ss_pred cccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 915 GCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 915 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.+....+.+++.+||++||++||||.||++.|+.+
T Consensus 256 --------------------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 256 --------------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp --------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=399.06 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=213.0
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..++||+|+||+||+|+.++++.||||+++... ..+++|.+|++++++++|||||+++++|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 5788999999999999999999988899999996443 2346799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|++.+++..... .+++..+++++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 81 MANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred cCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999998765433 588999999999999999999999 999999999999999999999999999987654432
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. ......||+.|+|||++.++.++.++|||||||++|||+| |+.||... ...++...+........+
T Consensus 156 ~---~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--~~~~~~~~i~~~~~~~~p------- 223 (258)
T d1k2pa_ 156 T---SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLRLYRP------- 223 (258)
T ss_dssp C---CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCCCCCC-------
T ss_pred e---eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--CHHHHHHHHHhCCCCCCc-------
Confidence 2 2334568999999999999999999999999999999998 78888753 334444444332211111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.....++.+++.+||++||++|||++||+++|.++
T Consensus 224 --------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 --------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 01135788999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=405.25 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=208.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
..++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 3457999999999999999999975 79999999985433 23456789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 96 mEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999987653 489999999999999999999999 999999999999999999999999999987654
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
... ......||+.|+|||++.++.++.++||||+||++|||++|+.||... ...+....+.........
T Consensus 169 ~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~~~~~~~~~~~----- 237 (293)
T d1yhwa1 169 EQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQ----- 237 (293)
T ss_dssp TTC----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHHCSCCCS-----
T ss_pred ccc----cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC--CHHHHHHHHHhCCCCCCC-----
Confidence 322 234467999999999999999999999999999999999999999753 222222222222111000
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
........+.+++.+|+++||++|||+.|+++|
T Consensus 238 --------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 --------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --------------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --------------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001123568899999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=407.65 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=210.0
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
.++|+..+.||+|+||+||+|++++++.||||++.... ...+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 35788889999999999999999988999999995432 334679999999999999999999998864 56789999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... ...+++..+++|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 88 y~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999876542 12489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
. .......||+.|+|||++.++.++.++|||||||++|||+||+.|+.... ...++.+.+........+
T Consensus 164 ~---~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~~i~~~~~~~~p------- 232 (272)
T d1qpca_ 164 Y---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRP------- 232 (272)
T ss_dssp E---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCCCCC-------
T ss_pred c---ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCCCCc-------
Confidence 1 22334578999999999999999999999999999999999877765432 334444444332211111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 921 NQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 921 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.....++.+++.+||+.||++||||+||++.|+...
T Consensus 233 --------------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 233 --------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 011346889999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-47 Score=407.98 Aligned_cols=257 Identities=26% Similarity=0.354 Sum_probs=212.8
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||+||+|+++ +|+.||||++.... ...++|.+|++++++++|||||+++++|.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 356888899999999999999986 68899999985432 34567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|+|.+++.... ...+++..+..|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 93 E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999997643 23689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.. .......|++.|+|||++.++.++.++|||||||++|||++|+.|+.... +...+.+.+........+
T Consensus 169 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-~~~~~~~~i~~~~~~~~~------ 238 (287)
T d1opja_ 169 TY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP------ 238 (287)
T ss_dssp SS---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHTTCCCCCC------
T ss_pred Cc---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-hHHHHHHHHhcCCCCCCC------
Confidence 22 22334568899999999999999999999999999999999888876532 333344443332211100
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.....++.+++.+||++||++||||+||++.|+..
T Consensus 239 ---------------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 239 ---------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ---------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=402.29 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=202.4
Q ss_pred ccccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEeccCC
Q 039922 688 NLIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYMPN 764 (973)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 764 (973)
++||+|+||+||+|.++ .++.||||++..........+.+.+|++++++++|||||+++++|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999865 356899999976555556677899999999999999999999999654 56899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCCcc
Q 039922 765 GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQSD 844 (973)
Q Consensus 765 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 844 (973)
|+|.++++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-Y 164 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-E
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc-c
Confidence 99999998643 589999999999999999999999 9999999999999999999999999999876544322 1
Q ss_pred ccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCccccc
Q 039922 845 DAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLNQL 923 (973)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 923 (973)
.......||+.|+|||++.++.++.++|||||||++|||+| |+.||... ...++...+..+.....+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~~~~~~~i~~~~~~~~p~--------- 233 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMGCPA--------- 233 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCCCCT---------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--CHHHHHHHHHcCCCCCCCc---------
Confidence 22334578999999999999999999999999999999998 89999753 3344444444332221111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 924 IDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 924 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
..+.++.+++.+||+.||++||||+||++.|+..
T Consensus 234 ------------~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 234 ------------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ------------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------------ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1135678999999999999999999999988763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=401.15 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=207.6
Q ss_pred CCCccc-cccccCCeeEEEEEEC---CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 683 HLTEQN-LIGSGGSCRVYKVKLK---SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 683 ~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
+|...+ +||+|+||+||+|.++ ++..||||++... ......+.|.+|++++++++|||||++++++.. +..|+|
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 355556 4999999999999765 3557999999643 334556789999999999999999999999875 457899
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++.... ..+++..+..++.|||+||+|||++ +|+||||||+||++++++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999986543 3589999999999999999999999 999999999999999999999999999987755
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcccc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCC 917 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||... ...++...+..+.....+
T Consensus 162 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~--~~~~~~~~i~~~~~~~~p---- 234 (285)
T d1u59a_ 162 DDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRMECP---- 234 (285)
T ss_dssp CSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CTHHHHHHHHTTCCCCCC----
T ss_pred cccc-cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCCCC----
Confidence 4322 122234568999999999999999999999999999999998 89999753 334455555443322111
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 918 RDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 918 ~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
...+.++.+++.+||+.||++||||.+|++.|+.
T Consensus 235 -----------------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 235 -----------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -----------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -----------------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1123567899999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=400.52 Aligned_cols=260 Identities=28% Similarity=0.411 Sum_probs=204.9
Q ss_pred cCCCCccccccccCCeeEEEEEECCC-----CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCee
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSG-----ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFN 755 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 755 (973)
.+.|+..++||+|+||.||+|++++. ..||||++.... .......|.+|++++++++|||||++++++.+.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 45688899999999999999987632 369999995433 344556789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchh
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKA 835 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 835 (973)
++||||+.+|++.+++..... .+++..+.+++.||+.|++|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999988876433 589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
+...... ........||+.|+|||++.++.++.++|||||||++|||++|+.|+.... ...++.+.+..+.....+
T Consensus 160 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~~~~~~-- 235 (283)
T d1mqba_ 160 LEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFRLPTP-- 235 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCCCCC--
T ss_pred ccCCCcc-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-CHHHHHHHHhccCCCCCc--
Confidence 6543321 112234568999999999999999999999999999999999877775432 334444444433222111
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
...+..+.+++.+||++||++||||.||++.|+.+
T Consensus 236 -------------------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 236 -------------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp -------------------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------------------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=398.12 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=200.0
Q ss_pred CccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec----CCeeEEEE
Q 039922 685 TEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG----QDFNILVY 759 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 759 (973)
+..++||+|+||+||+|++. +++.||+|++..........+.+.+|++++++++|||||++++++.. +...|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999986 68899999997655555666789999999999999999999999864 45679999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEeCCCCCCEEeC-CCCceEEeccCcchhc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPA--IVHRDVKSHNILLD-AEMVPRVADFGLAKAL 836 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGl~~~~ 836 (973)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999997654 589999999999999999999998 6 99999999999996 5789999999999764
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.... ....+.+.+......
T Consensus 166 ~~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-~~~~~~~~i~~~~~~------ 231 (270)
T d1t4ha_ 166 RAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKP------ 231 (270)
T ss_dssp CTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCC------
T ss_pred cCC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-cHHHHHHHHHcCCCC------
Confidence 322 1234689999999998865 69999999999999999999999996432 223333332221111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.. ++ .....++.+++.+|+++||++|||+.|+++|
T Consensus 232 -~~----~~---------~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 -AS----FD---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -GG----GG---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cc----cC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00 11 1112457899999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=402.87 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=206.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
+.|++.+.||+|+||+||+|+++ +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 45888999999999999999986 7899999999643 33445678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 y~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 90 FCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999999875433 589999999999999999999999 99999999999999999999999999987653321
Q ss_pred CCccccccccccccCcccccccc-----CCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAY-----TKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||+.|+|||++. +..++.++||||+||++|||++|+.||... ...+....+........
T Consensus 165 ----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~--~~~~~~~~i~~~~~~~~--- 235 (288)
T d2jfla1 165 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--NPMRVLLKIAKSEPPTL--- 235 (288)
T ss_dssp ----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS--CGGGHHHHHHHSCCCCC---
T ss_pred ----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCCCC---
Confidence 1233467999999999984 456889999999999999999999999753 23333333332211100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. .......++.+++.+|+++||++|||+.|+++|
T Consensus 236 --------~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 --------A--------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --------S--------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --------C--------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 001223568899999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=405.63 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=196.4
Q ss_pred ccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 678 DDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
+++.+.|+..+.||+|+||+||+|+.+ +|+.||||++.+.... ...+.+.+|+.++++++|||||++++++.+++..|
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 466778999999999999999999986 7899999999654332 33456889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC---CCCceEEeccCcc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD---AEMVPRVADFGLA 833 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~ 833 (973)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+|||++
T Consensus 84 lvmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999997643 589999999999999999999999 999999999999994 5789999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
+...... ......||+.|+|||++.++.++.++||||+||++|||++|+.||... ...+....+.......+.
T Consensus 158 ~~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 158 KMEDPGS-----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE--NDAKLFEQILKAEYEFDS 230 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHTTCCCCCT
T ss_pred EEccCCC-----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHhccCCCCCC
Confidence 8664332 233467999999999999999999999999999999999999999753 233344433332221110
Q ss_pred ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
. ........+.+++.+|+++||++|||+.|+++|
T Consensus 231 ~------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 P------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp T------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred c------------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 001223568899999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=411.81 Aligned_cols=272 Identities=22% Similarity=0.306 Sum_probs=207.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
.++|+..+.||+|+||+||+|+.. +|+.||+|++.... .....+.+.+|+.++++++|||||+++++|.+++..|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356889999999999999999976 78999999996543 3445577899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ + +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999998654 48999999999999999999996 5 899999999999999999999999999987654
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH-HHhccCCCccc-
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT-EATLSSPERGC- 916 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~- 916 (973)
.. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||............... .+.....+...
T Consensus 158 ~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 158 SM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred Cc------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 32 23468999999999999999999999999999999999999999764322111110000 00000000000
Q ss_pred ---------------cCccccccc---CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 917 ---------------CRDLNQLID---PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 917 ---------------~~~l~~~~d---~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.....+..+ ..............++.+++.+|+++||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000000 0000000001123568899999999999999999999885
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.7e-46 Score=409.53 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=215.0
Q ss_pred ccccccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC
Q 039922 674 SFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ 752 (973)
Q Consensus 674 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 752 (973)
....+.+.++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+.++++++|||||++++++.++
T Consensus 18 ~l~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred cCCCCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3444567789999999999999999999976 7999999999533 345567789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC--CCceEEecc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA--EMVPRVADF 830 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Df 830 (973)
+..|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred CEEEEEEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeec
Confidence 99999999999999999986532 3599999999999999999999999 9999999999999964 678999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
|+++.+.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+..+.+......
T Consensus 171 G~a~~~~~~~-----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~ 243 (350)
T d1koaa2 171 GLTAHLDPKQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWN 243 (350)
T ss_dssp TTCEECCTTS-----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCC
T ss_pred chheeccccc-----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC
Confidence 9998764432 234467999999999999999999999999999999999999999753 334444444333222
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+... .......+.+++.+|+++||++|||++|+++|
T Consensus 244 ~~~~~------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDDSA------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCCGG------------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCccc------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11100 01123567899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=401.32 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=205.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.+.. ......+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 356899999999999999999985 79999999985332 1223446789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+..
T Consensus 87 mEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999987654 589999999999999999999999 999999999999999999999999999987654
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..++.+.+......
T Consensus 161 ~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~-------- 228 (288)
T d1uu3a_ 161 ESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKIIKLEYD-------- 228 (288)
T ss_dssp -----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTTCCC--------
T ss_pred CCcc--cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc--CHHHHHHHHHcCCCC--------
Confidence 3221 2233467999999999999999999999999999999999999999753 333333333222111
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVE 964 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 964 (973)
+. .....++.+++.+|+++||++|||++|+.+
T Consensus 229 ---------~p-----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 ---------FP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---------CC-----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---------CC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 00 011346789999999999999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.1e-46 Score=407.15 Aligned_cols=261 Identities=20% Similarity=0.281 Sum_probs=215.4
Q ss_pred eccccccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec
Q 039922 673 VSFNEDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG 751 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 751 (973)
+......+.+.|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+
T Consensus 20 ~~~~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 97 (352)
T d1koba_ 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED 97 (352)
T ss_dssp CCCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred ccCCCCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34444566778999999999999999999975 7999999999543 33455678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC--CCCceEEec
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD--AEMVPRVAD 829 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D 829 (973)
++..|+||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++ +++.+||+|
T Consensus 98 ~~~~~ivmE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~D 172 (352)
T d1koba_ 98 KYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID 172 (352)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECC
T ss_pred CCEEEEEEEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEee
Confidence 999999999999999998876543 2589999999999999999999999 999999999999998 678999999
Q ss_pred cCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 830 FGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 830 fGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
||+++.+.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+....+.....
T Consensus 173 FGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~ 245 (352)
T d1koba_ 173 FGLATKLNPDE-----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDW 245 (352)
T ss_dssp CTTCEECCTTS-----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHCCC
T ss_pred cccceecCCCC-----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCC
Confidence 99998765432 234467899999999999999999999999999999999999999752 33344444443322
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+... ......++.+++.+|+++||++|||+.|+++|
T Consensus 246 ~~~~~~------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 246 EFDEDA------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCSST------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCccc------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 211100 01123567899999999999999999999886
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-46 Score=402.88 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=203.2
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCC-chhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHK-PETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.+.|+..+.||+|+||+||+|+.. +|+.||||++...... ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 345888999999999999999975 7889999999655433 34456789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||||++|++..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 94 ~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999987665432 589999999999999999999999 999999999999999999999999999986532
Q ss_pred cCCCccccccccccccCccccccccC---CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYT---KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
. ....||+.|+|||++.+ +.++.++|||||||++|||++|+.||... ...+....+......
T Consensus 168 ~--------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--~~~~~~~~i~~~~~~----- 232 (309)
T d1u5ra_ 168 A--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNESP----- 232 (309)
T ss_dssp B--------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCC-----
T ss_pred C--------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCC-----
Confidence 2 23579999999999863 46899999999999999999999999753 222222222221111
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+.. ......+.+++.+|+++||++|||++|+++|
T Consensus 233 -----------~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 -----------ALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -----------CCSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----------CCCC----CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 0000 1123568899999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=396.29 Aligned_cols=257 Identities=30% Similarity=0.396 Sum_probs=205.7
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|++.+.||+|+||+||+|++++++.||||++.... ...+.|.+|+.++++++|+|||++++++.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 5688899999999999999999988899999995332 335679999999999999999999999854 567899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+++|+|..++..... ..++|.+++.++.||+.||+|||+. +|+||||||+|||+|+++.+||+|||+++.......
T Consensus 93 ~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999988875422 2589999999999999999999999 999999999999999999999999999987644332
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
.......||+.|+|||++.++.++.++|||||||++|||++|+.|+.... ...+...++........+
T Consensus 169 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~~~~~~~~~-------- 236 (285)
T d1fmka3 169 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCP-------- 236 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCCCCC--------
T ss_pred ---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCCCCC--------
Confidence 22334568999999999999999999999999999999999888776542 334444544433211100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
.....++.+++.+||+.||++||+|++|+++|+....
T Consensus 237 -------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 237 -------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -------------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1123568899999999999999999999999987543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=403.96 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=207.1
Q ss_pred CCCCccccccccCCeeEEEEEECC-C-----CEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS-G-----ETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 754 (973)
++|+..++||+|+||+||+|+... + ..||+|++.... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 568889999999999999998752 2 369999985433 233445788999999998 89999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCC
Q 039922 755 NILVYEYMPNGSLADMLHEKGR--------------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKS 814 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 814 (973)
.|+||||+++|+|.++++.... ...+++..++.++.||++||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999976432 13488999999999999999999999 999999999
Q ss_pred CCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCC
Q 039922 815 HNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPS 893 (973)
Q Consensus 815 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~ 893 (973)
+||+++.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hccccccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999876554332 22334568999999999999999999999999999999998 89998653
Q ss_pred CCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 894 FGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
.....+.+.+........+ .....++.+++.+||+.||++||||+||+++|.-
T Consensus 271 -~~~~~~~~~~~~~~~~~~p---------------------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 -PVDANFYKLIQNGFKMDQP---------------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -CCSHHHHHHHHTTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CHHHHHHHHHhcCCCCCCC---------------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 2333344443332211111 1113568899999999999999999999999953
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=397.41 Aligned_cols=258 Identities=22% Similarity=0.281 Sum_probs=211.8
Q ss_pred cccccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC----CchhHHHHHHHHHHHhcCCCCCeeeEEeEEec
Q 039922 677 EDDILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH----KPETETVFRSEIETLGRVRHGNVVKLLMCCSG 751 (973)
Q Consensus 677 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 751 (973)
.+++.++|+..+.||+|+||+||+|+.+ +|+.||||++.+... .....+.+.+|+.++++++|||||++++++.+
T Consensus 5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3456678999999999999999999985 799999999965432 22346789999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC----ceEE
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM----VPRV 827 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl 827 (973)
++..|+|||||++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred CCEEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEe
Confidence 999999999999999999997654 589999999999999999999999 999999999999998876 4999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+....+...
T Consensus 159 ~DfG~a~~~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~ 231 (293)
T d1jksa_ 159 IDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAV 231 (293)
T ss_dssp CCCTTCEECTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTT
T ss_pred cchhhhhhcCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC--CHHHHHHHHHhc
Confidence 9999998764332 233467899999999999999999999999999999999999999753 233333333222
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....+. -.. ......+.+++.+|+++||++|||++|++++
T Consensus 232 ~~~~~~---------~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 NYEFED---------EYF---------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCCCH---------HHH---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCc---------hhc---------CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111000 000 0123567899999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=388.91 Aligned_cols=251 Identities=30% Similarity=0.399 Sum_probs=200.1
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-CCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-QDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 760 (973)
++|+..+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++|||||+++++|.+ .+..|+|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 45777889999999999999986 889999999532 344678999999999999999999999865 456899999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+++|+|.+++.... ...+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 82 y~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 999999999997542 12489999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
....++..|+|||++.++.++.++|||||||++|||+| |+.||... ...++..++....+...+
T Consensus 158 -------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~~~~~------ 222 (262)
T d1byga_ 158 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAP------ 222 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCCCCCC------
T ss_pred -------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCCCC------
Confidence 22457889999999999999999999999999999998 56666542 445566665443222110
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
.....++.+++.+||+.||++||||.||+++|+.++.
T Consensus 223 ---------------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 ---------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1112567899999999999999999999999998763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-45 Score=393.95 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=212.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|+..+.||+|+||+||+|+.+ +++.||||++... ......++|.+|++++++++||||++++++|...+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 357889999999999999999874 4578999998543 334456789999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCC
Q 039922 755 NILVYEYMPNGSLADMLHEKGR---------------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVK 813 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 813 (973)
.++||||+++|+|.+++..... ...+++..++.|+.|++.||+|||+. +|+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 9999999999999999864321 12478899999999999999999999 99999999
Q ss_pred CCCEEeCCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCC-CCCC
Q 039922 814 SHNILLDAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKR-PNDP 892 (973)
Q Consensus 814 p~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~-p~~~ 892 (973)
|+|||+|+++.+||+|||+++.+...... .......|++.|+|||++.+..++.++|||||||++|||++|.. ||..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccceEECCCCcEEEccchhheeccCCccc--cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999876544322 22334568899999999999999999999999999999999975 5543
Q ss_pred CCCCchhHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 893 SFGENKDIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
....++...+..+.....+ ...+.++.+++.+||++||++||||.||+++|++++
T Consensus 246 --~~~~e~~~~v~~~~~~~~p---------------------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 --MAHEEVIYYVRDGNILACP---------------------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --SCHHHHHHHHHTTCCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCHHHHHHHHHcCCCCCCC---------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2344455554443322110 112346889999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=391.04 Aligned_cols=257 Identities=28% Similarity=0.354 Sum_probs=207.8
Q ss_pred cccccccCCeeEEEEEECCC----CEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-CCeeEEEEec
Q 039922 687 QNLIGSGGSCRVYKVKLKSG----ETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG-QDFNILVYEY 761 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 761 (973)
.++||+|+||+||+|++.++ ..||||++.. .......++|.+|++++++++|||||++++++.. ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46899999999999997632 2589999953 2345556789999999999999999999999865 5688999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
|++|+|.++++.... ..++..+++++.|+|.||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999876433 578889999999999999999999 999999999999999999999999999988765544
Q ss_pred CccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
..........||+.|+|||++.++.++.++||||||+++|||+||+.||.... ...++..++..+.....+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i~~g~~~~~p-------- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP-------- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCC--------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCCCCc--------
Confidence 33333445678999999999999999999999999999999999998887532 233344444433222111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhccc
Q 039922 922 QLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDKS 971 (973)
Q Consensus 922 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 971 (973)
.....++.+++.+||+.||++||+|.||+++|+++..
T Consensus 257 -------------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 -------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0113568899999999999999999999999988643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=392.62 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=209.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++.+... .....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 356889999999999999999985 799999999954321 223456688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
||||++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999998754 488999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..++.+.+.......+
T Consensus 158 ~~----~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~--~~~~~~~~i~~~~~~~p------ 225 (337)
T d1o6la_ 158 DG----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFP------ 225 (337)
T ss_dssp TT----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC------
T ss_pred CC----cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc--CHHHHHHHHhcCCCCCC------
Confidence 22 2234468999999999999999999999999999999999999999763 33444444433221110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
.....++.+++.+|+++||++||+ +.|+++|
T Consensus 226 ----------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 ----------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 011345788999999999999994 8888875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=385.96 Aligned_cols=255 Identities=23% Similarity=0.301 Sum_probs=198.5
Q ss_pred CCCCccccccccCCeeEEEEEECC----CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS----GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
++|+..+.||+|+||.||+|++.. +..||||++... ......+.+.+|++++++++|||||++++++. ++..|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 578889999999999999998752 356899988433 34455677999999999999999999999996 467899
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
||||+++|++.+++.... ..+++..++.++.||++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999876543 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
.... .......||+.|+|||++.++.++.++|||||||++|||++ |..||... ...++...+........+
T Consensus 160 ~~~~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~--~~~~~~~~i~~~~~~~~~--- 231 (273)
T d1mp8a_ 160 DSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERLPMP--- 231 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCCCC---
T ss_pred CCcc---eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCCCC---
Confidence 4322 12234568999999999999999999999999999999998 78888653 344555544433222111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
...+..+.+++.+||+.||++|||+.||+++|+.+
T Consensus 232 ------------------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 232 ------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=392.25 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=203.0
Q ss_pred CCCccccccccCCeeEEEEEEC-CCC----EEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGE----TVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
+|+..++||+|+||+||+|++. +|+ +||+|++.... .....+.+.+|++++++++|||||+++++|.++ ..++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 5888999999999999999875 444 58999885432 334567799999999999999999999999875 4577
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQ 837 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 837 (973)
++||+.+|+|.+++..... .+++..+++++.|||.||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8899999999998876533 689999999999999999999999 99999999999999999999999999998875
Q ss_pred ccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCccc
Q 039922 838 SQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERGC 916 (973)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..... .......||+.|+|||++.++.++.++|||||||++|||+| |..||... ...++...+..+.....+.
T Consensus 163 ~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--~~~~~~~~i~~~~~~~~p~-- 236 (317)
T d1xkka_ 163 AEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPP-- 236 (317)
T ss_dssp TTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CGGGHHHHHHHTCCCCCCT--
T ss_pred ccccc--ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCCCCc--
Confidence 44322 22334568999999999999999999999999999999999 67777643 3444555555443221111
Q ss_pred cCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 917 CRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 917 ~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
.....+.+++.+||+.||++|||+.||+++|+..
T Consensus 237 -------------------~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 237 -------------------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -------------------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1235678999999999999999999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=390.16 Aligned_cols=271 Identities=26% Similarity=0.280 Sum_probs=203.1
Q ss_pred cCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC----eeE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD----FNI 756 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 756 (973)
.+.|...+.||+|+||.||+|++. |+.||||++... .......+.|+..+..++|||||++++++.+++ ..|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 346777889999999999999975 899999998321 222223344666667889999999999997643 578
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC-----VPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
+|||||++|+|.++++.. .++|..+++++.|+|.||+|+|+.. .++|+||||||+|||+++++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999999864 4899999999999999999999731 2399999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCC------CCCCCChhhHHHHHHHHHcCCCCCCCCCCCch-------
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKK------VTEKSDVYSFGVVLMELVTGKRPNDPSFGENK------- 898 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~------- 898 (973)
+++.................||++|+|||++.+.. ++.++|||||||++|||+||..|+........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99887655433333345578999999999987543 56789999999999999999988754211100
Q ss_pred --hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 899 --DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 899 --~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.....+...... +..+|.+.......+....+.+++.+||+.||++||||.||+++|+++.
T Consensus 234 ~~~~~~~~~~~~~~-----------~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVEEMRKVVCE-----------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHHHHHHHHTT-----------SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhc-----------cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 011111111111 1112222222223456677999999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=392.32 Aligned_cols=261 Identities=26% Similarity=0.360 Sum_probs=199.6
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEec-CC
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSG-QD 753 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~ 753 (973)
++|+..+.||+|+||.||+|++. +++.||||++.... .....+.+.+|...+.++ +|+|||++++++.. ++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 56889999999999999999864 34689999985433 334455677777777776 68899999998765 45
Q ss_pred eeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeC
Q 039922 754 FNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLD 820 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 820 (973)
..++|||||++|+|.++++.... ...+++..+..++.||++||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 68999999999999999975421 23488999999999999999999999 999999999999999
Q ss_pred CCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCC-CCCCCCCCchh
Q 039922 821 AEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKR-PNDPSFGENKD 899 (973)
Q Consensus 821 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~-p~~~~~~~~~~ 899 (973)
+++.+||+|||+++........ .......||+.|+|||++.++.++.++|||||||++|||+||.. ||.. ......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~-~~~~~~ 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-VKIDEE 245 (299)
T ss_dssp GGGCEEECC------CCSCTTS--CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCCSHH
T ss_pred CCCcEEEccCcchhhccccccc--cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC-CCHHHH
Confidence 9999999999999876544321 22344679999999999999999999999999999999999765 5543 333444
Q ss_pred HHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 900 IVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
+...+..+.....+. ....++.+++.+||+.||++||||+||+++|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~---------------------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 246 FCRRLKEGTRMRAPD---------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHTCCCCCCT---------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCc---------------------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 444444433221110 11346889999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-44 Score=388.14 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=206.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 759 (973)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+.. ......+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999985 79999999985332 12234567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhcccc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQ 839 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 839 (973)
||+++|++.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887654 478888899999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 840 EGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+.......+
T Consensus 158 -------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~~~~p------- 221 (316)
T d1fota_ 158 -------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRFP------- 221 (316)
T ss_dssp -------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHCCCCCC-------
T ss_pred -------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc--CHHHHHHHHHcCCCCCC-------
Confidence 23467999999999999999999999999999999999999999753 33333333333221100
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 920 LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 920 l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
......+.+++.+|+++||++|+ |++|+++|
T Consensus 222 ---------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 ---------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 01125678999999999999996 89999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.9e-44 Score=379.88 Aligned_cols=254 Identities=25% Similarity=0.316 Sum_probs=208.5
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc-------hhHHHHHHHHHHHhcCC-CCCeeeEEeEEec
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP-------ETETVFRSEIETLGRVR-HGNVVKLLMCCSG 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 751 (973)
.++|+..+.||+|+||+||+|+.. +|+.||||++.+..... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 467899999999999999999975 78999999996543221 12346788999999997 9999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 752 QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 752 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
++..|+||||+++|+|.++++... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999997654 589999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccC------CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHH
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT------KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVT 905 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 905 (973)
+++.+..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||... ......+.+.
T Consensus 156 ~a~~~~~~~~-----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~--~~~~~~~~i~ 228 (277)
T d1phka_ 156 FSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIM 228 (277)
T ss_dssp TCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHH
T ss_pred heeEccCCCc-----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC--CHHHHHHHHH
Confidence 9987654322 234679999999998853 35688999999999999999999999753 3333333333
Q ss_pred HHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 906 EATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 906 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......+.. .......++.+++.+|+++||++|||+.||+++
T Consensus 229 ~~~~~~~~~------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNYQFGSP------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCCCCCTT------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCCCCCCCc------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 332221100 001223578899999999999999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=390.19 Aligned_cols=254 Identities=18% Similarity=0.254 Sum_probs=209.8
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEE
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 757 (973)
++.++|++.+.||+|+||+||+|+.+ +|+.||||++... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 56788999999999999999999986 7889999999533 2345568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCC--CceEEeccCcchh
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAE--MVPRVADFGLAKA 835 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGl~~~ 835 (973)
|||||++|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++.
T Consensus 79 vmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence 999999999999997643 2589999999999999999999999 99999999999999854 5899999999986
Q ss_pred ccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 836 LQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
..... ......+|+.|+|||...+..++.++||||+||++|||++|+.||... ...+....+.......+..
T Consensus 154 ~~~~~-----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~- 225 (321)
T d1tkia_ 154 LKPGD-----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEE- 225 (321)
T ss_dssp CCTTC-----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCCHH-
T ss_pred cccCC-----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCChh-
Confidence 54322 233457899999999999999999999999999999999999999753 3334444443332211100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+ ....++.+++.+|+++||++|||+.|+++|
T Consensus 226 --------~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 --------AFK---------EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --------HHT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------hcc---------CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 113567899999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=384.50 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=199.0
Q ss_pred CCCCccccccccCCeeEEEEEEC--CC--CEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK--SG--ETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
++|+..+.||+|+||.||+|+.. ++ ..||||++.+... .....+.|.+|++++++++|||||++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45888899999999999999864 23 3789999865432 33455789999999999999999999999975 4678
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|++.+++..... .+++..++.++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998876432 589999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
...... ........|+..|+|||++.+..++.++|||||||++|||+| |+.||... ...+...++.......+.
T Consensus 162 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~~~~~~i~~~~~~~~~-- 236 (273)
T d1u46a_ 162 PQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPR-- 236 (273)
T ss_dssp CC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCCCC--
T ss_pred ccCCCc-ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHHHHHHHHHhCCCCCCC--
Confidence 544322 122334567889999999999999999999999999999998 89998652 344444444332211000
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
....+..+.+++.+||++||++||||.||.+.|++.
T Consensus 237 ------------------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 ------------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011235688999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.1e-44 Score=382.13 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=204.3
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC---
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD--- 753 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 753 (973)
.+.++|++.+.||+|+||+||+|+.. +|+.||||++.+... .....+.+.+|++++++++|||||++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 35577999999999999999999975 799999999975543 3345567999999999999999999999987643
Q ss_pred -eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 754 -FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 754 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++..+++|||.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred ceEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhh
Confidence 4789999999999999887654 589999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
+......... ........||+.|+|||++.+..++.++||||+||++|||+||+.||... ...+....+...... +
T Consensus 158 ~~~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~~~~~~~~-~ 233 (277)
T d1o6ya_ 158 ARAIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVREDPI-P 233 (277)
T ss_dssp CEECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCCC-C
T ss_pred hhhhcccccc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--CHHHHHHHHHhcCCC-C
Confidence 8765433221 12234567999999999999999999999999999999999999999753 222222221111110 0
Q ss_pred CccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhhc
Q 039922 913 ERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-SMRRVVELLRVD 969 (973)
Q Consensus 913 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~ 969 (973)
+ .... ...+.++.+++.+|+++||++|| |++++.+.|.+.
T Consensus 234 ~--------~~~~---------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 P--------SARH---------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp G--------GGTS---------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C--------chhc---------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0 0000 11235788999999999999999 899999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=386.46 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=214.8
Q ss_pred CCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 754 (973)
++|+..++||+|+||.||+|++. +++.||||++.... .......+.+|+.+++++ +|||||++++++.+++.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 57888899999999999999863 46789999996443 345566789999999999 69999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe
Q 039922 755 NILVYEYMPNGSLADMLHEKGR---------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 819 (973)
.++||||+++|+|.++++.... ...+++..+.+++.||+.|++|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 9999999999999999976432 22588999999999999999999999 99999999999999
Q ss_pred CCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchh
Q 039922 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKD 899 (973)
Q Consensus 820 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~ 899 (973)
+.++.+|++|||.++........ .......||+.|+|||++.++.++.++|||||||++|||+|++.|+.........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccCcccccccchheeccCCCcc--eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999877544332 2234467899999999999999999999999999999999966666554444455
Q ss_pred HHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 900 IVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
+.+.+........+ ......+.+++.+||++||++||||.||+++|+++
T Consensus 257 ~~~~i~~~~~~~~~---------------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 FYKMIKEGFRMLSP---------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHTCCCCCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCc---------------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 55555444322111 11235688999999999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-44 Score=386.87 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=203.4
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCC--EEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecCCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGE--TVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 757 (973)
++|+..++||+|+||+||+|+++ +|. .||||++.... .....+.+.+|+++++++ +|||||+++++|.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 46778899999999999999876 444 47888875332 234456799999999998 79999999999999999999
Q ss_pred EEeccCCCChhhhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCc
Q 039922 758 VYEYMPNGSLADMLHEK-------------GRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMV 824 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 824 (973)
||||+++|+|.++++.. .....+++..+.+++.|||.||.|+|+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 99999999999999754 1234689999999999999999999999 9999999999999999999
Q ss_pred eEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHH
Q 039922 825 PRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWV 904 (973)
Q Consensus 825 ~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 904 (973)
+||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|..|+... ....++.+.+
T Consensus 166 ~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i 239 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 239 (309)
T ss_dssp EEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHG
T ss_pred eEEcccccccccccccc-----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHH
Confidence 99999999976543322 22356899999999999999999999999999999999987654332 2334444444
Q ss_pred HHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhc
Q 039922 905 TEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVD 969 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 969 (973)
........+ .....++.+++.+||++||++||||.||+++|+.+
T Consensus 240 ~~~~~~~~~---------------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 240 PQGYRLEKP---------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp GGTCCCCCC---------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCC---------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 332211100 11235788999999999999999999999998774
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-43 Score=389.79 Aligned_cols=248 Identities=23% Similarity=0.265 Sum_probs=207.8
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCC-CCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGT-HKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 758 (973)
.++|++.+.||+|+||.||+|+.+ +|+.||||++.+.. ......+.+.+|+.+++.++|||||++++++...+..++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 357999999999999999999986 79999999985322 1223345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999997654 489999999999999999999999 999999999999999999999999999987643
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||... ........+.......+
T Consensus 194 ~-------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~~~~p------ 258 (350)
T d1rdqe_ 194 R-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFP------ 258 (350)
T ss_dssp C-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC------
T ss_pred c-------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--CHHHHHHHHhcCCCCCC------
Confidence 2 23467999999999999999999999999999999999999999753 33333343333221110
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
.....++.+++.+|+++||++|+ |++|+++|
T Consensus 259 ----------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 259 ----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 01135678999999999999994 89999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=381.40 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=206.6
Q ss_pred CCCCccccccccCCeeEEEEEECC--------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcC-CCCCeeeEEeEEecC
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKS--------GETVAVKRLLGGTHKPETETVFRSEIETLGRV-RHGNVVKLLMCCSGQ 752 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 752 (973)
++|...+.||+|+||.||+|+... +..||||++.... .......+.+|...+.++ +|||||+++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 578888999999999999998642 3479999986443 334456788888888888 799999999999999
Q ss_pred CeeEEEEeccCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEe
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGR-------------SGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILL 819 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 819 (973)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999975532 23589999999999999999999999 99999999999999
Q ss_pred CCCCceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHc-CCCCCCCCCCCch
Q 039922 820 DAEMVPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVT-GKRPNDPSFGENK 898 (973)
Q Consensus 820 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 898 (973)
+.++.+||+|||+++........ .......|++.|+|||++.++.++.++|||||||++|||++ |..||... ...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~--~~~ 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVE 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHH
T ss_pred cCCCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC--CHH
Confidence 99999999999999877654332 22344678999999999999999999999999999999998 57676542 333
Q ss_pred hHHHHHHHHhccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 899 DIVRWVTEATLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
++.+.+..+.....+. ....++.+++.+|+++||++||||.||++.|+++-
T Consensus 245 ~~~~~i~~~~~~~~p~---------------------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ELFKLLKEGHRMDKPS---------------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHTTCCCCCCS---------------------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCc---------------------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 4444444332221110 11346889999999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=381.38 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=211.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC------CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCe
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK------SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDF 754 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 754 (973)
.++|+..+.||+|+||+||+|.+. +++.||||++... ........|.+|++++++++|||||++++++..++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 367888899999999999999864 3578999999643 344555678999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEE
Q 039922 755 NILVYEYMPNGSLADMLHEKG-------RSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRV 827 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 827 (973)
.++||||+++|+|.+++.... ....+++..+.+++.|+|+||+|||++ +|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence 999999999999999886431 223478999999999999999999999 9999999999999999999999
Q ss_pred eccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHH
Q 039922 828 ADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEA 907 (973)
Q Consensus 828 ~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 907 (973)
+|||+++........ .......||+.|+|||.+.++.++.++||||||+++|||+||+.|+... ....+..+.+...
T Consensus 175 ~DFGla~~~~~~~~~--~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEG 251 (308)
T ss_dssp CCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTT
T ss_pred eecccceeccCCcce--eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhC
Confidence 999999876544331 2233356899999999999999999999999999999999986444332 2334444444332
Q ss_pred hccCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhhcc
Q 039922 908 TLSSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRVDK 970 (973)
Q Consensus 908 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 970 (973)
.....+ ......+.+++.+||+++|++||||.||+++|++..
T Consensus 252 ~~~~~p---------------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 252 GLLDKP---------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp CCCCCC---------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCc---------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 221111 111356899999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-43 Score=388.35 Aligned_cols=251 Identities=23% Similarity=0.259 Sum_probs=199.7
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHH---HHHHHHhcCCCCCeeeEEeEEecCCeeE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFR---SEIETLGRVRHGNVVKLLMCCSGQDFNI 756 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~ 756 (973)
++|++.++||+|+||.||+|+.+ +|+.||||++.+... .......+. +|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999986 799999999853221 111222233 4577788889999999999999999999
Q ss_pred EEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhc
Q 039922 757 LVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKAL 836 (973)
Q Consensus 757 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 836 (973)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999998654 478999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCcc
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERG 915 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.... .....||+.|+|||++.. ..++.++||||+||++|||+||+.||...... +... +.......+..
T Consensus 158 ~~~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~-~~~~~~~~~~~- 227 (364)
T d1omwa3 158 SKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHE-IDRMTLTMAVE- 227 (364)
T ss_dssp SSSC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHH-HHHHSSSCCCC-
T ss_pred CCCc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHH-HHHhcccCCCC-
Confidence 4332 234579999999999875 56899999999999999999999999764322 2222 22222111100
Q ss_pred ccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039922 916 CCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPS-----MRRVVEL 965 (973)
Q Consensus 916 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 965 (973)
+. .....++.+++.+|+++||++||| ++|+++|
T Consensus 228 ------------~~-----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 228 ------------LP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ------------CC-----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ------------CC-----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00 012356789999999999999999 6888765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=379.80 Aligned_cols=266 Identities=24% Similarity=0.289 Sum_probs=198.5
Q ss_pred cccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCch---hHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEecc
Q 039922 687 QNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPE---TETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEYM 762 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 762 (973)
.++||+|+||+||+|+++ +|+.||||++........ ..+.+.+|+.++++++|||||++++++..++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999976 699999999864432221 2346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCCC
Q 039922 763 PNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEGQ 842 (973)
Q Consensus 763 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 842 (973)
+++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 887776655432 3588899999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCccc
Q 039922 843 SDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDLN 921 (973)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 921 (973)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||... ...+....+.+............ ..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~--~~~~~l~~i~~~~~~~~~~~~~~-~~ 229 (299)
T d1ua2a_ 156 ---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--SDLDQLTRIFETLGTPTEEQWPD-MC 229 (299)
T ss_dssp ---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCTTTSSS-TT
T ss_pred ---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC--CHHHHHHHHHHhcCCCChhhccc-hh
Confidence 23345799999999998654 5799999999999999999999999753 33333333433322211111111 00
Q ss_pred cccc-CCCC-CCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 922 QLID-PRMD-LSTCD-----YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 922 ~~~d-~~l~-~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
...+ .... ..... ......+.+++.+|+++||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 1000 0000 00000 1123578899999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-43 Score=376.77 Aligned_cols=275 Identities=23% Similarity=0.299 Sum_probs=205.1
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|++.+.||+|+||+||+|++. +|+.||||++..........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999975 79999999996544434445678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
|+.+ ++.+++.... ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9964 5555544332 23589999999999999999999999 99999999999999999999999999998764332
Q ss_pred CCccccccccccccCccccccccCCC-CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKK-VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
.......||+.|+|||...... ++.++||||+||++|||++|+.||... ...+....+...... +.......
T Consensus 157 ----~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~--~~~~~~~~i~~~~~~-~~~~~~~~ 229 (298)
T d1gz8a_ 157 ----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--SEIDQLFRIFRTLGT-PDEVVWPG 229 (298)
T ss_dssp ----BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCC-CCTTTSTT
T ss_pred ----ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC--CHHHHHHHHHHhcCC-Cchhhccc
Confidence 2234467999999999877655 578999999999999999999999753 222222222222211 11111111
Q ss_pred ccccccCCCC---CCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--Hhh
Q 039922 920 LNQLIDPRMD---LSTCD-----YEEAEKVLNVALMCTSDFPINRPSMRRVVEL--LRV 968 (973)
Q Consensus 920 l~~~~d~~l~---~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~ 968 (973)
.....+.... ..... ......+.+++.+|+++||++|||++|+++| +++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 1111111000 00011 1123578899999999999999999999987 544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=385.37 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=202.9
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCC-CchhHHHHHHHHHHHh-cCCCCCeeeEEeEEecCCeeEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTH-KPETETVFRSEIETLG-RVRHGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 758 (973)
++|+..+.||+|+||+||+|+.+ +|+.||||++.+... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56888999999999999999986 799999999954321 1223344556666654 68999999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQS 838 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 838 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999998654 478999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccC
Q 039922 839 QEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCR 918 (973)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...++...+.......+
T Consensus 156 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~~p------ 223 (320)
T d1xjda_ 156 GD----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPFYP------ 223 (320)
T ss_dssp TT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC------
T ss_pred cc----ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCC------
Confidence 32 2234467999999999999999999999999999999999999999753 33344443333221100
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039922 919 DLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMR-RVVE 964 (973)
Q Consensus 919 ~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 964 (973)
.....++.+++.+|+++||++||++. |+++
T Consensus 224 ----------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 ----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01135678999999999999999995 6754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=384.21 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=200.1
Q ss_pred cccccCCCCccc-cccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhc-CCCCCeeeEEeEEec--
Q 039922 677 EDDILPHLTEQN-LIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGR-VRHGNVVKLLMCCSG-- 751 (973)
Q Consensus 677 ~~~~~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~-- 751 (973)
...+.++|.+.+ +||+|+||+||+|++. +|+.||||++.. ...+.+|++++.+ .+|||||+++++|.+
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 345677888764 6999999999999975 799999999842 2346789988655 489999999999865
Q ss_pred --CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCceE
Q 039922 752 --QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVPR 826 (973)
Q Consensus 752 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~k 826 (973)
+...|+|||||++|+|.+++...+ ...+++..+..++.||+.||+|||+. +|+||||||+||++++ ++.+|
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEE
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccc
Confidence 467899999999999999997643 23589999999999999999999999 9999999999999985 56799
Q ss_pred EeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHH
Q 039922 827 VADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTE 906 (973)
Q Consensus 827 l~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 906 (973)
|+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+..
T Consensus 155 l~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~--~~~~~~~~~ 227 (335)
T d2ozaa1 155 LTDFGFAKETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKT 227 (335)
T ss_dssp ECCCTTCEECCCCCC-----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC--C--------
T ss_pred ccccceeeeccCCCc-----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH--HHHHHHHHH
Confidence 999999987654322 3346799999999999999999999999999999999999999965321 111111111
Q ss_pred HhccCCCccccCcccccccCCCCCCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 907 ATLSSPERGCCRDLNQLIDPRMDLSTC-DYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 907 ~~~~~~~~~~~~~l~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.... ........ ......++.+++.+|+++||++|||+.|+++|
T Consensus 228 ~i~~---------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRM---------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCS---------------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhc---------------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 00000000 01235678999999999999999999999885
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-42 Score=374.29 Aligned_cols=271 Identities=22% Similarity=0.276 Sum_probs=205.3
Q ss_pred CCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEec
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYEY 761 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 761 (973)
++|+..++||+|+||+||+|++++|+.||||++..........+.+.+|+.++++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57899999999999999999999999999999965544444467799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccCC
Q 039922 762 MPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQEG 841 (973)
Q Consensus 762 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 841 (973)
+.++.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9876666665433 3599999999999999999999999 999999999999999999999999999987654322
Q ss_pred CccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCcc
Q 039922 842 QSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRDL 920 (973)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 920 (973)
......|++.|+|||.+.+. .++.++||||+||++|||++|+.||... ...+....+.......... .....
T Consensus 156 ----~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~--~~~~~~~~i~~~~~~~~~~-~~~~~ 228 (286)
T d1ob3a_ 156 ----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV--SEADQLMRIFRILGTPNSK-NWPNV 228 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTT-TSTTG
T ss_pred ----ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC--CHHHHHHHHHHhhCCCChh-hccch
Confidence 12335688999999998754 5689999999999999999999999753 2222222222222111111 11111
Q ss_pred ccccc--CCCCC------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 921 NQLID--PRMDL------STCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 921 ~~~~d--~~l~~------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+... ..... ..........+.+++.+|+++||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 00000 00011123578899999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=373.29 Aligned_cols=273 Identities=23% Similarity=0.266 Sum_probs=200.0
Q ss_pred cCCCCccccccccCCeeEEEEEEC-C-CCEEEEEEecCCCCCchhHHHHHHHHHHHhcC---CCCCeeeEEeEEec----
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-S-GETVAVKRLLGGTHKPETETVFRSEIETLGRV---RHGNVVKLLMCCSG---- 751 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 751 (973)
-++|++.+.||+|+||+||+|++. + ++.||||++............+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 357999999999999999999974 4 66799999865433333333456677776665 79999999999853
Q ss_pred -CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 752 -QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 752 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
....+++|||++++.+....... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 35679999999877665444332 23588999999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+....+......
T Consensus 161 g~~~~~~~~-----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCC
T ss_pred hhhhhhccc-----ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC--CHHHHHHHHHHhhCC
Confidence 998764332 2344568999999999999999999999999999999999999999753 233333333332222
Q ss_pred CCCccccCccc---ccc-cCC-CCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLN---QLI-DPR-MDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~---~~~-d~~-l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
......+.... ... ... .............+.+++.+|+++||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11111101000 000 000 00000111223567889999999999999999999886
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=370.03 Aligned_cols=278 Identities=20% Similarity=0.247 Sum_probs=203.7
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec-------
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG------- 751 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 751 (973)
-.++|++.+.||+|+||+||+|++. +|+.||||++..........+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3578999999999999999999975 89999999986655555556778899999999999999999998855
Q ss_pred -CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEecc
Q 039922 752 -QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADF 830 (973)
Q Consensus 752 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 830 (973)
++..|+||||++++.+..+.... ..++...++.++.||+.||+|||+. +|+||||||+|||+++++.+|++||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 34578999999877666544332 2578889999999999999999999 9999999999999999999999999
Q ss_pred CcchhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhc
Q 039922 831 GLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATL 909 (973)
Q Consensus 831 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 909 (973)
|+++.+...............||+.|+|||++.+. .++.++||||+||++|||++|+.||... ........+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~--~~~~~~~~i~~~~~ 239 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLCG 239 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC--CHHHHHHHHHHhcC
Confidence 99987664443333334446799999999998755 6899999999999999999999999753 33333333433333
Q ss_pred cCCCccccC----cccccccCCCCCCCCCHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 910 SSPERGCCR----DLNQLIDPRMDLSTCDYE------EAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 910 ~~~~~~~~~----~l~~~~d~~l~~~~~~~~------~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..++..... ...+.+...........+ ....+.+++.+|+++||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 222211111 011111100000011111 12356789999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=367.28 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=196.6
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCc----hhHHHHHHHHHHHhcCC--CCCeeeEEeEEecCC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKP----ETETVFRSEIETLGRVR--HGNVVKLLMCCSGQD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 753 (973)
.++|++.++||+|+||+||+|+.. +|+.||||++.+..... .....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 457999999999999999999976 79999999986432221 11234668999999986 899999999999999
Q ss_pred eeEEEEeccCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-CCceEEeccC
Q 039922 754 FNILVYEYMPN-GSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-EMVPRVADFG 831 (973)
Q Consensus 754 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 831 (973)
..|+||||+.+ +++.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 99999999975 57778876543 589999999999999999999999 9999999999999985 4799999999
Q ss_pred cchhccccCCCccccccccccccCccccccccCCCC-CCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKV-TEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+++..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... .. +......
T Consensus 157 ~a~~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~----i~~~~~~ 222 (273)
T d1xwsa_ 157 SGALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EE----IIRGQVF 222 (273)
T ss_dssp TCEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH----HHHCCCC
T ss_pred cceecccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hH----HhhcccC
Confidence 99765322 2334679999999999987665 56789999999999999999999641 11 1111110
Q ss_pred CCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+.+. ...++.+++.+|+++||++|||++|++++
T Consensus 223 -------------~~~~---------~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 -------------FRQR---------VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -------------CSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------------CCCC---------CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 13568899999999999999999999885
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=357.69 Aligned_cols=272 Identities=23% Similarity=0.276 Sum_probs=211.3
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCCeeEEEEe
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQDFNILVYE 760 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 760 (973)
++|++.+.||+|+||+||+|++. +|+.||||+++...........+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999985 78999999997665555667789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcchhccccC
Q 039922 761 YMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAKALQSQE 840 (973)
Q Consensus 761 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 840 (973)
++.++++..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999988888776543 578999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCccccccccccccCccccccccCCC-CCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCCccccCc
Q 039922 841 GQSDDAMSCVAGSYGYIAPEYAYTKK-VTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPERGCCRD 919 (973)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
. ......++..|+|||++.+.. ++.++||||+||++|||++|+.||.... +..+....+.......... ....
T Consensus 156 ~----~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~ 229 (292)
T d1unla_ 156 R----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEE-QWPS 229 (292)
T ss_dssp S----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHHHHHHHHHHHCCCCTT-TCTT
T ss_pred c----cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-CHHHHHHHHHhhcCCCChh-hhhh
Confidence 2 223345778899999887655 6899999999999999999999986532 2233333333322221111 1111
Q ss_pred cccccc--------CCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 920 LNQLID--------PRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 920 l~~~~d--------~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
..+..+ ...............+.+++.+|+++||.+|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 0001111112234567899999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=368.69 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=199.3
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD---- 753 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 753 (973)
++.++|+..+.||+|+||+||+|+++ +|+.||||++..........+.+.+|++++++++|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 46678999999999999999999976 6999999999766555566678899999999999999999999997654
Q ss_pred --eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccC
Q 039922 754 --FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFG 831 (973)
Q Consensus 754 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 831 (973)
..|+||||+ +++|..+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 569999999 56787776543 489999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhcc
Q 039922 832 LAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLS 910 (973)
Q Consensus 832 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||... +..+....+......
T Consensus 167 ~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~--~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 167 LARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS--DHLDQLKEIMKVTGT 237 (346)
T ss_dssp TCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCC
T ss_pred ceeccCCc-------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC--ChHHHHHHHHhccCC
Confidence 99865332 334679999999999876 45789999999999999999999999753 222222211111111
Q ss_pred CCCccccCc------------ccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 911 SPERGCCRD------------LNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 911 ~~~~~~~~~------------l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.+. ..... +.+.....+ ..........+.+++.+|++.||++|||+.|+++|
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 238 PPA-EFVQRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCH-HHHHTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcH-HHHhhhcchhhhhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000 000000000 00001123467889999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=367.30 Aligned_cols=266 Identities=25% Similarity=0.280 Sum_probs=193.4
Q ss_pred CCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC------Cee
Q 039922 683 HLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ------DFN 755 (973)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 755 (973)
+|+..++||+|+||+||+|++. +|+.||||++...... ..+|++++++++|+||++++++|... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5788899999999999999986 7999999999654322 34699999999999999999998542 346
Q ss_pred EEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcch
Q 039922 756 ILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAK 834 (973)
Q Consensus 756 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~ 834 (973)
|+||||++++.+....+.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 89999997654444333222334689999999999999999999999 999999999999999775 89999999998
Q ss_pred hccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ..+....+.+.......
T Consensus 172 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~--~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 172 QLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp ECCTTSC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCCCH
T ss_pred hccCCcc-----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC--HHHHHHHHHHHhCCChH
Confidence 7644322 334679999999998765 578999999999999999999999997532 22222111111100000
Q ss_pred --------ccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 --------RGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 --------~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
........+.....+. .........++.+++.+|+++||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhhhccchhhccccccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000000 00111234568899999999999999999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2e-40 Score=362.04 Aligned_cols=295 Identities=27% Similarity=0.501 Sum_probs=194.7
Q ss_pred cchhhHHHHHHHhhhccCCCCCccCCccCCCCCCCC--ccceeEEcCCC--CceeEeecCCCccCC--CCCCCccCcccc
Q 039922 25 SLHGDAEILIRVKSDQLDDPNRKLGDWVRTSQQSPC--NWTGITCETQN--QSVDGIDLSGFDLSG--GFPNGFCRIRTL 98 (973)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~d~~~~~~sw~~~~~~~~C--~w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~~~~l~~L 98 (973)
|.+.|++||++||+++ .||. .++||.. ++||| .|+||+|++.+ .||+.|+|++++++| .+|+++++|++|
T Consensus 3 c~~~e~~aLl~~k~~~-~~~~-~l~sW~~--~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDL-GNPT-TLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp SCHHHHHHHHHHHHHT-TCCG-GGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCHHHHHHHHHHHHHC-CCCC-cCCCCCC--CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 4678999999999997 5664 6999964 46899 49999998754 489999999999998 478888888888
Q ss_pred ceeccCC-CcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecC
Q 039922 99 RNLNLSD-NYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLG 177 (973)
Q Consensus 99 ~~L~Ls~-n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 177 (973)
++|||++ |+++|.+|. .++++++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..++++++|++++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~-~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPP-AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCG-GGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccc-ccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 8888876 677666553 35555555555555555555445445555555555555555444444444444444444444
Q ss_pred CcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCC-CEEEccCCcccc
Q 039922 178 GNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFL-SNLDLSDNFLSG 256 (973)
Q Consensus 178 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~ 256 (973)
+|.+++.+|.. ++.+..+ +.+++++|++++
T Consensus 158 ~n~l~~~ip~~-------------------------------------------------~~~l~~l~~~l~~~~n~l~~ 188 (313)
T d1ogqa_ 158 GNRISGAIPDS-------------------------------------------------YGSFSKLFTSMTISRNRLTG 188 (313)
T ss_dssp SSCCEEECCGG-------------------------------------------------GGCCCTTCCEEECCSSEEEE
T ss_pred ccccccccccc-------------------------------------------------cccccccccccccccccccc
Confidence 44444444443 4343333 555566666665
Q ss_pred cCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCC
Q 039922 257 KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASN 336 (973)
Q Consensus 257 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l 336 (973)
..|..+..+..+ .++++++...+.+|..+..+++++.+++++|.+++.++......+|+.|+|++|+++|.+|+.+.++
T Consensus 189 ~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L 267 (313)
T d1ogqa_ 189 KIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267 (313)
T ss_dssp ECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGC
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCC
Confidence 555555555433 4666666666666666666666666666666666555443333467777777777777778888888
Q ss_pred CccceeeeccccccCCCCCCccCCCCccceeeeccc-ccc
Q 039922 337 PNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTND-FTG 375 (973)
Q Consensus 337 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~ 375 (973)
++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|
T Consensus 268 ~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 268 KFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp TTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred CCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence 8888888888888887774 5777888888888876 444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=362.06 Aligned_cols=275 Identities=19% Similarity=0.237 Sum_probs=199.6
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecCC----e
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQD----F 754 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 754 (973)
+.++|++.+.||+|+||+||+|+.. +|+.||||++.+.. .....+.+.+|++++++++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 4567999999999999999999875 89999999995432 3445567889999999999999999999987543 2
Q ss_pred eEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 755 NILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 755 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.+++++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 34555667799999999753 489999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCCCccccccccccccCccccccccC-CCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCCC
Q 039922 835 ALQSQEGQSDDAMSCVAGSYGYIAPEYAYT-KKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSPE 913 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
........ ........||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ..+..............
T Consensus 158 ~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~--~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 158 VADPDHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPSQ 234 (345)
T ss_dssp ECCGGGCB-CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCH
T ss_pred eccCCCcc-ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC--HHHHHHHHhhhccCCCh
Confidence 76543322 122345679999999999854 567889999999999999999999997532 22222222111111100
Q ss_pred ccccCcc----cccccCCCCCCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 914 RGCCRDL----NQLIDPRMDLSTCDY-----EEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 914 ~~~~~~l----~~~~d~~l~~~~~~~-----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....... ............... ....++.+++.+|+++||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 000000000000000 112468899999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-39 Score=349.08 Aligned_cols=259 Identities=22% Similarity=0.294 Sum_probs=197.5
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCee-eEEeEEecCCeeEEEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVV-KLLMCCSGQDFNILVY 759 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~ 759 (973)
++|++.+.||+|+||.||+|++. +|+.||||++..... .+++.+|+++++.++|++++ .+.+++.+++..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 57999999999999999999975 789999998864432 23477899999999877654 5556667788999999
Q ss_pred eccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC---CCceEEeccCcchhc
Q 039922 760 EYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA---EMVPRVADFGLAKAL 836 (973)
Q Consensus 760 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl~~~~ 836 (973)
||+ ++++.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||+++.+
T Consensus 83 e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEc-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999 5677776654432 589999999999999999999999 9999999999999864 557999999999887
Q ss_pred cccCCCc---cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCch--hHHHHHHHHhccC
Q 039922 837 QSQEGQS---DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENK--DIVRWVTEATLSS 911 (973)
Q Consensus 837 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~ 911 (973)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~~ 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-KMST 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH-HHHS
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc-cCCC
Confidence 5443221 1223456799999999999999999999999999999999999999976422211 11111111 1110
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
+. .... ...+.++.+++..|++.+|++||+++++.+.|+.
T Consensus 236 ~~-------~~~~----------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 236 PI-------EVLC----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp CH-------HHHT----------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred Ch-------hHhc----------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00 0000 1123568899999999999999999998887765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=358.79 Aligned_cols=270 Identities=21% Similarity=0.213 Sum_probs=196.7
Q ss_pred ccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEec------C
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSG------Q 752 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 752 (973)
+.++|++.++||+|+||+||+|++. +|+.||||++..........+.+.+|+.++++++|||||+++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4578999999999999999999986 79999999997666666666788999999999999999999999964 3
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
...|+||||+.++ +.+.+.. .+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||+
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 6789999999655 4444432 478999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccCC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSSP 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
++...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||... +.......+........
T Consensus 166 ~~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~--~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 166 ARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--DYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCC
T ss_pred hhcccccc-----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC--CHHHHHHHHHHhccCCC
Confidence 87654322 234467899999999999999999999999999999999999999753 22222221111111100
Q ss_pred Cccc------------------cCcccccccCCC-CCC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 913 ERGC------------------CRDLNQLIDPRM-DLS-TCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 913 ~~~~------------------~~~l~~~~d~~l-~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
+..+ .......+.... ... .........+.+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000011111110 000 1112346688999999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-39 Score=355.59 Aligned_cols=260 Identities=21% Similarity=0.251 Sum_probs=197.2
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEec--CCeeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSG--QDFNIL 757 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~l 757 (973)
++|++.++||+|+||+||+|+.. +|+.||||++.. ...+.+.+|++++++++ ||||+++++++.. ....++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 57999999999999999999985 789999999842 22456889999999996 9999999999874 456899
Q ss_pred EEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCC-ceEEeccCcchhc
Q 039922 758 VYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEM-VPRVADFGLAKAL 836 (973)
Q Consensus 758 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~ 836 (973)
||||+++++|.++.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 999999999987642 488999999999999999999999 999999999999998655 6899999999876
Q ss_pred cccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHH------------HH
Q 039922 837 QSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIV------------RW 903 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~------------~~ 903 (973)
..... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........... .+
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 181 HPGQE-----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp CTTCC-----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred cCCCc-----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 54322 3345789999999998765 479999999999999999999999976432211111 11
Q ss_pred HHHHhccCCCccccCcccccccC-------CCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 904 VTEATLSSPERGCCRDLNQLIDP-------RMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~l~~~~d~-------~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
.......... ........ .............++.+++.+|+++||++|||++|+++|
T Consensus 256 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 256 IDKYNIELDP-----RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHTTCCCCG-----GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccCc-----ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111000 00000000 000001111224568899999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-39 Score=346.02 Aligned_cols=261 Identities=19% Similarity=0.214 Sum_probs=205.9
Q ss_pred cCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC-CCeeeEEeEEecCCeeEEE
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH-GNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 758 (973)
-++|++.+.||+|+||+||+|++. +|+.||||++..... ...+++|++.++.++| +|++.+++++..+...++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 357899999999999999999976 789999998854332 2236778888988875 8999999999999999999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCC-----CCceEEeccCcc
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDA-----EMVPRVADFGLA 833 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGl~ 833 (973)
|||+ +++|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 9999 6899998876543 589999999999999999999999 9999999999999974 578999999999
Q ss_pred hhccccCCCc---cccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC-chhHHHHHHHHhc
Q 039922 834 KALQSQEGQS---DDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE-NKDIVRWVTEATL 909 (973)
Q Consensus 834 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~ 909 (973)
+......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 8765433221 12234567999999999999999999999999999999999999999764322 2222222322222
Q ss_pred cCCCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhh
Q 039922 910 SSPERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRPSMRRVVELLRV 968 (973)
Q Consensus 910 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 968 (973)
..+. .++. ...+.++.+++..|++.+|++||+++.+.+.+++
T Consensus 234 ~~~~-------~~l~----------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 234 STPL-------RELC----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HSCH-------HHHT----------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CCCh-------HHhc----------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 2110 0110 0112568889999999999999999998887765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=356.94 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=202.4
Q ss_pred cCCCCccccccccCCeeEEEEEEC----CCCEEEEEEecCCCC--CchhHHHHHHHHHHHhcCCC-CCeeeEEeEEecCC
Q 039922 681 LPHLTEQNLIGSGGSCRVYKVKLK----SGETVAVKRLLGGTH--KPETETVFRSEIETLGRVRH-GNVVKLLMCCSGQD 753 (973)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~ 753 (973)
.++|+..+.||+|+||+||+|+.. +|+.||||++.+... .....+.+.+|++++++++| |||+++++++.+.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999863 588999999854321 22334567889999999977 79999999999999
Q ss_pred eeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCcc
Q 039922 754 FNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGLA 833 (973)
Q Consensus 754 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 833 (973)
..++||||+.+|+|.+++.... ...+..+..++.||+.|++|+|+. +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999998765 367888899999999999999999 9999999999999999999999999999
Q ss_pred hhccccCCCccccccccccccCccccccccCC--CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 834 KALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK--KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+.+..... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... +....+.......
T Consensus 177 ~~~~~~~~---~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 177 KEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS 251 (322)
T ss_dssp EECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHC
T ss_pred hhhccccc---ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcccC
Confidence 87644332 223346789999999998754 4678999999999999999999999764221 2222222222111
Q ss_pred CCccccCcccccccCCCCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039922 912 PERGCCRDLNQLIDPRMDLSTCDYEEAEKVLNVALMCTSDFPINRP-----SMRRVVEL 965 (973)
Q Consensus 912 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 965 (973)
.+. + ......++.+++.+|+++||++|| |++|+++|
T Consensus 252 ~~~-------------~-----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 EPP-------------Y-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCC-------------C-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCC-------------C-----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 110 0 012246788899999999999999 58999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=361.37 Aligned_cols=271 Identities=18% Similarity=0.234 Sum_probs=202.6
Q ss_pred cccCCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCeeeEEeEEecC-----
Q 039922 679 DILPHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNVVKLLMCCSGQ----- 752 (973)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 752 (973)
++.++|++.++||+|+||+||+|++. +|+.||||++.+........+.+.+|++++++++|||+|++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 45678999999999999999999975 799999999976665566667889999999999999999999998643
Q ss_pred CeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEeccCc
Q 039922 753 DFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVADFGL 832 (973)
Q Consensus 753 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 832 (973)
...+++|+|+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|++|||.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 3446677788899999998643 489999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCCCccccccccccccCccccccccCC-CCCCCCChhhHHHHHHHHHcCCCCCCCCCCCchhHHHHHHHHhccC
Q 039922 833 AKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTK-KVTEKSDVYSFGVVLMELVTGKRPNDPSFGENKDIVRWVTEATLSS 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+..... ......|+..|+|||+..+. .++.++||||+||++|+|++|+.||... +.......+.......
T Consensus 168 a~~~~~-------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~--~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 168 ARHTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--DHIDQLKLILRLVGTP 238 (348)
T ss_dssp --CCTG-------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCC
T ss_pred hcccCc-------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCC
Confidence 875432 23346789999999987665 4688999999999999999999999753 3333333333322221
Q ss_pred CCccccC----cccccccCCCCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039922 912 PERGCCR----DLNQLIDPRMDLSTCD-----YEEAEKVLNVALMCTSDFPINRPSMRRVVEL 965 (973)
Q Consensus 912 ~~~~~~~----~l~~~~d~~l~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 965 (973)
....... ................ ......+.+++.+|++.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 1100000 0000000000000000 1123567899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-34 Score=321.28 Aligned_cols=269 Identities=20% Similarity=0.200 Sum_probs=191.8
Q ss_pred CCCCccccccccCCeeEEEEEEC-CCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-----------CCCeeeEEeEE
Q 039922 682 PHLTEQNLIGSGGSCRVYKVKLK-SGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-----------HGNVVKLLMCC 749 (973)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 749 (973)
++|++.++||+|+||+||+|+.. +|+.||||++.+. ....+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 35999999999999999999985 7999999999432 334456778888888775 57899999887
Q ss_pred ec--CCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEeCCCCCCEEeCCCC---
Q 039922 750 SG--QDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHN-DCVPAIVHRDVKSHNILLDAEM--- 823 (973)
Q Consensus 750 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~--- 823 (973)
.. ....+++|+++..+...............++..+..++.||+.|++|||+ . +|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 64 34566777776555443333333344568899999999999999999998 6 899999999999998665
Q ss_pred ---ceEEeccCcchhccccCCCccccccccccccCccccccccCCCCCCCCChhhHHHHHHHHHcCCCCCCCCCCC----
Q 039922 824 ---VPRVADFGLAKALQSQEGQSDDAMSCVAGSYGYIAPEYAYTKKVTEKSDVYSFGVVLMELVTGKRPNDPSFGE---- 896 (973)
Q Consensus 824 ---~~kl~DfGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~---- 896 (973)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||......
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccceeeEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 3999999998754322 23467999999999999999999999999999999999999999754211
Q ss_pred -chhHHHHHHHHhccCCCcc----------------ccCcccccccCC-----CCCCCCCHHHHHHHHHHHHhccCCCCC
Q 039922 897 -NKDIVRWVTEATLSSPERG----------------CCRDLNQLIDPR-----MDLSTCDYEEAEKVLNVALMCTSDFPI 954 (973)
Q Consensus 897 -~~~~~~~~~~~~~~~~~~~----------------~~~~l~~~~d~~-----l~~~~~~~~~~~~l~~l~~~cl~~dP~ 954 (973)
.......+... ...+.. ............ ............++.+++.+|+++||+
T Consensus 240 ~~~~~~~~~~~l--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 240 DDDHIAQIIELL--GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp HHHHHHHHHHHH--CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hhHHHHHHHHHh--CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 01111111110 000000 000000000000 001122356678899999999999999
Q ss_pred CCCCHHHHHHH
Q 039922 955 NRPSMRRVVEL 965 (973)
Q Consensus 955 ~Rps~~evl~~ 965 (973)
+|||++|+++|
T Consensus 318 ~Rpta~e~L~H 328 (362)
T d1q8ya_ 318 KRADAGGLVNH 328 (362)
T ss_dssp TCBCHHHHHTC
T ss_pred HCcCHHHHhcC
Confidence 99999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.6e-31 Score=291.01 Aligned_cols=252 Identities=29% Similarity=0.464 Sum_probs=177.8
Q ss_pred cCcEEEccCCcCCC--CCCccccCCCccceeeecc-ccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhh
Q 039922 314 SLESLNLNDNYFTG--EIPESLASNPNLVQLKLFN-NSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCI 390 (973)
Q Consensus 314 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 390 (973)
+++.|+|++|.++| .+|..+.++++|++|+|++ |+++|.+|..++++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 46667777777766 4678888888888888876 78888888888888888888888888887777766666666666
Q ss_pred hcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCC
Q 039922 391 IIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT 470 (973)
Q Consensus 391 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~ 470 (973)
++++|++.+.+|..+++++.|+++++++|.+.+.+|..+..+..+ ++.+++++|+++
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l-----------------------~~~l~~~~n~l~ 187 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-----------------------FTSMTISRNRLT 187 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----------------------CCEEECCSSEEE
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccc-----------------------cccccccccccc
Confidence 666666666666666666666666666666666555555544433 144555555555
Q ss_pred CCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcccc
Q 039922 471 GEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELG 550 (973)
Q Consensus 471 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 550 (973)
+..|..+..+..+ .+++++|.+.+.+|..+..+++|+.+++++|.+++.+| .++.+++|+.|+|++|+|+|.+|.+|+
T Consensus 188 ~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~ 265 (313)
T d1ogqa_ 188 GKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT 265 (313)
T ss_dssp EECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHh
Confidence 5555555555433 57777777777777777777777777777777775544 567777777778877877777777777
Q ss_pred ccccccEEecCCCcCccccChhhhcc-cccceeccCCc-Cccc
Q 039922 551 NLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNK-LYGE 591 (973)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~-l~g~ 591 (973)
++++|++|||++|+|+|.+|. +..+ .|+.+++++|+ ++|.
T Consensus 266 ~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 266 QLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp GCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred CCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 788888888888888877774 3555 67777777776 5553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=6.8e-29 Score=278.54 Aligned_cols=193 Identities=26% Similarity=0.348 Sum_probs=107.6
Q ss_pred ccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcce
Q 039922 331 ESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKT 410 (973)
Q Consensus 331 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 410 (973)
..+..+++++.+++++|.+++..| +..+++|++|++++|++++. ..+..+++
T Consensus 191 ~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--------------------------~~l~~l~~ 242 (384)
T d2omza2 191 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--------------------------GTLASLTN 242 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--------------------------GGGGGCTT
T ss_pred cccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--------------------------chhhcccc
Confidence 334455556666666666554332 33445555666655555421 12333444
Q ss_pred eeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcC
Q 039922 411 LNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQ 490 (973)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 490 (973)
|+.|++++|.+++.. .+..+++|+.|++++|++++.. .+..++.++.+.++.|.+++ ...+..+++++.|++++
T Consensus 243 L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~ 316 (384)
T d2omza2 243 LTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYF 316 (384)
T ss_dssp CSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCS
T ss_pred cchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCC
Confidence 444444444444322 1344444444444444444321 24455555666666666653 22356666777777777
Q ss_pred CcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCC
Q 039922 491 NRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSN 563 (973)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (973)
|++++. + .+..+++|++|++++|+|++ ++ .+.++++|++|+|++|+|++..| +.++++|++|+|++|
T Consensus 317 n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 317 NNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 777643 2 26667777777777777763 33 46677777777777777775433 667777777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=2.5e-28 Score=273.94 Aligned_cols=355 Identities=22% Similarity=0.323 Sum_probs=230.5
Q ss_pred ECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcc
Q 039922 151 DLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANL 230 (973)
Q Consensus 151 ~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l 230 (973)
.++.+.+++.+. ...+.+|++|++++|+|+.. +.+..+++|++|+|++|+++.+
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l---------------------- 81 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI---------------------- 81 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC----------------------
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC----------------------
Confidence 444555554433 23455566666666666643 3455566666666666655431
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhh
Q 039922 231 IGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETI 310 (973)
Q Consensus 231 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 310 (973)
| .++++++|++|++++|++++.. .++++++|+.|++++|.+++..+ ......+..+....|.+....+..
T Consensus 82 ----~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~- 151 (384)
T d2omza2 82 ----T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS- 151 (384)
T ss_dssp ----G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGT-
T ss_pred ----c-cccCCccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccccc-
Confidence 1 2455666666666666666432 25566666666666666554322 223344555555555544322211
Q ss_pred hcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhh
Q 039922 311 AAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCI 390 (973)
Q Consensus 311 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 390 (973)
................ ...+.............|... ....+..+++++.+
T Consensus 152 ----------------------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l 202 (384)
T d2omza2 152 ----------------------GLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESL 202 (384)
T ss_dssp ----------------------TCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEE
T ss_pred ----------------------ccccccccccccccch-----hhhhccccccccccccccccc--ccccccccccccee
Confidence 1111111111111111 111222223333333333322 22333444555555
Q ss_pred hcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCC
Q 039922 391 IIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFT 470 (973)
Q Consensus 391 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~ 470 (973)
++++|.+++..| +...++|++|++++|++++. ..+..+++|+.+++++|++++.. .+..+++|+.|++++|.++
T Consensus 203 ~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~ 276 (384)
T d2omza2 203 IATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQIS 276 (384)
T ss_dssp ECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCC
T ss_pred eccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccC
Confidence 555555554433 45667899999999999853 46888999999999999998754 4888999999999999998
Q ss_pred CCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcccc
Q 039922 471 GEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELG 550 (973)
Q Consensus 471 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 550 (973)
+.. .+..+..++.++++.|++++ +..+..+++++.|++++|++++.. .+..+++|+.|+|++|+|++ +| .|.
T Consensus 277 ~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~ 348 (384)
T d2omza2 277 NIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLA 348 (384)
T ss_dssp CCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGG
T ss_pred CCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHc
Confidence 553 37788999999999999985 345888999999999999999654 38899999999999999984 54 699
Q ss_pred ccccccEEecCCCcCccccChhhhcc-cccceeccCC
Q 039922 551 NLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHN 586 (973)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N 586 (973)
++++|++|+|++|++++..| +..+ +|+.|++++|
T Consensus 349 ~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 99999999999999997655 7778 8999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=2.3e-25 Score=240.88 Aligned_cols=269 Identities=24% Similarity=0.334 Sum_probs=211.2
Q ss_pred CccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCc
Q 039922 60 CNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD 139 (973)
Q Consensus 60 C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~ 139 (973)
|.|++|.|+... ++ .+|+.+. +++++|||++|+|+ .++..+|.++++|++|++++|.+....|.
T Consensus 10 c~~~~~~C~~~~------------L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 10 CHLRVVQCSDLG------------LE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp EETTEEECTTSC------------CC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred ecCCEEEecCCC------------CC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchh
Confidence 789999998532 22 3555553 57999999999998 78878899999999999999999988899
Q ss_pred cccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcch
Q 039922 140 FSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSK 219 (973)
Q Consensus 140 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~ 219 (973)
.|..+++|++|++++|+++. +|..+ ...++.|++.+|.+.+..+..+.....++.++...|....
T Consensus 74 ~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~------------ 138 (305)
T d1xkua_ 74 AFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS------------ 138 (305)
T ss_dssp TTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG------------
T ss_pred hhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccc------------
Confidence 99999999999999999984 55533 4679999999999998877778888888888888876532
Q ss_pred hHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccc
Q 039922 220 LENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQ 299 (973)
Q Consensus 220 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 299 (973)
....+..+..+++|+.+++++|.++. +|..+ +++|++|++++|..++..+..+.+++.++.|++++
T Consensus 139 -----------~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~ 204 (305)
T d1xkua_ 139 -----------SGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204 (305)
T ss_dssp -----------GGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS
T ss_pred -----------cCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccc
Confidence 22334566777888888888888873 44433 56888888888888888888888888888888888
Q ss_pred cccCCCChhhhhcc-cCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCc------cCCCCccceeeeccc
Q 039922 300 NNLTGNLPETIAAM-SLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDL------GKYSNLEYFDVSTND 372 (973)
Q Consensus 300 N~l~~~~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l------~~l~~L~~L~Ls~N~ 372 (973)
|.+++..+..+... +|++|+|++|+|+ .+|+++..+++|++|+|++|+|+......| ..+.+|+.|+|++|+
T Consensus 205 n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~ 283 (305)
T d1xkua_ 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283 (305)
T ss_dssp SCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSS
T ss_pred ccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCc
Confidence 88887666666543 6888888888887 557788888888888888888884433232 346677888888887
Q ss_pred cc
Q 039922 373 FT 374 (973)
Q Consensus 373 l~ 374 (973)
+.
T Consensus 284 ~~ 285 (305)
T d1xkua_ 284 VQ 285 (305)
T ss_dssp SC
T ss_pred Cc
Confidence 65
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.1e-25 Score=238.26 Aligned_cols=221 Identities=25% Similarity=0.304 Sum_probs=154.5
Q ss_pred ecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECc-CCc
Q 039922 78 DLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLS-RNN 156 (973)
Q Consensus 78 ~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls-~n~ 156 (973)
+.++.+++ .+|..+. +++++|+|++|+|+ .+++.+|.++++|++|++++|.+....+..+..+..++.++.+ .|.
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 34444555 4555443 56899999999998 7888899999999999999999999889999999999999876 466
Q ss_pred CCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCc
Q 039922 157 FSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPD 236 (973)
Q Consensus 157 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~ 236 (973)
++...|..|.++++|++|++++|.+....+..+....+|+.+++++|.++.++ +..+..+++|++|++++|++.+..+.
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~-~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP-DDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC-TTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccC-hhHhccccchhhcccccCcccccchh
Confidence 77777888999999999999999998888888999999999999999987642 33444455555555555555444444
Q ss_pred cccCCCCCCEEEccCCcccccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccC
Q 039922 237 SIGKLAFLSNLDLSDNFLSGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT 303 (973)
Q Consensus 237 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 303 (973)
.+.++++|+++++++|++++..|..|.++++|++|++++|++.+..+..|..+++|+.|++++|++.
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 4555555555555555555444555555555555555555555444444555555555555555544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=7.8e-25 Score=236.70 Aligned_cols=242 Identities=21% Similarity=0.300 Sum_probs=113.3
Q ss_pred cceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecc
Q 039922 292 LLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTN 371 (973)
Q Consensus 292 L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 371 (973)
++.+|-+++.++ .+|..+. .++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++|
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~-~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEecCCCCC-ccCCCCC-CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 344444444444 2232221 24555555555555443445555666666666666666544555666666666666666
Q ss_pred cccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccc--cccCcccCCCCCccEEEeecCcccCCC
Q 039922 372 DFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQ--GELPSKFWGLPEVDFFEMYNNRFEGSI 449 (973)
Q Consensus 372 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~ 449 (973)
+++.. |..+ ...+..|.+.+|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++.+|.
T Consensus 90 ~l~~l-~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~----- 161 (305)
T d1xkua_ 90 QLKEL-PEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN----- 161 (305)
T ss_dssp CCSBC-CSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC-----
T ss_pred ccCcC-ccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCC-----
Confidence 55522 2211 123333333444443333333333444444444444322 1222334444444444444444
Q ss_pred CCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccc
Q 039922 450 SPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLT 529 (973)
Q Consensus 450 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 529 (973)
++ .+|..+ +++|+.|++++|.+++..+..|.+++.++.|++++|++++..+..+.+++
T Consensus 162 -------------------l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 162 -------------------IT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp -------------------CC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred -------------------cc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 43 222221 33455555555555444444455555555555555555544444555555
Q ss_pred cceeeeeccCcccCCCCccccccccccEEecCCCcCc
Q 039922 530 ALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 530 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
+|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 5555555555554 34445555555555555555554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.4e-25 Score=239.60 Aligned_cols=252 Identities=17% Similarity=0.163 Sum_probs=134.4
Q ss_pred EccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCccC
Q 039922 319 NLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFS 398 (973)
Q Consensus 319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 398 (973)
+.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|++++|++.+..+..+.....+..+...
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~----- 88 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS----- 88 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC-----
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc-----
Confidence 34444444 3343332 345556666666554444455555566666665555554444333333333333221
Q ss_pred CCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhh
Q 039922 399 GKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQIC 478 (973)
Q Consensus 399 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 478 (973)
..|.++...+..|.++++|+.|++++|.+....+..+...++|+.+++++|++++..+..|.
T Consensus 89 ------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~ 150 (284)
T d1ozna_ 89 ------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150 (284)
T ss_dssp ------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred ------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhc
Confidence 22333333344444444444444444444444444455555555555555555544455555
Q ss_pred cCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEE
Q 039922 479 TLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSL 558 (973)
Q Consensus 479 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 558 (973)
.+++|+.|++++|++++..+.+|.++++|+++++++|++++..|..|..+++|++||+++|++++..|..|..+++|++|
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE
Confidence 56666666666666665555666666666666666666666666666666666666666666665555666666666666
Q ss_pred ecCCCcCccccChhhhcccccceeccCCcCcccCCCCC
Q 039922 559 DLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDF 596 (973)
Q Consensus 559 ~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p~~~ 596 (973)
+|++|++.+.-+...-...++.+....+.+.+..|..+
T Consensus 231 ~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp ECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred EecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchHH
Confidence 66666666543321111134555555566665555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.9e-22 Score=212.65 Aligned_cols=201 Identities=22% Similarity=0.163 Sum_probs=100.0
Q ss_pred CCCCccceeeecccccccCCccccccCCchhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEE
Q 039922 359 KYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFF 438 (973)
Q Consensus 359 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 438 (973)
+...+.+++.+++.++. +|..+. +.++.|+|++|+|++..+..|.++++|++|+|++|+|+... .+..+++|+.|
T Consensus 8 ~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccc
Confidence 44555667777777773 444331 34555555555555444445555555555555555554322 23445555555
Q ss_pred EeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccc
Q 039922 439 EMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFT 518 (973)
Q Consensus 439 ~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 518 (973)
+|++|+++.. +..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|+
T Consensus 83 ~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccccc-ccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 5555555432 334444455555555555554444444444445555555555554443444444445555555555554
Q ss_pred cccCcccCccccceeeeeccCcccCCCCccccccccccEEecCCCcCc
Q 039922 519 GELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 519 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
+..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++.
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 444444444555555555555554 44444444444555555555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2.9e-22 Score=211.16 Aligned_cols=197 Identities=21% Similarity=0.162 Sum_probs=106.4
Q ss_pred chhhhcccCccCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecC
Q 039922 387 LQCIIIFNNRFSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILING 466 (973)
Q Consensus 387 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~ 466 (973)
+..++.+++.++ .+|..+. +++++|+|++|+|++..+..|.++++|+.|+|++|+|+... .+..+++|+.|++++
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEECCS
T ss_pred CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccccc
Confidence 333455555555 2344332 34555555555555555555555555555555555555321 234555555555555
Q ss_pred CcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCC
Q 039922 467 NNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIP 546 (973)
Q Consensus 467 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 546 (973)
|+++ ..+..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|+|++..+
T Consensus 87 N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~ 165 (266)
T d1p9ag_ 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (266)
T ss_dssp SCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred cccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCc
Confidence 5555 234455555555555555555554445555555555555555555554444555555555555555555555444
Q ss_pred ccccccccccEEecCCCcCccccChhhhcc-cccceeccCCcCcc
Q 039922 547 PELGNLAVLTSLDLSSNLLTGEIPLELTKL-KLNQFNISHNKLYG 590 (973)
Q Consensus 547 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~l~~l~l~~N~l~g 590 (973)
..|..+++|++|||++|+|+ .+|.++..+ .|+.|+|++|++.+
T Consensus 166 ~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 55555555555555555555 555555555 55555555555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=7.4e-22 Score=196.61 Aligned_cols=165 Identities=17% Similarity=0.158 Sum_probs=120.1
Q ss_pred CccccccccCCeeEEEEEECCCCEEEEEEecCCCCC----------------chhHHHHHHHHHHHhcCCCCCeeeEEeE
Q 039922 685 TEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHK----------------PETETVFRSEIETLGRVRHGNVVKLLMC 748 (973)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~niv~l~~~ 748 (973)
.+.++||+|+||+||+|+..+|+.||||+++..... ........+|...+.++.|.++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356799999999999999999999999987532110 1112345678899999999999988866
Q ss_pred EecCCeeEEEEeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeCCCCCCEEeCCCCceEEe
Q 039922 749 CSGQDFNILVYEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDCVPAIVHRDVKSHNILLDAEMVPRVA 828 (973)
Q Consensus 749 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 828 (973)
.. .+++|||++++.+.+ ++......++.|++.+++|||+. +|+||||||+|||+++++ ++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEE
Confidence 32 379999998755432 23344567899999999999999 999999999999998654 8999
Q ss_pred ccCcchhccccCCCccccccccccccCccc------cccccCCCCCCCCChhhHHHHH
Q 039922 829 DFGLAKALQSQEGQSDDAMSCVAGSYGYIA------PEYAYTKKVTEKSDVYSFGVVL 880 (973)
Q Consensus 829 DfGl~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Dv~slG~~l 880 (973)
|||.|........ ..|.. .|+ ..+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~------------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW------------REILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH------------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc------------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999865432110 00111 011 235778899999976544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=1e-18 Score=192.14 Aligned_cols=69 Identities=23% Similarity=0.334 Sum_probs=45.2
Q ss_pred CCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEe
Q 039922 480 LRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLD 559 (973)
Q Consensus 480 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 559 (973)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|... ..|+.|.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~ 350 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLR 350 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEE
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeE
Confidence 456777777777777 56643 456777777777777 56643 456777888888887 566533 2455555
Q ss_pred c
Q 039922 560 L 560 (973)
Q Consensus 560 L 560 (973)
+
T Consensus 351 ~ 351 (353)
T d1jl5a_ 351 M 351 (353)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.81 E-value=5.3e-18 Score=186.31 Aligned_cols=59 Identities=25% Similarity=0.424 Sum_probs=33.9
Q ss_pred CCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcc
Q 039922 457 PKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRN 524 (973)
Q Consensus 457 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 524 (973)
++|++|++++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|..
T Consensus 284 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~ 342 (353)
T d1jl5a_ 284 PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI 342 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC
T ss_pred CCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc
Confidence 44555555555555 34432 456666777777766 45543 345667777777766 55553
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=4.6e-22 Score=227.80 Aligned_cols=115 Identities=23% Similarity=0.273 Sum_probs=80.4
Q ss_pred CcccEEecCCcccCCcc-cccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEE
Q 039922 169 PVLKVLNLGGNLLSGLI-PSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNL 247 (973)
Q Consensus 169 ~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L 247 (973)
++|++||+++|++++.. .+.+..+++|+.|+|++|.++.. .+ ..+...+..+++|++|
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~----------~~-----------~~l~~~L~~~~~L~~L 60 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA----------RC-----------KDISSALRVNPALAEL 60 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHH----------HH-----------HHHHHHHHTCTTCCEE
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHH----------HH-----------HHHHHHHhcCCCCCEE
Confidence 36899999999998642 34567788999999999987531 11 1234456677888888
Q ss_pred EccCCccccc----CCcCCCC-CCCCCEEEccCCcCccc----CchhccCCCccceeeccccccCC
Q 039922 248 DLSDNFLSGK----IPHSFSG-LASIEQIELFDNQLSGE----LPESLSNLTTLLRLDISQNNLTG 304 (973)
Q Consensus 248 ~Ls~N~l~~~----~~~~~~~-l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 304 (973)
||++|.|+.. +...+.. ..+|++|++++|++++. ++..+..+++|++|++++|.++.
T Consensus 61 dLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp ECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred ECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 8888887632 2233332 34788888888888743 34566778888888888888764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.3e-21 Score=224.04 Aligned_cols=111 Identities=20% Similarity=0.204 Sum_probs=73.3
Q ss_pred cccceeccCCCcccCcCCcCcCCCcCCccEEecccccccc----cCCccccCCCCCCEEECcCCcCCCC----CCcccC-
Q 039922 96 RTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIG----ELPDFSREFANLQVLDLSRNNFSGD----IPESFG- 166 (973)
Q Consensus 96 ~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~----~~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~- 166 (973)
.+|+.||++.|++++.--...++.++++|+|+|++|.++. .++..+..+++|++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3678888888888753323345677788888888887762 3455667778888888888877521 122222
Q ss_pred CCCcccEEecCCcccCCc----ccccccccccccEeeccCcCCC
Q 039922 167 RFPVLKVLNLGGNLLSGL----IPSFLGNLTELTHFELGYNPLK 206 (973)
Q Consensus 167 ~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~ 206 (973)
..++|++|+|++|+++.. ++..+..+++|++|+|++|.+.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 234678888888877643 3445666777777777777664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.4e-18 Score=173.55 Aligned_cols=208 Identities=22% Similarity=0.284 Sum_probs=109.4
Q ss_pred ccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEE
Q 039922 95 IRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVL 174 (973)
Q Consensus 95 l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 174 (973)
++++..++++.+++++.+ .+..+.+|++|++++|.|.. + ..++.+++|++|++++|.+++..| +..+++|++|
T Consensus 18 l~~~~~~~l~~~~~~d~~---~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV---TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE---CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHhCCCCcCCcC---CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 444555667777666543 23455666666666666553 2 235666666666666666664332 5666666666
Q ss_pred ecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcc
Q 039922 175 NLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL 254 (973)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 254 (973)
++++|.++.. ..+.++++|+.++++++..... ..+...+.++.+.++++.+
T Consensus 91 ~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~---------------------------~~~~~~~~~~~l~~~~~~~ 141 (227)
T d1h6ua2 91 ELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV---------------------------TPLAGLSNLQVLYLDLNQI 141 (227)
T ss_dssp ECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC---------------------------GGGTTCTTCCEEECCSSCC
T ss_pred cccccccccc--cccccccccccccccccccccc---------------------------chhccccchhhhhchhhhh
Confidence 6666666532 2355566666666665554321 1123344455555555555
Q ss_pred cccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCcccc
Q 039922 255 SGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLA 334 (973)
Q Consensus 255 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 334 (973)
.... .+.+.++|++|++++|.+++. ..++++++|+.|+|++|+++ +. + .+.
T Consensus 142 ~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~-----------------------~l-~-~l~ 192 (227)
T d1h6ua2 142 TNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-----------------------DI-S-PLA 192 (227)
T ss_dssp CCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC-----------------------CC-G-GGG
T ss_pred chhh--hhccccccccccccccccccc--hhhcccccceecccCCCccC-----------------------CC-h-hhc
Confidence 4221 234445555555555555422 12444455555555554444 22 1 245
Q ss_pred CCCccceeeeccccccCCCCCCccCCCCccceeee
Q 039922 335 SNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVS 369 (973)
Q Consensus 335 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 369 (973)
++++|++|+|++|++++. + .+.++++|++|+++
T Consensus 193 ~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 193 SLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp GCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred CCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence 555666666666665532 2 25556666666655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.3e-18 Score=178.36 Aligned_cols=203 Identities=20% Similarity=0.322 Sum_probs=108.9
Q ss_pred EEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhcccCc
Q 039922 317 SLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFNNR 396 (973)
Q Consensus 317 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 396 (973)
.++++.+++++.+ .+..+.+|+.|++.+|.++. + ..+..+++|++|++++|++++..|
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~------------------ 80 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP------------------ 80 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG------------------
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc------------------
Confidence 3445555555432 33455666666666666663 3 245666666666666666553211
Q ss_pred cCCCCCCccCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchh
Q 039922 397 FSGKIPESYGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQ 476 (973)
Q Consensus 397 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~ 476 (973)
+..+++|+++++++|.++.. ..+.++++|+.+++++++..+ ...+...+.+..+.++++.+.... .
T Consensus 81 --------l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~--~ 146 (227)
T d1h6ua2 81 --------LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNIS--P 146 (227)
T ss_dssp --------GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCCCCG--G
T ss_pred --------cccccccccccccccccccc--ccccccccccccccccccccc--cchhccccchhhhhchhhhhchhh--h
Confidence 44445555555555555421 134455555555555554443 223444455555555555554322 2
Q ss_pred hhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCcccccccccc
Q 039922 477 ICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLT 556 (973)
Q Consensus 477 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 556 (973)
+..+++|+.|++++|++++.. .++++++|+.|+|++|++++ ++ .++++++|++|+|++|+|++ +| .+.++++|+
T Consensus 147 ~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~ 220 (227)
T d1h6ua2 147 LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLF 220 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCC
T ss_pred hccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCC
Confidence 455566666666666665322 25566666666666666653 22 25566666666666666663 33 256666666
Q ss_pred EEecC
Q 039922 557 SLDLS 561 (973)
Q Consensus 557 ~L~Ls 561 (973)
.|+++
T Consensus 221 ~L~ls 225 (227)
T d1h6ua2 221 IVTLT 225 (227)
T ss_dssp EEEEE
T ss_pred EEEee
Confidence 66665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.9e-18 Score=171.76 Aligned_cols=176 Identities=23% Similarity=0.222 Sum_probs=135.3
Q ss_pred CccceeEEcCCCCceeEeecCCCccCCCCCCCccCccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCc
Q 039922 60 CNWTGITCETQNQSVDGIDLSGFDLSGGFPNGFCRIRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPD 139 (973)
Q Consensus 60 C~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~ 139 (973)
|.|..|.|+. ++++ .+|+.+. +++++|+|++|+|++.++...|.++++|++|+|++|.+.+..+.
T Consensus 8 C~~~~v~Cs~------------~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 72 (192)
T d1w8aa_ 8 CEGTTVDCTG------------RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72 (192)
T ss_dssp EETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT
T ss_pred EcCCEEEEeC------------CCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccc
Confidence 6777777754 3344 4565553 68999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcch
Q 039922 140 FSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSK 219 (973)
Q Consensus 140 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~ 219 (973)
.+..+++|++|+|++|+|+...|..|.++++|++|+|++|+|+++.|..|.++++|++|+|++|.+... .....-...
T Consensus 73 ~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~--~~~~~~~~~ 150 (192)
T d1w8aa_ 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN--CHLAWFAEW 150 (192)
T ss_dssp TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS--GGGHHHHHH
T ss_pred ccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc--cchHHHhhh
Confidence 999999999999999999988888999999999999999999999999999999999999999988642 111111223
Q ss_pred hHHHhhccCcccccCCccccCCCCCCEEEccCCccc
Q 039922 220 LENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLS 255 (973)
Q Consensus 220 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 255 (973)
++.+.+..+.+....|.. +..++.++|+.|.++
T Consensus 151 l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 151 LRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp HHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred hhhhcccCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence 444444444444444432 223344444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.3e-18 Score=176.39 Aligned_cols=220 Identities=16% Similarity=0.182 Sum_probs=122.7
Q ss_pred CcEEEccCCcCCCCCCccccCCCccceeeeccccccCCCCCCccCCCCccceeeecccccccCCccccccCCchhhhccc
Q 039922 315 LESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKLPDDLGKYSNLEYFDVSTNDFTGELPRFLCFRNKLQCIIIFN 394 (973)
Q Consensus 315 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 394 (973)
.+.++.+++.++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|++++|.+...++
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~---------------- 70 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE---------------- 70 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEEC----------------
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceee----------------
Confidence 356666766666 5555442 467777777777764444456777777777777776653221
Q ss_pred CccCCCCCCccCCcceeeEEEcc-CCccccccCcccCCCCCccEEEeecCcccCCCCC-CCCCCCCcceEeecCCcCCCC
Q 039922 395 NRFSGKIPESYGECKTLNYLRFG-GNELQGELPSKFWGLPEVDFFEMYNNRFEGSISP-SISNAPKLTGILINGNNFTGE 472 (973)
Q Consensus 395 n~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~~L~~L~L~~N~l~~~ 472 (973)
+..|..++.++++.+. .|.+....+..|.++++|+.+++++|++....+. .+..+..+..+...++.+...
T Consensus 71 -------~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 71 -------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp -------SSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE
T ss_pred -------ccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 2344555555555544 3455555566666666666666666666543221 223344444555555555544
Q ss_pred CchhhhcCC-cCcEEeCcCCcccCCCcccccccccc-ceeeccccccccccCcccCccccceeeeeccCcccCCCCcccc
Q 039922 473 VPSQICTLR-QLQAVDLSQNRFSGHLPTCITQLNKL-QQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELG 550 (973)
Q Consensus 473 ~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 550 (973)
.+..+..++ .++.|++++|+++...+..+. ..++ +.+++++|+|+...+..|.++++|++|+|++|+|+...+..|.
T Consensus 144 ~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~ 222 (242)
T d1xwdc1 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 222 (242)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred cccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence 444444443 566666766666633333333 3333 3334566666633344566666666666666666643344566
Q ss_pred ccccccEEecC
Q 039922 551 NLAVLTSLDLS 561 (973)
Q Consensus 551 ~l~~L~~L~Ls 561 (973)
++++|+.+++.
T Consensus 223 ~l~~L~~l~~~ 233 (242)
T d1xwdc1 223 NLKKLRARSTY 233 (242)
T ss_dssp TCCEEESSSEE
T ss_pred CCcccccCcCC
Confidence 66666665554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=6.4e-18 Score=167.86 Aligned_cols=157 Identities=25% Similarity=0.301 Sum_probs=104.5
Q ss_pred CCcceEeecCCcCCCCC-chhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeee
Q 039922 457 PKLTGILINGNNFTGEV-PSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLN 535 (973)
Q Consensus 457 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 535 (973)
+++++|+|++|+|++.+ +..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 45666666666665433 44566777777777777777777777777777777777777777766677777777777777
Q ss_pred eccCcccCCCCccccccccccEEecCCCcCccccChhhhcccccceeccCCcCcccCCCCCcccccccccCCCCCCCCC
Q 039922 536 LSTNQLTGTIPPELGNLAVLTSLDLSSNLLTGEIPLELTKLKLNQFNISHNKLYGEVPSDFDHDLFISSLLDNPGLCSP 614 (973)
Q Consensus 536 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~l~~l~l~~N~l~g~~p~~~~~~~~~~~~~~n~~~c~~ 614 (973)
|++|+|++..|.+|..+++|++|+|++|++.+..+.....-.++.+.+..|.+.+..|..+.. .....+..|...|.+
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l~~-~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRD-VQIKDLPHSEFKCSS 186 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTTT-SBGGGSCTTTCCCCC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChhhcC-CEeeecCHhhCcCCC
Confidence 777777766666777777777777777777754432221114556667777777766665432 233445556556654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=9.5e-18 Score=173.73 Aligned_cols=220 Identities=11% Similarity=0.051 Sum_probs=146.3
Q ss_pred cceeeccccccCCCChhhhhcccCcEEEccCCcCCCCCCccccCCCccceeeeccccccCCC-CCCccCCCCccceeeec
Q 039922 292 LLRLDISQNNLTGNLPETIAAMSLESLNLNDNYFTGEIPESLASNPNLVQLKLFNNSFSGKL-PDDLGKYSNLEYFDVST 370 (973)
Q Consensus 292 L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~ 370 (973)
.+.++.+++.++ .+|..+. .++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|..+++++++++..
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~-~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC-SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CCEEEEeCCCCC-CcCCCCC-CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 367888888888 5555443 47999999999999666678999999999999999998654 44688899999998874
Q ss_pred -ccccccCCccccccCCchhhhcccCccCCCCC-CccCCcceeeEEEccCCccccccCcccCCCC-CccEEEeecCcccC
Q 039922 371 -NDFTGELPRFLCFRNKLQCIIIFNNRFSGKIP-ESYGECKTLNYLRFGGNELQGELPSKFWGLP-EVDFFEMYNNRFEG 447 (973)
Q Consensus 371 -N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~ 447 (973)
|++....+..|..+++|+.+++.+|++....+ ..+..+..+..+..+++.+....+..|.+++ .++.+++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 67887777778888888888888887764333 2344556666666666666655555555443 44445555544443
Q ss_pred CCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCc-EEeCcCCcccCCCccccccccccceeeccccccccccCcccC
Q 039922 448 SISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ-AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLN 526 (973)
Q Consensus 448 ~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 526 (973)
. .+..+ ...+++ .+++++|+++...+..|.++++|++|+|++|+|+...+..|.
T Consensus 168 i------------------------~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~ 222 (242)
T d1xwdc1 168 I------------------------HNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 222 (242)
T ss_dssp E------------------------CTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred c------------------------ccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence 2 22222 223333 334556666633334566666777777777776644445566
Q ss_pred ccccceeeeecc
Q 039922 527 SLTALIVLNLST 538 (973)
Q Consensus 527 ~l~~L~~L~Ls~ 538 (973)
++++|+.+++.+
T Consensus 223 ~l~~L~~l~~~~ 234 (242)
T d1xwdc1 223 NLKKLRARSTYN 234 (242)
T ss_dssp TCCEEESSSEES
T ss_pred CCcccccCcCCC
Confidence 666666666543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.3e-17 Score=168.15 Aligned_cols=184 Identities=20% Similarity=0.262 Sum_probs=97.0
Q ss_pred ccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEec
Q 039922 97 TLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNL 176 (973)
Q Consensus 97 ~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 176 (973)
++...+++.+.+++.++. ..+.+|++|++++|.+.... .++.+++|++|+|++|.+++. + .++.+++|++|++
T Consensus 25 ~~i~~~l~~~~~~~~~~~---~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l 97 (210)
T d1h6ta2 25 ETIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFL 97 (210)
T ss_dssp HHHHHHTTCSCTTSEECH---HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEEC
T ss_pred HHHHHHhCcCccCCccCH---HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccc
Confidence 334445555555544432 23455666666666655322 255566666666666666643 2 2566666666666
Q ss_pred CCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccc
Q 039922 177 GGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSG 256 (973)
Q Consensus 177 ~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 256 (973)
++|+|++. | .+.++++|+.|++++|.+... ..+..+++|+.++++.|.+.+ +..+..+++|+++++++|++++
T Consensus 98 ~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~---~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 98 DENKVKDL-S-SLKDLKKLKSLSLEHNGISDI---NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC---GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred cccccccc-c-ccccccccccccccccccccc---ccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 66666643 2 356666666666666665431 123333333333333333322 1234445556666666666654
Q ss_pred cCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeecc
Q 039922 257 KIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDIS 298 (973)
Q Consensus 257 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 298 (973)
.. .++++++|++|++++|+++. ++ .+.++++|+.|+|+
T Consensus 171 i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 171 IV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 22 25556666666666666653 22 35555666666554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=9.9e-18 Score=167.51 Aligned_cols=141 Identities=28% Similarity=0.389 Sum_probs=62.1
Q ss_pred cCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCc
Q 039922 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 484 (973)
+..+++|++|++++|++++..+ +.++++|+.|++++|.+... +.+..++.|+.|++++|.+... ..+..+++|+
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~ 131 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTLFNNQITDI--DPLKNLTNLN 131 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCS
T ss_pred cccCCCcCcCccccccccCccc--ccCCcccccccccccccccc--cccccccccccccccccccccc--cccchhhhhH
Confidence 3444555555555555543322 44444555555544444322 1244444444444444444321 1234444455
Q ss_pred EEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccE
Q 039922 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTS 557 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 557 (973)
.|++++|+++ .++ .+..+++|+.|++++|++++. + .++++++|+.|++++|++++ +| .++.+++|++
T Consensus 132 ~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 132 RLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLES 198 (199)
T ss_dssp EEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred Hhhhhhhhhc-ccc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence 5555555444 222 344444444444444444422 1 24444444444444444442 22 2444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.3e-17 Score=168.24 Aligned_cols=145 Identities=24% Similarity=0.356 Sum_probs=75.8
Q ss_pred cCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCc
Q 039922 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 484 (973)
+..+++|++|++++|++++.. .+..+++|+.|++++|++++. +.+..+++|+.|++++|.+.. + ..+..+++|+
T Consensus 64 l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l--~~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~ 137 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE 137 (210)
T ss_dssp GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCC
T ss_pred HhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccccc--ccccccccccccccccccccc-c-cccccccccc
Confidence 444555555555555555432 234455555555555555432 134555555555555555542 2 2355555666
Q ss_pred EEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCccccccccccEEecC
Q 039922 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDLS 561 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 561 (973)
.+++++|.+++ +..+..+++|+.+++++|++++. + .+.++++|+.|+|++|+|+ .+| .|.++++|++|+|+
T Consensus 138 ~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp EEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEE
T ss_pred ccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEcc
Confidence 66666666552 22345555666666666666532 2 2555666666666666665 233 35556666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=3.1e-17 Score=163.83 Aligned_cols=169 Identities=29% Similarity=0.369 Sum_probs=97.8
Q ss_pred ccccceeccCCCcccCcCCcCcCCCcCCccEEecccccccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEE
Q 039922 95 IRTLRNLNLSDNYFNGTLSSQSLSPCFHLQVLALDYNVFIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVL 174 (973)
Q Consensus 95 l~~L~~L~Ls~n~l~~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 174 (973)
+++...+.++.+++++.++ ...+.++++|++++|.+.. + +.++.+++|++|+|++|++++..| ++++++|++|
T Consensus 17 l~~~i~~~l~~~~~~~~~~---~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L 89 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 89 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC---HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHhCCCCCCCccC---HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence 3444455666666665433 2345666677777776653 2 235667777777777777775432 6777777777
Q ss_pred ecCCcccCCcccccccccccccEeeccCcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcc
Q 039922 175 NLGGNLLSGLIPSFLGNLTELTHFELGYNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFL 254 (973)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 254 (973)
++++|.+.... .+.++++|++|++++|.+... +.+..+++|+.|++++|++
T Consensus 90 ~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~---------------------------~~~~~l~~L~~L~l~~n~l 140 (199)
T d2omxa2 90 LMNNNQIADIT--PLANLTNLTGLTLFNNQITDI---------------------------DPLKNLTNLNRLELSSNTI 140 (199)
T ss_dssp ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC---------------------------GGGTTCTTCSEEECCSSCC
T ss_pred ccccccccccc--ccccccccccccccccccccc---------------------------cccchhhhhHHhhhhhhhh
Confidence 77777766432 366777777777777765431 1233445555555555555
Q ss_pred cccCCcCCCCCCCCCEEEccCCcCcccCchhccCCCccceeeccccccC
Q 039922 255 SGKIPHSFSGLASIEQIELFDNQLSGELPESLSNLTTLLRLDISQNNLT 303 (973)
Q Consensus 255 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 303 (973)
.. + +.+..+++|++|++.+|++++. ..++++++|+.|++++|+++
T Consensus 141 ~~-~-~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 141 SD-I-SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CC-C-GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred cc-c-ccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCC
Confidence 42 1 2355555555555555555532 12555555555555555555
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=5.9e-16 Score=163.61 Aligned_cols=85 Identities=24% Similarity=0.312 Sum_probs=48.9
Q ss_pred CcCCccEEeccccccccc-CCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCc-ccCCc-ccccccccccc
Q 039922 119 PCFHLQVLALDYNVFIGE-LPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGN-LLSGL-IPSFLGNLTEL 195 (973)
Q Consensus 119 ~l~~L~~L~L~~n~~~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L 195 (973)
...+|++|+|+++.+.+. ++..+..+++|++|+|+++.+.+..+..++.+++|++|+|+++ .++.. +...+.++++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 344566666666655432 3444566666666666666666555556666666666666663 44421 11223456666
Q ss_pred cEeeccCc
Q 039922 196 THFELGYN 203 (973)
Q Consensus 196 ~~L~Ls~n 203 (973)
++|+++++
T Consensus 124 ~~L~ls~c 131 (284)
T d2astb2 124 DELNLSWC 131 (284)
T ss_dssp CEEECCCC
T ss_pred cccccccc
Confidence 66666664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4.6e-14 Score=127.90 Aligned_cols=103 Identities=24% Similarity=0.314 Sum_probs=73.7
Q ss_pred ceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccceeeeeccC
Q 039922 460 TGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTN 539 (973)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (973)
+.|++++|+++ .++ .+..+++|++|++++|+|+ .+|+.++.+++|+.|++++|+|++ +| .++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 35667777776 333 3677777888888888887 567677777888888888888773 44 4777788888888888
Q ss_pred cccCCC-CccccccccccEEecCCCcCcc
Q 039922 540 QLTGTI-PPELGNLAVLTSLDLSSNLLTG 567 (973)
Q Consensus 540 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~ 567 (973)
+|++.. ...+..+++|++|++++|++++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 887432 2457777888888888888763
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=3.8e-14 Score=135.28 Aligned_cols=110 Identities=25% Similarity=0.261 Sum_probs=66.7
Q ss_pred CCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccce
Q 039922 453 ISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALI 532 (973)
Q Consensus 453 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 532 (973)
+.++.++++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 445555666666666665 33444555666666666666666 333 356666666666666666644444455566666
Q ss_pred eeeeccCcccCCCC--ccccccccccEEecCCCcCc
Q 039922 533 VLNLSTNQLTGTIP--PELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 533 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~ 566 (973)
.|+|++|+|+. ++ ..+..+++|++|++++|+++
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccc
Confidence 66666666653 33 34566666677777776665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2.3e-15 Score=159.02 Aligned_cols=115 Identities=20% Similarity=0.202 Sum_probs=70.7
Q ss_pred CCcceEeecCC--cCCCC-CchhhhcCCcCcEEeCcCC-cccCCCccccccccccceeeccc-cccccccCcccCccccc
Q 039922 457 PKLTGILINGN--NFTGE-VPSQICTLRQLQAVDLSQN-RFSGHLPTCITQLNKLQQLELQE-NMFTGELPRNLNSLTAL 531 (973)
Q Consensus 457 ~~L~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L 531 (973)
++|+.|+++++ .++.. +......+++|++|++++| .+++.....+.++++|++|+|++ +.+++.....++++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 34555555543 23221 2223345778888888775 46666667777788888888888 46776666777788888
Q ss_pred eeeeeccCccc-CCCCccccccccccEEecCCCcCccccChhhhc
Q 039922 532 IVLNLSTNQLT-GTIPPELGNLAVLTSLDLSSNLLTGEIPLELTK 575 (973)
Q Consensus 532 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 575 (973)
+.|+++++ ++ +.++.....+|+ |++..+++++..++.+..
T Consensus 228 ~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 228 KTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFTTIARPTIGN 268 (284)
T ss_dssp CEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSCCTTCSSCSS
T ss_pred CEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCCCCCCCccCc
Confidence 88888776 33 222222233444 445777887666655543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=2.9e-15 Score=163.51 Aligned_cols=110 Identities=22% Similarity=0.311 Sum_probs=49.2
Q ss_pred CCCCCEEEccCCcCccc-----CchhccCCCccceeeccccccCCCCh----hhhhc-ccCcEEEccCCcCCCCCC----
Q 039922 265 LASIEQIELFDNQLSGE-----LPESLSNLTTLLRLDISQNNLTGNLP----ETIAA-MSLESLNLNDNYFTGEIP---- 330 (973)
Q Consensus 265 l~~L~~L~L~~n~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~-~~L~~L~L~~N~l~~~~p---- 330 (973)
.++|++|++++|++... +...+..+++|+.|+|++|.++.... ..+.. .+|++|+|++|.|++...
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~ 264 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 264 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH
Confidence 34455555555554321 12233444455555555555432111 11111 245555555555543211
Q ss_pred cccc--CCCccceeeeccccccCCC----CCCcc-CCCCccceeeeccccc
Q 039922 331 ESLA--SNPNLVQLKLFNNSFSGKL----PDDLG-KYSNLEYFDVSTNDFT 374 (973)
Q Consensus 331 ~~~~--~l~~L~~L~L~~N~l~~~~----p~~l~-~l~~L~~L~Ls~N~l~ 374 (973)
+.+. ..+.|++|++++|+++... ...+. ++++|++|+|++|++.
T Consensus 265 ~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 265 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 1121 1245666666666665321 12221 3556677777777665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=4.8e-14 Score=134.51 Aligned_cols=127 Identities=19% Similarity=0.141 Sum_probs=78.7
Q ss_pred cCCcceeeEEEccCCccccccCcccCCCCCccEEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCc
Q 039922 405 YGECKTLNYLRFGGNELQGELPSKFWGLPEVDFFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQ 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 484 (973)
+.+..++++|+|++|+|+.. +..+.. +++|+.|++++|+|+. + +.+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~------------------------l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~ 66 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGAT------------------------LDQFDAIDFSDNEIRK-L-DGFPLLRRLK 66 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGG------------------------TTCCSEEECCSSCCCE-E-CCCCCCSSCC
T ss_pred ccCcCcCcEEECCCCCCCcc-Cccccc------------------------cccCCEEECCCCCCCc-c-CCcccCcchh
Confidence 44555666666666666532 333344 4445555555555542 2 2355666777
Q ss_pred EEeCcCCcccCCCccccccccccceeeccccccccccC-cccCccccceeeeeccCcccCCCCc----cccccccccEEe
Q 039922 485 AVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELP-RNLNSLTALIVLNLSTNQLTGTIPP----ELGNLAVLTSLD 559 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ 559 (973)
+|++++|+++...+..+..+++|+.|+|++|+|+.... ..+..+++|+.|++++|.++ ..|. .+..+|+|++||
T Consensus 67 ~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 67 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred hhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 77777777764444445567777777777777763211 45677788888888888887 3443 467788888887
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=1.6e-15 Score=165.58 Aligned_cols=36 Identities=22% Similarity=0.248 Sum_probs=20.9
Q ss_pred cCcEEEccCCcCCCC----CCccccCCCccceeeeccccc
Q 039922 314 SLESLNLNDNYFTGE----IPESLASNPNLVQLKLFNNSF 349 (973)
Q Consensus 314 ~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l 349 (973)
.|+.|+|++|.+... +...+...++|+.|+++++..
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~ 71 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT
T ss_pred CCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcc
Confidence 577777777766432 223344556666666666544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.8e-13 Score=123.97 Aligned_cols=117 Identities=21% Similarity=0.269 Sum_probs=80.9
Q ss_pred EEEeecCcccCCCCCCCCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccc
Q 039922 437 FFEMYNNRFEGSISPSISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENM 516 (973)
Q Consensus 437 ~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (973)
.|+|++|+++.. +.+..+++|++|++++|.|+ .+|..++.+++|++|++++|+|+ .+| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~l--~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC--CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC--cccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 455555555432 24667777777777777777 56667788888888888888887 344 47788888888888888
Q ss_pred ccccc-CcccCccccceeeeeccCcccCCC--Cc-cccccccccEE
Q 039922 517 FTGEL-PRNLNSLTALIVLNLSTNQLTGTI--PP-ELGNLAVLTSL 558 (973)
Q Consensus 517 l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~--p~-~~~~l~~L~~L 558 (973)
|+... ...+..+++|+.|++++|++++.. +. .+..+|+|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 87433 256788888888888888887321 22 23446776665
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=5.6e-12 Score=119.07 Aligned_cols=106 Identities=18% Similarity=0.142 Sum_probs=70.6
Q ss_pred cceEeecCCcCCCCCchhhhcCCcCcEEeCcCC-cccCCCccccccccccceeeccccccccccCcccCccccceeeeec
Q 039922 459 LTGILINGNNFTGEVPSQICTLRQLQAVDLSQN-RFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLS 537 (973)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 537 (973)
.+.++.+++++. ..|..+..+++|++|++++| .|+...+.+|.++++|+.|+|++|+|+...|.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 445666666665 45666666777777777655 4665555667777777777777777776666777777777777777
Q ss_pred cCcccCCCCccccccccccEEecCCCcCc
Q 039922 538 TNQLTGTIPPELGNLAVLTSLDLSSNLLT 566 (973)
Q Consensus 538 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (973)
+|+|+ .+|.......+|+.|+|++|++.
T Consensus 89 ~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCc-ccChhhhccccccccccCCCccc
Confidence 77777 34443333345777777777775
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=4.9e-14 Score=139.47 Aligned_cols=110 Identities=22% Similarity=0.321 Sum_probs=57.3
Q ss_pred CCCCCCcceEeecCCcCCCCCchhhhcCCcCcEEeCcCCcccCCCccccccccccceeeccccccccccCcccCccccce
Q 039922 453 ISNAPKLTGILINGNNFTGEVPSQICTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGELPRNLNSLTALI 532 (973)
Q Consensus 453 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 532 (973)
+..+++|+.|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+. + +.+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSS
T ss_pred HhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccccccc
Confidence 333444444444444444 222 3555555666666666555 344444444556666666666553 2 2355556666
Q ss_pred eeeeccCcccCCCC--ccccccccccEEecCCCcCccc
Q 039922 533 VLNLSTNQLTGTIP--PELGNLAVLTSLDLSSNLLTGE 568 (973)
Q Consensus 533 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~ 568 (973)
.|+|++|+|+. ++ ..+..+++|+.|+|++|+++..
T Consensus 119 ~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 119 VLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp EEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred ccccccchhcc-ccccccccCCCccceeecCCCccccC
Confidence 66666666652 22 2455566666666666665543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=3.9e-12 Score=120.20 Aligned_cols=111 Identities=19% Similarity=0.204 Sum_probs=96.4
Q ss_pred hcCCcCcEEeCcCCcccCCCccccccccccceeecccc-ccccccCcccCccccceeeeeccCcccCCCCcccccccccc
Q 039922 478 CTLRQLQAVDLSQNRFSGHLPTCITQLNKLQQLELQEN-MFTGELPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLT 556 (973)
Q Consensus 478 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 556 (973)
+.....+.++++++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|++..|.+|..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 44556778999999998 67888999999999999877 59977778899999999999999999987788999999999
Q ss_pred EEecCCCcCccccChhhh-cccccceeccCCcCcc
Q 039922 557 SLDLSSNLLTGEIPLELT-KLKLNQFNISHNKLYG 590 (973)
Q Consensus 557 ~L~Ls~N~l~~~~p~~l~-~l~l~~l~l~~N~l~g 590 (973)
+|||++|+|+ .+|.... .+.|+.|+|++|++.+
T Consensus 84 ~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp EEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred ceeccCCCCc-ccChhhhccccccccccCCCcccC
Confidence 9999999999 5666544 4489999999998864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=6.1e-14 Score=138.77 Aligned_cols=144 Identities=26% Similarity=0.327 Sum_probs=92.1
Q ss_pred ccEEeccccc-ccccCCccccCCCCCCEEECcCCcCCCCCCcccCCCCcccEEecCCcccCCcccccccccccccEeecc
Q 039922 123 LQVLALDYNV-FIGELPDFSREFANLQVLDLSRNNFSGDIPESFGRFPVLKVLNLGGNLLSGLIPSFLGNLTELTHFELG 201 (973)
Q Consensus 123 L~~L~L~~n~-~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 201 (973)
++.+++..+. -...++..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+. +|..+..+++|++|+++
T Consensus 25 ~~~~~l~~~~~~i~~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~ 101 (198)
T d1m9la_ 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWIS 101 (198)
T ss_dssp CSCEECCBCCTTCCCCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECS
T ss_pred cceeeeecccCchhhhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccc-ccccccccccccccccc
Confidence 4444554331 122345567777788888888887773 43 47777778888888887774 35555556677777777
Q ss_pred CcCCCCCCCCccccCcchhHHHhhccCcccccCCccccCCCCCCEEEccCCcccccCC-cCCCCCCCCCEEEccCCcCcc
Q 039922 202 YNPLKSSPLPSSVGNLSKLENLWAAKANLIGEIPDSIGKLAFLSNLDLSDNFLSGKIP-HSFSGLASIEQIELFDNQLSG 280 (973)
Q Consensus 202 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~ 280 (973)
+|+++.+ +.+.++++|++|++++|+++.... ..+..+++|+.|++++|.+..
T Consensus 102 ~N~i~~l---------------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 102 YNQIASL---------------------------SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp EEECCCH---------------------------HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccc---------------------------ccccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 7776531 124556677888888888774322 356777788888888877764
Q ss_pred cCchh----------ccCCCccceee
Q 039922 281 ELPES----------LSNLTTLLRLD 296 (973)
Q Consensus 281 ~~p~~----------l~~l~~L~~L~ 296 (973)
..+.. +..+++|+.||
T Consensus 155 ~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 155 DYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred CcccccchhhHHHHHHHHCCCcCEeC
Confidence 33321 45567777766
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=7.3e-09 Score=97.94 Aligned_cols=84 Identities=23% Similarity=0.203 Sum_probs=41.9
Q ss_pred hhhcCCcCcEEeCcCCcccCC--CccccccccccceeeccccccccccCcccCccccceeeeeccCcccCCCCc------
Q 039922 476 QICTLRQLQAVDLSQNRFSGH--LPTCITQLNKLQQLELQENMFTGELPRNLNSLTALIVLNLSTNQLTGTIPP------ 547 (973)
Q Consensus 476 ~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------ 547 (973)
.+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|.+++....
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 334456666666666666532 123344556666666666666532222222333455566666665543322
Q ss_pred -cccccccccEEe
Q 039922 548 -ELGNLAVLTSLD 559 (973)
Q Consensus 548 -~~~~l~~L~~L~ 559 (973)
.+..+|+|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 133455555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.34 E-value=1.5e-08 Score=95.71 Aligned_cols=85 Identities=20% Similarity=0.144 Sum_probs=42.7
Q ss_pred CcEEeCcCCcccCCCccccccccccceeeccccccccc--cCcccCccccceeeeeccCcccCCCCccccccccccEEec
Q 039922 483 LQAVDLSQNRFSGHLPTCITQLNKLQQLELQENMFTGE--LPRNLNSLTALIVLNLSTNQLTGTIPPELGNLAVLTSLDL 560 (973)
Q Consensus 483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 560 (973)
+..++..+|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|||++|+|+...+-.+.....|+.|+|
T Consensus 44 ~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L 122 (162)
T d1koha1 44 DVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122 (162)
T ss_dssp CCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCC
T ss_pred hhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeec
Confidence 333334444333 3333444556666666666666632 1233455666666666666665322222333345566666
Q ss_pred CCCcCccc
Q 039922 561 SSNLLTGE 568 (973)
Q Consensus 561 s~N~l~~~ 568 (973)
++|++++.
T Consensus 123 ~~Npl~~~ 130 (162)
T d1koha1 123 DGNSLSDT 130 (162)
T ss_dssp TTSTTSSS
T ss_pred CCCCcCcC
Confidence 66666543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.18 E-value=1.5e-06 Score=89.13 Aligned_cols=144 Identities=15% Similarity=0.087 Sum_probs=94.8
Q ss_pred ccCCCCccccccccCCeeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCC-CCCeeeEEeEEecCCeeEEE
Q 039922 680 ILPHLTEQNLIGSGGSCRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVR-HGNVVKLLMCCSGQDFNILV 758 (973)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 758 (973)
..+.|+..+..+-++.+.||++.. +++.+++|+..... ......+.+|...++.+. +--+.+++.+...++..++|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 344555555444344578999865 46778888874322 122234567777777664 33356777888888899999
Q ss_pred EeccCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 039922 759 YEYMPNGSLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHNDC----------------------------------- 803 (973)
Q Consensus 759 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 803 (973)
|+++++.++.+..... .....++.++++.++.||+..
T Consensus 89 ~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999988776543221 112335566666677777531
Q ss_pred ---------------------CCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 804 ---------------------VPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 804 ---------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
.+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1248899999999999987666799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=1.1e-05 Score=81.92 Aligned_cols=130 Identities=18% Similarity=0.144 Sum_probs=84.1
Q ss_pred cccccCC-eeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCC--CCeeeEEeEEecCCeeEEEEeccCCC
Q 039922 689 LIGSGGS-CRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRH--GNVVKLLMCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 689 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 765 (973)
.+..|.. +.||++...++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||+++++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3455554 67999998888889999774332 1235667777766642 23566778878888889999999876
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 039922 766 SLADMLHEKGRSGSLDWSIRFSIAQGAAKGLAYLHND------------------------------------------- 802 (973)
Q Consensus 766 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------- 802 (973)
++.+.. ... ...+.+++..++-||+.
T Consensus 92 ~~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 92 DLLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp ETTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 553311 010 11223333444444421
Q ss_pred ------------CCCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 803 ------------CVPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 803 ------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11248999999999999987777899998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.60 E-value=1e-05 Score=76.01 Aligned_cols=110 Identities=16% Similarity=0.224 Sum_probs=62.7
Q ss_pred CCCcceEeecCC-cCCCC----CchhhhcCCcCcEEeCcCCcccC----CCccccccccccceeeccccccccc----cC
Q 039922 456 APKLTGILINGN-NFTGE----VPSQICTLRQLQAVDLSQNRFSG----HLPTCITQLNKLQQLELQENMFTGE----LP 522 (973)
Q Consensus 456 ~~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p 522 (973)
.++|++|+|+++ .++.. +-..+...+.|++|+|++|.+.. .+...+...+.|++|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 455666666653 34322 22234556677777777777753 2223444556777777777777643 23
Q ss_pred cccCccccceeeeeccCcccCC-------CCccccccccccEEecCCCcC
Q 039922 523 RNLNSLTALIVLNLSTNQLTGT-------IPPELGNLAVLTSLDLSSNLL 565 (973)
Q Consensus 523 ~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l 565 (973)
..+...++|+.|+|++|.+... +...+...+.|+.|+++.+..
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 3455566777777777765421 223334456677777766543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.38 E-value=2.6e-05 Score=73.20 Aligned_cols=40 Identities=13% Similarity=0.206 Sum_probs=20.8
Q ss_pred CCCCCCEEECcCC-cCCCC----CCcccCCCCcccEEecCCcccC
Q 039922 143 EFANLQVLDLSRN-NFSGD----IPESFGRFPVLKVLNLGGNLLS 182 (973)
Q Consensus 143 ~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~L~~n~l~ 182 (973)
+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.+.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 3456666666653 34321 1223444555666666666554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.17 E-value=0.00047 Score=74.10 Aligned_cols=78 Identities=19% Similarity=0.190 Sum_probs=47.1
Q ss_pred cccccccCCeeEEEEEECC-CCEEEEEEecCC-----CCCchhHHHHHHHHHHHhcCC-C--CCeeeEEeEEecCCeeEE
Q 039922 687 QNLIGSGGSCRVYKVKLKS-GETVAVKRLLGG-----THKPETETVFRSEIETLGRVR-H--GNVVKLLMCCSGQDFNIL 757 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 757 (973)
.+.||.|....||++...+ ++.|+||.-... ...+....+...|.+.++.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999998764 678999965321 111112223455777776653 2 345555554 3455679
Q ss_pred EEeccCCCC
Q 039922 758 VYEYMPNGS 766 (973)
Q Consensus 758 v~e~~~~gs 766 (973)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.93 E-value=0.00098 Score=69.59 Aligned_cols=67 Identities=16% Similarity=0.100 Sum_probs=44.7
Q ss_pred eeEEEEEECCCCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCe--eeEE-----eEEecCCeeEEEEeccCCC
Q 039922 696 CRVYKVKLKSGETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV--VKLL-----MCCSGQDFNILVYEYMPNG 765 (973)
Q Consensus 696 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g 765 (973)
-.||+++.++|+.|++|+..... ...+++..|...+..+....+ +..+ ..+..++..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 58999999999999999885332 234557778887777643222 1111 1234466788999999754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.77 E-value=0.0001 Score=68.84 Aligned_cols=111 Identities=22% Similarity=0.256 Sum_probs=60.0
Q ss_pred CCCCcceEeecC-CcCCCC----CchhhhcCCcCcEEeCcCCcccCC----Cccccccccccceeeccccccccc----c
Q 039922 455 NAPKLTGILING-NNFTGE----VPSQICTLRQLQAVDLSQNRFSGH----LPTCITQLNKLQQLELQENMFTGE----L 521 (973)
Q Consensus 455 ~~~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 521 (973)
+.++|++|++++ +.++.. +-..+...++|++|+|++|.++.. +-..+...+.++.+++++|.++.. +
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 345566666655 334322 222344566677777777766532 222344456677777777766532 2
Q ss_pred CcccCccccceeee--eccCcccC----CCCccccccccccEEecCCCcC
Q 039922 522 PRNLNSLTALIVLN--LSTNQLTG----TIPPELGNLAVLTSLDLSSNLL 565 (973)
Q Consensus 522 p~~~~~l~~L~~L~--Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 565 (973)
...+...++|+.++ +++|.+.. .+...+...+.|+.|+++.|..
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 34455566666533 34566642 2333445566777777766654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.52 E-value=0.00021 Score=66.67 Aligned_cols=42 Identities=14% Similarity=0.171 Sum_probs=21.6
Q ss_pred ccCCCCCCEEECcC-CcCCCC----CCcccCCCCcccEEecCCcccC
Q 039922 141 SREFANLQVLDLSR-NNFSGD----IPESFGRFPVLKVLNLGGNLLS 182 (973)
Q Consensus 141 ~~~l~~L~~L~Ls~-n~l~~~----~p~~~~~l~~L~~L~L~~n~l~ 182 (973)
..+.+.|++|+|++ +.++.. +-..+...++|++|+|++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 34456666666665 344421 1223344555666666666554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.89 E-value=0.012 Score=62.90 Aligned_cols=73 Identities=23% Similarity=0.274 Sum_probs=47.2
Q ss_pred cccccccCCeeEEEEEECC--------CCEEEEEEecCCCCCchhHHHHHHHHHHHhcCCCCCe-eeEEeEEecCCeeEE
Q 039922 687 QNLIGSGGSCRVYKVKLKS--------GETVAVKRLLGGTHKPETETVFRSEIETLGRVRHGNV-VKLLMCCSGQDFNIL 757 (973)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~l 757 (973)
++.|+-|-.=.+|++..++ .+.|.+++.- .. .......+|..+++.+.-.++ .++++++.+ ..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3567778888999998754 3567777663 21 122345678888888853344 467776642 57
Q ss_pred EEeccCCCCh
Q 039922 758 VYEYMPNGSL 767 (973)
Q Consensus 758 v~e~~~~gsL 767 (973)
||||+++..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999976443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.80 E-value=0.012 Score=60.58 Aligned_cols=31 Identities=19% Similarity=0.367 Sum_probs=27.3
Q ss_pred CCCeEEeCCCCCCEEeCCCCceEEeccCcch
Q 039922 804 VPAIVHRDVKSHNILLDAEMVPRVADFGLAK 834 (973)
Q Consensus 804 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 834 (973)
..++||+|+.+.||+++++...-+.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3489999999999999998877899999764
|